,CID,name,smiles,7.1-Drug Indication,8.1-Pharmacodynamics,8.2-MeSH Pharmacological Classification,"8.5-Absorption, Distribution and Excretion",8.6-Metabolism/Metabolites,8.7-Biological Half-Life
0,100001,N-Benzoylhistidine,C1=CC=C(C=C1)C(=O)NC(CC2=CN=CN2)C(=O)O,,,,,,
1,100002,"Nagilactone F,8-epoxy-",CC(C)C1C23C(O2)C4C5C(C3=CC(=O)O1)(CCCC5(C(=O)O4)C)C,,,,,,
2,100003,"[6-(Acetyloxymethyl)-10,11-dihydroxy-1,10-dimethyl-5-oxo-4,14-dioxatricyclo[9.2.1.03,7]tetradeca-2,6-dien-8-yl] 2-methylprop-2-enoate",CC(=C)C(=O)OC1CC(C2(CCC(O2)(C=C3C1=C(C(=O)O3)COC(=O)C)C)O)(C)O,,,,,,
3,100004,Dihydrocondylocarpine,CCC1C2CCN3C1C4(CC3)C5=CC=CC=C5NC4=C2C(=O)OC,,,,,,
4,100005,N-Benzoyl-L-phenylalaninol,C1=CC=C(C=C1)CC(CO)NC(=O)C2=CC=CC=C2,,,,,,
5,100006,"1,4-Dihydro-1-(4-aminophenyl)-4-(1-methylethyl)-3(2H)-isoquinolinone",CC(C)C1C2=CC=CC=C2C(NC1=O)C3=CC=C(C=C3)N,,,,,,
6,100007,"Acetamide, 2-(ethylamino)-N-(4-(1,2,3,4-tetrahydro-4,4-dimethyl-3-oxo-1-isoquinolinyl)phenyl)-",CCNCC(=O)NC1=CC=C(C=C1)C2C3=CC=CC=C3C(C(=O)N2)(C)C,,,,,,
7,100008,"2,4(1H,3H)-Pyrimidinedione, 5-fluoro-1-(tetrahydro-2-thienyl)-",C1CC(SC1)N2C=C(C(=O)NC2=O)F,,,,,,
8,100009,Arctolide,CC(=O)OC1CC2C3(CC4C(CC2(C1=C)O)C(=C)C(=O)O4)CO3,,,,,,
9,100010,"N-(2,3-Dihydroxypropyl)-2-nitro-1H-imidazole-1-acetamide",C1=CN(C(=N1)[N+](=O)[O-])CC(=O)NCC(CO)O,,,,,,
10,100011,"Spiro(androstan-3,2'-oxiran)-17-one",CC12CCC3(CC1CCC4C2CCC5(C4CCC5=O)C)CO3,,,,,,
11,100012,"[3-acetyloxy-2-methyl-6-[[3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-2,4-dihydro-1H-tetracen-1-yl]oxy]oxan-4-yl] acetate",CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)OC(=O)C)OC(=O)C,,,,,,
12,100013,"2-[(2-Amino-5-carbamoyloxy-3,4-dihydroxypentanoyl)amino]-2-[5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]acetic acid",C1=CN(C(=O)NC1=O)C2C(C(C(O2)C(C(=O)O)NC(=O)C(C(C(COC(=O)N)O)O)N)O)O,,,,,,
13,100014,7-Deoxynogarol,CC1(CCC2=C(C3=C(C=C2C1)C(=O)C4=C5C(=CC(=C4C3=O)O)C6(C(C(C(C(O5)O6)O)N(C)C)O)C)O)O,,,,,,
14,100015,"5-Fluoro-1-[3-hydroxy-4-(hydroxymethyl)cyclopentyl]pyrimidine-2,4-dione",C1C(CC(C1CO)O)N2C=C(C(=O)NC2=O)F,,,,,,
15,100016,Zebularine,C1=CN(C(=O)N=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,,,,,,
16,100017,Nimbolide,CC1=C2C(CC1C3=COC=C3)OC4C2(C(C5(C6C4OC(=O)C6(C=CC5=O)C)C)CC(=O)OC)C,,,,,,
17,100018,"2-[2-[[17-[2-[6-[[3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4,5-trihydroxyoxan-2-yl]oxy-6-methylhept-5-en-2-yl]-12-hydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol",CC(=CCCC(C)(C1CCC2(C1C(CC3C2(CCC4C3(CCC(C4(C)C)OC5C(C(C(C(O5)CO)O)O)OC6C(C(C(C(O6)CO)O)O)O)C)C)O)C)OC7C(C(C(C(O7)COC8C(C(C(O8)CO)O)O)O)O)O)C,,,,,,
18,100019,3-sec-Butyl-6-methyluracil,CCC(C)N1C(=O)C=C(NC1=O)C,,,,,,
19,100020,Thaliporphine,CN1CCC2=CC(=C(C3=C2C1CC4=CC(=C(C=C43)OC)OC)O)OC,,,,,,
20,100021,Diosbulbin D,CC12CC(OC(=O)C1CC(=O)C3C2CC4CC3C(=O)O4)C5=COC=C5,,,,,,
21,100022,"2-[6-Amino-2-(4-methoxyphenyl)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol",COC1=CC=C(C=C1)C2=NC(=C3C(=N2)N(C=N3)C4C(C(C(O4)CO)O)O)N,,,,,,
22,100023,"(9-Acetyloxy-6,10-dimethyl-3-methylidene-2-oxo-3a,4,5,8,9,11a-hexahydrocyclodeca[b]furan-4-yl) 4-hydroxy-2-(hydroxymethyl)but-2-enoate",CC1=CCC(C(=CC2C(C(C1)OC(=O)C(=CCO)CO)C(=C)C(=O)O2)C)OC(=O)C,,,,,,
23,100024,"ethyl 3-(4-aminophenyl)-2-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)propanoate",CCOC(=O)C(CC1=CC=C(C=C1)N)N2C(=O)C3=CC=CC=C3C2=O,,,,,,
24,100025,"[6-(Ethoxymethyl)-10,11-dihydroxy-1,10-dimethyl-5-oxo-4,14-dioxatricyclo[9.2.1.03,7]tetradeca-2,6-dien-8-yl] 2-methylprop-2-enoate",CCOCC1=C2C(CC(C3(CCC(O3)(C=C2OC1=O)C)O)(C)O)OC(=O)C(=C)C,,,,,,
25,100026,Desoxylimonin,CC1(C2CC(=O)C3(C(C24COC(=O)CC4O1)CCC5(C3=CC(=O)OC5C6=COC=C6)C)C)C,,,,,,
26,100027,Limonol,CC1(C2CC(C3(C(C24COC(=O)CC4O1)CCC5(C36C(O6)C(=O)OC5C7=COC=C7)C)C)O)C,,,,,,
27,100028,2-Amino-4-sec-butylphenol,CCC(C)C1=CC(=C(C=C1)O)N,,,,,,
28,100029,"Guanidine, 2-cyano-1-(3-pyridyl)-3-(tetrahydrofurfuryl)-",C1CC(OC1)CN=C(NC#N)NC2=CN=CC=C2,,,,,,
29,100030,7-Oxabicyclo[4.1.0]heptan-2-one,C1CC2C(O2)C(=O)C1,,,,,,
30,100031,"7-Oxabicyclo[4.1.0]heptan-2-one, 1-methyl-4-(1-methylethenyl)-",CC(=C)C1CC2C(O2)(C(=O)C1)C,,,,,,
31,100032,"2-Propanol, 1-[bis(2-hydroxyethyl)amino]-3-(octyloxy)-",CCCCCCCCOCC(CN(CCO)CCO)O,,,,,,
32,100033,"1,11,12,13,15-Pentahydroxypicras-3-ene-2,16-dione",CC1=CC(=O)C(C2(C1CC3C4(C2C(C(C(C4C(C(=O)O3)O)(C)O)O)O)C)C)O,,,,,,
33,100034,"5a,7,8,8a-Tetrahydro-3-hydroxy-7,7-dimethyl-1-oxo-3H,6H-3a,8b-methano-1H-indeno[4,5-c]furan-4-carbaldehyde",CC1(CC2C=C(C34CC3(C2C1)C(=O)OC4O)C=O)C,,,,,,
34,100035,"(4,5,17-Trihydroxy-6,14,18-trimethyl-9,16-dioxo-3,10-dioxapentacyclo[9.8.0.01,7.04,19.013,18]nonadec-14-en-8-yl) 3-hydroxy-3-methylbutanoate",CC1C2C(C(=O)OC3C24COC(C1O)(C4C5(C(C3)C(=CC(=O)C5O)C)C)O)OC(=O)CC(C)(C)O,,,,,,
35,100036,Ekatetrone,C1C2=CC3=C(C(=C2C(OC1=O)CC(=O)N)O)C(=O)C4=C(C3=O)C=CC=C4O,,,,,,
36,100037,"Colchicine, 10-demethoxy-10-(methylthio)-17,17,17-trifluoro-",COC1=C(C(=C2C(=C1)CCC(C3=CC(=O)C(=CC=C32)SC)NC(=O)C(F)(F)F)OC)OC,,,,,,
37,100038,Bis(helenalinyl)malonate,CC1CC2C(C(C3(C1C=CC3=O)C)OC(=O)CC(=O)OC4C5C(CC(C6C4(C(=O)C=C6)C)C)OC(=O)C5=C)C(=C)C(=O)O2,,,,,,
38,100039,Clofop-isobutyl,CC(C)COC(=O)C(C)OC1=CC=C(C=C1)OC2=CC=C(C=C2)Cl,,,,,,
39,100040,4'-Benzyloxy-2-bromopropiophenone,CC(C(=O)C1=CC=C(C=C1)OCC2=CC=CC=C2)Br,,,,,,
40,100041,"Benzamide, N-(((4-ethylphenyl)amino)carbonyl)-2,6-difluoro-",CCC1=CC=C(C=C1)NC(=O)NC(=O)C2=C(C=CC=C2F)F,,,,,,
41,100042,"3-Methoxy-7,9,10,11,11a,12-hexahydrobenzo[f]pyrrolo[1,2-b]isoquinoline",COC1=CC2=C(C=C1)C3=C(CN4CCCC4C3)C=C2,,,,,,
42,100043,"7,8-Dimethoxy-1,2,3,5,10,10a-hexahydropyrrolo(1,2-b)isoquinoline",COC1=C(C=C2CN3CCCC3CC2=C1)OC,,,,,,
43,100044,CU4-From florida state university,CC1CC2C(C(C(C(C(=O)C3C1O3)(C)O)OC(=O)C(=C)C)OC(=O)C(=C)C)C(=C)C(=O)O2,,,,,,
44,100045,"5-Ethoxy-6-[1-(4-methoxyphenyl)ethyl]-1,3-benzodioxole",CCOC1=CC2=C(C=C1C(C)C3=CC=C(C=C3)OC)OCO2,,,,,,
45,100046,"4,6-Di-t-butyl-2-(alpha-methyl-4-methoxybenzyl)phenol",CC(C1=CC=C(C=C1)OC)C2=C(C(=CC(=C2)C(C)(C)C)C(C)(C)C)O,,,,,,
46,100047,"N,N'-Bis(thiazol-2-yl)-1,1-ethanediamine",CC(NC1=NC=CS1)NC2=NC=CS2,,,,,,
47,100048,Methionylphenylalanine,CSCCC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)N,,,,,,
48,100049,N-(N-((Benzyloxy)carbonyl)-L-isoleucyl)-L-valine,CCC(C)C(C(=O)NC(C(C)C)C(=O)O)NC(=O)OCC1=CC=CC=C1,,,,,,
49,100050,N-Benzyloxycarbonylphenylalanyl-valine,CC(C)C(C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)OCC2=CC=CC=C2,,,,,,
50,100051,"(2,5-Dioxopyrrolidin-1-yl) 3-methyl-2-(phenylmethoxycarbonylamino)butanoate",CC(C)C(C(=O)ON1C(=O)CCC1=O)NC(=O)OCC2=CC=CC=C2,,,,,,
51,100052,"1-[3-Hydroxy-4-(hydroxymethyl)cyclopentyl]-5-iodopyrimidine-2,4-dione",C1C(CC(C1CO)O)N2C=C(C(=O)NC2=O)I,,,,,,
52,100053,9-(2-Amino-2-deoxy-d-xylofuranosyl) adenine,C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)CO)O)N)N,,,,,,
53,100054,"Spiro(cyclopentane-1,4'(1'H)-(2,7)naphthyridine)-1',3'(2'H)-dione, 3-hydroxy-, trans-(+)-",C1CC2(CC1O)C3=C(C=NC=C3)C(=O)NC2=O,,,,,,
54,100055,Nicandrenone,CC(C1CC2(C(O2)(C(O1)O)C)C)C3=CC4=C(C=C3)C5C(CC4)C6(C(=O)C=CCC6(C7C5O7)O)C,,,,,,
55,100056,11-Oxahomoaminopterin,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)OCCC2=CN=C3C(=N2)C(=NC(=N3)N)N,,,,,,
56,100057,"[11-(Ethylamino)-7-hydroxy-5,12-dimethyl-10,13-dioxo-2,5-diazatetracyclo[7.4.0.02,7.04,6]trideca-1(9),11-dien-8-yl]methyl carbamate",CCNC1=C(C(=O)C2=C(C1=O)C(C3(N2CC4C3N4C)O)COC(=O)N)C,,,,,,
57,100058,"methyl 7-hydroxy-7-(hydroxymethyl)-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4a,7a-dihydro-1H-cyclopenta[c]pyran-4-carboxylate",COC(=O)C1=COC(C2C1C=CC2(CO)O)OC3C(C(C(C(O3)CO)O)O)O,,,,,,
58,100059,"2-Hydroxy-5-(3,4-dichlorophenyl)-6,7-bis(hydroxymethyl)-2,3-dihydro-1H-pyrrolizine bis(2-propylcarbamate)",CC(C)NC(=O)OCC1=C2CC(CN2C(=C1COC(=O)NC(C)C)C3=CC(=C(C=C3)Cl)Cl)O,,,,,,
59,100060,"2-Propenamide, N-methyl-3-(5,10,11,11a-tetrahydro-9-hydroxy-11-methoxy-8-methyl-5-oxo-1H-pyrrolo(2,1-c)(1,4)benzodiazepin-2-yl)-",CC1=C(C2=C(C=C1)C(=O)N3C=C(CC3C(N2)OC)C=CC(=O)NC)O,,,,,,
60,100061,1-Chloro-1-(2-chlorophenyl)propan-2-one,CC(=O)C(C1=CC=CC=C1Cl)Cl,,,,,,
61,100062,2-[[3-Amino-2-hydroxy-4-(4-hydroxyphenyl)butanoyl]amino]-4-methylpentanoic acid,CC(C)CC(C(=O)O)NC(=O)C(C(CC1=CC=C(C=C1)O)N)O,,,,,,
62,100063,"L-Cysteine, S-[2-(4-pyridinyl)ethyl]-",C1=CN=CC=C1CCSCC(C(=O)O)N,,,,,,
63,100064,"N-(4-formyl-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl)acetamide",CC(=O)NC1CCC2=C(C(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC)C=O,,,,,,
64,100065,"Acetamide, N-(4-cyano-5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)-, (S)-",CC(=O)NC1CCC2=C(C(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC)C#N,,,,,,
65,100066,"Diphenyl (2,2,2-trichloro-1-hydroxyethyl)phosphonate",C1=CC=C(C=C1)OP(=O)(C(C(Cl)(Cl)Cl)O)OC2=CC=CC=C2,,,,,,
66,100067,Syringaresinol,COC1=CC(=CC(=C1O)OC)C2C3COC(C3CO2)C4=CC(=C(C(=C4)OC)O)OC,,,,,,
67,100068,Gorgost-5-en-3-ol,CC(C)C(C)C1(CC1C(C)C2CCC3C2(CCC4C3CC=C5C4(CCC(C5)O)C)C)C,,,,,,
68,100069,"2-Acetyl-1-((3,4-dimethoxyphenyl)methyl)-1,2,3,4-tetrahydro-6,7-dimethoxyisoquinoline",CC(=O)N1CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC,,,,,,
69,100070,"1,2-Bis(glycidyloxy)benzene",C1C(O1)COC2=CC=CC=C2OCC3CO3,,,,,,
70,100071,4-Carbethoxy-2-ethyl-3-methyl-2-cyclohexen-1-one,CCC1=C(C(CCC1=O)C(=O)OCC)C,,,,,,
71,100072,Claussequinone,COC1=CC(=O)C(=CC1=O)C2CC3=C(C=C(C=C3)O)OC2,,,,,,
72,100073,"Benzo(3,4)furo(3',4':6,7)cycloocta(1,2-f)(1,3)benzodioxol-3(1H)-one, 14-(acetyloxy)-3a,4,14,14a-tetrahydro-6,7,8-trimethoxy-, stereoisomer",CC(=O)OC1C2COC(=O)C2CC3=CC(=C(C(=C3C4=CC5=C(C=C14)OCO5)OC)OC)OC,,,,,,
73,100074,Kemptide,CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)NC(CCCN=C(N)N)C(=O)NC(C)C(=O)NC(CO)C(=O)NC(CC(C)C)C(=O)NCC(=O)O)N,,,,,,
74,100075,"8,9-Didehydro-1,6,8-trimethylergoline",CC1=CC2C(CC3=CN(C4=CC=CC2=C34)C)N(C1)C,,,,,,
75,100076,1-Methylfestuclavine,CC1CC2C(CC3=CN(C4=CC=CC2=C34)C)N(C1)C,,,,,,
76,100077,"7,9-dimethyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline",CC1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)C,,,,,,
77,100078,[3-Docosanoyloxy-2-[3-(4-hydroxy-3-methoxyphenyl)prop-2-enoyloxy]propyl] docosanoate,CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCCCCCC)OC(=O)C=CC1=CC(=C(C=C1)O)OC,,,,,,
78,100079,Lomevactone,CC1CC(C(C(=O)O1)C2=CC=CC=C2)C3=CC=C(C=C3)Cl,,,,,,
79,100080,"Tetrahydro-3,4-diphenyl-6-methyl-2H-pyran-2-one",CC1CC(C(C(=O)O1)C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
80,100081,N-Carbobenzoxy-DL-phenylalanine,C1=CC=C(C=C1)CC(C(=O)O)NC(=O)OCC2=CC=CC=C2,,,,,,
81,100082,Glycyl-leucyl-glycyl-glycine,CC(C)CC(C(=O)NCC(=O)NCC(=O)O)NC(=O)CN,,,,,,
82,100083,Glycyl-tyrosyl-glycine,C1=CC(=CC=C1CC(C(=O)NCC(=O)O)NC(=O)CN)O,,,,,,
83,100084,Acetylalanyl-alanyl-alanyl-alanine,CC(C(=O)NC(C)C(=O)NC(C)C(=O)NC(C)C(=O)O)NC(=O)C,,,,,,
84,100085,N-[N-[(phenylmethoxy)carbonyl]-L-isoleucyl]-L-methionine,CCC(C)C(C(=O)NC(CCSC)C(=O)O)NC(=O)OCC1=CC=CC=C1,,,,,,
85,100086,N-[(benzyloxy)carbonyl]leucylalanine,CC(C)CC(C(=O)NC(C)C(=O)O)NC(=O)OCC1=CC=CC=C1,,,,,,
86,100087,N-(N-((Phenylmethoxy)carbonyl)-L-leucyl)glycine,CC(C)CC(C(=O)NCC(=O)O)NC(=O)OCC1=CC=CC=C1,,,,,,
87,100088,N-(N-((Benzyloxy)carbonyl)-L-leucyl)-L-valine,CC(C)CC(C(=O)NC(C(C)C)C(=O)O)NC(=O)OCC1=CC=CC=C1,,,,,,
88,100089,"alpha-D-glucopyranose, 4,6-O-(phenylmethylene)-",C1C2C(C(C(C(O2)O)O)O)OC(O1)C3=CC=CC=C3,,,,,,
89,100090,Carbobenzoxyphenylalanylmethionine,CSCCC(C(=O)O)NC(=O)C(CC1=CC=CC=C1)NC(=O)OCC2=CC=CC=C2,,,,,,
90,100091,1-(N-((Phenylmethoxy)carbonyl)-L-phenylalanyl)-L-proline,C1CC(N(C1)C(=O)C(CC2=CC=CC=C2)NC(=O)OCC3=CC=CC=C3)C(=O)O,,,,,,
91,100092,"Thymidine, 5'-((bromoacetyl)amino)-5'-deoxy-",CC1=CN(C(=O)NC1=O)C2CC(C(O2)CNC(=O)CBr)O,,,,,,
92,100093,10-Propargylaminopterin,C#CCN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,,,,,,
93,100094,Oglufanide,C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)N,"['Investigated for use/treatment in hepatitis (viral, C).']","[""Oglufanide regulates the body's innate immune response to defeat invading germs and cancer cells. It may control or reverse the suppression of the immune system which the hepatitis virus uses to defeat our normally healthy defenses.""]",,,,
94,100095,N2-(tert-Butoxycarbonyl)-N6-formyl-L-lysine,CC(C)(C)OC(=O)NC(CCCCNC=O)C(=O)O,,,,,,
95,100096,"L-Phenylalanine, N-(N-glycyl-L-alanyl)-",CC(C(=O)NC(CC1=CC=CC=C1)C(=O)O)NC(=O)CN,,,,,,
96,100097,Gly-gly-his,C1=C(NC=N1)CC(C(=O)O)NC(=O)CNC(=O)CN,,,,,,
97,100098,"L-Alanine, N-L-alpha-glutamyl-",CC(C(=O)O)NC(=O)C(CCC(=O)O)N,,,,,,
98,100099,gamma-Glutamylglycine,C(CC(=O)NCC(=O)O)C(C(=O)O)N,,,,,,
99,100100,gamma-Glutamyl-glycyl-glycine,C(CC(=O)NCC(=O)NCC(=O)O)C(C(=O)O)N,,,,,,
100,100101,"N-Acetylphenylalanyl-3,5-diiodotyrosine",CC(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC2=CC(=C(C(=C2)I)O)I)C(=O)O,,,,,,
101,100102,"tert-Butyl (S)-(2-((2,5-dioxo-1-pyrrolidinyl)oxy)-2-oxo-1-((4-(benzyloxy)phenyl)methyl)ethyl)carbamate",CC(C)(C)OC(=O)NC(CC1=CC=C(C=C1)OCC2=CC=CC=C2)C(=O)ON3C(=O)CCC3=O,,,,,,
102,100103,2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-methylpentanoic acid,CCC(C)C(C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13,,,,,,
103,100104,N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-methionine,CSCCC(C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13,,,,,,
104,100105,Fmoc-DL-Phe-OH,C1=CC=C(C=C1)CC(C(=O)O)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24,,,,,,
105,100106,(S)-1-(((9H-Fluoren-9-YL)methoxy)carbonyl)pyrrolidine-2-carboxylic acid,C1CC(N(C1)C(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24)C(=O)O,,,,,,
106,100107,2-(((9H-Fluoren-9-yl)methoxy)carbonylamino)-3-(1H-indol-3-yl)propanoic acid,C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)NC(CC4=CNC5=CC=CC=C54)C(=O)O,,,,,,
107,100108,2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)propanoic acid,CC(C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13,,,,,,
108,100109,N2-((9H-Fluoren-9-ylmethoxy)carbonyl)-L-asparagine,C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)NC(CC(=O)N)C(=O)O,,,,,,
109,100110,3-(1-benzylimidazol-4-yl)-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid,C1=CC=C(C=C1)CN2C=C(N=C2)CC(C(=O)O)NC(=O)OCC3C4=CC=CC=C4C5=CC=CC=C35,,,,,,
110,100111,3-tert-butylsulfanyl-2-(9H-fluoren-9-ylmethoxycarbonylamino)propanoic acid,CC(C)(C)SCC(C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13,,,,,,
111,100112,(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(tert-butoxy)phenyl)propanoic acid,CC(C)(C)OC1=CC=C(C=C1)CC(C(=O)O)NC(=O)OCC2C3=CC=CC=C3C4=CC=CC=C24,,,,,,
112,100113,6-{[(Tert-butoxy)carbonyl]amino}-2-({[(9H-fluoren-9-YL)methoxy]carbonyl}amino)hexanoic acid,CC(C)(C)OC(=O)NCCCCC(C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13,,,,,,
113,100114,2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-amino-5-oxopentanoic acid,C1=CC=C2C(=C1)C(C3=CC=CC=C32)COC(=O)NC(CCC(=O)N)C(=O)O,,,,,,
114,100115,2-({[(9H-Fluoren-9-YL)methoxy]carbonyl}amino)-3-methylbutanoic acid,CC(C)C(C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13,,,,,,
115,100116,N-(tert-Butyloxycarbonyl)-L-threonine,CC(C(C(=O)O)NC(=O)OC(C)(C)C)O,,,,,,
116,100117,2-((tert-Butoxycarbonyl)amino)-3-(4-hydroxyphenyl)propanoic acid,CC(C)(C)OC(=O)NC(CC1=CC=C(C=C1)O)C(=O)O,,,,,,
117,100118,(S)-2-Amino-3-benzylthio-N-(4-nitrophenyl)propionamide,C1=CC=C(C=C1)CSCC(C(=O)NC2=CC=C(C=C2)[N+](=O)[O-])N,,,,,,
118,100119,2-Formamido-4-methylpentanoic acid,CC(C)CC(C(=O)O)NC=O,,,,,,
119,100120,Einecs 248-101-0,CC(C(=O)NC(C)C(=O)NC(C)C(=O)OC)NC(=O)C,,,,,,
120,100121,Succinimido N-(tert-butoxycarbonyl)isoleucinate,CCC(C)C(C(=O)ON1C(=O)CCC1=O)NC(=O)OC(C)(C)C,,,,,,
121,100122,N-Formyl-dl-phenylalanine,C1=CC=C(C=C1)CC(C(=O)O)NC=O,,,,,,
122,100123,N-Formyl-dl-valine,CC(C)C(C(=O)O)NC=O,,,,,,
123,100124,"2,5-Dioxopyrrolidin-1-yl 2-((tert-butoxycarbonyl)amino)-4-methylpentanoate",CC(C)CC(C(=O)ON1C(=O)CCC1=O)NC(=O)OC(C)(C)C,,,,,,
124,100125,"O-2,6-Dichlorobenzyl-N-tert-butoxycarbonyl-L-tyrosine",CC(C)(C)OC(=O)NC(CC1=CC=C(C=C1)OCC2=C(C=CC=C2Cl)Cl)C(=O)O,,,,,,
125,100126,"2-Tert-butoxycarbonylamino-propionic acid 2,5-dioxopyrrolidin-1-yl ester",CC(C(=O)ON1C(=O)CCC1=O)NC(=O)OC(C)(C)C,,,,,,
126,100127,"(3S,4S)-4-[(2S,6R,8S,9R,10R)-9-hydroxy-4,6,8,10-tetramethyl-7-oxododec-4-en-2-yl]-3-methyloxetan-2-one",CC[C@@H](C)[C@H]([C@H](C)C(=O)[C@H](C)C=C(C)C[C@H](C)[C@H]1[C@@H](C(=O)O1)C)O,,,,,,
127,100128,"(3S,4S)-3-ethyl-4-[(2S,6R,8S,9R,10R)-9-hydroxy-4,6,8,10-tetramethyl-7-oxododec-4-en-2-yl]oxetan-2-one",CC[C@H]1[C@@H](OC1=O)[C@@H](C)CC(=C[C@@H](C)C(=O)[C@@H](C)[C@@H]([C@H](C)CC)O)C,,,,,,
128,100129,N-[(benzyloxy)carbonyl]leucylleucine,CC(C)CC(C(=O)NC(CC(C)C)C(=O)O)NC(=O)OCC1=CC=CC=C1,,,,,,
129,100130,"L-Glutamic acid, N-L-alpha-glutamyl-",C(CC(=O)O)C(C(=O)NC(CCC(=O)O)C(=O)O)N,,,,,,
130,100131,2-[2-[(2-Aminoacetyl)amino]propanoylamino]-4-methylpentanoic acid,CC(C)CC(C(=O)O)NC(=O)C(C)NC(=O)CN,,,,,,
131,100132,Colchifoline,COC1=CC=C2C(=CC1=O)C(CCC3=CC(=C(C(=C32)OC)OC)OC)NC(=O)CO,,,,,,
132,100133,N-Hydroxyacetyldemecolcine,CN(C1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC)C(=O)CO,,,,,,
133,100134,2-Isobutyl-3-oxo-4-chloro-2-butylcarbonate,CC(C)COC(=O)OC(C)C(=O)CCl,,,,,,
134,100135,N-(N-Acetyl-3-phenyl-L-alanyl)-3-phenyl-L-alanine,CC(=O)NC(CC1=CC=CC=C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O,,,,,,
135,100136,N-Formylmethionylvaline,CC(C)C(C(=O)O)NC(=O)C(CCSC)NC=O,,,,,,
136,100137,"1-Phenyl-1,2,3,4-tetrahydroisoquinoline",C1CNC(C2=CC=CC=C21)C3=CC=CC=C3,,,,,,
137,100138,N-(p-Hydroxyphenyl)-L-glutamine,C1=CC(=CC=C1NC(=O)CCC(C(=O)O)N)O,,,,,,
138,100139,2-(Piperidin-1-yl)cyclohexan-1-one,C1CCN(CC1)C2CCCCC2=O,,,,,,
139,100140,"[5,10-Dihydroxy-7-methoxy-2-methyl-6-(3-methylbut-1-enyl)-4-oxo-1,3-dihydroanthracen-2-yl] acetate",CC(C)C=CC1=C(C2=C(C3=C(CC(CC3=O)(C)OC(=O)C)C=C2C=C1OC)O)O,,,,,,
140,100141,"2-Bromo-8-chloro-1,1,9-trimethyl-5-methylidenespiro[5.5]undec-8-en-3-ol",CC1=C(CC2(CC1)C(=C)CC(C(C2(C)C)Br)O)Cl,,,,,,
141,100142,"3,7-Dihydro-7-(2-(((4-bromophenyl)phenylmethyl)amino)ethyl)-1,3-dimethyl-1H-purine-2,6-dione",CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCNC(C3=CC=CC=C3)C4=CC=C(C=C4)Br,,,,,,
142,100143,"1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-7-(2-(((4-methoxyphenyl)phenylmethyl)amino)-ethyl)-",CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCNC(C3=CC=CC=C3)C4=CC=C(C=C4)OC,,,,,,
143,100144,"1H-Purine-2,6-dione, 3,7-dihydro-7-(2-(((3-chlorophenyl)phenylmethyl)amino)ethyl)-1,3-dimethyl-",CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCNC(C3=CC=CC=C3)C4=CC(=CC=C4)Cl,,,,,,
144,100145,"1-(2,3-Dideoxy-alpha-D-erythro-hex-2-enopyranosyl)-2-nitro-1H-imidazole",C1=CC(OC(C1O)CO)N2C=CN=C2[N+](=O)[O-],,,,,,
145,100146,Dihydrolenperone,C1CN(CCC1C(C2=CC=C(C=C2)F)O)CCCC(=O)C3=CC=C(C=C3)F,,,,,,
146,100147,12-Hydroxystearamide,CCCCCCC(CCCCCCCCCCC(=O)N)O,,,,,,
147,100148,6-Amino-2-{[(tert-butoxy)carbonyl]amino}hexanoic acid,CC(C)(C)OC(=O)NC(CCCCN)C(=O)O,,,,,,
148,100149,N-Hydroxysuccinimidyl t-butoxycarbonylmethionine,CC(C)(C)OC(=O)NC(CCSC)C(=O)ON1C(=O)CCC1=O,,,,,,
149,100150,CID 100150,C1=CC(=CC=C1C(=O)NC(CCC(=O)O)C(=O)O)NCC2=CC3=C(NC(=NC3=O)N)N=C2,,,,,,
150,100151,"(2R,3R)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-5-methoxy-2,3-dihydropyrano[3,2-h][1,4]benzodioxin-9-one",COC1=C(C=CC(=C1)C2C(OC3=C4C(=CC(=C3O2)OC)C=CC(=O)O4)CO)O,,,,,,
151,100152,"(2Z,4E)-4-[Cyano(beta-D-glucopyranosyloxy)methylene]-2-hexenedioic acid",C(C1C(C(C(C(O1)OC(=C(CC(=O)O)C=CC(=O)O)C#N)O)O)O)O,,,,,,
152,100153,"1H-Imidazole-1-ethanol, alpha-(1-aziridinylmethyl)-2-nitro-",C1CN1CC(CN2C=CN=C2[N+](=O)[O-])O,,,"['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)', 'Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells. (See all compounds classified as Radiation-Sensitizing Agents.)']",,,
153,100154,"5-[(2S)-2-hydroxy-2-(3,4,5-trimethoxyphenyl)ethyl]-2-methoxyphenol",COC1=C(C=C(C=C1)C[C@@H](C2=CC(=C(C(=C2)OC)OC)OC)O)O,,,,,,
154,100155,O-Benzoylserine,C1=CC=C(C=C1)C(=O)OCC(C(=O)O)N,,,,,,
155,100156,"3,4-Disuccinyldianhydrogalactitol",C1C(O1)C(C(C2CO2)OC(=O)CCC(=O)O)OC(=O)CCC(=O)O,,,,,,
156,100157,"Rotenone, dihydro-dihydroxy-",CC(CO)(C1CC2=C(O1)C=CC3=C2OC4COC5=CC(=C(C=C5C4C3=O)OC)OC)O,,,,,,
157,100158,Cyanocycline A,CC1=C(C(=O)C2=C(C1=O)C3C4C5C(CC(N5C)C(N4C2CO)C#N)C6N3CCO6)OC,,,,,,
158,100159,CID 100159,CC1CCC2=C(C(=O)OC23C14C(O4)C(C3)(C)C)CO,,,,,,
159,100160,"2,4-Diaminobutylsulfanylphosphonic acid",C(CN)C(CSP(=O)(O)O)N,,,,,,
160,100161,"N,N'-(1,2-Di-4-pyridinyl-1,2-ethanediyl)bis(3,5-dimethylbenzamide)",CC1=CC(=CC(=C1)C(=O)NC(C2=CC=NC=C2)C(C3=CC=NC=C3)NC(=O)C4=CC(=CC(=C4)C)C)C,,,,,,
161,100162,Acetomycin,C[C@@H]1[C@@H](OC(=O)[C@]1(C)C(=O)C)OC(=O)C,,,,,,
162,100163,"(7-methyl-2,3,5,6,7,8-hexahydro-1H-pyrrolizin-1-yl) 4-methoxybenzoate",CC1CCN2C1C(CC2)OC(=O)C3=CC=C(C=C3)OC,,,,,,
163,100164,"Piperidine, 1,3,5-trimethyl-",CC1CC(CN(C1)C)C,,,,,,
164,100165,"1,3-Cyclopentanediol",C1CC(CC1O)O,,,,,,
165,100166,"N-(p-(3,3-Dimethyl-1-triazeno)benzoyl)-3-phenylalanine",CN(C)N=NC1=CC=C(C=C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O,,,,,,
166,100167,"4-Isobutyloxazolidine-2,5-dione",CC(C)CC1C(=O)OC(=O)N1,,,,,,
167,100168,Leucine enkephalinamide,CC(C)CC(C(=O)N)NC(=O)C(CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)C(CC2=CC=C(C=C2)O)N,,,,,,
168,100169,Dalamid,CC(C(=O)NCC(=O)NC(CC1=CC=CC=C1)C(=O)NC(CCSC)C(=O)N)NC(=O)C(CC2=CC=C(C=C2)O)N,,,,,,
169,100170,CID 100170,CCOC(=O)N1CCN(CC1)C(=NNC(C)C2=CC=CC=[N+]2[O-])S,,,,,,
170,100171,"2-Ethoxy-N-(1,2,3,10-tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl)acetamide",CCOCC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)OC)OC,,,,,,
171,100172,"(11-Hydroxy-4-methyl-10,15-dimethylidene-14-oxo-5,8,13-trioxatetracyclo[10.3.0.04,6.07,9]pentadecan-2-yl) 2-methylbut-2-enoate",CC=C(C)C(=O)OC1CC2(C(O2)C3C(O3)C(=C)C(C4C1C(=C)C(=O)O4)O)C,,,,,,
172,100173,"N-(2,3-Dihydroxy-1,10-dimethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl)acetamide",CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)OC)O)O,,,,,,
173,100174,"1,2-Didemethylcolchicine",CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)OC)O)O)OC,,,,,,
174,100175,N-(Phenoxyacetyl)deacetylcolchicine,COC1=CC=C2C(=CC1=O)C(CCC3=CC(=C(C(=C32)OC)OC)OC)NC(=O)COC4=CC=CC=C4,,,,,,
175,100176,"Acetamide, N-(6,7,8,10-tetrahydro-4,11-dimethoxy-10-oxoheptaleno(1,2-e)-1,3-benzodioxol-8-yl)-, (S)-",CC(=O)NC1CCC2=CC(=C3C(=C2C4=CC=C(C(=O)C=C14)OC)OCO3)OC,,,,,,
176,100177,2-[[2-Chloroethyl(nitroso)carbamoyl]amino]-3-hydroxybutanoic acid,CC(C(C(=O)O)NC(=O)N(CCCl)N=O)O,,,,,,
177,100178,2-[[2-Chloroethyl(nitroso)carbamoyl]amino]-3-oxidanyl-propanoic acid,C(CCl)N(C(=O)NC(CO)C(=O)O)N=O,,,,,,
178,100179,Neodulin,C1C2C(C3=C(O1)C=C4C(=C3)C=CO4)OC5=CC6=C(C=C25)OCO6,,,,,,
179,100180,25-Dihydrosaframycin A,CC1=C(C(=O)C2=C(C1=O)CC3C4C5=C(CC(N4C)C(N3C2CNC(=O)C(C)O)C#N)C(=O)C(=C(C5=O)OC)C)OC,,,,,,
180,100181,"Pyrimidine, 2,2'-(o-chlorobenzylidenediimino)di-",C1=CC=C(C(=C1)C(NC2=NC=CC=N2)NC3=NC=CC=N3)Cl,,,,,,
181,100182,"Pyrimidine, 2,2'-(2,6-dichlorobenzylidenediimino)di-",C1=CC(=C(C(=C1)Cl)C(NC2=NC=CC=N2)NC3=NC=CC=N3)Cl,,,,,,
182,100183,"Pyrazine, 2,2'-(2,6-dichlorobenzylidenediimino)di-",C1=CC(=C(C(=C1)Cl)C(NC2=NC=CN=C2)NC3=NC=CN=C3)Cl,,,,,,
183,100184,Cyanomorpholinoadriamycin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N6CCOCC6C#N)O,,,"['Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)', 'Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. (See all compounds classified as Cross-Linking Reagents.)']",,,
184,100185,Salsolinol-1-carboxylic acid,CC1(C2=CC(=C(C=C2CCN1)O)O)C(=O)O,,,,,,
185,100186,"1H-Imidazole-1-ethanol, alpha-((2-methyl-1-aziridinyl)methyl)-2-nitro-",CC1CN1CC(CN2C=CN=C2[N+](=O)[O-])O,,,,,,
186,100187,"6-Nitrobenzo[d]isothiazol-3(2H)-one 1,1-dioxide",C1=CC2=C(C=C1[N+](=O)[O-])S(=O)(=O)NC2=O,,,,,,
187,100188,Cornigerine,CC(=O)NC1CCC2=CC3=C(C(=C2C4=CC=C(C(=O)C=C14)OC)OC)OCO3,,,,,,
188,100189,"Benz(f)isoquinolin-9-ol, 1,2,3,4,4a,5,6,10b-octahydro-10b-methyl-3-(3-methyl-2-butenyl)-",CC(=CCN1CCC2(C(C1)CCC3=C2C=C(C=C3)O)C)C,,,,,,
189,100190,"alpha-((2,2-Dimethyl-1-aziridinyl)methyl)-2-nitro-1H-imidazole-1-ethanol",CC1(CN1CC(CN2C=CN=C2[N+](=O)[O-])O)C,,,,,,
190,100191,Podophyllotoxin-thenyliden-glucosid [German],COC1=CC(=CC(=C1OC)OC)C2C3C(COC3=O)C(C4=CC5=C(C=C24)OCO5)OC6C(C(C7C(O6)COC(O7)C8=CC=CS8)O)O,,,,,,
191,100192,"1-Benzyl-2,6-dimethylpiperidine",CC1CCCC(N1CC2=CC=CC=C2)C,,,,,,
192,100193,1-Phenyl-7-oxabicyclo[4.1.0]heptane,C1CCC2(C(C1)O2)C3=CC=CC=C3,,,,,,
193,100194,"1-Methyl-4-phenyl-1,2,3,6-tetrahydro-3-pyridinol",CN1CC=C(C(C1)O)C2=CC=CC=C2,,,,,,
194,100195,"3-(p-Chlorophenyl)-2-ethyl-2,3,5,6-tetrahydroimidazo(2,1-b)thiazol-3-ol",CCC1C(N2CCN=C2S1)(C3=CC=C(C=C3)Cl)O,,,,,,
195,100196,5-Iminocyanomorpholinoadriamycin,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=N)C(=CC=C5)OC)O)(C(=O)CO)O)N6CCOCC6C#N)O,,,,,,
196,100197,"3,3,6-Trimethylhepta-1,5-dien-4-ol",CC(=CC(C(C)(C)C=C)O)C,,,,,,
197,100198,N'-(2-oxothiolan-3-yl)but-2-enediamide,C1CSC(=O)C1NC(=O)C=CC(=O)N,,,,,,
198,100199,Burchellin,CC1C(OC2=CC(=O)C(=CC12CC=C)OC)C3=CC4=C(C=C3)OCO4,,,,,,
199,100200,1-(2-Hydroxypropyl)-3-phenylurea,CC(CNC(=O)NC1=CC=CC=C1)O,,,,,,
200,100201,"2-[[2-(3,4-dimethoxyphenyl)-2,3-dihydrochromen-4-ylidene]amino]oxy-N,N-diethylethanamine",CCN(CC)CCON=C1CC(OC2=CC=CC=C12)C3=CC(=C(C=C3)OC)OC,,,,,,
201,100202,"1,2-Benzisothiazoline-3-acetic acid, isopropyl ester, 1,1-dioxide",CC(C)OC(=O)CC1C2=CC=CC=C2S(=O)(=O)N1,,,,,,
202,100203,Alkannin-beta-hydroxyisovalerate,CC(=CCC(C1=CC(=O)C2=C(C=CC(=C2C1=O)O)O)OC(=O)CC(C)(C)O)C,,,,,,
203,100204,2-Chlorobutyronitrile,CCC(C#N)Cl,,,,,,
204,100205,Heppso,C1CN(CCN1CCO)CC(CS(=O)(=O)O)O,,,,,,
205,100206,Virantmycin,CC(=C(C)CCC1(C(CC2=C(N1)C=CC(=C2)C(=O)O)Cl)COC)C,,,,,,
206,100207,"4-Hydroxy-6-methyl-3-methylidene-2-oxo-3a,4,7,8,11,11a-hexahydrocyclodeca[b]furan-10-carbaldehyde",CC1=CC(C2C(CC(=CCC1)C=O)OC(=O)C2=C)O,,,,,,
207,100208,"L-Valinamide, N,N-dimethyl-L-valyl-N-[(1S,2R)-2-methoxy-4-[(2S)-2-[(1R,2R)-1-methoxy-2-methyl-3-oxo-3-[[(1S)-2-phenyl-1-(2-thiazolyl)ethyl]amino]propyl]-1-pyrrolidinyl]-1-[(1S)-1-methylpropyl]-4-oxobutyl]-N-methyl-",CCC(C)C(C(CC(=O)N1CCCC1C(C(C)C(=O)NC(CC2=CC=CC=C2)C3=NC=CS3)OC)OC)N(C)C(=O)C(C(C)C)NC(=O)C(C(C)C)N(C)C,,,,,,
208,100209,"1-(Bromomethyl)-1,2,4-trichloro-5-(2-chloroethenyl)-5-methylcyclohexane",CC1(CC(C(CC1Cl)Cl)(CBr)Cl)C=CCl,,,,,,
209,100210,3-(Bis(2-hydroxyethyl)amino)-2-hydroxypropane-1-sulfonic acid,C(CO)N(CCO)CC(CS(=O)(=O)O)O,,,,,,
210,100211,2-Hydroxy-3-((1-hydroxy-2-methylpropan-2-yl)amino)propane-1-sulfonic acid,CC(C)(CO)NCC(CS(=O)(=O)O)O,,,,,,
211,100212,CID 100212,C1=NC(=C(N1)CC(C(=O)O)N)[N+](=O)[O-],,,,,,
212,100213,CID 100213,CCC1(C(=O)NC(=NC1=O)S)C2=CC=C(C=C2)C,,,,,,
213,100214,"1,4-Bis((oxiranylmethyl)amino)-9,10-anthracenedione",C1C(O1)CNC2=C3C(=C(C=C2)NCC4CO4)C(=O)C5=CC=CC=C5C3=O,,,,,,
214,100215,Glechomafuran,CC1=COC2=C1CC3C(O3)(CCC4C(C2)(O4)C)C,,,,,,
215,100216,Puntarenine,COC1=C(C2=C(C=C1)C3C(=O)C4=CC5=C(C=C4CCN3C(=O)C2)OCO5)OC,,,,,,
216,100217,CID 100217,CC[C@H]1C[C@@H]2C[C@@H]3[C@H]1N(C2)CCC4=C3NC5=CC=CC=C45,,,,,,
217,100218,CID 100218,CC=C1CN([C@H]2CC3=C(C(=O)C[C@@H]1C2C(=O)OC)NC4=CC=CC=C34)C,,,,,,
218,100219,Aplysistatin,C[C@]12CC[C@@H](C([C@@H]1CC=C3[C@@H](O2)COC3=O)(C)C)Br,,,,,,
219,100220,"5,8-Quinolinedione, 7-(heptadecylthio)-6-hydroxy-",CCCCCCCCCCCCCCCCCSC1=C(C2=C(C=CC=N2)C(=O)C1=O)O,,,,,,
220,100221,N(6)-(dimethylallyl)adenosine 5'-monophosphate,CC(=CCNC1=C2C(=NC=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)C,,,,,,
221,100222,"3-beta-Ribofuranosylthieno(2,3-d)pyrimidin-4-one",C1=CSC2=C1C(=O)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
222,100223,4-(3-Methyl-1-triazenyl)benzamide,CN=NNC1=CC=C(C=C1)C(=O)N,,,,,,
223,100224,"1,8-Octanediamine, N,N'-bis(3-bromo-9-acridinyl)-",C1=CC=C2C(=C1)C(=C3C=CC(=CC3=N2)Br)NCCCCCCCCNC4=C5C=CC(=CC5=NC6=CC=CC=C64)Br,,,,,,
224,100225,"1,8-Octanediamine, N,N'-bis(2-chloro-6-methoxy-9-acridinyl)-",COC1=CC2=C(C=C1)C(=C3C=C(C=CC3=N2)Cl)NCCCCCCCCNC4=C5C=C(C=CC5=NC6=C4C=CC(=C6)OC)Cl,,,,,,
225,100226,"2-Tert-butylpropane-1,3-diol",CC(C)(C)C(CO)CO,,,,,,
226,100227,"4-Cinnamylidene-2-hydroxy-5-methoxycyclohexa-2,5-dien-1-one",COC1=CC(=O)C(=CC1=CC=CC2=CC=CC=C2)O,,,,,,
227,100228,"7-((4-Nitrobenzyl)thio)-3-(beta-D-ribofuranosyl)pyrazolo(4,3-d)pyrimidine",C1=CC(=CC=C1CSC2=NC=NC3=C2C=NN3[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O)[N+](=O)[O-],,,,,,
228,100229,"(3|A,7|A)-8-oxo-12,13-epoxytrichothec-9-ene-3,7,15-triyl triacetate",CC1=C[C@@H]2[C@]([C@@H](C1=O)OC(=O)C)(C3(C[C@H]([C@H]([C@@]34CO4)O2)OC(=O)C)C)COC(=O)C,,,,,,
229,100230,Thalmidine,CN1CCC2=CC3=C(C=C2[C@@H]1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)C[C@H]6C7=C(O3)C(=C(C=C7CCN6C)OC)OC)OC)OC,,,,,,
230,100231,Obaberine,CN1CCC2=CC(=C(C3=C2[C@@H]1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)C[C@@H]6C7=CC(=C(C=C7CCN6C)OC)O3)OC)OC)OC,,,,,,
231,100232,Dimethylgermanone,C[Ge](=O)C,,,,,,
232,100233,"Phosphoramidic acid, N-amidino-, diphenyl ester",C1=CC=C(C=C1)OP(=O)(N=C(N)N)OC2=CC=CC=C2,,,,,,
233,100234,"4(3H)-Pyrimidinone, 3-(2-chlorophenyl)-2-(methylthio)-",CSC1=NC=CC(=O)N1C2=CC=CC=C2Cl,,,,,,
234,100235,"4(3H)-Pyrimidinone, 2-(methylthio)-3-phenyl-",CSC1=NC=CC(=O)N1C2=CC=CC=C2,,,,,,
235,100236,"4(3H)-Pyrimidinone, 3-(2-methylphenyl)-2-(methylthio)-",CC1=CC=CC=C1N2C(=O)C=CN=C2SC,,,,,,
236,100237,"4(3H)-Pyrimidinone, 3-(2-methoxyphenyl)-2-(methylthio)-",COC1=CC=CC=C1N2C(=O)C=CN=C2SC,,,,,,
237,100238,"4(3H)-Pyrimidinone, 2-(methylthio)-3-(3-(trifluoromethyl)phenyl)-",CSC1=NC=CC(=O)N1C2=CC=CC(=C2)C(F)(F)F,,,,,,
238,100239,N-(2-(2-Hydroxyphenyl)-2H-benzotriazol-5-yl)methacrylamide,CC(=C)C(=O)NC1=CC2=NN(N=C2C=C1)C3=CC=CC=C3O,,,,,,
239,100240,2-Methyl-6-propoxypyrazine,CCCOC1=NC(=CN=C1)C,,,,,,
240,100241,"N-(2,2,6,6-Tetramethylpiperidin-4-yl)acetamide",CC(=O)NC1CC(NC(C1)(C)C)(C)C,,,,,,
241,100242,Digitopurpone,CC1=CC(=C2C(=C1O)C(=O)C3=C(C2=O)C=CC=C3O)O,,,,,,
242,100243,Verrucarin E,CC(=O)C1=CNC=C1CO,,,,,,
243,100244,1-(2-Hydroxyethyl)-3-nitro-4-pyrazolecarboxamide,C1=C(C(=NN1CCO)[N+](=O)[O-])C(=O)N,,,,,,
244,100245,4-Methacryloxybenzoic acid,CC(=C)C(=O)C1=CC=C(C=C1)C(=O)O,,,,,,
245,100246,"(1S,17S,19R)-9-hydroxy-4,5-dimethoxy-16-oxa-24-azapentacyclo[15.7.1.18,12.02,7.019,24]hexacosa-2,4,6,8,10,12(26),13-heptaen-15-one",COC1=C(C=C2C(=C1)[C@@H]3C[C@H](C[C@@H]4N3CCCC4)OC(=O)C=CC5=CC2=C(C=C5)O)OC,,,,,,
246,100247,"(1S,17S,19R)-4,9-dihydroxy-5-methoxy-16-oxa-24-azapentacyclo[15.7.1.18,12.02,7.019,24]hexacosa-2,4,6,8,10,12(26),13-heptaen-15-one",COC1=C(C=C2[C@@H]3C[C@H](C[C@@H]4N3CCCC4)OC(=O)C=CC5=CC(=C(C=C5)O)C2=C1)O,,,,,,
247,100248,4'-Hydroxypapaverine,COC1=C(C=CC(=C1)CC2=NC=CC3=CC(=C(C=C32)OC)OC)O,,,,,,
248,100249,CID 100249,COC1=C(C=C(C=C1)CC2=C3C=C(C(=O)C=C3C=CN2)OC)OC,,,,,,
249,100250,6-Fluorobenzo(a)pyrene,C1=CC=C2C(=C1)C3=C4C(=C2F)C=CC5=CC=CC(=C54)C=C3,,,,,,
250,100251,"(3aS,6aR,8S,9aR,9bS)-3,6,9-trimethylidene-8-[(2R,3R,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3a,4,5,6a,7,8,9a,9b-octahydroazuleno[4,5-b]furan-2-one",C=C1CC[C@@H]2[C@@H]([C@@H]3[C@H]1C[C@@H](C3=C)O[C@H]4[C@@H](C([C@@H](C(O4)CO)O)O)O)OC(=O)C2=C,,,,,,
251,100252,Ribavirin monophosphate,C1=NC(=NN1[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O)O)O)C(=O)N,,,"['Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)', 'Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)']",,,
252,100253,2'-Fluoro-2'-deoxyadenosine,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)F)N,,,,,,
253,100254,"trans-1-(2-Chloroethyl)-3-(2,6-dihydroxy-4-methylcyclohexyl)-1-nitrosourea",CC1C[C@H](C([C@H](C1)O)NC(=O)N(CCCl)N=O)O,,,,,,
254,100255,Methotrexate-gamma-aspartate,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)N[C@@H](CC(=O)O)C(=O)O)C(=O)O,,,,,,
255,100256,"9,10-Anthracenedione, 1,4-bis((2-(ethylamino)ethyl)amino)-",CCNCCNC1=C2C(=C(C=C1)NCCNCC)C(=O)C3=CC=CC=C3C2=O,,,,,,
256,100257,Thalrugosine,CN1CCC2=CC(=C3C=C2[C@@H]1CC4=CC=C(C=C4)OC5=C(C=CC(=C5)C[C@@H]6C7=C(O3)C(=C(C=C7CCN6C)OC)O)OC)OC,,,,,,
257,100258,"Oxyacanthan, 5,6,6',7,12'-pentamethoxy-2,2'-dimethyl-, (1'alpha)-",CN1CCC2=CC(=C3C=C2[C@@H]1CC4=CC(=C(C=C4)OC)OC5=CC=CC(=C5)C[C@H]6C7=C(CCN6C)C(=C(C(=C7O3)OC)OC)OC)OC,,,,,,
258,100259,(4-Chlorophenyl)-cyanoimino-oxidoazanium,C1=CC(=CC=C1[N+](=NC#N)[O-])Cl,,,,,,
259,100260,6-Methoxy-Quinoxaline,CC1=CC(=O)C2=C(O1)C=C3C=C(C(=C(C3=C2O)O)C)OC,,,,,,
260,100261,"2-Propen-1-one, 1-(1H-benzimidazol-2-yl)-3-(4-(dimethylamino)phenyl)-",CN(C)C1=CC=C(C=C1)C=CC(=O)C2=NC3=CC=CC=C3N2,,,,,,
261,100262,"Isoquinoline, 1-amino-3-(3-pyridyl)-",C1=CC=C2C(=C1)C=C(N=C2N)C3=CN=CC=C3,,,,,,
262,100263,"Acridine, 9-chloro-3-nitro-",C1=CC=C2C(=C1)C(=C3C=CC(=CC3=N2)[N+](=O)[O-])Cl,,,,,,
263,100264,"Pyrimido(4,5-b)quinoline-2,4(3H,10H)-dione, 3,10-dimethyl-",CN1C2=CC=CC=C2C=C3C1=NC(=O)N(C3=O)C,,,,,,
264,100265,"3,5-Bis(trifluoromethyl)benzohydrazide",C1=C(C=C(C=C1C(F)(F)F)C(F)(F)F)C(=O)NN,,,,,,
265,100266,Methotrexate-gamma-methylamide,CNC(=O)CCC(C(=O)O)NC(=O)C1=CC=C(C=C1)N(C)CC2=CN=C3C(=N2)C(=NC(=N3)N)N,,,,,,
266,100267,"Carbamic acid, (1-methylethyl)-, (5-(3,4-dichlorophenyl)-2,3-dihydro-1H-pyrrolizine-6,7-diyl)bis(methylene) ester",CC(C)NC(=O)OCC1=C2CCCN2C(=C1COC(=O)NC(C)C)C3=CC(=C(C=C3)Cl)Cl,,,,,,
267,100268,Rpcnu,CC(=O)O[C@@H]1COC([C@@H]([C@@H]1OC(=O)C)OC(=O)C)NC(=O)N(CCCl)N=O,,,,,,
268,100269,Bofumustine,CC1(O[C@@H]2[C@H](OC([C@@H]2O1)NC(=O)N(CCCl)N=O)COC(=O)C3=CC=C(C=C3)[N+](=O)[O-])C,,,,,,
269,100270,"1H-Tetrazole, 1-ethyl-5-phenyl-",CCN1C(=NN=N1)C2=CC=CC=C2,,,,,,
270,100271,"Piperazine, 1-((6-amino-1,2,3,4-tetrahydro-1,3-dimethyl-2,4-dioxo-5-pyrimidinyl)carbonyl)-4-phenyl-",CN1C(=C(C(=O)N(C1=O)C)C(=O)N2CCN(CC2)C3=CC=CC=C3)N,,,,,,
271,100272,"5-Pyrimidinecarboxamide, 1,2,3,4-tetrahydro-6-amino-1,3-dimethyl-2,4-dioxo-N-(4-ethoxyphenyl)-",CCOC1=CC=C(C=C1)NC(=O)C2=C(N(C(=O)N(C2=O)C)C)N,,,,,,
272,100273,"[(2R,3S,5R,6S)-3,4,6-trihydroxy-5-(3-nitropropanoyloxy)oxan-2-yl]methyl 3-nitropropanoate",C(C[N+](=O)[O-])C(=O)OC[C@@H]1[C@H](C([C@H]([C@H](O1)O)OC(=O)CC[N+](=O)[O-])O)O,,,,,,
273,100274,Karakin,C(C[N+](=O)[O-])C(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)OC(=O)CC[N+](=O)[O-])OC(=O)CC[N+](=O)[O-])O)O,,,,,,
274,100275,Cibarian,C(C[N+](=O)[O-])C(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)OC(=O)CC[N+](=O)[O-])O)O)O,,,,,,
275,100276,"9,10-Anthracenedione, 1,4-bis((1-(piperazinyl)ethyl)amino)-",C1CN(CCN1)CCNC2=C3C(=C(C=C2)NCCN4CCNCC4)C(=O)C5=CC=CC=C5C3=O,,,,,,
276,100277,CID 100277,CCOC(=O)C1=C(SC2=C1CCCC2)NC(=NC)S,,,,,,
277,100278,1-(prop-1-en-2-yl)-1H-benzo[d]imidazol-2(3H)-one,CC(=C)N1C2=CC=CC=C2NC1=O,,,,,,
278,100279,"Diethyl 1',4'-dihydro-2',6'-dimethyl-(3,4'-bipyridine)-3',5'-dicarboxylate",CCOC(=O)C1=C(NC(=C(C1C2=CN=CC=C2)C(=O)OCC)C)C,,,,,,
279,100280,5-(2-Hydroxypropyl)-5-phenylbarbituric acid,CC(CC1(C(=O)NC(=O)NC1=O)C2=CC=CC=C2)O,,,,,,
280,100281,Chlorohyssopifolin A,C[C@](CCl)(C(=O)O[C@H]1CC(=C)[C@@H]2C[C@@H]([C@@]([C@@H]2C3[C@@H]1C(=C)C(=O)O3)(CCl)O)O)O,,,,,,
281,100282,"9,10-Anthracenedione, 1,4-bis[(2-aminoethyl)amino]-",C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3C2=O)NCCN)NCCN,,,,,,
282,100283,CID 100283,CC=C(C)C(=O)OC1[C@H]2C(=CC(=O)[C@H]([C@@]2([C@@H]3[C@@]45[C@@H]1OC(=O)C[C@H]4[C@H]([C@H]([C@@]3(OC5)O)O)C)C)O)C,,,,,,
283,100284,"(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]-5-(dimethylamino)-5-oxopentanoic acid",CN(C)C(=O)CC[C@@H](C(=O)O)NC(=O)C1=CC=C(C=C1)N(C)CC2=CN=C3C(=N2)C(=NC(=N3)N)N,,,,,,
284,100285,"ethyl N-[5-amino-3-(4-chlorophenyl)-1,2-dihydropyrido[3,4-b]pyrazin-7-yl]carbamate",CCOC(=O)NC1=NC(=C2C(=C1)NCC(=N2)C3=CC=C(C=C3)Cl)N,,,,,,
285,100286,"2-[4-(3,4-Dichlorobenzoyl)phenoxy]-2-methylpropanoic acid",CC(C)(C(=O)O)OC1=CC=C(C=C1)C(=O)C2=CC(=C(C=C2)Cl)Cl,,,,,,
286,100287,"3,3-Bis(iodomethyl)oxetane",C1C(CO1)(CI)CI,,,,,,
287,100288,"1,3,5,7-Tetraazabicyclo[3.3.1]nonane, 3,7-diacetyl-",CC(=O)N1CN2CN(C1)CN(C2)C(=O)C,,,,,,
288,100289,"[(7S,8R)-7-hydroxy-4-oxido-5,6,7,8-tetrahydro-3H-pyrrolizin-4-ium-1-yl]methyl (2R)-2,3-dihydroxy-2-[(1R)-1-methoxyethyl]-3-methylbutanoate",C[C@H]([C@](C(=O)OCC1=CC[N+]2([C@H]1[C@H](CC2)O)[O-])(C(C)(C)O)O)OC,,,,,,
289,100290,CID 100290,C[C@H]1CC[C@H]2[C@@]([C@@]3(CC[C@@H]4[C@H]([C@@H]3CN2C1)C[C@H]5[C@H]4CC(=O)[C@@H]6[C@@]5(CC[C@@H](C6)O)C)C)(C)O,,,,,,
290,100291,"methyl (2R)-2-[(2R,12bS)-3-ethylidene-2,4,6,7,12,12b-hexahydro-1H-indolo[2,3-a]quinolizin-2-yl]-3-hydroxypropanoate",CC=C1CN2CCC3=C([C@@H]2C[C@@H]1[C@H](CO)C(=O)OC)NC4=CC=CC=C34,,,,,,
291,100292,"1H-Pyrrolo(3,4-d)pyrimidine-2,4(3H,6H)-dione, 3,7-diphenyl-5-methyl-",CC1=C2C(=C(N1)C3=CC=CC=C3)NC(=O)N(C2=O)C4=CC=CC=C4,,,,,,
292,100293,"6H-Pyrrolo(3,4-d)pyrimidine, 2,4,5-trimethyl-7-phenyl-",CC1=C2C(=NC(=NC2=C(N1)C3=CC=CC=C3)C)C,,,,,,
293,100294,"6H-Pyrrolo(3,4-d)pyrimidine, 2,5-dimethyl-4,7-diphenyl-",CC1=C2C(=C(N1)C3=CC=CC=C3)N=C(N=C2C4=CC=CC=C4)C,,,,,,
294,100295,CID 100295,CC1=C2C(=NC(=C2NC(=C1C(=O)C)C)C3=CC=CC=C3)C,,,,,,
295,100296,"[(2R,7R,9R,10R)-11-acetyloxy-2-(hydroxymethyl)-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-10-yl] acetate",CC1=C[C@@H]2[C@](CC1)(C3(C([C@H]([C@H](C34CO4)O2)OC(=O)C)OC(=O)C)C)CO,,,,,,
296,100297,CID 100297,C1=CN(C(=O)N=C1S)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O,,,,,,
297,100298,"Urea, (3-(3,3-dimethyl-1-triazenyl)phenyl)-",CN(C)N=NC1=CC=CC(=C1)NC(=O)N,,,,,,
298,100299,Tocladesine,C1[C@@H]2[C@H]([C@H]([C@@H](O2)N3C4=NC=NC(=C4N=C3Cl)N)O)OP(=O)(O1)O,,,"['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)', 'Biologically active substances whose activities affect or play a role in the functioning of the immune system. (See all compounds classified as Immunologic Factors.)']",,,
299,100300,"Benzene, 1,3-dimethyl-2-nitroso-",CC1=C(C(=CC=C1)C)N=O,,,,,,
300,100301,CID 100301,C[C@@H]([C@H]1CC[C@@H]2[C@@]1([C@H](CC3C2[C@H]4[C@H](O4)[C@@]5([C@@]3(C(=O)C=CC5)C)O)O)C)[C@]6(C[C@]7([C@](O7)(C(=O)O6)C)C)C,,,,,,
301,100302,Amaralin,C[C@@H]1C[C@H]2[C@H](C[C@]3([C@H]1[C@@H]4[C@H]([C@@H]3O)O4)C)C(=C)C(=O)O2,,,,,,
302,100303,"1,4-Bis((5-hydroxypentyl)amino)-9,10-anthracenedione",C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3C2=O)NCCCCCO)NCCCCCO,,,,,,
303,100304,"Urea, N-phenyl-N'-1,3,4-thiadiazol-2-yl-",C1=CC=C(C=C1)NC(=O)NC2=NN=CS2,,,,,,
304,100305,CID 100305,C1=NN(C(=O)N=C1S)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,,,,,,
305,100306,CID 100306,COC1=C([C@H]([C@](C=C1Br)(CC#N)O)O)Br.COC1=C([C@@H]([C@@](C=C1Br)(CC#N)O)O)Br,,,,,,
306,100307,(+-)-Aeroplysinin I,COC1=C([C@H]([C@](C=C1Br)(CC#N)O)O)Br,,,,,,
307,100308,Aeroplysinin I,COC1=C([C@@H]([C@@](C=C1Br)(CC#N)O)O)Br,,,,,,
308,100309,Paragracine,CC1=C2C(=NC(=N2)NC)C3=C(C=C1)NC(=N3)N(C)C,,,,,,
309,100310,Benzyloxycarbonylserine,C1=CC=C(C=C1)COC(=O)N[C@@H](CO)C(=O)O,,,,,,
310,100311,Carbonylbis(L-methionine p-nitrophenylester),CSCC[C@@H](C(=O)OC1=CC=C(C=C1)[N+](=O)[O-])NC(=O)N[C@@H](CCSC)C(=O)OC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
311,100312,"methyl (2R,3S)-2-amino-3-hydroxybutanoate",C[C@@H]([C@H](C(=O)OC)N)O,,,,,,
312,100313,Malabaricone C,C1=CC(=C(C(=C1)O)C(=O)CCCCCCCCC2=CC(=C(C=C2)O)O)O,,,,,,
313,100314,"(2S,3S,4S)-4-[(6R)-6-carboxyhepta-2,4-dien-2-yl]-3-(carboxymethyl)pyrrolidine-2-carboxylic acid",C[C@H](C=CC=C(C)[C@H]1CN[C@@H]([C@H]1CC(=O)O)C(=O)O)C(=O)O,,,,,,
314,100315,Homoaerothionin,COC1=C([C@@H]([C@]2(CC(=NO2)C(=O)NCCCCCNC(=O)C3=NO[C@@]4(C3)C=C(C(=C([C@@H]4O)Br)OC)Br)C=C1Br)O)Br,,,,,,
315,100316,CID 100316,C1=CC=C(C=C1)NC(=NC2=NC=CC=N2)S,,,,,,
316,100317,"1-Piperazineethanol, 4-(4-nitro-5-benzofurazanyl)-",C1CN(CCN1CCO)C2=C(C3=NON=C3C=C2)[N+](=O)[O-],,,,,,
317,100318,2-(3-Nitropyridin-2-yl)sulfanylpyrimidine,C1=CC(=C(N=C1)SC2=NC=CC=N2)[N+](=O)[O-],,,,,,
318,100319,2-(3-nitropyridin-2-yl)sulfanyl-1H-pyrimidin-6-one,C1=CC(=C(N=C1)SC2=NC=CC(=O)N2)[N+](=O)[O-],,,,,,
319,100320,"2-((2,4-Dinitrophenyl)thio)-4(3H)-pyrimidinone",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])SC2=NC=CC(=O)N2,,,,,,
320,100321,N-Acryloylglycine,C=CC(=O)NCC(=O)O,,,,,,
321,100322,"3,5-Dibromo-1-hydroxy-4-oxo-2,5-cyclohexadien-1-ethylacetate",CCOC(=O)CC1(C=C(C(=O)C(=C1)Br)Br)O,,,,,,
322,100323,"Ethyl 2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)acetate",CCOC(=O)CC1(C=CC(=O)C=C1)O,,,,,,
323,100324,Dienone B,C1=C(C(=O)C(=CC1(CC(=O)N)O)Br)Br,,,,,,
324,100325,CID 100325,CC(=NN=C(N1CCCCC1)S)C2=CC=CC=N2,,,,,,
325,100326,CID 100326,CC(=O)C=C(C1=CC=CC=C1)C2=C(OC3=CC=CC=C3C2=O)O,,,,,,
326,100327,2'-Chloro-2'-deoxyadenosine,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)Cl)N,,,,,,
327,100328,"2(1H)-Naphthalenone, octahydro-",C1CCC2CC(=O)CCC2C1,,,,,,
328,100329,Asterriquinone,CC(C)(C=C)N1C=C(C2=CC=CC=C21)C3=C(C(=O)C(=C(C3=O)O)C4=CN(C5=CC=CC=C54)C(C)(C)C=C)O,,,,,,
329,100330,CID 100330,COC1=CC(=O)C2=C(C3=C(C=CC(=C3O)O)OC2=C1)O,,,,,,
330,100331,"N-(p-(((2,4-Diamino-5-methyl-6-quinazolinyl)methyl)amino)benzoyl)-L-glutamic acid",CC1=C(C=CC2=C1C(=NC(=N2)N)N)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O,,,,,,
331,100332,Loliolide,C[C@@]12C[C@H](CC(C1=CC(=O)O2)(C)C)O,,,,,,
332,100333,1-Pyrenyloxirane,C1C(O1)C2=C3C=CC4=CC=CC5=C4C3=C(C=C5)C=C2,,,,,,
333,100334,Coumarin 6,CCN(CC)C1=CC2=C(C=C1)C=C(C(=O)O2)C3=NC4=CC=CC=C4S3,,,,,,
334,100335,Coumarin 30,CCN(CC)C1=CC2=C(C=C1)C=C(C(=O)O2)C3=NC4=CC=CC=C4N3C,,,,,,
335,100336,Coumarin 106,C1CC2=C(C1)C(=O)OC3=C2C=C4CCCN5C4=C3CCC5,,,,,,
336,100337,"Picras-3-ene-2,16-dione, 11,20-epoxy-1,11,12-trihydroxy-6-((3-methyl-1-oxo-2-butenyl)oxy)-, (1beta,6alpha,11beta,12alpha)-",C[C@@H]1[C@@H]2CC(=O)O[C@H]3C24CO[C@@]([C@@H]1O)([C@@H]4[C@@]5([C@@H]([C@H]3OC(=O)C=C(C)C)C(=CC(=O)[C@H]5O)C)C)O,,,,,,
337,100338,CID 100338,C1=CC=C(C=C1)NC(=NC2=CC=CC=C2N)S,,,,,,
338,100339,"Rhodanine, 3-(p-iodophenyl)-",C1C(=O)N(C(=S)S1)C2=CC=C(C=C2)I,,,,,,
339,100340,CID 100340,C1=CC(=CC#N)[C@@H]([C@H]([C@@H]1O)O)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)CO)O)O)O,,,,,,
340,100341,Griffonilide,C1=CC2=CC(=O)O[C@@H]2[C@H]([C@@H]1O)O,,,,,,
341,100342,"Pyrrolo(3,4-e)(1,4)diazepin-2(1H)-one, 3,7-dihydro-6,7-dimethyl-8-ethyl-5-phenyl-",CCC1=C2C(=C(N1C)C)C(=NCC(=O)N2)C3=CC=CC=C3,,,,,,
342,100343,"5-(2-Fluorophenyl)-6-methyl-3,7-dihydropyrrolo[3,4-e][1,4]diazepin-2(1H)-one",CC1=C2C(=CN1)NC(=O)CN=C2C3=CC=CC=C3F,,,,,,
343,100344,"4-Oxazolecarboxamide, 5-methyl-2-phenyl-",CC1=C(N=C(O1)C2=CC=CC=C2)C(=O)N,,,,,,
344,100345,"N,N-dimethyl-2-(5-nitrofuran-2-yl)ethenamine",CN(C)C=CC1=CC=C(O1)[N+](=O)[O-],,,,,,
345,100346,CID 100346,CC1=NC2=C(C(=NCCCC3=CC=CC=C3)C(=CC2=N1)N(O)O)[N+](=O)[O-],,,,,,
346,100347,"1H-Benzimidazole, 4,6-dinitro-2-methyl-5-(4-morpholinyl)-",CC1=NC2=C(C(=C(C=C2N1)[N+](=O)[O-])N3CCOCC3)[N+](=O)[O-],,,,,,
347,100348,CID 100348,CC1=NC2=C(C(=NCC3=CC=CC=C3)C(=CC2=N1)N(O)O)[N+](=O)[O-],,,,,,
348,100349,CID 100349,CC1=NC2=C(C(=NCCO)C(=CC2=N1)N(O)O)[N+](=O)[O-],,,,,,
349,100350,"1H-Benzimidazole, 4,6-dinitro-2-methyl-5-(1-piperidinyl)-",CC1=NC2=C(C(=C(C=C2N1)[N+](=O)[O-])N3CCCCC3)[N+](=O)[O-],,,,,,
350,100351,CID 100351,CC1=NC2=C(C(=C(C=C2N1)N(O)O)N=C3C=CC(=O)C=C3)[N+](=O)[O-],,,,,,
351,100352,CID 100352,CC1=NC2=C(C(=NC3=CC=CC=C3)C(=CC2=N1)N(O)O)[N+](=O)[O-],,,,,,
352,100353,"1H-Benzimidazole, 4,6-dinitro-2-methyl-5-(4-methyl-1-piperazinyl)-",CC1=NC2=C(C(=C(C=C2N1)[N+](=O)[O-])N3CCN(CC3)C)[N+](=O)[O-],,,,,,
353,100354,"2-Methyl-4,6-dinitro-5-(4-phenylpiperazin-1-yl)-1h-benzimidazole",CC1=NC2=C(C(=C(C=C2N1)[N+](=O)[O-])N3CCN(CC3)C4=CC=CC=C4)[N+](=O)[O-],,,,,,
354,100355,CID 100355,C1=CC=C(C=C1)CN=C2C(=CC3=NC=NC3=C2[N+](=O)[O-])N(O)O,,,,,,
355,100356,"1H-Benzimidazol-5-amine, N,N-dimethyl-4,6-dinitro-",CN(C)C1=C(C=C2C(=C1[N+](=O)[O-])N=CN2)[N+](=O)[O-],,,,,,
356,100357,CID 100357,CN=C1C(=CC2=NC=NC2=C1[N+](=O)[O-])N(O)O,,,,,,
357,100358,"1H-Benzimidazole, 4,6-dinitro-5-(4-morpholinyl)-",C1COCCN1C2=C(C=C3C(=C2[N+](=O)[O-])N=CN3)[N+](=O)[O-],,,,,,
358,100359,"1H-Benzimidazole, 4,6-dinitro-5-(1-piperidinyl)-",C1CCN(CC1)C2=C(C=C3C(=C2[N+](=O)[O-])N=CN3)[N+](=O)[O-],,,,,,
359,100360,CID 100360,C1=CC=C(C=C1)N=C2C(=CC3=NC=NC3=C2[N+](=O)[O-])N(O)O,,,,,,
360,100361,CID 100361,C1=CC(=O)C=CC1=NC2=C(C=C3C(=C2[N+](=O)[O-])N=CN3)N(O)O,,,,,,
361,100362,CID 100362,C1=C(C(=NCCO)C(=C2C1=NC=N2)[N+](=O)[O-])N(O)O,,,,,,
362,100363,CID 100363,CC=CC1=CC(=O)[C@@H]([C@H]1O)O,,,,,,
363,100364,"1-(2-chloroethyl)-1-nitroso-3-[(2R,3S,4R)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl]urea",C(CCl)N(C(=O)N[C@@H](C=O)[C@@H]([C@H](C(CO)O)O)O)N=O,,,,,,
364,100365,CID 100365,CC(=NNC(=NC1=CC=CC=C1)S)C2=CC=CC=N2,,,,,,
365,100366,1-Decylpiperidine N-oxide,CCCCCCCCCC[N+]1(CCCCC1)[O-],,,,,,
366,100367,1-Dodecylpiperidine 1-oxide,CCCCCCCCCCCC[N+]1(CCCCC1)[O-],,,,,,
367,100368,1-Pentadecylpiperidine N-oxide,CCCCCCCCCCCCCCC[N+]1(CCCCC1)[O-],,,,,,
368,100369,1-Hexadecylpyridine N-oxide,CCCCCCCCCCCCCCCC[N+]1(CCCCC1)[O-],,,,,,
369,100370,1-Tetradecylperhydroazepine N-oxide,CCCCCCCCCCCCCC[N+]1(CCCCCC1)[O-],,,,,,
370,100371,"Anthraquinone, 1,4-bis((2-(methylamino)ethyl)amino)-",CNCCNC1=C2C(=C(C=C1)NCCNC)C(=O)C3=CC=CC=C3C2=O,,,,,,
371,100372,"9,10-Anthracenedione, 1,4-bis((2-(propylamino)ethyl)amino)-",CCCNCCNC1=C2C(=C(C=C1)NCCNCCC)C(=O)C3=CC=CC=C3C2=O,,,,,,
372,100373,"(1S,7S,9R)-4-(1H-imidazol-5-ylmethylidene)-9-(2-methylbut-3-en-2-yl)-2,5,16-triazatetracyclo[7.7.0.02,7.010,15]hexadeca-10,12,14-triene-3,6-dione",CC(C)(C=C)[C@@]12C[C@H]3C(=O)NC(=CC4=CN=CN4)C(=O)N3[C@@H]1NC5=CC=CC=C25,,,,,,
373,100374,"1,1,2,2,3,3,4,4,5,5,6,6,6-Tridecafluorohexane-1-sulphonyl chloride",C(C(C(C(F)(F)S(=O)(=O)Cl)(F)F)(F)F)(C(C(F)(F)F)(F)F)(F)F,,,,,,
374,100375,"7H-Furo(3,2-g)(1)benzopyran-7-one, 3-(methoxymethyl)-2,5,9-trimethyl-",CC1=CC(=O)OC2=C(C3=C(C=C12)C(=C(O3)C)COC)C,,,,,,
375,100376,alpha-Aspartyl methotrexate,CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@H](CC(=O)O)C(=O)O,,,,,,
376,100377,CID 100377,C[C@@H]1CCC[C@@]2([C@]1(C[C@@]3(C2)C(=C)COC3=O)C)C,,,,,,
377,100378,"4H-Naphtho(1,2-b)pyran-4-one, 2-(dimethylamino)-",CN(C)C1=CC(=O)C2=C(O1)C3=CC=CC=C3C=C2,,,,,,
378,100379,"4H-Naphtho(1,2-b)pyran-4-one, 2-(ethylmethylamino)-",CCN(C)C1=CC(=O)C2=C(O1)C3=CC=CC=C3C=C2,,,,,,
379,100380,8-(3-Pyridyl)theophylline,CN1C2=C(C(=O)N(C1=O)C)NC(=N2)C3=CN=CC=C3,,,,,,
380,100381,N-[2-(Hydroxyimino)ethyl]-2-phenylethanimidic acid,C1=CC=C(C=C1)CC(=O)NCC=NO,,,,,,
381,100382,"1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-8-((phenylmethyl)amino)-",CN1C2=C(C(=O)N(C1=O)C)NC(=N2)NCC3=CC=CC=C3,,,,,,
382,100383,2-Propoxyacetic acid,CCCOCC(=O)O,,,,,,
383,100384,"Acetic acid, phosphono-, 1-propyl ester",CCCOC(=O)CP(=O)(O)O,,,,,,
384,100385,"Acetic acid, phosphono-, 1-octyl ester",CCCCCCCCOC(=O)CP(=O)(O)O,,,,,,
385,100386,"Silane, trimethyl[p-(trimethylstannyl)phenyl]-",C[Si](C)(C)C1=CC=C(C=C1)[Sn](C)(C)C,,,,,,
386,100387,CID 100387,CCCCCCCC[SnH](CCCCCCCC)CCCCCCCC.CC(=O)O,,,,,,
387,100388,CID 100388,CCCCCCCC[Sn]CCCCCCCC.CCCCOC(=O)C[S-].CCCCOC(=O)C[S-],,,,,,
388,100389,CID 100389,COC1=CC(=CC(=C1O)OC)C2=CC(=C3C(=CC(=O)C=C3O2)O)O,,,,,,
389,100390,"Imidazole-5-carboxaldehyde, 1-methyl-2-nitro-",CN1C(=CN=C1[N+](=O)[O-])C=O,,,,,,
390,100391,4-Hydroxycarbaryl glucoside,CNC(=O)OC1=CC=C(C2=CC=CC=C21)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
391,100392,5-Hydroxycarbaryl glucoside,CNC(=O)OC1=CC=CC2=C1C=CC=C2O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
392,100393,beta-Aspartyl methylamide,CNC(=O)C[C@@H](C(=O)O)N,,,,,,
393,100394,"Pyridazine, 3,6-dimethoxy-4-nitro-, 1-oxide",COC1=[N+](N=C(C(=C1)[N+](=O)[O-])OC)[O-],,,,,,
394,100395,"Pyridazine, 6-chloro-3-methoxy-4-nitro-, 1-oxide",COC1=N[N+](=C(C=C1[N+](=O)[O-])Cl)[O-],,,,,,
395,100396,"Pyridazine, 6-chloro-3-ethoxy-4-nitro-, 1-oxide",CCOC1=N[N+](=C(C=C1[N+](=O)[O-])Cl)[O-],,,,,,
396,100397,"Cinnoline, 4-nitro-, 1-oxide",C1=CC=C2C(=C1)C(=CN=[N+]2[O-])[N+](=O)[O-],,,,,,
397,100398,"(10a,12a-dimethyl-2-oxo-3,4,4a,4b,5,6,6a,7,8,9,10,10b,11,12-tetradecahydro-1H-naphtho[2,1-f]quinolin-8-yl) 2-[4-[bis(2-chloroethyl)amino]phenoxy]acetate",CC12CCC(CC1CCC3C2CCC4(C3CCC(=O)N4)C)OC(=O)COC5=CC=C(C=C5)N(CCCl)CCCl,,,,,,
398,100399,CID 100399,CC1=CC2=CC(=O)C(=C(C2=C(O1)O)O)OC,,,,,,
399,100400,"N,N-Bis(2-chloroethyl)-4-methylaniline",CC1=CC=C(C=C1)N(CCCl)CCCl,,,,,,
400,100401,"N,N-bis(2-chloroethyl)-4-(2-phenylethenyl)aniline",C1=CC=C(C=C1)C=CC2=CC=C(C=C2)N(CCCl)CCCl,,,,,,
401,100402,"Urea, (p-(bis(2-chloroethyl)amino)phenyl)-",C1=CC(=CC=C1NC(=O)N)N(CCCl)CCCl,,,,,,
402,100403,"1,3-Butanedione, 1-(2-phenyl-1H-indol-3-yl)-",CC(=O)CC(=O)C1=C(NC2=CC=CC=C21)C3=CC=CC=C3,,,,,,
403,100404,"1,4-Butanedione, 1-(1-methyl-2-phenyl-1H-indol-3-yl)-4-(4-morpholinyl)-",CN1C2=CC=CC=C2C(=C1C3=CC=CC=C3)C(=O)CC(=O)CN4CCOCC4,,,,,,
404,100405,"1,3-Propanedione, 1-(4-(2-(diethylamino)ethoxy)phenyl)-3-(1-methyl-2-phenyl-1H-indol-3-yl)-",CCN(CC)CCOC1=CC=C(C=C1)C(=O)CC(=O)C2=C(N(C3=CC=CC=C32)C)C4=CC=CC=C4,,,,,,
405,100406,"2-Chloro-1-(2-phenyl-1H-indol-3-yl)-1,3-butanedione",CC(=O)C(C(=O)C1=C(NC2=CC=CC=C21)C3=CC=CC=C3)Cl,,,,,,
406,100407,"Ethanone, 2-(4-morpholinyl)-1-(2-phenyl-1H-indol-3-yl)-",C1COCCN1CC(=O)C2=C(NC3=CC=CC=C32)C4=CC=CC=C4,,,,,,
407,100408,"Ethanone, 1-(2-phenyl-1H-indol-3-yl)-2-(1-piperidinyl)-",C1CCN(CC1)CC(=O)C2=C(NC3=CC=CC=C32)C4=CC=CC=C4,,,,,,
408,100409,"Ethanone, 2-(4-methyl-1-piperazinyl)-1-(2-phenyl-1H-indol-3-yl)-",CN1CCN(CC1)CC(=O)C2=C(NC3=CC=CC=C32)C4=CC=CC=C4,,,,,,
409,100410,"1,3-Butanedione, 1-(1-methyl-2-phenyl-1H-indol-3-yl)-",CC(=O)CC(=O)C1=C(N(C2=CC=CC=C21)C)C3=CC=CC=C3,,,,,,
410,100411,"2,5-Cyclohexadien-1-one, 4-hydroxy-4-methyl-",CC1(C=CC(=O)C=C1)O,,,,,,
411,100412,"4-(5-Tert-butyl-1-phenylpyrazolidin-3-ylidene)oxolane-2,3-dione",CC(C)(C)C1CC(=C2COC(=O)C2=O)NN1C3=CC=CC=C3,,,,,,
412,100413,4-Chloroindole-3-acetic acid,C1=CC2=C(C(=C1)Cl)C(=CN2)CC(=O)O,,,,,,
413,100414,2-(2-Bromoethyl)oxirane,C1C(O1)CCBr,,,,,,
414,100415,5-Chloro-2-methylbenzenesulfonyl chloride,CC1=C(C=C(C=C1)Cl)S(=O)(=O)Cl,,,,,,
415,100416,2'-Deoxysangivamycin,C1[C@@H]([C@H](O[C@H]1N2C=C(C3=C(N=CN=C32)N)C(=O)N)CO)O,,,,,,
416,100417,3'-Deoxysangivamycin,C1[C@H](O[C@H]([C@@H]1O)N2C=C(C3=C(N=CN=C32)N)C(=O)N)CO,,,,,,
417,100418,Chamuvaritin,C1C2=CC=CC=C2OC3=C(C(=C(C(=C31)O)C(=O)CCC4=CC=CC=C4)O)CC5=CC=CC=C5O,,,,,,
418,100419,"(13R,17R)-17-[(1R,2S)-1,2-dihydroxyheptyl]-1,5,10-triazabicyclo[11.4.0]heptadec-15-en-11-one",CCCCC[C@@H]([C@@H]([C@H]1C=CC[C@H]2N1CCCNCCCCNC(=O)C2)O)O,,,,,,
419,100420,"Benzenesulfonamide, 4-(9-acridinylamino)-",C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)NC4=CC=C(C=C4)S(=O)(=O)N,,,,,,
420,100421,Diethyl 2-chlorobut-2-enedioate,CCOC(=O)C=C(C(=O)OCC)Cl,,,,,,
421,100422,"1,4-Dimethyl 2-iodobut-2-enedioate",COC(=O)C=C(C(=O)OC)I,,,,,,
422,100423,"8,8'-Dioxo-6,6'-azopurine",C1=NC2=C(C(=N1)N=NC3=NC=NC4=C3NC(=O)N4)NC(=O)N2,,,,,,
423,100424,3-[4-(3-Hydroxyphenyl)hexan-3-yl]phenol,CCC(C1=CC(=CC=C1)O)C(CC)C2=CC(=CC=C2)O,,,,,,
424,100425,N6-Palmitoyl lysine,CCCCCCCCCCCCCCCC(=O)NCCCC[C@@H](C(=O)O)N,,,,,,
425,100426,"Quino(2,3-b)acridine-7,14-dione, 5,12-dihydro-2,9-dimethoxy-",COC1=CC2=C(C=C1)NC3=CC4=C(C=C3C2=O)NC5=C(C4=O)C=C(C=C5)OC,,,,,,
426,100427,Palifosfamide,C(CCl)NP(=O)(NCCCl)O,"['Investigated for use/treatment in cancer/tumors (unspecified), lymphoma (unspecified), and sarcoma.']",,"['A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026) (See all compounds classified as Antineoplastic Agents, Alkylating.)']",,,
427,100428,"2,2'-Diphenylene chlorophosphonate",C1=CC=C2C(=C1)C3=CC=CC=C3OP(=O)(O2)Cl,,,,,,
428,100429,"Phosphonic diamide, N,N,N',N'-tetramethyl-P-1-piperidinyl-(9CI)",CN(C)P(=O)(N1CCCCC1)N(C)C,,,,,,
429,100430,"6-(Thiophen-2-yl)-1,3,5-triazine-2,4-diamine",C1=CSC(=C1)C2=NC(=NC(=N2)N)N,,,,,,
430,100431,"Phosphoric triamide, (hydroxymethyl)pentamethyl-",CN(C)P(=O)(N(C)C)N(C)CO,,,,,,
431,100432,"Benzamide, N-(((4-bromophenyl)amino)carbonyl)-2,6-difluoro-",C1=CC(=C(C(=C1)F)C(=O)NC(=O)NC2=CC=C(C=C2)Br)F,,,,,,
432,100433,"Benzamide, 2,6-difluoro-N-(((4-(phenylmethoxy)phenyl)amino)carbonyl)-",C1=CC=C(C=C1)COC2=CC=C(C=C2)NC(=O)NC(=O)C3=C(C=CC=C3F)F,,,,,,
433,100434,"2-(m-Methoxyphenyl)-5,6-dihydro-s-triazolo(5,1-a)isoquinoline",COC1=CC=CC(=C1)C2=NN3CCC4=CC=CC=C4C3=N2,,,,,,
434,100435,N-Methylmercaptoacetamide,CC(=O)NSC,,,,,,
435,100436,"Imidazole-5-methanol, 2-nitro-alpha,alpha,1-trimethyl-",CC(C)(C1=CN=C(N1C)[N+](=O)[O-])O,,,,,,
436,100437,Terphenyllin,COC1=C(C(=C(C(=C1)C2=CC=C(C=C2)O)OC)O)C3=CC=C(C=C3)O,,,,,,
437,100438,"Methanol, (6-(3,3,3-tribromopropyl)-s-triazine-2,4-diyldinitrilo)tetra-",C(CC(Br)(Br)Br)C1=NC(=NC(=N1)N(CO)CO)N(CO)CO,,,,,,
438,100439,"1,1'-Oxalyldiimidazole",C1=CN(C=N1)C(=O)C(=O)N2C=CN=C2,,,,,,
439,100440,Cairomycin B,C1CCNC(=O)CC2C(=O)NC(C1)C(=O)N2,,,,,,
440,100441,"2-(Imidazo[1,2-a]pyrimidin-2-yl)acetic acid",C1=CN2C=C(N=C2N=C1)CC(=O)O,,,,,,
441,100442,N-(1-(4-((((Cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-5-methyl-3-isoxazolecarboxamide,CC1=CC(=NO1)C(=O)NC(C)C2=CC=C(C=C2)S(=O)(=O)NC(=O)NC3CCCCC3,,,,,,
442,100443,4'-O-Methyldoxorubicin,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)OC,,,,,,
443,100444,CID 100444,CC(=NN=C(N1CCC(CC1)O)S)C2=CC=CC=N2,,,,,,
444,100445,"Carbamic acid, (5-amino-1,2-dihydro-3-(2-phenylethyl)pyrido(3,4-b)pyrazin-7-yl)-, ethyl ester",CCOC(=O)NC1=NC(=C2C(=C1)NCC(=N2)CCC3=CC=CC=C3)N,,,,,,
445,100446,Carbonyl cyanide-4-nitro-2-chlorophenylhydrazone,C1=CC(=C(C=C1[N+](=O)[O-])Cl)NN=C(C#N)C#N,,,,,,
446,100447,"Propanedinitrile, ((4-chloro-2,6-dibromophenyl)hydrazono)-",C1=C(C=C(C(=C1Br)NN=C(C#N)C#N)Br)Cl,,,,,,
447,100448,Thiophene A,CC#CC1=CC=C(S1)C#CC#CC=C,,,,,,
448,100449,Benzylideneaminoguanidine,C1=CC=C(C=C1)C=NN=C(N)N,,,,,,
449,100450,"3-Hydroxy-4,5-bis(hydroxymethyl)-2-(3-methylbut-2-en-1-yl)phenyl 2,4-dihydroxy-6-methylbenzoate",CC1=CC(=CC(=C1C(=O)OC2=C(C(=C(C(=C2)CO)CO)O)CC=C(C)C)O)O,,,,,,
450,100451,"Tetradec-6-en-8,10,12-triyn-3-one",CCC(=O)CCC=CC#CC#CC#CC,,,,,,
451,100452,"2-(3,5-Dinitropyridin-2-yl)sulfanylpyrimidine",C1=CN=C(N=C1)SC2=C(C=C(C=N2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
452,100453,"2,4-Bis[(2,4-dinitrophenyl)sulfanyl]pyrimidine",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])SC2=NC(=NC=C2)SC3=C(C=C(C=C3)[N+](=O)[O-])[N+](=O)[O-],,,,,,
453,100454,CID 100454,CCCC[SnH](CCCC)F.CCCC[SnH](CCCC)F.O,,,,,,
454,100455,Dibutyl(fluoro)stannane,CCCC[SnH](CCCC)F,,,,,,
455,100456,"Imidazole, 2-nitro-1-(p-nitrobenzyl)-",C1=CC(=CC=C1CN2C=CN=C2[N+](=O)[O-])[N+](=O)[O-],,,,,,
456,100457,"1H-Cyclopent(f)isoquinoline, 2,3,4,7,8,9-hexahydro-5,6-dimethoxy-3-(2,2-diphenylethyl)-",COC1=C(C2=C(CCN(C2)CC(C3=CC=CC=C3)C4=CC=CC=C4)C5=C1CCC5)OC,,,,,,
457,100458,"1H-Cyclopent(h)isoquinoline, 2,3,4,7,8,9-hexahydro-5,6-dimethoxy-2-(2,2-diphenylethyl)-",COC1=C(C2=C(CN(CC2)CC(C3=CC=CC=C3)C4=CC=CC=C4)C5=C1CCC5)OC,,,,,,
458,100459,"N-(4-(2-(2,3-Dihydrobenzo(b)furan-7-carboxamido)ethyl)benzenesulfonyl)-N'-cyclohexylurea",C1CCC(CC1)NC(=O)NS(=O)(=O)C2=CC=C(C=C2)CCNC(=O)C3=CC=CC4=C3OCC4,,,,,,
459,100460,"N,N-Diethylcyclophosphamide",CCN(CC)P1(=O)NCCCO1,,,,,,
460,100461,1-(1-methyl-5-nitroimidazol-2-yl)-N-[4-[(1-methyl-5-nitroimidazol-2-yl)methylideneamino]piperazin-1-yl]methanimine,CN1C(=CN=C1C=NN2CCN(CC2)N=CC3=NC=C(N3C)[N+](=O)[O-])[N+](=O)[O-],,,,,,
461,100462,"10H-Phenothiazine-10-carboxamide, N,N-bis(2-(((methylamino)carbonyl)oxy)ethyl)-",CNC(=O)OCCN(CCOC(=O)NC)C(=O)N1C2=CC=CC=C2SC3=CC=CC=C31,,,,,,
462,100463,"10H-Phenothiazine-10-carboxamide, N,N-bis(2-(((phenylamino)carbonyl)oxy)ethyl)-2-methoxy-",COC1=CC2=C(C=C1)SC3=CC=CC=C3N2C(=O)N(CCOC(=O)NC4=CC=CC=C4)CCOC(=O)NC5=CC=CC=C5,,,,,,
463,100464,"3(2H)-Furanone, 2,2-dimethyl-5-phenyl-",CC1(C(=O)C=C(O1)C2=CC=CC=C2)C,,,,,,
464,100465,"N-(1,1-dioxo-1,4-thiazinan-4-yl)-1-[2-(1-methyl-5-nitroimidazol-2-yl)-1,3-thiazol-4-yl]methanimine",CN1C(=CN=C1C2=NC(=CS2)C=NN3CCS(=O)(=O)CC3)[N+](=O)[O-],,,,,,
465,100466,"4-Morpholinamine,n-[[2-(5-nitro-2-thienyl)-4-thiazolyl]methylene]-",C1COCCN1N=CC2=CSC(=N2)C3=CC=C(S3)[N+](=O)[O-],,,,,,
466,100467,"1-[2-(5-nitrothiophen-2-yl)-1,3-thiazol-4-yl]-N-piperidin-1-ylmethanimine",C1CCN(CC1)N=CC2=CSC(=N2)C3=CC=C(S3)[N+](=O)[O-],,,,,,
467,100468,"1-[2-(5-nitrothiophen-2-yl)-1,3-thiazol-4-yl]-N-thiomorpholin-4-ylmethanimine",C1CSCCN1N=CC2=CSC(=N2)C3=CC=C(S3)[N+](=O)[O-],,,,,,
468,100469,"1-[2-(5-nitrofuran-2-yl)-1,3-thiazol-4-yl]-N-piperidin-1-ylmethanimine",C1CCN(CC1)N=CC2=CSC(=N2)C3=CC=C(O3)[N+](=O)[O-],,,,,,
469,100470,"3,5,7-Trimethylisoxazolo(3,4-d)pyrimidine-4,6(5H,7H)-dione",CC1=C2C(=NO1)N(C(=O)N(C2=O)C)C,,,,,,
470,100471,CID 100471,CC=CC=CC1=CC2=CC3=C(C(=O)C2=C(N1)O)C4(CC3)C(=C5C(=C4O)C(=O)C6=C(C5=O)C(=O)C=C(C6=O)OC)O,,,,,,
471,100472,Difenpiramide,C1=CC=C(C=C1)C2=CC=C(C=C2)CC(=O)NC3=CC=CC=N3,,,"['Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)']",,,
472,100473,"N,N'-Bis(4-hydroxycyclohexyl)-N'-nitrosourea",C1CC(CCC1NC(=O)N(C2CCC(CC2)O)N=O)O,,,,,,
473,100474,3-Heptyl-4-hydroxy-7-methoxy-2-methylquinoline,CCCCCCCC1=C(NC2=C(C1=O)C=CC(=C2)OC)C,,,,,,
474,100475,"2,4-Diamino-6-(5-trifluoromethylphenyl)thioquinazoline",C1=CC(=CC(=C1)SC2=CC3=C(C=C2)N=C(N=C3N)N)C(F)(F)F,,,,,,
475,100476,2-(2-Methylsulfinyl-1-phenylethenyl)thiophene,CS(=O)C=C(C1=CC=CC=C1)C2=CC=CS2,,,,,,
476,100477,"5-Butoxy-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]-5-oxopentanoic acid",CCCCOC(=O)CCC(C(=O)O)NC(=O)C1=CC=C(C=C1)N(C)CC2=CN=C3C(=N2)C(=NC(=N3)N)N,,,,,,
477,100478,Dimethyl (p-methoxybenzylidene)malonate,COC1=CC=C(C=C1)C=C(C(=O)OC)C(=O)OC,,,,,,
478,100479,"Methyl 2,2,2-trichloroacetimidate",COC(=N)C(Cl)(Cl)Cl,,,,,,
479,100480,"N-[4-[[3-[(4-acetamidophenyl)methylideneamino]-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene]methyl]phenyl]acetamide",CC(=O)NC1=CC=C(C=C1)C=C2C(=O)N(C(=S)S2)N=CC3=CC=C(C=C3)NC(=O)C,,,,,,
480,100481,"Dihydro-alpha,alpha,alpha',alpha'-tetramethyl-2-oxo-2H,4H-pyrimidine-1,3-dipropionic acid",CC(C)(CN1CCCN(C1=O)CC(C)(C)C(=O)O)C(=O)O,,,,,,
481,100482,CID 100482,CC(=NN=C(N)S)C=CC1=CC=CC=C1,,,,,,
482,100483,1-[2-(Methylsulfinyl)ethyl]-2-nitro-1h-imidazole,CS(=O)CCN1C=CN=C1[N+](=O)[O-],,,,,,
483,100484,Methyl 3-methyl-2-nitro-3H-imidazole-4-carboxylate,CN1C(=CN=C1[N+](=O)[O-])C(=O)OC,,,,,,
484,100485,"1,4-Benzenediol, 2-(3-methyl-2-butenyl)-",CC(=CCC1=C(C=CC(=C1)O)O)C,,,,,,
485,100486,"5H-1,2,4-Benzotriazepin-5-one, 1,4-dihydro-7-chloro-4-methyl-",CN1C=NNC2=C(C1=O)C=C(C=C2)Cl,,,,,,
486,100487,"5H-1,2,4-Benzotriazepin-5-one, 1,4-dihydro-7-chloro-4-ethyl-",CCN1C=NNC2=C(C1=O)C=C(C=C2)Cl,,,,,,
487,100488,"1H-1,2,4-Benzotriazepine-3-carboxamide, 4,5-dihydro-7-chloro-N,N-diethyl-4-methyl-5-oxo-",CCN(CC)C(=O)C1=NNC2=C(C=C(C=C2)Cl)C(=O)N1C,,,,,,
488,100489,5-Nitro-2-(2-pyridinyl)-1H-benzimidazole,C1=CC=NC(=C1)C2=NC3=C(N2)C=C(C=C3)[N+](=O)[O-],,,,,,
489,100490,CID 100490,C1C(=NC2=CC=CC=C2N=C1S)C3=CC=C(C=C3)SC4=CC=CC=C4,,,,,,
490,100491,CID 100491,C1=CC=NC(=C1)C2=NC(=CC=C2)C(=N)S,,,,,,
491,100492,Diphyllin,COC1=C(C=C2C(=C1)C(=C3C(=C2O)COC3=O)C4=CC5=C(C=C4)OCO5)OC,,,,,,
492,100493,1-p-Chlorobenzyl-1H-indazole-3-carboxylic acid,C1=CC=C2C(=C1)C(=NN2CC3=CC=C(C=C3)Cl)C(=O)O,,,,,,
493,100494,"1,4-Dimorpholino-7-phenylpyrido(3,4-d)pyridazine",C1COCCN1C2=NN=C(C3=CN=C(C=C32)C4=CC=CC=C4)N5CCOCC5,,,,,,
494,100495,Pentyl anthranilate,CCCCCOC(=O)C1=CC=CC=C1N,,,,,,
495,100496,Decyl benzoate,CCCCCCCCCCOC(=O)C1=CC=CC=C1,,,,,,
496,100497,CID 100497,CC1=NC2=C(C(=NCCC3=CC(=C(C=C3)OC)OC)C(=CC2=N1)N(O)O)[N+](=O)[O-],,,,,,
497,100498,CID 100498,CC1=NC2=C(C(=NCCN3CCNC3=O)C(=CC2=N1)N(O)O)[N+](=O)[O-],,,,,,
498,100499,CID 100499,COC1=C(C=C(C=C1)CCN=C2C(=CC3=NC=NC3=C2[N+](=O)[O-])N(O)O)OC,,,,,,
499,100500,CID 100500,C1CN(C(=O)N1)CCN=C2C(=CC3=NC=NC3=C2[N+](=O)[O-])N(O)O,,,,,,
500,100501,CID 100501,C1=CC=NC(=C1)N=NC2=C(C=C3C(=C2[N+](=O)[O-])N=CN3)N(O)O,,,,,,
501,100502,"Benzenamine, N,N'-(1,4-phenylenedimethylidyne)bis[3-ethynyl-",C#CC1=CC(=CC=C1)N=CC2=CC=C(C=C2)C=NC3=CC=CC(=C3)C#C,,,,,,
502,100503,Monopropyl Phthalate,CCCOC(=O)C1=CC=CC=C1C(=O)O,,,,,,
503,100504,5-Butyl-o-cresol,CCCCC1=CC(=C(C=C1)C)O,,,,,,
504,100505,CID 100505,CCCCCCCCCCC(=O)O.CC(C)[SnH](C(C)C)C(C)C,,,,,,
505,100506,5-Chloro-2-nitrobenzonitrile,C1=CC(=C(C=C1Cl)C#N)[N+](=O)[O-],,,,,,
506,100507,"[2-Chloro-1-(2,4,5-tribromophenyl)ethenyl] dimethyl phosphate",COP(=O)(OC)OC(=CCl)C1=CC(=C(C=C1Br)Br)Br,,,,,,
507,100508,1-(p-Chlorophenyl)silatrane,C1CO[Si]2(OCCN1CCO2)C3=CC=C(C=C3)Cl,,,,,,
508,100509,"Benzene, 4-chloro-2-nitro-1-(2-propynyloxy)-",C#CCOC1=C(C=C(C=C1)Cl)[N+](=O)[O-],,,,,,
509,100510,"1H-Imidazole-1-acetamide, N-(2-(acetyloxy)ethyl)-2-nitro-",CC(=O)OCCNC(=O)CN1C=CN=C1[N+](=O)[O-],,,,,,
510,100511,"Pyrimidine, 2((1-methyl-4-nitro-1H-imidazol-5-yl)thio)-",CN1C=NC(=C1SC2=NC=CC=N2)[N+](=O)[O-],,,,,,
511,100512,"Pyrimidine, 5-methyl-2-((3-nitro-2-pyridinyl)thio)-",CC1=CN=C(N=C1)SC2=C(C=CC=N2)[N+](=O)[O-],,,,,,
512,100513,"Pyrimidine, 4-methoxy-5-nitro-6-(2-pyrimidinylthio)-",COC1=C(C(=NC=N1)SC2=NC=CC=N2)[N+](=O)[O-],,,,,,
513,100514,"3-((1-Methyl-4-nitro-5-imidazolyl)thio)-1H-1,2,4-triazole",CN1C=NC(=C1SC2=NC=NN2)[N+](=O)[O-],,,,,,
514,100515,"5,12-Naphthacenedione, 7,8,9,10-tetrahydro-8-acetyl-10-((3-(((S)-2-amino-4-methyl-1-oxopentyl)amino)-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-",C[C@H]1C([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)C)O)NC(=O)[C@H](CC(C)C)N)O,,,,,,
515,100516,10-Deazaaminopterin,C1=CC(=CC=C1CCC2=CN=C3C(=N2)C(=NC(=N3)N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,"['Inhibitors of the enzyme, dihydrofolate reductase (TETRAHYDROFOLATE DEHYDROGENASE), which converts dihydrofolate (FH2) to tetrahydrofolate (FH4). They are frequently used in cancer chemotherapy. (From AMA, Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Folic Acid Antagonists.)', 'Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)']",,,
516,100517,2-Pyridin-2-ylsulfanylpyrimidine,C1=CC=NC(=C1)SC2=NC=CC=N2,,,,,,
517,100518,"5-Nitro-4,6-bis(pyrimidin-2-ylsulfanyl)pyrimidine",C1=CN=C(N=C1)SC2=C(C(=NC=N2)SC3=NC=CC=N3)[N+](=O)[O-],,,,,,
518,100519,"4-(3,5-Dinitropyridin-2-yl)sulfanylpyrimidine",C1=CN=CN=C1SC2=C(C=C(C=N2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
519,100520,"5-Nitro-2-pyrimidin-4-ylsulfanyl-1,3-thiazole",C1=CN=CN=C1SC2=NC=C(S2)[N+](=O)[O-],,,,,,
520,100521,"Thymidine, 5'-(2,2-dimethylpropanoate)",CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COC(=O)C(C)(C)C)O,,,,,,
521,100522,"Propane, 1,1,1,3-tetranitro-",C(C[N+](=O)[O-])C([N+](=O)[O-])([N+](=O)[O-])[N+](=O)[O-],,,,,,
522,100523,CID 100523,CN1C(=CN=C1S)C(=O)OC,,,,,,
523,100524,Amiprofos-methyl,CC1=CC(=C(C=C1)OP(=S)(NC(C)C)OC)[N+](=O)[O-],,,,,,
524,100525,2-Chloroethyl trifluoromethanesulfonate,C(CCl)OS(=O)(=O)C(F)(F)F,,,,,,
525,100526,N-Acetyldopamine,CC(=O)NCCC1=CC(=C(C=C1)O)O,,,,,,
526,100527,"Cyclopenta[c][1]benzopyran-4(1H)-one, 7-(dimethylamino)-2,3-dihydro-",CN(C)C1=CC2=C(C=C1)C3=C(CCC3)C(=O)O2,,,,,,
527,100528,Arctiin,COC1=C(C=C(C=C1)C[C@H]2COC(=O)[C@@H]2CC3=CC(=C(C=C3)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)OC)OC,,,,,,
528,100529,"3,4,5-Trichlorobenzene-1,2-diamine",C1=C(C(=C(C(=C1Cl)Cl)Cl)N)N,,,,,,
529,100530,"2-Amino-4,6-dimethylphenol",CC1=CC(=C(C(=C1)N)O)C,,,,,,
530,100531,"Carbonic acid, 1-methyl-1-(1-methyl-2-nitro-1H-imidazol-5-yl)ethyl phenyl ester",CC(C)(C1=CN=C(N1C)[N+](=O)[O-])OC(=O)OC2=CC=CC=C2,,,,,,
531,100532,"2,6-Heptanedione",CC(=O)CCCC(=O)C,,,,,,
532,100533,Thymidine-5'-carboxylic acid,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)C(=O)O)O,,,,,,
533,100534,"Guanidine, N-cyano-N'-cyclopropyl-N''-3-pyridinyl-",C1CC1N=C(NC#N)NC2=CN=CC=C2,,,,,,
534,100535,"Guanidine, 1-tert-butyl-3-(2-chloro-3-pyridyl)-2-cyano-",CC(C)(C)N=C(NC#N)NC1=C(N=CC=C1)Cl,,,,,,
535,100536,"Acetamide, N-(((1,1-dimethylpropyl)amino)(3-pyridinylamino)methylene)-2,2,2-trifluoro-",CCC(C)(C)N=C(NC1=CN=CC=C1)NC(=O)C(F)(F)F,,,,,,
536,100537,"Guanidine, N-(1,1-dimethylpropyl)-N'-3-pyridinyl-N''-2-thiazolyl-",CCC(C)(C)N=C(NC1=CN=CC=C1)NC2=NC=CS2,,,,,,
537,100538,"1,3-Benzenedicarbonitrile, 4-hydroxy-2,5,6-trichloro-, acetate",CC(=O)OC1=C(C(=C(C(=C1Cl)Cl)C#N)Cl)C#N,,,,,,
538,100539,"Benzonitrile, 4-(1-oxopropoxy)-2,3,5,6-tetrachloro-",CCC(=O)OC1=C(C(=C(C(=C1Cl)Cl)C#N)Cl)Cl,,,,,,
539,100540,"Dodecanoic acid, 4-cyano-2,3,5,6-tetrachlorophenyl ester",CCCCCCCCCCCC(=O)OC1=C(C(=C(C(=C1Cl)Cl)C#N)Cl)Cl,,,,,,
540,100541,"Benzoic acid, 3,4-dichloro-, 4-cyano-2,3,5,6-tetrachlorophenyl ester",C1=CC(=C(C=C1C(=O)OC2=C(C(=C(C(=C2Cl)Cl)C#N)Cl)Cl)Cl)Cl,,,,,,
541,100542,"1,4-Benzenedicarbonitrile, 2-methylamino-3,5,6-trifluoro-",CNC1=C(C(=C(C(=C1F)C#N)F)F)C#N,,,,,,
542,100543,"1,4-Benzenedicarbonitrile, 6-(hexylamino)-2,3,5-trifluoro-",CCCCCCNC1=C(C(=C(C(=C1F)C#N)F)F)C#N,,,,,,
543,100544,Methyl 2-(dimethylamino)-n-{[{[(methoxycarbonyl)(methyl)amino]sulfanyl}(methyl)carbamoyl]oxy}-2-oxoethanimidothioate,CN(C)C(=O)C(=NOC(=O)N(C)SN(C)C(=O)OC)SC,,,,,,
544,100545,"1H-Isoindol-1-one, 2-((3,4-dichlorophenyl)methyl)-2,3-dihydro-",C1C2=CC=CC=C2C(=O)N1CC3=CC(=C(C=C3)Cl)Cl,,,,,,
545,100546,"N-(4-Chlorophenyl)-N,2-dihydroxyacetamide",C1=CC(=CC=C1N(C(=O)CO)O)Cl,,,,,,
546,100547,"Ethyl 4-amino-2-[(2,4-dinitrophenyl)thio]pyrimidine-5-carboxylate",CCOC(=O)C1=CN=C(N=C1N)SC2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
547,100548,"2-(2,4-Dinitrophenyl)selanylpyrimidine",C1=CN=C(N=C1)[Se]C2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
548,100549,1-(5-(Tetradecyloxy)-2-furanyl)ethanone,CCCCCCCCCCCCCCOC1=CC=C(O1)C(=O)C,,,,,,
549,100550,"(3,3'-Bimorpholine)-2,2'-dione, 3,3',5,5,5',5'-hexamethyl-",CC1(COC(=O)C(N1)(C)C2(C(=O)OCC(N2)(C)C)C)C,,,,,,
550,100551,1beta-D-Ribofuranosyl-5-fluoropyrimidin-2(1H)-one,C1=C(C=NC(=O)N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)F,,,,,,
551,100552,4-Amino-1-(5-chloro-5-deoxy-beta-D-arabinofuranosyl)-2(1H)-pyrimidinone,C1=CN(C(=O)N=C1N)[C@H]2[C@H]([C@@H]([C@H](O2)CCl)O)O,,,,,,
552,100553,CID 100553,CC(=NN=C(N1CCCC1)S)C2=CC=CC=N2,,,,,,
553,100554,"5-[(6,7,8-Trimethoxyquinazolin-4-yl)amino]pentan-1-ol",COC1=C(C(=C2C(=C1)C(=NC=N2)NCCCCCO)OC)OC,,,,,,
554,100555,"1-(1,3-Benzodioxol-5-yl)-1-isopropylurea",CC(C)N(C1=CC2=C(C=C1)OCO2)C(=O)N,,,,,,
555,100556,"1,2-Dihydro-6-hydroxy-4-methyl-2-oxo-1-(phenylamino)nicotinonitrile",CC1=CC(=O)N(C(=C1C#N)O)NC2=CC=CC=C2,,,,,,
556,100557,"1,3,5-Triazine-2-acetamide, 1,4,5,6-tetrahydro-N-(2-methoxyphenyl)-4,6-dioxo-",COC1=CC=CC=C1NC(=O)CC2=NC(=O)NC(=O)N2,,,,,,
557,100558,5-Methyl-N(4)-hydroxycytosine,CC1=C(NC(=O)N=C1)NO,,,,,,
558,100559,CID 100559,CC(=NN=C(N1CCC1)S)C2=CC=CC=N2,,,,,,
559,100560,"N'-(2-Cyanophenyl)-N,N-dimethylformamidine",CN(C)C=NC1=CC=CC=C1C#N,,,,,,
560,100561,"Indazole, 1-acetyl-3-chloro-6-nitro-",CC(=O)N1C2=C(C=CC(=C2)[N+](=O)[O-])C(=N1)Cl,,,,,,
561,100562,Dihydro-5-azaorotic acid,C1(NC(=O)NC(=O)N1)C(=O)O,,,,,,
562,100563,3-[4-(4-Fluorophenyl)piperazin-1-yl]-1-phenylbut-2-en-1-one,CC(=CC(=O)C1=CC=CC=C1)N2CCN(CC2)C3=CC=C(C=C3)F,,,,,,
563,100564,3-(4-Chlorophenyl)-2-methyl-1-(4-phenylpiperazin-1-yl)prop-2-en-1-one,CC(=CC1=CC=C(C=C1)Cl)C(=O)N2CCN(CC2)C3=CC=CC=C3,,,,,,
564,100565,2-Methyl-3-(4-nitrophenyl)-1-piperidin-1-ylprop-2-en-1-one,CC(=CC1=CC=C(C=C1)[N+](=O)[O-])C(=O)N2CCCCC2,,,,,,
565,100566,2-methyl-3-(4-nitrophenyl)-N-propan-2-ylprop-2-enamide,CC(C)NC(=O)C(=CC1=CC=C(C=C1)[N+](=O)[O-])C,,,,,,
566,100567,1-(4-Fluorophenyl)-3-[4-(4-fluorophenyl)piperazin-1-yl]but-2-en-1-one,CC(=CC(=O)C1=CC=C(C=C1)F)N2CCN(CC2)C3=CC=C(C=C3)F,,,,,,
567,100568,1-(3-Fluorophenyl)-3-[4-[3-(trifluoromethyl)phenyl]piperazin-1-yl]but-2-en-1-one,CC(=CC(=O)C1=CC(=CC=C1)F)N2CCN(CC2)C3=CC=CC(=C3)C(F)(F)F,,,,,,
568,100569,1-(3-Fluorophenyl)-3-[4-(4-fluorophenyl)piperazin-1-yl]but-2-en-1-one,CC(=CC(=O)C1=CC(=CC=C1)F)N2CCN(CC2)C3=CC=C(C=C3)F,,,,,,
569,100570,"2H-1-Benzopyran, 4-(4-(2-bromoethoxy)phenyl)-7-methoxy-2,2-dimethyl-3-phenyl-",CC1(C(=C(C2=C(O1)C=C(C=C2)OC)C3=CC=C(C=C3)OCCBr)C4=CC=CC=C4)C,,,,,,
570,100571,"N,N'-Bis(1-methyl-2-pyrrolidinylidene)-1,2-ethanediamine",CN1CCCC1=NCCN=C2CCCN2C,,,,,,
571,100572,Eremanthin,CC1=CC[C@@H]2[C@@H]([C@@H]3[C@H]1CCC3=C)OC(=O)C2=C,,,,,,
572,100573,"Morpholine, 4-(2-(2-nitro-1H-imidazol-1-yl)ethyl)-",C1COCCN1CCN2C=CN=C2[N+](=O)[O-],,,,,,
573,100574,"9,10-Anthracenedione, 1,4-dihydroxy-2,3-dimethyl-",CC1=C(C(=C2C(=C1O)C(=O)C3=CC=CC=C3C2=O)O)C,,,,,,
574,100575,"Urea, N-(2-((2-chloroethyl)sulfinyl)ethyl)-N'-cyclohexyl-N-nitroso-",C1CCC(CC1)NC(=O)N(CCS(=O)CCCl)N=O,,,,,,
575,100576,"2,4-Bis(1,1-dimethylethyl)-6-((4-methoxyphenyl)methyl)-1-methoxybenzene",CC(C)(C)C1=CC(=C(C(=C1)C(C)(C)C)OC)CC2=CC=C(C=C2)OC,,,,,,
576,100577,"2,4-di-tert-Butyl-6-(4-methoxybenzyl)phenol",CC(C)(C)C1=CC(=C(C(=C1)C(C)(C)C)O)CC2=CC=C(C=C2)OC,,,,,,
577,100578,"5-Ethoxy-6-((4-methoxyphenyl)methyl)-1,3-benzodioxole",CCOC1=CC2=C(C=C1CC3=CC=C(C=C3)OC)OCO2,,,,,,
578,100579,4-(Methylsulfinyl)butanenitrile,CS(=O)CCCC#N,,,,,,
579,100580,4-Nitroestrone 3-methyl ether,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4[N+](=O)[O-])OC,,,,,,
580,100581,Ethyl chloromethane sulfonate,CCOS(=O)(=O)CCl,,,,,,
581,100582,Thiiranepropanenitrile,C1C(S1)CCC#N,,,,,,
582,100583,"2H-1,3-Diazepin-2-one, 1,3,4,6-tetrahydro-1-beta-D-ribofuranosyl-",C1C=CCN(C(=O)N1)[C@H]2[C@@H]([C@@H](C(O2)CO)O)O,,,,,,
583,100584,Cyclohexylserine,C1CCC(CC1)(C(=O)O)NO,,,,,,
584,100585,Lavendamycin,CC1=C2C3=CC=CC=C3NC2=C(N=C1C(=O)O)C4=NC5=C(C=C4)C(=O)C=C(C5=O)N,,,,,,
585,100586,Bipholar,C1=CC=C(C=C1)OP(=O)(N(CCCl)CCCl)OC2=CC=CC=C2,,,,,,
586,100587,"Urea, N-(2-(2-chloroethoxy)ethyl)-N'-cyclohexyl-N-nitroso-",C1CCC(CC1)NC(=O)N(CCOCCCl)N=O,,,,,,
587,100588,"Urea, N'-cyclohexyl-N-(2-((2-hydroxyethyl)thio)ethyl)-N-nitroso-",C1CCC(CC1)NC(=O)N(CCSCCO)N=O,,,,,,
588,100589,"Disulfanediyldipropane-3,1-diyl bis((2-chloroethyl)nitrosocarbamate)",C(COC(=O)N(CCCl)N=O)CSSCCCOC(=O)N(CCCl)N=O,,,,,,
589,100590,"3,4,5-Trihydroxybenzohydroxamic acid",C1=C(C=C(C(=C1O)O)O)C(=O)NO,,,,,,
590,100591,CID 100591,COC1=CC2=CC=C(OC2=C(C1=O)OC)O,,,,,,
591,100592,"3-(4-bromophenyl)-1-[4-(4-bromophenyl)-1,3-thiazol-2-yl]-1H-pyrazol-5-amine",C1=CC(=CC=C1C2=NN(C(=C2)N)C3=NC(=CS3)C4=CC=C(C=C4)Br)Br,,,,,,
592,100593,"2-Methyl-1,4-dinitropyrrole",CC1=CC(=CN1[N+](=O)[O-])[N+](=O)[O-],,,,,,
593,100594,Saframycin A,CC1=C(C(=O)C2=C(C1=O)C[C@H]3[C@H]4C5=C(C[C@H](N4C)[C@@H](N3[C@H]2CNC(=O)C(=O)C)C#N)C(=O)C(=C(C5=O)OC)C)OC,,,"['Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)', 'Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)']",,,
594,100595,1-Methyl-2-(methylsulfonyl)-5-nitro-1h-imidazole,CN1C(=CN=C1S(=O)(=O)C)[N+](=O)[O-],,,,,,
595,100596,"5-(1,3-Benzodioxol-5-yl)-N-phenyl-1,3,4-oxadiazol-2-amine",C1OC2=C(O1)C=C(C=C2)C3=NN=C(O3)NC4=CC=CC=C4,,,,,,
596,100597,N-Acetylmescaline,CC(=O)NCCC1=CC(=C(C(=C1)OC)OC)OC,,,,,,
597,100598,Phosphonol,CNCCCNCCSP(=O)(O)O,,,"['Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. (See all compounds classified as Radiation-Protective Agents.)']",,,
598,100599,"3,7-Dideazaguanine",C1=CNC2=C1C(=O)NC(=C2)N,,,,,,
599,100600,CID 100600,CC1=C2C=C(C(=O)C=C2OC(=C1)O)CN(C)CC(=O)O,,,,,,
600,100601,2'-Bromo-3-nitrosalicylanilide,C1=CC=C(C(=C1)NC(=O)C2=C(C(=CC=C2)[N+](=O)[O-])O)Br,,,,,,
601,100602,"N,N'-Bisacrylylcystamine",C=CC(=O)NCCSSCCNC(=O)C=C,,,,,,
602,100603,"Naphtho(2,1-b)furan, 4-methoxy-2-nitro-",COC1=CC2=CC=CC=C2C3=C1OC(=C3)[N+](=O)[O-],,,,,,
603,100604,CID 100604,C1=CC2=C(C=C1O)C(=C3C(=CC(=O)C=C3O2)O)O,,,,,,
604,100605,Hippadine,C1OC2=C(O1)C=C3C(=C2)C4=CC=CC5=C4N(C3=O)C=C5,,,,,,
605,100606,Hepsulfam,C(CCCOS(=O)(=O)N)CCCOS(=O)(=O)N,,,"['Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. (See all compounds classified as Alkylating Agents.)']",,,
606,100607,CID 100607,C1CCC(=NN=C(N2CCOCC2)S)C(=NN=C(N3CCOCC3)S)C1,,,,,,
607,100608,"2,6-Dihydroxy-3-cyanopyridine",C1=CC(=O)NC(=C1C#N)O,,,,,,
608,100609,"5H-Indeno(1,2-c)pyridazin-3-one, 2,3-dihydro-",C1C2=CC=CC=C2C3=NNC(=O)C=C31,,,,,,
609,100610,"3-Chloro-5h-indeno[1,2-c]pyridazine",C1C2=CC=CC=C2C3=NN=C(C=C31)Cl,,,,,,
610,100611,"5H-Indeno[1,2-c]pyridazine",C1C2=C(C3=CC=CC=C31)N=NC=C2,,,,,,
611,100612,"5H-Indeno(1,2-c)pyridazin-3-one, 2,3-dihydro-2-methyl-",CN1C(=O)C=C2CC3=CC=CC=C3C2=N1,,,,,,
612,100613,"3,4-Furandimethanol, diacetate",CC(=O)OCC1=COC=C1COC(=O)C,,,,,,
613,100614,1-(Pyrrolidinocarbonylmethyl)piperazine,C1CCN(C1)C(=O)CN2CCNCC2,,,,,,
614,100615,Violaceol i,CC1=CC(=C(C(=C1)OC2=CC(=CC(=C2O)O)C)O)O,,,,,,
615,100616,2-Methyl-4-nitrosoresorcinol,CC1=C(C=CC(=C1O)N=O)O,,,,,,
616,100617,Xanthotoxol acetate,CC(=O)OC1=C2C(=CC3=C1OC=C3)C=CC(=O)O2,,,,,,
617,100618,"2,2'-Dithiobis(4-tert-butyl-1-isopropyl-1H-imidazole)",CC(C)N1C=C(N=C1SSC2=NC(=CN2C(C)C)C(C)(C)C)C(C)(C)C,,,,,,
618,100619,"1,2-Benzisothiazole, 3-piperidino-, 1,1-dioxide",C1CCN(CC1)C2=NS(=O)(=O)C3=CC=CC=C32,,,,,,
619,100620,"3-Chloromethylthiochromone-1,1-dioxide",C1=CC=C2C(=C1)C(=O)C(=CS2(=O)=O)CCl,,,,,,
620,100621,Isobutyl 2-isobutoxyquinoline-1(2H)-carboxylate,CC(C)COC1C=CC2=CC=CC=C2N1C(=O)OCC(C)C,,,,,,
621,100622,1-(Morpholinocarbonylmethyl)piperazine,C1CN(CCN1)CC(=O)N2CCOCC2,,,,,,
622,100623,"S-(4,6-Dimethylpyrimidin-2-yl) O-(p-methoxybenzyl) thiocarbonate",CC1=CC(=NC(=N1)SC(=O)OCC2=CC=C(C=C2)OC)C,,,,,,
623,100624,"9-Octadecenoic acid (9Z)-, dodecyl ester",CCCCCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
624,100625,"5,4'-Dihydroxy-3,6,7,8,3'-pentamethoxyflavone",COC1=C(C=CC(=C1)C2=C(C(=O)C3=C(C(=C(C(=C3O2)OC)OC)OC)O)OC)O,,,,,,
625,100626,CID 100626,COC1=CC2=C(OC3=C(C(=O)C=C4C3=C2C(=C1OC)OC4=O)OC)O,,,,,,
626,100627,propan-2-yl N'-[N'-(4-chlorophenyl)carbamimidoyl]carbamimidate,CC(C)OC(=NC(=NC1=CC=C(C=C1)Cl)N)N,,,,,,
627,100628,"1,4-Acridinedione, 5-amino-3,6-dimethoxy-",COC1=C(C2=NC3=C(C=C2C=C1)C(=O)C=C(C3=O)OC)N,,,,,,
628,100629,"1,4-Acridinedione, 5-amino-2,3-bis(1-aziridinyl)-6-methoxy-",COC1=C(C2=NC3=C(C=C2C=C1)C(=O)C(=C(C3=O)N4CC4)N5CC5)N,,,,,,
629,100630,Neridienone A,CC(=O)C1=CC[C@@H]2[C@@]1([C@@H](C[C@H]3[C@H]2C=CC4=CC(=O)CC[C@]34C)O)C,,,,,,
630,100631,"2H-1,5-Benzodiazepin-2-one, 1,3-dihydro-4-(dimethylamino)-",CN(C)C1=NC2=CC=CC=C2NC(=O)C1,,,,,,
631,100632,Methylaminopropylaminopropylthiophosphorate,CNCCCNCCCSP(=O)(O)O,,,,,,
632,100633,Karanjin,COC1=C(OC2=C(C1=O)C=CC3=C2C=CO3)C4=CC=CC=C4,,,,,,
633,100634,CID 100634,C1=CC=C(C=C1)N=NC2=NC3=C(N2)C(=O)N=C(N3)N,,,,,,
634,100635,CID 100635,C1=CC(=CC=C1N=NC2=NC3=C(N2)C(=O)N=C(N3)N)Br,,,,,,
635,100636,CID 100636,CC1=CC=C(C=C1)N=NC2=NC3=C(N2)C(=O)N=C(N3)N,,,,,,
636,100637,"2,4-Dimethylphenylhydroxylamine",CC1=CC(=C(C=C1)NO)C,,,,,,
637,100638,"3H-1,2,3-Triazolo(4,5-d)pyrimidin-7-amine, 5-(methylsulfonyl)-3-beta-D-ribofuranosyl-",CS(=O)(=O)C1=NC(=C2C(=N1)N(N=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N,,,,,,
638,100639,"Carbamic acid, (5-amino-3-phenylpyrido(3,4-b)pyrazin-7-yl)-, ethyl ester",CCOC(=O)NC1=NC(=C2C(=C1)N=CC(=N2)C3=CC=CC=C3)N,,,,,,
639,100640,9-Phenoxyacridine,C1=CC=C(C=C1)OC2=C3C=CC=CC3=NC4=CC=CC=C42,,,,,,
640,100641,7-Amino-4-(trifluoromethyl)coumarin,C1=CC2=C(C=C1N)OC(=O)C=C2C(F)(F)F,,,,,,
641,100642,"1-Iodo-9,10-anthraquinone",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=CC=C3)I,,,,,,
642,100643,5-(3-Aminophenyl)tetrazole,C1=CC(=CC(=C1)N)C2=NNN=N2,,,,,,
643,100644,"4,6-Dichloro-5-nitro-2-phenylpyrimidine",C1=CC=C(C=C1)C2=NC(=C(C(=N2)Cl)[N+](=O)[O-])Cl,,,,,,
644,100645,"5,6-Dimethyl-3-oxo-2,3-dihydropyridazine-4-carbonitrile",CC1=C(C(=O)NN=C1C)C#N,,,,,,
645,100646,1-Methyl-4-[2-(4-nitrophenyl)ethenyl]benzene,CC1=CC=C(C=C1)C=CC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
646,100647,"Phenanthrene, 9-propyl-",CCCC1=CC2=CC=CC=C2C3=CC=CC=C31,,,,,,
647,100648,"Benzamide, 2-((2-oxopropyl)amino)-",CC(=O)CNC1=CC=CC=C1C(=O)N,,,,,,
648,100649,"Propanedinitrile, ((4-chloro-2,5-dimethoxyphenyl)hydrazono)-",COC1=CC(=C(C=C1NN=C(C#N)C#N)OC)Cl,,,,,,
649,100650,"Benz[g]isoquinoline-5,10-dione",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C=NC=C3,,,,,,
650,100651,Clomesone,CS(=O)(=O)CS(=O)(=O)OCCCl,,,['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)'],,,
651,100652,5'-Chloroacetamido-5'-deoxythymidine,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CNC(=O)CCl)O,,,,,,
652,100653,"Thiosulfuric acid, S-(2-((1-methylheptyl)amino)ethyl) ester",CCCCCCC(C)NCCSS(=O)(=O)O,,,,,,
653,100654,CID 100654,C1=CC2=C3C=NNC(=C3N=C2C=C1)NN,,,,,,
654,100655,"2-Naphthalenecarboxylic acid, 4-[[2-chloro-5-(trifluoromethyl)phenyl]azo]-3-hydroxy-",C1=CC=C2C(=C1)C=C(C(=C2N=NC3=C(C=CC(=C3)C(F)(F)F)Cl)O)C(=O)O,,,,,,
655,100656,CID 100656,C[C@H]1CCC2[C@]3(CC[C@@H](C([C@@H]3CC[C@]2([C@]14CC5C(O4)C(=CC(=O)C5=O)C)C)(C)C)O)C,,,,,,
656,100657,Diphenyl ditelluride,C1=CC=C(C=C1)[Te][Te]C2=CC=CC=C2,,,,,,
657,100658,Disuccinimidyl suberate,C1CC(=O)N(C1=O)OC(=O)CCCCCCC(=O)ON2C(=O)CCC2=O,,,,,,
658,100659,Rapanone,CCCCCCCCCCCCCC1=C(C(=O)C=C(C1=O)O)O,,,,,,
659,100660,"3H-Pyrazol-3-one, 2-(4-aminophenyl)-2,4-dihydro-5-(1-pyrrolidinyl)-",C1CCN(C1)C2=NN(C(=O)C2)C3=CC=C(C=C3)N,,,,,,
660,100661,"Tetrahydro-3-(phenylmethyl)-1H,7H-pyrazolo(1,2-a)(1,2,5)triazepine-1,5(2H)-dione",C1CN2C(=O)CN(CC(=O)N2C1)CC3=CC=CC=C3,,,,,,
661,100662,"Tetrahydro-3-phenyl-1H,7H-pyrazolo(1,2-a)(1,2,5)triazepine-1,5(2H)-dione",C1CN2C(=O)CN(CC(=O)N2C1)C3=CC=CC=C3,,,,,,
662,100663,"3-(2-Methoxy-ethyl)-2,3,4,5,7,12-hexahydro-1H-(1,2,5)triazepino(1,2-b)phthalazin-1,5-dione",COCCN1CC(=O)N2CC3=CC=CC=C3CN2C(=O)C1,,,,,,
663,100664,N-Methyl butyrohydroxamic acid,CCCC(=O)N(C)O,,,,,,
664,100665,Selenazofurin,C1=C(N=C([Se]1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)C(=O)N,,,"['Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)', 'Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)']",,,
665,100666,"N-[(1-hydroxypyridin-2-ylidene)methylimino]-3,4-dimethoxybenzenesulfonamide",COC1=C(C=C(C=C1)S(=O)(=O)N=NC=C2C=CC=CN2O)OC,,,,,,
666,100667,4-Nitrophenyl bromoacetate,C1=CC(=CC=C1[N+](=O)[O-])OC(=O)CBr,,,,,,
667,100668,"Carbamic acid, (5-amino-3-(2,4-dichlorophenyl)-1,2-dihydropyrido(3,4-b)pyrazin-7-yl)-, ethyl ester",CCOC(=O)NC1=NC(=C2C(=C1)NCC(=N2)C3=C(C=C(C=C3)Cl)Cl)N,,,,,,
668,100669,"Carbamic acid, (5-amino-1,2-dihydro-3-(4-methylphenyl)pyrido(3,4-b)pyrazin-7-yl)-, ethyl ester",CCOC(=O)NC1=NC(=C2C(=C1)NCC(=N2)C3=CC=C(C=C3)C)N,,,"['Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)', 'Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)', 'Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)']",,,
669,100670,"D-1-Deoxy-1-(bis(2-chloroethyl)amino)-2,3,4,6-O-tetraacetylglucopyranose",CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H](C(O1)N(CCCl)CCCl)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
670,100671,"N,N-Bis(2-chloroethyl)-L-glucopyranosylamine 2,3,4,6-tetraacetate",CC(=O)OC[C@H]1[C@@H]([C@H]([C@@H](C(O1)N(CCCl)CCCl)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
671,100672,"1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-7-(2-((diphenylmethyl)amino)ethyl)-",CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCNC(C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
672,100673,"Benzamide, N-(1-piperidinylmethyl)-",C1CCN(CC1)CNC(=O)C2=CC=CC=C2,,,,,,
673,100674,N-(thiadiazol-5-ylmethylidene)hydroxylamine,C1=C(SN=N1)C=NO,,,,,,
674,100675,"3,7-Dihydro-7-(4-aminophenyl)-1,3-dimethyl-1H-purine-2,6-dione",CN1C2=C(C(=O)N(C1=O)C)N(C=N2)C3=CC=C(C=C3)N,,,,,,
675,100676,"1H-Purine-2,6-dione, 3,7-dihydro-7-(4-amino-2-chlorophenyl)-1,3-dimethyl-",CN1C2=C(C(=O)N(C1=O)C)N(C=N2)C3=C(C=C(C=C3)N)Cl,,,,,,
676,100677,"1H-Purine-2,6-dione, 3,7-dihydro-7-(4-amino-2-methylphenyl)-1,3-dimethyl-",CC1=C(C=CC(=C1)N)N2C=NC3=C2C(=O)N(C(=O)N3C)C,,,,,,
677,100678,"Carbamic acid, (5-amino-3-phenyl-2H-pyrido(4,3-b)-1,4-oxazin-7-yl)-, ethyl ester",CCOC(=O)NC1=NC(=C2C(=C1)OCC(=N2)C3=CC=CC=C3)N,,,,,,
678,100679,"Carbamic acid, (5-amino-3-(3,4-dimethylphenyl)-1,2-dihydropyrido(3,4-b)pyrazin-7-yl)-, ethyl ester",CCOC(=O)NC1=NC(=C2C(=C1)NCC(=N2)C3=CC(=C(C=C3)C)C)N,,,,,,
679,100680,"Carbamic acid, (5-amino-1,2-dihydro-1-methyl-3-phenylpyrido(3,4-b)pyrazin-7-yl)-, ethyl ester",CCOC(=O)NC1=NC(=C2C(=C1)N(CC(=N2)C3=CC=CC=C3)C)N,,,,,,
680,100681,"2,5-Dioxopyrrolidin-1-yl 4-(4-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)phenyl)butanoate",C1CC(=O)N(C1=O)OC(=O)CCCC2=CC=C(C=C2)N3C(=O)C=CC3=O,,,,,,
681,100682,N-Succinimidyl 3-(2-pyridyldithio)propionate,C1CC(=O)N(C1=O)OC(=O)CCSSC2=CC=CC=N2,,,"['Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. (See all compounds classified as Cross-Linking Reagents.)']",,,
682,100683,"2-Amino-8-(beta-ribofuranosyl)imidazo(1,2-a)-1,3,5-triazin-4-one",C1=CN2C(=NC(=NC2=O)N)N1[C@@H]3[C@H]([C@H]([C@@H](O3)CO)O)O,,,,,,
683,100684,CID 100684,C1=CNC2=C1NC(=NC2=O)N,,,,,,
684,100685,"Pyrimido(4,5-b)quinoline-2,4(3H,10H)-dione, 8-hydroxy-10-methyl-",CN1C2=CC(=O)C=CC2=CC3=C1NC(=O)NC3=O,,,,,,
685,100686,"4-Chloro-6,7,8-trimethoxyquinazoline",COC1=C(C(=C2C(=C1)C(=NC=N2)Cl)OC)OC,,,,,,
686,100687,"6,7-Bis(1-aziridinyl)-5,8-quinazolinedione",C1CN1C2=C(C(=O)C3=NC=NC=C3C2=O)N4CC4,,,,,,
687,100688,"Carbamic acid, (5-amino-3-(4-fluorophenyl)-1,2-dihydropyrido(3,4-b)pyrazin-7-yl)-, ethyl ester",CCOC(=O)NC1=NC(=C2C(=C1)NCC(=N2)C3=CC=C(C=C3)F)N,,,,,,
688,100689,"1-(Furan-3-yl)pentane-1,4-dione",CC(=O)CCC(=O)C1=COC=C1,,,,,,
689,100690,CID 100690,C[C@H]([C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C2NC(=NC3=O)N)O)O)O,,,,,,
690,100691,"Ethyl (5-amino-3-(2,4-dimethylphenyl)-1,2-dihydropyrido(3,4-b)pyrazin-7-yl)carbamate",CCOC(=O)NC1=NC(=C2C(=C1)NCC(=N2)C3=C(C=C(C=C3)C)C)N,,,,,,
691,100692,2-Nitro-1-alpha-D-ribofuranosyl-1H-imidazole,C1=CN(C(=N1)[N+](=O)[O-])[C@@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,,,,,,
692,100693,"(+-)-N-(2,5-Dioxo-1-(phenylmethyl)-3-pyrrolidinyl)methanesulfonamide",CS(=O)(=O)NC1CC(=O)N(C1=O)CC2=CC=CC=C2,,,,,,
693,100694,CID 100694,COC(=O)CCSC(=NCC1=CC=CC=C1)S,,,,,,
694,100695,"1H-Pyrazole-4-carboxamide, 5-amino-1-(6-hydrazino-3-pyridazinyl)-",C1=CC(=NN=C1NN)N2C(=C(C=N2)C(=O)N)N,,,,,,
695,100696,4-(2-Sulfosulfanylethylamino)butylcyclohexane,C1CCC(CC1)CCCCNCCSS(=O)(=O)O,,,,,,
696,100697,"2H-1,3-Thiazine-2,4(3H)-dione, dihydro-3-phenyl-",C1CSC(=O)N(C1=O)C2=CC=CC=C2,,,,,,
697,100698,3-Furonitrile,C1=COC=C1C#N,,,,,,
698,100699,"(2R,4S,5R,10S,12S,14R,15R,18R)-5-[(2R)-2-hydroxy-1-methylsulfinylpropan-2-yl]-10,15-dimethyl-3,6,13,17-tetraoxahexacyclo[8.7.1.02,4.04,9.012,14.015,18]octadec-8-ene-7,16-dione",C[C@]12C[C@H]3[C@H](O3)[C@]4([C@@H]1C([C@@H]5[C@]6(C2=CC(=O)O[C@@H]6[C@](C)(CS(=O)C)O)O5)OC4=O)C,,,,,,
699,100700,"Pyrimidine, 5,5'-methylenebis(2-(N-(1-benzyl-4-piperidyl)methylamino)-",CN(C1CCN(CC1)CC2=CC=CC=C2)C3=NC=C(C=N3)CC4=CN=C(N=C4)N(C)C5CCN(CC5)CC6=CC=CC=C6,,,,,,
700,100701,"3-Thiophenecarboxylic acid, 2-((4-morpholinylacetyl)amino)-4-phenyl-, ethyl ester",CCOC(=O)C1=C(SC=C1C2=CC=CC=C2)NC(=O)CN3CCOCC3,,,,,,
701,100702,"3-Thiophenecarboxylic acid, 4-phenyl-2-((1-piperidinylacetyl)amino)-, ethyl ester",CCOC(=O)C1=C(SC=C1C2=CC=CC=C2)NC(=O)CN3CCCCC3,,,,,,
702,100703,2-Ethyl-N-(2-(hydroxyamino)-2-oxoethyl)butanamide,CCC(CC)C(=O)NCC(=O)NO,,,,,,
703,100704,4-Chloro-3-sulphamoylbenzenesulphonyl chloride,C1=CC(=C(C=C1S(=O)(=O)Cl)S(=O)(=O)N)Cl,,,,,,
704,100705,"2-[1-(4,4-Dimethylthiosemicarbazono)ethyl]pyridine 1-oxide",CC(=C1C=CC=CN1O)N=NC(=S)N(C)C,,,,,,
705,100706,"1,2,3-Benzenetriamine, 5-(trifluoromethyl)-(9CI)",C1=C(C=C(C(=C1N)N)N)C(F)(F)F,,,,,,
706,100707,Bis(beta-carboxyethyl)tin dichloride,C(C[Sn](CCC(=O)O)(Cl)Cl)C(=O)O,,,,,,
707,100708,Bimolane,C1COCCN1CN2C(=O)CN(CC2=O)CCN3CC(=O)N(C(=O)C3)CN4CCOCC4,,,"['Drugs used to potentiate the effectiveness of radiation therapy in destroying unwanted cells. (See all compounds classified as Radiation-Sensitizing Agents.)', 'Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)']",,,
708,100709,"4-Pyridazinecarbonitrile, 5,6-bis(4-chlorophenyl)-2,3-dihydro-3-oxo-",C1=CC(=CC=C1C2=C(C(=O)NN=C2C3=CC=C(C=C3)Cl)C#N)Cl,,,,,,
709,100710,"4-Pyridazinecarbonitrile, 5,6-bis(4-chlorophenyl)-2,3-dihydro-2-(2-hydroxyethyl)-3-oxo-",C1=CC(=CC=C1C2=C(C(=O)N(N=C2C3=CC=C(C=C3)Cl)CCO)C#N)Cl,,,,,,
710,100711,"4-Acetyl-2-(2'-hydroxyethyl)-5,6-bis(4-chlorophenyl)-2H-pyridazin-3-one",CC(=O)C1=C(C(=NN(C1=O)CCO)C2=CC=C(C=C2)Cl)C3=CC=C(C=C3)Cl,,,,,,
711,100712,"Propionitrile, 3-(1-(p-tolylsulfonyl)hydrazino)-",CC1=CC=C(C=C1)S(=O)(=O)N(CCC#N)N,,,,,,
712,100713,"1-(6,7-Dimethoxy-5-propyl-1,3-benzodioxol-4-yl)ethanone",CCCC1=C(C2=C(C(=C1OC)OC)OCO2)C(=O)C,,,,,,
713,100714,Aminomalonic acid,C(C(=O)O)(C(=O)O)N,,,,,,
714,100715,Solstitialin,C=C1CC[C@@H]2[C@@H]([C@@H]3[C@H]1C[C@@H](C3=C)O)OC(=O)[C@@]2(CO)O,,,,,,
715,100716,Solstitialin A 13-acetate,CC(=O)OC[C@@]1([C@@H]2CCC(=C)[C@@H]3C[C@@H](C(=C)[C@@H]3[C@H]2OC1=O)O)O,,,,,,
716,100717,"(2S,3R,4S,5R)-2-(4-amino-5H-pyrrolo[3,2-d]pyrimidin-6-yl)-5-(hydroxymethyl)oxolane-3,4-diol",C1=C(NC2=C1N=CN=C2N)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
717,100718,"1,2,4,5-Benzenetetracarboxylic 1,2:4,5-diimide, N,N'-bis(4-(piperidino)but-2-ynyl)-",C1CCN(CC1)CC#CCN2C(=O)C3=CC4=C(C=C3C2=O)C(=O)N(C4=O)CC#CCN5CCCCC5,,,,,,
718,100719,CID 100719,C=CCN=C(NC1=CC=CC=N1)S,,,,,,
719,100720,CID 100720,C[C@H]([C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C2NC=NC3=O)O)O)O,,,,,,
720,100721,TR-2 Mycotoxin,CC(C)(C[C@H]1C2=C([C@@H]([C@@]3(N1C(=O)[C@@H]4CCCN4C3=O)O)O)C5=C(N2)C=C(C=C5)OC)O,,,,,,
721,100722,"1-(1,3-Dioxobutyl)pyrrolidine",CC(=O)CC(=O)N1CCCC1,,,,,,
722,100723,Ethyl N-succinimidoxyacetate,CCOC(=O)CON1C(=O)CCC1=O,,,,,,
723,100724,2-Fluoroethyl (methylsulfonyl)methanesulfonate,CS(=O)(=O)CS(=O)(=O)OCCF,,,,,,
724,100725,"Methanesulfonic acid, (methylsulfonyl)-, ethyl ester",CCOS(=O)(=O)CS(=O)(=O)C,,,,,,
725,100726,"2,8,9-Trioxa-5-aza-1-silabicyclo(3.3.3)undecane, 1-(m-chlorophenoxy)-",C1CO[Si]2(OCCN1CCO2)OC3=CC(=CC=C3)Cl,,,,,,
726,100727,"Ethyl 3-oxo-1,2-benzoxazole-2(3h)-carboxylate",CCOC(=O)N1C(=O)C2=CC=CC=C2O1,,,,,,
727,100728,"1,2-Benisoxazole-2(3H)-carboxylic acid, 5-bromo-3-oxo-, ethyl ester",CCOC(=O)N1C(=O)C2=C(O1)C=CC(=C2)Br,,,,,,
728,100729,"Urea, (5-chloro-2,3-dihydro-2-oxo-6-benzoxazolyl)-",C1=C2C(=CC(=C1Cl)NC(=O)N)OC(=O)N2,,,,,,
729,100730,"Urea, (5-chloro-2,3-dihydro-3-methyl-2-oxo-6-benzoxazolyl)-",CN1C2=C(C=C(C(=C2)Cl)NC(=O)N)OC1=O,,,,,,
730,100731,"(1S,2S,4S,5'R,6R,7S,8R,9S,13R)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-16,18-diene-6,2'-oxane]",C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CCC5[C@H]4CC=C6[C@@]5(CCC=C6)C)C)C)OC1,,,,,,
731,100732,"1-(4-Diethylaminobenzyl)-4-n-hexyl-2,3-dioxopiperazine",CCCCCCN1CCN(C(=O)C1=O)CC2=CC=C(C=C2)N(CC)CC,,,,,,
732,100733,"3,4-Dihydroxybenzyl alcohol",C1=CC(=C(C=C1CO)O)O,,,,,,
733,100734,2-Bromoethyl (methylsulfonyl)methanesulfonate,CS(=O)(=O)CS(=O)(=O)OCCBr,,,,,,
734,100735,"Urea, 1,1'-tetramethylenebis(3-(2-chloroethyl)-3-nitroso-",C(CCNC(=O)N(CCCl)N=O)CNC(=O)N(CCCl)N=O,,,,,,
735,100736,4-(N-(2-Chloroethyl)-N-nitrosocarbamoyl)morpholine,C1COCCN1C(=O)N(CCCl)N=O,,,,,,
736,100737,"beta-Alanine, N-((2-chloroethyl)nitrosocarbamoyl)-",C(CNC(=O)N(CCCl)N=O)C(=O)O,,,,,,
737,100738,"Urea, N-(2-chloroethyl)-N-nitroso-N'-(2-pyridinylmethyl)-",C1=CC=NC(=C1)CNC(=O)N(CCCl)N=O,,,,,,
738,100739,"Urea, 1-(carbamoylmethyl)-3-(2-chloroethyl)-3-nitroso-",C(CCl)N(C(=O)NCC(=O)N)N=O,,,,,,
739,100740,"Urea, 1-(2-chloroethyl)-1-nitroso-3-(tetrahydro-3-thienyl)-, S,S-dioxide",C1CS(=O)(=O)CC1NC(=O)N(CCCl)N=O,,,,,,
740,100741,"Glycine, N-(((2-chloroethyl)nitrosoamino)carbonyl)-",C(CCl)N(C(=O)NCC(=O)O)N=O,,,,,,
741,100742,"4-methyl-6,7,8,9-tetrahydro-2H-[1]benzofuro[3,2-g]chromen-2-one",CC1=CC(=O)OC2=CC3=C(C=C12)C4=C(O3)CCCC4,,,,,,
742,100743,CID 100743,C1=CC=C2C(=C1)C=C3C(=C4C=CC=CC4=[N+]3[O-])N2O,,,,,,
743,100744,"Indole-2-carboxamide, N,N-dimethyl-5-methoxy-",CN(C)C(=O)C1=CC2=C(N1)C=CC(=C2)OC,,,,,,
744,100745,CID 100745,C[C@@H]([C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C2N=CN=C3S)O)O)O,,,,,,
745,100746,N-(9H-Fluoren-9-yl)benzamide,C1=CC=C(C=C1)C(=O)NC2C3=CC=CC=C3C4=CC=CC=C24,,,,,,
746,100747,2-(2-Thenyl)sulfonyl-5-bromopyrimidine,C1=CSC(=C1)CS(=O)(=O)C2=NC=C(C=N2)Br,,,,,,
747,100748,"4-Pyrimidinamine, 2-((3-nitro-2-pyridinyl)thio)-",C1=CC(=C(N=C1)SC2=NC=CC(=N2)N)[N+](=O)[O-],,,,,,
748,100749,CID 100749,CC1=NN=C2N1NC(=C3C2=NC4=CC=CC=C43)Cl,,,,,,
749,100750,"4,4,10,10-Tetramethyl-1,3,7,9-tetraazaspiro[5.5]undecane-2,8-dione",CC1(CC2(CC(NC(=O)N2)(C)C)NC(=O)N1)C,,,,,,
750,100751,Dehydroneotenone,COC1=CC2=C(C=C1C3=COC4=C(C3=O)C=C5C=COC5=C4)OCO2,,,,,,
751,100752,"4,4'-Azoxybispyridine 1,1'-dioxide",C1=CN(C=CC1=N[N+](=O)C2=CC=[N+](C=C2)[O-])[O-],,,,,,
752,100753,"1-[1,6-dihydroxy-3-methyl-8-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxynaphthalen-2-yl]ethanone",CC1=CC2=CC(=CC(=C2C(=C1C(=O)C)O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O,,,,,,
753,100754,5-Styrylresorcinol,C1=CC=C(C=C1)C=CC2=CC(=CC(=C2)O)O,,,,,,
754,100755,"2,3-Dihydro-2-(2-hydroxyethyl)-3-oxo-5,6-diphenyl-4-pyridazinecarbonitrile",C1=CC=C(C=C1)C2=C(C(=O)N(N=C2C3=CC=CC=C3)CCO)C#N,,,,,,
755,100756,"1(6H)-Pyridazineacetic acid, 5-cyano-6-oxo-3,4-diphenyl-, ethyl ester",CCOC(=O)CN1C(=O)C(=C(C(=N1)C2=CC=CC=C2)C3=CC=CC=C3)C#N,,,,,,
756,100757,"1(6H)-Pyridazineacetic acid, 5-cyano-6-oxo-3,4-diphenyl-",C1=CC=C(C=C1)C2=C(C(=O)N(N=C2C3=CC=CC=C3)CC(=O)O)C#N,,,,,,
757,100758,"4-Pyridazinecarbonitrile, 5,6-bis(2-chlorophenyl)-2,3-dihydro-2-(2-hydroxyethyl)-3-oxo-",C1=CC=C(C(=C1)C2=C(C(=O)N(N=C2C3=CC=CC=C3Cl)CCO)C#N)Cl,,,,,,
758,100759,"1(6H)-Pyridazinepropanoic acid, 5-cyano-6-oxo-3,4-diphenyl-",C1=CC=C(C=C1)C2=C(C(=O)N(N=C2C3=CC=CC=C3)CCC(=O)O)C#N,,,,,,
759,100760,"Butanedioic acid, mono(2-(3,4-bis(4-chlorophenyl)-5-cyano-6-oxo-1(6H)-pyridazinyl)ethyl) ester",C1=CC(=CC=C1C2=C(C(=O)N(N=C2C3=CC=C(C=C3)Cl)CCOC(=O)CCC(=O)O)C#N)Cl,,,,,,
760,100761,"4-Pyridazinecarbonitrile, 5,6-bis(4-fluorophenyl)-2,3-dihydro-2-(2-hydroxyethyl)-3-oxo-",C1=CC(=CC=C1C2=C(C(=O)N(N=C2C3=CC=C(C=C3)F)CCO)C#N)F,,,,,,
761,100762,"5,6-Bis(3,4-dichlorophenyl)-2-(2-hydroxyethyl)-3-oxo-2,3-dihydro-4-pyridazinecarbonitrile",C1=CC(=C(C=C1C2=C(C(=O)N(N=C2C3=CC(=C(C=C3)Cl)Cl)CCO)C#N)Cl)Cl,,,,,,
762,100763,"4-Pyridazinecarbonitrile, 2,3-dihydro-2-methyl-3-oxo-5,6-diphenyl-",CN1C(=O)C(=C(C(=N1)C2=CC=CC=C2)C3=CC=CC=C3)C#N,,,,,,
763,100764,"Pyrazine, 2,2'-(o-chlorobenzylidenediimino)di-",C1=CC=C(C(=C1)C(NC2=NC=CN=C2)NC3=NC=CN=C3)Cl,,,,,,
764,100765,"2,2-Diethoxyacetamide",CCOC(C(=O)N)OCC,,,,,,
765,100766,Adodato,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CSC(CCCCCN)CCN)O)O)N,,,,,,
766,100767,"Pyridino(1,2-a)imidazo(5,4-b)indole",C1=CC=C2C(=C1)C3=C(N2)N4C=CC=CC4=N3,,,,,,
767,100768,Eupatoriochromene,CC(=O)C1=C(C=C2C(=C1)C=CC(O2)(C)C)O,,,,,,
768,100769,CID 100769,CCCC(=O)OC1=C2C(=C(C(=C(O2)C3=CC=C(C=C3)OC)O)O)C(=O)C=C1OC,,,,,,
769,100770,Phenyl 4-phenyl-1-(phenylmethyl)-4-piperidyl ketone,C1CN(CCC1(C2=CC=CC=C2)C(=O)C3=CC=CC=C3)CC4=CC=CC=C4,,,,,,
770,100771,Obovatol,C=CCC1=CC=C(C=C1)OC2=CC(=CC(=C2O)O)CC=C,,,,,,
771,100772,6-methoxy-2-phenyl-4H-thiochromen-4-one,COC1=CC2=C(C=C1)SC(=CC2=O)C3=CC=CC=C3,,,,,,
772,100773,Sarmustine,CN(CC(=O)N)C(=O)N(CCCl)N=O,,,['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)'],,,
773,100774,"4H-1-Benzothiopyran-4-one, 7-methoxy-2-phenyl-",COC1=CC2=C(C=C1)C(=O)C=C(S2)C3=CC=CC=C3,,,,,,
774,100775,1-(p-Anilinobenzyl)piperidine,C1CCN(CC1)CC2=CC=C(C=C2)NC3=CC=CC=C3,,,,,,
775,100776,1-(p-Anilinobenzyl)-4-methyl-piperazine,CN1CCN(CC1)CC2=CC=C(C=C2)NC3=CC=CC=C3,,,,,,
776,100777,4-(p-Anilinobenzyl)-morpholine,C1COCCN1CC2=CC=C(C=C2)NC3=CC=CC=C3,,,,,,
777,100778,1-(p-Anilinobenzyl)pyrrolidine,C1CCN(C1)CC2=CC=C(C=C2)NC3=CC=CC=C3,,,,,,
778,100779,N-(4-Morpholinyl)methyl-2-phenylsuccinimide,C1COCCN1CN2C(=O)CC(C2=O)C3=CC=CC=C3,,,,,,
779,100780,Nepodin,CC1=CC2=C(C(=CC=C2)O)C(=C1C(=O)C)O,,,,,,
780,100781,Tuberostemonine,CC[C@@H]1[C@H]2CCCCN3[C@H]2[C@H](C[C@H]3[C@@H]4C[C@@H](C(=O)O4)C)[C@@H]5[C@H]1OC(=O)[C@H]5C,,,,,,
781,100782,"5-Pyrimidinecarboxamide, hexahydro-2,4,6-trioxo-N-phenyl-",C1=CC=C(C=C1)NC(=O)C2=C(NC(=O)NC2=O)O,,,,,,
782,100783,"Acetamide, N-(4,7-dimethyldipyrido(1,2-a:3',2'-d)imidazol-3-yl)-",CC1=CC2=NC3=C(C(=CN=C3N2C=C1)NC(=O)C)C,,,,,,
783,100784,N-(5-acetamidopentyl)acetamide,CC(=O)NCCCCCNC(=O)C,,,,,,
784,100785,"5-Ethyldihydro-5-(p-tolyl)-1H,5H-pyrimidine-4,6-dione",CCC1(C(=O)NCNC1=O)C2=CC=C(C=C2)C,,,,,,
785,100786,1-(4-Chlorophenyl)-3-(4-methyl-1-piperazinyl)-2-propyn-1-one,CN1CCN(CC1)C#CC(=O)C2=CC=C(C=C2)Cl,,,,,,
786,100787,3-Chloro-6-hydrazinopyridazine,C1=CC(=NN=C1NN)Cl,,,,,,
787,100788,2beta-Arabinofuranosylthiazole-4-carboxamide,C1=C(N=C(S1)[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O)C(=O)N,,,,,,
788,100789,Coumarin 339,CC1=CC(=O)OC2=C1C=C3CCCNC3=C2,,,,,,
789,100790,"2H-Pyrano[3,2-g]quinolin-2-one, 6,7,8,9-tetrahydro-4-(trifluoromethyl)-",C1CC2=CC3=C(C=C2NC1)OC(=O)C=C3C(F)(F)F,,,,,,
790,100791,"1,1-Ethanediamine, N,N'-dipyrazinyl-",CC(NC1=NC=CN=C1)NC2=NC=CN=C2,,,,,,
791,100792,"2,4(1H,3H)-Pyrimidinedione, 5-methyl-1-(3-((7-oxo-7H-furo(3,2-g)(1)benzopyran-9-yl)oxy)propyl)-",CC1=CN(C(=O)NC1=O)CCCOC2=C3C(=CC4=C2OC=C4)C=CC(=O)O3,,,,,,
792,100793,"2,4(1H,3H)-Pyrimidinedione, 5-methyl-1-(6-((7-oxo-7H-furo(3,2-g)(1)benzopyran-9-yl)oxy)hexyl)-",CC1=CN(C(=O)NC1=O)CCCCCCOC2=C3C(=CC4=C2OC=C4)C=CC(=O)O3,,,,,,
793,100794,3-Iodo-4-hydroxy-5-nitrobenzamide,C1=C(C=C(C(=C1[N+](=O)[O-])O)I)C(=O)N,,,,,,
794,100795,"1,7-Phenanthroline-5,6-dione",C1=CC2=C(C(=O)C(=O)C3=C2N=CC=C3)N=C1,,,,,,
795,100796,"2,5-Pyrrolidinedione, 1-[[(4-nitrophenyl)acetyl]oxy]-",C1CC(=O)N(C1=O)OC(=O)CC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
796,100797,CID 100797,CC1=NN=C2N1NC=C3C2=NC4=CC=CC=C43,,,,,,
797,100798,"2-Phenyl-3-thioxohexahydro-1H-pyrrolo[1,2-c]imidazol-1-one",C1CC2C(=O)N(C(=S)N2C1)C3=CC=CC=C3,,,,,,
798,100799,CID 100799,COC1=CC(=O)C2=C(C=C(OC2=C1)O)C3=C(C=CC(=C3)O)O,,,,,,
799,100800,Thioacetamide-S-oxide,CC(=S=O)N,,,,,,
800,100801,Effusol,CC1=C(C=CC2=C1CCC3=C2C(=CC(=C3)O)C=C)O,,,,,,
801,100802,Cytochlor,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=NC2=O)N)Cl)CO)O,,,,,,
802,100803,CID 100803,C[C@@]12COP(=O)(O[C@H]1[C@H]([C@@H](O2)N3C=NC(=C3N)C(=O)N)O)O,,,,,,
803,100804,"Benzoic acid, 4-(3-((acetyloxy)methyl)-3-methyl-1-triazenyl)-, methyl ester",CC(=O)OCN(C)N=NC1=CC=C(C=C1)C(=O)OC,,,,,,
804,100805,"1,3,5-Triazin-2(1H)-one, 1-(2,6-dimethylphenyl)-4-(methylamino)-",CC1=C(C(=CC=C1)C)N2C=NC(=NC2=O)NC,,,,,,
805,100806,2-(4-Methyl-1-piperazinylmethyl)acrylophenone,CN1CCN(CC1)CC(=C)C(=O)C2=CC=CC=C2,,,,,,
806,100807,6-Chlorosaccharin,C1=CC2=C(C=C1Cl)S(=O)(=O)NC2=O,,,,,,
807,100808,"Benzenesulfonamide, N-(2-chloro-5-(trifluoromethyl)phenyl)-4-fluoro-",C1=CC(=CC=C1F)S(=O)(=O)NC2=C(C=CC(=C2)C(F)(F)F)Cl,,,,,,
808,100809,"Benzenesulfonamide, N-(4-chloro-2-(trifluoromethyl)phenyl)-4-fluoro-",C1=CC(=CC=C1F)S(=O)(=O)NC2=C(C=C(C=C2)Cl)C(F)(F)F,,,,,,
809,100810,"Pyrazole, methylenebis(4-nitro-",C1=C(C=NN1CN2C=C(C=N2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
810,100811,"1H-Pyrazole, 1,1'-methylenebis(4-bromo-",C1=C(C=NN1CN2C=C(C=N2)Br)Br,,,,,,
811,100812,"2,5-Dihydro-2-(4-methoxyphenyl)-3H-pyrazolo(4,3-c)quinolin-3-one",COC1=CC=C(C=C1)N2C(=O)C3=C(N2)C4=CC=CC=C4N=C3,,,,,,
812,100813,Physcion-beta-D-glucoside,CC1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=C(C=C3O[C@H]4[C@@H]([C@H](C([C@H](O4)CO[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)O)O)O)OC,,,,,,
813,100814,Magon,CC1=CC(=C(C=C1)NC(=O)C2=CC3=CC=CC=C3C(=C2O)N=NC4=CC=CC=C4O)C,,,,,,
814,100815,"2H-1,4-Benzodiazepin-2-one, 1,3-dihydro-7-chloro-5-(2-chlorophenyl)-1-(2-(dimethylamino)ethyl)-",CN(C)CCN1C(=O)CN=C(C2=C1C=CC(=C2)Cl)C3=CC=CC=C3Cl,,,,,,
815,100816,"1,4-Benzenediol, 2-(2H-benzotriazol-2-yl)-",C1=CC2=NN(N=C2C=C1)C3=C(C=CC(=C3)O)O,,,,,,
816,100817,R47P3X83BD,C1=CC2=C(C=C(C(=C2N=C1)O)CN(CCO)CCO)[N+](=O)[O-],,,,,,
817,100818,2-Nitrothiophen-3-amine,C1=CSC(=C1N)[N+](=O)[O-],,,,,,
818,100819,Amphimedine,CN1C=C2C(=CC1=O)C3=NC4=CC=CC=C4C5=C3C(=NC=C5)C2=O,,,,,,
819,100820,"Acetamide, N,N'-1,6-hexanediylbis[N-acetyl-",CC(=O)N(CCCCCCN(C(=O)C)C(=O)C)C(=O)C,,,,,,
820,100821,1-(Pentafluoropropionyl)imidazole,C1=CN(C=N1)C(=O)C(C(F)(F)F)(F)F,,,,,,
821,100822,"1,3-Dimethyl-3-acetyltriazene",CC(=O)N(C)N=NC,,,,,,
822,100823,ethyl N-methyl-N-(methyldiazenyl)carbamate,CCOC(=O)N(C)N=NC,,,,,,
823,100824,"2-[[4-[(2,4-Diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]-5-[(2-methylpropan-2-yl)oxy]-5-oxopentanoic acid",CC(C)(C)OC(=O)CCC(C(=O)O)NC(=O)C1=CC=C(C=C1)N(C)CC2=CN=C3C(=N2)C(=NC(=N3)N)N,,,,,,
824,100825,"2-(Bis(2-(2,6-dioxomorpholino)ethyl)amino)acetic acid",C1C(=O)OC(=O)CN1CCN(CCN2CC(=O)OC(=O)C2)CC(=O)O,,,,,,
825,100826,N-Isopropyl-1-piperazineacetamide,CC(C)NC(=O)CN1CCNCC1,,,,,,
826,100827,"4-Morpholinecarboxamide, N-(4-fluorophenyl)-",C1COCCN1C(=O)NC2=CC=C(C=C2)F,,,,,,
827,100828,"1,1'-(1,3-Phenylene)bis(2-phenylethanedione)",C1=CC=C(C=C1)C(=O)C(=O)C2=CC(=CC=C2)C(=O)C(=O)C3=CC=CC=C3,,,,,,
828,100829,1-Pentafluorobenzoyl-1H-imidazole,C1=CN(C=N1)C(=O)C2=C(C(=C(C(=C2F)F)F)F)F,,,,,,
829,100830,"N(1),N(10)-Bis(4-nitrobenzoyl)spermidine",C1=CC(=CC=C1C(=O)NCCCCNCCCNC(=O)C2=CC=C(C=C2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
830,100831,"1-[3-[2-(4-fluorophenyl)-1,3-dioxolan-2-yl]propyl]-N-(2-nitrophenyl)piperidin-4-amine",C1CN(CCC1NC2=CC=CC=C2[N+](=O)[O-])CCCC3(OCCO3)C4=CC=C(C=C4)F,,,,,,
831,100832,"Acetamide, 2,2,2-trifluoro-N-4-morpholinyl-",C1COCCN1NC(=O)C(F)(F)F,,,,,,
832,100833,CID 100833,CN(CC1=NC2=C(NC(=NC2=NC1=O)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
833,100834,1-Bromonon-4-en-6-yne,CCC#CC=CCCCBr,,,,,,
834,100835,12-(1-Ethoxyethoxy)dodec-5-en-3-yne,CCC#CC=CCCCCCCOC(C)OCC,,,,,,
835,100836,Dodec-7-en-9-yn-1-ol,CCC#CC=CCCCCCCO,,,,,,
836,100837,Dodec-7-en-9-ynoxy(trimethyl)silane,CCC#CC=CCCCCCCO[Si](C)(C)C,,,,,,
837,100838,Methyl 3-(bromomethyl)-2-benzofurancarboxylate,COC(=O)C1=C(C2=CC=CC=C2O1)CBr,,,,,,
838,100839,m-((4-((4-(Bis(2-hydroxyethyl)amino)phenyl)azo)-1-naphthyl)azo)benzenesulphonic acid,C1=CC=C2C(=C1)C(=CC=C2N=NC3=CC(=CC=C3)S(=O)(=O)O)N=NC4=CC=C(C=C4)N(CCO)CCO,,,,,,
839,100840,Bis(2-hydroxyethyl)methyloctylammonium toluene-p-sulphonate,CCCCCCCC[N+](C)(CCO)CCO.CC1=CC=C(C=C1)S(=O)(=O)[O-],,,,,,
840,100841,"N,N-Bis(2-hydroxyethyl)-N-methyl-1-octanaminium",CCCCCCCC[N+](C)(CCO)CCO,,,,,,
841,100842,"[2-(9-Fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl)-2-oxoethyl] octadeca-9,12-dienoate",CCCCCC=CCC=CCCCCCCCC(=O)OCC(=O)C1(C(CC2C1(CC(C3(C2CCC4=CC(=O)C=CC43C)F)O)C)C)O,,,,,,
842,100843,"Bis(3,5,5-trimethylhexyl) quinoxaline-2,3-dicarboxylate",CC(CCOC(=O)C1=NC2=CC=CC=C2N=C1C(=O)OCCC(C)CC(C)(C)C)CC(C)(C)C,,,,,,
843,100844,"2,3-Bis[(3,5,5-trimethylhexyl)oxy]quinoxaline",CC(CCOC1=NC2=CC=CC=C2N=C1OCCC(C)CC(C)(C)C)CC(C)(C)C,,,,,,
844,100845,"4,8-Dimethylnon-7-enal",CC(CCC=C(C)C)CCC=O,,,,,,
845,100846,4-Ethyl-4-phenylpiperidine,CCC1(CCNCC1)C2=CC=CC=C2,,,,,,
846,100847,"5-((4,5-Dihydro-3-methyl-5-oxo-1-(4-((2-(sulphooxy)ethyl)sulphonyl)phenyl)-1H-pyrazol-4-yl)azo)-2,4-dimethoxybenzenesulphonic acid",CC1=NN(C(=O)C1N=NC2=CC(=C(C=C2OC)OC)S(=O)(=O)O)C3=CC(=CC=C3)S(=O)(=O)CCOS(=O)(=O)O,,,,,,
847,100848,Bis[3-(formylamino)propyl](4-methoxy-3-nitrobenzyl)methylammonium chloride,C[N+](CCCNC=O)(CCCNC=O)CC1=CC(=C(C=C1)OC)[N+](=O)[O-].[Cl-],,,,,,
848,100849,"N,N-Bis[3-(formylamino)propyl]-N-methyl-4-methoxy-3-nitrobenzenemethanaminium",C[N+](CCCNC=O)(CCCNC=O)CC1=CC(=C(C=C1)OC)[N+](=O)[O-],,,,,,
849,100850,"Ethyl 12-[7-(11-ethoxy-11-oxoundecyl)-2,3,10-trimethyl-6,11-dioxo-1,4-dioxa-10-aza-7-azoniacyclododec-7-yl]dodecanoate",CCOC(=O)CCCCCCCCCCC[N+]1(CCN(C(=O)COC(C(OCC1=O)C)C)C)CCCCCCCCCCC(=O)OCC,,,,,,
850,100851,2-(Methylthio)propionic acid,CC(C(=O)O)SC,,,,,,
851,100852,1-(4-Chloro-o-tolyl)piperazine,CC1=C(C=CC(=C1)Cl)N2CCNCC2,,,,,,
852,100853,N-Acetylsolasodine,CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)O)C)C)C)N(C1)C(=O)C,,,,,,
853,100854,"Phosphonic acid, [2-[[(2-chloroethoxy)(2-chloroethyl)phosphinyl]oxy]ethyl]-, bis(2-chloroethyl) ester",C(CP(=O)(OCCCl)OCCCl)OP(=O)(CCCl)OCCCl,,,,,,
854,100855,Tributylammonium 2-ethylhexanoate,CCCCC(CC)C(=O)O.CCCCN(CCCC)CCCC,,,,,,
855,100856,Betaine phosphate,C[N+](C)(C)CC(=O)O.OP(=O)(O)[O-],,,,,,
856,100857,CID 100857,CN(CC(=O)O)C(=NP(=O)(O)[O-])N.[Na+],,,,,,
857,100858,"d-Glucose, 6-(dihydrogen phosphate), barium salt",C([C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O)O)O)O)OP(=O)([O-])[O-].[Ba+2],,,,,,
858,100859,CID 100859,C([C@@H]1C([C@@H]([C@H](C(O1)O)O)O)O)OP(=O)(O)O,,,,,,
859,100860,Bromopentakis(bromomethyl)benzene,C(C1=C(C(=C(C(=C1CBr)CBr)Br)CBr)CBr)Br,,,,,,
860,100861,"3-(2-chloroethyl)-2,8-dimethyl-4H-pyrido[1,2-a]pyrimidin-4-one",CC1=CC2=NC(=C(C(=O)N2C=C1)CCCl)C,,,,,,
861,100862,X-Pcnu,CC(=O)O[C@@H]1CO[C@H]([C@@H]([C@H]1OC(=O)C)OC(=O)C)NC(=O)N(CCCl)N=O,,,,,,
862,100863,1-Methyl 2-sulfopalmitate,CCCCCCCCCCCCCCC(C(=O)OC)S(=O)(=O)O,,,,,,
863,100864,"N-(Aminocarbonyl)-2,2-dimethylpropionamide",CC(C)(C)C(=O)NC(=O)N,,,,,,
864,100865,CID 100865,CC(C[O-])O.[Na+],,,,,,
865,100866,"Methanaminium, N,N,N-trimethyl-, salt with 2-ethylhexanoic acid (1:1)",CCCCC(CC)C(=O)[O-].C[N+](C)(C)C,,,,,,
866,100867,Ethyl 4-amino-1-piperidinecarboxylate,CCOC(=O)N1CCC(CC1)N,,,,,,
867,100868,2-(4-Fluorophenyl)pyridine,C1=CC=NC(=C1)C2=CC=C(C=C2)F,,,,,,
868,100869,CID 100869,C1=CC=C2C(=C1)C=C(C(=C2N=NC3=C(C=C(C=C3)[N+](=O)O)Cl)O)C(=O)N=C4C=CC(=NC(=O)C5=CC6=CC=CC=C6C(=C5[O-])N=NC7=C(C=C(C=C7)N(O)O)Cl)C(=C4)Cl,,,,,,
869,100870,CID 100870,C1=CC=C2C(=C1)C=C(C(=C2N=NC3=C(C=C(C=C3)[N+](=O)O)Cl)O)C(=O)N=C4C=CC(=NC(=O)C5=CC6=CC=CC=C6C(=C5O)N=NC7=C(C=C(C=C7)N(O)O)Cl)C(=C4)Cl,,,,,,
870,100871,"4,7,10,13-Tetraoxatetradecan-2-ol",CC(COCCOCCOCCOC)O,,,,,,
871,100872,"Diethyl (((3-(((3-ethoxy-2-(ethoxycarbonyl)-1,3-dioxopropyl)amino)methyl)-3,5,5-trimethylcyclohexyl)amino)carbonyl)malonate",CCOC(=O)C(C(=O)NCC1CC(C(CC1C)(C)C)NC(=O)C(C(=O)OCC)C(=O)OCC)C(=O)OCC,,,,,,
872,100873,1-(4-Chlorophenyl)cyclohexanecarboxylic acid,C1CCC(CC1)(C2=CC=C(C=C2)Cl)C(=O)O,,,,,,
873,100874,Allyl pentafluoropropionate,C=CCOC(=O)C(C(F)(F)F)(F)F,,,,,,
874,100875,"Benzenamine, N,N-dimethyl-, sulfate (1:1)",CN(C)C1=CC=CC=C1.OS(=O)(=O)O,,,,,,
875,100876,CID 100876,CC1=CC(=NN=C2C3=C(C=C(C=C3)NC(=O)C)C(=CC2=O)S(=O)(=O)O)C(=O)C(=C1)N(O)O,,,,,,
876,100877,"3,3-Dimethyl-1-(1H-1,2,4-triazol-1-yl)butan-2-one",CC(C)(C)C(=O)CN1C=NC=N1,,,,,,
877,100878,CID 100878,CN1C(=NC(=O)C(=O)N1)S,,,,,,
878,100879,"7-Amino-3-{[(2-methyl-5,6-dioxo-1,2,5,6-tetrahydro-1,2,4-triazin-3-yl)sulfanyl]methyl}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",CN1C(=NC(=O)C(=O)N1)SCC2=C(N3C([C@@H](C3=O)N)SC2)C(=O)O,,,,,,
879,100880,"9H-Carbazole, 1,3,6,8-tetrachloro-",C1=C(C=C(C2=C1C3=C(N2)C(=CC(=C3)Cl)Cl)Cl)Cl,,,,,,
880,100881,"Methyl 1,4-dimethylcyclohex-3-ene-1-carboxylate",CC1=CCC(CC1)(C)C(=O)OC,,,,,,
881,100882,"(1R,13S)-1,13-dimethyl-10-(2-phenylethyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;hydrobromide",C[C@@H]1C2CC3=C([C@@]1(CCN2CCC4=CC=CC=C4)C)C=C(C=C3)O.Br,,,,,,
882,100883,"(1R,13S)-1,13-dimethyl-10-(2-phenylethyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol",C[C@@H]1C2CC3=C([C@@]1(CCN2CCC4=CC=CC=C4)C)C=C(C=C3)O,,,,,,
883,100884,4-(((Heptadecafluorooctyl)sulphonyl)methylamino)butyl acrylate,CN(CCCCOC(=O)C=C)S(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
884,100885,2-Hydroxypropan-2-yl 2-ethylhexanoate,CCCCC(CC)C(=O)OC(C)(C)O,,,,,,
885,100886,Hept-4-en-2-ol,CCC=CCC(C)O,,,,,,
886,100887,"[1,1'-Biphenyl]-4-carbonitrile, 4'-(nonyloxy)-",CCCCCCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C#N,,,,,,
887,100888,"2,9-Bis(3-methoxypropyl)anthra(2,1,9-def:6,5,10-d'e'f')diisoquinoline-1,3,8,10(2H,9H)-tetrone",COCCCN1C(=O)C2=C3C(=CC=C4C3=C(C=C2)C5=C6C4=CC=C7C6=C(C=C5)C(=O)N(C7=O)CCCOC)C1=O,,,,,,
888,100889,N-(2-Ethylhexyl)-1-(phenylazo)naphthalen-2-amine,CCCCC(CC)CNC1=C(C2=CC=CC=C2C=C1)N=NC3=CC=CC=C3,,,,,,
889,100890,3-(2-Methylpropoxy)propanenitrile,CC(C)COCCC#N,,,,,,
890,100891,"4-(3-Methyl-2-butenyl)-4-cyclopentene-1,3-dione",CC(=CCC1=CC(=O)CC1=O)C,,,,,,
891,100892,"5-Isobutylimidazolidine-2,4-dione",CC(C)CC1C(=O)NC(=O)N1,,,,,,
892,100893,"1-Propanamine, 3-(pentadecyloxy)-",CCCCCCCCCCCCCCCOCCCN,,,,,,
893,100894,CID 100894,CC1=CSC(=N1)[N-]S(=O)(=O)C2=CC=C(C=C2)N.[Na+],,,,,,
894,100895,"2,2'-Oxybis(5,5-bis(bromomethyl)-1,3,2-dioxaphosphorinane) 2,2'-dioxide",C1C(COP(=O)(O1)OP2(=O)OCC(CO2)(CBr)CBr)(CBr)CBr,,,,,,
895,100896,"3,3'-Oxybis(8,9-dibromo-2,4-dioxa-3-phosphaspiro(5.5)undecane) 3,3'-disulphide",C1CC2(CC(C1Br)Br)COP(=S)(OC2)OP3(=S)OCC4(CCC(C(C4)Br)Br)CO3,,,,,,
896,100897,Einecs 261-515-6,CCCC1C(COP(=S)(O1)OP2(=S)OCC(C(O2)CCC)(C)C)(C)C,,,,,,
897,100898,"2,2'-Oxybis(4-isopropyl-5,5-dimethyl-1,3,2-dioxaphosphorinane) 2,2'-disulphide",CC(C)C1C(COP(=S)(O1)OP2(=S)OCC(C(O2)C(C)C)(C)C)(C)C,,,,,,
898,100899,"2,3-Dihydro-2,5-dimethyl-1,4-dithiin 1,1,4,4-tetraoxide",CC1CS(=O)(=O)C(=CS1(=O)=O)C,,,,,,
899,100900,5-(1-Hydroxyethyl)oxolan-2-one,CC(C1CCC(=O)O1)O,,,,,,
900,100901,CID 100901,CCCCOCC(CS(=O)(=O)[O-])O.[Na+],,,,,,
901,100902,3-Butoxy-2-hydroxypropane-1-sulfonic acid,CCCCOCC(CS(=O)(=O)O)O,,,,,,
902,100903,CID 100903,CCCCCCOCC(CS(=O)(=O)[O-])O.[Na+],,,,,,
903,100904,3-Hexoxy-2-hydroxypropane-1-sulfonic acid,CCCCCCOCC(CS(=O)(=O)O)O,,,,,,
904,100905,CID 100905,CCCCC(CC)COCC(CS(=O)(=O)[O-])O.[Na+],,,,,,
905,100906,3-(2-Ethylhexoxy)-2-hydroxypropane-1-sulfonic acid,CCCCC(CC)COCC(CS(=O)(=O)O)O,,,,,,
906,100907,"Tetradecabromo-1,4-diphenoxybenzene",C1(=C(C(=C(C(=C1Br)Br)OC2=C(C(=C(C(=C2Br)Br)Br)Br)Br)Br)Br)OC3=C(C(=C(C(=C3Br)Br)Br)Br)Br,,,,,,
907,100908,1-Methoxyprop-1-en-2-ylbenzene,CC(=COC)C1=CC=CC=C1,,,,,,
908,100909,2-[Bis(carboxymethyl)amino]glutaric acid,C(CC(=O)O)C(C(=O)O)N(CC(=O)O)CC(=O)O,,,,,,
909,100910,6-Phenylhexan-3-one,CCC(=O)CCCC1=CC=CC=C1,,,,,,
910,100911,Dipotassium 4-(dodecyloxy)-4-oxo-2-sulfonatobutanoate,CCCCCCCCCCCCOC(=O)CC(C(=O)[O-])S(=O)(=O)[O-].[K+].[K+],,,,,,
911,100912,4-Lauryl sulfosuccinate,CCCCCCCCCCCCOC(=O)CC(C(=O)O)S(=O)(=O)O,,,,,,
912,100913,3-amino-N-[6-(3-aminobut-2-enoylamino)hexyl]but-2-enamide,CC(=CC(=O)NCCCCCCNC(=O)C=C(C)N)N,,,,,,
913,100914,"1,1'-(Methylenebis(2-ethyl-4,1-phenylene))bis-1H-pyrrole-2,5-dione",CCC1=C(C=CC(=C1)CC2=CC(=C(C=C2)N3C(=O)C=CC3=O)CC)N4C(=O)C=CC4=O,,,,,,
914,100915,"1-(4-((4-(2,5-Dihydro-2,5-dioxo-1H-pyrrol-1-yl)-3-ethylphenyl)methyl)phenyl)-1H-pyrrole-2,5-dione",CCC1=C(C=CC(=C1)CC2=CC=C(C=C2)N3C(=O)C=CC3=O)N4C(=O)C=CC4=O,,,,,,
915,100916,"Bis(2-ethylhexyl) hydrogen benzene-1,2,4-tricarboxylate",CCCCC(CC)COC(=O)C1=CC(=C(C=C1)C(=O)OCC(CC)CCCC)C(=O)O,,,,,,
916,100917,1-Hydroxy-4-((4-(2-hydroxyethoxy)phenyl)amino)anthraquinone,C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3C2=O)O)NC4=CC=C(C=C4)OCCO,,,,,,
917,100918,"N-[5-(Diethylamino)-2-[(3,5-dinitro-2-thienyl)azo]phenyl]acetamide",CCN(CC)C1=CC(=C(C=C1)N=NC2=C(C=C(S2)[N+](=O)[O-])[N+](=O)[O-])NC(=O)C,,,,,,
918,100919,Diethylene glycol adipate,C(CCC(=O)OCCOCCO)CC(=O)O,,,,,,
919,100920,"Phosphonothioic acid, methyl-, O-ethyl O-6-quinolyl ester",CCOP(=S)(C)OC1=CC2=C(C=C1)N=CC=C2,,,,,,
920,100921,"Phosphorodithioic acid, O,O-dimethyl ester, S-ester with N-(mercaptomethyl)succinimide",COP(=S)(OC)SCN1C(=O)CCC1=O,,,,,,
921,100922,"2-Phenylbutyl 2-(dimethylamino)-3,4,5-trimethoxybenzoate",CCC(COC(=O)C1=CC(=C(C(=C1N(C)C)OC)OC)OC)C2=CC=CC=C2,,,,,,
922,100923,"Benzenesulfonamide, 4-amino-2,5-dichloro-N-ethyl-",CCNS(=O)(=O)C1=C(C=C(C(=C1)Cl)N)Cl,,,,,,
923,100924,3-(Trimethoxysilyl)propyl acetate,CC(=O)OCCC[Si](OC)(OC)OC,,,,,,
924,100925,Methacrylic acid nonafluorobutyl ester,CC(=C)C(=O)OC(C(C(C(F)(F)F)(F)F)(F)F)(F)F,,,,,,
925,100926,"4'-Methoxy[1,1'-biphenyl]-2,5-diol",COC1=CC=C(C=C1)C2=C(C=CC(=C2)O)O,,,,,,
926,100927,"1,3-Dioxolane, 4-methyl-2-[2-(methylthio)ethyl]-",CC1COC(O1)CCSC,,,,,,
927,100928,"2,6-Dihydroxy-N-(2-hydroxyethyl)benzamide",C1=CC(=C(C(=C1)O)C(=O)NCCO)O,,,,,,
928,100929,"3-((Aminoacetyl)amino)-5-(((2-hydroxyethyl)amino)carbonyl)-2,4,6-triiodobenzoic acid",C(CO)NC(=O)C1=C(C(=C(C(=C1I)NC(=O)CN)I)C(=O)O)I,,,,,,
929,100930,"Pyrazine, 2-[(methylthio)methyl]-",CSCC1=NC=CN=C1,,,,,,
930,100931,((Furfurylthio)methyl)pyrazine,C1=COC(=C1)CSCC2=NC=CN=C2,,,,,,
931,100932,"1-[3-[3-(3-Nitrophenyl)prop-2-enyl]-3,8-diazabicyclo[3.2.1]octan-8-yl]propan-1-one",CCC(=O)N1C2CCC1CN(C2)CC=CC3=CC(=CC=C3)[N+](=O)[O-],,,,,,
932,100933,"9,12,15-Octadecatrienoyl chloride, (9Z,12Z,15Z)-",CCC=CCC=CCC=CCCCCCCCC(=O)Cl,,,,,,
933,100934,"2-Chloro-6beta,9-difluoro-11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 17,21-di(acetate)",CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@H](C4=CC(=O)C(=C[C@@]43C)Cl)F)F)O)C)OC(=O)C,,,,,,
934,100935,"(R*,R*)-S,S'-(2,3-Diacetoxybutane-1,4-diyl) bis(thioacetate)",CC(=O)OC(CSC(=O)C)C(CSC(=O)C)OC(=O)C,,,,,,
935,100936,Cyclododecyl formate,C1CCCCCC(CCCCC1)OC=O,,,,,,
936,100937,4-Acetoxy-2-methylbut-2-enyl acetate,CC(=CCOC(=O)C)COC(=O)C,,,,,,
937,100938,"2,3b-Methano-3bH-cyclopenta(1,3)cyclopropa(1,2)benzene-4-methanol, octahydro-7,7,8,8-tetramethyl-, acetate",CC(=O)OCC1CCC(C23C14C2CC(C3)C4(C)C)(C)C,,,,,,
938,100939,"2,3b-Methano-3bH-cyclopenta[1,3]cyclopropa[1,2]benzene-4-methanol, octahydro-7,7,8,8-tetramethyl-",CC1(CCC(C23C14C2CC(C4)C3(C)C)CO)C,,,,,,
939,100940,"Octahydro-7,7,8,8-tetramethyl-2,3b-methano-3bH-cyclopenta[1,3]cyclopropa[1,2]benzene-4-carbaldehyde",CC1(CCC(C23C14C2CC(C4)C3(C)C)C=O)C,,,,,,
940,100941,"2,3b-Methano-3bH-cyclopenta[1,3]cyclopropa[1,2]benzene-4-methanol, octahydro-7,7,8,8-tetramethyl-, formate",CC1(CCC(C23C14C2CC(C4)C3(C)C)COC=O)C,,,,,,
941,100942,"1-(1,3,4,5,6,7-Hexahydro-1,1,5,5-tetramethyl-2H-2,4a-methanonaphthalen-8-yl)ethan-1-one",CC(=O)C1=C2C(C3CCC2(C3)C(CC1)(C)C)(C)C,,,,,,
942,100943,"1-(Octahydro-7,7,8,8-tetramethyl-2,3b-methano-3bH-cyclopenta(1,3)cyclopropa(1,2)benzen-4-yl)ethanone",CC(=O)C1CCC(C23C14C2CC(C3)C4(C)C)(C)C,,,,,,
943,100944,"1,4-Pentadien-3-ol, 3-methyl-1-(2,6,6-trimethyl-1-cyclohexen-1-yl)-",CC1=C(C(CCC1)(C)C)C=CC(C)(C=C)O,,,,,,
944,100945,"2,5-Dichloro-N,N-bis(2-hydroxyethyl)-4-((2-methyl-1H-indol-3-yl)azo)benzenesulphonamide",CC1=C(C2=CC=CC=C2N1)N=NC3=CC(=C(C=C3Cl)S(=O)(=O)N(CCO)CCO)Cl,,,,,,
945,100946,"1,3-Bis[(2-ethylhexyl)oxy]propan-2-ol",CCCCC(CC)COCC(COCC(CC)CCCC)O,,,,,,
946,100947,"2,3-Bis[(2-ethylhexyl)oxy]propan-1-ol",CCCCC(CC)COCC(CO)OCC(CC)CCCC,,,,,,
947,100948,"2-Propenoic acid, 2-[ethyl[(pentadecafluoroheptyl)sulfonyl]amino]ethyl ester",CCN(CCOC(=O)C=C)S(=O)(=O)C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
948,100949,1-(2-Nitrophenyl)piperazine,C1CN(CCN1)C2=CC=CC=C2[N+](=O)[O-],,,,,,
949,100950,1-Acetylpiperidine-4-carbonyl chloride,CC(=O)N1CCC(CC1)C(=O)Cl,,,,,,
950,100951,2-[(2-Hydroxyethyl)amino]ethyl octadec-9-enoate,CCCCCCCCC=CCCCCCCCC(=O)OCCNCCO,,,,,,
951,100952,Dichloromethyltetradecylsilane,CCCCCCCCCCCCCC[Si](C)(Cl)Cl,,,,,,
952,100953,Dichlorohexadecylmethylsilane,CCCCCCCCCCCCCCCC[Si](C)(Cl)Cl,,,,,,
953,100954,"2',4'-Difluoro(1,1'-biphenyl)-4-yl acetate",CC(=O)OC1=CC=C(C=C1)C2=C(C=C(C=C2)F)F,,,,,,
954,100955,"4-(2,4-Difluorophenyl)phenol",C1=CC(=CC=C1C2=C(C=C(C=C2)F)F)O,,,,,,
955,100956,2-Chlorododecanoyl chloride,CCCCCCCCCCC(C(=O)Cl)Cl,,,,,,
956,100957,"5,7-Dihydro-5,5,7,7-tetramethyl-3-(3-nitrophenyl)furo[3,4-e]-1,2,4-triazine",CC1(C2=C(C(O1)(C)C)N=NC(=N2)C3=CC(=CC=C3)[N+](=O)[O-])C,,,,,,
957,100958,"2,2',2''-[(Methylstannylidyne)tris(thio)]triethyl triacetate",CC(=O)OCCS[Sn](C)(SCCOC(=O)C)SCCOC(=O)C,,,,,,
958,100959,Butyltintris[2-(octanoyloxy)ethylmercaptide],CCCCCCCC(=O)OCCS[Sn](CCCC)(SCCOC(=O)CCCCCCC)SCCOC(=O)CCCCCCC,,,,,,
959,100960,CID 100960,CCCCCCCC[Sn]CCCCCCCC.CCCCCCCC(=O)OCC[S-].CCCCCCCC(=O)OCC[S-],,,,,,
960,100961,Methyltintris(2-mercaptoethyl nonanoate),CCCCCCCCC(=O)OCCS[Sn](C)(SCCOC(=O)CCCCCCCC)SCCOC(=O)CCCCCCCC,,,,,,
961,100962,"Butanenitrile, 4-(methylthio)-",CSCCCC#N,,,,,,
962,100963,"2-Pentanone, 5-(ethylamino)-",CCNCCCC(=O)C,,,,,,
963,100964,"2'-anilino-6'-[ethyl(p-tolyl)amino]-3'-methylspiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one",CCN(C1=CC=C(C=C1)C)C2=CC3=C(C=C2)C4(C5=CC=CC=C5C(=O)O4)C6=C(O3)C=C(C(=C6)NC7=CC=CC=C7)C,,,,,,
964,100965,Octadecyl 2-ethylhexanoate,CCCCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC,,,,,,
965,100966,CID 100966,CCCCCCCCCCCCCCCCCC(=O)OCC[S-].CCCCCCCCCCCCCCCCCC(=O)OCC[S-].C[Sn]C,,,,,,
966,100967,2-Mercaptoethyl stearate,CCCCCCCCCCCCCCCCCC(=O)OCCS,,,,,,
967,100968,Ethyl 2-methyl-4-oxo-6-pentylcyclohex-2-ene-1-carboxylate,CCCCCC1CC(=O)C=C(C1C(=O)OCC)C,,,,,,
968,100969,Ethyl 3-bromo-2-methylpropanoate,CCOC(=O)C(C)CBr,,,,,,
969,100970,"5,10-Dioxo-5H,10H-diimidazo(1,5-a:1',5'-d)pyrazine-1,6-dicarbonyl dichloride",C1=NC(=C2N1C(=O)C3=C(N=CN3C2=O)C(=O)Cl)C(=O)Cl,,,,,,
970,100971,Octyltintris(2-ethylhexyl 3-mercaptopropionate),CCCCCCCC[Sn](SCCC(=O)OCC(CC)CCCC)(SCCC(=O)OCC(CC)CCCC)SCCC(=O)OCC(CC)CCCC,,,,,,
971,100972,"Allyl 1,1,2,3,3,3-hexafluoropropyl ether",C=CCOC(C(C(F)(F)F)F)(F)F,,,,,,
972,100973,Methylcarbamoylethyl acrylate,CNC(=O)CCOC(=O)C=C,,,,,,
973,100974,Methyl 4-amino-5-thiocyanato-o-anisate,COC1=CC(=C(C=C1C(=O)OC)SC#N)N,,,,,,
974,100975,"2-[(2-Carboxyethylcarbonyl)oxymethyl]quinoxaline 1,4-dioxide",C1=CC=C2C(=C1)N(C(=C[N+]2=O)COC(=O)CCC(=O)O)[O-],,,,,,
975,100976,alpha-(Methoxyimino)-2-furanacetyl chloride,CON=C(C1=CC=CO1)C(=O)Cl,,,,,,
976,100977,6-((2-Methyl-1-oxoallyl)amino)hexanoic acid,CC(=C)C(=O)NCCCCCC(=O)O,,,,,,
977,100978,CID 100978,CCCCCCCC[Sn]CCCCCCCC.CCCCC(CC)COC(=O)CC[S-].CCCCC(CC)COC(=O)CC[S-],,,,,,
978,100979,"2,6-Difluorobenzophenone",C1=CC=C(C=C1)C(=O)C2=C(C=CC=C2F)F,,,,,,
979,100980,"Pentanamide, N-(5-amino-2-chlorophenyl)-4,4-dimethyl-3-oxo-",CC(C)(C)C(=O)CC(=O)NC1=C(C=CC(=C1)N)Cl,,,,,,
980,100981,"2-Naphthalenecarboxamide, N-(2,5-dichlorophenyl)-3-hydroxy-",C1=CC=C2C=C(C(=CC2=C1)C(=O)NC3=C(C=CC(=C3)Cl)Cl)O,,,,,,
981,100982,Hexachlororuthenium,Cl[Ru](Cl)(Cl)(Cl)(Cl)Cl,,,,,,
982,100983,2-Hydroxy-3-(3-(trimethoxysilyl)propoxy)propyl methacrylate,CC(=C)C(=O)OCC(COCCC[Si](OC)(OC)OC)O,,,,,,
983,100984,"1-(3,4-Methylenedioxybenzyl)-4-(2-pyridyl)piperazine",C1CN(CCN1CC2=CC3=C(C=C2)OCO3)C4=CC=CC=N4,,,,,,
984,100985,"1-(2-Bromoethyl)-2,4-dibromobenzene",C1=CC(=C(C=C1Br)Br)CCBr,,,,,,
985,100986,"3,5,5-Trimethylhexyl 3,5,5-trimethylhexanoate",CC(CCOC(=O)CC(C)CC(C)(C)C)CC(C)(C)C,,,,,,
986,100987,Ethyl o-toluenesulphonate,CCOS(=O)(=O)C1=CC=CC=C1C,,,,,,
987,100988,"2-Naphthalenesulfonic acid, 6-amino-5-((4-chloro-5-methyl-2-sulfophenyl)azo)-4-hydroxy-",CC1=CC(=C(C=C1Cl)S(=O)(=O)O)N=NC2=C(C=CC3=CC(=CC(=C32)O)S(=O)(=O)O)N,,,,,,
988,100989,"2,4,6-Trichlorophenyl acetoacetate",CC(=O)CC(=O)OC1=C(C=C(C=C1Cl)Cl)Cl,,,,,,
989,100990,4-Isopropylbenzyl acetate,CC(C)C1=CC=C(C=C1)COC(=O)C,,,,,,
990,100991,Isodecyl palmitate,CCCCCCCCCCCCCCCC(=O)OCCCCCCCC(C)C,,,,,,
991,100992,"Isodecyl 3,5,5-trimethylhexanoate",CC(C)CCCCCCCOC(=O)CC(C)CC(C)(C)C,,,,,,
992,100993,Isotridecyl isononanoate,CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C,,,,,,
993,100994,"Pentadecanoic acid, anhydride",CCCCCCCCCCCCCCC(=O)OC(=O)CCCCCCCCCCCCCC,,,,,,
994,100995,"3,6,9,12-Tetraoxatetradecane-1,14-diyl diacrylate",C=CC(=O)OCCOCCOCCOCCOCCOC(=O)C=C,,,,,,
995,100996,"1,3-Benzodioxole, 5-(dimethoxymethyl)-",COC(C1=CC2=C(C=C1)OCO2)OC,,,,,,
996,100997,"Benzenamine, 4,4'-(1,2-ethanediyl)bis[N-[(4-butoxyphenyl)methylene]-",CCCCOC1=CC=C(C=C1)C=NC2=CC=C(C=C2)CCC3=CC=C(C=C3)N=CC4=CC=C(C=C4)OCCCC,,,,,,
997,100998,3-(Tetradecanoylamino)propyl(carboxymethyl)dimethylammonium,CCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(=O)O,,,,,,
998,100999,2-[(Acetyloxy)methoxy]ethyl acetate,CC(=O)OCCOCOC(=O)C,,,,,,
999,101000,"Methyl 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulphonate",COS(=O)(=O)C1=CC=CC2=C1C=CC(=C2[O-])[N+]#N,,,,,,
1000,101001,1-Hydroxy-5-methoxysulfonylnaphthalene-2-diazonium,COS(=O)(=O)C1=CC=CC2=C1C=CC(=C2O)[N+]#N,,,,,,
1001,101002,Aminophenazone gentisate,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)C.C1=CC(=C(C=C1O)C(=O)O)O,,,,,,
1002,101003,2-Furfurylthio-3-methylpyrazine,CC1=NC=CN=C1SCC2=CC=CO2,,,,,,
1003,101004,2-Methyl-5-(furfurylthio)pyrazine,CC1=CN=C(C=N1)SCC2=CC=CO2,,,,,,
1004,101005,2-Methyl-6-(furfurylthio)pyrazine,CC1=CN=CC(=N1)SCC2=CC=CO2,,,,,,
1005,101006,"1,2-Dihydro-6-hydroxy-1,4-dimethyl-2-oxo-5-[[3-[(phenylsulphonyl)oxy]phenyl]azo]nicotinonitrile",CC1=C(C(=O)N(C(=C1C#N)O)C)N=NC2=CC(=CC=C2)OS(=O)(=O)C3=CC=CC=C3,,,,,,
1006,101007,2-Amino-6-hydroxypyridine,C1=CC(=O)NC(=C1)N,,,,,,
1007,101008,CID 101008,C1=CC2=C3C(=C1)C=CC4=C(C=CC(=C43)C=C2)S(=O)(=O)[O-].[Na+],,,,,,
1008,101009,1-Pyrenesulfonic acid,C1=CC2=C3C(=C1)C=CC4=C(C=CC(=C43)C=C2)S(=O)(=O)O,,,,,,
1009,101010,"2-Methyl-4-propyl-1,3-oxathiane",CCCC1CCOC(S1)C,,,,,,
1010,101011,"1,1'-Methylenebis(4-(2,3-epoxypropoxy)cyclohexane)",C1CC(CCC1CC2CCC(CC2)OCC3CO3)OCC4CO4,,,,,,
1011,101012,Methyl 3-sulfamoylthiophene-2-carboxylate,COC(=O)C1=C(C=CS1)S(=O)(=O)N,,,,,,
1012,101013,Methyl 4-amino-2-methoxy-5-nitrobenzoate,COC1=CC(=C(C=C1C(=O)OC)[N+](=O)[O-])N,,,,,,
1013,101014,"Methyl 4,5-diamino-2-methoxybenzoate",COC1=CC(=C(C=C1C(=O)OC)N)N,,,,,,
1014,101015,6-Methoxy-1H-benzotriazole-5-carboxylic acid methyl ester,COC1=CC2=NNN=C2C=C1C(=O)OC,,,,,,
1015,101016,4-Amino-2-methoxy-5-nitrobenzoic acid,COC1=CC(=C(C=C1C(=O)O)[N+](=O)[O-])N,,,,,,
1016,101017,"4,5-Diamino-o-anisic acid",COC1=CC(=C(C=C1C(=O)O)N)N,,,,,,
1017,101018,6-Methoxy-1H-benzotriazole-5-carboxylic acid,COC1=CC2=NNN=C2C=C1C(=O)O,,,,,,
1018,101019,Dimethyl 4-iodophthalate,COC(=O)C1=C(C=C(C=C1)I)C(=O)OC,,,,,,
1019,101020,"2,2-Diethylpent-4-enenitrile",CCC(CC)(CC=C)C#N,,,,,,
1020,101021,(S)-3-Phenylpiperidine,C1C[C@H](CNC1)C2=CC=CC=C2,,,,,,
1021,101022,"5-Bromo-6-methylpyridine-2,3-diamine",CC1=C(C=C(C(=N1)N)N)Br,,,,,,
1022,101023,"1,1-Dimethyl-2-phenylethyl isobutyrate",CC(C)C(=O)OC(C)(C)CC1=CC=CC=C1,,,,,,
1023,101024,"(Z)-2-(Bromomethyl)-4-(4-bromophenoxymethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolane",C1C(OC(O1)(CBr)C2=C(C=C(C=C2)Cl)Cl)COC3=CC=C(C=C3)Br,,,,,,
1024,101025,"4-[([1,1'-Biphenyl]-4-yloxy)methyl]-2-(bromomethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolane",C1C(OC(O1)(CBr)C2=C(C=C(C=C2)Cl)Cl)COC3=CC=C(C=C3)C4=CC=CC=C4,,,,,,
1025,101026,"1,2-Ethanediol, 1-(2-chlorophenyl)-",C1=CC=C(C(=C1)C(CO)O)Cl,,,,,,
1026,101027,"Methyl 2,2-dimethyl-4,6-dioxocyclohexanecarboxylate",CC1(CC(=O)CC(=O)C1C(=O)OC)C,,,,,,
1027,101028,"1H-Xantheno[2,1,9-def]isoquinoline-2(3H)-ethanesulfonic acid, 9-methoxy-1,3-dioxo-",COC1=CC2=C(C=C1)OC3=CC=C4C5=C(C=CC2=C35)C(=O)N(C4=O)CCS(=O)(=O)O,,,,,,
1028,101029,"Undeca-2,4-dien-1-ol",CCCCCCC=CC=CCO,,,,,,
1029,101030,Pyrrole-3-carboxylic acid,C1=CNC=C1C(=O)O,,,,,,
1030,101031,"Ethaneperoxoic acid, phenoxy-, 1,1,3,3-tetramethylbutyl ester",CC(C)(C)CC(C)(C)OOC(=O)COC1=CC=CC=C1,,,,,,
1031,101032,2-Chloroethyl 3-nitro-p-toluate,CC1=C(C=C(C=C1)C(=O)OCCCl)[N+](=O)[O-],,,,,,
1032,101033,1-Chloro-5-oxoproline,C1CC(=O)N(C1C(=O)O)Cl,,,,,,
1033,101034,N-(5-Chloro-2-methoxy-4-nitrophenyl)benzamide,COC1=CC(=C(C=C1NC(=O)C2=CC=CC=C2)Cl)[N+](=O)[O-],,,,,,
1034,101035,"1,2,3,4-Tetrahydro-2,2,4,7-tetramethylquinoline",CC1CC(NC2=C1C=CC(=C2)C)(C)C,,,,,,
1035,101036,4-Fluoro-3-methylphenyl 4-fluorophenyl ketone,CC1=C(C=CC(=C1)C(=O)C2=CC=C(C=C2)F)F,,,,,,
1036,101037,(2-Fluoro-5-methylphenyl) phenyl ketone,CC1=CC(=C(C=C1)F)C(=O)C2=CC=CC=C2,,,,,,
1037,101038,"2-(Hydroxymethyl)-2-(((1-oxooctyl)oxy)methyl)propane-1,3-diyl dioctanoate",CCCCCCCC(=O)OCC(CO)(COC(=O)CCCCCCC)COC(=O)CCCCCCC,,,,,,
1038,101039,6-Amino-4-hydroxy-5-((4-((((4-methylcyclohexyl)oxy)carbonyl)amino)-2-sulphophenyl)azo)naphthalene-2-sulphonic acid,CC1CCC(CC1)OC(=O)NC2=CC(=C(C=C2)N=NC3=C(C=CC4=CC(=CC(=C43)O)S(=O)(=O)O)N)S(=O)(=O)O,,,,,,
1039,101040,3-(p-Dimethylaminophenylazo)pyridine 1-oxide,CN(C)C1=CC=C(C=C1)N=NC2=C[N+](=CC=C2)[O-],,,,,,
1040,101041,N2-(1-Oxododecyl)-L-lysine,CCCCCCCCCCCC(=O)NC(CCCCN)C(=O)O,,,,,,
1041,101042,"N,2-Diisopropyl-2,3-dimethylbutyramide",CC(C)C(C)(C(C)C)C(=O)NC(C)C,,,,,,
1042,101043,"N-(tert-Butyl)-2-isopropyl-2,3-dimethylbutyramide",CC(C)C(C)(C(C)C)C(=O)NC(C)(C)C,,,,,,
1043,101044,"N-Ethyl-2-isopropyl-2,4-dimethylvaleramide",CCNC(=O)C(C)(CC(C)C)C(C)C,,,,,,
1044,101045,"2-sec-Butyl-N-ethyl-2,3-dimethylvaleramide",CCC(C)C(C)(C(C)CC)C(=O)NCC,,,,,,
1045,101046,"N,2,2-Triethylbutyramide",CCC(CC)(CC)C(=O)NCC,,,,,,
1046,101047,"N-Ethyl-2,2,4-trimethylvaleramide",CCNC(=O)C(C)(C)CC(C)C,,,,,,
1047,101048,"4-(2,5-Dimethoxy-4-nitrophenyl)morpholine",COC1=CC(=C(C=C1N2CCOCC2)OC)[N+](=O)[O-],,,,,,
1048,101049,CID 101049,C[Si](C)(C1=CC=CC=C1)[O-].[K+],,,,,,
1049,101050,CID 101050,[Li+].[Li+].C1=CC=C2C(=C1)C=C(C(=C2CC3=C(C(=CC4=CC=CC=C43)C(=O)[O-])O)O)C(=O)[O-],,,,,,
1050,101051,"Silane, [(3-methoxy-1-methylene-2-propenyl)oxy]trimethyl-",COC=CC(=C)O[Si](C)(C)C,,,,,,
1051,101052,"Ethyl 2,2-dimethyloctanoate",CCCCCCC(C)(C)C(=O)OCC,,,,,,
1052,101053,CID 101053,CC1C2C(CCC1=CC(=O)OCCN(C)C)C3(CCC(C(C3CC2O)(C)C)O)C.Cl,,,,,,
1053,101054,"2-(dimethylamino)ethyl 2-(7,10-dihydroxy-1,4b,8,8-tetramethyl-3,4,4a,5,6,7,8a,9,10,10a-decahydro-1H-phenanthren-2-ylidene)acetate",CC1C2C(CCC1=CC(=O)OCCN(C)C)C3(CCC(C(C3CC2O)(C)C)O)C,,,,,,
1054,101055,"8-Chloro-3,4-dihydro-5-methoxy-4-oxo-2H-1-benzothiopyran-2-acetic acid",COC1=C2C(=O)CC(SC2=C(C=C1)Cl)CC(=O)O,,,,,,
1055,101056,"2-(4-(1,3-Dihydro-1,3-dioxo-2H-isoindol-2-yl)phenyl)propionic acid",CC(C1=CC=C(C=C1)N2C(=O)C3=CC=CC=C3C2=O)C(=O)O,,,,,,
1056,101057,1-(1-Oxohexadecyl)-L-proline,CCCCCCCCCCCCCCCC(=O)N1CCCC1C(=O)O,,,,,,
1057,101058,"(Tetrabromo-1,4-phenylene)bismethylene diacrylate",C=CC(=O)OCC1=C(C(=C(C(=C1Br)Br)COC(=O)C=C)Br)Br,,,,,,
1058,101059,(Pentabromophenyl)methyl acrylate,C=CC(=O)OCC1=C(C(=C(C(=C1Br)Br)Br)Br)Br,,,,,,
1059,101060,"2-Bromo-3,3-dimethoxypropionaldehyde",COC(C(C=O)Br)OC,,,,,,
1060,101061,"[1,1'-Biphenyl]-4-carbonitrile, 4'-decyl-",CCCCCCCCCCC1=CC=C(C=C1)C2=CC=C(C=C2)C#N,,,,,,
1061,101062,"8-Chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylic acid",CC1=NC(=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4F)C(=O)O,,,,,,
1062,101063,1-Hydroperoxy-4-methylpentan-2-one,CC(C)CC(=O)COO,,,,,,
1063,101064,1-(Chloromethyl)-2-iodobenzene,C1=CC=C(C(=C1)CCl)I,,,,,,
1064,101065,"7-[2-(5-Cyclohexyl-3-hydroxypent-1-ynyl)-3,5-dihydroxycyclopentyl]hept-5-enoic acid",C1CCC(CC1)CCC(C#CC2C(CC(C2CC=CCCCC(=O)O)O)O)O,,,,,,
1065,101066,"2,5-Dimethyl-3-pyrroline",CC1C=CC(N1)C,,,,,,
1066,101067,"2,4-Diamino-5-(3-methoxybenzyl)pyrimidine",COC1=CC=CC(=C1)CC2=CN=C(N=C2N)N,,,,,,
1067,101068,3-Chloro-2-nitroaniline,C1=CC(=C(C(=C1)Cl)[N+](=O)[O-])N,,,,,,
1068,101069,"N-(2,5-Dichloro-3-thienyl)acetamide",CC(=O)NC1=C(SC(=C1)Cl)Cl,,,,,,
1069,101070,1-(4-Methyl-2-nitrophenyl)pyrrolidine,CC1=CC(=C(C=C1)N2CCCC2)[N+](=O)[O-],,,,,,
1070,101071,"Phenyl(((2,2,2-trichloroethoxy)carbonyl)amino)acetic acid",C1=CC=C(C=C1)C(C(=O)O)NC(=O)OCC(Cl)(Cl)Cl,,,,,,
1071,101072,Ibuprofenamide,CC(C)CC1=CC=C(C=C1)C(C)C(=O)N,,,,,,
1072,101073,"Phosphonium, tetrabutyl-, salt with 1,3-dimethyl 5-sulfo-1,3-benzenedicarboxylate (1:1)",CCCC[P+](CCCC)(CCCC)CCCC.COC(=O)C1=CC(=CC(=C1)S(=O)(=O)[O-])C(=O)OC,,,,,,
1073,101074,"4-((2,5-Dimethoxyphenyl)azo)-N,N-dimethylaniline",CN(C)C1=CC=C(C=C1)N=NC2=C(C=CC(=C2)OC)OC,,,,,,
1074,101075,"Aluminum, tetrachloro-mu-1,2-ethanediyldi-",C(C[Al](Cl)Cl)[Al](Cl)Cl,,,,,,
1075,101076,CID 101076,[CH2-][CH2-],,,,,,
1076,101077,"3,3-Dimethyl-1,2-butanediol",CC(C)(C)C(CO)O,,,,,,
1077,101078,"1,3-Dibenzyl-2-oxoimidazolidine-4,5-dicarboxylic acid",C1=CC=C(C=C1)CN2C(C(N(C2=O)CC3=CC=CC=C3)C(=O)O)C(=O)O,,,,,,
1078,101079,"1H-Benzimidazol-2-amine, 5-(4-aminophenyl)-",C1=CC(=CC=C1C2=CC3=C(C=C2)N=C(N3)N)N,,,,,,
1079,101080,2-Hydroxypropyl valerate,CCCCC(=O)OCC(C)O,,,,,,
1080,101081,CID 101081,CCCC[Sn]CCCC.CC(C)COC(=O)C=CC(=O)O.CC(C)COC(=O)C=CC(=O)O,,,,,,
1081,101082,"1,3,6,8-Pyrenetetrasulfonic acid, tetrasodium salt",C1=CC2=C3C(=C(C=C2S(=O)(=O)[O-])S(=O)(=O)[O-])C=CC4=C(C=C(C1=C43)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
1082,101083,Isopropyl 2-pyridyl ketone,CC(C)C(=O)C1=CC=CC=N1,,,,,,
1083,101084,"Benzoic acid, 2-(4-dodecylbenzoyl)-",CCCCCCCCCCCCC1=CC=C(C=C1)C(=O)C2=CC=CC=C2C(=O)O,,,,,,
1084,101085,"Carbamic acid, (3,4-dichlorophenyl)-, 2-[butyl[4-(2,2-dicyanoethenyl)-3-methylphenyl]amino]ethyl ester",CCCCN(CCOC(=O)NC1=CC(=C(C=C1)Cl)Cl)C2=CC(=C(C=C2)C=C(C#N)C#N)C,,,,,,
1085,101086,Methyl 4-(((4-chlorophenyl)imino)methyl)benzoate,COC(=O)C1=CC=C(C=C1)C=NC2=CC=C(C=C2)Cl,,,,,,
1086,101087,2-Ethylhexyl nonanoate,CCCCCCCCC(=O)OCC(CC)CCCC,,,,,,
1087,101088,CID 101088,CC1C2C(CCC1=CC(=O)OCCN(C)C)C3(CCC(C(C3CC2O)(C)C)OC(=O)CC(C)(C)O)C.Cl,,,,,,
1088,101089,"[7-[2-[2-(dimethylamino)ethoxy]-2-oxoethylidene]-9-hydroxy-1,1,4a,8-tetramethyl-3,4,4b,5,6,8,8a,9,10,10a-decahydro-2H-phenanthren-2-yl] 3-hydroxy-3-methylbutanoate",CC1C2C(CCC1=CC(=O)OCCN(C)C)C3(CCC(C(C3CC2O)(C)C)OC(=O)CC(C)(C)O)C,,,,,,
1089,101090,2-(2-(2-(Tetradecyloxy)ethoxy)ethoxy)ethyl myristate,CCCCCCCCCCCCCCOCCOCCOCCOC(=O)CCCCCCCCCCCCC,,,,,,
1090,101091,"1,3,2-Dioxaphosphorinane, 2,2'-[(2,2-dimethyl-1,3-propanediyl)bis(oxy)]bis[5,5-dimethyl-",CC1(COP(OC1)OCC(C)(C)COP2OCC(CO2)(C)C)C,,,,,,
1091,101092,"2,4,8,10-Tetraoxa-3,9-diphosphaspiro[5.5]undecane, 3,9-diphenyl-, 3,9-dioxide",C1C2(COP(=O)(O1)C3=CC=CC=C3)COP(=O)(OC2)C4=CC=CC=C4,,,,,,
1092,101093,2-Methoxyethyl 2-butenoate,CC=CC(=O)OCCOC,,,,,,
1093,101094,"Cyclopropanecarboxylic acid, 3-(2,2-dichloroethenyl)-2,2-dimethyl-, ethyl ester",CCOC(=O)C1C(C1(C)C)C=C(Cl)Cl,,,,,,
1094,101095,CID 101095,CC1C2C(CCC1=CC(=O)OCCN(C)C)[C@@]3(CC[C@H](C(C3CC2=O)(C)C)OC(=O)CCCl)C.OS(=O)(=O)O,,,,,,
1095,101096,CID 101096,CC1C2C(CCC1=CC(=O)OCCN(C)C)[C@@]3(CC[C@H](C(C3CC2=O)(C)C)OC(=O)CCCl)C,,,,,,
1096,101097,"1-Butene, 2-methyl-4-[(3-methyl-2-butenyl)oxy]-",CC(=CCOCCC(=C)C)C,,,,,,
1097,101098,Potassium 2-chloro-4-nitrobenzoate,C1=CC(=C(C=C1[N+](=O)[O-])Cl)C(=O)[O-].[K+],,,,,,
1098,101099,"2,4(1h,3h)-Pyrimidinedione, 6-[(methylthio)methyl]-",CSCC1=CC(=O)NC(=O)N1,,,,,,
1099,101100,Gostatin,C1C(C(=O)C(=C(N1)C(=O)O)CC(=O)O)N,,,,,,
1100,101101,Punctatin A,CC1(CC2C1(CCC3(C2(C=CC3O)CO)C)O)C,,,,,,
1101,101102,4-Hydroxyphenylbutazone,CCCCC1(C(=O)N(N(C1=O)C2=CC=CC=C2)C3=CC=CC=C3)O,,,,,,
1102,101103,CID 101103,C[C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H]2CC[C@]3([C@@H](C2)CCC4C3CC[C@]5([C@@]4(CC[C@@H]5C6=CC(=O)OC6)O)C)C)OC)OC)O,,,,,,
1103,101104,2-Phenylpent-4-enoic acid,C=CCC(C1=CC=CC=C1)C(=O)O,,,,,,
1104,101105,Leucogen,CCOC(=O)C(C1NC(CS1)C(=O)O)C2=CC=CC=C2,['Active immunisation of cats from eight weeks of age against feline leukaemia for the prevention of persistent viraemia and clinical signs of the related disease.'],,,,,
1105,101106,Meperidinic acid,CN1CCC(CC1)(C2=CC=CC=C2)C(=O)O,,,,,,
1106,101107,"1-(4-Chlorophenyl)ethane-1,2-diol",C1=CC(=CC=C1C(CO)O)Cl,,,,,,
1107,101108,"1,5-dihydroxy-2,2,5,7-tetramethylspiro[1H-indene-6,1'-cyclopropane]-4-one",CC1=C2C(C(C=C2C(=O)C(C13CC3)(C)O)(C)C)O,,,,,,
1108,101109,"1,5-dihydroxy-2-(hydroxymethyl)-2,5,7-trimethylspiro[1H-indene-6,1'-cyclopropane]-4-one",CC1=C2C(C(C=C2C(=O)C(C13CC3)(C)O)(C)CO)O,,,,,,
1109,101110,"5-Methyl-7,16-dioxahexacyclo[13.6.1.01,8.04,21.09,14.018,22]docosa-9(14),11-diene-10,13,17-trione",CC1COC2C3=C(C4C5C26CCC1C6CCC5C(=O)O4)C(=O)C=CC3=O,,,,,,
1110,101111,"N-(3,5-Dinitrobenzoyl)leucine",CC(C)C[C@@H](C(=O)O)NC(=O)C1=CC(=CC(=C1)[N+](=O)[O-])[N+](=O)[O-],,,,,,
1111,101112,2-(2-Chloroacetamido)-3-methylbutanoic acid,CC(C)C(C(=O)O)NC(=O)CCl,,,,,,
1112,101113,"3-Chloro-1,2,3-triphenyl-1-propanone",C1=CC=C(C=C1)C(C(C2=CC=CC=C2)Cl)C(=O)C3=CC=CC=C3,,,,,,
1113,101114,N-Benzoyl-DL-threonine,CC(C(C(=O)O)NC(=O)C1=CC=CC=C1)O,,,,,,
1114,101115,"2,6,6-Trimethyl-2-hydroxycyclohexanone",CC1(CCCC(C1=O)(C)O)C,,,,,,
1115,101116,"Cyclohexanone, 2-trityloxymethyl-",C1CCC(=O)C(C1)COC(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
1116,101117,1-Bromocyclohexanecarboxamide,C1CCC(CC1)(C(=O)N)Br,,,,,,
1117,101118,2-Bromopropanamide,CC(C(=O)N)Br,,,,,,
1118,101119,alpha-(1-((2-Hydroxyethyl)amino)-1-methylethyl)benzyl alcohol,CC(C)(C(C1=CC=CC=C1)O)NCCO,,,,,,
1119,101120,2-Bromo-1-tetralone,C1CC2=CC=CC=C2C(=O)C1Br,,,,,,
1120,101121,2-Hydroxypropiophenone,CC(C(=O)C1=CC=CC=C1)O,,,,,,
1121,101122,2-Aminoheptanedioic acid,C(CCC(=O)O)CC(C(=O)O)N,,,,,,
1122,101123,Safrole oxide,C1C(O1)CC2=CC3=C(C=C2)OCO3,,,,,,
1123,101124,Isocolchiceinamide,CC(=O)NC1CCC2=CC(=C(C(=C2C3=C1C=C(C(=O)C=C3)N)OC)OC)OC,,,,,,
1124,101125,"N-(9-ethoxy-1,2,3-trimethoxy-10-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl)acetamide",CCOC1=CC2=C(C=CC1=O)C3=C(C(=C(C=C3CCC2NC(=O)C)OC)OC)OC,,,,,,
1125,101126,N-Methylisocolchicine,CC(=O)N(C)C1CCC2=CC(=C(C(=C2C3=C1C=C(C(=O)C=C3)OC)OC)OC)OC,,,,,,
1126,101127,"Acetamide, N-(10-(butylamino)-5,6,7,9-tetrahydro-1,2,3-trimethoxy-9-oxobenzo(a)heptalen-7-yl)-, (S)-",CCCCNC1=CC=C2C(=CC1=O)C(CCC3=CC(=C(C(=C32)OC)OC)OC)NC(=O)C,,,,,,
1127,101128,"N,N-Dimethylcolchiceinamide",CC(=O)NC1CCC2=CC(=C(C(=C2C3=CC=C(C(=O)C=C13)N(C)C)OC)OC)OC,,,,,,
1128,101129,"Thiodicarbonic acid ((HO)C(O)SC(S)(OH)), 1-ethyl 3-(1-methylpropyl) ester",CCC(C)OC(=S)SC(=O)OCC,,,,,,
1129,101130,"2,3-Dihydro-2-methylbenzofuran",CC1CC2=CC=CC=C2O1,,,,,,
1130,101131,2-Ethylhexyl octanoate,CCCCCCCC(=O)OCC(CC)CCCC,,,,,,
1131,101132,"2-Methyl-2-phenyl-1,3-oxathiolane",CC1(OCCS1)C2=CC=CC=C2,,,,,,
1132,101133,2-(p-Chlorophenyl)-N-methylsuccinimide,CN1C(=O)CC(C1=O)C2=CC=C(C=C2)Cl,,,,,,
1133,101134,1-Phenylpropyl acetate,CCC(C1=CC=CC=C1)OC(=O)C,,,,,,
1134,101135,2-Methyl-1-phenylbutan-2-ol,CCC(C)(CC1=CC=CC=C1)O,,,,,,
1135,101136,"6-Hydroxy-2,7-dimethyloctan-4-one",CC(C)CC(=O)CC(C(C)C)O,,,,,,
1136,101137,"1,3-Dioxolane, 4-methyl-2-(2-phenylethenyl)-",CC1COC(O1)C=CC2=CC=CC=C2,,,,,,
1137,101138,Serinamide,C([C@@H](C(=O)N)N)O,,,,,,
1138,101139,"Benzene, 1,1'-(1,1,3-trimethyl-1,3-propanediyl)bis-",CC(CC(C)(C)C1=CC=CC=C1)C2=CC=CC=C2,,,,,,
1139,101140,"3-(1,3-Benzodioxol-5-yl)-1-methylpropyl acetate",CC(CCC1=CC2=C(C=C1)OCO2)OC(=O)C,,,,,,
1140,101141,"1,3-Benzodioxol-5-ylmethyl 2,2-dimethyl-3-(2-methyl-1-propenyl)cyclopropanecarboxylate",CC(=CC1C(C1(C)C)C(=O)OCC2=CC3=C(C=C2)OCO3)C,,,,,,
1141,101142,"2-Chlorocyclohexyl 2,4-dinitrophenyl sulfone",C1CCC(C(C1)S(=O)(=O)C2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-])Cl,,,,,,
1142,101143,Colchinoic acid,CC(=O)NC1CCC2=CC(=C(C(=C2C3=C1C=C(C=C3)C(=O)O)OC)OC)OC,,,,,,
1143,101144,"5-(4-Methyl-1,3-dioxolan-2-yl)-1,3-benzodioxole",CC1COC(O1)C2=CC3=C(C=C2)OCO3,,,,,,
1144,101145,Amyl lactate,CCCCCOC(=O)C(C)O,,,,,,
1145,101146,"2,5-Bis(4-methylphenoxy)cyclohexane-1,4-dione",CC1=CC=C(C=C1)OC2CC(=O)C(CC2=O)OC3=CC=C(C=C3)C,,,,,,
1146,101147,"Lactic acid, acetate, cyclohexyl ester",CC(C(=O)OC1CCCCC1)OC(=O)C,,,,,,
1147,101148,1-(4-Methoxyphenyl)ethanol,CC(C1=CC=C(C=C1)OC)O,,,,,,
1148,101149,"2-(1-Ethylpentyl)-1,3-dioxan-5-ol",CCCCC(CC)C1OCC(CO1)O,,,,,,
1149,101150,"3-Cyclohexene-1-carboxaldehyde, 2,4,6-trimethyl-",CC1CC(=CC(C1C=O)C)C,,,,,,
1150,101151,4-(p-Methoxyphenyl)-2-butanol,CC(CCC1=CC=C(C=C1)OC)O,,,,,,
1151,101152,"5-(5-Methyl-1,3-dioxan-4-yl)-1,3-benzodioxole",CC1COCOC1C2=CC3=C(C=C2)OCO3,,,,,,
1152,101153,Pinol,CC1=CCC2CC1OC2(C)C,,,,,,
1153,101154,"cis-1,2,3,4-Tetrahydro-2-phenyl-1-naphthaleneacetic acid",C1CC2=CC=CC=C2C(C1C3=CC=CC=C3)CC(=O)O,,,,,,
1154,101155,"Diallyl 4-cyclohexene-1,2-dicarboxylate",C=CCOC(=O)C1CC=CCC1C(=O)OCC=C,,,,,,
1155,101156,"2-Oxazoline, 2-(8,10-heptadecadienyl)-5-methyl-",CCCCCCC=CC=CCCCCCCCC1=NCC(O1)C,,,,,,
1156,101157,"2-(8,11-Heptadecadienyl)-5-methyl-2-oxazoline",CCCCCC=CCC=CCCCCCCCC1=NCC(O1)C,,,,,,
1157,101158,(2-Ethyl-1-hydroxyhexyl)phosphonic acid,CCCCC(CC)C(O)P(=O)(O)O,,,,,,
1158,101159,"2-Oxazoline, 5-methyl-2-undecyl-",CCCCCCCCCCCC1=NCC(O1)C,,,,,,
1159,101160,"3-(p-Nonylphenoxy)propane-1,2-diol",CCCCCCCCCC1=CC=C(C=C1)OCC(CO)O,,,,,,
1160,101161,Diallyl hexahydrophthalate,C=CCOC(=O)C1CCCCC1C(=O)OCC=C,,,,,,
1161,101162,"2,3,4,4a,9,9a-Hexahydro-1H-carbazole",C1CCC2C(C1)C3=CC=CC=C3N2,,,,,,
1162,101163,Ethyl 2-cyano-2-(cyclohex-1-enyl)propionate,CCOC(=O)C(C)(C#N)C1=CCCCC1,,,,,,
1163,101164,"2(3H)-Furanone, 3-chlorodihydro-",C1COC(=O)C1Cl,,,,,,
1164,101165,"2,3-Dimethylcholanthrene",CC1CC2=C3C1=C(C=CC3=CC4=C2C=CC5=CC=CC=C54)C,,,,,,
1165,101166,"alpha-D-Glucopyranose, 1-thio-, pentaacetate",CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)SC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
1166,101167,"3-(4-chlorophenyl)-1,5-diphenyl-4,5-dihydro-1H-pyrazole",C1C(N(N=C1C2=CC=C(C=C2)Cl)C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
1167,101168,"1-Propanone, 2,3-dibromo-3-(4-nitrophenyl)-1-phenyl-",C1=CC=C(C=C1)C(=O)C(C(C2=CC=C(C=C2)[N+](=O)[O-])Br)Br,,,,,,
1168,101169,2-Hydroxypropyl benzoate,CC(COC(=O)C1=CC=CC=C1)O,,,,,,
1169,101170,2-Hydroxyhydroquinonephthalein,C1=CC=C2C(=C1)C(=O)OC23C4=CC(=C(C=C4OC5=CC(=C(C=C35)O)O)O)O,,,,,,
1170,101171,2-Methylglutaraldehyde,CC(CCC=O)C=O,,,,,,
1171,101172,Dihydroxypropyltheobromine,CN1C=NC2=C1C(=O)N(C(=O)N2C)CC(CO)O,,,,,,
1172,101173,"2-Amino-N,3-dihydroxypropanamide",C(C(C(=O)NO)N)O,,,,,,
1173,101174,3-(4-Chlorophenoxy)-2-hydroxypropanoic acid,C1=CC(=CC=C1OCC(C(=O)O)O)Cl,,,,,,
1174,101175,2-(1-Cyclohexenyl)cyclohexanone,C1CCC(=CC1)C2CCCCC2=O,,,,,,
1175,101176,Benzyloxycarbonyltryptophan,C1=CC=C(C=C1)COC(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)O,,,,,,
1176,101177,"4H-1,3-Thiazin-4-one, tetrahydro-3-methyl-2-phenyl-",CN1C(SCCC1=O)C2=CC=CC=C2,,,,,,
1177,101178,"2-Phenyl-1,3-thiazinan-4-one",C1CSC(NC1=O)C2=CC=CC=C2,,,,,,
1178,101179,Histidylglycine,C1=C(NC=N1)C[C@@H](C(=O)NCC(=O)O)N,,,,,,
1179,101180,Histidylalanine,C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CN=CN1)N,,,,,,
1180,101181,2-(4-Phenylphenoxy)propanoic acid,CC(C(=O)O)OC1=CC=C(C=C1)C2=CC=CC=C2,,,,,,
1181,101182,2-(4-Hydroxyphenoxy)propanoic acid,CC(C(=O)O)OC1=CC=C(C=C1)O,,,,,,
1182,101183,N-Chloroacetyl-L-tryptophan,C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC(=O)CCl,,,,,,
1183,101184,N-Acetyl-D-phenylalanine,CC(=O)N[C@H](CC1=CC=CC=C1)C(=O)O,,,,,,
1184,101185,Tetrahydroxyaminopterin,C1C(NC2=C(N=C(N=C2N1)N)N)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
1185,101186,H-Asp(OBzl)-OH,C1=CC=C(C=C1)COC(=O)C[C@@H](C(=O)O)N,,,,,,
1186,101187,Glycyltyrosinamide,C1=CC(=CC=C1C[C@@H](C(=O)N)NC(=O)CN)O,,,,,,
1187,101188,1-(Dimethylamino)cyclohexanecarbonitrile,CN(C)C1(CCCCC1)C#N,,,,,,
1188,101189,"(2R,3S,4S)-5-[(2,4-dinitrophenyl)hydrazinylidene]pentane-1,2,3,4-tetrol",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])NN=C[C@@H]([C@@H]([C@@H](CO)O)O)O,,,,,,
1189,101190,Tetrahydroamethopterin,CN(CC1CNC2=NC(=NC(=C2N1)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
1190,101191,alpha-Hydroxypyridine-3-methanesulphonic acid,C1=CC(=CN=C1)C(O)S(=O)(=O)O,,,,,,
1191,101192,3-(1-Hydroxyethyl)pyridine,CC(C1=CN=CC=C1)O,,,,,,
1192,101193,"N-(2,4-Dinitrophenyl)-L-tryptophan",C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)O)NC3=C(C=C(C=C3)[N+](=O)[O-])[N+](=O)[O-],,,,,,
1193,101194,"1,5-Dimethyl-2-pyrrolidinone",CC1CCC(=O)N1C,,,,,,
1194,101195,"Glutarimide, N-methyl-2-phthalimido-",CN1C(=O)CCC(C1=O)N2C(=O)C3=CC=CC=C3C2=O,,,,,,
1195,101196,"Tetramethyl 7,9-dimethyl-9aH-quinolizine-1,2,3,4-tetracarboxylate",CC1=CC(=CN2C1C(=C(C(=C2C(=O)OC)C(=O)OC)C(=O)OC)C(=O)OC)C,,,,,,
1196,101197,"1,1-Dimethyl-2-(alpha-methylphenethyl)hydrazine",CC(CC1=CC=CC=C1)NN(C)C,,,,,,
1197,101198,4-Fluoro-DL-tryptophan,C1=CC2=C(C(=C1)F)C(=CN2)CC(C(=O)O)N,,,,,,
1198,101199,Norbornyl acetate,CC(=O)OC1CC2CCC1C2,,,,,,
1199,101200,Deazaminopterin,C1=CC(=CC=C1C(=O)N[C@@H](CCC(=O)O)C(=O)O)NCC2=CC3=C(C=C2)N=C(N=C3N)N,,,,,,
1200,101201,"Spiro[3H-1,4-benzodiazepine-3,2'-oxirane]-2,5(1H,4H)-dione, 3'-(3-hydroxyphenyl)-4-methyl-, cis-(-)-",CN1C(=O)C2=CC=CC=C2NC(=O)C13C(O3)C4=CC(=CC=C4)O,,,,,,
1201,101202,"Methyl 5'-(furan-3-yl)-6,8a-dimethyl-2'-oxospiro[3,4,4a,6,7,8-hexahydronaphthalene-5,3'-oxolane]-1-carboxylate",CC1CCC2(C(C13CC(OC3=O)C4=COC=C4)CCC=C2C(=O)OC)C,,,,,,
1202,101203,"5,7-Dihydroxy-2-[4-hydroxy-3,5-bis(3-methylbut-2-enyl)phenyl]-2,3-dihydrochromen-4-one",CC(=CCC1=CC(=CC(=C1O)CC=C(C)C)C2CC(=O)C3=C(C=C(C=C3O2)O)O)C,,,,,,
1203,101204,trans-Dihydronarciclasine,C1[C@H]2[C@H]([C@@H]([C@@H]([C@H]1O)O)O)NC(=O)C3=C(C4=C(C=C23)OCO4)O,,,,,,
1204,101205,2beta-Xylofuranosylthiazole-4-carboxamide,C1=C(N=C(S1)[C@H]2[C@@H]([C@H]([C@H](O2)CO)O)O)C(=O)N,,,,,,
1205,101206,"2,6-Pyridinedicarboxamide, N,N,N',N'-tetraethyl-",CCN(CC)C(=O)C1=NC(=CC=C1)C(=O)N(CC)CC,,,,,,
1206,101207,"2,2,7,7-Tetramethyl-3,6-dithia-2,7-disilaoctane",C[Si](C)(C)SCCS[Si](C)(C)C,,,,,,
1207,101208,Methyl 4-(3-(hydroxymethyl)-3-methyl-1-triazenyl)benzoate,CN(CO)N=NC1=CC=C(C=C1)C(=O)OC,,,,,,
1208,101209,2-Cyanobenzaldehyde,C1=CC=C(C(=C1)C=O)C#N,,,,,,
1209,101210,"1,2,3,4-Naphthalenetetrol",C1=CC=C2C(=C1)C(=C(C(=C2O)O)O)O,,,,,,
1210,101211,Chimaphilin,CC1=CC2=C(C=C1)C(=O)C=C(C2=O)C,,,,,,
1211,101212,n-Acetyl-n-(4-hydroxyphenyl)acetamide,CC(=O)N(C1=CC=C(C=C1)O)C(=O)C,,,,,,
1212,101213,"Urea, 3-(2-bromoethyl)-1-(2-naphthyl)-",C1=CC=C2C=C(C=CC2=C1)NC(=O)NCCBr,,,,,,
1213,101214,"5,5'-Dithiodiuracil",C1=C(C(=O)NC(=O)N1)SSC2=CNC(=O)NC2=O,,,,,,
1214,101215,"Benzenesulfonamide, p-bromo-N-methyl-",CNS(=O)(=O)C1=CC=C(C=C1)Br,,,,,,
1215,101216,"p-Toluenesulfonamide, N-(2-hydroxyethyl)-N-methyl-, p-toluenesulfonate",CC1=CC=C(C=C1)S(=O)(=O)N(C)CCOS(=O)(=O)C2=CC=C(C=C2)C,,,,,,
1216,101217,"2,4(1H,3H)-Quinazolinedione, 1,3-dimethyl-",CN1C2=CC=CC=C2C(=O)N(C1=O)C,,,,,,
1217,101218,"9-Methoxy-7H-furo(3,2-g)(1)benzopyran-7-thione",COC1=C2C(=CC3=C1OC=C3)C=CC(=S)O2,,,,,,
1218,101219,"1,2-Anthraquinone",C1=CC=C2C=C3C(=CC2=C1)C=CC(=O)C3=O,,,,,,
1219,101220,"(E,E)-1,5-Bis(p-methoxyphenyl)penta-1,4-dien-3-one",COC1=CC=C(C=C1)C=CC(=O)C=CC2=CC=C(C=C2)OC,,,,,,
1220,101221,Benzophenone azine,C1=CC=C(C=C1)C(=NN=C(C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
1221,101222,2-(Methylamino)benzamide,CNC1=CC=CC=C1C(=O)N,,,,,,
1222,101223,"7H-Furo(3,2-g)(1)benzopyran-7-one, 5,6-dimethyl-",CC1=C(C(=O)OC2=C1C=C3C=COC3=C2)C,,,,,,
1223,101224,"5beta-Pregn-16-en-20-one, 3beta-hydroxy-, acetate",CC(=O)C1=CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@@H](C4)OC(=O)C)C)C,,,,,,
1224,101225,Taraxasteryl acetate,C[C@H]1[C@@H]2[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CCC4([C@@]3(CC[C@]2(CCC1=C)C)C)C)(C)C)OC(=O)C)C,,,,,,
1225,101226,N-Butyrylbenzamide,CCCC(=O)NC(=O)C1=CC=CC=C1,,,,,,
1226,101227,CID 101227,C1=CC=C(C=C1)C(=O)C=CC2=CC=CC=C2[N+](=O)[O-],,,,,,
1227,101228,"1-Propanol, 2,2-diethoxy-1,1-diphenyl-",CCOC(C)(C(C1=CC=CC=C1)(C2=CC=CC=C2)O)OCC,,,,,,
1228,101229,6-Chloro-5-nitropyrimidin-4-amine,C1=NC(=C(C(=N1)Cl)[N+](=O)[O-])N,,,,,,
1229,101230,N-Methylbenzilamide,CNC(=O)C(C1=CC=CC=C1)(C2=CC=CC=C2)O,,,,,,
1230,101231,N-(4-methylpent-3-en-2-ylidene)hydroxylamine,CC(=CC(=NO)C)C,,,,,,
1231,101232,"N-Butyl-2,2-diphenylacetamide",CCCCNC(=O)C(C1=CC=CC=C1)C2=CC=CC=C2,,,,,,
1232,101233,"Propionamide, 2-ethylthio-2-methyl-",CCSC(C)(C)C(=O)N,,,,,,
1233,101234,"Propanedioic acid, (2-phenylethyl)-",C1=CC=C(C=C1)CCC(C(=O)O)C(=O)O,,,,,,
1234,101235,2-Bromo-2-methylpropanamide,CC(C)(C(=O)N)Br,,,,,,
1235,101236,"6,6-Diphenylfulvene",C1=CC=C(C=C1)C(=C2C=CC=C2)C3=CC=CC=C3,,,,,,
1236,101237,(2-Aminophenyl)phosphonic acid,C1=CC=C(C(=C1)N)P(=O)(O)O,,,,,,
1237,101238,4-(Hydroxyamino)benzenesulfonamide,C1=CC(=CC=C1NO)S(=O)(=O)N,,,,,,
1238,101239,Isoclavicin,C1COC2=C(C1=O)COC2=O,,,,,,
1239,101240,N-((4-(Acetylamino)phenyl)sulphonyl)acetamide,CC(=O)NC1=CC=C(C=C1)S(=O)(=O)NC(=O)C,,,,,,
1240,101241,Hexafluoroacetone semicarbazone,C(=NNC(=O)N)(C(F)(F)F)C(F)(F)F,,,,,,
1241,101242,ethyl 2-(1H-indol-3-yl)-2-oxoacetate,CCOC(=O)C(=O)C1=CNC2=CC=CC=C21,,,,,,
1242,101243,Ethyl 5-acetamido-2-furoate,CCOC(=O)C1=CC=C(O1)NC(=O)C,,,,,,
1243,101244,4-(p-Chlorophenylazo)phenol,C1=CC(=CC=C1N=NC2=CC=C(C=C2)Cl)O,,,,,,
1244,101245,"4,4'-Dihydroxyazobenzene",C1=CC(=CC=C1N=NC2=CC=C(C=C2)O)O,,,,,,
1245,101246,N-Anilinophthalimide,C1=CC=C(C=C1)NN2C(=O)C3=CC=CC=C3C2=O,,,,,,
1246,101247,Deoxyglucopyranosylthymine,CC1=CN(C(=O)NC1=O)[C@H]2C[C@H]([C@@H]([C@H](O2)CO)O)O,,,,,,
1247,101248,"Acetamide, N-1H-tetrazol-5-yl-",CC(=O)NC1=NNN=N1,,,,,,
1248,101249,2-(4-Fluorophenyl)-2-oxoacetaldehyde,C1=CC(=CC=C1C(=O)C=O)F,,,,,,
1249,101250,"N,N-Diphenylbenzamide",C1=CC=C(C=C1)C(=O)N(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
1250,101251,"15H-Cyclopenta(a)phenanthrene, 12-ethyl-16,17-dihydro-",CCC1=CC2=C(C=CC3=CC=CC=C32)C4=C1CCC4,,,,,,
1251,101252,Tolazine,CC1=CC2=NC3=CC=CC=C3N=C2C=C1,,,,,,
1252,101253,Melicopicine,CN1C2=CC=CC=C2C(=O)C3=C1C(=C(C(=C3OC)OC)OC)OC,,,,,,
1253,101254,2-Fluoro-4-nitroaniline,C1=CC(=C(C=C1[N+](=O)[O-])F)N,,,,,,
1254,101255,CID 101255,C[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C2NC(=NC3=O)N)O)O,,,,,,
1255,101256,4-Deoxypodophyllotoxin,COC1=CC(=CC(=C1OC)OC)[C@@H]2[C@H]3[C@H](CC4=CC5=C(C=C24)OCO5)COC3=O,,,,,,
1256,101257,Tirucallol,C[C@@H](CCC=C(C)C)[C@@H]1CC[C@]2([C@]1(CCC3=C2CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)C)C,,,,,,
1257,101258,"Methane, dichloro(methylsulfonyl)-",CS(=O)(=O)C(Cl)Cl,,,,,,
1258,101259,2-(4-Fluorophenyl)-1H-benzimidazole,C1=CC=C2C(=C1)NC(=N2)C3=CC=C(C=C3)F,,,,,,
1259,101260,2-Fluoro-2-butenedioic acid,C(=C(C(=O)O)F)C(=O)O,,,,,,
1260,101261,"4,4'-Dimethoxy(bi-1,4-cyclohexadien-1-yl)-3,3',6,6'-tetraone",COC1=CC(=O)C(=CC1=O)C2=CC(=O)C(=CC2=O)OC,,,,,,
1261,101262,3-Pentadecylveratrole,CCCCCCCCCCCCCCCC1=C(C(=CC=C1)OC)OC,,,,,,
1262,101263,2-Aminoethanesulfonamide,C(CS(=O)(=O)N)N,,,,,,
1263,101264,5-Fluoronicotinamide,C1=C(C=NC=C1F)C(=O)N,,,,,,
1264,101265,"3,5-Difluorobenzoic acid",C1=C(C=C(C=C1F)F)C(=O)O,,,,,,
1265,101266,6-Methyl-2-pyridinecarbaldehyde oxime,CC1=NC(=CC=C1)C=NO,,,,,,
1266,101267,2-Methoxyethyl hydroxyacetate,COCCOC(=O)CO,,,,,,
1267,101268,2-(Isopropylthio)ethanol,CC(C)SCCO,,,,,,
1268,101269,"Glyceryl 1,3-distearate",CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCCCCCCCC)O,,,,,,
1269,101270,5-(3-Ethyl-1-triazenyl)imidazole-4-carboxamide,CCN=NNC1=C(NC=N1)C(=O)N,,,,,,
1270,101271,"Phosphonic acid, (1-naphthylmethyl)-, diethyl ester",CCOP(=O)(CC1=CC=CC2=CC=CC=C21)OCC,,,,,,
1271,101272,"Phenol, 2,4,6-trichloro-, propanoate",CCC(=O)OC1=C(C=C(C=C1Cl)Cl)Cl,,,,,,
1272,101273,Di-o-tolyl 4-morpholinephosphonate,CC1=CC=CC=C1OP(=O)(N2CCOCC2)OC3=CC=CC=C3C,,,,,,
1273,101274,Pentachlorophenyl butyrate,CCCC(=O)OC1=C(C(=C(C(=C1Cl)Cl)Cl)Cl)Cl,,,,,,
1274,101275,N-(2-Chlorophenyl)butanamide,CCCC(=O)NC1=CC=CC=C1Cl,,,,,,
1275,101276,"6-methoxy-7-[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-2-one",COC1=C(C=C2C(=C1)C=CC(=O)O2)OC3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
1276,101277,Pachyrrhizin,COC1=CC2=C(C=C1C3=CC4=C(C=C5C(=C4)C=CO5)OC3=O)OCO2,,,,,,
1277,101278,2-[(4-Methoxyphenyl)methylene]heptan-1-AL,CCCCCC(=CC1=CC=C(C=C1)OC)C=O,,,,,,
1278,101279,"Benzamide, 4-(1,1-dimethylethyl)-N,N-diethyl-",CCN(CC)C(=O)C1=CC=C(C=C1)C(C)(C)C,,,,,,
1279,101280,6-Bromouracil,C1=C(NC(=O)NC1=O)Br,,,,,,
1280,101281,Pentachlorophenyl-p-chlorobenzoate,C1=CC(=CC=C1C(=O)OC2=C(C(=C(C(=C2Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
1281,101282,"Bis(2,4-dinitrophenyl)carbonate",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])OC(=O)OC2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
1282,101283,"4-((1,3-Benzodioxol-5-ylmethylene)amino)benzoic acid",C1OC2=C(O1)C=C(C=C2)C=NC3=CC=C(C=C3)C(=O)O,,,,,,
1283,101284,"2,2,2-Trifluoro-N-(4-methoxyphenyl)acetamide",COC1=CC=C(C=C1)NC(=O)C(F)(F)F,,,,,,
1284,101285,"1,3-Benzodioxole-5-methanol, formate",C1OC2=C(O1)C=C(C=C2)COC=O,,,,,,
1285,101286,4-(1-Ethylpropyl)pyridine,CCC(CC)C1=CC=NC=C1,,,,,,
1286,101287,Phenol oxazoline,C1COC(=N1)C2=CC=C(C=C2)O,,,,,,
1287,101288,"Acenaphtho(1,2-d)thiazol-8-amine",C1=CC2=C3C(=C1)C4=C(C3=CC=C2)SC(=N4)N,,,,,,
1288,101289,"2-(((2,4-Dichlorophenyl)methylene)amino)benzoic acid",C1=CC=C(C(=C1)C(=O)O)N=CC2=C(C=C(C=C2)Cl)Cl,,,,,,
1289,101290,"Benzoic acid, 2-(((4-methoxyphenyl)methylene)amino)-",COC1=CC=C(C=C1)C=NC2=CC=CC=C2C(=O)O,,,,,,
1290,101291,"Benzeneacetic acid, 4-chloro-alpha-(4-chlorophenyl)-, ethyl ester",CCOC(=O)C(C1=CC=C(C=C1)Cl)C2=CC=C(C=C2)Cl,,,,,,
1291,101292,4-chloro-N-ethylbenzamide,CCNC(=O)C1=CC=C(C=C1)Cl,,,,,,
1292,101293,2-Bromo-5-nitroanisole,COC1=C(C=CC(=C1)[N+](=O)[O-])Br,,,,,,
1293,101294,2-Bromo-1-(3-methoxyphenyl)ethanone,COC1=CC=CC(=C1)C(=O)CBr,,,,,,
1294,101295,"(2Z)-2,3-Diphenyl-2-butenedinitrile",C1=CC=C(C=C1)C(=C(C#N)C2=CC=CC=C2)C#N,,,,,,
1295,101296,4-Amino-2-methoxyphenol,COC1=C(C=CC(=C1)N)O,,,,,,
1296,101297,"1,2,7-Trimethylnaphthalene",CC1=CC2=C(C=C1)C=CC(=C2C)C,,,,,,
1297,101298,"Urea, 1-methyl-1-nitroso-3-(1,2,3,4-tetrahydro-2,4-dioxo-5-pyrimidinyl)-",CN(C(=O)NC1=CNC(=O)NC1=O)N=O,,,,,,
1298,101299,CID 101299,C1=NC(=O)C2=NSNC2=N1,,,,,,
1299,101300,Dicentrine,CN1CCC2=CC3=C(C4=C2[C@@H]1CC5=CC(=C(C=C54)OC)OC)OCO3,,,,,,
1300,101301,Corydaline,C[C@@H]1[C@@H]2C3=CC(=C(C=C3CCN2CC4=C1C=CC(=C4OC)OC)OC)OC,,,['Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)'],,,
1301,101302,"Benzenesulfonamide, p-chloro-N-propyl-",CCCNS(=O)(=O)C1=CC=C(C=C1)Cl,,,,,,
1302,101303,"Benzenesulfonamide, N-butyl-4-chloro-",CCCCNS(=O)(=O)C1=CC=C(C=C1)Cl,,,,,,
1303,101304,N4-Acetyl-N'-diethylsulfanilamide,CCN(CC)S(=O)(=O)C1=CC=C(C=C1)NC(=O)C,,,,,,
1304,101305,N-(4-Bromophenyl)phthalimide,C1=CC=C2C(=C1)C(=O)N(C2=O)C3=CC=C(C=C3)Br,,,,,,
1305,101306,"Ethene, 1,1-diphenyl-2,2-dichloro-",C1=CC=C(C=C1)C(=C(Cl)Cl)C2=CC=CC=C2,,,,,,
1306,101307,"Benzene, 1-chloro-4-(2,2,2-trichloro-1-phenylethyl)-",C1=CC=C(C=C1)C(C2=CC=C(C=C2)Cl)C(Cl)(Cl)Cl,,,,,,
1307,101308,Dihexyl succinate,CCCCCCOC(=O)CCC(=O)OCCCCCC,,,,,,
1308,101309,4-bromo-N-isobutylbenzenesulfonamide,CC(C)CNS(=O)(=O)C1=CC=C(C=C1)Br,,,,,,
1309,101310,4-Methyl-N-(2-methylpropyl)benzenesulfonamide,CC1=CC=C(C=C1)S(=O)(=O)NCC(C)C,,,,,,
1310,101311,N-(2-Bromophenyl)benzamide,C1=CC=C(C=C1)C(=O)NC2=CC=CC=C2Br,,,,,,
1311,101312,"N,N-Dibenzylbenzamide",C1=CC=C(C=C1)CN(CC2=CC=CC=C2)C(=O)C3=CC=CC=C3,,,,,,
1312,101313,"1H-Isoindole-1,3(2H)-dione, 2-(2-nitrophenyl)-",C1=CC=C2C(=C1)C(=O)N(C2=O)C3=CC=CC=C3[N+](=O)[O-],,,,,,
1313,101314,N-(4-nitrophenyl)phthalimide,C1=CC=C2C(=C1)C(=O)N(C2=O)C3=CC=C(C=C3)[N+](=O)[O-],,,,,,
1314,101315,Heptyl phenylacetate,CCCCCCCOC(=O)CC1=CC=CC=C1,,,,,,
1315,101316,"2,2,2-Trifluoro-n-[3-(trifluoromethyl)phenyl]acetamide",C1=CC(=CC(=C1)NC(=O)C(F)(F)F)C(F)(F)F,,,,,,
1316,101317,"1-beta-D-Arabinofuranosyl-5-fluoro-(1H,3H)-pyrimidine-2,4-dione",C1=C(C(=O)NC(=O)N1[C@H]2[C@H]([C@@H]([C@H](O2)CO)O)O)F,,,,,,
1317,101318,CID 101318,C12=NSNC1=NC(=O)NC2=O,,,,,,
1318,101319,"Anthranilic acid, N-(o-nitrophenyl)-",C1=CC=C(C(=C1)C(=O)O)NC2=CC=CC=C2[N+](=O)[O-],,,,,,
1319,101320,"N-(2,6-Dimethylphenyl)propionamide",CCC(=O)NC1=C(C=CC=C1C)C,,,,,,
1320,101321,"N-(2,6-Dimethylphenyl)benzamide",CC1=C(C(=CC=C1)C)NC(=O)C2=CC=CC=C2,,,,,,
1321,101322,2-(2-Hydroxyethoxy)ethyl myristate,CCCCCCCCCCCCCC(=O)OCCOCCO,,,,,,
1322,101323,2-(2-Hydroxyethoxy)ethyl palmitate,CCCCCCCCCCCCCCCC(=O)OCCOCCO,,,,,,
1323,101324,Diethylene glycol dipalmitate,CCCCCCCCCCCCCCCC(=O)OCCOCCOC(=O)CCCCCCCCCCCCCCC,,,,,,
1324,101325,2-Anthracenecarboxylic acid,C1=CC=C2C=C3C=C(C=CC3=CC2=C1)C(=O)O,,,,,,
1325,101326,"Ethane, 1,1-bis(4-chlorophenyl)-2,2-dibromo-",C1=CC(=CC=C1C(C2=CC=C(C=C2)Cl)C(Br)Br)Cl,,,,,,
1326,101327,N-(3-chlorophenyl)-3-nitrobenzamide,C1=CC(=CC(=C1)[N+](=O)[O-])C(=O)NC2=CC(=CC=C2)Cl,,,,,,
1327,101328,"3-(1,3-Benzodioxol-5-yl)-1-(4-methylphenyl)prop-2-en-1-one",CC1=CC=C(C=C1)C(=O)C=CC2=CC3=C(C=C2)OCO3,,,,,,
1328,101329,2-(1-Methylheptylidene)hydrazinecarboxamide,CCCCCCC(=NNC(=O)N)C,,,,,,
1329,101330,Cyclohexyl 2-hydroxybenzoate,C1CCC(CC1)OC(=O)C2=CC=CC=C2O,,,,,,
1330,101331,Methyl 2-(4-tert-butylphenoxy)acetate,CC(C)(C)C1=CC=C(C=C1)OCC(=O)OC,,,,,,
1331,101332,"Benzenesulfonic acid, p-bromo-, p-nitrophenyl ester",C1=CC(=CC=C1[N+](=O)[O-])OS(=O)(=O)C2=CC=C(C=C2)Br,,,,,,
1332,101333,"2,2,2-Trichloro-n-(2,5-dichlorophenyl)acetamide",C1=CC(=C(C=C1Cl)NC(=O)C(Cl)(Cl)Cl)Cl,,,,,,
1333,101334,N-[1-(4-methylphenyl)ethylidene]hydroxylamine,CC1=CC=C(C=C1)C(=NO)C,,,,,,
1334,101335,2-(Allyloxy)benzaldehyde,C=CCOC1=CC=CC=C1C=O,,,,,,
1335,101336,Ethyl 3-(4-chlorophenyl)-3-oxopropanoate,CCOC(=O)CC(=O)C1=CC=C(C=C1)Cl,,,,,,
1336,101337,"2-Propenoic acid, 2-cyano-3-(4-methoxyphenyl)-, ethyl ester",CCOC(=O)C(=CC1=CC=C(C=C1)OC)C#N,,,,,,
1337,101338,Isobutyl laurate,CCCCCCCCCCCC(=O)OCC(C)C,,,,,,
1338,101339,4-chloro-N-methylbenzamide,CNC(=O)C1=CC=C(C=C1)Cl,,,,,,
1339,101340,"Phenol, 2-methyl-4-(phenylazo)-",CC1=C(C=CC(=C1)N=NC2=CC=CC=C2)O,,,,,,
1340,101341,Friedelanol,C[C@H]1[C@@H](CC[C@@H]2[C@@]1(CC[C@H]3[C@]2(CC[C@@]4([C@@]3(CC[C@@]5([C@H]4CC(CC5)(C)C)C)C)C)C)C)O,,,,,,
1341,101342,"1-(3-Fluorophenyl)-1H-pyrrole-2,5-dione",C1=CC(=CC(=C1)F)N2C(=O)C=CC2=O,,,,,,
1342,101343,"1-Acetyl-3-((2,3,4,6-tetra-O-acetyl-beta-D-glucopyranosyl)oxy)-1H-indole",CC(=O)N1C=C(C2=CC=CC=C21)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)COC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
1343,101344,"1,4-Dipiperidino-2-butyne",C1CCN(CC1)CC#CCN2CCCCC2,,,,,,
1344,101345,"Benzamide, 4-nitro-N-2-pyridinyl-",C1=CC=NC(=C1)NC(=O)C2=CC=C(C=C2)[N+](=O)[O-],,,,,,
1345,101346,"2-Propenoic acid, 3-(2-bromophenyl)-",C1=CC=C(C(=C1)C=CC(=O)O)Br,,,,,,
1346,101347,"2,7-Dimethyl-9h-fluorene",CC1=CC2=C(C=C1)C3=C(C2)C=C(C=C3)C,,,,,,
1347,101348,"Phosphinic acid, diethyl-, anhydride with diethyl phosphorothionate",CCOP(=S)(OCC)OP(=O)(CC)CC,,,,,,
1348,101349,"Phosphonic acid, (o-bromophenyl)-",C1=CC=C(C(=C1)P(=O)(O)O)Br,,,,,,
1349,101350,"O,O-Diethyl ethylphosphonothioate",CCOP(=S)(CC)OCC,,,,,,
1350,101351,p-Tolylphosphonic acid,CC1=CC=C(C=C1)P(=O)(O)O,,,,,,
1351,101352,"Benzenesulfonamide, N,N-bis(2-cyanoethyl)-",C1=CC=C(C=C1)S(=O)(=O)N(CCC#N)CCC#N,,,,,,
1352,101353,"9,10-Phenanthrenediol, monoacetate",CC(=O)OC1=C(C2=CC=CC=C2C3=CC=CC=C31)O,,,,,,
1353,101354,"Phosphoric acid, bis(1-isobutyl-3-methylbutyl) ester",CC(C)CC(CC(C)C)OP(=O)(O)OC(CC(C)C)CC(C)C,,,,,,
1354,101355,"3-Methoxy-2,5-toluquinone",CC1=CC(=O)C=C(C1=O)OC,,,,,,
1355,101356,"1,5-Bis(tetrahydro-2-furyl)-3-pentanol propionate",CCC(=O)OC(CCC1CCCO1)CCC2CCCO2,,,,,,
1356,101357,N-(4-Bromophenyl)benzamide,C1=CC=C(C=C1)C(=O)NC2=CC=C(C=C2)Br,,,,,,
1357,101358,CID 101358,C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O)O)O)N=C(N=C2S)N,,,,,,
1358,101359,3-(4-Fluorobenzoyl)propionic acid,C1=CC(=CC=C1C(=O)CCC(=O)O)F,,,,,['P-Fluorobenzoylpropionic acid and 4-(4-chlorophenyl)-4-hydroxypiperidine is a known human metabolite of haloperidol.'],
1359,101360,"1-(4-nitrophenyl)-4,5-dihydro-1H-1,2,3-triazole",C1CN(N=N1)C2=CC=C(C=C2)[N+](=O)[O-],,,,,,
1360,101361,"2-Hexenoic acid,2-cyano-3-methyl-, ethyl ester",CCCC(=C(C#N)C(=O)OCC)C,,,,,,
1361,101362,4-Pentenophenone,C=CCCC(=O)C1=CC=CC=C1,,,,,,
1362,101363,"1,1-Diethoxydecane",CCCCCCCCCC(OCC)OCC,,,,,,
1363,101364,"1,1-Diethoxyoctane",CCCCCCCC(OCC)OCC,,,,,,
1364,101365,Ethyl 2-(methylamino)benzoate,CCOC(=O)C1=CC=CC=C1NC,,,,,,
1365,101366,Propyl 3-(4-methoxyphenyl)acrylate,CCCOC(=O)C=CC1=CC=C(C=C1)OC,,,,,,
1366,101367,"Carbanilic acid, 3-chloro-, 2-butenylene ester",C1=CC(=CC(=C1)Cl)NC(=O)OCC#CCOC(=O)NC2=CC(=CC=C2)Cl,,,,,,
1367,101368,Dodecylsulfonylacetic acid,CCCCCCCCCCCCS(=O)(=O)CC(=O)O,,,,,,
1368,101369,"(2,6-Dimethylphenoxy)acetic acid",CC1=C(C(=CC=C1)C)OCC(=O)O,,,,,,
1369,101370,"1,2,3,4-Tetrahydro-2-naphthoic acid",C1CC2=CC=CC=C2CC1C(=O)O,,,,,,
1370,101371,Diethylstilbestrol pinacolone,CCC(=O)C(CC)(C1=CC=C(C=C1)O)C2=CC=C(C=C2)O,,,,,,
1371,101372,Benzamidoacetonitrile,C1=CC=C(C=C1)C(=O)NCC#N,,,,,,
1372,101373,"4-Morpholinepropanoic acid, methyl ester",COC(=O)CCN1CCOCC1,,,,,,
1373,101374,N-Dodecyl-N-methylaniline,CCCCCCCCCCCCN(C)C1=CC=CC=C1,,,,,,
1374,101375,"Benzil, 3,5'-dinitro-",C1=CC(=CC(=C1)[N+](=O)[O-])C(=O)C(=O)C2=CC(=CC=C2)[N+](=O)[O-],,,,,,
1375,101376,CID 101376,C1=CC=NC(=C1)C=C2C(=O)N=C(S2)S,,,,,,
1376,101377,CID 101377,C1=CN=CC=C1C=C2C(=O)N=C(S2)S,,,,,,
1377,101378,"Urea, 1,1'-pentamethylenebis(3-methyl-3-nitroso-",CN(C(=O)NCCCCCNC(=O)N(C)N=O)N=O,,,,,,
1378,101379,Demissidine,C[C@H]1CC[C@@H]2[C@H]([C@H]3[C@@H](N2C1)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@@H]6[C@@]5(CC[C@@H](C6)O)C)C)C,,,,,,
1379,101380,4-(2-Anthryl)butanoic acid,C1=CC=C2C=C3C=C(C=CC3=CC2=C1)CCCC(=O)O,,,,,,
1380,101381,"2,5-Diamino-3,4-thiophenedicarbonitrile",C(#N)C1=C(SC(=C1C#N)N)N,,,,,,
1381,101382,6-Methylaminopurine arabinoside,CNC1=C2C(=NC=N1)N(C=N2)[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
1382,101383,N-Diphenylacetylglycine,C1=CC=C(C=C1)C(C2=CC=CC=C2)C(=O)NCC(=O)O,,,,,,
1383,101384,"4-Hexenoic acid, cis + trans",CC=CCCC(=O)O,,,,,,
1384,101385,CID 101385,C[C@H]([C@@]1([C@H]([C@H]([C@@H](O1)N2C=NC3=C2N=CN=C3S)O)O)C)O,,,,,,
1385,101386,3-Benzoylbenzoic acid,C1=CC=C(C=C1)C(=O)C2=CC(=CC=C2)C(=O)O,,,,,,
1386,101387,7-Methyl-2-fluorobenz[a]anthracene,CC1=C2C=CC3=C(C2=CC4=CC=CC=C14)C=C(C=C3)F,,,,,,
1387,101388,"Benzoic acid, p-(3-methyl-3-nitrosoureido)-",CN(C(=O)NC1=CC=C(C=C1)C(=O)O)N=O,,,,,,
1388,101389,"O,O,O-Tris(4-nitrophenyl) thiophosphate",C1=CC(=CC=C1[N+](=O)[O-])OP(=S)(OC2=CC=C(C=C2)[N+](=O)[O-])OC3=CC=C(C=C3)[N+](=O)[O-],,,,,,
1389,101390,2-Phenoxyacetohydrazide,C1=CC=C(C=C1)OCC(=O)NN,,,,,,
1390,101391,Chloroethylmethylnitrosourea,CN(C(=O)NCCCl)N=O,,,,,,
1391,101392,Hydroxypyruvaldehyde,C(C(=O)C=O)O,,,,,,
1392,101393,Hexyl methyl phthalate,CCCCCCOC(=O)C1=CC=CC=C1C(=O)OC,,,,,,
1393,101394,CID 101394,C1=CC2=C(C=C1Cl)SC(=N2)S,,,,,,
1394,101395,CID 101395,C1=CC=C(C=C1)C(=O)NNC(=NC2=CC=CC=C2)S,,,,,,
1395,101396,"Carbamic acid, (benzoyloxy)-, ethyl ester",CCOC(=O)NOC(=O)C1=CC=CC=C1,,,,,,
1396,101397,"Benzene, 1,1'-((methylsulfonyl)methylene)bis(4-chloro-",CS(=O)(=O)C(C1=CC=C(C=C1)Cl)C2=CC=C(C=C2)Cl,,,,,,
1397,101398,CID 101398,C1=CC=C(C=C1)C=C2C(=O)N=C(S2)NC3=CC=CC=C3,,,,,,
1398,101399,2-(Formylamino)benzoic acid,C1=CC=C(C(=C1)C(=O)O)NC=O,,,,,,
1399,101400,"7-Hydroxy-5-methyl-2-methylthio-s-triazolo[1,5-a]pyrimidine",CC1=CC(=O)N2C(=N1)N=C(N2)SC,,,,,,
1400,101401,4-Amino-4'-iodobiphenyl,C1=CC(=CC=C1C2=CC=C(C=C2)I)N,,,,,,
1401,101402,4-(4-Methoxyphenoxy)aniline,COC1=CC=C(C=C1)OC2=CC=C(C=C2)N,,,,,,
1402,101403,"Anthranilic acid, N-(m-nitrophenyl)-",C1=CC=C(C(=C1)C(=O)O)NC2=CC(=CC=C2)[N+](=O)[O-],,,,,,
1403,101404,"Benzenesulfonamide, N-(4-chloro-2,6-dinitrophenyl)-4-methyl-",CC1=CC=C(C=C1)S(=O)(=O)NC2=C(C=C(C=C2[N+](=O)[O-])Cl)[N+](=O)[O-],,,,,,
1404,101405,"2,5-Dimethoxy-1,4-benzoquinone",COC1=CC(=O)C(=CC1=O)OC,,,,,,
1405,101406,1-Chloro-2-(ethylsulfonyl)ethane,CCS(=O)(=O)CCCl,,,,,,
1406,101407,Methyl(aziridinyl)phosphine oxide,CP(=O)(N1CC1)N2CC2,,,,,,
1407,101408,"Phosphorodiamidic acid, tetramethyl-, methyl ester",CN(C)P(=O)(N(C)C)OC,,,,,,
1408,101409,"1,1'-Spirobi[1H-indene]-5,5',6,6',7,7'-hexol, 2,2',3,3'-tetrahydro-3,3,3',3'-tetramethyl-",CC1(CC2(CC(C3=CC(=C(C(=C32)O)O)O)(C)C)C4=C(C(=C(C=C41)O)O)O)C,,,,,,
1409,101410,"1,1,1-Tris(methanesulfonyloxymethyl)propane",CCC(COS(=O)(=O)C)(COS(=O)(=O)C)COS(=O)(=O)C,,,,,,
1410,101411,5-Carbethoxyuracil,CCOC(=O)C1=CNC(=O)NC1=O,,,,,,
1411,101412,2-Amino-5-fluorobenzoic acid,C1=CC(=C(C=C1F)C(=O)O)N,,,,,,
1412,101413,Thiodipin,C1CN1P(=S)(N2CC2)N3CCN(CC3)P(=S)(N4CC4)N5CC5,,,,,,
1413,101414,Phenidet,C1CN1P(=O)(NC2=CC=CC=C2)N3CC3,,,,,,
1414,101415,N-phenyldiazenyl-N-propylpropan-1-amine,CCCN(CCC)N=NC1=CC=CC=C1,,,,,,
1415,101416,"3,3-Bis(1-methylethyl)-1-phenyl-1-triazene",CC(C)N(C(C)C)N=NC1=CC=CC=C1,,,,,,
1416,101417,2-methyl-N-(2-methylpropyl)-N-phenyldiazenylpropan-1-amine,CC(C)CN(CC(C)C)N=NC1=CC=CC=C1,,,,,,
1417,101418,9-(6-Deoxy-alpha-L-mannofuranosyl)adenine,C[C@@H]([C@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C(N=CN=C32)N)O)O)O,,,,,,
1418,101419,"1,3,7-Triethylxanthine",CCN1C=NC2=C1C(=O)N(C(=O)N2CC)CC,,,,,,
1419,101420,"1,3-Diethylxanthine",CCN1C2=C(C(=O)N(C1=O)CC)NC=N2,,,,,,
1420,101421,"1,3-Dibutylxanthine",CCCCN1C2=C(C(=O)N(C1=O)CCCC)NC=N2,,,,,,
1421,101422,"Theophylline, 7-(2-propynyl)-",CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC#C,,,,,,
1422,101423,"4,4''-Dinitro-p-terphenyl",C1=CC(=CC=C1C2=CC=C(C=C2)[N+](=O)[O-])C3=CC=C(C=C3)[N+](=O)[O-],,,,,,
1423,101424,Bis(2-nitrophenyl) diselenide,C1=CC=C(C(=C1)[N+](=O)[O-])[Se][Se]C2=CC=CC=C2[N+](=O)[O-],,,,,,
1424,101425,"Nicotinic acid, 2-(((p-acetamido)phenyl)sulfonyl)hydrazide",CC(=O)NC1=CC=C(C=C1)S(=O)(=O)NNC(=O)C2=CN=CC=C2,,,,,,
1425,101426,Aminoacethydrazide,C(C(=O)NN)N,,,,,,
1426,101427,"Ethanol, 2,2',2'',2'''-((2,6-di-4-morpholinylpyrimido(5,4-d)pyrimidine-4,8-diyl)dinitrilo)tetrakis-",C1COCCN1C2=NC3=C(C(=N2)N(CCO)CCO)N=C(N=C3N(CCO)CCO)N4CCOCC4,,,,,,
1427,101428,"2,2',2'',2'''-(Pyrimido(5,4-d)pyrimidine-2,4,6,8-tetrayltetrakis(methylimino))tetrakisethanol",CN(CCO)C1=NC(=NC2=C1N=C(N=C2N(C)CCO)N(C)CCO)N(C)CCO,,,,,,
1428,101429,"1H-Purin-6-amine, N-dodecyl-",CCCCCCCCCCCCNC1=NC=NC2=C1NC=N2,,,,,,
1429,101430,N6-Phenyladenosine,C1=CC=C(C=C1)NC2=C3C(=NC=N2)N(C=N3)[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O,,,,,,
1430,101431,CID 101431,C1[C@@H]([C@H](O[C@H]1N2C=CC(=NC2=O)S)CO)O,,,,,,
1431,101432,"Methanone, (2,5-dimethoxy-4-nitrophenyl)phenyl-",COC1=CC(=C(C=C1C(=O)C2=CC=CC=C2)OC)[N+](=O)[O-],,,,,,
1432,101433,CID 101433,CC1=NC(=O)C(=C(N1)N)OS(=O)(=O)O,,,,,,
1433,101434,"2,3-Pyridinedicarboxylic acid, dihydrazide",C1=CC(=C(N=C1)C(=O)NN)C(=O)NN,,,,,,
1434,101435,"Cyclohexane-1,4-dicarbonitrile",C1CC(CCC1C#N)C#N,,,,,,
1435,101436,N4-Methylcytidine,CNC1=NC(=O)N(C=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,,,,,,
1436,101437,(4-Acetamidophenoxy)acetic acid,CC(=O)NC1=CC=C(C=C1)OCC(=O)O,,,,,,
1437,101438,1H-Indazol-5-ol,C1=CC2=C(C=C1O)C=NN2,,,,,,
1438,101439,N-(2-Chloroethyl)benzamide,C1=CC=C(C=C1)C(=O)NCCCl,,,,,,
1439,101440,CID 101440,CC1=NN=C(N1C)S,,,,,,
1440,101441,"1-Cyano-2,3-bis(hydroxymethyl)guanidine",C(NC(=NCO)NC#N)O,,,,,,
1441,101442,"(2,4,6-Triamino-5-pyrimidinylazo)benzene-4-sulfonic acid",C1=CC(=CC=C1N=NC2=C(N=C(N=C2N)N)N)S(=O)(=O)O,,,,,,
1442,101443,"(p-((2,4,6-Triamino-5-pyrimidinyl)azo)phenyl)phosphonic acid",C1=CC(=CC=C1N=NC2=C(N=C(N=C2N)N)N)P(=O)(O)O,,,,,,
1443,101444,1-(3-Chlorophenyl)-4-(3-chloropropyl)piperazine,C1CN(CCN1CCCCl)C2=CC(=CC=C2)Cl,,,,,,
1444,101445,Propiolamide,C#CC(=O)N,,,,,,
1445,101446,7-Allyltheophylline,CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CC=C,,,,,,
1446,101447,CID 101447,C1=CC=C2C(=C1)C(=C3C=CC=CC3=N2)S,,,,,,
1447,101448,4-[(Dimethylhydrazinylidene)methyl]-5-(hydroxymethyl)-2-methylpyridin-3-ol,CC1=NC=C(C(=C1O)C=NN(C)C)CO,,,,,,
1448,101449,CID 101449,CCOC(=C(C#N)C(=N)S)C,,,,,,
1449,101450,Benzyl selenocyanate,C1=CC=C(C=C1)C[Se]C#N,,,,,,
1450,101451,"3,5-Dibromobenzene-1,2-diamine",C1=C(C=C(C(=C1N)N)Br)Br,,,,,,
1451,101452,"4-Phenylpiperidine-2,6-dione",C1C(CC(=O)NC1=O)C2=CC=CC=C2,,,,,,
1452,101453,"3-(3,4-Dichlorophenyl)-1,1-bis(2-hydroxyethyl)urea",C1=CC(=C(C=C1NC(=O)N(CCO)CCO)Cl)Cl,,,,,,
1453,101454,"2-Butynylamine, N,N,1,1-tetramethyl-",CC#CC(C)(C)N(C)C,,,,,,
1454,101455,Ethoxymethylenecyanoacetic acid methyl ester,CCOC=C(C#N)C(=O)OC,,,,,,
1455,101456,"3-(Methylthio)-1,2,4-thiadiazol-5-amine",CSC1=NSC(=N1)N,,,,,,
1456,101457,"Glycine, N-(1-naphthalenylcarbonyl)-",C1=CC=C2C(=C1)C=CC=C2C(=O)NCC(=O)O,,,,,,
1457,101458,"5,6-Dimethylbenz(c)acridine",CC1=C(C2=CC3=CC=CC=C3N=C2C4=CC=CC=C14)C,,,,,,
1458,101459,"1,3,4-Thiadiazol-2-amine, 5-(ethylthio)-",CCSC1=NN=C(S1)N,,,,,,
1459,101460,2-Bromobenzohydrazide,C1=CC=C(C(=C1)C(=O)NN)Br,,,,,,
1460,101461,"N-(2-Bromoethyl)-3,4,5-trimethoxybenzamide",COC1=CC(=CC(=C1OC)OC)C(=O)NCCBr,,,,,,
1461,101462,4-Chloro-19-nortestosterone acetate,CC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=C(C(=O)CC[C@H]34)Cl)C,,,,,,
1462,101463,"2,2'-Biimidazole",C1=CN=C(N1)C2=NC=CN2,,,,,,
1463,101464,Phenothiazine-10-carboxamide,C1=CC=C2C(=C1)N(C3=CC=CC=C3S2)C(=O)N,,,,,,
1464,101465,22-Oxocholesterol,C[C@@H]([C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)C(=O)CCC(C)C,,,,,,
1465,101466,N-Cyclopropylisonicotinamide,C1CC1NC(=O)C2=CC=NC=C2,,,,,,
1466,101467,4-(5-Nitro-2-furanyl)-N-phenyl-2-thiazolamine,C1=CC=C(C=C1)NC2=NC(=CS2)C3=CC=C(O3)[N+](=O)[O-],,,,,,
1467,101468,CID 101468,C[C@@]12CCC3=CC(=O)CC[C@]3([C@@H]1CC[C@]4([C@H]2CC[C@@H]4O)C)C,,,,,,
1468,101469,"2,4-Dibromo-6-nitrophenol",C1=C(C=C(C(=C1[N+](=O)[O-])O)Br)Br,,,,,,
1469,101470,"1-(4-Chlorophenyl)-3,4-dibromo-2,5-pyrrolidinedione",C1=CC(=CC=C1N2C(=O)C(C(C2=O)Br)Br)Cl,,,,,,
1470,101471,"5-Amino-2,4-dichlorophenol",C1=C(C(=CC(=C1O)Cl)Cl)N,,,,,,
1471,101472,"Acetamide, N-(5-((phenylmethyl)thio)-1,3,4-thiadiazol-2-yl)-",CC(=O)NC1=NN=C(S1)SCC2=CC=CC=C2,,,,,,
1472,101473,[[3-Hydroxy-5-(hydroxymethyl)-2-methylpyridin-4-yl]methylideneamino]urea,CC1=NC=C(C(=C1O)C=NNC(=O)N)CO,,,,,,
1473,101474,Testosterone benzoate,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)C4=CC=CC=C4)CCC5=CC(=O)CC[C@]35C,,,,,,
1474,101475,CID 101475,CC1=CC(=O)N=C(N1)NC2=NC3=CC=CC=C3N2,,,,,,
1475,101476,o-Carboxybenzhydroxamic acid,C1=CC=C(C(=C1)C(=O)NO)C(=O)O,,,,,,
1476,101477,"2,2'-Oxybis(5,5-dimethyl-1,3,2-dioxaborinane)",B1(OCC(CO1)(C)C)OB2OCC(CO2)(C)C,,,,,,
1477,101478,CID 101478,CN=C(C1=CC=CC=C1)S,,,,,,
1478,101479,2-chloro-N-(2-methylphenyl)acetamide,CC1=CC=CC=C1NC(=O)CCl,,,,,,
1479,101480,"p-Toluenesulfonamide, N-(2-dimethylaminoethyl)-",CC1=CC=C(C=C1)S(=O)(=O)NCCN(C)C,,,,,,
1480,101481,1H-indole-3-carbaldehyde oxime,C1=CC=C2C(=C1)C(=CN2)C=NO,,,,,,
1481,101482,1-pyridin-3-yl-N-(pyridin-3-ylmethylideneamino)methanimine,C1=CC(=CN=C1)C=NN=CC2=CN=CC=C2,,,,,,
1482,101483,1-(3-Methoxyphenyl)urea,COC1=CC=CC(=C1)NC(=O)N,,,,,,
1483,101484,2'-Chloro-2'-deoxyuridine,C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)Cl,,,,,,
1484,101485,"2,3-Dichlorobut-2-enedinitrile",C(#N)C(=C(C#N)Cl)Cl,,,,,,
1485,101486,Picolinealdehyde-2-quinolylhydrazone,C1=CC=C2C(=C1)C=CC(=N2)NN=CC3=CC=CC=N3,,,,,,
1486,101487,"1-(2,4-Dinitrophenyl)pyrazole",C1=CN(N=C1)C2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
1487,101488,CID 101488,C1CCN(CC1)C2=NC(=C3C(=N2)N=C(N3)S)N,,,,,,
1488,101489,CID 101489,CC1=C2C(=C3C=C(C=CC3=N2)[N+](=O)[O-])C=CN1,,,,,,
1489,101490,"Morpholine, 4-(methoxymethyl)-",COCN1CCOCC1,,,,,,
1490,101491,"3-Hydroxy-2,4,5-trihydroxymethylpyridine",C1=C(C(=C(C(=N1)CO)O)CO)CO,,,,,,
1491,101492,2-Amino-5-(2-hydroxyethyl)pyrimidin-4-ol,C1=C(C(=O)NC(=N1)N)CCO,,,,,,
1492,101493,"P-Toluidine, N-methyl-N-nitroso-",CC1=CC=C(C=C1)N(C)N=O,,,,,,
1493,101494,5-Bromo-2-hydroxypyrimidine,C1=C(C=NC(=O)N1)Br,,,,,,
1494,101495,"N-[bis(aziridin-1-yl)phosphoryl]-5-methyl-1,3,4-thiadiazol-2-amine",CC1=NN=C(S1)NP(=O)(N2CC2)N3CC3,,,,,,
1495,101496,2-[2-(5-Nitrofuryl)vinyl]quinoline,C1=CC=C2C(=C1)C=CC(=N2)C=CC3=CC=C(O3)[N+](=O)[O-],,,,,,
1496,101497,5-Fluoro-4-hydroxypyrimidine,C1=C(C(=O)NC=N1)F,,,,,,
1497,101498,5-Fluoropyrimidin-2-one,C1=C(C=NC(=O)N1)F,,,,,,
1498,101499,"Acetamide, N-(acetyloxy)-N-methyl-",CC(=O)N(C)OC(=O)C,,,,,,
1499,101500,2-[2-(5-nitro-2-furyl)vinyl]quinoline N-oxide,C1=CC=C2C(=C1)C=CC(=[N+]2[O-])C=CC3=CC=C(O3)[N+](=O)[O-],,,,,,
1500,101501,2-[2-(5-Nitro-2-furyl)vinyl]quinoline-4-carboxylic acid amide,C1=CC=C2C(=C1)C(=CC(=N2)C=CC3=CC=C(O3)[N+](=O)[O-])C(=O)N,,,,,,
1501,101502,"Hydrazine, 1-acetyl-2-(p-butoxybenzyl)-",CCCCOC1=CC=C(C=C1)CNNC(=O)C,,,,,,
1502,101503,"Hydrazine, 1-(p-acetamidobenzyl)-2-acetyl-",CC(=O)NC1=CC=C(C=C1)CNNC(=O)C,,,,,,
1503,101504,"1H-Imidazole-4,5-dicarboxamide, N,N'-dimethyl-",CNC(=O)C1=C(N=CN1)C(=O)NC,,,,,,
1504,101505,[Hydroxymethyl-[4-[2-(5-nitrofuran-2-yl)ethenyl]pyrimidin-2-yl]amino]methanol,C1=CN=C(N=C1C=CC2=CC=C(O2)[N+](=O)[O-])N(CO)CO,,,,,,
1505,101506,((4-(2-(5-Nitro-2-furyl)vinyl)-2-quinolyl)imino)dimethanol,C1=CC=C2C(=C1)C(=CC(=N2)N(CO)CO)C=CC3=CC=C(O3)[N+](=O)[O-],,,,,,
1506,101507,2'-Deoxy-2'-fluorocytidine,C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)F,,,,,,
1507,101508,"2,4(1H,3H)-Pyrimidinedione, 1-(3-chloro-3-deoxy-beta-D-arabinofuranosyl)-",C1=CN(C(=O)NC1=O)[C@H]2[C@H]([C@@H]([C@H](O2)CO)Cl)O,,,,,,
1508,101509,CID 101509,C1=NC2=C(N1)C(=NC=N2)N(N=O)O,,,,,,
1509,101510,2'-Chlorothymidine,CC1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)Cl,,,,,,
1510,101511,N(6)-Methoxyadenine,CONC1=NC=NC2=C1NC=N2,,,,,,
1511,101512,"6,6'-Azopurine",C1=NC2=C(N1)C(=NC=N2)N=NC3=NC=NC4=C3NC=N4,,,,,,
1512,101513,2-Amino-N6-hydroxyadenine,C1=NC2=C(N1)C(=NC(=N2)N)NO,,,['Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)'],,,
1513,101514,"1H-1,2,3-Triazolo(4,5-d)pyrimidin-7-amine, N-hydroxy-",C1=NC2=NNN=C2C(=N1)NO,,,,,,
1514,101515,2-Chloro-N-hydroxyadenine,C1=NC2=C(N1)C(=NC(=N2)Cl)NO,,,,,,
1515,101516,N-Methoxyadenosine,CONC1=C2C(=NC=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
1516,101517,"Adenine, N-hydroxy-N-methyl-",CN(C1=NC=NC2=C1NC=N2)O,,,,,,
1517,101518,"(2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-[hydroxy(methyl)amino]purin-9-yl]oxolane-3,4-diol",CN(C1=NC=NC2=C1N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
1518,101519,Myomontanone,C[C@H]1CC(=C(C1)C(=O)C2=COC=C2)CC(C)C,,,,,,
1519,101520,Tingenone,C[C@@H]1C[C@@H]2[C@@](CC[C@]3([C@]2(CC[C@@]4(C3=CC=C5C4=CC(=O)C(=C5C)O)C)C)C)(CC1=O)C,,,"['Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)']",,,
1520,101521,4-Acetyl-4-phenylpiperidine,CC(=O)C1(CCNCC1)C2=CC=CC=C2,,,,,,
1521,101522,"4-[3-[(3,4-Dimethoxyphenyl)methyl]-4-methoxy-2-(methoxymethyl)butyl]-1,2-dimethoxybenzene",COCC(CC1=CC(=C(C=C1)OC)OC)C(CC2=CC(=C(C=C2)OC)OC)COC,,,,,,
1522,101523,Elsinochrome A,CC(=O)[C@@H]1[C@H](C2=C3C4=C1C(=C(C5=C4C(=C6C3=C(C(=O)C=C6OC)C(=C2OC)O)C(=CC5=O)OC)O)OC)C(=O)C,,,,,,
1523,101524,Becatecarin,CCN(CC)CCN1C(=O)C2=C3C4=C(C(=CC=C4)Cl)NC3=C5C(=C2C1=O)C6=C(N5[C@H]7[C@@H]([C@H]([C@@H]([C@H](O7)CO)OC)O)O)C(=CC=C6)Cl,"['Investigated for use/treatment in cancer/tumors (unspecified), liver cancer, gastric cancer, and leukemia (unspecified).']",,,,,
1524,101525,Primisulfuron-methyl,COC(=O)C1=CC=CC=C1S(=O)(=O)NC(=O)NC2=NC(=CC(=N2)OC(F)F)OC(F)F,,,,,"['The major pathway in the metabolism of primisulfuron-methyl in the rat and other large animals involves hydroxylation of the pyrimidine ring, followed by hydrolysis and/or glucuronic acid conjugation.', 'In maize, a major metabolite is the O-glucoside of 5-hydroxy-primisulfuron. At harvest time, no residues >0.05 mg/kg are detectable in the grain and fodder of maize.']",
1525,101526,Moxifloxacin Hydrochloride,COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O.Cl,"['Acute Exacerbation of Chronic Bronchitis, Community Acquired Pneumonia, Complicated Intra-Abdominal Infection, Complicated Skin and Skin Structure Infections, Pelvic Inflammatory Disease, Treatment of acute bacterial sinusitis']",,"['Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)', 'Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)']",,,
1526,101527,"7-[(4aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid",COC1=C2C(=CC(=C1N3C[C@@H]4CCCNC4C3)F)C(=O)C(=CN2C5CC5)C(=O)O,,,,,,
1527,101528,"6alpha,9-Difluoro-11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione 21-acetate",CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C)O,,,,,,
1528,101529,"3,4-Dihydroxyphenyl-a-methylalanine",CC(C1=CC(=C(C=C1)O)O)C(C(=O)O)N,,,,,,
1529,101530,"[(3S,5S,8R,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl] acetate",CC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(C=C[C@H](C4)O)C)C,,,,,,
1530,101531,"2,3-Bis(p-hydroxyphenyl)valeronitrile",CCC(C1=CC=C(C=C1)O)C(C#N)C2=CC=C(C=C2)O,,,,,,
1531,101532,Synephrine tartrate,CNCC(C1=CC=C(C=C1)O)O.CNCC(C1=CC=C(C=C1)O)O.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O,,,,,,
1532,101533,2-(Dimethylamino)ethyl benzilate hydrochloride,CN(C)CCOC(=O)C(C1=CC=CC=C1)(C2=CC=CC=C2)O.Cl,,,,,,
1533,101534,Tetrabarbital,CCCC(CC)C1(C(=O)NC(=O)NC1=O)CC,,,,,,
1534,101535,"5-Methyl-4,4-diphenyl-6-piperidinohexan-3-one",CCC(=O)C(C1=CC=CC=C1)(C2=CC=CC=C2)C(C)CN3CCCCC3,,,,,,
1535,101536,Ethyl 2-hydroxy-2-methylbutanoate,CCC(C)(C(=O)OCC)O,,,,,,
1536,101537,"3-Hydroxy-2,2-bis(hydroxymethyl)propyl 12-hydroxyoctadec-9-enoate",CCCCCCC(CC=CCCCCCCCC(=O)OCC(CO)(CO)CO)O,,,,,,
1537,101538,2-Methyl-4-isopropylcyclohexyl hydroperoxide,CC1CC(CCC1OO)C(C)C,,,,,,
1538,101539,"3-Buten-2-one, 4-(2,5,6,6-tetramethyl-1(or 2)-cyclohexen-1-yl)-",CC1CCC(=C(C1(C)C)C=CC(=O)C)C,,,,,,
1539,101540,Terebic acid,CC1(C(CC(=O)O1)C(=O)O)C,,,,,,
1540,101541,Pregnanediol V,C[C@H]([C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)C)O,,,,,,
1541,101542,"Benzenemethanesulfonic acid, alpha-hydroxy-4-methoxy-",COC1=CC=C(C=C1)C(O)S(=O)(=O)O,,,,,,
1542,101543,3'-Uridylic acid,C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)OP(=O)(O)O)O,,,,,,
1543,101544,2'-Cytidylic acid,C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)OP(=O)(O)O,,,,,,
1544,101545,CID 101545,CC1[C@H]([C@H]([C@@H]([C@@H](O1)O)O)O)O,,,,,,
1545,101546,"Ethyl 2,4-dichloro-3-oxobutyrate",CCOC(=O)C(C(=O)CCl)Cl,,,,,,
1546,101547,"Butyl 2,4-dichloro-3-oxobutyrate",CCCCOC(=O)C(C(=O)CCl)Cl,,,,,,
1547,101548,"2-Methylheptyl 8-methylnonyl benzene-1,2-dicarboxylate",CCCCCC(C)COC(=O)C1=CC=CC=C1C(=O)OCCCCCCCC(C)C,,,,,,
1548,101549,Vetiverol,CC1CC(C=C(C2C1CC(=C(C)C)C2)C)O,,,,,,
1549,101550,6-Methyl-3-cyclohexene-1-carboxaldehyde,CC1CC=CCC1C=O,,,,,,
1550,101551,"2,2'-Thiobis(4,6-di-sec-pentylphenol)",CCCC(C)C1=CC(=C(C(=C1)SC2=CC(=CC(=C2O)C(C)CCC)C(C)CCC)O)C(C)CCC,,,,,,
1551,101552,Rha(a1-6)Hex,C[C@H]1[C@@H]([C@H]([C@H]([C@@H](O1)OCC2[C@H]([C@@H]([C@@H]([C@@H](O2)O)O)O)O)O)O)O,,,,,,
1552,101553,Benzylephedrine,CC(C(C1=CC=CC=C1)O)N(C)CC2=CC=CC=C2,,,,,,
1553,101554,Methyl alpha-D-xylopyranoside,CO[C@@H]1[C@@H]([C@H]([C@@H](CO1)O)O)O,,,,,,
1554,101555,"Benzoic acid, 2-[[2-methyl-3-[4-(1-methylethyl)phenyl]propylidene]amino]-, methyl ester",CC(C)C1=CC=C(C=C1)CC(C)C=NC2=CC=CC=C2C(=O)OC,,,,,,
1555,101556,"2-Hydroxy-1,3-diphenylpropan-1-one",C1=CC=C(C=C1)CC(C(=O)C2=CC=CC=C2)O,,,,,,
1556,101557,"1,2-Propanediol, 3-(ethyl(3-methylphenyl)amino)-",CCN(CC(CO)O)C1=CC=CC(=C1)C,,,,,,
1557,101558,"N-[2-(3,4-Dimethoxyphenyl)-1-methylethyl]-4-ethoxy-3-methoxyphenylacetamide",CCOC1=C(C=C(C=C1)CC(=O)NC(C)CC2=CC(=C(C=C2)OC)OC)OC,,,,,,
1558,101559,N-(2-Aminoethyl)-N-(2-hydroxyethyl)octadec-9-enamide,CCCCCCCCC=CCCCCCCCC(=O)N(CCN)CCO,,,,,,
1559,101560,Oxydipropyl dibenzoate,CC(COCC(C)OC(=O)C1=CC=CC=C1)OC(=O)C2=CC=CC=C2,,,,,,
1560,101561,"2,3,4-Trihydroxybutanal",C(C(C(C=O)O)O)O,,,,,,
1561,101562,"(2S)-oxolane-2,3,4-triol",C1C(C([C@H](O1)O)O)O,,,,,,
1562,101563,(1-Carboxylatoundecyl)trimethylammonium,CCCCCCCCCCC(C(=O)[O-])[N+](C)(C)C,,,,,,
1563,101564,"1-Carboxylato-N,N,N-trimethyl-1-undecanaminium",CCCCCCCCCCC(C(=O)O)[N+](C)(C)C,,,,,,
1564,101565,2-(Trimethylammonio)octadecanoate,CCCCCCCCCCCCCCCCC(C(=O)[O-])[N+](C)(C)C,,,,,,
1565,101566,"1-Carboxylato-N,N,N-trimethyl-1-heptadecanaminium",CCCCCCCCCCCCCCCCC(C(=O)O)[N+](C)(C)C,,,,,,
1566,101567,Lactic anhydride,CC(C(=O)OC(=O)C(C)O)O,,,,,,
1567,101568,Potassium;phenol,C1=CC=C(C=C1)O.[K+],,,,,,
1568,101569,Dibenzyldimethylammonium chloride,C[N+](C)(CC1=CC=CC=C1)CC2=CC=CC=C2.[Cl-],,,,,,
1569,101570,Dibenzyldimethylammonium,C[N+](C)(CC1=CC=CC=C1)CC2=CC=CC=C2,,,,,,
1570,101571,2-[Bis(2-ethylhexyl)amino]ethanol,CCCCC(CC)CN(CCO)CC(CC)CCCC,,,,,,
1571,101572,CID 101572,CCCCCCC(CC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCC(CCCCCC)OC(=O)C)OC(=O)CCCCCCCC=CCC(CCCCCC)OC(=O)C)OC(=O)C,,,,,,
1572,101573,2-[Benzyl(1-methyl-2-phenoxyethyl)amino]ethanol,CC(COC1=CC=CC=C1)N(CCO)CC2=CC=CC=C2,,,,,,
1573,101574,9-(Sulphooxy)octadecanoic acid,CCCCCCCCCC(CCCCCCCC(=O)O)OS(=O)(=O)O,,,,,,
1574,101575,"4-(Benzothiazol-2-ylthio)-2,6-dimethylmorpholine",CC1CN(CC(O1)C)SC2=NC3=CC=CC=C3S2,,,,,,
1575,101576,"Pyridine, 4-(2-phenylethenyl)-",C1=CC=C(C=C1)C=CC2=CC=NC=C2,,,,,,
1576,101577,2-[(1-Methyl-2-phenoxyethyl)amino]ethanol,CC(COC1=CC=CC=C1)NCCO,,,,,,
1577,101578,"2-(2-Iodoethyl)-1,3-dioxolane-4-methanol",C1C(OC(O1)CCI)CO,,,,,,
1578,101579,2-Octadec-9-enoyloxypropyl octadec-9-enoate,CCCCCCCCC=CCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
1579,101580,Bis(octadec-9-enyl) but-2-enedioate,CCCCCCCCC=CCCCCCCCCOC(=O)C=CC(=O)OCCCCCCCCC=CCCCCCCCC,,,,,,
1580,101581,"2,6,10,14,19,23,27,31-Octamethyldotriaconta-6,8,10,12,14,16,18,20,22,24,26,30-dodecaen-2-ol",CC(=CCCC(=CC=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC=C(C)CCCC(C)(C)O)C)C)C)C,,,,,,
1581,101582,12-hydroxy-N-(2-hydroxyethyl)octadec-9-enamide,CCCCCCC(CC=CCCCCCCCC(=O)NCCO)O,,,,,,
1582,101583,Undec-9-EN-1-OL,CC=CCCCCCCCCO,,,,,,
1583,101584,Benzquinamide hydrochloride,CCN(CC)C(=O)C1CN2CCC3=CC(=C(C=C3C2CC1OC(=O)C)OC)OC.Cl,,,,,,
1584,101585,"5,6,7,8-Tetrahydro-6,7-dimethylpteridine",CC1C(NC2=NC=NC=C2N1)C,,,,,,
1585,101586,"3-[2-[1-(5,6-Dimethylhept-3-en-2-yl)-7a-methyl-1,2,3,3a,6,7-hexahydroinden-4-yl]ethenyl]-4-methylcyclohex-3-en-1-ol",CC1=C(CC(CC1)O)C=CC2=CCCC3(C2CCC3C(C)C=CC(C)C(C)C)C,,,,,,
1586,101587,Hexocyclium metilsulfate,C[N+]1(CCN(CC1)CC(C2CCCCC2)(C3=CC=CC=C3)O)C.COS(=O)(=O)[O-],,,,,,
1587,101588,"1-Phenanthrenecarboxylic acid, 1,2,3,4,4a,4b,5,6,7,9,10,10a-dodecahydro-1,4a-dimethyl-7-(1-methylethyl)-, oxydi-2,1-ethanediyl ester, (1R,1'R,4aS,4'aS,4bS,4'bS,7S,7'S,10aR,10'aR)-",CC(C)C1CCC2C(=C1)CCC3C2(CCCC3(C)C(=O)OCCOCCOC(=O)C4(CCCC5(C4CCC6=CC(CCC65)C(C)C)C)C)C,,,,,,
1588,101589,"4-[[4-(Diethylamino)phenyl]-(4-diethylazaniumylidenecyclohexa-2,5-dien-1-ylidene)methyl]-3-sulfobenzenesulfonate",CCN(CC)C1=CC=C(C=C1)C(=C2C=CC(=[N+](CC)CC)C=C2)C3=C(C=C(C=C3)S(=O)(=O)[O-])S(=O)(=O)O,,,,,,
1589,101590,"Quinolinium, 2-[2-[4-(dimethylamino)phenyl]ethenyl]-1-ethyl-, iodide (1:1)",CC[N+]1=C(C=CC2=CC=CC=C21)C=CC3=CC=C(C=C3)N(C)C.[I-],,,,,,
1590,101591,1-Ethyl-2-[4-(dimethylamino)styryl]quinolinium,CC[N+]1=C(C=CC2=CC=CC=C21)C=CC3=CC=C(C=C3)N(C)C,,,,,,
1591,101592,"1,1-Bis(phenethyloxy)ethane",CC(OCCC1=CC=CC=C1)OCCC2=CC=CC=C2,,,,,,
1592,101593,"1-Ethoxy-1,3,3-trimethoxypropane",CCOC(CC(OC)OC)OC,,,,,,
1593,101594,"2-Propanol, 1-[(2-aminoethyl)amino]-",CC(CNCCN)O,,,,,,
1594,101595,Vomicine,CN1CC[C@]23[C@@H]4[C@H]5[C@@H](CC2=O)C(=CCO[C@H]5CC(=O)N4C6=C3C=CC=C6O)C1,,,,,,
1595,101596,"(1S,4R,5S,9R,10R,12R,13R,14S)-5,9-dimethyl-16-propan-2-yltetracyclo[10.2.2.01,10.04,9]hexadec-15-ene-5,13,14-tricarboxylic acid",CC(C)C1=C[C@@]23CC[C@@H]4[C@@]([C@H]2C[C@@H]1[C@H]([C@@H]3C(=O)O)C(=O)O)(CCC[C@]4(C)C(=O)O)C,,,,,,
1596,101597,Cycrimine hydrochloride,C1CCN(CC1)CCC(C2CCCC2)(C3=CC=CC=C3)O.Cl,,,,,,
1597,101598,"Benzeneethanol, alpha-(2-(dimethylamino)-1-methylethyl)-alpha-phenyl-",CC(CN(C)C)C(C1=CC=CC=C1)C(C2=CC=CC=C2)O,,,,,,
1598,101599,Silver citrate,C(C(=O)[O-])C(CC(=O)[O-])(C(=O)[O-])O.[Ag+].[Ag+].[Ag+],,,,,,
1599,101600,Hexakis(2-ethylbutyl) diorthosilicate,CCC(C)CCO[Si](OCCC(C)CC)(OCCC(C)CC)O[Si](OCCC(C)CC)(OCCC(C)CC)OCCC(C)CC,,,,,,
1600,101601,Dioxybis(1-methylpropylidene) hydroperoxide,CCC(C)OOOOOOC(C)CC,,,,,,
1601,101602,Dihydroabietyl alcohol,CC(C)C1CCC2C(=C1)CCC3C2(CCCC3(C)CO)C,,,,,,
1602,101603,Pilocarpidine,CC[C@H]1[C@H](COC1=O)CC2=CN=CN2,,,,,,
1603,101604,Nopyl acetate,CC(=O)OCCC1=CCC2CC1C2(C)C,,,,,,
1604,101605,Chlorcyclizine dihydrochloride,CN1CCN(CC1)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl.Cl,,,,,,
1605,101606,Isooctylhydrocupreine,CCC1CN2CCC1CC2C(C3=C4C=C(C=CC4=NC=C3)OCCCCCC(C)C)O,,,,,,
1606,101607,"(R)-[(2S,5R)-2-amino-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol;formic acid",COC1=CC2=C(C=CN=C2C=C1)[C@H]([C@@]3(CC4CCN3C[C@@H]4C=C)N)O.C(=O)O,,,,,,
1607,101608,CID 101608,COC1=CC2=C(C=CN=C2C=C1)[C@H]([C@@]3(CC4CCN3CC4C=C)N)O,,,,,,
1608,101609,Uridine 2'-phosphate,C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)OP(=O)(O)O,,,,,,
1609,101610,2-Diethylaminoethyl alpha-phenylvalerate hydrochloride,CCCC(C1=CC=CC=C1)C(=O)OCCN(CC)CC.Cl,,,,,,
1610,101611,Propivan,CCCC(C1=CC=CC=C1)C(=O)OCCN(CC)CC,,,,,,
1611,101612,Episesamin,C1[C@H]2[C@H](CO[C@@H]2C3=CC4=C(C=C3)OCO4)[C@@H](O1)C5=CC6=C(C=C5)OCO6,,,,,,
1612,101613,"2,5-Dimethylpiperazine (R-(R*,R*))-tartrate (1:1)",CC1CNC(CN1)C.C(C(C(=O)O)O)(C(=O)O)O,,,,,,
1613,101614,CID 101614,C1=CC=C(C=C1)NC2=NC(=NC(=N2)NC3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)NC5=NC(=NC(=N5)NC6=CC=CC=C6)NC7=CC=CC=C7)S(=O)(=O)[O-])S(=O)(=O)[O-])NC8=CC=CC=C8.[Na+].[Na+],,,,,,
1614,101615,Lobeline HCl,CN1[C@@H](CCC[C@@H]1CC(=O)C2=CC=CC=C2)C[C@@H](C3=CC=CC=C3)O.Cl,,,,,,
1615,101616,Lobeline,CN1[C@@H](CCC[C@@H]1CC(=O)C2=CC=CC=C2)C[C@@H](C3=CC=CC=C3)O,['Investigated for use/treatment in addictions.'],,"['Agents that mimic neural transmission by stimulation of the nicotinic receptors on postganglionic autonomic neurons. Drugs that indirectly augment ganglionic transmission by increasing the release or slowing the breakdown of acetylcholine or by non-nicotinic effects on postganglionic neurons are not included here nor are the nonspecific cholinergic agonists. (See all compounds classified as Ganglionic Stimulants.)', 'Drugs that bind to and activate nicotinic cholinergic receptors (RECEPTORS, NICOTINIC). Nicotinic agonists act at postganglionic nicotinic receptors, at neuroeffector junctions in the peripheral nervous system, and at nicotinic receptors in the central nervous system. Agents that function as neuromuscular depolarizing blocking agents are included here because they activate nicotinic receptors, although they are used clinically to block nicotinic transmission. (See all compounds classified as Nicotinic Agonists.)', 'Drugs used for their effects on the respiratory system. (See all compounds classified as Respiratory System Agents.)']",,,
1616,101617,(1-Phenylpentyl) hydrogen succinate,CCCCC(C1=CC=CC=C1)OC(=O)CCC(=O)O,,,,,,
1617,101618,Leucinocaine mesylate,CCN(CC)C(CC(C)C)COC(=O)C1=CC=C(C=C1)N.CS(=O)(=O)O,,,,,,
1618,101619,Piperoxan hydrochloride,C1CCN(CC1)CC2COC3=CC=CC=C3O2.Cl,,,,,,
1619,101620,"3-Tropanyl p-nitrophenylacetate, hydrochloride",CN1C2CCC1CC(C2)OC(=O)CC3=CC=C(C=C3)[N+](=O)[O-].Cl,,,,,,
1620,101621,(8-Methyl-8-azabicyclo[3.2.1]octan-3-yl) 2-(4-nitrophenyl)acetate,CN1C2CCC1CC(C2)OC(=O)CC3=CC=C(C=C3)[N+](=O)[O-],,,,,,
1621,101622,CID 101622,CCCCCCCCCC(CCCCCCCC(=O)OC)OS(=O)(=O)[O-].[Na+],,,,,,
1622,101623,Methyl 9-(sulfooxy)octadecanoate,CCCCCCCCCC(CCCCCCCC(=O)OC)OS(=O)(=O)O,,,,,,
1623,101624,CID 101624,CCCCCCCCC(CCCCCCCCC(=O)OCCC)OS(=O)(=O)[O-].[Na+],,,,,,
1624,101625,10-(Sulfooxy)octadecanoic acid 1-propyl ester,CCCCCCCCC(CCCCCCCCC(=O)OCCC)OS(=O)(=O)O,,,,,,
1625,101626,Methoxyhydroxymercuripropylsuccinylurea,COC(CNC(=O)NC(=O)CCC(=O)O)C[Hg].O,,,,,,
1626,101627,"9-Octadecenoic acid, 12-hydroxy-, 2,3-dihydroxypropyl ester, (9Z,12R)-",CCCCCCC(CC=CCCCCCCCC(=O)OCC(CO)O)O,,,,,,
1627,101628,"3,7-Dimethyloct-7-enal",CC(CCCC(=C)C)CC=O,,,,,,
1628,101629,7-Oxabicyclo[4.1.0]heptane-3-carbonitrile,C1CC2C(O2)CC1C#N,,,,,,
1629,101630,2-Hydroxypropyl 12-hydroxyoctadec-9-enoate,CCCCCCC(CC=CCCCCCCCC(=O)OCC(C)O)O,,,,,,
1630,101631,"(2R,3R)-2,3-dihydroxybutanedioic acid;(1S,9R,10S)-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol",CN1CC[C@@]23CCCC[C@@H]2[C@H]1CC4=C3C=C(C=C4)O.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O,,,,,,
1631,101632,"1,2,3-Propanetricarboxylic acid, 2-(acetyloxy)-, tris(2-ethylhexyl) ester",CCCCC(CC)COC(=O)CC(CC(=O)OCC(CC)CCCC)(C(=O)OCC(CC)CCCC)OC(=O)C,,,,,,
1632,101633,"9-Octadecenoic acid (9Z)-, (tetrahydro-3-furanyl)methyl ester",CCCCCCCCC=CCCCCCCCC(=O)OCC1CCOC1,,,,,,
1633,101634,CID 101634,CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=C(OC4=CC(=O)C(=C(C4=C3O)O)CO)C5=CC(=C(C=C5)O)O)O)O)O)O)O)O,,,,,,
1634,101635,"2-(3,4-Dihydroxyphenyl)valeramide",CCCC(C1=CC(=C(C=C1)O)O)C(=O)N,,,,,,
1635,101636,"Benzo[4,5]indolo[1,2-a]quinazoline",C1=CC=C2C(=C1)C=CC3=C2C=C4N3C5=CC=CC=C5C=N4,,,,,,
1636,101637,"Aldosterone, monoacetate",CC(=O)OCC(=O)[C@H]1CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)O)C=O,,,,,,
1637,101638,DL-Histidyl-DL-histidine,C1=C(NC=N1)CC(C(=O)NC(CC2=CN=CN2)C(=O)O)N,,,,,,
1638,101639,"1,1,2,2,3,3,4,4,4a,5,5,6,6,7,8,8,8a-Heptadecafluorodecahydro-7-(trifluoromethyl)naphthalene",C12(C(C(C(C(C1(F)F)(C(F)(F)F)F)(F)F)(F)F)(C(C(C(C2(F)F)(F)F)(F)F)(F)F)F)F,,,,,,
1639,101640,"1,1,2,2,3,3,4,4,5,6-Decafluoro-5,6-bis(trifluoromethyl)cyclohexane",C1(C(C(C(C(C1(F)F)(F)F)(F)F)(F)F)(C(F)(F)F)F)(C(F)(F)F)F,,,,,,
1640,101641,1-Chloroheptadecafluorooctane,C(C(C(C(C(F)(F)Cl)(F)F)(F)F)(F)F)(C(C(C(F)(F)F)(F)F)(F)F)(F)F,,,,,,
1641,101642,"2,2,3,3,4,4,5,5,5-Nonafluoropentyl acrylate",C=CC(=O)OCC(C(C(C(F)(F)F)(F)F)(F)F)(F)F,,,,,,
1642,101643,"Di(1,3-dimethyl-n-butyl) fluorophosphate",CC(C)CC(C)OP(=O)(OC(C)CC(C)C)F,,,,,,
1643,101644,"Trimethyl(2,2,3,3-tetrafluorocyclobutyl)silane",C[Si](C)(C)C1CC(C1(F)F)(F)F,,,,,,
1644,101645,"2H-Pyran, 2-butoxy-3,4-dihydro-4-phenyl-",CCCCOC1CC(C=CO1)C2=CC=CC=C2,,,,,,
1645,101646,CID 101646,C(C(CO)O)O.[SbH3],,,,,,
1646,101647,2-Fluoro-4-[2-(methylamino)propyl]phenol,CC(CC1=CC(=C(C=C1)O)F)NC,,,,,,
1647,101648,"7-Tridecanone, 1,13-difluoro-",C(CCCC(=O)CCCCCF)CCCF,,,,,,
1648,101649,CID 101649,C1(C(C(C(C(C1(F)F)(F)F)(F)S(=O)(=O)O)(F)F)(F)F)(C(C(F)(F)F)(F)F)F.[KH],,,,,,
1649,101650,"1,2,2,3,3,4,5,5,6,6-decafluoro-4-(1,1,2,2,2-pentafluoroethyl)cyclohexane-1-sulfonic Acid",C1(C(C(C(C(C1(F)F)(F)F)(F)S(=O)(=O)O)(F)F)(F)F)(C(C(F)(F)F)(F)F)F,,,,,,
1650,101651,"2,2,3,3,4,4,5,5,6-Nonafluoro-6-(heptafluoropropyl)tetrahydro-2H-pyran",C1(C(C(OC(C1(F)F)(F)F)(C(C(C(F)(F)F)(F)F)(F)F)F)(F)F)(F)F,,,,,,
1651,101652,"1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8-Heptadecafluorooctane",C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
1652,101653,"1,2-Dibromodecafluorocyclohexane",C1(C(C(C(C(C1(F)F)(F)Br)(F)Br)(F)F)(F)F)(F)F,,,,,,
1653,101654,CID 101654,CC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@]3([C@]2(CCC4=CC(=O)CC[C@@]43C)C)F)O)C)O,,,,,,
1654,101655,"1-Propanol, 1-ethoxy-2,2,3,3,3-pentafluoro-",CCOC(C(C(F)(F)F)(F)F)O,,,,,,
1655,101656,"Perfluoro-N,N-bis(perfluoroethyl)propylamine",C(C(N(C(C(F)(F)F)(F)F)C(C(F)(F)F)(F)F)(F)F)(C(F)(F)F)(F)F,,,,,,
1656,101657,[2-(Trifluoromethyl)phenyl]glycolic acid,C1=CC=C(C(=C1)C(C(=O)O)O)C(F)(F)F,,,,,,
1657,101658,3-(Trifluoromethyl)mandelic acid,C1=CC(=CC(=C1)C(F)(F)F)C(C(=O)O)O,,,,,,
1658,101659,"N,N'-Dicyclohexylphosphorodiamidic fluoride",C1CCC(CC1)NP(=O)(NC2CCCCC2)F,,,,,,
1659,101660,Spirilene,CC(=CCCN1CCC2(CC1)C(=O)NCN2C3=CC=CC=C3)C4=CC=C(C=C4)F,,,,,,
1660,101661,CID 101661,CC1(O[C@@H]2[C@H](O[C@H]([C@@H]2O1)N3C=NC4=C3NC(=NC4=O)N)CO)C,,,,,,
1661,101662,5-Fluoronorvaline,C(CC(C(=O)O)N)CF,,,,,,
1662,101663,3-Fluoro-5-bromotyrosine,C1=C(C=C(C(=C1F)O)Br)CC(C(=O)O)N,,,,,,
1663,101664,3-Fluoro-5-iodotyrosine,C1=C(C=C(C(=C1F)O)I)CC(C(=O)O)N,,,,,,
1664,101665,Glyceryl 1-monofluoroacetate,C(C(COC(=O)CF)O)O,,,,,,
1665,101666,"(2,2,3,3-Tetrafluorocyclobutyl)methanol",C1C(C(C1(F)F)(F)F)CO,,,,,,
1666,101667,"6-alpha-Fluoro-17-alpha,21-dihydroxy-16-alpha-methylpregn-4-ene-3,20-dione",C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)CC[C@@]4([C@H]3CC[C@@]2([C@]1(C(=O)CO)O)C)C)F,,,,,,
1667,101668,Ethyl chlorofluoroacetate,CCOC(=O)C(F)Cl,,,,,,
1668,101669,"1,2-Dichloro-2-fluoropropane",CC(CCl)(F)Cl,,,,,,
1669,101670,"2-Chloro-1-(chloromethoxy)-1,1,2-trifluoroethane",C(OC(C(F)Cl)(F)F)Cl,,,,,,
1670,101671,1-Fluoropropan-2-ol,CC(CF)O,,,,,,
1671,101672,"2-Chloro-1,1-difluoropropane",CC(C(F)F)Cl,,,,,,
1672,101673,"1,1,2,3-Tetrachloro-1,3,3-trifluoropropane",C(C(F)(F)Cl)(C(F)(Cl)Cl)Cl,,,,,,
1673,101674,2alpha-Methyl-9alpha-fluorocortisol,C[C@@H]1C[C@]2(C(=CC1=O)CC[C@@H]3[C@@]2([C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O)F)C,,,,,,
1674,101675,CID 101675,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC2=C(C(=O)CCC2(C)C)C)C)C,,,,,,
1675,101676,CID 101676,C[C@H]1C[C@@H]2[C@@H]([C@H](C(=O)O2)C)[C@@H](C3=C(C(=O)C[C@H]13)C)O,,,,,,
1676,101677,"11-Fluoroundecane-1,2-diol",C(CCCCC(CO)O)CCCCF,,,,,,
1677,101678,CID 101678,C[C@H]1[C@H]2[C@@](CC[C@@]3([C@@]2(CC[C@]4([C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)O)C)C)C)C)C)(CC=C1C)C,,,,,,
1678,101679,"(3R)-6,8a-dimethyl-3-propan-2-yl-1,2,3,4,5,8-hexahydroazulen-3a-ol",CC1=CCC2(CC[C@@H](C2(CC1)O)C(C)C)C,,,,,,
1679,101680,Camphene hydrate,CC1(C2CCC(C2)C1(C)O)C,,,,,,
1680,101681,Camphidine,C[C@@]12CC[C@@H](C1(C)C)CNC2,,,,,,
1681,101682,16-Hydroxy-strychnine,C1C=C2CN3C[C@H](C45C3C[C@@H]2[C@@H]6[C@@H]4N(C(=O)C[C@@H]6O1)C7=CC=CC=C57)O,,,,,,
1682,101683,"3-beta-(beta-D-Cymarosyloxy)-5,14,19-trihydroxy-5-beta-card-20(22)-enolide",CC1C(C(CC(O1)OC2CCC3(C4CCC5(C6(CCC5(C4CCC3(C2)O)O)COC(=O)C=C6)C)CO)OC)O,,,,,,
1683,101684,"12-Methyl-5-azatetracyclo[7.4.3.01,10.05,10]hexadecan-16-one",CC1CC23CCCN4C2(C1)C(CCC4)C(=O)CC3,,,,,,
1684,101685,Neopin,CN1CCC23C4C(CC=C2C1CC5=C3C(=C(C=C5)OC)O4)O,,,,,,
1685,101686,Conimin,C[C@H]1[C@H]2CC[C@@H]3[C@@]2(CC[C@H]4[C@H]3CC=C5[C@@]4(CC[C@@H](C5)NC)C)CN1,,,,,,
1686,101687,Ambreinolide(cis-A/B),CC1(CCCC2(C1CCC3(C2CCC(=O)O3)C)C)C,,,,,,
1687,101688,"3-Hydroxy-17-(7-hydroxy-6-methyl-3-oxoheptan-2-yl)-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,17-dodecahydrocyclopenta[a]phenanthren-16-one",CC(CCC(=O)C(C)C1C(=O)CC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)CO,,,,,,
1688,101689,Pisatin,COC1=CC2=C(C=C1)[C@@H]3[C@](CO2)(C4=CC5=C(C=C4O3)OCO5)O,,,['Substances that are destructive to protozoans. (See all compounds classified as Antiprotozoal Agents.)'],,,
1689,101690,Cycloeucalenol,C[C@H]1[C@@H]2CC[C@H]3[C@@]4(CC[C@@H]([C@]4(CC[C@@]35[C@@]2(C5)CC[C@@H]1O)C)[C@H](C)CCC(=C)C(C)C)C,,,,,,
1690,101691,Einecs 207-424-7,C1C2C(C(C(C(O2)(CO1)O)O)O)O,,,,,,
1691,101692,"Spirostan-3-one, (5alpha,25R)-",C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@@H]6[C@@]5(CCC(=O)C6)C)C)C)OC1,,,,,,
1692,101693,"3-Chloro-3,7-dimethylocta-1,6-diene",CC(=CCCC(C)(C=C)Cl)C,,,,,,
1693,101694,"(1R,2S,4S,6S,7S,10S)-7-methyl-5-oxapentacyclo[8.8.0.02,7.04,6.011,16]octadeca-11(16),12,14-trien-14-ol",C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H]4[C@H]2O4)CCC5=C3C=CC(=C5)O,,,,,,
1694,101695,"2,6,6-Trimethyl-2-cyclohexen-1-acetaldehyde",CC1=CCCC(C1CC=O)(C)C,,,,,,
1695,101696,"3-Buten-2-ol, 4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-",CC1=CCCC(C1C=CC(C)O)(C)C,,,,,,
1696,101697,"6-(3,7,12,16,20,24-Hexamethylpentacosa-1,3,5,7,9,11,13,15,17,19,23-undecaen-1-yl)-1,5,5-trimethylcyclohex-1-ene",CC1=CCCC(C1C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC=C(C)CCC=C(C)C)C)C)(C)C,,,,,,
1697,101698,2-(3-Carboxycyclopentyl)-2-methylpropionic acid,CC(C)(C1CCC(C1)C(=O)O)C(=O)O,,,,,,
1698,101699,Eburnamine,CC[C@]12CCCN3[C@H]1C4=C(CC3)C5=CC=CC=C5N4[C@@H](C2)O,,,,,,
1699,101700,"1H-Cyclopenta[a]phenanthrene, 17-(1,5-dimethylhexyl)hexadecahydro-4,4,10,13,14-pentamethyl-, [5S-[5alpha,8beta,9alpha,10beta,13beta,14alpha,17beta(S*)]]-",CC(C)CCCC(C)C1CCC2(C1(CCC3C2CCC4C3(CCCC4(C)C)C)C)C,,,,,,
1700,101701,Funtumidine,C[C@@H]([C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@H](C4)N)C)C)O,,,,,,
1701,101702,Funtumine,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@H](C4)N)C)C,,,,,,
1702,101703,"(3S,9R,10S,13R,14R,17R)-17-[(2R,5R)-5,6-dimethylhept-3-en-2-yl]-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol",C[C@H](C=C[C@H](C)C(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@@H]3C2=CC=C4[C@]3(CC[C@@H](C4)O)C)C,,,,,,
1703,101704,D-Lysergic acid monoethylamide,CCNC(=O)C1CN(C2CC3=CNC4=CC=CC(=C34)C2=C1)C,,,,,,
1704,101705,"17-(5-ethyl-6-methylhept-3-en-2-yl)-10,13-dimethyl-2,3,4,9,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol",CCC(C=CC(C)C1CCC2C1(CCC3C2=CC=C4C3(CCC(C4)O)C)C)C(C)C,,,,,,
1705,101706,"1-Ethyl-7-hydroxy-2-methyl-1,2,3,4,4a,9,10,10a-octahydrophenanthrene-2-carboxylic acid",CCC1C2CCC3=C(C2CCC1(C)C(=O)O)C=CC(=C3)O,,,,,,
1706,101707,Berbine,C1CN2CC3=CC=CC=C3CC2C4=CC=CC=C41,,,,,,
1707,101708,"1,2,4a,5,6,8a-Hexahydro-1-isopropyl-4,7-dimethylnaphthalene",CC1=CC2C(CC1)C(=CCC2C(C)C)C,,,,,,
1708,101709,Anhydroecgonine,CN1C2CCC1C(=CC2)C(=O)O,,,,,,
1709,101710,Iridodiol,CC1CCC(C1CO)C(C)CO,,,,,,
1710,101711,Hydrocinchonine,CCC1CN2CCC1CC2C(C3=CC=NC4=CC=CC=C34)O,,,,,,
1711,101712,Phillyrin,COC1=C(C=C(C=C1)[C@H]2[C@H]3CO[C@@H]([C@H]3CO2)C4=CC(=C(C=C4)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O)OC)OC,,,,,,
1712,101713,"D-gluco-Heptonic acid, (2xi)-",C(C(C(C(C(C(C(=O)O)O)O)O)O)O)O,,,,,,
1713,101714,"6-(Hydroxymethoxy)hexane-1,2,3,4,5-pentol",C(C(C(C(C(COCO)O)O)O)O)O,,,,,,
1714,101715,"1,2,3,4,5-Cyclohexanepentol",C1C(C(C(C(C1O)O)O)O)O,,,,,,
1715,101716,Globulol,CC1CCC2C1C3C(C3(C)C)CCC2(C)O,,,,,,
1716,101717,"Norbornane, 2,2-dimethyl-5-methylene-",CC1(CC2CC1CC2=C)C,,,,,,
1717,101718,"(5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid",CC1(C(N2[C@H](S1)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C,,,,,,
1718,101719,"2,6,10,14,19,23,27,31-Octamethyldotriaconta-2,6,10,14,18,22,26,30-octaene",CC(=CCCC(=CCCC(=CCCC(=CCCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C)C)C)C,,,,,,
1719,101720,CID 101720,CC(=C)CCC=C(C)C=C,,,,,,
1720,101721,Urea hydrochloride,C(=O)(N)N.Cl,,,,,,
1721,101722,"1-Amino-2,2,2-trichloroethanol",C(C(Cl)(Cl)Cl)(N)O,,,,,,
1722,101723,"15-(1,2-Dihydroxy-2,6,6-trimethylcyclohexyl)-4,9,13-trimethylpentadeca-2,4,6,8,10,12,14-heptaenoic acid",CC(=CC=CC=C(C)C=CC(=O)O)C=CC=C(C)C=CC1(C(CCCC1(C)O)(C)C)O,,,,,,
1723,101724,3-Chlorobornan-2-one,CC1(C2CCC1(C(=O)C2Cl)C)C,,,,,,
1724,101725,CID 101725,CC1(C(CCC1(C)C(=O)[O-])C(=O)O)C.[Na+],,,,,,
1725,101726,Eldoral,CCC1(C(=O)NC(=O)NC1=O)N2CCCCC2,,,"['Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. (See all compounds classified as Adrenergic Uptake Inhibitors.)', 'Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system. (See all compounds classified as Antidepressive Agents, Tricyclic.)']",,,
1726,101727,"1,2-Didehydrocrinan-3-ol",C1CN2CC3=CC4=C(C=C3C15C2CC(C=C5)O)OCO4,,,,,,
1727,101728,"3-(10,13-Dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)butanoic acid (non-preferred name)",CC(CC(=O)O)C1CCC2C1(CCC3C2CCC4C3(CCCC4)C)C,,,,,,
1728,101729,Cyclolaudenol,C[C@H](CC[C@H](C)C(=C)C)[C@H]1CC[C@@]2([C@@]1(CC[C@]34[C@H]2CC[C@@H]5[C@]3(C4)CC[C@@H](C5(C)C)O)C)C,,,,,,
1729,101730,Chloral cyanohydrin,C(#N)C(C(Cl)(Cl)Cl)O,,,,,,
1730,101731,beta-Patchoulene,CC1CCC2=C1CC3CCC2(C3(C)C)C,,,,,,
1731,101732,Einecs 208-215-3,C(=O)(C(=O)O)N.N,,,,,,
1732,101733,"17-(5,6-Dimethylhept-3-en-2-yl)-10,13-dimethyl-1,2,3,4,6,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-3,5,6-triol",CC(C)C(C)C=CC(C)C1CCC2C1(CCC3C2=CC(C4(C3(CCC(C4)O)C)O)O)C,,,,,,
1733,101734,"Ergosta-5,7-dien-3-ol",CC(C)C(C)CCC(C)C1CCC2C1(CCC3C2=CC=C4C3(CCC(C4)O)C)C,,,,,,
1734,101735,"Cholest-5-ene, 3-bromo-, (3beta)-",CC(C)CCCC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)Br)C)C,,,,,,
1735,101736,"Disodium 1,2-disulfoethane-1,2-bis(olate)",C(C([O-])S(=O)(=O)O)([O-])S(=O)(=O)O.[Na+].[Na+],,,,,,
1736,101737,Glyoxal bisulfite,C(C(O)S(=O)(=O)O)(O)S(=O)(=O)O,,,,,,
1737,101738,Antipyrine salicylate,CC1=CC(=O)N(N1C)C2=CC=CC=C2.C1=CC=C(C(=C1)C(=O)O)O,,,,,,
1738,101739,Humulinic acid,CC(C)CC(=O)C1=C(C(C(=C1O)CC=C(C)C)O)O,,,,,,
1739,101740,"Stigmasta-5,7-dien-3-ol",CCC(CCC(C)C1CCC2C1(CCC3C2=CC=C4C3(CCC(C4)O)C)C)C(C)C,,,,,,
1740,101741,Cholesteryl butyrate,CCCC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC[C@@H]4[C@H](C)CCCC(C)C)C)C,,,,,,
1741,101742,1-[(6-Chloro-2-methoxyacridin-9-yl)amino]-3-(diethylamino)propan-2-ol,CCN(CC)CC(CNC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC)O,,,,,,
1742,101743,Cinchonidine sulfate,C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@@H](C3=CC=NC4=CC=CC=C34)O.OS(=O)(=O)O,,,,,,
1743,101744,Cinchonidine,C=C[C@H]1CN2CC[C@H]1C[C@H]2[C@@H](C3=CC=NC4=CC=CC=C34)O,,,,,,
1744,101745,8-(3-Dimethylamino-1-methylpropylamino)-6-quinolinol,CC(CCN(C)C)NC1=C2C(=CC(=C1)O)C=CC=N2,,,,,,
1745,101746,Sesamolin,C1[C@H]2[C@H](CO[C@@H]2OC3=CC4=C(C=C3)OCO4)[C@H](O1)C5=CC6=C(C=C5)OCO6,,,,,,
1746,101747,Diammonium meso-galactarate,C(C(C(C(=O)O)O)O)(C(C(=O)O)O)O.N.N,,,,,,
1747,101748,Peracitol,C(C(C(C(C(C(CO)O)O)O)O)O)O,,,,,,
1748,101749,Galgravin,C[C@@H]1[C@@H]([C@H](O[C@H]1C2=CC(=C(C=C2)OC)OC)C3=CC(=C(C=C3)OC)OC)C,,,,,,
1749,101750,alpha-Camphorene,CC(=CCCC1=CCC(CC1)C(=C)CCC=C(C)C)C,,,,,,
1750,101751,"Disodium ethene-1,1-diolate",C=C([O-])[O-].[Na+].[Na+],,,,,,
1751,101752,"Ethene-1,1-diol",C=C(O)O,,,,,,
1752,101753,Sodium trithiocarbonate,C(=S)([S-])[S-].[Na+].[Na+],,,,,,
1753,101754,"exo-1,5,5-Trimethylbicyclo(2.2.1)heptan-2-ol",C[C@]12C[C@H](C[C@@H]1O)C(C2)(C)C,,,,,,
1754,101755,"endo-1,5,5-Trimethylbicyclo(2.2.1)heptan-2-ol",C[C@]12C[C@H](C[C@H]1O)C(C2)(C)C,,,,,,
1755,101756,"2-Propenoic acid, 3-phenyl-, 4-[(aminocarbonyl)amino]phenyl ester",C1=CC=C(C=C1)C=CC(=O)OC2=CC=C(C=C2)NC(=O)N,,,,,,
1756,101757,p-Tolylmercury chloride,CC1=CC=C(C=C1)[Hg]Cl,,,,,,
1757,101758,"1,3-Dilaurin",CCCCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCCCC)O,,,,,,
1758,101759,"2,4-Decadienoic acid,(2E,4E)-",CCCCCC=CC=CC(=O)O,,,,,,
1759,101760,Crivelline,CN1C[C@@]2([C@]3([C@@H]1C[C@H](C=C3)OC)C4=CC5=C(C=C4CO2)OCO5)O,,,,,,
1760,101761,Erythrodiol,C[C@]12CC[C@@H](C([C@@H]1CC[C@@]3([C@@H]2CC=C4[C@]3(CC[C@@]5([C@H]4CC(CC5)(C)C)CO)C)C)(C)C)O,,,,,,
1761,101762,Allotetrahydrocortisone,C[C@]12CC[C@H](C[C@@H]1CC[C@@H]3[C@@H]2C(=O)C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O,,,,,,
1762,101763,Magnesium phthalate,C1=CC=C(C(=C1)C(=O)[O-])C(=O)[O-].[Mg+2],,,,,,
1763,101764,"(R)-[(2S,5S)-5-ethenyl-1-azoniabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol;iodide",COC1=CC2=C(C=CN=C2C=C1)[C@H]([C@@H]3CC4CC[NH+]3C[C@H]4C=C)O.[I-],,,,,,
1764,101765,CID 101765,C1=CC=C(C(=C1)C(=O)[O-])N.[Na+],,,,,,
1765,101766,Nonadecafluoro-9-iodononane,C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(C(C(C(C(F)(F)I)(F)F)(F)F)(F)F)(F)F,,,,,,
1766,101767,"Allopregnane-3beta,20alpha-diol",C[C@@H]([C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@@H](C4)O)C)C)O,,,,,,
1767,101768,CID 101768,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@]2(C=CC4=CC(=O)CC[C@]34C)C)C,,,,,,
1768,101769,CID 101769,C[C@H](CCCC(C)C)[C@]1(CC[C@@H]2[C@@]1(CC=C3C2=CC[C@@H]4[C@@]3(CC[C@@H](C4)O)C)C)C,,,,,,
1769,101770,Zymostenol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CCC3=C2CC[C@@H]4[C@@]3(CC[C@@H](C4)O)C)C,,,,,,
1770,101771,Tetrahydrodeoxycorticosterone,C[C@]12CC[C@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4C(=O)CO)C)O,,,"['Agents capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general ANESTHESIA, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site. (See all compounds classified as Anesthetics.)', 'Endogenous compounds or drugs that affect neuronal excitability through modulation of specific ionotropic receptors (e.g., GABA-A RECEPTORS). Endogenous neurosteroids are steroid hormones de novo synthesized by neurons and glial cells from steroid metabolite precursors (e.g., PREGNENOLONE). (See all compounds classified as Neurosteroids.)', 'Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)']",,,
1771,101772,6alpha-Fluoroprednisolone-21-acetate,CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2C[C@@H](C4=CC(=O)C=C[C@]34C)F)O)C)O,,,,,,
1772,101773,"3alpha,17alpha-Dihydroxy-5beta-pregnan-20-one",CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)C)O,,,,,,
1773,101774,"3alpha,6alpha-Dihydroxy-5beta-pregnan-20-one",CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C[C@@H]([C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,,,,,,
1774,101775,4-Cholesten-6beta-ol-3-one,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C[C@H](C4=CC(=O)CC[C@]34C)O)C,,,,,,
1775,101776,"2,3,4,6-Tetra-O-acetyl-alpha-D-glucopyranosyl bromide",CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)Br)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
1776,101777,"2,4,5-Triphenyl-2-imidazoline",C1=CC=C(C=C1)C2C(N=C(N2)C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
1777,101778,Benzoin ethyl ether,CCOC(C1=CC=CC=C1)C(=O)C2=CC=CC=C2,,,,,,
1778,101779,CID 101779,[C@H]([C@@H]([C@H](C(=O)[O-])O)O)([C@@H](C(=O)O)O)O.[K+],,,,,,
1779,101780,"(4S,5S)-2,3,4,5-tetrahydroxyhexanedioic acid",[C@@H]([C@@H](C(=O)O)O)(C(C(C(=O)O)O)O)O,,,,,,
1780,101781,Flavanomarein,C1[C@H](OC2=C(C1=O)C=CC(=C2O)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)C4=CC(=C(C=C4)O)O,,,,,,
1781,101782,"1,2:5,6-Di-O-isopropylidene-alpha-D-glucofuranose",CC1(OC[C@H](O1)[C@@H]2[C@@H]([C@@H]3[C@H](O2)OC(O3)(C)C)O)C,,,,,,
1782,101783,"Diazene, bis(4-ethoxyphenyl)-",CCOC1=CC=C(C=C1)N=NC2=CC=C(C=C2)OCC,,,,,,
1783,101784,Calcium;3-phenylprop-2-enoate,C1=CC=C(C=C1)C=CC(=O)[O-].C1=CC=C(C=C1)C=CC(=O)[O-].[Ca+2],,,,,,
1784,101785,"14,17,21-Trihydroxypregn-4-ene-3,20-dione",C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@]3(CC[C@@]4(C(=O)CO)O)O)C,,,,,,
1785,101786,18-Hydroxyprogesterone,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)CO,,,,,,
1786,101787,"3alpha,11alpha-Dihydroxy-5beta-pregnan-20-one",CC(=O)[C@H]1CC[C@@H]2[C@@]1(C[C@H]([C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,,,,,,
1787,101788,11beta-Hydroxyprogesterone,CC(=O)[C@H]1CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)O)C,,,"['Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY. (See all compounds classified as Progestins.)']",,,
1788,101789,"3-beta-Hydroxy-5-alpha-pregnane-11,20-dione",CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@@H](C4)O)C)C,,,,,,
1789,101790,Allotetrahydrocorticosterone,C[C@]12CC[C@H](C[C@@H]1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@H]4C(=O)CO)C)O)O,,,,,,
1790,101791,"3alpha,17,21-Trihydroxy-5alpha-pregnan-20-one",C[C@]12CC[C@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O,,,,,,
1791,101792,"3beta,17,21-Trihydroxy-5beta-pregnan-20-one",C[C@]12CC[C@@H](C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O,,,,,,
1792,101793,"17alpha-Hydroxypregn-4-ene-3,20-dione",CC(=O)[C@@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O,,,,,,
1793,101794,17beta-Hydroxy-1alpha-methylandrost-4-ene-3-one,C[C@H]1CC(=O)C=C2[C@]1([C@H]3CC[C@]4([C@H]([C@@H]3CC2)CC[C@@H]4O)C)C,,,,,,
1794,101795,Homopterocarpin,COC1=CC2=C(C=C1)[C@@H]3COC4=C([C@@H]3O2)C=CC(=C4)OC,,,,,,
1795,101796,Oxythiamine chloride hydrochloride,CC1=C(SC=[N+]1CC2=CN=C(NC2=O)C)CCO.Cl.[Cl-],,,"['Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Antimetabolites.)']",,,
1796,101797,"2,4-Dimethylaniline acetate",CC1=CC(=C(C=C1)N)C.CC(=O)O,,,,,,
1797,101798,Methyl alpha-D-mannopyranoside,CO[C@@H]1[C@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O,,,,,,
1798,101799,Helicin,C1=CC=C(C(=C1)C=O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,,,,,,
1799,101800,2-(beta-d-Glucosyloxy)-cinnamic acid,C1=CC=C(C(=C1)C=CC(=O)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,,,,,,
1800,101801,"O,O-Dimethyl O-(3-nitrophenyl) phosphorothioate",COP(=S)(OC)OC1=CC=CC(=C1)[N+](=O)[O-],,,,,,
1801,101802,"1,3,6,8-Nonatetraen-5-one, 1,9-diphenyl-",C1=CC=C(C=C1)C=CC=CC(=O)C=CC=CC2=CC=CC=C2,,,,,,
1802,101803,Bis(2-ethoxyethyl) but-2-enedioate,CCOCCOC(=O)C=CC(=O)OCCOCC,,,,,,
1803,101804,"4-Oxooctadeca-9,11,13-trienoic acid",CCCCC=CC=CC=CCCCCC(=O)CCC(=O)O,,,,,,
1804,101805,3-Methylbutyl octadec-9-enoate,CCCCCCCCC=CCCCCCCCC(=O)OCCC(C)C,,,,,,
1805,101806,Methenamine camphorate,C[C@]1(CC[C@@H](C1(C)C)C(=O)O)C(=O)O.C1N2CN3CN1CN(C2)C3.C1N2CN3CN1CN(C2)C3,,,,,,
1806,101807,d-Camphoric acid,C[C@]1(CC[C@@H](C1(C)C)C(=O)O)C(=O)O,,,,,,
1807,101808,CID 101808,CN1CC[C@]23C4[C@@H]1CC5=C2C(=C(C=C5)OCC6=CC=CC=C6)OC3[C@H](C=C4)O.Cl,,,,,,
1808,101809,CID 101809,CN1CC[C@]23C4[C@@H]1CC5=C2C(=C(C=C5)OCC6=CC=CC=C6)OC3[C@H](C=C4)O,,,,,,
1809,101810,Quillaic acid,C[C@]12CC[C@@H]([C@@]([C@@H]1CC[C@@]3([C@@H]2CC=C4[C@]3(C[C@H]([C@@]5([C@H]4CC(CC5)(C)C)C(=O)O)O)C)C)(C)C=O)O,,,,,,
1810,101811,"Estra-1,3,5(10)-triene-3,17beta-diol bis(cyclopentanepropionate)",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)CCC4CCCC4)CCC5=C3C=CC(=C5)OC(=O)CCC6CCCC6,,,,,,
1811,101812,"2',3'-Cyclic AMP",C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@H]4[C@@H]([C@H](O3)CO)OP(=O)(O4)O)N,,,,,,
1812,101813,Pseudotropine benzoate hydrochloride,CN1C2CCC1CC(C2)OC(=O)C3=CC=CC=C3.Cl,,,,,,
1813,101814,Triethanolamine hydrochloride,C(CO)N(CCO)CCO.Cl,,,,,,
1814,101815,"(1S,4aR,5S,8aR)-5-(4-carboxy-3-methylbut-3-enyl)-1,4a-dimethyl-6-methylidene-3,4,5,7,8,8a-hexahydro-2H-naphthalene-1-carboxylic acid",CC(=CC(=O)O)CC[C@H]1C(=C)CC[C@@H]2[C@@]1(CCC[C@]2(C)C(=O)O)C,,,,,,
1815,101816,"17-alpha,21-Dihydroxypregn-4-ene-3,20-dione 21-acetate",CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O,,,,,,
1816,101817,"Pregnane-3alpha,17alpha-diol-11,20-dione",CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)C)O,,,,,,
1817,101818,Apocholic acid,C[C@H](CCC(=O)O)[C@H]1CCC2=C3CC[C@@H]4C[C@@H](CC[C@@]4([C@H]3C[C@@H]([C@]12C)O)C)O,,,,,,
1818,101819,"17-Methyl-5alpha-androstane-3beta,17beta-diol",C[C@]12CC[C@@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C)O)C)O,,,,,,
1819,101820,4-Chloro-6-hydrazino-m-benzenedisulfonamide,C1=C(C(=CC(=C1Cl)S(=O)(=O)N)S(=O)(=O)N)NN,,,,,,
1820,101821,"m-Benzenedisulfonamide, 4-chloro-5-hydrazino-",C1=C(C=C(C(=C1NN)Cl)S(=O)(=O)N)S(=O)(=O)N,,,,,,
1821,101822,"Aluminum;octadeca-9,12-dienoate",CCCCCC=CCC=CCCCCCCCC(=O)[O-].CCCCCC=CCC=CCCCCCCCC(=O)[O-].CCCCCC=CCC=CCCCCCCCC(=O)[O-].[Al+3],,,,,,
1822,101823,CID 101823,CC(=C(C)CCC(=CC=CC(=O)C)C)C,,,,,,
1823,101824,"Calcium bis((mercaptoacetato(2-)-O,S)aurate(1-))",C(C(=O)[O-])[S-].C(C(=O)[O-])[S-].[Ca+2].[Au+].[Au+],,,,,,
1824,101825,Methyl 3-(3-nitrophenyl)prop-2-enoate,COC(=O)C=CC1=CC(=CC=C1)[N+](=O)[O-],,,,,,
1825,101826,Testosterone nicotinate,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)C4=CN=CC=C4)CCC5=CC(=O)CC[C@]35C,,,,,,
1826,101827,4-Methoxybenzenediazonium hexafluorophosphate,COC1=CC=C(C=C1)[N+]#N.F[P-](F)(F)(F)(F)F,,,,,,
1827,101828,4-Methoxybenzenediazonium,COC1=CC=C(C=C1)[N+]#N,,,,,,
1828,101829,"Boron, (N-butyl-1-butanamine)trifluoro-, (T-4)-",B(F)(F)F.CCCCNCCCC,,,,,,
1829,101830,Magnesium 2-methylpropane chloride,C[C-](C)C.[Mg+2].[Cl-],,,,,,
1830,101831,"Phosphonic acid, (1-(difluoromethyl)-2,2-difluoro-1-hydroxyethyl)-, diethyl ester",CCOP(=O)(C(C(F)F)(C(F)F)O)OCC,,,,,,
1831,101832,Fluorotripropylstannane,CCC[Sn](CCC)(CCC)F,,,,,,
1832,101833,(1-Carboxylatotridecyl)trimethylammonium,CCCCCCCCCCCCC(C(=O)[O-])[N+](C)(C)C,,,,,,
1833,101834,"N,N,N-Trimethyl-1-carboxy-1-tridecanaminium",CCCCCCCCCCCCC(C(=O)O)[N+](C)(C)C,,,,,,
1834,101835,"6,10-Dimethyl-5-undecen-2-one",CC(C)CCCC(=CCCC(=O)C)C,,,,,,
1835,101836,Bromobutylmagnesium,CCC[CH2-].[Mg+2].[Br-],,,,,,
1836,101837,Butylmagnesium chloride,CCC[CH2-].[Mg+2].[Cl-],,,,,,
1837,101838,"Magnesium, bromopentyl-",CCCC[CH2-].[Mg+2].[Br-],,,,,,
1838,101839,Octadec-9-en-1-yl acetate,CCCCCCCCC=CCCCCCCCCOC(=O)C,,,,,,
1839,101840,Iodoxybenzene,C1=CC=C(C=C1)I(=O)=O,,,,,,
1840,101841,(Benzylamine)trifluoroboron,B(F)(F)F.C1=CC=C(C=C1)CN,,,,,,
1841,101842,"1,1,2,3,4,5,6-Heptachlorocyclohexane",C1(C(C(C(C(C1Cl)Cl)(Cl)Cl)Cl)Cl)Cl,,,,,,
1842,101843,3-Fluoro-4-methoxy-cinnamic acid,COC1=C(C=C(C=C1)C=CC(=O)O)F,,,,,,
1843,101844,Norhexobarbital,C1CCC(=CC1)CC2C(=O)NC(=O)NC2=O,,,,,,
1844,101845,CID 101845,CCCC(C)C1(C(=NC(=NC1=O)S)[O-])CCSC.[Na+],,,,,,
1845,101846,Tetraethylammonium p-toluenesulfonate,CC[N+](CC)(CC)CC.CC1=CC=C(C=C1)S(=O)(=O)[O-],,,,,,
1846,101847,4-(Diethylamino)benzenediazonium hexafluorophosphate,CCN(CC)C1=CC=C(C=C1)[N+]#N.F[P-](F)(F)(F)(F)F,,,,,,
1847,101848,Bis[(5-nitrofuran-2-yl)methylidene]hydrazine,C1=C(OC(=C1)[N+](=O)[O-])C=NN=CC2=CC=C(O2)[N+](=O)[O-],,,,,,
1848,101849,11beta-Hydroxyetiocholanolone,C[C@]12CC[C@H](C[C@H]1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CCC4=O)C)O)O,,,,,,
1849,101850,11-Ketoetiocholanolone,C[C@]12CC[C@H](C[C@H]1CC[C@@H]3[C@@H]2C(=O)C[C@]4([C@H]3CCC4=O)C)O,,,,,,
1850,101851,CID 101851,COC1=CC2=C(C=CN=C2C=C1)[C@@H]([C@@H]3CC4CCN3C[C@@H]4C=C)O.C1=CC=C(C=C1)C(=O)O,,,,,,
1851,101852,Hydroxymethyloxostannane,C[Sn](=O)O,,,,,,
1852,101853,"Aluminum, bromodiethyl-",CC[Al](CC)Br,,,,,,
1853,101854,"4,8-Decadienal, 5,9-dimethyl-",CC(=CCCC(=CCCC=O)C)C,,,,,,
1854,101855,Dichloro(diisopropoxy)titanium,CC(C)O.CC(C)O.Cl[Ti]Cl,,,,,,
1855,101856,"3,5-Bis(trifluoromethyl)benzoyl chloride",C1=C(C=C(C=C1C(F)(F)F)C(F)(F)F)C(=O)Cl,,,,,,
1856,101857,"(8R,9S,13S,14S,17R)-13-ethyl-17-ethynyl-3-methoxy-4,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-ol",CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3CC=C(C4)OC,,,,,,
1857,101858,"3-Oxopregn-4-ene-21,17-carbolactone",C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]45CCC(=O)O5)C,,,,,,
1858,101859,6-alpha-Fluoro-isoflupredone,C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1CC[C@@]2(C(=O)CO)O)C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O,,,,,,
1859,101860,"[(8'R,9'S,10'R,13'S,14'S,17'S)-17'-acetyl-6',10',13'-trimethylspiro[1,3-dioxolane-2,3'-2,4,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene]-17'-yl] acetate",CC1=C2CC3(CC[C@@]2([C@H]4CC[C@]5([C@H]([C@@H]4C1)CC[C@]5(C(=O)C)OC(=O)C)C)C)OCCO3,,,,,,
1860,101861,7-Oxocholesteryl acetate,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C(=O)C=C4[C@@]3(CC[C@@H](C4)OC(=O)C)C)C,,,,,,
1861,101862,Tetramethylammonium methyl sulphate,C[N+](C)(C)C.COS(=O)(=O)[O-],,,,,,
1862,101863,Dimethyl chlorophosphate,COP(=O)(OC)Cl,,,,,,
1863,101864,"Aluminum, bis(dodecanoato-kappaO)hydroxy-",CCCCCCCCCCCC(=O)[O-].CCCCCCCCCCCC(=O)[O-].[OH-].[Al+3],,,,,,
1864,101865,Methyl-3 penteneoate,CC=CCC(=O)OC,,,,,,
1865,101866,Lead butyrate,CCCC(=O)[O-].CCCC(=O)[O-].[Pb+2],,,,,,
1866,101867,"Dilithiumato(3-) 1,3-dihydroxypropan-2-yl phosphatato(3-)",[Li+].[Li+].C(C(CO)OP(=O)([O-])[O-])O,,,,,,
1867,101868,(Carboxylatomethyl)dimethyl(octadecyl)ammonium,CCCCCCCCCCCCCCCCCC[N+](C)(C)CC(=O)[O-],,,,,,
1868,101869,"n-(Carboxymethyl)-n,n-dimethyloctadecan-1-aminium",CCCCCCCCCCCCCCCCCC[N+](C)(C)CC(=O)O,,,,,,
1869,101870,5-Methylbicyclo[2.2.1]hept-2-ene,CC1CC2CC1C=C2,,,,,,
1870,101871,2-(Hydroxymethylene)cyclohexan-1-one,C1CCC(=O)C(=CO)C1,,,,,,
1871,101872,Phenylpentene,CCCC=CC1=CC=CC=C1,,,,,,
1872,101873,"Quinolinium, 1-ethyl-6-methyl-, iodide",CC[N+]1=CC=CC2=C1C=CC(=C2)C.[I-],,,,,,
1873,101874,1-Ethyl-6-methylquinolinium,CC[N+]1=CC=CC2=C1C=CC(=C2)C,,,,,,
1874,101875,Diphenylarsane,C1=CC=C(C=C1)[AsH]C2=CC=CC=C2,,,,,,
1875,101876,CID 101876,C1=CC(=C(C=C1S(=O)(=O)[O-])C(=O)O)O.[Na+],,,,,,
1876,101877,Cycloundecanecarboxylic acid,C1CCCCCC(CCCC1)C(=O)O,,,,,,
1877,101878,CID 101878,C1=CC2=C(C=C(C=C2)O)C(=C1)S(=O)(=O)[O-].[Na+],,,,,,
1878,101879,CID 101879,CN(C)C1=CC=C(C=C1)N=NC2=CC=CC=C2C(=O)[O-].[Na+],,,,,,
1879,101880,CID 101880,CN(C)C1=CC=C(C=C1)N=NC2=CC=C(C=C2)C(=O)[O-].[Na+],,,,,,
1880,101881,"(1R,9S,10R,11S)-4-methoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-3,11-diol",CN1CC[C@]23CCC[C@@H]([C@H]2[C@@H]1CC4=C3C(=C(C=C4)OC)O)O,,,,,,
1881,101882,2-Chloroacetohydrazide hydrochloride,C(C(=O)NN)Cl.Cl,,,,,,
1882,101883,Chloroacetyl hydrazine,C(C(=O)NN)Cl,,,,,,
1883,101884,Hexamethonium iodide,C[N+](C)(C)CCCCCC[N+](C)(C)C.[I-].[I-],,,"['Agents having as their major action the interruption of neural transmission at nicotinic receptors on postganglionic autonomic neurons. Because their actions are so broad, including blocking of sympathetic and parasympathetic systems, their therapeutic use has been largely supplanted by more specific drugs. They may still be used in the control of blood pressure in patients with acute dissecting aortic aneurysm and for the induction of hypotension in surgery. (See all compounds classified as Ganglionic Blockers.)', 'Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)', 'Drugs that bind to nicotinic cholinergic receptors (RECEPTORS, NICOTINIC) and block the actions of acetylcholine or cholinergic agonists. Nicotinic antagonists block synaptic transmission at autonomic ganglia, the skeletal neuromuscular junction, and at central nervous system nicotinic synapses. (See all compounds classified as Nicotinic Antagonists.)']",,,
1884,101885,2-[Dimethyl(octadec-9-enyl)azaniumyl]acetate,CCCCCCCCC=CCCCCCCCC[N+](C)(C)CC(=O)[O-],,,,,,
1885,101886,"N-(Carboxymethyl)-N,N-dimethyloctadec-9-en-1-aminium",CCCCCCCCC=CCCCCCCCC[N+](C)(C)CC(=O)O,,,,,,
1886,101887,Dibutylhydroaluminum,CCCC[AlH]CCCC,,,,,,
1887,101888,4-Chlorophenylmagnesium bromide,C1=CC(=CC=[C-]1)Cl.[Mg+2].[Br-],,,,,,
1888,101889,"(4aS,8aR)-1-methyldecahydroquinoline",CN1CCC[C@H]2[C@H]1CCCC2,,,,,,
1889,101890,"Phenol, 2,6-dimethyl-, acetate",CC1=C(C(=CC=C1)C)OC(=O)C,,,,,,
1890,101891,CID 101891,[Li+].[CH-]1C2=CC=CC=C2C3=CC=CC=C31,,,,,,
1891,101892,8aH-fluorene,C1=CC2C=C3C=CC=CC3=C2C=C1,,,,,,
1892,101893,"1-Naphthalenediazonium, 2-hydroxy-4-sulfo-, inner salt",C1=CC=C2C(=C1)C(=CC(=C2[N+]#N)O)S(=O)(=O)[O-],,,,,,
1893,101894,1-Hydroxy-4-sulphonatonaphthalene-2-diazonium,C1=CC=C2C(=C1)C(=CC(=C2O)[N+]#N)S(=O)(=O)[O-],,,,,,
1894,101895,"1-Amino-3,3-diphenyl-1-propanoneoxime",C1=CC=C(C=C1)C(CC(=NO)N)C2=CC=CC=C2,,,,,,
1895,101896,1-((4-Chlorophenyl)benzyl)piperazine hydrochloride,C1CN(CCN1)C(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl,,,,,,
1896,101897,"2,7-Dibenzylidene cycloheptanone",C1CCC(=CC2=CC=CC=C2)C(=O)C(=CC3=CC=CC=C3)C1,,,,,,
1897,101898,"Pregn-5-ene-3beta,20beta-diol",C[C@H]([C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)O,,,,,,
1898,101899,"Trisodium 8-aminonaphthalene-1,3,6-trisulphonate",C1=C2C=C(C=C(C2=C(C=C1S(=O)(=O)[O-])N)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
1899,101900,"3-Pyrrolidin-1-ylandrosta-3,5-dien-17-one",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC=C4[C@@]3(CCC(=C4)N5CCCC5)C,,,,,,
1900,101901,"17,21-Dihydroxy-16beta-methylpregna-1,4,9(11)-triene-3,20-dione 21-acetate",C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4(C3=CC[C@@]2([C@]1(C(=O)COC(=O)C)O)C)C,,,,,,
1901,101902,n-{1-(Benzoylamino)-4-[(diaminomethylidene)amino]butyl}-4-nitrobenzamide hydrochloride(1:1),C1=CC=C(C=C1)C(=O)NC(CCCN=C(N)N)NC(=O)C2=CC=C(C=C2)[N+](=O)[O-].Cl,,,,,,
1902,101903,N-[1-benzamido-4-(diaminomethylideneamino)butyl]-4-nitrobenzamide,C1=CC=C(C=C1)C(=O)NC(CCCN=C(N)N)NC(=O)C2=CC=C(C=C2)[N+](=O)[O-],,,,,,
1903,101904,"9,11beta-Epoxy-17-hydroxy-16beta-methyl-3,20-dioxo-9beta-pregna-1,4-diene-21-yl acetate",C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]35[C@@H](O5)C[C@@]2([C@]1(C(=O)COC(=O)C)O)C)C,,,,,,
1904,101905,Nandrolone cyclohexylpropionate,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)CCC4CCCCC4)CCC5=CC(=O)CC[C@H]35,,,,,,
1905,101906,Hecogenin acetate,C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(C(=O)C[C@H]5[C@H]4CC[C@@H]6[C@@]5(CC[C@@H](C6)OC(=O)C)C)C)C)OC1,,,,,,
1906,101907,Methylmagnesium Iodide,[CH3-].[Mg+2].[I-],,,,,,
1907,101908,Methylaluminium dichloride,C[Al](Cl)Cl,,,,,,
1908,101909,"Magnesium, bromo(1-methylethyl)-",C[CH-]C.[Mg+2].[Br-],,,,,,
1909,101910,3-Aminoaspartic acid,[C@H](C(C(=O)O)N)(C(=O)O)N,,,,,,
1910,101911,"L-Isoleucine, ethyl ester",CCC(C)[C@@H](C(=O)OCC)N,,,,,,
1911,101912,Triethylindium,CC[In](CC)CC,,,,,,
1912,101913,"2-Penten-1-ol, 3-methyl-, acetate",CCC(=CCOC(=O)C)C,,,,,,
1913,101914,Ethylmagnesium Bromide,C[CH2-].[Mg+2].[Br-],,,,,,
1914,101915,"1,3-Propanediol, 2-(octadecyloxy)-",CCCCCCCCCCCCCCCCCCOC(CO)CO,,,,,,
1915,101916,Bromopropylmagnesium,CC[CH2-].[Mg+2].[Br-],,,,,,
1916,101917,"Ethane-1,2-diyl dioctadec-9-enoate",CCCCCCCCC=CCCCCCCCC(=O)OCCOC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
1917,101918,"Lithium, bicyclo[2.2.1]hept-1-yl-",[Li+].C1C[C-]2CCC1C2,,,,,,
1918,101919,o-Tolylmagnesium Bromide,CC1=CC=CC=[C-]1.[Mg+2].[Br-],,,,,,
1919,101920,2-Cyano-3-hydroxypyridine,C1=CC(=C(N=C1)C#N)O,,,,,,
1920,101921,"(1s,5s)-3,3,5-Trimethylcyclohexanol",C[C@@H]1C[C@@H](CC(C1)(C)C)O,,,,,,
1921,101922,CID 101922,C1=CC(=C(C(=C1)O)C(=O)[O-])O.[Na+],,,,,,
1922,101923,"(1S-(1alpha,3beta,5beta,7alpha))-3,8,8-Trimethyl-4-oxatricyclo(5.1.0.03,5)octane",C[C@]12C[C@H]3[C@H](C3(C)C)C[C@H]1O2,,,,,,
1923,101924,"3-Buten-2-one, 4-(4-nitrophenyl)-",CC(=O)C=CC1=CC=C(C=C1)[N+](=O)[O-],,,,,,
1924,101925,Meprylcaine hydrochloride,CCCNC(C)(C)COC(=O)C1=CC=CC=C1.Cl,,,,,,
1925,101926,"2,3-Dimethyl-1,4-dioxaspiro[4.11]hexadecane",CC1C(OC2(O1)CCCCCCCCCCC2)C,,,,,,
1926,101927,5alpha-Androstan-17-one,C[C@]12CCCC[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C,,,,,,
1927,101928,Androst-2-en-17-one,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CC[C@@H]4[C@@]3(CC=CC4)C,,,,,,
1928,101929,Basic blue 6,C[N+](=C1C=CC2=NC3=C(C=CC4=CC=CC=C43)OC2=C1)C.[Cl-],,,,,,
1929,101930,N-[(4-amino-2-methylpyrimidin-5-yl)methyl]-N-[5-hydroxy-3-(propyldisulfanyl)pent-2-en-2-yl]formamide;hydrochloride,CCCSSC(=C(C)N(CC1=CN=C(N=C1N)C)C=O)CCO.Cl,,,,,,
1930,101931,"3-Oxopregn-4-ene-21,17alpha-carbolactone",C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@]45CCC(=O)O5)C,,,,,,
1931,101932,"Quinolinium, 1-ethyl-2-[(1-ethyl-2(1H)-quinolinylidene)methyl]-, iodide",CCN1C(=CC2=[N+](C3=CC=CC=C3C=C2)CC)C=CC4=CC=CC=C41.[I-],,,,,,
1932,101933,"Betamethasone 9,11-Epoxide",C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]35[C@@H](O5)C[C@@]2([C@]1(C(=O)CO)O)C)C,,,,,,
1933,101934,"Cholest-4-ene-3,6-dione",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC(=O)C4=CC(=O)CC[C@]34C)C,,,,,,
1934,101935,"Benzoselenazolium, 3-ethyl-2-[5-(3-ethyl-2(3H)-benzoselenazolylidene)-1,3-pentadienyl]-, ethyl sulfate",CCN1C2=CC=CC=C2[Se]C1=CC=CC=CC3=[N+](C4=CC=CC=C4[Se]3)CC.CCOS(=O)(=O)[O-],,,,,,
1935,101936,"3-Ethyl-2-[5-[3-ethylbenzoselenazol-2(3H)-ylidene]-1,3-pentadienyl]benzoselenazol-3-ium",CCN1C2=CC=CC=C2[Se]C1=CC=CC=CC3=[N+](C4=CC=CC=C4[Se]3)CC,,,,,,
1936,101937,"Naphtho[1,2-d]thiazolium, 1-ethyl-2-[3-(1-ethylnaphtho[1,2-d]thiazol-2(1H)-ylidene)-2-methyl-1-propenyl]-, chloride",CCN1C(=CC(=CC2=[N+](C3=C(S2)C=CC4=CC=CC=C43)CC)C)SC5=C1C6=CC=CC=C6C=C5.[Cl-],,,,,,
1937,101938,"1-ethyl-2-[3-(1-ethylnaphtho[1,2-d][1,3]thiazol-2(1H)-ylidene)-2-methylprop-1-en-1-yl]naphtho[1,2-d][1,3]thiazol-1-ium",CCN1C(=CC(=CC2=[N+](C3=C(S2)C=CC4=CC=CC=C43)CC)C)SC5=C1C6=CC=CC=C6C=C5,,,,,,
1938,101939,Thallium(I) formate,C(=O)[O-].[Tl+],,,,,,
1939,101940,Methyltin trichloride,C[Sn](Cl)(Cl)Cl,,,,,,
1940,101941,(Dimethylamino)trimethylstannane,CN(C)[Sn](C)(C)C,,,,,,
1941,101942,CID 101942,CC(C)C(=O)[O-].[Na+],,,,,,
1942,101943,CID 101943,CC(C)[CH2-].CC(C)[CH2-].CC(C)[CH2-].CC(C)[CH2-].O.[AlH+2].[AlH+2],,,,,,
1943,101944,CID 101944,CCCC[S-].CCCC[S-].C[Sn]C,,,,,,
1944,101945,"Octa-1,3,7-triene",C=CCCC=CC=C,,,,,,
1945,101946,"1,6-Hexanediamine, N,N'-dibutylidene-",CCCC=NCCCCCCN=CCCC,,,,,,
1946,101947,CID 101947,C[N+]1=CC=CC(=C1)C(=O)N.[Cl-],,,,,,
1947,101948,CID 101948,CC[C@H](C)[C@H]1C(=O)C(=C(N1)[O-])C(=O)C.[Na+],,,,,,
1948,101949,CID 101949,CC[C@H](C)[C@H]1C(=O)C(=C(N1)O)C(=O)C,,,,,,
1949,101950,"(8R,9S,13S,14S,17S)-13-ethyl-3-methoxy-1,4,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-ol",CC[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3CC=C(C4)OC,,,,,,
1950,101951,"17-Methylpregn-4-ene-3,20-dione",CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)C,,,,,,
1951,101952,Diosgenin acetate,C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5(CC[C@@H](C6)OC(=O)C)C)C)C)OC1,,,,,,
1952,101953,Cholest-5-en-3beta-yl hexanoate,CCCCCC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC[C@@H]4[C@H](C)CCCC(C)C)C)C,,,,,,
1953,101954,CID 101954,C#[C-].[Na+],,,,,,
1954,101955,"Magnesium, chloro(1-methylethyl)-",C[CH-]C.[Mg+2].[Cl-],,,,,,
1955,101956,Tetrakis(2-ethylhexyl) titanate,CCCCC(CC)C[O-].CCCCC(CC)C[O-].CCCCC(CC)C[O-].CCCCC(CC)C[O-].[Ti+4],,,,,,
1956,101957,"Butanenitrile, 4,4'-(dichlorosilylene)bis-",C(CC#N)C[Si](CCCC#N)(Cl)Cl,,,,,,
1957,101958,2-(Ethylamino)ethyl hydrogen sulphate,CCNCCOS(=O)(=O)O,,,,,,
1958,101959,"Phenol, 2-methoxy-6-(1-propenyl)-",CC=CC1=C(C(=CC=C1)OC)O,,,,,,
1959,101960,"Stannane, trimethyl(2,4,6-trimethylphenyl)-",CC1=CC(=C(C(=C1)C)[Sn](C)(C)C)C,,,,,,
1960,101961,ZINC bisbenzenide,C1=CC=[C-]C=C1.C1=CC=[C-]C=C1.[Zn+2],,,,,,
1961,101962,Imiphos,CC1N(CCS1)P(=O)(N2CC2)N3CC3,,,,,,
1962,101963,"3-Methoxyestra-2,5(10)-dien-17beta-ol",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C3CC=C(C4)OC,,,,,,
1963,101964,16-Dehydroprogesterone,CC(=O)C1=CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,,,,,,
1964,101965,"2,3,5-Triphenyltetrazolium bromide",C1=CC=C(C=C1)C2=NN([N+](=N2)C3=CC=CC=C3)C4=CC=CC=C4.[Br-],,,['Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)'],,,
1965,101966,"16alpha,17-Epoxyprogesterone",CC(=O)[C@]12[C@H](O1)C[C@@H]3[C@@]2(CC[C@H]4[C@H]3CCC5=CC(=O)CC[C@]45C)C,,,,,,
1966,101967,Pregnanetriol,C[C@@H]([C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)C)O)O,,,,,,
1967,101968,N2-((5-(Dimethylamino)-1-naphthyl)sulphonyl)-L-glutamine,CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)NC(CCC(=O)N)C(=O)O,,,,,,
1968,101969,"17-Hydroxy-3-methoxy-6-methylpregna-3,5-dien-20-one acetate",CC1=C2C=C(CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3C1)CC[C@@]4(C(=O)C)OC(=O)C)C)C)OC,,,,,,
1969,101970,Meprednisone Acetate,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@H]3C(=O)C[C@@]2([C@]1(C(=O)COC(=O)C)O)C)C,,,,,,
1970,101971,CID 101971,COC1=CC2=C(C[C@H]3[C@H]4[C@@]2(CCCC4)CCN3CCC5=CC=CC=C5)C=C1.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O,,,,,,
1971,101972,CID 101972,COC1=CC2=C(C[C@H]3[C@H]4[C@@]2(CCCC4)CCN3CCC5=CC=CC=C5)C=C1,,,,,,
1972,101973,CID 101973,[Li+].C#[C-],,,,,,
1973,101974,"1,6,10-Dodecatrien-3-ol, 3,7,11-trimethyl-, 3-formate, (3S)-",CC(=CCCC(=CCC[C@@](C)(C=C)OC=O)C)C,,,,,,
1974,101975,"L-Cysteine, S-propyl-",CCCSC[C@@H](C(=O)O)N,,,,,,
1975,101976,"3,5,9-Undecatrien-2-one, 3,6,10-trimethyl-",CC(=CCCC(=CC=C(C)C(=O)C)C)C,,,,,,
1976,101977,D-Citronellol,C[C@H](CCC=C(C)C)CCO,,,,,,
1977,101978,"2,2-Dimethylpropyl 3-(dimethylamino)-2-methylprop-2-enoate",CC(=CN(C)C)C(=O)OCC(C)(C)C,,,,,,
1978,101979,Dipentyltin dichloride,CCCCC[Sn](CCCCC)(Cl)Cl,,,,,,
1979,101980,CID 101980,CCCCCC=CCC=CCCCCCCCC(=O)OOCC,,,,,,
1980,101981,CID 101981,[CH2-]C1=CC=CC=C1.[Na+],,,,,,
1981,101982,Hexahydro-2-benzimidazolinone,C1CCC2C(C1)NC(=O)N2,,,,,,
1982,101983,Toluene-d3,[2H]C([2H])([2H])C1=CC=CC=C1,,,,,,
1983,101984,"2-Propenoic acid, 3-(3-pyridinyl)-",C1=CC(=CN=C1)C=CC(=O)O,,,,,,
1984,101985,Butan-2-one phenylhydrazone,CCC(=NNC1=CC=CC=C1)C,,,,,,
1985,101986,"Guanidine, (2,4-dichlorobenzyl)-, monohydrochloride",C1=CC(=C(C=C1Cl)Cl)CN=C(N)N.Cl,,,,,,
1986,101987,N-Benzyloxycarbonyl-L-proline,C1C[C@H](N(C1)C(=O)OCC2=CC=CC=C2)C(=O)O,,,,,,
1987,101988,"Estra-1,3,5(10),16-tetraen-3-ol",C[C@]12CC[C@H]3[C@H]([C@@H]1CC=C2)CCC4=C3C=CC(=C4)O,,,,,,
1988,101989,Androstenol,C[C@]12CC[C@H]3[C@H]([C@@H]1CC=C2)CC[C@@H]4[C@@]3(CC[C@H](C4)O)C,,,,,,
1989,101990,"1-(2,4-Dimethoxyphenyl)-3-phenylprop-2-en-1-one",COC1=CC(=C(C=C1)C(=O)C=CC2=CC=CC=C2)OC,,,,,,
1990,101991,"Diethyl 1,4-dihydro-2,6-dimethyl-4-propylpyridine-3,5-dicarboxylate",CCCC1C(=C(NC(=C1C(=O)OCC)C)C)C(=O)OCC,,,,,,
1991,101992,"(2r,3r,4s,5r,6s)-2-(Hydroxymethyl)-6-(2-Nitrophenyl)sulfanyl-Oxane-3,4,5-Triol",C1=CC=C(C(=C1)[N+](=O)[O-])S[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O,,,,,,
1992,101993,"1,3-Bis[4-(dimethylamino)phenyl]prop-2-en-1-one",CN(C)C1=CC=C(C=C1)C=CC(=O)C2=CC=C(C=C2)N(C)C,,,,,,
1993,101994,6-Dehydroprogesterone,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=CC4=CC(=O)CC[C@]34C)C,,,,,,
1994,101995,4-Chloroprogesterone,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=C(C(=O)CC[C@]34C)Cl)C,,,,,,
1995,101996,Androsterone acetate,CC(=O)O[C@@H]1CC[C@]2([C@H](C1)CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C)C,,,,,,
1996,101997,"(20R)-5beta-Pregnane-3alpha,17,20-triol",C[C@H]([C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)C)O)O,,,,,,
1997,101998,CID 101998,CC(=C1C=CC(=O)C=C1O)N=NC2=C(C=C(C=C2)N(O)O)[N+](=O)[O-],,,,,,
1998,101999,CID 101999,C1CN(CCN1)CCCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl.Cl,,,,,,
1999,102000,CID 102000,C1CN(CCN1)CCCC=C2C3=CC=CC=C3SC4=C2C=C(C=C4)Cl,,,,,,
2000,102001,"1,4-Cyclohexanebis(methylamine), N,N'-bis(3-norbornylmethyl)-, dihydrochloride, (E)-",C1CC(CCC1CNCC2CC3CCC2C3)CNCC4CC5CCC4C5.Cl.Cl,,,,,,
2001,102002,N-(2-bicyclo[2.2.1]heptanylmethyl)-1-[4-[(2-bicyclo[2.2.1]heptanylmethylamino)methyl]cyclohexyl]methanamine,C1CC(CCC1CNCC2CC3CCC2C3)CNCC4CC5CCC4C5,,,,,,
2002,102003,"11beta,16alpha,17,21-Tetrahydroxypregn-4-ene-3,20-dione",C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3C[C@H]([C@@]4(C(=O)CO)O)O)C)O,,,,,,
2003,102004,CID 102004,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)[O-])O)O)N.[Na+],,,,,,
2004,102005,"3beta,21-Dihydroxy-16alpha-methylpregn-5-en-20-one 21-acetate",C[C@@H]1C[C@H]2[C@@H]3CC=C4C[C@H](CC[C@@]4([C@H]3CC[C@@]2([C@H]1C(=O)COC(=O)C)C)C)O,,,,,,
2005,102006,11-Dehydrocorticosterone acetate,CC(=O)OCC(=O)[C@H]1CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,,,,,,
2006,102007,"(20R)-5beta-Pregnane-3alpha,20-diol diacetate",C[C@H]([C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)OC(=O)C)C)C)OC(=O)C,,,,,,
2007,102008,6-Ketocholestanol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC(=O)[C@@H]4[C@@]3(CC[C@@H](C4)O)C)C,,,,,,
2008,102009,Pseudococaine tartrate,CN1[C@H]2CC[C@@H]1[C@@H]([C@H](C2)OC(=O)C3=CC=CC=C3)C(=O)OC.[C@@H]([C@H](C(=O)O)O)(C(=O)O)O,,,,,,
2009,102010,CID 102010,CN1[C@H]2CC[C@@H]1[C@@H](C(C2)OC(=O)C3=CC=CC=C3)C(=O)OC,,,,,,
2010,102011,Algestone acetophenide,CC(=O)[C@@]12[C@@H](C[C@@H]3[C@@]1(CC[C@H]4[C@H]3CCC5=CC(=O)CC[C@]45C)C)OC(O2)(C)C6=CC=CC=C6,,,"['Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)', 'Compounds that interact with PROGESTERONE RECEPTORS in target tissues to bring about the effects similar to those of PROGESTERONE. Primary actions of progestins, including natural and synthetic steroids, are on the UTERUS and the MAMMARY GLAND in preparation for and in maintenance of PREGNANCY. (See all compounds classified as Progestins.)', 'Oral contraceptives which owe their effectiveness to synthetic preparations. (See all compounds classified as Contraceptives, Oral, Synthetic.)', 'Contraceptive agents that act on the ENDOCRINE SYSTEM. (See all compounds classified as Contraceptive Agents, Hormonal.)']",,,
2011,102012,Cholesterol isobutyrate,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OC(=O)C(C)C)C)C,,,,,,
2012,102013,7-Dehydrocholesterol benzoate,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3C2=CC=C4[C@@]3(CC[C@@H](C4)OC(=O)C5=CC=CC=C5)C)C,,,,,,
2013,102014,Cholesteryl heptanoate,CCCCCCC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC[C@@H]4[C@H](C)CCCC(C)C)C)C,,,,,,
2014,102015,Cholesteryl octanoate,CCCCCCCC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC[C@@H]4[C@H](C)CCCC(C)C)C)C,,,,,,
2015,102016,"[(3S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] decanoate",CCCCCCCCCC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H](C3CC=C2C1)CC[C@@H]4[C@H](C)CCCC(C)C)C)C,,,,,,
2016,102017,Tetraethylammonium acetate,CC[N+](CC)(CC)CC.CC(=O)[O-],,,,,,
2017,102018,"3-Hydroxypropane-1,2-diyl bis(dihydrogenphosphate)",C(C(COP(=O)(O)O)OP(=O)(O)O)O,,,,,,
2018,102019,3-Quinuclidinone hydrochloride,C1CN2CCC1C(=O)C2.Cl,,,,,,
2019,102020,3-Thiophen-3-ylprop-2-enoic acid,C1=CSC=C1C=CC(=O)O,,,,,,
2020,102021,"Ethanone, 1-(2-hydroxyphenyl)-, oxime, (E)-",CC(=NO)C1=CC=CC=C1O,,,,,,
2021,102022,"(3R,4R,5R)-5-[(1S)-1,2-dihydroxyethyl]-3,4-dihydroxyoxolan-2-one",C([C@@H]([C@@H]1[C@@H]([C@H](C(=O)O1)O)O)O)O,,,,,,
2022,102023,(+)-N-Methylephedrine,C[C@H]([C@H](C1=CC=CC=C1)O)N(C)C,,,,,,
2023,102024,"2-Cyclohexen-1-ol, 2-methyl-5-(1-methylethenyl)-, acetate, cis-",CC1=CC[C@H](C[C@H]1OC(=O)C)C(=C)C,,,,,,
2024,102025,Di-o-tolylcarbodiimide,CC1=CC=CC=C1N=C=NC2=CC=CC=C2C,,,,,,
2025,102026,"[2-Chloro-1-(2,4-dibromophenyl)ethenoxy]-dimethoxy-sulfanylidene-lambda5-phosphane",COP(=S)(OC)OC(=CCl)C1=C(C=C(C=C1)Br)Br,,,,,,
2026,102027,"O-(1-(4-Bromo-2-chlorophenyl)-2-chloroethenyl) O,O-dimethyl phosphorothioate",COP(=S)(OC)OC(=CCl)C1=C(C(=CC=C1)Br)Cl,,,,,,
2027,102028,5alpha-Androstan-3-one,C[C@@]12CCC[C@H]1[C@@H]3CC[C@H]4CC(=O)CC[C@@]4([C@H]3CC2)C,,,,,,
2028,102029,11-Ketoandrosterone,C[C@]12CC[C@H](C[C@@H]1CC[C@@H]3[C@@H]2C(=O)C[C@]4([C@H]3CCC4=O)C)O,,,,,,
2029,102030,16alpha-Hydroxydehydroepiandrosterone,C[C@]12CC[C@@H](CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3C[C@H](C4=O)O)C)O,,,,,,
2030,102031,2-Methoxyestriol,C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H]([C@@H]2O)O)CCC4=CC(=C(C=C34)OC)O,,,,,,
2031,102032,CID 102032,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3C=CC(=C4)OS(=O)(=O)[O-].[K+],,,,,,
2032,102033,"trans-N,N'-Bis(2-bromobenzyl)-1,4-cyclohexanebis(methylamine) dihydrochloride",C1CC(CCC1CNCC2=CC=CC=C2Br)CNCC3=CC=CC=C3Br.Cl.Cl,,,,,,
2033,102034,N-[(2-bromophenyl)methyl]-1-[4-[[(2-bromophenyl)methylamino]methyl]cyclohexyl]methanamine,C1CC(CCC1CNCC2=CC=CC=C2Br)CNCC3=CC=CC=C3Br,,,,,,
2034,102035,"1,4-Cyclohexanebis(methylamine), N,N'-bis(2-methylbenzyl)-, dihydrochloride",CC1=CC=CC=C1CNCC2CCC(CC2)CNCC3=CC=CC=C3C.Cl.Cl,,,,,,
2035,102036,N-[(2-methylphenyl)methyl]-1-[4-[[(2-methylphenyl)methylamino]methyl]cyclohexyl]methanamine,CC1=CC=CC=C1CNCC2CCC(CC2)CNCC3=CC=CC=C3C,,,,,,
2036,102037,"trans-N,N'-Bis(1,1,3,3-tetramethylbutyl)-1,4-cyclohexanebis(methylamine) dihydrochloride",CC(C)(C)CC(C)(C)NCC1CCC(CC1)CNC(C)(C)CC(C)(C)C.Cl.Cl,,,,,,
2037,102038,"2,4,4-trimethyl-N-[[4-[(2,4,4-trimethylpentan-2-ylamino)methyl]cyclohexyl]methyl]pentan-2-amine",CC(C)(C)CC(C)(C)NCC1CCC(CC1)CNC(C)(C)CC(C)(C)C,,,,,,
2038,102039,"N,N'-Bis(4-bromobenzyl)-1,4-cyclohexanebis(methylamine) dihydrochloride",C1CC(CCC1CNCC2=CC=C(C=C2)Br)CNCC3=CC=C(C=C3)Br.Cl.Cl,,,,,,
2039,102040,N-[(4-bromophenyl)methyl]-1-[4-[[(4-bromophenyl)methylamino]methyl]cyclohexyl]methanamine,C1CC(CCC1CNCC2=CC=C(C=C2)Br)CNCC3=CC=C(C=C3)Br,,,,,,
2040,102041,"N,N'-Bis(4-chlorobenzyl)-1,4-cyclohexanebis(methylamine) dihydrochloride",C1CC(CCC1CNCC2=CC=C(C=C2)Cl)CNCC3=CC=C(C=C3)Cl.Cl.Cl,,,,,,
2041,102042,N-[(4-chlorophenyl)methyl]-1-[4-[[(4-chlorophenyl)methylamino]methyl]cyclohexyl]methanamine,C1CC(CCC1CNCC2=CC=C(C=C2)Cl)CNCC3=CC=C(C=C3)Cl,,,,,,
2042,102043,"1,4-Cyclohexanebis(methylamine), N,N'-bis(3-chlorobenzyl)-, dihydrochloride",C1CC(CCC1CNCC2=CC(=CC=C2)Cl)CNCC3=CC(=CC=C3)Cl.Cl.Cl,,,,,,
2043,102044,N-[(3-chlorophenyl)methyl]-1-[4-[[(3-chlorophenyl)methylamino]methyl]cyclohexyl]methanamine,C1CC(CCC1CNCC2=CC(=CC=C2)Cl)CNCC3=CC(=CC=C3)Cl,,,,,,
2044,102045,Diphenoxydiphenylsilane,C1=CC=C(C=C1)O[Si](C2=CC=CC=C2)(C3=CC=CC=C3)OC4=CC=CC=C4,,,,,,
2045,102046,Colpormon,CC(=O)O[C@@H]1C[C@H]2[C@@H]3CCC4=C([C@H]3CC[C@@]2(C1=O)C)C=CC(=C4)OC(=O)C,,,,,,
2046,102047,Benzyl octyl phthalate,CCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCC2=CC=CC=C2,,,,,,
2047,102048,"2-(1,1'-Biphenyl)-4-yl-5-(1-naphthyl)-1,3,4-oxadiazole",C1=CC=C(C=C1)C2=CC=C(C=C2)C3=NN=C(O3)C4=CC=CC5=CC=CC=C54,,,,,,
2048,102049,"N,N'-Bis(2,6-dichlorobenzyl)-1,4-cyclohexanebis(methylamine) dihydrochloride",C1CC(CCC1CNCC2=C(C=CC=C2Cl)Cl)CNCC3=C(C=CC=C3Cl)Cl.Cl.Cl,,,,,,
2049,102050,"N-[(2,6-dichlorophenyl)methyl]-1-[4-[[(2,6-dichlorophenyl)methylamino]methyl]cyclohexyl]methanamine",C1CC(CCC1CNCC2=C(C=CC=C2Cl)Cl)CNCC3=C(C=CC=C3Cl)Cl,,,,,,
2050,102051,"N,N'-Bis(2-methylthiobenzyl)-1,4-cyclohexanebis(methylamine) dihydrochloride",CSC1=CC=CC=C1CNCC2CCC(CC2)CNCC3=CC=CC=C3SC.Cl.Cl,,,,,,
2051,102052,N-[(2-methylsulfanylphenyl)methyl]-1-[4-[[(2-methylsulfanylphenyl)methylamino]methyl]cyclohexyl]methanamine,CSC1=CC=CC=C1CNCC2CCC(CC2)CNCC3=CC=CC=C3SC,,,,,,
2052,102053,"N,N'-Bis(3,4-dichlorobenzyl)-1,4-cyclohexanebis(methylamine) dihydrochloride",C1CC(CCC1CNCC2=CC(=C(C=C2)Cl)Cl)CNCC3=CC(=C(C=C3)Cl)Cl.Cl.Cl,,,,,,
2053,102054,"N-[(3,4-dichlorophenyl)methyl]-1-[4-[[(3,4-dichlorophenyl)methylamino]methyl]cyclohexyl]methanamine",C1CC(CCC1CNCC2=CC(=C(C=C2)Cl)Cl)CNCC3=CC(=C(C=C3)Cl)Cl,,,,,,
2054,102055,"9-Fluoro-11beta,21-dihydroxypregna-1,4,16-triene-3,20-dione 21-acetate",CC(=O)OCC(=O)C1=CC[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C,,,,,,
2055,102056,"11alpha,17,21-Trihydroxypregn-4-ene-3,20-dione 21-acetate",CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@H]([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)O)C)O,,,,,,
2056,102057,"1,4-Cyclohexanebis(methylamine), N,N'-bis(2,4,6-trimethylbenzyl)-, dihydrochloride",CC1=CC(=C(C(=C1)C)CNCC2CCC(CC2)CNCC3=C(C=C(C=C3C)C)C)C.Cl.Cl,,,,,,
2057,102058,"N-[(2,4,6-trimethylphenyl)methyl]-1-[4-[[(2,4,6-trimethylphenyl)methylamino]methyl]cyclohexyl]methanamine",CC1=CC(=C(C(=C1)C)CNCC2CCC(CC2)CNCC3=C(C=C(C=C3C)C)C)C,,,,,,
2058,102059,"N,N'-Bis(2-nitrobenzyl)-1,4-cyclohexanebis(methylamine) dihydrochloride",C1CC(CCC1CNCC2=CC=CC=C2[N+](=O)[O-])CNCC3=CC=CC=C3[N+](=O)[O-].Cl.Cl,,,,,,
2059,102060,N-[(2-nitrophenyl)methyl]-1-[4-[[(2-nitrophenyl)methylamino]methyl]cyclohexyl]methanamine,C1CC(CCC1CNCC2=CC=CC=C2[N+](=O)[O-])CNCC3=CC=CC=C3[N+](=O)[O-],,,,,,
2060,102061,"1,4-Cyclohexanebis(methylamine), N,N'-bis(4-dimethylaminobenzyl)-, tetrahydrochloride",CN(C)C1=CC=C(C=C1)CNCC2CCC(CC2)CNCC3=CC=C(C=C3)N(C)C.Cl.Cl.Cl.Cl,,,,,,
2061,102062,"4-[[[4-[[[4-(dimethylamino)phenyl]methylamino]methyl]cyclohexyl]methylamino]methyl]-N,N-dimethylaniline",CN(C)C1=CC=C(C=C1)CNCC2CCC(CC2)CNCC3=CC=C(C=C3)N(C)C,,,,,,
2062,102063,"Benzoic acid, 2-[bis[4-(dimethylamino)phenyl]methyl]-5-(dimethylamino)-",CN(C)C1=CC=C(C=C1)C(C2=CC=C(C=C2)N(C)C)C3=C(C=C(C=C3)N(C)C)C(=O)O,,,,,,
2063,102064,"2-[4-[3-[3-(Trifluoromethyl)phenothiazin-10-yl]propyl]-1,4-diazepan-1-yl]ethanol;dihydrochloride",C1CN(CCN(C1)CCO)CCCN2C3=C(C=C(C=C3)C(F)(F)F)SC4=CC=CC=C42.Cl.Cl,,,,,,
2064,102065,"2-[4-[3-[3-(Trifluoromethyl)phenothiazin-10-yl]propyl]-1,4-diazepan-1-yl]ethanol",C1CN(CCN(C1)CCO)CCCN2C3=C(C=C(C=C3)C(F)(F)F)SC4=CC=CC=C42,,,,,,
2065,102066,"1,4-Cyclohexanebis(methylamine), N,N'-bis(2,3-dimethoxybenzyl)-, dihydrochloride",COC1=CC=CC(=C1OC)CNCC2CCC(CC2)CNCC3=C(C(=CC=C3)OC)OC.Cl.Cl,,,,,,
2066,102067,"N-[(2,3-dimethoxyphenyl)methyl]-1-[4-[[(2,3-dimethoxyphenyl)methylamino]methyl]cyclohexyl]methanamine",COC1=CC=CC(=C1OC)CNCC2CCC(CC2)CNCC3=C(C(=CC=C3)OC)OC,,,,,,
2067,102068,"N,N'-Bis(1-naphthylmethyl)-1,4-cyclohexanebis(methylamine) dihydrochloride",C1CC(CCC1CNCC2=CC=CC3=CC=CC=C32)CNCC4=CC=CC5=CC=CC=C54.Cl.Cl,,,,,,
2068,102069,"N,N'-Bis(1-naphthylmethyl)-1alpha,4alpha-cyclohexanedi(methanamine)",C1CC(CCC1CNCC2=CC=CC3=CC=CC=C32)CNCC4=CC=CC5=CC=CC=C54,,,,,,
2069,102070,"1,4-Cyclohexanebis(methylamine), N,N'-bis((2-trifluoromethyl)benzyl)-, dihydrochloride, (E)-",C1CC(CCC1CNCC2=CC=CC=C2C(F)(F)F)CNCC3=CC=CC=C3C(F)(F)F.Cl.Cl,,,,,,
2070,102071,N-[[2-(trifluoromethyl)phenyl]methyl]-1-[4-[[[2-(trifluoromethyl)phenyl]methylamino]methyl]cyclohexyl]methanamine,C1CC(CCC1CNCC2=CC=CC=C2C(F)(F)F)CNCC3=CC=CC=C3C(F)(F)F,,,,,,
2071,102072,"N,N'-Bis(2-naphthylmethyl)-1,4-cyclohexanebis(methylamine) dihydrochloride",C1CC(CCC1CNCC2=CC3=CC=CC=C3C=C2)CNCC4=CC5=CC=CC=C5C=C4.Cl.Cl,,,,,,
2072,102073,N-(naphthalen-2-ylmethyl)-1-[4-[(naphthalen-2-ylmethylamino)methyl]cyclohexyl]methanamine,C1CC(CCC1CNCC2=CC3=CC=CC=C3C=C2)CNCC4=CC5=CC=CC=C5C=C4,,,,,,
2073,102074,"5alpha-Bromo-6,19-epoxycholestan-3beta-ol acetate",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C[C@@H]4[C@@]5([C@@]3(CC[C@@H](C5)OC(=O)C)CO4)Br)C,,,,,,
2074,102075,"2,2'-Thiobis(4-nonylphenol)",CCCCCCCCCC1=CC(=C(C=C1)O)SC2=C(C=CC(=C2)CCCCCCCCC)O,,,,,,
2075,102076,Tris(pentafluorophenyl)phosphine,C1(=C(C(=C(C(=C1F)F)P(C2=C(C(=C(C(=C2F)F)F)F)F)C3=C(C(=C(C(=C3F)F)F)F)F)F)F)F,,,,,,
2076,102077,methyl 3-[3-acetamido-4-[(2-chloro-4-nitrophenyl)diazenyl]-N-(3-methoxy-3-oxopropyl)anilino]propanoate,CC(=O)NC1=C(C=CC(=C1)N(CCC(=O)OC)CCC(=O)OC)N=NC2=C(C=C(C=C2)[N+](=O)[O-])Cl,,,,,,
2077,102078,"2,2'-Thiobis(4-dodecylphenol)",CCCCCCCCCCCCC1=CC(=C(C=C1)O)SC2=C(C=CC(=C2)CCCCCCCCCCCC)O,,,,,,
2078,102079,Bis(cyclopentadienyl)manganese,[CH-]1C=CC=C1.[CH-]1C=CC=C1.[Mn+2],,,,,,
2079,102080,"Cyclopenta-1,3-diene;cyclopenta-2,4-diene-1-carboxylic acid;iron(2+)",C1C=CC=[C-]1.C1=CC([C-]=C1)C(=O)O.[Fe+2],,,,,,
2080,102081,"1,3-Cyclopentadiene-5-carboxylic acid",C1=CC(C=C1)C(=O)O,,,,,,
2081,102082,((Dimethylamino)methyl)ferrocene,CN(C)CC1=CC=C[CH-]1.[CH-]1C=CC=C1.[Fe+2],,,,,,
2082,102083,"Dimethyl(1,3-cyclopentadienylmethyl)amine",CN(C)CC1=CC=CC1,,,,,,
2083,102084,"Cyclopenta-1,3-diene;1-cyclopenta-1,3-dien-1-ylbutan-1-one;iron(2+)",CCCC(=O)C1=CC=C[CH-]1.[CH-]1C=CC=C1.[Fe+2],,,,,,
2084,102085,"1-Butyryl-1,3-cyclopentadiene",CCCC(=O)C1=CC=CC1,,,,,,
2085,102086,Tris(cyclopentadienyl)gadolinium(III),[CH-]1C=CC=C1.[CH-]1C=CC=C1.[CH-]1C=CC=C1.[Gd+3],,,,,,
2086,102087,"Tris(eta5-cyclopenta-2,4-dien-1-yl)lutetium",[CH-]1C=CC=C1.[CH-]1C=CC=C1.[CH-]1C=CC=C1.[Lu+3],,,,,,
2087,102088,"Tris(eta5-cyclopenta-2,4-dien-1-yl)terbium",[CH-]1C=CC=C1.[CH-]1C=CC=C1.[CH-]1C=CC=C1.[Tb+3],,,,,,
2088,102089,"Tris(eta5-2,4-cyclopentadien-1-yl)neodymium",[CH-]1C=CC=C1.[CH-]1C=CC=C1.[CH-]1C=CC=C1.[Nd+3],,,,,,
2089,102090,Isodecylamine,CC(C)CCCCCCCN,,,,,,
2090,102091,Bis(cyclopentadienyl)ruthenium,[CH-]1C=CC=C1.[CH-]1C=CC=C1.[Ru+2],,,,,,
2091,102092,Bis-pi-cyclopentadienyldichlorozirconium,[CH-]1C=CC=C1.[CH-]1C=CC=C1.Cl[Zr+2]Cl,,,,,,
2092,102093,Dichlorozirconium(2+),Cl[Zr+2]Cl,,,,,,
2093,102094,"Cyclopenta-2,4-diene-1-carboxylic acid;iron(2+)",C1=CC([C-]=C1)C(=O)O.C1=CC([C-]=C1)C(=O)O.[Fe+2],,,,,,
2094,102095,Tris(cyclopentadienyl)yttrium(III),[CH-]1C=CC=C1.[CH-]1C=CC=C1.[CH-]1C=CC=C1.[Y+3],,,,,,
2095,102096,Tris(cyclopentadienyl)ytterbium(III),[CH-]1C=CC=C1.[CH-]1C=CC=C1.[CH-]1C=CC=C1.[Yb+3],,,,,,
2096,102097,Tris(cyclopentadienyl)cerium,[CH-]1C=CC=C1.[CH-]1C=CC=C1.[CH-]1C=CC=C1.[Ce+3],,,,,,
2097,102098,"Tris(eta5-cyclopenta-2,4-dien-1-yl)scandium",[CH-]1C=CC=C1.[CH-]1C=CC=C1.[CH-]1C=CC=C1.[Sc+3],,,,,,
2098,102099,"Tris(eta5-cyclopenta-2,4-dien-1-yl)samarium",[CH-]1C=CC=C1.[CH-]1C=CC=C1.[CH-]1C=CC=C1.[Sm+3],,,,,,
2099,102100,Dilithium glycerophosphate,[Li+].[Li+].C(C(COP(=O)([O-])[O-])O)O,,,,,,
2100,102101,CID 102101,C1=CC=C(C(=C1)O)S(=O)(=O)[O-].[Na+],,,,,,
2101,102102,CID 102102,[SeH2].[Ag].[Ag],,,,,,
2102,102103,Gold(III) hydroxide,O.O.O.[Au],,,,,,
2103,102104,Gold oxide (Au2O),O.[Au].[Au],,,,,,
2104,102105,Gold sulfide (Au2S),[SH-].[Au].[Au+],,,,,,
2105,102106,Barium selenide (BaSe),[Se]=[Ba],,,,,,
2106,102107,Calcium selenide,[Ca]=[Se],,,,,,
2107,102108,Cobalt selenide,[Co]=[Se],,,,,,
2108,102109,Potassium hydrosulfide,[SH-].[K+],,,,,,
2109,102110,Rhenium trioxide,O=[Re](=O)=O,,,,,,
2110,102111,"Carbonic acid, decynyl methyl ester",CC#CCCCCCCCOC(=O)OC,,,,,,
2111,102112,Einecs 215-415-4,C1=CC=C2C(=C1)C(=O)OC23C4=CC(=C(C(=C4OC5=C(C(=C(C=C35)Br)[O-])Br)Br)[O-])Br.[Pb+2],,,,,,
2112,102113,CID 102113,CCCCCCCCCCCCCCCC(=O)O.C([C@H]([C@@H]1C(=O)C(=C(O1)O)O)O)O,,,,,,
2113,102114,Calcium camphorsulfonate,CC1([C@@H]2CC[C@]1(C(=O)C2)CS(=O)(=O)[O-])C.CC1([C@@H]2CC[C@]1(C(=O)C2)CS(=O)(=O)[O-])C.[Ca+2],,,,,,
2114,102115,"1,2-Benzenedicarboxylic acid, cyclohexyl ester",C1CCC(CC1)O.C1=CC=C(C(=C1)C(=O)O)C(=O)O,,,,,,
2115,102116,"Abietic acid, glyceryl ester",CC(C)C1=CC2=CC[C@@H]3[C@@]([C@H]2CC1)(CCC[C@@]3(C)C(=O)O)C.C(C(CO)O)O,,,,,,
2116,102117,"Mannitan, monohexadecanoate",CCCCCCCCCCCCCCCC(=O)O.C([C@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O)O,,,,,,
2117,102118,Citrosalic acid,C1OC(=O)C(O1)(CC(=O)OC2=CC=CC=C2C(=O)O)CC(=O)OC3=CC=CC=C3C(=O)O,,,,,,
2118,102119,Streptolin A,C1[C@H]([C@@H]2[C@@H](C(=O)N1)N=C(N2)N[C@H]3C([C@@H]([C@H]([C@H](O3)CO)OC(=O)N)O)NC(=O)CC(CCCNC(=O)CC(CCCN)N)N)O,,,,,,
2119,102120,Cedrenyl acetate,C[C@@H]1CC[C@@H]2[C@]13CC=C([C@H](C3)C2(C)C)COC(=O)C,,,,,,
2120,102121,Desoxycortone enanthate,CCCCCCC(=O)OCC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,,,,,,
2121,102122,Nandrolone acetate,CC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@H]34)C,,,,,,
2122,102123,"5-Benzylidene-3-[(2-hydroxyphenyl)methylideneamino]-2-sulfanylidene-1,3-thiazolidin-4-one",C1=CC=C(C=C1)C=C2C(=O)N(C(=S)S2)N=CC3=CC=CC=C3O,,,,,,
2123,102124,Chlorosarin,CC(C)OP(=O)(C)Cl,,,,,,
2124,102125,"N,N'-Bis(2,4-dichlorobenzyl)-1,4-cyclohexanebis(methylamine) dihydrochloride",C1CC(CCC1CNCC2=C(C=C(C=C2)Cl)Cl)CNCC3=C(C=C(C=C3)Cl)Cl.Cl.Cl,,,,,,
2125,102126,"N-[(2,4-dichlorophenyl)methyl]-1-[4-[[(2,4-dichlorophenyl)methylamino]methyl]cyclohexyl]methanamine",C1CC(CCC1CNCC2=C(C=C(C=C2)Cl)Cl)CNCC3=C(C=C(C=C3)Cl)Cl,,,,,,
2126,102127,"N,N'-Bis(2-methoxybenzyl)-1,4-cyclohexanebis(methylamine) dihydrochloride",COC1=CC=CC=C1CNCC2CCC(CC2)CNCC3=CC=CC=C3OC.Cl.Cl,,,,,,
2127,102128,N-[(2-methoxyphenyl)methyl]-1-[4-[[(2-methoxyphenyl)methylamino]methyl]cyclohexyl]methanamine,COC1=CC=CC=C1CNCC2CCC(CC2)CNCC3=CC=CC=C3OC,,,,,,
2128,102129,"trans-N,N'-Bis(cyclohexylmethyl)-1,4-cyclohexanebis(methylamine) dihydrochloride",C1CCC(CC1)CNCC2CCC(CC2)CNCC3CCCCC3.Cl.Cl,,,,,,
2129,102130,N-(cyclohexylmethyl)-N-[(4-{[(cyclohexylmethyl)amino]methyl}cyclohexyl)methyl]amine,C1CCC(CC1)CNCC2CCC(CC2)CNCC3CCCCC3,,,,,,
2130,102131,"9,10[1',2']-Benzenoanthracene-9(10H)-methanol",C1=CC=C2C(=C1)C3C4=CC=CC=C4C2(C5=CC=CC=C35)CO,,,,,,
2131,102132,"3-beta,17-alpha,21-Trihydroxypregn-5-en-20-one 21-acetate",CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)O,,,,,,
2132,102133,"Pregnane-3,11,20-trione",CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CC[C@H]4[C@@]3(CCC(=O)C4)C)C,,,,,,
2133,102134,"Hydroquinine, hydrochloride",CCC1CN2CCC1CC2C(C3=C4C=C(C=CC4=NC=C3)OC)O.Cl,,,,,,
2134,102135,Methyl glycyrrhetinate,C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)(C)C(=O)OC,,,,,,
2135,102136,[1-[2-(Dimethylamino)ethoxy-hydroxyphosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] octadec-9-enoate,CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN(C)C)OC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
2136,102137,"[2-[(5R,8S,9S,10S,13S,14S)-17-hydroxy-10,13-dimethyl-3,11-dioxo-1,2,4,5,6,7,8,9,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate",CC(=O)OCC(=O)C1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CC[C@H]4[C@@]3(CCC(=O)C4)C)C)O,,,,,,
2137,102138,Ethanol-d6,[2H]C([2H])([2H])C([2H])([2H])O[2H],,,,,,
2138,102139,"6beta-Fluoro-3beta,5alpha,17-trihydroxy-16alpha-methylpregnan-20-one 3-acetate",C[C@@H]1C[C@H]2[C@@H]3C[C@H]([C@]4(C[C@H](CC[C@@]4([C@H]3CC[C@@]2([C@]1(C(=O)C)O)C)C)OC(=O)C)O)F,,,,,,
2139,102140,11-Deoxyflurandrenolone,C[C@]12CCC(=O)C=C1[C@H](C[C@@H]3[C@@H]2CC[C@]4([C@H]3C[C@@H]5[C@]4(OC(O5)(C)C)C(=O)CO)C)F,,,,,,
2140,102141,4-Ethoxypent-3-en-2-one,CCOC(=CC(=O)C)C,,,,,,
2141,102142,"9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregn-4-ene-3,20-dione 21-acetate",C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COC(=O)C)O)C)O)F)C,,,,,,
2142,102143,CID 102143,CCCCCCCCOP(=O)([O-])OCCCCCCCC.[Na+],,,,,,
2143,102144,"1,4-Cyclohexanebis(methylamine), N,N'-bis(4-methylbenzyl)-, dihydrochloride",CC1=CC=C(C=C1)CNCC2CCC(CC2)CNCC3=CC=C(C=C3)C.Cl.Cl,,,,,,
2144,102145,N-[(4-methylphenyl)methyl]-1-[4-[[(4-methylphenyl)methylamino]methyl]cyclohexyl]methanamine,CC1=CC=C(C=C1)CNCC2CCC(CC2)CNCC3=CC=C(C=C3)C,,,,,,
2145,102146,Bolasterone,C[C@@H]1CC2=CC(=O)CC[C@@]2([C@@H]3[C@@H]1[C@@H]4CC[C@]([C@]4(CC3)C)(C)O)C,,,"['These compounds stimulate anabolism and inhibit catabolism. They stimulate the development of muscle mass, strength, and power. (See all compounds classified as Anabolic Agents.)']",,,
2146,102147,"11-beta,17-alpha,21-Trihydroxy-6-alpha-methylpregn-4-ene-3,20-dione",C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)CC4)C)O)C)(C(=O)CO)O,,,,,,
2147,102148,Chloro(methyl)(phenyl)silane,C[SiH](C1=CC=CC=C1)Cl,,,,,,
2148,102149,"3beta,11alpha,17-Trihydroxy-16alpha-methyl-5alpha-pregnan-20-one",C[C@@H]1C[C@H]2[C@@H]3CC[C@H]4C[C@H](CC[C@@]4([C@H]3[C@@H](C[C@@]2([C@]1(C(=O)C)O)C)O)C)O,,,,,,
2149,102150,Androstenediol 3-acetate,CC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC[C@@H]4O)C)C,,,,,,
2150,102151,"N,N-Bis(2,4-dinitrophenyl)-L-histidine",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])N(C2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-])[C@@H](CC3=CN=CN3)C(=O)O,,,,,,
2151,102152,6beta-Acetoxyprogesterone,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C[C@H](C4=CC(=O)CC[C@]34C)OC(=O)C)C,,,,,,
2152,102153,"Pseudourea, 2-(2-aminoethyl)-1-ethyl-2-thio-, dihydrobromide",CCN=C(N)SCCN.Br.Br,,,,,,
2153,102154,1-Ethyl-2-(2-aminoethyl)isothiourea,CCN=C(N)SCCN,,,,,,
2154,102155,"[(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR)-9-acetyloxy-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysen-3a-yl]methyl acetate",CC(=C)[C@@H]1CC[C@]2(C1[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)OC(=O)C)C)COC(=O)C,,,,,,
2155,102156,"Acetic acid, chloro-, compd. with N,N-dimethylformamide (1:1)",CN(C)C=O.C(C(=O)O)Cl,,,,,,
2156,102157,"1,1,1,2,2,3,4,5,5,6,6,6-Dodecafluoro-3,4-bis(trifluoromethyl)hexane",C(C(C(C(F)(F)F)(F)F)(C(F)(F)F)F)(C(C(F)(F)F)(F)F)(C(F)(F)F)F,,,,,,
2157,102158,CID 102158,CC(=O)O.C1C(=O)NC(=O)N1N=CC2=CC=C(O2)[N+](=O)[O-],,,,,,
2158,102159,(E)-3-(4-bromophenyl)-1-phenyl-prop-2-en-1-one,C1=CC=C(C=C1)C(=O)C=CC2=CC=C(C=C2)Br,,,,,,
2159,102160,Methyl N2-benzoyl-L-argininate monohydrochloride,COC(=O)[C@H](CCCN=C(N)NC(=O)C1=CC=CC=C1)N.Cl,,,,,,
2160,102161,Methyl 2-amino-5-[[amino(benzamido)methylidene]amino]pentanoate,COC(=O)C(CCCN=C(N)NC(=O)C1=CC=CC=C1)N,,,,,,
2161,102162,Capri Blue,CC[N+](=C1C=C2C(=NC3=C(O2)C=C(C=C3)N(C)C)C=C1C)CC.[Cl-],,,,,,
2162,102163,"1,6-Divinylperfluorohexane",C=CC(C(C(C(C(C(C=C)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
2163,102164,"11alpha,17beta-Dihydroxy-17-methylandrost-4-en-3-one",C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@@H](C[C@]4([C@H]3CC[C@]4(C)O)C)O,,,,,,
2164,102165,"17,21-Dihydroxypregn-4-ene-3,20-dione 17,21-di(acetate)",CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)OC(=O)C,,,,,,
2165,102166,"3beta-Hydroxy-16-methylpregna-5,16-dien-20-one",CC1=C([C@]2(CC[C@H]3[C@H]([C@@H]2C1)CC=C4[C@@]3(CC[C@@H](C4)O)C)C)C(=O)C,,,,,,
2166,102167,"6alpha,16alpha-Dimethylprogesterone",C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)CC[C@@]4([C@H]3CC[C@@]2([C@H]1C(=O)C)C)C)C,,,,,,
2167,102168,"6-beta,16-alpha-Dimethylprogesterone",C[C@@H]1C[C@H]2[C@@H]3C[C@H](C4=CC(=O)CC[C@@]4([C@H]3CC[C@@]2([C@H]1C(=O)C)C)C)C,,,,,,
2168,102169,Methyl beta-L-arabinopyranoside,CO[C@@H]1[C@@H]([C@H]([C@H](CO1)O)O)O,,,,,,
2169,102170,"2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9-Hexadecafluorononyl methacrylate",CC(=C)C(=O)OCC(C(C(C(C(C(C(C(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
2170,102171,CID 102171,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)COS(=O)(=O)[O-])O)C)O.[Na+],,,,,,
2171,102172,Cortisol 21-sulfate,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CC[C@@]4(C(=O)COS(=O)(=O)O)O)C)O,,,,,,
2172,102173,O-Trimethylsilylcholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O[Si](C)(C)C)C)C,,,,,,
2173,102174,"3-beta,17-alpha-Dihydroxypregn-5-en-20-one 3-acetate",CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OC(=O)C)C)C)O,,,,,,
2174,102175,N6-Methyladenosine,CNC1=C2C(=NC=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
2175,102176,"Glycine, N-ethyl-N-[(heptadecafluorooctyl)sulfonyl]-, ethyl ester",CCN(CC(=O)OCC)S(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
2176,102177,"[2-[(6S,8S,10R,13S,14S,16R,17R)-6-fluoro-17-hydroxy-10,13,16-trimethyl-3-oxo-2,6,7,8,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxoethyl] acetate",C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)CC[C@@]4(C3=CC[C@@]2([C@]1(C(=O)COC(=O)C)O)C)C)F,,,,,,
2177,102178,21-Deoxycortisone,CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O,,,,,,
2178,102179,"6beta-Fluoro-5alpha,17,21-trihydroxy-16alpha-methylpregnane-3,20-dione 21-acetate",C[C@@H]1C[C@H]2[C@@H]3C[C@H]([C@]4(CC(=O)CC[C@@]4([C@H]3CC[C@@]2(C1(C(=O)COC(=O)C)O)C)C)O)F,,,,,,
2179,102180,"9-Fluoro-11beta-hydroxy-6alpha-methylpregna-1,4-diene-3,20-dione",C[C@H]1C[C@H]2[C@@H]3CC[C@@H]([C@]3(C[C@@H]([C@@]2([C@@]4(C1=CC(=O)C=C4)C)F)O)C)C(=O)C,,,,,,
2180,102181,(3beta)-Stigmast-5-en-3-yl benzoate,CC[C@H](CC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OC(=O)C5=CC=CC=C5)C)C)C(C)C,,,,,,
2181,102182,Cholesteryl laurate,CCCCCCCCCCCC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC[C@@H]4[C@H](C)CCCC(C)C)C)C,,,,,,
2182,102183,6-Nitrocholest-5-en-3-beta-yl acetate,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC(=C4[C@@]3(CC[C@@H](C4)OC(=O)C)C)[N+](=O)[O-])C,,,,,,
2183,102184,"16-alpha,17-alpha-Epoxy-3-beta-hydroxy-16-beta-methylpregn-5-en-20-one",CC(=O)[C@]12[C@]3(CC[C@H]4[C@H]([C@@H]3C[C@]1(O2)C)CC=C5[C@@]4(CC[C@@H](C5)O)C)C,,,,,,
2184,102185,"6,6-Dimethyl-1-phenyl-1,6-dihydro-1,3,5-triazine-2,4-diamine hydrochloride",CC1(N=C(N=C(N1C2=CC=CC=C2)N)N)C.Cl,,,,,,
2185,102186,Di(tert-butyl) methyldiperoxysuccinate,CC(CC(=O)OOC(C)(C)C)C(=O)OOC(C)(C)C,,,,,,
2186,102187,"Pyrrolidinium, 1,1'-pentamethylenebis(1-methyl-, diiodide",C[N+]1(CCCC1)CCCCC[N+]2(CCCC2)C.[I-].[I-],,,,,,
2187,102188,"3-(3-Phenyl-2-propynyl)-8-propionyl-3,8-diazabicyclo(3.2.1)octane",CCC(=O)N1C2CCC1CN(C2)CC#CC3=CC=CC=C3,,,,,,
2188,102189,4-Nitrobenzenediazonium toluene-4-sulphonate,CC1=CC=C(C=C1)S(=O)(=O)[O-].C1=CC(=CC=C1[N+]#N)[N+](=O)[O-],,,,,,
2189,102190,"(2R,3S,4S,5S)-2,3,4,5,6-pentahydroxyhexanal",C([C@@H]([C@@H]([C@@H]([C@H](C=O)O)O)O)O)O,,,,,,
2190,102191,"D-lyxo-Hexose, 2-deoxy-",C(C=O)[C@H]([C@H]([C@@H](CO)O)O)O,,,,,,
2191,102192,"Androst-5-ene-3beta,17alpha-diol",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@H]2O)CC=C4[C@@]3(CC[C@@H](C4)O)C,,,,,,
2192,102193,"1,4-Cyclohexanebis(methylamine), N,N'-bis(1-cyclohexenylmethyl)-, diacetate, (E)-",CC(=O)O.CC(=O)O.C1CCC(=CC1)CNCC2CCC(CC2)CNCC3=CCCCC3,,,,,,
2193,102194,N-(cyclohexen-1-ylmethyl)-1-[4-[(cyclohexen-1-ylmethylamino)methyl]cyclohexyl]methanamine,C1CCC(=CC1)CNCC2CCC(CC2)CNCC3=CCCCC3,,,,,,
2194,102195,"[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] 3-phenylprop-2-enoate",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OC(=O)C=CC5=CC=CC=C5)C)C,,,,,,
2195,102196,"9-Bromo-6alpha-fluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 21-acetate",C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COC(=O)C)O)C)O)Br)C)F,,,,,,
2196,102197,6-Chloroguanosine,C1=NC2=C(N1[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O)N=C(N=C2Cl)N,,,,,,
2197,102198,9-Arabinofuranosyladenine,C1=NC(=C2C(=N1)N(C=N2)C3[C@H]([C@@H]([C@H](O3)CO)O)O)N,,,,,,
2198,102199,Bason,CCC(C)(C#CBr)O,,,,,,
2199,102200,Testosterone 3-cyclohexylpropionate,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)CCC4CCCCC4)CCC5=CC(=O)CC[C@]35C,,,,,,
2200,102201,"Undecamethylenediamine, N,N'-bis(o-chlorobenzyl)-, dihydrochloride",C1=CC=C(C(=C1)CNCCCCCCCCCCCNCC2=CC=CC=C2Cl)Cl.Cl.Cl,,,,,,
2201,102202,"N,N'-bis[(2-chlorophenyl)methyl]undecane-1,11-diamine",C1=CC=C(C(=C1)CNCCCCCCCCCCCNCC2=CC=CC=C2Cl)Cl,,,,,,
2202,102203,Methandriol diacetate,CC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC[C@]4(C)OC(=O)C)C)C,,,,,,
2203,102204,Magnesium bicarbonate,C(=O)(O)[O-].C(=O)(O)[O-].[Mg+2],,,,,,
2204,102205,Androstenediol diacetate,CC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC[C@@H]4OC(=O)C)C)C,,,,,,
2205,102206,CID 102206,C1CCC(=NCC1)[O-].[Na+],,,,,,
2206,102207,"1,1-Dimethylethyl 3-phenyl-2-propeneperoxoate",CC(C)(C)OOC(=O)C=CC1=CC=CC=C1,,,,,,
2207,102208,"Phenol, 4-isothiocyanato-",C1=CC(=CC=C1N=C=S)O,,,,,,
2208,102209,Einecs 218-369-3,C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]35[C@@H](O5)C[C@@]2([C@]1(C(=O)COC(=O)C(C)(C)C)O)C)C)F,,,,,,
2209,102210,Gestonorone,CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@H]34)C)O,,,,,,
2210,102211,CID 102211,CC1(O[C@@H]2[C@H](O[C@H]([C@@H]2O1)N3C=NC4=C3NC=NC4=O)CO)C,,,,,,
2211,102212,2'-O-Methyluridine,CO[C@@H]1[C@@H]([C@H](O[C@H]1N2C=CC(=O)NC2=O)CO)O,,,,,,
2212,102213,2'-O-Methyladenosine,CO[C@@H]1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)N)CO)O,,,,,,
2213,102214,2-(Perfluorodecyl)ethyl methacrylate,CC(=C)C(=O)OCCC(C(C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
2214,102215,Perhydroacenaphthene,C1CC2CCCC3C2C(C1)CC3,,,,,,
2215,102216,7-beta-D-Ribofuranosyl-7H-purine,C1=C2C(=NC=N1)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
2216,102217,"1-Butanol, antimony(3+) salt",CCCC[O-].CCCC[O-].CCCC[O-].[Sb+3],,,,,,
2217,102218,2-Hydroxy-4-decyloxybenzophenone,CCCCCCCCCCOC1=CC(=C(C=C1)C(=O)C2=CC=CC=C2)O,,,,,,
2218,102219,CID 102219,[Li+].[B+3].[CH3-].[CH3-].[CH3-].[CH3-],,,,,,
2219,102220,Etafenone hydrochloride,CCN(CC)CCOC1=CC=CC=C1C(=O)CCC2=CC=CC=C2.Cl,,,['Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)'],,,
2220,102221,"5alpha,6alpha-Epoxy-3beta-hydroxypregnan-20-one",CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C[C@H]4[C@@]5([C@@]3(CC[C@@H](C5)O)C)O4)C,,,,,,
2221,102222,"Benzothiazolium, 3-ethyl-2-[(3-ethyl-2(3H)-benzothiazolylidene)methyl]-, iodide",CCN1C2=CC=CC=C2SC1=CC3=[N+](C4=CC=CC=C4S3)CC.[I-],,,,,,
2222,102223,3-Ethyl-2-[3-ethylbenzothiazole-2(3H)-ylidenemethyl]benzothiazole-3-ium,CCN1C2=CC=CC=C2SC1=CC3=[N+](C4=CC=CC=C4S3)CC,,,,,,
2223,102224,6beta-Hydroperoxycholest-4-en-3-one,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C[C@H](C4=CC(=O)CC[C@]34C)OO)C,,,,,,
2224,102225,6-Dehydroestrone,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)C=CC4=C3C=CC(=C4)O,,,,,,
2225,102226,(+)-Muscarine Iodide,C[C@H]1[C@@H](C[C@H](O1)C[N+](C)(C)C)O.[I-],,,,,,
2226,102227,"1,2,3,4,5,6-Cyclohexanehexacarboxylic acid",C1(C(C(C(C(C1C(=O)O)C(=O)O)C(=O)O)C(=O)O)C(=O)O)C(=O)O,,,,,,
2227,102228,Diphenyliodonium iodide,C1=CC=C(C=C1)[I+]C2=CC=CC=C2.[I-],,,['Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)'],,,
2228,102229,"1,4-Cyclohexanediamine, N,N'-bis(2-chlorobenzyl)-, dihydrochloride, (Z)-",C1CC(CCC1NCC2=CC=CC=C2Cl)NCC3=CC=CC=C3Cl.Cl.Cl,,,,,,
2229,102230,"1-N,4-N-bis[(2-chlorophenyl)methyl]cyclohexane-1,4-diamine",C1CC(CCC1NCC2=CC=CC=C2Cl)NCC3=CC=CC=C3Cl,,,,,,
2230,102231,Bicyclo[2.2.1]heptane-2-carbonitrile,C1CC2CC1CC2C#N,,,,,,
2231,102232,Estriol tripropionate,CCC(=O)O[C@@H]1C[C@H]2[C@@H]3CCC4=C([C@H]3CC[C@@]2([C@H]1OC(=O)CC)C)C=CC(=C4)OC(=O)CC,,,,,,
2232,102233,"5alpha-Cholestane-3,6-dione",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC(=O)[C@@H]4[C@@]3(CCC(=O)C4)C)C,,,,,,
2233,102234,"3-Tropanyl p-tolylacetate, hydrochloride",CC1=CC=C(C=C1)CC(=O)OC2C[C@H]3CC[C@@H](C2)N3C.Cl,,,,,,
2234,102235,"p-Tolylacetic acid (1beta,5beta)-tropan-3alpha-yl ester",CC1=CC=C(C=C1)CC(=O)OC2C[C@H]3CC[C@@H](C2)N3C,,,,,,
2235,102236,"2,2,3,3,4,4,5,5,6,6,7,7-Dodecafluoroheptyl methacrylate",CC(=C)C(=O)OCC(C(C(C(C(C(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
2236,102237,"1-Octanesulfonamide, N-butyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-(2-hydroxyethyl)-",CCCCN(CCO)S(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
2237,102238,Adenylyl-(2'-5')-adenosine,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)O[C@@H]4[C@@H]([C@H](O[C@H]4N5C=NC6=C(N=CN=C65)N)CO)O)O)O)N,,,,,,
2238,102239,"Methyl 3alpha,7alpha-diacetoxy-5beta-chol-11-en-24-oate",C[C@H](CCC(=O)OC)[C@H]1CC[C@@H]2[C@@]1(C=C[C@H]3[C@H]2C(C[C@H]4[C@@]3(CC[C@H](C4)OC(=O)C)C)OC(=O)C)C,,,,,,
2239,102240,"2-(2-(2,3-Dihydro-5-methyl-3-oxo-2-phenyl-1-(4-sulphonatobutyl)-1H-pyrazol-4-yl)-3-(6-methoxy-3-methyl-3H-benzothiazol-2-ylidene)prop-1-enyl)-6-methoxy-3-methylbenzothiazolium",CC1=C(C(=O)N(N1CCCCS(=O)(=O)[O-])C2=CC=CC=C2)C(=CC3=[N+](C4=C(S3)C=C(C=C4)OC)C)C=C5N(C6=C(S5)C=C(C=C6)OC)C,,,,,,
2240,102241,"4-[4-[1-(6-Methoxy-3-methyl-1,3-benzothiazol-3-ium-2-yl)-3-(6-methoxy-3-methyl-1,3-benzothiazol-2-ylidene)prop-1-en-2-yl]-5-methyl-3-oxo-2-phenylpyrazol-1-yl]butane-1-sulfonic acid",CC1=C(C(=O)N(N1CCCCS(=O)(=O)O)C2=CC=CC=C2)C(=CC3=[N+](C4=C(S3)C=C(C=C4)OC)C)C=C5N(C6=C(S5)C=C(C=C6)OC)C,,,,,,
2241,102242,Methoxydienone,CC[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3CC=C(C4)OC,,,,,,
2242,102243,"6alpha,9-Difluoro-11beta,21-dihydroxypregna-1,4,16-triene-3,20-dione 21-acetate",CC(=O)OCC(=O)C1=CC[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)F)O)C,,,,,,
2243,102244,"2-Hexenoic acid,5-methyl-, ethyl ester, (2E)-",CCOC(=O)C=CCC(C)C,,,,,,
2244,102245,"6beta-Fluoro-3beta,5alpha,17,21-tetrahydroxy-16alpha-methylpregnan-20-one 21-acetate",C[C@@H]1C[C@H]2[C@@H]3C[C@H]([C@]4(C[C@H](CC[C@@]4([C@H]3CC[C@@]2([C@]1(C(=O)COC(=O)C)O)C)C)O)O)F,,,,,,
2245,102246,2-(((Heptadecafluorooctyl)sulphonyl)propylamino)ethyl acrylate,CCCN(CCOC(=O)C=C)S(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
2246,102247,Boldenone Acetate,CC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)C,,,,,,
2247,102248,Oct-2-enyl acetate,CCCCCC=CCOC(=O)C,,,,,,
2248,102249,"1,4-Cyclohexanediamine, N,N'-bis(2-chlorobenzyl)-, diacetate, (E)-",CC(=O)O.CC(=O)O.C1CC(CCC1NCC2=CC=CC=C2Cl)NCC3=CC=CC=C3Cl,,,,,,
2249,102250,3-Hydroxy-20-oxo-5-pregnen-17alpha-yl acetate,CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)OC(=O)C,,,,,,
2250,102251,(Z)-Methyl icos-11-enoate,CCCCCCCCC=CCCCCCCCCCC(=O)OC,,,,,,
2251,102252,Dibutylammonium dibutyldithiocarbamate,CCCCNCCCC.CCCCN(CCCC)C(=S)S,,,,,,
2252,102253,"Benzoxazole, 2,2'-(1,2-ethenediyldi-4,1-phenylene)bis[5-methyl-",CC1=CC2=C(C=C1)OC(=N2)C3=CC=C(C=C3)C=CC4=CC=C(C=C4)C5=NC6=C(O5)C=CC(=C6)C,,,,,,
2253,102254,"5-Tert-butyl-2-[4-[2-[4-(5-tert-butyl-1,3-benzoxazol-2-yl)phenyl]ethenyl]phenyl]-1,3-benzoxazole",CC(C)(C)C1=CC2=C(C=C1)OC(=N2)C3=CC=C(C=C3)C=CC4=CC=C(C=C4)C5=NC6=C(O5)C=CC(=C6)C(C)(C)C,,,,,,
2254,102255,"Morpholine, 4-(2-methyl-1-propenyl)-",CC(=CN1CCOCC1)C,,,,,,
2255,102256,"N,N-Dimethylmorpholinium iodide",C[N+]1(CCOCC1)C.[I-],,,,,,
2256,102257,"4,4-Dimethylmorpholin-4-ium",C[N+]1(CCOCC1)C,,,,,,
2257,102258,Uridine monophosphate-uridine,C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O[C@@H]3[C@H](O[C@H]([C@@H]3O)N4C=CC(=O)NC4=O)CO)O)O,,,,,,
2258,102259,"3beta-Acetoxy-ergosta-5,7,22-triene",C[C@H](C=C[C@H](C)C(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3C2=CC=C4[C@@]3(CC[C@@H](C4)OC(=O)C)C)C,,,,,,
2259,102260,"2-Butenedioic acid (2Z)-, 1-(2-propen-1-yl) ester",C=CCOC(=O)C=CC(=O)O,,,,,,
2260,102261,4-Cyclohexyloxy-4-oxobut-2-enoic acid,C1CCC(CC1)OC(=O)C=CC(=O)O,,,,,,
2261,102262,"2-Butenedioic acid (2Z)-, monododecyl ester",CCCCCCCCCCCCOC(=O)C=CC(=O)O,,,,,,
2262,102263,Ethyl pent-2-enoate,CCC=CC(=O)OCC,,,,,,
2263,102264,"3-Methyl-n,n,n-tris(3-methylbutyl)butan-1-aminium 2,4,6-trinitrophenolate",CC(C)CC[N+](CCC(C)C)(CCC(C)C)CCC(C)C.C1=C(C=C(C(=C1[N+](=O)[O-])[O-])[N+](=O)[O-])[N+](=O)[O-],,,,,,
2264,102265,Chlorprothixene HCl,CN(C)CCC=C1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl.Cl,,,,,,
2265,102266,Methylisopropoxy-(2-dimethylaminoethylthio)phosphine oxide oxalate,CC(C)OP(=O)(C)SCCN(C)C.C(=O)(C(=O)O)O,,,,,,
2266,102267,"Phosphonothioic acid, methyl-, S-(2-(dimethylamino)ethyl) O-(1-methylethyl) ester",CC(C)OP(=O)(C)SCCN(C)C,,,,,,
2267,102268,Methylisopropoxy-(2-dimethylaminoethyl)phosphine oxide oxalate,CC(C)OP(=O)(C)OCCN(C)C.C(=O)(C(=O)O)O,,,,,,
2268,102269,"N,N-dimethyl-2-[methyl(propan-2-yloxy)phosphoryl]oxyethanamine",CC(C)OP(=O)(C)OCCN(C)C,,,,,,
2269,102270,"1-((2-Hydroxynaphthyl)methyl)-2-naphthyl 6-diazo-5,6-dihydro-5-oxonaphthalene-1-sulphonate",C1=CC=C2C(=C1)C=CC(=C2CC3=C(C=CC4=CC=CC=C43)OS(=O)(=O)C5=CC=CC6=C5C=CC(=C6[O-])[N+]#N)O,,,,,,
2270,102271,1-Hydroxy-5-[1-[(2-hydroxynaphthalen-1-yl)methyl]naphthalen-2-yl]oxysulfonylnaphthalene-2-diazonium,C1=CC=C2C(=C1)C=CC(=C2CC3=C(C=CC4=CC=CC=C43)OS(=O)(=O)C5=CC=CC6=C5C=CC(=C6O)[N+]#N)O,,,,,,
2271,102272,"Pyridinium, 2-ethenyl-1-(2-propenyl)-, bromide",C=CC[N+]1=CC=CC=C1C=C.[Br-],,,,,,
2272,102273,1-Allyl-2-vinylpyridinium,C=CC[N+]1=CC=CC=C1C=C,,,,,,
2273,102274,CID 102274,CCCCCCCCC=CCCCCCCCC(=O)OC[C@@H]([C@]1(C(=O)C(=C(O1)O)O)C)O,,,,,,
2274,102275,Cyclohexyldimethylammonium chloride,CN(C)C1CCCCC1.Cl,,,,,,
2275,102276,Deoxy-5-methylcytidylic acid,CC1=CN(C(=O)N=C1N)[C@H]2C[C@@H]([C@H](O2)COP(=O)(O)O)O,,,,,,
2276,102277,"Tetrasodium 7,16-dichloro-6,15-dihydroanthrazine-5,9,14,18-tetrayltetrakis(sulphate)",C1=CC=C2C(=C1)C(=C3C=C(C4=C(C3=C2OS(=O)(=O)[O-])NC5=C(N4)C6=C(C7=CC=CC=C7C(=C6C=C5Cl)OS(=O)(=O)[O-])OS(=O)(=O)[O-])Cl)OS(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
2277,102278,(25R)-5alpha-Spirostan-3beta-yl acetate,C[C@@H]1CC[C@@]2([C@H]([C@H]3[C@@H](O2)C[C@@H]4[C@@]3(CC[C@H]5[C@H]4CC[C@@H]6[C@@]5(CC[C@@H](C6)OC(=O)C)C)C)C)OC1,,,,,,
2278,102279,"Disodium 16,17-dimethoxyanthra(9,1,2-cde)benzo(rst)pentaphene-5,10-diyl bis(sulphate)",COC1=C2C3=C4C(=C(C5=CC=CC=C5C4=C1)OS(=O)(=O)[O-])C=CC3=C6C=CC7=C(C8=CC=CC=C8C9=CC(=C2C6=C79)OC)OS(=O)(=O)[O-].[Na+].[Na+],,,,,,
2279,102280,"[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] octadeca-9,12,15-trienoate",CCC=CCC=CCC=CCCCCCCCC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC[C@@H]4[C@H](C)CCCC(C)C)C)C,,,,,,
2280,102281,"Docosa-4,8,12,15,19-pentaenoic acid",CCC=CCCC=CCC=CCCC=CCCC=CCCC(=O)O,,,,,,
2281,102282,Ammonium trihydrogen ethylenediaminetetraacetate,C(CN(CC(=O)O)CC(=O)O)N(CC(=O)O)CC(=O)O.N,,,,,,
2282,102283,3-[(4-Fluorophenyl)methylene]-2-benzofuran-1(3H)-one,C1=CC=C2C(=C1)C(=CC3=CC=C(C=C3)F)OC2=O,,,,,,
2283,102284,"9-Fluoro-11beta,16alpha,17,21-tetrahydroxypregna-1,4-diene-3,20-dione 21-(hydrogen succinate)",C[C@]12C[C@@H]([C@]3([C@H]([C@@H]1C[C@H]([C@@]2(C(=O)COC(=O)CCC(=O)O)O)O)CCC4=CC(=O)C=C[C@@]43C)F)O,,,,,,
2284,102285,Orazamide dihydrate,C1=C(NC(=O)NC1=O)C(=O)O.C1=NC(=C(N1)C(=O)N)N.O.O,,,,,,
2285,102286,"22,23-Dihydroergosteryl acetate, non-irradiated",C[C@H](CCC(C)C(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3C2=CC=C4[C@@]3(CC[C@@H](C4)OC(=O)C)C)C,,,,,,
2286,102287,"2,5-didehydro-D-gluconic acid",C(C(=O)[C@H]([C@@H](C(=O)C(=O)O)O)O)O,,,,,,
2287,102288,"(2R,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexanal",C([C@H]([C@H]([C@H]([C@H](C=O)O)O)O)O)O,,,,,,
2288,102289,"2-Oxohexyl 9-fluoro-11,17-dihydroxy-16-methyl-3-oxoandrosta-1,4-diene-17-carboxylate",CCCCC(=O)COC(=O)[C@]1([C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)O,,,,,,
2289,102290,N-(1-Oxo-9-octadecen-1-yl)glycine,CCCCCCCCC=CCCCCCCCC(=O)NCC(=O)O,,,,,,
2290,102291,"2-Naphthalenesulfonic acid, 7,7'-(carbonyldiimino)bis(4-hydroxy-3-((2-hydroxy-5-sulfophenyl)azo)-, tetrasodium salt",C1=CC2=C(C(=C(C=C2C=C1NC(=O)NC3=CC4=CC(=C(C(=C4C=C3)S(=O)(=O)[O-])N=NC5=C(C=CC(=C5)S(=O)(=O)[O-])O)O)S(=O)(=O)[O-])N=NC6=C(C=CC(=C6)S(=O)(=O)[O-])O)O.[Na+].[Na+].[Na+].[Na+],,,,,,
2291,102292,4-Hydroxy-7-[[7-hydroxy-6-[(2-hydroxy-5-sulfophenyl)diazenyl]-5-sulfonaphthalen-2-yl]carbamoylamino]-3-[(2-hydroxy-5-sulfophenyl)diazenyl]naphthalene-2-sulfonic acid,C1=CC2=C(C(=C(C=C2C=C1NC(=O)NC3=CC4=CC(=C(C(=C4C=C3)S(=O)(=O)O)N=NC5=C(C=CC(=C5)S(=O)(=O)O)O)O)S(=O)(=O)O)N=NC6=C(C=CC(=C6)S(=O)(=O)O)O)O,,,,,,
2292,102293,"2-Ethylpropane-1,3-diol",CCC(CO)CO,,,,,,
2293,102294,4-Methyl-1-morpholin-4-ylpent-1-en-3-one,CC(C)C(=O)C=CN1CCOCC1,,,,,,
2294,102295,"1,3-Dimethyl-1,3-diphenyl-1,3-divinyldisiloxane",C[Si](C=C)(C1=CC=CC=C1)O[Si](C)(C=C)C2=CC=CC=C2,,,,,,
2295,102296,"Butyl octadeca-9,12-dienoate",CCCCCC=CCC=CCCCCCCCC(=O)OCCCC,,,,,,
2296,102297,"Phosphine, tricyclohexyl-, compd. with carbon disulfide (1:1)",C1CCC(CC1)P(C2CCCCC2)C3CCCCC3.C(=S)=S,,,,,,
2297,102298,"24-Methylcholesta-5,22-dien-3beta-ol",C[C@H](C=CC(C)C(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,,,,,,
2298,102299,Diisopropoxy-(2-dimethylaminoethylthio)phosphine oxide oxalate,CC(C)OP(=O)(OC(C)C)SCCN(C)C.C(=O)(C(=O)O)O,,,,,,
2299,102300,"2-di(propan-2-yloxy)phosphorylsulfanyl-N,N-dimethylethanamine",CC(C)OP(=O)(OC(C)C)SCCN(C)C,,,,,,
2300,102301,Methylethoxy-(2-dimethylaminoethylthio)phosphine oxide oxalate,CCOP(=O)(C)SCCN(C)C.C(=O)(C(=O)O)O,,,,,,
2301,102302,Medemo,CCOP(=O)(C)SCCN(C)C,,,,,,
2302,102303,Aldona ethyl enol ether,CCOC1=CC2=CC[C@@H]3[C@@H]([C@]2(CC1)C)CC[C@]4([C@H]3CC[C@@]45CCC(=O)O5)C,,,,,,
2303,102304,CID 102304,CCNC1=C(C=C(C=C1)CCN=C2C=CC(=CC3=C(C=C(C=C3)S(=O)(=O)[O-])S(=O)(=O)O)C=C2C)C.[Na+],,,,,,
2304,102305,"4-[[4-[2-[4-(Ethylamino)-3-methylphenyl]ethylimino]-3-methylcyclohexa-2,5-dien-1-ylidene]methyl]benzene-1,3-disulfonic acid",CCNC1=C(C=C(C=C1)CCN=C2C=CC(=CC3=C(C=C(C=C3)S(=O)(=O)O)S(=O)(=O)O)C=C2C)C,,,,,,
2305,102306,CID 102306,CC(CC(=O)[O-])CC(C)(C)C.[Na+],,,,,,
2306,102307,"2,3-Dimethylbenzothiazolium p-toluenesulphonate",CC1=CC=C(C=C1)S(=O)(=O)[O-].CC1=[N+](C2=CC=CC=C2S1)C,,,,,,
2307,102308,"2,3-Dimethyl-1,3-benzothiazol-3-ium",CC1=[N+](C2=CC=CC=C2S1)C,,,,,,
2308,102309,"1,4-Cyclohexanebis(methylamine), N,N'-bis(2-hydroxybenzyl)-, diacetate",CC(=O)O.CC(=O)O.C1CC(CCC1CNCC2=CC=CC=C2O)CNCC3=CC=CC=C3O,,,,,,
2309,102310,2-[[[4-[[(2-Hydroxyphenyl)methylamino]methyl]cyclohexyl]methylamino]methyl]phenol,C1CC(CCC1CNCC2=CC=CC=C2O)CNCC3=CC=CC=C3O,,,,,,
2310,102311,"2,3,7,8,12,13,17,18-Octaethyl-21H,23H-porphine",CCC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)CC)CC)C(=C4CC)CC)C(=C3CC)CC)CC,,,,,,
2311,102312,O-Benzylhydroxylamine hydrochloride,C1=CC=C(C=C1)CON.Cl,,,,,,
2312,102313,O-Benzylhydroxylamine,C1=CC=C(C=C1)CON,,,,,,
2313,102314,(17beta)-17-(((Cyclohexylmethoxy)carbonyl)oxy)androst-4-en-3-one,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2OC(=O)OCC4CCCCC4)CCC5=CC(=O)CC[C@]35C,,,,,,
2314,102315,CID 102315,C1=CC=C(C=C1)[Hg].C1=CC=C(C=C1)[Hg].C(=CC(=O)O)C(=O)O,,,,,,
2315,102316,"Methyl 4-[(5,6-dimethyl-2-benzoxazolyl)vinyl]benzoate",CC1=CC2=C(C=C1C)OC(=N2)C=CC3=CC=C(C=C3)C(=O)OC,,,,,,
2316,102317,[Bis(trifluoroacetoxy)iodo]benzene,C1=CC=C(C=C1)I(OC(=O)C(F)(F)F)OC(=O)C(F)(F)F,,,,,,
2317,102318,2-(Diphenylamino)-5-[2-(3-ethyl-2(3H)-benzoxazolylidene)ethylidene]-4(5H)-thiazolone,CCN1C2=CC=CC=C2OC1=CC=C3C(=O)N=C(S3)N(C4=CC=CC=C4)C5=CC=CC=C5,,,,,,
2318,102319,"4(5H)-Thiazolone, 2-(diphenylamino)-5-[(3-ethyl-2(3H)-benzothiazolylidene)ethylidene]-",CCN1C2=CC=CC=C2SC1=CC=C3C(=O)N=C(S3)N(C4=CC=CC=C4)C5=CC=CC=C5,,,,,,
2319,102320,CID 102320,CC(=O)C1=CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@]2(CC[C@@H]4[C@@]3(CC[C@@H](C4)OC(=O)C)C)C)C,,,,,,
2320,102321,"3(2H)-Pyridazinone, 2-(2-(diethylamino)ethyl)-4-methyl-6-phenyl-, hydrochloride",CCN(CC)CCN1C(=O)C(=CC(=N1)C2=CC=CC=C2)C.Cl,,,,,,
2321,102322,2-[2-(Diethylamino)ethyl]-4-methyl-6-phenylpyridazin-3-one,CCN(CC)CCN1C(=O)C(=CC(=N1)C2=CC=CC=C2)C,,,,,,
2322,102323,4-Nitrobenzoyl azide,C1=CC(=CC=C1C(=O)N=[N+]=[N-])[N+](=O)[O-],,,,,,
2323,102324,CID 102324,C1=CC(=CC=C1C(=O)N[N+]#N)[N+](=O)[O-],,,,,,
2324,102325,Methyl 15-tetracosenoate,CCCCCCCCC=CCCCCCCCCCCCCCC(=O)OC,,,,,,
2325,102326,"2,6-Dimethylhept-3-ene",CC(C)CC=CC(C)C,,,,,,
2326,102327,"D-Glucaro-3,6-lactone",[C@H]1([C@@H](C(=O)O[C@@H]1[C@@H](C(=O)O)O)O)O,,,,,,
2327,102328,2-Hydroxymethylene Ethisterone,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)C(=CO)C[C@]34C,,,,,,
2328,102329,Dinonyl but-2-enedioate,CCCCCCCCCOC(=O)C=CC(=O)OCCCCCCCCC,,,,,,
2329,102330,Dimethyl (dimethoxyphosphinyl)succinate,COC(=O)CC(C(=O)OC)P(=O)(OC)OC,,,,,,
2330,102331,2-[2-(3-Chlorophenyl)hydrazinylidene]acetonitrile,C1=CC(=CC(=C1)Cl)NN=CC#N,,,,,,
2331,102332,Methyl fluorophosphoryl choline iodide,C[N+](C)(C)CCOP(=O)(C)F.[I-],,,,,,
2332,102333,Flurandrenolide acetate,CC(=O)OCC(=O)[C@@]12[C@@H](C[C@@H]3[C@@]1(C[C@@H]([C@H]4[C@H]3C[C@@H](C5=CC(=O)CC[C@]45C)F)O)C)OC(O2)(C)C,,,,,,
2333,102334,"3-Ethoxy-17-hydroxy-6-(trifluoromethyl)pregna-3,5-diene-20-one acetate",CCOC1=CC2=C(C[C@@H]3[C@@H]([C@]2(CC1)C)CC[C@]4([C@H]3CC[C@@]4(C(=O)C)OC(=O)C)C)C(F)(F)F,,,,,,
2334,102335,2-Chloropentafluoropropene,C(=C(F)F)(C(F)(F)F)Cl,,,,,,
2335,102336,Phenyl beta-D-galactopyranoside,C1=CC=C(C=C1)O[C@H]2[C@@H]([C@H]([C@H]([C@H](O2)CO)O)O)O,,,,,,
2336,102337,Methyl N-acetyl-L-tryptophanate,CC(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)OC,,,,,,
2337,102338,Bayer 47416,CNC(=O)C(C(=O)NC)SP(=O)(OC)OC,,,,,,
2338,102339,"S-(2-(Ethylamino)-1-((ethylamino)carbonyl)-2-oxoethyl) O,O-dimethyl phosphorodithioate",CCNC(=O)C(C(=O)NCC)SP(=S)(OC)OC,,,,,,
2339,102340,(Z)-4-methoxypent-3-en-2-one,CC(=CC(=O)C)OC,,,,,,
2340,102341,"N,N'-Bis(2-pyridylmethylene)ethylenediamine",C1=CC=NC(=C1)C=NCCN=CC2=CC=CC=N2,,,,,,
2341,102342,3beta-Hydroxypregn-5-ene,CC[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C,,,,,,
2342,102343,Ethyl-4-[4-ethoxybenzylideneamino]cinnamate,CCOC1=CC=C(C=C1)C=NC2=CC=C(C=C2)C=CC(=O)OCC,,,,,,
2343,102344,i-Cholesterol methyl ether,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C[C@H]([C@@]45[C@@]3(CC[C@@H]4C5)C)OC)C,,,,,,
2344,102345,"7-Methyldibenzo[h,rst]pentaphene",CC1=CC2=C(C=C1)C3=CC4=CC=CC=C4C5=C3C6=C(C=C5)C7=CC=CC=C7C=C26,,,,,,
2345,102346,Phenyl tetra-O-acetyl-beta-D-galactopyranoside,CC(=O)OC[C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)OC2=CC=CC=C2)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
2346,102347,Demalon,C[C@H]1CC(=O)C[C@H]2[C@]1([C@H]3CC[C@]4([C@H]([C@@H]3CC2)CC[C@]4(C)O)C)C,,,,,,
2347,102348,Bromoform-d,[2H]C(Br)(Br)Br,,,,,,
2348,102349,1-Prop-1-enyl-3-(trifluoromethyl)benzene,CC=CC1=CC(=CC=C1)C(F)(F)F,,,,,,
2349,102350,Cholesteryl iodide,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)I)C)C,,,,,,
2350,102351,2-Hexadienal,CC(=O)C=CC=C,,,,,,
2351,102352,"1-Octanesulfonamide, N,N'-[phosphinicobis(oxy-2,1-ethanediyl)]bis[N-ethyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-",CCN(CCOP(=O)(O)OCCN(CC)S(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)S(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
2352,102353,1-Benzyl-2-trimethylacetylhydrazine hydrochloride,CC(C)(CNNCC1=CC=CC=C1)C(=O)O.Cl,,,,,,
2353,102354,"3-(2-Benzylhydrazinyl)-2,2-dimethylpropanoic acid",CC(C)(CNNCC1=CC=CC=C1)C(=O)O,,,,,,
2354,102355,O-Methyl S-phenyl ethylphosphonodithioate,CCP(=S)(OC)SC1=CC=CC=C1,,,,,,
2355,102356,"3,3-Dichloroprop-1-enylsulfanylmethylsulfanyl-dimethoxy-sulfanylidene-lambda5-phosphane",COP(=S)(OC)SCSC=CC(Cl)Cl,,,,,,
2356,102357,Carbethoxymethylmethylpiperidinium iodide,CCOC(=O)C[N+]1(CCCCC1)C.[I-],,,,,,
2357,102358,1-Methyl-1-(ethoxycarbonylmethyl)piperidine-1-ium,CCOC(=O)C[N+]1(CCCCC1)C,,,,,,
2358,102359,CID 102359,CC(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=NC3=C2N=CN=C3S)OC(=O)C)OC(=O)C,,,,,,
2359,102360,2-Pentyl-2-nonenal,CCCCCCC=C(CCCCC)C=O,,,,,,
2360,102361,"4-Oxazolidinone, 3-ethyl-5-[2-(3-ethyl-2(3H)-benzothiazolylidene)-1-methylethylidene]-2-thioxo-",CCN1C2=CC=CC=C2SC1=CC(=C3C(=O)N(C(=S)O3)CC)C,,,,,,
2361,102362,3-(3-Methylphenyl)prop-2-enoic acid,CC1=CC(=CC=C1)C=CC(=O)O,,,,,,
2362,102363,"Phosphonium, triethylphenyl-, iodide",CC[P+](CC)(CC)C1=CC=CC=C1.[I-],,,,,,
2363,102364,Phenyltriethylphosphorane,CC[P+](CC)(CC)C1=CC=CC=C1,,,,,,
2364,102365,"11beta,21-Dihydroxypregna-1,4,16-triene-3,20-dione 21-acetate",CC(=O)OCC(=O)C1=CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)C=C[C@]34C)O)C,,,,,,
2365,102366,"Methyl 3,7-dihydroxycholan-24-oate",C[C@H](CCC(=O)OC)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CCC(C4)O)C)O)C,,,,,,
2366,102367,"D-glycero-D-gulo-Heptonic acid, delta-lactone",C([C@H]([C@@H]1[C@@H]([C@H]([C@H](C(=O)O1)O)O)O)O)O,,,,,,
2367,102368,"2,4,5-Trichlorophenyl N-((benzyloxy)carbonyl)-L-valinate",CC(C)C(C(=O)OC1=CC(=C(C=C1Cl)Cl)Cl)NC(=O)OCC2=CC=CC=C2,,,,,,
2368,102369,"Thiazolium, 3-ethyl-2-[3-(3-ethyl-2-thiazolidinylidene)-1-propenyl]-4,5-dihydro-, iodide",CCN1CCSC1=CC=CC2=[N+](CCS2)CC.[I-],,,,,,
2369,102370,"3-Ethyl-2-[3-(3-ethylthiazolidin-2-ylidene)-1-propenyl]-4,5-dihydrothiazol-3-ium",CCN1CCSC1=CC=CC2=[N+](CCS2)CC,,,,,,
2370,102371,4-Hydroxy-4-(octadecylimino)but-2-enoic acid,CCCCCCCCCCCCCCCCCCNC(=O)C=CC(=O)O,,,,,,
2371,102372,"N1,N2-Bis(3-phenyl-2-propen-1-ylidene)-1,2-ethanediamine",C1=CC=C(C=C1)C=CC=NCCN=CC=CC2=CC=CC=C2,,,,,,
2372,102373,Testosterone Valerate,CCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,,,,,,
2373,102374,"Methyl 2,3,4,6-tetra-O-methyl-alpha-D-mannopyranoside",COC[C@@H]1[C@H]([C@@H]([C@@H]([C@H](O1)OC)OC)OC)OC,,,,,,
2374,102375,"2-Methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2-butenal",CC1=C(C(CCC1)(C)C)CC=C(C)C=O,,,,,,
2375,102376,"Octadecanoic acid, 12-hydroxy-, calcium salt (2:1)",CCCCCCC(CCCCCCCCCCC(=O)[O-])O.CCCCCCC(CCCCCCCCCCC(=O)[O-])O.[Ca+2],,,,,,
2376,102377,Terephthalic acid hexamethylenediamine salt (1:1),C1=CC(=CC=C1C(=O)O)C(=O)O.C(CCCN)CCN,,,,,,
2377,102378,"2-Methyl-1-(3-sulphonatopropyl)naphtho(1,2-d)thiazolium",CC1=[N+](C2=C(S1)C=CC3=CC=CC=C32)CCCS(=O)(=O)[O-],,,,,,
2378,102379,"Naphtho[1,2-d]thiazolium, 2-methyl-1-(3-sulfopropyl)-, inner salt",CC1=[N+](C2=C(S1)C=CC3=CC=CC=C32)CCCS(=O)(=O)O,,,,,,
2379,102380,"1-(3,5,5-Trimethyl-2-cyclohexen-1-ylidene)-2-propanone",CC1=CC(=CC(=O)C)CC(C1)(C)C,,,,,,
2380,102381,"Phosphoric acid, 3-chloropropyl 2,2-dichlorovinyl ethyl ester",CCOP(=O)(OCCCCl)OC=C(Cl)Cl,,,,,,
2381,102382,2-Amino-strychnine,C1CN2CC3=CCOC4CC(=O)N5C6[C@H]4[C@H]3C[C@H]2[C@@]61C7=C5C=CC(=C7)N,,,,,,
2382,102383,CID 102383,CC1=CC=CC=C1NC[O-].[K+],,,,,,
2383,102384,(2-Methylanilino)methanol,CC1=CC=CC=C1NCO,,,,,,
2384,102385,Tetrakis(salicylideneaminoethyl)methane,C1=CC=C(C(=C1)C=NCC(CN=CC2=CC=CC=C2O)(CN=CC3=CC=CC=C3O)CN=CC4=CC=CC=C4O)O,,,,,,
2385,102386,CID 102386,CC(=C(C)N=O)NO.CC(=C(C)N=O)NO.[Co],,,,,,
2386,102387,"Cholest-5-en-3-ol (3beta)-, nitrate",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O[N+](=O)[O-])C)C,,,,,,
2387,102388,"1-[(3S,6R,8R,9S,10R,13S,14S,16R,17R)-6-fluoro-3,5,17-trihydroxy-10,13,16-trimethyl-2,3,4,6,7,8,9,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone",C[C@@H]1C[C@H]2[C@@H]3C[C@H](C4(C[C@H](CC[C@@]4([C@H]3CC[C@@]2([C@]1(C(=O)C)O)C)C)O)O)F,,,,,,
2388,102389,"3beta-Hydroxypregna-5,16-dien-20-one 3-propionate",CCC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC=C4C(=O)C)C)C,,,,,,
2389,102390,"Benzaldehyde, 2-hydroxy-, hydrazone",C1=CC=C(C(=C1)C=NN)O,,,,,,
2390,102391,"Phosphoric acid, diethyl 1-methyl-2-(methylthio)ethenyl ester",CCOP(=O)(OCC)OC(=CSC)C,,,,,,
2391,102392,"1,1'-(4-Chloro-1-butenylidene)bis(4-fluorobenzene)",C1=CC(=CC=C1C(=CCCCl)C2=CC=C(C=C2)F)F,,,,,,
2392,102393,"9(10H)-Anthracenone, 10,10'-(1,2-ethenediylidene)bis-",C1=CC=C2C(=C1)C(=C=C=C3C4=CC=CC=C4C(=O)C5=CC=CC=C53)C6=CC=CC=C6C2=O,,,,,,
2393,102394,"3,3-Dimethylacryloyl chloride",CC(=CC(=O)Cl)C,,,,,,
2394,102395,"N,1,3-triethyl-2-[2-(3-ethyl-4-oxo-2-sulfanylidene-1,3-thiazolidin-5-ylidene)ethylidene]benzimidazole-5-sulfonamide",CCNS(=O)(=O)C1=CC2=C(C=C1)N(C(=CC=C3C(=O)N(C(=S)S3)CC)N2CC)CC,,,,,,
2395,102396,Direct Blue 67,CC1=CC(=C(C=C1N=NC2=C3C(=CC(=C2)S(=O)(=O)[O-])C=C(C=C3O)S(=O)(=O)[O-])OC)N=NC4=C(C=C5C=C(C=CC5=C4O)NC6=CC=CC=C6)S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
2396,102397,Sirius Supra Blue F3R,CC1=CC(=C(C=C1N=NC2=C3C(=CC(=C2)S(=O)(=O)O)C=C(C=C3O)S(=O)(=O)O)OC)N=NC4=C(C=C5C=C(C=CC5=C4O)NC6=CC=CC=C6)S(=O)(=O)O,,,,,,
2397,102398,Ethyl 3-[(diethoxymethylsilyl)oxy]-2-butenoate,CCOC(=O)C=C(C)O[Si](C)(OCC)OCC,,,,,,
2398,102399,O-alpha-D-Glucopyranosyl-(1.6)-O-alpha-D-glucopyranosyl-(1.6)-D-glucose,C([C@H]1[C@@H]([C@H]([C@@H]([C@@H](O1)OC[C@@H]2[C@H]([C@@H]([C@H]([C@H](O2)OC[C@H]([C@H]([C@@H]([C@H](C=O)O)O)O)O)O)O)O)O)O)O)O,,,,,,
2399,102400,"Methanamine, N-(phenylmethylene)-, N-oxide",C[N+](=CC1=CC=CC=C1)[O-],,,,,,
2400,102401,N-[(2-methylphenyl)methylidene]hydroxylamine,CC1=CC=CC=C1C=NO,,,,,,
2401,102402,Triethylsulfonium bromide,CC[S+](CC)CC.[Br-],,,,,,
2402,102403,"Cholesterol, methanesulfonate",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OS(=O)(=O)C)C)C,,,,,,
2403,102404,"17-Hydroxypregn-5-ene-3,20-dione cyclic bis(ethylene acetal)",C[C@]12CCC3(CC1=CC[C@@H]4[C@@H]2CC[C@]5([C@H]4CC[C@@]5(C6(OCCO6)C)O)C)OCCO3,,,,,,
2404,102405,"11,21-Dihydroxy-6-methylpregna-4,17-dien-3-one",C[C@H]1C[C@H]2[C@@H]3CCC(=CCO)[C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)CC4)C)O)C,,,,,,
2405,102406,"11beta,21-Dihydroxy-6alpha-methylpregna-4,17(20)-dien-3-one 21-acetate",C[C@H]1C[C@H]2[C@@H]3CCC(=CCOC(=O)C)[C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)CC4)C)O)C,,,,,,
2406,102407,"Acetic acid;2-(2-heptadec-8-enyl-4,5-dihydroimidazol-1-yl)ethanol",CCCCCCCCC=CCCCCCCCC1=NCCN1CCO.CC(=O)O,,,,,,
2407,102408,Calcium bis(N-acetyl-DL-methioninate),CC(=O)NC(CCSC)C(=O)[O-].CC(=O)NC(CCSC)C(=O)[O-].[Ca+2],,,,,,
2408,102409,Testosterone butyrate,CCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C,,,,,,
2409,102410,"Benzaldehyde, 4-amino-, oxime",C1=CC(=CC=C1C=NO)N,,,,,,
2410,102411,2-Methylpropyl 3-[4-(dimethylamino)phenyl]-2-propenoate,CC(C)COC(=O)C=CC1=CC=C(C=C1)N(C)C,,,,,,
2411,102412,3-Benzylidenepentan-2-one,CCC(=CC1=CC=CC=C1)C(=O)C,,,,,,
2412,102413,"Benzenamine, 4-[(4-imino-2,5-cyclohexadien-1-ylidene)phenylmethyl]-, monohydrochloride",C1=CC=C(C=C1)C(=C2C=CC(=N)C=C2)C3=CC=C(C=C3)N.Cl,,,,,,
2413,102414,"4-[(4-Imino-2,5-cyclohexadien-1-ylidene)phenylmethyl]benzenamine",C1=CC=C(C=C1)C(=C2C=CC(=N)C=C2)C3=CC=C(C=C3)N,,,,,,
2414,102415,"1,3,4,6,7,8,8-Heptachlorohexahydro-4,7-methanoisobenzofuran-5(3H)-one",C12C(C(OC1Cl)Cl)C3(C(=O)C(C2(C3(Cl)Cl)Cl)Cl)Cl,,,,,,
2415,102416,4-Nitrophenyl 2-acetamido-2-deoxy-beta-D-glucopyranoside,CC(=O)N[C@@H]1[C@H]([C@@H]([C@H](O[C@H]1OC2=CC=C(C=C2)[N+](=O)[O-])CO)O)O,,,,,,
2416,102417,Cholesterol chloroacetate,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OC(=O)CCl)C)C,,,,,,
2417,102418,S-(5'-Deoxy-5'-adenosyl)methionine iodide,C[S+](CCC(C(=O)O)N)CC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O.[I-],,,,,,
2418,102419,CID 102419,C=CC1CN=C(O1)S,,,,,,
2419,102420,"Bis(aziridin-1-yl)-sulfanylidene-(2,2,6,6-tetramethyl-1-oxidopiperidin-1-ium-4-yl)oxy-lambda5-phosphane",CC1(CC(CC([NH+]1[O-])(C)C)OP(=S)(N2CC2)N3CC3)C,,,,,,
2420,102421,"Bis(aziridin-1-yl)-sulfanylidene-(2,2,6,6-tetramethyl-1-oxidopiperidin-4-yl)oxy-lambda5-phosphane",CC1(CC(CC(N1[O-])(C)C)OP(=S)(N2CC2)N3CC3)C,,,,,,
2421,102422,"3-(Perfluorononyl)-1,2-propanediol-1-phosphate",C(C(COP(=O)(O)O)O)C(C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
2422,102423,CID 102423,CC(C)CC(=CC(=O)C)[O-].CC(C)CC(=CC(=O)C)[O-].[Pd+2],,,,,,
2423,102424,2-Keto-L-gulonic acid,C([C@@H]([C@H]([C@@H](C(=O)C(=O)O)O)O)O)O,,,['Precursor forms of vitamins. (See all compounds classified as Provitamins.)'],,,
2424,102425,Decahydro-1-naphthol,C1CCC2C(C1)CCCC2O,,,,,,
2425,102426,Hexylcaine hydrochloride,CC(CNC1CCCCC1)OC(=O)C2=CC=CC=C2.Cl,,,,,,
2426,102427,CID 102427,C1=CC=C(C=C1)NNC(=CN=NC2=CC=CC=C2)C(C(C(CO)O)O)O,,,,,,
2427,102428,Eucatropine hydrochloride,CC1CC(CC(N1C)(C)C)OC(=O)C(C2=CC=CC=C2)O.Cl,,,,,,
2428,102429,"Propane-1,2,3-triyl trilactate",CC(C(=O)OCC(COC(=O)C(C)O)OC(=O)C(C)O)O,,,,,,
2429,102430,2-Hydroxytetracosanoic acid,CCCCCCCCCCCCCCCCCCCCCCC(C(=O)O)O,,,,,,
2430,102431,"3-[(2,6-Dideoxyhexopyranosyl)oxy]-14,16-dihydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CC(C5C6=CC(=O)OC6)O)O)C)C)O)O,,,,,,
2431,102432,Cedr-8(15)-ene,CC1CCC2C13CCC(=C)C(C3)C2(C)C,,,,,,
2432,102433,Zinc tartrate,[C@@H]([C@H](C(=O)[O-])O)(C(=O)[O-])O.[Zn+2],,,,,,
2433,102434,CID 102434,CC1C(C(C(C(O1)OCC2C(C(C(C(O2)OC3=CC(=O)C4=C(C=C(OC4=C3)C5=CC=C(C=C5)O)O)O)O)O)O)O)O,,,,,,
2434,102435,"2,2,6-Trimethylpiperidin-4-yl benzoate hydrochloride",CC1CC(CC(N1)(C)C)OC(=O)C2=CC=CC=C2.Cl,,,,,,
2435,102436,"2-[3,4-Dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-[[3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]oxane-3,4,5-triol",C(C1C(C(C(O1)(CO)OCC2C(C(C(C(O2)OC3(C(C(C(O3)CO)O)O)CO)O)O)O)O)O)O,,,,,,
2436,102437,"2,6,6-Trimethylcyclohex-2-ene-1-carboxylic acid",CC1=CCCC(C1C(=O)O)(C)C,,,,,,
2437,102438,4-Hydroxy-3-methylpentan-2-one,CC(C(C)O)C(=O)C,,,,,,
2438,102439,6-Methoxycinchonan-9-ol,COC1CC2CC(N1CC2C=C)C(C3=CC=NC4=CC=CC=C34)O,,,,,,
2439,102440,CID 102440,CCCCCC(=O)NC1C2N(C1=O)C(C(S2)(C)C)C(=O)[O-].[Na+],,,,,,
2440,102441,Flavicin,CCCCCC(=O)NC1C2N(C1=O)C(C(S2)(C)C)C(=O)O,,,,,,
2441,102442,2-Methylbut-3-yn-1-ol,CC(CO)C#C,,,,,,
2442,102443,Isoterpinolene,CC1CCC(=C(C)C)C=C1,,,,,,
2443,102444,"1,3-Diaminopentane",CCC(CCN)N,,,,,,
2444,102445,11-Fluoro-3-methylundecanoic acid,CC(CCCCCCCCF)CC(=O)O,,,,,,
2445,102446,sec-Butyllithium,[Li+].CC[CH-]C,,,,,,
2446,102447,"2,3-Dichloropentane",CCC(C(C)Cl)Cl,,,,,,
2447,102448,"4-Ethoxy-2,3-dihydroxy-4-oxobutanoic acid",CCOC(=O)C(C(C(=O)O)O)O,,,,,,
2448,102449,"2,3-Bis(nitrooxy)succinic acid",C(C(C(=O)O)O[N+](=O)[O-])(C(=O)O)O[N+](=O)[O-],,,,,,
2449,102450,"13,14-Dihydroxydocosanoic acid",CCCCCCCCC(C(CCCCCCCCCCCC(=O)O)O)O,,,,,,
2450,102451,"1,2-Dibromohexane",CCCCC(CBr)Br,,,,,,
2451,102452,Di-sec-butyl fluorophosphate,CCC(C)OP(=O)(OC(C)CC)F,,,,,,
2452,102453,1-Methylheptyl stearate,CCCCCCCCCCCCCCCCCC(=O)OC(C)CCCCCC,,,,,,
2453,102454,"1,2,3-Tribromobutane",CC(C(CBr)Br)Br,,,,,,
2454,102455,Menthyl borate,B(O[C@@H]1C[C@@H](CC[C@H]1C(C)C)C)(O[C@@H]2C[C@@H](CC[C@H]2C(C)C)C)O[C@@H]3C[C@@H](CC[C@H]3C(C)C)C,,,,,,
2455,102456,(S)-3-Amino-4-(2-naphthylamino)-4-oxobutyric acid,C1=CC=C2C=C(C=CC2=C1)NC(=O)C(CC(=O)O)N,,,,,,
2456,102457,8-Methyl-8-azabicyclo[3.2.1]octan-3-yl 2-hydroxy-2-phenylacetate hydrochloride,CN1C2CCC1CC(C2)OC(=O)C(C3=CC=CC=C3)O.Cl,,,,,,
2457,102458,"2-Naphthalenol, 2,3,4,4a,5,6,7,8-octahydro-2,5,5-trimethyl-",CC1(CCCC2=CC(CCC21)(C)O)C,,,,,,
2458,102459,"3,7,11,15-Tetramethylhexadecan-1-ol",CC(C)CCCC(C)CCCC(C)CCCC(C)CCO,,,,,,
2459,102460,(Pentafluorophenyl)glycolic acid,C1(=C(C(=C(C(=C1F)F)F)F)F)C(C(=O)O)O,,,,,,
2460,102461,"((1S,4aR,4bR,10aR)-7-Isopropyl-1,4a-dimethyl-1,2,3,4,4a,4b,5,6,10,10a-decahydrophenanthren-1-yl)methanol",CC(C)C1=CC2=CCC3C(CCCC3(C2CC1)C)(C)CO,,,,,,
2461,102462,"2-Naphthalenol, 1,2,3,4,5,6,7,8-octahydro-2,5,5-trimethyl-, (2S)-",CC1(CCCC2=C1CCC(C2)(C)O)C,,,,,,
2462,102463,3-Aminoazepan-2-one,C1CCNC(=O)C(C1)N,,,,,,
2463,102464,"1-Chloro-1,2,2,3,3-pentafluoropropane",C(C(C(F)Cl)(F)F)(F)F,,,,,,
2464,102465,tert-Amyl peroxy-2-ethylhexanoate,CCCCC(CC)C(=O)OOC(C)(C)CC,,,,,,
2465,102466,Glycyl-dl-serine,C(C(C(=O)O)NC(=O)CN)O,,,,,,
2466,102467,"Methyl 2,6-diaminohexanoate",COC(=O)C(CCCCN)N,,,,,,
2467,102468,Glycylleucine,CC(C)CC(C(=O)O)NC(=O)CN,,,,,,
2468,102469,1-(2-Chloropropyl)piperidine,CC(CN1CCCCC1)Cl,,,,,,
2469,102470,1-(4-Fluorophenyl)propan-1-ol,CCC(C1=CC=C(C=C1)F)O,,,,,,
2470,102471,1-(4-Fluorophenyl)butan-1-ol,CCCC(C1=CC=C(C=C1)F)O,,,,,,
2471,102472,"2,4,6-Tri(propan-2-yl)-1,3,5-dioxaphosphinane",CC(C)C1OC(PC(O1)C(C)C)C(C)C,,,,,,
2472,102473,"2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(1-cyclohexen-1-yl)-5-ethyl-1-methyl-",CCC1(C(=O)NC(=O)N(C1=O)C)C2=CCCCC2,,,,,,
2473,102474,1-Phenyl-4-piperidino-2-pyrrolidinone,C1CCN(CC1)C2CC(=O)N(C2)C3=CC=CC=C3,,,,,,
2474,102475,Leucine-beta-naphthylamide,CC(C)C[C@@H](C(=O)NC1=CC2=CC=CC=C2C=C1)N,,,,,,
2475,102476,"2,2'-Oxybis(5-ethyl-5-methyl-1,3,2-dioxaphosphorinane) 2,2'-dioxide",CCC1(COP(=O)(OC1)OP2(=O)OCC(CO2)(C)CC)C,,,,,,
2476,102477,(S)-2-Amino-N-(2-naphthyl)-3-phenylpropionamide,C1=CC=C(C=C1)C[C@@H](C(=O)NC2=CC3=CC=CC=C3C=C2)N,,,,,,
2477,102478,"1-(4-(2-(Dimethylamino)ethoxy)phenyl)-1,2-diphenylbutan-1-ol",CCC(C1=CC=CC=C1)C(C2=CC=CC=C2)(C3=CC=C(C=C3)OCCN(C)C)O,,,,,,
2478,102479,L-Leucine hydrochloride,CC(C)C[C@@H](C(=O)O)N.Cl,,,,,,
2479,102480,Diethyl 2-bromononanedioate,CCOC(=O)CCCCCCC(C(=O)OCC)Br,,,,,,
2480,102481,"3,6-Dimethylhept-5-en-2-one",CC(CC=C(C)C)C(=O)C,,,,,,
2481,102482,1-Diethylamino-2-chloropropane,CCN(CC)CC(C)Cl,,,,,,
2482,102483,"1,2-Dimethylpyrrolidine",CC1CCCN1C,,,,,,
2483,102484,Octopamine hydrochloride,C1=CC(=CC=C1C(CN)O)O.Cl,,,,,,
2484,102485,CID 102485,C1C2CC3C24C1CC4(C3)CO,,,,,,
2485,102486,"Trichloro(2-chloro-2,3,3-trifluorocyclobutyl)silane",C1C(C(C1(F)F)(F)Cl)[Si](Cl)(Cl)Cl,,,,,,
2486,102487,2-Dioxocyclohexaneacetic acid,C1CCC(=O)C(C1)C(=O)C(=O)O,,,,,,
2487,102488,4-Amino-1-phenylpyrrolidin-2-one hydrochloride,C1C(CN(C1=O)C2=CC=CC=C2)N.Cl,,,,,,
2488,102489,4-Amino-1-phenylpyrrolidin-2-one,C1C(CN(C1=O)C2=CC=CC=C2)N,,,,,,
2489,102490,"1,4-Benzenediamine, N-(1-methylpropyl)-N'-phenyl-",CCC(C)NC1=CC=C(C=C1)NC2=CC=CC=C2,,,,,,
2490,102491,Methyl 2-ethylhexanoate,CCCCC(CC)C(=O)OC,,,,,,
2491,102492,"3,3'-(Dodecylimino)bispropane-1,2-diol",CCCCCCCCCCCCN(CC(CO)O)CC(CO)O,,,,,,
2492,102493,2-Propylhexan-1-ol,CCCCC(CCC)CO,,,,,,
2493,102494,2-Ethylheptan-1-ol,CCCCCC(CC)CO,,,,,,
2494,102495,2-Methyloctan-1-ol,CCCCCCC(C)CO,,,,,,
2495,102496,"3-(Dodecylamino)propane-1,2-diol",CCCCCCCCCCCCNCC(CO)O,,,,,,
2496,102497,"2,4-Dimethylcyclohexanone",CC1CCC(=O)C(C1)C,,,,,,
2497,102498,alpha-Cyclopropyl-4-fluorobenzyl alcohol,C1CC1C(C2=CC=C(C=C2)F)O,,,,,,
2498,102499,"8-Methyl-3a,4,5,7a-tetrahydro-4,7-methano-2-benzofuran-1,3-dione",CC1C2CC=C1C3C2C(=O)OC3=O,,,,,,
2499,102500,Einecs 212-697-0,CCC12CCC3=C(C1=CCC2=O)CCC4=C3C=CC(=C4)OC,,,,,,
2500,102501,"N,N'-(1,2-Dihydroxyethylene)bisacrylamide",C=CC(=O)NC(C(NC(=O)C=C)O)O,,,,,,
2501,102502,Metanephrine hydrochloride,CNCC(C1=CC(=C(C=C1)O)OC)O.Cl,,,,,,
2502,102503,DL-2-Benzamido-5-guanidino-N-2-naphthylvaleramide hydrochloride,C1=CC=C(C=C1)C(=O)NC(CCCN=C(N)N)C(=O)NC2=CC3=CC=CC=C3C=C2.Cl,,,,,,
2503,102504,"3,4-Hexanediol",CCC(C(CC)O)O,,,,,,
2504,102505,Bromo(1-methylpropyl)magnesium,CC[CH-]C.[Mg+2].[Br-],,,,,,
2505,102506,Chipman RP-13378,CC(=O)NC(C(=O)NC)SP(=S)(OC)OC,,,,,,
2506,102507,"8,8-Dimethoxy-2,6-dimethyloct-2-ene",CC(CCC=C(C)C)CC(OC)OC,,,,,,
2507,102508,"Thiosulfuric acid, S-(2-((1-propylhexyl)amino)ethyl) ester",CCCCCC(CCC)NCCSS(=O)(=O)O,,,,,,
2508,102509,"Thiosulfuric acid, S-(2-((1-propylpentyl)amino)ethyl) ester",CCCCC(CCC)NCCSS(=O)(=O)O,,,,,,
2509,102510,"Thiosulfuric acid, S-(2-((1-ethylhexyl)amino)ethyl) ester",CCCCCC(CC)NCCSS(=O)(=O)O,,,,,,
2510,102511,"Thiosulfuric acid, S-(2-((1-ethylheptyl)amino)ethyl) ester",CCCCCCC(CC)NCCSS(=O)(=O)O,,,,,,
2511,102512,2-(3-Decyl)aminoethanethiol hydrogen sulfate (ester),CCCCCCCC(CC)NCCSS(=O)(=O)O,,,,,,
2512,102513,2-(2-Ethylhexyl)aminoethanethiol hydrogen sulfate (ester),CCCCC(CC)CNCCSS(=O)(=O)O,,,,,,
2513,102514,"Thiosulfuric acid, S-(2-((1-methyloctyl)amino)ethyl) ester",CCCCCCCC(C)NCCSS(=O)(=O)O,,,,,,
2514,102515,2-Methylhexanal,CCCCC(C)C=O,,,,,,
2515,102516,6-Methyloctan-2-one,CCC(C)CCCC(=O)C,,,,,,
2516,102517,N-[2-((2-[(2-Aminopropanoyl)amino]propanoyl)amino)propanoyl]alanine,CC(C(=O)NC(C)C(=O)NC(C)C(=O)NC(C)C(=O)O)N,,,,,,
2517,102518,"Pent-2-yne-1,4-diol",CC(C#CCO)O,,,,,,
2518,102519,2-(2-Heptyl)aminoethanethiol hydrogen sulfate (ester),CCCCCC(C)NCCSS(=O)(=O)O,,,,,,
2519,102520,2-(2-Decyl)aminoethanethiol hydrogen sulfate (ester),CCCCCCCCC(C)NCCSS(=O)(=O)O,,,,,,
2520,102521,2-(2-Undecyl)aminoethanethiol hydrogen sulfate (ester),CCCCCCCCCC(C)NCCSS(=O)(=O)O,,,,,,
2521,102522,"2,4-Dimethyl-2-imidazoline",CC1CN=C(N1)C,,,,,,
2522,102523,5-Oxopyrrolidine-2-carbohydrazide,C1CC(=O)NC1C(=O)NN,,,,,,
2523,102524,2-Butylcyclopentanone,CCCCC1CCCC1=O,,,,,,
2524,102525,2-(4-Chlorophenyl)propanoic acid,CC(C1=CC=C(C=C1)Cl)C(=O)O,,,,,,
2525,102526,2-(4-Hydroxyphenyl)propanoic acid,CC(C1=CC=C(C=C1)O)C(=O)O,,,,,,
2526,102527,"1,4-Dioxaspiro(4.5)decane, 7,7,9-trimethyl-",CC1CC(CC2(C1)OCCO2)(C)C,,,,,,
2527,102528,4-[1-Hydroxy-3-(methylamino)propyl]phenol;hydrochloride,CNCCC(C1=CC=C(C=C1)O)O.Cl,,,,,,
2528,102529,4-[1-Hydroxy-3-(methylamino)propyl]phenol,CNCCC(C1=CC=C(C=C1)O)O,,,,,,
2529,102530,DL-Homophenylalanine,C1=CC=C(C=C1)CCC(C(=O)O)N,,,,,,
2530,102531,"5-(3,4-Dihydroxybenzyl)-5-methylhydantoin",CC1(C(=O)NC(=O)N1)CC2=CC(=C(C=C2)O)O,,,,,,
2531,102532,"2-Methyl-1,4-dioxaspiro[4.11]hexadecane",CC1COC2(O1)CCCCCCCCCCC2,,,,,,
2532,102533,Phenylalanine O-benzyl ester,C1=CC=C(C=C1)CC(C(=O)OCC2=CC=CC=C2)N,,,,,,
2533,102534,"Ecane-2,10-dione (non-preferred name)",CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)OC2CC(C(C(O2)C)O)(C)OC)C)OC3C(C(CC(O3)C)NC)O)(C)O)C)C)O)(C)O,,,,,,
2534,102535,"2-[2,3-Di(octadeca-9,12-dienoyloxy)propoxy-hydroxyphosphoryl]oxyethyl-trimethylazanium",CCCCCC=CCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCC=CCCCCC,,,,,,
2535,102536,4-Bromooctane,CCCCC(CCC)Br,,,,,,
2536,102537,"Methyl 2,6,10-trimethylundecanoate",CC(C)CCCC(C)CCCC(C)C(=O)OC,,,,,,
2537,102538,"Furan, 2-ethyltetrahydro-",CCC1CCCO1,,,,,,
2538,102539,"4-Methyl1,3-dithiolan-2-iminium chloride",CC1CSC(=N)S1.Cl,,,,,,
2539,102540,"4-Methyl-1,3-dithiolan-2-imine",CC1CSC(=N)S1,,,,,,
2540,102541,Propylhexedrine hydrochloride,CC(CC1CCCCC1)NC.Cl,,,,,,
2541,102542,Normetanephrine hydrochloride,COC1=C(C=CC(=C1)C(CN)O)O.Cl,,,,,,
2542,102543,"1,3-Dihydro-3,3-dimethyl-1-phenylisobenzofuran-1-ol",CC1(C2=CC=CC=C2C(O1)(C3=CC=CC=C3)O)C,,,,,,
2543,102544,2-Amino-3-(4-(4-hydroxyphenoxy)phenyl)propanoic acid,C1=CC(=CC=C1CC(C(=O)O)N)OC2=CC=C(C=C2)O,,,,,,
2544,102545,1-Mercapto-2-propanol,CC(CS)O,,,,,,
2545,102546,Bis-(2-ethylhexanoyl) peroxide,CCCCC(CC)C(=O)OOC(=O)C(CC)CCCC,,,,,,
2546,102547,"1,2-Distearoylphosphatidylethanolamine",CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCCCCCCCC,,,,,,
2547,102548,"2,3-Bis(hexadecyloxy)propan-1-ol",CCCCCCCCCCCCCCCCOCC(CO)OCCCCCCCCCCCCCCCC,,,,,,
2548,102549,"5-Decyne-4,7-diol",CCCC(C#CC(CCC)O)O,,,,,,
2549,102550,"2(3H)-Furanone, 5-ethenyldihydro-5-methyl-",CC1(CCC(=O)O1)C=C,,,,,,
2550,102551,3-(2-Aminopropyl)phenol,CC(CC1=CC(=CC=C1)O)N,,,,,['3-(2-Aminopropyl)phenol is a known human metabolite of (R)-m-Methoxyamphetamine.'],
2551,102552,CID 102552,CC(C)CC1C(=O)N(C(=N1)S)C,,,,,,
2552,102553,"6,6-Dimethyl-2-methylenebicyclo[3.1.1]hept-3-yl acetate",CC(=O)OC1CC2CC(C1=C)C2(C)C,,,,,,
2553,102554,1-Phenyl-2-benzylaminopropane,CC(CC1=CC=CC=C1)NCC2=CC=CC=C2,,,,,['1-Phenyl-2-benzylaminopropane is a known human metabolite of zinc968306.'],
2554,102555,"3-(p-Propionyl-o-methoxyphenoxy)-1,2-propanediol",CCC(=O)C1=CC(=C(C=C1)OCC(CO)O)OC,,,,,,
2555,102556,Dansyl asparagine,CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)NC(CC(=O)N)C(=O)O,,,,,,
2556,102557,Dansylphenylalanine,CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)NC(CC3=CC=CC=C3)C(=O)O,,,,,,
2557,102558,"N,1-Bis((5-(dimethylamino)-1-naphthyl)sulphonyl)-L-histidine",CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)NC(CC3=CN(C=N3)S(=O)(=O)C4=CC=CC5=C4C=CC=C5N(C)C)C(=O)O,,,,,,
2558,102559,Tri-sec-butylborane,B(C(C)CC)(C(C)CC)C(C)CC,,,,,,
2559,102560,Ethyl 2-aminopropanoate hydrochloride,CCOC(=O)C(C)N.Cl,,,,,,
2560,102561,CID 102561,CCC(C(=O)[O-])C1(CCCCC1)O.[Na+],,,,,,
2561,102562,"2H-2,4a-Methanonaphthalene, 1,3,4,5,6,7-hexahydro-1,1,5,5-tetramethyl-, (2S)-",CC1(CCC=C2C13CCC(C3)C2(C)C)C,,,,,,
2562,102563,"4-(3,3-Dimethylbicyclo[2.2.1]hept-2-ylidene)-2-methyl-1-butanol",CC(CC=C1C2CCC(C2)C1(C)C)CO,,,,,,
2563,102564,"4-(Furan-3-yl)-1,7-dimethyloctahydro-2h-quinolizine",CC1CCC2C(CCC(N2C1)C3=COC=C3)C,,,,,,
2564,102565,Menthyl acetoacetate,CC1CCC(C(C1)OC(=O)CC(=O)C)C(C)C,,,,,,
2565,102566,"[4-(3,3-Dimethyl-2-bicyclo[2.2.1]heptanyl)-3-methylbutyl] acetate",CC(CCOC(=O)C)CC1C2CCC(C2)C1(C)C,,,,,,
2566,102567,2-Isopropyl-5-methylcyclohexyl phenylacetate,CC1CCC(C(C1)OC(=O)CC2=CC=CC=C2)C(C)C,,,,,,
2567,102568,2-Amino-6-(((benzyloxy)carbonyl)amino)hexanoic acid,C1=CC=C(C=C1)COC(=O)NCCCCC(C(=O)O)N,,,,,,
2568,102569,N-Carbobenzoxyalanine 4-nitrophenyl ester,CC(C(=O)OC1=CC=C(C=C1)[N+](=O)[O-])NC(=O)OCC2=CC=CC=C2,,,,,,
2569,102570,Cyclohexyl 2-ethylhexyl phthalate,CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OC2CCCCC2,,,,,,
2570,102571,"N,N'-Bis(beta-methylphenethyl)-1,4-cyclohexanebis(methylamine) dihydrochloride",CC(CC1=CC=CC=C1)NCC2CCC(CC2)CNC(C)CC3=CC=CC=C3.Cl.Cl,,,,,,
2571,102572,1-phenyl-N-[[4-[(1-phenylpropan-2-ylamino)methyl]cyclohexyl]methyl]propan-2-amine,CC(CC1=CC=CC=C1)NCC2CCC(CC2)CNC(C)CC3=CC=CC=C3,,,,,,
2572,102573,2-(2-Chloroacetamido)propanoic acid,CC(C(=O)O)NC(=O)CCl,,,,,,
2573,102574,6-Oxylysin,C(CC(C(=O)O)N)CC(N)O,,,,,,
2574,102575,"2-Methyl-1,4-diazabicyclo[2.2.2]octane",CC1CN2CCN1CC2,,,,,,
2575,102576,Tetrahydro-2-isocyanato-2H-pyran,C1CCOC(C1)N=C=O,,,,,,
2576,102577,2-Amino-2-(thiophen-3-yl)acetic acid,C1=CSC=C1C(C(=O)O)N,,,,,,
2577,102578,6-(Isopropyl)-3-methylcyclohex-2-en-1-yl acetate,CC1=CC(C(CC1)C(C)C)OC(=O)C,,,,,,
2578,102579,"4,9,12,12-Tetramethyl-5-oxatricyclo[8.2.0.04,6]dodecane",CC1CCC2C(O2)(CCC3C1CC3(C)C)C,,,,,,
2579,102580,"1H-Indene-5-ethanol, 2,3-dihydro-beta,1,1,2,3,3-hexamethyl-",CC1C(C2=C(C1(C)C)C=C(C=C2)C(C)CO)(C)C,,,,,,
2580,102581,3-(Morpholin-4-yl)-3-phenyl-3-(thiophen-2-yl)propan-1-ol,C1COCCN1C(CCO)(C2=CC=CC=C2)C3=CC=CS3,,,,,,
2581,102582,"5-[2-(Furan-3-yl)ethyl]-1,4a-dimethyl-6-methylidenedecahydronaphthalene-1-carboxylic acid",CC12CCCC(C1CCC(=C)C2CCC3=COC=C3)(C)C(=O)O,,,,,,
2582,102583,10-(3-(Dimethylamino)-2-methylpropyl)-2-methoxyphenothiazine monohydrochloride,CC(CN1C2=CC=CC=C2SC3=C1C=C(C=C3)OC)CN(C)C.Cl,,,,,,
2583,102584,"1,4-Cyclohexanebis(methylamine), N,N'-bis(3,4,5,6-tetrahydropyran-2-ylmethyl)-, dihydrochloride, (E)-",C1CCOC(C1)CNCC2CCC(CC2)CNCC3CCCCO3.Cl.Cl,,,,,,
2584,102585,N-(oxan-2-ylmethyl)-1-[4-[(oxan-2-ylmethylamino)methyl]cyclohexyl]methanamine,C1CCOC(C1)CNCC2CCC(CC2)CNCC3CCCCO3,,,,,,
2585,102586,"1,4-Cyclohexanebis(methylamine), N,N'-bis(3-methylcyclohexyl)-, diacetate, (E)-",CC1CCCC(C1)NCC2CCC(CC2)CNC3CCCC(C3)C.CC(=O)O.CC(=O)O,,,,,,
2586,102587,3-methyl-N-[[4-[[(3-methylcyclohexyl)amino]methyl]cyclohexyl]methyl]cyclohexan-1-amine,CC1CCCC(C1)NCC2CCC(CC2)CNC3CCCC(C3)C,,,,,,
2587,102588,"N,N'-Di-2-naphthyl-L-cystinediamide",C1=CC=C2C=C(C=CC2=C1)NC(=O)C(CSSCC(C(=O)NC3=CC4=CC=CC=C4C=C3)N)N,,,,,,
2588,102589,Valerylferrocene,CCCCC(=O)C1=CC=C[CH-]1.[CH-]1C=CC=C1.[Fe+2],,,,,,
2589,102590,"1-Cyclopenta-1,3-dien-1-ylpentan-1-one",CCCCC(=O)C1=CC=CC1,,,,,,
2590,102591,"Ketone, ferrocenyl phenyl (8CI)",[CH-]1C=CC=C1.[CH-]1C=CC=C1C(=O)C2=CC=CC=C2.[Fe+2],,,,,,
2591,102592,"Cyclopenta-1,3-dien-1-yl(phenyl)methanone",C1C=CC=C1C(=O)C2=CC=CC=C2,,,,,,
2592,102593,"Cyclopenta-1,3-diene;cyclopenta-2,4-dien-1-ylmethanol;iron(2+)",C1C=CC=[C-]1.C1=CC([C-]=C1)CO.[Fe+2],,,,,,
2593,102594,"2,4-Cyclopentadienylmethanol",C1=CC(C=C1)CO,,,,,,
2594,102595,"Ferrocene, pentyl-",CCCCCC1=CC=C[CH-]1.[CH-]1C=CC=C1.[Fe+2],,,,,,
2595,102596,"1,3-Cyclopentadiene, 1-pentyl",CCCCCC1=CC=CC1,,,,,,
2596,102597,"1,1'-Dibutylferrocene",CCCCC1=CC=C[CH-]1.CCCCC1=CC=C[CH-]1.[Fe+2],,,,,,
2597,102598,n-Butyl cyclopentadiene,CCCCC1=CC=CC1,,,,,,
2598,102599,Neopentylferrocene,CC(C)(C)CC1=CC=C[CH-]1.[CH-]1C=CC=C1.[Fe+2],,,,,,
2599,102600,"1-(2,2-Dimethylpropyl)-1,3-cyclopentadiene",CC(C)(C)CC1=CC=CC1,,,,,,
2600,102601,Zinc 1-glycerophosphate,C(C(COP(=O)([O-])[O-])O)O.[Zn+2],,,,,,
2601,102602,1-Acetyl-2-ethylferrocene,CCC1=C([CH-]C=C1)C(=O)C.[CH-]1C=CC=C1.[Fe+2],,,,,,
2602,102603,"1-(2-Ethylcyclopenta-1,3-dien-1-yl)ethanone",CCC1=C(CC=C1)C(=O)C,,,,,,
2603,102604,"6,10-Dimethylundec-9-en-2-one",CC(CCCC(=O)C)CCC=C(C)C,,,,,,
2604,102605,Bis(2-ethylhexyl) 3-hydroxypropyl phosphate,CCCCC(CC)COP(=O)(OCCCO)OCC(CC)CCCC,,,,,,
2605,102606,"Octadecanoic acid, hydroxy-, monoester with 1,2,3-propanetriol",CCCCCCCCCCCCCCCCC(C(=O)OC(CO)CO)O,,,,,,
2606,102607,6-Hydroxyoctadecanoic acid,CCCCCCCCCCCCC(CCCCC(=O)O)O,,,,,,
2607,102608,5-(Isopropyl)-2-methylcyclohexen-1-yl acetate,CC1C=CCC(C1OC(=O)C)C(C)C,,,,,,
2608,102609,"2-(Hexadecanoyloxy)propionic acid, monoester with glycerol",CCCCCCCCCCCCCCCC(=O)OC(C)C(=O)OCC(CO)O,,,,,,
2609,102610,Glyceryl lactostearate,CCCCCCCCCCCCCCCCCC(=O)O.CC(C(=O)O)O.C(C(CO)O)O,,,,,,
2610,102611,"Linalool, oxide",CC(=CCCC(C)(C1CO1)O)C,,,,,,
2611,102612,"Calcium 3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate",CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C.CC1(C(N2C(S1)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)[O-])C.[Ca+2],,,,,,
2612,102613,alpha-((Isopropylamino)methyl)vanillyl alcohol hydrochloride,CC(C)NCC(C1=CC(=C(C=C1)O)OC)O.Cl,,,,,,
2613,102614,"2,3-Bis(4-hydroxyphenyl)propionitrile",C1=CC(=CC=C1CC(C#N)C2=CC=C(C=C2)O)O,,,,,,
2614,102615,"1,2-Distearoyl-rac-glycerol",CCCCCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCCCC,,,,,,
2615,102616,CID 102616,CC1CSC(=N1)S,,,,,,
2616,102617,CID 102617,CCC1CSC(=N1)S,,,,,,
2617,102618,"1,2-Epoxy-3-methylbutane",CC(C)C1CO1,,,,,,
2618,102619,"N,N'-Bis(3-cyclohexenylmethyl)-1,4-cyclohexanebis(methylamine) dihydrochloride",C1CC=CC(C1)CNCC2CCC(CC2)CNCC3CCCC=C3.Cl.Cl,,,,,,
2619,102620,N-(cyclohex-2-en-1-ylmethyl)-1-[4-[(cyclohex-2-en-1-ylmethylamino)methyl]cyclohexyl]methanamine,C1CC=CC(C1)CNCC2CCC(CC2)CNCC3CCCC=C3,,,,,,
2620,102621,"2,2-Dichloro-1-methylcyclopropanecarboxylic acid",CC1(CC1(Cl)Cl)C(=O)O,,,,,,
2621,102622,"6a,7,10,10a-Tetrahydro-1-methoxy-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran",CCCCCC1=CC2=C(C3CC(=CCC3C(O2)(C)C)C)C(=C1)OC,,,,,,
2622,102623,Ethyl 1-benzyl-4-oxopiperidine-3-carboxylate hydrochloride,CCOC(=O)C1CN(CCC1=O)CC2=CC=CC=C2.Cl,,,,,,
2623,102624,Ethyl 1-benzyl-4-oxopiperidine-3-carboxylate,CCOC(=O)C1CN(CCC1=O)CC2=CC=CC=C2,,,,,,
2624,102625,(R)-1-Methyl-5-(1-methylvinyl)cyclohexene,CC1=CCCC(C1)C(=C)C,,,,,,
2625,102626,"3-[(2-Hydroxyethyl)thio]-1,2-propanediol",C(CSCC(CO)O)O,,,,,,
2626,102627,Bromal trifluoroacetamide,C(C(Br)(Br)Br)(NC(=O)C(F)(F)F)O,,,,,,
2627,102628,3-Dimethylamino-2-methyl-1-phenyl-o-tolylpropanol hydrochloride,CC1=CC=CC=C1C(C2=CC=CC=C2)(C(C)CN(C)C)O.Cl,,,,,,
2628,102629,3-(Dimethylamino)-2-methyl-1-(2-methylphenyl)-1-phenylpropan-1-ol,CC1=CC=CC=C1C(C2=CC=CC=C2)(C(C)CN(C)C)O,,,,,,
2629,102630,2-Bromo-2-phenylacetophenone,C1=CC=C(C=C1)C(C(=O)C2=CC=CC=C2)Br,,,,,,
2630,102631,"2,3-Dimethylcyclohexanol",CC1CCCC(C1C)O,,,,,,
2631,102632,m-(3-Butyl-1-methyl-3-pyrrolidinyl)phenol,CCCCC1(CCN(C1)C)C2=CC(=CC=C2)O,,,,,,
2632,102633,alpha-Isopropyl-alpha-(2-(benzylmethylamino)ethyl)-1-naphthylacetamide,CC(C)C(CCN(C)CC1=CC=CC=C1)(C2=CC=CC3=CC=CC=C32)C(=O)N,,,,,,
2633,102634,alpha-Isopropyl-alpha-(ethylmethylaminoethyl)-1-naphthylacetamide,CCN(C)CCC(C1=CC=CC2=CC=CC=C21)(C(C)C)C(=O)N,,,,,,
2634,102635,2-[2-(Dimethylamino)ethyl]-4-methyl-2-(naphthalen-1-yl)pentanimidic acid,CC(C)CC(CCN(C)C)(C1=CC=CC2=CC=CC=C21)C(=O)N,,,,,,
2635,102636,alpha-Methyl-alpha-(2-dimethylaminoethyl)-1-naphthylacetamide,CC(CCN(C)C)(C1=CC=CC2=CC=CC=C21)C(=O)N,,,,,,
2636,102637,alpha-Isopropyl-alpha-(2-piperidinoethyl)-1-naphthylacetamide,CC(C)C(CCN1CCCCC1)(C2=CC=CC3=CC=CC=C32)C(=O)N,,,,,,
2637,102638,"Butyramide, 2-ethyl-2-(1-naphthyl)-4-piperidino-",CCC(CCN1CCCCC1)(C2=CC=CC3=CC=CC=C32)C(=O)N,,,,,,
2638,102639,alpha-Ethyl-alpha-(2-morpholinoethyl)-1-naphthylacetamide,CCC(CCN1CCOCC1)(C2=CC=CC3=CC=CC=C32)C(=O)N,,,,,,
2639,102640,alpha-Isopropyl-alpha-(2-morpholinoethyl)-1-naphthylacetamide,CC(C)C(CCN1CCOCC1)(C2=CC=CC3=CC=CC=C32)C(=O)N,,,,,,
2640,102641,2-Phenylbutyric acid anhydride,CCC(C1=CC=CC=C1)C(=O)OC(=O)C(CC)C2=CC=CC=C2,,,,,,
2641,102642,2-Methylbutanoic anhydride,CCC(C)C(=O)OC(=O)C(C)CC,,,,,,
2642,102643,"2-(1,2-Dichloroethyl)pyridine hydrochloride",C1=CC=NC(=C1)C(CCl)Cl.Cl,,,,,,
2643,102644,"2-(1,2-Dichloroethyl)pyridine",C1=CC=NC(=C1)C(CCl)Cl,,,,,,
2644,102645,"1,1'-(Dodecylimino)dipropan-2-ol",CCCCCCCCCCCCN(CC(C)O)CC(C)O,,,,,,
2645,102646,"Ethanol, 2-[2-[2-[(2-ethylhexyl)oxy]ethoxy]ethoxy]-",CCCCC(CC)COCCOCCOCCO,,,,,,
2646,102647,Ethyl 4-methylhexanoate,CCC(C)CCC(=O)OCC,,,,,,
2647,102648,2-Methoxy-4-methyl-1-(propan-2-yl)cyclohexane,CC1CCC(C(C1)OC)C(C)C,,,,,,
2648,102649,alpha-Fluorophenylacetic acid,C1=CC=C(C=C1)C(C(=O)O)F,,,,,,
2649,102650,2-Methyl-1-tetralone,CC1CCC2=CC=CC=C2C1=O,,,,,,
2650,102651,"N2-(2,4-Dinitrophenyl)-L-arginine",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])NC(CCCN=C(N)N)C(=O)O,,,,,,
2651,102652,"3,7,11-Trimethyl-1-dodecyn-3-ol",CC(C)CCCC(C)CCCC(C)(C#C)O,,,,,,
2652,102653,alpha-Isopropyl-alpha-(2-(diethylamino)ethyl)-1-naphthylacetamide,CCN(CC)CCC(C1=CC=CC2=CC=CC=C21)(C(C)C)C(=O)N,,,,,,
2653,102654,4-(2-Hydroxypropoxy)but-2-yn-1-ol,CC(COCC#CCO)O,,,,,,
2654,102655,1-[4-(2-Hydroxypropoxy)but-2-ynoxy]propan-2-ol,CC(COCC#CCOCC(C)O)O,,,,,,
2655,102656,"Oxirane, 2-[(1-propen-1-yloxy)methyl]-",CC=COCC1CO1,,,,,,
2656,102657,Tetrahydro-2-furyl acetate,CC(=O)OC1CCCO1,,,,,,
2657,102658,"1,5-Dihydro-3-isopropyl-8-methyl-[1,3]dioxepino[5,6-C]pyridin-9-OL",CC1=NC=C2COC(OCC2=C1O)C(C)C,,,,,,
2658,102659,"Silane, dichloro(3-chloro-2-methylpropyl)methyl-",CC(C[Si](C)(Cl)Cl)CCl,,,,,,
2659,102660,"5-Methyl-1,3-oxathiolan-2-one O-(methylcarbamoyl)oxime",CC1CSC(=NOC(=O)NC)O1,,,,,,
2660,102661,Hexane-3-thiol,CCCC(CC)S,,,,,,
2661,102662,"1,1,1,2,3,3-Hexafluoro-2-(heptafluoropropoxy)-3-((trifluorovinyl)oxy)propane",C(=C(F)F)(OC(C(C(F)(F)F)(OC(C(C(F)(F)F)(F)F)(F)F)F)(F)F)F,,,,,,
2662,102663,"Propane, 1-bromo-1-chloro-2,2,3,3-tetrafluoro-",C(C(C(Cl)Br)(F)F)(F)F,,,,,,
2663,102664,2-Ethylhexyl iodide,CCCCC(CC)CI,,,,,,
2664,102665,2-Ethylhexyl nitrite,CCCCC(CC)CON=O,,,,,,
2665,102666,"Methyl 2,5-dioxooxazolidine-4-propionate",COC(=O)CCC1C(=O)OC(=O)N1,,,,,,
2666,102667,Pinocarveol,CC1(C2CC1C(=C)C(C2)O)C,,,,,,
2667,102668,Phenglutarimide hydrochloride,CCN(CC)CCC1(CCC(=O)NC1=O)C2=CC=CC=C2.Cl,,,"['Drugs that bind to but do not activate CHOLINERGIC RECEPTORS, thereby blocking the actions of ACETYLCHOLINE or cholinergic agonists. (See all compounds classified as Cholinergic Antagonists.)']",,,
2668,102669,Phenglutarimide,CCN(CC)CCC1(CCC(=O)NC1=O)C2=CC=CC=C2,,,"['Drugs that bind to but do not activate CHOLINERGIC RECEPTORS, thereby blocking the actions of ACETYLCHOLINE or cholinergic agonists. (See all compounds classified as Cholinergic Antagonists.)']",,,
2669,102670,2-(((Benzyloxy)carbonyl)amino)-3-(tert-butoxy)propanoic acid,CC(C)(C)OCC(C(=O)O)NC(=O)OCC1=CC=CC=C1,,,,,,
2670,102671,5-Bromodihydro-5-methyluracil,CC1(CNC(=O)NC1=O)Br,,,,,,
2671,102672,N-Formylglutamate,C(CC(=O)O)C(C(=O)O)NC=O,,,,,,
2672,102673,"2,3-Dihydro-2-phenyl-4-benzopyrone (2,3-dihydro-2-phenyl-4H-1-benzopyran-4-ylidene)hydrazone",C1C(OC2=CC=CC=C2C1=NN=C3CC(OC4=CC=CC=C34)C5=CC=CC=C5)C6=CC=CC=C6,,,,,,
2673,102674,"(2-Phenyl-2,3-dihydrochromen-4-ylidene)hydrazine",C1C(OC2=CC=CC=C2C1=NN)C3=CC=CC=C3,,,,,,
2674,102675,"N,O-Bis(2,4-dinitrophenyl)-L-tyrosine",C1=CC(=CC=C1CC(C(=O)O)NC2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-])OC3=C(C=C(C=C3)[N+](=O)[O-])[N+](=O)[O-],,,,,,
2675,102676,"DL-2-(2,4-Dinitroanilino)-4-(methylsulphinyl)butyric acid",CS(=O)CCC(C(=O)O)NC1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-],,,,,,
2676,102677,"3-Methyl-2,3-dihydrofuran",CC1COC=C1,,,,,,
2677,102678,Alexidine dihydrochloride,CCCCC(CC)CN=C(N)NC(=NCCCCCCN=C(N)NC(=NCC(CC)CCCC)N)N.Cl.Cl,,,,,,
2678,102679,"Bicyclo[2.2.2]oct-7-ene-2,3,5,6-tetracarboxylic Dianhydride",C1=CC2C3C(C1C4C2C(=O)OC4=O)C(=O)OC3=O,,,,,,
2679,102680,"3-Cyclohexene-1-carboxaldehyde, 2,2,4-trimethyl-",CC1=CC(C(CC1)C=O)(C)C,,,,,,
2680,102681,2-tert-Butylcyclohexanone,CC(C)(C)C1CCCCC1=O,,,,,,
2681,102682,Benzyl 2-amino-4-methylpentanoate,CC(C)CC(C(=O)OCC1=CC=CC=C1)N,,,,,,
2682,102683,"1,4-Dimethyl-4-vinylcyclohexene",CC1=CCC(CC1)(C)C=C,,,,,,
2683,102684,Photocitral A,CC1CCC(C1C=O)C(=C)C,,,,,,
2684,102685,(S)-2-Guanidinopropanoic acid,CC(C(=O)O)N=C(N)N,,,,,,
2685,102686,"1-[3-(2,3-Diphenylprop-2-enyl)-3,8-diazabicyclo[3.2.1]octan-8-yl]propan-1-one",CCC(=O)N1C2CCC1CN(C2)CC(=CC3=CC=CC=C3)C4=CC=CC=C4,,,,,,
2686,102687,"Phosphorothioic acid, O,O-dimethyl ester, S-ester with 1,2-bis(methoxycarbonyl)ethanethiol",COC(=O)CC(C(=O)OC)SP(=O)(OC)OC,,,,,,
2687,102688,Ethyl 2-amino-3-phenylpropanoate,CCOC(=O)C(CC1=CC=CC=C1)N,,,,,,
2688,102689,"3-{2-[(4-Chlorophenyl)(phenyl)methoxy]ethyl}-1,3-oxazinane--hydrogen chloride (1/1)",C1CN(COC1)CCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl.Cl,,,,,,
2689,102690,"3-[2-[(4-Chlorophenyl)-phenylmethoxy]ethyl]-1,3-oxazinane",C1CN(COC1)CCOC(C2=CC=CC=C2)C3=CC=C(C=C3)Cl,,,,,,
2690,102691,CID 102691,CCC(=O)N1C2CCC1N(CC2)CC=CC=CC3=CC=CC=C3,,,,,,
2691,102692,2-Ethoxypentane,CCCC(C)OCC,,,,,,
2692,102693,p-(1-Methylheptyl)phenol,CCCCCCC(C)C1=CC=C(C=C1)O,,,,,,
2693,102694,"1,4-Cyclohexanebis(methylamine), N,N'-bis(5-norbornen-2-ylmethyl)-, dihydrochloride, trans-",C1CC(CCC1CNCC2CC3CC2C=C3)CNCC4CC5CC4C=C5.Cl.Cl,,,,,,
2694,102695,N-(2-bicyclo[2.2.1]hept-5-enylmethyl)-1-[4-[(2-bicyclo[2.2.1]hept-5-enylmethylamino)methyl]cyclohexyl]methanamine,C1CC(CCC1CNCC2CC3CC2C=C3)CNCC4CC5CC4C=C5,,,,,,
2695,102696,3-(4-Benzoyl-3-hydroxyphenoxy)-2-hydroxypropyl methacrylate,CC(=C)C(=O)OCC(COC1=CC(=C(C=C1)C(=O)C2=CC=CC=C2)O)O,,,,,,
2696,102697,Oxazepam acetate,CC(=O)OC1C(=O)NC2=C(C=C(C=C2)Cl)C(=N1)C3=CC=CC=C3,,,,,,
2697,102698,1-(3-Chlorophenyl)-5-[(4-methoxy-2-nitrophenyl)azo]-3-methylbarbituric acid,CN1C(=O)C(C(=O)N(C1=O)C2=CC(=CC=C2)Cl)N=NC3=C(C=C(C=C3)OC)[N+](=O)[O-],,,,,,
2698,102699,2-Amino-4-methoxy-4-oxobutanoic acid,COC(=O)CC(C(=O)O)N,,,,,,
2699,102700,3-Methyl-4-heptanol,CCCC(C(C)CC)O,,,,,,
2700,102701,"3,3,5-Trimethylcyclohexanecarboxaldehyde",CC1CC(CC(C1)(C)C)C=O,,,,,,
2701,102702,2-(Isopropyl)-5-methylcyclohexanecarbaldehyde,CC1CCC(C(C1)C=O)C(C)C,,,,,,
2702,102703,3-Hydroxybutyl acetate,CC(CCOC(=O)C)O,,,,,,
2703,102704,4-Methyl-9H-fluoren-9-ol,CC1=C2C(=CC=C1)C(C3=CC=CC=C32)O,,,,,,
2704,102705,Tris(2-ethylhexyl)amine,CCCCC(CC)CN(CC(CC)CCCC)CC(CC)CCCC,,,,,,
2705,102706,"2,6-Dimethyloct-7-en-4-one",CC(C)CC(=O)CC(C)C=C,,,,,,
2706,102707,"O,O-Diethyl S-(1,2,2-trichloroethyl) phosphorothioate",CCOP(=O)(OCC)SC(C(Cl)Cl)Cl,,,,,,
2707,102708,"[[(1,1-Dimethylpent-4-en-2-ynyl)oxy]methyl]oxirane",CC(C)(C#CC=C)OCC1CO1,,,,,,
2708,102709,"1,2,3,4,7,7-Hexachloro-5-(2,2,3,3-tetrafluorocyclobutyl)bicyclo[2.2.1]hept-2-ene",C1C(C2(C(=C(C1(C2(Cl)Cl)Cl)Cl)Cl)Cl)C3CC(C3(F)F)(F)F,,,,,,
2709,102710,Fenethylline hydrochloride,CC(CC1=CC=CC=C1)NCCN2C=NC3=C2C(=O)N(C(=O)N3C)C.Cl,,,"['A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)']",,,
2710,102711,"2-(2,2,3-Trimethyl-4-oxocyclopentyl)ethyl acetate",CC1C(=O)CC(C1(C)C)CCOC(=O)C,,,,,,
2711,102712,"2,5-Dimethylpyrrolidine-1-propanol",CC1CCC(N1CCCO)C,,,,,,
2712,102713,"7-(2-Chloropropyl)-3,7-dihydro-1,3-dimethyl-1H-purine-2,6-dione",CC(CN1C=NC2=C1C(=O)N(C(=O)N2C)C)Cl,,,,,,
2713,102714,"3,4,6,7,8,9-Hexahydro-4,6,6,9,9-pentamethyl-1H-naphtho[2,3-c]pyran",CC1COCC2=CC3=C(C=C12)C(CCC3(C)C)(C)C,,,,,,
2714,102715,"6-Fluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-yl 2,2-dimethylpropanoate",CC1CC2C3CC(C4=CC(=O)C=CC4(C3C(CC2(C1(C(=O)COC(=O)C(C)(C)C)O)C)O)C)F,,,,,,
2715,102716,2-tert-Butoxytetrahydrofuran,CC(C)(C)OC1CCCO1,,,,,,
2716,102717,Tetrahydro-2-(2-phenylethoxy)-2H-pyran,C1CCOC(C1)OCCC2=CC=CC=C2,,,,,,
2717,102718,2-(Hexyloxy)tetrahydro-2H-pyran,CCCCCCOC1CCCCO1,,,,,,
2718,102719,Trimeprazine hydrochloride,CC(CN1C2=CC=CC=C2SC3=CC=CC=C31)CN(C)C.Cl,,,,,,
2719,102720,3-(2-Bornyl)cyclohexan-1-ol,CC1(C2CCC1(C(C2)C3CCCC(C3)O)C)C,,,,,,
2720,102721,"1-[2-(2,3-Dihydroxypropoxy)phenyl]propan-1-one",CCC(=O)C1=CC=CC=C1OCC(CO)O,,,,,,
2721,102722,"3-([1,1'-Biphenyl]-4-yloxy)propane-1,2-diol",C1=CC=C(C=C1)C2=CC=C(C=C2)OCC(CO)O,,,,,,
2722,102723,"Phenol, 4,4'-bicyclo[2.2.1]hept-2-ylidenebis-",C1CC2CC1CC2(C3=CC=C(C=C3)O)C4=CC=C(C=C4)O,,,,,,
2723,102724,"Phenol, 4,4'-(octahydro-4,7-methano-5H-inden-5-ylidene)bis-",C1CC2C(C1)C3CC2CC3(C4=CC=C(C=C4)O)C5=CC=C(C=C5)O,,,,,,
2724,102725,"2,3,4,5,6-Pentafluorobenzhydrol",C1=CC=C(C=C1)C(C2=C(C(=C(C(=C2F)F)F)F)F)O,,,,,,
2725,102726,alpha-(sec-Butyl)-alpha-(2-piperidinoethyl)-1-naphthylacetamide,CC(C)CC(CCN1CCCCC1)(C2=CC=CC3=CC=CC=C32)C(=O)N,,,,,,
2726,102727,n-Acetyltyrosinamide,CC(=O)NC(=O)C(CC1=CC=C(C=C1)O)N,,,,,,
2727,102728,"1-(3,5-Di-O-acetyl-2-deoxy-5-C-iodopentofuranosyl)-4-hydroxypyrimidin-2(1H)-one",CC(=O)OC1CC(OC1C(OC(=O)C)I)N2C=CC(=O)NC2=O,,,,,,
2728,102729,3-Methyl-1-phenylpent-1-yn-3-ol,CCC(C)(C#CC1=CC=CC=C1)O,,,,,,
2729,102730,4-Methyl-4-penten-2-ol,CC(CC(=C)C)O,,,,,,
2730,102731,4-Methylpropranolol,CC1=CC=C(C2=CC=CC=C12)OCC(CNC(C)C)O,,,,,,
2731,102732,"Ethyl 4-[[4-(ethoxycarbonyl)phenyl]azo]-4,5-dihydro-5-oxo-1-phenyl-1h-pyrazole-3-carboxylate",CCOC(=O)C1=CC=C(C=C1)N=NC2C(=NN(C2=O)C3=CC=CC=C3)C(=O)OCC,,,,,,
2732,102733,"Ethyl 4-[(2,5-dichlorophenyl)azo]-4,5-dihydro-5-oxo-1-phenyl-1h-pyrazole-3-carboxylate",CCOC(=O)C1=NN(C(=O)C1N=NC2=C(C=CC(=C2)Cl)Cl)C3=CC=CC=C3,,,,,,
2733,102734,2-(4-Chlorophenyl)-3-methylbutanenitrile,CC(C)C(C#N)C1=CC=C(C=C1)Cl,,,,,,
2734,102735,"1-[3-(2-Methyl-3-phenylprop-2-enyl)-3,8-diazabicyclo[3.2.1]octan-8-yl]propan-1-one",CCC(=O)N1C2CCC1CN(C2)CC(=CC3=CC=CC=C3)C,,,,,,
2735,102736,CID 102736,C1=CC(=CC=C1N(CCCCl)CCCl)S(=O)(=O)N,,,,,,
2736,102737,sec-Butyl isovalerate,CCC(C)OC(=O)CC(C)C,,,,,,
2737,102738,"nicotine N,N'-dioxide",C[N+]1(CCCC1C2=C[N+](=CC=C2)[O-])[O-],,,,,,
2738,102739,"2-Chlorotrideca-3,11-dien-5,7,9-triyn-1-ol",CC=CC#CC#CC#CC=CC(CO)Cl,,,,,,
2739,102740,"2,3,3,3-Tetrafluoro-2-(perfluoropropoxy)propanoyl fluoride",C(=O)(C(C(F)(F)F)(OC(C(C(F)(F)F)(F)F)(F)F)F)F,,,,,,
2740,102741,"2-(10,11-Dihydro-5h-dibenzo[b,f]azepin-5-yl)-n,n-dimethylpropan-1-amine",CC(CN(C)C)N1C2=CC=CC=C2CCC3=CC=CC=C31,,,,,,
2741,102742,"5H-Dibenz(b,f)azepine, 10,11-dihydro-5-(2'-(N,N-dimethylamino)-2'-methyl)ethyl-",CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)N(C)C,,,,,,
2742,102743,"2,6-Dibromo-3,3,5,5-tetramethylcyclohexan-1-one",CC1(CC(C(C(=O)C1Br)Br)(C)C)C,,,,,,
2743,102744,"N,N'-Dicyclohexyl-1,4-cyclohexenebis(methylamine) diacetate",CC(=O)O.CC(=O)O.C1CCC(CC1)NCC2CCC(=CC2)CNC3CCCCC3,,,,,,
2744,102745,N-[[4-[(cyclohexylamino)methyl]cyclohex-3-en-1-yl]methyl]cyclohexanamine,C1CCC(CC1)NCC2CCC(=CC2)CNC3CCCCC3,,,,,,
2745,102746,"N,N'-Bis(cyclohexylmethyl)-1,4-cyclohexenebis(methylamine) diacetate",CC(=O)O.CC(=O)O.C1CCC(CC1)CNCC2CCC(=CC2)CNCC3CCCCC3,,,,,,
2746,102747,1-cyclohexyl-N-[[4-[(cyclohexylmethylamino)methyl]cyclohex-3-en-1-yl]methyl]methanamine,C1CCC(CC1)CNCC2CCC(=CC2)CNCC3CCCCC3,,,,,,
2747,102748,"N,N'-Bis(1-indanyl)-1,4-cyclohexenebis(methylamine) dihydrochloride",C1CC(=CCC1CNC2CCC3=CC=CC=C23)CNC4CCC5=CC=CC=C45.Cl.Cl,,,,,,
2748,102749,"N-[[4-[(2,3-dihydro-1H-inden-1-ylamino)methyl]cyclohex-3-en-1-yl]methyl]-2,3-dihydro-1H-inden-1-amine",C1CC(=CCC1CNC2CCC3=CC=CC=C23)CNC4CCC5=CC=CC=C45,,,,,,
2749,102750,"Naphthalene, 1,2,3,4-tetrahydro-1,1,2,4,4,7-hexamethyl-",CC1CC(C2=C(C1(C)C)C=C(C=C2)C)(C)C,,,,,,
2750,102751,"3-(1,3-Dimethylpyrrolidin-3-yl)phenol",CC1(CCN(C1)C)C2=CC(=CC=C2)O,,,,,,
2751,102752,"2,3-Dimethylbutanal",CC(C)C(C)C=O,,,,,,
2752,102753,1-Cyclohexyl-1-propyl acetate,CCC(C1CCCCC1)OC(=O)C,,,,,,
2753,102754,(2-Bromopropyl)benzene,CC(CC1=CC=CC=C1)Br,,,,,,
2754,102755,6-Chloro-2-phenylhexanenitrile,C1=CC=C(C=C1)C(CCCCCl)C#N,,,,,,
2755,102756,p-nitrophenyl N-[(benzyloxy)carbonyl]-L-isoleucinate,CCC(C)C(C(=O)OC1=CC=C(C=C1)[N+](=O)[O-])NC(=O)OCC2=CC=CC=C2,,,,,,
2756,102757,Naphthalen-2-yl 2-benzamido-3-phenylpropanoate,C1=CC=C(C=C1)CC(C(=O)OC2=CC3=CC=CC=C3C=C2)NC(=O)C4=CC=CC=C4,,,,,,
2757,102758,m-(3-Ethyl-1-methyl-3-pyrrolidinyl)phenol,CCC1(CCN(C1)C)C2=CC(=CC=C2)O,,,,,,
2758,102759,"2-(2-(2-(Oxiranylmethoxy)ethoxy)ethyl)spiro(1,3-dioxane-5,3'-(7)oxabicyclo(4.1.0)heptane)",C1CC2(CC3C1O3)COC(OC2)CCOCCOCC4CO4,,,,,,
2759,102760,1-Ethyl-3-methylpiperidine,CCN1CCCC(C1)C,,,,,,
2760,102761,3-Chloro-1-ethylpiperidine,CCN1CCCC(C1)Cl,,,,,,
2761,102762,2-(4-Chlorophenyl)propanenitrile,CC(C#N)C1=CC=C(C=C1)Cl,,,,,,
2762,102763,2-(2-aminoacetamido)-3-(1H-indol-3-yl)propanoic acid,C1=CC=C2C(=C1)C(=CN2)CC(C(=O)O)NC(=O)CN,,,,,,
2763,102764,"1-(4-Nitrophenyl)propane-1,2,3-triol",C1=CC(=CC=C1C(C(CO)O)O)[N+](=O)[O-],,,,,,
2764,102765,[(p-Isopropylphenoxy)methyl]oxirane,CC(C)C1=CC=C(C=C1)OCC2CO2,,,,,,
2765,102766,2-[(4-Bromophenoxy)methyl]oxirane,C1C(O1)COC2=CC=C(C=C2)Br,,,,,,
2766,102767,Dipropyl tartrate,CCCOC(=O)C(C(C(=O)OCCC)O)O,,,,,,
2767,102768,Diisopropyl tartrate,CC(C)OC(=O)C(C(C(=O)OC(C)C)O)O,,,,,,
2768,102769,"3,6,10-trimethyl-3a,4,5,8,9,11a-hexahydro-3H-cyclodeca[b]furan-2-one",CC1C2CCC(=CCCC(=CC2OC1=O)C)C,,,,,,
2769,102770,"alpha,3,3-Trimethylbicyclo(2.2.1)heptane-2-butanol",CC(CCCC1C2CCC(C2)C1(C)C)O,,,,,,
2770,102771,"2,4,4-Trimethylcyclohexanone",CC1CC(CCC1=O)(C)C,,,,,,
2771,102772,Menthyl formate,CC1CCC(C(C1)OC=O)C(C)C,,,,,,
2772,102773,Fencamfamine hydrochloride,CCNC1C2CCC(C2)C1C3=CC=CC=C3.Cl,,,"['A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)', 'Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)']",,,
2773,102774,"4-Hexyl-1,3-dioxane",CCCCCCC1CCOCO1,,,,,,
2774,102775,"2-Propanol, 1,1'-(hexadecylimino)bis-",CCCCCCCCCCCCCCCCN(CC(C)O)CC(C)O,,,,,,
2775,102776,"3,4-Dihydro-4-methyl-2H-pyran",CC1CCOC=C1,,,,,,
2776,102777,Z-Orn(Z)-OH,C1=CC=C(C=C1)COC(=O)NCCCC(C(=O)O)NC(=O)OCC2=CC=CC=C2,,,,,,
2777,102778,"8-Methyl-5-(propan-2-yl)nona-6,8-dien-2-one",CC(C)C(CCC(=O)C)C=CC(=C)C,,,,,,
2778,102779,"4,7-Methano-1H-indene, 3a,4,5,6,7,7a-hexahydro-5-(2-propenyloxy)-",C=CCOC1CC2CC1C3C2CC=C3,,,,,,
2779,102780,Methyl 2-phenylbutanoate,CCC(C1=CC=CC=C1)C(=O)OC,,,,,,
2780,102781,N5-(Imino(nitroamino)methyl)-N2-((phenylmethoxy)carbonyl)-L-ornithine,C1=CC=C(C=C1)COC(=O)NC(CCCN=C(N)N[N+](=O)[O-])C(=O)O,,,,,,
2781,102782,1-(Thiophen-2-yl)ethanol,CC(C1=CC=CS1)O,,,,,,
2782,102783,"3,4-Dihydro-2,5,7,8-tetramethyl-2-(4,8,12-trimethyltridecyl)-2H-benzopyran-6-yl dihydrogen phosphate",CC1=C(C(=C(C2=C1OC(CC2)(C)CCCC(C)CCCC(C)CCCC(C)C)C)OP(=O)(O)O)C,,,,,,
2783,102784,"Sodium 4,5-dihydro-1-(2-hydroxyethyl)-1-(2-hydroxy-3-sulphonatopropyl)-2-undecyl-1H-imidazolium hydroxide",CCCCCCCCCCCC1=NCC[N+]1(CCO)CC(CS(=O)(=O)[O-])O.[OH-].[Na+],,,,,,
2784,102785,"2-Hydroxy-3-[1-(2-hydroxyethyl)-2-undecyl-4,5-dihydroimidazol-1-ium-1-yl]propane-1-sulfonic acid",CCCCCCCCCCCC1=NCC[N+]1(CCO)CC(CS(=O)(=O)O)O,,,,,,
2785,102786,alpha-[(2-Nitrophenyl)azo]-1H-benzimidazole-2-acetamide,C1=CC=C2C(=C1)NC(=N2)C(C(=O)N)N=NC3=CC=CC=C3[N+](=O)[O-],,,,,,
2786,102787,9-(3-(Dimethylamino)propyl)-2-(trifluoromethyl)thioxanthen-9-ol,CN(C)CCCC1(C2=CC=CC=C2SC3=C1C=C(C=C3)C(F)(F)F)O,,,,,,
2787,102788,5-Phenylpentan-2-ol,CC(CCCC1=CC=CC=C1)O,,,,,,
2788,102789,"Heptane, 1-chloro-3-methyl-",CCCCC(C)CCCl,,,,,,
2789,102790,"Hexane, 1-chloro-3,4-dimethyl-",CCC(C)C(C)CCCl,,,,,,
2790,102791,"1,2-Dichloro-1,1,2-trifluoro-2-(trifluoromethoxy)ethane",C(C(F)(F)Cl)(OC(F)(F)F)(F)Cl,,,,,,
2791,102792,5-Methyl 4-fluoroglutamate,COC(=O)C(CC(C(=O)O)N)F,,,,,,
2792,102793,trans-2-Phenyl-1-cyclohexanol,C1CC[C@H]([C@@H](C1)C2=CC=CC=C2)O,,,,,,
2793,102794,"3,3-Dimethoxybutan-2-ol",CC(C(C)(OC)OC)O,,,,,,
2794,102795,CID 102795,CC(C)CC(C)OC(=O)CC(C(=O)OC(C)CC(C)C)S(=O)(=O)[O-].[Na+],,,,,,
2795,102796,Sulfosuccinic acid di(1-methylisopentyl) ester,CC(C)CC(C)OC(=O)CC(C(=O)OC(C)CC(C)C)S(=O)(=O)O,,,,,,
2796,102797,"N,N'-Bis(cyclohexylethyl)-1,4-cyclohexenebis(methylamine) diacetate",CC(=O)O.CC(=O)O.C1CCC(CC1)CCNCC2CCC(=CC2)CNCCC3CCCCC3,,,,,,
2797,102798,2-cyclohexyl-N-[[4-[(2-cyclohexylethylamino)methyl]cyclohex-3-en-1-yl]methyl]ethanamine,C1CCC(CC1)CCNCC2CCC(=CC2)CNCCC3CCCCC3,,,,,,
2798,102799,"N,N'-Bis(o-chlorobenzyl)-1,4-cyclohexenebis(methylamine) dihydrochloride",C1CC(=CCC1CNCC2=CC=CC=C2Cl)CNCC3=CC=CC=C3Cl.Cl.Cl,,,,,,
2799,102800,N-[(2-chlorophenyl)methyl]-1-[4-[[(2-chlorophenyl)methylamino]methyl]cyclohex-3-en-1-yl]methanamine,C1CC(=CCC1CNCC2=CC=CC=C2Cl)CNCC3=CC=CC=C3Cl,,,,,,
2800,102801,"But-2-enedioic acid--N,N'-[cyclohexane-1,3-diylbis(methylene)]bis[1-(2-chlorophenyl)methanamine] (2/1)",C1CC(CC(C1)CNCC2=CC=CC=C2Cl)CNCC3=CC=CC=C3Cl.C(=CC(=O)O)C(=O)O.C(=CC(=O)O)C(=O)O,,,,,,
2801,102802,1-(2-chlorophenyl)-N-[[3-[[(2-chlorophenyl)methylamino]methyl]cyclohexyl]methyl]methanamine,C1CC(CC(C1)CNCC2=CC=CC=C2Cl)CNCC3=CC=CC=C3Cl,,,,,,
2802,102803,4-(1-Hydroxyethyl)phenol,CC(C1=CC=C(C=C1)O)O,,,,,,
2803,102804,"(-)-2,3-Dimethylbutane-1,2,3-tricarboxylic acid",CC(C)(C(=O)O)C(C)(CC(=O)O)C(=O)O,,,,,,
2804,102805,"6,10-Dodecadien-1-yn-3-ol, 3,7,11-trimethyl-",CC(=CCCC(=CCCC(C)(C#C)O)C)C,,,,,,
2805,102806,"Methyl N6-((1,1-dimethylethoxy)carbonyl)-N2-((phenylmethoxy)carbonyl)-L-lysinate",CC(C)(C)OC(=O)NCCCCC(C(=O)OC)NC(=O)OCC1=CC=CC=C1,,,,,,
2806,102807,2-Acetamido-5-guanidinopentanoic acid,CC(=O)NC(CCCN=C(N)N)C(=O)O,,,,,,
2807,102808,"2-(1,3-Dioxo-1,3-dihydro-2H-isoindol-2-yl)-4-methylpentanoic acid",CC(C)CC(C(=O)O)N1C(=O)C2=CC=CC=C2C1=O,,,,,,
2808,102809,"1,4-Dichlorobutane-2,3-diol",C(C(C(CCl)O)O)Cl,,,,,,
2809,102810,"1-Aziridineethanol, beta-phenyl-",C1CN1C(CO)C2=CC=CC=C2,,,,,,
2810,102811,"2-Propenoic acid, 2-hydroxybutyl ester",CCC(COC(=O)C=C)O,,,,,,
2811,102812,2-Bromo-1-phenylethanol,C1=CC=C(C=C1)C(CBr)O,,,,,,
2812,102813,Brilliant Yellow 6G,CC1=CC(=C(C=C1N=NC(C(=O)C)C(=O)NC2=CC=CC=C2)S(=O)(=O)[O-])C3=C(C=C(C(=C3)C)N=NC(C(=O)C)C(=O)NC4=CC=CC=C4)S(=O)(=O)[O-].[Na+].[Na+],,,,,,
2813,102814,"4,4'-Bis[(1-anilino-1,3-dioxobutan-2-yl)diazenyl]-5,5'-dimethyl[1,1'-biphenyl]-2,2'-disulfonic acid",CC1=CC(=C(C=C1N=NC(C(=O)C)C(=O)NC2=CC=CC=C2)S(=O)(=O)O)C3=C(C=C(C(=C3)C)N=NC(C(=O)C)C(=O)NC4=CC=CC=C4)S(=O)(=O)O,,,,,,
2814,102815,"Butanethioic acid, 3-methyl-, S-(1-methylpropyl) ester",CCC(C)SC(=O)CC(C)C,,,,,,
2815,102816,2-Heptyltetrahydrofuran,CCCCCCCC1CCCO1,,,,,,
2816,102817,2-Methylbutyl propionate,CCC(C)COC(=O)CC,,,,,,
2817,102818,(S)-4-[[2-[(4-nitrophenyl)amino]-2-oxo-1-(phenylmethyl)ethyl]amino]-4-oxobutyric acid,C1=CC=C(C=C1)CC(C(=O)NC2=CC=C(C=C2)[N+](=O)[O-])NC(=O)CCC(=O)O,,,,,,
2818,102819,"(3-Hydroxy-2-octadeca-9,12-dienoyloxypropyl) octadeca-9,12-dienoate",CCCCCC=CCC=CCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCC=CCC=CCCCCC,,,,,,
2819,102820,Isobutyl 2-methylbutyrate,CCC(C)C(=O)OCC(C)C,,,,,,
2820,102821,Barium bis(2-ethylhexanoate),CCCCC(CC)C(=O)[O-].CCCCC(CC)C(=O)[O-].[Ba+2],,,,,,
2821,102822,Strontium 2-ethylhexanoate,CCCCC(CC)C(=O)[O-].CCCCC(CC)C(=O)[O-].[Sr+2],,,,,,
2822,102823,beta-Methyl-1H-indole-1-propionic acid,CC(CC(=O)O)N1C=CC2=CC=CC=C21,,,,,,
2823,102824,"4,4'-Bis(2,3-epoxypropoxy)biphenyl",C1C(O1)COC2=CC=C(C=C2)C3=CC=C(C=C3)OCC4CO4,,,,,,
2824,102825,Tricyclohexyl borate,B(OC1CCCCC1)(OC2CCCCC2)OC3CCCCC3,,,,,,
2825,102826,"4-nitrophenyl N-[(1,1-dimethylethoxy)carbonyl]-L-alaninate",CC(C(=O)OC1=CC=C(C=C1)[N+](=O)[O-])NC(=O)OC(C)(C)C,,,,,,
2826,102827,BOC-DL-Methionine,CC(C)(C)OC(=O)NC(CCSC)C(=O)O,,,,,,
2827,102828,Methyl 2-methylstearate,CCCCCCCCCCCCCCCCC(C)C(=O)OC,,,,,,
2828,102829,2-Methylheptadecan-1-ol,CCCCCCCCCCCCCCCC(C)CO,,,,,,
2829,102830,"Perfluoro-5,6-dimethyl-4,7-dioxadecane",C(C(C(F)(F)F)(OC(C(C(F)(F)F)(F)F)(F)F)F)(C(F)(F)F)(OC(C(C(F)(F)F)(F)F)(F)F)F,,,,,,
2830,102831,4-Amino-5-oxo-1-(p-sulphophenyl)-2-pyrazoline-3-carboxylic acid,C1=CC(=CC=C1N2C(=O)C(C(=N2)C(=O)O)N)S(=O)(=O)O,,,,,,
2831,102832,"1,2-Dimethylcyclopropane",CC1CC1C,,,,,,
2832,102833,5-Hexylfuran-2(5H)-one,CCCCCCC1C=CC(=O)O1,,,,,,
2833,102834,"Methyl (R)-4,5-dihydro-2-methylthiazole-4-carboxylate",CC1=NC(CS1)C(=O)OC,,,,,,
2834,102835,2-(3-Methyl-2-butenyl)cyclopentanone,CC(=CCC1CCCC1=O)C,,,,,,
2835,102836,Tetradecylsuccinic acid,CCCCCCCCCCCCCCC(CC(=O)O)C(=O)O,,,,,,
2836,102837,Hexadecylsuccinic acid,CCCCCCCCCCCCCCCCC(CC(=O)O)C(=O)O,,,,,,
2837,102838,Octylsuccinic acid,CCCCCCCCC(CC(=O)O)C(=O)O,,,,,,
2838,102839,Decyl hydrogen succinate,CCCCCCCCCCC(CC(=O)O)C(=O)O,,,,,,
2839,102840,8-Heptadecanol,CCCCCCCCCC(CCCCCCC)O,,,,,,
2840,102841,"2-Amino-3-(3,4-dimethoxyphenyl)-2-methylpropanenitrile",CC(CC1=CC(=C(C=C1)OC)OC)(C#N)N,,,,,,
2841,102842,"1,20-Difluoro-9,12-dimethylicosane",CC(CCCCCCCCF)CCC(C)CCCCCCCCF,,,,,,
2842,102843,"4,6,6-Trimethyloxepan-2-one",CC1CC(=O)OCC(C1)(C)C,,,,,,
2843,102844,"4,7-Dimethyloct-6-en-3-one",CCC(=O)C(C)CC=C(C)C,,,,,,
2844,102845,"5-Hepten-2-one, 3-ethyl-6-methyl-",CCC(CC=C(C)C)C(=O)C,,,,,,
2845,102846,3-Methylhexan-2-one,CCCC(C)C(=O)C,,,,,,
2846,102847,3-Methyl-4-phenylbutan-2-one,CC(CC1=CC=CC=C1)C(=O)C,,,,,,
2847,102848,3-Methylpyrrolidin-2-one,CC1CCNC1=O,,,,,,
2848,102849,(2-(1-Ethoxyethoxy)ethyl)benzene,CCOC(C)OCCC1=CC=CC=C1,,,,,,
2849,102850,2-Methyloctanenitrile,CCCCCCC(C)C#N,,,,,,
2850,102851,"4,7-Methanoindan, 1,4,5,6,7,8,8-heptachloro-3a,4,7,7a-tetrahydro-",C1CC(C2C1C3(C(=C(C2(C3(Cl)Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
2851,102852,3-Methylpiperidine-1-carbaldehyde,CC1CCCN(C1)C=O,,,,,,
2852,102853,"4-nitrophenyl N2,N6-bis[(1,1-dimethylethoxy)carbonyl]-L-lysinate",CC(C)(C)OC(=O)NCCCCC(C(=O)OC1=CC=C(C=C1)[N+](=O)[O-])NC(=O)OC(C)(C)C,,,,,,
2853,102854,"6,7,8,9,10,10-Hexachloro-1,5,5a,6,9,9a-hexahydro-3-methyl-6,9-methano-2,4-benzodioxepin",CC1OCC2C(CO1)C3(C(=C(C2(C3(Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
2854,102855,2-Methylbutyl hexanoate,CCCCCC(=O)OCC(C)CC,,,,,,
2855,102856,(3-Glycidyloxypropyl)triethoxysilane,CCO[Si](CCCOCC1CO1)(OCC)OCC,,,,,,
2856,102857,"Propanenitrile, 2-(trichlorosilyl)-",CC(C#N)[Si](Cl)(Cl)Cl,,,,,,
2857,102858,2-Bromononanoic acid,CCCCCCCC(C(=O)O)Br,,,,,,
2858,102859,2-Bromoundecanoic acid,CCCCCCCCCC(C(=O)O)Br,,,,,,
2859,102860,3-Bromobutyric acid,CC(CC(=O)O)Br,,,,,,
2860,102861,Methyl dihydrojasmonate,CCCCCC1C(CCC1=O)CC(=O)OC,,,,,,
2861,102862,3-Allyl-6-methylhept-5-en-2-one,CC(=CCC(CC=C)C(=O)C)C,,,,,,
2862,102863,Hexafluoropropene oxide trimer,C(=O)(C(C(F)(F)F)(OC(C(C(F)(F)F)(OC(C(C(F)(F)F)(F)F)(F)F)F)(F)F)F)F,,,,,,
2863,102864,"8-Methoxy-6-(p-methoxyphenyl)-13-methyl-6,12-methano-12H-dibenzo(d,g)(1,3)dioxocin-3-ol acetate",CC1C2C3=C(C(=CC=C3)OC)OC1(OC4=C2C=CC(=C4)OC(=O)C)C5=CC=C(C=C5)OC,,,,,,
2864,102865,"Oxirane, ((4-ethenylphenoxy)methyl)-",C=CC1=CC=C(C=C1)OCC2CO2,,,,,,
2865,102866,2-Acetyl-4-methyl-1-phenylpyrazolidin-3-one,CC1CN(N(C1=O)C(=O)C)C2=CC=CC=C2,,,,,,
2866,102867,"Butanedioic acid, ((diethoxyphosphinyl)thio)-, diethyl ester",CCC(=O)OCC(OC(=O)CC)SP(=O)(OCC)OCC,,,,,,
2867,102868,CID 102868,CCC1(C(=NC(=O)N1)S)C,,,,,,
2868,102869,"1-[4-(2,3-Dihydroxypropoxy)phenyl]propan-1-one",CCC(=O)C1=CC=C(C=C1)OCC(CO)O,,,,,,
2869,102870,Methyl 3-oxotetrahydrothiophene-2-carboxylate,COC(=O)C1C(=O)CCS1,,,,,,
2870,102871,4-Fluoroglutamic acid,C(C(C(=O)O)N)C(C(=O)O)F,,,,,,
2871,102872,"Triethyl 1,3-difluoro-2-hydroxypropane-1,2,3-tricarboxylate",CCOC(=O)C(C(C(C(=O)OCC)F)(C(=O)OCC)O)F,,,,,,
2872,102873,"2-Butanamine, N-ethyl-3-methyl-",CCNC(C)C(C)C,,,,,,
2873,102874,"Hexahydro-4,8-ethano-1H,3H-benzo(1,2-c:4,5-c')difuran-1,3,5,7-tetrone",C1CC2C3C(C1C4C2C(=O)OC4=O)C(=O)OC3=O,,,,,,
2874,102875,CID 102875,CCCCCCC(CC=CCCCCCCCC(=O)O)O.C(CO)N(CCO)CCO,,,,,,
2875,102876,Ethylenebis(N-4-carboxy-2-pyrrolidone),C1C(CN(C1=O)CCN2CC(CC2=O)C(=O)O)C(=O)O,,,,,,
2876,102877,"2,4-Bis(1-phenylethyl)phenol",CC(C1=CC=CC=C1)C2=CC(=C(C=C2)O)C(C)C3=CC=CC=C3,,,,,,
2877,102878,"Phosphonic acid, P-phenyl-, bis(1-methylpropyl) ester",CCC(C)OP(=O)(C1=CC=CC=C1)OC(C)CC,,,,,,
2878,102879,2-alpha-Tropanyl p-nitrophenylacetate hydrochloride,CN1C2CCC1C(CC2)OC(=O)CC3=CC=C(C=C3)[N+](=O)[O-].Cl,,,,,,
2879,102880,(8-Methyl-8-azabicyclo[3.2.1]octan-2-yl) 2-(4-nitrophenyl)acetate,CN1C2CCC1C(CC2)OC(=O)CC3=CC=C(C=C3)[N+](=O)[O-],,,,,,
2880,102881,alpha-Ethyl-alpha-(2-dimethylaminoethyl)-1-naphthylacetamide,CCC(CCN(C)C)(C1=CC=CC2=CC=CC=C21)C(=O)N,,,,,,
2881,102882,"Valeramide, 3-methyl-2-(2-morpholinoethyl)-2-(1-naphthyl)-",CC(C)CC(CCN1CCOCC1)(C2=CC=CC3=CC=CC=C32)C(=O)N,,,,,,
2882,102883,"2,3-Dihydro-5-methoxy-7,8-dimethyl-2-phenyl-4H-1-benzopyran-4-one",CC1=CC(=C2C(=O)CC(OC2=C1C)C3=CC=CC=C3)OC,,,,,,
2883,102884,Tert-butyl pyrrolidine-2-carboxylate,CC(C)(C)OC(=O)C1CCCN1,,,,,,
2884,102885,"4-Isopropyloxazolidine-2,5-dione",CC(C)C1C(=O)OC(=O)N1,,,,,,
2885,102886,11-Fluoro-4-methylundecanoic acid,CC(CCCCCCCF)CCC(=O)O,,,,,,
2886,102887,"5-(2,2-Dimethyl-1,3-dioxolan-4-yl)-2,2-dimethyl-3a,6a-dihydrofuro[2,3-d][1,3]dioxol-6-ol",CC1(OCC(O1)C2=C(C3C(O2)OC(O3)(C)C)O)C,,,,,,
2887,102888,"2,2'-Iminobispropiononitrile",CC(C#N)NC(C)C#N,,,,,,
2888,102889,"1,2-Dibromo-2,2-dichloroethyl methyl phenyl phosphate",COP(=O)(OC1=CC=CC=C1)OC(C(Cl)(Cl)Br)Br,,,,,,
2889,102890,"2,2,2-Trichloro-1-isopropoxyethanol",CC(C)OC(C(Cl)(Cl)Cl)O,,,,,,
2890,102891,Tri-O-acetyl-D-glucal,CC(=O)OCC1C(C(C=CO1)OC(=O)C)OC(=O)C,,,,,,
2891,102892,"3-Isobutylhexahydropyrrolo[1,2-a]pyrazine-1,4-dione",CC(C)CC1C(=O)N2CCCC2C(=O)N1,,,,,,
2892,102893,2-Methyldodecanoic acid,CCCCCCCCCCC(C)C(=O)O,,,,,,
2893,102894,2-Ethyldodecanoic acid,CCCCCCCCCCC(CC)C(=O)O,,,,,,
2894,102895,2-Ethyldecanoic acid,CCCCCCCCC(CC)C(=O)O,,,,,,
2895,102896,CID 102896,CC(C1=CC(=CC=C1)C(=O)OC)N2C=CN=C2S,,,,,,
2896,102897,"2,3-Epoxy-5-vinylnorbornane",C=CC1CC2CC1C3C2O3,,,,,,
2897,102898,Bicyclononadiene diepoxide,C1C2CC3C(C2CC4C1O4)O3,,,,,,
2898,102899,"Butyl 2,3,4,4-tetrachloro-3-butenoate",CCCCOC(=O)C(C(=C(Cl)Cl)Cl)Cl,,,,,,
2899,102900,"Benzoic acid, 2-[2-(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)diazenyl]-",CC1=NN(C(=O)C1N=NC2=CC=CC=C2C(=O)O)C3=CC=CC=C3,,,,,,
2900,102901,DL-Methioninol,CSCCC(CO)N,,,,,,
2901,102902,Chloro(phenyl)acetyl chloride,C1=CC=C(C=C1)C(C(=O)Cl)Cl,,,,,,
2902,102903,Bis(2-ethylhexyl) succinate,CCCCC(CC)COC(=O)CCC(=O)OCC(CC)CCCC,,,,,,
2903,102904,"Hexanamide, 2-[2,4-bis(1,1-dimethylpropyl)phenoxy]-n-[4-[(2,2,3,3,4,4,4-heptafluoro-1-oxobutyl)amino]-3-hydroxyphenyl]-",CCCCC(C(=O)NC1=CC(=C(C=C1)NC(=O)C(C(C(F)(F)F)(F)F)(F)F)O)OC2=C(C=C(C=C2)C(C)(C)CC)C(C)(C)CC,,,,,,
2904,102905,"2,3,3,3-Tetrafluoro-2-(trifluoromethoxy)propionyl fluoride",C(=O)(C(C(F)(F)F)(OC(F)(F)F)F)F,,,,,,
2905,102906,"Cyclobutene, 3,4-dichloro-",C1=CC(C1Cl)Cl,,,,,,
2906,102907,Mepazine hydrochloride,CN1CCCC(C1)CN2C3=CC=CC=C3SC4=CC=CC=C42.Cl,,,,,,
2907,102908,"Valeramide, 2-(2-dimethylaminoethyl)-3-methyl-2-phenyl-",CCC(C)C(CCN(C)C)(C1=CC=CC=C1)C(=O)N,,,,,,
2908,102909,"Valeramide, 3-methyl-2-phenyl-2-(2-piperidinoethyl)-",CCC(C)C(CCN1CCCCC1)(C2=CC=CC=C2)C(=O)N,,,,,,
2909,102910,2-Methoxy-2-phenylethanol,COC(CO)C1=CC=CC=C1,,,,,,
2910,102911,2-Methoxycyclohexan-1-ol,COC1CCCCC1O,,,,,,
2911,102912,2-Isopropoxycyclohexan-1-ol,CC(C)OC1CCCCC1O,,,,,,
2912,102913,2-tert-Butyloxycyclohexan-1-ol,CC(C)(C)OC1CCCCC1O,,,,,,
2913,102914,3-Heptyldihydrofuran-2(3H)-one,CCCCCCCC1CCOC1=O,,,,,,
2914,102915,"1,2-Dibromo-1-ethoxyethane",CCOC(CBr)Br,,,,,,
2915,102916,Ethyl 2-ethylhexanoate,CCCCC(CC)C(=O)OCC,,,,,,
2916,102917,"3-[(2-Hydroxydodecyl)oxy]propane-1,2-diol",CCCCCCCCCCC(COCC(CO)O)O,,,,,,
2917,102918,3-Acetyl-3-chlorodihydrofuran-2(3H)-one,CC(=O)C1(CCOC1=O)Cl,,,,,,
2918,102919,(3-Chloro-2-hydroxypropyl)dimethyloctadecylammonium chloride,CCCCCCCCCCCCCCCCCC[N+](C)(C)CC(CCl)O.[Cl-],,,,,,
2919,102920,"N-(3-Chloro-2-hydroxypropyl)-N,N-dimethyl-1-octadecanaminium",CCCCCCCCCCCCCCCCCC[N+](C)(C)CC(CCl)O,,,,,,
2920,102921,2-Mercaptopropanol,CC(CO)S,,,,,,
2921,102922,"2,2'-Thiodipropanol",CC(CO)SC(C)CO,,,,,,
2922,102923,Aluminium 2-ethylhexanoate,CCCCC(CC)C(=O)[O-].CCCCC(CC)C(=O)[O-].CCCCC(CC)C(=O)[O-].[Al+3],,,,,,
2923,102924,"Hexaneperoxoic acid, 2-ethyl-, 1,1-dimethylethyl ester",CCCCC(CC)C(=O)OOC(C)(C)C,,,,,,
2924,102925,"1,2-Cyclohexanedione, 4-methyl-",CC1CCC(=O)C(=O)C1,,,,,,
2925,102926,D-manno-2-Heptulose,C(C(C(C(C(C(=O)CO)O)O)O)O)O,,,,,,
2926,102927,"Octahydro-4-(oxiranylmethoxy)-2,5-methano-2H-indeno(1,2-b)oxirene",C1C2CC(C1C3C2C4C(C3)O4)OCC5CO5,,,,,,
2927,102928,4'-Methoxyflavanone,COC1=CC=C(C=C1)C2CC(=O)C3=CC=CC=C3O2,,,,,,
2928,102929,S-Acetylglutathione,CC(=O)SCC(C(=O)NCC(=O)O)NC(=O)CCC(C(=O)O)N,,,,,,
2929,102930,2-Amino-4-(tert-butoxy)-4-oxobutanoic acid,CC(C)(C)OC(=O)CC(C(=O)O)N,,,,,,
2930,102931,"2,3-Dihydroxypropyl nonan-1-oate",CCCCCCCCC(=O)OCC(CO)O,,,,,,
2931,102932,"Acetic acid 4,5-diacetoxy-6-acetoxymethyl-2-bromo-tetrahydro-pyran-3-yl ester",CC(=O)OCC1C(C(C(C(O1)Br)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
2932,102933,"(5-Acetamido-3,4-diacetyloxy-6-chlorooxan-2-yl)methyl acetate",CC(=O)NC1C(C(C(OC1Cl)COC(=O)C)OC(=O)C)OC(=O)C,,,,,,
2933,102934,"2-Isobutyl-4-methyl-1,3-dioxane",CC1CCOC(O1)CC(C)C,,,,,,
2934,102935,"2,2,4-Trimethylhexane-1,6-diol",CC(CCO)CC(C)(C)CO,,,,,,
2935,102936,"2,4,4-Trimethylhexane-1,6-diol",CC(CC(C)(C)CCO)CO,,,,,,
2936,102937,"1,4-Dihydro-1,4-methano-5,8-naphthalenediol",C1C2C=CC1C3=C(C=CC(=C23)O)O,,,,,,
2937,102938,2-acetamido-3-(4-hydroxyphenyl)-N-(4-nitrophenyl)propanamide,CC(=O)NC(CC1=CC=C(C=C1)O)C(=O)NC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
2938,102939,"Valeramide, 3-methyl-2-(2-morpholinoethyl)-2-phenyl-",CCC(C)C(CCN1CCOCC1)(C2=CC=CC=C2)C(=O)N,,,,,,
2939,102940,"Tetrakis(2-ethylhexyl) benzene-1,2,4,5-tetracarboxylate",CCCCC(CC)COC(=O)C1=CC(=C(C=C1C(=O)OCC(CC)CCCC)C(=O)OCC(CC)CCCC)C(=O)OCC(CC)CCCC,,,,,,
2940,102941,"2-Propenoic acid, 2-methyl-, thiiranylmethyl ester",CC(=C)C(=O)OCC1CS1,,,,,,
2941,102942,"2,4-bis-[N,N'-di-(carboxymethyl)-aminomethyl]fluorescein",C1=CC=C2C(=C1)C(=O)OC23C4=C(C=C(C=C4)O)OC5=C3C=C(C(=C5CN(CC(=O)O)CC(=O)O)O)CN(CC(=O)O)CC(=O)O,,,,,,
2942,102943,Bis(2-ethylhexyl) phenylphosphonate,CCCCC(CC)COP(=O)(C1=CC=CC=C1)OCC(CC)CCCC,,,,,,
2943,102944,1-(2-Amino-5-chlorophenyl)-1-phenylethanol,CC(C1=CC=CC=C1)(C2=C(C=CC(=C2)Cl)N)O,,,,,,
2944,102945,N-Benzyloxycarbonyl-L-isoleucine,CCC(C)C(C(=O)O)NC(=O)OCC1=CC=CC=C1,,,,,,
2945,102946,"6-Methoxy-2-phenyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxine-7,8-diol",COC1C(C(C2C(O1)COC(O2)C3=CC=CC=C3)O)O,,,,,,
2946,102947,Bis(2-ethylhexyl) phenyl phosphite,CCCCC(CC)COP(OCC(CC)CCCC)OC1=CC=CC=C1,,,,,,
2947,102948,"N,N'-Bis(1,3-dimethylbutylidene)hexane-1,6-diamine",CC(C)C(C)C=NCCCCCCN=CC(C)C(C)C,,,,,,
2948,102949,"Dimethyl 2,2'-(sulphonylbis(methylene))bis(3-oxoacetoacetate)",CC(=O)C(CS(=O)(=O)CC(C(=O)C)C(=O)OC)C(=O)OC,,,,,,
2949,102950,DL-Lanthionine,C(C(C(=O)O)N)SCC(C(=O)O)N,,,,,,
2950,102951,"1-Bromo-4,5,6,7,8,8-hexachloro-3,4,7,7A-tetrahydro-4,7-methano-1H-indene",C1=CC(C2C1C3(C(=C(C2(C3(Cl)Cl)Cl)Cl)Cl)Cl)Br,,,,,,
2951,102952,Oxiranylmethyl p-vinylbenzoate,C=CC1=CC=C(C=C1)C(=O)OCC2CO2,,,,,,
2952,102953,Methyl tetrahydro-5-methyl-4-oxo-3-furoate,CC1C(=O)C(CO1)C(=O)OC,,,,,,
2953,102954,"Cyclohexaneacetic acid, 3,3,5-trimethyl-",CC1CC(CC(C1)(C)C)CC(=O)O,,,,,,
2954,102955,"9,10-Anthracenedione, 1-amino-4-hydroxy-2-(3-hydroxybutoxy)-",CC(CCOC1=C(C2=C(C(=C1)O)C(=O)C3=CC=CC=C3C2=O)N)O,,,,,,
2955,102956,"Erythronolide A, 12-deoxy-",CCC1C(C(C(C(=O)C(CC(C(C(C(C(C(=O)O1)C)O)C)O)(C)O)C)C)O)C,,,,,,
2956,102957,2-Methyl-3-pentyloxirane,CCCCCC1C(O1)C,,,,,,
2957,102958,Z-Dl-Ala-Gly-OH,CC(C(=O)NCC(=O)O)NC(=O)OCC1=CC=CC=C1,,,,,,
2958,102959,3-(3-Hydroxyphenyl)-3-hydroxypropanoic acid,C1=CC(=CC(=C1)O)C(CC(=O)O)O,,,,,,
2959,102960,Alanylhistidine,CC(C(=O)NC(CC1=CN=CN1)C(=O)O)N,,,,,,
2960,102961,4-nitrophenyl N2-[(benzyloxy)carbonyl]-L-asparaginate,C1=CC=C(C=C1)COC(=O)NC(CC(=O)N)C(=O)OC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
2961,102962,CID 102962,CC(C1=CC(=CC=C1)N=C2C=CC(=O)C3=C2C(=O)C4=C(C=CC(=O)C4=C3O)N(O)O)O,,,,,,
2962,102963,CID 102963,CC(C1=CC(=CC=C1)N=C2C=CC(=O)C3=C2C(=C4C(=O)C=CC(=C4C3=O)N(O)O)O)O,,,,,,
2963,102964,"2-Propanol, 1,1'-(1,2-ethanediyldiimino)bis-",CC(CNCCNCC(C)O)O,,,,,,
2964,102965,Dihydro-5-methyl-5-(3-methylbutyl)furan-2(3H)-one,CC(C)CCC1(CCC(=O)O1)C,,,,,,
2965,102966,2-Oxo-cyclopentanepropionic acid,C1CC(C(=O)C1)CCC(=O)O,,,,,,
2966,102967,"2,4,5-Trimethyl-1,3-dioxolane",CC1C(OC(O1)C)C,,,,,,
2967,102968,6-Ethyltetrahydro-2H-pyran-2-one,CCC1CCCC(=O)O1,,,,,,
2968,102969,N5-Benzyloxycarbonyl-L-ornithine,C1=CC=C(C=C1)COC(=O)NCCCC(C(=O)O)N,,,,,,
2969,102970,Carbobenzyloxy-L-proline p-nitrophenyl ester,C1CC(N(C1)C(=O)OCC2=CC=CC=C2)C(=O)OC3=CC=C(C=C3)[N+](=O)[O-],,,,,,
2970,102971,"2-Amino-1-phenyl-1,3-propanediol",C1=CC=C(C=C1)C(C(CO)N)O,,,,,,
2971,102972,p-(1-Ethylhexyl)phenol,CCCCCC(CC)C1=CC=C(C=C1)O,,,,,,
2972,102973,p-(1-Propylpentyl)phenol,CCCCC(CCC)C1=CC=C(C=C1)O,,,,,,
2973,102974,"4-(3-Chloropropyl)-4-(4-fluorophenyl)-1,3-dioxolane",C1C(OCO1)(CCCCl)C2=CC=C(C=C2)F,,,,,,
2974,102975,"2,2-Dichloroethenyl 2,3-dichloropropyl ethyl phosphate",CCOP(=O)(OCC(CCl)Cl)OC=C(Cl)Cl,,,,,,
2975,102976,1-(4-Chloro-1-phenylbutyl)-4-fluorobenzene,C1=CC=C(C=C1)C(CCCCl)C2=CC=C(C=C2)F,,,,,,
2976,102977,"2-(4-(2,3-Epoxypropoxy)phenyl)-6-oxabicyclo(3.1.0)hexane",C1CC2C(C1C3=CC=C(C=C3)OCC4CO4)O2,,,,,,
2977,102978,"5,6-Dichloro-1-ethyl-3-(3-sulfobutyl)-2-[3-[5,6-dichloro-1-ethyl-3-(3-sulfobutyl)-2,3-dihydro-1H-benzimidazole-2-ylidene]-1-propenyl]-1H-benzimidazole-3-ium",CCN1C2=CC(=C(C=C2[N+](=C1C=CC=C3N(C4=CC(=C(C=C4N3CCC(C)S(=O)(=O)O)Cl)Cl)CC)CCC(C)S(=O)(=O)O)Cl)Cl,,,,,,
2978,102979,(S)-alpha-Amino-N-2-naphthyl-1H-indole-3-propionamide,C1=CC=C2C=C(C=CC2=C1)NC(=O)C(CC3=CNC4=CC=CC=C43)N,,,,,,
2979,102980,(2S-trans)-4-Hydroxy-N-2-naphthylpyrrolidine-2-carboxamide,C1CC(NC1)C(=O)NC2=CC3=CC=CC=C3C(=C2)O,,,,,,
2980,102981,"3,5-Dimethylhex-1-en-3-ol",CC(C)CC(C)(C=C)O,,,,,,
2981,102982,"2H-Perfluoro-5-methyl-3,6-dioxanonane",C(C(F)(F)F)(OC(C(C(F)(F)F)(OC(C(C(F)(F)F)(F)F)(F)F)F)(F)F)F,,,,,,
2982,102983,"Propane, 1,1,1,2,3,3-hexafluoro-2-(heptafluoropropoxy)-3-(1,2,2-trifluoro-2-(1,2,2,2-tetrafluoroethoxy)-1-(trifluoromethyl)ethoxy)-",C(C(F)(F)F)(OC(C(C(F)(F)F)(OC(C(C(F)(F)F)(OC(C(C(F)(F)F)(F)F)(F)F)F)(F)F)F)(F)F)F,,,,,,
2983,102984,1-Methyl-4-(propan-2-ylidene)cyclohex-2-en-1-yl hydroperoxide,CC(=C1CCC(C=C1)(C)OO)C,,,,,,
2984,102985,Einecs 222-058-8,C[C@]12C[C@@H]([C@H]3[C@H]([C@@H]1CC[C@@]2(C(=O)COC(=O)C4CC=CCC4C(=O)O)O)CCC5=CC(=O)C=C[C@]35C)O,,,,,,
2985,102986,"tert-Butyl (S)-4-((2,5-dioxo-1-pyrrolidinyl)oxy)-4-oxo-3-(((phenylmethoxy)carbonyl)amino)butyrate",CC(C)(C)OC(=O)CC(C(=O)ON1C(=O)CCC1=O)NC(=O)OCC2=CC=CC=C2,,,,,,
2986,102987,Tolpropamine hydrochloride,CC1=CC=C(C=C1)C(CCN(C)C)C2=CC=CC=C2.Cl,,,,,,
2987,102988,p-Nitrophenyl N-(tert-butoxycarbonyl)-L-leucinate,CC(C)CC(C(=O)OC1=CC=C(C=C1)[N+](=O)[O-])NC(=O)OC(C)(C)C,,,,,,
2988,102989,1-Methyl-2-(4-methylphenyl)piperidine,CC1=CC=C(C=C1)C2CCCCN2C,,,,,,
2989,102990,"3a,4,5,6,7,7a-Hexahydro-4,7-methano-1H-inden-6-ol",C1C=CC2C1C3CC2CC3O,,,,,,
2990,102991,Di(tetrahydrofurfuryl) phthalate,C1CC(OC1)COC(=O)C2=CC=CC=C2C(=O)OCC3CCCO3,,,,,,
2991,102992,"2-Vinylspiro(1,3-dioxane-5,3'-(7)oxabicyclo(4.1.0)heptane)",C=CC1OCC2(CCC3C(C2)O3)CO1,,,,,,
2992,102993,"2,4-Dimethyl-1,3-dioxolane",CC1COC(O1)C,,,,,,
2993,102994,"(2,5-Dioxopyrrolidin-1-yl) 3-methyl-2-(phenylmethoxycarbonylamino)pentanoate",CCC(C)C(C(=O)ON1C(=O)CCC1=O)NC(=O)OCC2=CC=CC=C2,,,,,,
2994,102995,"2,5-Dioxopyrrolidin-1-yl 1-(tert-butoxycarbonyl)prolinate",CC(C)(C)OC(=O)N1CCCC1C(=O)ON2C(=O)CCC2=O,,,,,,
2995,102996,2-(Octadecanoylamino)pentanedioic acid,CCCCCCCCCCCCCCCCCC(=O)NC(CCC(=O)O)C(=O)O,,,,,,
2996,102997,"(2,5-Dioxopyrrolidin-1-yl) 3-phenyl-2-(phenylmethoxycarbonylamino)propanoate",C1CC(=O)N(C1=O)OC(=O)C(CC2=CC=CC=C2)NC(=O)OCC3=CC=CC=C3,,,,,,
2997,102998,"Benzyl (S)-2-(((2,5-dioxo-1-pyrrolidinyl)oxy)carbonyl)pyrrolidine-1-carboxylate",C1CC(N(C1)C(=O)OCC2=CC=CC=C2)C(=O)ON3C(=O)CCC3=O,,,,,,
2998,102999,"Benzyl (S)-(1-(((2,5-dioxo-1-pyrrolidinyl)oxy)carbonyl)-3-methylbutyl)carbamate",CC(C)CC(C(=O)ON1C(=O)CCC1=O)NC(=O)OCC2=CC=CC=C2,,,,,,
2999,103000,"Oxaziridine, 2-methyl-3-phenyl-",CN1C(O1)C2=CC=CC=C2,,,,,,
3000,103001,"2-Bromo-1,1-diethoxypropane",CCOC(C(C)Br)OCC,,,,,,
3001,103002,4-Methylhex-2-ene,CCC(C)C=CC,,,,,,
3002,103003,3-Ethylhex-1-ene,CCCC(CC)C=C,,,,,,
3003,103004,2-Ethyl-3-methyl-1-pentene,CCC(C)C(=C)CC,,,,,,
3004,103005,"3-(5,5,6-Trimethylbicyclo[2.2.1]hept-2-yl)cyclohexanol",CC1C2CC(C1(C)C)CC2C3CCCC(C3)O,,,,,,
3005,103006,"2-Naphthalenecarboxylic acid, 1,2-dihydro-",C1C(C=CC2=CC=CC=C21)C(=O)O,,,,,,
3006,103007,8-Isopropyl-8-azabicyclo[3.2.1]octan-3-ol,CC(C)N1C2CCC1CC(C2)O,,,,,,
3007,103008,Acetylpseudotropine,CC(=O)OC1CC2CCC(C1)N2C,,,,,,
3008,103009,8-Isopropyl-8-azabicyclo[3.2.1]octan-3-one,CC(C)N1C2CCC1CC(=O)C2,,,,,,
3009,103010,3-sec-Butylsydnone,CCC(C)[N+]1=NOC(=C1)[O-],,,,,,
3010,103011,3-butan-2-yl-2H-oxadiazol-3-ium-5-one,CCC(C)[N+]1=CC(=O)ON1,,,,,,
3011,103012,Chromium(III) 2-ethylhexanoate,CCCCC(CC)C(=O)[O-].CCCCC(CC)C(=O)[O-].CCCCC(CC)C(=O)[O-].[Cr+3],,,,,,
3012,103013,"3-Hydrazinyltetrahydrothiophene 1,1-dioxide",C1CS(=O)(=O)CC1NN,,,,,,
3013,103014,Benfurodil,CC1=C(OC2=C1C=C(C=C2)C3=CC(=O)OC3)C(C)O,,,,,,
3014,103015,"1-(2,3-Epoxypropoxy)-2,2-bis[(2,3-epoxypropoxy)methyl]butane",CCC(COCC1CO1)(COCC2CO2)COCC3CO3,,,,,,
3015,103016,2-(4-Chlorophenyl)-3-(furan-2-yl)propanoic acid,C1=COC(=C1)CC(C2=CC=C(C=C2)Cl)C(=O)O,,,,,,
3016,103017,1-Phenylethyl valerate,CCCCC(=O)OC(C)C1=CC=CC=C1,,,,,,
3017,103018,1-Phenylethyl hexanoate,CCCCCC(=O)OC(C)C1=CC=CC=C1,,,,,,
3018,103019,"13,26-Dimethyl-2,15-dioxa-12,25-diazatricyclo[22.2.2.2~11,14~]triacontane-3,16-dione",CC1C2CCC(N1)CCCCCCCC(=O)OC3CCC(CCCCCCCC(=O)O2)NC3C,,,,,,
3019,103020,2-Phenylpiperidine,C1CCNC(C1)C2=CC=CC=C2,,,,,,
3020,103021,2-Hydroxy-3-(2-methylphenoxy)propyl o-acetylsalicylate,CC1=CC=CC=C1OCC(COC(=O)C2=CC=CC=C2OC(=O)C)O,,,,,,
3021,103022,1-[4-(2-Methylbutan-2-yl)phenoxy]butan-2-yl prop-2-yn-1-yl sulfite,CCC(COC1=CC=C(C=C1)C(C)(C)CC)OS(=O)OCC#C,,,,,,
3022,103023,"(3S)-2-(1,2-dihydroxyethyl)oxolane-3,4-diol",C1C([C@@H](C(O1)C(CO)O)O)O,,,,,,
3023,103024,"3-beta,17-alpha-Dihydroxy-16-beta-methylpregn-5-en-20-one",C[C@H]1C[C@H]2[C@@H]3CC=C4C[C@H](CC[C@@]4([C@H]3CC[C@@]2([C@]1(C(=O)C)O)C)C)O,,,,,,
3024,103025,2-Benzylaziridine,C1C(N1)CC2=CC=CC=C2,,,,,,
3025,103026,1-Deoxy-1-nitro-D-glucitol,C([C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O)[N+](=O)[O-],,,,,,
3026,103027,trans-Dioxathion,CCOP(=S)(OCC)S[C@H]1[C@@H](OCCO1)SP(=S)(OCC)OCC,,,,,,
3027,103028,cis-Dioxathion,CCOP(=S)(OCC)S[C@@H]1[C@@H](OCCO1)SP(=S)(OCC)OCC,,,,,,
3028,103029,"6,10,14-Trimethylpentadeca-4,5-dien-2-one",CC(C)CCCC(C)CCCC(=C=CCC(=O)C)C,,,,,,
3029,103030,"Dimethyl alpha,alpha'-dichlorotricyclo(3.3.1.13,7)decane-1,3-diacetate",COC(=O)C(C12CC3CC(C1)CC(C3)(C2)C(C(=O)OC)Cl)Cl,,,,,,
3030,103031,"2-(2,4-Hexadiynylidene)-1,6-dioxaspiro[4.4]non-3-ene",CC#CC#CC=C1C=CC2(O1)CCCO2,,,,,,
3031,103032,4-Hydroxypent-2-enal,CC(C=CC=O)O,,,,,,
3032,103033,"5-Isopropylimidazolidine-2,4-dione",CC(C)C1C(=O)NC(=O)N1,,,,,,
3033,103034,"(R)-(+)-N,N-Dimethyl-1-phenylethylamine",C[C@H](C1=CC=CC=C1)N(C)C,,,,,,
3034,103035,"9,10-Dichloro-12-hydroxyoctadecanoic acid",CCCCCCC(CC(C(CCCCCCCC(=O)O)Cl)Cl)O,,,,,,
3035,103036,"Peroxide, acetyl (octadecyloxy)carbonyl",CCCCCCCCCCCCCCCCCCOC(=O)OOC(=O)C,,,,,,
3036,103037,"Benzoic acid, 4-butyl-, 2-methyl-1,4-phenylene ester",CCCCC1=CC=C(C=C1)C(=O)OC2=CC(=C(C=C2)OC(=O)C3=CC=C(C=C3)CCCC)C,,,,,,
3037,103038,"4-Methyl-4'-pentyl-1,1'-biphenyl",CCCCCC1=CC=C(C=C1)C2=CC=C(C=C2)C,,,,,,
3038,103039,"Propanoic acid, 3,3-dichloro-2,2-dimethyl-",CC(C)(C(Cl)Cl)C(=O)O,,,,,,
3039,103040,"2-Anthracenecarboxylic acid, 1-amino-9,10-dihydro-4-[(4-methylphenyl)amino]-9,10-dioxo-, methyl ester",CC1=CC=C(C=C1)NC2=C3C(=C(C(=C2)C(=O)OC)N)C(=O)C4=CC=CC=C4C3=O,,,,,,
3040,103041,"2-[4-[2-[4-(3-Methyl-1,2,4-oxadiazol-5-yl)phenyl]ethenyl]phenyl]-1,3-benzoxazole",CC1=NOC(=N1)C2=CC=C(C=C2)C=CC3=CC=C(C=C3)C4=NC5=CC=CC=C5O4,,,,,,
3041,103042,"Ethanol, 2,2'-[(2-hydroxyethyl)imino]bis-, 1,1'-diacetate",CC(=O)OCCN(CCO)CCOC(=O)C,,,,,,
3042,103043,3-Chloro-4-(dimethylamino)benzenediazonium tetrafluoroborate,[B-](F)(F)(F)F.CN(C)C1=C(C=C(C=C1)[N+]#N)Cl,,,,,,
3043,103044,"Benzenediazonium, 3-chloro-4-(dimethylamino)-",CN(C)C1=C(C=C(C=C1)[N+]#N)Cl,,,,,,
3044,103045,"1-Butanesulfonic acid, 4-[(4-amino-3-methylphenyl)(1-methylethyl)amino]-",CC1=C(C=CC(=C1)N(CCCCS(=O)(=O)O)C(C)C)N,,,,,,
3045,103046,"Octanoic acid, 3-(5-(1,1-dimethylethyl)-1,3,4-thiadiazol-2-yl)-1-methyl-2-oxo-4-imidazolidinyl ester",CCCCCCCC(=O)OC1CN(C(=O)N1C2=NN=C(S2)C(C)(C)C)C,,,,,,
3046,103047,4-Heptyl-N-phenylaniline,CCCCCCCC1=CC=C(C=C1)NC2=CC=CC=C2,,,,,,
3047,103048,4-Heptyl-N-(4-heptylphenyl)aniline,CCCCCCCC1=CC=C(C=C1)NC2=CC=C(C=C2)CCCCCCC,,,,,,
3048,103049,"Phenol, 2-(1-ethylcyclopentyl)-4,6-dimethyl-",CCC1(CCCC1)C2=CC(=CC(=C2O)C)C,,,,,,
3049,103050,"2-Chloro-3-dodecyl-1,4-naphthoquinone",CCCCCCCCCCCCC1=C(C(=O)C2=CC=CC=C2C1=O)Cl,,,,,,
3050,103051,CID 103051,CCCCCCCCC=CCCCCCCCC(=O)NC1=C(C=C(C=C1)OC)S(=O)(=O)[O-].[Na+],,,,,,
3051,103052,5-Methoxy-2-(octadec-9-enoylamino)benzenesulfonic acid,CCCCCCCCC=CCCCCCCCC(=O)NC1=C(C=C(C=C1)OC)S(=O)(=O)O,,,,,,
3052,103053,CID 103053,CCCCCCCCOCCCN(CCC(=O)O)CCC(=O)[O-].[Na+],,,,,,
3053,103054,N-(2-Carboxyethyl)-N-[3-(octyloxy)propyl]-beta-alanine,CCCCCCCCOCCCN(CCC(=O)O)CCC(=O)O,,,,,,
3054,103055,CID 103055,CCCCCCCCCCOCCCN(CCC(=O)O)CCC(=O)[O-].[Na+],,,,,,
3055,103056,"3,3'-{[3-(Decyloxy)propyl]azanediyl}dipropanoic acid (non-preferred name)",CCCCCCCCCCOCCCN(CCC(=O)O)CCC(=O)O,,,,,,
3056,103057,"Acetic acid, cyano-, anhydride with acetic acid",CC(=O)OC(=O)CC#N,,,,,,
3057,103058,"Ethanaminium, 2-[[2-cyano-3-[4-(diethylamino)phenyl]-1-oxo-2-propenyl]oxy]-N,N,N-trimethyl-, chloride",CCN(CC)C1=CC=C(C=C1)C=C(C#N)C(=O)OCC[N+](C)(C)C.[Cl-],,,,,,
3058,103059,"2-({2-Cyano-3-[4-(diethylamino)phenyl]prop-2-enoyl}oxy)-N,N,N-trimethylethan-1-aminium",CCN(CC)C1=CC=C(C=C1)C=C(C#N)C(=O)OCC[N+](C)(C)C,,,,,,
3059,103060,"2-Naphthalenesulfonic acid, 7-[(4-aminobenzoyl)amino]-3-[(5-chloro-2-methoxyphenyl)azo]-4-hydroxy-",COC1=C(C=C(C=C1)Cl)N=NC2=C(C=C3C=C(C=CC3=C2O)NC(=O)C4=CC=C(C=C4)N)S(=O)(=O)O,,,,,,
3060,103061,"Propanamide, 3-[(2-cyanoethyl)[4-[(4-nitrophenyl)azo]phenyl]amino]-N-ethyl-",CCNC(=O)CCN(CCC#N)C1=CC=C(C=C1)N=NC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
3061,103062,"9,10-Anthracenedione, 1-(ethylamino)-4-(methylamino)-",CCNC1=C2C(=C(C=C1)NC)C(=O)C3=CC=CC=C3C2=O,,,,,,
3062,103063,"2-Naphthalenesulfonic acid, 7-[(4-aminobenzoyl)amino]-3-[[4-(benzoylamino)phenyl]azo]-4-hydroxy-",C1=CC=C(C=C1)C(=O)NC2=CC=C(C=C2)N=NC3=C(C=C4C=C(C=CC4=C3O)NC(=O)C5=CC=C(C=C5)N)S(=O)(=O)O,,,,,,
3063,103064,"Benzenediazonium, 2-methoxy-4-((3-sulfophenyl)azo)-, chloride",COC1=C(C=CC(=C1)N=NC2=CC(=CC=C2)S(=O)(=O)O)[N+]#N.[Cl-],,,,,,
3064,103065,2-Methoxy-4-[(3-sulfophenyl)diazenyl]benzenediazonium,COC1=C(C=CC(=C1)N=NC2=CC(=CC=C2)S(=O)(=O)O)[N+]#N,,,,,,
3065,103066,"1,4-Benzenedisulfonic acid, 2-((4-amino-6-sulfo-1-naphthalenyl)azo)-, trisodium salt",C1=CC2=C(C=CC(=C2C=C1S(=O)(=O)[O-])N)N=NC3=C(C=CC(=C3)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
3066,103067,"2-[(4-Amino-6-sulfonaphthalen-1-yl)diazenyl]benzene-1,4-disulfonic acid",C1=CC2=C(C=CC(=C2C=C1S(=O)(=O)O)N)N=NC3=C(C=CC(=C3)S(=O)(=O)O)S(=O)(=O)O,,,,,,
3067,103068,CID 103068,C1=CC(=C(C=C1N)S(=O)(=O)[O-])NC2=CC3=C(C=C2)NC(=O)N3.[Na+],,,,,,
3068,103069,"5-Amino-2-[(2-oxo-1,3-dihydrobenzimidazol-5-yl)amino]benzenesulfonic acid",C1=CC(=C(C=C1N)S(=O)(=O)O)NC2=CC3=C(C=C2)NC(=O)N3,,,,,,
3069,103070,CID 103070,C1=CC(=CC=C1CCBr)S(=O)(=O)[O-].[Na+],,,,,,
3070,103071,4-(2-Bromoethyl)benzenesulfonic Acid,C1=CC(=CC=C1CCBr)S(=O)(=O)O,,,,,,
3071,103072,"Benzenesulfonic acid, 4-chloro-3-[4-[[4-(dimethylamino)phenyl]methylene]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]-",CC1=NN(C(=O)C1=CC2=CC=C(C=C2)N(C)C)C3=C(C=CC(=C3)S(=O)(=O)O)Cl,,,,,,
3072,103073,"Benzenesulfonic acid, 3,3'-((4,6-dihydroxy-1,3-phenylene)bis(azo))bis-, disodium salt",C1=CC(=CC(=C1)S(=O)(=O)[O-])N=NC2=CC(=C(C=C2O)O)N=NC3=CC(=CC=C3)S(=O)(=O)[O-].[Na+].[Na+],,,,,,
3073,103074,"3-[[2,4-Dihydroxy-5-[(3-sulfophenyl)diazenyl]phenyl]diazenyl]benzenesulfonic acid",C1=CC(=CC(=C1)S(=O)(=O)O)N=NC2=CC(=C(C=C2O)O)N=NC3=CC(=CC=C3)S(=O)(=O)O,,,,,,
3074,103075,"Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[(4-methoxyphenyl)azo]-, disodium salt",COC1=CC=C(C=C1)N=NC2=CC(=C(C=C2)C=CC3=C(C=C(C=C3)N=NC4=CC=C(C=C4)OC)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
3075,103076,"Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[(4-methoxyphenyl)azo]-",COC1=CC=C(C=C1)N=NC2=CC(=C(C=C2)C=CC3=C(C=C(C=C3)N=NC4=CC=C(C=C4)OC)S(=O)(=O)O)S(=O)(=O)O,,,,,,
3076,103077,"Benzenethiol, 4-dodecyl-, hydrogen phosphorodithioate",CCCCCCCCCCCCC1=CC=C(C=C1)SP(=O)(O)SC2=CC=C(C=C2)CCCCCCCCCCCC,,,,,,
3077,103078,"Zinc, bis(O,O-bis(4-dodecylphenyl) phosphorodithioato-kappaS,kappaS')-, (T-4)-",CCCCCCCCCCCCC1=CC=C(C=C1)SP(=O)([O-])SC2=CC=C(C=C2)CCCCCCCCCCCC.CCCCCCCCCCCCC1=CC=C(C=C1)SP(=O)([O-])SC2=CC=C(C=C2)CCCCCCCCCCCC.[Zn+2],,,,,,
3078,103079,"Ethanethiol, 2-(4-nonylphenoxy)-, hydrogen phosphorodithioate",CCCCCCCCCC1=CC=C(C=C1)OCCSP(=O)(O)SCCOC2=CC=C(C=C2)CCCCCCCCC,,,,,,
3079,103080,1-(Cycloprop-2-en-1-yl)-2-methylbenzene,CC1=CC=CC=C1C2C=C2,,,,,,
3080,103081,CID 103081,C1=CC2=C(C(=C1)[N+](=O)[O-])C(=O)C3=C(C2=O)C(=N)C=CC3=[N+](O)[O-],,,,,,
3081,103082,"Bis((2,2'-(oxybis(4,1-phenyleneazo-4,1-phenylene(ethylimino)))ethyl)triethylammonium) dichloride",CCN(CC[N+](CC)(CC)CC)C1=CC=C(C=C1)N=NC2=CC=C(C=C2)OC3=CC=C(C=C3)N=NC4=CC=C(C=C4)N(CC)CC[N+](CC)(CC)CC.[Cl-].[Cl-],,,,,,
3082,103083,"2,2'-[Oxybis[4,1-phenyleneazo-4,1-phenylene(ethylimino)]]bis(N,N,N-triethylethanaminium)",CCN(CC[N+](CC)(CC)CC)C1=CC=C(C=C1)N=NC2=CC=C(C=C2)OC3=CC=C(C=C3)N=NC4=CC=C(C=C4)N(CC)CC[N+](CC)(CC)CC,,,,,,
3083,103084,"1-Octanaminium, N,N,N-trimethyl-, methyl sulfate",CCCCCCCC[N+](C)(C)C.COS(=O)(=O)[O-],,,,,,
3084,103085,"1-Tetradecanaminium, N,N,N-trimethyl-, methyl sulfate",CCCCCCCCCCCCCC[N+](C)(C)C.COS(=O)(=O)[O-],,,,,,
3085,103086,"1H-Naphth[2,3-f]isoindole-1,3,5,10(2H)-tetrone, 4,11-diamino-2-[3-(2-methoxyethoxy)propyl]-",COCCOCCCN1C(=O)C2=C(C3=C(C(=C2C1=O)N)C(=O)C4=CC=CC=C4C3=O)N,,,,,,
3086,103087,"Benzenesulfonic acid, 4-[4-[5-[1,5-dihydro-3-methyl-5-oxo-1-(4-sulfophenyl)-4H-pyrazol-4-ylidene]-1,3-pentadienyl]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]-",CC1=NN(C(=O)C1C=CC=CC=C2C(=NN(C2=O)C3=CC=C(C=C3)S(=O)(=O)O)C)C4=CC=C(C=C4)S(=O)(=O)O,,,,,,
3087,103088,"1-Propanaminium, N-[2-[bis(2-hydroxypropyl)amino]ethyl]-2-hydroxy-N-(2-hydroxypropyl)-N-methyl-, di-(9Z)-9-octadecenoate (ester), methyl sulfate (salt)",CCCCCCCCC=CCCCCCCCC(=O)OC(C)CN(CC[N+](C)(CC(C)O)CC(C)OC(=O)CCCCCCCCC=CCCCCCCC)CC(C)O.COS(=O)(=O)[O-],,,,,,
3088,103089,2-Hydroxy-N-{2-[(2-hydroxypropyl){2-[(octadec-9-enoyl)oxy]propyl}amino]ethyl}-N-methyl-N-{2-[(octadec-10-enoyl)oxy]propyl}propan-1-aminium,CCCCCCCCC=CCCCCCCCC(=O)OC(C)CN(CC[N+](C)(CC(C)O)CC(C)OC(=O)CCCCCCCCC=CCCCCCCC)CC(C)O,,,,,,
3089,103090,2-[Hexadec-1-enyl(dimethyl)azaniumyl]acetate,CCCCCCCCCCCCCCC=C[N+](C)(C)CC(=O)[O-],,,,,,
3090,103091,Carboxymethyl-hexadec-1-enyl-dimethylazanium,CCCCCCCCCCCCCCC=C[N+](C)(C)CC(=O)O,,,,,,
3091,103092,"Acetamide, N-[2-[(4,5-dicyano-1-methyl-1H-imidazol-2-yl)azo]-5-[ethyl(phenylmethyl)amino]phenyl]-",CCN(CC1=CC=CC=C1)C2=CC(=C(C=C2)N=NC3=NC(=C(N3C)C#N)C#N)NC(=O)C,,,,,,
3092,103093,"Acetamide, N-[2-[[4-[(2,6-dichloro-4-nitrophenyl)azo]-2-methoxy-5-methylphenyl]azo]-5-(diethylamino)phenyl]-",CCN(CC)C1=CC(=C(C=C1)N=NC2=C(C=C(C(=C2)C)N=NC3=C(C=C(C=C3Cl)[N+](=O)[O-])Cl)OC)NC(=O)C,,,,,,
3093,103094,"1-Heptadecanamine, N,N-dimethyl-, acetate",CCCCCCCCCCCCCCCCCN(C)C.CC(=O)O,,,,,,
3094,103095,"beta-Alanine, N-[5-(acetylamino)-2-methoxyphenyl]-N-[2-(acetyloxy)ethyl]-, methyl ester",CC(=O)NC1=CC(=C(C=C1)OC)N(CCC(=O)OC)CCOC(=O)C,,,,,,
3095,103096,(3-Aminophenyl)diethanolamine dibenzoate,C1=CC=C(C=C1)C(=O)OCCN(CCOC(=O)C2=CC=CC=C2)C3=CC=CC(=C3)N,,,,,,
3096,103097,"Benzenemethanaminium, N,N-bis(2-hydroxyethyl)-N-pentadecyl-, chloride",CCCCCCCCCCCCCCC[N+](CCO)(CCO)CC1=CC=CC=C1.[Cl-],,,,,,
3097,103098,"N,N-Bis(2-hydroxyethyl)-N-pentadecylbenzenemethanaminium",CCCCCCCCCCCCCCC[N+](CCO)(CCO)CC1=CC=CC=C1,,,,,,
3098,103099,Benzyldodecylbis(2-hydroxypropyl)ammonium chloride,CCCCCCCCCCCC[N+](CC1=CC=CC=C1)(CC(C)O)CC(C)O.[Cl-],,,,,,
3099,103100,"N-Dodecyl-N,N-bis(2-hydroxypropyl)benzenemethanaminium",CCCCCCCCCCCC[N+](CC1=CC=CC=C1)(CC(C)O)CC(C)O,,,,,,
3100,103101,Benzylbis(2-hydroxypropyl)octadecylammonium chloride,CCCCCCCCCCCCCCCCCC[N+](CC1=CC=CC=C1)(CC(C)O)CC(C)O.[Cl-],,,,,,
3101,103102,"N,N-Bis(2-hydroxypropyl)-N-octadecylbenzenemethanaminium",CCCCCCCCCCCCCCCCCC[N+](CC1=CC=CC=C1)(CC(C)O)CC(C)O,,,,,,
3102,103103,CID 103103,CCCCCCCC[N+](CC1=CC=CC=C1)(CC(C)O)CC(C)O.[Cl-],,,,,,
3103,103104,"N,N-Bis(2-hydroxypropyl)-N-octylbenzenemethanaminium",CCCCCCCC[N+](CC1=CC=CC=C1)(CC(C)O)CC(C)O,,,,,,
3104,103105,CID 103105,CCCCCCCCCCCCCC[N+](CC1=CC=CC=C1)(CC(C)O)CC(C)O.[Cl-],,,,,,
3105,103106,"N,N-Bis(2-hydroxypropyl)-N-tetradecylbenzenemethanaminium",CCCCCCCCCCCCCC[N+](CC1=CC=CC=C1)(CC(C)O)CC(C)O,,,,,,
3106,103107,CID 103107,CCCCCCCCCC[N+](CC1=CC=CC=C1)(CC(C)O)CC(C)O.[Cl-],,,,,,
3107,103108,"N-Decyl-N,N-bis(2-hydroxypropyl)benzenemethanaminium",CCCCCCCCCC[N+](CC1=CC=CC=C1)(CC(C)O)CC(C)O,,,,,,
3108,103109,"Carboxymethyl-dimethyl-octadeca-9,12-dienylazanium",CCCCCC=CCC=CCCCCCCCC[N+](C)(C)CC(=O)O,,,,,,
3109,103110,Heptadecyl(carboxymethyl)dimethylaminium,CCCCCCCCCCCCCCCCC[N+](C)(C)CC(=O)O,,,,,,
3110,103111,"1-Decanaminium, N,N,N-trimethyl-, methyl sulfate",CCCCCCCCCC[N+](C)(C)C.COS(=O)(=O)[O-],,,,,,
3111,103112,"2H-Naphth[2,3-f]isoindole-2-propanaminium, 4,11-diamino-1,3,5,10-tetrahydro-N,N,N-trimethyl-1,3,5,10-tetraoxo-, methyl sulfate",C[N+](C)(C)CCCN1C(=O)C2=C(C3=C(C(=C2C1=O)N)C(=O)C4=CC=CC=C4C3=O)N.COS(=O)(=O)[O-],,,,,,
3112,103113,"4,11-Diamino-1,3,5,10-tetrahydro-N,N,N-trimethyl-1,3,5,10-tetraoxo-2H-naphth[2,3-f]isoindole-2-propan-1-aminium",C[N+](C)(C)CCCN1C(=O)C2=C(C3=C(C(=C2C1=O)N)C(=O)C4=CC=CC=C4C3=O)N,,,,,,
3113,103114,Hexadecyltrimethylammonium methyl sulphate,CCCCCCCCCCCCCCCC[N+](C)(C)C.COS(=O)(=O)[O-],,,"['Substances used on humans and other animals that destroy harmful microorganisms or inhibit their activity. They are distinguished from DISINFECTANTS, which are used on inanimate objects. (See all compounds classified as Anti-Infective Agents, Local.)']",,,
3114,103115,(2-Hydroxyethyl)(2-((2-hydroxyethyl)(palmitoyl)amino)ethyl)(2-((2-hydroxyethyl)(2-(palmitoyloxy)ethyl)amino)ethyl)methylammonium methyl sulphate,CCCCCCCCCCCCCCCC(=O)N(CC[N+](C)(CCN(CCO)CCOC(=O)CCCCCCCCCCCCCCC)CCO)CCO.COS(=O)(=O)[O-],,,,,,
3115,103116,N-(2-Hydroxyethyl)-N-[2-[(2-hydroxyethyl)(1-oxohexadecyl)amino]ethyl]-2-[(2-hydroxyethyl)[2-[(1-oxohexadecyl)oxy]ethyl]amino]-N-methylethanaminium,CCCCCCCCCCCCCCCC(=O)N(CC[N+](C)(CCN(CCO)CCOC(=O)CCCCCCCCCCCCCCC)CCO)CCO,,,,,,
3116,103117,Einecs 265-356-3,CCCCCCCCCCCCCCCCCC(=O)OCCN1CCN(CC1)CCOC(=O)CCCCCCCCCCCCCCCCC.COS(=O)(=O)O.COS(=O)(=O)O,,,,,,
3117,103118,2-[4-(2-Octadecanoyloxyethyl)piperazin-1-yl]ethyl octadecanoate,CCCCCCCCCCCCCCCCCC(=O)OCCN1CCN(CC1)CCOC(=O)CCCCCCCCCCCCCCCCC,,,,,,
3118,103119,"1-Methyl-1,4-bis(2-((1-oxohexadecyl)oxy)ethyl)piperazinium methyl sulphate",CCCCCCCCCCCCCCCC(=O)OCCN1CC[N+](CC1)(C)CCOC(=O)CCCCCCCCCCCCCCC.CS(=O)(=O)[O-],,,,,,
3119,103120,"1-Methyl-1,4-bis[2-[(1-oxohexadecyl)oxy]ethyl]piperazinium",CCCCCCCCCCCCCCCC(=O)OCCN1CC[N+](CC1)(C)CCOC(=O)CCCCCCCCCCCCCCC,,,,,,
3120,103121,"Piperazinium, 1-methyl-1,4-bis(2-(stearoyloxy)ethyl)-, methyl sulfate",CCCCCCCCCCCCCCCCCC(=O)OCCN1CC[N+](CC1)(C)CCOC(=O)CCCCCCCCCCCCCCCC.COS(=O)(=O)[O-],,,,,,
3121,103122,2-[4-(2-Heptadecanoyloxyethyl)-4-methylpiperazin-4-ium-1-yl]ethyl octadecanoate,CCCCCCCCCCCCCCCCCC(=O)OCCN1CC[N+](CC1)(C)CCOC(=O)CCCCCCCCCCCCCCCC,,,,,,
3122,103123,"Benzeneethanaminium, 4-((4-(diethylamino)-2-methylphenyl)azo)-N,N,N-trimethyl-beta-oxo-, (T-4)-tetrachlorozincate(2-) (2:1)",CCN(CC)C1=CC(=C(C=C1)N=NC2=CC=C(C=C2)C(=O)C[N+](C)(C)C)C.CCN(CC)C1=CC(=C(C=C1)N=NC2=CC=C(C=C2)C(=O)C[N+](C)(C)C)C.[Cl-].[Cl-].[Cl-].[Cl-].[Zn+2],,,,,,
3123,103124,"4-[[4-(Diethylamino)-2-methylphenyl]azo]-N,N,N-trimethyl-beta-oxobenzeneethanaminium",CCN(CC)C1=CC(=C(C=C1)N=NC2=CC=C(C=C2)C(=O)C[N+](C)(C)C)C,,,,,,
3124,103125,"Benzaldehyde, 4-[bis[2-(benzoyloxy)ethyl]amino]-",C1=CC=C(C=C1)C(=O)OCCN(CCOC(=O)C2=CC=CC=C2)C3=CC=C(C=C3)C=O,,,,,,
3125,103126,Trisodium 4-[[1-hydroxy-6-[[[(5-hydroxy-7-sulphonato-2-naphthyl)amino]carbonyl]amino]-3-sulphonato-2-naphthyl]azo]benzoate,C1=CC(=CC=C1C(=O)[O-])N=NC2=C(C=C3C=C(C=CC3=C2O)NC(=O)NC4=CC5=CC(=CC(=C5C=C4)O)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
3126,103127,4-[[1-Hydroxy-6-[(5-hydroxy-7-sulfonaphthalen-2-yl)carbamoylamino]-3-sulfonaphthalen-2-yl]diazenyl]benzoic acid,C1=CC(=CC=C1C(=O)O)N=NC2=C(C=C3C=C(C=CC3=C2O)NC(=O)NC4=CC5=CC(=CC(=C5C=C4)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
3127,103128,4-1-Hydroxy-6-5-hydroxy-6-(2-methyl-4-sulphonatophenyl)azo-7-sulphonato-2-naphthylaminocarbonylamino-3-sulph onato-2-naphthylazobenzoate (sodium salt),CC1=C(C=CC(=C1)S(=O)(=O)[O-])N=NC2=C(C=C3C=C(C=CC3=C2O)NC(=O)NC4=CC5=CC(=C(C(=C5C=C4)O)N=NC6=CC=C(C=C6)C(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
3128,103129,4-[[1-Hydroxy-6-[[[[5-hydroxy-6-[(2-methyl-4-sulfophenyl)azo]-7-sulfo-2-naphthalenyl]amino]carbonyl]amino]-3-sulfo-2-naphthalenyl]azo]benzoic acid,CC1=C(C=CC(=C1)S(=O)(=O)O)N=NC2=C(C=C3C=C(C=CC3=C2O)NC(=O)NC4=CC5=CC(=C(C(=C5C=C4)O)N=NC6=CC=C(C=C6)C(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
3129,103130,CID 103130,C1=CC(=CC=C1C(=O)[O-])N=NC2=C(C3=C(C=C2)C=C(C=C3)NC(=O)NC4=CC5=CC(=C(C(=C5C=C4)O)N=NC6=CC=C(C=C6)C(=O)[O-])S(=O)(=O)[O-])O.[O-]S(=O)=O.[Na+].[Na+].[Na+].[Na+],,,,,,
3130,103131,4-[[6-[[6-[(4-Carboxyphenyl)diazenyl]-5-hydroxy-7-sulfonaphthalen-2-yl]carbamoylamino]-1-hydroxynaphthalen-2-yl]diazenyl]benzoic acid,C1=CC(=CC=C1C(=O)O)N=NC2=C(C3=C(C=C2)C=C(C=C3)NC(=O)NC4=CC5=CC(=C(C(=C5C=C4)O)N=NC6=CC=C(C=C6)C(=O)O)S(=O)(=O)O)O,,,,,,
3131,103132,"6-Benzothiazolecarboxylic acid, 2-amino-, compd. with 2,2',2''-nitrilotris(ethanol) (1:1)",C1=CC2=C(C=C1C(=O)O)SC(=N2)N.C(CO)N(CCO)CCO,,,,,,
3132,103133,CID 103133,[Li+].C1=CC2=C(C=C1S(=O)(=O)[O-])SC(=N2)N,,,,,,
3133,103134,"7-Benzothiazolesulfonic acid, 2-[4-(5-amino-6-methyl-2-naphthalenyl)phenyl]-6-methyl-",CC1=C(C2=C(C=C1)C=C(C=C2)C3=CC=C(C=C3)C4=NC5=C(S4)C(=C(C=C5)C)S(=O)(=O)O)N,,,,,,
3134,103135,CID 103135,CC1=CC2=C(C(=C1)S(=O)(=O)[O-])SC(=N2)C3=CC=C(C=C3)N.[Na+],,,,,,
3135,103136,"2-(4-Aminophenyl)-5-methyl-1,3-benzothiazole-7-sulfonic acid",CC1=CC2=C(C(=C1)S(=O)(=O)O)SC(=N2)C3=CC=C(C=C3)N,,,,,,
3136,103137,"6-Benzothiazolesulfonic acid, 2-[[4-[[(2-chlorophenyl)methyl]ethylamino]-2-methylphenyl]azo]-",CCN(CC1=CC=CC=C1Cl)C2=CC(=C(C=C2)N=NC3=NC4=C(S3)C=C(C=C4)S(=O)(=O)O)C,,,,,,
3137,103138,"7-Benzothiazolesulfonic acid, 2-(4-((1-(hydroxymethyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl)azo)phenyl)-6-methyl-, compd. with 2,2'-iminobis(ethanol) (1:1)",CC1=C(C2=C(C=C1)N=C(S2)C3=CC=C(C=C3)N=NC4C(=NN(C4=O)CO)C)S(=O)(=O)O.C(CO)NCCO,,,,,,
3138,103139,"2-[4-[[1-(Hydroxymethyl)-3-methyl-5-oxo-4,5-dihydro-1H-pyrazole-4-yl]azo]phenyl]-6-methyl-7-benzothiazolesulfonic acid",CC1=C(C2=C(C=C1)N=C(S2)C3=CC=C(C=C3)N=NC4C(=NN(C4=O)CO)C)S(=O)(=O)O,,,,,,
3139,103140,"1-(3-Sulfopropyl)-2-[[3-(3-sulfopropyl)-2(3H)-benzothiazolylidene]methyl]quinolinium hydroxide, inner salt",C1=CC=C2C(=C1)C=CC(=[N+]2CCCS(=O)(=O)[O-])C=C3N(C4=CC=CC=C4S3)CCCS(=O)(=O)O,,,,,,
3140,103141,1-(3-Sulfonatopropyl)-2-[[3-(3-sulfopropyl)benzothiazol-2(3H)-ylidene]methyl]quinolinium,C1=CC=C2C(=C1)C=CC(=[N+]2CCCS(=O)(=O)O)C=C3N(C4=CC=CC=C4S3)CCCS(=O)(=O)O,,,,,,
3141,103142,"Acetamide, N-[2-[(4,5-dicyano-1H-imidazol-2-yl)azo]-5-[ethyl(phenylmethyl)amino]phenyl]-",CCN(CC1=CC=CC=C1)C2=CC(=C(C=C2)N=NC3=NC(=C(N3)C#N)C#N)NC(=O)C,,,,,,
3142,103143,CID 103143,CC1=CC=C(C=C1)NC2=C3C(=C(C=C2)NC(=O)C4=CC=C(C=C4)N(O)O)C(=O)C5=C(C3=O)C(=NC6=CC=C(C=C6)C)C=CC5=NC7=CC=C(C=C7)C,,,,,,
3143,103144,"Benzamide, N-[5-[bis(2-hydroxyethyl)amino]-2-[(4-nitrophenyl)azo]phenyl]-",C1=CC=C(C=C1)C(=O)NC2=C(C=CC(=C2)N(CCO)CCO)N=NC3=CC=C(C=C3)[N+](=O)[O-],,,,,,
3144,103145,"7H-Benz(de)anthracen-7-one, 2-bromo-",C1=CC=C2C(=C1)C3=C4C(=CC(=C3)Br)C=CC=C4C2=O,,,,,,
3145,103146,5-((4-Aminophenyl)azo)-3-methylsalicylic acid,CC1=CC(=CC(=C1O)C(=O)O)N=NC2=CC=C(C=C2)N,,,,,,
3146,103147,"Benzoic acid, 2-((3-(((2-ethoxyphenyl)amino)carbonyl)-2-hydroxy-1-naphthalenyl)azo)-, butyl ester",CCCCOC(=O)C1=CC=CC=C1N=NC2=C(C(=CC3=CC=CC=C32)C(=O)NC4=CC=CC=C4OCC)O,,,,,,
3147,103148,6-Amino-2-methylquinoline,CC1=NC2=C(C=C1)C=C(C=C2)N,,,,,,
3148,103149,CID 103149,C(CS)C(=O)[O-].[K+],,,,,,
3149,103150,"2-Propanol, 1,1'-(decylimino)bis-",CCCCCCCCCCN(CC(C)O)CC(C)O,,,,,,
3150,103151,"Propanenitrile, 3-[[4-[(2-chloro-4-nitrophenyl)azo]-3-methylphenyl](2-hydroxyethyl)amino]-",CC1=C(C=CC(=C1)N(CCC#N)CCO)N=NC2=C(C=C(C=C2)[N+](=O)[O-])Cl,,,,,,
3151,103152,"2-Propanol, 1,1'-(octadecadienylimino)bis-",CCCCCCC=CCCC=CCCCCCCN(CC(C)O)CC(C)O,,,,,,
3152,103153,"2-Propanol, 1,1'-(octadecenylimino)bis-",CCCCCCCCCCC=CCCCCCCN(CC(C)O)CC(C)O,,,,,,
3153,103154,"Diphenyl [carbonylbis(imino-4,1-phenylenemethylene-4,1-phenylene)]biscarbamate",C1=CC=C(C=C1)OC(=O)NC2=CC=C(C=C2)CC3=CC=C(C=C3)NC(=O)NC4=CC=C(C=C4)CC5=CC=C(C=C5)NC(=O)OC6=CC=CC=C6,,,,,,
3154,103155,"beta-Alanine, N-[5-(acetylamino)-2-methoxyphenyl]-, methyl ester",CC(=O)NC1=CC(=C(C=C1)OC)NCCC(=O)OC,,,,,,
3155,103156,CID 103156,CCOC(=O)C(=CC1=CC=C(C=C1)N(CCOC(=O)C2=CC=CC=C2)CCOC(=O)C3=CC=CC=C3)C#N,,,,,,
3156,103157,CID 103157,CC1=CC(=O)N(C(=N1)[O-])C(C)(C)C.[Na+],,,,,,
3157,103158,"Benzenamine, 4,4'-methylenebis[2-[(4-aminophenyl)methyl]-",C1=CC(=CC=C1CC2=C(C=CC(=C2)CC3=CC(=C(C=C3)N)CC4=CC=C(C=C4)N)N)N,,,,,,
3158,103159,"Ethanol, 2-[2-(tridecyloxy)ethoxy]-, hydrogen phosphate",CCCCCCCCCCCCCOCCOCCOP(=O)(O)OCCOCCOCCCCCCCCCCCCC,,,,,,
3159,103160,"Disulfide, 2,4-dimethylphenyl 2,5-dimethylphenyl",CC1=CC(=C(C=C1)SSC2=C(C=CC(=C2)C)C)C,,,,,,
3160,103161,"Disulfide, 2,4-dimethylphenyl 2,6-dimethylphenyl",CC1=CC(=C(C=C1)SSC2=C(C=CC=C2C)C)C,,,,,,
3161,103162,"Disulfide, 2,4-dimethylphenyl 3,4-dimethylphenyl",CC1=CC(=C(C=C1)SSC2=CC(=C(C=C2)C)C)C,,,,,,
3162,103163,"Dinaphtho(1',2',3':3,4;3'',2'',1'':9,10)perylo(1,12-def)(1,3)oxazepine",C1=CC=C2C(=C1)C=C3C=CC4=C5C=CC6=CC7=CC=CC=C7C8=CC9=C(C5=C68)C1=C(C=C2C3=C41)N=CO9,,,,,,
3163,103164,"Phenol, 2-[[[[2-[[(2-hydroxyphenyl)methylene]amino]cyclopentyl]methyl]imino]methyl]-",C1CC(C(C1)N=CC2=CC=CC=C2O)CN=CC3=CC=CC=C3O,,,,,,
3164,103165,"Phenol, 2,2'-[(2-methyl-1,5-pentanediyl)bis(nitrilomethylidyne)]bis-",CC(CCCN=CC1=CC=CC=C1O)CN=CC2=CC=CC=C2O,,,,,,
3165,103166,"Disulfide, 2,3-dimethylphenyl 2,4-dimethylphenyl",CC1=CC(=C(C=C1)SSC2=CC=CC(=C2C)C)C,,,,,,
3166,103167,"Disulfide, 2,3-dimethylphenyl 2,6-dimethylphenyl",CC1=C(C(=CC=C1)SSC2=C(C=CC=C2C)C)C,,,,,,
3167,103168,"Disulfide, 2,3-dimethylphenyl 3,4-dimethylphenyl",CC1=C(C(=CC=C1)SSC2=CC(=C(C=C2)C)C)C,,,,,,
3168,103169,"Disulfide, 2,3-dimethylphenyl 3,5-dimethylphenyl",CC1=C(C(=CC=C1)SSC2=CC(=CC(=C2)C)C)C,,,,,,
3169,103170,"Cyclohexanamine, N,N-diethyl-, hydrochloride",C.CCN(CC)C1CCCCC1,,,,,,
3170,103171,"Cyclohexanamine, N,N-diethyl-, sulfate (2:1)",CCN(CC)C1CCCCC1.CCN(CC)C1CCCCC1.OS(=O)(=O)O,,,,,,
3171,103172,"Carbamic acid, [4-[(4-isocyanatocyclohexyl)methyl]cyclohexyl]-, oxydi-2,1-ethanediyl ester",C1CC(CCC1CC2CCC(CC2)N=C=O)NC(=O)OCCOCCOC(=O)NC3CCC(CC3)CC4CCC(CC4)N=C=O,,,,,,
3172,103173,"Naphth[2,1-d]oxazolium, 3-ethyl-2-[3-(3-ethylnaphth[2,1-d]oxazol-2(3H)-ylidene)-1-propenyl]-, bromide",CCN1C2=C(C3=CC=CC=C3C=C2)OC1=CC=CC4=[N+](C5=C(O4)C6=CC=CC=C6C=C5)CC.[Br-],,,,,,
3173,103174,"3-Ethyl-2-[3-(3-ethylnaphth[2,1-d]oxazol-2(3H)-ylidene)-1-propenyl]naphth[2,1-d]oxazol-3-ium",CCN1C2=C(C3=CC=CC=C3C=C2)OC1=CC=CC4=[N+](C5=C(O4)C6=CC=CC=C6C=C5)CC,,,,,,
3174,103175,"2-(Dimethylamino)ethyl chlorosulfite, hydrochloride",CN(C)CCOS(=O)Cl.Cl,,,,,,
3175,103176,Chloridosulfurous acid 2-(dimethylamino)ethyl ester,CN(C)CCOS(=O)Cl,,,,,,
3176,103177,Dihydroxybis(ammonium lactato)titanium,CC(C(=O)O)O.CC(C(=O)O)O.N.N.O.O.[Ti],,,,,,
3177,103178,"Spiro[cyclohexane-1,2'-[1,3]dioxolo[4,5-f]benzothiazolium], 7'-ethyl-6'-[2-[(7'-ethylspiro[cyclohexane-1,2'-[1,3]dioxolo[4,5-f]benzothiazol]-6'(7'H)-ylidene)methyl]-1-butenyl]-, iodide",CCC(=CC1=[N+](C2=CC3=C(C=C2S1)OC4(O3)CCCCC4)CC)C=C5N(C6=CC7=C(C=C6S5)OC8(O7)CCCCC8)CC.[I-],,,,,,
3178,103179,"6-[2-[(7-Ethylspiro[1,3-dioxolo[4,5-f]benzothiazole-2,1'-cyclohexane]-6(7H)-ylidene)methyl]-1-butenyl]-7-ethylspiro[1,3-dioxolo[4,5-f]benzothiazole-2,1'-cyclohexane]-7-ium",CCC(=CC1=[N+](C2=CC3=C(C=C2S1)OC4(O3)CCCCC4)CC)C=C5N(C6=CC7=C(C=C6S5)OC8(O7)CCCCC8)CC,,,,,,
3179,103180,"Ethanol, 2-[2-[[4-[(2-bromo-4,6-dinitrophenyl)azo]-1-naphthalenyl]amino]ethoxy]-",C1=CC=C2C(=C1)C(=CC=C2N=NC3=C(C=C(C=C3Br)[N+](=O)[O-])[N+](=O)[O-])NCCOCCO,,,,,,
3180,103181,"Benzoic acid, 2-hydroxy-5-((4-((((4-((3-sulfophenyl)azo)phenyl)amino)carbonyl)amino)phenyl)azo)-",C1=CC(=CC(=C1)S(=O)(=O)O)N=NC2=CC=C(C=C2)NC(=O)NC3=CC=C(C=C3)N=NC4=CC(=C(C=C4)O)C(=O)O,,,,,,
3181,103182,"Disulfide, 2,4-dimethylphenyl 3,5-dimethylphenyl",CC1=CC(=C(C=C1)SSC2=CC(=CC(=C2)C)C)C,,,,,,
3182,103183,"Disulfide, 2,5-dimethylphenyl 2,6-dimethylphenyl",CC1=CC(=C(C=C1)C)SSC2=C(C=CC=C2C)C,,,,,,
3183,103184,"Disulfide, 2,5-dimethylphenyl 3,5-dimethylphenyl",CC1=CC(=C(C=C1)C)SSC2=CC(=CC(=C2)C)C,,,,,,
3184,103185,"Disulfide, 2,6-dimethylphenyl 3,4-dimethylphenyl",CC1=C(C(=CC=C1)C)SSC2=CC(=C(C=C2)C)C,,,,,,
3185,103186,"Disulfide, 2,6-dimethylphenyl 3,5-dimethylphenyl",CC1=C(C(=CC=C1)C)SSC2=CC(=CC(=C2)C)C,,,,,,
3186,103187,"Disulfide, 3,4-dimethylphenyl 3,5-dimethylphenyl",CC1=C(C=C(C=C1)SSC2=CC(=CC(=C2)C)C)C,,,,,,
3187,103188,Dodecyl dihydrogen phosphate;morpholine,CCCCCCCCCCCCOP(=O)(O)O.C1COCCN1.C1COCCN1,,,,,,
3188,103189,"Phosphoric acid, dodecyl ester, compd. with 2,2'-iminobis(ethanol)",CCCCCCCCCCCCOP(=O)(O)O.C(CO)NCCO,,,,,,
3189,103190,Einecs 265-421-6,CCCCCCCCCCCCOP(=O)(O)O.C(CO)NCCO.C(CO)NCCO,,,,,,
3190,103191,CID 103191,[Li+].C1=CC=C2C(=C1)C(=O)C(C2=O)C3=NC4=C(C=C3)C=C(C=C4)C5=NC6=C(S5)C(=CC=C6)S(=O)(=O)[O-],,,,,,
3191,103192,"2-[2-(1,3-Dioxoinden-2-yl)quinolin-6-yl]-1,3-benzothiazole-7-sulfonic acid",C1=CC=C2C(=C1)C(=O)C(C2=O)C3=NC4=C(C=C3)C=C(C=C4)C5=NC6=C(S5)C(=CC=C6)S(=O)(=O)O,,,,,,
3192,103193,"Sulfuric acid, monododecyl ester, compd. with 2-(diethylamino)ethanol (1:1)",CCCCCCCCCCCCOS(=O)(=O)O.CCN(CC)CCO,,,,,,
3193,103194,Diammonium tetradecyl phosphate,CCCCCCCCCCCCCCOP(=O)(O)O.N.N,,,,,,
3194,103195,Bis(bis(2-hydroxyethyl)ammonium) tetradecyl phosphate,CCCCCCCCCCCCCCOP(=O)(O)O.C(CO)NCCO.C(CO)NCCO,,,,,,
3195,103196,Ammonium tetradecyl hydrogen phosphate,CCCCCCCCCCCCCCOP(=O)(O)O.N,,,,,,
3196,103197,Morpholinium tetradecyl hydrogen phosphate,CCCCCCCCCCCCCCOP(=O)(O)O.C1COCCN1,,,,,,
3197,103198,Dimorpholinium tetradecyl phosphate,CCCCCCCCCCCCCCOP(=O)(O)O.C1COCCN1.C1COCCN1,,,,,,
3198,103199,Cyclohexyldiethylammonium tetradecyl sulphate,CCCCCCCCCCCCCCOS(=O)(=O)O.CCN(CC)C1CCCCC1,,,,,,
3199,103200,"Eicosane, 1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,17,17,18,18-heptatriacontafluoro-20-iodo-",C(CI)C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
3200,103201,"1-Eicosanol, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,17,17,18,18,19,19,20,20,20-heptatriacontafluoro-",C(CO)C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
3201,103202,"1-Octadecanol, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16,17,17,18,18,18-tritriacontafluoro-",C(CO)C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
3202,103203,"6-Benzothiazolesulfonic acid, 2-amino-, compd. with 2,2',2''-nitrilotris(ethanol) (1:1)",C1=CC2=C(C=C1S(=O)(=O)O)SC(=N2)N.C(CO)N(CCO)CCO,,,,,,
3203,103204,CID 103204,CCCCCCCCC=CC=CCCCCOP(=O)(O)OCCCCC=CC=CCCCCCCCC,,,,,,
3204,103205,CID 103205,CCCCCCCCCCCCCCC=COP(=O)(O)OCC=CCCCCCCCCCCCCC,,,,,,
3205,103206,CID 103206,CCCCCCCCC=CC=CCCCCCCOP(=O)(O)OCCCCCCCCC=CC=CCCCCCC,,,,,,
3206,103207,"1-Methyl-1,3-propanediyl(5-isocyanato-2(or 4)-methylphenyl)carbamate",CC(CCOC(=O)NC1=CC=CC(=C1)CN=C=O)OC(=O)NC2=CC=CC(=C2)CN=C=O,,,,,,
3207,103208,"Carbamic acid, [methyl-3-[[[[(1-methylpropylidene)amino]oxy]carbonyl]amino]phenyl]-, 1-methyl-1,3-propanediyl ester",CCC(=NOC(=O)NC1=CC(=CC=C1)N(C)C(=O)OCCC(C)OC(=O)N(C)C2=CC=CC(=C2)NC(=O)ON=C(C)CC)C,,,,,,
3208,103209,"Carbamic acid, (3-isocyanatomethylphenyl)-, 1,4-butanediyl ester",C1=CC(=CC(=C1)NC(=O)OCCCCOC(=O)NC2=CC=CC(=C2)CN=C=O)CN=C=O,,,,,,
3209,103210,"3-Methyl-5-(2,2,3-trimethylcyclopent-3-enyl)-pent-3-en-2-one",CC1=CCC(C1(C)C)CC=C(C)C(=O)C,,,,,,
3210,103211,"4-Hexen-3-one, 6-(2,2,3-trimethyl-3-cyclopenten-1-yl)-",CCC(=O)C=CCC1CC=C(C1(C)C)C,,,,,,
3211,103212,Sandalore,CC1=CCC(C1(C)C)CCC(C)C(C)O,,,"['A substance, extract, or preparation for diffusing or imparting an agreeable or attractive smell, especially a fluid containing fragrant natural oils extracted from flowers, woods, etc., or similar synthetic oils. (Random House Unabridged Dictionary, 2d ed) (See all compounds classified as Perfume.)']",,,
3212,103213,"2-Butenal, 2-ethyl-4-(2,2,3-trimethyl-3-cyclopenten-1-yl)-",CCC(=CCC1CC=C(C1(C)C)C)C=O,,,,,,
3213,103214,"1H-Naphth[2,3-f]isoindole-1,3,5,10(2H)-tetrone, 4,11-diamino-2-ethyl-",CCN1C(=O)C2=C(C3=C(C(=C2C1=O)N)C(=O)C4=CC=CC=C4C3=O)N,,,,,,
3214,103215,"Benzoic acid, 5-[[4-[2-[4-[[2,6-diamino-3-methyl-5-[(4-sulfophenyl)azo]phenyl]azo]-2-sulfophenyl]ethenyl]-3-sulfophenyl]azo]-2-hydroxy-3-methyl-, tetralithium salt",[Li+].[Li+].[Li+].[Li+].CC1=CC(=CC(=C1O)C(=O)[O-])N=NC2=CC(=C(C=C2)C=CC3=C(C=C(C=C3)N=NC4=C(C(=CC(=C4N)N=NC5=CC=C(C=C5)S(=O)(=O)[O-])C)N)S(=O)(=O)[O-])S(=O)(=O)[O-],,,,,,
3215,103216,"5-[[4-[2-[4-[[2,6-Diamino-3-methyl-5-[(4-sulfophenyl)diazenyl]phenyl]diazenyl]-2-sulfophenyl]ethenyl]-3-sulfophenyl]diazenyl]-2-hydroxy-3-methylbenzoic acid",CC1=CC(=CC(=C1O)C(=O)O)N=NC2=CC(=C(C=C2)C=CC3=C(C=C(C=C3)N=NC4=C(C(=CC(=C4N)N=NC5=CC=C(C=C5)S(=O)(=O)O)C)N)S(=O)(=O)O)S(=O)(=O)O,,,,,,
3216,103217,Einecs 265-461-4,CCCCCCCCCCOP(=O)(O)O.C1COCCN1.C1COCCN1,,,,,,
3217,103218,"Phosphoric acid, decyl ester, compd. with 2,2'-iminobis(ethanol)",CCCCCCCCCCOP(=O)(O)O.C(CO)NCCO,,,,,,
3218,103219,"Sulfuric acid, monodecyl ester, compd. with N,N-diethylcyclohexanamine (1:1)",CCCCCCCCCCOS(=O)(=O)O.CCN(CC)C1CCCCC1,,,,,,
3219,103220,CID 103220,CC1=CC=C(C=C1)S(=O)(=O)[O-].CON1C2=CC=CC=C2C(=C1C3=CC=CC=C3)C=CC4=[N+](C5=NC6=CC=CC=C6N=C5N4CC=C)CC=C,,,,,,
3220,103221,"1,3-Diallyl-2-[2-(1-methoxy-2-phenyl-1H-indole-3-yl)ethenyl]-1H-imidazo[4,5-b]quinoxaline-3-ium",CON1C2=CC=CC=C2C(=C1C3=CC=CC=C3)C=CC4=[N+](C5=NC6=CC=CC=C6N=C5N4CC=C)CC=C,,,,,,
3221,103222,CID 103222,C=CCCCCCCCCCCCCOS(=O)(=O)[O-].[Na+],,,,,,
3222,103223,Tetradec-13-enyl hydrogen sulfate,C=CCCCCCCCCCCCCOS(=O)(=O)O,,,,,,
3223,103224,Tetradec-13-en-1-yl dihydrogen phosphate,C=CCCCCCCCCCCCCOP(=O)(O)O,,,,,,
3224,103225,"Ethanaminium, N-(4-(bis(4-(diethylamino)phenyl)methylene)-2,5-cyclohexadien-1-ylidene)-N-ethyl-, (T-4)-tetrachlorozincate(2-) (2:1)",CCN(CC)C1=CC=C(C=C1)C(=C2C=CC(=[N+](CC)CC)C=C2)C3=CC=C(C=C3)N(CC)CC.CCN(CC)C1=CC=C(C=C1)C(=C2C=CC(=[N+](CC)CC)C=C2)C3=CC=C(C=C3)N(CC)CC.[Cl-].[Cl-].[Cl-].[Cl-].[Zn+2],,,,,,
3225,103226,"2,2'-Iminobisethyl diacetate",CC(=O)OCCNCCOC(=O)C,,,,,,
3226,103227,"Sulfuric acid, monomethyl ester, compd. with 2,2'-(methylimino)bis[ethanol] (1:1)",CN(CCO)CCO.COS(=O)(=O)O,,,,,,
3227,103228,"Ethanol, 2,2'-((3-nitrophenyl)imino)bis-, dibenzoate (ester)",C1=CC=C(C=C1)C(=O)OCCN(CCOC(=O)C2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-],,,,,,
3228,103229,"Ethyl (9,10-dihydro-4-hydroxy-9,10-dioxo-1-anthracenyl)carbamate",CCOC(=O)NC1=C2C(=C(C=C1)O)C(=O)C3=CC=CC=C3C2=O,,,,,,
3229,103230,"4-Oxazolidinone, 3-ethyl-5-[2-(3-ethyl-2-thiazolidinylidene)-1-methylethylidene]-2-thioxo-",CCN1CCSC1=CC(=C2C(=O)N(C(=S)O2)CC)C,,,,,,
3230,103231,"3H-Indolium, 2-[[(4-ethoxyphenyl)methylhydrazono]methyl]-1,3,3-trimethyl-, chloride",CCOC1=CC=C(C=C1)N(C)N=CC2=[N+](C3=CC=CC=C3C2(C)C)C.[Cl-],,,,,,
3231,103232,"2-[[2-(4-Ethoxyphenyl)-2-methylhydrazono]methyl]-1,3,3-trimethyl-3H-indolium",CCOC1=CC=C(C=C1)N(C)N=CC2=[N+](C3=CC=CC=C3C2(C)C)C,,,,,,
3232,103233,Vat Violet 1,C1=CC2=C(C=C1Cl)C(=O)C3=CC=C4C5=C6C(=CC=C7C6=C(C=C5)C8=C(C7=O)C=C(C=C8)Cl)C9=C4C3=C2C=C9,,,,,,
3233,103234,"Acetamide, 2-cyano-N-[(ethylamino)carbonyl]-2-(methoxyimino)-, (2E)-2-butenedioate",CCNC(=O)NC(=O)C(=NOC)C#N.C(=CC(=O)O)C(=O)O,,,,,,
3234,103235,"1,4-Cyclohexanedimethanamine, 1-ethyl-",CCC1(CCC(CC1)CN)CN,,,,,,
3235,103236,"N,N-dimethylcyclohexanamine;octadec-9-enoic acid",CCCCCCCCC=CCCCCCCCC(=O)O.CN(C)C1CCCCC1,,,,,,
3236,103237,Diethanolamine cetyl phosphate,CCCCCCCCCCCCCCCCOP(=O)(O)O.C(CO)NCCO,,,,,,
3237,103238,Einecs 265-485-5,CCCCCCCCCCCCCCCCOP(=O)(O)O.N.N,,,,,,
3238,103239,CID 103239,C=CCCCCCCCCCCCCC=COP(=O)(O)O,,,,,,
3239,103240,"Benzenesulfonic acid, 3,3'-[(9,10-dihydro-9,10-dioxo-1,4-anthracenediyl)diimino]bis[2,4,6-triethyl-",CCC1=CC(=C(C(=C1NC2=C3C(=C(C=C2)NC4=C(C(=C(C=C4CC)CC)S(=O)(=O)O)CC)C(=O)C5=CC=CC=C5C3=O)CC)S(=O)(=O)O)CC,,,,,,
3240,103241,"Benzenemethanol, 4-amino-alpha-(4-amino-2-methylphenyl)-alpha-(2-chlorophenyl)-2-methyl-",CC1=C(C=CC(=C1)N)C(C2=C(C=C(C=C2)N)C)(C3=CC=CC=C3Cl)O,,,,,,
3241,103242,"5(4H)-Isoxazolone, 3-phenyl-4-[2-(phenylamino)ethenyl]-",C1=CC=C(C=C1)C2=NOC(=O)C2C=CNC3=CC=CC=C3,,,,,,
3242,103243,"1,3-Benzenediamine, 4-[(3-aminophenyl)azo]-, monoacetate",CC(=O)O.C1=CC(=CC(=C1)N=NC2=C(C=C(C=C2)N)N)N,,,,,,
3243,103244,"Formic acid, compd. with 4-((3-aminophenyl)azo)-1,3-benzenediamine (1:1)",C1=CC(=CC(=C1)N=NC2=C(C=C(C=C2)N)N)N.C(=O)O,,,,,,
3244,103245,"m-Phenylenediamine, 4-((m-aminophenyl)azo)-, monoglycolate",C1=CC(=CC(=C1)N=NC2=C(C=C(C=C2)N)N)N.C(C(=O)O)O,,,,,,
3245,103246,"1H-Benz[de]isoquinoline-1,3(2H)-dione, 6,7-dimethoxy-2-(phenylmethyl)-",COC1=C2C(=CC=C3C2=C(C=C1)C(=O)N(C3=O)CC4=CC=CC=C4)OC,,,,,,
3246,103247,"2-Propenoic acid, 2-methyl-, 2-[4-[1-methyl-1-[4-[2-[2-[(2-methyl-1-oxo-2-propenyl)oxy]ethoxy]ethoxy]phenyl]ethyl]phenoxy]ethyl ester",CC(=C)C(=O)OCCOCCOC1=CC=C(C=C1)C(C)(C)C2=CC=C(C=C2)OCCOC(=O)C(=C)C,,,,,,
3247,103248,"Methanaminium, N-(4-(bis(4-(dimethylamino)phenyl)methylene)-2,5-cyclohexadien-1-ylidene)-N-methyl-, (T-4)-tetrachlorozincate(2-) (2:1)",CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=C(C=C3)N(C)C.CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=C(C=C3)N(C)C.[Cl-].[Cl-].[Cl-].[Cl-].[Zn+2],,,,,,
3248,103249,"1,4-Benzenediamine, N,N,N'-tris(1-methylethyl)-",CC(C)NC1=CC=C(C=C1)N(C(C)C)C(C)C,,,,,,
3249,103250,"Phosphoric acid, monodecyl ester, monoammonium salt",CCCCCCCCCCOP(=O)(O)O.N,,,,,,
3250,103251,"Phosphoric acid, monodecyl ester, diammonium salt",CCCCCCCCCCOP(=O)(O)O.N.N,,,,,,
3251,103252,Azane;dodecyl dihydrogen phosphate,CCCCCCCCCCCCOP(=O)(O)O.N.N,,,,,,
3252,103253,Ammonium dodecyl hydrogen phosphate,CCCCCCCCCCCCOP(=O)(O)O.N,,,,,,
3253,103254,"1H-Isoindole-1,3(2H)-dione, 2-(9,10-dihydro-4,5-dinitro-9,10-dioxo-1-anthracenyl)-",C1=CC=C2C(=C1)C(=O)N(C2=O)C3=C4C(=C(C=C3)[N+](=O)[O-])C(=O)C5=C(C4=O)C=CC=C5[N+](=O)[O-],,,,,,
3254,103255,"Calcium bis(ethyl 3,5-di-tert-butyl-4-hydroxybenzylphosphonate)",CCOP(=O)(CC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C)[O-].CCOP(=O)(CC1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C)[O-].[Ca+2],,,,,,
3255,103256,"Carbamic acid, (aminoiminomethyl)methyl-, dimethyl deriv., ethyl ester",CCOC(=O)NCC(=NC)NC,,,,,,
3256,103257,"1,3,6-Naphthalenetrisulfonic acid, 8-hydroxy-7-[[4'-[(2-hydroxy-1-naphthalenyl)azo][1,1'-biphenyl]-4-yl]azo]-, trilithium salt",[Li+].[Li+].[Li+].C1=CC=C2C(=C1)C=CC(=C2N=NC3=CC=C(C=C3)C4=CC=C(C=C4)N=NC5=C(C6=C(C=C(C=C6C=C5S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])O)O,,,,,,
3257,103258,C.I. Direct Violet 22,C1=CC=C2C(=C1)C=CC(=C2N=NC3=CC=C(C=C3)C4=CC=C(C=C4)N=NC5=C(C6=C(C=C(C=C6C=C5S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)O)O,,,,,,
3258,103259,"1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14,15,15,16,16-Tritriacontafluoro-18-iodooctadecane",C(CI)C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
3259,103260,"7-((4-Amino-3-methoxyphenyl)azo)-1,3-naphthalenedisulfonic acid, disodium salt",COC1=C(C=CC(=C1)N=NC2=CC3=C(C=C(C=C3C=C2)S(=O)(=O)[O-])S(=O)(=O)[O-])N.[Na+].[Na+],,,,,,
3260,103261,"1,3-Naphthalenedisulfonic acid, 7-((4-amino-3-methoxyphenyl)azo)-",COC1=C(C=CC(=C1)N=NC2=CC3=C(C=C(C=C3C=C2)S(=O)(=O)O)S(=O)(=O)O)N,,,,,,
3261,103262,"1,5-Naphthalenedisulfonic acid, 3-[(4-amino-2-methoxy-5-methylphenyl)azo]-",CC1=CC(=C(C=C1N)OC)N=NC2=CC3=C(C=CC=C3S(=O)(=O)O)C(=C2)S(=O)(=O)O,,,,,,
3262,103263,"1,3-Naphthalenedisulfonic acid, 7-[[4-[[4-[(4-amino-2-methylphenyl)azo]-2-methylphenyl]azo]-2-methylphenyl]azo]-",CC1=C(C=CC(=C1)N)N=NC2=CC(=C(C=C2)N=NC3=CC(=C(C=C3)N=NC4=CC5=C(C=C(C=C5C=C4)S(=O)(=O)O)S(=O)(=O)O)C)C,,,,,,
3263,103264,"1,3-Naphthalenedisulfonic acid, 7,7'-[(4,6-dihydroxy-1,3-phenylene)bis(azo)]bis-",C1=CC(=CC2=C(C=C(C=C21)S(=O)(=O)O)S(=O)(=O)O)N=NC3=CC(=C(C=C3O)O)N=NC4=CC5=C(C=C(C=C5C=C4)S(=O)(=O)O)S(=O)(=O)O,,,,,,
3264,103265,Einecs 265-533-5,COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C4C=C(C=CC4=CC(=C3O)S(=O)(=O)[O-])S(=O)(=O)[O-])OC)N=NC5=C6C=CC(=CC6=CC(=C5O)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
3265,103266,"3-Hydroxy-4-[[4-[4-[(2-hydroxy-3,6-disulfonaphthalen-1-yl)diazenyl]-3-methoxyphenyl]-2-methoxyphenyl]diazenyl]naphthalene-2,6-disulfonic acid",COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C4C=C(C=CC4=CC(=C3O)S(=O)(=O)O)S(=O)(=O)O)OC)N=NC5=C6C=CC(=CC6=CC(=C5O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
3266,103267,"1,3-Naphthalenedisulfonic acid, 7-((3-methoxy-4-((sulfomethyl)amino)phenyl)azo)-, monosodium salt",COC1=C(C=CC(=C1)N=NC2=CC3=C(C=C(C=C3C=C2)S(=O)(=O)[O-])S(=O)(=O)[O-])NCS(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
3267,103268,"7-[[3-Methoxy-4-(sulfomethylamino)phenyl]diazenyl]naphthalene-1,3-disulfonic acid",COC1=C(C=CC(=C1)N=NC2=CC3=C(C=C(C=C3C=C2)S(=O)(=O)O)S(=O)(=O)O)NCS(=O)(=O)O,,,,,,
3268,103269,"1,3-Naphthalenedisulfonic acid, 7-((2-methyl-4-((4-nitrobenzoyl)amino)phenyl)azo)-, disodium salt",CC1=C(C=CC(=C1)NC(=O)C2=CC=C(C=C2)[N+](=O)[O-])N=NC3=CC4=C(C=C(C=C4C=C3)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
3269,103270,"7-[[2-Methyl-4-[(4-nitrobenzoyl)amino]phenyl]diazenyl]naphthalene-1,3-disulfonic acid",CC1=C(C=CC(=C1)NC(=O)C2=CC=C(C=C2)[N+](=O)[O-])N=NC3=CC4=C(C=C(C=C4C=C3)S(=O)(=O)O)S(=O)(=O)O,,,,,,
3270,103271,Hexadecyl morpholinium hydrogen phosphate,CCCCCCCCCCCCCCCCOP(=O)(O)O.C1COCCN1,,,,,,
3271,103272,Dimorpholinium hexadecyl phosphate,CCCCCCCCCCCCCCCCOP(=O)(O)O.C1COCCN1.C1COCCN1,,,,,,
3272,103273,"Benzenemethanaminium, N-hexadecyl-N,N-bis(2-hydroxyethyl)-, chloride",CCCCCCCCCCCCCCCC[N+](CCO)(CCO)CC1=CC=CC=C1.[Cl-],,,,,,
3273,103274,"N-Hexadecyl-N,N-bis(2-hydroxyethyl)benzenemethanaminium",CCCCCCCCCCCCCCCC[N+](CCO)(CCO)CC1=CC=CC=C1,,,,,,
3274,103275,Hexadecylbis(2-hydroxypropyl)benzylammonium chloride,CCCCCCCCCCCCCCCC[N+](CC1=CC=CC=C1)(CC(C)O)CC(C)O.[Cl-],,,,,,
3275,103276,"N,N-Bis(2-hydroxypropyl)-N-hexadecylbenzenemethanaminium",CCCCCCCCCCCCCCCC[N+](CC1=CC=CC=C1)(CC(C)O)CC(C)O,,,,,,
3276,103277,Cyclohexyldiethylammonium hexadecyl sulphate,CCCCCCCCCCCCCCCCOS(=O)(=O)O.CCN(CC)C1CCCCC1,,,,,,
3277,103278,"Benzenamine, 4,4'-[(2,6-dichlorophenyl)methylene]bis[2,6-dimethyl-",CC1=CC(=CC(=C1N)C)C(C2=CC(=C(C(=C2)C)N)C)C3=C(C=CC=C3Cl)Cl,,,,,,
3278,103279,"Disulfide, bis(3,5-dimethylphenyl)",CC1=CC(=CC(=C1)SSC2=CC(=CC(=C2)C)C)C,,,,,,
3279,103280,Choline methyl sulphate,C[N+](C)(C)CCO.COS(=O)(=O)[O-],,,,,,
3280,103281,"4,5-Dicyano-1H-imidazole-2-diazonium chloride",C(#N)C1=C(N=C(N1)[N+]#N)C#N.[Cl-],,,,,,
3281,103282,"4,5-dicyano-1H-imidazole-2-diazonium",C(#N)C1=C(N=C(N1)[N+]#N)C#N,,,,,,
3282,103283,"1H-Imidazo[4,5-b]quinoxalinium, 2-[2-(2,5-dihydro-2-methyl-5-oxo-3-phenyl-4-isoxazolyl)ethenyl]-1,3-dimethyl-, salt with 4-methylbenzenesulfonic acid (1:1)",CC1=CC=C(C=C1)S(=O)(=O)[O-].CN1C(=[N+](C2=NC3=CC=CC=C3N=C21)C)C=CC4=C(N(OC4=O)C)C5=CC=CC=C5,,,,,,
3283,103284,"1,3-Dimethyl-2-[2-(2-methyl-3-phenyl-5-oxo-2,5-dihydroisoxazole-4-yl)ethenyl]-1H-imidazo[4,5-b]quinoxaline-3-ium",CN1C(=[N+](C2=NC3=CC=CC=C3N=C21)C)C=CC4=C(N(OC4=O)C)C5=CC=CC=C5,,,,,,
3284,103285,"1H-Indene-5-carboxamide, 2-(3,4-dihydro-3-oxo-2-quinolinyl)-N-(4-dodecylphenyl)-2,3-dihydro-1,3-dioxo-",CCCCCCCCCCCCC1=CC=C(C=C1)NC(=O)C2=CC3=C(C=C2)C(=O)C(C3=O)C4=NC5=CC=CC=C5CC4=O,,,,,,
3285,103286,Diammonium octadecyl phosphate,CCCCCCCCCCCCCCCCCCOP(=O)(O)O.N.N,,,,,,
3286,103287,2-(2-Hydroxyethylamino)ethanol;octadecyl dihydrogen phosphate,CCCCCCCCCCCCCCCCCCOP(=O)(O)O.C(CO)NCCO.C(CO)NCCO,,,,,,
3287,103288,Morpholine;octadecyl dihydrogen phosphate,CCCCCCCCCCCCCCCCCCOP(=O)(O)O.C1COCCN1,,,,,,
3288,103289,Morpholine;octadecyl dihydrogen phosphate,CCCCCCCCCCCCCCCCCCOP(=O)(O)O.C1COCCN1.C1COCCN1,,,,,,
3289,103290,"Sulfuric acid, monooctadecyl ester, compd. with N,N-diethylcyclohexanamine (1:1)",CCCCCCCCCCCCCCCCCCOS(=O)(=O)O.CCN(CC)C1CCCCC1,,,,,,
3290,103291,"Phosphoric acid, octyl ester, compd. with 2,2'-iminobis[ethanol] (1:1)",CCCCCCCCOP(=O)(O)O.C(CO)NCCO,,,,,,
3291,103292,CID 103292,CCCCCCCCOP(=O)(O)O.C1COCCN1,,,,,,
3292,103293,Octyl dihydrogen phosphate-morpholine(1:2),CCCCCCCCOP(=O)(O)O.C1COCCN1.C1COCCN1,,,,,,
3293,103294,Hexadec-15-en-1-yl dihydrogen phosphate,C=CCCCCCCCCCCCCCCOP(=O)(O)O,,,,,,
3294,103295,"2,4-Diisobutylphenol",CC(C)CC1=CC(=C(C=C1)O)CC(C)C,,,,,,
3295,103296,"3-Thiazolidineacetic acid, 5-[(3-methyl-2-thiazolidinylidene)ethylidene]-4-oxo-2-thioxo-",CN1CCSC1=CC=C2C(=O)N(C(=S)S2)CC(=O)O,,,,,,
3296,103297,"1,6-Naphthalenedisulfonic acid, 4-amino-3-[[4'-[(1-amino-4-sulfo-2-naphthalenyl)azo]-3,3'-dimethyl[1,1'-biphenyl]-4-yl]azo]-, trisodium salt",CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C4=CC=CC=C4C(=C3)S(=O)(=O)[O-])N)C)N=NC5=CC(=C6C=CC(=CC6=C5N)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
3297,103298,"4-Amino-3-[[4-[4-[(1-amino-4-sulfonaphthalen-2-yl)diazenyl]-3-methylphenyl]-2-methylphenyl]diazenyl]naphthalene-1,6-disulfonic acid",CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C4=CC=CC=C4C(=C3)S(=O)(=O)O)N)C)N=NC5=CC(=C6C=CC(=CC6=C5N)S(=O)(=O)O)S(=O)(=O)O,,,,,,
3298,103299,"Trisodium 4-amino-3-[(e)-{4'-[(e)-(1-amino-4-sulfonatonaphthalen-2-yl)diazenyl]-3,3'-dimethylbiphenyl-4-yl}diazenyl]naphthalene-1,7-disulfonate",CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C4=CC=CC=C4C(=C3)S(=O)(=O)[O-])N)C)N=NC5=CC(=C6C=C(C=CC6=C5N)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
3299,103300,"4-Amino-3-[[4-[4-[(1-amino-4-sulfonaphthalen-2-yl)diazenyl]-3-methylphenyl]-2-methylphenyl]diazenyl]naphthalene-1,7-disulfonic acid",CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C4=CC=CC=C4C(=C3)S(=O)(=O)O)N)C)N=NC5=CC(=C6C=C(C=CC6=C5N)S(=O)(=O)O)S(=O)(=O)O,,,,,,
3300,103301,"2-Naphthalenesulfonic acid, 1-amino-4-[(5-chloro-4-methyl-2-sulfophenyl)azo]-, calcium salt (1:1)",CC1=CC(=C(C=C1Cl)N=NC2=CC(=C(C3=CC=CC=C32)N)S(=O)(=O)[O-])S(=O)(=O)[O-].[Ca+2],,,,,,
3301,103302,1-Amino-4-[(5-chloro-4-methyl-2-sulfophenyl)azo]-2-naphthalenesulfonic acid,CC1=CC(=C(C=C1Cl)N=NC2=CC(=C(C3=CC=CC=C32)N)S(=O)(=O)O)S(=O)(=O)O,,,,,,
3302,103303,"2-Naphthalenesulfonic acid, 1-amino-4-[(5-chloro-4-methyl-2-sulfophenyl)azo]-, strontium salt (1:1)",CC1=CC(=C(C=C1Cl)N=NC2=CC(=C(C3=CC=CC=C32)N)S(=O)(=O)[O-])S(=O)(=O)[O-].[Sr+2],,,,,,
3303,103304,"2-Naphthalenesulfonic acid, 6-amino-4-hydroxy-5-[[2-(trifluoromethyl)phenyl]azo]-, compd. with 2,2'-iminobis[ethanol] (1:1)",C1=CC=C(C(=C1)C(F)(F)F)N=NC2=C(C=CC3=CC(=CC(=C32)O)S(=O)(=O)O)N.C(CO)NCCO,,,,,,
3304,103305,"2-Naphthalenesulfonic acid, 6-amino-4-hydroxy-5-((2-(trifluoromethyl)phenyl)azo)-",C1=CC=C(C(=C1)C(F)(F)F)N=NC2=C(C=CC3=CC(=CC(=C32)O)S(=O)(=O)O)N,,,,,,
3305,103306,"2-Naphthalenesulfonic acid, 1-amino-4-[(4-methyl-2-sulfophenyl)azo]-, calcium salt (1:1)",CC1=CC(=C(C=C1)N=NC2=CC(=C(C3=CC=CC=C32)N)S(=O)(=O)[O-])S(=O)(=O)[O-].[Ca+2],,,,,,
3306,103307,1-Amino-4-[(4-methyl-2-sulfophenyl)diazenyl]naphthalene-2-sulfonic acid,CC1=CC(=C(C=C1)N=NC2=CC(=C(C3=CC=CC=C32)N)S(=O)(=O)O)S(=O)(=O)O,,,,,,
3307,103308,"2-Naphthalenesulfonic acid, 3-(phenylazo)-7,7'-ureylenebis(4-hydroxy-, disodium salt",C1=CC=C(C=C1)N=NC2=C(C=C3C=C(C=CC3=C2O)NC(=O)NC4=CC5=CC(=CC(=C5C=C4)O)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
3308,103309,4-Hydroxy-7-[(5-hydroxy-7-sulfonaphthalen-2-yl)carbamoylamino]-3-phenyldiazenylnaphthalene-2-sulfonic acid,C1=CC=C(C=C1)N=NC2=C(C=C3C=C(C=CC3=C2O)NC(=O)NC4=CC5=CC(=CC(=C5C=C4)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
3309,103310,Isononyl propionate,CCC(=O)OCCCCCCC(C)C,,,,,,
3310,103311,"2-[[5-Methyl-3-(3-sulfopropyl)-2(3H)-benzothiazolylidene]methyl]-1-(3-sulfopropyl)quinolinium hydroxide, inner salt",CC1=CC2=C(C=C1)SC(=CC3=[N+](C4=CC=CC=C4C=C3)CCCS(=O)(=O)[O-])N2CCCS(=O)(=O)O,,,,,,
3311,103312,1-(3-Sulfopropyl)-2-[3-(3-sulfopropyl)-5-methylbenzothiazole-2(3H)-ylidenemethyl]quinolinium,CC1=CC2=C(C=C1)SC(=CC3=[N+](C4=CC=CC=C4C=C3)CCCS(=O)(=O)O)N2CCCS(=O)(=O)O,,,,,,
3312,103313,"1,3-Naphthalenedisulfonic acid, 7-[(4-amino-2-methoxy-5-methylphenyl)azo]-",CC1=CC(=C(C=C1N)OC)N=NC2=CC3=C(C=C(C=C3C=C2)S(=O)(=O)O)S(=O)(=O)O,,,,,,
3313,103314,"5-[[4-[Bis[2-(2-chloroethylsulfonyl)ethyl]amino]-6-chloro-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[(4-sulfophenyl)diazenyl]naphthalene-2,7-disulfonic acid",C1=CC(=CC=C1N=NC2=C(C3=C(C=C(C=C3C=C2S(=O)(=O)O)S(=O)(=O)O)NC4=NC(=NC(=N4)Cl)N(CCS(=O)(=O)CCCl)CCS(=O)(=O)CCCl)O)S(=O)(=O)O,,,,,,
3314,103315,"N,N'-Bis(3-methylphenyl)-N,N'-bis(phenyl)benzidine",CC1=CC(=CC=C1)N(C2=CC=CC=C2)C3=CC=C(C=C3)C4=CC=C(C=C4)N(C5=CC=CC=C5)C6=CC=CC(=C6)C,,,,,,
3315,103316,2-[(2-Hydroxyethyl)(1-oxohexadecyl)amino]ethyl palmitate,CCCCCCCCCCCCCCCC(=O)N(CCO)CCOC(=O)CCCCCCCCCCCCCCC,,,,,,
3316,103317,Trisodium 7-((((6-((o-anisyl)azo)-5-hydroxy-7-sulphonato-2-naphthyl)amino)carbonyl)amino)-4-hydroxy-3-((6-sulphonato-2-naphthyl)azo)naphthalene-2-sulphonate,COC1=CC=CC=C1N=NC2=C(C=C3C=C(C=CC3=C2O)NC(=O)NC4=CC5=CC(=C(C(=C5C=C4)O)N=NC6=CC7=C(C=C6)C=C(C=C7)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
3317,103318,4-Hydroxy-7-[[[[5-hydroxy-6-(2-methoxyphenylazo)-7-sulfo-2-naphthalenyl]amino]carbonyl]amino]-3-(6-sulfo-2-naphthalenylazo)-2-naphthalenesulfonic acid,COC1=CC=CC=C1N=NC2=C(C=C3C=C(C=CC3=C2O)NC(=O)NC4=CC5=CC(=C(C(=C5C=C4)O)N=NC6=CC7=C(C=C6)C=C(C=C7)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
3318,103319,"[1,1'-Biphenyl]-4-carboxylic acid, 4'-pentyl-, 2-cyano-4-heptylphenyl ester",CCCCCCCC1=CC(=C(C=C1)OC(=O)C2=CC=C(C=C2)C3=CC=C(C=C3)CCCCC)C#N,,,,,,
3319,103320,"Carbamic acid, (aminoiminomethyl)methyl-, dimethyl deriv., ethyl ester, monohydrochloride",CCOC(=O)N(C)C=NN(C)C.Cl,,,,,,
3320,103321,ethyl N-[(dimethylhydrazinylidene)methyl]-N-methylcarbamate,CCOC(=O)N(C)C=NN(C)C,,,,,,
3321,103322,"1-Hydroxy-4-nitro-N,N-dioctadecylnaphthalene-2-carboxamide",CCCCCCCCCCCCCCCCCCN(CCCCCCCCCCCCCCCCCC)C(=O)C1=C(C2=CC=CC=C2C(=C1)[N+](=O)[O-])O,,,,,,
3322,103323,"1-(2-((4-((2-Chloro-4-nitrophenyl)azo)-m-tolyl)ethylamino)ethyl)pyrrolidine-2,5-dione",CCN(CCN1C(=O)CCC1=O)C2=CC(=C(C=C2)N=NC3=C(C=C(C=C3)[N+](=O)[O-])Cl)C,,,,,,
3323,103324,"1H-Isoindole-1,3(2H)-dione, 2-[2-[ethyl[4-[(4-nitrophenyl)azo]phenyl]amino]ethyl]-",CCN(CCN1C(=O)C2=CC=CC=C2C1=O)C3=CC=C(C=C3)N=NC4=CC=C(C=C4)[N+](=O)[O-],,,,,,
3324,103325,"6-(2,2-Dicyanovinyl)-1-(2-(2-benzothiazolylthio)ethyl)-1,2,3,4-tetrahydro-2,2,4-trimethylquinoline",CC1CC(N(C2=C1C=C(C=C2)C=C(C#N)C#N)CCSC3=NC4=CC=CC=C4S3)(C)C,,,,,,
3325,103326,"Acetamide, N-[2-[(2,6-dibromo-4-nitrophenyl)azo]-5-[[2-(2-ethoxyethoxy)ethyl]ethylamino]phenyl]-",CCN(CCOCCOCC)C1=CC(=C(C=C1)N=NC2=C(C=C(C=C2Br)[N+](=O)[O-])Br)NC(=O)C,,,,,,
3326,103327,"2-Naphthalenecarboxamide, 1-hydroxy-4-((4-methoxyphenyl)azo)-N-(2-(3-pentadecylphenoxy)butyl)-",CCCCCCCCCCCCCCCC1=CC(=CC=C1)OC(CC)CNC(=O)C2=C(C3=CC=CC=C3C(=C2)N=NC4=CC=C(C=C4)OC)O,,,,,,
3327,103328,"2-Naphthalenecarboxamide, 4-amino-1-hydroxy-N,N-dioctadecyl-",CCCCCCCCCCCCCCCCCCN(CCCCCCCCCCCCCCCCCC)C(=O)C1=C(C2=CC=CC=C2C(=C1)N)O,,,,,,
3328,103329,"2-Naphthalenecarboxylic acid, 1-hydroxy-4-nitro-, phenyl ester",C1=CC=C(C=C1)OC(=O)C2=C(C3=CC=CC=C3C(=C2)[N+](=O)[O-])O,,,,,,
3329,103330,CID 103330,CC1=CC(=O)N(C(=N1)[O-])CC(C)C.[Na+],,,,,,
3330,103331,3-Isobutyl-6-methyluracil,CC1=CC(=O)N(C(=O)N1)CC(C)C,,,,,,
3331,103332,"Titanium, tetrakis((2-ethyl-3-hydroxyhexyl)oxy)-",[H+].[H+].[H+].[H+].CCCC(C(CC)C[O-])[O-].CCCC(C(CC)C[O-])[O-].CCCC(C(CC)C[O-])[O-].CCCC(C(CC)C[O-])[O-].[Ti+4],,,,,,
3332,103333,"4-Furazancarboxamide, N,5-dimethyl-",CC1=NON=C1C(=O)NC,,,,,,
3333,103334,Monoammonium 4-sulfophthalate,C1=CC(=C(C=C1S(=O)(=O)[O-])C(=O)O)C(=O)O.[NH4+],,,,,,
3334,103335,"Molybdate (Mo2O72-), dihydrogen, compd. with 1,3,5-triazine-2,4,6-triamine (1:1)",C.C1(=NC(=NC(=N1)N)N)N.C1(=NC(=NC(=N1)N)N)N,,,,,,
3335,103336,"1,8-Diamino-2,7-dibromo-4,5-dihydroxyanthraquinone",C1=C(C2=C(C(=C1Br)N)C(=O)C3=C(C2=O)C(=CC(=C3N)Br)O)O,,,,,,
3336,103337,"n,n-Dimethyl-3-phenoxybenzamide",CN(C)C(=O)C1=CC(=CC=C1)OC2=CC=CC=C2,,,,,,
3337,103338,"Benzamide, 3-(2,5-dimethylphenoxy)-N-methyl-",CC1=CC(=C(C=C1)C)OC2=CC=CC(=C2)C(=O)NC,,,,,,
3338,103339,3-Chloro-5-methoxyphenol,COC1=CC(=CC(=C1)O)Cl,,,,,,
3339,103340,1-Hexanesulfonyl fluoride,CCCCCCS(=O)(=O)F,,,,,,
3340,103341,"2,7-Naphthalenedisulfonic acid, 5-((4-chloro-6-(methylphenylamino)-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-((4-methoxy-2-sulfophenyl)azo)-",CN(C1=CC=CC=C1)C2=NC(=NC(=N2)NC3=C4C(=CC(=C3)S(=O)(=O)O)C=C(C(=C4O)N=NC5=C(C=C(C=C5)OC)S(=O)(=O)O)S(=O)(=O)O)Cl,,,,,,
3341,103342,Disodium 4-[2-(12-hydroxyoctadec-9-enamido)ethoxy]-4-oxo-3-sulfonatobutanoate,CCCCCCC(CC=CCCCCCCCC(=O)NCCOC(=O)C(CC(=O)[O-])S(=O)(=O)[O-])O.[Na+].[Na+],,,,,,
3342,103343,4-[2-(12-Hydroxyoctadec-9-enoylamino)ethoxy]-4-oxo-3-sulfobutanoic acid,CCCCCCC(CC=CCCCCCCCC(=O)NCCOC(=O)C(CC(=O)O)S(=O)(=O)O)O,,,,,,
3343,103344,"1,4,6,10,12,15,16,19-Octaoxatrispiro[4.2.2.4.2.2]nonadecane",C1COC2(O1)OCC3(CO2)COC4(OCCO4)OC3,,,,,,
3344,103345,"Benzothiazolium, 2,5-dimethyl-3-(3-sulfopropyl)-, inner salt",CC1=CC2=C(C=C1)SC(=[N+]2CCCS(=O)(=O)[O-])C,,,,,,
3345,103346,"3-(2,5-Dimethyl-1,3-benzothiazol-3-ium-3-YL)-1-propanesulfonate",CC1=CC2=C(C=C1)SC(=[N+]2CCCS(=O)(=O)O)C,,,,,,
3346,103347,"Ethanamine, N-ethyl-N-hydroxy-, sulfate (1:1) (salt)",CCN(CC)O.OS(=O)(=O)O,,,,,,
3347,103348,CID 103348,C1CSC(=CC=C(C#N)S(=O)(=O)CCCCCCCCCCC(=O)[O-])N1CCCS(=O)(=O)[O-].[Na+].[Na+],,,,,,
3348,103349,CID 103349,C1CSC(=CC=C(C#N)S(=O)(=O)CCCCCCCCCCC(=O)O)N1CCCS(=O)(=O)O,,,,,,
3349,103350,CID 103350,CCCCCCCCCCCCC(C(=O)NC1=CC(=C(C=C1)Cl)NC2=NN(C(=O)C2N=NC3=CC(=C(C=C3)OC)OC)C4=C(C=C(C=C4Cl)Cl)Cl)OC5=CC(=C(C=C5)O)C(C)(C)C,,,,,,
3350,103351,"2-Butanol, 4,4'-(1,2-ethanediyldinitrilo)bis-",CC(CC=NCCN=CCC(C)O)O,,,,,,
3351,103352,"Benzenesulfonamide, N-(6-chloro-8-((4-(diethylamino)-2-methylphenyl)imino)-5,8-dihydro-5-oxo-1-naphthalenyl)-4-methyl-",CCN(CC)C1=CC(=C(C=C1)N=C2C=C(C(=O)C3=C2C(=CC=C3)NS(=O)(=O)C4=CC=C(C=C4)C)Cl)C,,,,,,
3352,103353,"9,10-Anthracenedione, 1,4,5,8-tetrakis((3-(dimethylamino)propyl)amino)-",CN(C)CCCNC1=C2C(=C(C=C1)NCCCN(C)C)C(=O)C3=C(C=CC(=C3C2=O)NCCCN(C)C)NCCCN(C)C,,,,,,
3353,103354,"1-Tridecanol, dihydrogen phosphate, compd. with N,N-dimethylcyclohexanamine (1:2)",CCCCCCCCCCCCCOP(=O)(O)O.CN(C)C1CCCCC1.CN(C)C1CCCCC1,,,,,,
3354,103355,"1-Tridecanol, hydrogen phosphate, compd. with N,N-dimethylcyclohexanamine (1:1)",CCCCCCCCCCCCCOP(=O)(O)OCCCCCCCCCCCCC.CN(C)C1CCCCC1,,,,,,
3355,103356,"2,2-Bis(3,4-dimethylphenyl)hexafluoropropane",CC1=C(C=C(C=C1)C(C2=CC(=C(C=C2)C)C)(C(F)(F)F)C(F)(F)F)C,,,,,,
3356,103357,CID 103357,CCCC[Sn]CCCC.CCCC[Sn]CCCC.CC(C)CCCCCOC(=O)C[S-].CC(C)CCCCCOC(=O)C[S-].C(COC(=O)C[S-])OC(=O)C[S-],,,,,,
3357,103358,"Decanoic acid, monoamide with N-(2-aminoethyl)-1,2-ethanediamine",CCCCCCCCCC(=O)NCCNCCN,,,,,,
3358,103359,1-(1-Naphthylmethyl)quinolinium chloride,C1=CC=C2C(=C1)C=CC=C2C[N+]3=CC=CC4=CC=CC=C43.[Cl-],,,,,,
3359,103360,1-(1-Naphthylmethyl)quinolinium,C1=CC=C2C(=C1)C=CC=C2C[N+]3=CC=CC4=CC=CC=C43,,,,,,
3360,103361,CID 103361,C1=CC(=CC=C1C(=O)O)NNC(=CN=NC2=CC=C(C=C2)C(=O)O)C(C(C(CO)O)O)O,,,,,,
3361,103362,"Benzamide, N-[4,5-dihydro-5-oxo-1-(2,4,6-trichlorophenyl)-1H-pyrazol-3-yl]-3-[[1-oxo-2-(3-pentadecylphenoxy)butyl]amino]-",CCCCCCCCCCCCCCCC1=CC(=CC=C1)OC(CC)C(=O)NC2=CC=CC(=C2)C(=O)NC3=NN(C(=O)C3)C4=C(C=C(C=C4Cl)Cl)Cl,,,,,,
3362,103363,Diacryl glycolyl titanate,C=CC(=O)O.C=CC(=O)O.C(C(=O)O)O.[Ti],,,,,,
3363,103364,"1-(Carboxylatomethyl)-2-heptadecyl-4,5-dihydro-1-[2-[(1-oxooctadecyl)amino]ethyl]imidazolium",CCCCCCCCCCCCCCCCCC1=NCC[N+]1(CCNC(=O)CCCCCCCCCCCCCCCCC)CC(=O)O,,,,,,
3364,103365,"[1,1'-Bicyclohexyl]-4-carbonitrile, 4'-propyl-, (trans,trans)-",CCCC1CCC(CC1)C2CCC(CC2)C#N,,,,,,
3365,103366,"[1,1'-Bicyclohexyl]-4-carbonitrile, 4'-pentyl-, (trans,trans)-",CCCCCC1CCC(CC1)C2CCC(CC2)C#N,,,,,,
3366,103367,"[1,1'-Bicyclohexyl]-4-carbonitrile, 4'-heptyl-, (trans,trans)-",CCCCCCCC1CCC(CC1)C2CCC(CC2)C#N,,,,,,
3367,103368,"7H,9H-(1)Benzopyrano(3',2':3,4)pyrido(2,1-b)quinazoline-6-carbonitrile, 3-(diethylamino)-7-imino-",CCN(CC)C1=CC2=C(C=C1)C=C3C(=C(C(=N)N4C3=NC5=CC=CC=C5C4)C#N)O2,,,,,,
3368,103369,"1,1,6,6-Tetraphosphono-1,6-dihydroxyhexane",C(CCC(O)(P(=O)(O)O)P(=O)(O)O)CC(O)(P(=O)(O)O)P(=O)(O)O,,,,,,
3369,103370,"Benzamide, N-[3-[(2-hydroxyethyl)sulfonyl]phenyl]-4-nitro-",C1=CC(=CC(=C1)S(=O)(=O)CCO)NC(=O)C2=CC=C(C=C2)[N+](=O)[O-],,,,,,
3370,103371,Dipotassium 2-phenoxyethyl phosphate,C1=CC=C(C=C1)OCCOP(=O)([O-])[O-].[K+].[K+],,,,,,
3371,103372,"Ethanol, 2-phenoxy-, phosphate",C1=CC=C(C=C1)OCCOP(=O)(O)O,,,,,,
3372,103373,"4H-1-Benzopyran-4-one, 2,3-dihydro-6,7-dimethoxy-2,2-dimethyl-",CC1(CC(=O)C2=CC(=C(C=C2O1)OC)OC)C,,,,,,
3373,103374,"4-Hydroxy-2,2,6,6-tetramethylpiperidine-4-carboxylic acid",CC1(CC(CC(N1)(C)C)(C(=O)O)O)C,,,,,,
3374,103375,"1-Undecene, 11,11-dimethoxy-",COC(CCCCCCCCC=C)OC,,,,,,
3375,103376,Cyclohexyl cyclopent-2-ene-1-acetate,C1CCC(CC1)OC(=O)CC2CCC=C2,,,,,,
3376,103377,"1-Naphthalenol, 1,2,3,4,4a,7,8,8a-octahydro-2,4a,5,8a-tetramethyl-, 1-formate",CC1CCC2(C(=CCCC2(C1OC=O)C)C)C,,,,,,
3377,103378,"2-(3,7-Dimethylocta-2,6-dienoxy)acetaldehyde",CC(=CCCC(=CCOCC=O)C)C,,,,,,
3378,103379,"Benzoic acid, 2-hydroxy-, (3Z)-3-hexenyl ester",CCC=CCCOC(=O)C1=CC=CC=C1O,,,,,,
3379,103380,But-2-enoic acid hex-3-enyl ester,CCC=CCCOC(=O)C=CC,,,,,,
3380,103381,"Cyclohexenebutanal, alpha,2,2,6-tetramethyl-",CC1=CCCC(C1C(C)CCC=O)(C)C,,,,,,
3381,103382,3-Methylpent-3-enyl 2-hydroxybenzoate,CC=C(C)CCOC(=O)C1=CC=CC=C1O,,,,,,
3382,103383,3-Methylpent-3-enyl 2-methylpropanoate,CC=C(C)CCOC(=O)C(C)C,,,,,,
3383,103384,"3,5-Diethyl-2,6-dimethylcyclohex-2-en-1-one",CCC1CC(=C(C(=O)C1C)C)CC,,,,,,
3384,103385,"1,3-Dioxane, 4,5,6-trimethyl-2-(phenylmethyl)-",CC1C(OC(OC1C)CC2=CC=CC=C2)C,,,,,,
3385,103386,"Ethanone, 1-bicyclo[2.2.1]hept-5-en-2-yl-, oxime",CC(=NO)C1CC2CC1C=C2,,,,,,
3386,103387,"Benzeneacetic acid, 2,2,2-trichloro-1-phenylethyl ester",C1=CC=C(C=C1)CC(=O)OC(C2=CC=CC=C2)C(Cl)(Cl)Cl,,,,,,
3387,103388,"2,6,10,10-Tetramethyl-1-oxaspiro(4.5)decan-7-one",CC1CCC2(O1)C(C(=O)CCC2(C)C)C,,,,,,
3388,103389,"Cyclohexene, 2-(3-ethoxy-1-butenyl)-1,3,3-trimethyl-",CCOC(C)C=CC1=C(CCCC1(C)C)C,,,,,,
3389,103390,Hex-3-en-1-yl 3-methylbut-2-enoate,CCC=CCCOC(=O)C=C(C)C,,,,,,
3390,103391,CID 103391,CC(CCC=C(C)C)CC(O)S(=O)(=O)[O-].[Na+],,,,,,
3391,103392,"1-Hydroxy-3,7-dimethyloct-6-ene-1-sulfonic acid",CC(CCC=C(C)C)CC(O)S(=O)(=O)O,,,,,,
3392,103393,"6-Octen-1-yn-3-ol, 3,7-dimethyl-, 3-propanoate",CCC(=O)OC(C)(CCC=C(C)C)C#C,,,,,,
3393,103394,"Benzenepropanol, beta-methyl-4-(1-methylethyl)-, triester with boric acid (H3BO3)",B(OCC(C)CC1=CC=C(C=C1)C(C)C)(OCC(C)CC2=CC=C(C=C2)C(C)C)OCC(C)CC3=CC=C(C=C3)C(C)C,,,,,,
3394,103395,"2-Propen-1-ol, 3-[4-(1,1-dimethylethyl)phenyl]-2-methyl-, triester with boric acid (H3BO3)",B(OCC(=CC1=CC=C(C=C1)C(C)(C)C)C)(OCC(=CC2=CC=C(C=C2)C(C)(C)C)C)OCC(=CC3=CC=C(C=C3)C(C)(C)C)C,,,,,,
3395,103396,"2,6-Octadien-1-ol, 3,7-dimethyl-, triester with boric acid (H3BO3), (2E,2'E,2''E)-",B(OCC=C(C)CCC=C(C)C)(OCC=C(C)CCC=C(C)C)OCC=C(C)CCC=C(C)C,,,,,,
3396,103397,"3-(4,8-Dimethylnon-7-enyl)-3-methyloxirane-2-carboxylic acid",CC(CCCC1(C(O1)C(=O)O)C)CCC=C(C)C,,,,,,
3397,103398,3-Methyl-3-octyloxirane-2-carboxylic acid,CCCCCCCCC1(C(O1)C(=O)O)C,,,,,,
3398,103399,3-Methyl-3-(4-methylpent-3-enyl)oxirane-2-carboxylic acid,CC(=CCCC1(C(O1)C(=O)O)C)C,,,,,,
3399,103400,"1,4-Dioxan-2-one, 3,3-dichloro-5-(1-methylpropoxy)-",CCC(C)OC1COC(=O)C(O1)(Cl)Cl,,,,,,
3400,103401,6-sec-Butylquinoline,CCC(C)C1=CC2=C(C=C1)N=CC=C2,,,,,,
3401,103402,"2,2,5-Trimethyl-5-pentylcyclopentanone",CCCCCC1(CCC(C1=O)(C)C)C,,,,,,
3402,103403,"2-Penten-1-ol, benzoate, (2Z)-",CCC=CCOC(=O)C1=CC=CC=C1,,,,,,
3403,103404,"Pyrazine, 2-ethoxymethyl-",CCOCC1=NC=CN=C1,,,,,,
3404,103405,"1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,14-Nonacosafluoro-16-iodohexadecane",C(CI)C(C(C(C(C(C(C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
3405,103406,"1,1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9-Nonadecafluoro-11-iodoundecane",C(CI)C(C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
3406,103407,"Pentanedioic acid, bis(2-(2-(2-butoxyethoxy)ethoxy)ethyl) ester",CCCCOCCOCCOCCOC(=O)CCCC(=O)OCCOCCOCCOCCCC,,,,,,
3407,103408,Bis(2-(2-(2-butoxyethoxy)ethoxy)ethyl) succinate,CCCCOCCOCCOCCOC(=O)CCC(=O)OCCOCCOCCOCCCC,,,,,,
3408,103409,Bis[2-[2-(2-butoxyethoxy)ethoxy]ethyl] adipate,CCCCOCCOCCOCCOC(=O)CCCCC(=O)OCCOCCOCCOCCCC,,,,,,
3409,103410,"4-Heptanamine, 2,6-dimethyl-",CC(C)CC(CC(C)C)N,,,,,,
3410,103411,3-Methylhexylamine,CCCC(C)CCN,,,,,,
3411,103412,"Benzenamine, N-butyl-2-methoxy-",CCCCNC1=CC=CC=C1OC,,,,,,
3412,103413,"Thiodicarbonic acid ((HO)C(O)SC(S)(OH)), 1-ethyl 3-(2-methylpropyl) ester",CCOC(=O)SC(=S)OCC(C)C,,,,,,
3413,103414,"Thiodicarbonic acid ((HO)C(O)SC(S)(OH)), 3-butyl 1-ethyl ester",CCCCOC(=S)SC(=O)OCC,,,,,,
3414,103415,"Thiodicarbonic acid ((HO)C(O)SC(S)(OH)), 3-(1,2-dimethylpropyl) 1-ethyl ester",CCOC(=O)SC(=S)OC(C)C(C)C,,,,,,
3415,103416,"Phenol, 4-(1-methylethyl)-, hydrogen phosphorodithioate",CC(C)C1=CC=C(C=C1)OP(=S)(OC2=CC=C(C=C2)C(C)C)S,,,,,,
3416,103417,"Phosphorodithioic acid O,O-bis(4-isopropylphenyl)S-sodium salt",CC(C)C1=CC=C(C=C1)OP(=S)(OC2=CC=C(C=C2)C(C)C)[S-].[Na+],,,,,,
3417,103418,CID 103418,CCC(C)OC(=NC)S,,,,,,
3418,103419,"1-Propanamine, 3-[2-(dimethylamino)ethoxy]-",CN(C)CCOCCCN,,,,,,
3419,103420,CID 103420,CCCCNCCCC.C1=CC=C2C(=C1)N=C(S2)S,,,,,,
3420,103421,CID 103421,CCN(CC)CC.C1=CC=C2C(=C1)N=C(S2)S,,,,,,
3421,103422,(2-(Methacryloyloxy)ethyl)dimethylammonium N-oxide,CC[N+](CC)(CCOC(=O)C(=C)C)[O-],,,,,,
3422,103423,4-Fluorophthalonitrile,C1=CC(=C(C=C1F)C#N)C#N,,,,,,
3423,103424,2-Methyldodecanonitrile,CCCCCCCCCCC(C)C#N,,,,,,
3424,103425,1-Methyl-3-(4-methyl-3-pentenyl)cyclohex-3-ene-1-carboxylic acid,CC(=CCCC1=CCCC(C1)(C)C(=O)O)C,,,,,,
3425,103426,Methyl 1-methyl-3-(4-methyl-3-pentenyl)-3-cyclohexene-1-carboxylate,CC(=CCCC1=CCCC(C1)(C)C(=O)OC)C,,,,,,
3426,103427,"2H-3,9a-Methano-1-benzoxepin-2-one, octahydro-3,6,6-trimethyl-",CC1(CCCC23C1CCC(C2)(C(=O)O3)C)C,,,,,,
3427,103428,"1-Benzyl-2,4-dichlorobenzene",C1=CC=C(C=C1)CC2=C(C=C(C=C2)Cl)Cl,,,,,,
3428,103429,Benzyltrichlorobenzene,C1=CC=C(C=C1)CC2=C(C=C(C=C2Cl)Cl)Cl,,,,,,
3429,103430,"1H-Imidazole-1-propanenitrile, 4,5-bis[(2-cyanoethoxy)methyl]-2-phenyl-",C1=CC=C(C=C1)C2=NC(=C(N2CCC#N)COCCC#N)COCCC#N,,,,,,
3430,103431,"Methanesulfonamide, N-(2-(4-hydrazinophenyl)ethyl)-, sulfate (2:1)",CS(=O)(=O)NCCC1=CC=C(C=C1)NN.CS(=O)(=O)NCCC1=CC=C(C=C1)NN.OS(=O)(=O)O,,,,,,
3431,103432,N-[2-(4-Hydrazinophenyl)ethyl]methanesulfonamide,CS(=O)(=O)NCCC1=CC=C(C=C1)NN,,,,,,
3432,103433,CID 103433,CC(=O)NC1=CC(=CC=C1)N2C(=NN=N2)S.C(CO)N(CCO)CCO,,,,,,
3433,103434,2-(4-Chlorophenyl)-4-(dimethylamino)-2-(pyridin-2-YL)butanenitrile,CN(C)CCC(C#N)(C1=CC=C(C=C1)Cl)C2=CC=CC=N2,,,,,,
3434,103435,alpha-(4-Bromophenyl)-alpha-(2-(dimethylamino)ethyl)pyridine-2-acetonitrile,CN(C)CCC(C#N)(C1=CC=C(C=C1)Br)C2=CC=CC=N2,,,,,,
3435,103436,"Amidosulfenyl chloride, methyl(phenylsulfonyl)-",CN(SCl)S(=O)(=O)C1=CC=CC=C1,,,,,,
3436,103437,CID 103437,C1=CC(=CC=C1C(=NO)C(F)(F)F)Cl,,,,,,
3437,103438,"N,N-Dimethyl-N-[3-[(1-oxooctadecyl)amino]propyl]benzenemethanaminium",CCCCCCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC1=CC=CC=C1,,,,,,
3438,103439,"1-Heptanesulfonyl chloride, 3,3,4,4,5,5,6,6,7,7,7-undecafluoro-",C(CS(=O)(=O)Cl)C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
3439,103440,"1-Undecanesulfonyl chloride, 3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,11-nonadecafluoro-",C(CS(=O)(=O)Cl)C(C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
3440,103441,CID 103441,C1(=[N+]([O-])[O-])C(=NC(=O)NC1=O)C(=O)O.[K+],,,,,,
3441,103442,"5-Nitro-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid",C1(=C(NC(=O)NC1=O)C(=O)O)[N+](=O)[O-],,,,,,
3442,103443,CID 103443,CCCCNC1=NC(=O)N=C(N1)NCCCC,,,,,,
3443,103444,"2H-Pyrrolium, 5-[2-[4-(dimethylamino)phenyl]ethenyl]-1-ethyl-3,4-dihydro-, iodide",CC[N+]1=C(CCC1)C=CC2=CC=C(C=C2)N(C)C.[I-],,,,,,
3444,103445,"5-[2-[4-(Dimethylamino)phenyl]ethenyl]-1-ethyl-3,4-dihydro-2H-pyrrol-1-ium",CC[N+]1=C(CCC1)C=CC2=CC=C(C=C2)N(C)C,,,,,,
3445,103446,"2,2,6,6-Tetramethylpiperidine-4-carboxylic acid",CC1(CC(CC(N1)(C)C)C(=O)O)C,,,,,,
3446,103447,"Cyclopentanone, 2-(2-octen-1-yl)-",CCCCCC=CCC1CCCC1=O,,,,,,
3447,103448,CID 103448,[Li+].C(C(=O)[O-])I,,,,,,
3448,103449,"2-[2,4-Bis(2-methylbutan-2-yl)phenoxy]-n-butyl-n-(4-{[(4-cyanophenyl)carbamoyl]amino}-3-hydroxyphenyl)acetamide",CCCCN(C1=CC(=C(C=C1)NC(=O)NC2=CC=C(C=C2)C#N)O)C(=O)COC3=C(C=C(C=C3)C(C)(C)CC)C(C)(C)CC,,,,,,
3449,103450,"2-Naphthalenecarboxamide, N-[4-[2,4-bis(1,1-dimethylpropyl)phenoxy]butyl]-4-[[4-[ethyl(2-hydroxyethyl)amino]-2-methylphenyl]imino]-1,4-dihydro-1-oxo-",CCC(C)(C)C1=CC(=C(C=C1)OCCCCNC(=O)C2=CC(=NC3=C(C=C(C=C3)N(CC)CCO)C)C4=CC=CC=C4C2=O)C(C)(C)CC,,,,,,
3450,103451,CID 103451,CCOC(=O)CC(=NC(C1=CC=CC=C1)C(=O)[O-])C.[K+],,,,,,
3451,103452,[(4-Ethoxy-4-oxobutan-2-ylidene)amino](phenyl)acetic acid,CCOC(=O)CC(=NC(C1=CC=CC=C1)C(=O)O)C,,,,,,
3452,103453,N-Ethyl-N-methylmorpholinium bromide,CC[N+]1(CCOCC1)C.[Br-],,,,,,
3453,103454,4-Ethyl-4-methylmorpholin-4-ium,CC[N+]1(CCOCC1)C,,,,,,
3454,103455,CID 103455,CC(=O)SC=C(NC1=NC2=CC=CC=C2S1)O.[Ag],,,,,,
3455,103456,"S-[2-(1,3-benzothiazol-2-ylamino)-2-hydroxyethenyl] ethanethioate",CC(=O)SC=C(NC1=NC2=CC=CC=C2S1)O,,,,,,
3456,103457,2-Chlorooctanoyl chloride,CCCCCCC(C(=O)Cl)Cl,,,,,,
3457,103458,S-(3-Chloro-2-methyl-3-oxopropyl) ethanethioate,CC(CSC(=O)C)C(=O)Cl,,,,,,
3458,103459,"1-Octyn-3-ol, 1-iodo-",CCCCCC(C#CI)O,,,,,,
3459,103460,"Decanal, 2-ethylidene-",CCCCCCCCC(=CC)C=O,,,,,,
3460,103461,"Phenol, 2,5-dimethyl-4-(1-methylcyclohexyl)-",CC1=CC(=C(C=C1O)C)C2(CCCCC2)C,,,,,,
3461,103462,"Phenol, 2,3-dimethyl-4-(1-methylcyclohexyl)-",CC1=C(C=CC(=C1C)O)C2(CCCCC2)C,,,,,,
3462,103463,"2-(2-Methyl-1-propenyl)-4,5-dimethyl-5,6-dihydro-2H-pyran",CC1COC(C=C1C)C=C(C)C,,,,,,
3463,103464,"Benzenediazonium, 4-(6-methyl-7-sulfo-2-benzothiazolyl)-, inner salt",CC1=C(C2=C(C=C1)N=C(S2)C3=CC=C(C=C3)[N+]#N)S(=O)(=O)[O-],,,,,,
3464,103465,4-(6-Methyl-7-sulfo-2-benzothiazolyl)benzenediazonium,CC1=C(C2=C(C=C1)N=C(S2)C3=CC=C(C=C3)[N+]#N)S(=O)(=O)O,,,,,,
3465,103466,CID 103466,COC1=CC=CC(=C1)C(O)S(=O)(=O)[O-].[Na+],,,,,,
3466,103467,Hydroxy-(3-methoxyphenyl)methanesulfonic acid,COC1=CC=CC(=C1)C(O)S(=O)(=O)O,,,,,,
3467,103468,CID 103468,CC(C[N+](CC1=CC=CC=C1)(C=CCCCCCCCCCCCCCCC=C)C(C)O)O.[Cl-],,,,,,
3468,103469,CID 103469,CC(C[N+](CC1=CC=CC=C1)(C=CCCCCCCCCCCCCCCC=C)C(C)O)O,,,,,,
3469,103470,"Benzenemethanaminium, N,N-bis(2-hydroxypropyl)-N-octadecenyl-, chloride",CC(C[N+](CCCCCCCCCCCCCCCCC=C)(CC1=CC=CC=C1)CC(C)O)O.[Cl-],,,,,,
3470,103471,Benzyl-bis(2-hydroxypropyl)-octadec-17-enylazanium,CC(C[N+](CCCCCCCCCCCCCCCCC=C)(CC1=CC=CC=C1)CC(C)O)O,,,,,,
3471,103472,"Acetamide, N-[3-[(2-cyanoethyl)(2-hydroxybutyl)amino]phenyl]-",CCC(CN(CCC#N)C1=CC=CC(=C1)NC(=O)C)O,,,,,,
3472,103473,(2-Ethylhexyl)ammonium bis(6-methylheptyl) phosphate,CCCCC(CC)CN.CC(C)CCCCCOP(=O)(O)OCCCCCC(C)C,,,,,,
3473,103474,Diisooctyl phosphate,CC(C)CCCCCOP(=O)(O)OCCCCCC(C)C,,,,,,
3474,103475,"Diazene, [(1,3-dihydro-1,1,3-trimethyl-2H-inden-2-ylidene)methyl](2-methoxyphenyl)-",CC1C2=CC=CC=C2C(C1=CN=NC3=CC=CC=C3OC)(C)C,,,,,,
3475,103476,CID 103476,CCCCCCCCC(CCCCCCCCCOC(=O)C)OS(=O)(=O)[O-].[Na+],,,,,,
3476,103477,10-(Sulfooxy)octadecyl acetate,CCCCCCCCC(CCCCCCCCCOC(=O)C)OS(=O)(=O)O,,,,,,
3477,103478,CID 103478,CCCCCCCCCC(CCCCCCCCOC(=O)C)OS(=O)(=O)[O-].[Na+],,,,,,
3478,103479,9-(Sulfooxy)octadecyl acetate,CCCCCCCCCC(CCCCCCCCOC(=O)C)OS(=O)(=O)O,,,,,,
3479,103480,CID 103480,CCCCCCCCC(CCCCCCCCC(=O)OC)S(=O)(=O)[O-].[Na+],,,,,,
3480,103481,18-Methoxy-18-oxooctadecane-9-sulfonic acid,CCCCCCCCC(CCCCCCCCC(=O)OC)S(=O)(=O)O,,,,,,
3481,103482,Disodium 9(or 10)-(sulfooxy)stearate,CCCCCCCCCC(CCCCCCCC(=O)[O-])OS(=O)(=O)[O-].[Na+].[Na+],,,,,,
3482,103483,Disodium 9-(sulfooxy)stearate,CCCCCCCCC(CCCCCCCCC(=O)[O-])OS(=O)(=O)[O-].[Na+].[Na+],,,,,,
3483,103484,10-(Sulphooxy)octadecanoic acid,CCCCCCCCC(CCCCCCCCC(=O)O)OS(=O)(=O)O,,,,,,
3484,103485,"[1,1'-Biphenyl]-4-carboxylic acid, 4'-(2-methylbutyl)-, 4-cyanophenyl ester",CCC(C)CC1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)OC3=CC=C(C=C3)C#N,,,,,,
3485,103486,"1-Tridecanol, dihydrogen phosphate, compd. with N,N-dimethylcyclohexanamine (1:1)",CCCCCCCCCCCCCOP(=O)(O)O.CN(C)C1CCCCC1,,,,,,
3486,103487,"4,4a,6,7,8,8a-Hexahydro-1,4-methanonaphthalen-5(1H)-one",C1CC2C3CC(C2C(=O)C1)C=C3,,,,,,
3487,103488,2-sec-Butyl-p-cresol,CCC(C)C1=C(C=CC(=C1)C)O,,,,,,
3488,103489,Ethyl cyclohexyl-3-thienylacetate,CCOC(=O)C(C1CCCCC1)C2=CSC=C2,,,,,,
3489,103490,14-Oxabicyclo[10.3.0]pentadec-10-ene,C1CCCCC2COCC2C=CCCC1,,,,,,
3490,103491,"Isopropyl 2-(2,4,5-trichlorophenoxy)propionate",CC(C)OC(=O)C(C)OC1=CC(=C(C=C1Cl)Cl)Cl,,,,,,
3491,103492,1-Methylbutyl acrylate,CCCC(C)OC(=O)C=C,,,,,,
3492,103493,"Dimethyl 2,3-dibromosuccinate",COC(=O)C(C(C(=O)OC)Br)Br,,,,,,
3493,103494,"1,2-Dimethyl-4,5-bis(1-phenylethyl)benzene",CC1=CC(=C(C=C1C)C(C)C2=CC=CC=C2)C(C)C3=CC=CC=C3,,,,,,
3494,103495,"(2-Hydroxy-3-((1-oxooctadecyl)oxy)propyl) hydrogen 2,3-diacetoxysuccinate",CCCCCCCCCCCCCCCCCC(=O)OCC(COC(=O)C(C(C(=O)O)OC(=O)C)OC(=O)C)O,,,,,,
3495,103496,"2,3-Diacetyloxybutanedioic acid",CC(=O)OC(C(C(=O)O)OC(=O)C)C(=O)O,,,,,,
3496,103497,1-Hydroxyprop-2-yl benzoate,CC(CO)OC(=O)C1=CC=CC=C1,,,,,,
3497,103498,"2-Amino-1-(4-methylsulfonylphenyl)-1,3-propanediol",CS(=O)(=O)C1=CC=C(C=C1)C(C(CO)N)O,,,,,,
3498,103499,"3-Methyl-4-(2,6,6-trimethyl-1-cyclohexen-1-yl)-3-buten-2-ol",CC1=C(C(CCC1)(C)C)C=C(C)C(C)O,,,,,,
3499,103500,4-Isothiocyanato-1-(methylthio)-1-butene,CSC=CCCN=C=S,,,,,,
3500,103501,Einecs 257-317-4,CC1CCC=C2C1(CC(=C(C)C)CC2)C,,,,,,
3501,103502,"Cyclopentanone, 2-(2E)-2-pentenyl-",CCC=CCC1CCCC1=O,,,,,,
3502,103503,Ethyl 2-(1-hydroxycyclohexyl)butanoate,CCC(C(=O)OCC)C1(CCCCC1)O,,,,,,
3503,103504,2-(5-Decynyloxy)tetrahydro-2H-pyran,CCCCC#CCCCCOC1CCCCO1,,,,,,
3504,103505,"2,4,6-Tris[[bis(2-hydroxypropyl)amino]methyl]phenol",CC(CN(CC1=CC(=C(C(=C1)CN(CC(C)O)CC(C)O)O)CN(CC(C)O)CC(C)O)CC(C)O)O,,,,,,
3505,103506,CID 103506,CC(C)(C)C(=O)NNC(=NC)S,,,,,,
3506,103507,Methyl 2-methyl-3-oxopropanoate,CC(C=O)C(=O)OC,,,,,,
3507,103508,Einecs 257-348-3,CC1(C2CCC1(C(=O)C2)CS(=O)(=O)[O-])C.C1=CC(=S)N(C=C1)[O-].C1=CC(=S)N(C=C1)[O-].[Al+3],,,,,,
3508,103509,"Ethanone, 1,2-diphenyl-2-[(tetrahydro-2H-pyran-2-yl)oxy]-",C1CCOC(C1)OC(C2=CC=CC=C2)C(=O)C3=CC=CC=C3,,,,,,
3509,103510,1-(1-Phenyl-3-dimethylaminopropyl)diphenylphosphine oxide,CN(C)CCC(C1=CC=CC=C1)P(=O)(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
3510,103511,1-(1-Phenyl-3-diethylaminopropyl)diphenylphosphine oxide,CCN(CC)CCC(C1=CC=CC=C1)P(=O)(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
3511,103512,"Phosphine oxide, diphenyl((1-phenyl-3-pyrrolidinyl)propyl)-",C1CCN(C1)CCC(C2=CC=CC=C2)P(=O)(C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
3512,103513,1-[3-(Diphenylphosphoryl)-3-phenylpropyl]piperidine,C1CCN(CC1)CCC(C2=CC=CC=C2)P(=O)(C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
3513,103514,4-[3-(Diphenylphosphoryl)-3-phenylpropyl]morpholine,C1COCCN1CCC(C2=CC=CC=C2)P(=O)(C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
3514,103515,(1-(1-Phenyl-3-dimethylamino-2-methyl)propyl)diphenylphosphine oxide,CC(CN(C)C)C(C1=CC=CC=C1)P(=O)(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
3515,103516,"Phosphonic acid, (alpha-(2-dimethylamino)ethyl)benzyl-, O,O-diethyl ester, hydrochloride",CCOP(=O)(C(CCN(C)C)C1=CC=CC=C1)OCC.Cl,,,,,,
3516,103517,"3-diethoxyphosphoryl-N,N-dimethyl-3-phenylpropan-1-amine",CCOP(=O)(C(CCN(C)C)C1=CC=CC=C1)OCC,,,,,,
3517,103518,"Phosphonic acid, (alpha-(2-diethylamino)ethyl)benzyl-, O,O-diethyl ester, hydrochloride",CCN(CC)CCC(C1=CC=CC=C1)P(=O)(OCC)OCC.Cl,,,,,,
3518,103519,"3-diethoxyphosphoryl-N,N-diethyl-3-phenylpropan-1-amine",CCN(CC)CCC(C1=CC=CC=C1)P(=O)(OCC)OCC,,,,,,
3519,103520,"Phosphonic acid, (alpha-(2-morpholino)ethyl)benzyl-, O,O-diethyl ester, hydrochloride",CCOP(=O)(C(CCN1CCOCC1)C2=CC=CC=C2)OCC.Cl,,,,,,
3520,103521,4-(3-Diethoxyphosphoryl-3-phenylpropyl)morpholine,CCOP(=O)(C(CCN1CCOCC1)C2=CC=CC=C2)OCC,,,,,,
3521,103522,(1-Phenyl-3-piperidinopropyl)diethylphosphine oxide hydrochloride,CCP(=O)(CC)C(CCN1CCCCC1)C2=CC=CC=C2.Cl,,,,,,
3522,103523,1-(3-Diethylphosphoryl-3-phenylpropyl)piperidine,CCP(=O)(CC)C(CCN1CCCCC1)C2=CC=CC=C2,,,,,,
3523,103524,"Phosphine oxide, diphenyl((1,1-diphenyl-3-dimethylamino-2-methyl)propyl)-, hydrochloride",CC(CN(C)C)C(C1=CC=CC=C1)(C2=CC=CC=C2)P(=O)(C3=CC=CC=C3)C4=CC=CC=C4.Cl,,,,,,
3524,103525,"3-diphenylphosphoryl-N,N,2-trimethyl-3,3-diphenylpropan-1-amine",CC(CN(C)C)C(C1=CC=CC=C1)(C2=CC=CC=C2)P(=O)(C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
3525,103526,"cis-Tetrahydropentalene-2,5(1H,3H)-dione",C1C2CC(=O)CC2CC1=O,,,,,,
3526,103527,"2-Propenoic acid, 2-(((phenylamino)carbonyl)oxy)propyl ester",CC(COC(=O)C=C)OC(=O)NC1=CC=CC=C1,,,,,,
3527,103528,(Methyl-2-phenoxyethoxy)propanol,CC(COC1=CC=CC=C1)OCCCO,,,,,,
3528,103529,Einecs 257-367-7,CC1C(C(CC(O1)OC2CCC3(C(C2)CCC4C3CC(C5(C4(CCC5C6=CC(=O)OC6)O)C)O)C)O)OC7CC(C(C(O7)C)OC8CC(C(C(O8)C)OC)OC)O,,,,,,
3529,103530,Einecs 257-368-2,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CCC7C8=CC(=O)OC8)O)C)OC(=O)C)C)C)C)O)OC,,,,,,
3530,103531,Methyl 2-(3-methylbenzothiazolylidene)dithioacetate,CN1C2=CC=CC=C2SC1=CC(=S)SC,,,,,,
3531,103532,1-Methyl-2-(trimethoxysilyl)ethyl methacrylate,CC(C[Si](OC)(OC)OC)OC(=O)C(=C)C,,,,,,
3532,103533,"1-Propanamine, 3-((2-ethylhexyl)oxy)-, acetate",CCCCC(CC)COCCCN.CC(=O)O,,,,,,
3533,103534,Methyl 2-ethylacetoacetate,CCC(C(=O)C)C(=O)OC,,,,,,
3534,103535,"2-[[1-(2-Amino-1,4,5,6-tetrahydropyrimidin-6-yl)-2-[[4-methyl-1-oxo-1-[(1-oxo-3-phenylpropan-2-yl)amino]pentan-2-yl]amino]-2-oxoethyl]carbamoylamino]-3-phenylpropanoic acid",CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C=O)NC(=O)C(C2CCN=C(N2)N)NC(=O)NC(CC3=CC=CC=C3)C(=O)O,,,['Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. (See all compounds classified as Serine Proteinase Inhibitors.)'],,,
3535,103536,"2-[[1-(2-Amino-1,4,5,6-tetrahydropyrimidin-6-yl)-2-[[3-methyl-1-oxo-1-[(1-oxo-3-phenylpropan-2-yl)amino]butan-2-yl]amino]-2-oxoethyl]carbamoylamino]-3-phenylpropanoic acid",CC(C)C(C(=O)NC(CC1=CC=CC=C1)C=O)NC(=O)C(C2CCN=C(N2)N)NC(=O)NC(CC3=CC=CC=C3)C(=O)O,,,,,,
3536,103537,Einecs 257-385-5,CCC(C)C(C(=O)NC(CC1=CC=CC=C1)C=O)NC(=O)C(C2CCN=C(N2)N)NC(=O)NC(CC3=CC=CC=C3)C(=O)O,,,,,,
3537,103538,"Ethyl 4-hydroxy-2,6,6-trimethylcyclohex-2-ene-1-carboxylate",CCOC(=O)C1C(=CC(CC1(C)C)O)C,,,,,,
3538,103539,"(2S-(2alpha(E),3beta))-2-(2-(3,4-Dihydro-6-methoxy-1(2H)-naphthylidene)ethyl)-2-ethyl-3-hydroxycyclopentan-1-one",CCC1(C(CCC1=O)O)CC=C2CCCC3=C2C=CC(=C3)OC,,,,,,
3539,103540,4-Chloro-1-(4-fluorophenyl)butan-1-ol,C1=CC(=CC=C1C(CCCCl)O)F,,,,,,
3540,103541,gamma-(4-Fluorophenyl)-gamma-butyrolactone,C1CC(=O)OC1C2=CC=C(C=C2)F,,,,,,
3541,103542,CID 103542,C1CC2CN=C(NC2C1)S,,,,,,
3542,103543,10-Bromodecyl tetrahydropyranyl ether,C1CCOC(C1)OCCCCCCCCCCBr,,,,,,
3543,103544,N-Propylamphetamine,CCCNC(C)CC1=CC=CC=C1,,,,,,
3544,103545,(+)-3-(Trifluoroacetyl)camphor,C[C@@]12CC[C@@H](C1(C)C)C(C2=O)C(=O)C(F)(F)F,,,,,,
3545,103546,Dimethyl (3-oxo-2-pentylcyclopentyl)malonate,CCCCCC1C(CCC1=O)C(C(=O)OC)C(=O)OC,,,,,,
3546,103547,"2H-Pyran, tetrahydro-2-(9-tetradecenyloxy)-",CCCCC=CCCCCCCCCOC1CCCCO1,,,,,,
3547,103548,Einecs 248-723-2,CC(=O)OCC1=C(N2C(C(C2=O)NC(=O)C(C3=CC=CC=C3)O)SC1)C(=O)O,,,,,,
3548,103549,5-Oxo-2'-salicyloyl-L-prolinohydrazide,C1CC(=O)NC1C(=O)NNC(=O)C2=CC=CC=C2O,,,,,,
3549,103550,Bis(2-hydroxypropyl) azelate,CC(COC(=O)CCCCCCCC(=O)OCC(C)O)O,,,,,,
3550,103551,Methyl 1-methylpyrrolidine-2-acetate,CN1CCCC1CC(=O)OC,,,,,,
3551,103552,"Ethanone, 1-(1-hydroxy-2-naphthalenyl)-, oxime",CC(=NO)C1=C(C2=CC=CC=C2C=C1)O,,,,,,
3552,103553,Methyl 3-hydroxyhexadecanoate,CCCCCCCCCCCCCC(CC(=O)OC)O,,,,,,
3553,103554,"Acetamide, N-(2-((2,6-dicyano-4-nitrophenyl)azo)-5-((2,3-dihydroxypropyl)ethylamino)phenyl)-",CCN(CC(CO)O)C1=CC(=C(C=C1)N=NC2=C(C=C(C=C2C#N)[N+](=O)[O-])C#N)NC(=O)C,,,,,,
3554,103555,"1,3,7-Nonatriene, 4,8-dimethyl-",CC(=CCCC(=CC=C)C)C,,,,,,
3555,103556,"4-(3-Heptadecyl-4,5-dihydro-4-methyl-5-oxo-1H-pyrazol-1-yl)benzenesulphonic acid",CCCCCCCCCCCCCCCCCC1=NN(C(=O)C1C)C2=CC=C(C=C2)S(=O)(=O)O,,,,,,
3556,103557,3-Ethyl-2-(3-(3-ethyl-4-methyl-3H-thiazol-2-ylidene)prop-1-enyl)benzoxazolium iodide,CCN1C2=CC=CC=C2OC1=CC=CC3=[N+](C(=CS3)C)CC.[I-],,,,,,
3557,103558,3-Ethyl-2-[3-(3-ethyl-4-methylthiazol-2(3H)-ylidene)-1-propenyl]benzoxazolium,CCN1C2=CC=CC=C2OC1=CC=CC3=[N+](C(=CS3)C)CC,,,,,,
3558,103559,"Carbonic acid, 2-(3-oxo-3-(2-oxocyclopentyl)propyl)-1,4-phenylene diethyl ester",CCOC(=O)OC1=CC(=C(C=C1)OC(=O)OCC)CCC(=O)C2CCCC2=O,,,,,,
3559,103560,CID 103560,CCCCCCCCCCOCC(CS(=O)(=O)[O-])O.[Na+],,,,,,
3560,103561,3-Decoxy-2-hydroxypropane-1-sulfonic acid,CCCCCCCCCCOCC(CS(=O)(=O)O)O,,,,,,
3561,103562,CID 103562,CCCCCCCCOCC(CS(=O)(=O)[O-])O.[Na+],,,,,,
3562,103563,2-Hydroxy-3-octoxypropane-1-sulfonic acid,CCCCCCCCOCC(CS(=O)(=O)O)O,,,,,,
3563,103564,"Benzenesulfonyl chloride, 4-[[4,4,5,5,5-pentafluoro-3-(pentafluoroethyl)-1,2,3-tris(trifluoromethyl)-1-pentenyl]oxy]-",C1=CC(=CC=C1OC(=C(C(C(C(F)(F)F)(F)F)(C(C(F)(F)F)(F)F)C(F)(F)F)C(F)(F)F)C(F)(F)F)S(=O)(=O)Cl,,,,,,
3564,103565,Dimethyl ((4-hydroxyphenyl)methylene)malonate,COC(=O)C(=CC1=CC=C(C=C1)O)C(=O)OC,,,,,,
3565,103566,"2H-Pyran, tetrahydro-2-(10-undecynyloxy)-",C#CCCCCCCCCCOC1CCCCO1,,,,,,
3566,103567,"5-Oxo-N,N-dipropylpyrrolidine-2-carboxamide",CCCN(CCC)C(=O)C1CCC(=O)N1,,,,,,
3567,103568,4-((5-Oxo-2-pyrrolidinyl)carbonyl)morpholine,C1CC(=O)NC1C(=O)N2CCOCC2,,,,,,
3568,103569,"N,N-Dihexyl-5-oxopyrrolidine-2-carboxamide",CCCCCCN(CCCCCC)C(=O)C1CCC(=O)N1,,,,,,
3569,103570,"5-Oxo-N,N-dipentylpyrrolidine-2-carboxamide",CCCCCN(CCCCC)C(=O)C1CCC(=O)N1,,,,,,
3570,103571,4-((Benzoyl-5-oxopyrrolidin-2-yl)carbonyl)morpholine,C1CC(=O)N(C1C(=O)N2CCOCC2)C(=O)C3=CC=CC=C3,,,,,,
3571,103572,"2-Chloro-1-(2,4,5-trichlorophenyl)ethenyl ethyl methyl phosphate",CCOP(=O)(OC)OC(=CCl)C1=CC(=C(C=C1Cl)Cl)Cl,,,,,,
3572,103573,2-(4-Fluorophenyl)propanenitrile,CC(C#N)C1=CC=C(C=C1)F,,,,,,
3573,103574,Ethyl thiazolidine-4-carboxylate,CCOC(=O)C1CSCN1,,,,,,
3574,103575,"ethyl 2-(1,1-dioxothiolan-3-yl)-3-oxo-1H-pyrazole-5-carboxylate",CCOC(=O)C1=CC(=O)N(N1)C2CCS(=O)(=O)C2,,,,,,
3575,103576,Einecs 257-585-2,CCN(CC)C1=CC2=C(C=C1)C=CC3(O2)C(=C4C=C5C=CC=CC5=CC4=CO3)C,,,,,,
3576,103577,"Methyl 7-(diethylamino)-2'-methylspiro(2H-1-benzopyran-2,3'-(3H)naphtho(2,1-b)pyran)-5'-carboxylate",CCN(CC)C1=CC2=C(C=C1)C=CC3(O2)C(=CC4=C(O3)C(=CC5=CC=CC=C54)C(=O)OC)C,,,,,,
3577,103578,"4-Hydroxy-2-(1-hydroxyethyl)-2,5-dimethylfuran-3(2H)-one",CC1=C(C(=O)C(O1)(C)C(C)O)O,,,,,,
3578,103579,"4-Hydroxy-2-(1-hydroxybutyl)-2,5-dimethylfuran-3(2H)-one",CCCC(C1(C(=O)C(=C(O1)C)O)C)O,,,,,,
3579,103580,"Ethyl 8-ethyl-5,6,7,8-tetrahydro-2-(methylthio)-5-oxopyrido(2,3-d)pyrimidine-6-carboxylate",CCN1CC(C(=O)C2=CN=C(N=C21)SC)C(=O)OCC,,,,,,
3580,103581,"p-((4,4,5,5,5-Pentafluoro-3-(pentafluoroethyl)-1,2,3-tris(trifluoromethyl)pent-1-enyl)oxy)-N-(3-(triethoxysilyl)propyl)benzenesulphonamide",CCO[Si](CCCNS(=O)(=O)C1=CC=C(C=C1)OC(=C(C(C(C(F)(F)F)(F)F)(C(C(F)(F)F)(F)F)C(F)(F)F)C(F)(F)F)C(F)(F)F)(OCC)OCC,,,,,,
3581,103582,Bis(octadec-9-enyl) 2-hydroxybutanedioate,CCCCCCCCC=CCCCCCCCCOC(=O)CC(C(=O)OCCCCCCCCC=CCCCCCCCC)O,,,,,,
3582,103583,N-(Furan-2-ylmethylene)-3-methylbutylamine,CC(C)CCN=CC1=CC=CO1,,,,,,
3583,103584,"4-(Methoxymethyl)-2-methyl-5-phenyl-4,5-dihydro-1,3-oxazole",CC1=NC(C(O1)C2=CC=CC=C2)COC,,,,,,
3584,103585,"Benzoxazolium, 3-ethyl-2-(3-(3-ethyl-5,6-dimethyl-2(3H)-benzoxazolylidene)-1-propenyl)-5,6-dimethyl-, iodide",CCN1C2=C(C=C(C(=C2)C)C)OC1=CC=CC3=[N+](C4=C(O3)C=C(C(=C4)C)C)CC.[I-],,,,,,
3585,103586,"3-Ethyl-2-[3-[3-ethyl-5,6-dimethylbenzoxazol-2(3H)-ylidene]-1-propenyl]-5,6-dimethylbenzoxazol-3-ium",CCN1C2=C(C=C(C(=C2)C)C)OC1=CC=CC3=[N+](C4=C(O3)C=C(C(=C4)C)C)CC,,,,,,
3586,103587,"2,3-Bis[(octadec-9-enoyl)oxy]propyl 2-(trimethylazaniumyl)ethyl phosphate",CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
3587,103588,"1,2-Dioleoyl PC",CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
3588,103589,Ethyl 2-hydroxyhexanoate,CCCCC(C(=O)OCC)O,,,,,,
3589,103590,N-(2-Oxothietan-3-yl)acetamide,CC(=O)NC1CSC1=O,,,,,,
3590,103591,2-Propenylidene-cyclobutene,C=CC=C1CC=C1,,,,,,
3591,103592,N-((5-(Dimethylamino)-1-naphthyl)sulphonyl)-L-tyrosine,CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)NC(CC3=CC=C(C=C3)O)C(=O)O,,,,,,
3592,103593,"(1,3-Dimethoxy-1,3-dimethylbutyl)(1,1-dimethylethyl)diazene",CC(C)(C)N=NC(C)(CC(C)(C)OC)OC,,,,,,
3593,103594,3-Bromo-N-(4-bromophenyl)-5-chloro-2-hydroxybenzenecarboximidoyl chloride,C1=CC(=CC=C1N=C(C2=C(C(=CC(=C2)Cl)Br)O)Cl)Br,,,,,,
3594,103595,1-(2-Hydroxy-5-nonylphenyl)-2-phenylethan-1-one oxime,CCCCCCCCCC1=CC(=C(C=C1)O)C(=NO)CC2=CC=CC=C2,,,,,,
3595,103596,"Benzothiazolium, 2-(2-ethoxy-1-propenyl)-3-(3-sulfobutyl)-, inner salt",CCOC(=CC1=[N+](C2=CC=CC=C2S1)CCC(C)S(=O)(=O)[O-])C,,,,,,
3596,103597,"4-[2-(2-Ethoxyprop-1-enyl)-1,3-benzothiazol-3-ium-3-yl]butane-2-sulfonic acid",CCOC(=CC1=[N+](C2=CC=CC=C2S1)CCC(C)S(=O)(=O)O)C,,,,,,
3597,103598,"5-Bromo-1H,5H-pyrimidine-4,6-dione",C1=NC(=O)C(C(=O)N1)Br,,,,,,
3598,103599,Ethyl 2-(4-(1-hydroxyethyl)phenoxy)isobutyrate,CCOC(=O)C(C)(C)OC1=CC=C(C=C1)C(C)O,,,,,,
3599,103600,"Ethyl 2-[4-(2,2-dichlorocyclopropyl)phenoxy]-2-methylpropionate",CCOC(=O)C(C)(C)OC1=CC=C(C=C1)C2CC2(Cl)Cl,,,,,,
3600,103601,4-Sec-butyl-2-tert-butylphenol,CCC(C)C1=CC(=C(C=C1)O)C(C)(C)C,,,,,,
3601,103602,"1-Benzyl-2,2,6,6-tetramethylpiperidin-4-ol",CC1(CC(CC(N1CC2=CC=CC=C2)(C)C)O)C,,,,,,
3602,103603,"cis-3a,4,9,9a-Tetrahydro-2,2-dimethylnaphtho(2,3-d)-1,3-dioxol-5-ol",CC1(OC2CC3=C(CC2O1)C(=CC=C3)O)C,,,,,,
3603,103604,"1-(tert-Butylamino)-3-((3a,4,9,9a-tetrahydro-2,2-dimethylnaphtho(2,3-d)-1,3-dioxol-5-yl)oxy)propan-2-ol",CC1(OC2CC3=C(CC2O1)C(=CC=C3)OCC(CNC(C)(C)C)O)C,,,,,,
3604,103605,"2-(3,3-Diethoxy-2-methylpropyl)bicyclo[2.2.1]heptane",CCOC(C(C)CC1CC2CCC1C2)OCC,,,,,,
3605,103606,"2-(3,3-Dimethoxy-2-methylpropyl)bicyclo[2.2.1]heptane",CC(CC1CC2CCC1C2)C(OC)OC,,,,,,
3606,103607,"3-Buten-2-ol, 4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-, acetate",CC1=CCCC(C1C=CC(C)OC(=O)C)(C)C,,,,,,
3607,103608,"2',4,4',6'-Tetrahydroxy-3-methoxychalcone",COC1=C(C=CC(=C1)C=CC(=O)C2=C(C=C(C=C2O)O)O)O,,,,,,
3608,103609,2-[(tert-Butyl)azo]-2-methylbutyronitrile,CCC(C)(C#N)N=NC(C)(C)C,,,,,,
3609,103610,"1H-Indene-5-carbonyl chloride, 2,3-dihydro-2-(3-hydroxy-2-quinolinyl)-1,3-dioxo-",C1=CC=C2C(=C1)C=C(C(=N2)C3C(=O)C4=C(C3=O)C=C(C=C4)C(=O)Cl)O,,,,,,
3610,103611,4-Amino-3-(4-fluorophenyl)butanoic acid,C1=CC(=CC=C1C(CC(=O)O)CN)F,,,,,,
3611,103612,Bis(3-methoxybutyl) peroxydicarbonate,CC(CCOOC(=O)C(=O)OOCCC(C)OC)OC,,,,,,
3612,103613,"3,3-Dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4-oxide",CC1(C(N2C(S1=O)C(C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C,,,,,,
3613,103614,1-Ethyl-2-(3-(1-ethyl-2-methyl-4(1H)-quinolylidene)prop-1-enyl)-4-methylquinolinium iodide,CCN1C(=CC(=CC=CC2=[N+](C3=CC=CC=C3C(=C2)C)CC)C4=CC=CC=C41)C.[I-],,,,,,
3614,103615,1-Ethyl-2-[3-(1-ethyl-2-methylquinolin-4(1H)-ylidene)-1-propenyl]-4-methylquinolinium,CCN1C(=CC(=CC=CC2=[N+](C3=CC=CC=C3C(=C2)C)CC)C4=CC=CC=C41)C,,,,,,
3615,103616,Diethyl methyl(3-oxocyclohexyl)malonate,CCOC(=O)C(C)(C1CCCC(=O)C1)C(=O)OCC,,,,,,
3616,103617,"1(3H)-Isobenzofuranone, 3-[4-hydroxy-2-methyl-5-(1-methylethyl)phenyl]-3-[2-methyl-5-(1-methylethyl)-4-(phosphonooxy)phenyl]-, compd. with 2-amino-2-methyl-1,3-propanediol (1:1)",CC1=CC(=C(C=C1C2(C3=CC=CC=C3C(=O)O2)C4=CC(=C(C=C4C)OP(=O)(O)O)C(C)C)C(C)C)O.CC(CO)(CO)N,,,,,,
3617,103618,2-[2-(1-Hydroxypropan-2-yloxy)-2-oxoethyl]tetradecanoic acid,CCCCCCCCCCCCC(CC(=O)OC(C)CO)C(=O)O,,,,,,
3618,103619,dimethyl (E)-3-methylpent-2-enedioate,CC(=CC(=O)OC)CC(=O)OC,,,,,,
3619,103620,2-Hydroxypropyl 5-oxo-L-prolinate,CC(COC(=O)[C@H]1CCC(=O)N1)O,,,,,,
3620,103621,2-[(4-Chloro-2-nitrophenyl)azo]-N-(4-ethoxyphenyl)-3-oxobutyramide,CCOC1=CC=C(C=C1)NC(=O)C(C(=O)C)N=NC2=C(C=C(C=C2)Cl)[N+](=O)[O-],,,,,,
3621,103622,"Benzamide, 4-((5-cyano-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-3-pyridinyl)azo)-N-(2-ethylhexyl)-",CCCCC(CC)CNC(=O)C1=CC=C(C=C1)N=NC2=C(C(=C(NC2=O)O)C#N)C,,,,,,
3622,103623,"2,2,3-Trimethylcyclopentaneethanol",CC1CCC(C1(C)C)CCO,,,,,,
3623,103624,3-(1H-imidazol-5-yl)-2-propenoic acid methyl ester,COC(=O)C=CC1=CN=CN1,,,,,,
3624,103625,Ethyl 1-methyl-3-phenylpiperidine-3-carboxylate,CCOC(=O)C1(CCCN(C1)C)C2=CC=CC=C2,,,,,,
3625,103626,"1,2,3,4-Tetrahydro-1,4-ethano-3-imino-2-methyl-4-phenylisoquinoline hydrochloride",CN1C2CCC(C1=N)(C3=CC=CC=C23)C4=CC=CC=C4.Cl,,,,,,
3626,103627,"9-Methyl-1-phenyl-9-azatricyclo[6.2.2.02,7]dodeca-2,4,6-trien-10-imine",CN1C2CCC(C1=N)(C3=CC=CC=C23)C4=CC=CC=C4,,,,,,
3627,103628,CID 103628,CNCC1COC2(O1)C3=CC=CC=C3CCC4=CC=CC=C24.C(=CC(=O)O)C(=O)O,,,,,,
3628,103629,"N-methyl-1-spiro[1,3-dioxolane-2,2'-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaene]-4-ylmethanamine",CNCC1COC2(O1)C3=CC=CC=C3CCC4=CC=CC=C24,,,,,,
3629,103630,1-Cyano-2-methyl-3-(2-(((5-methyl-1H-imidazol-4-yl)methyl)thio)ethyl)isothiourea,CC1=C(N=CN1)CSCCN=C(NC#N)SC,,,,,,
3630,103631,"1,4-Butanediylbis[oxy(2-hydroxy-3,1-propanediyl)] diacrylate",C=CC(=O)OCC(COCCCCOCC(COC(=O)C=C)O)O,,,,,,
3631,103632,Triquinolin-8-yl phosphate,C1=CC2=C(C(=C1)OP(=O)(OC3=CC=CC4=C3N=CC=C4)OC5=CC=CC6=C5N=CC=C6)N=CC=C2,,,,,,
3632,103633,"1-(((3-(((Aziridin-1-ylcarbonyl)amino)methyl)-3,5,5-trimethylcyclohexyl)amino)carbonyl)aziridine",CC1(CC(CC(C1)(C)CNC(=O)N2CC2)NC(=O)N3CC3)C,,,,,,
3633,103634,"1,3,5-Tris(2,3-dibromopropyl)-1,3,5-triazinane-2,4,6-trione",C(C(CBr)Br)N1C(=O)N(C(=O)N(C1=O)CC(CBr)Br)CC(CBr)Br,,,,,,
3634,103635,"Benzothiazolium, 2-[[(1,3-dihydro-1,3-dimethyl-2H-benzimidazol-2-ylidene)methyl]azo]-3-methyl-, methyl sulfate",CN1C2=CC=CC=C2[N+](=C1C=NN=C3N(C4=CC=CC=C4S3)C)C.COS(=O)(=O)[O-],,,,,,
3635,103636,"2-[(1,3-Dimethyl-2,3-dihydro-1H-benzimidazol-2-ylidene)methylazo]-3-methylbenzothiazol-3-ium",CN1C2=CC=CC=C2[N+](=C1C=NN=C3N(C4=CC=CC=C4S3)C)C,,,,,,
3636,103637,"2-Naphthalenecarboxylic acid, 4-[1-(acetyloxy)-3-oxo-1H,3H-naphtho[1,8-cd]pyran-1-yl]-1-hydroxy-, methyl ester",CC(=O)OC1(C2=CC=CC3=C2C(=CC=C3)C(=O)O1)C4=CC(=C(C5=CC=CC=C54)O)C(=O)OC,,,,,,
3637,103638,2-(2-((5-Bromo-3-ethyl-3H-benzothiazol-2-ylidene)methyl)but-1-enyl)-6-chloro-1-(3-sulphonatopropyl)quinolinium,CCC(=CC1=[N+](C2=C(C=C1)C=C(C=C2)Cl)CCCS(=O)(=O)[O-])C=C3N(C4=C(S3)C=CC(=C4)Br)CC,,,,,,
3638,103639,"3-[2-[2-[(5-Bromo-3-ethyl-1,3-benzothiazol-2-ylidene)methyl]but-1-enyl]-6-chloroquinolin-1-ium-1-yl]propane-1-sulfonic acid",CCC(=CC1=[N+](C2=C(C=C1)C=C(C=C2)Cl)CCCS(=O)(=O)O)C=C3N(C4=C(S3)C=CC(=C4)Br)CC,,,,,,
3639,103640,CID 103640,CNCC1COC2(O1)C3=CC=CC=C3C=CC4=CC=CC=C24.C(=CC(=O)O)C(=O)O,,,,,,
3640,103641,"N-methyl-1-spiro[1,3-dioxolane-2,2'-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaene]-4-ylmethanamine",CNCC1COC2(O1)C3=CC=CC=C3C=CC4=CC=CC=C24,,,,,,
3641,103642,CID 103642,CCNCC1COC2(O1)C3=CC=CC=C3C=CC4=CC=CC=C24.C(=CC(=O)O)C(=O)O,,,,,,
3642,103643,"N-(spiro[1,3-dioxolane-2,2'-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaene]-4-ylmethyl)ethanamine",CCNCC1COC2(O1)C3=CC=CC=C3C=CC4=CC=CC=C24,,,,,,
3643,103644,CID 103644,CCCNCC1COC2(O1)C3=CC=CC=C3C=CC4=CC=CC=C24.C(=CC(=O)O)C(=O)O,,,,,,
3644,103645,"N-(spiro[1,3-dioxolane-2,2'-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaene]-4-ylmethyl)propan-1-amine",CCCNCC1COC2(O1)C3=CC=CC=C3C=CC4=CC=CC=C24,,,,,,
3645,103646,"2'-((4-Chlorophenyl)amino)-6'-(diethylamino)-3'-methylspiro(isobenzofuran-1(3H),9'-(9H)xanthene)-3-one",CCN(CC)C1=CC2=C(C=C1)C3(C4=CC=CC=C4C(=O)O3)C5=C(O2)C=C(C(=C5)NC6=CC=C(C=C6)Cl)C,,,,,,
3646,103647,CID 103647,CCCCCCCCN(CCCCCCCC)NC=C1C(=C2C3=C(C1=NC(=O)C(=CC=CC(C(C(C(C(C(C(C(C=COC4(C(=O)C2=C(O4)C(=C3O)C)C)OC)C)OC(=O)C)C)O)C)O)C)C)O)O,,,,,,
3647,103648,"3-Cyclohexene-1-carboxaldehyde, 1-methyl-3-(4-methyl-3-penten-1-yl)-",CC(=CCCC1=CCCC(C1)(C)C=O)C,,,,,,
3648,103649,"3-Cyclohexene-1-carboxaldehyde, 3-(4-methyl-3-pentenyl)-",CC(=CCCC1=CCCC(C1)C=O)C,,,,,,
3649,103650,"3-Amino-1-(1,3-benzodioxol-5-yl)-1,4,5,6,7,7a-hexahydro-2H-indol-2-one",C1CCC2=C(C(=O)N(C2C1)C3=CC4=C(C=C3)OCO4)N,,,,,,
3650,103651,2-Cyano-N-(1-methylpropyl)acetamide,CCC(C)NC(=O)CC#N,,,,,,
3651,103652,"Propylene glycol, phosphate",CC(CO)O.OP(=O)(O)O,,,,,,
3652,103653,2-Methylbutyl benzoate,CCC(C)COC(=O)C1=CC=CC=C1,,,,,,
3653,103654,"2-Methoxy-4-(4,4,6-trimethyl-1,3-dioxan-2-yl)phenol",CC1CC(OC(O1)C2=CC(=C(C=C2)O)OC)(C)C,,,,,,
3654,103655,"2-Ethoxy-4-(4,4,6-trimethyl-1,3-dioxan-2-yl)phenol",CCOC1=C(C=CC(=C1)C2OC(CC(O2)(C)C)C)O,,,,,,
3655,103656,1-Octyn-4-ol,CCCCC(CC#C)O,,,,,,
3656,103657,CID 103657,C=CCOCC(CS(=O)(=O)[O-])O.[Na+],,,,,,
3657,103658,2-Hydroxy-3-(allyloxy)-1-propanesulfonic acid,C=CCOCC(CS(=O)(=O)O)O,,,,,,
3658,103659,"Bicyclo(2.2.1)heptane-2-carboxylic acid, 3,3-dimethyl-, methyl ester",CC1(CC2CC(C1C2)C(=O)OC)C,,,,,,
3659,103660,"3,6,7-Trimethyloct-6-en-1-yn-3-ol",CC(=C(C)CCC(C)(C#C)O)C,,,,,,
3660,103661,CID 103661,C1=CC(=CC=C1OC(=C(C(C(C(F)(F)F)(F)F)(C(C(F)(F)F)(F)F)C(F)(F)F)C(F)(F)F)C(F)(F)F)S(=O)(=O)[O-].[Na+],,,,,,
3661,103662,"4-[1,1,1,5,5,6,6,6-Octafluoro-4-(1,1,2,2,2-pentafluoroethyl)-3,4-bis(trifluoromethyl)hex-2-en-2-yl]oxybenzenesulfonic acid",C1=CC(=CC=C1OC(=C(C(C(C(F)(F)F)(F)F)(C(C(F)(F)F)(F)F)C(F)(F)F)C(F)(F)F)C(F)(F)F)S(=O)(=O)O,,,,,,
3662,103663,Digoxin EP Impurity E,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CC(C7(C6(CC(C7C8=CC(=O)OC8)O)O)C)O)C)C)C)O)O,,,,,,
3663,103664,1-(2-Cyclohexyl-1-methylethyl)hydrazine hydrochloride,CC(CC1CCCCC1)NN.Cl,,,,,,
3664,103665,1-Cyclohexylpropan-2-ylhydrazine,CC(CC1CCCCC1)NN,,,,,,
3665,103666,"3,4-Dibromobut-1-ene-1,4-diol",C(=CO)C(C(O)Br)Br,,,,,,
3666,103667,Dimethyl 4-((3-aminophenyl)hydroxymethyl)phthalate,COC(=O)C1=C(C=C(C=C1)C(C2=CC(=CC=C2)N)O)C(=O)OC,,,,,,
3667,103668,Decahydro-2-naphthyl acrylate,C=CC(=O)OC1CCC2CCCCC2C1,,,,,,
3668,103669,Einecs 258-101-2,CC(=CC1=[N+](C2=CC=CC=C2[Se]1)CCCS(=O)(=O)[O-])C=C3N(C4=CC=CC=C4[Se]3)CCCS(=O)(=O)O,,,,,,
3669,103670,2-[2-Methyl-3-[3-(3-sulfopropyl)benzoselenazole-2-ylidene]-1-propenyl]-3-(3-sulfopropyl)benzoselenazole-3-ium,CC(=CC1=[N+](C2=CC=CC=C2[Se]1)CCCS(=O)(=O)O)C=C3N(C4=CC=CC=C4[Se]3)CCCS(=O)(=O)O,,,,,,
3670,103671,3-(2-Hydroxyethyl)-2-(3-(3-(2-hydroxyethyl)-3H-benzothiazol-2-ylidene)-2-methylprop-1-enyl)benzothiazolium bromide,CC(=CC1=[N+](C2=CC=CC=C2S1)CCO)C=C3N(C4=CC=CC=C4S3)CCO.[Br-],,,,,,
3671,103672,3-(2-Hydroxyethyl)-2-[3-[3-(2-hydroxyethyl)benzothiazol-2(3H)-ylidene]-2-methyl-1-propenyl]benzothiazol-3-ium,CC(=CC1=[N+](C2=CC=CC=C2S1)CCO)C=C3N(C4=CC=CC=C4S3)CCO,,,,,,
3672,103673,"Benzaldehyde, 4-methyl-, hydrazone",CC1=CC=C(C=C1)C=NN,,,,,,
3673,103674,3-(Chloromethyl)-1-methylpiperidine,CN1CCCC(C1)CCl,,,,,,
3674,103675,3-Methoxyallylidenemalonitrile,COC=CC=C(C#N)C#N,,,,,,
3675,103676,CID 103676,CCCCNCC1COC2(O1)C3=CC=CC=C3COC4=CC=CC=C24.C(=CC(=O)O)C(=O)O,,,,,,
3676,103677,"N-(spiro[1,3-dioxolane-2,11'-6H-benzo[c][1]benzoxepine]-4-ylmethyl)butan-1-amine",CCCCNCC1COC2(O1)C3=CC=CC=C3COC4=CC=CC=C24,,,,,,
3677,103678,CID 103678,CNCC1COC2(O1)C3=CC=CC=C3COC4=CC=CC=C24.C(=CC(=O)O)C(=O)O,,,,,,
3678,103679,"N-methyl-1-spiro[1,3-dioxolane-2,11'-6H-benzo[c][1]benzoxepine]-4-ylmethanamine",CNCC1COC2(O1)C3=CC=CC=C3COC4=CC=CC=C24,,,,,,
3679,103680,CID 103680,CCCNCC1COC2(O1)C3=CC=CC=C3COC4=CC=CC=C24.C(=CC(=O)O)C(=O)O,,,,,,
3680,103681,"N-(spiro[1,3-dioxolane-2,11'-6H-benzo[c][1]benzoxepine]-4-ylmethyl)propan-1-amine",CCCNCC1COC2(O1)C3=CC=CC=C3COC4=CC=CC=C24,,,,,,
3681,103682,CID 103682,CC(C)CNCC1COC2(O1)C3=CC=CC=C3COC4=CC=CC=C24.C(=CC(=O)O)C(=O)O,,,,,,
3682,103683,"2-methyl-N-(spiro[1,3-dioxolane-2,11'-6H-benzo[c][1]benzoxepine]-4-ylmethyl)propan-1-amine",CC(C)CNCC1COC2(O1)C3=CC=CC=C3COC4=CC=CC=C24,,,,,,
3683,103684,"2-(4-(tert-Butyl)-2-cyclopentylphenoxy)-N-(3,5-dichloro-2-hydroxy-p-tolyl)propionamide",CC1=C(C=C(C(=C1Cl)O)NC(=O)C(C)OC2=C(C=C(C=C2)C(C)(C)C)C3CCCC3)Cl,,,,,,
3684,103685,[4-(1-Bromoethyl)phenyl](thiophen-2-yl)methanone,CC(C1=CC=C(C=C1)C(=O)C2=CC=CS2)Br,,,,,,
3685,103686,2-[4-(Thien-2-ylcarbonyl)phenyl]propiononitrile,CC(C#N)C1=CC=C(C=C1)C(=O)C2=CC=CS2,,,,,,
3686,103687,2-Methyloxirane-2-carbaldehyde,CC1(CO1)C=O,,,,,,
3687,103688,Ethyl 3-p-tolyloxirane-2-carboxylate,CCOC(=O)C1C(O1)C2=CC=C(C=C2)C,,,,,,
3688,103689,(Methylamino)(methylimino)methanesulphonic acid,CNC(=NC)S(=O)(=O)O,,,,,,
3689,103690,"1,4:5,8-Dimethanonaphthalene-2-methanamine, decahydro-",C1CC2CC1C3C2C4CC3CC4CN,,,,,,
3690,103691,"1,4:5,8:9,10-Trimethanoanthracene-2-methanamine, tetradecahydro-",C1CC2CC1C3C2C4CC3C5C4C6CC5CC6CN,,,,,,
3691,103692,4-(Methylsulfanyl)-2-propanamidobutanoic acid,CCC(=O)NC(CCSC)C(=O)O,,,,,,
3692,103693,"3-(2,4-Bis(dimethylamino)phenyl)-6-(dimethylamino)-3-(4-(dimethylamino)phenyl)phthalide",CN(C)C1=CC=C(C=C1)C2(C3=C(C=C(C=C3)N(C)C)C(=O)O2)C4=C(C=C(C=C4)N(C)C)N(C)C,,,,,,
3693,103694,"3-(2,4-Bis(dimethylamino)phenyl)-3-(4-(diethylamino)-o-tolyl)phthalide",CCN(CC)C1=CC(=C(C=C1)C2(C3=CC=CC=C3C(=O)O2)C4=C(C(=CC=C4)N(C)C)N(C)C)C,,,,,,
3694,103695,"Cyclohexanecarboxaldehyde, 2,2,6-trimethyl-",CC1CCCC(C1C=O)(C)C,,,,,,
3695,103696,1-Chloro-amitriptyline,CN(C)CCC=C1C2=C(CCC3=CC=CC=C31)C(=CC=C2)Cl,,,,,,
3696,103697,"Butanamide, N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-2-[2-(4-nitrophenyl)diazenyl]-3-oxo-",CC(=O)C(C(=O)NC1=CC2=C(C=C1)NC(=O)N2)N=NC3=CC=C(C=C3)[N+](=O)[O-],,,,,,
3697,103698,"1,4-Cyclohexanediylbis(methylene) bismethacrylate",CC(=C)C(=O)OCC1CCC(CC1)COC(=O)C(=C)C,,,,,,
3698,103699,"1,2,7,8-Octanetetrol",C(CCC(CO)O)CC(CO)O,,,,,,
3699,103700,3-Ethyl-5-methylheptane,CCC(C)CC(CC)CC,,,,,,
3700,103701,Einecs 258-249-8,CC=C(C=O)N1CCCCC1,,,,,,
3701,103702,Dihydro-5-methyl-5-pentylfuran-2(3H)-one,CCCCCC1(CCC(=O)O1)C,,,,,,
3702,103703,Bis(2-hydroxypropyl) methylenesuccinate,CC(COC(=O)CC(=C)C(=O)OCC(C)O)O,,,,,,
3703,103704,"(3-Ethyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2h-pyrido[2,1-a]isoquinolin-2-ylidene)propanedinitrile",CCC1CN2CCC3=CC(=C(C=C3C2CC1=C(C#N)C#N)OC)OC,,,,,,
3704,103705,"1(3H)-Isobenzofuranone, 3-[2,4-bis(dimethylamino)phenyl]-4,5,6,7-tetrachloro-3-[4-(diethylamino)-2-methylphenyl]-",CCN(CC)C1=CC(=C(C=C1)C2(C3=C(C(=C(C(=C3Cl)Cl)Cl)Cl)C(=O)O2)C4=C(C=C(C=C4)N(C)C)N(C)C)C,,,,,,
3705,103706,"2-(3-Fluoro-4-methoxy-alpha-phenoxybenzyl)-3,4,5,6-tetrahydropyrimidine",COC1=C(C=C(C=C1)C(C2=NCCCN2)OC3=CC=CC=C3)F,,,,,,
3706,103707,"1-Butyl-2-[ethoxy(phenyl)methyl]-5-methyl-1,4,5,6-tetrahydropyrimidine",CCCCN1CC(CN=C1C(C2=CC=CC=C2)OCC)C,,,,,,
3707,103708,2-Bromo-N-(4-ethoxyphenyl)-3-methylbutyramide,CCOC1=CC=C(C=C1)NC(=O)C(C(C)C)Br,,,,,,
3708,103709,"Pyridinium, 3-carbamoyl-1-(7-chloro-5-(2-chlorophenyl)-2,3-dihydro-2-oxo-1H-1,4-benzodiazepin-3-yl)-, chloride",C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)[N+]4=CC=CC(=C4)C(=O)N)Cl.[Cl-],,,,,,
3709,103710,"1-[7-Chloro-5-(2-chlorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]pyridin-1-ium-3-carboxamide",C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)[N+]4=CC=CC(=C4)C(=O)N)Cl,,,,,,
3710,103711,"Pyridinium, 1-(7-chloro-5-(2-chlorophenyl)-2,3-dihydro-2-oxo-1H-1,4-benzodiazepin-3-yl)-, chloride",C1=CC=[N+](C=C1)C2C(=O)NC3=C(C=C(C=C3)Cl)C(=N2)C4=CC=CC=C4Cl.[Cl-],,,,,,
3711,103712,"7-Chloro-5-(2-chlorophenyl)-3-pyridin-1-ium-1-yl-1,3-dihydro-1,4-benzodiazepin-2-one",C1=CC=[N+](C=C1)C2C(=O)NC3=C(C=C(C=C3)Cl)C(=N2)C4=CC=CC=C4Cl,,,,,,
3712,103713,"Morpholinium, 4-(7-chloro-5-(2-chlorophenyl)-2,3-dihydro-2-oxo-1H-1,4-benzodiazepin-3-yl)-4-(2-hydroxyethyl)-, chloride",C1COCC[N+]1(CCO)C2C(=O)NC3=C(C=C(C=C3)Cl)C(=N2)C4=CC=CC=C4Cl.[Cl-],,,,,,
3713,103714,"7-Chloro-5-(2-chlorophenyl)-3-[4-(2-hydroxyethyl)morpholin-4-ium-4-yl]-1,3-dihydro-1,4-benzodiazepin-2-one",C1COCC[N+]1(CCO)C2C(=O)NC3=C(C=C(C=C3)Cl)C(=N2)C4=CC=CC=C4Cl,,,,,,
3714,103715,"Pyridinium, 1-(7-chloro-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-3-(diethylcarbamoyl)-, chloride",CCN(CC)C(=O)C1=C[N+](=CC=C1)C2C(=O)NC3=C(C=C(C=C3)Cl)C(=N2)C4=CC=CC=C4.[Cl-],,,,,,
3715,103716,"1-(7-chloro-2-oxo-5-phenyl-1,3-dihydro-1,4-benzodiazepin-3-yl)-N,N-diethylpyridin-1-ium-3-carboxamide",CCN(CC)C(=O)C1=C[N+](=CC=C1)C2C(=O)NC3=C(C=C(C=C3)Cl)C(=N2)C4=CC=CC=C4,,,,,,
3716,103717,"Pyridinium, 1-(7-chloro-5-(2-chlorophenyl)-2,3-dihydro-2-oxo-1H-1,4-benzodiazepin-3-yl)-3-(diethylcarbamoyl)-, chloride",CCN(CC)C(=O)C1=C[N+](=CC=C1)C2C(=O)NC3=C(C=C(C=C3)Cl)C(=N2)C4=CC=CC=C4Cl.[Cl-],,,,,,
3717,103718,"1-[7-chloro-5-(2-chlorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]-N,N-diethylpyridin-1-ium-3-carboxamide",CCN(CC)C(=O)C1=C[N+](=CC=C1)C2C(=O)NC3=C(C=C(C=C3)Cl)C(=N2)C4=CC=CC=C4Cl,,,,,,
3718,103719,"4,7-Methano-1H-indene, 3a,4,5,6,7,7a-hexahydro-5-methoxy-",COC1CC2CC1C3C2CC=C3,,,,,,
3719,103720,"5-Ethoxy-3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene",CCOC1CC2CC1C3C2CC=C3,,,,,,
3720,103721,4-Ethyloxazolidine,CCC1COCN1,,,,,,
3721,103722,CID 103722,CC(CCCC(C)(C)OC)CC=CC(=CC(=O)O)C.N,,,,,,
3722,103723,"3,7,11-Trimethyldodeca-2,4-dienoic acid",CC(C)CCCC(C)CC=CC(=CC(=O)O)C,,,,,,
3723,103724,"Azane;3,7,11-trimethyldodeca-2,4-dienoic acid",CC(C)CCCC(C)CC=CC(=CC(=O)O)C.N,,,,,,
3724,103725,2-(3-(3-Ethyl-3H-benzothiazol-2-ylidene)isobut-1-enyl)-3-(3-sulphonatopropyl)benzothiazolium,CCN1C2=CC=CC=C2SC1=CC(=CC3=[N+](C4=CC=CC=C4S3)CCCS(=O)(=O)[O-])C,,,,,,
3725,103726,"3-[2-[3-(3-Ethyl-1,3-benzothiazol-2-ylidene)-2-methylprop-1-enyl]-1,3-benzothiazol-3-ium-3-yl]propane-1-sulfonic acid",CCN1C2=CC=CC=C2SC1=CC(=CC3=[N+](C4=CC=CC=C4S3)CCCS(=O)(=O)O)C,,,,,,
3726,103727,"2-(4-Methoxy-alpha-phenoxybenzyl)-3,4,5,6-tetrahydropyrimidine",COC1=CC=C(C=C1)C(C2=NCCCN2)OC3=CC=CC=C3,,,,,,
3727,103728,"1,5-Decalindiol",C1CC2C(CCCC2O)C(C1)O,,,,,,
3728,103729,"3-(Cyclohexylamino)propane-1,2-diol",C1CCC(CC1)NCC(CO)O,,,,,,
3729,103730,"7-[(1R,2R,3R,5S)-3-(1-ethoxyethoxy)-2-[(3S)-3-(1-ethoxyethoxy)oct-1-enyl]-5-hydroxycyclopentyl]hept-5-enoic acid",CCCCC[C@@H](C=C[C@H]1[C@@H](C[C@@H]([C@@H]1CC=CCCCC(=O)O)O)OC(C)OCC)OC(C)OCC,,,,,,
3730,103731,"1-(2,6-Dichlorophenyl)ethanol",CC(C1=C(C=CC=C1Cl)Cl)O,,,,,,
3731,103732,"3,7-Dimethyloctane-1,6-diol",CC(C)C(CCC(C)CCO)O,,,,,,
3732,103733,(Bicyclo[2.2.1]hept-2-yl)methyl acetate,CC(=O)OCC1CC2CCC1C2,,,,,,
3733,103734,(Bicyclo(2.2.1)hept-2-yl)methyl benzoate,C1CC2CC1CC2COC(=O)C3=CC=CC=C3,,,,,,
3734,103735,3-Methylpentyl 2-methylbut-2-enoate,CCC(C)CCOC(=O)C(=CC)C,,,,,,
3735,103736,CID 103736,CCCC[SnH].CC(C)CCCCCOC(=O)C=CC(=O)O.CC(C)CCCCCOC(=O)C=CC(=O)O.CC(C)CCCCCOC(=O)C=CC(=O)O,,,,,,
3736,103737,"2H-1-Benzopyran-2,6-diol, 3,4-dihydro-2,5,7,8-tetramethyl-",CC1=C(C2=C(CCC(O2)(C)O)C(=C1O)C)C,,,,,,
3737,103738,Methyl 2-hydroxy-3-methyl-4-oxocyclohex-2-ene-1-carboxylate,CC1=C(C(CCC1=O)C(=O)OC)O,,,,,,
3738,103739,"5-(3,5-Di-sec-butylcyclopent-1-enyl)-5-hydroxy-3-oxovaleric acid",CCC(C)C1CC(C(=C1)C(CC(=O)CC(=O)O)O)C(C)CC,,,,,,
3739,103740,"2,2,5,9-Tetramethyldeca-4,8-dienal",CC(=CCCC(=CCC(C)(C)C=O)C)C,,,,,,
3740,103741,CID 103741,CCN1C2=CC(=C(C=C2[N+](=C1C=CC=C3N(C4=CC(=C(C=C4N3CC)Cl)Cl)CC)CC(=NS(=O)(=O)C)[O-])Cl)Cl,,,,,,
3741,103742,"2-[5,6-dichloro-2-[3-(5,6-dichloro-1,3-diethylbenzimidazol-2-ylidene)prop-1-enyl]-3-ethylbenzimidazol-1-ium-1-yl]-N-methylsulfonylacetamide",CCN1C2=CC(=C(C=C2[N+](=C1C=CC=C3N(C4=CC(=C(C=C4N3CC)Cl)Cl)CC)CC(=O)NS(=O)(=O)C)Cl)Cl,,,,,,
3742,103743,"1-(1,2,3,4,6,7,8,8a-Octahydro-8,8-dimethyl-2-naphthyl)ethan-1-one",CC(=O)C1CCC2=CCCC(C2C1)(C)C,,,,,,
3743,103744,"1,4-Cyclohexanedimethanol Bis(2-ethylhexanoate)",CCCCC(CC)C(=O)OCC1CCC(CC1)COC(=O)C(CC)CCCC,,,,,,
3744,103745,"Pyridinium, 4-carbamoyl-1-(7-chloro-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-, chloride",CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)[N+]3=CC=C(C=C3)C(=O)N)C4=CC=CC=C4.[Cl-],,,,,,
3745,103746,"1-(7-chloro-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl)pyridin-1-ium-4-carboxamide",CN1C2=C(C=C(C=C2)Cl)C(=NC(C1=O)[N+]3=CC=C(C=C3)C(=O)N)C4=CC=CC=C4,,,,,,
3746,103747,"3,4,5-Trimethylhexan-1-ol",CC(C)C(C)C(C)CCO,,,,,,
3747,103748,"1H-Isoindol-3-amine, 1-(2-amino-4-imino-5(4H)-thiazolylidene)-",C1=CC=C2C(=C1)C(=NC2=N)C3=C(N=C(S3)N)N,,,,,,
3748,103749,"2,3-Dimethylnon-2-enenitrile",CCCCCCC(=C(C)C#N)C,,,,,,
3749,103750,"[2-Hydroxy-3-[(1-oxohexadecyl)oxy]propyl] hydrogen 2,3-diacetoxysuccinate",CCCCCCCCCCCCCCCC(=O)OCC(COC(=O)C(C(C(=O)O)OC(=O)C)OC(=O)C)O,,,,,,
3750,103751,alpha-Phenyl-alpha-(2-piperidinoethyl)-beta-ethylbutyronitrile hydrochloride,CCC(C)C(CCN1CCCCC1)(C#N)C2=CC=CC=C2.Cl,,,,,,
3751,103752,2-Phenyl-2-(2-piperidinoethyl)-3-methylvaleronitrile,CCC(C)C(CCN1CCCCC1)(C#N)C2=CC=CC=C2,,,,,,
3752,103753,CID 103753,CCCCC(CC)COC(=O)CC[S-].CCCCC(CC)COC(=O)CC[S-].CCCC[Sn]CCCC,,,,,,
3753,103754,But-2-enedioic acid;3-(dimethylamino)-2-methyl-1-phenylpropan-1-one,CC(CN(C)C)C(=O)C1=CC=CC=C1.C(=CC(=O)O)C(=O)O,,,,,,
3754,103755,But-2-enedioic acid;2-[(dimethylamino)methyl]-1-phenylpentan-1-one,CCCC(CN(C)C)C(=O)C1=CC=CC=C1.C(=CC(=O)O)C(=O)O,,,,,,
3755,103756,2-[(Dimethylamino)methyl]-1-phenylpentan-1-one,CCCC(CN(C)C)C(=O)C1=CC=CC=C1,,,,,,
3756,103757,"2,2-Dimethyl-3-(dimethylamino)-4'-(methylsulfonyl)-propiophenone hydrochloride",CC(C)(CN(C)C)C(=O)C1=CC=C(C=C1)S(=O)(=O)C.Cl,,,,,,
3757,103758,"3-(Dimethylamino)-2,2-dimethyl-1-(4-methylsulfonylphenyl)propan-1-one",CC(C)(CN(C)C)C(=O)C1=CC=C(C=C1)S(=O)(=O)C,,,,,,
3758,103759,"1,3-Dimethyl-2,3-dihydroquinolin-4(1h)-one",CC1CN(C2=CC=CC=C2C1=O)C,,,,,,
3759,103760,"7-Chloro-1,3-dimethyl-1,2,3,4-tetrahydro-4-quinolinone",CC1CN(C2=C(C1=O)C=CC(=C2)Cl)C,,,,,,
3760,103761,"1,3-Dimethyl-7-methoxy-1,2,3,4-tetrahydro-4-quinolinone",CC1CN(C2=C(C1=O)C=CC(=C2)OC)C,,,,,,
3761,103762,"4-Hydroxy-1,3,3-trimethyl-3,4-dihydroquinolin-2(1h)-one",CC1(C(C2=CC=CC=C2N(C1=O)C)O)C,,,,,,
3762,103763,"2H-1-Benzopyran-6-ol, 3,4-dihydro-2-methoxy-2,5,7,8-tetramethyl-",CC1=C(C2=C(CCC(O2)(C)OC)C(=C1O)C)C,,,,,,
3763,103764,"3,3'-Dihexyloxacarbocyanine iodide",CCCCCCN1C2=CC=CC=C2OC1=CC=CC3=[N+](C4=CC=CC=C4O3)CCCCCC.[I-],,,"['Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)']",,,
3764,103765,3-Hexyl-2-[3-(3-hexylbenzoxazol-2(3H)-ylidene)-1-propenyl]benzoxazol-3-ium,CCCCCCN1C2=CC=CC=C2OC1=CC=CC3=[N+](C4=CC=CC=C4O3)CCCCCC,,,,,,
3765,103766,"2,3-Dibutyloxirane",CCCCC1C(O1)CCCC,,,,,,
3766,103767,2-Ethylhexyl isodecyl phthalate,CCCCC(CC)COC(=O)C1=CC=CC=C1C(=O)OCCCCCCCC(C)C,,,,,,
3767,103768,"2-((3-(carboxymethyl)-2(3H)-benzothiazolylidene)methyl)-1-ethylquinolinium, inner salt",CC[N+]1=C(C=CC2=CC=CC=C21)C=C3N(C4=CC=CC=C4S3)CC(=O)[O-],,,,,,
3768,103769,2-[[3-(Carboxymethyl)benzothiazol-2(3H)-ylidene]methyl]-1-ethylquinolinium,CC[N+]1=C(C=CC2=CC=CC=C21)C=C3N(C4=CC=CC=C4S3)CC(=O)O,,,,,,
3769,103770,"4,11-Diamino-2-(2,3-diphenylpropyl)-1H-naphth(2,3-f)isoindole-1,3,5,10(2H)-tetrone",C1=CC=C(C=C1)CC(CN2C(=O)C3=C(C4=C(C(=C3C2=O)N)C(=O)C5=CC=CC=C5C4=O)N)C6=CC=CC=C6,,,,,,
3770,103771,1-Phenylbutan-2-amine,CCC(CC1=CC=CC=C1)N,,,,,,
3771,103772,1-(2-Chloroethyl)-2-methylpiperidine,CC1CCCCN1CCCl,,,,,,
3772,103773,"5,6-Dichloro-2-(3-(5,6-dichloro-1-ethyl-1,3-dihydro-3-(4-sulphobutyl)-2H-benzimidazol-2-ylidene)-1-propenyl)-1-ethyl-3-(4-sulphobutyl)-1H-benzimidazolium",CCN1C2=CC(=C(C=C2[N+](=C1C=CC=C3N(C4=CC(=C(C=C4N3CCCCS(=O)(=O)O)Cl)Cl)CC)CCCCS(=O)(=O)O)Cl)Cl,,,,,,
3773,103774,"1(2H)-Quinolineethanol, 3,4-dihydro-2,2,4-trimethyl-",CC1CC(N(C2=CC=CC=C12)CCO)(C)C,,,,,,
3774,103775,"alpha-(((4,5-Dihydro-1H-imidazol-2-yl)amino)methyl)benzyl alcohol",C1CN=C(N1)NCC(C2=CC=CC=C2)O,,,,,,
3775,103776,5-Methyl-2-(propan-2-yl)cyclohexyl dihydrogen borate,B(O)(O)OC1CC(CCC1C(C)C)C,,,,,,
3776,103777,2-Methoxy-4-nitrophenyl 5-oxo-L-prolinate,COC1=C(C=CC(=C1)[N+](=O)[O-])OC(=O)C2CCC(=O)N2,,,,,,
3777,103778,"Dispiro(cyclohexane-1,2'(3'H)-quinazoline-4'(4'aH),1''-cyclohexane), 5',6',7',8'-tetrahydro-",C1CCC2(CC1)C3CCCCC3=NC4(N2)CCCCC4,,,,,,
3778,103779,"Tetradecanoyl chloride, 2-bromo-",CCCCCCCCCCCCC(C(=O)Cl)Br,,,,,,
3779,103780,2-(1-Ethoxyethoxy)propanenitrile,CCOC(C)OC(C)C#N,,,,,,
3780,103781,"N-((1-Acetyl-1,2,3,4-tetrahydro-6-methyl-7-nitro-2-quinolyl)methyl)-N-isopropylacetamide",CC1=CC2=C(C=C1[N+](=O)[O-])N(C(CC2)CN(C(C)C)C(=O)C)C(=O)C,,,,,,
3781,103782,"Bis(oxiranylmethyl) 2,2,4(or 2,4,4)-trimethyladipate",CC(CC(=O)OCC1CO1)CC(C)(C)C(=O)OCC2CO2,,,,,,
3782,103783,"2,2,4-Trimethyladipic acid",CC(CC(=O)O)CC(C)(C)C(=O)O,,,,,,
3783,103784,2-Isopropylindan-1-one,CC(C)C1CC2=CC=CC=C2C1=O,,,,,,
3784,103785,"Isopropyl 3,5,5-trimethylhexanoate",CC(C)OC(=O)CC(C)CC(C)(C)C,,,,,,
3785,103786,"1,2-Bis(4-fluorophenyl)-2-hydroxyethanone",C1=CC(=CC=C1C(C(=O)C2=CC=C(C=C2)F)O)F,,,,,,
3786,103787,"1,3,3-Trimethyl-6-azabicyclo[3.2.1]octane",CC1(CC2CC(C1)(CN2)C)C,,,,,,
3787,103788,3-(Methylthio)-2-butanone,CC(C(=O)C)SC,,,,,,
3788,103789,Dibutyltin;12-hydroxyoctadecanoic acid,CCCCCCC(CCCCCCCCCCC(=O)O)O.CCCCCCC(CCCCCCCCCCC(=O)O)O.CCCC[Sn]CCCC,,,,,,
3789,103790,[(2-Ethylhexyl)oxy]acetaldehyde,CCCCC(CC)COCC=O,,,,,,
3790,103791,"3-Chlorobutane-1,2-diol",CC(C(CO)O)Cl,,,,,,
3791,103792,"N,N-Diethyl-2-(phenyl-(p-tolyl)methoxy)ethylamine hydrochloride",CCN(CC)CCOC(C1=CC=CC=C1)C2=CC=C(C=C2)C.Cl,,,,,,
3792,103793,"N,N-diethyl-2-[(4-methylphenyl)-phenylmethoxy]ethanamine",CCN(CC)CCOC(C1=CC=CC=C1)C2=CC=C(C=C2)C,,,,,,
3793,103794,Isopropyl 3-methyl-3-(p-isobutylphenyl)oxirane-2-carboxylate,CC(C)CC1=CC=C(C=C1)C2(C(O2)C(=O)OC(C)C)C,,,,,,
3794,103795,"alpha,alpha',2,5-Tetramethylpiperazine-1,4-diethanol",CC1CN(C(CN1CC(C)O)C)CC(C)O,,,,,,
3795,103796,"1-Cyclohexene-1-propanal, 4-(1-methylethenyl)-",CC(=C)C1CCC(=CC1)CCC=O,,,,,,
3796,103797,3-(4-Isopropenyl-1-cyclohexen-1-yl)-2-methylpropanal,CC(CC1=CCC(CC1)C(=C)C)C=O,,,,,,
3797,103798,Eicosenylsuccinic anhydride,C=CCCCCCCCCCCCCCCCCCCC1CC(=O)OC1=O,,,,,,
3798,103799,"Benzoic acid, 3,3'-(1,2-ethenediylbis((3-sulfo-4,1-phenylene)azo))bis(6-hydroxy-5-methyl-, tetralithium salt",[Li+].[Li+].[Li+].[Li+].CC1=CC(=CC(=C1O)C(=O)[O-])N=NC2=CC(=C(C=C2)C=CC3=C(C=C(C=C3)N=NC4=C(C=C(C=C4C)O)C(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-],,,,,,
3799,103800,2-{[4-(2-{4-[(3-Carboxy-4-hydroxy-5-methylphenyl)diazenyl]-2-sulfophenyl}ethenyl)-3-sulfophenyl]diazenyl}-5-hydroxy-3-methylbenzoic acid,CC1=CC(=CC(=C1O)C(=O)O)N=NC2=CC(=C(C=C2)C=CC3=C(C=C(C=C3)N=NC4=C(C=C(C=C4C)O)C(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
3800,103801,"Tetrakis(2-ethylhexyl) bicyclo[2.2.2]oct-7-ene-2,3,5,6-tetracarboxylate",CCCCC(CC)COC(=O)C1C2C=CC(C1C(=O)OCC(CC)CCCC)C(C2C(=O)OCC(CC)CCCC)C(=O)OCC(CC)CCCC,,,,,,
3801,103802,"2,2,2-Trifluoro-1-(9-anthryl)ethanol",C1=CC=C2C(=C1)C=C3C=CC=CC3=C2C(C(F)(F)F)O,,,,,,
3802,103803,"1-(2,2-Dimethoxyethoxy)-2-ethylhexane",CCCCC(CC)COCC(OC)OC,,,,,,
3803,103804,9-(3-Chloropropyl)-6-fluoro-2-(trifluoromethyl)-9H-thioxanthene,C1=CC2=C(C=C1C(F)(F)F)C(C3=C(S2)C=C(C=C3)F)CCCCl,,,,,,
3804,103805,"2-Propenoic acid, 3-(4-(bis(2-(acetyloxy)ethyl)amino)-2-methylphenyl)-2-cyano-, methyl ester",CC1=C(C=CC(=C1)N(CCOC(=O)C)CCOC(=O)C)C=C(C#N)C(=O)OC,,,,,,
3805,103806,N-butylidenehydroxylamine;dibutyltin;hydrate,CCCC[Sn]CCCC.CCCC[Sn]CCCC.CCCC=NO.CCCC=NO.O,,,,,,
3806,103807,Methyl 3-acetoxyacrylate,CC(=O)OC=CC(=O)OC,,,,,,
3807,103808,Butyl 3-hydroxybutanoate,CCCCOC(=O)CC(C)O,,,,,,
3808,103809,CID 103809,CC(C)NCC1COC2(O1)C3=CC=CC=C3C=CC4=CC=CC=C24.C(=CC(=O)O)C(=O)O,,,,,,
3809,103810,"N-(spiro[1,3-dioxolane-2,2'-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaene]-4-ylmethyl)propan-2-amine",CC(C)NCC1COC2(O1)C3=CC=CC=C3C=CC4=CC=CC=C24,,,,,,
3810,103811,"2,2-Bis((allyloxy)methyl)butyl hydrogen maleate",CCC(COCC=C)(COCC=C)COC(=O)C=CC(=O)O,,,,,,
3811,103812,6-Methyl-2-(3-oxo-1-benzothiophen-2-ylidene)-1-benzothiophen-3-one,CC1=CC2=C(C=C1)C(=O)C(=C3C(=O)C4=CC=CC=C4S3)S2,,,,,,
3812,103813,"Benzo[b]thiophen-3(2H)-one, 2-[[4-(dimethylamino)phenyl]imino]-",CN(C)C1=CC=C(C=C1)N=C2C(=O)C3=CC=CC=C3S2,,,,,,
3813,103814,"2,3,4,4a,5,6,7,8-Octahydro-4,4a-dimethyl-6-(1-methylvinyl)-2-naphthol",CC1CC(C=C2C1(CC(CC2)C(=C)C)C)O,,,,,,
3814,103815,"2,6-Dimethylthiomorpholine",CC1CNCC(S1)C,,,,,,
3815,103816,"1,3,3-Trimethyl-1-phenylindan-5-ol",CC1(CC(C2=C1C=C(C=C2)O)(C)C3=CC=CC=C3)C,,,,,,
3816,103817,"Piperidine, 1-(N-(alpha-methylbenzyl)glycyl)-2,2,6,6-tetramethyl-",CC(C1=CC=CC=C1)NC(=O)CN2C(CCCC2(C)C)(C)C,,,,,,
3817,103818,"1-(N,N-Diethylglycyl)-4-phenyl-2,2,6,6-tetramethylpiperidine",CCN(CC)C(=O)CN1C(CC(CC1(C)C)C2=CC=CC=C2)(C)C,,,,,,
3818,103819,"1-(2,3-Dichloropropyl)-2-methyl-5-nitroimidazole",CC1=NC=C(N1CC(CCl)Cl)[N+](=O)[O-],,,,,,
3819,103820,"(2-Methyl-5-phenyl-4,5-dihydro-1,3-oxazol-4-yl)methanol",CC1=NC(C(O1)C2=CC=CC=C2)CO,,,,,,
3820,103821,2-Propyl-2-heptenyl acetate,CCCCC=C(CCC)COC(=O)C,,,,,,
3821,103822,"16-(Acetyloxy)-3-[(2,6-dideoxyhexopyranosyl)oxy]-14-hydroxycard-20(22)-enolide",CC1C(C(CC(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CC(C5C6=CC(=O)OC6)OC(=O)C)O)C)C)O)O,,,,,,
3822,103823,Diisopropylidene mannitol,CC1(OCC(O1)C(C(C2COC(O2)(C)C)O)O)C,,,,,,
3823,103824,6'-N-Acetylsisomicin,CC(=O)NCC1=CCC(C(O1)OC2(COC(C(C2NC)O)OC3C(CC(C(C3O)O)N)N)C)N,,,,,,
3824,103825,"7-Methoxy-3,7-dimethyloct-1-ene",CC(CCCC(C)(C)OC)C=C,,,,,,
3825,103826,"2,6-Dimethyloct-7-en-2-yl acetate",CC(CCCC(C)(C)OC(=O)C)C=C,,,,,,
3826,103827,CID 103827,CC(C)(C1=CC=CC=C1)C2=CC=C(C=C2)C3=C(C(=CC(=C3)C(C)(C)C4=CC=CC=C4)C(=O)[O-])O.CC(C)(C1=CC=CC=C1)C2=CC=C(C=C2)C3=C(C(=CC(=C3)C(C)(C)C4=CC=CC=C4)C(=O)[O-])O.[Zn+2],,,,,,
3827,103828,2-Hydroxy-5-(2-phenylpropan-2-yl)-3-[4-(2-phenylpropan-2-yl)phenyl]benzoic acid,CC(C)(C1=CC=CC=C1)C2=CC=C(C=C2)C3=C(C(=CC(=C3)C(C)(C)C4=CC=CC=C4)C(=O)O)O,,,,,,
3828,103829,CID 103829,CC(C1=CC=CC=C1)C2=CC(=C(C(=C2)C(=O)[O-])O)C(C)C3=CC=CC=C3.CC(C1=CC=CC=C1)C2=CC(=C(C(=C2)C(=O)[O-])O)C(C)C3=CC=CC=C3.[Zn+2],,,,,,
3829,103830,"2-hydroxy-3,5-bis(1-phenylethyl)benzoic Acid",CC(C1=CC=CC=C1)C2=CC(=C(C(=C2)C(=O)O)O)C(C)C3=CC=CC=C3,,,,,,
3830,103831,"1,5,7-Octatrien-3-ol, 3,7-dimethyl-, 3-acetate",CC(=C)C=CCC(C)(C=C)OC(=O)C,,,,,,
3831,103832,Disodium 2-(p-(gamma-phenylpropylamino)benzenesulfonamido)pyridine,C1=CC=C(C=C1)C(CC(NC2=CC=C(C=C2)S(=O)(=O)NC3=CC=CC=N3)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
3832,103833,"1-Phenyl-3-[4-(pyridin-2-ylsulfamoyl)anilino]propane-1,3-disulfonic acid",C1=CC=C(C=C1)C(CC(NC2=CC=C(C=C2)S(=O)(=O)NC3=CC=CC=N3)S(=O)(=O)O)S(=O)(=O)O,,,,,,
3833,103834,3-Chlorobutanenitrile,CC(CC#N)Cl,,,,,,
3834,103835,"Decahydro-2,5,5,8a-tetramethylnaphthalen-1-acetaldehyde",CC1CCC2C(CCCC2(C1CC=O)C)(C)C,,,,,,
3835,103836,"Decahydro-2,5,5,8a-tetramethylnaphthalene-1-ethanol",CC1CCC2C(CCCC2(C1CCO)C)(C)C,,,,,,
3836,103837,Ethyl 4-(hydroxyimino)piperidine-1-carboxylate,CCOC(=O)N1CCC(=NO)CC1,,,,,,
3837,103838,"6-(5-Chloro-1,8-naphthyridin-2-yl)-2,3,6,7-tetrahydro-7-oxo-5H-1,4-dithiino(2,3-c)pyrrol-5-yl 4-methylpiperazine-1-carboxylate",CN1CCN(CC1)C(=O)OC2C3=C(C(=O)N2C4=NC5=NC=CC(=C5C=C4)Cl)SCCS3,,,,,,
3838,103839,"6-(7-chloro-1,8-naphthyridin-2-yl)-7-hydroxy-3,4a,7,7a-tetrahydro-2H-[1,4]dithiino[2,3-c]pyrrol-5-one",C1CSC2C(S1)C(N(C2=O)C3=NC4=C(C=C3)C=CC(=N4)Cl)O,,,,,,
3839,103840,"N-(4,5-Dihydro-4-methyl-5-oxo-1-phenyl-1H-pyrazol-3-yl)methacrylamide",CC1C(=NN(C1=O)C2=CC=CC=C2)NC(=O)C(=C)C,,,,,,
3840,103841,2-[2-[2-(2-Hydroxyethoxy)ethoxy]ethoxy]ethyl 2-ethylhexanoate,CCCCC(CC)C(=O)OCCOCCOCCOCCO,,,,,,
3841,103842,"4,6-Bis(1-phenylethyl)-m-xylene",CC1=CC(=C(C=C1C(C)C2=CC=CC=C2)C(C)C3=CC=CC=C3)C,,,,,,
3842,103843,4-Amino-N-(2-ethylhexyl)benzenesulphonamide,CCCCC(CC)CNS(=O)(=O)C1=CC=C(C=C1)N,,,,,,
3843,103844,"1(2H)-Quinolineethanol, 3,4-dihydro-2,7-dimethyl-",CC1CCC2=C(N1CCO)C=C(C=C2)C,,,,,,
3844,103845,"1(2H)-Quinolineethanol, 3,4-dihydro-2,2,4,7-tetramethyl-",CC1CC(N(C2=C1C=CC(=C2)C)CCO)(C)C,,,,,,
3845,103846,Diisotridecyl maleate,CC(C)CCCCCCCCCCOC(=O)C=CC(=O)OCCCCCCCCCCC(C)C,,,,,,
3846,103847,Diisodecyl maleate,CC(C)CCCCCCCOC(=O)C=CC(=O)OCCCCCCCC(C)C,,,,,,
3847,103848,6-(2-Chloroethanesulfonyl)bicyclo[2.2.1]heptane-2-carbonyl chloride,C1C2CC(C1C(C2)S(=O)(=O)CCCl)C(=O)Cl,,,,,,
3848,103849,"1,2-Propanediol didecanoate",CCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCC,,,,,,
3849,103850,CID 103850,CC(=C)C=CCC(C)(C=C)O,,,,,,
3850,103851,"6,10-Dimethylundeca-5,9-dien-2-ol",CC(CCC=C(C)CCC=C(C)C)O,,,,,,
3851,103852,4-(4-Methylpenten-3-yl)cyclohex-3-ene-1-methyl acetate,CC(=CCCC1=CCC(CC1)COC(=O)C)C,,,,,,
3852,103853,3-[(2-Ethylhexyl)oxy]-2-hydroxypropyl palmitate,CCCCCCCCCCCCCCCC(=O)OCC(COCC(CC)CCCC)O,,,,,,
3853,103854,"4-Methyl-6-(2,6,6-trimethylcyclohex-1-en-1-yl)hexa-2,4-dienal",CC1=C(C(CCC1)(C)C)CC=C(C)C=CC=O,,,,,,
3854,103855,"2,6-Dimethyl-8-(2,6,6-trimethyl-1-cyclohexen-1-yl)octa-2,4,6-trienal",CC1=C(C(CCC1)(C)C)CC=C(C)C=CC=C(C)C=O,,,,,,
3855,103856,"2-Ethyl-2-(((2-methyl-1-oxopentadecyl)oxy)methyl)propane-1,3-diyl bis(2-methylpentadecanoate)",CCCCCCCCCCCCCC(C)C(=O)OCC(CC)(COC(=O)C(C)CCCCCCCCCCCCC)COC(=O)C(C)CCCCCCCCCCCCC,,,,,,
3856,103857,"1,4-Anhydro-D-glucitol tetraacetate",CC(=O)OCC(C1C(C(CO1)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
3857,103858,Methyl 2-mercaptopropionate,CC(C(=O)OC)S,,,,,,
3858,103859,"Benzoic acid, 4-[1-[[[5-[[4-[2,4-bis(1,1-dimethylpropyl)phenoxy]-1-oxobutyl]amino]-2-chlorophenyl]amino]carbonyl]-3,3-dimethyl-2-oxobutoxy]-",CCC(C)(C)C1=CC(=C(C=C1)OCCCC(=O)NC2=CC(=C(C=C2)Cl)NC(=O)C(C(=O)C(C)(C)C)OC3=CC=C(C=C3)C(=O)O)C(C)(C)CC,,,,,,
3859,103860,2-(6-Bromohexyloxy)tetrahydro-2H-pyran,C1CCOC(C1)OCCCCCCBr,,,,,,
3860,103861,4-Nitrobenzyl 7-amino-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,C1C(=C(N2C(S1)C(C2=O)N)C(=O)OCC3=CC=C(C=C3)[N+](=O)[O-])Cl,,,,,,
3861,103862,4-Methyl-2-propylpentan-1-ol,CCCC(CC(C)C)CO,,,,,,
3862,103863,"4,4,5,5,6,6,7,7,8,8,9,9,10,11,11,11-Hexadecafluoro-2-hydroxy-10-(trifluoromethyl)undecyl dihydrogen phosphate",C(C(COP(=O)(O)O)O)C(C(C(C(C(C(C(C(F)(F)F)(C(F)(F)F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
3863,103864,"(2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,13,14,15,15,15-Octacosafluoro-14-(trifluoromethyl)pentadecyl)oxirane",C1C(O1)CC(C(C(C(C(C(C(C(C(C(C(C(C(C(F)(F)F)(C(F)(F)F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
3864,103865,"5-Isopropenyl-beta,2-dimethylcyclopent-1-ene-1-propyl acetate",CC1=C(C(CC1)C(=C)C)CC(C)COC(=O)C,,,,,,
3865,103866,"2-Propenoic acid, 3-(4-aminophenyl)-, hydrochloride",C1=CC(=CC=C1C=CC(=O)O)N.Cl,,,,,,
3866,103867,"5-Methoxy-1,3,3-trimethyl-2-(2-(1-methyl-2-phenyl-1H-indol-3-yl)vinyl)-3H-indolium chloride",CC1(C2=C(C=CC(=C2)OC)[N+](=C1C=CC3=C(N(C4=CC=CC=C43)C)C5=CC=CC=C5)C)C.[Cl-],,,,,,
3867,103868,"5-Methoxy-1,3,3-trimethyl-2-[2-(1-methyl-2-phenyl-1H-indol-3-yl)ethenyl]-3H-indolium",CC1(C2=C(C=CC(=C2)OC)[N+](=C1C=CC3=C(N(C4=CC=CC=C43)C)C5=CC=CC=C5)C)C,,,,,,
3868,103869,"2-(2-(4-((2-Cyanoethyl)ethylamino)phenyl)vinyl)-1,3,3-trimethyl-3H-indolium chloride",CCN(CCC#N)C1=CC=C(C=C1)C=CC2=[N+](C3=CC=CC=C3C2(C)C)C.[Cl-],,,,,,
3869,103870,"2-[2-[4-[(2-Cyanoethyl)ethylamino]phenyl]ethenyl]-1,3,3-trimethyl-3H-indolium",CCN(CCC#N)C1=CC=C(C=C1)C=CC2=[N+](C3=CC=CC=C3C2(C)C)C,,,,,,
3870,103871,"N,N'-Bis(1,4-dimethylpentyl)-2,4-toluenediamine",CC1=C(C=C(C=C1)NC(C)CCC(C)C)NC(C)CCC(C)C,,,,,,
3871,103872,"Butyl 3-hydroxy-3,5-dimethylhex-4-enoate",CCCCOC(=O)CC(C)(C=C(C)C)O,,,,,,
3872,103873,3-[(Acetyloxy)methyl]-7-amino-7-methoxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,CC(=O)OCC1=C(N2C(C(C2=O)(N)OC)SC1)C(=O)O,,,,,,
3873,103874,"2,6-Dimethylhept-5-enenitrile",CC(CCC=C(C)C)C#N,,,,,,
3874,103875,3-Methyl-5-phenylpentanenitrile,CC(CCC1=CC=CC=C1)CC#N,,,,,,
3875,103876,"1-Hexanol, trimethyl-, formate",CC(C)C(C)CC(C)COC=O,,,,,,
3876,103877,Einecs 259-003-2,C=CCCCCCCC(CC(=O)[O-])C(=O)[O-].[Na+].[Na+],,,,,,
3877,103878,"1,5-Anhydro-D-glucitol 3,4,6-tridodecanoate",CCCCCCCCCCCC(=O)OCC1C(C(C(CO1)O)OC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCCC,,,,,,
3878,103879,1-Formyl-3-methyl-5-(3-methyl-3-hydroxybutyl)-3-cyclohexene,CC1=CC(CC(C1)C=O)CCC(C)(C)O,,,,,,
3879,103880,[2-[[4-[(2-Chloro-4-nitrophenyl)azo]phenyl]ethylamino]ethyl](2-hydroxypropyl)dimethylammonium chloride,CCN(CC[N+](C)(C)CC(C)O)C1=CC=C(C=C1)N=NC2=C(C=C(C=C2)[N+](=O)[O-])Cl.[Cl-],,,,,,
3880,103881,2-[p-(2-Chloro-4-nitrophenylazo)-N-ethylanilino]ethyl(2-hydroxypropyl)dimethylaminium,CCN(CC[N+](C)(C)CC(C)O)C1=CC=C(C=C1)N=NC2=C(C=C(C=C2)[N+](=O)[O-])Cl,,,,,,
3881,103882,2-Ethylhexadecanoic acid,CCCCCCCCCCCCCCC(CC)C(=O)O,,,,,,
3882,103883,"[[5-(2-methoxyethyl)-1,3-oxathiolan-4-ylidene]amino] N-methylcarbamate",CNC(=O)ON=C1C(OCS1)CCOC,,,,,,
3883,103884,"3H-Indolium, 2-(2-(4-(dimethylamino)phenyl)ethenyl)-1,3,3-trimethyl-, chloride",CC1(C2=CC=CC=C2[N+](=C1C=CC3=CC=C(C=C3)N(C)C)C)C.[Cl-],,,,,,
3884,103885,"2-[2-[4-(Dimethylamino)phenyl]ethenyl]-1,3,3-trimethyl-3H-indolium",CC1(C2=CC=CC=C2[N+](=C1C=CC3=CC=C(C=C3)N(C)C)C)C,,,,,,
3885,103886,"2-(4,4-Bis(4-(dimethylamino)phenyl)buta-1,3-dienyl)-1,3,3-trimethyl-3H-indolium chloride",CC1(C2=CC=CC=C2[N+](=C1C=CC=C(C3=CC=C(C=C3)N(C)C)C4=CC=C(C=C4)N(C)C)C)C.[Cl-],,,,,,
3886,103887,"2-[4,4-Bis[4-(dimethylamino)phenyl]-1,3-butadienyl]-1,3,3-trimethyl-3H-indolium",CC1(C2=CC=CC=C2[N+](=C1C=CC=C(C3=CC=C(C=C3)N(C)C)C4=CC=C(C=C4)N(C)C)C)C,,,,,,
3887,103888,"Benzenamine, 4-[2-(2,3-dihydro-1,3,3-trimethyl-1H-indol-2-yl)ethenyl]-N,N-dimethyl-",CC1(C(N(C2=CC=CC=C21)C)C=CC3=CC=C(C=C3)N(C)C)C,,,,,,
3888,103889,"Benzenamine, 4,4'-(4-(2,3-dihydro-1,3,3-trimethyl-1H-indol-2-yl)-1,3-butadienylidene)bis(N,N-dimethyl-",CC1(C(N(C2=CC=CC=C21)C)C=CC=C(C3=CC=C(C=C3)N(C)C)C4=CC=C(C=C4)N(C)C)C,,,,,,
3889,103890,"Cyclohexaneethanol, 1-hydroxy-5-methyl-2-(1-methylethyl)-",CC1CCC(C(C1)(CCO)O)C(C)C,,,,,,
3890,103891,"2-(11-Hydroxy-3-oxo-3H-dibenzo[C,H]xanthen-7-YL)benzoic acid",C1=CC=C(C(=C1)C2=C3C=CC4=CC(=O)C=CC4=C3OC5=C2C=CC6=C5C=CC(=C6)O)C(=O)O,,,,,,
3891,103892,"Phenol, 2(or 4)-[[bis(2-hydroxyethyl)amino]methyl]-",C1=CC=C(C(=C1)CN(CCO)CCO)O,,,,,,
3892,103893,Ethylmethylphosphinic acid,CCP(=O)(C)O,,,,,,
3893,103894,Ethylmethylphosphinic anhydride,CCP(=O)(C)OP(=O)(C)CC,,,,,,
3894,103895,"(E)-3,7-dimethylocta-2,6-dienyl octanoate",CCCCCCCC(=O)OCC=C(C)CCC=C(C)C,,,,,,
3895,103896,CID 103896,C1=CC(=NNC1=O)[O-].[K+],,,,,,
3896,103897,N-Benzoyl-2'-deoxycytidine 3'-benzoate,C1[C@@H]([C@H](O[C@H]1N2C=CC(=NC2=O)NC(=O)C3=CC=CC=C3)CO)OC(=O)C4=CC=CC=C4,,,,,,
3897,103898,N-Benzoyl-2'-deoxyadenosine 3'-benzoate,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)NC(=O)C4=CC=CC=C4)CO)OC(=O)C5=CC=CC=C5,,,,,,
3898,103899,Beryllon II,C1=C2C=C(C=C(C2=C(C=C1S(=O)(=O)[O-])N=NC3=C(C4=C(C=C(C=C4C=C3S(=O)(=O)[O-])S(=O)(=O)[O-])O)O)O)S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
3899,103900,"4,5-Dihydroxy-3-((8-hydroxy-3,6-disulfonaphthalen-1-yl)diazenyl)naphthalene-2,7-disulfonic acid",C1=C2C=C(C=C(C2=C(C=C1S(=O)(=O)O)N=NC3=C(C4=C(C=C(C=C4C=C3S(=O)(=O)O)S(=O)(=O)O)O)O)O)S(=O)(=O)O,,,,,,
3900,103901,"Isopropyl 4-(2,4-dichlorophenoxy)butyrate",CC(C)OC(=O)CCCOC1=C(C=C(C=C1)Cl)Cl,,,,,,
3901,103902,1-(1-(4-Heptylphenyl)vinyl)-4-propoxybenzene,CCCCCCCC1=CC=C(C=C1)C(=C)C2=CC=C(C=C2)OCCC,,,,,,
3902,103903,p-(1-(p-Pentylphenyl)vinyl)anisole,CCCCCC1=CC=C(C=C1)C(=C)C2=CC=C(C=C2)OC,,,,,,
3903,103904,"1-Butanone, 3-methyl-2-(1-methylethyl)-1-phenyl-",CC(C)C(C(C)C)C(=O)C1=CC=CC=C1,,,,,,
3904,103905,1-(Naphthalen-1-yl)but-3-en-2-one,C=CC(=O)CC1=CC=CC2=CC=CC=C21,,,,,,
3905,103906,"2,6-Bis((3-methoxypropyl)amino)-4-methylnicotinonitrile",CC1=CC(=NC(=C1C#N)NCCCOC)NCCCOC,,,,,,
3906,103907,"3-Methylpyridine-2,6-diamine",CC1=C(N=C(C=C1)N)N,,,,,,
3907,103908,(2S)-4-methylsulfanyl-2-(octadec-9-enoylamino)butanoic acid,CCCCCCCCC=CCCCCCCCC(=O)N[C@@H](CCSC)C(=O)O,,,,,,
3908,103909,"Hexahydro-1,3,5-tripentyl-1,3,5-triazine",CCCCCN1CN(CN(C1)CCCCC)CCCCC,,,,,,
3909,103910,CID 103910,C(=O)O.C(=O)O.O.[AlH3],,,,,,
3910,103911,1-(2-Methoxyethyl)pyrrolidin-2-one,COCCN1CCCC1=O,,,,,,
3911,103912,"Dipotassium 2,5-dihydroxybenzene-1,3-disulphonate",C1=C(C=C(C(=C1S(=O)(=O)[O-])O)S(=O)(=O)[O-])O.[K+].[K+],,,,,,
3912,103913,"2,5-dihydroxybenzene-1,3-disulfonic Acid",C1=C(C=C(C(=C1S(=O)(=O)O)O)S(=O)(=O)O)O,,,,,,
3913,103914,2-Methyl-1-(3-sulphonatopropyl)quinolinium,CC1=[N+](C2=CC=CC=C2C=C1)CCCS(=O)(=O)[O-],,,,,,
3914,103915,3-(2-Methylquinolin-1-ium-1-yl)propane-1-sulfonic acid,CC1=[N+](C2=CC=CC=C2C=C1)CCCS(=O)(=O)O,,,,,,
3915,103916,"1,3-Propanedione, 1,3-di-2-naphthalenyl-",C1=CC=C2C=C(C=CC2=C1)C(=O)CC(=O)C3=CC4=CC=CC=C4C=C3,,,,,,
3916,103917,Sodium 4-methyl-3-nitrobenzenesulphonate,CC1=C(C=C(C=C1)S(=O)(=O)[O-])[N+](=O)[O-].[Na+],,,,,,
3917,103918,CID 103918,CC1=CC(=O)N=C2N1NC(=N2)C,,,,,,
3918,103919,CID 103919,COCN=C(N)S,,,,,,
3919,103920,N-tert-Butylcyclohexylamine,CC(C)(C)NC1CCCCC1,,,,,,
3920,103921,Undecyl hydrogen phthalate,CCCCCCCCCCCOC(=O)C1=CC=CC=C1C(=O)O,,,,,,
3921,103922,Octadecyl chloroformate,CCCCCCCCCCCCCCCCCCOC(=O)Cl,,,,,,
3922,103923,"N-(2-Aminoethyl)-N,N'-dioctylethylenediamine",CCCCCCCCNCCN(CCCCCCCC)CCN,,,,,,
3923,103924,6-Aminofluorescein,C1=CC2=C(C=C1N)C3(C4=C(C=C(C=C4)O)OC5=C3C=CC(=C5)O)OC2=O,,,,,,
3924,103925,3-(Aminocarbonyl)-1-(3-sulphonatopropyl)pyridinium,C1=CC(=C[N+](=C1)CCCS(=O)(=O)[O-])C(=O)N,,,,,,
3925,103926,3-(Aminocarbonyl)-1-(3-sulfonatopropyl)pyridinium,C1=CC(=C[N+](=C1)CCCS(=O)(=O)O)C(=O)N,,,,,,
3926,103927,"Phenol, 2-[(2-nitrophenyl)azo]-4-(1,1,3,3-tetramethylbutyl)-",CC(C)(C)CC(C)(C)C1=CC(=C(C=C1)O)N=NC2=CC=CC=C2[N+](=O)[O-],,,,,,
3927,103928,"2,4,6-Tris[[bis(2-hydroxyethyl)amino]methyl]phenol",C1=C(C=C(C(=C1CN(CCO)CCO)O)CN(CCO)CCO)CN(CCO)CCO,,,,,,
3928,103929,Octadec-9-enyl 3-methylbutanoate,CCCCCCCCC=CCCCCCCCCOC(=O)CC(C)C,,,,,,
3929,103930,CID 103930,C1=C2C=C(C(=CC2=CC(=C1O)S(=O)(=O)O)S(=O)(=O)[O-])O.[Na+],,,,,,
3930,103931,2-Nitrophenyl selenocyanate,C1=CC=C(C(=C1)[N+](=O)[O-])[Se]C#N,,,,,,
3931,103932,"2,6-Dibromo-4-methylanisole",CC1=CC(=C(C(=C1)Br)OC)Br,,,,,,
3932,103933,2-((2-Hydroxyethyl)amino)ethyl methacrylate,CC(=C)C(=O)OCCNCCO,,,,,,
3933,103934,"Phosphine oxide, diphenyl((alpha-phenyl-alpha-((2-dimethylamino)ethyl))benzyl)-, hydrochloride",CN(C)CCC(C1=CC=CC=C1)(C2=CC=CC=C2)P(=O)(C3=CC=CC=C3)C4=CC=CC=C4.Cl,,,,,,
3934,103935,"3-diphenylphosphoryl-N,N-dimethyl-3,3-diphenylpropan-1-amine",CN(C)CCC(C1=CC=CC=C1)(C2=CC=CC=C2)P(=O)(C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
3935,103936,"1-[3-(Diphenylphosphoryl)-3,3-diphenylpropyl]piperidine",C1CCN(CC1)CCC(C2=CC=CC=C2)(C3=CC=CC=C3)P(=O)(C4=CC=CC=C4)C5=CC=CC=C5,,,,,,
3936,103937,"Phosphine oxide, diphenyl((1,1-diphenyl-3-morpholino)propyl)-, hydrochloride",C1COCCN1CCC(C2=CC=CC=C2)(C3=CC=CC=C3)P(=O)(C4=CC=CC=C4)C5=CC=CC=C5.Cl,,,,,,
3937,103938,"4-(3-Diphenylphosphoryl-3,3-diphenylpropyl)morpholine",C1COCCN1CCC(C2=CC=CC=C2)(C3=CC=CC=C3)P(=O)(C4=CC=CC=C4)C5=CC=CC=C5,,,,,,
3938,103939,"Phosphine oxide, diphenyl((alpha-phenyl-alpha-(3-dimethylamino)propyl)benzyl)-, hydrochloride",CN(C)CCCC(C1=CC=CC=C1)(C2=CC=CC=C2)P(=O)(C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
3939,103940,3-Decyn-1-ol,CCCCCCC#CCCO,,,,,,
3940,103941,2-(((Phenylamino)carbonyl)oxy)ethyl methacrylate,CC(=C)C(=O)OCCOC(=O)NC1=CC=CC=C1,,,,,,
3941,103942,"alpha,alpha-Bis(p-hydroxyphenyl)-o-cresol",C1=CC=C(C(=C1)C(C2=CC=C(C=C2)O)C3=CC=C(C=C3)O)O,,,,,,
3942,103943,Isononanenitrile,CC(C)CCCCCC#N,,,,,,
3943,103944,n-[3-(Dipropylamino)phenyl]acetamide,CCCN(CCC)C1=CC=CC(=C1)NC(=O)C,,,,,,
3944,103945,"Phosphine oxide, diphenyl((1,1-diphenyl-3-diethylamino)propyl)-, hydrochloride",CCN(CC)CCC(C1=CC=CC=C1)(C2=CC=CC=C2)P(=O)(C3=CC=CC=C3)C4=CC=CC=C4.Cl,,,,,,
3945,103946,"3-diphenylphosphoryl-N,N-diethyl-3,3-diphenylpropan-1-amine",CCN(CC)CCC(C1=CC=CC=C1)(C2=CC=CC=C2)P(=O)(C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
3946,103947,"Phosphine oxide, diphenyl((1,1-diphenyl-3-pyrrolidinyl)propyl)-, hydrochloride",C1CCN(C1)CCC(C2=CC=CC=C2)(C3=CC=CC=C3)P(=O)(C4=CC=CC=C4)C5=CC=CC=C5.Cl,,,,,,
3947,103948,"1-(3-Diphenylphosphoryl-3,3-diphenylpropyl)pyrrolidine",C1CCN(C1)CCC(C2=CC=CC=C2)(C3=CC=CC=C3)P(=O)(C4=CC=CC=C4)C5=CC=CC=C5,,,,,,
3948,103949,"Benzenesulfonic acid, 2-amino-3,5-dichloro-4-methyl-",CC1=C(C=C(C(=C1Cl)N)S(=O)(=O)O)Cl,,,,,,
3949,103950,9-Methyldecan-1-ol,CC(C)CCCCCCCCO,,,,,,
3950,103951,"Spiro[1H-isoindole-1,9'-[9H]xanthen]-3(2H)-one, 2-(2-chlorophenyl)-3',6'-bis(diethylamino)-",CCN(CC)C1=CC2=C(C=C1)C3(C4=C(O2)C=C(C=C4)N(CC)CC)C5=CC=CC=C5C(=O)N3C6=CC=CC=C6Cl,,,,,,
3951,103952,CID 103952,C(O)S(=O)(=O)[O-].[K+],,,,,,
3952,103953,5-Methyl-3-methylene-5-hexen-2-one,CC(=C)CC(=C)C(=O)C,,,,,,
3953,103954,Dimethyl 5-bromoisophthalate,COC(=O)C1=CC(=CC(=C1)Br)C(=O)OC,,,,,,
3954,103955,"12-Acetoxy-1,3-dodecadiene",CC(=O)OCCCCCCCCC=CC=C,,,,,,
3955,103956,9-Oxo-9H-thioxanthene-3-carbonitrile,C1=CC=C2C(=C1)C(=O)C3=C(S2)C=C(C=C3)C#N,,,,,,
3956,103957,"9-Oxo-9H-thioxanthene-3-carbonitrile 10,10-dioxide",C1=CC=C2C(=C1)C(=O)C3=C(S2(=O)=O)C=C(C=C3)C#N,,,,,,
3957,103958,N-(2-phenoxyphenyl)methanesulfonamide,CS(=O)(=O)NC1=CC=CC=C1OC2=CC=CC=C2,,,,,,
3958,103959,Phenyl N-phenylphosphoramidochloridate,C1=CC=C(C=C1)NP(=O)(OC2=CC=CC=C2)Cl,,,,,,
3959,103960,"Benzenesulfonamide, N-(3,5-dichloro-4-hydroxyphenyl)-",C1=CC=C(C=C1)S(=O)(=O)NC2=CC(=C(C(=C2)Cl)O)Cl,,,,,,
3960,103961,"Benzenesulfonamide, N-(3,5-dibromo-4-hydroxyphenyl)-",C1=CC=C(C=C1)S(=O)(=O)NC2=CC(=C(C(=C2)Br)O)Br,,,,,,
3961,103962,"Naphtho[1,2-d]thiazole, 2-(methylthio)-",CSC1=NC2=C(S1)C=CC3=CC=CC=C32,,,,,,
3962,103963,CID 103963,C1=CC2=C(C=CC(=C2)S(=O)(=O)[O-])C=C1S(=O)(=O)O.[Na+],,,,,,
3963,103964,CID 103964,C1=CC(=CC2=C1C=CC(=C2)S(=O)(=O)[O-])S(=O)(=O)O.[Na+],,,,,,
3964,103965,3'-Methylpropiophenone,CCC(=O)C1=CC=CC(=C1)C,,,,,,
3965,103966,3-(Tris(acetoxy)silyl)propyl methacrylate,CC(=C)C(=O)OCCC[Si](OC(=O)C)(OC(=O)C)OC(=O)C,,,,,,
3966,103967,"Ethyl 1,4-dioxa-8-azaspiro[4.5]decane-8-carboxylate",CCOC(=O)N1CCC2(CC1)OCCO2,,,,,,
3967,103968,"1,1'-(4-Iodobutylidene)bis(4-fluorobenzene)",C1=CC(=CC=C1C(CCCI)C2=CC=C(C=C2)F)F,,,,,,
3968,103969,alpha-PCCH,C1=C([C@H]([C@H]([C@@H]([C@H]1Cl)Cl)Cl)Cl)Cl,,,,,,
3969,103970,3-Heptafluorobutyryl-(+)-camphor,C[C@@]12CC[C@@H](C1(C)C)C(C2=O)C(=O)C(C(C(F)(F)F)(F)F)(F)F,,,,,,
3970,103971,"Benzene, 1-methyl-3-(4-methylphenoxy)-",CC1=CC=C(C=C1)OC2=CC=CC(=C2)C,,,,,,
3971,103972,"Propanoic acid, 3,3'-(methylphosphinylidene)bis-",CP(=O)(CCC(=O)O)CCC(=O)O,,,,,,
3972,103973,"1-Propanol, 3,3',3''-phosphinylidynetris-",C(CO)CP(=O)(CCCO)CCCO,,,,,,
3973,103974,"Phenol, 2-cyclohexyl-6-(1,1-dimethylethyl)-4-methyl-",CC1=CC(=C(C(=C1)C(C)(C)C)O)C2CCCCC2,,,,,,
3974,103975,5-Ethyl-4-methylthiazol-2(3H)-one,CCC1=C(NC(=O)S1)C,,,,,,
3975,103976,Ethylenebis(methylphosphinic) acid,CP(=O)(CCP(=O)(C)O)O,,,,,,
3976,103977,N-(3-(Dimethylamino)propyl)-D-gluconamide,CN(C)CCCNC(=O)[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O,,,,,,
3977,103978,Isopropyl pentadecanoate,CCCCCCCCCCCCCCC(=O)OC(C)C,,,,,,
3978,103979,CID 103979,CCCCCCCCOC(=O)C=CC(=O)O.CCCCCCCCOC(=O)C=CC(=O)O.CCCCCCCCOC(=O)C=CC(=O)O.CCCC[SnH],,,,,,
3979,103980,1-Amino-2-bromo-4-((3-(dimethylamino)propyl)amino)anthraquinone,CN(C)CCCNC1=CC(=C(C2=C1C(=O)C3=CC=CC=C3C2=O)N)Br,,,,,,
3980,103981,CID 103981,CCCCCCCCC=CCCCCCCCCN(C)CC(=O)[O-].[Na+],,,,,,
3981,103982,"Glycine, N-methyl-N-9-octadecenyl-",CCCCCCCCC=CCCCCCCCCN(C)CC(=O)O,,,,,,
3982,103983,N-Methyl-2-chloroethyl-2-hydroxyethylamine,CN(CCO)CCCl,,,,,,
3983,103984,(3-Bromopropyl)trimethoxysilane,CO[Si](CCCBr)(OC)OC,,,,,,
3984,103985,Chloro(p-chlorophenyl)magnesium,C1=CC(=CC=[C-]1)Cl.[Mg+2].[Cl-],,,,,,
3985,103986,Hexadecyl hydrogen phthalate,CCCCCCCCCCCCCCCCOC(=O)C1=CC=CC=C1C(=O)O,,,,,,
3986,103987,"2-Naphthalenesulfonic acid, 4-hydroxy-3-[(4-methoxy-2-sulfophenyl)azo]-7-(methylamino)-",CNC1=CC2=CC(=C(C(=C2C=C1)O)N=NC3=C(C=C(C=C3)OC)S(=O)(=O)O)S(=O)(=O)O,,,,,,
3987,103988,5-Iodoisophthalic acid,C1=C(C=C(C=C1C(=O)O)I)C(=O)O,,,,,,
3988,103989,4-[(4-Aminophenyl)methyl]-2-ethylaniline,CCC1=C(C=CC(=C1)CC2=CC=C(C=C2)N)N,,,,,,
3989,103990,"N-(2-Hydroxy-1,1-dimethylethyl)undecanamide",CCCCCCCCCCC(=O)NC(C)(C)CO,,,,,,
3990,103991,"1h,1h,2h,2h-Perfluorooctyltriethoxysilane",CCO[Si](CCC(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(OCC)OCC,,,,,,
3991,103992,Methyl 1-methyl-2-pyrroleacetate,CN1C=CC=C1CC(=O)OC,,,,,,
3992,103993,"3',5'-Dihydroxyacetophenone",CC(=O)C1=CC(=CC(=C1)O)O,,,,,,
3993,103994,"4-((9,10-Dihydro-9,10-dioxo-1-anthryl)azo)-3-hydroxy-2-naphthoic acid",C1=CC=C2C(=C1)C=C(C(=C2N=NC3=CC=CC4=C3C(=O)C5=CC=CC=C5C4=O)O)C(=O)O,,,,,,
3994,103995,"4-[(2,5-Dichlorophenyl)azo]-3-hydroxy-2-naphthoic acid",C1=CC=C2C(=C1)C=C(C(=C2N=NC3=C(C=CC(=C3)Cl)Cl)O)C(=O)O,,,,,,
3995,103996,N-(3-Amino-4-chlorophenyl)acetamide,CC(=O)NC1=CC(=C(C=C1)Cl)N,,,,,,
3996,103997,"N-[2-[(2-Bromo-4,6-dinitrophenyl)azo]-5-(diallylamino)-4-methoxyphenyl]acetamide",CC(=O)NC1=CC(=C(C=C1N=NC2=C(C=C(C=C2Br)[N+](=O)[O-])[N+](=O)[O-])OC)N(CC=C)CC=C,,,,,,
3997,103998,Diethyl (pyrrolidin-1-ylmethyl)phosphonate,CCOP(=O)(CN1CCCC1)OCC,,,,,,
3998,103999,CID 103999,COCNC(=NCOC)S,,,,,,
3999,104000,"2-Propanesulfenamide, N,N',N''-phosphinylidynetris[N-phenyl-",CC(C)SN(C1=CC=CC=C1)P(=O)(N(C2=CC=CC=C2)SC(C)C)N(C3=CC=CC=C3)SC(C)C,,,,,,
4000,104001,2-Methoxy-5-((methylamino)sulphonyl)benzoic acid,CNS(=O)(=O)C1=CC(=C(C=C1)OC)C(=O)O,,,,,,
4001,104002,"9,10-Anthracenedione, 1-amino-5-[(2,4-dibromophenyl)amino]-4,8-dihydroxy-",C1=CC(=C(C=C1Br)Br)NC2=C3C(=C(C=C2)O)C(=O)C4=C(C=CC(=C4C3=O)O)N,,,,,,
4002,104003,N-(3-(Tributoxysilyl)propyl)ethylenediamine,CCCCO[Si](CCCNCCN)(OCCCC)OCCCC,,,,,,
4003,104004,"Acetamide, N-(2-((2-bromo-4,6-dinitrophenyl)azo)-5-(cyclohexylamino)-4-methoxyphenyl)-",CC(=O)NC1=CC(=C(C=C1N=NC2=C(C=C(C=C2Br)[N+](=O)[O-])[N+](=O)[O-])OC)NC3CCCCC3,,,,,,
4004,104005,"Acetamide, N-(2-((2-bromo-4,6-dinitrophenyl)azo)-5-(ethyl(phenylmethyl)amino)phenyl)-",CCN(CC1=CC=CC=C1)C2=CC(=C(C=C2)N=NC3=C(C=C(C=C3Br)[N+](=O)[O-])[N+](=O)[O-])NC(=O)C,,,,,,
4005,104006,"Acetamide, N-[2-[(2-cyano-4-nitrophenyl)azo]-5-[[2-(2,5-dioxo-1-pyrrolidinyl)ethyl]ethylamino]phenyl]-",CCN(CCN1C(=O)CCC1=O)C2=CC(=C(C=C2)N=NC3=C(C=C(C=C3)[N+](=O)[O-])C#N)NC(=O)C,,,,,,
4006,104007,5-(Chlorosulfonyl)-2-methoxybenzoic acid,COC1=C(C=C(C=C1)S(=O)(=O)Cl)C(=O)O,,,,,,
4007,104008,Dansylaziridine,CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)N3CC3,,,,,,
4008,104009,4-(4-Methylphenyl)butanol,CC1=CC=C(C=C1)CCCCO,,,,,,
4009,104010,2-(Ethylanilino)ethyl benzoate,CCN(CCOC(=O)C1=CC=CC=C1)C2=CC=CC=C2,,,,,,
4010,104011,"4-((4-Chloro-2-methoxyphenyl)azo)-N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-hydroxynaphthalene-2-carboxamide",COC1=C(C=CC(=C1)Cl)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)NC4=CC5=C(C=C4)NC(=O)N5)O,,,,,,
4011,104012,"N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-hydroxy-4-[[2-methoxy-5-methyl-4-[(methylamino)sulphonyl]phenyl]azo]naphthalene-2-carboxamide",CC1=CC(=C(C=C1S(=O)(=O)NC)OC)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)NC4=CC5=C(C=C4)NC(=O)N5)O,,,,,,
4012,104013,N-Docosyl-D-gluconamide,CCCCCCCCCCCCCCCCCCCCCCNC(=O)[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O,,,,,,
4013,104014,N-L-Prolyl-L-isoleucine,CC[C@@H](C)[C@@H](C(=O)O)NC(=O)[C@@H]1CCCN1,,,,,,
4014,104015,"Nickel, bis(3-(2-(4-chlorophenyl)diazenyl-kappaN2)-2,4(1H,3H)-quinolinedionato-kappaO4)-",C1=CC=C2C(=C1)C(=C(C(=O)N2)N=NC3=CC=C(C=C3)Cl)[O-].C1=CC=C2C(=C1)C(=C(C(=O)N2)N=NC3=CC=C(C=C3)Cl)[O-].[Ni+2],,,,,,
4015,104016,CID 104016,C1=CC=C2C(=C1)C(=O)C(=C(N2)O)N=NC3=CC=C(C=C3)Cl,,,,,,
4016,104017,"2,5-Diethyl-3,4-diphenylcyclopentadienone",CCC1=C(C(=C(C1=O)CC)C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
4017,104018,"Methyl N-(3-amino-2,4,6-triiodobenzoyl)-N-phenyl-beta-alaninate",COC(=O)CCN(C1=CC=CC=C1)C(=O)C2=C(C(=C(C=C2I)I)N)I,,,,,,
4018,104019,"N,N'-Bis(2,4,6-tribromophenyl)adipamide",C1=C(C=C(C(=C1Br)NC(=O)CCCCC(=O)NC2=C(C=C(C=C2Br)Br)Br)Br)Br,,,,,,
4019,104020,"Ethyl 2,4-dichloropyrimidine-5-carboxylate",CCOC(=O)C1=CN=C(N=C1Cl)Cl,,,,,,
4020,104021,4-(3-(Trifluoromethyl)phenyl)piperazine-1-ethyl 2-aminobenzoate,C1CN(CCN1CCOC(=O)C2=CC=CC=C2N)C3=CC=CC(=C3)C(F)(F)F,,,,,,
4021,104022,"Benzenepropanoic acid, 2,5-bis[(ethoxycarbonyl)oxy]-",CCOC(=O)OC1=CC(=C(C=C1)OC(=O)OCC)CCC(=O)O,,,,,,
4022,104023,"Octadecanamide, N,N'-[iminobis(2,1-ethanediylimino-2,1-ethanediyl)]bis-",CCCCCCCCCCCCCCCCCC(=O)NCCNCCNCCNCCNC(=O)CCCCCCCCCCCCCCCCC,,,,,,
4023,104024,4-(4-Aminobenzyl)-N-ethylaniline,CCNC1=CC=C(C=C1)CC2=CC=C(C=C2)N,,,,,,
4024,104025,"Benzoic acid, 2-amino-5-[(4-aminophenyl)methyl]-, methyl ester",COC(=O)C1=C(C=CC(=C1)CC2=CC=C(C=C2)N)N,,,,,,
4025,104026,CID 104026,CC(=C)C(=O)OCCOP(=O)O,,,,,,
4026,104027,Isononyl acrylate,CC(C)CCCCCCOC(=O)C=C,,,,,,
4027,104028,Pyrimidin-4(5h)-one,C1C=NC=NC1=O,,,,,,
4028,104029,CID 104029,CC1=C(C=CC(=C1)Cl)N=NN(C)CC(=O)[O-].[Na+],,,,,,
4029,104030,2-[[(4-Chloro-2-methylphenyl)diazenyl]-methylamino]acetic acid,CC1=C(C=CC(=C1)Cl)N=NN(C)CC(=O)O,,,,,,
4030,104031,CID 104031,CC1=CC=C(C=C1)N=NN(C)CC(=O)[O-].[Na+],,,,,,
4031,104032,(Dodecylthio)acetonitrile,CCCCCCCCCCCCSCC#N,,,,,,
4032,104033,"4-(2,4-Di-tert-pentylphenoxy)butan-1-amine",CCC(C)(C)C1=CC(=C(C=C1)OCCCCN)C(C)(C)CC,,,,,,
4033,104034,"1,3-Isobenzofurandione, 4,6-dichloro-",C1=C(C=C(C2=C1C(=O)OC2=O)Cl)Cl,,,,,,
4034,104035,"Cyclohexanamine, N-cyclohexyl-N-[[(dimethylamino)thioxomethyl]thio]-",CN(C)C(=S)SN(C1CCCCC1)C2CCCCC2,,,,,,
4035,104036,4-[2-(2-Methylprop-2-enoyloxy)ethoxy]-4-oxobut-2-enoic acid,CC(=C)C(=O)OCCOC(=O)C=CC(=O)O,,,,,,
4036,104037,4-(1-Pyrrolidinyl)benzaldehyde,C1CCN(C1)C2=CC=C(C=C2)C=O,,,,,,
4037,104038,3-Methoxypropane-1-sulfonic acid,COCCCS(=O)(=O)O,,,,,,
4038,104039,5-Chloro-2-methyl-3-(3-sulphonatopropyl)benzoxazolium,CC1=[N+](C2=C(O1)C=CC(=C2)Cl)CCCS(=O)(=O)[O-],,,,,,
4039,104040,5-Chloro-2-methyl-1-sulfopropylbenzoxazole,CC1=[N+](C2=C(O1)C=CC(=C2)Cl)CCCS(=O)(=O)O,,,,,,
4040,104041,2-Methyl-5-phenyl-3-(3-sulphonatobutyl)benzoxazolium,CC1=[N+](C2=C(O1)C=CC(=C2)C3=CC=CC=C3)CCC(C)S(=O)(=O)[O-],,,,,,
4041,104042,"4-(2-Methyl-5-phenyl-1,3-benzoxazol-3-ium-3-yl)butane-2-sulfonic acid",CC1=[N+](C2=C(O1)C=CC(=C2)C3=CC=CC=C3)CCC(C)S(=O)(=O)O,,,,,,
4042,104043,Benzyl (20beta)-3beta-hydroxy-12-oxoolean-12-en-29-oate,C[C@]12CC[C@](C[C@H]1C3=CC(=O)[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)(C)C(=O)OCC6=CC=CC=C6,,,,,,
4043,104044,"2,2'-Diethyl dihydrogen 4,4'-carbonylbisphthalate",CCOC(=O)C1=C(C=CC(=C1)C(=O)C2=CC(=C(C=C2)C(=O)O)C(=O)OCC)C(=O)O,,,,,,
4044,104045,CID 104045,C1=CC=C(C=C1)C(=O)SC2=NN=C(S2)S,,,,,,
4045,104046,CID 104046,[Li+].CC1=C(C=CC(=C1)N=NC2=C(C=C(C=C2)N=NC3=CC(=CC=C3)S(=O)(=O)[O-])OC)O,,,,,,
4046,104047,"N,N-diethyl-3'-methyl-2,2'-spirobi[2H-1-benzopyran]-7-amine",CCN(CC)C1=CC2=C(C=C1)C=CC3(O2)C(=CC4=CC=CC=C4O3)C,,,,,,
4047,104048,"(1-Methylethylidene)bis(4,1-phenyleneoxy-3,1-propanediyl) diacrylate",CC(C)(C1=CC=C(C=C1)OCCCOC(=O)C=C)C2=CC=C(C=C2)OCCCOC(=O)C=C,,,,,,
4048,104049,"Bis[[[(2,3-dihydro-1,5-dimethyl-3-oxo-2-phenyl-1H-pyrazol)-4-yl]methylamino]methanesulfonic acid]calcium salt",CC1=C(C(=O)N(N1C)C2=CC=CC=C2)CNCS(=O)(=O)[O-].CC1=C(C(=O)N(N1C)C2=CC=CC=C2)CNCS(=O)(=O)[O-].[Ca+2],,,,,,
4049,104050,"Isooctadecanoic acid, isohexadecyl ester",CC(C)CCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C,,,,,,
4050,104051,Calcium bis(phenylacetate),C1=CC=C(C=C1)CC(=O)[O-].C1=CC=C(C=C1)CC(=O)[O-].[Ca+2],,,,,,
4051,104052,"3,8-Diamino-6-phenylphenanthridine",C1=CC=C(C=C1)C2=C3C=C(C=CC3=C4C=CC(=CC4=N2)N)N,,,,,,
4052,104053,"Ethylene glycol, phosphated",C(CO)O.OP(=O)(O)O,,,,,,
4053,104054,CID 104054,[B+3].COC1=CC(=C(C=C1[N+]#N)OC)N2CCOCC2.[F-].[F-].[F-].[F-],,,,,,
4054,104055,(4-Acetamidophenacyl)trimethylammonium chloride,CC(=O)NC1=CC=C(C=C1)C(=O)C[N+](C)(C)C.[Cl-],,,,,,
4055,104056,"N,N,N-Trimethyl-4-(acetylamino)benzoylmethanaminium",CC(=O)NC1=CC=C(C=C1)C(=O)C[N+](C)(C)C,,,,,,
4056,104057,Deceth-4 phosphate,CCCCCCCCCCOCCO.OP(=O)(O)O,,,,,,
4057,104058,2-(3-Nitrophenyl)ethanol,C1=CC(=CC(=C1)[N+](=O)[O-])CCO,,,,,,
4058,104059,6-Morpholinopyridin-3-amine,C1COCCN1C2=NC=C(C=C2)N,,,,,,
4059,104060,"N2-Ethylpyridine-2,5-diamine",CCNC1=NC=C(C=C1)N,,,,,,
4060,104061,"2,2',2''-Nitrilotris[n-(2-hydroxyethyl)acetamide]",C(CO)NC(=O)CN(CC(=O)NCCO)CC(=O)NCCO,,,,,,
4061,104062,tert-Butyl 1-methyl-1-(4-tolyl)ethyl peroxide,CC1=CC=C(C=C1)C(C)(C)OOC(C)(C)C,,,,,,
4062,104063,"Benzenamine, 2-nonyl-N-phenyl-",CCCCCCCCCC1=CC=CC=C1NC2=CC=CC=C2,,,,,,
4063,104064,2-(4-Dodecylphenyl)-1H-indole,CCCCCCCCCCCCC1=CC=C(C=C1)C2=CC3=CC=CC=C3N2,,,,,,
4064,104065,"Benzenamine, N,N-diethyl-4-(2-thiazolylazo)-",CCN(CC)C1=CC=C(C=C1)N=NC2=NC=CS2,,,,,,
4065,104066,1-Methyl-4-[(propan-2-yl)peroxy]cyclohexane,CC1CCC(CC1)OOC(C)C,,,,,,
4066,104067,"2,2-Dipropylpentanoic acid",CCCC(CCC)(CCC)C(=O)O,,,,,,
4067,104068,4-(2-Bromoethyl)benzoic acid,C1=CC(=CC=C1CCBr)C(=O)O,,,,,,
4068,104069,"alpha,alpha-Diisopropylphenethyl alcohol",CC(C)C(CC1=CC=CC=C1)(C(C)C)O,,,,,,
4069,104070,"1H,3H-Naphtho[1,8-cd]pyran-6-sulfonic acid, 1,3-dioxo-",C1=CC2=C(C=CC3=C2C(=C1)C(=O)OC3=O)S(=O)(=O)O,,,,,,
4070,104071,"1,2,3,6-Tetrahydro-1,3-dimethyl-2,6-dioxo-7H-purine-7-butyric acid",CN1C2=C(C(=O)N(C1=O)C)N(C=N2)CCCC(=O)O,,,,,,
4071,104072,2-Amino-5-(aminomethyl)naphthalene-1-sulphonic acid,C1=CC(=C2C=CC(=C(C2=C1)S(=O)(=O)O)N)CN,,,,,,
4072,104073,"Benzenamine, N-(2-chloroethyl)-4-[(2-chloro-4-nitrophenyl)azo]-N-methyl-",CN(CCCl)C1=CC=C(C=C1)N=NC2=C(C=C(C=C2)[N+](=O)[O-])Cl,,,,,,
4073,104074,D-Glycero-D-ido-heptono-delta-lactone,C([C@H]([C@@H]1[C@@H]([C@H]([C@@H](C(=O)O1)O)O)O)O)O,,,,,,
4074,104075,(3-Bromopropyl)triethoxysilane,CCO[Si](CCCBr)(OCC)OCC,,,,,,
4075,104076,"9beta,11beta-Epoxy-21-hydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 21-acetate",C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]35[C@@H](O5)C[C@@]2([C@H]1C(=O)COC(=O)C)C)C,,,,,,
4076,104077,"N-(alpha,alpha-Dimethylphenethyl)formamide",CC(C)(CC1=CC=CC=C1)NC=O,,,,,,
4077,104078,Ethyl 3-(3-nitrophenyl)-3-oxopropanoate,CCOC(=O)CC(=O)C1=CC(=CC=C1)[N+](=O)[O-],,,,,,
4078,104079,Tin di(octanolate),CCCCCCCC[O-].CCCCCCCC[O-].[Sn+2],,,,,,
4079,104080,"2,4-Dinitrobenzenebutyric acid",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])CCCC(=O)O,,,,,,
4080,104081,N-(4-Bromo-3-ethylphenyl)acetamide,CCC1=C(C=CC(=C1)NC(=O)C)Br,,,,,,
4081,104082,"1-Naphthalenesulfonic acid, 3-diazo-3,4-dihydro-4-oxo-, ar'-(1-methylethyl)[1,1'-biphenyl]-4-yl ester",CC(C)C1=CC=C(C=C1)C2=CC=C(C=C2)OS(=O)(=O)C3=CC(=C(C4=CC=CC=C43)[O-])[N+]#N,,,,,,
4082,104083,1-Hydroxy-4-[4-(4-propan-2-ylphenyl)phenoxy]sulfonylnaphthalene-2-diazonium,CC(C)C1=CC=C(C=C1)C2=CC=C(C=C2)OS(=O)(=O)C3=CC(=C(C4=CC=CC=C43)O)[N+]#N,,,,,,
4083,104084,CID 104084,C1C(=NN(C1=O)C2=CC=C(C=C2)S(=O)(=O)O)C(=O)[O-].[Na+],,,,,,
4084,104085,Einecs 257-678-8,CC(=O)OCC1=C(N2C(C(C2=O)(NC(=O)CC3=CC=CS3)OC)SC1)C(=O)O,,,,,,
4085,104086,"Ethanone, 1-(4-hydroxy-3,5-dinitrophenyl)-",CC(=O)C1=CC(=C(C(=C1)[N+](=O)[O-])O)[N+](=O)[O-],,,,,,
4086,104087,"4'-Chloro-3',5'-dinitroacetophenone",CC(=O)C1=CC(=C(C(=C1)[N+](=O)[O-])Cl)[N+](=O)[O-],,,,,,
4087,104088,2-Bromo-n-[2-(2-fluorobenzoyl)-4-nitrophenyl]acetamide,C1=CC=C(C(=C1)C(=O)C2=C(C=CC(=C2)[N+](=O)[O-])NC(=O)CBr)F,,,,,,
4088,104089,2-Bromo-N-[2-(2-chlorobenzoyl)-4-nitrophenyl]acetamide,C1=CC=C(C(=C1)C(=O)C2=C(C=CC(=C2)[N+](=O)[O-])NC(=O)CBr)Cl,,,,,,
4089,104090,Hexadecyl chloroacetate,CCCCCCCCCCCCCCCCOC(=O)CCl,,,,,,
4090,104091,"4-Hydroxy-3,5-dinitrobenzaldehyde",C1=C(C=C(C(=C1[N+](=O)[O-])O)[N+](=O)[O-])C=O,,,,,,
4091,104092,"1H-Isoindole, 1,1,3,4,5,6,7-heptachloro-",C12=C(C(=C(C(=C1Cl)Cl)Cl)Cl)C(N=C2Cl)(Cl)Cl,,,,,,
4092,104093,"2-((4-Amino-2-methoxyphenyl)amino)-5-((2-hydroxyethyl)amino)-2,5-cyclohexa-2,5-diene-1,4-dione",COC1=C(C=CC(=C1)N)NC2=CC(=O)C(=CC2=O)NCCO,,,,,,
4093,104094,HC Green no. 1,C1=CC(=CC=C1NC2=CC(=O)C(=CC2=O)NCCO)N(CCO)CCO,,,,,,
4094,104095,"1-(3,4,5-Trimethoxybenzyl)piperazine",COC1=CC(=CC(=C1OC)OC)CN2CCNCC2,,,,,,
4095,104096,"2-Sulfanylethyl octadeca-9,12-dienoate",CCCCCC=CCC=CCCCCCCCC(=O)OCCS,,,,,,
4096,104097,Methyl (methylsulphinyl)acetate,COC(=O)CS(=O)C,,,,,,
4097,104098,Methyl 3-chloro-2-hydroxybenzoate,COC(=O)C1=C(C(=CC=C1)Cl)O,,,,,,
4098,104099,2-Chloroethyl 2-(4-chlorophenoxy)-2-methylpropionate,CC(C)(C(=O)OCCCl)OC1=CC=C(C=C1)Cl,,,,,,
4099,104100,Tris(dodecylthio)methylstannane,CCCCCCCCCCCCS[Sn](C)(SCCCCCCCCCCCC)SCCCCCCCCCCCC,,,,,,
4100,104101,CID 104101,C1=CC(=C(C=C1Cl)[O-])Cl.[Na+],,,,,,
4101,104102,Trimethyl-3-(((tridecafluorohexyl)sulphonyl)amino)propylammonium chloride,C[N+](C)(C)CCCNS(=O)(=O)C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F.[Cl-],,,,,,
4102,104103,3-(Tridecafluorohexylsulfonylamino)propyltrimethylaminium,C[N+](C)(C)CCCNS(=O)(=O)C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
4103,104104,"6-Amino-2,3-dihydro-1,3-dioxo-1H-benz(de)isoquinoline-5-sulphonic acid",C1=CC2=C3C(=C1)C(=O)NC(=O)C3=CC(=C2N)S(=O)(=O)O,,,,,,
4104,104105,"1,1'-(Methylenebis(oxy))bis(2,4,6-tribromobenzene)",C1=C(C=C(C(=C1Br)OCOC2=C(C=C(C=C2Br)Br)Br)Br)Br,,,,,,
4105,104106,2-(4-Acetylphenoxy)-2-methylpropanoic acid,CC(=O)C1=CC=C(C=C1)OC(C)(C)C(=O)O,,,,,,
4106,104107,Ethyl 2-(4-vinylphenoxy)isobutyrate,CCOC(=O)C(C)(C)OC1=CC=C(C=C1)C=C,,,,,,
4107,104108,1-Benzyl-4-methylquinolinium chloride,CC1=CC=[N+](C2=CC=CC=C12)CC3=CC=CC=C3.[Cl-],,,,,,
4108,104109,1-Benzyl-4-methylquinolin-1-ium,CC1=CC=[N+](C2=CC=CC=C12)CC3=CC=CC=C3,,,,,,
4109,104110,"2,4-Bis(tert-butyl)-6-[(2-nitrophenyl)azo]phenol",CC(C)(C)C1=CC(=C(C(=C1)N=NC2=CC=CC=C2[N+](=O)[O-])O)C(C)(C)C,,,,,,
4110,104111,"Phenol, 2,4-bis(1,1-dimethylpropyl)-6-[(2-nitrophenyl)azo]-",CCC(C)(C)C1=CC(=C(C(=C1)N=NC2=CC=CC=C2[N+](=O)[O-])O)C(C)(C)CC,,,,,,
4111,104112,"Phenol, 2-[(4-chloro-2-nitrophenyl)azo]-4,6-bis(1,1-dimethylethyl)-",CC(C)(C)C1=CC(=C(C(=C1)N=NC2=C(C=C(C=C2)Cl)[N+](=O)[O-])O)C(C)(C)C,,,,,,
4112,104113,"Cyclohexanamine, N-chloro-",C1CCC(CC1)NCl,,,,,,
4113,104114,"1-(2,4-Diethylphenyl)ethan-1-one",CCC1=CC(=C(C=C1)C(=O)C)CC,,,,,,
4114,104115,"2,4,5-Triethoxybenzophenone",CCOC1=CC(=C(C=C1C(=O)C2=CC=CC=C2)OCC)OCC,,,,,,
4115,104116,CID 104116,CC1=CC(=C(C=C1Cl)S(=O)(=O)O)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)[O-])O.CC1=CC(=C(C=C1Cl)S(=O)(=O)O)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)[O-])O.[Ca+2],,,,,,
4116,104117,"2-Amino-1H-thioxantheno(2,1,9-def)isoquinoline-1,3(2H)-dione",C1=CC=C2C(=C1)C3=C4C(=CC=C5C4=C(C=C3)C(=O)N(C5=O)N)S2,,,,,,
4117,104118,"1-Amino-4-((4-((3-((2-chloroethyl)sulphonyl)benzoyl)methylamino)-2-sulphophenyl)amino)-9,10-dihydro-9,10-dioxoanthracene-2-sulphonicacid",CN(C1=CC(=C(C=C1)NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)O)S(=O)(=O)O)C(=O)C5=CC(=CC=C5)S(=O)(=O)CCCl,,,,,,
4118,104119,CID 104119,CCCCCC[C@H](CC=CCCCCCCCC(=O)NCCNCCO)O,,,,,,
4119,104120,CID 104120,CCCCCCCCOP(=O)(O)[O-].[K+],,,,,,
4120,104121,"Urea, 1-acetyl-3-ethylnitroso-",CCN(C(=O)NC(=O)C)N=O,,,,,,
4121,104122,7-Octenyltrichlorosilane,C=CCCCCCC[Si](Cl)(Cl)Cl,,,,,,
4122,104123,"Octane-1,8-diylbis(trichlorosilane)",C(CCCC[Si](Cl)(Cl)Cl)CCC[Si](Cl)(Cl)Cl,,,,,,
4123,104124,7-Octenyltrimethoxysilane,CO[Si](CCCCCCC=C)(OC)OC,,,,,,
4124,104125,"Ethanol, 2-[(6-amino-2-naphthalenyl)sulfonyl]-",C1=CC2=C(C=CC(=C2)S(=O)(=O)CCO)C=C1N,,,,,,
4125,104126,Isopropyl hydrogen adipate,CC(C)OC(=O)CCCCC(=O)O,,,,,,
4126,104127,1-Amino-2-bromo-4-(3-chloroanilino)anthraquinone,C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3NC4=CC(=CC=C4)Cl)Br)N,,,,,,
4127,104128,Einecs 257-761-9,CCCCCC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@H]34)C,,,,,,
4128,104129,"Carbamic acid, [[3-(aminomethyl)phenyl]methyl]-",C1=CC(=CC(=C1)CNC(=O)O)CN,,,,,,
4129,104130,CID 104130,[Li+].CC1=NN(C(=C1N=NC2=CC(=C(C=C2Cl)S(=O)(=O)[O-])Cl)N)C3=CC=CC=C3,,,,,,
4130,104131,"Acetic acid, [4-[(1-amino-9,10-dihydro-4-hydroxy-9,10-dioxo-2-anthracenyl)oxy]phenoxy]-, ethyl ester",CCOC(=O)COC1=CC=C(C=C1)OC2=C(C3=C(C(=C2)O)C(=O)C4=CC=CC=C4C3=O)N,,,,,,
4131,104132,"Methyl (4-((1-amino-9,10-dihydro-4-hydroxy-9,10-dioxo-2-anthryl)oxy)phenoxy)acetate",COC(=O)COC1=CC=C(C=C1)OC2=C(C3=C(C(=C2)O)C(=O)C4=CC=CC=C4C3=O)N,,,,,,
4132,104133,"N,N'-(2,5-dichloro-1,4-phenylene)bis[4-[[2-chloro-5-(trifluoromethyl)phenyl]azo]-3-hydroxynaphthalene-2-carboxamide]",C1=CC=C2C(=C1)C=C(C(=C2N=NC3=C(C=CC(=C3)C(F)(F)F)Cl)O)C(=O)NC4=CC(=C(C=C4Cl)NC(=O)C5=CC6=CC=CC=C6C(=C5O)N=NC7=C(C=CC(=C7)C(F)(F)F)Cl)Cl,,,,,,
4133,104134,"4,4'-((9,10-Dihydro-9,10-dioxo-1,4-anthrylene)bis(iminoethylene))bis(benzenesulphonamide)",C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3C2=O)NCCC4=CC=C(C=C4)S(=O)(=O)N)NCCC5=CC=C(C=C5)S(=O)(=O)N,,,,,,
4134,104135,Disperse Blue 148,CCN(CCC(=O)OC)C1=CC=C(C=C1)N=NC2=C3C=C(C=CC3=NS2)[N+](=O)[O-],,,,,,
4135,104136,"1,3-Isobenzofurandione, 4,4'-[(1-methylethylidene)bis(4,1-phenyleneoxy)]bis-",CC(C)(C1=CC=C(C=C1)OC2=CC=CC3=C2C(=O)OC3=O)C4=CC=C(C=C4)OC5=CC=CC6=C5C(=O)OC6=O,,,,,,
4136,104137,"Acetamide, N-[4-methoxy-3-[(phenylmethyl)amino]phenyl]-",CC(=O)NC1=CC(=C(C=C1)OC)NCC2=CC=CC=C2,,,,,,
4137,104138,Cobalt(2+) neodecanoate,CC(C)(C)CC(C)(C)CC(=O)[O-].CC(C)(C)CC(C)(C)CC(=O)[O-].[Co+2],,,,,,
4138,104139,"Resorcinol, 5-methyl-2,4,6-triiodo-",CC1=C(C(=C(C(=C1I)O)I)O)I,,,,,,
4139,104140,"2,2,6-Trimethylhept-5-enal",CC(=CCCC(C)(C)C=O)C,,,,,,
4140,104141,"6-Bromo-1,4-benzodioxane",C1COC2=C(O1)C=CC(=C2)Br,,,,,,
4141,104142,"2H-Anthra[1,2-d][1,3]oxazine-4,7,12(1H)-trione, 6-nitro-",C1NC2=C3C(=C(C=C2C(=O)O1)[N+](=O)[O-])C(=O)C4=CC=CC=C4C3=O,,,,,,
4142,104143,"4-Amino-2,5-dimethoxy-N-phenylbenzenesulfonamide",COC1=CC(=C(C=C1N)OC)S(=O)(=O)NC2=CC=CC=C2,,,,,,
4143,104144,"Ethanol, 2-((4,6-bis(dimethylamino)-s-triazin-2-yl)methylamino)-",CN(C)C1=NC(=NC(=N1)N(C)CCO)N(C)C,,,,,,
4144,104145,"1-(2-((2-((2-((2-Aminoethyl)amino)ethyl)amino)ethyl)amino)ethyl)pyrrolidine-2,5-dione",C1CC(=O)N(C1=O)CCNCCNCCNCCN,,,,,,
4145,104146,Tris(isopropenyloxy)phenyl silane,CC(=C)O[Si](C1=CC=CC=C1)(OC(=C)C)OC(=C)C,,,,,,
4146,104147,2-Chloro-4-nitrobenzyl alcohol,C1=CC(=C(C=C1[N+](=O)[O-])Cl)CO,,,,,,
4147,104148,C.I. Disperse Green 5,C1=CC=C(C=C1)NC2=C3C(=C(C=C2)NC4=CC=CC=C4)C(=O)C5=C(C=CC(=C5C3=O)O)O,,,,,,
4148,104149,"1-Tetradecanol, hydrogen sulfate, ammonium salt",CCCCCCCCCCCCCCOS(=O)(=O)O.N,,,,,,
4149,104150,Ethyl butylacetylaminopropionate,CCCCN(CCC(=O)OCC)C(=O)C,,,,,,
4150,104151,Lauroyl lysine,CCCCCCCCCCCC(=O)NCCCC[C@@H](C(=O)O)N,,,,,,
4151,104152,L-Lysine acetate,CC(=O)O.C(CCN)C[C@@H](C(=O)O)N,,,,,,
4152,104153,"1(3H)-Isobenzofuranone, 3,3-bis(4-(sulfooxy)phenyl)-, dipotassium salt",C1=CC=C2C(=C1)C(=O)OC2(C3=CC=C(C=C3)OS(=O)(=O)[O-])C4=CC=C(C=C4)OS(=O)(=O)[O-].[K+].[K+],,,,,,
4153,104154,"Dipotassium 1-oxo-3H-isobenzofuran-3,3-diylbis(p-phenylene) bis(sulphate)",C1=CC=C2C(=C1)C(=O)OC2(C3=CC=C(C=C3)OS(=O)(=O)O)C4=CC=C(C=C4)OS(=O)(=O)O,,,,,,
4154,104155,Dioctadecyl peroxydicarbonate,CCCCCCCCCCCCCCCCCCOOC(=O)C(=O)OOCCCCCCCCCCCCCCCCCC,,,,,,
4155,104156,3-tert-Butyl-5-methylanisole,CC1=CC(=CC(=C1)OC)C(C)(C)C,,,,,,
4156,104157,Dichlorobis(dimethyl orthoborato-O'')titanium,B(O)(OC)OC.B(O)(OC)OC.Cl[Ti]Cl,,,,,,
4157,104158,Boric acid hydrogen dimethyl ester,B(O)(OC)OC,,,,,,
4158,104159,N-methyl-4-sulfanylbutanamide,CNC(=O)CCCS,,,,,,
4159,104160,2-[2-(2-Hydroxyethoxy)ethoxy]ethyl acetate,CC(=O)OCCOCCOCCO,,,,,,
4160,104161,"Benzoic acid, 2-methyl-, cadmium salt",CC1=CC=CC=C1C(=O)[O-].CC1=CC=CC=C1C(=O)[O-].[Cd+2],,,,,,
4161,104162,"Benzenamine, 2,2'-[sulfonylbis(4,1-phenyleneoxy)]bis-",C1=CC=C(C(=C1)N)OC2=CC=C(C=C2)S(=O)(=O)C3=CC=C(C=C3)OC4=CC=CC=C4N,,,,,,
4162,104163,"1,3-Bis[3-(dimethylamino)propyl]urea",CN(C)CCCNC(=O)NCCCN(C)C,,,,,,
4163,104164,"Acetamide, 2-[(4-methylphenyl)sulfonyl]-",CC1=CC=C(C=C1)S(=O)(=O)CC(=O)N,,,,,,
4164,104165,"2,6-Diisobutylphenol",CC(C)CC1=C(C(=CC=C1)CC(C)C)O,,,,,,
4165,104166,"3,5-Diisobutylphenol",CC(C)CC1=CC(=CC(=C1)O)CC(C)C,,,,,,
4166,104167,N-[(3-butoxy-2-hydroxypropyl)-dimethylazaniumyl]-2-methylprop-2-enimidate,CCCCOCC(C[N+](C)(C)N=C(C(=C)C)[O-])O,,,,,,
4167,104168,(3-Butoxy-2-hydroxypropyl)-dimethyl-(2-methylprop-2-enoylamino)azanium,CCCCOCC(C[N+](C)(C)NC(=O)C(=C)C)O,,,,,,
4168,104169,2-Hydrazinobenzoic acid hydrochloride,C1=CC=C(C(=C1)C(=O)O)NN.Cl,,,,,,
4169,104170,Decyl hexanoate,CCCCCCCCCCOC(=O)CCCCC,,,,,,
4170,104171,"[1,1'-Biphenyl]-4-carbonitrile, 4'-(pentyloxy)-",CCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C#N,,,,,,
4171,104172,"[1,1'-Biphenyl]-4-carbonitrile, 4'-(heptyloxy)-",CCCCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C#N,,,,,,
4172,104173,"[1,1'-Biphenyl]-4-carbonitrile, 4'-(octyloxy)-",CCCCCCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C#N,,,,,,
4173,104174,Prop-1-en-2-yl 4-methylcyclohexane-1-carboxylate,CC1CCC(CC1)C(=O)OC(=C)C,,,,,,
4174,104175,"Decanoic acid, 2-(2-(nonylphenoxy)ethoxy)ethyl ester",CCCCCCCCCC1=CC=C(C=C1)OCCOCCOC(=O)CCCCCCCCC,,,,,,
4175,104176,"trans-4-Phenyl-1,2,3,4-tetrahydro-1-naphthylamine hydrochloride",C1C[C@H](C2=CC=CC=C2[C@@H]1C3=CC=CC=C3)N.Cl,,,,,,
4176,104177,"(1R,4S)-4-phenyl-1,2,3,4-tetrahydronaphthalen-1-amine",C1C[C@H](C2=CC=CC=C2[C@@H]1C3=CC=CC=C3)N,,,,,,
4177,104178,"1-Naphthylamine, 1,2,3,4-tetrahydro-4-phenyl-, hydrochloride, (Z)-",C1C[C@H](C2=CC=CC=C2[C@H]1C3=CC=CC=C3)N.Cl,,,,,,
4178,104179,"(1R,4R)-4-phenyl-1,2,3,4-tetrahydronaphthalen-1-amine",C1C[C@H](C2=CC=CC=C2[C@H]1C3=CC=CC=C3)N,,,,,,
4179,104180,Tametraline hydrochloride,CN[C@@H]1CC[C@H](C2=CC=CC=C12)C3=CC=CC=C3.Cl,,,,,,
4180,104181,"N-methyl-4-phenyl-1,2,3,4-tetrahydronaphthalen-1-amine",CNC1CCC(C2=CC=CC=C12)C3=CC=CC=C3,,,,,,
4181,104182,"Methyl-(4-phenyl-1,2,3,4-tetrahydro-naphthalen-1-yl)-amine",CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC=CC=C3,,,,,,
4182,104183,6-Amino-5-((2-sulpho-4-((2-(sulphooxy)ethyl)sulphonyl)phenyl)azo)naphthalene-1-sulphonic acid,C1=CC2=C(C=CC(=C2N=NC3=C(C=C(C=C3)S(=O)(=O)CCOS(=O)(=O)O)S(=O)(=O)O)N)C(=C1)S(=O)(=O)O,,,,,,
4183,104184,"7H-[1]Benzopyrano[3',2':3,4]pyrido[1,2-a]benzimidazole-6-carbonitrile, 3-(diethylamino)-7-oxo-",CCN(CC)C1=CC2=C(C=C1)C=C3C(=C(C(=O)N4C3=NC5=CC=CC=C54)C#N)O2,,,,,,
4184,104185,"7H-[1]Benzopyrano[3',2':3,4]pyrido[1,2-a]benzimidazole-6-carbonitrile, 3-(diethylamino)-7-imino-",CCN(CC)C1=CC2=C(C=C1)C=C3C(=C(C(=N)N4C3=NC5=CC=CC=C54)C#N)O2,,,,,,
4185,104186,"1-Amino-4-(butylamino)-9,10-dihydro-9,10-dioxoanthracene-2,3-dicarbonitrile",CCCCNC1=C2C(=C(C(=C1C#N)C#N)N)C(=O)C3=CC=CC=C3C2=O,,,,,,
4186,104187,"4-Amino-1-(ethylamino)-5,6-dioxophenanthrene-3-sulfonic acid",CCNC1=CC(=C(C2=C1C=CC3=C2C(=O)C(=O)C=C3)N)S(=O)(=O)O,,,,,,
4187,104188,"1-Amino-4-(ethylamino)-9,10-dihydro-9,10-dioxoanthracene-2,3-dicarbonitrile",CCNC1=C2C(=C(C(=C1C#N)C#N)N)C(=O)C3=CC=CC=C3C2=O,,,,,,
4188,104189,"Ethanol, 2-[(4-methoxy-3-nitrophenyl)sulfonyl]-",COC1=C(C=C(C=C1)S(=O)(=O)CCO)[N+](=O)[O-],,,,,,
4189,104190,Dodecyl acetoacetate,CCCCCCCCCCCCOC(=O)CC(=O)C,,,,,,
4190,104191,"Bis(2-(dimethylamino)ethanolato-N,O)dimethoxytitanium",CN(C)CCO.CN(C)CCO.CO.CO.[Ti],,,,,,
4191,104192,"3,3-Dimethyl-1-(m-methylthiophenyl)triazene",CN(C)N=NC1=CC(=CC=C1)SC,,,,,,
4192,104193,CID 104193,C1=CC(=CC=C1N2C(=NN=N2)S)O,,,,,,
4193,104194,"Phosphoric acid, mono(4-nitrophenyl) ester, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1)",C1=CC(=CC=C1[N+](=O)[O-])OP(=O)(O)O.C(C(CO)(CO)N)O,,,,,,
4194,104195,3-(o-Tolyloxy)-1-propanol,CC1=CC=CC=C1OCCCO,,,,,,
4195,104196,Methyl 4-chlorophenylacetate,COC(=O)CC1=CC=C(C=C1)Cl,,,,,,
4196,104197,2-(2-Aminothiazol-5-yl)acetic acid,C1=C(SC(=N1)N)CC(=O)O,,,,,,
4197,104198,Sodium triaqua(3-hydroxy-4-((2-hydroxy-1-naphthyl)azo)-7-nitronaphthalene-1-sulphonato(3-))chromate(1-),C1=CC=C2C(=C1)C=CC(=C2N=NC3=C4C=CC(=CC4=C(C=C3[O-])S(=O)(=O)[O-])[N+](=O)[O-])[O-].O.O.O.[Na+].[Cr+2],,,,,,
4198,104199,7-(Dioxidoamino)-3-oxo-4-[(2-oxonaphthalen-1-ylidene)hydrazinylidene]naphthalene-1-sulfonic acid,C1=CC=C2C(=C1)C=CC(=O)C2=NN=C3C4=C(C=C(C=C4)N([O-])[O-])C(=CC3=O)S(=O)(=O)O,,,,,,
4199,104200,"3-Bromo-2,2-dimethylpropyl bromochlorophosphate",CC(C)(COP(=O)(Cl)Br)CBr,,,,,,
4200,104201,"1-Hexadecanaminium, N,N-dihexadecyl-N-methyl-, chloride",CCCCCCCCCCCCCCCC[N+](C)(CCCCCCCCCCCCCCCC)CCCCCCCCCCCCCCCC.[Cl-],,,,,,
4201,104202,Methyltricetylaminium,CCCCCCCCCCCCCCCC[N+](C)(CCCCCCCCCCCCCCCC)CCCCCCCCCCCCCCCC,,,,,,
4202,104203,"Trisodium 5-amino-3-((4-((4-((7-amino-1-hydroxy-3-sulphonato-2-naphthyl)azo)phenyl)azo)phenyl)azo)-4-hydroxynaphthalene-2,7-disulphonate",C1=CC(=CC=C1N=NC2=CC=C(C=C2)N=NC3=C(C=C4C=CC(=CC4=C3O)N)S(=O)(=O)[O-])N=NC5=C(C6=C(C=C(C=C6C=C5S(=O)(=O)[O-])S(=O)(=O)[O-])N)O.[Na+].[Na+].[Na+],,,,,,
4203,104204,"5-Amino-3-((4-((4-((7-amino-1-hydroxy-3-sulpho-2-naphthyl)azo)phenyl)azo)phenyl)azo)-4-hydroxynaphthalene-2,7-disulphonic acid",C1=CC(=CC=C1N=NC2=CC=C(C=C2)N=NC3=C(C=C4C=CC(=CC4=C3O)N)S(=O)(=O)O)N=NC5=C(C6=C(C=C(C=C6C=C5S(=O)(=O)O)S(=O)(=O)O)N)O,,,,,,
4204,104205,"2,7-Naphthalenedisulfonic acid, 5-amino-3-[[4-[[4-[(6-amino-1-hydroxy-3-sulfo-2-naphthalenyl)azo]phenyl]azo]phenyl]azo]-4-hydroxy-, trisodium salt",C1=CC(=CC=C1N=NC2=CC=C(C=C2)N=NC3=C(C=C4C=C(C=CC4=C3O)N)S(=O)(=O)[O-])N=NC5=C(C6=C(C=C(C=C6C=C5S(=O)(=O)[O-])S(=O)(=O)[O-])N)O.[Na+].[Na+].[Na+],,,,,,
4205,104206,"5-Amino-3-((4-((4-((6-amino-1-hydroxy-3-sulpho-2-naphthyl)azo)phenyl)azo)phenyl)azo)-4-hydroxynaphthalene-2,7-disulphonic acid",C1=CC(=CC=C1N=NC2=CC=C(C=C2)N=NC3=C(C=C4C=C(C=CC4=C3O)N)S(=O)(=O)O)N=NC5=C(C6=C(C=C(C=C6C=C5S(=O)(=O)O)S(=O)(=O)O)N)O,,,,,,
4206,104207,Butyl 5-oxocyclopent-1-ene-1-heptanoate,CCCCOC(=O)CCCCCCC1=CCCC1=O,,,,,,
4207,104208,"6-Cyclopentyl-2,4-xylenol",CC1=CC(=C(C(=C1)C2CCCC2)O)C,,,,,,
4208,104209,"Phosphoric acid, mono(4-nitrophenyl) ester, compd. with cyclohexanamine (1:2)",C1CCC(CC1)N.C1CCC(CC1)N.C1=CC(=CC=C1[N+](=O)[O-])OP(=O)(O)O,,,,,,
4209,104210,CID 104210,C(CO)N=C(S)[S-].C(CO)N=C(S)[S-].[Ni+2],,,,,,
4210,104211,CID 104211,C(CO)N=C(S)S,,,,,,
4211,104212,Nickel(2+) bis[bis(2-hydroxyethyl)carbamodithioate],C(CO)N(CCO)C(=S)[S-].C(CO)N(CCO)C(=S)[S-].[Ni+2],,,,,,
4212,104213,3-Bromo-5-nitrotoluene,CC1=CC(=CC(=C1)Br)[N+](=O)[O-],,,,,,
4213,104214,2-[(2-Hydroxyethyl)octadecylamino]ethyl stearate,CCCCCCCCCCCCCCCCCCN(CCO)CCOC(=O)CCCCCCCCCCCCCCCCC,,,,,,
4214,104215,p-Dodecylbenzenesulphonyl chloride,CCCCCCCCCCCCC1=CC=C(C=C1)S(=O)(=O)Cl,,,,,,
4215,104216,CID 104216,C1=NC(=O)C(=C(N1)N)N.OS(=O)(=O)O,,,,,,
4216,104217,"Benzoic acid, 4-(1,1-dimethylethyl)-, magnesium salt",CC(C)(C)C1=CC=C(C=C1)C(=O)[O-].CC(C)(C)C1=CC=C(C=C1)C(=O)[O-].[Mg+2],,,,,,
4217,104218,"Benzoic acid, 4-(1,1-dimethylethyl)-, calcium salt",CC(C)(C)C1=CC=C(C=C1)C(=O)[O-].CC(C)(C)C1=CC=C(C=C1)C(=O)[O-].[Ca+2],,,,,,
4218,104219,"Benzenediazonium, 2,5-diethoxy-4-[(4-methylphenyl)thio]-, sulfate (1:1)",CCOC1=CC(=C(C=C1[N+]#N)OCC)SC2=CC=C(C=C2)C.OS(=O)(=O)[O-],,,,,,
4219,104220,"Benzenediazonium, 2,5-diethoxy-4-[(4-methylphenyl)thio]-",CCOC1=CC(=C(C=C1[N+]#N)OCC)SC2=CC=C(C=C2)C,,,,,,
4220,104221,Laurimin,CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC1=CC=CC=C1.[Cl-],,,,,,
4221,104222,"N,N-Dimethyl-N-[3-[(1-oxododecyl)amino]propyl]benzenemethanaminium",CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC1=CC=CC=C1,,,,,,
4222,104223,3-(Trifluoromethyl)phenethylamine,C1=CC(=CC(=C1)C(F)(F)F)CCN,,,,,['2-(3-(Trifluoromethyl)phenyl)ethanamine is a known human metabolite of (s)-norfenfluramine.'],
4223,104224,"Undecane, 1,1-dimethoxy-",CCCCCCCCCCC(OC)OC,,,,,,
4224,104225,"3,3,4,4,4-Pentafluorobutyl methacrylate",CC(=C)C(=O)OCCC(C(F)(F)F)(F)F,,,,,,
4225,104226,CID 104226,C1=CC(=CC=C1NN)S(=O)(=O)[O-].[Na+],,,,,,
4226,104227,CID 104227,C1=CC(=CN=C1)[O-].[Na+],,,,,,
4227,104228,5-(Aminosulphonyl)-2-methoxybenzoyl chloride,COC1=C(C=C(C=C1)S(=O)(=O)N)C(=O)Cl,,,,,,
4228,104229,"Benzenediazonium, 2,5-diethoxy-4-((4-methoxybenzoyl)amino)-, (T-4)-tetrachlorozincate(2-) (2:1)",CCOC1=CC(=C(C=C1NC(=O)C2=CC=C(C=C2)OC)OCC)[N+]#N.CCOC1=CC(=C(C=C1NC(=O)C2=CC=C(C=C2)OC)OCC)[N+]#N.[Cl-].[Cl-].[Cl-].[Cl-].[Zn+2],,,,,,
4229,104230,"2,5-Diethoxy-4-[(4-methoxybenzoyl)amino]benzenediazonium",CCOC1=CC(=C(C=C1NC(=O)C2=CC=C(C=C2)OC)OCC)[N+]#N,,,,,,
4230,104231,2-Phenylthio-5-trifluoromethylbenzoic acid,C1=CC=C(C=C1)SC2=C(C=C(C=C2)C(F)(F)F)C(=O)O,,,,,,
4231,104232,"Acetamide, N-[5-[bis(2-methoxyethyl)amino]-2-[(2-cyano-4-nitrophenyl)azo]phenyl]-",CC(=O)NC1=C(C=CC(=C1)N(CCOC)CCOC)N=NC2=C(C=C(C=C2)[N+](=O)[O-])C#N,,,,,,
4232,104233,4-((2-Chlorophenyl)azo)-3-hydroxy-2-naphthoic acid,C1=CC=C2C(=C1)C=C(C(=C2N=NC3=CC=CC=C3Cl)O)C(=O)O,,,,,,
4233,104234,"Glycine, N-methyl-N-(1-oxotetradecyl)-",CCCCCCCCCCCCCC(=O)N(C)CC(=O)O,,,,,,
4234,104235,"N,N-Dimethyl-N-[3-[(1-oxododecyl)amino]propyl]-3-sulfonato-1-propanaminium",CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CCCS(=O)(=O)O,,,,,,
4235,104236,CID 104236,COC1=CC=C(C=C1)N=C2C=CC(=N)C3=C2C(=C4C(=O)C=CC(=C4C3=O)N(O)O)O,,,,,,
4236,104237,3-(Chloromethyl)-4-methoxybenzaldehyde,COC1=C(C=C(C=C1)C=O)CCl,,,,,,
4237,104238,3-Carboxylato-1-(2-hydroxyethyl)pyridinium,C1=CC(=C[N+](=C1)CCO)C(=O)[O-],,,,,,
4238,104239,pyridinebetaine A,C1=CC(=C[N+](=C1)CCO)C(=O)O,,,,,,
4239,104240,"5,5'-Sulphinylbisresorcinol",C1=C(C=C(C=C1O)S(=O)C2=CC(=CC(=C2)O)O)O,,,,,,
4240,104241,"[(1R,4R,5R)-6,6-dimethyl-4-bicyclo[3.1.1]heptanyl]methanamine",CC1([C@@H]2CC[C@H]([C@H]1C2)CN)C,,,,,,
4241,104242,PPG-10 Oleyl ether,CCCCCCCCC=CCCCCCCCCOCCCO,,,,,,
4242,104243,"N-[2-[(2,6-Dibromo-4-nitrophenyl)azo]-5-(diethylamino)phenyl]acetamide",CCN(CC)C1=CC(=C(C=C1)N=NC2=C(C=C(C=C2Br)[N+](=O)[O-])Br)NC(=O)C,,,,,,
4243,104244,Einecs 258-020-2,CCN(CC)C1=CC=CC(=C1NC(=O)C)N=NC2=C(C=C(C=C2)[N+](=O)[O-])C#N,,,,,,
4244,104245,5-Ethyl-5-p-tolylbarbituric acid,CCC1(C(=O)NC(=O)NC1=O)C2=CC=C(C=C2)C,,,,,,
4245,104246,"9,10-Anthracenedione, 2,2'-(1,3,4-oxadiazole-2,5-diyl)bis[1-amino-",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3)C4=NN=C(O4)C5=C(C6=C(C=C5)C(=O)C7=CC=CC=C7C6=O)N)N,,,,,,
4246,104247,2-(Perfluorobutyl)ethyl acrylate,C=CC(=O)OCCC(C(C(C(F)(F)F)(F)F)(F)F)(F)F,,,,,,
4247,104248,"Benzenediazonium, 2,5-dimethoxy-4-(4-morpholinyl)-, (T-4)-tetrachlorozincate(2-) (2:1)",COC1=CC(=C(C=C1[N+]#N)OC)N2CCOCC2.COC1=CC(=C(C=C1[N+]#N)OC)N2CCOCC2.[Cl-].[Cl-].[Cl-].[Cl-].[Zn+2],,,,,,
4248,104249,"Bis(2-aminoethanolato-N,O)dioxomolybdenum",C(CO)N.C(CO)N.O=[Mo]=O,,,,,,
4249,104250,2-[2-[2-(Dodecyloxy)ethoxy]ethoxy]ethyl dihydrogen phosphate,CCCCCCCCCCCCOCCOCCOCCOP(=O)(O)O,,,,,,
4250,104251,4-Hydroxycarbazole,C1=CC=C2C(=C1)C3=C(N2)C=CC=C3O,,,,,,
4251,104252,2-Chloro-3-methoxypyridine,COC1=C(N=CC=C1)Cl,,,,,,
4252,104253,"2-((4-((4,6-Dichloro-1,3,5-triazin-2-yl)amino)phenyl)sulphonyl)ethyl hydrogen sulphate",C1=CC(=CC=C1NC2=NC(=NC(=N2)Cl)Cl)S(=O)(=O)CCOS(=O)(=O)O,,,,,,
4253,104254,"cis-1-(2,2,6-Trimethylcyclohexyl)ethanone",C[C@@H]1CCCC([C@@H]1C(=O)C)(C)C,,,,,,
4254,104255,CID 104255,CC1=C(C=C(C=C1)C(=O)[O-])N(CCCl)CCCl.[Na+],,,,,,
4255,104256,CID 104256,CC1=C(C=C(C=C1)C(=O)NC(CC2=CC=CC=C2)C(=O)[O-])N(CCCl)CCCl.[Na+],,,,,,
4256,104257,2-[[3-[Bis(2-chloroethyl)amino]-4-methylbenzoyl]amino]-3-phenylpropanoic acid,CC1=C(C=C(C=C1)C(=O)NC(CC2=CC=CC=C2)C(=O)O)N(CCCl)CCCl,,,,,,
4257,104258,CID 104258,CC1=C(C=C(C=C1)C(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)[O-])N(CCCl)CCCl.[Na+],,,,,,
4258,104259,CID 104259,CC1=C(C=C(C=C1)C(=O)NC(CC2=CC=C(C=C2)O)C(=O)O)N(CCCl)CCCl,,,,,,
4259,104260,N6-(1-Oxooctadecyl)-L-lysine,CCCCCCCCCCCCCCCCCC(=O)NCCCC[C@@H](C(=O)O)N,,,,,,
4260,104261,"9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 21-pivalate",C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COC(=O)C(C)(C)C)O)C)O)F)C,,,,,,
4261,104262,Beclomethasone valerate,CCCCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)Cl)O)C)C)C(=O)CO,,,,,,
4262,104263,CID 104263,CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C(=O)[O-].CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)C(=O)[O-].[Ni+2],,,,,,
4263,104264,"Adipic acid, esters with pentaerythritol",C(CCC(=O)O)CC(=O)O.C(C(CO)(CO)CO)O,,,,,,
4264,104265,2-Hydroxyethyl methacrylate phosphate,CC(=C)C(=O)OCCO.OP(=O)(O)O,,,,,,
4265,104266,CID 104266,CCCC[SnH+]CCCC.CCCC[Sn]CCCC.CC(C)CCCCCOC(=O)C[S-].CC(C)CCCCCOC(=O)C[S-].[SH-],,,,,,
4266,104267,"10-Bromonaphth(2,3-c)acridine-5,8,14(13H)-trione",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C4=C(C=C3)C(=O)C5=C(N4)C=CC(=C5)Br,,,,,,
4267,104268,4-(4-((2-Methyl-4-(((p-tolyl)sulphonyl)oxy)phenyl)azo)anilino)-3-nitrobenzenesulphonic acid,CC1=CC=C(C=C1)S(=O)(=O)OC2=CC(=C(C=C2)N=NC3=CC=C(C=C3)NC4=C(C=C(C=C4)S(=O)(=O)O)[N+](=O)[O-])C,,,,,,
4268,104269,2-(2-Hydroxyethoxy)ethyl chloroacetate,C(COCCOC(=O)CCl)O,,,,,,
4269,104270,1-Bromo-6-methylheptane,CC(C)CCCCCBr,,,,,,
4270,104271,Isooctyl gallate,CC(C)CCCCCOC(=O)C1=CC(=C(C(=C1)O)O)O,,,,,,
4271,104272,Isoeicosanol,CC(C)CCCCCCCCCCCCCCCCCO,,,,,,
4272,104273,3-(Dimethylamino)-N-((dimethylamino)methyl)propionamide,CN(C)CCC(=O)NCN(C)C,,,,,,
4273,104274,tert-butyl N-[(2S)-4-methyl-1-oxopentan-2-yl]carbamate;N-cyclohexylcyclohexanamine,CC(C)C[C@@H](C=O)NC(=O)OC(C)(C)C.C1CCC(CC1)NC2CCCCC2,,,,,,
4274,104275,tert-butyl N-[(2S)-4-methyl-1-oxopentan-2-yl]carbamate,CC(C)C[C@@H](C=O)NC(=O)OC(C)(C)C,,,,,,
4275,104276,N-(2-Carboxyethyl)-N-octyl-beta-alanine,CCCCCCCCN(CCC(=O)O)CCC(=O)O,,,,,,
4276,104277,"3,9-Bis(p-nonylphenoxy)-2,4,8,10-tetraoxa-3,9-diphosphaspiro(5.5)undecane",CCCCCCCCCC1=CC=C(C=C1)OP2OCC3(CO2)COP(OC3)OC4=CC=C(C=C4)CCCCCCCCC,,,,,,
4277,104278,Tris(4-aminophenyl) thiophosphate,C1=CC(=CC=C1N)OP(=S)(OC2=CC=C(C=C2)N)OC3=CC=C(C=C3)N,,,,,,
4278,104279,CID 104279,C(S(=O)(=O)O)S(=O)(=O)O.C(S(=O)(=O)O)S(=O)(=O)O.C(S(=O)(=O)O)S(=O)(=O)O.[AlH3].[AlH3],,,,,,
4279,104280,"9-Fluoro-11beta,17,21-trihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 21-(3,3-dimethylbutyrate)",C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COC(=O)CC(C)(C)C)O)C)O)F)C,,,,,,
4280,104281,CID 104281,CCCCCCCC[SnH].CCOC(=O)COC(=O)C=CC(=O)O.CCOC(=O)C=CC(=O)O.CC=CC(=O)O,,,,,,
4281,104282,4-(2-Ethoxy-2-oxoethoxy)-4-oxobut-2-enoic acid,CCOC(=O)COC(=O)C=CC(=O)O,,,,,,
4282,104283,"9,10-Anthracenedione, 2,2'-[1,4-phenylenebis(1,3,4-oxadiazole-5,2-diyl)]bis[1-amino-",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3)C4=NN=C(O4)C5=CC=C(C=C5)C6=NN=C(O6)C7=C(C8=C(C=C7)C(=O)C9=CC=CC=C9C8=O)N)N,,,,,,
4283,104284,"2-(3-Methoxypropyl)-9(or 10)-methylbenzimidazo(2,1-b)benzo(lmn)(3,8)phenanthroline-1,3,6(2H)-trione",CC1=CC2=C(C=C1)N3C(=N2)C4=C5C(=CC=C6C5=C(C=C4)C(=O)N(C6=O)CCCOC)C3=O,,,,,,
4284,104285,Dipropyl tetrasulfide,CCCSSSSCCC,,,,,,
4285,104286,"Benzenesulfonic acid, 3-[[4-[(2-ethoxy-5-methylphenyl)azo]-1-naphthalenyl]azo]-",CCOC1=C(C=C(C=C1)C)N=NC2=CC=C(C3=CC=CC=C32)N=NC4=CC(=CC=C4)S(=O)(=O)O,,,,,,
4286,104287,"Acetamide, N-[2-[(2-bromo-4,6-dinitrophenyl)azo]-5-(diethylamino)phenyl]-",CCN(CC)C1=CC(=C(C=C1)N=NC2=C(C=C(C=C2Br)[N+](=O)[O-])[N+](=O)[O-])NC(=O)C,,,,,,
4287,104288,"[1,1'-Biphenyl]-4-carbonitrile, 4'-butyl-",CCCCC1=CC=C(C=C1)C2=CC=C(C=C2)C#N,,,,,,
4288,104289,4-Cyano-4'-octylbiphenyl,CCCCCCCCC1=CC=C(C=C1)C2=CC=C(C=C2)C#N,,,,,,
4289,104290,"[1,1'-Biphenyl]-4-carbonitrile, 4'-nonyl-",CCCCCCCCCC1=CC=C(C=C1)C2=CC=C(C=C2)C#N,,,,,,
4290,104291,"[1,1'-Biphenyl]-4-carbonitrile, 4'-propoxy-",CCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C#N,,,,,,
4291,104292,"[1,1'-Biphenyl]-4-carbonitrile, 4'-butoxy-",CCCCOC1=CC=C(C=C1)C2=CC=C(C=C2)C#N,,,,,,
4292,104293,4-Propylbenzoyl chloride,CCCC1=CC=C(C=C1)C(=O)Cl,,,,,,
4293,104294,Methionylmethionine,CSCCC(C(=O)NC(CCSC)C(=O)O)N,,,,,,
4294,104295,Butyl (4-chlorophenoxy)acetate,CCCCOC(=O)COC1=CC=C(C=C1)Cl,,,,,,
4295,104296,4-[4-(Diethylamino)-2-hydroxybenzoyl]isophthalic acid,CCN(CC)C1=CC(=C(C=C1)C(=O)C2=C(C=C(C=C2)C(=O)O)C(=O)O)O,,,,,,
4296,104297,2-(4-Diethylamino-2-hydroxybenzoyl)terephthalic acid,CCN(CC)C1=CC(=C(C=C1)C(=O)C2=C(C=CC(=C2)C(=O)O)C(=O)O)O,,,,,,
4297,104298,"Ethyl 3,7,12-trioxo-5betacholan-24-oate",CCOC(=O)CC[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(C(=O)C[C@H]3[C@H]2C(=O)C[C@H]4[C@@]3(CCC(=O)C4)C)C,,,,,,
4298,104299,1-Butyl-4-methylnaphthalene,CCCCC1=CC=C(C2=CC=CC=C12)C,,,,,,
4299,104300,"1,3-Benzenediol, 4-(2-pyridinylazo)-, disodium salt",C1=CC=NC(=C1)N=NC2=C(C=C(C=C2)[O-])[O-].[Na+].[Na+],,,"['Colorless, endogenous or exogenous pigment precursors that may be transformed by biological mechanisms into colored compounds; used in biochemical assays and in diagnosis as indicators, especially in the form of enzyme substrates. Synonym: chromogens (not to be confused with pigment-synthesizing bacteria also called chromogens). (See all compounds classified as Chromogenic Compounds.)']",,,
4300,104301,"4-Hydroxy-1-(2-hydroxyethyl)-2,2,6,6-tetramethylpiperidine",CC1(CC(CC(N1CCO)(C)C)O)C,,,,,,
4301,104302,Bis(thiocarboxy) tetrasulphide,C(=O)(S)SSSSC(=O)S,,,,,,
4302,104303,"2-Propenoic acid, (4-methyl-1,3-phenylene)bis(iminocarbonyloxy(2-methyl-2,1-ethanediyl)) ester",CC1=C(C=C(C=C1)NC(=O)OC(C)COC(=O)C=C)NC(=O)OC(C)COC(=O)C=C,,,,,,
4303,104304,"2-Naphthalenecarboxamide, N,N'-(3,3'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis[3-hydroxy-, disodium salt",COC1=C(C=CC(=C1)C2=CC(=C(C=C2)NC(=O)C3=CC4=CC=CC=C4C=C3[O-])OC)NC(=O)C5=CC6=CC=CC=C6C=C5[O-].[Na+].[Na+],,,,,,
4304,104305,4-((2-Chloro-4-nitrophenyl)azo)aniline,C1=CC(=CC=C1N)N=NC2=C(C=C(C=C2)[N+](=O)[O-])Cl,,,,,,
4305,104306,Tris(3-ethylphenyl) phosphate,CCC1=CC(=CC=C1)OP(=O)(OC2=CC=CC(=C2)CC)OC3=CC=CC(=C3)CC,,,,,,
4306,104307,6-Methylheptanal,CC(C)CCCCC=O,,,,,,
4307,104308,"2-Anthracenecarboxamide, 1-amino-N-(3-bromo-9,10-dihydro-9,10-dioxo-2-anthracenyl)-9,10-dihydro-9,10-dioxo-",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3)C(=O)NC4=C(C=C5C(=C4)C(=O)C6=CC=CC=C6C5=O)Br)N,,,,,,
4308,104309,"1,4,5,8-Tetrakis(phenylthio)anthraquinone",C1=CC=C(C=C1)SC2=C3C(=C(C=C2)SC4=CC=CC=C4)C(=O)C5=C(C=CC(=C5C3=O)SC6=CC=CC=C6)SC7=CC=CC=C7,,,,,,
4309,104310,Propyl 4-hydroxy-3-methoxyphenylacetate,CCCOC(=O)CC1=CC(=C(C=C1)O)OC,,,,,,
4310,104311,"1,10-Phenanthrolinedisulfonic acid, 4,7-diphenyl-, disodium salt",C1=CC(=CC=C1C2=C3C=CC4=C(C=CN=C4C3=NC=C2)C5=CC=C(C=C5)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
4311,104312,"4,7-Diphenyl-1,10-phenanthroline 4',4''-disulfonic acid",C1=CC(=CC=C1C2=C3C=CC4=C(C=CN=C4C3=NC=C2)C5=CC=C(C=C5)S(=O)(=O)O)S(=O)(=O)O,,,,,,
4312,104313,"2,2-Diethoxybutane",CCC(C)(OCC)OCC,,,,,,
4313,104314,4-tert-Butyl-2-cyclopentylphenol,CC(C)(C)C1=CC(=C(C=C1)O)C2CCCC2,,,,,,
4314,104315,4-(4-(tert-Butyl)-2-cyclopentylphenoxy)butylamine,CC(C)(C)C1=CC(=C(C=C1)OCCCCN)C2CCCC2,,,,,,
4315,104316,"N-(4-(2-Cyclopentyl-4-(1,1-dimethylethyl)phenoxy)butyl)-1-hydroxynaphthalene-2-carboxamide",CC(C)(C)C1=CC(=C(C=C1)OCCCCNC(=O)C2=C(C3=CC=CC=C3C=C2)O)C4CCCC4,,,,,,
4316,104317,"2,6-Dichloropyridin-3-ol",C1=CC(=NC(=C1O)Cl)Cl,,,,,,
4317,104318,3-Hydroxy-N-isopropylpyridine-2-carboxamide,CC(C)NC(=O)C1=C(C=CC=N1)O,,,,,,
4318,104319,Ethylene bis(hydroxyacetate),C(COC(=O)CO)OC(=O)CO,,,,,,
4319,104320,Diethyl methyl(4-(2-thienylcarbonyl)phenyl)malonate,CCOC(=O)C(C)(C1=CC=C(C=C1)C(=O)C2=CC=CS2)C(=O)OCC,,,,,,
4320,104321,4-Ethylphenyl 2-thienyl ketone,CCC1=CC=C(C=C1)C(=O)C2=CC=CS2,,,,,,
4321,104322,Diphenyl m-ethylphenyl phosphate,CCC1=CC(=CC=C1)OP(=O)(OC2=CC=CC=C2)OC3=CC=CC=C3,,,,,,
4322,104323,"Butane, 1-[2-[2-(1,1-dimethylethoxy)ethoxy]ethoxy]-",CCCCOCCOCCOC(C)(C)C,,,,,,
4323,104324,2-[2-(2-Methoxyethoxy)ethoxy]-2-methylpropane,CC(C)(C)OCCOCCOC,,,,,,
4324,104325,2-[2-(2-Ethoxyethoxy)ethoxy]-2-methylpropane,CCOCCOCCOC(C)(C)C,,,,,,
4325,104326,"1,3-Naphthalenedisulfonic acid, 4-amino-5-hydroxy-, sodium salt",C1=CC2=C(C(=C1)O)C(=C(C=C2S(=O)(=O)[O-])S(=O)(=O)[O-])N.[Na+].[Na+],,,,,,
4326,104327,"4,4'-(Propane-1,3-diyldi(piperidine-1,4-diyl))bis(7-nitroquinazoline)",C1CN(CCC1CCCC2CCN(CC2)C3=NC=NC4=C3C=CC(=C4)[N+](=O)[O-])C5=NC=NC6=C5C=CC(=C6)[N+](=O)[O-],,,,,,
4327,104328,"Isooctadecanamide, N,N-bis(2-hydroxyethyl)-",CC(C)CCCCCCCCCCCCCCC(=O)N(CCO)CCO,,,,,,
4328,104329,"Benzoic acid, 4-[(1-oxohexyl)oxy]-, 4-propylphenyl ester",CCCCCC(=O)OC1=CC=C(C=C1)C(=O)OC2=CC=C(C=C2)CCC,,,,,,
4329,104330,N-Diazoacetylglycine propylamide,CCCNCC(=O)NC(=O)C=[N+]=[N-],,,,,,
4330,104331,CID 104331,CCCNCC(=O)NC(=C[N+]#N)O,,,,,,
4331,104332,N-Diazoacetylglycine isopropylamide,CC(C)NCC(=O)NC(=O)C=[N+]=[N-],,,,,,
4332,104333,CID 104333,CC(C)NCC(=O)NC(=C[N+]#N)O,,,,,,
4333,104334,"Acetonitrile, (dodecylsulfonyl)-",CCCCCCCCCCCCS(=O)(=O)CC#N,,,,,,
4334,104335,2-(4-(Diethylamino)-2-methylbenzoyl)benzoic acid,CCN(CC)C1=CC(=C(C=C1)C(=O)C2=CC=CC=C2C(=O)O)C,,,,,,
4335,104336,"2,3,4,5-Tetrachloro-6-[4-(diethylamino)-2-methylbenzoyl]benzoic acid",CCN(CC)C1=CC(=C(C=C1)C(=O)C2=C(C(=C(C(=C2Cl)Cl)Cl)Cl)C(=O)O)C,,,,,,
4336,104337,"4,5-Dihydro-3-(pyridin-4-yl)-2H-benz(g)indazole",C1CC2=C(C3=CC=CC=C31)NN=C2C4=CC=NC=C4,,,,,,
4337,104338,Coumarin 500,CCNC1=CC2=C(C=C1)C(=CC(=O)O2)C(F)(F)F,,,,,,
4338,104339,Dodecane diisothiourea dihydrobromide,C(CCCCCCSC(=N)N)CCCCCSC(=N)N.Br.Br,,,,,,
4339,104340,12-Carbamimidoylsulfanyldodecyl carbamimidothioate,C(CCCCCCSC(=N)N)CCCCCSC(=N)N,,,,,,
4340,104341,Einecs 258-217-3,C[C@@H]1CCCC([C@H]1C(=O)C)(C)C,,,,,,
4341,104342,2-Benzyl-4-methylphenol,CC1=CC(=C(C=C1)O)CC2=CC=CC=C2,,,,,,
4342,104343,"beta-Alanine, N-[5-(acetylamino)-2-methoxyphenyl]-, ethyl ester",CCOC(=O)CCNC1=C(C=CC(=C1)NC(=O)C)OC,,,,,,
4343,104344,Einecs 258-227-8,CN(C)C1=CC=C(C=C1)NC2=C3C(=C(C=C2)O)C=CC4=C3C(=O)C(=O)C=C4,,,,,,
4344,104345,2-(Carbamoyloxy)ethyl ethyl (2-cyanoethyl)phosphonate,CCOP(=O)(CCC#N)OCCOC(=O)N,,,,,,
4345,104346,"4,5-Diethyl-2,4-dihydro-3H-1,2,4-triazol-3-one",CCC1=NNC(=O)N1CC,,,,,,
4346,104347,"Cholest-5-en-3-ol (3beta)-, 2-propenyl carbonate",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OC(=O)OCC=C)C)C,,,,,,
4347,104348,"2-Methyl-1,4-diacetoxy-buta-1,3-diene",CC(=COC(=O)C)C=COC(=O)C,,,,,,
4348,104349,"2,2'-(Heptylimino)bisethanol",CCCCCCCN(CCO)CCO,,,,,,
4349,104350,"2,2,4,4-Tetramethyl-1,3-cyclobutanediyl bismethacrylate",CC(=C)C(=O)OC1C(C(C1(C)C)OC(=O)C(=C)C)(C)C,,,,,,
4350,104351,"1,3-Propanediamine, N-[3-(dodecyloxy)propyl]-",CCCCCCCCCCCCOCCCNCCCN,,,,,,
4351,104352,"Benzoic acid, 4-(hexyloxy)-, 4-[(4-butyl-2-cyanophenoxy)carbonyl]phenyl ester",CCCCCCOC1=CC=C(C=C1)C(=O)OC2=CC=C(C=C2)C(=O)OC3=C(C=C(C=C3)CCCC)C#N,,,,,,
4352,104353,4-Butyl-2-nitrophenol,CCCCC1=CC(=C(C=C1)O)[N+](=O)[O-],,,,,,
4353,104354,4-((4-(Hexyloxy)benzoyl)oxy)benzoic acid,CCCCCCOC1=CC=C(C=C1)C(=O)OC2=CC=C(C=C2)C(=O)O,,,,,,
4354,104355,Dodecanoyl-bis(2-hydroxyethyl)-tetradecanoylazanium,CCCCCCCCCCCCCC(=O)[N+](CCO)(CCO)C(=O)CCCCCCCCCCC,,,,,,
4355,104356,"Amidosulfenyl chloride, methyl((4-methylphenyl)sulfonyl)-",CC1=CC=C(C=C1)S(=O)(=O)N(C)SCl,,,,,,
4356,104357,"N,N,N',N'-Tetrakis(2-hydroxyethyl)nonanediamide",C(CCCC(=O)N(CCO)CCO)CCCC(=O)N(CCO)CCO,,,,,,
4357,104358,Betaine aspartate,C[N+](C)(C)CC(=O)O.C([C@@H](C(=O)[O-])N)C(=O)O,,,,,,
4358,104359,Bis(2-methylpropyl) (2-methylpropyl)phosphonate,CC(C)COP(=O)(CC(C)C)OCC(C)C,,,,,,
4359,104360,Isotridecyl phosphate,CC(C)CCCCCCCCCCO.OP(=O)(O)O,,,,,,
4360,104361,Caulophyllogenin,C[C@]12CC[C@@H]([C@@]([C@@H]1CC[C@@]3([C@@H]2CC=C4[C@]3(C[C@H]([C@@]5([C@H]4CC(CC5)(C)C)C(=O)O)O)C)C)(C)CO)O,,,,,,
4361,104362,"2,4-Dicyclopentylphenol",C1CCC(C1)C2=CC(=C(C=C2)O)C3CCCC3,,,,,,
4362,104363,"N-(2-Aminoethyl)-N'-(2-(4,5-dihydro-2-undecyl-1H-imidazol-1-yl)ethyl)ethylenediamine",CCCCCCCCCCCC1=NCCN1CCNCCNCCN,,,,,,
4363,104364,Bismuth;octadec-9-enoate,CCCCCCCCC=CCCCCCCCC(=O)[O-].CCCCCCCCC=CCCCCCCCC(=O)[O-].CCCCCCCCC=CCCCCCCCC(=O)[O-].[Bi+3],,,,,,
4364,104365,CID 104365,COC1=CC(=C(C=C1)N=NC2=C(C=C3C=C(C=CC3=C2[O-])NC4=NC(=NC(=N4)NCCO)NC5=CC6=CC(=C(C(=C6C=C5)[O-])N=NC7=C(C=CC(=C7)S(=O)(=O)[O-])O)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Cu+2],,,,,,
4365,104366,"4-Hydroxy-7-[[4-(2-hydroxyethylamino)-6-[[5-hydroxy-6-[(2-hydroxy-5-sulfophenyl)diazenyl]-7-sulfonaphthalen-2-yl]amino]-1,3,5-triazin-2-yl]amino]-3-[(4-methoxy-2-sulfophenyl)diazenyl]naphthalene-2-sulfonic acid",COC1=CC(=C(C=C1)N=NC2=C(C=C3C=C(C=CC3=C2O)NC4=NC(=NC(=N4)NCCO)NC5=CC6=CC(=C(C(=C6C=C5)O)N=NC7=C(C=CC(=C7)S(=O)(=O)O)O)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
4366,104367,"3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,12,12,12-Icosafluoro-11-(trifluoromethyl)dodecyl acrylate",C=CC(=O)OCCC(C(C(C(C(C(C(C(C(C(F)(F)F)(C(F)(F)F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
4367,104368,"3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,14,14,14-Tetracosafluoro-13-(trifluoromethyl)tetradecyl acrylate",C=CC(=O)OCCC(C(C(C(C(C(C(C(C(C(C(C(F)(F)F)(C(F)(F)F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
4368,104369,"4,6-Diethylresorcinol",CCC1=CC(=C(C=C1O)O)CC,,,,,,
4369,104370,"2,2',2'',2'''-(1,4-Dithiane-2,5-diylidenetetrakis(thio))tetrakisacetic acid",C1C(SCC(S1)(SCC(=O)O)SCC(=O)O)(SCC(=O)O)SCC(=O)O,,,,,,
4370,104371,3-((4-Hydroxyphenyl)amino)propanesulphonic acid,C1=CC(=CC=C1NCCCS(=O)(=O)O)O,,,,,,
4371,104372,Einecs 258-281-2,COCC1[C@@H]2CC(=O)[C@H]1C=C2,,,,,,
4372,104373,"Nonane, 2,2-dimethoxy-",CCCCCCCC(C)(OC)OC,,,,,,
4373,104374,"1-Ethyl-3,5-bis(hydroxymethyl)-1,3,5-triazine-2,4,6(1H,3H,5H)-trione",CCN1C(=O)N(C(=O)N(C1=O)CO)CO,,,,,,
4374,104375,"Methanone, [4-[[4-(2-benzoxazolyl)phenyl]methoxy]-2-hydroxyphenyl]phenyl-",C1=CC=C(C=C1)C(=O)C2=C(C=C(C=C2)OCC3=CC=C(C=C3)C4=NC5=CC=CC=C5O4)O,,,,,,
4375,104376,(4-Pyridylthio)acetyl chloride,C1=CN=CC=C1SCC(=O)Cl,,,,,,
4376,104377,"3-(Bromomethyl)-1,2,4,5-tetrafluorobenzene",C1=C(C(=C(C(=C1F)F)CBr)F)F,,,,,,
4377,104378,"1-(2,6-Dimethylphenoxy)acetone",CC1=C(C(=CC=C1)C)OCC(=O)C,,,,,,
4378,104379,Ethyl 2-(chloromethyl)-3-furoate,CCOC(=O)C1=C(OC=C1)CCl,,,,,,
4379,104380,"Disodium;4-(7-methoxy-3,7-dimethyloctylidene)-3-methylpent-2-enedioate",CC(CCCC(C)(C)OC)CC=C(C(=CC(=O)[O-])C)C(=O)[O-].[Na+].[Na+],,,,,,
4380,104381,"4-(7-Methoxy-3,7-dimethyloctylidene)-3-methylpent-2-enedioic acid",CC(CCCC(C)(C)OC)CC=C(C(=CC(=O)O)C)C(=O)O,,,,,,
4381,104382,p-Nitrosopropiophenone,CCC(=O)C1=CC=C(C=C1)N=O,,,,,,
4382,104383,p-Methylaminopropiophenone,CCC(=O)C1=CC=C(C=C1)NC,,,,,,
4383,104384,"2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-(acetyloxy)-",CC(=O)OC1C(=O)NC(=O)NC1=O,,,,,,
4384,104385,Methyltintris(isooctyl 3-mercaptoproprionate),CC(C)CCCCCOC(=O)CCS[Sn](C)(SCCC(=O)OCCCCCC(C)C)SCCC(=O)OCCCCCC(C)C,,,,,,
4385,104386,Isooctyl 3-mercaptopropionate,CC(C)CCCCCOC(=O)CCS,,,,,,
4386,104387,Hexadec-11-en-7-ynyl acetate,CCCCC=CCCC#CCCCCCCOC(=O)C,,,,,,
4387,104388,"2,6-Dichloro-N,N-dimethylbenzamide",CN(C)C(=O)C1=C(C=CC=C1Cl)Cl,,,,,,
4388,104389,"Tetramethyl propane-1,2,2,3-tetracarboxylate",COC(=O)CC(CC(=O)OC)(C(=O)OC)C(=O)OC,,,,,,
4389,104390,"Hydrazinium, 1-(2-((4-((2,6-dichloro-4-nitrophenyl)azo)phenyl)ethylamino)ethyl)-1,1-dimethyl-, chloride",CCN(CC[N+](C)(C)N)C1=CC=C(C=C1)N=NC2=C(C=C(C=C2Cl)[N+](=O)[O-])Cl.[Cl-],,,,,,
4390,104391,"1-[2-[4-(2,6-Dichloro-4-nitrophenylazo)phenyl(ethyl)amino]ethyl]-1,1-dimethylhydrazinium",CCN(CC[N+](C)(C)N)C1=CC=C(C=C1)N=NC2=C(C=C(C=C2Cl)[N+](=O)[O-])Cl,,,,,,
4391,104392,3-Nitro-N-phenylsulphanilamide,C1=CC=C(C=C1)NS(=O)(=O)C2=CC(=C(C=C2)N)[N+](=O)[O-],,,,,,
4392,104393,"2,4,5-Trichlorophenyl N-(N-((1,1-dimethylethoxy)carbonyl)-L-alanyl)glycinate",C[C@@H](C(=O)NCC(=O)OC1=CC(=C(C=C1Cl)Cl)Cl)NC(=O)OC(C)(C)C,,,,,,
4393,104394,"Isoquinolinium, 2-(2-propenyl)-, bromide",C=CC[N+]1=CC2=CC=CC=C2C=C1.[Br-],,,,,,
4394,104395,2-Allylisoquinolinium,C=CC[N+]1=CC2=CC=CC=C2C=C1,,,,,,
4395,104396,"1,21-Docosadiene",C=CCCCCCCCCCCCCCCCCCCC=C,,,,,,
4396,104397,"Benzothiazolium, 5-chloro-2-methyl-3-(4-sulfobutyl)-, inner salt",CC1=[N+](C2=C(S1)C=CC(=C2)Cl)CCCCS(=O)(=O)[O-],,,,,,
4397,104398,"4-(5-Chloro-2-methyl-1,3-benzothiazol-3-ium-3-yl)butane-1-sulfonic acid",CC1=[N+](C2=C(S1)C=CC(=C2)Cl)CCCCS(=O)(=O)O,,,,,,
4398,104399,"14-(p-Isooctylphenoxy)-3,6,9,12-tetraoxatetradecan-1-ol",CC(C)CCCCCC1=CC=C(C=C1)OCCOCCOCCOCCOCCO,,,,,,
4399,104400,Isopropyl thiophene-3-acetate,CC(C)OC(=O)CC1=CSC=C1,,,,,,
4400,104401,Iodomethyl pivalate,CC(C)(C)C(=O)OCI,,,,,,
4401,104402,"Propanenitrile, 3,3'-((2-((2-cyanoethoxy)methyl)-2-ethyl-1,3-propanediyl)bis(oxy))bis-",CCC(COCCC#N)(COCCC#N)COCCC#N,,,,,,
4402,104403,"1-Pyrroline, 3,3-diphenyl-2-ethyl-",CCC1=NCCC1(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
4403,104404,"Pyridinium, 4-carbamoyl-1-(7-chloro-5-(2-chlorophenyl)-2,3-dihydro-2-oxo-1H-1,4-benzodiazepin-3-yl)-, chloride",C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)[N+]4=CC=C(C=C4)C(=O)N)Cl.[Cl-],,,,,,
4404,104405,"1-[7-Chloro-5-(2-chlorophenyl)-2-oxo-1,3-dihydro-1,4-benzodiazepin-3-yl]pyridin-1-ium-4-carboxamide",C1=CC=C(C(=C1)C2=NC(C(=O)NC3=C2C=C(C=C3)Cl)[N+]4=CC=C(C=C4)C(=O)N)Cl,,,,,,
4405,104406,Ethyl oxo(piperidin-1-YL)acetate,CCOC(=O)C(=O)N1CCCCC1,,,,,,
4406,104407,4-(2-(6-Methoxy-2-naphthyl)-1-thioxoethyl)morpholine,COC1=CC2=C(C=C1)C=C(C=C2)CC(=S)N3CCOCC3,,,,,,
4407,104408,Propyl 2-methylbut-2-enoate,CCCOC(=O)C(=CC)C,,,,,,
4408,104409,"2,2''-Dimethyl-p-terphenyl",CC1=CC=CC=C1C2=CC=C(C=C2)C3=CC=CC=C3C,,,,,,
4409,104410,"2,3,4,5,6-Pentabromostyrene",C=CC1=C(C(=C(C(=C1Br)Br)Br)Br)Br,,,,,,
4410,104411,Pentabromo(2-bromoethyl)benzene,C(CBr)C1=C(C(=C(C(=C1Br)Br)Br)Br)Br,,,,,,
4411,104412,Boc-pyr-OH,CC(C)(C)OC(=O)N1[C@@H](CCC1=O)C(=O)O,,,,,,
4412,104413,"2-Butanone, 4-[2,5-bis(acetyloxy)-3,4,6-trimethylphenyl]-",CC1=C(C(=C(C(=C1OC(=O)C)C)CCC(=O)C)OC(=O)C)C,,,,,,
4413,104414,N-(2-((4-((Dimethylamino)sulphonyl)-2-nitrophenyl)thio)phenyl)formamide,CN(C)S(=O)(=O)C1=CC(=C(C=C1)SC2=CC=CC=C2NC=O)[N+](=O)[O-],,,,,,
4414,104415,CID 104415,CC1=NN=C(N1NC2=CC=C(C=C2)S(=O)(=O)O)S,,,,,,
4415,104416,3-Propoxyprop-1-yne,CCCOCC#C,,,,,,
4416,104417,"1,3-Bis(2-methylpropoxy)propan-2-ol",CC(C)COCC(COCC(C)C)O,,,,,,
4417,104418,4-((4-Chloro-2-methylphenyl)azo)-N-(3-chlorophenyl)-3-hydroxynaphthalene-2-carboxamide,CC1=C(C=CC(=C1)Cl)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)NC4=CC(=CC=C4)Cl)O,,,,,,
4418,104419,1-Bromo-3-octene,CCCCC=CCCBr,,,,,,
4419,104420,Pentaerythritol monobehenate,CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(CO)(CO)CO,,,,,,
4420,104421,2-Ethoxy-6-methylpyrazine,CCOC1=NC(=CN=C1)C,,,,,,
4421,104422,Didocosylamine,CCCCCCCCCCCCCCCCCCCCCCNCCCCCCCCCCCCCCCCCCCCCC,,,,,,
4422,104423,1-(4-Hydroxy-3-methoxyphenyl)nonan-3-one,CCCCCCC(=O)CCC1=CC(=C(C=C1)O)OC,,,,,,
4423,104424,10-Undecenenitrile,C=CCCCCCCCCC#N,,,,,,
4424,104425,Nonyl propionate,CCCCCCCCCOC(=O)CC,,,,,,
4425,104426,"Phosphorous acid, (1-methylethylidene)di-4,1-phenylene tetrakis[(3-ethyl-3-oxetanyl)methyl] ester",CCC1(COC1)COP(OCC2(COC2)CC)OC3=CC=C(C=C3)C(C)(C)C4=CC=C(C=C4)OP(OCC5(COC5)CC)OCC6(COC6)CC,,,,,,
4426,104427,"Propanamide, 3-methoxy-N,N-dimethyl-",CN(C)C(=O)CCOC,,,,,,
4427,104428,Heptanedial,C(CCC=O)CCC=O,,,,,,
4428,104429,"1,3-Isobenzofurandione, 4-[4-[1-[4-[(1,3-dihydro-1,3-dioxo-5-isobenzofuranyl)oxy]phenyl]-1-methylethyl]phenoxy]-",CC(C)(C1=CC=C(C=C1)OC2=CC3=C(C=C2)C(=O)OC3=O)C4=CC=C(C=C4)OC5=CC=CC6=C5C(=O)OC6=O,,,,,,
4429,104430,n-[3-(Dimethylamino)propyl]propanamide,CCC(=O)NCCCN(C)C,,,,,,
4430,104431,N-(3-(Dimethylamino)propyl)butyramide,CCCC(=O)NCCCN(C)C,,,,,,
4431,104432,"3-(Dimethylamino)-1-(4-fluorophenyl)-2,2-dimethylpropan-1-one",CC(C)(CN(C)C)C(=O)C1=CC=C(C=C1)F,,,,,,
4432,104433,"1-(4-Chlorophenyl)-3-(dimethylamino)-2,2-dimethylpropan-1-one",CC(C)(CN(C)C)C(=O)C1=CC=C(C=C1)Cl,,,,,,
4433,104434,"2,2-Dimethyl-3-(dimethylamino)-4'-(methylthio)-propiophenone",CC(C)(CN(C)C)C(=O)C1=CC=C(C=C1)SC,,,,,,
4434,104435,"1-(4-Tert-butylphenyl)-3-(dimethylamino)-2,2-dimethylpropan-1-one",CC(C)(C)C1=CC=C(C=C1)C(=O)C(C)(C)CN(C)C,,,,,,
4435,104436,"2,4-Quinolinedione, 1,2,3,4-tetrahydro-7-chloro-1,3,3-trimethyl-",CC1(C(=O)C2=C(C=C(C=C2)Cl)N(C1=O)C)C,,,,,,
4436,104437,"2,4-Quinolinedione, 1,2,3,4-tetrahydro-7-methoxy-1,3,3-trimethyl-",CC1(C(=O)C2=C(C=C(C=C2)OC)N(C1=O)C)C,,,,,,
4437,104438,"7-Chloro-1,3,3-trimethyl-1,2,3,4-tetrahydro-4-quinolinone",CC1(CN(C2=C(C1=O)C=CC(=C2)Cl)C)C,,,,,,
4438,104439,"4-Quinolinone, 1,2,3,4-tetrahydro-7-methoxy-1,3,3-trimethyl-",CC1(CN(C2=C(C1=O)C=CC(=C2)OC)C)C,,,,,,
4439,104440,"Quinoline, 1,2,3,4-tetrahydro-1,3,3-trimethyl-",CC1(CC2=CC=CC=C2N(C1)C)C,,,,,,
4440,104441,N-Methyl-2-propylpentylamine hydrochloride,CCCC(CCC)CNC.Cl,,,,,,
4441,104442,N-methyl-2-propylpentan-1-amine,CCCC(CCC)CNC,,,,,,
4442,104443,N-Ethyl-2-propylpentylamine hydrochloride,CCCC(CCC)CNCC.Cl,,,,,,
4443,104444,N-ethyl-2-propylpentan-1-amine,CCCC(CCC)CNCC,,,,,,
4444,104445,"Pentane-1,5-diyl bis(3-bromopropionate)",C(CCOC(=O)CCBr)CCOC(=O)CCBr,,,,,,
4445,104446,Ditridecyl peroxydicarbonate,CCCCCCCCCCCCCOC(=O)OOC(=O)OCCCCCCCCCCCCC,,,,,,
4446,104447,Dimyristyl peroxydicarbonate,CCCCCCCCCCCCCCOC(=O)OOC(=O)OCCCCCCCCCCCCCC,,,,,,
4447,104448,3-Amino-2-methylphenol,CC1=C(C=CC=C1O)N,,,,,,
4448,104449,CID 104449,CCCC[SnH].CC(C)CCCCCSCCC(=O)O.CC(C)CCCCCSCCC(=O)O.CC(C)CCCCCSCCC(=O)O,,,,,,
4449,104450,3-(6-Methylheptylsulfanyl)propanoic acid,CC(C)CCCCCSCCC(=O)O,,,,,,
4450,104451,2-((4-Chlorophenyl)acetyl)benzoic acid,C1=CC=C(C(=C1)C(=O)CC2=CC=C(C=C2)Cl)C(=O)O,,,,,,
4451,104452,4-(4-chlorobenzyl)phthalazin-1(2H)-one,C1=CC=C2C(=C1)C(=NNC2=O)CC3=CC=C(C=C3)Cl,,,,,,
4452,104453,"2-Pentenenitrile, 3-methyl-5-phenyl-, (2Z)-",CC(=CC#N)CCC1=CC=CC=C1,,,,,,
4453,104454,Ethyl 2-amino-4-thiazoleacetate,CCOC(=O)CC1=CSC(=N1)N,,,,,,
4454,104455,"6-O-(2,3,4,6-Tetra-O-acetyl-beta-D-glucopyranosyl)-D-glucose 2,3,4,5-tetraacetate",CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)OC[C@H]([C@H]([C@@H]([C@H](C=O)OC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
4455,104456,"Methyl N,N-dibutyl-beta-alaninate",CCCCN(CCCC)CCC(=O)OC,,,,,,
4456,104457,"1,3-Dimethyl-5-(2-fluorophenyl)biuret",CNC(=O)N(C)C(=O)NC1=CC=CC=C1F,,,,,,
4457,104458,2-(Methylsulfonyl)ethyl carbonochloridate,CS(=O)(=O)CCOC(=O)Cl,,,,,,
4458,104459,2-(Methylsulphonyl)ethyl 4-nitrophenyl carbonate,CS(=O)(=O)CCOC(=O)OC1=CC=C(C=C1)[N+](=O)[O-],,,,,,
4459,104460,6-Nitrofluorescein diacetate,CC(=O)OC1=CC2=C(C=C1)C3(C4=C(O2)C=C(C=C4)OC(=O)C)C5=C(C=CC(=C5)[N+](=O)[O-])C(=O)O3,,,,,,
4460,104461,"7H-Benzimidazo[2,1-a]benzo[3,4][2]benzothiopyrano[7,8,1-def]isoquinolin-7-one",C1=CC=C2C(=C1)C3=C4C(=CC=C5C4=C(C=C3)C(=O)N6C5=NC7=CC=CC=C76)S2,,,,,,
4461,104462,"8H-benzimidazo[2,1-a]thioxantheno[2,1,9-def]isoquinolin-8-one",C1=CC=C2C(=C1)C3=C4C(=CC=C5C4=C(C=C3)C6=NC7=CC=CC=C7N6C5=O)S2,,,,,,
4462,104463,"4-[(e)-(4-Amino-2,6-dimethylphenyl)diazenyl]benzenesulfonicacid",CC1=CC(=CC(=C1N=NC2=CC=C(C=C2)S(=O)(=O)O)C)N,,,,,,
4463,104464,3-Amino-4-chlorobenzonitrile,C1=CC(=C(C=C1C#N)N)Cl,,,,,,
4464,104465,Isobutyl (2-hydroxyethyl)methylphosphinate,CC(C)COP(=O)(C)CCO,,,,,,
4465,104466,Methylvinylphosphinic acid,CP(=O)(C=C)O,,,,,,
4466,104467,"2-Methyl-1,2-oxaphospholane 2-oxide",CP1(=O)CCCO1,,,,,,
4467,104468,"3,4,5-Tribromo-2-thenoic acid",C1(=C(SC(=C1Br)Br)C(=O)O)Br,,,,,,
4468,104469,2-((4-Methoxybenzyl)amino)ethanol,COC1=CC=C(C=C1)CNCCO,,,,,,
4469,104470,2-((3-(Dimethylamino)propyl)amino)ethanol,CN(C)CCCNCCO,,,,,,
4470,104471,"1,3-Dioxepin, 4,7-dihydro-2-methyl-2-(3-methylbutyl)-",CC(C)CCC1(OCC=CCO1)C,,,,,,
4471,104472,"1,3-Dioxepin, 2-(1-ethylpropyl)-4,7-dihydro-",CCC(CC)C1OCC=CCO1,,,,,,
4472,104473,Decyl isooctyl phthalate,CCCCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCC(C)C,,,,,,
4473,104474,"Pyridinium, 3-(aminocarbonyl)-1-(4-morpholinylcarbonyl)-, chloride",C1COCCN1C(=O)[N+]2=CC=CC(=C2)C(=O)N.[Cl-],,,,,,
4474,104475,3-(Aminocarbonyl)-1-[(4-morpholinyl)carbonyl]pyridinium,C1COCCN1C(=O)[N+]2=CC=CC(=C2)C(=O)N,,,,,,
4475,104476,(-)-trans-Myrtanol,CC1([C@H]2CC[C@@H]([C@@H]1C2)CO)C,,,,,,
4476,104477,"N,N,2,2-Tetramethyl-1,3-propanediamine",CC(C)(CN)CN(C)C,,,,,,
4477,104478,Einecs 258-503-8,C[C@]1(CC[C@@H](C1(C)C)C(=O)O)C(=O)O.C1N2CN3CN1CN(C2)C3,,,,,,
4478,104479,"Benzenamine, 4,4'-[(phenylmethoxy)methylene]bis[N,N-dimethyl-",CN(C)C1=CC=C(C=C1)C(C2=CC=C(C=C2)N(C)C)OCC3=CC=CC=C3,,,,,,
4479,104480,Butyl 5-sulphamoyl-o-anisate,CCCCOC(=O)C1=C(C=CC(=C1)S(=O)(=O)N)OC,,,,,,
4480,104481,Sodium diisobutyl dithiophosphinate,CC(C)COP(=S)(OCC(C)C)[S-].[Na+],,,,,,
4481,104482,"Dimethyl 4,4'-(1,2-ethanediylbis(oxy))bis(3-chlorobenzoate)",COC(=O)C1=CC(=C(C=C1)OCCOC2=C(C=C(C=C2)C(=O)OC)Cl)Cl,,,,,,
4482,104483,Butoxychloromagnesium,CCCC[O-].[Mg+2].[Cl-],,,,,,
4483,104484,Hex-2-enyl formate,CCCC=CCOC=O,,,,,,
4484,104485,Hex-2-enyl butyrate,CCCC=CCOC(=O)CCC,,,,,,
4485,104486,"1,1-Diethoxyundecane",CCCCCCCCCCC(OCC)OCC,,,,,,
4486,104487,"1,1-Diethoxydodecane",CCCCCCCCCCCC(OCC)OCC,,,,,,
4487,104488,CID 104488,C1C(=NN(C1=O)C2=C(C=C(C=C2Cl)Cl)Cl)NC3=C(C=CC(=C3)N)Cl,,,,,,
4488,104489,"1-(2-Diethylaminoethyl)-3-phenyl-2,4(1H,3H)-quinazolinedione hydrochloride",CCN(CC)CCN1C2=CC=CC=C2C(=O)N(C1=O)C3=CC=CC=C3.Cl,,,,,,
4489,104490,"1-[2-(Diethylamino)ethyl]-3-phenylquinazoline-2,4-dione",CCN(CC)CCN1C2=CC=CC=C2C(=O)N(C1=O)C3=CC=CC=C3,,,,,,
4490,104491,"2,4(1H,3H)-Quinazolinedione, 1-(2-morpholinoethyl)-3-phenyl-, hydrochloride",C1COCCN1CCN2C3=CC=CC=C3C(=O)N(C2=O)C4=CC=CC=C4.Cl,,,,,,
4491,104492,"1-[2-(4-Morpholinyl)ethyl]-3-phenyl-2,4(1H,3H)-quinazolinedione",C1COCCN1CCN2C3=CC=CC=C3C(=O)N(C2=O)C4=CC=CC=C4,,,,,,
4492,104493,Diethylaminoethyl diphenylhydroxypropionate hydrochloride,CCN(CC)CCOC(=O)CC(C1=CC=CC=C1)(C2=CC=CC=C2)O.Cl,,,,,,
4493,104494,Diethylaminoethyl diphenylhydroxypropionate,CCN(CC)CCOC(=O)CC(C1=CC=CC=C1)(C2=CC=CC=C2)O,,,,,,
4494,104495,"1,6-Dihydro-2-hydroxy-1-methyl-6-oxonicotinonitrile",CN1C(=O)C=CC(=C1O)C#N,,,,,,
4495,104496,CID 104496,[Li+].CCCCCCC(CCCCCCCCCCC(=O)OC)[O-],,,,,,
4496,104497,ZINC bis(didodecylcarbamodithioate),CCCCCCCCCCCCN(CCCCCCCCCCCC)C(=S)[S-].CCCCCCCCCCCCN(CCCCCCCCCCCC)C(=S)[S-].[Zn+2],,,,,,
4497,104498,Didodecyldithiocarbamic acid,CCCCCCCCCCCCN(CCCCCCCCCCCC)C(=S)S,,,,,,
4498,104499,2-Ethyl-6-isopropylaniline,CCC1=C(C(=CC=C1)C(C)C)N,,,,,,
4499,104500,"N,N',N'',N'''-(1,1-Dimethyl-1-disilanyl-2-ylidyne)tetrabutylamine",CCCCN[Si](C)(C)[Si](NCCCC)(NCCCC)NCCCC,,,,,,
4500,104501,"1,4-Anhydro-D-xylitol",C1[C@@H]([C@H]([C@H](O1)CO)O)O,,,,,,
4501,104502,4-(2-Chloroethyl)benzyl chloride,C1=CC(=CC=C1CCCl)CCl,,,,,,
4502,104503,"5-((4-Chloro-6-(4-nonylphenoxy)-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-(phenylazo)naphthalene-2,7-disulphonic acid",CCCCCCCCCC1=CC=C(C=C1)OC2=NC(=NC(=N2)NC3=C4C(=CC(=C3)S(=O)(=O)O)C=C(C(=C4O)N=NC5=CC=CC=C5)S(=O)(=O)O)Cl,,,,,,
4503,104504,"1,1'-((6-(Pyridin-4-yl)-1,3,5-triazine-2,4-diyl)diimino)bisanthraquinone",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=CC=C3)NC4=NC(=NC(=N4)C5=CC=NC=C5)NC6=CC=CC7=C6C(=O)C8=CC=CC=C8C7=O,,,,,,
4504,104505,Oxydiethylene tetrakis(2-chloroethyl) bisphosphate,C(COP(=O)(OCCCl)OCCCl)OCCOP(=O)(OCCCl)OCCCl,,,,,,
4505,104506,"Bis((5-ethyl-1,3-dioxan-5-yl)methyl) thioperoxydicarbonate",CCC1(COCOC1)COC(=S)SSC(=S)OCC2(COCOC2)CC,,,,,,
4506,104507,10-Bromodecanol,C(CCCCCBr)CCCCO,,,,,,
4507,104508,"2,2-Bis(4-(2,3-dicarboxyphenoxy)phenyl)propane",CC(C)(C1=CC=C(C=C1)OC2=CC=CC(=C2C(=O)O)C(=O)O)C3=CC=C(C=C3)OC4=CC=CC(=C4C(=O)O)C(=O)O,,,,,,
4508,104509,"Benzenamine, N,N-dimethyl-4-((4-(methylamino)phenyl)methyl)-",CNC1=CC=C(C=C1)CC2=CC=C(C=C2)N(C)C,,,,,,
4509,104510,CID 104510,CCCCCCCCC=CC[C@@H](CCCCCC(=O)O)O.CCCC[SnH](CCCC)CCCC,,,,,,
4510,104511,CID 104511,CCCCCCCCC=CC[C@@H](CCCCCC(=O)O)O,,,,,,
4511,104512,"Acetaldehyde, (octyloxy)-",CCCCCCCCOCC=O,,,,,,
4512,104513,"2-Isobutyl-4,5-dimethylthiazole",CC1=C(SC(=N1)CC(C)C)C,,,,,,
4513,104514,"Propanenitrile, 3,3',3'',3'''-[(2,3,5,6-tetramethyl-1,4-phenylene)bis(methylenephosphinylidyne)]tetrakis-",CC1=C(C(=C(C(=C1CP(=O)(CCC#N)CCC#N)C)C)CP(=O)(CCC#N)CCC#N)C,,,,,,
4514,104515,"9H-Xanthene-3,6-diamine, N,N,N',N'-tetramethyl-",CN(C)C1=CC2=C(CC3=C(O2)C=C(C=C3)N(C)C)C=C1,,,,,,
4515,104516,"4-Hydroxy-1,5-naphthyridine-3-carboxylic acid",C1=CC2=C(C(=O)C(=CN2)C(=O)O)N=C1,,,,,,
4516,104517,"Succinimido (1,5-naphthyridin-3-yl)formate",C1CC(=O)N(C1=O)OC(=O)C2=CNC3=C(C2=O)N=CC=C3,,,,,,
4517,104518,CID 104518,C1=CC=C(C=C1)C(=O)N=C(NC2=CC=CC=C2O)S,,,,,,
4518,104519,CID 104519,CC1(C(=O)N(C(=N1)S)CC=C)C,,,,,,
4519,104520,"1-Propanaminium, N,N,N-trimethyl-3-[[(nonafluorobutyl)sulfonyl]amino]-, chloride",C[N+](C)(C)CCCNS(=O)(=O)C(C(C(C(F)(F)F)(F)F)(F)F)(F)F.[Cl-],,,,,,
4520,104521,3-(Nonafluorobutylsulfonylamino)propyltrimethylaminium,C[N+](C)(C)CCCNS(=O)(=O)C(C(C(C(F)(F)F)(F)F)(F)F)(F)F,,,,,,
4521,104522,"2H-1-Benzopyran-2-one, 7-(dimethylamino)-4-(trifluoromethyl)-",CN(C)C1=CC2=C(C=C1)C(=CC(=O)O2)C(F)(F)F,,,,,,
4522,104523,"2H-Pyrano[3,2-g]quinolin-2-one, 6,7,8,9-tetrahydro-9-methyl-4-(trifluoromethyl)-",CN1CCCC2=CC3=C(C=C21)OC(=O)C=C3C(F)(F)F,,,,,,
4523,104524,2-Amino-4-chloro-5-methylphenol,CC1=CC(=C(C=C1Cl)N)O,,,,,,
4524,104525,9-Anthryl trifluoromethyl ketone,C1=CC=C2C(=C1)C=C3C=CC=CC3=C2C(=O)C(F)(F)F,,,,,,
4525,104526,"4-Methyl-2,6-diphenylpyridine",CC1=CC(=NC(=C1)C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
4526,104527,"alpha-5,9-Dimethyl-9-hydroxy-2'-methoxy-2(N)-methyl-6,7-benzomorphan hydrochloride",C[C@]12CCN([C@H](C1(C)O)CC3=C2C=C(C=C3)OC)C.Cl,,,,,,
4527,104528,CID 104528,C[C@]12CCN(C(C1(C)O)CC3=C2C=C(C=C3)OC)C,,,,,,
4528,104529,2-[(3-Fluorophenyl)thio]-5-(trifluoromethyl)benzoic acid,C1=CC(=CC(=C1)SC2=C(C=C(C=C2)C(F)(F)F)C(=O)O)F,,,,,,
4529,104530,6-Fluoro-2-(trifluoromethyl)-9H-thioxanthen-9-one,C1=CC2=C(C=C1C(F)(F)F)C(=O)C3=C(S2)C=C(C=C3)F,,,,,,
4530,104531,"2-Cyclohexen-1-one, 3,5,5-trimethyl-2-(2-propenyl)-",CC1=C(C(=O)CC(C1)(C)C)CC=C,,,,,,
4531,104532,(R)-5-Oxotetrahydrofuran-2-carboxylic acid,C1CC(=O)O[C@H]1C(=O)O,,,,,,
4532,104533,"2-Furancarbonyl chloride, tetrahydro-5-oxo-, (2R)-",C1CC(=O)O[C@H]1C(=O)Cl,,,,,,
4533,104534,"tert-Butyl 2,2-dimethylperoxybutyrate",CCC(C)(C)C(=O)OOC(C)(C)C,,,,,,
4534,104535,"Zinc, (1-(2-amino-4-imino-5(4H)-thiazolylidene)-1H-isoindol-3-amine)dichloro-",C1=CC=C2C(=C1)C(=NC2=N)C3=C(N=C(S3)N)N.[Cl-].[Cl-].[Zn+2],,,,,,
4535,104536,Triethanolamine lauroyl glutamate,CCCCCCCCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)O.C(CO)N(CCO)CCO,,,,,,
4536,104537,"2,2-Dimethyldisilane-1,1,1,2-tetrayl tetraacetate",CC(=O)O[Si](C)(C)[Si](OC(=O)C)(OC(=O)C)OC(=O)C,,,,,,
4537,104538,"2,2,2-Trimethyldisilane-1,1,1-triyl triacetate",CC(=O)O[Si](OC(=O)C)(OC(=O)C)[Si](C)(C)C,,,,,,
4538,104539,(4Z)-4-(4-methylcyclohex-3-en-1-ylidene)pentanal,CC1=CCC(=C(C)CCC=O)CC1,,,,,,
4539,104540,O-Benzyl-L-tyrosine toluene-p-sulphonate,CC1=CC=C(C=C1)S(=O)(=O)O.C1=CC=C(C=C1)COC(=O)[C@H](CC2=CC=C(C=C2)O)N,,,,,,
4540,104541,(S)-Benzyl 2-amino-3-(4-hydroxyphenyl)propanoate,C1=CC=C(C=C1)COC(=O)[C@H](CC2=CC=C(C=C2)O)N,,,,,,
4541,104542,"1-(2',4'-Difluoro(1,1'-biphenyl)-4-yl)ethan-1-one",CC(=O)C1=CC=C(C=C1)C2=C(C=C(C=C2)F)F,,,,,,
4542,104543,"2-Bromo-4-fluoro-1,1'-biphenyl",C1=CC=C(C=C1)C2=C(C=C(C=C2)F)Br,,,,,,
4543,104544,Isodecyl hydrogen adipate,CC(C)CCCCCCCOC(=O)CCCCC(=O)O,,,,,,
4544,104545,(S)-5-[(4-Amino-4-carboxy-1-oxobutyl)amino]-2-nitrobenzoic acid,C1=CC(=C(C=C1NC(=O)CC[C@@H](C(=O)O)N)C(=O)O)[N+](=O)[O-],,,,,,
4545,104546,Triacetoxy(3-chloropropyl)silane,CC(=O)O[Si](CCCCl)(OC(=O)C)OC(=O)C,,,,,,
4546,104547,"Octadecanamide, N,N'-[1,2-ethanediylbis(imino-2,1-ethanediyl)]bis-",CCCCCCCCCCCCCCCCCC(=O)NCCNCCNCCNC(=O)CCCCCCCCCCCCCCCCC,,,,,,
4547,104548,Ammonium 2-(sulphonatooxy)ethyl methacrylate,CC(=C)C(=O)OCCOS(=O)(=O)O.N,,,,,,
4548,104549,"2-Propenoic acid, 2-methyl-, 2-(sulfooxy)ethyl ester",CC(=C)C(=O)OCCOS(=O)(=O)O,,,,,,
4549,104550,"Benzothiazolium, 5-chloro-2-methyl-3-(3-sulfobutyl)-, inner salt",CC1=[N+](C2=C(S1)C=CC(=C2)Cl)CCC(C)S(=O)(=O)[O-],,,,,,
4550,104551,"4-(5-Chloro-2-methyl-1,3-benzothiazol-3-ium-3-yl)butane-2-sulfonic acid",CC1=[N+](C2=C(S1)C=CC(=C2)Cl)CCC(C)S(=O)(=O)O,,,,,,
4551,104552,"2-Naphthalenamine, N-(1-methylethyl)-",CC(C)NC1=CC2=CC=CC=C2C=C1,,,,,,
4552,104553,"15,15-Dimethyl-2,5,8,11,14-pentaoxahexadecane",CC(C)(C)OCCOCCOCCOCCOC,,,,,,
4553,104554,CID 104554,CCOCCO.CCOCCO.CCOCCO.[AlH3],,,,,,
4554,104555,"1,3,5-Triazine-1,3,5(2H,4H,6H)-triethanol, compd. with bromine (1:1)",C.C1N(CN(CN1CCO)CCO)CCO,,,,,,
4555,104556,Grotan,C1N(CN(CN1CCO)CCO)CCO,,,,,,
4556,104557,"Methanaminium, N,N,N-trimethyl-, salt with 1-propene-1,1,2,3,3-pentacarbonitrile (1:1)",C[N+](C)(C)C.C(=C(C#N)C(=C(C#N)C#N)C#N)=[N-],,,,,,
4557,104558,CID 104558,C(=C(C#N)C(=C(C#N)C#N)C#N)=N,,,,,,
4558,104559,Methyl 11-(dichloromethylsilyl)undecanoate,COC(=O)CCCCCCCCCC[Si](C)(Cl)Cl,,,,,,
4559,104560,N-(2-Aminoethyl)-2-anisamide,COC1=CC=CC=C1C(=O)NCCN,,,,,,
4560,104561,"2,5-Dichlorophenyl dichlorophosphate",C1=CC(=C(C=C1Cl)OP(=O)(Cl)Cl)Cl,,,,,,
4561,104562,6-Amino-1-propyluracil,CCCN1C(=CC(=O)NC1=O)N,,,,,,
4562,104563,"Uracil, 6-amino-3-methyl-1-propyl-",CCCN1C(=CC(=O)N(C1=O)C)N,,,,,,
4563,104564,2-(N-Ethyl-4-formylanilino)ethyl benzoate,CCN(CCOC(=O)C1=CC=CC=C1)C2=CC=C(C=C2)C=O,,,,,,
4564,104565,"5-Acenaphthylenesulfonic acid, 1,2-dihydro-",C1CC2=CC=C(C3=CC=CC1=C23)S(=O)(=O)O,,,,,,
4565,104566,"2,2'-(Sulphonylbis((2,6-dibromo-4,1-phenylene)oxy))bisethanol",C1=C(C=C(C(=C1Br)OCCO)Br)S(=O)(=O)C2=CC(=C(C(=C2)Br)OCCO)Br,,,,,,
4566,104567,"1,1,3,3-Tetramethylindan-5-ol",CC1(CC(C2=C1C=CC(=C2)O)(C)C)C,,,,,,
4567,104568,"6-(tert-Butyl)-1,1,3,3-tetramethylindan-5-ol",CC1(CC(C2=CC(=C(C=C21)C(C)(C)C)O)(C)C)C,,,,,,
4568,104569,"1,1,3,3,6-Pentamethylindan-4-ol",CC1=CC2=C(C(=C1)O)C(CC2(C)C)(C)C,,,,,,
4569,104570,"1,1,3,3,7-Pentamethylindan-5-ol",CC1=CC(=CC2=C1C(CC2(C)C)(C)C)O,,,,,,
4570,104571,"1-Ethyl-1,3,3-trimethylindan-5-ol",CCC1(CC(C2=C1C=CC(=C2)O)(C)C)C,,,,,,
4571,104572,"2',3'-Dihydro-3',3'-dimethylspiro(cyclohexane-1,1'-(1H)indene)-5'-ol",CC1(CC2(CCCCC2)C3=C1C=C(C=C3)O)C,,,,,,
4572,104573,"6'-(tert-Butyl)-2',3'-dihydro-3',3'-dimethylspiro(cyclohexane-1,1'-(1H)indene)-5'-ol",CC1(CC2(CCCCC2)C3=CC(=C(C=C31)O)C(C)(C)C)C,,,,,,
4573,104574,"6-Chloro-1,1,3,3-tetramethylindan-5-ol",CC1(CC(C2=CC(=C(C=C21)O)Cl)(C)C)C,,,,,,
4574,104575,"1,2,3,6,7,8-Hexahydro-1,1,3,3,6,6,8,8-octamethyl-as-indacen-4-ol",CC1(CC(C2=C3C(=C(C=C21)O)C(CC3(C)C)(C)C)(C)C)C,,,,,,
4575,104576,CID 104576,C(C(=O)O)SC1=NN=C(S1)S,,,,,,
4576,104577,"1-(N,N-Diethylglycyl)-2,2,5,5-tetramethylpyrrolidine",CCN(CC)C(=O)CN1C(CCC1(C)C)(C)C,,,,,,
4577,104578,"1-(N,N-Diethylglycyl)-2,2,5,5-tetramethyl-3-pyrroline",CCN(CC)C(=O)CN1C(C=CC1(C)C)(C)C,,,,,,
4578,104579,"Piperidine, 1-(N,N-diethylglycyl)-2,2,6,6-tetramethyl-",CCN(CC)C(=O)CN1C(CCCC1(C)C)(C)C,,,,,,
4579,104580,"1-(N-(2-Furylmethyl)glycyl)-2,2,6,6-tetramethylpiperidine",CC1(CCCC(N1CC(=O)NCC2=CC=CO2)(C)C)C,,,,,,
4580,104581,"1-(N-Benzylglycyl)-2,2,6,6-tetramethylpiperidine",CC1(CCCC(N1C(=O)CNCC2=CC=CC=C2)(C)C)C,,,,,,
4581,104582,"Piperidine, 1-(N-benzyl-N-methylglycyl)-2,2,6,6-tetramethyl-",CC1(CCCC(N1C(=O)CN(C)CC2=CC=CC=C2)(C)C)C,,,,,,
4582,104583,"Pyridine, 1,2,3,6-tetrahydro-1-(N,N-diethylglycyl)-2,2,6,6-tetramethyl-",CCN(CC)CC(=O)N1C(CC=CC1(C)C)(C)C,,,,,,
4583,104584,"Pyridine, 4-butyl-1-(N,N-diethylglycyl)-1,2,3,6-tetrahydro-2,2,6,6-tetramethyl-",CCCCC1=CC(N(C(C1)(C)C)C(=O)CN(CC)CC)(C)C,,,,,,
4584,104585,"Pyridine, 1,2,3,6-tetrahydro-4-butyl-1-((1-pyrrolidinyl)acetyl)-2,2,6,6-tetramethyl-",CCCCC1=CC(N(C(C1)(C)C)C(=O)CN2CCCC2)(C)C,,,,,,
4585,104586,"Pyridine, 4-butyl-1-(piperidinoacetyl)-1,2,3,6-tetrahydro-2,2,6,6-tetramethyl-",CCCCC1=CC(N(C(C1)(C)C)C(=O)CN2CCCCC2)(C)C,,,,,,
4586,104587,"Pyridine, 1,2,3,6-tetrahydro-4-butyl-1-((hexahydro-1H-azepinyl)acetyl)-2,2,6,6-tetramethyl-",CCCCC1=CC(N(C(C1)(C)C)C(=O)CN2CCCCCC2)(C)C,,,,,,
4587,104588,"Pyridine, 1,2,3,6-tetrahydro-1-(N-benzyl-N-methylglycyl)-4-butyl-2,2,6,6-tetramethyl-",CCCCC1=CC(N(C(C1)(C)C)C(=O)CN(C)CC2=CC=CC=C2)(C)C,,,,,,
4588,104589,"Pyridine, 1,2,3,6-tetrahydro-1-(N,N-dimethylglycyl)-4-phenyl-2,2,6,6-tetramethyl-",CC1(CC(=CC(N1C(=O)CN(C)C)(C)C)C2=CC=CC=C2)C,,,,,,
4589,104590,"Pyridine, 1,2,3,6-tetrahydro-1-(N,N-diethylglycyl)-4-phenyl-2,2,6,6-tetramethyl-",CCN(CC)CC(=O)N1C(CC(=CC1(C)C)C2=CC=CC=C2)(C)C,,,,,,
4590,104591,"Pyridine, 1,2,3,6-tetrahydro-1-(N-butylglycyl)-4-phenyl-2,2,6,6-tetramethyl-",CCCCNCC(=O)N1C(CC(=CC1(C)C)C2=CC=CC=C2)(C)C,,,,,,
4591,104592,"Pyridine, 1,2,3,6-tetrahydro-1-(morpholinoacetyl)-4-phenyl-2,2,6,6-tetramethyl-",CC1(CC(=CC(N1C(=O)CN2CCOCC2)(C)C)C3=CC=CC=C3)C,,,,,,
4592,104593,"Pyridine, 1,2,3,6-tetrahydro-1-((4-methyl-1-piperazinyl)acetyl)-4-phenyl-2,2,6,6-tetramethyl-",CC1(CC(=CC(N1C(=O)CN2CCN(CC2)C)(C)C)C3=CC=CC=C3)C,,,,,,
4593,104594,"beta-Alanine, N-(3-methoxy-3-oxopropyl)-N-phenyl-, methyl ester",COC(=O)CCN(CCC(=O)OC)C1=CC=CC=C1,,,,,,
4594,104595,"[4-Chloro-6-(ethylamino)-1,3,5-triazin-2-yl]cyanamide",CCNC1=NC(=NC(=N1)Cl)NC#N,,,,,,
4595,104596,"Ethanol, 2-(2-(2-(2-(methylphenoxy)ethoxy)ethoxy)ethoxy)-",CC1=CC=C(C=C1)OCCOCCOCCOCCO,,,,,,
4596,104597,CID 104597,CCC(=CC(=O)CC)[O-].CCC(=CC(=O)CC)[O-].CCC(=CC(=O)CC)[O-].[Cr+3],,,,,,
4597,104598,Veratryl acetate,CC(=O)OCC1=CC(=C(C=C1)OC)OC,,,,,,
4598,104599,"4,4'-Diaminodiphenylamine Sulfate",C1=CC(=CC=C1N)NC2=CC=C(C=C2)N.OS(=O)(=O)O,,,,,,
4599,104600,5-Butyryloxy-5-(1-phenylethyl)barbituric acid,CCCC(=O)OC1(C(=O)NC(=O)NC1=O)CCC2=CC=CC=C2,,,,,,
4600,104601,5-Cyclopropylcarbonyloxy-5-(1-phenylethyl)barbituric acid,C1CC1C(=O)OC2(C(=O)NC(=O)NC2=O)CCC3=CC=CC=C3,,,,,,
4601,104602,"2(1H)-Quinolinone, 1-ethyl-6-methyl-",CCN1C2=C(C=CC1=O)C=C(C=C2)C,,,,,,
4602,104603,"2(1H)-Quinolinone, 1-ethyl-",CCN1C(=O)C=CC2=CC=CC=C21,,,,,,
4603,104604,"Piperidine, 1-((4-methyl-1-piperazinyl)acetyl)-2,2,6,6-tetramethyl-",CC1(CCCC(N1C(=O)CN2CCN(CC2)C)(C)C)C,,,,,,
4604,104605,"N-(5-Amino-2,4-dimethylphenyl)acetamide",CC1=CC(=C(C=C1N)NC(=O)C)C,,,,,,
4605,104606,"3-Chloro-4,5-difluoronitrobenzene",C1=C(C=C(C(=C1F)F)Cl)[N+](=O)[O-],,,,,,
4606,104607,5-Chloro-1-(piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one,C1CNCCC1N2C3=C(C=C(C=C3)Cl)NC2=O,,,,,['5-Chloro-1-(piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one is a known human metabolite of domperidone.'],
4607,104608,Ethyl 4-((4-chloro-2-nitrophenyl)amino)piperidine-1-carboxylate,CCOC(=O)N1CCC(CC1)NC2=C(C=C(C=C2)Cl)[N+](=O)[O-],,,,,,
4608,104609,Ethyl 4-((2-amino-4-chlorophenyl)amino)piperidine-1-carboxylate,CCOC(=O)N1CCC(CC1)NC2=C(C=C(C=C2)Cl)N,,,,,,
4609,104610,"Ethyl 4-(5-chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)piperidine-1-carboxylate",CCOC(=O)N1CCC(CC1)N2C3=C(C=C(C=C3)Cl)NC2=O,,,,,,
4610,104611,"Ethyl 4-(2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)piperidine-1-carboxylate",CCOC(=O)N1CCC(CC1)N2C3=CC=CC=C3NC2=O,,,,,,
4611,104612,"3-Amino-2,1-benzisothiazole-5-sulphonic acid",C1=CC2=NSC(=C2C=C1S(=O)(=O)O)N,,,,,,
4612,104613,2-[2-(1-Naphthylamino)ethoxy]ethanol,C1=CC=C2C(=C1)C=CC=C2NCCOCCO,,,,,,
4613,104614,"1H-1,2,3-Triazole-4,5-dicarbonitrile",C(#N)C1=NNN=C1C#N,,,,,,
4614,104615,N-Butyl-N-(2-chloroethyl)aniline,CCCCN(CCCl)C1=CC=CC=C1,,,,,,
4615,104616,"2-Butenedioic acid (2Z)-, diisononyl ester",CC(C)CCCCCCOC(=O)C=CC(=O)OCCCCCCC(C)C,,,,,,
4616,104617,CID 104617,C=C(C(=O)[O-])OP(=O)(O)O.[Na+],,,,,,
4617,104618,Fructose 1-(barium phosphate),C([C@H]([C@H]([C@@H](C(=O)COP(=O)([O-])[O-])O)O)O)O.[Ba+2],,,,,,
4618,104619,CID 104619,C([C@@H]1[C@H]([C@@H]([C@H]([C@H](O1)OP(=O)(O)[O-])O)O)O)O.[K+],,,,,,
4619,104620,"4,5-Dimethyl-2-propyloxazole",CCCC1=NC(=C(O1)C)C,,,,,,
4620,104621,"Phosphoric acid, monododecyl monotetradecyl ester",CCCCCCCCCCCCCCOP(=O)(O)OCCCCCCCCCCCC,,,,,,
4621,104622,But-2-enedioic acid;2-[2-[2-[4-[[4-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]ethoxy]ethoxy]ethanol,C1CN(CCN1CCOCCOCCO)CC2=CC=C(C=C2)C3=CC=C(C=C3)Cl.C(=CC(=O)O)C(=O)O,,,,,,
4622,104623,2-[2-[2-[4-[[4-(4-Chlorophenyl)phenyl]methyl]piperazin-1-yl]ethoxy]ethoxy]ethanol,C1CN(CCN1CCOCCOCCO)CC2=CC=C(C=C2)C3=CC=C(C=C3)Cl,,,,,,
4623,104624,CID 104624,CCCSC(=NCC)S,,,,,,
4624,104625,gamma-Carboxyglutamic acid,C([C@@H](C(=O)O)N)C(C(=O)O)C(=O)O,,,,,,
4625,104626,Methylbis[(2-methylbut-3-YN-2-YL)oxy]phenylsilane,CC(C)(C#C)O[Si](C)(C1=CC=CC=C1)OC(C)(C)C#C,,,,,,
4626,104627,"Ethyl 3-oxopregna-4,6-diene-21,17alpha-carbolactone-21-carboxylate",CCOC(=O)C1C[C@@]2(CC[C@@H]3[C@@]2(CC[C@H]4[C@H]3C=CC5=CC(=O)CC[C@]45C)C)OC1=O,,,,,,
4627,104628,"Ethyl hydrogen 7alpha-(acetylthio)-17alpha-hydroxy-3-oxopregn-4-ene-21,21-dicarboxylate gamma-lactone",CCOC(=O)C1C[C@@]2(CC[C@@H]3[C@@]2(CC[C@H]4[C@H]3C(CC5=CC(=O)CC[C@]45C)SC(=O)C)C)OC1=O,,,,,,
4628,104629,"6,7-Dihydro-6-phenethyl-5H-dibenz(c,e)azepine",C1C2=CC=CC=C2C3=CC=CC=C3CN1CCC4=CC=CC=C4,,,,,,
4629,104630,1-(Dibromomethyl)-3-phenoxybenzene,C1=CC=C(C=C1)OC2=CC=CC(=C2)C(Br)Br,,,,,,
4630,104631,1-(Dichloromethyl)-3-phenoxybenzene,C1=CC=C(C=C1)OC2=CC=CC(=C2)C(Cl)Cl,,,,,,
4631,104632,CID 104632,CC1=CC=C(C=C1)N=C(S)SSC(=NC2=CC=C(C=C2)C)S,,,,,,
4632,104633,"21-Diazopregn-4-ene-3,20-dione",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)C=[N+]=[N-])CCC4=CC(=O)CC[C@]34C,,,,,,
4633,104634,CID 104634,C[C@]12CCC3[C@H]([C@@H]1CCC2C(=C[N+]#N)O)CCC4=CC(=O)CC[C@]34C,,,,,,
4634,104635,Triisononyl trimellitate,CC(C)CCCCCCOC(=O)C1=CC(=C(C=C1)C(=O)OCCCCCCC(C)C)C(=O)OCCCCCCC(C)C,,,,,,
4635,104636,"1H-Pyrrole-2,5-dione, 1-(4-(naphthalenylamino)phenyl)-",C1=CC=C2C(=C1)C=CC=C2C3=C(C=C(C=C3)N4C(=O)C=CC4=O)N,,,,,,
4636,104637,Palladium diamino dichloride,N.N.[Cl-].[Cl-].[Pd],,,,,,
4637,104638,3-Phenyl-4-propylpyridine,CCCC1=C(C=NC=C1)C2=CC=CC=C2,,,,,,
4638,104639,"4-(4-Chlorophenyl)dihydro-2H-pyran-2,6(3H)-dione",C1C(CC(=O)OC1=O)C2=CC=C(C=C2)Cl,,,,,,
4639,104640,"3,6,9,12,15-Pentaoxabicyclo(15.3.1)henicosa-1(21),17,19-triene",C1COCCOCC2=CC(=CC=C2)COCCOCCO1,,,,,,
4640,104641,"2,7-Bis(1,1,3,3-tetramethylbutyl)-10H-phenothiazine",CC(C)(C)CC(C)(C)C1=CC2=C(C=C1)SC3=C(N2)C=CC(=C3)C(C)(C)CC(C)(C)C,,,,,,
4641,104642,CID 104642,C1=CC2=C(C=C1S(=O)(=O)[O-])NC(=N2)S.[Na+],,,,,,
4642,104643,CID 104643,C1=CC2=C(C=C1S(=O)(=O)O)NC(=N2)S,,,,,,
4643,104644,7-Chloro-1H-indole,C1=CC2=C(C(=C1)Cl)NC=C2,,,,,,
4644,104645,"Bis(2,6-dimethylheptan-4-yl) but-2-enedioate",CC(C)CC(CC(C)C)OC(=O)C=CC(=O)OC(CC(C)C)CC(C)C,,,,,,
4645,104646,"3,5,6-tri-O-.benzyl-1,2-O-isopropylidene-alpha-D-glucofuranose",CC1(O[C@@H]2[C@H]([C@H](O[C@@H]2O1)[C@@H](COCC3=CC=CC=C3)OCC4=CC=CC=C4)OCC5=CC=CC=C5)C,,,,,,
4646,104647,"1H-Cyclopent(b)anthracene-5,10-dione, 2,3-dihydro-",C1CC2=CC3=C(C=C2C1)C(=O)C4=CC=CC=C4C3=O,,,,,,
4647,104648,CID 104648,[B+3].C1CCN(C1)C2=C(C=C(C=C2)[N+]#N)Cl.[F-].[F-].[F-].[F-],,,,,,
4648,104649,3-Chloro-4-(1-pyrrolidinyl)benzenediazonium,C1CCN(C1)C2=C(C=C(C=C2)[N+]#N)Cl,,,,,,
4649,104650,"beta-Alanine, N-(3-ethoxy-3-oxopropyl)-N-(3-hydroxypropyl)-, ethyl ester",CCOC(=O)CCN(CCCO)CCC(=O)OCC,,,,,,
4650,104651,"beta-Alanine, N-(3-chloropropyl)-N-(3-ethoxy-3-oxopropyl)-, ethyl ester",CCOC(=O)CCN(CCCCl)CCC(=O)OCC,,,,,,
4651,104652,"2,3,5-Trichloro-4-methylpyridine",CC1=C(C(=NC=C1Cl)Cl)Cl,,,,,,
4652,104653,Phenethyl 4-oxovalerate,CC(=O)CCC(=O)OCCC1=CC=CC=C1,,,,,,
4653,104654,Euparone,CC(=O)C1=CC2=CC(=C(C=C2O1)O)C(=O)C,,,,,,
4654,104655,"Acetamide, N-[2-[(2-bromo-4,6-dinitrophenyl)azo]-4-methoxy-5-(methylamino)phenyl]-",CC(=O)NC1=CC(=C(C=C1N=NC2=C(C=C(C=C2Br)[N+](=O)[O-])[N+](=O)[O-])OC)NC,,,,,,
4655,104656,"Acetamide, N-[2-[(2-bromo-4,6-dinitrophenyl)azo]-5-[(2-cyanoethyl)amino]-4-methoxyphenyl]-",CC(=O)NC1=CC(=C(C=C1N=NC2=C(C=C(C=C2Br)[N+](=O)[O-])[N+](=O)[O-])OC)NCCC#N,,,,,,
4656,104657,CID 104657,CCCCCCCCCCCCCCCC(=O)OCC=C(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C,,,,,,
4657,104658,"4-(2,4-Dimethoxybenzoyl)morpholine",COC1=CC(=C(C=C1)C(=O)N2CCOCC2)OC,,,,,,
4658,104659,(3-Ethylphenyl)methanol,CCC1=CC(=CC=C1)CO,,,,,,
4659,104660,"1,5-Decadiyne",CCCCC#CCCC#C,,,,,,
4660,104661,Dec-5-en-1-yne,CCCCC=CCCC#C,,,,,,
4661,104662,"1H-Imidazole-4-ethanamine, N,5-dimethyl-",CC1=C(N=CN1)CCNC,,,,,,
4662,104663,"4,6-Bis(allyloxy)-N-butyl-1,3,5-triazin-2-amine",CCCCNC1=NC(=NC(=N1)OCC=C)OCC=C,,,,,,
4663,104664,CID 104664,CC(=O)N=C1C=CC(=CC1=N)N(O)O,,,,,,
4664,104665,"1,3-Didecanoylglycerol",CCCCCCCCCC(=O)OCC(COC(=O)CCCCCCCCC)O,,,,,,
4665,104666,"Tetradecanamide, N-[2-[(2-hydroxyethyl)amino]ethyl]-",CCCCCCCCCCCCCC(=O)NCCNCCO,,,,,,
4666,104667,"Androst-5-ene-3-beta,17-alpha-diol di(acetate)",CC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC[C@H]4OC(=O)C)C)C,,,,,,
4667,104668,"1,3-Benzenedicarboxylic acid, 5-phenoxy-, dimethyl ester",COC(=O)C1=CC(=CC(=C1)OC2=CC=CC=C2)C(=O)OC,,,,,,
4668,104669,7-Methylisoquinoline,CC1=CC2=C(C=C1)C=CN=C2,,,,,,
4669,104670,CID 104670,C([C@H]([C@H]([C@@H]([C@H](C=O)O)O)O)O)OP(=O)(O)[O-].[Na+],,,,,,
4670,104671,Zinc trifluoromethanesulfonate,C(F)(F)(F)S(=O)(=O)[O-].C(F)(F)(F)S(=O)(=O)[O-].[Zn+2],,,,,,
4671,104672,"1,2,3,4-Tetrahydroquinolin-8-amine",C1CC2=C(C(=CC=C2)N)NC1,,,,,,
4672,104673,5-Chloro-2-(1H-tetrazol-5-yl)aniline,C1=CC(=C(C=C1Cl)N)C2=NNN=N2,,,,,,
4673,104674,(4-Butoxyphenoxy)acetyl chloride,CCCCOC1=CC=C(C=C1)OCC(=O)Cl,,,,,,
4674,104675,"2-Naphthalenesulfonamide, 6,7-dihydroxy-",C1=CC(=CC2=CC(=C(C=C21)O)O)S(=O)(=O)N,,,,,,
4675,104676,3-Hydroxy-N-(3-hydroxyphenyl)naphthalene-2-carboxamide,C1=CC=C2C=C(C(=CC2=C1)C(=O)NC3=CC(=CC=C3)O)O,,,,,,
4676,104677,2-Nitro-4-thiocyanatoaniline,C1=CC(=C(C=C1SC#N)[N+](=O)[O-])N,,,,,,
4677,104678,6-Amino-1-isobutyl-3-methyl-5-nitrosouracil,CC(C)CN1C(=C(C(=O)N(C1=O)C)N=O)N,,,,,,
4678,104679,Butyl 3-methyl-2-butenoate,CCCCOC(=O)C=C(C)C,,,,,,
4679,104680,"Octane, 6-chloro-2,6-dimethyl-",CCC(C)(CCCC(C)C)Cl,,,,,,
4680,104681,"N-(3-(Isononyloxy)propyl)propane-1,3-diamine",CC(C)CCCCCCOCCCNCCCN,,,,,,
4681,104682,3-Ethynylaniline,C#CC1=CC(=CC=C1)N,,,,,,
4682,104683,"1,3-Bis(3-nitrophenoxy)benzene",C1=CC(=CC(=C1)OC2=CC(=CC=C2)OC3=CC=CC(=C3)[N+](=O)[O-])[N+](=O)[O-],,,,,,
4683,104684,"Carbonic acid, (1-methylethylidene)bis(2,6-dibromo-4,1-phenylene) bis(2,4,6-tribromophenyl) ester",CC(C)(C1=CC(=C(C(=C1)Br)OC(=O)OC2=C(C=C(C=C2Br)Br)Br)Br)C3=CC(=C(C(=C3)Br)OC(=O)OC4=C(C=C(C=C4Br)Br)Br)Br,,,,,,
4684,104685,Tris(4-dodecylphenyl) phosphite,CCCCCCCCCCCCC1=CC=C(C=C1)OP(OC2=CC=C(C=C2)CCCCCCCCCCCC)OC3=CC=C(C=C3)CCCCCCCCCCCC,,,,,,
4685,104686,"5,9,14,18-Anthrazinetetrol, 7,16-dichloro-6,15-dihydro-, tetrakis(hydrogen sulfate) (ester), tetrapotassium salt",C1=CC=C2C(=C1)C(=C3C=C(C4=C(C3=C2OS(=O)(=O)[O-])NC5=C(N4)C6=C(C7=CC=CC=C7C(=C6C=C5Cl)OS(=O)(=O)[O-])OS(=O)(=O)[O-])Cl)OS(=O)(=O)[O-].[K+].[K+].[K+].[K+],,,,,,
4686,104687,[[4-[[2-(4-Cyclohexylphenoxy)ethyl]ethylamino]-2-methylphenyl]methylene]malononitrile,CCN(CCOC1=CC=C(C=C1)C2CCCCC2)C3=CC(=C(C=C3)C=C(C#N)C#N)C,,,,,,
4687,104688,((4-((2-(2-Cyclohexylphenoxy)ethyl)ethylamino)-2-methylphenyl)methylene)malononitrile,CCN(CCOC1=CC=CC=C1C2CCCCC2)C3=CC(=C(C=C3)C=C(C#N)C#N)C,,,,,,
4688,104689,2-Nitro-p-toluenesulphonyl chloride,CC1=CC(=C(C=C1)S(=O)(=O)Cl)[N+](=O)[O-],,,,,,
4689,104690,"(4-Chlorophenyl) (4-hydroxy-3,5-dimethoxyphenyl) ketone",COC1=CC(=CC(=C1O)OC)C(=O)C2=CC=C(C=C2)Cl,,,,,,
4690,104691,"Cyclopent-1-ene-1,2-dicarbonitrile",C1CC(=C(C1)C#N)C#N,,,,,,
4691,104692,CID 104692,C1=CC(=CC(=C1)S(=O)(=O)[O-])C=O.[K+],,,,,,
4692,104693,3-Formylbenzenesulfonic acid,C1=CC(=CC(=C1)S(=O)(=O)O)C=O,,,,,,
4693,104694,"1H-Azepine-1-carboxamide, N,N'-(methylenedi-4,1-phenylene)bis[hexahydro-2-oxo-",C1CCC(=O)N(CC1)C(=O)NC2=CC=C(C=C2)CC3=CC=C(C=C3)NC(=O)N4CCCCCC4=O,,,,,,
4694,104695,"Ethanol, 2-((2-(bis(phenylmethyl)amino)ethyl)amino)-",C1=CC=C(C=C1)CN(CCNCCO)CC2=CC=CC=C2,,,,,,
4695,104696,"Ethanol, 2-((2-(bis(phenylmethyl)amino)ethyl)(phenylmethyl)amino)-",C1=CC=C(C=C1)CN(CCN(CC2=CC=CC=C2)CC3=CC=CC=C3)CCO,,,,,,
4696,104697,"Ethanol, 2-((2-((phenylmethyl)amino)ethyl)amino)-",C1=CC=C(C=C1)CNCCNCCO,,,,,,
4697,104698,CID 104698,CC(=O)O[C@@H]1CO[C@H]([C@@H]([C@@H]1OC(=O)C)OC(=O)C)NC(=O)N(CCl)N=O,,,,,,
4698,104699,"1,3,5-Triazine-2,4-disulfenamide, 6-(diethylamino)-N,N,N',N'-tetraethyl-",CCN(CC)C1=NC(=NC(=N1)SN(CC)CC)SN(CC)CC,,,,,,
4699,104700,2-Bromo-4-phenylpyridine,C1=CC=C(C=C1)C2=CC(=NC=C2)Br,,,,,,
4700,104701,"2-Naphthalenecarboxamide, 4-[[(3-aminophenyl)sulfonyl]amino]-N-[4-[2,4-bis(1,1-dimethylpropyl)phenoxy]butyl]-1-hydroxy-",CCC(C)(C)C1=CC(=C(C=C1)OCCCCNC(=O)C2=C(C3=CC=CC=C3C(=C2)NS(=O)(=O)C4=CC=CC(=C4)N)O)C(C)(C)CC,,,,,,
4701,104702,"2-Naphthalenecarboxamide, 4-[[(4-aminophenyl)sulfonyl]amino]-N-[4-[2,4-bis(1,1-dimethylpropyl)phenoxy]butyl]-1-hydroxy-",CCC(C)(C)C1=CC(=C(C=C1)OCCCCNC(=O)C2=C(C3=CC=CC=C3C(=C2)NS(=O)(=O)C4=CC=C(C=C4)N)O)C(C)(C)CC,,,,,,
4702,104703,"Benzenesulfonamide, N-(5-hydroxy-1-naphthalenyl)-4-methyl-",CC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC3=C2C=CC=C3O,,,,,,
4703,104704,"Methanesulfonamide, N-(5-hydroxy-1-naphthalenyl)-",CS(=O)(=O)NC1=CC=CC2=C1C=CC=C2O,,,,,,
4704,104705,CID 104705,CS(=O)(=O)C1=C(C=CC(=C1)N(O)O)N=NC2=C3C(=NS(=O)(=O)C4=CC(=CC=C4)S(=O)(=O)F)C=CC=C3C(=O)C=C2,,,,,,
4705,104706,"1,3,5-Triazine, 2,4,6-tris(pentabromophenoxy)-",C1(=C(C(=C(C(=C1Br)Br)Br)Br)Br)OC2=NC(=NC(=N2)OC3=C(C(=C(C(=C3Br)Br)Br)Br)Br)OC4=C(C(=C(C(=C4Br)Br)Br)Br)Br,,,,,,
4706,104707,"[1,1':4',1''-Terphenyl]-4-carbonitrile, 4''-pentyl-",CCCCCC1=CC=C(C=C1)C2=CC=C(C=C2)C3=CC=C(C=C3)C#N,,,,,,
4707,104708,"Nicotinamide, N-(alpha,alpha-difluoro-p-tolyl)-, hydrochloride",C1=CC(=CN=C1)C(=O)NC2=CC=C(C=C2)C(F)F.Cl,,,,,,
4708,104709,N-[4-(difluoromethyl)phenyl]pyridine-3-carboxamide,C1=CC(=CN=C1)C(=O)NC2=CC=C(C=C2)C(F)F,,,,,,
4709,104710,"1,3-Dioxolane-2-methanamine, N-(2,6-dimethylphenyl)-",CC1=C(C(=CC=C1)C)NCC2OCCO2,,,,,,
4710,104711,"5-Amino-2-(2-chloro-4,6-dimethylphenyl)-2,4-dihydro-3H-pyrazol-3-one",CC1=CC(=C(C(=C1)Cl)N2C(=O)CC(=N2)N)C,,,,,,
4711,104712,"9,10-Anthracenedione, 1-amino-4-hydroxy-2-(4-methoxyphenoxy)-",COC1=CC=C(C=C1)OC2=C(C3=C(C(=C2)O)C(=O)C4=CC=CC=C4C3=O)N,,,,,,
4712,104713,CID 104713,CCCCCCCNC(=NCCCCCCC)S,,,,,,
4713,104714,4-Decylbenzoyl chloride,CCCCCCCCCCC1=CC=C(C=C1)C(=O)Cl,,,,,,
4714,104715,Methyl 4-octylbenzoate,CCCCCCCCC1=CC=C(C=C1)C(=O)OC,,,,,,
4715,104716,"1,3-Dibromonaphthalen-2-amine",C1=CC=C2C(=C1)C=C(C(=C2Br)N)Br,,,,,,
4716,104717,"Benzenesulfonamide, N-(1,3-dibromo-2-naphthalenyl)-4-methyl-",CC1=CC=C(C=C1)S(=O)(=O)NC2=C(C3=CC=CC=C3C=C2Br)Br,,,,,,
4717,104718,"N,N-Diethyl-4-((5-nitro-2-thiazolyl)azo)benzenamine",CCN(CC)C1=CC=C(C=C1)N=NC2=NC=C(S2)[N+](=O)[O-],,,,,,
4718,104719,"Acetamide, N-[5-(diethylamino)-2-[(2-iodo-4,6-dinitrophenyl)azo]-4-methoxyphenyl]-",CCN(CC)C1=C(C=C(C(=C1)NC(=O)C)N=NC2=C(C=C(C=C2I)[N+](=O)[O-])[N+](=O)[O-])OC,,,,,,
4719,104720,"Acetamide, N-[5-(diethylamino)-2-[(2-iodo-4,6-dinitrophenyl)azo]phenyl]-",CCN(CC)C1=CC(=C(C=C1)N=NC2=C(C=C(C=C2I)[N+](=O)[O-])[N+](=O)[O-])NC(=O)C,,,,,,
4720,104721,"2-Acetyl-3,5-dimethylpyrazine",CC1=CN=C(C(=N1)C)C(=O)C,,,,,,
4721,104722,"2-Acetyl-3,6-dimethylpyrazine",CC1=CN=C(C(=N1)C(=O)C)C,,,,,,
4722,104723,"(2S,3R,4R,5S,6R)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol;hydrate",C([C@@H]1[C@H]([C@H]([C@H]([C@H](O1)O)O)O)O)O.O,,,,,,
4723,104724,CID 104724,C([C@@H]1C([C@H]([C@H](C(O1)O)O)O)O)O,,,,,,
4724,104725,CID 104725,[134CsH],,,,,,
4725,104726,Americium-241,[241Am],,,,,,
4726,104727,Aluminum Cation,[Al+3],,,,,,
4727,104728,Plutonium-240,[240Pu],,,,,,
4728,104729,Cobalt(2+),[Co+2],,,,,,
4729,104730,Cobalt,[Co],,,"['A group of chemical elements that are needed in minute quantities for the proper growth, development, and physiology of an organism. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) (See all compounds classified as Trace Elements.)']","['Inhaled metallic powder... is retained in the lungs and subsequently absorbed slowly.', 'In primary rhabdomyosarcomata, induced in rat by implantation of powdered metallic cobalt at least 50% of inducing metal that accum in nuclei of each tumor, is bound by the nucleoli. Remainder is distributed approx equally between nuclear sap and chromatin.', 'Cobalt taken up orally is ... eliminated with the feces /between 60 and 95%/. Of the cobalt given iv ... only 11% could be detected in feces. /Cobalt/', 'Once absorbed by inhalation ... cobalt (with biological half-life of a few days ) is eliminated mainly with urine.', '/Dermal Absorption/ Four humans who placed their right hands into a box filled with hard metal dust (5-15% cobalt metal, 95-85% tungsten carbide) for 90 minutes showed an increase in urinary cobalt levels by an order of magnitude in the post-exposure samples, remaining elevated for as long as 48 to 60 hours Similarly, cobalt was detected in the fingernails of three volunteers who placed their fingers in cobalt solution 10 min/day for 7 days, even after the cessation of exposure. These findings demonstrate that cobalt from these metal dusts can be absorbed through the skin. /Hard metal dust/']",,"['Whole body (depends on compound and route): 5 days to 4 years;  [TDR, p. 379]', 'It appears that independent of exposure route (inhalation, injection or ingestion), most of  the cobalt will be eliminated rapidly /in humans/. A small proportion is, however, eliminated  slowly, having a biological half-time in the order of yr.', 'Following exposure of humans to physiologically insoluble cobalt compounds (cobalt metal, cobalt oxides), clearance from the body, assessed by both urinary/fecal clearance as well as a reduction in whole-body retention, appears to follow three-phase kinetics. The first phase, likely representing mucociliary clearance of particles deposited in the tracheobronchial region, has a half-time on the order of 2-44 hours. The second phase, with a half-time on the order of 10-78 days, may represent macrophage-mediated clearance of cobalt particles from the lung. The third clearance phase, representing tong-term clearance from the lungs, has a half-time on the order of years. /Insoluble cobalt compounds/']"
4730,104731,[(2S)-2-acetyloxy-3-hydroxypropyl] octadec-9-enoate,CCCCCCCCC=CCCCCCCCC(=O)OC[C@H](CO)OC(=O)C,,,,,,
4731,104732,CID 104732,CCN(CC)CCOC(=O)C1CCCCC1C2CCCCC2.CC1=NC=C(C(=C1O)CO)CO.CC(C1=CC=CC=C1)(C2=CC=CC=N2)OCCN(C)C.C(CC(=O)O)C(=O)O.Cl.Cl,,,,,,
4732,104733,CID 104733,CCN(CC)CCOC(=O)C1CCCCC1C2CCCCC2,,,,,,
4733,104734,Arsenic(3+),[As+3],,,,,,
4734,104735,4-Methoxy-N-methylbenzeneethanamine,CNCCC1=CC=C(C=C1)OC,,,,,,
4735,104736,CID 104736,C(C(=O)O)C(CC(=O)[O-])(C(=O)O)O.C(C(=O)O)C(CC(=O)[O-])(C(=O)O)[O-].[KH].[KH].[KH].[Bi+3],,,,,,
4736,104737,Arsenic(5+),[As+5],,,,,,
4737,104738,CID 104738,C[C@H]1[C@@H](C[C@@]2(C([C@H]([C@H](O2)[C@H](C[C@@H]([C@H](C)[C@@H]([C@H](C)C=C(C)C(=CC=CC(=CC#N)C)C)O)O)OC)C)(C)C)OC1CC=CC3=COC(=N3)[C@@H](C)CCNC(=O)[C@H]([C@H]([C@H](COC)N(C)C)O)O)O,,,,,,
4738,104739,"2-Amino-3,4,8-trimethyl-3H-imidazo[4,5-f]quinoxaline",CC1=CC2=NC=C(N=C2C3=C1N(C(=N3)N)C)C,,,"['Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)', 'Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)']",,,
4739,104740,CID 104740,C[C@H]1[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@@H](NC(=O)[C@@H](NC(=O)C(NC(=O)C(=C)N(C(=O)CC[C@@H](NC1=O)C(=O)O)C)C)CC(C)C)C(=O)O)C)CCC[N+](=N)N)C=CC(=C[C@H](C)[C@@H](C)CC2CCCCC2)C,,,,,,
4740,104741,Fulvestrant,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)[C@@H](CC4=C3C=CC(=C4)O)CCCCCCCCCS(=O)CCCC(C(F)(F)F)(F)F,"['For the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy, as monotherapy or in combination with other antineoplastic agents.']",['Fulvestrant for intramuscular administration is an estrogen receptor antagonist without known agonist effects.'],"['Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)', 'Compounds and drugs that bind to and block or inhibit the activation of ESTROGEN RECEPTORS. (See all compounds classified as Estrogen Receptor Antagonists.)']","['Fulvestrant was rapidly cleared by the hepatobiliary route with excretion primarily via the feces (approximately 90%). Renal elimination was negligible (less than 1%).', '3 to 5 L/kg', 'Peak plasma concentrations of fulvestrant are attained approximately 7 days after IM administration and persist for at least 1 month. Steady-state plasma fulvestrant concentrations usually are achieved within 3-6 months when the drug is administered once-monthly by IM injection.', 'Fulvestrant appears to be rapidly and extensively distributed, principally into the extravascular space', '99% (mainly VLDL, LDL, and HDL lipoprotein fractions).', 'Has been shown to cross the placenta and distribute into milk in rats.', 'For more Absorption, Distribution and Excretion (Complete) data for FULVESTRANT (8 total), please visit the HSDB record page.']","['Metabolism of fulvestrant appears to involve combinations of a number of possible biotransformation pathways analogous to those of endogenous steroids, including oxidation, aromatic hydroxylation, conjugation with glucuronic acid and/or sulphate at the 2, 3 and 17 positions of the steroid nucleus, and oxidation of the side chain sulphoxide. Identified metabolites are either less active or exhibit similar activity to fulvestrant in antiestrogen models. Studies using human liver preparations and recombinant human enzymes indicate that cytochrome P-450 3A4 (CYP 3A4) is the only P-450 isoenzyme involved in the oxidation of fulvestrant; however, the relative contribution of P-450 and non-P-450 routes in vivo is unknown.', 'Biotransformation and disposition of fulvestrant in humans have been determined following intramuscular and intravenous administration of 14C-labeled fulvestrant. Metabolism of fulvestrant appears to involve combinations of a number of possible biotransformation pathways analogous to those of endogenous steroids, including oxidation, aromatic hydroxylation, conjugation with glucuronic acid and/or sulphate at the 2, 3 and 17 positions of the steroid nucleus, and oxidation of the side chain sulphoxide.', 'Metabolites of fulvestrant exhibit pharmacologic activity that is similar to or less than that of the parent compound.', 'In vitro studies indicate that CYP3A4 is the only enzyme involved in fulvestrant oxidation; however, the relative contribution of CYP and non-CYP routes in vivo currently is not known.']","['40 days', 'The elimination half-life of fulvestrant is about 40 days.']"
4741,104742,H-Tyr-Ala-Gly-N(Me)Phe-Gly-ol,C[C@@H](C(=O)NCC(=O)N(C)[C@@H](CC1=CC=CC=C1)C(=O)NCCO)NC(=O)[C@H](CC2=CC=C(C=C2)O)N,,,,,,
4742,104743,Manganese-54,[54Mn],,,,,,
4743,104744,Aflatoxicol,COC1=C2C3=C([C@H](CC3)O)C(=O)OC2=C4[C@@H]5C=CO[C@@H]5OC4=C1,,,"['Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)']",,,
4744,104745,Propionate,CCC(=O)[O-],,,,,,
4745,104746,Mafosfamide,C1COP(=O)(NC1SCCS(=O)(=O)O)N(CCCl)CCCl,,,"['Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)', 'Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)']",,,
4746,104747,Tegafur-Uracil,C1CC(OC1)N2C=C(C(=O)NC2=O)F.C1=CNC(=O)NC1=O,['Tegafur-uracil is indicated for the first line treatment of metastatic colorectal cancer with concomitant administration of calcium folinate. Colorectal cancer is the third most diagnosed cancer and 30% of the cases can present the metastatic state.'],"[""The use of the combination of tegafur and uracil allows increasing the oral bioavailability, improving the pharmacokinetic behavior of the delivered 5-fluoruracil and increasing the half-life of tegafur. The effect of this combo drug can ameliorate the usage by reducing the dosage frequency which tends to be uncomfortable for the patients. The effect of tegafur's metabolites results in a decreased thymidine synthesis, DNA synthesis, disrupted RNA function and tumor cell cytotoxicity.""]","['Antimetabolites that are useful in cancer chemotherapy. (See all compounds classified as Antimetabolites, Antineoplastic.)']","['The absorption into systemic circulation is very rapid and the peak concentration is reached within 1-2 hours. After a single dose of tegafur/uracil of 300 mg/m2/day in three divided doses, tegafur plasma concentration of >1000 ng/ml are maintained throughout the 8-hour dosing interval, whereas uracil concentrations decline rapidly following the peak concentration. The plasma concentration of 5-fluorouracil peaks at 30-60 min after administration with 200 ng/ml and remain detectable for 8-hour dosing interval. There is no significant long-term accumulation of either uracil, tegafur or 5-fluorouracil.', 'Less than 20% of the administered dose of tegafur is excreted intact in the urine following the oral administration.', 'The volume of distribution of tegafur is reported to be 59 L while the uracil volume of distribution of 474 L.', 'The reported clearance of tegafur when administered in the form of tegafur/uracil ranged from 47 to 175 ml/min']","[""Tegafur is bioactivated to 5-fluorouracil by the liver microsomal cytochrome P450 enzymes, mainly the CYP 2A6. This bioactivation is marked by the presence of C-5' oxidation and C-2' hydrolysis. The 5-fluorouracil is later transformed into its active metabolite 5-fluorodeoxyuridine-monophosphate and 5-fluorouridine-triphosphate. More than 80% of the administered dose is eliminated due to the metabolism of dihydropyridine dehydrogenase. Some other metabolic products include 3'-hydroxy tegafur, 4'-hydroxy tegafur and dihydro tegafur which all of them are significantly less cytotoxic than 5-fluorouracil.""]",['The presence of uracil generates an increase in the half-life of tegafur and it is registered to be of 11 hours. The elimination half-life of uracil is of 20-40 minutes.']
4747,104748,Hydrogen sulfite,OS(=O)[O-],,,,,,
4748,104749,Ruthenium-103,[103Ru],,,,,,
4749,104750,"(2S,3R,4R,5R,6S)-2-[(2R,4S,5R,6R)-4-hydroxy-2-(hydroxymethyl)-6-[[(2S,10R,11S,14S,15R,16S,17R,20S,23S)-10,14,16,20-tetramethyl-22-azahexacyclo[12.10.0.02,11.05,10.015,23.017,22]tetracos-4-en-7-yl]oxy]-5-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl]oxy-6-methyloxane-3,4,5-triol",C[C@H]1CC[C@@H]2[C@H]([C@H]3[C@@H](N2C1)CC4[C@@]3(CC[C@H]5[C@H]4CC=C6[C@@]5(CCC(C6)O[C@H]7[C@@H]([C@H](C([C@H](O7)CO)O[C@H]8[C@@H]([C@@H]([C@H]([C@@H](O8)C)O)O)O)O)O[C@H]9[C@@H]([C@@H]([C@H]([C@@H](O9)C)O)O)O)C)C)C,,,,,,
4750,104751,Bapta,C1=CC=C(C(=C1)N(CC(=O)O)CC(=O)O)OCCOC2=CC=CC=C2N(CC(=O)O)CC(=O)O,,,"['Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)', 'Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)']",,,
4751,104752,Tritium oxide,[3H]O[3H],,,,"['The biokinetics of tritium during continuous ingestion of tritiated water and tritiated wheat were investigated to estimate the radiation dose rates at the end of two modes of chronic exposure.  Wistar strain male rats continuously ingested tritiated water as drinking water and tritiated wheat as food for 14 weeks. Urine and tissue samples were obtained and total tritium in the fresh wet samples and organically bound tritium (OBT) in the freeze-dried samples were determined. The biokinetics of tritium was different between the two modes of exposure. The concentration of total tritium in the tissues exposed to tritiated water attained a steady-state condition by 2-3 weeks. The steady-state condition in the case of exposure to tritiated wheat was not observed for 10 weeks after the start of exposure in the majority of tissues. The relatively efficient and prolonged OBT formation during chronic exposure to tritiated wheat resulted in relatively high incorporation and retention of tritium in the tissues compared with those for exposure to the same activity of tritiated water.Radiation dose rates estimated at the end of continuous ingestion showed that tritiated wheat gave higher dose rates than tritiated water by a factor of 1.3 to 4.5, but the factors were within 2.0 in the majority of tissues except for small intestine and adipose tissue.', 'Scarce published data on the long-term excretion of tritiated water from the human body have been re-evaluated in order to develop a biokinetic model describing the retention in the human body of 3H from tritiated water (HTO) that could be used for both prospective and retrospective radiation protection. A three-component exponential function is proposed to describe the elimination of 3H from HTO with biological half-times of 10 d (99.00%), 40 d (0.98%) and 350 d (0.02%) respectively. The model predicts a committed effective dose of 1.7 x 10(-11) Sv Bq(-1), comparable with that of the current ICRP Publication 56 and 72 models, and estimates the retention of 3H to within a factor of about 2 of the measured values up to 40 d after intake and about 5 at times longer than 100 d. The derivation of the model and the uncertainties associated with the various parameters are discussed.', 'Wistar strain male rats were continuously given tritiated water or tritiated wheat as drinking water or food for 70 days. During the ingestion, the tritium incorporation into rat tissues was examined in both wet and dry samples of liver, kidney, testis and blood. The concentration of organically bound tritium (OBT) in dry tissues of rats exposed to tritiated water (HTO) and (3)H-food (tritiated wheat) attained an equilibrium within 2-3 weeks after the exposure. The concentration of OBT in dry tissues of rats exposed to HTO also reached an equilibrium within 3-4 weeks after the exposure. However, rats exposed to (3)H-food, except for the liver, such an equilibrium state was not reached in other tissues and the OBT concentrations increased gradually throughout the exposure. The relative concentrations of total (3)H and OBT at the end of the chronic ingestion of (3)H food (70 day), expressed in percentages of the total activity were 1 and 9 times higher than those in rats exposed to HTO, respectively. In both groups, OBT as well as total (3)H was almost uniformly distributed among the tissues examined.', '/Tritiated water/ HTO rapidly crosses the placenta. Since the fetus has a higher water concentration than an adult, the dose to the fetus is about 40 to 70% higher than to the mother.']",,['Tritium ... is excreted from the body with an effective half-life in the order of 10 days.']
4752,104753,CID 104753,C1CN2C(=N)N([C@H]([C@H]3[C@]2(C1(O)O)N=C(N3)N)COC(=O)N)O,,,,,,
4753,104754,CID 104754,[89SrH2],,,,,,
4754,104755,Silver ion,[Ag+],,,,,,
4755,104756,"2,3-Epoxyaflatoxin B1",COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4[C@@H]5[C@@H]6[C@@H](O6)O[C@@H]5OC4=C1,,,"['Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)']",,,
4756,104757,Aflatoxin Q1,COC1=C2C3=C(C(=O)C[C@@H]3O)C(=O)OC2=C4[C@@H]5C=CO[C@@H]5OC4=C1,,,,,,
4757,104758,CID 104758,CC1=NC(=O)C2=C(N1)C=CC(=C2)CN(C)C3=CC=C(S3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
4758,104759,Acetyldeoxynivalenol,CC1=CC2C(C(C1=O)O)(C3(CC(C(C34CO4)O2)OC(=O)C)C)CO,,,,,,
4759,104760,Yttrium-90,[90Y],,,,,,
4760,104761,CID 104761,CCOC1=CC2C(=NC3C=CC(=O)C=C3O2)C=C1,,,,,,
4761,104762,Mizoribine,C1=NC(=C(N1[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O)O)C(=O)N,,,"['Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)', 'Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)', 'Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)', 'Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)', 'Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)', 'Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)']",,,
4762,104763,Trichothecene,CC1[C@H]2CC[C@@]1([C@]3(CCC(=C[C@H]3O2)C)C)C,,,,,,
4763,104764,Dehydromonocrotaline,C[C@H]1C(=O)O[C@@H]2CCN3C2=C(COC(=O)[C@]([C@]1(C)O)(C)O)C=C3,,,"['Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. (See all compounds classified as Cross-Linking Reagents.)', 'Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. (See all compounds classified as Alkylating Agents.)']",,,
4764,104765,CID 104765,CC(C(=O)O)O.[NaH].[Na+].[Cl-].[Cl-].[Cl-].[Cl-].[K+].[Ca+2],,,,,,
4765,104766,"(1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid",C1C[C@](C[C@@H]1C(=O)O)(C(=O)O)N,,,"['Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)']",,,
4766,104767,CID 104767,C1[C@@H]2[C@H]([C@H]([C@@H](O2)N3C4=C(C(=O)N=C(N4)N)N=C3Br)O)OP(=O)(O1)O,,,,,,
4767,104768,Blutron,CC(C)C1=CC=C(C=C1)NC(=O)N(C)C.C1=CC(=CC(=C1)OC2=C(C=CC=N2)C(=O)NC3=C(C=C(C=C3)F)F)C(F)(F)F,,,,,,
4768,104769,Esmolol hydrochloride,CC(C)NCC(COC1=CC=C(C=C1)CCC(=O)OC)O.Cl,,,['Drugs that bind to and block the activation of ADRENERGIC BETA-1 RECEPTORS. (See all compounds classified as Adrenergic beta-1 Receptor Antagonists.)'],"['It is not known whether esmolol and/or ASL 8123 cross the placenta in humans, but the drug has been shown to cross the placenta in animals. In animals, fetal artery esmolol concentrations were about 10% of maternal concentrations at the completion of infusion. It also is not known whether esmolol and/or ASL 8123 are distributed into milk.', 'Following IV administration, esmolol is rapidly and widely distributed. The apparent volumes of distribution of esmolol and its de-esterifed metabolite (ASL 8123) in healthy adults are approximately 3.4 and 0.41 l/kg, respectively, following iv administration. In healthy adults, the volumes of distribution of esmolol in the central compartment and at steady state are approximately 0.87 and 1.2 l/kg, respectively, following IV administration. The apparent volume of distribution appears to be decreased in patients undergoing coronary artery bypass surgery and increased in patients with renal impairment undergoing peritoneal dialysis and in patients with liver cirrhosis.', 'Following IV administration in rats, esmolol is ditributed into liver and kidneys, but only minimally into CSF, spleen, or testes.', 'In vitro, esmolol is approximately 55% bound to plasma proteins, mainly albumin and alpha-1-acid glycoprotein. Protein binding of esmolol to alpha-1-acid glycoprotein does not appear to be concentration dependent at esmolol concentrations of 3-110 ug/ml. In vitro, ASL 8123 is approximately 10% bound to plasma proteins.', 'For more Absorption, Distribution and Excretion (Complete) data for ESMOLOL HYDROCHLORIDE (10 total), please visit the HSDB record page.']","['Esmolol is rapidly and extensively metabolized via esterases (probably arylesterase), principally in the cytosol of erythrocytes. Metabolism of the drug also may occur in highly perfused tissues that contain esterases (eg, liver, kidneys). Hydrolysis of the methyl ester moiety results in formation of the de-esterified (free acid) metabolite, 4-(2-hydroxy-3-((1-methylethyl)amino) propoxy)benzenepropanoic acid (ASL 8123), and methanol. Esmolol does not appear to be susceptible to hydrolysis via serum cholinesterase (pseudocholinesterase), acetylcholinesterase, or carbonic anhydrase. It is estimated that about 83% of an esmolol dose is metabolized to ASL 8123. ASL 8123 has a low affinity for beta-adrenergic receptors, exhibiting only minimal (about 1,000- to 1,500-fold less potent than esmolol) beta-blocking activity in animals and no appreciable blockade in humans. Unlike esmolol, ASL 8123 is eliminated principally by the kidneys, and the elimination half-life of the metabolite may be increased up to tenfold in patients with renal impairment; however, such accumulation is not thought to be clinically important since ASL 8123 has only minimal beta-blocking activity. The amount of methanol formed during hydrolysis of the drug does not appear to be clinically important. Following IV infusion of esmolol hydrochloride doses of 300 ug/kg per minute for up to l6 hours of 150 ug/kg per minute for 24 hours, blood methanol concentrations ranged from 2.8-5.9 or 2.9-13.2 ug/ml, respectively, being less than 2% of those usually associated with methanol toxicity.']","['Following IV infusion in adults, the half life of esmolol averages about 2 minutes in the initial distribution phase and about 9 minutes (range: 5-23 minutes) in the terminal elimination phase, although considerable interindividual variation in blood elimination half life exists.', 'Free acid metabolite: approx 3.7 hr (increased up to tenfold in renal failure)']"
4769,104770,Chlorate,[O-]Cl(=O)=O,,,,,,
4770,104771,Mercury-203,[203Hg],,,,,,
4771,104772,"N-Butyl-11-[(7R,8R,9S,13S,14S,17S)-3,17-dihydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[A]phenanthren-7-YL]-N-methylundecanamide",CCCCN(C)C(=O)CCCCCCCCCC[C@@H]1CC2=C(C=CC(=C2)O)[C@@H]3[C@@H]1[C@@H]4CC[C@@H]([C@]4(CC3)C)O,,,['Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. (See all compounds classified as Estrogen Antagonists.)'],,,
4772,104773,"3-[2-[4-[2-[3-(3,11-dimethyl-1,7-dioxaspiro[5.5]undecan-2-yl)-1-hydroxybutyl]-4-hydroxy-3-methylidenespiro[4a,7,8,8a-tetrahydro-4H-pyrano[3,2-b]pyran-6,5'-oxolane]-2'-yl]but-3-en-2-yl]-11-hydroxy-4-methyl-1,7-dioxaspiro[5.5]undec-4-en-8-yl]-2-hydroxy-2-methylpropanoic acid",CC1CCC2(C(CCCO2)C)OC1C(C)CC(C3C(=C)C(C4C(O3)CCC5(O4)CCC(O5)C=CC(C)C6CC(=CC7(O6)C(CCC(O7)CC(C)(C(=O)O)O)O)C)O)O,,,,,,
4773,104774,Desethylamiodarone,CCCCC1=C(C2=CC=CC=C2O1)C(=O)C3=CC(=C(C(=C3)I)OCCNCC)I,,,,,['N-Desethylamiodarone is a known human metabolite of amiodarone.'],
4774,104775,Butyrate,CCCC(=O)[O-],,,,,,
4775,104776,Niobium-95,[95Nb],,,,,,
4776,104777,1-Nitrosopyrene,C1=CC2=C3C(=C1)C=CC4=C(C=CC(=C43)C=C2)N=O,,,,,,
4777,104778,Carbidopa and levodopa,C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)NN.C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O,,,"['Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)', 'Agents used in the treatment of Parkinson&apos;s disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)', 'Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)']",,,
4778,104779,CID 104779,[85SrH2],,,,,,
4779,104780,CID 104780,CC1=C[C@@H]2[C@](C[C@@H]1O)(C3([C@@H]([C@H]([C@H](C34CO4)O2)O)O)C)CO,,,,,,
4780,104781,tert-Butylbicyclophosphorothionate,CC(C)(C)C12COP(=S)(OC1)OC2,,,"['Substances that act in the brain stem or spinal cord to produce tonic or clonic convulsions, often by removing normal inhibitory tone. They were formerly used to stimulate respiration or as antidotes to barbiturate overdose. They are now most commonly used as experimental tools. (See all compounds classified as Convulsants.)']",,,
4781,104782,Cadmium-109,[109Cd],,,,,,
4782,104783,Neptunium-237,[237Np],,,,,,
4783,104784,Iron fe-59,[59Fe],,,,,,
4784,104785,Unii-45EY9cgm08,O=[AsH]=O,,,,,,
4785,104786,Chromium-51,[51Cr],,,,,,
4786,104787,Dpdpe,CC1([C@H](C(=O)NCC(=O)N[C@H](C(=O)N[C@H](C(SS1)(C)C)C(=O)O)CC2=CC=CC=C2)NC(=O)[C@H](CC3=CC=C(C=C3)O)N)C,,,"['Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function. (See all compounds classified as Neurotransmitter Agents.)', 'Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)']",,,
4787,104788,CID 104788,C1[C@H](C(C23N1C(=N[C@H]([C@@H]2NC(=N3)N)COC(=O)N)N)(O)O)OS(=O)(=O)O,,,,,,
4788,104789,CID 104789,[LiH].[LiH].C1=C(C=C2C3=C1C(=C(C=C3C(=O)N(C2=O)C(=O)NN)S(=O)(=O)O)N)S(=O)(=O)O,,,,,,
4789,104790,"6-Amino-2-carbazoyl-1,3-diketo-benzo[de]isoquinoline-5,8-disulfonic acid",C1=C(C=C2C3=C1C(=C(C=C3C(=O)N(C2=O)C(=O)NN)S(=O)(=O)O)N)S(=O)(=O)O,,,,,,
4790,104791,"Selenium, ion(4+)",[Se+4],,,,,,
4791,104792,2-[N-(carboxymethyl)-2-[2-[2-[carboxymethyl-[2-oxo-2-(2-oxopropoxy)ethyl]amino]phenoxy]ethoxy]anilino]acetic acid,CC(=O)COC(=O)CN(CC(=O)O)C1=CC=CC=C1OCCOC2=CC=CC=C2N(CC(=O)O)CC(=O)O,,,,,,
4792,104793,CID 104793,C[C@H]1[C@H](C2[C@@H](O2)C3=CC(=O)[C@@]4(C[C@]13C)[C@@](O4)(C)C=O)C(=O)C,,,,,,
4793,104794,"1-(6-((3-Methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2NCCCCCCN4C(=O)C=CC4=O)CCC5=C3C=CC(=C5)OC,,,"['Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)', 'Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. (See all compounds classified as Phosphodiesterase Inhibitors.)']",,,
4794,104795,"(2S,3S,4R,5S)-5-(6-amino-9H-purin-9-yl)-N-ethyl-3,4-dihydroxy-tetrahydrofuran-2-carboxamide",CCNC(=O)[C@@H]1[C@H]([C@H](C(O1)N2C=NC3=C(N=CN=C32)N)O)O,,,,,,
4795,104796,"17-Hydroxyandrost-4-ene-3,11-dione",C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2C(=O)C[C@]4([C@H]3CCC4O)C,,,,,,
4796,104797,CID 104797,[7BeH2],,,,,,
4797,104798,Strontium ion,[Sr+2],,,,,,
4798,104799,Fotemustine,CCOP(=O)(C(C)NC(=O)N(CCCl)N=O)OCC,,,['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)'],"['The pharmacokinetics and metabolism of intravenously infused (14)C-fotemustine (about 100 mg/sq m) were examined in 2 cancer patients. Plasma levels of radioactivity increased to a maximum of 4.1 and 5.5 ug equivalents per g when the infusion stopped then declined triexponentially with mean half-lives of about 1/2, 10 and 80 hr for the initial, mid and terminal phases, respectively. Plasma levels of intact drug were lower, with maximum levels of 1.1 and 2.8 micrograms/ml, and declined monophasically with a half-life of about 24 min. Plasma clearance was high (1426 and 764 mL/min) with the volume of distribution based on areas of 47.7 and 26.4 L. Most of the radioactivity was eliminated in urine (50.1 and 61.3%) over 7 days with smaller amounts in the feces (6.8 and 0.3%) and only minimal quantities (under 0.1%) as expired carbon dioxide. ...', 'After administration in /humans/ of the drug labelled with (14)C on the chloroethyl group, the radioactivity is slowly eliminated with a terminal half-life of 83 hours. About 50 to 60% of the radioactivity administered is detected in the urine, 30 to 40% of which is detected during the first 24 hours, but the unchanged molecule is not detected in the urine. 5% of the radioactivity is eliminated in the feces and less than 0.2% in the form of expired CO2.', 'In /humans/, during administration by intravenous infusion, the plasma levels of fotemustine are close to the steady-state value after 45 minutes. After the end of the infusion, plasma levels go down rapidly and three hours later the molecule can no longer be detected in the blood.', 'In animals, the tissue distribution is rapid and very extensive. Fotemustine crosses the blood-brain barrier (2 to 5 minutes after bolus administration in the rat, it is detected in the brain at sufficiently high levels to be active).']",['The pharmacokinetics and metabolism of intravenously infused (14)C-fotemustine (about 100 mg/sq m) were examined in 2 cancer patients. ... Metabolites of fotemustine were identified as chloroethanol and N-nitroso-1-imidazolone-ethyl-diethylphosphonate in plasma and as 1-hydantoin-ethyl-diethyl-phosphonate and acetic acid in urine.'],"['After administration in /humans/ of the drug labelled with (14)C on the chloroethyl group, the radioactivity is slowly eliminated with a terminal half-life of 83 hours.', 'The pharmacokinetics and metabolism of intravenously infused (14)C-fotemustine (about 100 mg/sq m) were examined in 2 cancer patients. Plasma levels of radioactivity increased to a maximum of 4.1 and 5.5 ug equivalents per g when the infusion stopped then declined triexponentially with mean half-lives of about 1/2, 10 and 80 hr for the initial, mid and terminal phases, respectively. ...']"
4799,104800,Iodine-125,[125IH],,,,,,
4800,104801,Curium-244,[244Cm],,,,,,
4801,104802,Arginyl-glycyl-aspartic acid,C(C[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)N)CN=C(N)N,,,['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)'],,,
4802,104803,Mivacurium mixture of isomers,C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C(=C3)OC)OC)OC)OC)OC)CCCOC(=O)CCC=CCCC(=O)OCCC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C(=C6)OC)OC)OC)OC)OC)C,,,,,,
4803,104804,Eudragit RL,CC(=C)C(=O)O.CC(=C)C(=O)O.CN(C)C,,,,,,
4804,104805,Calcium hydrogen phosphate dihydrate,O.O.OP(=O)([O-])[O-].[Ca+2],"['For use as an over the counter calcium and phosphate supplement, antacid, or a source of calcium and phosphate in toothpaste.']","['Calcium phosphate reacts with acid in the stomach to raise the pH. In toothpaste it provides a source of calcium and phosphate ions to support remineralization of the teeth. As a supplement it provides a source of calcium and phospate, both of which are important ions in bone homeostasis.']",,,,
4805,104806,Oxido nitrite,N(=O)O[O-],,,,,,
4806,104807,2-((3-Aminopropyl)amino)ethanethiol,C(CN)CNCCS,,,"['Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. (See all compounds classified as Radiation-Protective Agents.)']",,,
4807,104808,CID 104808,CC(=O)C1=CCCC[C@@H]2CC[C@H]1N2,,,,,,
4808,104809,Icr-191 dihydrochloride,COC1=CC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCNCCCl.Cl.Cl,,,,,,
4809,104810,Barium ion,[Ba+2],,,,,,
4810,104811,Oxyphenbutazone hydrate,CCCCC1C(=O)N(N(C1=O)C2=CC=C(C=C2)O)C3=CC=CC=C3.O,,,"['Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)']",,,
4811,104812,Orthosilicate,[O-][Si]([O-])([O-])[O-],,,,,,
4812,104813,D-glutamate(1-),C(CC(=O)O)[C@H](C(=O)[O-])N,,,,,,
4813,104814,Cerium-141,[141Ce],,,,,,
4814,104815,Cuprous ion,[Cu+],['Treatment and prophylaxis of bleeding in patients with haemophilia A (congenital factor-VIII deficiency).'],,,,,
4815,104816,Krypton-85,[85Kr],,,,,,
4816,104817,"(5-Hydroxy-4,6-dimethylpyridin-3-yl)methyl phosphate",CC1=C(C(=NC=C1COP(=O)([O-])[O-])C)O,,,"['A group of water-soluble vitamins, some of which are COENZYMES. (See all compounds classified as Vitamin B Complex.)']",,,
4817,104818,"N,N''-Sulfonylbisurea",C(=O)(N)NS(=O)(=O)NC(=O)N,,,,,,
4818,104819,2-Trimethylarsoniumylethanolate,C[As+](C)(C)CC[O-],,,,,,
4819,104820,Arsenocholine,C[As+](C)(C)CCO,,,,,,
4820,104821,CID 104821,CC12[C@@H](N(C(=N)N3C1(C(C(C3)OS(=O)(=O)O)(O)O)N=C(N2)N)O)COC(=O)N,,,,,,
4821,104822,"1,4-Dihydropyridine",C1C=CNC=C1,,,['A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)'],,,
4822,104823,Nitrosomethylurea,C(NC(=O)N)N=O,,,"['Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. (See all compounds classified as Alkylating Agents.)']",,,
4823,104824,"2-Butanol, 1-((2,3-dihydro-7-methyl-1H-inden-4-yl)oxy)-3-((1-methylethyl)amino)-, (2R,3R)-rel-",CC1=C2CCCC2=C(C=C1)OC[C@@H]([C@@H](C)NC(C)C)O,,,"['Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)']",,,
4824,104825,Aflatoxin B2A,COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4[C@@H]5C[C@@H](O[C@@H]5OC4=C1)O,,,,,,
4825,104826,CID 104826,C[C@@H]1C[C@]2([C@H]3[C@H]4[C@]1([C@@H]5C=C(C(=O)[C@]5(CC(=C4)COC(=O)CC6=CC(=C(C=C6)O)OC)O)C)OC(O3)(O2)CC7=CC=CC=C7)C(=C)C,,,,,,
4826,104827,Methylene Blue trihydrate,CN(C)C1=CC2=C(C=C1)N=C3C=CC(=[N+](C)C)C=C3S2.O.O.O.[Cl-],,,['Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)'],,,
4827,104828,Silver-110,[110Ag],,,,,,
4828,104829,CID 104829,CC1=C[C@@H]2[C@]([C@@H](C1=O)O)(C3(C[C@H]([C@H](C34CO4)O2)O)C)CC(=O)C,,,,,,
4829,104830,"12-Hydroxy-5,13,25-trimethylspiro[2,10,16,23-tetraoxatetracyclo[22.2.1.03,8.08,25]heptacosa-4,18,20-triene-26,2'-oxirane]-11,17,22-trione",CC1CCOC(=O)C=CC=CC(=O)OC2CC3C4(C2(C5(CCC(=CC5O3)C)COC(=O)C1O)C)CO4,,,,,,
4830,104831,CID 104831,[140BaH2],,,,,,
4831,104832,CID 104832,C1CC(=O)C2=C(OC3=C4[C@@H]5C=CO[C@H]5OC4=CC(=O)C3=C21)O,,,,,,
4832,104833,"2,4-Pyrrolidinedione, 3-acetyl-5-(1-methylpropyl)-",CCC(C)C1C(=O)C(C(=O)N1)C(=O)C,,,,,,
4833,104834,"1-[bis(4-chlorophenyl)methyl]-3-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-2H-imidazole;chloride",C1N(C=CN1C(C2=CC=C(C=C2)Cl)C3=CC=C(C=C3)Cl)CC(C4=C(C=C(C=C4)Cl)Cl)OCC5=C(C=C(C=C5)Cl)Cl.[Cl-],,,,,,
4834,104835,"1-[bis(4-chlorophenyl)methyl]-3-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-2H-imidazole",C1N(C=CN1C(C2=CC=C(C=C2)Cl)C3=CC=C(C=C3)Cl)CC(C4=C(C=C(C=C4)Cl)Cl)OCC5=C(C=C(C=C5)Cl)Cl,,,,,,
4835,104836,Plicatic acid,COC1=CC(=CC(=C1O)O)[C@H]2C3=CC(=C(C=C3C[C@]([C@@]2(C(=O)O)O)(CO)O)OC)O,,,,,,
4836,104837,CID 104837,C[C@H]([C@@H]1[C@H]2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O.CC1(C[C@@H]1C(=O)NC(=CCCCCSC[C@H](C(=O)O)N)C(=O)O)C,,,,,,
4837,104838,Imipenem,C[C@H]([C@@H]1[C@H]2CC(=C(N2C1=O)C(=O)O)SCCN=CN)O,"['Imipenem is indicated, in combination with [cilastatin] with or without [relebactam], for the treatment of bacterial infections including respiratory, skin, bone, gynecologic, urinary tract, and intra-abdominal as well as septicemia and endocarditis.']",['Imipenem is a beta-lactam antibiotic belongings to the subgroup of carbapenems. Imipenem is active against aerobic and anaerobic Gram positive as well as Gram negative bacteria including <i>Pseudomonas aeruginosa</i> and the <i>Enterococcus</i>. It exerts a bactericidal effects by disrupting cell wall synthesis.'],['Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)'],"['Imipenem is not effectively absorbed from the gastrointestinal tract and therefore must be administered parenterally. The bioavailability of the IM injection is 89%.', 'Approximately 70% of imipenem is excreted in the urine as the parent drug.', 'The reported volume of distribution for imipenem ranges from 0.23-0.31 L/kg.', 'The total clearance of imipenem is 0.2 L/h/kg. When used alone, the renal clearance is 0.05 L/h/kg. In combination with cilastatin the renal clearance of imipenem is 0.15 L/h/kg, likely due to the increased concentration of the parent drug.']",['Imipenem is metabolized by renal dehydropeptidase.'],"['When given via IV injection imipenem has a half-life of 1 h. The apparent half-life of the IM injection ranges from 1.3-5.1 h, likely due to slower absorption form the injection site.']"
4838,104839,CID 104839,CCCC[C@H](C)[C@@H]([C@@H](C[C@H](C)C[C@H](CCCCCC[C@@H]([C@@H](C)N)N)O)OC(=O)CC(CC(=O)O)C(=O)O)OC(=O)CC(CC(=O)O)C(=O)O,,,,,,
4839,104840,Cremophor EL,C1CO1.C(C(CO)O)O,,,"['Agents that modify interfacial tension of water; usually substances that have one lipophilic and one hydrophilic group in the molecule; includes soaps, detergents, emulsifiers, dispersing and wetting agents, and several groups of antiseptics. (See all compounds classified as Surface-Active Agents.)']",,,
4840,104841,N-(2-((8-(Bis(carboxymethyl)amino)-6-methoxy-2-quinolinyl)methoxy)-4-methylphenyl)-N-(carboxymethyl)glycine,CC1=CC(=C(C=C1)N(CC(=O)O)CC(=O)O)OCC2=NC3=C(C=C(C=C3C=C2)OC)N(CC(=O)O)CC(=O)O,,,,,,
4841,104842,7-Ethyl-10-hydroxycamptothecin,CCC1=C2CN3C(=CC4=C(C3=O)COC(=O)[C@@]4(CC)O)C2=NC5=C1C=C(C=C5)O,['Investigated for use/treatment in colorectal cancer.'],"['SN-38 (7-ethyl-10-hydroxycamptothecin) is the active metabolite of Irinotecan (CPT-11). Irinotecan is a topoisomerase I inhibitor commercially available as Camptosar®. SN-38 has been found to be 200–2000 times more cytotoxic than CPT-11, but has not been used as an anticancer drug due to its poor solubility in pharmaceutically acceptable solvents and low affinity to lipid membranes. SN-38 also undergoes a reversible conversion to an inactive open lactone ring structure at physiological pH. LE-SN-38 is a novel lipsome based formulation containing liposomes of uniform size distribution (<200 nm). Drug entrapment efficiency of the formulation is>95%.']",['Compounds that inhibit the activity of DNA TOPOISOMERASE I. (See all compounds classified as Topoisomerase I Inhibitors.)'],,,
4842,104843,Ergovaline,CC(C)[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C)NC(=O)[C@H]4CN([C@@H]5CC6=CNC7=CC=CC(=C67)C5=C4)C)O,,,['Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)'],,,
4843,104844,Cobalt-58,[58Co],,,,,,
4844,104845,Alfaxalone,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@H](C4)O)C)C,,,"['Endogenous compounds or drugs that affect neuronal excitability through modulation of specific ionotropic receptors (e.g., GABA-A RECEPTORS). Endogenous neurosteroids are steroid hormones de novo synthesized by neurons and glial cells from steroid metabolite precursors (e.g., PREGNENOLONE). (See all compounds classified as Neurosteroids.)', 'Agents capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general ANESTHESIA, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site. (See all compounds classified as Anesthetics.)']",,,
4845,104846,Californium-252,[252Cf],,,,,,
4846,104847,CID 104847,C[C@H]1CCC[C@@H](CCCC=CC2=C(C(=CC(=C2)O)O)C(=O)O1)O,,,,,,
4847,104848,Gonyautoxin 1,C1C(C(C23N1C(=N)N(C(C2N=C(N3)N)COC(=O)N)O)(O)O)OS(=O)(=O)O,,,,,,
4848,104849,Rimonabant hydrochloride,CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl.Cl,,,"['Agents that increase energy expenditure and weight loss by neural and metabolic regulation. (See all compounds classified as Anti-Obesity Agents.)', 'Compounds that inhibit or block the activity of CANNABINOID RECEPTORS. (See all compounds classified as Cannabinoid Receptor Antagonists.)']",,,
4849,104850,Rimonabant,CC1=C(N(N=C1C(=O)NN2CCCCC2)C3=C(C=C(C=C3)Cl)Cl)C4=CC=C(C=C4)Cl,"['For use in conjunction with diet and exercise for patients with a body mass index greater than 30 kg/m<sup>2</sup>, or patients wih a BMI greater than 27 kg/m<sup>2</sup> with associated risk factors, such as type 2 diabetes or dyslipidaemia.']","['In the RIO-North America trial, 3040 patients were randomized to receive either placebo or one of two doses of rimonabant (5 mg or 20 mg per day). Patients taking 20 mg rimonabant had significant weigh loss, decrease in waist circumference, improved insulin sensitivity, and increases in HDL cholesterol, compared to patients on placebo.']","['Agents that increase energy expenditure and weight loss by neural and metabolic regulation. (See all compounds classified as Anti-Obesity Agents.)', 'Compounds that inhibit or block the activity of CANNABINOID RECEPTORS. (See all compounds classified as Cannabinoid Receptor Antagonists.)']",['Undetermined'],"['Hepatic, CYP3A4 involved.']",['6 to 9 days with normal BMI and 16 days if BMI is greater than 30']
4850,104851,Cobalt-57,[57Co],,,,,,
4851,104852,lambda2-Plumbane,[212PbH2],,,,,,
4852,104853,"(E)-7,8-Dihydrobenzo(a)pyrene-7,8-diol",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4C=C[C@@H]([C@H]5O)O)C=C2,,,,,,
4853,104854,Plutonium-241,[241Pu],,,,,,
4854,104855,"2-Amino-3,7,8-trimethylimidazo(4,5-f)quinoxaline",CC1=C(N=C2C(=N1)C=CC3=C2N=C(N3C)N)C,,,,,,
4855,104856,4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol,CN(CCCC(C1=CN=CC=C1)O)N=O,,,,,"['4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) is a known thirdhand smoke metabolite of 4-(Methylnitrosoamino)-1-(3-pyridinyl)-1-butanone (NNK).', '4-(methylnitrosamino)-1-(3- pyridyl)-1-butanol has known human metabolites that include (2S,3S,4S,5R,6R)-3,4,5-Trihydroxy-6-[3-[1-hydroxy-4-[methyl(nitroso)amino]butyl]pyridin-1-ium-1-yl]oxane-2-carboxylic acid.']",
4856,104857,4-Keto 13-cis-Retinoic Acid,CC1=C(C(CCC1=O)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C,,,,,,
4857,104858,S-nitrosoglutathione,C(CC(=O)N[C@@H](CSN=O)C(=O)NCC(=O)O)[C@@H](C(=O)O)N,,,"['Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)', 'Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)', 'Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)', 'A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81) (See all compounds classified as Nitric Oxide Donors.)', 'Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)', 'Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)']",,,
4858,104859,CID 104859,CC1=CC2=C(CCC2=O)C3=C1C4=CC=CC=C4CC3,,,,,,
4859,104860,Altertoxin I,C1C[C@]2([C@@H]3[C@H](CC(=O)C4=C(C=CC(=C34)C5=C2C(=C(C=C5)O)C1=O)O)O)O,,,,,,
4860,104861,"(2S,3aR,7aS)-1-[(2R)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid",CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@H](C)C(=O)N2[C@H]3CCCC[C@@H]3C[C@H]2C(=O)O,,,,,,
4861,104862,Verruculogen TR 1,CC(=CC1N2C3=C(C=CC(=C3)OC)C4=C2C(CC(OO1)(C)C)N5C(=O)C6CCCN6C(=O)C5(C4O)O)C,,,,,,
4862,104863,"2H-Pyrido(4,3-b)carbazol-9-ol, 2,5,11-trimethyl-",CC1=C2C=CN(C=C2C(=C3C1=NC4=C3C=C(C=C4)O)C)C,,,,,,
4863,104864,CID 104864,C1CC1CN2CC[C@]34[C@@H]5C6C(C[C@]3([C@@H]2CC7=C4C(=C(C=C7)O)O5)O)C8=CC=CC=C8N6,,,,,,
4864,104865,Bosentan,CC(C)(C)C1=CC=C(C=C1)S(=O)(=O)NC2=C(C(=NC(=N2)C3=NC=CC=N3)OCCO)OC4=CC=CC=C4OC,"['Used in the treatment of pulmonary arterial hypertension (PAH), to improve exercise ability and to decrease the rate of clinical worsening (in patients with WHO Class III or IV symptoms).']","[""Bosentan belongs to a class of drugs known as endothelin receptor antagonists (ERAs). Patients with PAH have elevated levels of endothelin, a potent blood vessel constrictor, in their plasma and lung tissue. Bosentan blocks the binding of endothelin to its receptors, thereby negating endothelin's deleterious effects.""]","['Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)', 'Compounds and drugs that bind to and inhibit or block the activation of ENDOTHELIN RECECPTORS. (See all compounds classified as Endothelin Receptor Antagonists.)']","['Absolute bioavailability is approximately 50% and food does not affect absorption.', 'Bosentan is eliminated by biliary excretion following metabolism in the liver.', '18 L', '4 L/h [patients with pulmonary arterial hypertension]']","['Bosentan is metabolized in the liver by the cytochrome P450 enzymes CYP2C9 and CYP3A4 (and possibly CYP2C19), producing three metabolites, one of which, Ro 48-5033, is pharmacologically active and may contribute 10 to 20% to the total activity of the parent compound.', 'Bosentan has known human metabolites that include 4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-hydroxyphenoxy)-[2,2-]bipyrimidinyl-4-yl]-benzenesulfonamide and Hydroxy Bosentan.']",['Terminal elimination half-life is about 5 hours in healthy adult subjects.']
4865,104866,Alert,COC(=O)NC1=NC2=CC=CC=C2N1.C[Si](CN1C=NC=N1)(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F,,,,,,
4866,104867,"7-[(2-Amino-2-carboxyethyl)thio]-2-[[(2,2-dimethylcyclopropyl)-oxomethyl]amino]-2-heptenoic acid",CC1(CC1C(=O)NC(=CCCCCSCC(C(=O)O)N)C(=O)O)C,,,['Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). (See all compounds classified as Protease Inhibitors.)'],,,
4867,104868,"[(1S,2S,6R,10S,11R,13S,14R,15R)-13-Acetyloxy-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-14-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] 3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoate",C[C@@H]1[C@H]([C@@]2([C@@H](C2(C)C)[C@H]3[C@]1([C@@H]4C=C(C(=O)[C@]4(CC(=C3)CO)O)C)O)OC(=O)C)OC(=O)C=C(C)C=CC=C(C)C=CC5=C(CCCC5(C)C)C,,,,,,
4868,104869,Selenium(6+),[Se+6],,,,,,
4869,104870,Talipexole dihydrochloride,C=CCN1CCC2=C(CC1)SC(=N2)N.Cl.Cl,,,"['Drugs that selectively bind to and activate alpha adrenergic receptors. (See all compounds classified as Adrenergic alpha-Agonists.)', 'Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)', 'Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)']",,,
4870,104871,Bicuculline methiodide,C[N+]1(CCC2=CC3=C(C=C2[C@H]1[C@H]4C5=C(C6=C(C=C5)OCO6)C(=O)O4)OCO3)C.[I-],,,,,,
4871,104872,"(5s)-6,6-Dimethyl-5-[(6r)-8-Oxo-6,8-Dihydrofuro[3,4-E][1,3]benzodioxol-6-Yl]-5,6,7,8-Tetrahydro[1,3]dioxolo[4,5-G]isoquinolin-6-Ium",C[N+]1(CCC2=CC3=C(C=C2[C@H]1[C@H]4C5=C(C6=C(C=C5)OCO6)C(=O)O4)OCO3)C,,,,,,
4872,104873,CID 104873,C[C@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CNC4=CC=CC(=C34)C2=C1)C.C(=CC(=O)O)C(=O)O,,,,,,
4873,104874,CID 104874,CC(=O)O[C@H]1C=C[C@H]2[C@@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)O)CCN3C,,,,,,
4874,104875,Thorium-234,[234Th],,,,,,
4875,104876,CID 104876,CON=C(C1=CSC(=N1)N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)CO)C(=O)O,,,,,,
4876,104877,"(2S)-1-[(2S,4S)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide;hydrate",CC(C)(C)NC(=O)[C@@H]1CN(CCN1C[C@H](C[C@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@@H](CC4=CC=CC=C34)O)O)CC5=CN=CC=C5.O,,,,,,
4877,104878,CID 104878,CC(C)(C)NC(=O)[C@@H]1CN(CCN1CC(C[C@H](CC2=CC=CC=C2)C(=O)N[C@@H]3[C@@H](CC4=CC=CC=C34)O)O)CC5=CN=CC=C5,,,,,,
4878,104879,"(2S,3S,4S,5R,6S)-6-[[(4S,4aR,7S,7aR,12bS)-7-hydroxy-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-9-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid",CN1CC[C@]23[C@@H]4[C@@H]1CC5=C2C(=C(C=C5)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)C(=O)O)O)O)O)O[C@H]3[C@H](C=C4)O,,,,,,
4879,104880,"Androsta-1,4,6-triene-3,17-dione",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)C=CC4=CC(=O)C=C[C@]34C,,,['Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)'],,,
4880,104881,3-Hydroxypregnan-20-one,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4[C@@]3(CCC(C4)O)C)C,['Treatment of postpartum depression'],,"['Agents capable of inducing a total or partial loss of sensation, especially tactile sensation and pain. They may act to induce general ANESTHESIA, in which an unconscious state is achieved, or may act locally to induce numbness or lack of sensation at a targeted site. (See all compounds classified as Anesthetics.)']",,,
4881,104882,Lanthanum-140,[140La],,,,,,
4882,104883,"Tin, ion (Sn2+)",[Sn+2],,,,,,
4883,104884,"[(1R,2S,4R,6R,9R,10R,11R,12S,14R,15R,18R)-14-acetyloxy-6-(furan-3-yl)-10-(2-methoxy-2-oxoethyl)-7,9,11,15-tetramethyl-3,17-dioxapentacyclo[9.6.1.02,9.04,8.015,18]octadec-7-en-12-yl] 2-methylbut-2-enoate",CC=C(C)C(=O)O[C@H]1C[C@H]([C@]2(CO[C@@H]3[C@@H]2[C@]1([C@H]([C@]4([C@@H]3O[C@H]5C4=C([C@@H](C5)C6=COC=C6)C)C)CC(=O)OC)C)C)OC(=O)C,,,,,,
4884,104885,"2-Phenoxy-4H-1,3,2-benzodioxaphosphorin 2-oxide",C1C2=CC=CC=C2OP(=O)(O1)OC3=CC=CC=C3,,,,,,
4885,104886,CID 104886,[45CaH2],,,,,,
4886,104887,CID 104887,O.O.O.[OH-].[OH-].[Mg+2].[AlH3],,,,,,
4887,104888,alpha-Artemether,C[C@@H]1CC[C@H]2[C@H]([C@@H](O[C@H]3[C@@]24[C@H]1CC[C@](O3)(OO4)C)OC)C,,,"['Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)']",,,
4888,104889,"(-)-trans-7,8-Dihydroxy-7,8-dihydrobenzo(a)pyrene",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4C=C[C@H]([C@@H]5O)O)C=C2,,,,,,
4889,104890,N-Nitrosothiazolidine-4-carboxylic acid,C1C(N(CS1)N=O)C(=O)O,,,,,,
4890,104891,"3-[(Dodeca-1,3,5,7,9-pentaen-1-yl)oxy]propane-1,2-diol",CCC=CC=CC=CC=CC=COC[C@H](CO)O,,,,,,
4891,104892,CID 104892,[206PbH2],,,,,,
4892,104893,"2-Pentenoic acid, 2-propyl-",CCCC(=CCC)C(=O)O,,,"['An agent that causes the production of physical defects in the developing embryo. (See all compounds classified as Teratogens.)', 'Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)']",,,
4893,104894,Antimony(3+),[Sb+3],,,,,,
4894,104895,"2-[(1r,2r,5r)-5-Hydroxy-2-(3-hydroxypropyl)cyclohexyl]-5-(2-methyloctan-2-yl)phenol",CCCCCCC(C)(C)C1=CC(=C(C=C1)[C@@H]2C[C@@H](CC[C@H]2CCCO)O)O,,,"['Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)', 'Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)']",,,
4895,104896,2-Propyl-4-pentenoic acid,CCCC(CC=C)C(=O)O,,,['An agent that causes the production of physical defects in the developing embryo. (See all compounds classified as Teratogens.)'],,['4-ene-valproate is a known human metabolite of valproic acid.'],
4896,104897,Lanthanum cation (3+),[La+3],,,,,,
4897,104898,CID 104898,C[C@]12CC[C@H](C[C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@H]4O)C)O.[C@@H]1([C@@H]([C@H](O[C@H]([C@@H]1O)O)C(=O)O)O)O,,,,,,
4898,104899,CID 104899,[C@H]1([C@H](O[C@H]([C@@H](C1O)O)O)C(=O)O)O,,,,,,
4899,104900,"3-Dodeca-1,3,5,7,9-pentaenoxypropane-1,2-diol",CCC=CC=CC=CC=CC=COCC(CO)O,,,,,,
4900,104901,6-Acryloyl-2-dimethylaminonaphthalene,CN(C)C1=CC2=C(C=C1)C=C(C=C2)C(=O)C=C,,,"['Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)']",,,
4901,104902,Tirilazad mesylate,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4(C3=CC[C@@]2([C@H]1C(=O)CN5CCN(CC5)C6=NC(=NC(=C6)N7CCCC7)N8CCCC8)C)C.CS(=O)(=O)O,,,"['Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)', 'Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)']",,,
4902,104903,Tirilazad,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4(C3=CC[C@@]2([C@H]1C(=O)CN5CCN(CC5)C6=NC(=NC(=C6)N7CCCC7)N8CCCC8)C)C,,,"['Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)', 'Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)']",,"['Tirilazad has known human metabolites that include (8S,10R,13S,14S,16R,17S)-17-[2-[4-(2,6-dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-6-hydroxy-10,13,16-trimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one, 17-[2-[4-(2,6-dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-6-hydroxy-10,13,16-trimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one, 17-[2-[4-[2-(3-hydroxypyrrolidin-1-yl)-6-pyrrolidin-1-ylpyrimidin-4-yl]piperazin-1-yl]acetyl]-10,13,16-trimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one, and 17-[2-[4-[6-(3-hydroxypyrrolidin-1-yl)-2-pyrrolidin-1-ylpyrimidin-4-yl]piperazin-1-yl]acetyl]-10,13,16-trimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one.']",
4903,104904,Ecgonine methyl ester,CN1[C@H]2CC[C@@H]1[C@H]([C@H](C2)O)C(=O)OC,,,['Agents that induce NARCOSIS. Narcotics include agents that cause somnolence or induced sleep (STUPOR); natural or synthetic derivatives of OPIUM or MORPHINE or any substance that has such effects. They are potent inducers of ANALGESIA and OPIOID-RELATED DISORDERS. (See all compounds classified as Narcotics.)'],,,
4904,104905,Nickel-63,[63Ni],,,,,,
4905,104906,Promethium-147,[147Pm],,,,,,
4906,104907,Europium-152,[152Eu],,,,,,
4907,104908,CID 104908,C[C@@H](CC1=CC=C(C=C1)OC)NC[C@H](C2=CC(=C(C=C2)O)NC=O)O.C(=CC(=O)O)C(=O)O,,,,,,
4908,104909,CID 104909,CC(CC1=CC=C(C=C1)OC)NC[C@H](C2=CC(=C(C=C2)O)NC=O)O,,,,,,
4909,104910,N-Nitrosomethyl(2-oxopropyl)amine,CC(=O)CN(C)N=O,,,,,,
4910,104911,WAY-100635 hydrochloride,COC1=CC=CC=C1N2CCN(CC2)CCN(C3=CC=CC=N3)C(=O)C4CCCCC4.Cl.Cl.Cl,,,"['Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)']",,,
4911,104912,"Formaldehyde, polymer with 4-(1,1-dimethylethyl)phenol",CC(C)(C)C1=CC=C(C=C1)O.C=O,,,,,,
4912,104913,Diacetyldichlorofluorescein,CC(=O)OC1=C(C=C2C(=C1)OC3=CC(=C(C=C3C24C5=CC=CC=C5C(=O)O4)Cl)OC(=O)C)Cl,,,,,,
4913,104914,CID 104914,C[C@@H]1[C@@H]2CC[C@@H](C2=C[C@]3([C@H](CC(=C3C([C@@H]1O)O[C@@H]4[C@@H]([C@H]([C@@H](C(O4)COC(C)(C)C=C)O)OC(=O)C)O)C(C)COC(=O)C)O)C)COC,,,,,,
4914,104915,CID 104915,C1[C@@H]2[C@H]([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)OP(=O)(O1)S,,,,,,
4915,104916,"2-phenylpyrazolo(4,3-c)quinolin-3(5H)-one",C1=CC=C(C=C1)N2C(=O)C3=C(N2)C4=CC=CC=C4N=C3,,,"['Substances that act in the brain stem or spinal cord to produce tonic or clonic convulsions, often by removing normal inhibitory tone. They were formerly used to stimulate respiration or as antidotes to barbiturate overdose. They are now most commonly used as experimental tools. (See all compounds classified as Convulsants.)', 'Endogenous compounds and drugs that bind to and activate GAMMA-AMINOBUTYRIC ACID receptors (RECEPTORS, GABA). (See all compounds classified as GABA Agonists.)', 'Drugs that bind to but do not activate GABA RECEPTORS, thereby blocking the actions of endogenous GAMMA-AMINOBUTYRIC ACID and GABA RECEPTOR AGONISTS. (See all compounds classified as GABA Antagonists.)']",,,
4916,104917,1-[1-(1-Benzothiophen-2-yl)ethyl]-3-hydroxyurea,CC(C1=CC2=CC=CC=C2S1)NC(=O)NO,,,,,,
4917,104918,CID 104918,CCCCN1C(=O)C(=CC=CC=C2N(C3=CC=CC=C3O2)CCCS(=O)(=O)[O-])C(=O)N(C1=O)CCCC.[Na+],,,,,,
4918,104919,"3-[2-[4-(1,3-Dibutyl-2,4,6-trioxo-1,3-diazinan-5-ylidene)but-2-enylidene]-1,3-benzoxazol-3-yl]propane-1-sulfonic acid",CCCCN1C(=O)C(=CC=CC=C2N(C3=CC=CC=C3O2)CCCS(=O)(=O)O)C(=O)N(C1=O)CCCC,,,,,,
4919,104920,Vanoxerine dihydrochloride,C1CN(CCN1CCCC2=CC=CC=C2)CCOC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F.Cl.Cl,,,['Drugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake. (See all compounds classified as Dopamine Uptake Inhibitors.)'],,,
4920,104921,Chromium(5+),[Cr+5],,,,,,
4921,104922,Dipropyl adipimidate dihydrochloride,CCCOC(=N)CCCCC(=N)OCCC.Cl.Cl,,,,,,
4922,104923,Dipropyl hexanediimidate,CCCOC(=N)CCCCC(=N)OCCC,,,,,,
4923,104924,"3-[4-[2-[[6-amino-9-[(3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxyoxolan-2-yl]purin-2-yl]amino]ethyl]phenyl]propanoic acid",CCNC(=O)[C@@H]1[C@H]([C@H](C(O1)N2C=NC3=C(N=C(N=C32)NCCC4=CC=C(C=C4)CCC(=O)O)N)O)O,,,,,,
4924,104925,Arriba,CCOP(=S)(OC1=CN=C(N=C1)C(C)(C)C)OC(C)C.CC1(C(C1C(=O)OC(C#N)C2=CC(=C(C=C2)F)OC3=CC=CC=C3)C=C(Cl)Cl)C,,,,,,
4925,104926,Cyfluthrin,CC1(C(C1C(=O)OC(C#N)C2=CC(=C(C=C2)F)OC3=CC=CC=C3)C=C(Cl)Cl)C,,,"['Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)']","['Nine male volunteers were exposed to the pyrethroid insecticide cyfluthrin. The study was performed in an exposure room, where an aerosol containing cyfluthrin was sprayed to obtain atmospheres with mean cyfluthrin concentrations of 160 and 40 ug/cu m. Four volunteers were exposed for 10, 30 and 60 min at 160 ug/cu m and another five volunteers were exposed for 60 min at 40 ug/cu m. For 160 ug/cu m exposure urine samples were collected before and immediately after exposure as well as for the periods 1-2, 2-3, 3-4, 4-5, 5-6, 6-12 and 12-24 hr after exposure. For 40 ug/cu m exposure urine samples were collected before and 2 hr after exposure. ... Of the metabolites, 93% was excreted within the first 24 hr (peak excretion rates between 0.5 and 3 hr) after inhalative exposure of 160 ug/cu m. ...  The amount of metabolites in urine depends on the applied dose, on the exposure time and shows interindividual differences.', '14C derived from the alcohol moiety was rapidly and completely excreted into urine and feces after single oral administration of 14C-alcohol labeled preparation to rats at 0.5 and 10 mg/kg, 55-70 and 25-35% of the dose being excreted into urine and feces, respectively. Excretion of 14C into bile was about 34%. The fat and sciatic nerve showed relatively higher 14C tissue residues.', 'The influence of the formulation vehicle on the rate of absorption of cyfluthrin was studied in groups of 14 fasted male Wistar rats given single doses by gavage of 10 mg/kg bw dissolved in either polyethylene glycol (PEG) 400 or a Cremophor EL:water emulsion. Two rats from each group were killed 0.5, 1, 2, 4, 6, 16, and 24 hr after treatment. The concentrations of cyfluthrin and its respective enantiomers were determined in the blood and stomach. When the compound was emulsified in the Cremophor EL:water solution, absorption was rapid; the  cis isomer was that most frequently detected within 30 min after treatment. Maximum peak blood concentrations occurred within 1 hr of treatment. Cyfluthrin emulsified in PEG 400 was not detected until 4 hr after administration, and peak blood levels were observed only 6 hr after treatment. Examination of the stomach contents revealed a larger quantity of cyfluthrin in the stomachs of rats treated with the drug in a PEG 400 emulsion', 'Four groups of 30 male and 24 female Mura:SPRA (SPF 68 Han) rats received 14C-radiolabelled cyfluthrin as either oral doses of 0.5 or 10 mg/kg bw or iv or intraduodenal doses of 0.5 mg/kg bw. Another group received unlabelled cyfluthrin orally once a day for 14 consecutive days, followed by a single oral dose of 0.5 mg/kg bw 14C-cyfluthrin. Excreta, organs, tissues, and blood samples were collected at several intervals and assayed for radiolabel.  After oral administration by any schedule, up to 80% of the labelled cyfluthrin was effectively absorbed by females and about 90% by males. ... Less than 2% of radiolabelled drug was present 48 hr after oral administration. No significant pulmonary excretion pathway exists, as < 0.001% was detected in the expired gaseous phase as 14CO21. About 98-99% of the orally administered dose was readily available for renal and fecal excretion ... . Males excreted two to three times more in the urine than in the feces, whereas the renal:fecal excretion ratio in females was 1.2-1.7:1 after oral administration. Consequently, the area under the curve (AUC) is two times larger for females than males.  Forty-eight hours after the iv injection, 93-95% of the dose was excreted, with a renal:fecal excretion ratio of 2.9:1 in males and 2.3:1 in females. Therefore, excretion depends somewhat on the route of administration and on sex. ... The residues found in the organs and tissues were influenced by the route of administration, as the mean relative concentration of cyfluthrin in the bodies of males and females at sacrifice was lower after oral administration (0.013) than after intravenous injection (0.06). Female rats had higher plasma concentrations after oral administration of the single high or low dose; 48 hr after administration, lower concentrations were detected in the bone and muscle of animals of each sex and in the testes of males rats. The sciatic nerve showed a similar relative concentration value, which may explain the toxic effects observed on the peripheral nervous system. Higher concentrations were detected in the spleen, adrenal glands, liver, and plasma of both males and females and in the ovaries. The renal fatty tissue concentration was about seven times higher after either oral or intravenous administration, whereas the mean concentration in brain was significantly lower ( p = 0.0006-0.006)...', 'For more Absorption, Distribution and Excretion (Complete) data for CYFLUTHRIN (9 total), please visit the HSDB record page.']","['Nine male volunteers were exposed to the pyrethroid insecticide cyfluthrin. ...  The main urinary cyfluthrin metabolites, cis-/trans-3-(2,2-dichlorovinyl)-2,2-dimethylycyclopropane carboxylic acid (DCCA) and 4-fluoro-3-phenoxybenzoic acid (FPBA), were determined. The limit of detection (LOD) for all metabolites was 0.0025 ug in an urine sample of 5 mL (0.5 ug/L). After inhalative exposure of 40 ug cyfluthrin/cu m air for 60 min, the amount of metabolites in urine collected in the first 2 hr after exposure was less than the LOD, namely 0.14 ug for cis-DCCA, 0.15-0.28 ug for trans-DCCA and 0.12-0.23 ug for FPBA. Of the metabolites, 93% was excreted within the first 24 hr (peak excretion rates between 0.5 and 3 hr) after inhalative exposure of 160 ug/cu m. ... The amount of metabolites in urine depends on the applied dose, on the exposure time and shows interindividual differences.', ""Eight hours after oral administration of 14C-labelled cyfluthrin at a dose of 10 mg/kg bw to three male Sprague-Dawley rats, about 60% of the labelled cyfluthrin was eliminated in the urine in conjugated forms. Conjugates of 4'-hydroxy-3-phenoxyfluorobenzoic acid (50%) were identified; a second major metabolite was identified after hydrochloric acid hydrolysis as a conjugate of 3-phenoxy-4-fluorohippuric acid (40%). These metabolites represented 33 and 27% of the administered radiolabel, respectively. A glycine conjugate constituted 2.5% of the conjugated metabolites."", ""In another study ... , four groups of five male and five female rats received 14C-cyfluthrin ... . The initial step in cyfluthrin biotransformation was ester hydrolysis, giving a 3-phenoxy-4-fluorobenzyl alcohol intermediate and the permethric acid fraction. The metabolism of permethric acid has been well established in the rat in studies with chemically similar pyrethroids. After ester hydrolysis, the 3-phenoxy-4-fluorobenzyl alcohol moiety was oxidized to the free metabolite 3-phenoxy-4-fluorobenzoic acid. This metabolite can then either be conjugated with glycine to form 3-phenoxy-4-fluorohippuric acid (a minor metabolite constituting < 3% of the recovered urinary radiolabel, dependent on neither sex nor dose) or hydroxylated to give 4'-hydroxy-3-phenoxy-4-fluorobenzoic acid (conjugates of which account for 41-50% of the total urinary radiolabel recovered from rats given one or multiple doses of cyfluthrin at 0.5 mg/kg bw). Females tended to excrete more of this metabolite as the free form in the faeces than did males. Males and females at the high dose (10 mg/kg bw) excreted about 35% of the administered dose as conjugates of 4'-hydroxy-3-phenoxy-4-fluorobenzoic acid, whereas females excreted about 5% more than males as the free metabolite. After repeated oral doses of 0.5 mg/kg bw for 14 days, 12-16% of labelled metabolite was found in the faeces as cyfluthrin, whereas < 1% was found when single oral doses were administered. After a single high dose of 10 mg/kg bw, 17-19% was recovered in the faeces as parent compound. The authors concluded that the metabolism of cyfluthrin is slightly dose-dependent."", 'The metabolic pathways for the breakdown of the pyrethroids vary little between mammalian species but vary somewhat with structure. ... Essentially, pyrethrum and allethrin are broken down mainly by oxidation of the isobutenyl side chain of the acid moiety and of the unsaturated side chain of the alcohol moiety with ester hydrolysis playing and important part, whereas for the other pyrethroids ester hydrolysis predominates. /Pyrethrum and pyrethroids/', 'For more Metabolism/Metabolites (Complete) data for CYFLUTHRIN (8 total), please visit the HSDB record page.']","['Nine male volunteers were exposed to the pyrethroid insecticide cyfluthrin. ...  The mean half-lives were 6.9 hr for cis-3-(2,2-dichlorovinyl)-2,2-dimethylycyclopropane carboxylic acid (cis-DCCA), 6.2 hr for trans- 3-(2,2-dichlorovinyl)-2,2-dimethylycyclopropane carboxylic acid (trans-DCCA) and 5.3 hr for 4-fluoro-3-phenoxybenzoic acid. The mean trans-:cis-DCCA ratio was 1.9 for the time course as well as for each subject. ...', '... A cyfluthrin elimination experiment showed that cyfluthrin metabolites are eliminated following first-order kinetics (t 1/2 = 6.4 hr )...']"
4926,104927,CID 104927,C1C[C@H]2[C@H]([C@H]([C@@H]1O2)CC=CCCCC(=O)O)CNNC(=O)NC3=CC=CC=C3,,,,,,
4927,104928,8-Chlorodiltiazem,CC(=O)OC1C(SC2=C(C=CC(=C2)Cl)N(C1=O)CCN(C)C)C3=CC=C(C=C3)OC,,,"['Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)', 'Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)', 'A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)']",,,
4928,104929,"1-(1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl)-3-(3-methylphenyl)urea",CC1=CC(=CC=C1)NC(=O)NC2C(=O)N(C3=CC=CC=C3C(=N2)C4=CC=CC=C4)C,,,,,,
4929,104930,Trimethylarsine oxide,C[As](=O)(C)C,,,,,,
4930,104931,Eudragit RS,CCOC(=O)C=C.CC(=C)C(=O)OC.CC(=C)C(=O)OCC[N+](C)(C)C.[Cl-],,,,,,
4931,104932,CID 104932,C1CCC(CC1)N.C1COP(=O)(N[C@H]1SCCS(=O)(=O)O)N(CCCl)CCCl,,,,,,
4932,104933,Trilazad mesylate,C[C@]12CC=C3[C@H]([C@@H]1CC[C@@H]2C(=O)CN4CCN(CC4)C5=NC(=NC(=C5)N6CCCC6)N7CCCC7)CCC8=CC(=O)C=C[C@@]83C.CS(=O)(=O)O,,,"['Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)', 'Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)', 'Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. (See all compounds classified as Radiation-Protective Agents.)', 'Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)']",,,
4933,104934,"(8S,10S,13S,14S,17S)-17-[2-[4-(2,6-dipyrrolidin-1-ylpyrimidin-4-yl)piperazin-1-yl]acetyl]-10,13-dimethyl-6,7,8,12,14,15,16,17-octahydrocyclopenta[a]phenanthren-3-one",C[C@]12CC=C3[C@H]([C@@H]1CC[C@@H]2C(=O)CN4CCN(CC4)C5=NC(=NC(=C5)N6CCCC6)N7CCCC7)CCC8=CC(=O)C=C[C@@]83C,,,"['Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)', 'Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)', 'Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)', 'Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. (See all compounds classified as Radiation-Protective Agents.)']",,,
4934,104935,CID 104935,C1C(N=C(S1)S)C(=O)O,,,,,,
4935,104936,1-Nitropyrene-3-ol,C1=CC2=C3C(=C1)C=CC4=C(C=C(C(=C43)C=C2)[N+](=O)[O-])O,,,,,['3-hydroxy-1-nitropyrene is a known human metabolite of 1-nitropyrene.'],
4936,104937,"N-[(15R,16S,17R,18S)-17-methoxy-17,18-dimethyl-5-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1,6,8,10,12,20,22,24,26-nonaen-16-yl]-N-methylbenzamide",C[C@]1([C@@H]([C@@H]2N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N(C7=C53)[C@]1(O2)C)CNC6=O)N(C)C(=O)C9=CC=CC=C9)OC,,,,,,
4937,104938,Lactose monohydrate,C([C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@@H]([C@@H]([C@H]2O)O)O)CO)O)O)O)O.O,,,,,,
4938,104939,CID 104939,C([C@@H]1C([C@@H]([C@H]([C@@H](O1)OC2[C@H](O[C@@H]([C@@H]([C@H]2O)O)O)CO)O)O)O)O,,,,,,
4939,104940,O-Methylsterigmatocystin,COC1=CC=CC2=C1C(=O)C3=C(C=C4C(=C3O2)[C@@H]5C=CO[C@@H]5O4)OC,,,,,,
4940,104941,CID 104941,C1=NC(=C2C(=N1)N(C=N2)C3[C@@H]([C@@H](C(O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)S)O)O)N,,,,,,
4941,104942,"3,3',4,4',5,5'-Hexabromobiphenyl",C1=C(C=C(C(=C1Br)Br)Br)C2=CC(=C(C(=C2)Br)Br)Br,,,,,,
4942,104943,2-(Diphenylmethyl)-N-((2-methoxyphenyl)methyl)-1-azabicyclo(2.2.2)octan-3-amine,COC1=CC=CC=C1CN[C@@H]2[C@@H](N3CCC2CC3)C(C4=CC=CC=C4)C5=CC=CC=C5,,,"['Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)', 'Drugs used to induce drowsiness or sleep or to reduce psychological excitement or anxiety. (See all compounds classified as Hypnotics and Sedatives.)']",,,
4943,104944,Benzene oxide,C1=CC2C(O2)C=C1,,,,,,
4944,104945,"(3R,4S)-2-[6-(cyclohexylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol",C1CCC(CC1)NC2=C3C(=NC=N2)N(C=N3)C4[C@@H]([C@@H](C(O4)CO)O)O,,,,,,
4945,104946,Lilly 117018,C1CCN(C1)CCOC2=CC=C(C=C2)C(=O)C3=C(SC4=C3C=CC(=C4)O)C5=CC=C(C=C5)O,,,"['A structurally diverse group of compounds distinguished from ESTROGENS by their ability to bind and activate ESTROGEN RECEPTORS but act as either an agonist or antagonist depending on the tissue type and hormonal milieu. They are classified as either first generation because they demonstrate estrogen agonist properties in the ENDOMETRIUM or second generation based on their patterns of tissue specificity. (Horm Res 1997;48:155-63) (See all compounds classified as Selective Estrogen Receptor Modulators.)', 'Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. (See all compounds classified as Estrogen Antagonists.)']",,,
4946,104947,CID 104947,C1[C@@H]([C@H](O[C@H]1N2C3=C(C(=O)N=C(N3)N)N=C2NC4=CC5=C(C=C4)C6=CC=CC=C6C5)CO)O,,,,,,
4947,104948,Phenyl-lambda2-stannane,C1=CC=C(C=C1)[SnH],,,,,,
4948,104949,"4,4''-Diamino-p-terphenyl",C1=CC(=CC=C1C2=CC=C(C=C2)N)C3=CC=C(C=C3)N,,,,,,
4949,104950,CID 104950,[67GaH3],,,,,,
4950,104951,CID 104951,[207PbH2],,,,,,
4951,104952,CID 104952,C1CN2C(=N[C@H]([C@H]3C2(C1(O)O)N=C(N3)N)CO)N,,,,,,
4952,104953,Hydroxymethyltrioxsalen,CC1=CC(=O)OC2=C(C3=C(C=C12)C(=C(O3)C)CO)C,,,"['Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. (See all compounds classified as Cross-Linking Reagents.)']",,,
4953,104954,"2-Hydroxyamino-1-methyl-6-phenylimidazo(4,5-b)pyridine",CN1C2=C(N=CC(=C2)C3=CC=CC=C3)N=C1NO,,,"['Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)', 'Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)']",,['N2-Hydroxy-PhIP has known human metabolites that include N2-Hydroxy-PhIP-N2-glucuronide and N2-Hydroxy-PhIP-N3-glucuronide.'],
4954,104955,1-(2-(3-(4-Methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole hydrochloride,COC1=CC=C(C=C1)CCCOC(CN2C=CN=C2)C3=CC=C(C=C3)OC.Cl,,,"['Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)', 'A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)']",,,
4955,104956,1-(2-(3-(4-Methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole,COC1=CC=C(C=C1)CCCOC(CN2C=CN=C2)C3=CC=C(C=C3)OC,,,"['A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)', 'Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)']",,,
4956,104957,Chromium(III) chloride hexahydrate,O.O.O.O.O.O.Cl[Cr](Cl)Cl,,,,,,
4957,104958,Neptunium-239,[239Np],,,,,,
4958,104959,CID 104959,COC(=O)C=CC(=O)N[C@@H]1CC[C@]2([C@@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)O)CCN3CC6CC6)O,,,,,,
4959,104960,CID 104960,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CSC=C3)C(=O)O)C(=O)O)C.C1[C@@H]2N(C1=O)[C@H](C(=CCO)O2)C(=O)O,,,,,,
4960,104961,alpha-Carboxy-alpha-3-thienylmethylpenicillin,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C(C3=CSC=C3)C(=O)O)C(=O)O)C,,,,,,
4961,104962,2-Amino-4-methyl-5-phosphonopent-3-enoic acid,CC(=CC(C(=O)O)N)CP(=O)(O)O,,,,,,
4962,104963,N-Methyl-N-nitrosoguanidine,CN(C(=N)N)N=O,,,,,,
4963,104964,Yttrium-91,[91Y],,,,,,
4964,104965,CID 104965,C[C@H](CCC(=O)NCCS(=O)(=O)O)[C@H]1CCC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C,,,,,,
4965,104966,Iodine I-132,[132IH],,,,,,
4966,104967,Cesium ion,[Cs+],,,,,,
4967,104968,"(3R,4S,5R)-2-[6-(cyclopentylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol",C1CCC(C1)NC2=C3C(=NC=N2)N(C=N3)C4[C@@H]([C@@H]([C@H](O4)CO)O)O,,,,,,
4968,104969,Arotinoid; Arotinoid ethyl ester,CCOC(=O)C1=CC=C(C=C1)C=C(C)C2=CC3=C(C=C2)C(CCC3(C)C)(C)C,,,['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)'],,,
4969,104970,"9-[3-(Diaminomethylideneamino)propyl]-2-ethylidene-12-(6-methoxy-3,5-dimethyl-7-phenylhepta-1,3-dienyl)-1,6,13-trimethyl-3,7,10,14,19-pentaoxo-1,4,8,11,15-pentazacyclononadecane-5,16-dicarboxylic acid",CC=C1C(=O)NC(C(C(=O)NC(C(=O)NC(C(C(=O)NC(CCC(=O)N1C)C(=O)O)C)C=CC(=CC(C)C(CC2=CC=CC=C2)OC)C)CCCN=C(N)N)C)C(=O)O,,,,,,
4970,104971,(~226~Rn)Radon,[226Rn],,,,,,
4971,104972,Norverapamil,CC(C)C(CCCNCCC1=CC(=C(C=C1)OC)OC)(C#N)C2=CC(=C(C=C2)OC)OC,,,['A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)'],,"['Norverapamil has known human metabolites that include 2-(3,4-dimethoxyphenyl)acetaldehyde, 5-Amino-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile, and D-715 (PR-22).']",
4972,104973,Chlorethylclonidine,CN(CCCl)CC1=CC(=C(C(=C1)Cl)NC2=NCCN2)Cl,,,"['Highly reactive chemicals that introduce alkyl radicals into biologically active molecules and thereby prevent their proper functioning. Many are used as antineoplastic agents, but most are very toxic, with carcinogenic, mutagenic, teratogenic, and immunosuppressant actions. They have also been used as components in poison gases. (See all compounds classified as Alkylating Agents.)', 'Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)']",,,
4973,104974,Saredutant,CC(=O)NC1(CCN(CC1)CC[C@H](CN(C)C(=O)C2=CC=CC=C2)C3=CC(=C(C=C3)Cl)Cl)C4=CC=CC=C4,['Investigated for use/treatment in depression and anxiety disorders.'],,,,,
4974,104975,"9,10-Epoxy-9,10-dihydrophenanthrene",C1=CC=C2C(=C1)C3C(O3)C4=CC=CC=C42,,,,,,
4975,104976,Molybdenum-99,[99Mo],,,,,,
4976,104977,1-Pyrenemethanol,C1=CC2=C3C(=C1)C=CC4=C(C=CC(=C43)C=C2)CO,,,,,['1-hydroxymethylpyrene has known human metabolites that include 1-Sulfooxymethylpyrene.'],
4977,104978,Fluo-3,CC1=CC(=C(C=C1)N(CC(=O)O)CC(=O)O)OCCOC2=C(C=CC(=C2)C3=C4C=C(C(=O)C=C4OC5=CC(=C(C=C53)Cl)O)Cl)N(CC(=O)O)CC(=O)O,,,"['Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)']",,,
4978,104979,CID 104979,[201TlH],,,,,,
4979,104980,"2-Methyl-1,2-di-4-pyridinyl-1-propanone",CC(C)(C1=CC=NC=C1)C(=O)C2=CC=NC=C2,,,,,,
4980,104981,Propidium iodide,CC[N+](C)(CC)CCC[N+]1=C2C=C(C=CC2=C3C=CC(=CC3=C1C4=CC=CC=C4)N)N.[I-].[I-],,,"['Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)', 'Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)', 'Agents that are capable of inserting themselves between the successive bases in DNA, thus kinking, uncoiling or otherwise deforming it and therefore preventing its proper functioning. They are used in the study of DNA. (See all compounds classified as Intercalating Agents.)']",,,
4981,104982,"(4-Acetyloxy-6,10-dimethyl-3-propan-2-yl-11-oxabicyclo[8.1.0]undec-6-en-2-yl) 3,4,5-trimethoxybenzoate",CC1=CCCC2(C(O2)C(C(C(C1)OC(=O)C)C(C)C)OC(=O)C3=CC(=C(C(=C3)OC)OC)OC)C,,,,,,
4982,104983,Laurdan,CCCCCCCCCCCC(=O)C1=CC2=C(C=C1)C=C(C=C2)N(C)C,,,"['Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)']",,,
4983,104984,CID 104984,C1=CC(=CC=C1OC2=CN=C(C=C2Cl)Cl)OC3=C(C=C(C=N3)Cl)Cl,,,,,,
4984,104985,CID 104985,C1[C@@H](C([C@@]23N1C(=N[C@H]([C@@H]2NC(=N3)N)COC(=O)NS(=O)(=O)O)N)(O)O)OS(=O)(=O)O,,,,,,
4985,104986,10-Aminocamptothecin,CC[C@@]1(C2=C(COC1=O)C(=O)N3CC4=C(C3=C2)N=C5C=CC(=CC5=C4)N)O,,,,,,
4986,104987,Benz(j)aceanthrylene,C1=CC=C2C(=C1)C=CC3=C2C=C4C=CC=C5C4=C3C=C5,,,,,,
4987,104988,"1-Pyrenol, 6-nitro-",C1=CC2=C(C=CC3=C2C4=C1C=CC(=C4C=C3)O)[N+](=O)[O-],,,,,['6-hydroxy-1-nitropyrene is a known human metabolite of 1-nitropyrene.'],
4988,104989,"Trichothec-9-ene-4,15-diol, 12,13-epoxy-, (4beta)-",CC1=C[C@@H]2[C@](CC1)(C3([C@@H](C[C@H](C34CO4)O2)O)C)CO,,,,,,
4989,104990,"1,2,3-Propanetriol, polymer with (chloromethyl)oxirane",C1C(O1)CCl.C(C(CO)O)O,,,,,,
4990,104991,CID 104991,C[C@H](CCCC(C)(C)O)[C@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@H](CC(C3=C)O)O)C,,,,,,
4991,104992,H-DL-Met(O2)-Glu-His-Phe-D-Lys-Phe-OH,CS(=O)(=O)CCC(C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CC2=CC=CC=C2)C(=O)N[C@H](CCCCN)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)O)N,,,,,,
4992,104993,"4H-1,3,2-Benzodioxaphosphorin, 2-(2-methylphenoxy)-, 2-oxide",CC1=CC=CC=C1OP2(=O)OCC3=CC=CC=C3O2,,,,,,
4993,104994,"1,N6-Ethenoadenine",C1=CN2C=NC3=C(C2=N1)NC=N3,,,['Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. (See all compounds classified as Mutagens.)'],,,
4994,104995,"8,16,18-Trimethoxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),12,15,17-tetraen-2-one",CC1CCCC(CCCC=CC2=C(C(=CC(=C2)OC)OC)C(=O)O1)OC,,,,,,
4995,104996,CID 104996,C1CN2C(=N[C@H]([C@H]3[C@]2(C1(O)O)N=C(N3)N)COC(=O)NS(=O)(=O)O)N,,,,,,
4996,104997,Pimonidazole hydrochloride,C1CCN(CC1)CC(CN2C=CN=C2[N+](=O)[O-])O.Cl,,,,,,
4997,104998,"2-Hydroxyamino-6-methyldipyrido(1,2-a:3',2'-d)imidazole",CC1=CC=CN2C1=NC3=C2N=C(C=C3)NO,,,,,"['N-hydroxy-2-amino-6-methyldipyrido[1,2-a:3p,2p-d]-imidazole has known human metabolites that include [(10-methyl-1,3,8-triazatricyclo[7.4.0.02,7]trideca-2(7),3,5,8,10,12-hexaen-4-yl)amino] hydrogen sulfate.']",
4998,104999,"Methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate",CCC1=C2C3=CC(=C(C=C3NC2=CN=C1C(=O)OC)OC)OC,,,"['Substances that act in the brain stem or spinal cord to produce tonic or clonic convulsions, often by removing normal inhibitory tone. They were formerly used to stimulate respiration or as antidotes to barbiturate overdose. They are now most commonly used as experimental tools. (See all compounds classified as Convulsants.)']",,,
4999,105000,Indolactam V,CC(C)[C@H]1C(=O)N[C@@H](CC2=CNC3=C2C(=CC=C3)N1C)CO,,,"['Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)']",,,
5000,105001,CID 105001,C1=CC(=CC=C1C(=O)[O-])O,,,,,,
5001,105002,"[(3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] (3R)-3-hydroxy-N-sulfooxypent-4-enimidothioate",C=C[C@@H](CC(=NOS(=O)(=O)O)SC1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)O,,,,,,
5002,105003,Kalzinol,COC1=C(C=CC(=C1)CC=C)O.O=[Zn],,,,,,
5003,105004,CID 105004,[24NaH],,,,,,
5004,105005,Thallium (I) ion,[Tl+],,,,,,
5005,105006,CID 105006,CCCC1=C(C=CC(=C1O)C(=O)C)OCC(COC2=C(C3=C(C=C2)C(=O)C=C(O3)C(=O)[O-])CCC)O.[Na+],,,,,,
5006,105007,7-[3-(4-Acetyl-3-hydroxy-2-propylphenoxy)-2-hydroxypropoxy]-4-oxo-8-propylchromene-2-carboxylic acid,CCCC1=C(C=CC(=C1O)C(=O)C)OCC(COC2=C(C3=C(C=C2)C(=O)C=C(O3)C(=O)O)CCC)O,,,['A class of drugs designed to prevent leukotriene synthesis or activity by blocking binding at the receptor level. (See all compounds classified as Leukotriene Antagonists.)'],,,
5007,105008,Paxilline,C[C@]12CC[C@H]3C(=CC(=O)[C@H](O3)C(C)(C)O)[C@@]1(CC[C@@H]4[C@@]2(C5=C(C4)C6=CC=CC=C6N5)C)O,,,['A class of drugs that act by inhibition of potassium efflux through cell membranes. Blockade of potassium channels prolongs the duration of ACTION POTENTIALS. They are used as ANTI-ARRHYTHMIA AGENTS and VASODILATOR AGENTS. (See all compounds classified as Potassium Channel Blockers.)'],,,
5008,105009,Prolinedithiocarbamate,C1C[C@H](NC1)C(=S)S,,,"['Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)', 'Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)']",,,
5009,105010,Methoxyfenozide,CC1=CC(=CC(=C1)C(=O)N(C(C)(C)C)NC(=O)C2=C(C(=CC=C2)OC)C)C,,,"['Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)']","['Forty two groups of Sprague Dawley rats (up to 5/sex/group) were dosed by oral gavage with either (14)C-t-butyl-, (14)C-A-Ring-, or (14)C-B-Ring-Methoxyfenozide at doses of 10 or 1000 mg/kg. Some treatments were performed by combining appropriate amount of non-labeled or (13)C-labeled Methoxyfenozide to the (14)C-Methoxyfenozide. Three types of experiments were performed: (1) determination of excretion, distribution, and mass balance 120 hours post dose; (2) pharmacokinetics in blood (Cmax and 1/2 Cmax); and (3) tissue distribution of (14)C at Cmax and 1/2 Cmax. The (14)C was mostly excreted during the first 24 hours with 58-77% of the administered dose recovered in the feces and 4-9% of the dose found in urine from day 0-1. The position of the carbon label did not alter the excretion profile significantly. Approximately, 0.07-0.23% of (14)C remained in the tissues, and 0.03-0.11% were recovered as (14)C-CO2 and volatile organics from day 0-5 post dose. The maximum concentrations of (14)C-Methoxyfenozide in the blood were observed at 15-30 minutes post dose for all three (14)C-labels. The highest tissue concentration of (14)C was in the liver. The (14)C residues were rapidly cleared from all organs in the rat. Based on the recovery of (14)C from the bile, urine, tissues and carcasses, 62-70% of the administered dose was systemically absorbed.', 'The tissue distribution of radioactivity was investigated after a single dose of A-ring-labelled or t-butyl-labelled methoxyfenozide administered by gavage (at Cmax, 1/2 Cmax and at 5 days after dosing at 10 or 1000 mg/kg bw), and after a single dose of B-ring-labelled methoxyfenozide (5 days after dosing at 10 mg/kg bw). Tissue distribution was also investigated after dosing with A-ring-labelled methoxyfenozide at 10 mg/kg bw as a pulse dose (5 days after dosing) and as a repeated dose (at 0.25 hr after the last dose, at about Cmax). Similar results were seen in all experiments. The absorbed radioactivity was widely distributed, with the highest concentration of absorbed radioactivity found in the liver at 0.5-2 hr after dosing (the higher concentrations found in the stomach and intestinal tract were attributed to largely unabsorbed material). ... Clearance from the body was extensive; 5 days after a single dose of 10 mg/kg bw, the highest percentage of radioactivity, representing <0.1% of the administered dose, was found in the liver.', 'The biliary excretion of radiolabel after a single oral dose of ((14)C-A-ring) methoxyfenozide at 10 mg/kg was investigated in bile-duct cannulated rats. Biliary excretion was rapid, with 22% (females) and 50% (males) of the administered dose being excreted within 12 hr. Overall, 38% (females) and 64% (males) of the radiolabel was excreted in bile within 72 hr. Considerable variability between individual animals was seen in cannulated female rats (bile, 13-55%; and urine, 5-43% within 72 hr), but the overall amount absorbed (in bile, urine, carcass and tissues) was similar for all four females (56-67%). Taking the biliary component into account, the overall extent of oral absorption of methoxyfenozide at a dose of 10 mg/kg bw was 60-70% in both sexes.', 'The dermal absorption in vivo of methoxyfenozide formulated as an aqueous flow-able liquid (RH-112,485 2F) or as a wettable powder (RH-112,485 280WP) was tested in rats in a study that was designed to comply with US EPA guidelines and GLP. The methoxyfenozide administered was uniformly labelled with (14)C on the methoxyphenyl ring; this is acceptable given the limited cleavage seen in studies of oral metabolism. To provide data on exposure to the concentrated product and in-use-dilutions, groups of four male Crl : CD BR rats received radiolabelled methoxyfenozide at three aqueous dilutions (0.025, 0.25, or 2.5% w/v), applied in a volume of 100 uL to a shaved area of about 10 sq cm for 1, 10, or 24 hr. Systemically absorbed methoxyfenozide was defined as the radiolabel found in the carcass, urine (plus urine funnel and cage washes), feces, and whole blood. For RH-112,485 2F, the total mean recovery of radiolabel in all groups ranged from 98% to 114%. After an exposure of 1, 10, or 24 hr to (14)C-labelled RH-112,485 2F formulation diluted in water to a concentration of 2.5, 0.25, or 0.025% w/v, a small amount of radiolabel (<1-4%) was systemically absorbed. For RH-112,485 280 WP, three animals with poor recoveries were excluded from further analysis. The total mean recovery of radiolabel in all groups ranged from 85% to 110%. After an exposure of 1, 10, or 24 hr to (14)C-labelled RH-112,485 280 WP at a concentration of 2.5, 0.25, or 0.025% w/v, <1-2% of radiolabel was systemically absorbed. Findings were similar for both formulations. The amount of radiolabel that was systemically absorbed did not increase linearly between the 10-hr and 24-hr exposure periods, indicating that most of the radiolabel that remained in or on the skin after washing was tightly bound and was not available for systemic absorption. This study shows that methoxyfenozide is poorly absorbed (<4%) after dermal exposure to either of the formulated products or in-use dilutions. The low rate of dermal absorption may be attributed to very low solubility in water (3.3 mg/L at 20 °C).']","['Forty two groups of Sprague Dawley rats (up to 5/sex/group) were dosed by oral gavage with either (14)C-t-butyl-, (14)C-A-Ring-, or (14)C-B-Ring-Methoxyfenozide at doses of 10 or 1000 mg/kg. ... (14)C- Methoxyfenozide was extensively metabolized into 32 metabolites (26 identified) isolated from urine and feces, and 24 metabolites were found and characterized from the bile. Seven metabolites comprised of 59-69% and 42-56% of the dose at 10 and 1000 mg/kg dose levels, respectively. Parent comprised of 14-26% and 30-39% of the administered (14)C at 10 and 1000 mg/kg dose levels, respectively.', 'Parent compound was found only in the feces (not in the urine or bile) and comprised 14-26% and 30-39% of the administered dose for animals at the lower and higher doses, respectively, indicating that animals at the lower dose metabolized a greater fraction of the administered dose compared with animals at the higher dose. Seven metabolites (M10, M14, M16, M22, M24, M28, M30) were found to be present in feces plus urine each at >2% of the administered dose. The predominant metabolites were M14 (desmethylated parent) and M24 (hydroxy methyl derivative). Parent compound plus these seven metabolites accounted for 74-90% of the administered dose (in feces plus urine) in all groups. For each of these groups, the total of parent plus identified metabolites accounted for >/= 83% of the administered dose, i.e. the metabolic profile of methoxyfenozide in feces and urine was well defined. Less than 5% of the administered dose was present as metabolites formed from the cleavage of the amide bridge.', 'Two metabolites, M16 (A-ring glucuronide of M14) and M26 (A-ring glucuronide of M24), were the main metabolites in bile. M16 was present at 13% and 18% in males and females respectively, M26 was present at 5% in males and 11% in females, all other metabolites represented <3% of the administered dose. The presence of M16 and M26 at higher concentrations in bile than in feces indicates that these two metabolites were subject to subsequent hydrolysis.', 'The primary /metabolic/ pathway probably involves demethylation of the A-ring methoxy moiety to form the corresponding phenol (M14), which is conjugated with glucuronic acid to form M16. Hydroxylation on the B-ring methyl moieties is also a significant metabolic pathway. Cleavage of methoxyfenozide to release either of the rings or the t-butyl group is only a minor pathway; none of the cleaved metabolites (M06, M07, M13, M32-36) were present at >2% of the dose. In males, however, cleaved metabolites represented up to about 50% of the metabolites found in urine. There was an indication that males cleaved more of the absorbed dose than did females, on the basis of urinary metabolite patterns.', 'Results for the animals receiving diets containing methoxyfenozide for 14 days plus a single dose of (14C) methoxyfenozide at 10 mg/kg bw by gavage showed evidence of induction of metabolism. Concentrations of M22, M28 and M30 increased, while concentrations of M14 and M24 were reduced relative to concentrations in animals that received only a single dose of (14C) methoxyfenozide at 10 mg/kg bw.']",
5010,105011,All-trans-retinoyl B-glucuronide,CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C(=O)O)O)O)O)C)C,,,,,,
5011,105012,Europium-154,[154Eu],,,,,,
5012,105013,CID 105013,[111InH3],,,,,,
5013,105014,"3,9,15-Tribenzyl-4,10,16-trimethyl-6,12,18-tri(propan-2-yl)-1,7,13-trioxa-4,10,16-triazacyclooctadecane-2,5,8,11,14,17-hexone",CC(C)C1C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)O1)CC2=CC=CC=C2)C)C(C)C)CC3=CC=CC=C3)C)C(C)C)CC4=CC=CC=C4)C,,,,,,
5014,105015,"Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether",C(OC(=C(F)F)C(F)(F)F)F,,,"['Gases or volatile liquids that vary in the rate at which they induce anesthesia; potency; the degree of circulation, respiratory, or neuromuscular depression they produce; and analgesic effects. Inhalation anesthetics have advantages over intravenous agents in that the depth of anesthesia can be changed rapidly by altering the inhaled concentration. Because of their rapid elimination, any postoperative respiratory depression is of relatively short duration. (From AMA Drug Evaluations Annual, 1994, p173) (See all compounds classified as Anesthetics, Inhalation.)']",,,
5015,105016,"9-(2-Deoxypentofuranosyl)-2-imino-8,9-dihydro-2H-purine-6,8-diol",C1[C@@H]([C@H](OC1N2C(N=C3C2=NC(=NC3=O)N)O)CO)O,,,,,,
5016,105017,CID 105017,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2C(F)(F)F)C(=O)OCCN=C(C3=CC=C(C=C3)N[N+]#N)[O-])C)C,,,,,,
5017,105018,CID 105018,CCOC(=O)C1=C(NC(=C(C1C2=CC=CC=C2C(F)(F)F)C(=O)OCCNC(=O)C3=CC=C(C=C3)N[N+]#N)C)C,,,,,,
5018,105019,"7,8,9,10-Tetrahydrobenzo[a]pyrene-7,8,9,10-tetrol",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4C(C(C(C5O)O)O)O)C=C2,,,,,,
5019,105020,"Benzo[a]pyrene-7,8-dione",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4C=CC(=O)C5=O)C=C2,,,,,,
5020,105021,"Fructose-2,6-diphosphate",C([C@@H]1[C@H]([C@@H]([C@](O1)(CO)OP(=O)(O)O)O)O)OP(=O)(O)O,,,,,,
5021,105022,1-Nitropyrene-8-ol,C1=CC2=C3C(=C(C=C2)O)C=CC4=C(C=CC1=C43)[N+](=O)[O-],,,,,['8-hydroxy-1-nitropyrene is a known human metabolite of 1-nitropyrene.'],
5022,105023,Deacetylanguidin,CC1=C[C@@H]2[C@](CC1)(C3([C@@H]([C@H]([C@H](C34CO4)O2)O)O)C)COC(=O)C,,,,,,
5023,105024,L-selenomethionine,C[Se]CC[C@@H](C(=O)O)N,,,,,,
5024,105025,CID 105025,CCC1(CCC(C2=CC3=C4C(=CNC4=C21)CC(NC(=O)C(N3C)C(C)C)CO)(C)CC(C)C)C,,,,,,
5025,105026,Carbon-13,[13CH4],,,,,,
5026,105027,CID 105027,[86RbH],,,,,,
5027,105028,CID 105028,CC(=O)N(C1=CC2=C(C=C1)C3=CC=CC=C3C2)C4=NC5=C(N4C6C[C@@H]([C@H](O6)CO)O)NC(=NC5=O)N,,,,,,
5028,105029,"21-(Acetyloxy)-11,17-dihydroxypregn-4-ene-3,20-dione",CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)O)C)O,,,,,,
5029,105030,CID 105030,C1=NC2=C(N1C3[C@@H]([C@@H](C(O3)COP(=O)(O)OP(=O)(O)S)O)O)NC(=NC2=O)N,,,,,,
5030,105031,"4-Oxo-4-[(1,5,9-trimethyl-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadecan-10-yl)oxy]butanoic acid",CC1CCC2C(C(OC3C24C1CCC(O3)(OO4)C)OC(=O)CCC(=O)O)C,['Treatment of severe malaria caused by Plasmodium falciparum'],,,"['Following administration to humans, artesunate is rapidly hydrolyzed to its principal active metabolite, dihydroartemisinin.  The pharmacokinetics of artesunate are characterized by marked inter-subject variability, differing significantly between healthy volunteers and infected patients, and among patients with different disease severity.', ""The pharmacokinetic of artesunate and dihydroartemisin are characterized by marked inter-subject variability. The pharmacokinetic parameters of artesunate and dihydroartemisinin differ significantly between healthy volunteers and infected patients, and among patients with different disease severity. Pharmacokinetic data from unbound plasma concentrations of artesunate or dihydroartemisinin should be interpreted with caution because the drug accumulates selectively in parasitized RBC's In in vitro experiments, accumulation of dihydroartemisinin in infected RBC's is in concentrations approximately 300-fold higher than those in plasma ."", 'The pharmacokinetics of oral dihydroartemisinin (DHA) following the dose of 2 and 4 mg/ kg body weight dihydroartemisinin and 4 mg/kg body weight oral artesunate (AS) were investigated in 20 healthy Thai volunteers (10 males, 10 females). All formulations were generally well tolerated. Oral DHA was rapidly absorbed from gastrointestinal tract with marked inter-individual variation. The pharmacokinetics of DHA following the two dose levels were similar and linearity in its kinetics was observed. Based on the model-independent pharmacokinetic analysis, median (95% CI) values for Cmax of 181 (120-306) and 360 (181-658) ng/ml were achieved at 1.5 hours following 2 and 4 mg/kg body weight dose, respectively. The corresponding values for AUC0-infinity, t1/2z, CL/f and Vz/f were 377 (199-1,128) vs 907 (324-2,289) ng.hr/mL, 0.96 (0.70-1.81) vs 1.2 (0.75-1.44) hours, 7.7 (4.3-12.3) vs 6.6 (3.1-10.1) L/kg, and 90.5 (28.6-178.2) vs 6.6 (3.1-10.1) mL/min/kg, respectively (2 vs 4 mg/kg dose). Oral AS was rapidly biotransformed to DHA, which was detectable in plasma as early as 15 minutes of AS dosing. Following 4 mg/kg dose, median (95% CI) value for Cmax of 519 (236-284) ng/mL was achieved at 0.7 (0.25-1.5) hours. AUC0-infinity, and t1/2z were 657 (362-2,079) ng.hr/mL, 0.74 (0.34-1.42) hours, respectively. Cmax of DHA following oral AS were significantly higher, but total systemic exposure was greater following oral DHA at the same dose level (4 mg/kg body weight). There was no significant sex difference in pharmacokinetics of DHA', 'The aims of this study were to determine the pharmacokinetic parameters of a single dose of 200 mg oral and rectal artesunate in healthy volunteers, and to suggest a rational dosage regimen for rectal administration. The study design was a randomized open cross-over study of 12 healthy volunteers... Pharmacokinetic parameters were derived from the main metabolite alpha-dihydroartemisinin data due to the rapid disappearance of artesunate from the plasma. Dihydroartemisinin following oral administration of artesunate had a significantly higher AUC(0-infinity) (P<0.05 95% confidence interval (CI) -1168.73, -667.61 ng x hr/mL(-1)) and Cmax (P<0.05; 95% CI -419.73, -171.44 ng/mL(-1)), and had shorter tmax (P<0.05; 95% CI -0.97, -0.10 hr) than that following rectal artesunate. There was no statistically significant difference in the elimination half-life between both routes of administration (P>0.05; 95% CI -0.14, 0.53 hr). The relative bioavailability of rectal artesunate was [mean (coefficient of variation %) 54.9 (24.8%) %].', 'For more Absorption, Distribution and Excretion (Complete) data for ARTESUNIC ACID (8 total), please visit the HSDB record page.']","['Following administration to humans, artesunate is rapidly hydrolyzed to its principle active metabolite, dihydroartemisinin. Data from in vitro studies with human liver microsomes and from clinical studies suggest that DHA-glucoronide (10-position) is the principal Phase II metabolite of DHA and that uridine diphosphate glucuronyl transferase isoforms 1A1, 1A8-9, or 2B7 may be the main conjugating enzyme.', 'Artemisinin is completely and rapidly absorbed after oral administration in rats.  However, a very low plasma level was obtained even after a dose of 300 mg/kg.  Liver was found to be the chief site of inactivation.  When artemisinin was given i.m., significant and more persistent plasma levels were detected.  Artemisinin was shown to pass the blood-brain and blood-placenta barriers after i.v. injection.  Very little unchanged artemisinin was found in the urine or feces in 48 hours regardless of the route of administration.  Metabolites identified after administration to humans include deoxyartemisinin, deoxydihydroartemisinin, and 9,10-dihydroxydeoxyartemisinin.']","['In volunteer studies, artsunate was cleared very rapidly (within minutes) by biotransformation to dihydroartemisinin, which was eliminated by with a half-life of approximately 45 minutes.']"
5031,105032,Dihydrorhodamine 123,COC(=O)C1=CC=CC=C1C2C3=C(C=C(C=C3)N)OC4=C2C=CC(=C4)N,,,,,,
5032,105033,"2-hydroxy-3-[11-hydroxy-2-[4-[4-hydroxy-2-[1-hydroxy-3-(11-methyl-1,7-dioxaspiro[5.5]undecan-2-yl)butyl]-3-methylidenespiro[4a,7,8,8a-tetrahydro-4H-pyrano[3,2-b]pyran-6,5'-oxolane]-2'-yl]but-3-en-2-yl]-4-methyl-1,7-dioxaspiro[5.5]undec-4-en-8-yl]-2-methylpropanoic acid",CC1CCCOC12CCCC(O2)C(C)CC(C3C(=C)C(C4C(O3)CCC5(O4)CCC(O5)C=CC(C)C6CC(=CC7(O6)C(CCC(O7)CC(C)(C(=O)O)O)O)C)O)O,,,,,,
5033,105034,Cyanate,C(=[N-])=O,,,,,,
5034,105035,Nitrosourea,C(=O)(N)NN=O,,,,,,
5035,105036,"4-Hydroxy-2',4',6'-trichlorobiphenyl",C1=CC(=CC=C1C2=C(C=C(C=C2Cl)Cl)Cl)O,,,,,,
5036,105037,Dehydroretronecine,C1CN2C=CC(=C2[C@@H]1O)CO,,,"['Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)']",,,
5037,105038,CID 105038,CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCCO)OC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
5038,105039,"3,4-Methylenedioxy-N-ethylamphetamine",CCNC(C)CC1=CC2=C(C=C1)OCO2,,,"['Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. (See all compounds classified as Adrenergic Uptake Inhibitors.)']",,,
5039,105040,CID 105040,C1C(CNC2=C1C(=O)N=C(N2)N)CCC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
5040,105041,"3-Methyl-3H-imidazo[4,5-f]quinoxalin-2-amine",CN1C2=C(C3=NC=CN=C3C=C2)N=C1N,,,,,,
5041,105042,CID 105042,C[C@@H]1CC[C@@]2(CC[C@@H]([C@@H](O2)[C@H](C)CC[C@@H]([C@H](C)C(=O)C[C@H]([C@@H]([C@@H](CC(C)C)OC(=O)C[C@H](C3=C(C(=O)OC3=O)C)O)OC)O)O)C)O[C@H]1CC[C@H](C)C(=O)C,,,,,,
5042,105043,CID 105043,[212BiH3],,,,,,
5043,105044,Des-arg(9)-bradykinin,C1C[C@H](N(C1)C(=O)[C@@H]2CCCN2C(=O)[C@H](CCCN=C(N)N)N)C(=O)NCC(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@@H](CO)C(=O)N4CCC[C@H]4C(=O)N[C@@H](CC5=CC=CC=C5)C(=O)O,,,,,,
5044,105045,CID 105045,C1=CC=C(C=C1)P(C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
5045,105046,"7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-(3-oxooctyl)cyclopentyl]hept-5-enoic acid",CCCCCC(=O)CC[C@H]1[C@@H](C[C@@H]([C@@H]1CC=CCCCC(=O)O)O)O,,,,,,
5046,105047,"[2-Bromo-1-(2,4-dichlorophenyl)ethenyl] diethyl phosphate",CCOP(=O)(OCC)OC(=CBr)C1=C(C=C(C=C1)Cl)Cl,,,,,,
5047,105048,Glyphosate-trimesium,C[S+](C)C.C(C(=O)[O-])NCP(=O)(O)O,,,,,,
5048,105049,99U9GL8Gbl,CCCCSC1=C(N(C2=C1C=C(C=C2)C(C)C)CC3=CC=C(C=C3)Cl)CC(C)(C)C(=O)O,,,,,,
5049,105050,(1S)-(+)-3-Carene,CC1=CCC2[C@H](C1)C2(C)C,,,,,,
5050,105051,CID 105051,C1C(N(C2=C(N1)NC(=NC2=O)N)C=O)CNC3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O.O.O.O.O.O.[CaH2],,,,,,
5051,105052,Calcium hydride (CaH2),[H-].[H-].[Ca+2],,,,,,
5052,105053,Potassium triiodide,[K+].I[I-]I,,,"['Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)', 'Drugs that act locally on cutaneous or mucosal surfaces to produce inflammation; those that cause redness due to hyperemia are rubefacients; those that raise blisters are vesicants and those that penetrate sebaceous glands and cause abscesses are pustulants; tear gases and mustard gases are also irritants. (See all compounds classified as Irritants.)', 'Agents acting to arrest the flow of blood. Absorbable hemostatics arrest bleeding either by the formation of an artificial clot or by providing a mechanical matrix that facilitates clotting when applied directly to the bleeding surface. These agents function more at the capillary level and are not effective at stemming arterial or venous bleeding under any significant intravascular pressure. (See all compounds classified as Hemostatics.)']",,,
5053,105054,Triiodide Ion,I[I-]I,,,,,,
5054,105055,Ytterbium (III) ion,[Yb+3],,,,,,
5055,105056,"methyl (1R,2S,3S,5S)-3-(4-fluorophenyl)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate",CN1[C@H]2CC[C@@H]1[C@H]([C@H](C2)C3=CC=C(C=C3)F)C(=O)OC,,,['Drugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake. (See all compounds classified as Dopamine Uptake Inhibitors.)'],,,
5056,105057,"Ethyl 7-oxo-7H-furo(3,2-g)(1)benzopyran-3-carboxylate",CCOC(=O)C1=COC2=C1C=C3C=CC(=O)OC3=C2,,,,,,
5057,105058,CID 105058,CCCCCCCCC=CCCCCCCCC(=O)OCC(CO)C(=O)C,,,,,,
5058,105059,"S-(1,1,2,2-Tetrafluoroethyl)cysteine",C([C@@H](C(=O)O)N)SC(C(F)F)(F)F,,,,,,
5059,105060,2-(4-(Bis(carboxymethyl)amino)-3-(2-(2-(bis(carboxymethyl)amino)-5-methylphenoxy)ethoxy)phenyl)-1H-indole-6-carboxylic acid,CC1=CC(=C(C=C1)N(CC(=O)O)CC(=O)O)OCCOC2=C(C=CC(=C2)C3=CC4=C(N3)C=C(C=C4)C(=O)O)N(CC(=O)O)CC(=O)O,,,"['Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)', 'Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)']",,,
5060,105061,"7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3S)-3-hydroxyoct-1-enyl]cyclopentyl]heptanoic acid",CCCCC[C@@H](C=C[C@H]1[C@@H](C[C@@H]([C@@H]1CCCCCCC(=O)O)O)O)O,,,,,,
5061,105062,"Chlorine, isotope of mass 36",[36ClH],,,,,,
5062,105063,Actinium-228,[228Ac],,,,,,
5063,105064,CID 105064,C1=CC2=C(C(=C1)[O-])N=CC=C2.C1=CC2=C(C(=C1)[O-])N=CC=C2.C1=CC2=C(C(=C1)[O-])N=CC=C2.[In+3],,,,,,
5064,105065,CID 105065,CCCCCCCCCCCCCC=C[C@H]([C@H](COP(=O)(O)O)N)O,,,,,,
5065,105066,Ethyl apovincaminate,CC[C@]12CCCN3[C@H]1C4=C(CC3)C5=CC=CC=C5N4C(=C2)C(=O)OCC,,,"['Drugs used to specifically facilitate learning or memory, particularly to prevent the cognitive deficits associated with dementias. These drugs act by a variety of mechanisms. (See all compounds classified as Nootropic Agents.)', 'Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)', 'Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)', 'Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. (See all compounds classified as Phosphodiesterase Inhibitors.)']",,,
5066,105067,4-(Methylnitrosoamino)-4-(3-pyridyl)-1-butanol,CN(C(CCCO)C1=CN=CC=C1)N=O,,,"['Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)']",,['Iso-NNAL is a known thirdhand smoke metabolite of 4-(Methylnitrosoamino)-1-(3-pyridinyl)-1-butanone (NNK).'],
5067,105068,Pyridinoline,C1=C(C(=C(C=[N+]1C[C@@H](CC[C@@H](C(=O)[O-])N)O)O)C[C@@H](C(=O)O)N)CC[C@@H](C(=O)O)N,,,,,,
5068,105069,(+)-Pyridinoline,C1=C(C(=C(C=[N+]1C[C@@H](CC[C@@H](C(=O)O)N)O)O)C[C@@H](C(=O)O)N)CC[C@@H](C(=O)O)N,,,,,,
5069,105070,CID 105070,C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N.[Na+],,,,,,
5070,105071,N-(5-Amino-5-carboxypentyl)-3-hydroxy-4-(2-amino-2-carboxyethyl)-5-(3-amino-3-carboxypropyl)pyridine,C1=C(C(=C(C=[N+]1CCCC[C@H](C(=O)[O-])N)O)C[C@@H](C(=O)O)N)CC[C@@H](C(=O)O)N,,,,,,
5071,105072,CID 105072,C1=C(C(=C(C=[N+]1CCCC[C@H](C(=O)O)N)O)CC(C(=O)O)N)CC[C@@H](C(=O)O)N,,,,,,
5072,105073,CID 105073,C1CC(OC1)N2C=C(C(=O)NC2=O)F.C1=C(NC=C(C1=O)Cl)O.C1(=NC(=O)NC(=O)N1)C(=O)O.[KH],,,,,,
5073,105074,Pregnenolone sulfate,CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OS(=O)(=O)O)C)C,,,,,,
5074,105075,Iron dextran,OS(=O)(=O)O.[Fe],['For treatment of patients with documented iron deficiency in whom oral administration is unsatisfactory or impossible. Also used to replenish body iron stores in Non-Dialysis Dependent-Chronic Kidney Disease (NDD-CKD) patients receiving or not receiving erythropoietin and in Hemodialysis Dependent (HDD-CKD) and Peritoneal Dialysis Dependent (PDD-CKD) - Chronic Kidney Disease patients receiving an erythropoietin.'],"['Iron dextran is a dark brown, slightly viscous sterile liquid complex of ferric hydroxide and dextran for intravenous or intramuscular use. It is for treatment of patients with documented iron deficiency in whom oral administration is unsatisfactory or impossible. Iron is essential to the formation of hemoglobin and to the function and formation of other heme and nonheme compounds. Untreated depletion of iron stores leads to iron-deficient erythropoiesis and, in turn, to iron deficiency anemia.']","['Agents which improve the quality of the blood, increasing the hemoglobin level and the number of erythrocytes. They are used in the treatment of anemias. (See all compounds classified as Hematinics.)']","['The major portion of intramuscular injections of iron dextran is absorbed within 72 hours; most of the remaining iron is absorbed over the ensuing 3 to 4 weeks.', 'Dextran, a polyglucose, is either metabolized or excreted.', 'Following intramuscular administration, iron dextran is absorbed from the site of injection primarily through the lymphatic system. Absorption takes place in two stages. Approximately 60% of the dose or iron dextran inected is absorbed within 72 hours of administration. Ninety percent of the dose is absorbed in the second, slower, phase lasting approximately 1 to 3 weeks in duration. The remaining 10% of the dose is gradually absorbed over a period of several months or longer.', 'Following IM or IV injection, iron dextran is gradually cleared from plasma by reticuloendothelial cells of liver, spleen, and bone marrow. Results of several studies indicate that /a/ variable portion of IV dose... may be stored in unusable form in bone marrow.', 'In vitro studies have shown that removal of iron dextran by dialysis is negligible.', '/MILK/ Traces of unmetabolized iron dextran are excreted in human milk.', 'For more Absorption, Distribution and Excretion (Complete) data for IRON DEXTRAN (6 total), please visit the HSDB record page.']","['Dextran, a polyglucose, is either metabolized or excreted.', 'Dextran, a polyglucose, is either metabolized or excreted. Only traces of unmetabolized iron dextran are excreted in the urine, bile or feces.']","['5 hours (some indications that it can be as long as 10 hours)', 'After intravenous injection of 2 mL of DexIron (100 mg iron) to renal dialysis patients ... the average half-life of iron dextran in serum was 58.9 hours, ranging from 9.4 to 87.4 hours in 20 patients.', 'Various studies involving intravenously administered (59)Fe iron dextran to iron deficient subjects, some of whom had coexisting diseases, have yielded half-life values ranging from 5 hours to more than 20 hours. The 5-hour value was determined for (59)Fe iron dextran from a study that used laboratory methods to separate the circulating (59)Fe iron dextran from the transferrin-bound (59)Fe. The 20-hour value reflects a half-life determined by measuring total (59)Fe, both circulating and bound. It should be understood that these half-life values do not represent clearance of iron from the body. Iron is not easily eliminated from the body and accumulation of iron can be toxic.']"
5075,105076,CID 105076,C1=NC2=C(N1CCO)C(=O)N=C(N2)N,,,,,,
5076,105077,"(2S)-N-[1-[(2-amino-2-oxoethyl)amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-1-[(10R,13S,16S,19S,22S)-13-(2-amino-2-oxoethyl)-16-(3-amino-3-oxopropyl)-19-benzyl-22-[(4-methoxyphenyl)methyl]-12,15,18,21,24-pentaoxo-7,8-dithia-11,14,17,20,23-pentazaspiro[5.19]pentacosane-10-carbonyl]pyrrolidine-2-carboxamide",COC1=CC=C(C=C1)C[C@H]2C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@@H](CSSC3(CCCCC3)CC(=O)N2)C(=O)N4CCC[C@H]4C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N)CC(=O)N)CCC(=O)N)CC5=CC=CC=C5,,,,,,
5077,105078,Ethyl beta-carboline-3-carboxylate,CCOC(=O)C1=NC=C2C(=C1)C3=CC=CC=C3N2,,,,,,
5078,105079,"2-Hydroxyamino-3-methylimidazolo(4,5-f)quinoline",CN1C2=C(C3=C(C=C2)N=CC=C3)N=C1NO,,,,,"['N-Hydroxy-2-amino-3-methylimidazo[4,5-f]quinoline (N-Hydroxy-IQ) is a known human metabolite of 2-Amino-3-methylimidazo(4,5-F)quinoline.']",
5079,105080,CID 105080,C1[C@H](C(C23N1C(=N[C@H]([C@@H]2NC(=N3)N)COC(=O)NS(=O)(=O)O)N)(O)O)OS(=O)(=O)O,,,,,,
5080,105081,CID 105081,C1CC2C(C1)C3CC2CC3OC(=S)S.[KH],,,,,,
5081,105082,"(2R)-2-acetamido-3-[(2R,3S,4R)-3-hydroxy-2-[(1S)-1-hydroxy-3-methyl-butyl]-4-methyl-5-oxo-pyrrolidine-2-carbonyl]sulfanyl-propanoic acid",C[C@@H]1[C@@H]([C@](NC1=O)([C@H](CC(C)C)O)C(=O)SC[C@@H](C(=O)O)NC(=O)C)O,,,,,,
5082,105083,(2S)-N-[(2-methoxyphenyl)methyl]-2-phenylpiperidin-3-amine,COC1=CC=CC=C1CNC2CCCN[C@H]2C3=CC=CC=C3,,,,,,
5083,105084,"(2R,4S)-2-(6-chloropyridin-3-yl)-7-azabicyclo[2.2.1]heptane",C1CC2[C@H](C[C@H]1N2)C3=CN=C(C=C3)Cl,,,,,,
5084,105085,"3,4-Dihydroxypyridine",C1=CNC=C(C1=O)O,,,,,,
5085,105086,"11,12-Epoxy-3-methylcholanthrene",CC1=C2CCC3=C2C(=CC4=C3C5C(O5)C6=CC=CC=C64)C=C1,,,,,,
5086,105087,"2-[(1R,2R)-3-oxo-2-pent-2-enylcyclopentyl]acetic acid",CCC=CC[C@@H]1[C@H](CCC1=O)CC(=O)O,,,,,,
5087,105088,Europium-155,[155Eu],,,,,,
5088,105089,beta-N-Methylamino-L-alanine,CNC[C@@H](C(=O)O)N,,,['Drugs that bind to and activate excitatory amino acid receptors. (See all compounds classified as Excitatory Amino Acid Agonists.)'],,,
5089,105090,CID 105090,C=CCCC(=NOS(=O)(=O)O)S[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O,,,,,,
5090,105091,"Methyl 2-[6-[bis(2-methoxy-2-oxoethyl)amino]-5-[2-[2-[bis(2-methoxy-2-oxoethyl)amino]-5-methylphenoxy]ethoxy]-1-benzofuran-2-yl]-1,3-oxazole-5-carboxylate",CC1=CC(=C(C=C1)N(CC(=O)OC)CC(=O)OC)OCCOC2=C(C=C3C(=C2)C=C(O3)C4=NC=C(O4)C(=O)OC)N(CC(=O)OC)CC(=O)OC,,,"['Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)']",,,
5091,105092,Benz(l)aceanthrylene,C1=CC=C2C(=C1)C=CC3=C2C4=C5C(=CC=CC5=C3)C=C4,,,,,,
5092,105093,Gold cation (3+),[Au+3],,,,,,
5093,105094,"N-phenyloctadeca-9,12-dienamide",CCCCCC=CCC=CCCCCCCCC(=O)NC1=CC=CC=C1,,,,,,
5094,105095,Aflatoxin G2A,COC1=C2C3=C(C(=O)OCC3)C(=O)OC2=C4C5CC(OC5OC4=C1)O,,,,,,
5095,105096,CID 105096,CC1=C[C@@H]2[C@](C[C@@H]1OC(=O)CC(C)C)(C3([C@@H]([C@H]([C@H](C34CO4)O2)C(=O)C)C(=O)C)C)CC(=O)C,,,,,,
5096,105097,2-Amino-5-phenylpyridine,C1=CC=C(C=C1)C2=CN=C(C=C2)N,,,,,,
5097,105098,Oxafun,CC1=C(SCCO1)C(=O)NC2=CC=CC=C2.CN(C)C(=S)SSC(=S)N(C)C,,,,,,
5098,105099,CID 105099,CCNC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)C6CCC(=O)N6,,,,,,
5099,105100,12-Deoxyphorbolphenylacetate,C[C@@H]1C[C@@]2(C(C2(C)C)[C@H]3[C@]1([C@@H]4C=C(C(=O)[C@]4(CC(=C3)CO)O)C)O)OC(=O)CC5=CC=CC=C5,,,['Drugs that act locally on cutaneous or mucosal surfaces to produce inflammation; those that cause redness due to hyperemia are rubefacients; those that raise blisters are vesicants and those that penetrate sebaceous glands and cause abscesses are pustulants; tear gases and mustard gases are also irritants. (See all compounds classified as Irritants.)'],,,
5100,105101,"2,3,4,5-Tetrachloro-4'-biphenylol",C1=CC(=CC=C1C2=CC(=C(C(=C2Cl)Cl)Cl)Cl)O,,,,,,
5101,105102,"2,4-Dioxaspiro[5.5]undec-8-ene, 3-(2-furanyl)-",C1CC2(CC=C1)COC(OC2)C3=CC=CO3,,,['Serine proteinase inhibitors which inhibit trypsin. They may be endogenous or exogenous compounds. (See all compounds classified as Trypsin Inhibitors.)'],,,
5102,105103,Quin2-acetoxymethyl ester,CC1=CC(=C(C=C1)N(CC(=O)OCOC(=O)C)CC(=O)OCOC(=O)C)OCC2=NC3=C(C=C(C=C3C=C2)OC)N(CC(=O)OCOC(=O)C)CC(=O)OCOC(=O)C,,,"['Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)', 'Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)']",,,
5103,105104,"n-Methyl-2-phenyl-n-[(5r,7s,8s)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]dec-8-yl]acetamide",CN([C@H]1CC[C@@]2(CCCO2)C[C@@H]1N3CCCC3)C(=O)CC4=CC=CC=C4,,,"['Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)', 'Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)']",,,
5104,105105,"(3S,4aS,10aR)-3-(ethylsulfamoylamino)-1-propyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-6-ol;hydrochloride",CCCN1C[C@H](C[C@H]2[C@H]1CC3=C(C2)C(=CC=C3)O)NS(=O)(=O)NCC.Cl,,,['Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)'],,,
5105,105106,"(3S,4aS,10aR)-3-(ethylsulfamoylamino)-1-propyl-3,4,4a,5,10,10a-hexahydro-2H-benzo[g]quinolin-6-ol",CCCN1C[C@H](C[C@H]2[C@H]1CC3=C(C2)C(=CC=C3)O)NS(=O)(=O)NCC,,,,,,
5106,105107,N-Benzylglucamine dithiocarbamate,C1=CC=C(C=C1)CN(C[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O)C(=S)S,,,['Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)'],,,
5107,105108,"(2S,3S,4S,5R)-6-[[(2S)-3-azido-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy]-3,4,5-trihydroxyoxane-2-carboxylic acid",CC1=CN(C(=O)NC1=O)C2CC([C@H](O2)COC3[C@@H]([C@H]([C@@H]([C@H](O3)C(=O)O)O)O)O)N=[N+]=[N-],,,,,,
5108,105109,1-(Isobutylamino)-3-(naphthalen-1-yloxy)propan-2-ol hydrochloride,CC(C)CNCC(COC1=CC=CC2=CC=CC=C21)O.Cl,,,,,,
5109,105110,"PROPRANOLOL, dl",CC(C)CNCC(COC1=CC=CC2=CC=CC=C21)O,,,,,,
5110,105111,Epipodophyllotoxin,COC1=CC(=CC(=C1OC)OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](C4=CC5=C(C=C24)OCO5)O,,,"['Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES. (See all compounds classified as Tubulin Modulators.)', 'Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)', 'Agents that soften, separate, and cause desquamation of the cornified epithelium or horny layer of skin. They are used to expose mycelia of infecting fungi or to treat corns, warts, and certain other skin diseases. (See all compounds classified as Keratolytic Agents.)']",,,
5111,105112,CID 105112,O[Se](=O)(=O)O.[NaH],,,,,,
5112,105113,Fumitremorgin B,CC(=CCN1C2=C(C=CC(=C2)OC)C3=C1[C@@H](N4C(=O)[C@@H]5CCCN5C(=O)[C@@]4([C@H]3O)O)C=C(C)C)C,,,,,,
5113,105114,CID 105114,[133BaH2],,,,,,
5114,105115,"(6R)-7-[4-(dimethylamino)phenyl]-N-hydroxy-4,6-dimethyl-7-oxohepta-2,4-dienamide",C[C@H](C=C(C)C=CC(=O)NO)C(=O)C1=CC=C(C=C1)N(C)C,,,,,,
5115,105116,"1,N6-Ethenodeoxyadenosine",C1[C@@H]([C@H](OC1N2C=NC3=C2N=CN4C3=NC=C4)CO)O,,,,,,
5116,105117,Dan-shen root extract,CC1=CCCC2=C1C=CC3=C2C(=O)C(=O)C4=C3OC=C4C.CC1=COC2=C1C(=O)C(=O)C3=C2C=CC4=C3CCCC4=C,,,,,,
5117,105118,Methylenetanshinquinone,CC1=COC2=C1C(=O)C(=O)C3=C2C=CC4=C3CCCC4=C,,,,,,
5118,105119,"1,2-Dihydrotanshinquinone",CC1=CCCC2=C1C=CC3=C2C(=O)C(=O)C4=C3OC=C4C,,,,,,
5119,105120,CID 105120,CC(C)CNCC(COC1=CC=C(C=C1)CCC(=O)OC)O,,,,,,
5120,105121,CID 105121,CO[C@@]1([C@@H]2N(C1=O)C(=C(CO2)CSC3=NN=NN3CCO)C(=O)O)NC(=O)CSC(F)(F)F.[NaH],,,,,,
5121,105122,"(6R,7R)-3-[[1-(2-hydroxyethyl)tetrazol-5-yl]sulfanylmethyl]-7-methoxy-8-oxo-7-[[2-(trifluoromethylsulfanyl)acetyl]amino]-5-oxa-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid",CO[C@@]1([C@@H]2N(C1=O)C(=C(CO2)CSC3=NN=NN3CCO)C(=O)O)NC(=O)CSC(F)(F)F,,,,,,
5122,105123,"(5R,8S,11R,12S,15S,18S,19S,22R)-15-[3-(diaminomethylideneamino)propyl]-8-[(4-hydroxyphenyl)methyl]-18-[(5S,6S)-6-methoxy-3,5-dimethyl-7-phenylhepta-1,3-dienyl]-1,5,12,19-tetramethyl-2-methylidene-3,6,9,13,16,20,25-heptaoxo-1,4,7,10,14,17,21-heptazacyclopentacosane-11,22-dicarboxylic acid",C[C@H]1[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)C(=C)N(C(=O)CC[C@@H](NC1=O)C(=O)O)C)C)CC2=CC=C(C=C2)O)C(=O)O)C)CCCN=C(N)N)C=CC(=C[C@H](C)[C@H](CC3=CC=CC=C3)OC)C,,,,,,
5123,105124,CID 105124,[H+].[H+].C1=CC=C(C=C1)COCC(C(=O)[O-])N(CCN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3],,,,,,
5124,105125,Gadobenate dimeglumine,C1=CC=C(C=C1)COCC(C(=O)O)N(CCN(CCN(CC(=O)O)CC(=O)O)CC(=O)O)CC(=O)O,,,['Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)'],"['Gadobenate ion has a rapid distribution half-life (reported as mean + or -  SD) of 0.084 + or - 0.012 to 0.605 + or - 0.072 hours. Volume of distribution of the central compartment ranged from 0.074:: 0.017 to 0.158 :: 0.038 L/kg, and estimates of volume of distribution by area ranged from 0.170+ or - 0.016 to 0.282+ or - 0.079 L/kg. These latter estimates are approximately equivalent to the average volume of extracellular body water in man. In vitro studies showed no appreciable binding of gadobenate ion to human serum proteins. /Gadobenate ion/', '... The pharmacokinetics were evaluated in rats, rabbits, dogs and monkeys after iv injections of non-labelled gadobenate dimeglumine and, for biodistribution studies, (153)-Gd-labelled gadobenate dimeglumine. Assays were performed by high performance liquid chromatography, X-ray fluorescence and gamma spectrometry. The binding of gadobenate ion to animal and human serum albumin was studied by equilibrium dialysis. ...  After iv injection gadobenate dimeglumine distributes into plasma and extracellular fluid as well as into the intrahepatocytic space. Gadobenate ion is cleared from plasma by renal and biliary excretion. It does not accumulate in specific tissues, except temporarily in tissues related to its elimination. Gadobenate ion is not metabolized. Its binding to plasma proteins is too weak to be detected by equilibrium dialysis. ...', 'Gadobenate ion is eliminated predominately via the kidneys, with 78% to 96% of an administered dose recovered in the urine. Total plasma clearance and renal clearance estimates of gadobenate ion were similar, ranging from 0.093 + or - 0.010 to 0.133 + o r- 0.270 L/hr/kg and 0.082+ or - 0.007 to 0.104  + or - 0.039 L/hr/kg, respectively. The clearance is similar to that of substances that are subject to glomerular filtration. The mean elimination half-life ranged from 1.17+ or - 0.26 to 2.02 + or - 0.60 hours. A small percentage ofthe administered dose (0.6% to 4%) is eliminated via the biliary route and recovered in feces.', 'It is not known to what extent gadobenate dimeglumine is excreted in human milk. It is known from rat experiments that less than 0.5% of the administered dose is transferred via milk from mother to neonates.', 'For more Absorption, Distribution and Excretion (Complete) data for GADOBENATE DIMEGLUMINE (7 total), please visit the HSDB record page.']","['There was no detectable biotransformation of gadobenate ion. Dissociation of gadobenate ion in vivo has been shown to be minimal, with less than 1% of the free chelating agent being recovered alone in feces.']","['Gadobenate ion is eliminated predominately via the kidneys, with 78% to 96% of an administered dose recovered in the urine. ... The mean elimination half-life ranged from 1.17+ or - 0.26 to 2.02 + or - 0.60 hours. ...', '... Fifteen children scheduled to undergo contrast-enhanced MRI for suspected disease of the central nervous system received a single intravenous injection of 0.1 mmol/kg gadobenate dimeglumine. ... 1.2 hr for terminal elimination half-life were determined across all age groups combined.', 'A single intravenous dose of 0.2 mmol/kg of Multihance was administered to 11 subjects (5 males and 6 females) with end-stage renal disease requiring hemodialysis ... . The mean elimination half-life on dialysis was 1.21 + or - 0.29 hours as compared with 42.4 + or - 24.4 hours when off dialysis.', 'A single intravenous dose of 0.2 mmol/kg of Multihance was administered to 20 subjects with impaired renal function (6 men and 3 women with moderate renal impairment (urine creatinine clearance > 30 to < 60 mL/min) and 5 men and 6 women with severe renal impairment (urine creatinine clearance > 10 to < 30 mL/min)). Mean estimates of the elimination half-life were 6.1 + or - 3.0 and 9.5 + or - 3.1 hours for the moderate and severe renal impairment groups, respectively as compared with 1.0 to 2.0 hours in healthy volunteers.', 'Gadobenate ion has a rapid distribution half-life (reported as mean + or - SD) of 0.084 + or -  0.012 to 0.605 + or -  0.072 hours.']"
5125,105126,CID 105126,C1=CC=C2C(=C1)C(=CN2)CC(=NOS(=O)(=O)O)SC3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
5126,105127,"Propionohydroxamic acid, N-(5-(3-((5-aminopentyl)hydroxycarbamoyl)propionamido)pentyl)-3-((5-(N-hydroxyacetamido)pentyl)carbamoyl)-, methanesulfonate (salt)",CC(=O)N(C)CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O.CS(=O)(=O)O,,,,,,
5127,105128,N-[5-[[4-[5-[acetyl(methyl)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide,CC(=O)N(C)CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O,,,,,,
5128,105129,Rhodium-106,[106Rh],,,,,,
5129,105130,Manganese(3+),[Mn+3],,,,,,
5130,105131,2-Bromoacetaldehyde,C(C=O)Br,,,,,['2-bromoacetaldehyde is a known human metabolite of 1_2-dibromoethane.'],
5131,105132,CID 105132,[208PbH2],,,,,,
5132,105133,"Mercury, ion (Hg1+)",[Hg+],,,,,,
5133,105134,CID 105134,C[C@@H]1C[C@@H]2[C@@H](C[C@@]3([C@H](O2)C[C@@H]4[C@H](O3)C(=CC(=O)O4)C)C)O[C@H]5[C@@H]1O[C@@H]6C[C@@H]7[C@@](C[C@@H]8[C@H](O7)CCC[C@@H]9[C@H](O8)C[C@@H]1[C@H](O9)C[C@@H]2[C@@](O1)([C@@H](C[C@@H](O2)CC(=C)CO)O)C)(O[C@@]6(CC5)C)C,,,,,,
5134,105135,"2-[(41-Hydroxy-4,8,10,46-tetramethyl-14-oxo-2,7,13,17,21,28,34,38,43,47-decaoxadecacyclo[25.24.0.03,22.06,20.08,18.012,16.029,48.033,46.035,44.037,42]henpentaconta-24,49-dien-39-yl)methyl]prop-2-enal",CC1CC2C(CC(=O)O2)OC3CC4C(CC(C5C(O4)CC=CCC6C(O5)CC=CC7C(O6)CCCC8C(O7)(CC9C(O8)CC2C(O9)C(CC(O2)CC(=C)C=O)O)C)C)OC3(C1)C,,,,,,
5135,105136,CID 105136,CC=C1C[C@H](C(C(=O)OCC2=CCN3[C@H]2C(CC3)OC1=C)(C)C)C,,,,,,
5136,105137,Ergosine,CC(C)C[C@H]1C(=O)N2CCC[C@H]2[C@]3(N1C(=O)[C@](O3)(C)NC(=O)[C@H]4CN([C@@H]5CC6=CNC7=CC=CC(=C67)C5=C4)C)O,,,,,,
5137,105138,Plutonium-237,[237Pu],,,,,,
5138,105139,Americium-243,[243Am],,,,,,
5139,105140,Iodine I-123,[123IH],,,,,,
5140,105141,"Copper, isotope of mass 64",[64Cu],,,,,,
5141,105142,Water-18O,[18OH2],,,,,,
5142,105143,Bismuth cation,[Bi+3],,,,,,
5143,105144,Palladium ion,[Pd+2],,,,,,
5144,105145,Gallium cation,[Ga+3],,,,,,
5145,105146,Cobaltic cation,[Co+3],,,,,,
5146,105147,Protactinium-231,[231Pa],,,,,,
5147,105148,Indium(3+),[In+3],,,,,,
5148,105149,CID 105149,[124SbH3],,,,,,
5149,105150,Thorium(4+),[Th+4],,,,,,
5150,105151,CID 105151,[204PbH2],,,,,,
5151,105152,Actinium-227,[227Ac],,,,,,
5152,105153,Rubidium ion,[Rb+],,,,,,
5153,105154,CID 105154,[44KH],,,,,,
5154,105155,Curium-243,[243Cm],,,,,,
5155,105156,Uranium-236,[236U],,,,,,
5156,105157,Praseodymium-144,[144Pr],,,,,,
5157,105158,CID 105158,[129TeH2],,,,,,
5158,105159,Europium(3+),[Eu+3],,,,,,
5159,105160,Platinum(4+),[Pt+4],,,,,,
5160,105161,CID 105161,[113SnH2],,,,,,
5161,105162,Fluorine-18,[18FH],,,,,,
5162,105163,Uranium-232,[232U],,,,,,
5163,105164,Ytterbium-169,[169Yb],,,,,,
5164,105165,CID 105165,[74AsH3],,,,,,
5165,105166,Platinum (II) ion,[Pt+2],,,,,,
5166,105167,CID 105167,[204TlH],,,,,,
5167,105168,Sulfur-32,[32SH2],,,,,,
5168,105169,CID 105169,[87SrH2],,,,,,
5169,105170,Technetium-94,[94Tc],,,,,,
5170,105171,CID 105171,[113InH3],,,,,,
5171,105172,Thallium(3+),[Tl+3],,,,,,
5172,105173,Yttrium-88,[88Y],,,,,,
5173,105174,Bromine-82,[82BrH],,,,,,
5174,105175,Iodine I-135,[135IH],,,,,,
5175,105176,Californium-249,[249Cf],,,,,,
5176,105177,"Ethanaminium, N-(2-hydroxyethyl)-N-[2-[(2-hydroxyethyl)(1-oxohexadecyl)amino]ethyl]-N-methyl-2-[(1-oxohexadecyl)oxy]-, methyl sulfate (salt)",CCCCCCCCCCCCCCCC(=O)N(CC[N+](C)(CCO)CCOC(=O)CCCCCCCCCCCCCCC)CCO.COS(=O)(=O)[O-],,,,,,
5177,105178,N-(2-Hydroxyethyl)-N-[2-[(2-hydroxyethyl)(1-oxohexadecyl)amino]ethyl]-N-methyl-2-[(1-oxohexadecyl)oxy]ethanaminium,CCCCCCCCCCCCCCCC(=O)N(CC[N+](C)(CCO)CCOC(=O)CCCCCCCCCCCCCCC)CCO,,,,,,
5178,105179,o-(Ethoxymethyl)anisole,CCOCC1=CC=CC=C1OC,,,,,,
5179,105180,"1-Propanaminium, 2-hydroxy-N-(2-((2-hydroxyethyl)(2-hydroxypropyl)amino)ethyl)-N-(2-hydroxypropyl)-N-methyl-, dioctadecanoate (ester), methyl sulfate (salt)",CCCCCCCCCCCCCCCCCC(=O)OC(C)C[N+](C)(CCN(CCO)CC(C)O)CC(C)OC(=O)CCCCCCCCCCCCCCCCC.COS(=O)(=O)[O-],,,,,,
5180,105181,2-[2-Hydroxyethyl(2-hydroxypropyl)amino]ethyl-methyl-bis(2-octadecanoyloxypropyl)azanium,CCCCCCCCCCCCCCCCCC(=O)OC(C)C[N+](C)(CCN(CCO)CC(C)O)CC(C)OC(=O)CCCCCCCCCCCCCCCCC,,,,,,
5181,105182,Bis(2-hydroxyethyl)ammonium tetradecyl hydrogen phosphate,CCCCCCCCCCCCCCOP(=O)(O)O.C(CO)NCCO,,,,,,
5182,105183,"hydrogen sulfate;N-methyl-N-[(1,3,3-trimethylindol-1-ium-2-yl)methylideneamino]aniline",CC1(C2=CC=CC=C2[N+](=C1C=NN(C)C3=CC=CC=C3)C)C.OS(=O)(=O)[O-],,,,,,
5183,105184,"1,3,3-Trimethyl-2-[(2-methyl-2-phenylhydrazono)methyl]-3H-indolium",CC1(C2=CC=CC=C2[N+](=C1C=NN(C)C3=CC=CC=C3)C)C,,,,,,
5184,105185,"Lead(2+) 4,6-dinitro-o-cresolate",CC1=CC(=CC(=C1[O-])[N+](=O)[O-])[N+](=O)[O-].CC1=CC(=CC(=C1[O-])[N+](=O)[O-])[N+](=O)[O-].[Pb+2],,,,,,
5185,105186,Trideceth-2 phosphate,CCCCCCCCCCCCCOCCOCCOP(=O)(O)O,,,,,,
5186,105187,"n-Tert-butyl-3-(2,5-dimethylphenoxy)benzamide",CC1=CC(=C(C=C1)C)OC2=CC=CC(=C2)C(=O)NC(C)(C)C,,,,,,
5187,105188,CID 105188,CCC(=CC1=[N+](C2=C(O1)C=CC(=C2)C3=CC=CC=C3)CC)OCC.CC1=CC=C(C=C1)S(=O)(=O)[O-],,,,,,
5188,105189,"2-(2-Ethoxybut-1-enyl)-3-ethyl-5-phenyl-1,3-benzoxazol-3-ium",CCC(=CC1=[N+](C2=C(O1)C=CC(=C2)C3=CC=CC=C3)CC)OCC,,,,,,
5189,105190,"Pyridinium, 1,1'-(1,6-hexanediylbis(imino(6-oxo-6,1-hexanediyl)))bis-, diperchlorate",C1=CC=[N+](C=C1)CCCCCC(=O)NCCCCCCNC(=O)CCCCC[N+]2=CC=CC=C2.[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O,,,,,,
5190,105191,"1,1'-[1,6-Hexanediylbis[imino(6-oxo-6,1-hexanediyl)]]bispyridinium",C1=CC=[N+](C=C1)CCCCCC(=O)NCCCCCCNC(=O)CCCCC[N+]2=CC=CC=C2,,,,,,
5191,105192,"3H-Indolium, 1-ethyl-2-[3-(1-ethyl-1,3-dihydro-3,3-dimethyl-2H-indol-2-ylidene)-1-propenyl]-3,3-dimethyl-, salt with 4-methylbenzenesulfonic acid (1:1)",CCN1C2=CC=CC=C2C(C1=CC=CC3=[N+](C4=CC=CC=C4C3(C)C)CC)(C)C.CC1=CC=C(C=C1)S(=O)(=O)[O-],,,,,,
5192,105193,"1-Ethyl-2-[(1E)-3-[1-ethyl-3,3-dimethyl-3H-indole-2(1H)-ylidene]-1-propenyl]-3,3-dimethyl-3H-indole-1-ium",CCN1C2=CC=CC=C2C(C1=CC=CC3=[N+](C4=CC=CC=C4C3(C)C)CC)(C)C,,,,,,
5193,105194,"Quinolinium, 1-butyl-4-[3-(3-ethyl-2(3H)-benzoselenazolylidene)-1-propenyl]-, iodide",CCCC[N+]1=CC=C(C2=CC=CC=C21)C=CC=C3N(C4=CC=CC=C4[Se]3)CC.[I-],,,,,,
5194,105195,1-Butyl-4-[3-(3-ethylbenzoselenazol-2(3H)-ylidene)-1-propenyl]quinolinium,CCCC[N+]1=CC=C(C2=CC=CC=C21)C=CC=C3N(C4=CC=CC=C4[Se]3)CC,,,,,,
5195,105196,"(4-(p,p'-Bis(dimethylamino)benzhydrylidene)cyclohexa-2,5-dien-1-ylidene)dimethylammonium m-((p-anilinophenyl)azo)benzenesulphonate",CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=C(C=C3)N(C)C.C1=CC=C(C=C1)NC2=CC=C(C=C2)N=NC3=CC(=CC=C3)S(=O)(=O)[O-],,,,,,
5196,105197,Tetraisopropyl bis(ditridecylphosphite) titanate,[H+].[H+].CCCCCCCCCCCCCOP([O-])OCCCCCCCCCCCCC.CCCCCCCCCCCCCOP([O-])OCCCCCCCCCCCCC.CC(C)[O-].CC(C)[O-].CC(C)[O-].CC(C)[O-].[Ti+4],,,,,,
5197,105198,Ditridecyl phosphonate,CCCCCCCCCCCCCOP(O)OCCCCCCCCCCCCC,,,,,,
5198,105199,"Bis(2,2-dimethylpropyl)aluminum hydride",CC(C)(C)C[AlH]CC(C)(C)C,,,,,,
5199,105200,"1,6-Hexanediol, 1,6-bis(hydrogen sulfate), compd. with N-butyl-N-ethyl-1-butanamine (1:2)",CCCCN(CC)CCCC.CCCCN(CC)CCCC.C(CCCS(=O)(=O)O)CCS(=O)(=O)O,,,,,,
5200,105201,"Hexane-1,6-disulfonic Acid",C(CCCS(=O)(=O)O)CCS(=O)(=O)O,,,,,,
5201,105202,"1,6-Hexanediol, compd. with N-butyl-N-ethyl-1-butanamine (1:2)",CCCCN(CC)CCCC.CCCCN(CC)CCCC.C(CCCO)CCO,,,,,,
5202,105203,"Benzothiazolium, 2-(2-ethoxy-1-buten-1-yl)-5-methoxy-3-(3-sulfopropyl)-, inner salt",CCC(=CC1=[N+](C2=C(S1)C=CC(=C2)OC)CCCS(=O)(=O)[O-])OCC,,,,,,
5203,105204,"3-[2-(2-Ethoxybut-1-enyl)-5-methoxy-1,3-benzothiazol-3-ium-3-yl]propane-1-sulfonic acid",CCC(=CC1=[N+](C2=C(S1)C=CC(=C2)OC)CCCS(=O)(=O)O)OCC,,,,,,
5204,105205,"Acetamide, 2-(dodecylsulfonyl)-",CCCCCCCCCCCCS(=O)(=O)CC(=O)N,,,,,,
5205,105206,"N,N'-Diethylquinoxaline-2,3-diamine",CCNC1=NC2=CC=CC=C2N=C1NCC,,,,,,
5206,105207,3-(3-Hydroxypropyl)-5-methoxy-2-methylbenzothiazolium iodide,CC1=[N+](C2=C(S1)C=CC(=C2)OC)CCCO.[I-],,,,,,
5207,105208,3-(3-Hydroxypropyl)-5-methoxy-2-methylbenzothiazol-3-ium,CC1=[N+](C2=C(S1)C=CC(=C2)OC)CCCO,,,,,,
5208,105209,CID 105209,CC(=NC1=CC2=CC=CC=C2C=C1Br)S,,,,,,
5209,105210,"Acetamide, N-(3-bromo-2-naphthalenyl)-",CC(=O)NC1=CC2=CC=CC=C2C=C1Br,,,,,,
5210,105211,"Phenol, 2,6-bis(1,1-dimethylethyl)-4-(1,1,3,3-tetramethylbutyl)-",CC(C)(C)CC(C)(C)C1=CC(=C(C(=C1)C(C)(C)C)O)C(C)(C)C,,,,,,
5211,105212,"1H-Imidazolium, 1-(carboxymethyl)-4,5-dihydro-1-(2-hydroxyethyl)-2-undecyl-, inner salt",CCCCCCCCCCCC1=NCC[N+]1(CCO)CC(=O)[O-],,,,,,
5212,105213,"1-(Carboxymethyl)-4,5-dihydro-1-(2-hydroxyethyl)-2-undecyl-1H-imidazolium",CCCCCCCCCCCC1=NCC[N+]1(CCO)CC(=O)O,,,,,,
5213,105214,2-(2-Octadec-9-enoyloxyethylsulfanyl)ethyl octadec-9-enoate,CCCCCCCCC=CCCCCCCCC(=O)OCCSCCOC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
5214,105215,"Benzoic acid, 4-[[(ethylphenylamino)methylene]amino]-, ethyl ester",CCN(C=NC1=CC=C(C=C1)C(=O)OCC)C2=CC=CC=C2,,,,,,
5215,105216,"N-(2-Aminoethyl)-N'-[2-[2-(8-heptadecenyl)-4,5-dihydro-1H-imidazol-1-YL]ethyl]ethylenediamine",CCCCCCCCC=CCCCCCCCC1=NCCN1CCNCCNCCN,,,,,,
5216,105217,CID 105217,CC1=CC2=NC(=C(NC2=CC1=O)C)C,,,,,,
5217,105218,"exo-5-Amino-5,6-dihydro-endo-dicyclopentadiene",C1C=CC2C1C3CC2CC3N,,,,,,
5218,105219,"1,3,2-Dioxaphosphorinane, 2,2'-[1,4-phenylenebis(methylene)]bis[5,5-dimethyl-, 2,2'-dioxide",CC1(COP(=O)(OC1)CC2=CC=C(C=C2)CP3(=O)OCC(CO3)(C)C)C,,,,,,
5219,105220,"1,3,2-Dioxaphosphorinane, 2,2'-[(2,5-dimethyl-1,4-phenylene)bis(methylene)]bis[5,5-dimethyl-, 2,2'-dioxide",CC1=CC(=C(C=C1CP2(=O)OCC(CO2)(C)C)C)CP3(=O)OCC(CO3)(C)C,,,,,,
5220,105221,"Phosphoric acid, monomethyl ester, compd. with 4-tert-dodecylbenzenamine (1:2)",CC(C)(C)CCCCCCCCC1=CC=C(C=C1)N.CC(C)(C)CCCCCCCCC1=CC=C(C=C1)N.COP(=O)(O)O,,,,,,
5221,105222,"4-(9,9-Dimethyldecyl)aniline",CC(C)(C)CCCCCCCCC1=CC=C(C=C1)N,,,,,,
5222,105223,CID 105223,CCCCCCCCCCCC(=O)OCCOCC[O-].[K+],,,,,,
5223,105224,"[1,1'-Biphenyl]-4-carbonitrile, 4'-undecyl-",CCCCCCCCCCCC1=CC=C(C=C1)C2=CC=C(C=C2)C#N,,,,,,
5224,105225,"Pyrimidine, 2,4-diamino-5-((2,6-dimethoxy-3-pyridyl)methyl)-",COC1=NC(=C(C=C1)CC2=CN=C(N=C2N)N)OC,,,,,,
5225,105226,"4-Chloro-2,5-diisopropoxynitrobenzene",CC(C)OC1=CC(=C(C=C1[N+](=O)[O-])OC(C)C)Cl,,,,,,
5226,105227,CID 105227,C1=CC(=C(C=C1NC2=NC(=O)C3=C2C(=C(C(=C3Cl)Cl)Cl)Cl)Cl)NC4=NC(=O)C5=C4C(=C(C(=C5Cl)Cl)Cl)Cl,,,,,,
5227,105228,Ethyl [(1-oxo-1-phenylpropan-2-ylidene)amino] carbonate,CCOC(=O)ON=C(C)C(=O)C1=CC=CC=C1,,,,,,
5228,105229,"2-Naphthalenecarboxamide, 4-[(4-chloro-2-methylphenyl)azo]-N-(2-ethoxyphenyl)-3-hydroxy-",CCOC1=CC=CC=C1NC(=O)C2=CC3=CC=CC=C3C(=C2O)N=NC4=C(C=C(C=C4)Cl)C,,,,,,
5229,105230,"Acetamide, N-[2-[(2,6-dicyano-4-nitrophenyl)azo]-5-[[2-(2-ethoxyethoxy)ethyl]ethylamino]phenyl]-",CCN(CCOCCOCC)C1=CC(=C(C=C1)N=NC2=C(C=C(C=C2C#N)[N+](=O)[O-])C#N)NC(=O)C,,,,,,
5230,105231,"1-Naphthalenol, 5-amino-, sulfate (2:1) (salt)",C1=CC2=C(C=CC=C2O)C(=C1)N.C1=CC2=C(C=CC=C2O)C(=C1)N.OS(=O)(=O)O,,,,,,
5231,105232,"Benzene, 1-[2-(2-chloroethoxy)ethoxy]-4-(1,1,3,3-tetramethylbutyl)-",CC(C)(C)CC(C)(C)C1=CC=C(C=C1)OCCOCCCl,,,,,,
5232,105233,"beta-Alanine, N-[3-(acetylamino)-4-[(4-nitrophenyl)azo]phenyl]-N-(3-ethoxy-3-oxopropyl)-, ethyl ester",CCOC(=O)CCN(CCC(=O)OCC)C1=CC(=C(C=C1)N=NC2=CC=C(C=C2)[N+](=O)[O-])NC(=O)C,,,,,,
5233,105234,CID 105234,C(=O)O.C(=O)O.[AlH3],,,,,,
5234,105235,3-Methyloct-3-yl acetate,CCCCCC(C)(CC)OC(=O)C,,,,,,
5235,105236,"2-(N-(1,1-Dihydroperfluorotridecylsulfonyl)-N-methylamino)ethyl acrylate",CN(CCOC(=O)C=C)S(=O)(=O)CC(C(C(C(C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
5236,105237,"2-(N-(1,1-Dihydroperfluoroundecylsulfonyl)-N-methylamino)ethyl acrylate",CN(CCOC(=O)C=C)S(=O)(=O)CC(C(C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
5237,105238,"2-(N-(1,1-Dihydroperfluorononylsulfonyl)-N-methylamino)ethyl acrylate",CN(CCOC(=O)C=C)S(=O)(=O)CC(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
5238,105239,"2-Propenoic acid, 2-[methyl[(2,2,3,3,4,4,5,5,6,6,7,7,7-tridecafluoroheptyl)sulfonyl]amino]ethyl ester",CN(CCOC(=O)C=C)S(=O)(=O)CC(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
5239,105240,"N-(Carboxymethyl)-N,N-dimethyl-3-(methyl((perfluorohexyl)ethylsulfonyl)amino)-1-propanaminium",CN(CCC[N+](C)(C)CC(=O)O)S(=O)(=O)CCC(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
5240,105241,"N-(2-Carboxyethyl)-N,N-dimethyl-3-[methyl[(perfluorohexyl)ethylsulfonyl]amino]-1-propanaminium",CN(CCC[N+](C)(C)CCC(=O)O)S(=O)(=O)CCC(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
5241,105242,Octadecyl heptanoate,CCCCCCCCCCCCCCCCCCOC(=O)CCCCCC,,,,,,
5242,105243,Indium trifluoracetate,C(=O)(C(F)(F)F)[O-].C(=O)(C(F)(F)F)[O-].[OH-].[In+3],,,,,,
5243,105244,"Ethanamine, N,N-dimethyl-2-(2-(methylbis(2-methylpropyl)phenoxy)ethoxy)-",CC1=CC(=CC(=C1OCCOCCN(C)C)CC(C)C)CC(C)C,,,,,,
5244,105245,Diisobutyl-o-cresol,CC1=CC(=CC(=C1O)CC(C)C)CC(C)C,,,,,,
5245,105246,Diisobutylphenoxyethoxyethyldimethylamine,CC(C)CC1=CC(=C(C=C1)OCCOCCN(C)C)CC(C)C,,,,,,
5246,105247,[2-(2-Chloroethoxy)ethoxy]bis(2-methylpropyl)benzene,CC(C)CC1=CC(=C(C=C1)OCCOCCCl)CC(C)C,,,,,,
5247,105248,1-[2-[2-(2-Chloroethoxy)ethoxy]ethoxy]-4-octylbenzene,CCCCCCCCC1=CC=C(C=C1)OCCOCCOCCCl,,,,,,
5248,105249,"(Formylimino)di-2,1-ethanediyl acrylate",C=CC(=O)OCCN(CCOC(=O)C=C)C=O,,,,,,
5249,105250,"N,N-Bis(2-acryloxyethyl)-6-acryloxyhexanamide",C=CC(=O)OCCCCCC(=O)N(CCOC(=O)C=C)CCOC(=O)C=C,,,,,,
5250,105251,"N,N-Bis(2-acryloxyethyl)-4-acryloxybutyramide",C=CC(=O)OCCCC(=O)N(CCOC(=O)C=C)CCOC(=O)C=C,,,,,,
5251,105252,CID 105252,C1=CC(=CC=C1C#N)NC(=O)N=C2C=CC(=CC2=O)N(O)O,,,,,,
5252,105253,"Benzoic acid, 2-amino-5-[(4-aminophenyl)methyl]-, ethyl ester",CCOC(=O)C1=C(C=CC(=C1)CC2=CC=C(C=C2)N)N,,,,,,
5253,105254,"Benzoic acid, 2-amino-5-((4-aminophenyl)methyl)-, butyl ester",CCCCOC(=O)C1=C(C=CC(=C1)CC2=CC=C(C=C2)N)N,,,,,,
5254,105255,"Benzoic acid, 2-amino-5-((4-amino-3-methoxyphenyl)methyl)-, methyl ester",COC1=C(C=CC(=C1)CC2=CC(=C(C=C2)N)C(=O)OC)N,,,,,,
5255,105256,"Benzoic acid, 2-amino-5-((4-amino-3-methoxyphenyl)methyl)-, ethyl ester",CCOC(=O)C1=C(C=CC(=C1)CC2=CC(=C(C=C2)N)OC)N,,,,,,
5256,105257,"Benzoic acid, 2-amino-5-((4-amino-3-methoxyphenyl)methyl)-, butyl ester",CCCCOC(=O)C1=C(C=CC(=C1)CC2=CC(=C(C=C2)N)OC)N,,,,,,
5257,105258,CID 105258,C(C(=O)[O-])NCO.[K+],,,,,,
5258,105259,"2-Naphthalenol, 1,1'-((phenylmethylene)bis((2-methyl-4,1-phenylene)azo))bis-",CC1=C(C=CC(=C1)C(C2=CC=CC=C2)C3=CC(=C(C=C3)N=NC4=C(C=CC5=CC=CC=C54)O)C)N=NC6=C(C=CC7=CC=CC=C76)O,,,,,,
5259,105260,"4,4'-[(Phenylmethylene)bis[(2-methyl-p-phenylene)azo]]bis[2,4-dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one]",CC1=C(C=CC(=C1)C(C2=CC=CC=C2)C3=CC(=C(C=C3)N=NC4C(=NN(C4=O)C5=CC=CC=C5)C)C)N=NC6C(=NN(C6=O)C7=CC=CC=C7)C,,,,,,
5260,105261,"1-[[4-[[4-[(2-Hydroxy-1-naphthyl)azo]-2,5-dimethylphenyl]phenylmethyl]-2-methylphenyl]azo]-2-naphthol",CC1=CC(=C(C=C1N=NC2=C(C=CC3=CC=CC=C32)O)C)C(C4=CC=CC=C4)C5=CC(=C(C=C5)N=NC6=C(C=CC7=CC=CC=C76)O)C,,,,,,
5261,105262,"5-[[4-[(3-Amino-3-oxopropyl)-(2-hydroxyethyl)amino]-6-anilino-1,3,5-triazin-2-yl]amino]-2-[2-[4-[[4-[(3-amino-3-oxopropyl)-(2-hydroxyethyl)amino]-6-anilino-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]ethenyl]benzenesulfonic acid",C1=CC=C(C=C1)NC2=NC(=NC(=N2)N(CCC(=O)N)CCO)NC3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)NC5=NC(=NC(=N5)NC6=CC=CC=C6)N(CCC(=O)N)CCO)S(=O)(=O)O)S(=O)(=O)O,,,,,,
5262,105263,"Violanthrone, nitro-",C1=CC=C2C(=C1)C3=C4C(=CC=C5C4=C(C=C3)C6=C7C5=CC=C8C7=C(C=C6)C9=C(C8=O)C=CC(=C9)[N+](=O)[O-])C2=O,,,,,,
5263,105264,"Dipotassium;4-[(3-oxo-1-benzothiophen-2-ylidene)methyl]benzene-1,3-disulfonate",C1=CC=C2C(=C1)C(=O)C(=CC3=C(C=C(C=C3)S(=O)(=O)[O-])S(=O)(=O)[O-])S2.[K+].[K+],,,,,,
5264,105265,"4-[(3-Oxo-1-benzothiophen-2-ylidene)methyl]benzene-1,3-disulfonic acid",C1=CC=C2C(=C1)C(=O)C(=CC3=C(C=C(C=C3)S(=O)(=O)O)S(=O)(=O)O)S2,,,,,,
5265,105266,"2H-1,2,3-Triazolo[4,5-b]pyridin-5-amine, 2-(4-methoxyphenyl)-",COC1=CC=C(C=C1)N2N=C3C=CC(=NC3=N2)N,,,,,,
5266,105267,"2,6-Pyridinediamine, 3-[(4-methoxyphenyl)azo]-, monohydrochloride",COC1=CC=C(C=C1)N=NC2=C(N=C(C=C2)N)N.Cl,,,,,,
5267,105268,"3-[(4-Methoxyphenyl)azo]-2,6-pyridinediamine",COC1=CC=C(C=C1)N=NC2=C(N=C(C=C2)N)N,,,,,,
5268,105269,"2H-1,2,3-Triazolo[4,5-b]pyridin-5-amine, 2-(3,4-dimethylphenyl)-",CC1=C(C=C(C=C1)N2N=C3C=CC(=NC3=N2)N)C,,,,,,
5269,105270,"2,6-Pyridinediamine, 3-[(3,4-dimethylphenyl)azo]-, monohydrochloride",CC1=C(C=C(C=C1)N=NC2=C(N=C(C=C2)N)N)C.Cl,,,,,,
5270,105271,"3-[(3,4-Dimethylphenyl)azo]-2,6-pyridinediamine",CC1=C(C=C(C=C1)N=NC2=C(N=C(C=C2)N)N)C,,,,,,
5271,105272,"Benzenamine, 4-[(2,4-dimethylphenyl)azo]-2-methyl-, monohydrochloride",CC1=CC(=C(C=C1)N=NC2=CC(=C(C=C2)N)C)C.Cl,,,,,,
5272,105273,"1,3,5-Tripropoxybenzene",CCCOC1=CC(=CC(=C1)OCCC)OCCC,,,,,,
5273,105274,"1H-Benzimidazole-2-carboxaldehyde, (3-methyl-2(3H)-benzothiazolylidene)hydrazone",CN1C2=CC=CC=C2SC1=NN=CC3=NC4=CC=CC=C4N3,,,,,,
5274,105275,"Benzenamine, 4-((2,3-dimethylphenyl)azo)-2,3-dimethyl-, monohydrochloride",CC1=C(C(=CC=C1)N=NC2=C(C(=C(C=C2)N)C)C)C.Cl,,,,,,
5275,105276,"4-(2,3-Xylylazo)-2,3-dimethylbenzenamine",CC1=C(C(=CC=C1)N=NC2=C(C(=C(C=C2)N)C)C)C,,,,,,
5276,105277,"7H-Benz[de]anthracen-7-one, 3,9-dichloro-",C1=CC2=C(C=CC3=C2C(=C1)C(=O)C4=C3C=CC(=C4)Cl)Cl,,,,,,
5277,105278,"Benzoic acid, 2-((1-(2,5-dichloro-4-sulfophenyl)-2,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl)azo)-",CC1=C(C(=O)N(N1)C2=CC(=C(C=C2Cl)S(=O)(=O)O)Cl)N=NC3=CC=CC=C3C(=O)O,,,,,,
5278,105279,"Acetamide, N-[2-[[4-(4-morpholinyl)phenyl]azo]-6-benzothiazolyl]-",CC(=O)NC1=CC2=C(C=C1)N=C(S2)N=NC3=CC=C(C=C3)N4CCOCC4,,,,,,
5279,105280,"Phenol, 4-((2-methoxy-5-methyl-4-((4-nitrophenyl)azo)phenyl)azo)-",CC1=CC(=C(C=C1N=NC2=CC=C(C=C2)[N+](=O)[O-])OC)N=NC3=CC=C(C=C3)O,,,,,,
5280,105281,"4-Oxo-5,8,11,14-tetraoxahexacos-2-en-1-oic acid",CCCCCCCCCCCCOCCOCCOCCOC(=O)C=CC(=O)O,,,,,,
5281,105282,"Benzoyl chloride, 4-(hexadecylamino)-",CCCCCCCCCCCCCCCCNC1=CC=C(C=C1)C(=O)Cl,,,,,,
5282,105283,"3-(Benzoyloxy)-4-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)naphthalene-1-sulphonyl chloride",CC1=NN(C(=O)C1N=NC2=C(C=C(C3=CC=CC=C32)S(=O)(=O)Cl)OC(=O)C4=CC=CC=C4)C5=CC=CC=C5,,,,,,
5283,105284,1-(Amylamino)-4-((2-ethylhexyl)amino)anthraquinone,CCC(CCCCN)CC1=C2C(=C(C=C1)CCCCCN)C(=O)C3=CC=CC=C3C2=O,,,,,,
5284,105285,Tris(5-norbornen-2-ylmethyl) phosphite,C1C2CC(C1C=C2)COP(OCC3CC4CC3C=C4)OCC5CC6CC5C=C6,,,,,,
5285,105286,"Benzoxazolium, 2-methyl-5-phenyl-3-(3-sulfopropyl)-, inner salt",CC1=[N+](C2=C(O1)C=CC(=C2)C3=CC=CC=C3)CCCS(=O)(=O)[O-],,,,,,
5286,105287,"3-(2-Methyl-5-phenyl-1,3-benzoxazol-3-ium-3-yl)propane-1-sulfonic acid",CC1=[N+](C2=C(O1)C=CC(=C2)C3=CC=CC=C3)CCCS(=O)(=O)O,,,,,,
5287,105288,"Benzamide, N-(4-amino-5-chloro-2-hydroxyphenyl)-, monohydrochloride",C1=CC=C(C=C1)C(=O)NC2=C(C=C(C(=C2)Cl)N)O.Cl,,,,,,
5288,105289,"1-Benzopyrylium, 4-ethoxy-2-(4-methoxyphenyl)-, methanesulfonate",CCOC1=CC(=[O+]C2=CC=CC=C21)C3=CC=C(C=C3)OC.CS(=O)(=O)[O-],,,,,,
5289,105290,4-Ethoxy-2-(4-methoxyphenyl)-1-benzopyrylium,CCOC1=CC(=[O+]C2=CC=CC=C21)C3=CC=C(C=C3)OC,,,,,,
5290,105291,4-Methoxy-2-(4-methoxyphenyl)-1-benzopyrylium methyl sulphate,COC1=CC=C(C=C1)C2=[O+]C3=CC=CC=C3C(=C2)OC.COS(=O)(=O)[O-],,,,,,
5291,105292,2-(4-Methoxyphenyl)-4-methoxy-1-benzopyrylium,COC1=CC=C(C=C1)C2=[O+]C3=CC=CC=C3C(=C2)OC,,,,,,
5292,105293,Ethyl 3-ethyl-2-methylbenzoselenazolium sulphate,CC[N+]1=C([Se]C2=CC=CC=C21)C.CCOS(=O)(=O)[O-],,,,,,
5293,105294,"1-Naphthalenesulfonamide, 4-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-3-hydroxy-N,N-bis(2-hydroxyethyl)-",CC1=NN(C(=O)C1N=NC2=C(C=C(C3=CC=CC=C32)S(=O)(=O)N(CCO)CCO)O)C4=CC=CC=C4,,,,,,
5294,105295,Octadec-9-enyl docosanoate,CCCCCCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCC=CCCCCCCCC,,,,,,
5295,105296,"Dodecanamide, N-[3-(4-morpholinyl)propyl]-",CCCCCCCCCCCC(=O)NCCCN1CCOCC1,,,,,,
5296,105297,"Tetradecanamide, N-[3-(4-morpholinyl)propyl]-",CCCCCCCCCCCCCC(=O)NCCCN1CCOCC1,,,,,,
5297,105298,"Dodecanamide, N-[3-(4-oxido-4-morpholinyl)propyl]-",CCCCCCCCCCCC(=O)NCCC[N+]1(CCOCC1)[O-],,,,,,
5298,105299,"Tetradecanamide, N-[3-(4-oxido-4-morpholinyl)propyl]-",CCCCCCCCCCCCCC(=O)NCCC[N+]1(CCOCC1)[O-],,,,,,
5299,105300,CID 105300,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOS(=O)(=O)[O-].[Na+],,,,,,
5300,105301,2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-Dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl hydrogen sulfate,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOS(=O)(=O)O,,,,,,
5301,105302,CID 105302,CCCCCCCCCCCCOCCOCCOCCOCCOS(=O)(=O)[O-].[Na+],,,,,,
5302,105303,2-[2-[2-(2-Dodecoxyethoxy)ethoxy]ethoxy]ethyl hydrogen sulfate,CCCCCCCCCCCCOCCOCCOCCOCCOS(=O)(=O)O,,,,,,
5303,105304,"3,6,9,12,15,18,21,24-Octaoxaheptatriacontanoic acid",CCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCC(=O)O,,,,,,
5304,105305,CID 105305,CCCCCCCCCCCC(=O)NCCN(CCO)CC(=O)[O-].[Na+],,,,,,
5305,105306,"Tetradecanamide, N-[3-[bis(2-hydroxyethyl)amino]propyl]-",CCCCCCCCCCCCCC(=O)NCCCN(CCO)CCO,,,,,,
5306,105307,"Hexadecanamide, N-[3-[bis(2-hydroxyethyl)amino]propyl]-",CCCCCCCCCCCCCCCC(=O)NCCCN(CCO)CCO,,,,,,
5307,105308,"Dodecanamide, N-[3-[bis(2-hydroxyethyl)oxidoamino]propyl]-",CCCCCCCCCCCC(=O)NCCC[N+](CCO)(CCO)[O-],,,,,,
5308,105309,"Tetradecanamide, N-[3-[bis(2-hydroxyethyl)oxidoamino]propyl]-",CCCCCCCCCCCCCC(=O)NCCC[N+](CCO)(CCO)[O-],,,,,,
5309,105310,"Hexadecanamide, N-[3-[bis(2-hydroxyethyl)oxidoamino]propyl]-",CCCCCCCCCCCCCCCC(=O)NCCC[N+](CCO)(CCO)[O-],,,,,,
5310,105311,"Octadecanamide, N-[3-[bis(2-hydroxyethyl)oxidoamino]propyl]-",CCCCCCCCCCCCCCCCCC(=O)NCCC[N+](CCO)(CCO)[O-],,,,,,
5311,105312,"1,3,5-Triazine-2,4-diamine, 6,6',6''-(1,3,6-hexanetriyl)tris-",C(CC1=NC(=NC(=N1)N)N)CC(CCC2=NC(=NC(=N2)N)N)C3=NC(=NC(=N3)N)N,,,,,,
5312,105313,Hexadecyl nicotinate,CCCCCCCCCCCCCCCCOC(=O)C1=CN=CC=C1,,,,,,
5313,105314,"3,6,9,12,15,18-Hexaoxaeicosan-1-ol, 20-(dinonylphenoxy)-, dihydrogen phosphate",CCCCCCCCCC1=C(C(=CC=C1)CCCCCCCCC)OCCOCCOCCOCCOCCOCCOCCOP(=O)(O)O,,,,,,
5314,105315,"3,6,9,12,15-Pentaoxaheptadecan-1-ol, 17-(nonylphenoxy)-, hydrogen phosphate",CCCCCCCCCC1=CC=CC=C1OCCOCCOCCOCCOCCOCCOP(=O)(O)OCCOCCOCCOCCOCCOCCOC2=CC=CC=C2CCCCCCCCC,,,,,,
5315,105316,"3,6,9,12,15,18,21,24-Octaoxahexacosan-1-ol, 26-(nonylphenoxy)-, hydrogen phosphate",CCCCCCCCCC1=CC=CC=C1OCCOCCOCCOCCOCCOCCOCCOCCOCCOP(=O)(O)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC2=CC=CC=C2CCCCCCCCC,,,,,,
5316,105317,"3,6,9,12,15,18-Hexaoxaeicosan-1-ol, 20-(dinonylphenoxy)-, hydrogen phosphate",CCCCCCCCCC1=C(C(=CC=C1)CCCCCCCCC)OCCOCCOCCOCCOCCOCCOCCOP(=O)(O)OCCOCCOCCOCCOCCOCCOCCOC2=C(C=CC=C2CCCCCCCCC)CCCCCCCCC,,,,,,
5317,105318,"3,6,9,12,15,18,21,24-Octaoxahexacosan-1-ol, 26-(dinonylphenoxy)-",CCCCCCCCCC1=C(C(=CC=C1)CCCCCCCCC)OCCOCCOCCOCCOCCOCCOCCOCCOCCO,,,,,,
5318,105319,"23-Methyl-3,6,9,12,15-pentaoxatetracosan-1-ol",CC(C)CCCCCCCOCCOCCOCCOCCOCCO,,,,,,
5319,105320,Deuterio trifluoromethanesulfonate,[2H]OS(=O)(=O)C(F)(F)F,,,,,,
5320,105321,"9,10-Anthracenedione, 1,4,5,8-tetrakis(phenylamino)-",C1=CC=C(C=C1)NC2=C3C(=C(C=C2)NC4=CC=CC=C4)C(=O)C5=C(C=CC(=C5C3=O)NC6=CC=CC=C6)NC7=CC=CC=C7,,,,,,
5321,105322,"Benzenesulfonic acid, thiazolo(5,4-d)thiazole-2,5-diylbis(methoxy-",COC1=C(C=C(C=C1)S(=O)(=O)O)C2=NC3=C(S2)N=C(S3)C4=C(C=CC(=C4)S(=O)(=O)O)OC,,,,,,
5322,105323,CID 105323,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOS(=O)(=O)[O-].[Na+],,,,,,
5323,105324,2-[2-[2-[2-[2-[2-(2-Dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl hydrogen sulfate,CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOS(=O)(=O)O,,,,,,
5324,105325,"2-Naphthalenesulfonic acid, 7-[[2-hydroxy-5-[(4-hydroxyphenyl)sulfonyl]phenyl]methyl]-",C1=CC(=CC2=C1C=CC(=C2)S(=O)(=O)O)CC3=C(C=CC(=C3)S(=O)(=O)C4=CC=C(C=C4)O)O,,,,,,
5325,105326,"Benzenecarboximidoyl chloride, N,N'-(9,10-dihydro-9,10-dioxo-2,6-anthracenediyl)bis-",C1=CC=C(C=C1)C(=NC2=CC3=C(C=C2)C(=O)C4=C(C3=O)C=CC(=C4)N=C(C5=CC=CC=C5)Cl)Cl,,,,,,
5326,105327,CID 105327,C1=CC=C(C(=C1)C(=O)[O-])N=NC2=C(C=C3C=CC(=CC3=C2O)N)S(=O)(=O)[O-].[Na+].[Na+],,,,,,
5327,105328,2-[(7-Amino-1-hydroxy-3-sulfonaphthalen-2-yl)diazenyl]benzoic acid,C1=CC=C(C(=C1)C(=O)O)N=NC2=C(C=C3C=CC(=CC3=C2O)N)S(=O)(=O)O,,,,,,
5328,105329,"Acetic acid, ((2-(aminocarbonyl)-5-chloro-3-methylphenyl)thio)-",CC1=CC(=CC(=C1C(=O)N)SCC(=O)O)Cl,,,,,,
5329,105330,"2lambda4-1,2,3-Benzodithiazole, 2,6-dichloro-4-methyl-",CC1=CC(=CC2=C1N=S(S2)Cl)Cl,,,,,,
5330,105331,"2-(2,5-Dichlorophenyl)-2,4-dihydro-4-((2-methoxyphenyl)azo)-5-methyl-3H-pyrazol-3-one",CC1=NN(C(=O)C1N=NC2=CC=CC=C2OC)C3=C(C=CC(=C3)Cl)Cl,,,,,,
5331,105332,"2,7-Naphthalenedisulfonic acid, 5-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-4-hydroxy-3-((4'-((2-hydroxy-3,6-disulfo-1-naphthalenyl)azo)-3,3'-dimethoxy(1,1'-biphenyl)-4-yl)azo)-, tetrasodium salt",CC1=NN(C(=O)C1N=NC2=C3C(=CC(=C2)S(=O)(=O)[O-])C=C(C(=C3O)N=NC4=C(C=C(C=C4)C5=CC(=C(C=C5)N=NC6=C7C=CC(=CC7=CC(=C6O)S(=O)(=O)[O-])S(=O)(=O)[O-])OC)OC)S(=O)(=O)[O-])C8=CC=CC=C8.[Na+].[Na+].[Na+].[Na+],,,,,,
5332,105333,"4-hydroxy-3-[[4-[4-[(2-hydroxy-3,6-disulfonaphthalen-1-yl)diazenyl]-3-methoxyphenyl]-2-methoxyphenyl]diazenyl]-5-[(3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-yl)diazenyl]naphthalene-2,7-disulfonic acid",CC1=NN(C(=O)C1N=NC2=C3C(=CC(=C2)S(=O)(=O)O)C=C(C(=C3O)N=NC4=C(C=C(C=C4)C5=CC(=C(C=C5)N=NC6=C7C=CC(=CC7=CC(=C6O)S(=O)(=O)O)S(=O)(=O)O)OC)OC)S(=O)(=O)O)C8=CC=CC=C8,,,,,,
5333,105334,CID 105334,CCOC1=CC=C(C=C1)N=NC2=C(C=C(C=C2)N=NC3=CC(=CC=C3)S(=O)(=O)[O-])OC.[Na+],,,,,,
5334,105335,3-[[4-[(4-Ethoxyphenyl)diazenyl]-3-methoxyphenyl]diazenyl]benzenesulfonic acid,CCOC1=CC=C(C=C1)N=NC2=C(C=C(C=C2)N=NC3=CC(=CC=C3)S(=O)(=O)O)OC,,,,,,
5335,105336,"Benzoic acid, 2-hydroxy-5-[[4-[[[[2-methoxy-4-[(3-sulfophenyl)azo]phenyl]amino]carbonyl]amino]phenyl]azo]-3-methyl-, disodium salt",CC1=CC(=CC(=C1O)C(=O)[O-])N=NC2=CC=C(C=C2)NC(=O)NC3=C(C=C(C=C3)N=NC4=CC(=CC=C4)S(=O)(=O)[O-])OC.[Na+].[Na+],,,,,,
5336,105337,2-Hydroxy-5-({4-[({2-methoxy-4-[(3-sulfophenyl)diazenyl]phenyl}carbamoyl)amino]phenyl}diazenyl)-3-methylbenzoic acid,CC1=CC(=CC(=C1O)C(=O)O)N=NC2=CC=C(C=C2)NC(=O)NC3=C(C=C(C=C3)N=NC4=CC(=CC=C4)S(=O)(=O)O)OC,,,,,,
5337,105338,"2,7-Naphthalenedisulfonic acid, 5-amino-3-[[4'-[(7-amino-1-hydroxy-3-sulfo-2-naphthalenyl)azo]-3,3'-dimethyl[1,1'-biphenyl]-4-yl]azo]-4-hydroxy-, trisodium salt",CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C=C4C=CC(=CC4=C3O)N)S(=O)(=O)[O-])C)N=NC5=C(C6=C(C=C(C=C6C=C5S(=O)(=O)[O-])S(=O)(=O)[O-])N)O.[Na+].[Na+].[Na+],,,,,,
5338,105339,"5-Amino-3-[[4-[4-[(7-amino-1-hydroxy-3-sulfonaphthalen-2-yl)diazenyl]-3-methylphenyl]-2-methylphenyl]diazenyl]-4-hydroxynaphthalene-2,7-disulfonic acid",CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C=C4C=CC(=CC4=C3O)N)S(=O)(=O)O)C)N=NC5=C(C6=C(C=C(C=C6C=C5S(=O)(=O)O)S(=O)(=O)O)N)O,,,,,,
5339,105340,"Acetamide, N-[5-[bis[2-(acetyloxy)ethyl]amino]-2-[(2-chloro-5-nitrophenyl)azo]phenyl]-",CC(=O)NC1=C(C=CC(=C1)N(CCOC(=O)C)CCOC(=O)C)N=NC2=C(C=CC(=C2)[N+](=O)[O-])Cl,,,,,,
5340,105341,"2,2'-((4-((4-Nitrophenyl)azo)phenyl)imino)bisethyl diacetate",CC(=O)OCCN(CCOC(=O)C)C1=CC=C(C=C1)N=NC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
5341,105342,CID 105342,C1=CC=C(C=C1)C(=NC2=CC3=C(C=C2)C(=O)C4=C(C3=O)C=CC(=C4)N=C(C5=CC=CC=C5)S)S,,,,,,
5342,105343,2-Propenyl [2-(2-oxo-1-imidazolidinyl)ethyl]carbamate,C=CCOC(=O)NCCN1CCNC1=O,,,,,,
5343,105344,"Cuprate(3-), (mu-(3-((5-(aminosulfonyl)-2-hydroxyphenyl)azo)-4-hydroxy-7-((((5-hydroxy-6-((2-hydroxy-4-sulfophenyl)azo)-7-sulfo-2-naphthalenyl)amino)carbonyl)amino)-2-naphthalenesulfonato(7-)))di-, trisodium",C1=CC2=C(C(=C(C=C2C=C1NC(=O)NC3=CC4=CC(=C(C(=C4C=C3)[O-])N=NC5=C(C=CC(=C5)S(=O)(=O)N)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])N=NC6=C(C=C(C=C6)S(=O)(=O)[O-])[O-])[O-].[Na+].[Na+].[Na+].[Cu+2].[Cu+2],,,,,,
5344,105345,4-Hydroxy-7-[[5-hydroxy-6-[(2-hydroxy-5-sulfamoylphenyl)diazenyl]-7-sulfonaphthalen-2-yl]carbamoylamino]-3-[(2-hydroxy-4-sulfophenyl)diazenyl]naphthalene-2-sulfonic acid,C1=CC2=C(C(=C(C=C2C=C1NC(=O)NC3=CC4=CC(=C(C(=C4C=C3)O)N=NC5=C(C=CC(=C5)S(=O)(=O)N)O)S(=O)(=O)O)S(=O)(=O)O)N=NC6=C(C=C(C=C6)S(=O)(=O)O)O)O,,,,,,
5345,105346,"Copper;disodium;5-[[2-methyl-4-[3-methyl-4-[2-[5-[(2-oxido-5-sulfonatophenyl)hydrazinylidene]-2,6-dioxocyclohex-3-en-1-ylidene]hydrazinyl]phenyl]phenyl]diazenyl]-2-oxidobenzoate",CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=CC(=C(C=C3)[O-])C(=O)[O-])C)NN=C4C(=O)C=CC(=NNC5=C(C=CC(=C5)S(=O)(=O)[O-])[O-])C4=O.[Na+].[Na+].[Cu+2],,,,,,
5346,105347,"2-Hydroxy-5-[[4-[4-[2-[5-[(2-hydroxy-5-sulfophenyl)hydrazinylidene]-2,6-dioxocyclohex-3-en-1-ylidene]hydrazinyl]-3-methylphenyl]-2-methylphenyl]diazenyl]benzoic acid",CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O)C)NN=C4C(=O)C=CC(=NNC5=C(C=CC(=C5)S(=O)(=O)O)O)C4=O,,,,,,
5347,105348,Ethoxy(ethyl carbonato-O')magnesium,CC[O-].CCOC(=O)[O-].[Mg+2],,,,,,
5348,105349,Ethyl hydrogen carbonate,CCOC(=O)O,,,,,,
5349,105350,"Benzoic acid, 3,3'-[carbonylbis(imino-4,1-phenyleneazo)]bis[6-hydroxy-5-methyl-, disodium salt",CC1=CC(=CC(=C1O)N=NC2=CC=C(C=C2)NC(=O)NC3=CC=C(C=C3)N=NC4=C(C(=CC(=C4)C(=O)[O-])C)O)C(=O)[O-].[Na+].[Na+],,,,,,
5350,105351,"3,3'-[Carbonylbis(azanediyl-4,1-phenylenediazene-2,1-diyl)]bis(4-hydroxy-5-methylbenzoic acid)",CC1=CC(=CC(=C1O)N=NC2=CC=C(C=C2)NC(=O)NC3=CC=C(C=C3)N=NC4=C(C(=CC(=C4)C(=O)O)C)O)C(=O)O,,,,,,
5351,105352,"Cuprate(4-), (mu-(5-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-3-((4'-((3,6-disulfo-2-hydroxy-1-naphthalenyl)azo)-3,3'-dihydroxy(1,1'-biphenyl)-4-yl)azo)-4-hydroxy-2,7-naphthalenedisulfonato(8-)))di-, tetrasodium",CC1=NN(C(=O)C1N=NC2=C3C(=CC(=C2)S(=O)(=O)[O-])C=C(C(=C3[O-])N=NC4=C(C=C(C=C4)C5=CC(=C(C=C5)N=NC6=C7C=CC(=CC7=CC(=C6[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])[O-])[O-])S(=O)(=O)[O-])C8=CC=CC=C8.[Na+].[Na+].[Na+].[Na+].[Cu+2].[Cu+2],,,,,,
5352,105353,"4-hydroxy-3-[[2-hydroxy-4-[3-hydroxy-4-[(2-hydroxy-3,6-disulfonaphthalen-1-yl)diazenyl]phenyl]phenyl]diazenyl]-5-[(3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-yl)diazenyl]naphthalene-2,7-disulfonic acid",CC1=NN(C(=O)C1N=NC2=C3C(=CC(=C2)S(=O)(=O)O)C=C(C(=C3O)N=NC4=C(C=C(C=C4)C5=CC(=C(C=C5)N=NC6=C7C=CC(=CC7=CC(=C6O)S(=O)(=O)O)S(=O)(=O)O)O)O)S(=O)(=O)O)C8=CC=CC=C8,,,,,,
5353,105354,"2,2'-Spirobi(2H-1-benzopyran), 3,3',4,4'-tetrahydro-4,4,4',4',7,7'-hexamethyl-6,6'-bis(octyloxy)-",CCCCCCCCOC1=CC2=C(C=C1C)OC3(CC2(C)C)CC(C4=C(O3)C=C(C(=C4)OCCCCCCCC)C)(C)C,,,,,,
5354,105355,Dodecanediperoxoic acid,C(CCCCCC(=O)OO)CCCCC(=O)OO,,,,,,
5355,105356,"Benzoic acid, 2-(dimethylamino)-, pentyl ester",CCCCCOC(=O)C1=CC=CC=C1N(C)C,,,,,,
5356,105357,"9,10-Anthracenedione, 1,5-dihydroxy-4,8-bis(hydroxyamino)-",C1=CC(=C2C(=C1NO)C(=C3C(=CC=C(C3=C2O)N=O)O)O)O,,,,,,
5357,105358,"9,10-Anthracenedione, 1,8-dihydroxy-4,5-bis(hydroxyamino)-",C1=CC(=C2C(=C1NO)C(=C3C(=CC=C(C3=C2O)O)N=O)O)O,,,,,,
5358,105359,"1,5-Dihydroxy-4,8-bis(hydroxy(hydroxymethyl)amino)anthraquinone",C1=CC(=C2C(=C1N(CO)O)C(=O)C3=C(C=CC(=C3C2=O)N(CO)O)O)O,,,,,,
5359,105360,"9,10-Anthracenedione, 1,8-dihydroxy-4,5-bis[hydroxy(hydroxymethyl)amino]-",C1=CC(=C2C(=C1N(CO)O)C(=O)C3=C(C=CC(=C3C2=O)O)N(CO)O)O,,,,,,
5360,105361,"4,4-Dimethyloxazolidinium toluenesulphonate",CC1=CC(=CC=C1)S(=O)(=O)O.CC1(COCN1)C,,,,,,
5361,105362,3-Methylbenzenesulfonic acid,CC1=CC(=CC=C1)S(=O)(=O)O,,,,,,
5362,105363,"1-Naphthalenesulfonic acid, 5-butyl-, compd. with 2-aminoethanol (1:1)",CCCCC1=C2C=CC=C(C2=CC=C1)S(=O)(=O)O.C(CO)N,,,,,,
5363,105364,5-butylnaphthalene-1-sulfonic Acid,CCCCC1=C2C=CC=C(C2=CC=C1)S(=O)(=O)O,,,,,,
5364,105365,"Cuprate(4-), [mu-[3-[[3,3'-di(hydroxy-kappaO)-4'-[[2-(hydroxy-kappaO)-3,6-disulfo-1-naphthalenyl]azo-kappaN1][1,1'-biphenyl]-4-yl]azo-kappaN1]-4-(hydroxy-kappaO)-2,7-naphthalenedisulfonato(8-)]]di-, tetrasodium",C1=CC(=C(C=C1C2=CC(=C(C=C2)N=NC3=C(C=C4C=C(C=CC4=C3[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])[O-])[O-])N=NC5=C6C=CC(=CC6=CC(=C5[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Cu+2].[Cu+2],,,,,,
5365,105366,"3-Hydroxy-4-[[2-hydroxy-4-[3-hydroxy-4-[(1-hydroxy-3,6-disulfonaphthalen-2-yl)diazenyl]phenyl]phenyl]diazenyl]naphthalene-2,7-disulfonic acid",C1=CC(=C(C=C1C2=CC(=C(C=C2)N=NC3=C(C=C4C=C(C=CC4=C3O)S(=O)(=O)O)S(=O)(=O)O)O)O)N=NC5=C6C=CC(=CC6=CC(=C5O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
5366,105367,CID 105367,CCCCCCCC1=NN=C(O1)S,,,,,,
5367,105368,"Thiobis[2-tert-butyl-5-methyl-4,1-phenylene] 3-(laurylthio)propionate",CCCCCCCCCCCCSCCC(=O)OC1=C(C=C(C(=C1)C)SC2=CC(=C(C=C2C)OC(=O)CCSCCCCCCCCCCCC)C(C)(C)C)C(C)(C)C,,,,,,
5368,105369,"Dipentaerythritol, stearate",CCCCCCCCCCCCCCCCCC(=O)O.C(C(CO)(CO)COCC(CO)(CO)CO)O,,,,,,
5369,105370,4-[2-[2-(Dodecylamino)ethylamino]ethylamino]-4-oxobut-2-enoic acid,CCCCCCCCCCCCNCCNCCNC(=O)C=CC(=O)O,,,,,,
5370,105371,"Ethylenediaminetetraacetic acid, compd. with triethanolamine",COC(=O)N(CCN(CC(=O)O)C(=O)OC)CC(=O)O.C(CO)N(CCO)CCO,,,,,,
5371,105372,"3,6-Bis(methoxycarbonyl)-3,6-diazaoctanedioic acid",COC(=O)N(CCN(CC(=O)O)C(=O)OC)CC(=O)O,,,,,,
5372,105373,"Ethanamine, N,N',N''-[(2,4,6,8,8-pentamethylcyclotetrasiloxane-2,4,6-triyl)tris(oxy)]tris[N-ethyl-",CCN(CC)O[Si]1(O[Si](O[Si](O[Si](O1)(C)ON(CC)CC)(C)ON(CC)CC)(C)C)C,,,,,,
5373,105374,Di(butylmethylpyrophosphato) ethylene titanate,[H+].[H+].CCCCOP(=O)(OC)OP(=O)([O-])[O-].CCCCOP(=O)(OC)OP(=O)([O-])[O-].C(C[O-])[O-].[Ti+4],,,,,,
5374,105375,Butyl methyl phosphono phosphate,CCCCOP(=O)(OC)OP(=O)(O)O,,,,,,
5375,105376,"3-(Benzoyloxy)-2,2-dimethylpropyl acrylate",CC(C)(COC(=O)C=C)COC(=O)C1=CC=CC=C1,,,,,,
5376,105377,"Propanamide, N-[5-[bis[2-(2-cyanoethoxy)ethyl]amino]-2-[(2-chloro-4,6-dinitrophenyl)azo]-4-methoxyphenyl]-",CCC(=O)NC1=CC(=C(C=C1N=NC2=C(C=C(C=C2Cl)[N+](=O)[O-])[N+](=O)[O-])OC)N(CCOCCC#N)CCOCCC#N,,,,,,
5377,105378,"Propanamide, N-[2-[(2-chloro-4,6-dinitrophenyl)azo]-5-[[2-(2-cyanoethoxy)ethyl]amino]-4-methoxyphenyl]-",CCC(=O)NC1=CC(=C(C=C1N=NC2=C(C=C(C=C2Cl)[N+](=O)[O-])[N+](=O)[O-])OC)NCCOCCC#N,,,,,,
5378,105379,"Benzene, dodecyldimethyl-",CCCCCCCCCCCCC1=CC=CC(=C1C)C,,,,,,
5379,105380,Tetrabromobisphenol A bis(2-hydroxyethyl) ether bis(acrylate),CC(C)(C1=CC(=C(C(=C1)Br)OCCOC(=O)C=C)Br)C2=CC(=C(C(=C2)Br)OCCOC(=O)C=C)Br,,,,,,
5380,105381,2-(2-Methoxyethoxy)-2-methylpropane,CC(C)(C)OCCOC,,,,,,
5381,105382,"2-Anthracenesulfonic acid, 4-[[3-(acetylamino)phenyl]amino]-1-amino-9,10-dihydro-9,10-dioxo-",CC(=O)NC1=CC=CC(=C1)NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)O,,,,,,
5382,105383,CID 105383,C1=CC=C(C=C1)C(=O)NC2=CC=CC3=C2C(=O)C4=C(C3=O)C(=CC=C4)N=NC(C5=NC(=O)C6=CC=CC=C6N5)C7=NC(=O)C8=CC=CC=C8N7,,,,,,
5383,105384,Benzyl neodecanoate,CC(C)(C)CCCCCC(=O)OCC1=CC=CC=C1,,,,,,
5384,105385,CID 105385,CCCCCCCCCCCCCCCCCCN(CCO)CC(=O)[O-].[Na+],,,,,,
5385,105386,N-(2-Hydroxyethyl)-N-octadecylglycine,CCCCCCCCCCCCCCCCCCN(CCO)CC(=O)O,,,,,,
5386,105387,"Butanamide, 4-hydroxy-N,N-bis(2-hydroxyethyl)-",C(CC(=O)N(CCO)CCO)CO,,,,,,
5387,105388,"Benzonitrile, 2-((4-(bis(2-(acetyloxy)ethyl)amino)-2-methylphenyl)azo)-5-nitro-",CC1=C(C=CC(=C1)N(CCOC(=O)C)CCOC(=O)C)N=NC2=C(C=C(C=C2)[N+](=O)[O-])C#N,,,,,,
5388,105389,2-(Methylsulfonyl)acetamide,CS(=O)(=O)CC(=O)N,,,,,,
5389,105390,"1-Triazene, 3-acetyl-3-methyl-1-(4-methylphenyl)-",CC1=CC=C(C=C1)N=NN(C)C(=O)C,,,,,,
5390,105391,"4-(Benzoylamino)-2,5-diethoxybenzenediazonium hexafluorophosphate",CCOC1=CC(=C(C=C1NC(=O)C2=CC=CC=C2)OCC)[N+]#N.F[P-](F)(F)(F)(F)F,,,,,,
5391,105392,"2,6-Nonadienenitrile",CCC=CCCC=CC#N,,,,,,
5392,105393,"9,10-Anthracenedione, 1-amino-4-hydroxy-2-[4-(2-oxopropoxy)phenoxy]-",CC(=O)COC1=CC=C(C=C1)OC2=C(C3=C(C(=C2)O)C(=O)C4=CC=CC=C4C3=O)N,,,,,,
5393,105394,Butyl 4-benzoylbenzoate,CCCCOC(=O)C1=CC=C(C=C1)C(=O)C2=CC=CC=C2,,,,,,
5394,105395,1-Bromo-3-(dimethoxymethyl)benzene,COC(C1=CC(=CC=C1)Br)OC,,,,,,
5395,105396,"Anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetrone, 2,9-bis(2-phenylethyl)-",C1=CC=C(C=C1)CCN2C(=O)C3=C4C(=CC=C5C4=C(C=C3)C6=C7C5=CC=C8C7=C(C=C6)C(=O)N(C8=O)CCC9=CC=CC=C9)C2=O,,,,,,
5396,105397,"Calcium 3,3'-thiobispropionate",C(CSCCC(=O)[O-])C(=O)[O-].[Ca+2],,,,,,
5397,105398,"1H-Pyrazol-5-amine, 4-[(2,4-dinitrophenyl)azo]-3-methyl-1-phenyl-",CC1=NN(C(=C1N=NC2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-])N)C3=CC=CC=C3,,,,,,
5398,105399,n-[3-(Dimethylamino)-4-methoxyphenyl]acetamide,CC(=O)NC1=CC(=C(C=C1)OC)N(C)C,,,,,,
5399,105400,N-(2-Amino-4-ethoxyphenyl)acetamide,CCOC1=CC(=C(C=C1)NC(=O)C)N,,,,,,
5400,105401,"N-((4-(3,5-Dichloropyridin-2-yl)oxyphenyl)carbamoyl)-2,6-difluorobenzamide",C1=CC(=C(C(=C1)F)C(=O)NC(=O)NC2=CC=C(C=C2)OC3=C(C=C(C=N3)Cl)Cl)F,,,,,,
5401,105402,Nonyl 3-mercaptopropionate,CCCCCCCCCOC(=O)CCS,,,,,,
5402,105403,CID 105403,CC(=CC(=O)C)[O-].CC(=CC(=O)C)[O-].CC(=CC(=O)C)[O-].[F-].[F-].[F-].[F-].[F-].[F-].[Si+4].[SbH3],,,,,,
5403,105404,CID 105404,CC(=CC(=O)C)[O-].CC(=CC(=O)C)[O-].CC(=CC(=O)C)[O-].[F-].[F-].[F-].[F-].[F-].[F-].[Si+4].[As+5],,,,,,
5404,105405,CID 105405,[B+3].CC(=CC(=O)C)[O-].CC(=CC(=O)C)[O-].[F-].[F-].[F-].[F-].[F-].[F-].[SbH3],,,,,,
5405,105406,"((Methylimino)dimethylene)diphosphonic acid, tetraethyl ester",CCOP(=O)(CN(C)CP(=O)(OCC)OCC)OCC,,,,,,
5406,105407,CID 105407,CCCCC(=CC1=CN=C(N1C)[N+](=O)[O-])[N+](=O)[O-],,,,,,
5407,105408,"Propanamide, N-(2-mercaptoethyl)-",CCC(=O)NCCS,,,,,,
5408,105409,"2-[[4-[(2,3-Dimethoxypropyl)ethylamino]phenyl]azo]-6-methoxy-3-methylbenzothiazolium chloride",CCN(CC(COC)OC)C1=CC=C(C=C1)N=NC2=[N+](C3=C(S2)C=C(C=C3)OC)C.[Cl-],,,,,,
5409,105410,"2-[[4-[(2,3-Dimethoxypropyl)ethylamino]phenyl]azo]-6-methoxy-3-methylbenzothiazol-3-ium",CCN(CC(COC)OC)C1=CC=C(C=C1)N=NC2=[N+](C3=C(S2)C=C(C=C3)OC)C,,,,,,
5410,105411,"Propanoic acid, 3-chloro-2-(chloromethyl)-2-methyl-",CC(CCl)(CCl)C(=O)O,,,,,,
5411,105412,CID 105412,CS(=O)(=O)C1=C(C=CC(=C1)N(O)O)N=NC2=C3C(=NS(=O)(=O)C4=CC(=CC=C4)S(=O)(=O)F)C=CC=C3C(=O)C(=C2)Cl,,,,,,
5412,105413,"Acetamide, N-[3-[[2-(2-ethoxyethoxy)ethyl]ethylamino]phenyl]-",CCN(CCOCCOCC)C1=CC=CC(=C1)NC(=O)C,,,,,,
5413,105414,"Benzenesulfonamide, 4-((4-ethoxyphenyl)amino)-N,N-dimethyl-3-nitro-",CCOC1=CC=C(C=C1)NC2=C(C=C(C=C2)S(=O)(=O)N(C)C)[N+](=O)[O-],,,,,,
5414,105415,5-Amino-1-hydroxy-2-naphthoic acid,C1=CC2=C(C=CC(=C2O)C(=O)O)C(=C1)N,,,,,,
5415,105416,Methyl (p-nitrobenzoyl)cyanoacetate,COC(=O)C(C#N)C(=O)C1=CC=C(C=C1)[N+](=O)[O-],,,,,,
5416,105417,"N-[5-[Ethyl(phenylmethyl)amino]-2-[[5-(ethylthio)-1,3,4-thiadiazol-2-yl]azo]phenyl]acetamide",CCN(CC1=CC=CC=C1)C2=CC(=C(C=C2)N=NC3=NN=C(S3)SCC)NC(=O)C,,,,,,
5417,105418,"9-Octadecenoic acid (9Z)-, (butylstannylidyne)tris(thio-2,1-ethanediyl) ester",CCCCCCCCC=CCCCCCCCC(=O)OCCS[Sn](CCCC)(SCCOC(=O)CCCCCCCC=CCCCCCCCC)SCCOC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
5418,105419,CID 105419,CCCCCCCCC=CCCCCCCCC(=O)OCC[S-].CCCCCCCCC=CCCCCCCCC(=O)OCC[S-].CCCC[Sn]CCCC,,,,,,
5419,105420,2-Butoxyethyl 4-(dimethylamino)benzoate,CCCCOCCOC(=O)C1=CC=C(C=C1)N(C)C,,,,,,
5420,105421,p-(tert-Butyl)benzyl acetate,CC(=O)OCC1=CC=C(C=C1)C(C)(C)C,,,,,,
5421,105422,"6-Diazo-5,6-dihydro-N-(4-hydroxyphenyl)-5-oxonaphthalene-1-sulphonamide",C1=CC2=C(C=CC(C2=O)[N+]#N)C(=C1)S(=O)(=O)NC3=CC=C(C=C3)[O-],,,,,,
5422,105423,5-[(4-hydroxyphenyl)sulfamoyl]-1-oxo-2H-naphthalene-2-diazonium,C1=CC2=C(C=CC(C2=O)[N+]#N)C(=C1)S(=O)(=O)NC3=CC=C(C=C3)O,,,,,,
5423,105424,"1,1-Diethyl-2-propylhydrazine",CCCNN(CC)CC,,,,,,
5424,105425,"3-But-2-enyl-2,4,4-trimethylcyclohex-2-en-1-one",CC=CCC1=C(C(=O)CCC1(C)C)C,,,,,,
5425,105426,"3-(3-Butenyl)-2,4,4-trimethylcyclohex-2-en-1-one",CC1=C(C(CCC1=O)(C)C)CCC=C,,,,,,
5426,105427,"Glyoxylonitrile, phenyl-, oxime, N-dimethylamino-O-ethylphosphoramidate",CCOP(=O)(N(C)C)ON=C(C#N)C1=CC=CC=C1,,,,,,
5427,105428,CID 105428,CCOP(=O)(NC)ON=C(C#N)C1=CC=C(C=C1)Cl,,,,,,
5428,105429,N-(2-Ethoxyethyl)benzylamine,CCOCCNCC1=CC=CC=C1,,,,,,
5429,105430,"3-Chloro-2,2-dimethylpropyl bis(dichloropropyl) phosphate",CC(C)(COP(=O)(OCCC(Cl)Cl)OCCC(Cl)Cl)CCl,,,,,,
5430,105431,3-Methyl-5-propylpyridine,CCCC1=CN=CC(=C1)C,,,,,,
5431,105432,"2,5-Dimethoxy-4-nitroamphetamine",CC(CC1=CC(=C(C=C1OC)[N+](=O)[O-])OC)N,,,,,,
5432,105433,4-Amino-N-hexylbenzenesulfonamide,CCCCCCNS(=O)(=O)C1=CC=C(C=C1)N,,,,,,
5433,105434,"6-Bromo-4-methyl-1-phenyl-3H-naphtho[1,2,3-de]quinoline-2,7-dione",CC1=CC(=C2C3=C1NC(=O)C(=C3C4=CC=CC=C4C2=O)C5=CC=CC=C5)Br,,,,,,
5434,105435,"2-Butoxy-1,3,2-dioxaphospholane 2-oxide",CCCCOP1(=O)OCCO1,,,,,,
5435,105436,"Ethyl 3,3-bis(tert-amylperoxy)butyrate",CCC(C)(C)OOC(C)(CC(=O)OCC)OOC(C)(C)CC,,,,,,
5436,105437,N-Allyltridecafluorohexanesulphonamide,C=CCNS(=O)(=O)C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
5437,105438,"1-Heptanesulfonamide, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-N-2-propenyl-",C=CCNS(=O)(=O)C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
5438,105439,"1-Heptanesulfonamide, N-ethyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-N-[3-(trichlorosilyl)propyl]-",CCN(CCC[Si](Cl)(Cl)Cl)S(=O)(=O)C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
5439,105440,CID 105440,CCN(CC(=O)[O-])S(=O)(=O)C(C(C(C(F)(F)F)(F)F)(F)F)(F)F.[K+],,,,,,
5440,105441,n-Ethyl-n-[(nonafluorobutyl)sulfonyl]glycine,CCN(CC(=O)O)S(=O)(=O)C(C(C(C(F)(F)F)(F)F)(F)F)(F)F,,,,,,
5441,105442,CID 105442,CCN(CC(=O)[O-])S(=O)(=O)C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F.[K+],,,,,,
5442,105443,"Glycine, N-ethyl-N-[(undecafluoropentyl)sulfonyl]-",CCN(CC(=O)O)S(=O)(=O)C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
5443,105444,CID 105444,CCN(CC(=O)[O-])S(=O)(=O)C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F.[K+],,,,,,
5444,105445,N-Ethyl-N-((tridecafluorohexyl)sulfonyl)glycine,CCN(CC(=O)O)S(=O)(=O)C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
5445,105446,"1-Heptanesulfonamide, N-[3-(dimethylamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-",CN(C)CCCNS(=O)(=O)C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
5446,105447,"2-Propenoic acid, 2-[methyl[(nonafluorobutyl)sulfonyl]amino]ethyl ester",CN(CCOC(=O)C=C)S(=O)(=O)C(C(C(C(F)(F)F)(F)F)(F)F)(F)F,,,,,,
5447,105448,2-(Methyl((undecafluoropentyl)sulphonyl)amino)ethyl acrylate,CN(CCOC(=O)C=C)S(=O)(=O)C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
5448,105449,"2-Propenoic acid, 2-[methyl[(tridecafluorohexyl)sulfonyl]amino]ethyl ester",CN(CCOC(=O)C=C)S(=O)(=O)C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
5449,105450,"3-(((Pentadecafluoroheptyl)sulfonyl)amino)-N,N,N-trimethyl-1-propanaminium iodide",C[N+](C)(C)CCCNS(=O)(=O)C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F.[I-],,,,,,
5450,105451,3-(Pentadecafluoroheptylsulfonylamino)propyltrimethylaminium,C[N+](C)(C)CCCNS(=O)(=O)C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
5451,105452,2-(Methyl((nonafluorobutyl)sulphonyl)amino)ethyl methacrylate,CC(=C)C(=O)OCCN(C)S(=O)(=O)C(C(C(C(F)(F)F)(F)F)(F)F)(F)F,,,,,,
5452,105453,"2-Propenoic acid, 2-methyl-, 2-[methyl[(undecafluoropentyl)sulfonyl]amino]ethyl ester",CC(=C)C(=O)OCCN(C)S(=O)(=O)C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
5453,105454,"2-Propenoic acid, 2-methyl-, 2-[methyl[(tridecafluorohexyl)sulfonyl]amino]ethyl ester",CC(=C)C(=O)OCCN(C)S(=O)(=O)C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
5454,105455,CID 105455,CCN(CC(=O)[O-])S(=O)(=O)C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F.[K+],,,,,,
5455,105456,"Glycine, N-ethyl-N-[(pentadecafluoroheptyl)sulfonyl]-",CCN(CC(=O)O)S(=O)(=O)C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
5456,105457,"Glycine, N-ethyl-N-[(nonafluorobutyl)sulfonyl]-, ethyl ester",CCN(CC(=O)OCC)S(=O)(=O)C(C(C(C(F)(F)F)(F)F)(F)F)(F)F,,,,,,
5457,105458,"Benzoic acid, 4-(1,1-dimethylethyl)-, compd. with 2,2'-iminobis[ethanol] (1:1)",CC(C)(C)C1=CC=C(C=C1)C(=O)O.C(CO)NCCO,,,,,,
5458,105459,"Cyclohexanecarboxylic acid, 4-butyl-, 4-ethoxyphenyl ester, trans-",CCCCC1CCC(CC1)C(=O)OC2=CC=C(C=C2)OCC,,,,,,
5459,105460,"Cyclohexanecarboxylic acid, 4-pentyl-, 4-methoxyphenyl ester, trans-",CCCCCC1CCC(CC1)C(=O)OC2=CC=C(C=C2)OC,,,,,,
5460,105461,"Cyclohexanecarboxylic acid, 4-pentyl-, 4-propoxyphenyl ester, trans-",CCCCCC1CCC(CC1)C(=O)OC2=CC=C(C=C2)OCCC,,,,,,
5461,105462,2-(3-Cyclohexenyl)ethyltrimethoxysilane,CO[Si](CCC1CCC=CC1)(OC)OC,,,,,,
5462,105463,N-(2-{[2-({2-[(2-Aminoethyl)amino]ethyl}amino)ethyl]amino}ethyl)octadec-9-enamide,CCCCCCCCC=CCCCCCCCC(=O)NCCNCCNCCNCCN,,,,,,
5463,105464,"Benzenamine, 4,4'-methylenebis[N-(1-methylpentylidene)-",CCCCC(=NC1=CC=C(C=C1)CC2=CC=C(C=C2)N=C(C)CCCC)C,,,,,,
5464,105465,"Bis(2,6-dimethyl-4-nitrophenyl) ((2,4-dioxo-1,3-diazetidine-1,3-diyl)bis(6-methyl-3,1-phenylene))biscarbamate",CC1=C(C=C(C=C1)N2C(=O)N(C2=O)C3=CC(=C(C=C3)C)NC(=O)OC4=C(C=C(C=C4C)N=O)C)NC(=O)OC5=C(C=C(C=C5C)N=O)C,,,,,,
5465,105466,"Benzenesulfonamide, 4-[(5-cyano-1,6-dihydro-2-hydroxy-1,4-dimethyl-6-oxo-3-pyridinyl)azo]-N-hexyl-",CCCCCCNS(=O)(=O)C1=CC=C(C=C1)N=NC2=C(C(=C(N(C2=O)C)O)C#N)C,,,,,,
5466,105467,CID 105467,CC1=C(C=CC(=C1)Cl)N=NN(C)CCS(=O)(=O)[O-].[Na+],,,,,,
5467,105468,2-[[(4-Chloro-2-methylphenyl)diazenyl]-methylamino]ethanesulfonic acid,CC1=C(C=CC(=C1)Cl)N=NN(C)CCS(=O)(=O)O,,,,,,
5468,105469,CID 105469,CN(CCS(=O)(=O)[O-])N=NC1=C(C=CC(=C1)Cl)OC.[Na+],,,,,,
5469,105470,2-[[(5-Chloro-2-methoxyphenyl)diazenyl]-methylamino]ethanesulfonic acid,CN(CCS(=O)(=O)O)N=NC1=C(C=CC(=C1)Cl)OC,,,,,,
5470,105471,CID 105471,CCN(C1=C(C=C(C=C1)S(=O)(=O)[O-])C(=O)O)N=NC2=C(C=CC(=C2)C(F)(F)F)Cl.[Na+],,,,,,
5471,105472,2-[[[2-Chloro-5-(trifluoromethyl)phenyl]diazenyl]-ethylamino]-5-sulfobenzoic acid,CCN(C1=C(C=C(C=C1)S(=O)(=O)O)C(=O)O)N=NC2=C(C=CC(=C2)C(F)(F)F)Cl,,,,,,
5472,105473,CID 105473,CC1=CC(=C(C=C1)OC)N=NN(C)CC(=O)[O-].[Na+],,,,,,
5473,105474,2-[[(2-Methoxy-5-methylphenyl)diazenyl]-methylamino]acetic acid,CC1=CC(=C(C=C1)OC)N=NN(C)CC(=O)O,,,,,,
5474,105475,"2-Naphthalenecarboxamide, 4-[[5-(aminocarbonyl)-2-methoxyphenyl]azo]-N-(4-chloro-2-methoxyphenyl)-3-hydroxy-",COC1=C(C=C(C=C1)C(=O)N)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)NC4=C(C=C(C=C4)Cl)OC)O,,,,,,
5475,105476,"2-Naphthalenecarboxamide, N-(4-chloro-2-methoxyphenyl)-3-hydroxy-4-[(2-methoxy-5-nitrophenyl)azo]-",COC1=C(C=C(C=C1)[N+](=O)[O-])N=NC2=C(C(=CC3=CC=CC=C32)C(=O)NC4=C(C=C(C=C4)Cl)OC)O,,,,,,
5476,105477,"2-Naphthalenecarboxamide, 4-[(4-chloro-2-methylphenyl)azo]-3-hydroxy-N-(2-methoxyphenyl)-",CC1=C(C=CC(=C1)Cl)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)NC4=CC=CC=C4OC)O,,,,,,
5477,105478,"[1,1'-Biphenyl]-4-carboxamide, 4'-heptyl-",CCCCCCCC1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)N,,,,,,
5478,105479,"[1,1'-Biphenyl]-4-carboxamide, 4'-pentyl-",CCCCCC1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)N,,,,,,
5479,105480,4-Acetamidophthalic acid,CC(=O)NC1=CC(=C(C=C1)C(=O)O)C(=O)O,,,,,,
5480,105481,2-Octadec-13-en-3-ynoxyoxane,CCCCC=CCCCCCCCCC#CCCOC1CCCCO1,,,,,,
5481,105482,Potassium indigotrisulfonate,C1=CC2=C(C=C1S(=O)(=O)[O-])C(=O)C(=N2)C3=C(C4=C(N3)C(=CC(=C4)S(=O)(=O)[O-])S(=O)(=O)[O-])O.[K+].[K+].[K+],,,,,,
5482,105483,"1H-Indole-5,7-disulfonic acid, 2-(1,3-dihydro-3-oxo-5-sulfo-2H-indol-2-ylidene)-2,3-dihydro-3-oxo-",C1=CC2=C(C=C1S(=O)(=O)O)C(=O)C(=N2)C3=C(C4=C(N3)C(=CC(=C4)S(=O)(=O)O)S(=O)(=O)O)O,,,,,,
5483,105484,"Ethanaminium, 2-cyano-N-ethyl-N,N-bis[2-[(1-oxoisooctadecyl)amino]ethyl]-, ethyl sulfate",CC[N+](CCC#N)(CCNC(=O)CCCCCCCCCCCCCCC(C)C)CCNC(=O)CCCCCCCCCCCCCCC(C)C.CCOS(=O)(=O)[O-],,,,,,
5484,105485,2-Cyanoethyl-ethyl-bis[2-(16-methylheptadecanoylamino)ethyl]azanium,CC[N+](CCC#N)(CCNC(=O)CCCCCCCCCCCCCCC(C)C)CCNC(=O)CCCCCCCCCCCCCCC(C)C,,,,,,
5485,105486,"1H-Imidazolium, 1-ethyl-4,5-dihydro-1-(2-hydroxyethyl)-2-isoheptadecyl-, ethyl sulfate (salt)",CC[N+]1(CCN=C1CCCCCCCCCCCCCCC(C)C)CCO.CCOS(=O)(=O)[O-],,,,,,
5486,105487,"1-Ethyl-1-(2-hydroxyethyl)-2-(15-methylhexadecyl)-4,5-dihydro-1H-imidazole-1-ium",CC[N+]1(CCN=C1CCCCCCCCCCCCCCC(C)C)CCO,,,,,,
5487,105488,"1-Benzyl-4,5-dihydro-1-(2-hydroxyethyl)-2-(15-methylhexadecyl)-1H-imidazolium chloride",CC(C)CCCCCCCCCCCCCCC1=NCC[N+]1(CCO)CC2=CC=CC=C2.[Cl-],,,,,,
5488,105489,"4,5-Dihydro-1-(2-hydroxyethyl)-2-(15-methylhexadecyl)-1-(phenylmethyl)imidazolium",CC(C)CCCCCCCCCCCCCCC1=NCC[N+]1(CCO)CC2=CC=CC=C2,,,,,,
5489,105490,Isostearaminopropalkonium chloride,CC(C)CCCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC1=CC=CC=C1.[Cl-],,,,,,
5490,105491,Benzyl-dimethyl-[3-(16-methylheptadecanoylamino)propyl]azanium,CC(C)CCCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC1=CC=CC=C1,,,,,,
5491,105492,"Ethanaminium, N-(2-cyanoethyl)-N-ethyl-2-hydroxy-N-(2-((1-oxoisooctadecyl)amino)ethyl)-, ethyl sulfate (salt)",CC[N+](CCC#N)(CCNC(=O)CCCCCCCCCCCCCCC(C)C)CCO.CCOS(=O)(=O)[O-],,,,,,
5492,105493,2-Cyanoethyl-ethyl-(2-hydroxyethyl)-[2-(16-methylheptadecanoylamino)ethyl]azanium,CC[N+](CCC#N)(CCNC(=O)CCCCCCCCCCCCCCC(C)C)CCO,,,,,,
5493,105494,"1-Propanaminium, N-ethyl-N,N-dimethyl-3-[(1-oxoisooctadecyl)amino]-, ethyl sulfate",CC[N+](C)(C)CCCNC(=O)CCCCCCCCCCCCCCC(C)C.CCOS(=O)(=O)[O-],,,,,,
5494,105495,"N-Ethyl-N,N-dimethyl-3-[(16-methylheptadecanoyl)amino]propan-1-aminium",CC[N+](C)(C)CCCNC(=O)CCCCCCCCCCCCCCC(C)C,,,,,,
5495,105496,"Ethanaminium, N-(2-cyanoethyl)-N-ethyl-N-(2-hydroxyethyl)-2-((1-oxodocosyl)amino)-, ethyl sulfate (salt)",CCCCCCCCCCCCCCCCCCCCCC(=O)NCC[N+](CC)(CCC#N)CCO.CCOS(=O)(=O)[O-],,,,,,
5496,105497,N-(2-Cyanoethyl)-N-ethyl-N-(2-hydroxyethyl)-2-[(1-oxodocosyl)amino]ethanaminium,CCCCCCCCCCCCCCCCCCCCCC(=O)NCC[N+](CC)(CCC#N)CCO,,,,,,
5497,105498,2-Cyanoethyl-ethyl-(2-hydroxyethyl)-[2-(octadec-9-enoylamino)ethyl]azanium;ethyl sulfate,CCCCCCCCC=CCCCCCCCC(=O)NCC[N+](CC)(CCC#N)CCO.CCOS(=O)(=O)[O-],,,,,,
5498,105499,2-Cyanoethyl-ethyl-(2-hydroxyethyl)-[2-(octadec-9-enoylamino)ethyl]azanium,CCCCCCCCC=CCCCCCCCC(=O)NCC[N+](CC)(CCC#N)CCO,,,,,,
5499,105500,"Ethanaminium, 2-cyano-N-ethyl-N,N-bis[2-[(1-oxodocosyl)amino]ethyl]-, ethyl sulfate",CCCCCCCCCCCCCCCCCCCCCC(=O)NCC[N+](CC)(CCC#N)CCNC(=O)CCCCCCCCCCCCCCCCCCCCC.CCOS(=O)(=O)[O-],,,,,,
5500,105501,"2-Cyano-N-ethyl-N,N-bis[2-[(1-oxodocosyl)amino]ethyl]ethanaminium",CCCCCCCCCCCCCCCCCCCCCC(=O)NCC[N+](CC)(CCC#N)CCNC(=O)CCCCCCCCCCCCCCCCCCCCC,,,,,,
5501,105502,"Ethanaminium, 2-cyano-N-ethyl-N,N-bis[2-[(1-oxooctadecyl)amino]ethyl]-, ethyl sulfate",CCCCCCCCCCCCCCCCCC(=O)NCC[N+](CC)(CCC#N)CCNC(=O)CCCCCCCCCCCCCCCCC.CCOS(=O)(=O)[O-],,,,,,
5502,105503,"2-Cyano-N-ethyl-N,N-bis[2-[(1-oxooctadecyl)amino]ethyl]ethanaminium",CCCCCCCCCCCCCCCCCC(=O)NCC[N+](CC)(CCC#N)CCNC(=O)CCCCCCCCCCCCCCCCC,,,,,,
5503,105504,2-Cyanoethyl-ethyl-bis[2-(octadec-9-enoylamino)ethyl]azanium;ethyl sulfate,CCCCCCCCC=CCCCCCCCC(=O)NCC[N+](CC)(CCC#N)CCNC(=O)CCCCCCCC=CCCCCCCCC.CCOS(=O)(=O)[O-],,,,,,
5504,105505,2-Cyanoethyl-ethyl-bis[2-(octadec-9-enoylamino)ethyl]azanium,CCCCCCCCC=CCCCCCCCC(=O)NCC[N+](CC)(CCC#N)CCNC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
5505,105506,(2-Cyanoethyl)ethyl(2-hydroxyethyl)(2-((1-oxooctadecyl)amino)ethyl)ammonium ethyl sulphate,CCCCCCCCCCCCCCCCCC(=O)NCC[N+](CC)(CCC#N)CCO.CCOS(=O)(=O)[O-],,,,,,
5506,105507,N-(2-Cyanoethyl)-N-ethyl-N-(2-hydroxyethyl)-2-[(1-oxooctadecyl)amino]ethanaminium,CCCCCCCCCCCCCCCCCC(=O)NCC[N+](CC)(CCC#N)CCO,,,,,,
5507,105508,CID 105508,CCCCCCCCCCCCCCCCCCOC(=O)CS(=O)(=O)[O-].[Na+],,,,,,
5508,105509,2-Octadecoxy-2-oxoethanesulfonic acid,CCCCCCCCCCCCCCCCCCOC(=O)CS(=O)(=O)O,,,,,,
5509,105510,1-Hydroxydecan-3-one,CCCCCCCC(=O)CCO,,,,,,
5510,105511,"Carbonic acid, (3Z)-3-hexenyl methyl ester",CCC=CCCOC(=O)OC,,,,,,
5511,105512,"3-(2-Ethylphenyl)-2,2-dimethylpropanal",CCC1=CC=CC=C1CC(C)(C)C=O,,,,,,
5512,105513,"3-(4-Ethylphenyl)-2,2-dimethylpropanal",CCC1=CC=C(C=C1)CC(C)(C)C=O,,,,,,
5513,105514,"Butanoic acid, 2-methylene-, 2-methylpropyl ester",CCC(=C)C(=O)OCC(C)C,,,,,,
5514,105515,"Benzenemethanol, 4-(1-methylethyl)-, formate",CC(C)C1=CC=C(C=C1)COC=O,,,,,,
5515,105516,2-Phenylethyl pivalate,CC(C)(C)C(=O)OCCC1=CC=CC=C1,,,,,,
5516,105517,"Ethanone, 1-(3-butyl-4-methylphenyl)-",CCCCC1=C(C=CC(=C1)C(=O)C)C,,,,,,
5517,105518,CID 105518,CCCCCCC=CC(=O)OCCCCC,,,,,,
5518,105519,"Acetamide, N-[5-[(2-hydroxyethyl)sulfonyl]-2,4-dimethoxyphenyl]-",CC(=O)NC1=CC(=C(C=C1OC)OC)S(=O)(=O)CCO,,,,,,
5519,105520,CID 105520,C1=CC(=NN=C2C=CC(=O)C=C2)C=CC1=NC3=C(C=C(C=C3)N(O)O)S(=O)(=O)[O-].[Na+],,,,,,
5520,105521,CID 105521,C1=CC(=NN=C2C=CC(=O)C=C2)C=CC1=NC3=C(C=C(C=C3)N(O)O)S(=O)(=O)O,,,,,,
5521,105522,"Acetamide, N-[2-[(2-bromo-4,6-dinitrophenyl)azo]-5-(ethylamino)-4-methoxyphenyl]-",CCNC1=C(C=C(C(=C1)NC(=O)C)N=NC2=C(C=C(C=C2Br)[N+](=O)[O-])[N+](=O)[O-])OC,,,,,,
5522,105523,"2-[[4-[(2,5-Dichlorophenyl)azo]-3-methylphenyl]ethylamino]ethanol",CCN(CCO)C1=CC(=C(C=C1)N=NC2=C(C=CC(=C2)Cl)Cl)C,,,,,,
5523,105524,"Benzenesulfonamide, 4-[(4-amino-5-methoxy-2-methylphenyl)azo]-N,N-dimethyl-",CC1=CC(=C(C=C1N=NC2=CC=C(C=C2)S(=O)(=O)N(C)C)OC)N,,,,,,
5524,105525,"Ethanol, 2,2'-[[2-methyl-4-[(4-nitrophenyl)azo]phenyl]imino]bis-",CC1=C(C=CC(=C1)N=NC2=CC=C(C=C2)[N+](=O)[O-])N(CCO)CCO,,,,,,
5525,105526,"1-((2-Hydroxyethyl)amino)-4-((3-hydroxypropyl)amino)anthracene-9,10-dione",C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3C2=O)NCCO)NCCCO,,,,,,
5526,105527,"9,10-Anthracenedione, 1-amino-2-bromo-4,5-dihydroxy-8-[(phenylmethyl)amino]-",C1=CC=C(C=C1)CNC2=C3C(=C(C=C2)O)C(=O)C4=C(C3=O)C(=C(C=C4O)Br)N,,,,,,
5527,105528,CID 105528,C1=CC=C2C(=C1)C(=CC=C2N=NC3=CC(=CC=C3)S(=O)(=O)[O-])N=NC4=CC=C(C=C4)N(CCO)CCO.[Na+],,,,,,
5528,105529,"1-Naphthalenesulfonic acid, 3-[[2,4-dimethoxy-6-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-4-hydroxy-",COC1=CC(=C(C(=C1)S(=O)(=O)CCOS(=O)(=O)O)N=NC2=C(C3=CC=CC=C3C(=C2)S(=O)(=O)O)O)OC,,,,,,
5529,105530,"Acetamide, N-[5-[(2-hydroxyethyl)sulfonyl]-2,4-dimethylphenyl]-",CC1=CC(=C(C=C1NC(=O)C)S(=O)(=O)CCO)C,,,,,,
5530,105531,"Acetamide, N-[3-[(2-hydroxyethyl)sulfonyl]-4-methoxyphenyl]-",CC(=O)NC1=CC(=C(C=C1)OC)S(=O)(=O)CCO,,,,,,
5531,105532,"Benzene, 1-(2-methoxyethoxy)-2,4-dinitro-",COCCOC1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-],,,,,,
5532,105533,"2,6-Nonadiene, 1,1-diethoxy-, (2E,6Z)-",CCC=CCCC=CC(OCC)OCC,,,,,,
5533,105534,"1-Cyclohexene-1-acetonitrile, 4-(1,1-dimethylethyl)-",CC(C)(C)C1CCC(=CC1)CC#N,,,,,,
5534,105535,"2,6-Nonadien-1-ol, formate, (2E,6Z)-",CCC=CCCC=CCOC=O,,,,,,
5535,105536,"2,7-Octadienenitrile, 3,7-dimethyl-",CC(=C)CCCC(=CC#N)C,,,,,,
5536,105537,"2,6-Nonadien-1-ol, acetate, (2E,6Z)-",CCC=CCCC=CCOC(=O)C,,,,,,
5537,105538,4-Cyclohexadecen-1-one,C1CCCCCC=CCCC(=O)CCCCC1,,,,,,
5538,105539,"Phenol, 2-methyl-, ammonium salt",CC1=CC=CC=C1O.N,,,,,,
5539,105540,"Acetic acid, hydroxy-, 2-aminoethyl ester",C(COC(=O)CO)N,,,,,,
5540,105541,"Nonanamide, N-[2-[[2-[[2-[(2-aminoethyl)amino]ethyl]amino]ethyl]amino]ethyl]-, monoacetate",CCCCCCCCC(=O)NCCNCCNCCNCCN.CC(=O)O,,,,,,
5541,105542,"Nonanamide, N-[2-[[2-[[2-[(2-aminoethyl)amino]ethyl]amino]ethyl]amino]ethyl]-",CCCCCCCCC(=O)NCCNCCNCCNCCN,,,,,,
5542,105543,"1-Propanamine, N-(phenylmethylene)-3-(trimethoxysilyl)-",CO[Si](CCCN=CC1=CC=CC=C1)(OC)OC,,,,,,
5543,105544,"1-Propanamine, N,N-dimethyl-3-(trimethoxysilyl)-, hydrochloride",CN(C)CCC[Si](OC)(OC)OC.Cl,,,,,,
5544,105545,"Dodecanamide, N-[2-[[3-(trimethoxysilyl)propyl]amino]ethyl]-, monohydrochloride",CCCCCCCCCCCC(=O)NCCNCCC[Si](OC)(OC)OC.Cl,,,,,,
5545,105546,N-[2-[[3-(Trimethoxysilyl)propyl]amino]ethyl]dodecanamide,CCCCCCCCCCCC(=O)NCCNCCC[Si](OC)(OC)OC,,,,,,
5546,105547,"Octadecanamide, N-[2-[[3-(trimethoxysilyl)propyl]amino]ethyl]-, monohydrochloride",CCCCCCCCCCCCCCCCCC(=O)NCCNCCC[Si](OC)(OC)OC.Cl,,,,,,
5547,105548,N-[2-[[3-(Trimethoxysilyl)propyl]amino]ethyl]octadecanamide,CCCCCCCCCCCCCCCCCC(=O)NCCNCCC[Si](OC)(OC)OC,,,,,,
5548,105549,"1-Propanamine, N-(1-phenylethylidene)-3-(triethoxysilyl)-",CCO[Si](CCCN=C(C)C1=CC=CC=C1)(OCC)OCC,,,,,,
5549,105550,"Cyclohexanecarboxylic acid, 4-propyl-, 4-(pentyloxy)phenyl ester",CCCCCOC1=CC=C(C=C1)OC(=O)C2CCC(CC2)CCC,,,,,,
5550,105551,"Cyclohexanecarboxylic acid, 4-pentyl-, 4-ethoxyphenyl ester",CCCCCC1CCC(CC1)C(=O)OC2=CC=C(C=C2)OCC,,,,,,
5551,105552,"Cyclohexanecarboxylic acid, 4-pentyl-, 4-(pentyloxy)phenyl ester",CCCCCC1CCC(CC1)C(=O)OC2=CC=C(C=C2)OCCCCC,,,,,,
5552,105553,4-(Aminomethyl)benzoic acid hydrochloride,C1=CC(=CC=C1CN)C(=O)O.Cl,,,,,,
5553,105554,Einecs 266-904-4,[H+].[H+].CC1=NN(C(=C1N=NC2=C(C=CC(=C2)S(=O)(=O)[O-])[O-])[O-])C3=CC=C(C=C3)S(=O)(=O)CCOS(=O)(=O)[O-].[Cu+2],,,,,,
5554,105555,4-hydroxy-3-[[5-methyl-3-oxo-2-[4-(2-sulfooxyethylsulfonyl)phenyl]-1H-pyrazol-4-yl]diazenyl]benzenesulfonic acid,CC1=C(C(=O)N(N1)C2=CC=C(C=C2)S(=O)(=O)CCOS(=O)(=O)O)N=NC3=C(C=CC(=C3)S(=O)(=O)O)O,,,,,,
5555,105556,"1,4-Benzenedicarboxylic acid, 2-[(1-ethyl-2-methyl-1H-indol-3-yl)carbonyl]-",CCN1C(=C(C2=CC=CC=C21)C(=O)C3=C(C=CC(=C3)C(=O)O)C(=O)O)C,,,,,,
5556,105557,4-[(1-Ethyl-2-methyl-1h-indol-3-yl)carbonyl]isophthalic acid,CCN1C(=C(C2=CC=CC=C21)C(=O)C3=C(C=C(C=C3)C(=O)O)C(=O)O)C,,,,,,
5557,105558,"1(3H)-Isobenzofuranone, 3-(diphenylamino)-3-(1-ethyl-2-methyl-1H-indol-3-yl)-",CCN1C(=C(C2=CC=CC=C21)C3(C4=CC=CC=C4C(=O)O3)N(C5=CC=CC=C5)C6=CC=CC=C6)C,,,,,,
5558,105559,"Benzoic acid, 2-((1-butyl-2-methyl-1H-indol-3-yl)carbonyl)-",CCCCN1C(=C(C2=CC=CC=C21)C(=O)C3=CC=CC=C3C(=O)O)C,,,,,,
5559,105560,"Amines, di-C14-18-alkylmethyl",CCCCCCCCCCCCCCCCN(C)CCCCCCCCCCCCCCCC,,,,,,
5560,105561,"Amines, tri-C14-18-alkyl",CCCCCCCCCCCCCCCCN(CCCCCCCCCCCCCCC)CCCCCCCCCCCCCCC,,,,,,
5561,105562,Fatty acids C14-C18 and C16-C18 unsaturated,C=CC=CC=CC=CC=CC=CC=CC(=O)O,,,,,,
5562,105563,"2,3-Dihydroxypropyl tridecanoate",CCCCCCCCCCCCC(=O)OCC(CO)O,,,,,,
5563,105564,Antifoam B,CCCCCCCC=CCC=CCC(=O)OC(C(CC(=O)O)O)O,,,,,,
5564,105565,CID 105565,CCCCCCCCCCCCCCCC(=O)OCCC(COC(=O)CC=CCCC=CCCCCCCCCCC)O,,,,,,
5565,105566,"Benzamide, 3-amino-4-methyl-, sulfate (2:1)",CC1=C(C=C(C=C1)C(=O)N)N.CC1=C(C=C(C=C1)C(=O)N)N.OS(=O)(=O)O,,,,,,
5566,105567,"9,10-Anthracenedione, 1,4-bis[(3-hydroxypropyl)amino]-",C1=CC=C2C(=C1)C(=O)C3=C(C=CC(=C3C2=O)NCCCO)NCCCO,,,,,,
5567,105568,CID 105568,CCCCCCCCC(CC(=O)O)C(=O)O.CCCC[SnH](CCCC)CCCC.CCCC[SnH](CCCC)CCCC,,,,,,
5568,105569,CID 105569,CC1=CC(=CC(=C1O)C(=O)[O-])N=NC2=CC=C(C=C2)N.[Na+],,,,,,
5569,105570,"9(10H)-Anthracenone, 10,10'-(3-oxo-1,2-cyclopropanediylidene)bis-",C1=CC=C2C(=C1)C(=C3C(=C4C5=CC=CC=C5C(=O)C6=CC=CC=C64)C3=O)C7=CC=CC=C7C2=O,,,,,,
5570,105571,"9(10H)-Anthracenone, 10,10',10''-(1,2,3-cyclopropanetriylidene)tris-",C1=CC=C2C(=C1)C(=C3C(=C4C5=CC=CC=C5C(=O)C6=CC=CC=C64)C3=C7C8=CC=CC=C8C(=O)C9=CC=CC=C97)C1=CC=CC=C1C2=O,,,,,,
5571,105572,Butyl (methylthio)acetate,CCCCOC(=O)CSC,,,,,,
5572,105573,Dipentaerythritol hexacetate,CC(=O)OCC(COCC(COC(=O)C)(COC(=O)C)COC(=O)C)(COC(=O)C)COC(=O)C,,,,,,
5573,105574,"Fatty acids, C5-9, hexaesters with dipentaerythritol",CCCCC(=O)OCC(CO)(CO)COCC(CO)(CO)CO,,,,,,
5574,105575,"Fatty acids, C5-9, tetraesters with pentaerythritol",CCCCCCCOCC(COCCCCCCC)(COCCCCCCC)COCCCCCCC,,,,,,
5575,105576,Pentaerythritol heptanoate phosphate,CCCCCCC(=O)OCC(CO)(CO)COP(=O)(O)O,,,,,,
5576,105577,"Alcohols, C20-28, ethoxylated",CCCCCCCCCCCCCCCCCCCCOCC,,,,,,
5577,105578,Salicylaldehyde guanylhydrazone,C1=CC=C(C(=C1)C=NN=C(N)N)O,,,,,,
5578,105579,"Phosphonic acid, dimethyl ester, compd. with tert-dodecanamine (1:1)",CC(C)(C)CCCCCCCCN.COP(O)OC,,,,,,
5579,105580,"2,5-Pyrrolidinedione, 3-(dodecenyl)-1-[(9Z)-1-oxo-9-octadecenyl]-",CCCCCCCCCCCCC1=CC(=O)N(C1=O)C(=O)CCCCCCCC=CCCCCCCCC,,,,,,
5580,105581,Diisostearyl tartrate,CC(C)CCCCCCCCCCCCCCCOC(=O)C(C(C(=O)OCCCCCCCCCCCCCCCC(C)C)O)O,,,,,,
5581,105582,Pentaerythritol diheptanoate,CCCCCCC(=O)OCC(CO)(CO)COC(=O)CCCCCC,,,,,,
5582,105583,CID 105583,CC1=C(C=CC(=C1)O)C2(C3=CC=CC=C3S(=O)(=O)O2)C4=C(C=C(C=C4)[O-])C.[Na+],,,,,,
5583,105584,"Benzenediazonium, 2-chloro-4-(diethylamino)-, (T-4)-tetrachlorozincate(2-) (2:1)",CCN(CC)C1=CC(=C(C=C1)[N+]#N)Cl.CCN(CC)C1=CC(=C(C=C1)[N+]#N)Cl.[Cl-].[Cl-].[Cl-].[Cl-].[Zn+2],,,,,,
5584,105585,2-Chloro-4-(diethylamino)benzenediazonium,CCN(CC)C1=CC(=C(C=C1)[N+]#N)Cl,,,,,,
5585,105586,"Nickel, (2-propanol)[[2,2'-(thio-kappaS)bis[4-(1,1,3,3-tetramethylbutyl)phenolato-kappaO]](2-)]-",CC(C)[O-].CC(C)(C)CC(C)(C)C1=CC(=C(C=C1)O)SC2=C(C=CC(=C2)C(C)(C)CC(C)(C)C)[O-].[Ni+2],,,,,,
5586,105587,"Benzenediazonium, 4-(bis(phenylmethyl)amino)-2-ethoxy-, (T-4)-tetrachlorozincate(2-) (2:1)",CCOC1=C(C=CC(=C1)N(CC2=CC=CC=C2)CC3=CC=CC=C3)[N+]#N.CCOC1=C(C=CC(=C1)N(CC2=CC=CC=C2)CC3=CC=CC=C3)[N+]#N.[Cl-].[Cl-].[Cl-].[Cl-].[Zn+2],,,,,,
5587,105588,4-[Bis(phenylmethyl)amino]-2-ethoxybenzenediazonium,CCOC1=C(C=CC(=C1)N(CC2=CC=CC=C2)CC3=CC=CC=C3)[N+]#N,,,,,,
5588,105589,"1-Undecene, 11,11-bis((3,7-dimethyl-6-octenyl)oxy)-",CC(CCC=C(C)C)CCOC(CCCCCCCCC=C)OCCC(C)CCC=C(C)C,,,,,,
5589,105590,"2-[Bis(3,7-dimethylocta-2,6-dienoxy)methyl]hept-1-enylbenzene",CCCCCC(=CC1=CC=CC=C1)C(OCC=C(C)CCC=C(C)C)OCC=C(C)CCC=C(C)C,,,,,,
5590,105591,p-(Dimethoxymethyl) cumene,CC(C)C1=CC=C(C=C1)C(OC)OC,,,,,,
5591,105592,"Nonane, 1,1-bis[(3,7-dimethyl-2,6-octadien-1-yl)oxy]-",CCCCCCCCC(OCC=C(C)CCC=C(C)C)OCC=C(C)CCC=C(C)C,,,,,,
5592,105593,"1-Undecene, 11,11-bis[(3,7-dimethyl-2,6-octadienyl)oxy]-",CC(=CCCC(=CCOC(CCCCCCCCC=C)OCC=C(C)CCC=C(C)C)C)C,,,,,,
5593,105594,Methyl 2-((2-phenylethylidene)amino)benzoate,COC(=O)C1=CC=CC=C1N=CCC2=CC=CC=C2,,,,,,
5594,105595,Benzylisopropyl propionate,CCC(=O)OC(C)(C)CC1=CC=CC=C1,,,,,,
5595,105596,"Ethanol, 2,2'-[[2-(boronooxy)ethyl]imino]bis-",B(O)(O)OCCN(CCO)CCO,,,,,,
5596,105597,"Naphthalenesulfonic acid, tert-dodecyl-",CCCCCCCCCC(C)(C)C1=CC=CC2=C1C(=CC=C2)S(=O)(=O)O,,,,,,
5597,105598,N-[2-[ethyl(2-hydroxyethyl)amino]ethyl]octadec-9-enamide,CCCCCCCCC=CCCCCCCCC(=O)NCCN(CC)CCO,,,,,,
5598,105599,CID 105599,CCCCCCCCC=CCCCCCCCC(=O)NCCN(CC)CCO.CCOS(=O)(=O)O,,,,,,
5599,105600,"1-Piperazineethanamine, monoacetate",CC(=O)O.C1CN(CCN1)CCN,,,,,,
5600,105601,CID 105601,C1=CC(=CC(=C1)S(=O)(=O)[O-])NN=C2C(=CC3=C(C2=O)C(=N)C(=NNC4=CC=C(C=C4)[N+](=O)[O-])C(=C3)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
5601,105602,CID 105602,C1=CC(=CC(=C1)S(=O)(=O)O)NN=C2C(=CC3=C(C2=O)C(=N)C(=NNC4=CC=C(C=C4)[N+](=O)[O-])C(=C3)S(=O)(=O)O)S(=O)(=O)O,,,,,,
5602,105603,"1H-Indole-5-sulfonic acid, 2-methyl-",CC1=CC2=C(N1)C=CC(=C2)S(=O)(=O)O,,,,,,
5603,105604,CID 105604,CCOC1=C(C=CC(=C1)N=NC2=CC(=CC=C2)S(=O)(=O)[O-])N.[Na+],,,,,,
5604,105605,3-[(4-Amino-3-ethoxyphenyl)diazenyl]benzenesulfonic acid,CCOC1=C(C=CC(=C1)N=NC2=CC(=CC=C2)S(=O)(=O)O)N,,,,,,
5605,105606,CID 105606,C1=CC=C(C(=C1)C(F)(F)F)N=NC2=C(C=CC3=CC(=CC(=C32)O)S(=O)(=O)[O-])N.[Na+],,,,,,
5606,105607,"Sodium;3-[2-[5-[(3-amino-4-nitrophenyl)hydrazinylidene]-4,6-dioxocyclohex-2-en-1-ylidene]hydrazinyl]-4-methoxybenzenesulfonate",COC1=C(C=C(C=C1)S(=O)(=O)[O-])NN=C2C=CC(=O)C(=NNC3=CC(=C(C=C3)[N+](=O)[O-])N)C2=O.[Na+],,,,,,
5607,105608,"3-[2-[5-[(3-Amino-4-nitrophenyl)hydrazinylidene]-4,6-dioxocyclohex-2-en-1-ylidene]hydrazinyl]-4-methoxybenzenesulfonic acid",COC1=C(C=C(C=C1)S(=O)(=O)O)NN=C2C=CC(=O)C(=NNC3=CC(=C(C=C3)[N+](=O)[O-])N)C2=O,,,,,,
5608,105609,"2,7-Naphthalenedisulfonic acid, 4-[[2,4-dihydroxy-5-[(4-nitrophenyl)azo]phenyl]azo]-5-hydroxy-",C1=CC(=CC=C1N=NC2=CC(=C(C=C2O)O)N=NC3=C4C(=CC(=C3)S(=O)(=O)O)C=C(C=C4O)S(=O)(=O)O)[N+](=O)[O-],,,,,,
5609,105610,CID 105610,C1=CC(=CC=C1C(=O)NC2=CC3=CC(=CC(=C3C=C2)O)S(=O)(=O)[O-])N.[Na+],,,,,,
5610,105611,"7-((4-((4-Amino-2-methylphenyl)azo)phenyl)azo)-1,3-naphthalenedisulfonic acid, disodium salt",CC1=C(C=CC(=C1)N)N=NC2=CC=C(C=C2)N=NC3=CC4=C(C=C(C=C4C=C3)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
5611,105612,"7-[[4-[(4-Amino-2-methylphenyl)diazenyl]phenyl]diazenyl]naphthalene-1,3-disulfonic acid",CC1=C(C=CC(=C1)N)N=NC2=CC=C(C=C2)N=NC3=CC4=C(C=C(C=C4C=C3)S(=O)(=O)O)S(=O)(=O)O,,,,,,
5612,105613,CID 105613,CCNS(=O)(=O)C1=C(C=C(C(=C1)Cl)N=NC2=C(NC3=C2C=CC=C3S(=O)(=O)[O-])C)Cl.[Na+],,,,,,
5613,105614,"3-[[2,5-dichloro-4-(ethylsulfamoyl)phenyl]diazenyl]-2-methyl-1H-indole-7-sulfonic acid",CCNS(=O)(=O)C1=C(C=C(C(=C1)Cl)N=NC2=C(NC3=C2C=CC=C3S(=O)(=O)O)C)Cl,,,,,,
5614,105615,CID 105615,CCNS(=O)(=O)C1=C(C=C(C(=C1)Cl)N=NC2=C(NC3=C2C=C(C=C3)S(=O)(=O)[O-])C)Cl.[Na+],,,,,,
5615,105616,"3-[[2,5-dichloro-4-(ethylsulfamoyl)phenyl]diazenyl]-2-methyl-1H-indole-5-sulfonic acid",CCNS(=O)(=O)C1=C(C=C(C(=C1)Cl)N=NC2=C(NC3=C2C=C(C=C3)S(=O)(=O)O)C)Cl,,,,,,
5616,105617,"1H-Indole-7-sulfonic acid, 2-methyl-",CC1=CC2=C(N1)C(=CC=C2)S(=O)(=O)O,,,,,,
5617,105618,CID 105618,C1=CC(=C(C2=C(C=C(C=C21)S(=O)(=O)[O-])O)N=NC3=C(C=CC(=C3)Cl)Cl)N.[Na+],,,,,,
5618,105619,"2-Naphthalenesulfonic acid, 6-amino-5-[(2,5-dichlorophenyl)azo]-4-hydroxy-",C1=CC(=C(C2=C(C=C(C=C21)S(=O)(=O)O)O)N=NC3=C(C=CC(=C3)Cl)Cl)N,,,,,,
5619,105620,2-chloro-N-ethylpropanamide,CCNC(=O)C(C)Cl,,,,,,
5620,105621,"Isooctadecanamide, N-[3-(dimethylamino)propyl]-",CC(C)CCCCCCCCCCCCCCC(=O)NCCCN(C)C,,,,,,
5621,105622,"Benzoic acid, 2-[(2-pentyl-2-nonenylidene)amino]-, methyl ester",CCCCCCC=C(CCCCC)C=NC1=CC=CC=C1C(=O)OC,,,,,,
5622,105623,"7-Octenenitrile, 7-methyl-3-methylene-",CC(=C)CCCC(=C)CC#N,,,,,,
5623,105624,1-Ethyl-2-[(3-ethyl-5-methoxy-2(3H)-benzoselenazolylidene)methyl]-6-methoxyquinolinium bromide,CCN1C2=C(C=CC(=C2)OC)[Se]C1=CC3=[N+](C4=C(C=C3)C=C(C=C4)OC)CC.[Br-],,,,,,
5624,105625,1-Ethyl-2-[(3-ethyl-5-methoxybenzoselenazol-2(3H)-ylidene)methyl]-6-methoxyquinolinium,CCN1C2=C(C=CC(=C2)OC)[Se]C1=CC3=[N+](C4=C(C=C3)C=C(C=C4)OC)CC,,,,,,
5625,105626,CID 105626,CCN1C2=C(C=CC(=C2)Cl)N(C1=CC=CC3=[N+](C4=C(O3)C5=CC=CC=C5C=C4)CC)CCC[N+](CC)(CC)CC.[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O,,,,,,
5626,105627,"2-[3-[[5-Chloro-3-ethyl-1,3-dihydro-1-[3-(triethylaminio)propyl]-2H-benzimidazol]-2-ylidene]-1-propenyl]-3-ethylnaphth[2,1-d]oxazol-3-ium",CCN1C2=C(C=CC(=C2)Cl)N(C1=CC=CC3=[N+](C4=C(O3)C5=CC=CC=C5C=C4)CC)CCC[N+](CC)(CC)CC,,,,,,
5627,105628,"3-Ethyl-2-[3-(3-ethyl-1,3-benzothiazol-3-ium-2-yl)-2-methylprop-2-enylidene]-1,3-benzothiazole;ethyl sulfate",CCN1C2=CC=CC=C2SC1=CC(=CC3=[N+](C4=CC=CC=C4S3)CC)C.CCOS(=O)(=O)[O-],,,,,,
5628,105629,"N-[2-(1-ethylbenzo[e][1,3]benzoxazol-1-ium-2-yl)ethenyl]aniline;ethyl sulfate",CC[N+]1=C(OC2=C1C3=CC=CC=C3C=C2)C=CNC4=CC=CC=C4.CCOS(=O)(=O)[O-],,,,,,
5629,105630,"N-[2-(1-ethylbenzo[e][1,3]benzoxazol-1-ium-2-yl)ethenyl]aniline",CC[N+]1=C(OC2=C1C3=CC=CC=C3C=C2)C=CNC4=CC=CC=C4,,,,,,
5630,105631,"Chromate(1-), bis(3-(4-((5-chloro-2-(hydroxy-kappaO)phenyl)azo-kappaN1)-4,5-dihydro-3-methyl-5-(oxo-kappaO)-1H-pyrazol-1-yl)benzenesulfonamidato(2-))-, sodium",CC1=NN(C(=C1N=NC2=C(C=CC(=C2)Cl)[O-])[O-])C3=CC(=CC=C3)S(=O)(=O)N.CC1=NN(C(=C1N=NC2=C(C=CC(=C2)Cl)[O-])[O-])C3=CC(=CC=C3)S(=O)(=O)N.[Na+].[Cr+3],,,,,,
5631,105632,1-[3-(Aminosulfonyl)phenyl]-3-methyl-4-[2-(2-hydroxy-5-chlorophenyl)hydrazono]-1H-pyrazole-5-one,CC1=C(C(=O)N(N1)C2=CC(=CC=C2)S(=O)(=O)N)N=NC3=C(C=CC(=C3)Cl)O,,,,,,
5632,105633,"Benzenesulfonic acid, 5-chloro-4-ethyl-2-[(2-hydroxy-1-naphthalenyl)azo]-, barium salt (2:1)",CCC1=CC(=C(C=C1Cl)S(=O)(=O)[O-])N=NC2=C(C=CC3=CC=CC=C32)O.CCC1=CC(=C(C=C1Cl)S(=O)(=O)[O-])N=NC2=C(C=CC3=CC=CC=C32)O.[Ba+2],,,,,,
5633,105634,5-Chloro-4-ethyl-2-[(2-hydroxynaphthalen-1-yl)diazenyl]benzene-1-sulfonic acid,CCC1=CC(=C(C=C1Cl)S(=O)(=O)O)N=NC2=C(C=CC3=CC=CC=C32)O,,,,,,
5634,105635,"Benzenesulfonic acid, 4-chloro-2-((2-hydroxy-1-naphthalenyl)azo)-5-methyl-, calcium salt (2:1)",CC1=CC(=C(C=C1Cl)N=NC2=C(C=CC3=CC=CC=C32)O)S(=O)(=O)[O-].CC1=CC(=C(C=C1Cl)N=NC2=C(C=CC3=CC=CC=C32)O)S(=O)(=O)[O-].[Ca+2],,,,,,
5635,105636,"C.I. Orange 46, calcium salt",CCC1=CC(=C(C=C1Cl)S(=O)(=O)[O-])N=NC2=C(C=CC3=CC=CC=C32)O.CCC1=CC(=C(C=C1Cl)S(=O)(=O)[O-])N=NC2=C(C=CC3=CC=CC=C32)O.[Ca+2],,,,,,
5636,105637,"1H-Naphth(2,3-f)isoindole-1,3,5,10(2H)-tetrone, 4,11-diamino-2-(2-butoxyethyl)-",CCCCOCCN1C(=O)C2=C(C3=C(C(=C2C1=O)N)C(=O)C4=CC=CC=C4C3=O)N,,,,,,
5637,105638,2-Methoxy-4-(morpholin-4-yl)benzenediazonium tetrachlorozincate (2:1),COC1=C(C=CC(=C1)N2CCOCC2)[N+]#N.COC1=C(C=CC(=C1)N2CCOCC2)[N+]#N.[Cl-].[Cl-].[Cl-].[Cl-].[Zn+2],,,,,,
5638,105639,2-Methoxy-4-morpholinobenzenediazonium,COC1=C(C=CC(=C1)N2CCOCC2)[N+]#N,,,,,,
5639,105640,"3-Oxazolidineethanesulfonic acid, 5-[1-methyl-2-(3-methyl-2(3H)-benzoxazolylidene)ethylidene]-4-oxo-2-thioxo-",CC(=C1C(=O)N(C(=S)O1)CCS(=O)(=O)O)C=C2N(C3=CC=CC=C3O2)C,,,,,,
5640,105641,CID 105641,CCC1=CC(=C(C=C1Cl)S(=O)(=O)[O-])N=NC2=C(C(=CC3=CC=CC=C32)C(=O)[O-])O.[Sr+2],,,,,,
5641,105642,4-(4-Chloro-5-ethyl-2-sulfophenylazo)-3-hydroxy-2-naphthalenecarboxylic acid,CCC1=CC(=C(C=C1Cl)S(=O)(=O)O)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)O)O,,,,,,
5642,105643,2-(Furan-2-ylmethylidene)octanal,CCCCCCC(=CC1=CC=CO1)C=O,,,,,,
5643,105644,"2-Naphthaleneacetaldehyde, 5,6,7,8-tetrahydro-",C1CCC2=C(C1)C=CC(=C2)CC=O,,,,,,
5644,105645,2-(Furan-2-ylmethylidene)heptanal,CCCCCC(=CC1=CC=CO1)C=O,,,,,,
5645,105646,"Benzoic acid, 2-((7-hydroxy-7-methyloctylidene)amino)-, ethyl ester",CCOC(=O)C1=CC=CC=C1N=CCCCCCC(C)(C)O,,,,,,
5646,105647,2-Methylallyl 2-ethylacrylate,CCC(=C)C(=O)OCC(=C)C,,,,,,
5647,105648,"1H-Indole, 1,1'-(2-phenylethylidene)bis-",C1=CC=C(C=C1)CC(N2C=CC3=CC=CC=C32)N4C=CC5=CC=CC=C54,,,,,,
5648,105649,"5,7-Decadien-2-one, 4,4,8-trimethyl-",CCC(=CC=CC(C)(C)CC(=O)C)C,,,,,,
5649,105650,"Benzenepropanoic acid, beta-oxo-, 4-methylphenyl ester",CC1=CC=C(C=C1)OC(=O)CC(=O)C2=CC=CC=C2,,,,,,
5650,105651,Methyl 2-(octylideneamino)benzoate,CCCCCCCC=NC1=CC=CC=C1C(=O)OC,,,,,,
5651,105652,Hept-3-enyl 2-methylpropanoate,CCCC=CCCOC(=O)C(C)C,,,,,,
5652,105653,"Benzoic acid, 2-[(3,7-dimethyl-2,6-octadien-1-ylidene)amino]-, methyl ester",CC(=CCCC(=CC=NC1=CC=CC=C1C(=O)OC)C)C,,,,,,
5653,105654,"1,3-Benzenediol, 4,6-bis[[4-(phenylamino)phenyl]azo]-",C1=CC=C(C=C1)NC2=CC=C(C=C2)N=NC3=CC(=C(C=C3O)O)N=NC4=CC=C(C=C4)NC5=CC=CC=C5,,,,,,
5654,105655,"[1,1'-Biphenyl]-2,5-dicarboxylic acid, 4'-methyl-, dimethyl ester",CC1=CC=C(C=C1)C2=C(C=CC(=C2)C(=O)OC)C(=O)OC,,,,,,
5655,105656,"Dimethyl 9-oxo-9H-fluorene-2,6-dicarboxylate",COC(=O)C1=CC2=C(C=C1)C3=C(C2=O)C=CC(=C3)C(=O)OC,,,,,,
5656,105657,Methyl (4-methylphenyl)methyl terephthalate,CC1=CC=C(C=C1)COC(=O)C2=CC=C(C=C2)C(=O)OC,,,,,,
5657,105658,"[1,1'-Biphenyl]-2,4'-dicarboxylic acid, 5-methyl-, dimethyl ester",CC1=CC(=C(C=C1)C(=O)OC)C2=CC=C(C=C2)C(=O)OC,,,,,,
5658,105659,Cobalt trimellitate,C1=CC(=C(C=C1C(=O)[O-])C(=O)[O-])C(=O)[O-].[Co+3],,,,,,
5659,105660,"6H-Dibenzo[b,d]pyran-4-carboxylic acid, 1-methyl-6-oxo-, methyl ester",CC1=C2C3=CC=CC=C3C(=O)OC2=C(C=C1)C(=O)OC,,,,,,
5660,105661,"6H-Dibenzo[b,d]pyran-4,8-dicarboxylic acid, 6-oxo-, dimethyl ester",COC(=O)C1=CC2=C(C=C1)C3=C(C(=CC=C3)C(=O)OC)OC2=O,,,,,,
5661,105662,N-[3-(dimethylamino)propyl]octadec-9-enamide;propanoic acid,CCCCCCCCC=CCCCCCCCC(=O)NCCCN(C)C.CCC(=O)O,,,,,,
5662,105663,Lauramidopropyl dimethylamine propionate,CCCCCCCCCCCC(=O)NCCCN(C)C.CCC(=O)O,,,,,,
5663,105664,2-tert-Butylcyclohexyl ethyl carbonate,CCOC(=O)OC1CCCCC1C(C)(C)C,,,,,,
5664,105665,"Methanedisulfonic acid, di-2-naphthalenyl-, disodium salt",C1=CC=C2C=C(C=CC2=C1)C(C3=CC4=CC=CC=C4C=C3)(S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
5665,105666,Di-2-naphthalenylmethanedisulfonic acid,C1=CC=C2C=C(C=CC2=C1)C(C3=CC4=CC=CC=C4C=C3)(S(=O)(=O)O)S(=O)(=O)O,,,,,,
5666,105667,"Propanediamide, 2-[[5-(benzoylamino)-9,10-dihydro-9,10-dioxo-1-anthracenyl]azo]-N,N'-bis(2,4-dichlorophenyl)-",C1=CC=C(C=C1)C(=O)NC2=CC=CC3=C2C(=O)C4=C(C3=O)C(=CC=C4)N=NC(C(=O)NC5=C(C=C(C=C5)Cl)Cl)C(=O)NC6=C(C=C(C=C6)Cl)Cl,,,,,,
5667,105668,Palmitamidopropylamine oxide,CCCCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)[O-],,,,,,
5668,105669,Methyl 3-(trimethoxysilyl)propyl methylphosphonate,CO[Si](CCCOP(=O)(C)OC)(OC)OC,,,,,,
5669,105670,"Cobaltate(3-), tris(6-hydroxy-5-nitroso-2-naphthalenesulfonato(2-))-, trisodium",C1=CC2=C(C=CC(=C2N=O)[O-])C=C1S(=O)(=O)[O-].C1=CC2=C(C=CC(=C2N=O)[O-])C=C1S(=O)(=O)[O-].C1=CC2=C(C=CC(=C2N=O)[O-])C=C1S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Co+3],,,,,,
5670,105671,"5-(Hydroxyimino)-6-oxo-5,6-dihydronaphthalene-2-sulfonic acid",C1=CC2=C(C=CC(=C2N=O)O)C=C1S(=O)(=O)O,,,,,,
5671,105672,"Benzenesulfonic acid, 4-chloro-3-[[4-[(sulfomethyl)amino]phenyl]azo]-, disodium salt",C1=CC(=CC=C1NCS(=O)(=O)[O-])N=NC2=C(C=CC(=C2)S(=O)(=O)[O-])Cl.[Na+].[Na+],,,,,,
5672,105673,4-Chloro-3-[[4-(sulfomethylamino)phenyl]diazenyl]benzenesulfonic acid,C1=CC(=CC=C1NCS(=O)(=O)O)N=NC2=C(C=CC(=C2)S(=O)(=O)O)Cl,,,,,,
5673,105674,"Benzoic acid, 2-((2-amino-5-hydroxy-7-sulfo-1-naphthalenyl)azo)-5-nitro-, monosodium salt",C1=CC(=C(C=C1[N+](=O)[O-])C(=O)O)N=NC2=C(C=CC3=C2C=C(C=C3O)S(=O)(=O)[O-])N.[Na+],,,,,,
5674,105675,2-((2-Amino-5-hydroxy-7-sulpho-1-naphthyl)azo)-5-nitrobenzoic acid,C1=CC(=C(C=C1[N+](=O)[O-])C(=O)O)N=NC2=C(C=CC3=C2C=C(C=C3O)S(=O)(=O)O)N,,,,,,
5675,105676,CID 105676,C1=C(C(=CC(=N)C1=O)Cl)N(O)O.Cl,,,,,,
5676,105677,CID 105677,C1=C(C=C(C(=O)C1=N)N(O)O)Cl.Cl,,,,,,
5677,105678,"1,3,5-Naphthalenetrisulfonic acid, 7-amino-, trisodium salt",C1=C(C=C(C2=C1C(=CC(=C2)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])N.[Na+].[Na+].[Na+],,,,,,
5678,105679,"7-Amino-1,3,5-naphthalenetrisulfonic acid",C1=C(C=C(C2=C1C(=CC(=C2)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)N,,,,,,
5679,105680,CID 105680,CC1(C2=CC=CC=C2[N+](=C1C=CNC3=C(C=C(C=C3)OC)OC)C)C.CC1(C2=CC=CC=C2[N+](=C1C=CNC3=C(C=C(C=C3)OC)OC)C)C.C1=CC2=C(C=C(C=C2)S(=O)(=O)[O-])C(=C1)S(=O)(=O)[O-],,,,,,
5680,105681,"1,7-Naphthalenedisulfonic acid",C1=CC2=C(C=C(C=C2)S(=O)(=O)O)C(=C1)S(=O)(=O)O,,,,,,
5681,105682,"1-Propene, 3-[3-(3-methoxypropoxy)propoxy]-",COCCCOCCCOCC=C,,,,,,
5682,105683,CID 105683,CCCCCCCCCCCCCCCCCC(=O)N(CCO)CCOC(=O)C=CC(=O)O.N,,,,,,
5683,105684,4-[2-[2-Hydroxyethyl(octadecanoyl)amino]ethoxy]-4-oxobut-2-enoic acid,CCCCCCCCCCCCCCCCCC(=O)N(CCO)CCOC(=O)C=CC(=O)O,,,,,,
5684,105685,"Benzenepropanoic acid, 3,5-dimethoxy-beta-oxo-4-(phenylmethoxy)-, phenylmethyl ester",COC1=CC(=CC(=C1OCC2=CC=CC=C2)OC)C(=O)CC(=O)OCC3=CC=CC=C3,,,,,,
5685,105686,"2,4,5-Triethoxybenzaldehyde",CCOC1=CC(=C(C=C1C=O)OCC)OCC,,,,,,
5686,105687,"2-Ethyl-1,3,5-trimethoxybenzene",CCC1=C(C=C(C=C1OC)OC)OC,,,,,,
5687,105688,"N-(3,5-Dihydroxyphenyl)benzamide",C1=CC=C(C=C1)C(=O)NC2=CC(=CC(=C2)O)O,,,,,,
5688,105689,Dimethyltin;dodecanoic acid;hydrate,CCCCCCCCCCCC(=O)O.CCCCCCCCCCCC(=O)O.C[Sn]C.C[Sn]C.O,,,,,,
5689,105690,CID 105690,CCCCCCCCC=CCCCCCCCC(=O)O.CCCCCCCCC=CCCCCCCCC(=O)O.CCCC[Sn]CCCC.CCCC[Sn]CCCC.O,,,,,,
5690,105691,CID 105691,CC1=CC(=C(C(=C1CNC(=O)C2=CC=CC=C2)C)NC3=CC(=C(C4=C3C(=O)C5=CC=CC=C5C4=O)N)S(=O)(=O)[O-])C.[Na+],,,,,,
5691,105692,"1-Amino-4-[3-(benzamidomethyl)-2,4,6-trimethylanilino]-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid",CC1=CC(=C(C(=C1CNC(=O)C2=CC=CC=C2)C)NC3=CC(=C(C4=C3C(=O)C5=CC=CC=C5C4=O)N)S(=O)(=O)O)C,,,,,,
5692,105693,CID 105693,CC1=C(C(=C(C(=C1CNC(=O)C2=CC=CC=C2)C)NC3=CC(=C(C4=C3C(=O)C5=CC=CC=C5C4=O)N)S(=O)(=O)[O-])C)CNC(=O)C6=CC=CC=C6.[Na+],,,,,,
5693,105694,"1-Amino-4-[3,5-bis(benzamidomethyl)-2,4,6-trimethylanilino]-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid",CC1=C(C(=C(C(=C1CNC(=O)C2=CC=CC=C2)C)NC3=CC(=C(C4=C3C(=O)C5=CC=CC=C5C4=O)N)S(=O)(=O)O)C)CNC(=O)C6=CC=CC=C6,,,,,,
5694,105695,"3-Pyridinemethanesulfonic acid, 5-((5-((4-chloro-6-(1-methylethoxy)-1,3,5-triazin-2-yl)amino)-2-sulfophenyl)azo)-1-ethyl-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-, disodium salt",CCN1C(=C(C(=C(C1=O)N=NC2=C(C=CC(=C2)NC3=NC(=NC(=N3)Cl)OC(C)C)S(=O)(=O)[O-])C)CS(=O)(=O)[O-])O.[Na+].[Na+],,,,,,
5695,105696,"4-[(4-Chloro-6-propan-2-yloxy-1,3,5-triazin-2-yl)amino]-2-[[1-ethyl-6-hydroxy-4-methyl-2-oxo-5-(sulfomethyl)pyridin-3-yl]diazenyl]benzenesulfonic acid",CCN1C(=C(C(=C(C1=O)N=NC2=C(C=CC(=C2)NC3=NC(=NC(=N3)Cl)OC(C)C)S(=O)(=O)O)C)CS(=O)(=O)O)O,,,,,,
5696,105697,"2,7-Naphthalenedisulfonic acid, 5-((4-chloro-6-((3-((4-chloro-6-(1-methylethoxy)-1,3,5-triazin-2-yl)amino)-4-sulfophenyl)amino)-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-((4-methyl-2-sulfophenyl)azo)-, tetrasodium salt",CC1=CC(=C(C=C1)N=NC2=C(C3=C(C=C(C=C3C=C2S(=O)(=O)[O-])S(=O)(=O)[O-])NC4=NC(=NC(=N4)NC5=CC(=C(C=C5)S(=O)(=O)[O-])NC6=NC(=NC(=N6)C(C)C)Cl)Cl)O)S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
5697,105698,"5-[[4-Chloro-6-[3-[(4-chloro-6-propan-2-yl-1,3,5-triazin-2-yl)amino]-4-sulfoanilino]-1,3,5-triazin-2-yl]amino]-4-hydroxy-3-[(4-methyl-2-sulfophenyl)diazenyl]naphthalene-2,7-disulfonic acid",CC1=CC(=C(C=C1)N=NC2=C(C3=C(C=C(C=C3C=C2S(=O)(=O)O)S(=O)(=O)O)NC4=NC(=NC(=N4)NC5=CC(=C(C=C5)S(=O)(=O)O)NC6=NC(=NC(=N6)C(C)C)Cl)Cl)O)S(=O)(=O)O,,,,,,
5698,105699,"3,7-Diamino-2-methoxyphenoxazin-5-ium chloride",COC1=CC2=NC3=C(C=C(C=C3)N)OC2=CC1=[NH2+].[Cl-],,,,,,
5699,105700,3-Imino-8-methoxy-3H-phenoxazin-7-amine,COC1=CC2=NC3=C(C=C(C=C3)N)OC2=CC1=N,,,,,,
5700,105701,"Ethanol, 2,2'-[(tetrahydro-4H-1,3,6,2-dioxazaborocin-2-yl)imino]bis-",B1(OCCNCCO1)N(CCO)CCO,,,,,,
5701,105702,"2-Naphthalenecarboxamide, N-(3-chloro-4-methylphenyl)-3-hydroxy-",CC1=C(C=C(C=C1)NC(=O)C2=CC3=CC=CC=C3C=C2O)Cl,,,,,,
5702,105703,"Benzenesulfonyl chloride, 3-(acetylbutylamino)-4-methoxy-",CCCCN(C1=C(C=CC(=C1)S(=O)(=O)Cl)OC)C(=O)C,,,,,,
5703,105704,"Benzenamine, 2-methyl-4-nitro-, sulfate (2:1)",CC1=C(C=CC(=C1)[N+](=O)[O-])N.CC1=C(C=CC(=C1)[N+](=O)[O-])N.OS(=O)(=O)O,,,,,,
5704,105705,2-Methoxy-5-nitroaniline hydrochloride,COC1=C(C=C(C=C1)[N+](=O)[O-])N.Cl,,,,,,
5705,105706,Diethyl dibutylphosphoramidate,CCCCN(CCCC)P(=O)(OCC)OCC,,,,,,
5706,105707,"1-Naphthalenesulfonic acid, 3-((2,4-dimethyl-5-((2-(sulfooxy)ethyl)sulfonyl)phenyl)azo)-4-hydroxy-",CC1=CC(=C(C=C1N=NC2=C(C3=CC=CC=C3C(=C2)S(=O)(=O)O)O)S(=O)(=O)CCOS(=O)(=O)O)C,,,,,,
5707,105708,"2-Naphthalenecarboxamide, N-(5-chloro-2-methoxyphenyl)-3-hydroxy-4-[(2-methyl-5-nitrophenyl)azo]-",CC1=C(C=C(C=C1)[N+](=O)[O-])N=NC2=C(C(=CC3=CC=CC=C32)C(=O)NC4=C(C=CC(=C4)Cl)OC)O,,,,,,
5708,105709,"2-Naphthalenecarboxamide, N-(5-chloro-2-methoxyphenyl)-3-hydroxy-4-((2-methoxy-5-nitrophenyl)azo)-",COC1=C(C=C(C=C1)Cl)NC(=O)C2=CC3=CC=CC=C3C(=C2O)N=NC4=C(C=CC(=C4)[N+](=O)[O-])OC,,,,,,
5709,105710,CID 105710,C1=CC=C(C=C1)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)O)O.[Cu],,,,,,
5710,105711,"Sodio(ethyl)(4-((4-(ethylamino)phenyl)(4-(ethyl(3-sulphonatobenzyl)amino)phenyl)methylene)cyclohexa-2,5-dien-1-ylidene)(3-sulphonatobenzyl)ammonium",CCNC1=CC=C(C=C1)C2=C(C=C(C=C2)CN(CC)C3=CC=C(C=C3)C=C4C=CC(=[N+](CC)CC5=CC(=CC=C5)S(=O)(=O)[O-])C=C4)S(=O)(=O)[O-].[Na+],,,,,,
5711,105712,"Ethyl-[4-[[4-[ethyl-[[4-[4-(ethylamino)phenyl]-3-sulfophenyl]methyl]amino]phenyl]methylidene]cyclohexa-2,5-dien-1-ylidene]-[(3-sulfophenyl)methyl]azanium",CCNC1=CC=C(C=C1)C2=C(C=C(C=C2)CN(CC)C3=CC=C(C=C3)C=C4C=CC(=[N+](CC)CC5=CC(=CC=C5)S(=O)(=O)O)C=C4)S(=O)(=O)O,,,,,,
5712,105713,CID 105713,C1=CC=C2C(=C1)C=C(C(=C2N=NC3=CC=C(C=C3)Cl)O)C(=O)O.[Cu],,,,,,
5713,105714,4-[(4-Chlorophenyl)diazenyl]-3-hydroxynaphthalene-2-carboxylic acid,C1=CC=C2C(=C1)C=C(C(=C2N=NC3=CC=C(C=C3)Cl)O)C(=O)O,,,,,,
5714,105715,"1,3-Benzenedisulfonic acid, 4-[bis[4-[ethyl(phenylmethyl)amino]phenyl]methyl]-",CCN(CC1=CC=CC=C1)C2=CC=C(C=C2)C(C3=CC=C(C=C3)N(CC)CC4=CC=CC=C4)C5=C(C=C(C=C5)S(=O)(=O)O)S(=O)(=O)O,,,,,,
5715,105716,"Benzenamine, 4,4'-[(2-chlorophenyl)methylene]bis[N-ethyl-2-methyl-",CCNC1=C(C=C(C=C1)C(C2=CC(=C(C=C2)NCC)C)C3=CC=CC=C3Cl)C,,,,,,
5716,105717,"2,7-Naphthalenedisulfonic acid, compd. with 4-(diethylamino)-alpha-(4-(diethylamino)phenyl)benzenemethanol (1:1)",CCN(CC)C1=CC=C(C=C1)C(C2=CC=C(C=C2)N(CC)CC)O.C1=CC2=C(C=C(C=C2)S(=O)(=O)O)C(=C1)S(=O)(=O)O,,,,,,
5717,105718,"2,7-Naphthalenedisulfonic acid, 4-[bis[4-(diethylamino)phenyl]methyl]-",CCN(CC)C1=CC=C(C=C1)C(C2=CC=C(C=C2)N(CC)CC)C3=C4C=CC(=CC4=CC(=C3)S(=O)(=O)O)S(=O)(=O)O,,,,,,
5718,105719,CID 105719,C1=CC2=C(C=C1C(=O)[O-])SC(=N2)N.[Na+],,,,,,
5719,105720,"6-Benzothiazolecarboxylic acid, 2-amino-, monohydrobromide",C1=CC2=C(C=C1C(=O)O)SC(=N2)N.Br,,,,,,
5720,105721,"Methyl 2,4-dihydroxyphenylglycolate",COC(=O)C(=O)C1=C(C=C(C=C1)O)O,,,,,,
5721,105722,"3,5-Dichloro-4-ethoxy-2-nitrotoluene",CCOC1=C(C=C(C(=C1Cl)[N+](=O)[O-])C)Cl,,,,,,
5722,105723,"Benzeneacetic acid, 2,4-dihydroxy-alpha-imino-, methyl ester, hydrochloride",COC(=O)C(=N)C1=C(C=C(C=C1)O)O.Cl,,,,,,
5723,105724,"2,4-Dihydroxy-alpha-iminobenzeneacetic acid methyl ester",COC(=O)C(=N)C1=C(C=C(C=C1)O)O,,,,,,
5724,105725,5-Chloro-4-ethoxy-2-nitrotoluene,CCOC1=C(C=C(C(=C1)[N+](=O)[O-])C)Cl,,,,,,
5725,105726,"3,5-Dichloro-4-ethoxytoluene",CCOC1=C(C=C(C=C1Cl)C)Cl,,,,,,
5726,105727,"Methyl 2,4-dihydroxyphenylacetate",COC(=O)CC1=C(C=C(C=C1)O)O,,,,,,
5727,105728,"5-Chloro-2,4-dihydroxybenzoic acid",C1=C(C(=CC(=C1Cl)O)O)C(=O)O,,,,,,
5728,105729,"5-Chloro-2,4-dihydroxybenzamide",C1=C(C(=CC(=C1Cl)O)O)C(=O)N,,,,,,
5729,105730,"Benzenamine, 2,5-dibutoxy-4-(4-morpholinyl)-",CCCCOC1=CC(=C(C=C1N)OCCCC)N2CCOCC2,,,,,,
5730,105731,"2,5-Dibutoxy-4-(1-pyrrolidinyl)aniline",CCCCOC1=CC(=C(C=C1N)OCCCC)N2CCCC2,,,,,,
5731,105732,"Benzenediazonium, 2,5-dibutoxy-4-(1-pyrrolidinyl)-, (T-4)-tetrachlorozincate(2-) (2:1)",CCCCOC1=CC(=C(C=C1[N+]#N)OCCCC)N2CCCC2.CCCCOC1=CC(=C(C=C1[N+]#N)OCCCC)N2CCCC2.[Cl-].[Cl-].[Cl-].[Cl-].[Zn+2],,,,,,
5732,105733,"2,5-Dibutoxy-4-(1-pyrrolidinyl)benzenediazonium",CCCCOC1=CC(=C(C=C1[N+]#N)OCCCC)N2CCCC2,,,,,,
5733,105734,"Pyrrolidine, 1-(2,5-dibutoxy-4-nitrophenyl)-",CCCCOC1=CC(=C(C=C1N2CCCC2)OCCCC)[N+](=O)[O-],,,,,,
5734,105735,"1,3-Benzenediol, 4,4'-(5-hydroxypentylidene)bis-",C1=CC(=C(C=C1O)O)C(CCCCO)C2=C(C=C(C=C2)O)O,,,,,,
5735,105736,"2,5-Diethoxy-N,N-diethylbenzene-1,4-diamine",CCN(CC)C1=C(C=C(C(=C1)OCC)N)OCC,,,,,,
5736,105737,"Benzenediazonium, 4-(diethylamino)-2,5-diethoxy-, (T-4)-tetrachlorozincate(2-) (2:1)",CCN(CC)C1=C(C=C(C(=C1)OCC)[N+]#N)OCC.CCN(CC)C1=C(C=C(C(=C1)OCC)[N+]#N)OCC.[Cl-].[Cl-].[Cl-].[Cl-].[Zn+2],,,,,,
5737,105738,"4-(Diethylamino)-2,5-diethoxybenzenediazonium",CCN(CC)C1=C(C=C(C(=C1)OCC)[N+]#N)OCC,,,,,,
5738,105739,"Benzenediazonium, 3-methoxy-4-(1-pyrrolidinyl)-, (T-4)-tetrachlorozincate(2-) (2:1)",COC1=C(C=CC(=C1)[N+]#N)N2CCCC2.COC1=C(C=CC(=C1)[N+]#N)N2CCCC2.[Cl-].[Cl-].[Cl-].[Cl-].[Zn+2],,,,,,
5739,105740,3-Methoxy-4-pyrrolizinobenzenediazonium,COC1=C(C=CC(=C1)[N+]#N)N2CCCC2,,,,,,
5740,105741,1-(2-Methoxy-4-nitrophenyl)pyrrolidine,COC1=C(C=CC(=C1)[N+](=O)[O-])N2CCCC2,,,,,,
5741,105742,1-(2-Methyl-4-nitrophenyl)pyrrolidine,CC1=C(C=CC(=C1)[N+](=O)[O-])N2CCCC2,,,,,,
5742,105743,"Benzeneacetic acid, alpha-imino-3,4-dimethoxy-, methyl ester, hydrochloride",COC1=C(C=C(C=C1)C(=N)C(=O)OC)OC.Cl,,,,,,
5743,105744,"alpha-Imino-3,4-dimethoxybenzeneacetic acid methyl ester",COC1=C(C=C(C=C1)C(=N)C(=O)OC)OC,,,,,,
5744,105745,"Ethyl 2,4-dihydroxyphenylacetate",CCOC(=O)CC1=C(C=C(C=C1)O)O,,,,,,
5745,105746,"1,4-Dichloro-2,5-diethoxybenzene",CCOC1=CC(=C(C=C1Cl)OCC)Cl,,,,,,
5746,105747,5-Chloro-4-ethoxy-3-methoxy-2-nitrotoluene,CCOC1=C(C=C(C(=C1OC)[N+](=O)[O-])C)Cl,,,,,,
5747,105748,CID 105748,[B+3].C1COCCN1C2=C(C=C(C=C2)[N+]#N)Cl.[F-].[F-].[F-].[F-],,,,,,
5748,105749,3-Chloro-4-(4-morpholinyl)benzenediazonium,C1COCCN1C2=C(C=C(C=C2)[N+]#N)Cl,,,,,,
5749,105750,1-(4-Hydroxyphenyl)-2-(methylamino)ethan-1-one hydrochloride,CNCC(=O)C1=CC=C(C=C1)O.Cl,,,,,,
5750,105751,"Benzoic acid, 5-chloro-2,4-dihydroxy-, methyl ester",COC(=O)C1=CC(=C(C=C1O)O)Cl,,,,,,
5751,105752,CID 105752,CC1=CC(=C(C=C1Cl)S(=O)(=O)[O-])N=NC2=C(C(=CC3=CC=CC=C32)C(=O)[O-])O.[Sr+2],,,,,,
5752,105753,3-(Benzo[f]quinolin-3-ylmethylidene)-2-benzofuran-1-one,C1=CC=C2C(=C1)C=CC3=C2C=CC(=N3)C=C4C5=CC=CC=C5C(=O)O4,,,,,,
5753,105754,"Propanediamide, 2-[[5-(benzoylamino)-9,10-dihydro-9,10-dioxo-1-anthracenyl]azo]-N,N'-bis(2,3-dichlorophenyl)-",C1=CC=C(C=C1)C(=O)NC2=CC=CC3=C2C(=O)C4=C(C3=O)C(=CC=C4)N=NC(C(=O)NC5=C(C(=CC=C5)Cl)Cl)C(=O)NC6=C(C(=CC=C6)Cl)Cl,,,,,,
5754,105755,"Bicyclo[7.2.0]undec-3-en-5-ol, 4,11,11-trimethyl-8-methylene-, acetate",CC1=CCC2C(CC2(C)C)C(=C)CCC1OC(=O)C,,,,,,
5755,105756,8-Methylnonyl propanoate,CCC(=O)OCCCCCCCC(C)C,,,,,,
5756,105757,"6-tert-Butyl-2,4-dimethylanisole",CC1=CC(=C(C(=C1)C(C)(C)C)OC)C,,,,,,
5757,105758,2-Ethoxy-5-methylpyrazine,CCOC1=NC=C(N=C1)C,,,,,,
5758,105759,2-Ethyl-6-methoxypyrazine,CCC1=CN=CC(=N1)OC,,,,,,
5759,105760,"Ethanamine, 2-chloro-N,N-diethyl-, sulfate (1:1)",CCN(CC)CCCl.OS(=O)(=O)O,,,,,,
5760,105761,"26-(4-Nonylphenoxy)-3,6,9,12,15,18,21,24-octaoxahexacosan-1-yl acetate",CCCCCCCCCC1=CC=C(C=C1)OCCOCCOCCOCCOCCOCCOCCOCCOCCOC(=O)C,,,,,,
5761,105762,4-[2-[2-[2-[2-[2-(2-Decoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-4-oxobut-2-enoic acid,CCCCCCCCCCOCCOCCOCCOCCOCCOCCOC(=O)C=CC(=O)O,,,,,,
5762,105763,"3,7-Decadien-1-ol",CCC=CCCC=CCCO,,,,,,
5763,105764,(4-Methylphenoxy)acetaldehyde,CC1=CC=C(C=C1)OCC=O,,,,,,
5764,105765,"Cyclododecane, propoxy-",CCCOC1CCCCCCCCCCC1,,,,,,
5765,105766,"1-(3,7-Dimethylocta-2,6-dienyl)indole",CC(=CCCC(=CCN1C=CC2=CC=CC=C21)C)C,,,,,,
5766,105767,"[4-(1,1-Dimethylethyl)-2-methylphenoxy]acetaldehyde",CC1=C(C=CC(=C1)C(C)(C)C)OCC=O,,,,,,
5767,105768,"Cyclopentanone, 2-(4-methylpentylidene)-",CC(C)CCC=C1CCCC1=O,,,,,,
5768,105769,2-(Diethoxymethyl)oct-1-enylbenzene,CCCCCCC(=CC1=CC=CC=C1)C(OCC)OCC,,,,,,
5769,105770,"Phosphorous acid, dibutyl ester, compd. with methyl-1H-benzotriazole (1:1)",CCCCOP(O)OCCCC.CC1=CC2=NNN=C2C=C1,,,,,,
5770,105771,"2,6-Bis[[bis(2-hydroxyethyl)amino]methyl]-4-dodecylphenol",CCCCCCCCCCCCC1=CC(=C(C(=C1)CN(CCO)CCO)O)CN(CCO)CCO,,,,,,
5771,105772,2-(2-Phenoxyethoxy)ethyl benzoate,C1=CC=C(C=C1)C(=O)OCCOCCOC2=CC=CC=C2,,,,,,
5772,105773,"Benzenediazonium, 4-methyl-2-nitro-, (T-4)-tetrachlorozincate(2-) (4:1)",CC1=CC(=C(C=C1)[N+]#N)[N+](=O)[O-].CC1=CC(=C(C=C1)[N+]#N)[N+](=O)[O-].CC1=CC(=C(C=C1)[N+]#N)[N+](=O)[O-].CC1=CC(=C(C=C1)[N+]#N)[N+](=O)[O-].[Cl-].[Cl-].[Cl-].[Cl-].[Zn+2],,,,,,
5773,105774,"Benzenediazonium, 2-methyl-5-nitro-, (T-4)-tetrachlorozincate(2-) (2:1)",CC1=C(C=C(C=C1)[N+](=O)[O-])[N+]#N.CC1=C(C=C(C=C1)[N+](=O)[O-])[N+]#N.[Cl-].[Cl-].[Cl-].[Cl-].[Zn+2],,,,,,
5774,105775,2-Methyl-5-nitrobenzenediazonium,CC1=C(C=C(C=C1)[N+](=O)[O-])[N+]#N,,,,,,
5775,105776,Dodecylbenzene sulfonic acid piperidine salt,CCCCCCCCCCCCOS(=O)(=O)C1=CC=CC=C1.C1CCNCC1,,,,,,
5776,105777,"2,2,6,6-Tetramethyl-4-piperidinecarbonitrile",CC1(CC(CC(N1)(C)C)C#N)C,,,,,,
5777,105778,"Octane-1,8-diyl bis(2,2,6,6-tetramethylpiperidine-4-carboxylate)",CC1(CC(CC(N1)(C)C)C(=O)OCCCCCCCCOC(=O)C2CC(NC(C2)(C)C)(C)C)C,,,,,,
5778,105779,"2,2,6,6-Tetramethylpiperidine-4-carbonyl chloride",CC1(CC(CC(N1)(C)C)C(=O)Cl)C,,,,,,
5779,105780,"Benzoic acid, 2,3,4,5-tetrachloro-6-[[(3-methoxypropyl)amino]carbonyl]-",COCCCNC(=O)C1=C(C(=C(C(=C1Cl)Cl)Cl)Cl)C(=O)O,,,,,,
5780,105781,"1H-Imidazolium, 1,3-dimethyl-2-((4-(methylamino)phenyl)azo)-, (T-4)-tetrachlorozincate(2-) (2:1)",CNC1=CC=C(C=C1)N=NC2=[N+](C=CN2C)C.CNC1=CC=C(C=C1)N=NC2=[N+](C=CN2C)C.[Cl-].[Cl-].[Cl-].[Cl-].[Zn+2],,,,,,
5781,105782,"1,3-Dimethyl-2-[[4-(methylamino)phenyl]azo]-1H-imidazol-3-ium",CNC1=CC=C(C=C1)N=NC2=[N+](C=CN2C)C,,,,,,
5782,105783,"1H-Imidazolium, 2-(8-heptadecenyl)-4,5-dihydro-1,3-bis(2-hydroxyethyl)-, chloride",CCCCCCCCC=CCCCCCCCC1=[N+](CCN1CCO)CCO.[Cl-],,,,,,
5783,105784,"2-(Heptadec-8-en-1-yl)-1,3-bis(2-hydroxyethyl)-4,5-dihydro-1H-imidazol-3-ium",CCCCCCCCC=CCCCCCCCC1=[N+](CCN1CCO)CCO,,,,,,
5784,105785,Einecs 267-354-8,CCCCCCCCCCCCCCCCCC(=O)NCCNCCCCNC(=O)N.CCOP(=O)(O)OCC,,,,,,
5785,105786,N-[2-[4-(carbamoylamino)butylamino]ethyl]octadecanamide,CCCCCCCCCCCCCCCCCC(=O)NCCNCCCCNC(=O)N,,,,,,
5786,105787,"Phosphoric acid, ethyl ester, compd. with N,N-dimethyl-1-dodecanamine",CCCCCCCCCCCCN(C)C.CCOP(=O)(O)O,,,,,,
5787,105788,"1,2,4-Benzenetricarboxylic acid, 1,2-bis(phenylmethyl) ester",C1=CC=C(C=C1)COC(=O)C2=C(C=C(C=C2)C(=O)O)C(=O)OCC3=CC=CC=C3,,,,,,
5788,105789,CID 105789,CCCCCCCCC=CCCCCCCCC(=O)NCCN(CC)CCNC(=O)CCCCCCCC=CCCCCCCCC.CCOS(=O)(=O)O,,,,,,
5789,105790,N-[2-[ethyl-[2-(octadec-9-enoylamino)ethyl]amino]ethyl]octadec-9-enamide,CCCCCCCCC=CCCCCCCCC(=O)NCCN(CC)CCNC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
5790,105791,"1H-Imidazolium, 1-ethyl-2-(8Z)-8-heptadecenyl-4,5-dihydro-1-[2-[[(9Z)-1-oxo-9-octadecenyl]amino]ethyl]-, ethyl sulfate",CCCCCCCCC=CCCCCCCCC1=NCC[N+]1(CC)CCNC(=O)CCCCCCCC=CCCCCCCCC.CCOS(=O)(=O)[O-],,,,,,
5791,105792,"1-Ethyl-2-(heptadec-8-en-1-yl)-1-{2-[(octadec-9-enoyl)amino]ethyl}-4,5-dihydro-1H-imidazol-1-ium",CCCCCCCCC=CCCCCCCCC1=NCC[N+]1(CC)CCNC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
5792,105793,"1-Propanaminium, N-ethyl-N,N-dimethyl-3-[(1-oxooctadecyl)amino]-, ethyl sulfate",CCCCCCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC.CCOS(=O)(=O)[O-],,,,,,
5793,105794,Ethyl[3-(stearoylamino)propyl]dimethylaminium,CCCCCCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC,,,,,,
5794,105795,"1-Tridecanol, dihydrogen phosphate, compd. with N,N-dimethyl-1-octadecanamine (1:1)",CCCCCCCCCCCCCCCCCCN(C)C.CCCCCCCCCCCCCOP(=O)(O)O,,,,,,
5795,105796,"Phosphoric acid, monooctyl ester, compd. with N,N-dimethyl-1-octadecanamine (1:1)",CCCCCCCCCCCCCCCCCCN(C)C.CCCCCCCCOP(=O)(O)O,,,,,,
5796,105797,"1-Propanamine, N,N-dipropyl-, acetate",CCCN(CCC)CCC.CC(=O)O,,,,,,
5797,105798,"1-Propanaminium, N-ethyl-N,N-dimethyl-3-((1-oxoeicosyl)amino)-, ethyl sulfate",CCCCCCCCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC.CCOS(=O)(=O)[O-],,,,,,
5798,105799,"N-Ethyl-N,N-dimethyl-3-[(1-oxoicosyl)amino]-1-propanaminium",CCCCCCCCCCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC,,,,,,
5799,105800,"Phosphoric acid, mono(3-methylbutyl) monooctyl ester, compd. with 2-(dibutylamino)ethanol (1:1)",CCCCCCCCOP(=O)(O)OCCC(C)C.CCCCN(CCCC)CCO,,,,,,
5800,105801,"Tetraethyl 4,4'-(2,2,2-trifluoro-1-(trifluoromethyl)ethylidene)bisphthalate",CCOC(=O)C1=C(C=C(C=C1)C(C2=CC(=C(C=C2)C(=O)OCC)C(=O)OCC)(C(F)(F)F)C(F)(F)F)C(=O)OCC,,,,,,
5801,105802,"Octanamide, N-[4-[[(aminocarbonyl)amino][4-(diethylamino)-2-methylphenyl]methyl]-2-methoxyphenyl]-",CCCCCCCC(=O)NC1=C(C=C(C=C1)C(C2=C(C=C(C=C2)N(CC)CC)C)NC(=O)N)OC,,,,,,
5802,105803,"1-Amino-4-(3-(((3,6-dichloropyridazin-4-yl)carbonyl)amino)-2,4,6-trimethyl-5-sulphoanilino)-9,10-dihydro-9,10-dioxoanthracene-2-sulphonic acid",CC1=C(C(=C(C(=C1NC(=O)C2=CC(=NN=C2Cl)Cl)C)S(=O)(=O)O)C)NC3=CC(=C(C4=C3C(=O)C5=CC=CC=C5C4=O)N)S(=O)(=O)O,,,,,,
5803,105804,CID 105804,C1=CC=C(C=C1)NN=C2C(=CC3=C(C2=O)C(=N)C(=NNC4=CC=C(C=C4)C5=NC6=C(N5)C=C(C=C6)N=NC7=CC=C(C=C7)O)C(=C3)S(=O)(=O)O)S(=O)(=O)O,,,,,,
5804,105805,"Phenoxazin-5-ium, 3-amino-7-(dimethylamino)-2-methoxy-, chloride (1:1)",C[N+](=C1C=CC2=NC3=C(C=C(C(=C3)OC)N)OC2=C1)C.[Cl-],,,,,,
5805,105806,3-Amino-7-dimethylamino-2-methoxyphenoxazin-5-ium,C[N+](=C1C=CC2=NC3=C(C=C(C(=C3)OC)N)OC2=C1)C,,,,,,
5806,105807,"Benzenesulfonic acid, 2,5-dichloro-4-(4-((4-chlorophenyl)azo)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)-",CC1=NN(C(=O)C1N=NC2=CC=C(C=C2)Cl)C3=CC(=C(C=C3Cl)S(=O)(=O)O)Cl,,,,,,
5807,105808,"2,5-Dimethoxy-4-[[2-oxo-1-[(phenylamino)carbonyl]propyl]azo]benzenediazonium chloride monohydrochloride",CC(=O)C(C(=O)NC1=CC=CC=C1)N=NC2=CC(=C(C=C2OC)[N+]#N)OC.Cl.[Cl-],,,,,,
5808,105809,"2,5-Dimethoxy-4-[2-[2-oxo-1-[(phenylamino)carbonyl]propyl]diazenyl]benzenediazonium",CC(=O)C(C(=O)NC1=CC=CC=C1)N=NC2=CC(=C(C=C2OC)[N+]#N)OC,,,,,,
5809,105810,"2-Naphthalenesulfonic acid, 6-(methylamino)-5-[[2-sulfo-4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-",CNC1=C(C2=C(C=C1)C=C(C=C2)S(=O)(=O)O)N=NC3=C(C=C(C=C3)S(=O)(=O)CCOS(=O)(=O)O)S(=O)(=O)O,,,,,,
5810,105811,"Benzamide, 4-amino-N-[4-(aminocarbonyl)phenyl]-3-methoxy-",COC1=C(C=CC(=C1)C(=O)NC2=CC=C(C=C2)C(=O)N)N,,,,,,
5811,105812,"Propanamide, N-[2-[(2-chloro-4,6-dinitrophenyl)azo]-5-(ethylamino)-4-(2-methoxyethoxy)phenyl]-",CCC(=O)NC1=CC(=C(C=C1N=NC2=C(C=C(C=C2Cl)[N+](=O)[O-])[N+](=O)[O-])OCCOC)NCC,,,,,,
5812,105813,"Imidazo[4,5-d]imidazole-2,5(1H,3H)-dione, tetrahydro-1,3,4,6-tetrakis[(2-hydroxyethoxy)methyl]-",C(COCN1C2C(N(C1=O)COCCO)N(C(=O)N2COCCO)COCCO)O,,,,,,
5813,105814,"5-(Benzoylamino)-2,4-dimethoxybenzenediazonium chloride hydrochloride",COC1=CC(=C(C=C1NC(=O)C2=CC=CC=C2)[N+]#N)OC.Cl.[Cl-],,,,,,
5814,105815,"5-Benzoylamino-2,4-dimethoxybenzenediazonium",COC1=CC(=C(C=C1NC(=O)C2=CC=CC=C2)[N+]#N)OC,,,,,,
5815,105816,Methyl 4-[(4-chlorophenyl)(methyl)amino]benzoate,CN(C1=CC=C(C=C1)C(=O)OC)C2=CC=C(C=C2)Cl,,,,,,
5816,105817,"Glycine, N-cyclohexyl-N-(9Z)-9-octadecenyl-",CCCCCCCCC=CCCCCCCCCN(CC(=O)O)C1CCCCC1,,,,,,
5817,105818,"Ethanaminium, N,N-dimethyl-2-[(1-oxooctadecyl)oxy]-N-[2-[(1-oxooctadecyl)oxy]ethyl]-, chloride",CCCCCCCCCCCCCCCCCC(=O)OCC[N+](C)(C)CCOC(=O)CCCCCCCCCCCCCCCCC.[Cl-],,,,,,
5818,105819,Bis[2-(stearoyloxy)ethyl]dimethylaminium,CCCCCCCCCCCCCCCCCC(=O)OCC[N+](C)(C)CCOC(=O)CCCCCCCCCCCCCCCCC,,,,,,
5819,105820,2-Hydroxyethyl methyl hydrogen phosphate,COP(=O)(O)OCCO,,,,,,
5820,105821,"[1,1'-Biphenyl]-2-carboxamide, 2'-methoxy-",COC1=CC=CC=C1C2=CC=CC=C2C(=O)N,,,,,,
5821,105822,Sodium copper nitrilotriacetate,C(C(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Cu+],,,,,,
5822,105823,"Palladate(2-), ((N,N'-1,2-cyclohexanediylbis(N-((carboxy-kappaO)methyl)glycinato-kappaN,kappaO))(4-))-, disodium, (OC-6-21)-",C1CCC(C(C1)N(CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Pd+2],,,,,,
5823,105824,Copper;2-diazonio-4-(2-sulfooxyethylsulfonyl)phenolate;4-oxido-7-(3-sulfopropanoylamino)naphthalene-2-sulfonate,C1=CC2=C(C=C(C=C2C=C1NC(=O)CCS(=O)(=O)O)S(=O)(=O)[O-])[O-].C1=CC(=C(C=C1S(=O)(=O)CCOS(=O)(=O)O)[N+]#N)[O-].[Cu+2],,,,,,
5824,105825,4-Hydroxy-7-(3-sulfopropanoylamino)naphthalene-2-sulfonic acid,C1=CC2=C(C=C(C=C2C=C1NC(=O)CCS(=O)(=O)O)S(=O)(=O)O)O,,,,,,
5825,105826,2-Hydroxy-5-(2-sulfooxyethylsulfonyl)benzenediazonium,C1=CC(=C(C=C1S(=O)(=O)CCOS(=O)(=O)O)[N+]#N)O,,,,,,
5826,105827,Ammonium zinc edetate,C(CN(CC(=O)O)CC(=O)[O-])N(CC(=O)O)CC(=O)[O-].N.N.[Zn+2],,,,,,
5827,105828,Methyl 3-(hexylthio)propionate,CCCCCCSCCC(=O)OC,,,,,,
5828,105829,CID 105829,CCCCCC=CCC=CCCCCCCCC(=O)OCC[S-].CCCCCC=CCC=CCCCCCCCC(=O)OCC[S-].CCCC[Sn]CCCC,,,,,,
5829,105830,(Methylstannylidyne)tris(thioethylene) trilaurate,CCCCCCCCCCCC(=O)OCCS[Sn](C)(SCCOC(=O)CCCCCCCCCCC)SCCOC(=O)CCCCCCCCCCC,,,,,,
5830,105831,2-Mercaptoethyl laurate,CCCCCCCCCCCC(=O)OCCS,,,,,,
5831,105832,CID 105832,CCCCCC=CCC=CCCCCCCCC(=O)OCC[S-].CCCCCC=CCC=CCCCCCCCC(=O)OCC[S-].C[Sn]C,,,,,,
5832,105833,CID 105833,CCCCCCCCCCCCCC(=O)OCC[S-].CCCCCCCCCCCCCC(=O)OCC[S-].CCCC[Sn]CCCC,,,,,,
5833,105834,2-Mercaptoethyl myristate,CCCCCCCCCCCCCC(=O)OCCS,,,,,,
5834,105835,"Methanesulfonic acid, mercapto-, disodium salt",C([S-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
5835,105836,Mercaptomethanesulfonic acid,C(S)S(=O)(=O)O,,,,,,
5836,105837,"1H-Pyrrole-2,5-dione, potassium silver(1+) salt (2:1:1)",C1=CC(=O)N=C1[O-].C1=CC(=O)N=C1[O-].[K+].[Ag+],,,,,,
5837,105838,Methyloctadecyldiethoxysilane,CCCCCCCCCCCCCCCCCC[Si](C)(OCC)OCC,,,,,,
5838,105839,Azidotrihexylsilane,CCCCCC[Si](CCCCCC)(CCCCCC)N=[N+]=[N-],,,,,,
5839,105840,"2-Cyclohexene-1-octanoic acid, 5-carboxy-4-hexyl-, compd. with 2,2',2''-nitrilotris(ethanol) (1:2)",CCCCCCC1C=CC(CC1C(=O)O)CCCCCCCC(=O)O.C(CO)N(CCO)CCO.C(CO)N(CCO)CCO,,,,,,
5840,105841,5-Carboxy-4-hexyl-2-cyclohexene-1-octanoic acid,CCCCCCC1C=CC(CC1C(=O)O)CCCCCCCC(=O)O,,,,,,
5841,105842,"Silanamine, 1,1-dichloro-1-ethyl-N,N-dimethyl-",CC[Si](N(C)C)(Cl)Cl,,,,,,
5842,105843,"p-(2,2-Diethoxyethyl)cumene",CCOC(CC1=CC=C(C=C1)C(C)C)OCC,,,,,,
5843,105844,Maltyl butyrate,CCCC(=O)OC1=C(OC=CC1=O)C,,,,,,
5844,105845,"Difluoro(furfurylamine-Nalpha,O1)boron(1+) fluoride",B(F)(F)F.C1=COC(=C1)CN,,,,,,
5845,105846,"1,2-Epoxynonadecane",CCCCCCCCCCCCCCCCCC1CO1,,,,,,
5846,105847,"3,6,9,12,15,18-Hexaoxahentriacontan-1-ol, acetate",CCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOC(=O)C,,,,,,
5847,105848,Trimethylolethane trilaurate,CCCCCCCCCCCC(=O)OCC(C)(COC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC,,,,,,
5848,105849,"9-Octadecenoic acid (9Z)-, 1-[(acetyloxy)methyl]-1,2-ethanediyl ester",CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)C)OC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
5849,105850,"Phosphoric acid, diethyl ester, compd. with N,N-dimethyl-1-octadecanamine (1:1)",CCCCCCCCCCCCCCCCCCN(C)C.CCOP(=O)(O)OCC,,,,,,
5850,105851,"Phosphoric acid, diethyl ester, compd. with N-methyl-N-octadecyl-1-octadecanamine (1:1)",CCCCCCCCCCCCCCCCCCN(C)CCCCCCCCCCCCCCCCCC.CCOP(=O)(O)OCC,,,,,,
5851,105852,"Phosphoric acid, diethyl ester, compd. with 2,2'-(octadecylimino)bis[ethanol] (1:1)",CCCCCCCCCCCCCCCCCCN(CCO)CCO.CCOP(=O)(O)OCC,,,,,,
5852,105853,"Phosphoric acid, monoethyl ester, compd. with 2,2'-(octadecylimino)bis(ethanol) (1:1)",CCCCCCCCCCCCCCCCCCN(CCO)CCO.CCOP(=O)(O)O,,,,,,
5853,105854,"Sulfuric acid, monoethyl ester, compd. with N-ethyl-1-octadecanamine (1:1)",CCCCCCCCCCCCCCCCCCNCC.CCOS(=O)(=O)O,,,,,,
5854,105855,Ethyl octadecyl amine,CCCCCCCCCCCCCCCCCCNCC,,,,,,
5855,105856,Pentaerythritol trilaurate,CCCCCCCCCCCC(=O)OCC(CO)(COC(=O)CCCCCCCCCCC)COC(=O)CCCCCCCCCCC,,,,,,
5856,105857,Trimethylolethane tridecanoate,CCCCCCCCCC(=O)OCC(C)(COC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC,,,,,,
5857,105858,Trimethylolethane trioctanoate,CCCCCCCC(=O)OCC(C)(COC(=O)CCCCCCC)COC(=O)CCCCCCC,,,,,,
5858,105859,"1-{2-[(2-Cyanoethyl)(icosanoyl)amino]ethyl}-1-methyl-2-nonadecyl-4,5-dihydro-1h-imidazol-1-ium methyl sulfate",CCCCCCCCCCCCCCCCCCCC1=NCC[N+]1(C)CCN(CCC#N)C(=O)CCCCCCCCCCCCCCCCCCC.COS(=O)(=O)[O-],,,,,,
5859,105860,"1-[2-[(2-Cyanoethyl)(1-oxoicosyl)amino]ethyl]-4,5-dihydro-1-methyl-2-nonadecyl-1H-imidazol-1-ium",CCCCCCCCCCCCCCCCCCCC1=NCC[N+]1(C)CCN(CCC#N)C(=O)CCCCCCCCCCCCCCCCCCC,,,,,,
5860,105861,"1-{2-[(2-Cyanoethyl)(dodecanoyl)amino]ethyl}-1-methyl-2-undecyl-4,5-dihydro-1h-imidazol-1-ium methyl sulfate",CCCCCCCCCCCC1=NCC[N+]1(C)CCN(CCC#N)C(=O)CCCCCCCCCCC.COS(=O)(=O)[O-],,,,,,
5861,105862,"1-[2-[(2-Cyanoethyl)(1-oxododecyl)amino]ethyl]-4,5-dihydro-1-methyl-2-undecyl-1H-imidazol-1-ium",CCCCCCCCCCCC1=NCC[N+]1(C)CCN(CCC#N)C(=O)CCCCCCCCCCC,,,,,,
5862,105863,"1-{2-[(2-Cyanoethyl)(docosanoyl)amino]ethyl}-1-ethyl-2-henicosyl-4,5-dihydro-1h-imidazol-1-ium ethyl sulfate",CCCCCCCCCCCCCCCCCCCCCC1=NCC[N+]1(CC)CCN(CCC#N)C(=O)CCCCCCCCCCCCCCCCCCCCC.CCOS(=O)(=O)[O-],,,,,,
5863,105864,"1-[2-[(2-Cyanoethyl)(1-oxodocosyl)amino]ethyl]-1-ethyl-2-henicosyl-4,5-dihydro-1H-imidazol-1-ium",CCCCCCCCCCCCCCCCCCCCCC1=NCC[N+]1(CC)CCN(CCC#N)C(=O)CCCCCCCCCCCCCCCCCCCCC,,,,,,
5864,105865,"1H-Imidazolium, 1-(2-((2-cyanoethyl)(1-oxooctadecyl)amino)ethyl)-1-ethyl-2-heptadecyl-4,5-dihydro-, ethyl sulfate",CCCCCCCCCCCCCCCCCC1=NCC[N+]1(CC)CCN(CCC#N)C(=O)CCCCCCCCCCCCCCCCC.CCOS(=O)(=O)[O-],,,,,,
5865,105866,"1-[2-[(2-Cyanoethyl)(1-oxooctadecyl)amino]ethyl]-1-ethyl-2-heptadecyl-4,5-dihydro-1H-imidazol-1-ium",CCCCCCCCCCCCCCCCCC1=NCC[N+]1(CC)CCN(CCC#N)C(=O)CCCCCCCCCCCCCCCCC,,,,,,
5866,105867,"Thiazolium, 3-ethyl-2-[3-(3-ethyl-2-thiazolidinylidene)-1-propenyl]-4,5-dihydro-, salt with 4-methylbenzenesulfonic acid (1:1)",CCN1CCSC1=CC=CC2=[N+](CCS2)CC.CC1=CC=C(C=C1)S(=O)(=O)[O-],,,,,,
5867,105868,"Spiro[cyclohexane-1,2'-[1,3]dioxolo[4,5-f]benzothiazole], 6'-methyl-",CC1=NC2=CC3=C(C=C2S1)OC4(O3)CCCCC4,,,,,,
5868,105869,"Spiro[1,3-benzodioxole-2,1'-cyclohexane], 5,5''-dithiobis[6-nitro-",C1CCC2(CC1)OC3=C(O2)C=C(C(=C3)[N+](=O)[O-])SSC4=CC5=C(C=C4[N+](=O)[O-])OC6(O5)CCCCC6,,,,,,
5869,105870,CID 105870,C1=CC(=CC=C1NN=C2C(=O)C=CC(=NNC3=C(C(=CC(=C3)S(=O)(=O)[O-])N=NC4=C(C=C(C=C4)N)N)O)C2=O)N=NC5=CC(=C(C=C5)O)C(=O)[O-].[Na+].[Na+],,,,,,
5870,105871,CID 105871,C1=CC(=CC=C1NN=C2C(=O)C=CC(=NNC3=C(C(=CC(=C3)S(=O)(=O)O)N=NC4=C(C=C(C=C4)N)N)O)C2=O)N=NC5=CC(=C(C=C5)O)C(=O)O,,,,,,
5871,105872,Diisotridecyl phenyl phosphite,CC(C)CCCCCCCCCCOP(OCCCCCCCCCCC(C)C)OC1=CC=CC=C1,,,,,,
5872,105873,"9,12-Octadecadienoic acid (9Z,12Z)-, isooctyl ester",CCCCCC=CCC=CCCCCCCCC(=O)OCCCCCC(C)C,,,,,,
5873,105874,CID 105874,CCCCCCCCCC(=O)OCC[S-].CCCCCCCCCC(=O)OCC[S-].C[Sn]C,,,,,,
5874,105875,2-Mercaptoethyl decanoate,CCCCCCCCCC(=O)OCCS,,,,,,
5875,105876,CID 105876,CCCCCCCC(=O)OCC[S-].CCCCCCCC(=O)OCC[S-].CCCC[Sn]CCCC,,,,,,
5876,105877,"beta-Alanine, N,N'-1,2-ethanediylbis[N-(2-carboxyethyl)-, tetrasodium salt",C(CN(CCC(=O)[O-])CCN(CCC(=O)[O-])CCC(=O)[O-])C(=O)[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
5877,105878,Ethylenediaminetetrapropionic acid,C(CN(CCC(=O)O)CCN(CCC(=O)O)CCC(=O)O)C(=O)O,,,,,,
5878,105879,"Bis(2-mercaptoethyl) 3,3'-thiodipropionate",C(CSCCC(=O)OCCS)C(=O)OCCS,,,,,,
5879,105880,"8-Oxa-3,5-dithia-4-stannaundecan-1-ol, 4-methyl-9-oxo-4-[[2-(1-oxopropoxy)ethyl]thio]-, propanoate",CCC(=O)OCCS[Sn](C)(SCCOC(=O)CC)SCCOC(=O)CC,,,,,,
5880,105881,"Ethanol, 2-mercapto-, 1-propanoate",CCC(=O)OCCS,,,,,,
5881,105882,CID 105882,CCCC[Sn]CCCC.CC(=O)OCC[S-].CC(=O)OCC[S-],,,,,,
5882,105883,CID 105883,CC(=O)OCC[S-].CC(=O)OCC[S-].C[Sn]C,,,,,,
5883,105884,CID 105884,CCCC[Sn]CCCC.CCC(=O)OCC[S-].CCC(=O)OCC[S-],,,,,,
5884,105885,Butyltintris[2-(decanoyloxy)ethylmercaptide],CCCCCCCCCC(=O)OCCS[Sn](CCCC)(SCCOC(=O)CCCCCCCCC)SCCOC(=O)CCCCCCCCC,,,,,,
5885,105886,CID 105886,CON(S(=O)(=O)O)S(=O)(=O)[O-].[Na+],,,,,,
5886,105887,Methoxy(sulfo)sulfamic acid,CON(S(=O)(=O)O)S(=O)(=O)O,,,,,,
5887,105888,3-(4-((2-Bromo-6-chloro-4-nitrophenyl)azo)-N-(2-hydroxyethyl)-m-toluidino)propionitrile,CC1=C(C=CC(=C1)N(CCC#N)CCO)N=NC2=C(C=C(C=C2Br)[N+](=O)[O-])Cl,,,,,,
5888,105889,"3-[2-Chloro-4-[(2,6-dichloro-4-nitrophenyl)azo]anilino]propiononitrile",C1=CC(=C(C=C1N=NC2=C(C=C(C=C2Cl)[N+](=O)[O-])Cl)Cl)NCCC#N,,,,,,
5889,105890,CID 105890,C1=CC(=CC(=C1)S(=O)(=O)[O-])N=NC2=CC=C(C=C2)NC(=O)NC3=CC=C(C=C3)N=NC4=CC(=C(C=C4)O)C(=O)[O-].[Na+].[Na+],,,,,,
5890,105891,Disodium 5-((4-((((4-((3-carboxylato-4-hydroxyphenyl)azo)phenyl)amino)carbonyl)amino)phenyl)azo)-3-methylsalicylate,CC1=CC(=CC(=C1O)C(=O)[O-])N=NC2=CC=C(C=C2)NC(=O)NC3=CC=C(C=C3)N=NC4=CC(=C(C=C4)O)C(=O)[O-].[Na+].[Na+],,,,,,
5891,105892,5-({4-[({4-[(3-Carboxy-4-hydroxyphenyl)diazenyl]phenyl}carbamoyl)amino]phenyl}diazenyl)-2-hydroxy-3-methylbenzoic acid,CC1=CC(=CC(=C1O)C(=O)O)N=NC2=CC=C(C=C2)NC(=O)NC3=CC=C(C=C3)N=NC4=CC(=C(C=C4)O)C(=O)O,,,,,,
5892,105893,Trimethyl[2-oxo-2-[[3-(triethoxysilyl)propyl]amino]ethyl]ammonium iodide,CCO[Si](CCCNC(=O)C[N+](C)(C)C)(OCC)OCC.[I-],,,,,,
5893,105894,"N,N,N-Trimethyl-2-oxo-2-[[3-(triethoxysilyl)propyl]amino]ethanaminium",CCO[Si](CCCNC(=O)C[N+](C)(C)C)(OCC)OCC,,,,,,
5894,105895,"Toluene-2,3-dicarbamic acid, bis(2-(dimethylamino)ethyl) ester",CC1=C(C(=CC=C1)NC(=O)OCCN(C)C)NC(=O)OCCN(C)C,,,,,,
5895,105896,Methyl 2-(decylideneamino)benzoate,CCCCCCCCCC=NC1=CC=CC=C1C(=O)OC,,,,,,
5896,105897,"Benzene, (2,2-dimethoxyethoxy)-",COC(COC1=CC=CC=C1)OC,,,,,,
5897,105898,"2,6-Octadien-1-ol, 3,7-dimethyl-, 2-aminobenzoate, (2E)-",CC(=CCCC(=CCOC(=O)C1=CC=CC=C1N)C)C,,,,,,
5898,105899,"Acetamide, N-(2-((2,4-dinitrophenyl)azo)-5-((2-hydroxy-3-phenoxypropyl)amino)-4-methoxyphenyl)-",CC(=O)NC1=CC(=C(C=C1N=NC2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-])OC)NCC(COC3=CC=CC=C3)O,,,,,,
5899,105900,4-tert-Amylcyclohexyl formate,CCC(C)(C)C1CCC(CC1)OC=O,,,,,,
5900,105901,"4-(1,1-Dimethylpropyl)cyclohexyl propionate",CCC(=O)OC1CCC(CC1)C(C)(C)CC,,,,,,
5901,105902,4-Allyl-5-(tert-butyl)-2-methoxyphenol,CC(C)(C)C1=CC(=C(C=C1CC=C)OC)O,,,,,,
5902,105903,"10-Undecenoic acid, 4-methylphenyl ester",CC1=CC=C(C=C1)OC(=O)CCCCCCCCC=C,,,,,,
5903,105904,"3,5,7-Triaza-1-azoniatricyclo(3.3.1.13,7)decane, 1-(1,3-benzodioxol-5-ylmethyl)-, chloride (1:1)",C1N2CN3CN1C[N+](C2)(C3)CC4=CC5=C(C=C4)OCO5.[Cl-],,,,,,
5904,105905,"1-(1,3-Benzodioxol-5-ylmethyl)-3,5,7-triaza-1-azoniatricyclo[3.3.1.13,7]decane",C1N2CN3CN1C[N+](C2)(C3)CC4=CC5=C(C=C4)OCO5,,,,,,
5905,105906,CID 105906,CC(C)(CO)N(C)C.C(=CC(=O)O)C(=O)O,,,,,,
5906,105907,"1(3H)-Isobenzofuranone, 3,3-bis(4-hydroxyphenyl)-, compd. with 2-(diethylamino)ethanol (1:1)",CCN(CC)CCO.C1=CC=C2C(=C1)C(=O)OC2(C3=CC=C(C=C3)O)C4=CC=C(C=C4)O,,,,,,
5907,105908,"4-((2,6-Dichloro-4-nitrophenyl)azo)-N,N-diethylaniline",CCN(CC)C1=CC=C(C=C1)N=NC2=C(C=C(C=C2Cl)[N+](=O)[O-])Cl,,,,,,
5908,105909,CID 105909,CCOC1=CC=C(C=C1)N=NC2=CC(=C(C=C2OC)N=NC3=CC=C(C=C3)S(=O)(=O)[O-])OC.[Na+],,,,,,
5909,105910,"4-({4-[(4-Ethoxyphenyl)diazenyl]-2,5-dimethoxyphenyl}diazenyl)benzene-1-sulfonic acid",CCOC1=CC=C(C=C1)N=NC2=CC(=C(C=C2OC)N=NC3=CC=C(C=C3)S(=O)(=O)O)OC,,,,,,
5910,105911,CID 105911,CCN(CCCS(=O)(=O)[O-])C1=CC(=C(C=C1)N=NC2=NC3=CC=CC=C3S2)C.[Na+],,,,,,
5911,105912,3-[[4-[(Benzothiazol-2-yl)azo]-3-methylphenyl]ethylamino]-1-propanesulfonic acid,CCN(CCCS(=O)(=O)O)C1=CC(=C(C=C1)N=NC2=NC3=CC=CC=C3S2)C,,,,,,
5912,105913,CID 105913,CCN(CCCS(=O)(=O)[O-])C1=CC=C(C=C1)N=NC2=C(C=CC(=C2)Cl)Cl.[Na+],,,,,,
5913,105914,"3-[4-[(2,5-dichlorophenyl)diazenyl]-N-ethylanilino]propane-1-sulfonic acid",CCN(CCCS(=O)(=O)O)C1=CC=C(C=C1)N=NC2=C(C=CC(=C2)Cl)Cl,,,,,,
5914,105915,"Acetamide, N-[5-[bis(2-cyanoethyl)amino]-2-[(2-bromo-4,6-dinitrophenyl)azo]-4-methoxyphenyl]-",CC(=O)NC1=CC(=C(C=C1N=NC2=C(C=C(C=C2Br)[N+](=O)[O-])[N+](=O)[O-])OC)N(CCC#N)CCC#N,,,,,,
5915,105916,"2-Anthracenesulfonic acid, 1-amino-4-[[4-[(chloroacetyl)amino]-3-sulfophenyl]amino]-9,10-dihydro-9,10-dioxo-, disodium salt",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3NC4=CC(=C(C=C4)NC(=O)CCl)S(=O)(=O)[O-])S(=O)(=O)[O-])N.[Na+].[Na+],,,,,,
5916,105917,"1-Amino-4-[4-[(2-chloroacetyl)amino]-3-sulfoanilino]-9,10-dioxoanthracene-2-sulfonic acid",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3NC4=CC(=C(C=C4)NC(=O)CCl)S(=O)(=O)O)S(=O)(=O)O)N,,,,,,
5917,105918,CID 105918,C1=CC=C(C=C1)NC2=C3C(=C(C=C2)N=NC4=CC(=CC=C4)Cl)C=CC=C3S(=O)(=O)[O-].[Na+],,,,,,
5918,105919,8-Anilino-5-[(3-chlorophenyl)diazenyl]naphthalene-1-sulfonic acid,C1=CC=C(C=C1)NC2=C3C(=C(C=C2)N=NC4=CC(=CC=C4)Cl)C=CC=C3S(=O)(=O)O,,,,,,
5919,105920,CID 105920,CC1=NN(C(=O)C1N=NC2=C(C3=CC=CC=C3C=C2)S(=O)(=O)[O-])C4=CC=CC=C4Cl.[K+],,,,,,
5920,105921,"2-{[1-(2-Chlorophenyl)-3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-4-yl]diazenyl}naphthalene-1-sulfonic acid",CC1=NN(C(=O)C1N=NC2=C(C3=CC=CC=C3C=C2)S(=O)(=O)O)C4=CC=CC=C4Cl,,,,,,
5921,105922,CID 105922,CC1=CC=CC=C1N=NC2=C3C=C(C=CC3=C(C=C2)N=NC4=CC=C(C=C4)N(CCO)CCO)S(=O)(=O)[O-].[Na+],,,,,,
5922,105923,5-({4-[Bis(2-hydroxyethyl)amino]phenyl}diazenyl)-8-[(2-methylphenyl)diazenyl]naphthalene-2-sulfonic acid,CC1=CC=CC=C1N=NC2=C3C=C(C=CC3=C(C=C2)N=NC4=CC=C(C=C4)N(CCO)CCO)S(=O)(=O)O,,,,,,
5923,105924,"1-Naphthalenediazonium, 4-((m-sulfophenyl)azo)-, chloride",C1=CC=C2C(=C1)C=CC=C2N=NC3=CC(=CC(=C3)S(=O)(=O)O)[N+]#N.[Cl-],,,,,,
5924,105925,3-(Naphthalen-1-yldiazenyl)-5-sulfobenzenediazonium,C1=CC=C2C(=C1)C=CC=C2N=NC3=CC(=CC(=C3)S(=O)(=O)O)[N+]#N,,,,,,
5925,105926,"Benzenesulfonic acid, 3,3'-[carbonylbis[imino(5-methoxy-2-methyl-4,1-phenylene)azo]]bis-, disodium salt",CC1=CC(=C(C=C1N=NC2=CC(=CC=C2)S(=O)(=O)[O-])OC)NC(=O)NC3=C(C=C(C(=C3)C)N=NC4=CC(=CC=C4)S(=O)(=O)[O-])OC.[Na+].[Na+],,,,,,
5926,105927,3-[[5-Methoxy-4-[[2-methoxy-5-methyl-4-[(3-sulfophenyl)diazenyl]phenyl]carbamoylamino]-2-methylphenyl]diazenyl]benzenesulfonic acid,CC1=CC(=C(C=C1N=NC2=CC(=CC=C2)S(=O)(=O)O)OC)NC(=O)NC3=C(C=C(C(=C3)C)N=NC4=CC(=CC=C4)S(=O)(=O)O)OC,,,,,,
5927,105928,"Disodium 6-[(e)-{4-[(e)-(4-ethoxyphenyl)diazenyl]phenyl}diazenyl]naphthalene-1,3-disulfonate",CCOC1=CC=C(C=C1)N=NC2=CC=C(C=C2)N=NC3=CC4=CC(=CC(=C4C=C3)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
5928,105929,"6-[[4-[(4-Ethoxyphenyl)diazenyl]phenyl]diazenyl]naphthalene-1,3-disulfonic acid",CCOC1=CC=C(C=C1)N=NC2=CC=C(C=C2)N=NC3=CC4=CC(=CC(=C4C=C3)S(=O)(=O)O)S(=O)(=O)O,,,,,,
5929,105930,Sodium 8-anilino-5-[(2-chloro-4-nitrophenyl)azo]naphthalene-1-sulphonate,C1=CC=C(C=C1)NC2=C3C(=C(C=C2)N=NC4=C(C=C(C=C4)[N+](=O)[O-])Cl)C=CC=C3S(=O)(=O)[O-].[Na+],,,,,,
5930,105931,8-Anilino-5-[(2-chloro-4-nitrophenyl)diazenyl]naphthalene-1-sulfonic acid,C1=CC=C(C=C1)NC2=C3C(=C(C=C2)N=NC4=C(C=C(C=C4)[N+](=O)[O-])Cl)C=CC=C3S(=O)(=O)O,,,,,,
5931,105932,"Tetrasodium;2-[4-[2-(4-amino-2-sulfonatophenyl)ethenyl]-3-sulfonatophenyl]benzo[e]benzotriazole-6,8-disulfonate",C1=CC(=C(C=C1N)S(=O)(=O)[O-])C=CC2=C(C=C(C=C2)N3N=C4C=CC5=C(C4=N3)C=C(C=C5S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
5932,105933,"2-[4-[2-(4-Amino-2-sulfophenyl)ethenyl]-3-sulfophenyl]benzo[e]benzotriazole-6,8-disulfonic acid",C1=CC(=C(C=C1N)S(=O)(=O)O)C=CC2=C(C=C(C=C2)N3N=C4C=CC5=C(C4=N3)C=C(C=C5S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
5933,105934,"9,10-Anthracenedione, 1-amino-4-hydroxy-2-(4-pentylphenoxy)-",CCCCCC1=CC=C(C=C1)OC2=C(C3=C(C(=C2)O)C(=O)C4=CC=CC=C4C3=O)N,,,,,,
5934,105935,CID 105935,CC1=CC(=C(C=C1)O)N=NC2=CC=C(C3=CC=CC=C32)N=NC4=CC(=CC=C4)S(=O)(=O)[O-].[Na+],,,,,,
5935,105936,"Benzenesulfonic acid, 3-[[4-[(2-hydroxy-5-methylphenyl)azo]-1-naphthalenyl]azo]-",CC1=CC(=C(C=C1)O)N=NC2=CC=C(C3=CC=CC=C32)N=NC4=CC(=CC=C4)S(=O)(=O)O,,,,,,
5936,105937,"Benzenediazonium, 2-methoxy-4-((2-methoxy-5-sulfophenyl)azo)-5-methyl-, chloride",CC1=CC(=C(C=C1N=NC2=C(C=CC(=C2)S(=O)(=O)O)OC)OC)[N+]#N.[Cl-],,,,,,
5937,105938,2-Methoxy-4-[(2-methoxy-5-sulfophenyl)diazenyl]-5-methylbenzenediazonium,CC1=CC(=C(C=C1N=NC2=C(C=CC(=C2)S(=O)(=O)O)OC)OC)[N+]#N,,,,,,
5938,105939,CID 105939,CC1=C(C(=C(C=C1)N)OC)N=NC2=CC(=C(C=C2)C=CC3=C(C=C(C=C3)N4N=C5C=CC6=C(C5=N4)C=C(C=C6S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
5939,105940,CID 105940,CC1=C(C(=C(C=C1)N)OC)N=NC2=CC(=C(C=C2)C=CC3=C(C=C(C=C3)N4N=C5C=CC6=C(C5=N4)C=C(C=C6S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
5940,105941,CID 105941,C1=CC(=CC=C1N)N=NC2=C(C=CC(=C2)S(=O)(=O)[O-])Cl.[Na+],,,,,,
5941,105942,"Benzenesulfonic acid, 3-[(4-aminophenyl)azo]-4-chloro-",C1=CC(=CC=C1N)N=NC2=C(C=CC(=C2)S(=O)(=O)O)Cl,,,,,,
5942,105943,"Benzoic acid, 2-[(2-amino-5-hydroxy-7-sulfo-1-naphthalenyl)azo]-5-nitro-, disodium salt",C1=CC(=C(C=C1[N+](=O)[O-])C(=O)O)N=NC2=C3C=CC(=CC3=C(C=C2N)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
5943,105944,2-[(2-Amino-4-hydroxy-6-sulfonaphthalen-1-yl)diazenyl]-5-nitrobenzoic acid,C1=CC(=C(C=C1[N+](=O)[O-])C(=O)O)N=NC2=C3C=CC(=CC3=C(C=C2N)O)S(=O)(=O)O,,,,,,
5944,105945,"1,3-Naphthalenedisulfonic acid, 6-((p-aminophenyl)azo)-, disodium salt",C1=CC(=CC=C1N)N=NC2=CC3=CC(=CC(=C3C=C2)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
5945,105946,"6-[(4-Aminophenyl)diazenyl]naphthalene-1,3-disulfonic acid",C1=CC(=CC=C1N)N=NC2=CC3=CC(=CC(=C3C=C2)S(=O)(=O)O)S(=O)(=O)O,,,,,,
5946,105947,CID 105947,C1=CC(=CC=C1C(=O)NC2=CC(=C(C=C2)NC(=O)C3=CC=C(C=C3)N)S(=O)(=O)[O-])N.[Na+],,,,,,
5947,105948,"2,5-Bis[(4-aminobenzoyl)amino]benzenesulfonic acid",C1=CC(=CC=C1C(=O)NC2=CC(=C(C=C2)NC(=O)C3=CC=C(C=C3)N)S(=O)(=O)O)N,,,,,,
5948,105949,CID 105949,CC1=NN(C(=O)C1N=NC2=CC=C(C=C2)O)C3=CC(=C(C=C3Cl)S(=O)(=O)[O-])Cl.[Na+],,,,,,
5949,105950,"2,5-dichloro-4-[4-[(4-hydroxyphenyl)diazenyl]-3-methyl-5-oxo-4H-pyrazol-1-yl]benzenesulfonic acid",CC1=NN(C(=O)C1N=NC2=CC=C(C=C2)O)C3=CC(=C(C=C3Cl)S(=O)(=O)O)Cl,,,,,,
5950,105951,"1,5-Naphthalenedisulfonic acid, 3-[(4-amino-5-methoxy-2-methylphenyl)azo]-, disodium salt",CC1=CC(=C(C=C1N=NC2=CC3=C(C=CC=C3S(=O)(=O)[O-])C(=C2)S(=O)(=O)[O-])OC)N.[Na+].[Na+],,,,,,
5951,105952,"1,5-Naphthalenedisulfonic acid, 3-[(4-amino-5-methoxy-2-methylphenyl)azo]-",CC1=CC(=C(C=C1N=NC2=CC3=C(C=CC=C3S(=O)(=O)O)C(=C2)S(=O)(=O)O)OC)N,,,,,,
5952,105953,4-(Phenylazo)naphthalene-1-diazonium chloride,C1=CC=C(C=C1)N=NC2=CC=C(C3=CC=CC=C32)[N+]#N.[Cl-],,,,,,
5953,105954,4-(Phenylazo)-1-naphthalenediazonium,C1=CC=C(C=C1)N=NC2=CC=C(C3=CC=CC=C32)[N+]#N,,,,,,
5954,105955,"1-Naphthalenediazonium, 6-sulfo-4-((p-sulfophenyl)azo)-, chloride",C1=CC(=CC=C1N=NC2=C3C=C(C=CC3=C(C=C2)[N+]#N)S(=O)(=O)O)S(=O)(=O)O.[Cl-],,,,,,
5955,105956,6-Sulfo-4-[(4-sulfophenyl)azo]-1-naphthalenediazonium,C1=CC(=CC=C1N=NC2=C3C=C(C=CC3=C(C=C2)[N+]#N)S(=O)(=O)O)S(=O)(=O)O,,,,,,
5956,105957,"Benzenediazonium, 2,5-dimethoxy-4-((4-sulfophenyl)azo)-, chloride",COC1=CC(=C(C=C1N=NC2=CC=C(C=C2)S(=O)(=O)O)OC)[N+]#N.[Cl-],,,,,,
5957,105958,"2,5-Dimethoxy-4-[(4-sulfophenyl)diazenyl]benzenediazonium",COC1=CC(=C(C=C1N=NC2=CC=C(C=C2)S(=O)(=O)O)OC)[N+]#N,,,,,,
5958,105959,"Poly(oxy-1,2-ethanediyl), alpha,alpha'-((hexylimino)di-2,1-ethanediyl)bis(omega-hydroxy-",C(CCC=NCCOCCO)CC=NCCOCCO,,,,,,
5959,105960,Phenylditolylmethane,CC1=CC=CC=C1C(C2=CC=CC=C2)C3=CC=CC=C3C,,,,,,
5960,105961,"1-(2-Carboxylatoethyl)-2-(heptadec-8-enyl)-4,5-dihydro-1-(2-hydroxyethyl)-1H-imidazolium",CCCCCCCCC=CCCCCCCCC1=NCC[N+]1(CCC(=O)[O-])CCO,,,,,,
5961,105962,"1-(2-Carboxyethyl)-2-(heptadec-8-en-1-yl)-1-(2-hydroxyethyl)-4,5-dihydro-1H-imidazol-1-ium",CCCCCCCCC=CCCCCCCCC1=NCC[N+]1(CCC(=O)O)CCO,,,,,,
5962,105963,"Benzenesulfonic acid, 3-chloro-4-ethyl-5-[(2-hydroxy-1-naphthalenyl)azo]-, barium salt (2:1)",CCC1=C(C=C(C=C1Cl)S(=O)(=O)[O-])N=NC2=C(C=CC3=CC=CC=C32)O.CCC1=C(C=C(C=C1Cl)S(=O)(=O)[O-])N=NC2=C(C=CC3=CC=CC=C32)O.[Ba+2],,,,,,
5963,105964,3-Chloro-4-ethyl-5-[(2-hydroxynaphthalen-1-yl)diazenyl]benzenesulfonic acid,CCC1=C(C=C(C=C1Cl)S(=O)(=O)O)N=NC2=C(C=CC3=CC=CC=C32)O,,,,,,
5964,105965,CID 105965,CC1=C(C=C(C=C1Cl)S(=O)(=O)[O-])N=NC2=C(C(=CC3=CC=CC=C32)C(=O)[O-])O.[Sr+2],,,,,,
5965,105966,4-[(3-Chloro-2-methyl-5-sulfophenyl)azo]-3-hydroxy-2-naphthalenecarboxylic acid,CC1=C(C=C(C=C1Cl)S(=O)(=O)O)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)O)O,,,,,,
5966,105967,CID 105967,CC1=C(C=C(C=C1Cl)S(=O)(=O)[O-])N=NC2=C(C(=CC3=CC=CC=C32)C(=O)[O-])O.[Ca+2],,,,,,
5967,105968,CID 105968,CC1=C(C=C(C=C1Cl)S(=O)(=O)[O-])N=NC2=C(C(=CC3=CC=CC=C32)C(=O)[O-])O.[Ba+2],,,,,,
5968,105969,"Anthra[2,1,9-def:6,5,10-d'e'f']diisoquinoline-1,3,8,10(2H,9H)-tetrone, 2-methyl-",CN1C(=O)C2=C3C(=CC=C4C3=C(C=C2)C5=C6C4=CC=C7C6=C(C=C5)C(=O)NC7=O)C1=O,,,,,,
5969,105970,3-Sulfophthalic acid,C1=CC(=C(C(=C1)S(=O)(=O)O)C(=O)O)C(=O)O,,,,,,
5970,105971,"Benzenesulfonic acid, 5-chloro-4-ethyl-2-nitro-",CCC1=CC(=C(C=C1Cl)S(=O)(=O)O)[N+](=O)[O-],,,,,,
5971,105972,"Benzenesulfonic acid, 3-chloro-4-ethyl-5-nitro-",CCC1=C(C=C(C=C1Cl)S(=O)(=O)O)[N+](=O)[O-],,,,,,
5972,105973,"Benzenesulfonic acid, 3-amino-5-chloro-4-ethyl-",CCC1=C(C=C(C=C1Cl)S(=O)(=O)O)N,,,,,,
5973,105974,"1,5-Naphthalenedisulfonic acid, 2-[(2-hydroxy-1-naphthalenyl)azo]-, barium salt (1:1)",C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C4=C(C=C3)C(=CC=C4)S(=O)(=O)[O-])S(=O)(=O)[O-])O.[Ba+2],,,,,,
5974,105975,"1,5-Naphthalenedisulfonic acid, 2-[(2-hydroxy-1-naphthalenyl)azo]-",C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C4=C(C=C3)C(=CC=C4)S(=O)(=O)O)S(=O)(=O)O)O,,,,,,
5975,105976,CID 105976,CCC1=C(C=C(C=C1Cl)S(=O)(=O)[O-])N=NC2=C(C(=CC3=CC=CC=C32)C(=O)[O-])O.[Ca+2],,,,,,
5976,105977,4-[(3-Chloro-2-ethyl-5-sulfophenyl)azo]-3-hydroxy-2-naphthalenecarboxylic acid,CCC1=C(C=C(C=C1Cl)S(=O)(=O)O)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)O)O,,,,,,
5977,105978,"Benzenesulfonic acid, 3-chloro-5-[(2-hydroxy-1-naphthalenyl)azo]-4-methyl-, barium salt (2:1)",CC1=C(C=C(C=C1Cl)S(=O)(=O)[O-])N=NC2=C(C=CC3=CC=CC=C32)O.CC1=C(C=C(C=C1Cl)S(=O)(=O)[O-])N=NC2=C(C=CC3=CC=CC=C32)O.[Ba+2],,,,,,
5978,105979,3-Chloro-5-[(2-hydroxynaphthalen-1-yl)diazenyl]-4-methylbenzenesulfonic acid,CC1=C(C=C(C=C1Cl)S(=O)(=O)O)N=NC2=C(C=CC3=CC=CC=C32)O,,,,,,
5979,105980,Tetrakis[(phosphonooxy)methyl]urea,C(N(COP(=O)(O)O)C(=O)N(COP(=O)(O)O)COP(=O)(O)O)OP(=O)(O)O,,,,,,
5980,105981,Dichlorodocosylmethylsilane,CCCCCCCCCCCCCCCCCCCCCC[Si](C)(Cl)Cl,,,,,,
5981,105982,"2,2-Bis(4-(3,4-dicarboxyphenoxy)phenyl)propane, tetrasodium salt",CC(CC1=CC=C(C=C1)OC2=CC(=C(C=C2)C(=O)[O-])C(=O)[O-])C3=CC=C(C=C3)OC4=CC(=C(C=C4)C(=O)[O-])C(=O)[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
5982,105983,"4-[4-[2-[4-(3,4-Dicarboxyphenoxy)phenyl]propyl]phenoxy]phthalic acid",CC(CC1=CC=C(C=C1)OC2=CC(=C(C=C2)C(=O)O)C(=O)O)C3=CC=C(C=C3)OC4=CC(=C(C=C4)C(=O)O)C(=O)O,,,,,,
5983,105984,Dihydrogen (4-hydroxy-3-((2-hydroxy-4-((2-(sulphooxy)ethyl)sulphonyl)phenyl)azo)naphthalene-1-sulphonato(4-))cuprate(2-),C1=CC=C2C(=C1)C(=CC(=C2[O-])N=NC3=C(C=C(C=C3)S(=O)(=O)CCOS(=O)(=O)O)[O-])S(=O)(=O)O.[Cu+2],,,,,,
5984,105985,4-Hydroxy-3-[[2-hydroxy-4-(2-sulfooxyethylsulfonyl)phenyl]diazenyl]naphthalene-1-sulfonic acid,C1=CC=C2C(=C1)C(=CC(=C2O)N=NC3=C(C=C(C=C3)S(=O)(=O)CCOS(=O)(=O)O)O)S(=O)(=O)O,,,,,,
5985,105986,Diethoxydivinylsilane,CCO[Si](C=C)(C=C)OCC,,,,,,
5986,105987,"Bicyclo[2.2.1]hept-2-ene, 6-ethenyl-2-methyl-",CC1=CC2CC(C1C2)C=C,,,,,,
5987,105988,"Naphtho(2,1-d)thiazolium, 2-methyl-3-(3-sulfopropyl)-, inner salt",CC1=[N+](C2=C(S1)C3=CC=CC=C3C=C2)CCCS(=O)(=O)[O-],,,,,,
5988,105989,"3-(2-Methylbenzo[g][1,3]benzothiazol-3-ium-3-yl)propane-1-sulfonic acid",CC1=[N+](C2=C(S1)C3=CC=CC=C3C=C2)CCCS(=O)(=O)O,,,,,,
5989,105990,"1,3-Dimethyl-1H-imidazo(4,5-b)quinoxalinium toluene-p-sulphonate",CC1=CC=C(C=C1)S(=O)(=O)[O-].CN1C=NC2=[N+](C3=CC=CC=C3N=C21)C,,,,,,
5990,105991,"1,4-Dimethylimidazo[4,5-b]quinoxalin-4-ium",CN1C=NC2=[N+](C3=CC=CC=C3N=C21)C,,,,,,
5991,105992,"beta-Alanine, N-(2-cyanoethyl)-N-phenyl-, methyl ester",COC(=O)CCN(CCC#N)C1=CC=CC=C1,,,,,,
5992,105993,"Benzenesulfonamide, 3-hydroxy-4-[[2-hydroxy-8-[(methylsulfonyl)amino]-1-naphthalenyl]azo]-",CS(=O)(=O)NC1=CC=CC2=C1C(=C(C=C2)O)N=NC3=C(C=C(C=C3)S(=O)(=O)N)O,,,,,,
5993,105994,Tetrahydrofurfuryl pentaethylene glycol acrylate,C=CC(=O)OCCOCCOCCOCCOCCOCC1CCCO1,,,,,,
5994,105995,"2-Propenoic acid, 1,3,5-triazine-2,4,6-triyltri-2,1-ethanediyl ester",C=CC(=O)OCCC1=NC(=NC(=N1)CCOC(=O)C=C)CCOC(=O)C=C,,,,,,
5995,105996,"Cyclohexanol, 1-methyl-4-(1-methylethenyl)-, formate",CC(=C)C1CCC(CC1)(C)OC=O,,,,,,
5996,105997,1-Methyl-4-(1-methylethylidene)cyclohexyl formate,CC(=C1CCC(CC1)(C)OC=O)C,,,,,,
5997,105998,CID 105998,COC1=CC=CC=C1N=NC2=C(C=C3C=C(C=CC3=C2[O-])NC(=O)NC4=CC5=CC(=C(C(=C5C=C4)[O-])N=NC6=C(C=CC(=C6)S(=O)(=O)[O-])O)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Cu+2],,,,,,
5998,105999,4-Hydroxy-7-[[5-hydroxy-6-[(2-hydroxy-5-sulfophenyl)diazenyl]-7-sulfonaphthalen-2-yl]carbamoylamino]-3-[(2-methoxyphenyl)diazenyl]naphthalene-2-sulfonic acid,COC1=CC=CC=C1N=NC2=C(C=C3C=C(C=CC3=C2O)NC(=O)NC4=CC5=CC(=C(C(=C5C=C4)O)N=NC6=C(C=CC(=C6)S(=O)(=O)O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
5999,106000,"Chromate(1-), diaqua(4-(4,5-dihydro-4-((2-(hydroxy-kappaO)-5-nitrophenyl)azo-kappaN1)-3-methyl-5-(oxo-kappaO)-1H-pyrazol-1-yl)benzenesulfonato(3-))hydroxy-, sodium",CC1=NN(C(=C1N=NC2=C(C=CC(=C2)[N+](=O)[O-])[O-])[O-])C3=CC=C(C=C3)S(=O)(=O)[O-].O.O.[OH-].[Na+].[Cr+3],,,,,,
6000,106001,"4-[4-[[3-(Dioxidoamino)-6-oxocyclohexa-2,4-dien-1-ylidene]hydrazinylidene]-3-methyl-5-oxopyrazol-1-yl]benzenesulfonic acid",CC1=NN(C(=O)C1=NN=C2C=C(C=CC2=O)N([O-])[O-])C3=CC=C(C=C3)S(=O)(=O)O,,,,,,
6001,106002,Dihydrogen bis(2-((2-hydroxy-1-naphthyl)azo)naphthalene-1-sulphonato(2-))magnesate(2-),C1=CC=C2C(=C1)C=CC(=C2N=NC3=CC4=CC=CC=C4C=C3S(=O)(=O)[O-])O.C1=CC=C2C(=C1)C=CC(=C2N=NC3=CC4=CC=CC=C4C=C3S(=O)(=O)[O-])O.[Mg+2],,,,,,
6002,106003,3-[(2-Hydroxynaphthalen-1-yl)diazenyl]naphthalene-2-sulfonic acid,C1=CC=C2C(=C1)C=CC(=C2N=NC3=CC4=CC=CC=C4C=C3S(=O)(=O)O)O,,,,,,
6003,106004,"Benzoic acid, 2-[(carboxymethyl)amino]-, dipotassium salt",C1=CC=C(C(=C1)C(=O)[O-])NCC(=O)[O-].[K+].[K+],,,,,,
6004,106005,CID 106005,CC1=C(C=CC(=C1)N=NN(C)CC(=O)[O-])NC(=O)C2=CC=CC=C2.[Na+],,,,,,
6005,106006,2-[[(4-Benzamido-3-methylphenyl)diazenyl]-methylamino]acetic acid,CC1=C(C=CC(=C1)N=NN(C)CC(=O)O)NC(=O)C2=CC=CC=C2,,,,,,
6006,106007,CID 106007,CCOC1=CC(=C(C=C1NC(=O)C2=CC=CC=C2)OCC)N=NN(C)CC(=O)[O-].[Na+],,,,,,
6007,106008,"[3-(4-Benzamido-2,5-diethoxyphenyl)-1-methyltriaz-2-en-1-yl]acetic acid",CCOC1=CC(=C(C=C1NC(=O)C2=CC=CC=C2)OCC)N=NN(C)CC(=O)O,,,,,,
6008,106009,"2-Naphthalenesulfonic acid, 6-amino-3-[(4-aminophenyl)azo]-4-hydroxy-",C1=CC(=CC=C1N)N=NC2=C(C=C3C=CC(=CC3=C2O)N)S(=O)(=O)O,,,,,,
6009,106010,CID 106010,CC(=O)NC1=CC=C(C=C1)N=NC2=C(C=C3C=CC(=CC3=C2O)N)S(=O)(=O)[O-].[Na+],,,,,,
6010,106011,3-[(4-Acetamidophenyl)diazenyl]-6-amino-4-hydroxynaphthalene-2-sulfonic acid,CC(=O)NC1=CC=C(C=C1)N=NC2=C(C=C3C=CC(=CC3=C2O)N)S(=O)(=O)O,,,,,,
6011,106012,CID 106012,CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=CC(=C(C=C3N)N)S(=O)(=O)[O-])C)N=NC4=CC(=C(C=C4)O)C(=O)[O-].[Na+].[Na+],,,,,,
6012,106013,"5-[[4-[4-[(2,4-Diamino-5-sulfophenyl)diazenyl]-3-methylphenyl]-2-methylphenyl]diazenyl]-2-hydroxybenzoic acid",CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=CC(=C(C=C3N)N)S(=O)(=O)O)C)N=NC4=CC(=C(C=C4)O)C(=O)O,,,,,,
6013,106014,"1,3-Naphthalenedisulfonic acid, 7-((4-aminophenyl)azo)-, disodium salt",C1=CC(=CC=C1N)N=NC2=CC3=C(C=C(C=C3C=C2)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
6014,106015,"7-((4-Aminophenyl)azo)naphthalene-1,3-disulphonic acid",C1=CC(=CC=C1N)N=NC2=CC3=C(C=C(C=C3C=C2)S(=O)(=O)O)S(=O)(=O)O,,,,,,
6015,106016,Potassium silver succinimide,C1CC(=O)N=C1[O-].C1CC(=O)N=C1[O-].[K+].[Ag+],,,,,,
6016,106017,"2,2-Dimethylpentyl methacrylate",CCCC(C)(C)COC(=O)C(=C)C,,,,,,
6017,106018,CID 106018,C1=CC=C2C(=C1)C(=C3C(=O)C=C4C(=C3C2=O)NC5=C(N4)C6=C(C=C5)C(=O)C7=CC=CC=C7C6=O)O,,,,,,
6018,106019,"9,10-Anthracenedione, 1-amino-5,8-dihydroxy-4-[(2-hydroxyethyl)amino]-",C1=CC(=C2C(=C1N)C(=O)C3=C(C=CC(=C3C2=O)O)O)NCCO,,,,,,
6019,106020,[4-[[4-(Diethylamino)-2-methylphenyl]azo]phenacyl]trimethylammonium chloride,CCN(CC)C1=CC(=C(C=C1)N=NC2=CC=C(C=C2)C(=O)C[N+](C)(C)C)C.[Cl-],,,,,,
6020,106021,"1-Propanaminium, 3,3'-[(9,10-dihydro-9,10-dioxo-1,4-anthracenediyl)diimino]bis[N,N,N-triethyl-, bis(ethyl sulfate)",CC[N+](CC)(CC)CCCNC1=C2C(=C(C=C1)NCCC[N+](CC)(CC)CC)C(=O)C3=CC=CC=C3C2=O.CCOS(=O)(=O)[O-].CCOS(=O)(=O)[O-],,,,,,
6021,106022,"3,3'-[Anthraquinone-1,4-diylbis(imino)]bis[N,N,N-triethyl-1-propaneaminium]",CC[N+](CC)(CC)CCCNC1=C2C(=C(C=C1)NCCC[N+](CC)(CC)CC)C(=O)C3=CC=CC=C3C2=O,,,,,,
6022,106023,"2-Anthracenesulfonic acid, 4-[[4-(acetylamino)phenyl]amino]-1-amino-9,10-dihydro-9,10-dioxo-, compd. with 2,2'-iminobis[ethanol] (1:1)",CC(=O)NC1=CC=C(C=C1)NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)O.C(CO)NCCO,,,,,,
6023,106024,"beta-Alanine, N-[5-(acetylamino)-4-[(2-bromo-4,6-dinitrophenyl)azo]-2-methoxyphenyl]-N-[2-(acetyloxy)ethyl]-, methyl ester",CC(=O)NC1=CC(=C(C=C1N=NC2=C(C=C(C=C2Br)[N+](=O)[O-])[N+](=O)[O-])OC)N(CCC(=O)OC)CCOC(=O)C,,,,,,
6024,106025,1-(p-Acetamidoanilino)-4-hydroxyanthraquinone,CC(=O)NC1=CC=C(C=C1)NC2=C3C(=C(C=C2)O)C(=O)C4=CC=CC=C4C3=O,,,,,,
6025,106026,"2-[N-(2-benzoyloxyethyl)-4-(1,2-dicyano-3-ethoxy-3-oxoprop-1-enyl)anilino]ethyl benzoate",CCOC(=O)C(=C(C#N)C1=CC=C(C=C1)N(CCOC(=O)C2=CC=CC=C2)CCOC(=O)C3=CC=CC=C3)C#N,,,,,,
6026,106027,Perfluorohexadecanoic acid,C(=O)(C(C(C(C(C(C(C(C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)O,,,,,,
6027,106028,CID 106028,CCC(=O)OCC[S-].CCC(=O)OCC[S-].C[Sn]C,,,,,,
6028,106029,"8-Oxa-3,5-dithia-4-stannaundecan-1-ol, 4-butyl-9-oxo-4-[[2-(1-oxopropoxy)ethyl]thio]-, propanoate",CCCC[Sn](SCCOC(=O)CC)(SCCOC(=O)CC)SCCOC(=O)CC,,,,,,
6029,106030,"2,2-Bis(hydroxymethyl)butyl 3-mercaptopropionate",CCC(CO)(CO)COC(=O)CCS,,,,,,
6030,106031,1-Triacontanol aluminum,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC[O-].CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC[O-].CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC[O-].[Al+3],,,,,,
6031,106032,"1-Octacosanol, aluminum salt",CCCCCCCCCCCCCCCCCCCCCCCCCCCC[O-].CCCCCCCCCCCCCCCCCCCCCCCCCCCC[O-].CCCCCCCCCCCCCCCCCCCCCCCCCCCC[O-].[Al+3],,,,,,
6032,106033,"1-Hexacosanol, aluminum salt",CCCCCCCCCCCCCCCCCCCCCCCCCC[O-].CCCCCCCCCCCCCCCCCCCCCCCCCC[O-].CCCCCCCCCCCCCCCCCCCCCCCCCC[O-].[Al+3],,,,,,
6033,106034,"1-Tetracosanol, aluminum salt",CCCCCCCCCCCCCCCCCCCCCCCC[O-].CCCCCCCCCCCCCCCCCCCCCCCC[O-].CCCCCCCCCCCCCCCCCCCCCCCC[O-].[Al+3],,,,,,
6034,106035,"1-Docosanol, aluminum salt",CCCCCCCCCCCCCCCCCCCCCC[O-].CCCCCCCCCCCCCCCCCCCCCC[O-].CCCCCCCCCCCCCCCCCCCCCC[O-].[Al+3],,,,,,
6035,106036,"1-Eicosanol, aluminum salt",CCCCCCCCCCCCCCCCCCCC[O-].CCCCCCCCCCCCCCCCCCCC[O-].CCCCCCCCCCCCCCCCCCCC[O-].[Al+3],,,,,,
6036,106037,"1-Tetradecanol, aluminum salt",CCCCCCCCCCCCCC[O-].CCCCCCCCCCCCCC[O-].CCCCCCCCCCCCCC[O-].[Al+3],,,,,,
6037,106038,"1-Propanol, 3-((3-(boronooxy)propyl)amino)-",B(O)(O)OCCCNCCCO,,,,,,
6038,106039,"1H-Isoindole-1,3(2H)-dione, 4,5,6,7-tetrachloro-2-cyclododecyl-",C1CCCCCC(CCCCC1)N2C(=O)C3=C(C2=O)C(=C(C(=C3Cl)Cl)Cl)Cl,,,,,,
6039,106040,"1H-Isoindole-1,3(2H)-dione, 4,5,6,7-tetrachloro-2-octyl-",CCCCCCCCN1C(=O)C2=C(C1=O)C(=C(C(=C2Cl)Cl)Cl)Cl,,,,,,
6040,106041,"1H-Isoindole-1,3(2H)-dione, 4,5,6,7-tetrachloro-2-cycloheptyl-",C1CCCC(CC1)N2C(=O)C3=C(C2=O)C(=C(C(=C3Cl)Cl)Cl)Cl,,,,,,
6041,106042,"1H-Isoindole-1,3(2H)-dione, 4,5,6,7-tetrachloro-2-heptyl-",CCCCCCCN1C(=O)C2=C(C1=O)C(=C(C(=C2Cl)Cl)Cl)Cl,,,,,,
6042,106043,"Benzoic acid, 2,3,4,5-tetrachloro-6-[(dihexylamino)carbonyl]-",CCCCCCN(CCCCCC)C(=O)C1=C(C(=C(C(=C1Cl)Cl)Cl)Cl)C(=O)O,,,,,,
6043,106044,Aluminum;triacontane,CCCCCCCCCCCCCCCCCCCCCCCCCCCCC[CH2-].CCCCCCCCCCCCCCCCCCCCCCCCCCCCC[CH2-].CCCCCCCCCCCCCCCCCCCCCCCCCCCCC[CH2-].[Al+3],,,,,,
6044,106045,"1,4-Cyclohexanediylbis(methylene) diacrylate",C=CC(=O)OCC1CCC(CC1)COC(=O)C=C,,,,,,
6045,106046,Tetratriacontyl methacrylate,CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCOC(=O)C(=C)C,,,,,,
6046,106047,"2-Butyne-1,4-diyl bismethacrylate",CC(=C)C(=O)OCC#CCOC(=O)C(=C)C,,,,,,
6047,106048,2-(Dimethylphosphino)ethyl methacrylate,CC(=C)C(=O)OCCP(C)C,,,,,,
6048,106049,"9,10-Anthracenedione, 1-methoxy-4-[(4-methylphenyl)amino]-",CC1=CC=C(C=C1)NC2=C3C(=C(C=C2)OC)C(=O)C4=CC=CC=C4C3=O,,,,,,
6049,106050,"Disodium 4-(((2,3-dichloro-6-quinoxalinyl)carbonyl)amino)-5-hydroxynaphthalene-2,7-disulphonate",C1=CC2=C(C=C1C(=O)NC3=C4C(=CC(=C3)S(=O)(=O)[O-])C=C(C=C4O)S(=O)(=O)[O-])N=C(C(=N2)Cl)Cl.[Na+].[Na+],,,,,,
6050,106051,"4-[[(2,3-Dichloro-6-quinoxalinyl)carbonyl]amino]-5-hydroxy-2,7-naphthalenedisulfonic acid",C1=CC2=C(C=C1C(=O)NC3=C4C(=CC(=C3)S(=O)(=O)O)C=C(C=C4O)S(=O)(=O)O)N=C(C(=N2)Cl)Cl,,,,,,
6051,106052,"Acetamide, N-[2,3-dihydro-2-(3-hydroxy-2-quinolinyl)-1,3-dioxo-1H-inden-5-yl]-",CC(=O)NC1=CC2=C(C=C1)C(=O)C(C2=O)C3=NC4=CC=CC=C4C=C3O,,,,,,
6052,106053,CID 106053,CNCC1=CC=C(C=C1)NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)[O-].[Na+],,,,,,
6053,106054,"1-Amino-9,10-dihydro-4-[[4-[(methylamino)methyl]phenyl]amino]-9,10-dioxoanthracene-2-sulphonic acid",CNCC1=CC=C(C=C1)NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)O,,,,,,
6054,106055,1-Amino-4-((4-((dimethylamino)methyl)phenyl)amino)anthraquinone monohydrochloride,CN(C)CC1=CC=C(C=C1)NC2=C3C(=C(C=C2)N)C(=O)C4=CC=CC=C4C3=O.Cl,,,,,,
6055,106056,"2-Anthracenesulfonic acid, 1-amino-9,10-dihydro-4-[[4-[(methylamino)methyl]-2-sulfophenyl]amino]-9,10-dioxo-, disodium salt",CNCC1=CC(=C(C=C1)NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
6056,106057,"1-Amino-9,10-dihydro-4-[[4-[(methylamino)methyl]-2-sulfophenyl]amino]-9,10-dioxo-2-anthracenesulfonic acid",CNCC1=CC(=C(C=C1)NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)O)S(=O)(=O)O,,,,,,
6057,106058,"Ethanaminium, 2-[ethyl(3-methylphenyl)amino]-N,N,N-trimethyl-, sulfate (1:1)",CCN(CC[N+](C)(C)C)C1=CC=CC(=C1)C.OS(=O)(=O)[O-],,,,,,
6058,106059,[2-(N-Ethyl-m-toluidino)ethyl]trimethylaminium,CCN(CC[N+](C)(C)C)C1=CC=CC(=C1)C,,,,,,
6059,106060,CID 106060,CN(C)CC1=CC=C(C=C1)NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)[O-].[Na+],,,,,,
6060,106061,"1-Amino-4-[4-[(dimethylamino)methyl]anilino]-9,10-dioxoanthracene-2-sulfonic acid",CN(C)CC1=CC=C(C=C1)NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)O,,,,,,
6061,106062,CID 106062,C1=CC(=O)C2=C(C3=C(C(=CC(=[N+]([O-])[O-])C3=O)[N+](=O)[O-])C(=O)C2=C1[N+](=O)O)O,,,,,,
6062,106063,CID 106063,C1=CC(=O)C2=C(C3=C(C(=CC(=[N+]([O-])[O-])C3=O)[N+](=O)O)C(=O)C2=C1[N+](=O)O)O,,,,,,
6063,106064,Methyl [4-[(4-amino-2-methylphenyl)azo]phenyl]carbamate,CC1=C(C=CC(=C1)N)N=NC2=CC=C(C=C2)NC(=O)OC,,,,,,
6064,106065,"Acetamide, N-[3-[(2-cyanoethyl)amino]-4-hydroxyphenyl]-",CC(=O)NC1=CC(=C(C=C1)O)NCCC#N,,,,,,
6065,106066,"Acetamide, N-[3-[(2-cyanoethyl)ethylamino]-4-ethoxyphenyl]-",CCN(CCC#N)C1=C(C=CC(=C1)NC(=O)C)OCC,,,,,,
6066,106067,"N,N-diethyl-4-[2-(1,3,3-trimethylindol-1-ium-2-yl)ethenyl]aniline;naphthalene-1,5-disulfonate",CCN(CC)C1=CC=C(C=C1)C=CC2=[N+](C3=CC=CC=C3C2(C)C)C.CCN(CC)C1=CC=C(C=C1)C=CC2=[N+](C3=CC=CC=C3C2(C)C)C.C1=CC2=C(C=CC=C2S(=O)(=O)[O-])C(=C1)S(=O)(=O)[O-],,,,,,
6067,106068,"Acetamide, N-[2-[(2-bromo-4,6-dinitrophenyl)azo]-5-[(2-cyanoethyl)ethylamino]-4-ethoxyphenyl]-",CCN(CCC#N)C1=C(C=C(C(=C1)NC(=O)C)N=NC2=C(C=C(C=C2Br)[N+](=O)[O-])[N+](=O)[O-])OCC,,,,,,
6068,106069,3-[Butyl[4-[(6-nitro-2-benzothiazolyl)azo]phenyl]amino]propiononitrile,CCCCN(CCC#N)C1=CC=C(C=C1)N=NC2=NC3=C(S2)C=C(C=C3)[N+](=O)[O-],,,,,,
6069,106070,"Poly(oxy-1,2-ethanediyl), alpha-(2,4-bis(1,1-dimethylpropyl)phenyl)-omega-hydroxy-",CCC(C)(C)C1=CC(=C(C=C1)OCCO)C(C)(C)CC,,,,,,
6070,106071,CID 106071,COC(=O)N(CCN(CC(=O)[O-])C(=O)OC)CC(=O)O.[K+],,,,,,
6071,106072,Potassium nickel ethylenediaminetetraacetate,COC(=O)N(CCN(CC(=O)[O-])C(=O)OC)CC(=O)[O-].[K+].[K+],,,,,,
6072,106073,"9,10-Anthracenedione, 6,7-dichloro-1,4-bis[(5,6,7,8-tetrahydro-1-naphthalenyl)amino]-",C1CCC2=C(C1)C=CC=C2NC3=C4C(=C(C=C3)NC5=CC=CC6=C5CCCC6)C(=O)C7=CC(=C(C=C7C4=O)Cl)Cl,,,,,,
6073,106074,CID 106074,CCOC(=C1C2=C3C(=C(C=C(C3=NC1=O)C)NC4=CC=C(C=C4)Cl)C(=O)C5=CC=CC=C52)O,,,,,,
6074,106075,"2H-1-Benzopyran-2-one, 7-[(2-amino-1-naphthalenyl)azo]-3-phenyl-",C1=CC=C(C=C1)C2=CC3=C(C=C(C=C3)N=NC4=C(C=CC5=CC=CC=C54)N)OC2=O,,,,,,
6075,106076,"Dimethyl 2-[[2-[(2-methoxyphenyl)amino]-2-oxo-1-(1,4,5,6-tetrahydro-4,6-dioxo-1,3,5-triazin-2-YL)ethyl]azo]terephthalate",COC1=CC=CC=C1NC(=O)C(C2=NC(=O)NC(=O)N2)N=NC3=C(C=CC(=C3)C(=O)OC)C(=O)OC,,,,,,
6076,106077,"1,4-Benzenedicarboxylic acid, 2-[(4-methylphenyl)amino]-5-(phenylamino)-",CC1=CC=C(C=C1)NC2=CC(=C(C=C2C(=O)O)NC3=CC=CC=C3)C(=O)O,,,,,,
6077,106078,"1,4-Benzenedisulfonic acid, 2,2'-[1,2-ethenediylbis[(3-sulfo-4,1-phenylene)imino[6-[(3-amino-3-oxopropyl)(2-hydroxyethyl)amino]-1,3,5-triazine-4,2-diyl]imino]]bis-, hexasodium salt",C1=CC(=C(C=C1NC2=NC(=NC(=N2)N(CCC(=O)N)CCO)NC3=C(C=CC(=C3)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])C=CC4=C(C=C(C=C4)NC5=NC(=NC(=N5)N(CCC(=O)N)CCO)NC6=C(C=CC(=C6)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],,,,,,
6078,106079,"2-[[4-[(3-Amino-3-oxopropyl)-(2-hydroxyethyl)amino]-6-[4-[2-[4-[[4-[(3-amino-3-oxopropyl)-(2-hydroxyethyl)amino]-6-(2,5-disulfoanilino)-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]ethenyl]-3-sulfoanilino]-1,3,5-triazin-2-yl]amino]benzene-1,4-disulfonic acid",C1=CC(=C(C=C1NC2=NC(=NC(=N2)N(CCC(=O)N)CCO)NC3=C(C=CC(=C3)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)C=CC4=C(C=C(C=C4)NC5=NC(=NC(=N5)N(CCC(=O)N)CCO)NC6=C(C=CC(=C6)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
6079,106080,"Propanenitrile, 3-((2-hydroxyethyl)(4-((5-nitro-2-benzothiazolyl)azo)phenyl)amino)-",C1=CC(=CC=C1N=NC2=NC3=C(S2)C=CC(=C3)[N+](=O)[O-])N(CCC#N)CCO,,,,,,
6080,106081,"Propanonitrile, 3-(ethyl(4-((2,6-dibromo-4-nitrophenyl)azo)-3-methylphenyl)amino)-",CCN(CCC#N)C1=CC(=C(C=C1)N=NC2=C(C=C(C=C2Br)[N+](=O)[O-])Br)C,,,,,,
6081,106082,"1,4-Bis((2,6-dimethylphenyl)amino)-6,7-dichloroanthraquinone",CC1=C(C(=CC=C1)C)NC2=C3C(=C(C=C2)NC4=C(C=CC=C4C)C)C(=O)C5=CC(=C(C=C5C3=O)Cl)Cl,,,,,,
6082,106083,CID 106083,CCC(C)(C)C1=CC=C(C=C1)OC2=CC(=C3C4=C(C5=CC=CC=C5C3=O)C(=C(O)OC6=CC=CC=C6)C(=O)N=C24)NC7=CC=CC=C7,,,,,,
6083,106084,4-[Methyl[(pentadecafluoroheptyl)sulfonyl]amino]butyl methacrylate,CC(=C)C(=O)OCCCCN(C)S(=O)(=O)C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
6084,106085,4-[Methyl[(nonafluorobutyl)sulfonyl]amino]butyl methacrylate,CC(=C)C(=O)OCCCCN(C)S(=O)(=O)C(C(C(C(F)(F)F)(F)F)(F)F)(F)F,,,,,,
6085,106086,4-[Methyl[(undecafluoropentyl)sulfonyl]amino]butyl methacrylate,CC(=C)C(=O)OCCCCN(C)S(=O)(=O)C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
6086,106087,"1-Heptanesulfonamide, N-ethyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-N-2-propenyl-",CCN(CC=C)S(=O)(=O)C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
6087,106088,Ammonium henicosafluorodecanesulphonate,C(C(C(C(C(C(F)(F)S(=O)(=O)[O-])(F)F)(F)F)(F)F)(F)F)(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F.[NH4+],,,,,,
6088,106089,2-Methoxy-6-sulpho-4-((7-sulpho-4-((3-sulphophenyl)azo)-1-naphthyl)azo)naphthalene-1-diazonium chloride,COC1=C(C2=C(C=C(C=C2)S(=O)(=O)O)C(=C1)N=NC3=C4C=C(C=CC4=CC(=C3)N=NC5=CC(=CC=C5)S(=O)(=O)O)S(=O)(=O)O)[N+]#N.[Cl-],,,,,,
6089,106090,2-Methoxy-6-sulfo-4-[[7-sulfo-3-[(3-sulfophenyl)diazenyl]naphthalen-1-yl]diazenyl]naphthalene-1-diazonium,COC1=C(C2=C(C=C(C=C2)S(=O)(=O)O)C(=C1)N=NC3=C4C=C(C=CC4=CC(=C3)N=NC5=CC(=CC=C5)S(=O)(=O)O)S(=O)(=O)O)[N+]#N,,,,,,
6090,106091,Trisodium 5-((4-((4-acetamidophenyl)azo)-7-sulphonatonaphthyl)azo)-8-((2-hydroxy-6-sulphonatonaphthyl)azo)naphthalene-2-sulphonate,C1=CC(=CC=C1CC(=O)N)N=NC2=C3C=CC(=CC3=C(C=C2)N=NC4=C5C=CC(=CC5=C(C=C4)N=NC6=C(C=CC7=C6C=CC(=C7)S(=O)(=O)[O-])O)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
6091,106092,5-[[4-[[4-[[4-(2-Amino-2-oxoethyl)phenyl]diazenyl]-7-sulfonaphthalen-1-yl]diazenyl]-7-sulfonaphthalen-1-yl]diazenyl]-6-hydroxynaphthalene-2-sulfonic acid,C1=CC(=CC=C1CC(=O)N)N=NC2=C3C=CC(=CC3=C(C=C2)N=NC4=C5C=CC(=CC5=C(C=C4)N=NC6=C(C=CC7=C6C=CC(=C7)S(=O)(=O)O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
6092,106093,"8-((4-((4-(Acetylamino)phenyl)azo)-7-sulfo-1-naphthalenyl)azo)-5-((2-hydroxy-6-sulfo-1-naphthalenyl)azo)-2-naphthalenesulfonic acid, trisodium salt",C1=CC(=CC=C1CC(=O)N)N=NC2=C3C=CC(=CC3=C(C=C2)N=NC4=C5C=C(C=CC5=C(C=C4)N=NC6=C(C=CC7=C6C=CC(=C7)S(=O)(=O)[O-])O)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
6093,106094,5-[[4-[[4-[[4-(2-Amino-2-oxoethyl)phenyl]diazenyl]-7-sulfonaphthalen-1-yl]diazenyl]-6-sulfonaphthalen-1-yl]diazenyl]-6-hydroxynaphthalene-2-sulfonic acid,C1=CC(=CC=C1CC(=O)N)N=NC2=C3C=CC(=CC3=C(C=C2)N=NC4=C5C=C(C=CC5=C(C=C4)N=NC6=C(C=CC7=C6C=CC(=C7)S(=O)(=O)O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
6094,106095,Trisodium 5-((4-((4-acetamidophenyl)azo)-6-sulphonatonaphthyl)azo)-8-((2-hydroxy-6-sulphonatonaphthyl)azo)naphthalene-2-sulphonate,C1=CC(=CC=C1CC(=O)N)N=NC2=C3C=C(C=CC3=C(C=C2)N=NC4=C5C=CC(=CC5=C(C=C4)N=NC6=C(C=CC7=C6C=CC(=C7)S(=O)(=O)[O-])O)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
6095,106096,5-[[4-[[4-[[4-(2-Amino-2-oxoethyl)phenyl]diazenyl]-6-sulfonaphthalen-1-yl]diazenyl]-7-sulfonaphthalen-1-yl]diazenyl]-6-hydroxynaphthalene-2-sulfonic acid,C1=CC(=CC=C1CC(=O)N)N=NC2=C3C=C(C=CC3=C(C=C2)N=NC4=C5C=CC(=CC5=C(C=C4)N=NC6=C(C=CC7=C6C=CC(=C7)S(=O)(=O)O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
6096,106097,"8-((4-((4-(Acetylamino)phenyl)azo)-6-sulfo-1-naphthalenyl)azo)-5-((2-hydroxy-6-sulfo-1-naphthalenyl)azo)-2-naphthalenesulfonic acid, trisodium salt",C1=CC(=CC=C1CC(=O)N)N=NC2=C3C=C(C=CC3=C(C=C2)N=NC4=C5C=C(C=CC5=C(C=C4)N=NC6=C(C=CC7=C6C=CC(=C7)S(=O)(=O)[O-])O)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
6097,106098,5-[[4-[[4-[[4-(2-Amino-2-oxoethyl)phenyl]diazenyl]-6-sulfonaphthalen-1-yl]diazenyl]-6-sulfonaphthalen-1-yl]diazenyl]-6-hydroxynaphthalene-2-sulfonic acid,C1=CC(=CC=C1CC(=O)N)N=NC2=C3C=C(C=CC3=C(C=C2)N=NC4=C5C=C(C=CC5=C(C=C4)N=NC6=C(C=CC7=C6C=CC(=C7)S(=O)(=O)O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
6098,106099,Disodium 5-((4-acetamidophenyl)azo)-8-((4-amino-6-sulphonatonaphthyl)azo)naphthalene-2-sulphonate,CC(=O)NC1=CC=C(C=C1)N=NC2=C3C=CC(=CC3=C(C=C2)N=NC4=C5C=CC(=CC5=C(C=C4)N)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
6099,106100,5-[[4-[(4-Acetamidophenyl)diazenyl]-7-sulfonaphthalen-1-yl]diazenyl]-8-aminonaphthalene-2-sulfonic acid,CC(=O)NC1=CC=C(C=C1)N=NC2=C3C=CC(=CC3=C(C=C2)N=NC4=C5C=CC(=CC5=C(C=C4)N)S(=O)(=O)O)S(=O)(=O)O,,,,,,
6100,106101,Disodium 8-((4-acetamidophenyl)azo)-5-((4-amino-7-sulphonatonaphthyl)azo)naphthalene-2-sulphonate,CC(=O)NC1=CC=C(C=C1)N=NC2=C3C=CC(=CC3=C(C=C2)N=NC4=C5C=C(C=CC5=C(C=C4)N)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
6101,106102,8-[[4-[(4-Acetamidophenyl)diazenyl]-7-sulfonaphthalen-1-yl]diazenyl]-5-aminonaphthalene-2-sulfonic acid,CC(=O)NC1=CC=C(C=C1)N=NC2=C3C=CC(=CC3=C(C=C2)N=NC4=C5C=C(C=CC5=C(C=C4)N)S(=O)(=O)O)S(=O)(=O)O,,,,,,
6102,106103,Disodium 8-((4-acetamidophenyl)azo)-5-((4-amino-6-sulphonatonaphthyl)azo)naphthalene-2-sulphonate,CC(=O)NC1=CC=C(C=C1)N=NC2=C3C=C(C=CC3=C(C=C2)N=NC4=C5C=CC(=CC5=C(C=C4)N)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
6103,106104,5-[[4-[(4-Acetamidophenyl)diazenyl]-6-sulfonaphthalen-1-yl]diazenyl]-8-aminonaphthalene-2-sulfonic acid,CC(=O)NC1=CC=C(C=C1)N=NC2=C3C=C(C=CC3=C(C=C2)N=NC4=C5C=CC(=CC5=C(C=C4)N)S(=O)(=O)O)S(=O)(=O)O,,,,,,
6104,106105,CID 106105,COC1=CC=CC=C1N=NC2=C3C=C(C=CC3=C(C=C2)N=NC4=CC=C(C=C4)O)S(=O)(=O)[O-].[Na+],,,,,,
6105,106106,5-[(4-Hydroxyphenyl)diazenyl]-8-[(2-methoxyphenyl)diazenyl]naphthalene-2-sulfonic acid,COC1=CC=CC=C1N=NC2=C3C=C(C=CC3=C(C=C2)N=NC4=CC=C(C=C4)O)S(=O)(=O)O,,,,,,
6106,106107,CID 106107,CCN(CCC#N)C1=CC=C(C=C1)N=NC2=CC=C(C=C2)N=NC3=CC=C(C=C3)S(=O)(=O)[O-].[Na+],,,,,,
6107,106108,4-{[4-({4-[(2-Cyanoethyl)(ethyl)amino]phenyl}diazenyl)phenyl]diazenyl}benzene-1-sulfonic acid,CCN(CCC#N)C1=CC=C(C=C1)N=NC2=CC=C(C=C2)N=NC3=CC=C(C=C3)S(=O)(=O)O,,,,,,
6108,106109,"Benzenesulfonic acid, 4-[[4-(chloroazo)-5-methoxy-2-methylphenyl]azo]-",CC1=CC(=C(C=C1N=NC2=CC=C(C=C2)S(=O)(=O)O)OC)N=NCl,,,,,,
6109,106110,"7-((4-Amino-3-methoxyphenyl)azo)-1,5-naphthalenedisulfonic acid, disodium salt",COC1=C(C=CC(=C1)N=NC2=CC3=C(C=CC=C3S(=O)(=O)[O-])C(=C2)S(=O)(=O)[O-])N.[Na+].[Na+],,,,,,
6110,106111,"1,5-Naphthalenedisulfonic acid, 3-[(4-amino-3-methoxyphenyl)azo]-",COC1=C(C=CC(=C1)N=NC2=CC3=C(C=CC=C3S(=O)(=O)O)C(=C2)S(=O)(=O)O)N,,,,,,
6111,106112,CID 106112,CC1=CC(=C(C(=C1Cl)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)[O-])O)S(=O)(=O)[O-])Cl.[Ca+2],,,,,,
6112,106113,"4-[(2,5-Dichloro-3-methyl-6-sulfophenyl)diazenyl]-3-hydroxynaphthalene-2-carboxylic acid",CC1=CC(=C(C(=C1Cl)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)O)O)S(=O)(=O)O)Cl,,,,,,
6113,106114,CID 106114,CC1=C(C=C(C(=C1Cl)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)[O-])O)S(=O)(=O)[O-])Cl.[Ca+2],,,,,,
6114,106115,"4-[(2,4-Dichloro-3-methyl-6-sulfophenyl)diazenyl]-3-hydroxynaphthalene-2-carboxylic acid",CC1=C(C=C(C(=C1Cl)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)O)O)S(=O)(=O)O)Cl,,,,,,
6115,106116,2-[4-[(4-Amino-5-methoxy-2-methylphenyl)azo]phenoxy]ethanol,CC1=CC(=C(C=C1N=NC2=CC=C(C=C2)OCCO)OC)N,,,,,,
6116,106117,"Propanenitrile, 3-[ethyl[3-methyl-4-[[2-(methylsulfonyl)-4-nitrophenyl]azo]phenyl]amino]-",CCN(CCC#N)C1=CC(=C(C=C1)N=NC2=C(C=C(C=C2)[N+](=O)[O-])S(=O)(=O)C)C,,,,,,
6117,106118,"2-Naphthalenesulfonic acid, 7-amino-4-hydroxy-8-[(3-sulfophenyl)azo]-",C1=CC(=CC(=C1)S(=O)(=O)O)N=NC2=C(C=CC3=C2C=C(C=C3O)S(=O)(=O)O)N,,,,,,
6118,106119,"2-Propenoic acid, 2-methyl-, 2-[ethyl[(tridecafluorohexyl)sulfonyl]amino]ethyl ester",CCN(CCOC(=O)C(=C)C)S(=O)(=O)C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
6119,106120,"2-Propenoic acid, 2-methyl-, 2-[ethyl[(undecafluoropentyl)sulfonyl]amino]ethyl ester",CCN(CCOC(=O)C(=C)C)S(=O)(=O)C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
6120,106121,"1-Octadecanaminium, N-ethyl-N,N-dioctadecyl-, ethyl sulfate",CCCCCCCCCCCCCCCCCC[N+](CC)(CCCCCCCCCCCCCCCCCC)CCCCCCCCCCCCCCCCCC.CCOS(=O)(=O)[O-],,,,,,
6121,106122,Ethyltrisoctadecylaminium,CCCCCCCCCCCCCCCCCC[N+](CC)(CCCCCCCCCCCCCCCCCC)CCCCCCCCCCCCCCCCCC,,,,,,
6122,106123,Sodium 2-[[4-[[4-[[P-tolylsulphonyl]oxy]phenyl]azo]phenyl]amino]-5-nitrobenzenesulphonate,CC1=CC=C(C=C1)S(=O)(=O)OC2=CC=C(C=C2)N=NC3=CC=C(C=C3)NC4=C(C=C(C=C4)[N+](=O)[O-])S(=O)(=O)[O-].[Na+],,,,,,
6123,106124,2-[4-({4-[(4-Methylbenzene-1-sulfonyl)oxy]phenyl}diazenyl)anilino]-5-nitrobenzene-1-sulfonic acid,CC1=CC=C(C=C1)S(=O)(=O)OC2=CC=C(C=C2)N=NC3=CC=C(C=C3)NC4=C(C=C(C=C4)[N+](=O)[O-])S(=O)(=O)O,,,,,,
6124,106125,CID 106125,CC(C)CCCCCOC(=O)C1=CC=CC=C1C(=O)OCC[S-].CC(C)CCCCCOC(=O)C1=CC=CC=C1C(=O)OCC[S-].C[Sn]C,,,,,,
6125,106126,2-Mercaptoethyl isooctyl phthalate,CC(C)CCCCCOC(=O)C1=CC=CC=C1C(=O)OCCS,,,,,,
6126,106127,"1-Dodecanaminium, N-dodecyl-N,N-dimethyl-, diisooctyl phosphate (1:1)",CCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCC.CCCCCCCCOP(=O)([O-])OCCCCCCCC,,,,,,
6127,106128,Didodecyldimethylammonium monoisooctyl phosphate (1:1),CCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCC.CCCCCCCCOP(=O)(O)[O-],,,,,,
6128,106129,"Benzenemethanaminium, N-hexadecenyl-N,N-bis(2-hydroxyethyl)-, chloride",C=CCCCCCCCCCCCCCC[N+](CCO)(CCO)CC1=CC=CC=C1.[Cl-],,,,,,
6129,106130,Benzyl-hexadec-15-enyl-bis(2-hydroxyethyl)azanium,C=CCCCCCCCCCCCCCC[N+](CCO)(CCO)CC1=CC=CC=C1,,,,,,
6130,106131,"Benzenemethanaminium, N,N-bis(2-hydroxyethyl)-N-tetradecenyl-, chloride",C=CCCCCCCCCCCCC[N+](CCO)(CCO)CC1=CC=CC=C1.[Cl-],,,,,,
6131,106132,Benzyl-bis(2-hydroxyethyl)-tetradec-13-enylazanium,C=CCCCCCCCCCCCC[N+](CCO)(CCO)CC1=CC=CC=C1,,,,,,
6132,106133,CID 106133,CCC=CCCCCCCCCCCCCCC[N+](CCO)(CCO)CC1=CC=CC=C1.[Cl-],,,,,,
6133,106134,CID 106134,CCC=CCCCCCCCCCCCCCC[N+](CCO)(CCO)CC1=CC=CC=C1,,,,,,
6134,106135,5-Tert-butyl-2-methoxy-4-prop-1-enylphenol,CC=CC1=CC(=C(C=C1C(C)(C)C)O)OC,,,,,,
6135,106136,"2-(4-Chlorophenyl)-4-[[4-chloro-2-(trifluoromethyl)phenyl]azo]-2,4-dihydro-5-methyl-3H-pyrazol-3-one",CC1=NN(C(=O)C1N=NC2=C(C=C(C=C2)Cl)C(F)(F)F)C3=CC=C(C=C3)Cl,,,,,,
6136,106137,3-Phenoxypropyl methacrylate,CC(=C)C(=O)OCCCOC1=CC=CC=C1,,,,,,
6137,106138,"Propanenitrile, 3,3'-[[4-[(2,6-dichloro-4-nitrophenyl)azo]phenyl]imino]bis-",C1=CC(=CC=C1N=NC2=C(C=C(C=C2Cl)[N+](=O)[O-])Cl)N(CCC#N)CCC#N,,,,,,
6138,106139,"2,2'-[[3-Chloro-4-[(4-nitrophenyl)azo]phenyl]imino]bisethyl diacetate",CC(=O)OCCN(CCOC(=O)C)C1=CC(=C(C=C1)N=NC2=CC=C(C=C2)[N+](=O)[O-])Cl,,,,,,
6139,106140,Einecs 267-761-0,C1=CC(=CC(=C1)SC#N)N2C(=O)C3=C4C(=CC=C5C4=C(C=C3)C6=C7C5=CC=C8C7=C(C=C6)C(=O)N(C8=O)C9=CC(=CC=C9)SC#N)C2=O,,,,,,
6140,106141,"2,2'-[[4-[(2,6-Dibromo-4-nitrophenyl)azo]-3-methylphenyl]imino]bisethyl diacetate",CC1=C(C=CC(=C1)N(CCOC(=O)C)CCOC(=O)C)N=NC2=C(C=C(C=C2Br)[N+](=O)[O-])Br,,,,,,
6141,106142,"Propanenitrile, 3-[[4-[(4-nitrophenyl)azo]phenyl][2-(1-oxopropoxy)ethyl]amino]-",CCC(=O)OCCN(CCC#N)C1=CC=C(C=C1)N=NC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
6142,106143,"9,10-Anthracenedione, 1-amino-4-hydroxy-2-[(2-hydroxyethyl)thio]-",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3O)SCCO)N,,,,,,
6143,106144,"beta-Alanine, N-[5-(acetylamino)-4-[(2-bromo-4,6-dinitrophenyl)azo]-2-methoxyphenyl]-N-(2-hydroxyethyl)-, ethyl ester",CCOC(=O)CCN(CCO)C1=C(C=C(C(=C1)NC(=O)C)N=NC2=C(C=C(C=C2Br)[N+](=O)[O-])[N+](=O)[O-])OC,,,,,,
6144,106145,"9,10-Anthracenedione, 1-amino-4-hydroxy-2-[(4-hydroxyphenyl)thio]-",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3O)SC4=CC=C(C=C4)O)N,,,,,,
6145,106146,2-Ethoxy-3-methylcyclopent-2-en-1-one,CCOC1=C(CCC1=O)C,,,,,,
6146,106147,"Methanesulfonic acid, [[2-methoxy-4-[(4-nitrophenyl)azo]phenyl]amino]-, monosodium salt",COC1=C(C=CC(=C1)N=NC2=CC=C(C=C2)[N+](=O)[O-])NCS(=O)(=O)[O-].[Na+],,,,,,
6147,106148,[2-Methoxy-4-[(4-nitrophenyl)diazenyl]anilino]methanesulfonic acid,COC1=C(C=CC(=C1)N=NC2=CC=C(C=C2)[N+](=O)[O-])NCS(=O)(=O)O,,,,,,
6148,106149,CID 106149,C1=CC=C(C=C1)N=NC2=C3C=C(C=CC3=C(C=C2)N=NC4=CC=C(C=C4)N(CCO)CCO)S(=O)(=O)[O-].[Na+],,,,,,
6149,106150,5-({4-[Bis(2-hydroxyethyl)amino]phenyl}diazenyl)-8-(phenyldiazenyl)naphthalene-2-sulfonic acid,C1=CC=C(C=C1)N=NC2=C3C=C(C=CC3=C(C=C2)N=NC4=CC=C(C=C4)N(CCO)CCO)S(=O)(=O)O,,,,,,
6150,106151,"1-Heptanesulfonamide, N-ethyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-N-[2-(phosphonooxy)ethyl]-",CCN(CCOP(=O)(O)O)S(=O)(=O)C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
6151,106152,"2,2'-Methylenebis(3,4,6-trichlorophenol) dipotassium salt",C1=C(C(=C(C(=C1Cl)Cl)CC2=C(C(=CC(=C2Cl)Cl)Cl)[O-])[O-])Cl.[K+].[K+],,,,,,
6152,106153,Trisodium 4-hydroxy-7-((((5-hydroxy-6-((2-methoxy-5-methyl-4-sulphonatophenyl)azo)-7-sulphonato-2-naphthyl)amino)carbonyl)amino)-3-((2-methoxyphenyl)azo)naphthalene-2-sulphonate,CC1=CC(=C(C=C1S(=O)(=O)[O-])OC)N=NC2=C(C=C3C=C(C=CC3=C2O)NC(=O)NC4=CC5=CC(=C(C(=C5C=C4)O)N=NC6=CC=CC=C6OC)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
6153,106154,4-Hydroxy-7-[[5-hydroxy-6-[(2-methoxy-5-methyl-4-sulfophenyl)diazenyl]-7-sulfonaphthalen-2-yl]carbamoylamino]-3-[(2-methoxyphenyl)diazenyl]naphthalene-2-sulfonic acid,CC1=CC(=C(C=C1S(=O)(=O)O)OC)N=NC2=C(C=C3C=C(C=CC3=C2O)NC(=O)NC4=CC5=CC(=C(C(=C5C=C4)O)N=NC6=CC=CC=C6OC)S(=O)(=O)O)S(=O)(=O)O,,,,,,
6154,106155,"Urea, tetrakis[methylene phosphoric acid]",C(N(CP(=O)(O)O)C(=O)N(CP(=O)(O)O)CP(=O)(O)O)P(=O)(O)O,,,,,,
6155,106156,"1,2,4,5-Benzenetetracarboxylic acid, diisooctyl ester",CC(C)CCCCCOC(=O)C1=CC(=C(C=C1C(=O)O)C(=O)O)C(=O)OCCCCCC(C)C,,,,,,
6156,106157,"Isotridecane, 1,1'-[(3,7-dimethyl-6-octenylidene)bis(oxy)]bis-",CC(C)CCCCCCCCCCOC(CC(C)CCC=C(C)C)OCCCCCCCCCCC(C)C,,,,,,
6157,106158,"Isononane, 1,1-diethoxy-",CCOC(CCCCCC(C)C)OCC,,,,,,
6158,106159,"Isotridecane, 1,1'-[(3,6-dimethyl-2,6-octadienylidene)bis(oxy)]bis-",CC=C(C)CC=C(C)CC(OCCCCCCCCCCC(C)C)OCCCCCCCCCCC(C)C,,,,,,
6159,106160,Ammonium 2-(2-(2-(decyloxy)ethoxy)ethoxy)ethyl sulphate,CCCCCCCCCCOCCOCCOCCOS(=O)(=O)O.N,,,,,,
6160,106161,2-{2-[2-(Decyloxy)ethoxy]ethoxy}ethyl hydrogen sulfate,CCCCCCCCCCOCCOCCOCCOS(=O)(=O)O,,,,,,
6161,106162,"Phenol, methylenebis(dinonyl-",CCCCCCCCCC1=C(C(=C(C=C1)CC2=C(C=C(C(=C2)CCCCCCCCC)CCCCCCCCC)O)O)CCCCCCCCC,,,,,,
6162,106163,"1H-Benzotriazole, 5-methyl-, sulfate (2:1)",CC1=CC2=NNN=C2C=C1.CC1=CC2=NNN=C2C=C1.OS(=O)(=O)O,,,,,,
6163,106164,Methyl 2-(2-benzylideneoctylideneamino)benzoate,CCCCCCC(=CC1=CC=CC=C1)C=NC2=CC=CC=C2C(=O)OC,,,,,,
6164,106165,Methyl 2-(dodecylideneamino)benzoate,CCCCCCCCCCCC=NC1=CC=CC=C1C(=O)OC,,,,,,
6165,106166,"3,6,9,12-Tetraazatetradecane-1,14-diamine, acetate",CC(=O)O.C(CNCCNCCNCCNCCN)N,,,,,,
6166,106167,"Benzenesulfonic acid, 4-dodecyl-, compd. with N-(2-aminoethyl)-1,2-ethanediamine (3:1)",CCCCCCCCCCCCC1=CC=C(C=C1)S(=O)(=O)O.CCCCCCCCCCCCC1=CC=C(C=C1)S(=O)(=O)O.CCCCCCCCCCCCC1=CC=C(C=C1)S(=O)(=O)O.C(CNCCN)N,,,,,,
6167,106168,Dibutylbis(triethylamine)difluorotin,CCC[CH2-].CCC[CH2-].CCN(CC)CC.CCN(CC)CC.[F-].[F-].[Sn+4],,,,,,
6168,106169,CID 106169,CC1=CC=C(C=C1)NN=C2C(=O)C=CC(=NNC3=CC=C(C=C3)S(=O)(=O)[O-])C2=O.[Na+],,,,,,
6169,106170,"4-[2-[5-[(4-Methylphenyl)hydrazinylidene]-4,6-dioxocyclohex-2-en-1-ylidene]hydrazinyl]benzenesulfonic acid",CC1=CC=C(C=C1)NN=C2C(=O)C=CC(=NNC3=CC=C(C=C3)S(=O)(=O)O)C2=O,,,,,,
6170,106171,Einecs 267-824-2,[H+].C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C=C(C4=CC=CC=C43)S(=O)(=O)[O-])[O-])[O-].C1=CC2=CC(=NN=C3C=CC(=CC3=O)N([O-])[O-])C(=O)C=C2C=C1.[Na+].[Cr+3],,,,,,
6171,106172,"3-[[4-(Dioxidoamino)-6-oxocyclohexa-2,4-dien-1-ylidene]hydrazinylidene]naphthalen-2-one",C1=CC2=CC(=NN=C3C=CC(=CC3=O)N([O-])[O-])C(=O)C=C2C=C1,,,,,,
6172,106173,CID 106173,CCCCCCN(CP(=O)(O)O)CP(=O)(O)[O-].[Na+],,,,,,
6173,106174,2-[Ethyl[(nonafluorobutyl)sulphonyl]amino]ethyl methacrylate,CCN(CCOC(=O)C(=C)C)S(=O)(=O)C(C(C(C(F)(F)F)(F)F)(F)F)(F)F,,,,,,
6174,106175,"2-Propenoic acid, 2-methyl-, 2-[ethyl[(pentadecafluoroheptyl)sulfonyl]amino]ethyl ester",CCN(CCOC(=O)C(=C)C)S(=O)(=O)C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
6175,106176,N-Ethylheptadecafluoro-N-(3-(trichlorosilyl)propyl)octanesulphonamide,CCN(CCC[Si](Cl)(Cl)Cl)S(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
6176,106177,"9,10-Anthracenedione, 2,3-dichloro-5,8-bis[(5,6,7,8-tetrahydro-2-naphthalenyl)amino]-",C1CCC2=C(C1)C=CC(=C2)NC3=C4C(=C(C=C3)NC5=CC6=C(CCCC6)C=C5)C(=O)C7=CC(=C(C=C7C4=O)Cl)Cl,,,,,,
6177,106178,CID 106178,C1CN2CCN(C2=N1)C=NN=C(N)N3CCN4C3=NCC4.Cl,,,,,,
6178,106179,CID 106179,C1CN2CCN(C2=N1)C=NN=C(N)N3CCN4C3=NCC4,,,,,,
6179,106180,(1E)-1-bromo-1-chloroprop-1-ene,CC=C(Cl)Br,,,,,,
6180,106181,1-Brom-2-chlorpropen,CC(=CBr)Cl,,,,,,
6181,106182,4-[Methyl[(tridecafluorohexyl)sulfonyl]amino]butyl methacrylate,CC(=C)C(=O)OCCCCN(C)S(=O)(=O)C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
6182,106183,"Methanaminium, N-[4-[bis[4-(dimethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-N-methyl-, acetate",CC(=O)[O-].CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=C(C=C3)N(C)C,,,,,,
6183,106184,Tetrakis(cyclononyloxy)silane,C1CCCCC(CCC1)O[Si](OC2CCCCCCCC2)(OC3CCCCCCCC3)OC4CCCCCCCC4,,,,,,
6184,106185,Gold octanethiolate,CCCCCCCC[S-].[Au+],,,,,,
6185,106186,Tungsten hexa(cyclononanolate),C1CCCCC(CCC1)O.C1CCCCC(CCC1)O.C1CCCCC(CCC1)O.C1CCCCC(CCC1)O.C1CCCCC(CCC1)O.C1CCCCC(CCC1)O.[W],,,,,,
6186,106187,Cyclononanol,C1CCCCC(CCC1)O,,,,,,
6187,106188,N-[4-({3-[(4-acetamidophenyl)methylidene]-5-methyl-2-oxocyclohexylidene}methyl)phenyl]acetamide,CC1CC(=CC2=CC=C(C=C2)NC(=O)C)C(=O)C(=CC3=CC=C(C=C3)NC(=O)C)C1,,,,,,
6188,106189,"2,6-Bis[(4-aminophenyl)methylidene]-4-methylcyclohexan-1-one;dihydrochloride",CC1CC(=CC2=CC=C(C=C2)N)C(=O)C(=CC3=CC=C(C=C3)N)C1.Cl.Cl,,,,,,
6189,106190,"2,6-Bis[(4-aminophenyl)methylidene]-4-methylcyclohexan-1-one",CC1CC(=CC2=CC=C(C=C2)N)C(=O)C(=CC3=CC=C(C=C3)N)C1,,,,,,
6190,106191,N-(3-(Dimethylamino)propyl)heptadecafluorooctanesulphonamide monohydrochloride,CN(C)CCCNS(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F.Cl,,,,,,
6191,106192,"1-Butanesulfonamide, N-ethyl-1,1,2,2,3,3,4,4,4-nonafluoro-N-[2-(phosphonooxy)ethyl]-",CCN(CCOP(=O)(O)O)S(=O)(=O)C(C(C(C(F)(F)F)(F)F)(F)F)(F)F,,,,,,
6192,106193,"1-Pentanesulfonamide, N-ethyl-1,1,2,2,3,3,4,4,5,5,5-undecafluoro-N-[2-(phosphonooxy)ethyl]-",CCN(CCOP(=O)(O)O)S(=O)(=O)C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
6193,106194,"1-Butanesulfonamide, N,N'-[phosphinicobis(oxy-2,1-ethanediyl)]bis[N-ethyl-1,1,2,2,3,3,4,4,4-nonafluoro-",CCN(CCOP(=O)(O)OCCN(CC)S(=O)(=O)C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)S(=O)(=O)C(C(C(C(F)(F)F)(F)F)(F)F)(F)F,,,,,,
6194,106195,Trimethyl-3-(((nonafluorobutyl)sulphonyl)amino)propylammonium iodide,C[N+](C)(C)CCCNS(=O)(=O)C(C(C(C(F)(F)F)(F)F)(F)F)(F)F.[I-],,,,,,
6195,106196,"2-Propenoic acid, 2-methyl-, 2-[methyl[(pentadecafluoroheptyl)sulfonyl]amino]ethyl ester",CC(=C)C(=O)OCCN(C)S(=O)(=O)C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
6196,106197,"1-Heptanesulfonamide, N-ethyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-N-(2-(phosphonooxy)ethyl)-, diammonium salt",CCN(CCOP(=O)(O)O)S(=O)(=O)C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F.N.N,,,,,,
6197,106198,Bis(2-ethylbutyl) but-2-enedioate,CCC(CC)COC(=O)C=CC(=O)OCC(CC)CC,,,,,,
6198,106199,"Acetamide, N-[3-[(2-cyanoethyl)methylamino]-4-methoxyphenyl]-",CC(=O)NC1=CC(=C(C=C1)OC)N(C)CCC#N,,,,,,
6199,106200,n-[4-Methoxy-3-(methylamino)phenyl]acetamide,CC(=O)NC1=CC(=C(C=C1)OC)NC,,,,,,
6200,106201,"1-Heptanesulfonamide, N-(3-(dimethylamino)propyl)-1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-, monohydrochloride",CN(C)CCCNS(=O)(=O)C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F.Cl.Cl,,,,,,
6201,106202,"3-Thiazolidinecarboxylic acid, 4-oxo-2-thioxo-, ethyl ester",CCOC(=O)N1C(=O)CSC1=S,,,,,,
6202,106203,"3-Thiazolidinecarboxylic acid, 4-oxo-2-thioxo-, methyl ester",COC(=O)N1C(=O)CSC1=S,,,,,,
6203,106204,CID 106204,[B+3].CCN(CCO)C1=CC(=C(C=C1)[N+]#N)C.[F-].[F-].[F-].[F-],,,,,,
6204,106205,4-[Ethyl(2-hydroxyethyl)amino]-2-methylbenzenediazonium,CCN(CCO)C1=CC(=C(C=C1)[N+]#N)C,,,,,,
6205,106206,Magnesium 8-quinolinolate,C1=CC2=C(C(=C1)[O-])N=CC=C2.C1=CC2=C(C(=C1)[O-])N=CC=C2.[Mg+2],,,,,,
6206,106207,"2-Amino-2-methyl-1-propanol, nitrate",CC(C)(CO)N.[N+](=O)(O)[O-],,,,,,
6207,106208,"Carbamic acid, (hydroxymethyl)-, 2-(1-methylethoxy)ethyl ester",CC(C)OCCOC(=O)NCO,,,,,,
6208,106209,"Disodium 4,5-bis(isopropyl)naphthalene-1,8-disulphonate",CC(C)C1=C2C(=CC=C(C2=C(C=C1)S(=O)(=O)[O-])S(=O)(=O)[O-])C(C)C.[Na+].[Na+],,,,,,
6209,106210,"4,5-Di(propan-2-yl)naphthalene-1,8-disulfonic acid",CC(C)C1=C2C(=CC=C(C2=C(C=C1)S(=O)(=O)O)S(=O)(=O)O)C(C)C,,,,,,
6210,106211,2-(Ethyl(2-((1-oxostearyl)amino)ethyl)amino)ethyl stearate mono(ethyl sulfate),CCCCCCCCCCCCCCCCCC(=O)NCCN(CC)CCOC(=O)CCCCCCCCCCCCCCCCC.CCOS(=O)(=O)O,,,,,,
6211,106212,Octadecanoic acid 2-[ethyl[2-[(1-oxooctadecyl)amino]ethyl]amino]ethyl ester,CCCCCCCCCCCCCCCCCC(=O)NCCN(CC)CCOC(=O)CCCCCCCCCCCCCCCCC,,,,,,
6212,106213,"1,3,5-Triallyl trihydrogen benzenehexacarboxylate",C=CCOC(=O)C1=C(C(=C(C(=C1C(=O)O)C(=O)OCC=C)C(=O)O)C(=O)OCC=C)C(=O)O,,,,,,
6213,106214,CID 106214,CC(=C(C)CCC=C(C)CC#N)C,,,,,,
6214,106215,"Benzoic acid, 4-(1,1-dimethylethyl)-, 1-methylethyl ester",CC(C)OC(=O)C1=CC=C(C=C1)C(C)(C)C,,,,,,
6215,106216,2-Isopropyl-3-methylthiopyrazine,CC(C)C1=NC=CN=C1SC,,,,,,
6216,106217,2-(Methyldithio)isobutyraldehyde,CC(C)(C=O)SSC,,,,,,
6217,106218,CID 106218,CCCCCCCCC=CCBr,,,,,,
6218,106219,Silver tert-nonyl mercaptide,CC(C)(C)CC(C)(C)C[S-].[Ag+],,,,,,
6219,106220,"2,2,4,4-Tetramethylpentane-1-thiol",CC(C)(C)CC(C)(C)CS,,,,,,
6220,106221,Einecs 267-924-6,[H+].CC1=NN(C(=C1N=NC2=C(C=CC(=C2)S(=O)(=O)NC)[O-])[O-])C3=CC=C(C=C3)Cl.CC1=NN(C(=C1N=NC2=C(C=CC(=C2)S(=O)(=O)NC)[O-])[O-])C3=CC=C(C=C3)Cl.[Co+3],,,,,,
6221,106222,3-[[2-(4-chlorophenyl)-5-methyl-3-oxo-1H-pyrazol-4-yl]diazenyl]-4-hydroxy-N-methylbenzenesulfonamide,CC1=C(C(=O)N(N1)C2=CC=C(C=C2)Cl)N=NC3=C(C=CC(=C3)S(=O)(=O)NC)O,,,,,,
6222,106223,Einecs 267-926-7,CC(=O)NC1=C2C(=CC(=C1)S(=O)(=O)[O-])C=C(C(=C2[O-])N=NC3=C(C=C(C=C3)C4=CC(=C(C=C4)N=NC5=C(C6=C(C=C(C=C6C=C5S(=O)(=O)[O-])S(=O)(=O)[O-])N)[O-])[O-])[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Cu+2].[Cu+2],,,,,,
6223,106224,"3-[[4-[4-[(8-Acetamido-1-hydroxy-3,6-disulfonaphthalen-2-yl)diazenyl]-3-hydroxyphenyl]-2-hydroxyphenyl]diazenyl]-5-amino-4-hydroxynaphthalene-2,7-disulfonic acid",CC(=O)NC1=C2C(=CC(=C1)S(=O)(=O)O)C=C(C(=C2O)N=NC3=C(C=C(C=C3)C4=CC(=C(C=C4)N=NC5=C(C6=C(C=C(C=C6C=C5S(=O)(=O)O)S(=O)(=O)O)N)O)O)O)S(=O)(=O)O,,,,,,
6224,106225,3-Chloro-4-methylbenzylamine,CC1=C(C=C(C=C1)CN)Cl,,,,,,
6225,106226,"Benzenemethanamine, N-ethyl-2-methoxy-N-[(2-methoxyphenyl)methyl]-",CCN(CC1=CC=CC=C1OC)CC2=CC=CC=C2OC,,,,,,
6226,106227,"1,3-Propanediamine, N,N'-diethyl-N-[3-(ethylamino)propyl]-",CCNCCCN(CC)CCCNCC,,,,,,
6227,106228,"N,N,N',N',2-Pentamethylpropane-1,3-diamine",CC(CN(C)C)CN(C)C,,,,,,
6228,106229,"1,2-Benzenedicarboxylic acid, monotridecyl ester, aluminum salt",CCCCCCCCCCCCCOC(=O)C1=CC=CC=C1C(=O)[O-].CCCCCCCCCCCCCOC(=O)C1=CC=CC=C1C(=O)[O-].CCCCCCCCCCCCCOC(=O)C1=CC=CC=C1C(=O)[O-].[Al+3],,,,,,
6229,106230,2-tridecoxycarbonylbenzoic Acid,CCCCCCCCCCCCCOC(=O)C1=CC=CC=C1C(=O)O,,,,,,
6230,106231,"N-(3-aminopropyl)but-2-ene-1,4-diamine",C(CN)CNCC=CCN,,,,,,
6231,106232,"4,7-Benzothiazoledisulfonic acid, 2-(4-aminophenyl)-6-methyl-",CC1=CC(=C2C(=C1S(=O)(=O)O)SC(=N2)C3=CC=C(C=C3)N)S(=O)(=O)O,,,,,,
6232,106233,"Propanediamide, N,N'-bis(2,3-dichlorophenyl)-2-[(9,10-dihydro-9,10-dioxo-1-anthracenyl)azo]-",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=CC=C3)N=NC(C(=O)NC4=C(C(=CC=C4)Cl)Cl)C(=O)NC5=C(C(=CC=C5)Cl)Cl,,,,,,
6233,106234,Trimethylolethane monononanoate,CCCCCCCCC(=O)OCC(C)(CO)CO,,,,,,
6234,106235,"Sulfuric acid, monododecyl ester, compd. with 2-(dibutylamino)ethanol (1:1)",CCCCCCCCCCCCOS(=O)(=O)O.CCCCN(CCCC)CCO,,,,,,
6235,106236,CID 106236,CC(C)COP(=O)([O-])OCC(C)C.[K+],,,,,,
6236,106237,"Octadecanamide, N-(2-((2-((2-((2-aminoethyl)amino)ethyl)amino)ethyl)amino)ethyl)-, monoacetate",CCCCCCCCCCCCCCCCCC(=O)NCCNCCNCCNCCN.CC(=O)O,,,,,,
6237,106238,"Phosphoric acid, bis(4-methylpentyl) ester, compd. with tris(2-hydroxyethyl)amine (1:1)",CC(C)CCCOP(=O)(O)OCCCC(C)C.C(CO)N(CCO)CCO,,,,,,
6238,106239,Phosphoric acid hydrogen bis(4-methylpentyl) ester,CC(C)CCCOP(=O)(O)OCCCC(C)C,,,,,,
6239,106240,CID 106240,CCCCCCCCC=CCCCCCCCC(=O)N(CCO)CCOC(=O)C=CC(=O)O.C(CO)NCCO,,,,,,
6240,106241,4-[2-[2-Hydroxyethyl(octadec-9-enoyl)amino]ethoxy]-4-oxobut-2-enoic acid,CCCCCCCCC=CCCCCCCCC(=O)N(CCO)CCOC(=O)C=CC(=O)O,,,,,,
6241,106242,Ammonium 4-butylnaphthalene-1-sulphonate,CCCCC1=CC=C(C2=CC=CC=C12)S(=O)(=O)O.N,,,,,,
6242,106243,4-Butyl-1-naphthalenesulfonic acid,CCCCC1=CC=C(C2=CC=CC=C12)S(=O)(=O)O,,,,,,
6243,106244,"1-Nonanol, 8-methyl-, hydrogen phosphate",CC(C)CCCCCCCOP(=O)(O)OCCCCCCCC(C)C,,,,,,
6244,106245,"Imidazo[4,5-d]imidazole-2,5(1H,3H)-dione, tetrahydro-1,3-bis(hydroxymethyl)-",C(N1C2C(NC(=O)N2)N(C1=O)CO)O,,,,,,
6245,106246,Bis(beta-(2-heptadecyl-1-imidazolinyl)ethyl)ammonium acetate,CCCCCCCCCCCCCCCCCC1=NCCN1CCNCCN2CCN=C2CCCCCCCCCCCCCCCCC.CC(=O)O,,,,,,
6246,106247,"1,1'-(Iminobisethylene)bis(2-heptadecyl-4,5-dihydro-1H-imidazole)",CCCCCCCCCCCCCCCCCC1=NCCN1CCNCCN2CCN=C2CCCCCCCCCCCCCCCCC,,,,,,
6247,106248,"Benzenediazonium, 4-(ethyl(2-hydroxyethyl)amino)-2-methyl-, trichlorozincate(1-)",CCN(CCO)C1=CC(=C(C=C1)[N+]#N)C.[Cl-].[Cl-].[Cl-].[Zn],,,,,,
6248,106249,(Dibutylamino)methanol,CCCCN(CCCC)CO,,,,,,
6249,106250,"2-Anthracenesulfonic acid, 1-amino-9,10-dihydro-4-[(4-hydroxyphenyl)amino]-9,10-dioxo-",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3NC4=CC=C(C=C4)O)S(=O)(=O)O)N,,,,,,
6250,106251,"4-Methyl-2-(1-methylpropyl)-1,3-dioxane",CCC(C)C1OCCC(O1)C,,,,,,
6251,106252,"1-Hexanesulfonamide, N-ethyl-1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-N-[2-(phosphonooxy)ethyl]-",CCN(CCOP(=O)(O)O)S(=O)(=O)C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
6252,106253,"4-((2-Ethoxyphenyl)azo)-2,4-dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one",CCOC1=CC=CC=C1N=NC2C(=NN(C2=O)C3=CC=CC=C3)C,,,,,,
6253,106254,Diammonium N-ethylheptadecafluoro-N-(2-(phosphonatooxy)ethyl)octanesulphonamidate,CCN(CCOP(=O)(O)O)S(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F.N.N,,,,,,
6254,106255,"2,7-Naphthalenedisulfonic acid, 3-((2,4-diaminophenyl)azo)-5-hydroxy-, disodium salt",C1=CC(=C(C=C1N)N)N=NC2=CC3=C(C=C(C=C3C=C2S(=O)(=O)[O-])S(=O)(=O)[O-])O.[Na+].[Na+],,,,,,
6255,106256,"3-[(2,4-Diaminophenyl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid",C1=CC(=C(C=C1N)N)N=NC2=CC3=C(C=C(C=C3C=C2S(=O)(=O)O)S(=O)(=O)O)O,,,,,,
6256,106257,"Thiodicarbonic acid ((HO)C(O)SC(S)(OH)), 1-ethyl 3-(1-methylethyl) ester",CCOC(=O)SC(=S)OC(C)C,,,,,,
6257,106258,"3,3-Bis(bromomethyl)pentane",CCC(CC)(CBr)CBr,,,,,,
6258,106259,2-(Dibutylamino)ethanol;octadec-9-enyl dihydrogen phosphate,CCCCCCCCC=CCCCCCCCCOP(=O)(O)O.CCCCN(CCCC)CCO,,,,,,
6259,106260,"Phosphoric acid, monodecyl ester, compd. with 2-(dibutylamino)ethanol",CCCCCCCCCCOP(=O)(O)O.CCCCN(CCCC)CCO,,,,,,
6260,106261,"1,3-Naphthalenedisulfonic acid, 7-((4-((((2-methoxy-4-((3-sulfophenyl)azo)phenyl)amino)carbonyl)amino)-2-methylphenyl)azo)-, trisodium salt",CC1=C(C=CC(=C1)NC(=O)NC2=C(C=C(C=C2)N=NC3=CC(=CC=C3)S(=O)(=O)[O-])OC)N=NC4=CC5=C(C=C(C=C5C=C4)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
6261,106262,"7-({4-[({2-Methoxy-4-[(3-sulfophenyl)diazenyl]phenyl}carbamoyl)amino]-2-methylphenyl}diazenyl)naphthalene-1,3-disulfonic acid",CC1=C(C=CC(=C1)NC(=O)NC2=C(C=C(C=C2)N=NC3=CC(=CC=C3)S(=O)(=O)O)OC)N=NC4=CC5=C(C=C(C=C5C=C4)S(=O)(=O)O)S(=O)(=O)O,,,,,,
6262,106263,CID 106263,CC1=CC=C(C=C1)S(=O)(=O)OC2=CC=C(C=C2)NC3=CC(=C(C4=C3C(=O)C5=CC=CC=C5C4=O)N)S(=O)(=O)[O-].[Na+],,,,,,
6263,106264,"2-Anthracenesulfonic acid, 1-amino-4-[[4-[[(4-methylphenyl)sulfonyl]oxy]phenyl]amino]-9,10-dihydro-9,10-dioxo-",CC1=CC=C(C=C1)S(=O)(=O)OC2=CC=C(C=C2)NC3=CC(=C(C4=C3C(=O)C5=CC=CC=C5C4=O)N)S(=O)(=O)O,,,,,,
6264,106265,5-(Acetylamino)-2-sulphobenzenediazonium chloride,CC(=O)NC1=CC(=C(C=C1)S(=O)(=O)O)[N+]#N.[Cl-],,,,,,
6265,106266,5-Acetylamino-2-sulfobenzenediazonium,CC(=O)NC1=CC(=C(C=C1)S(=O)(=O)O)[N+]#N,,,,,,
6266,106267,"Benzenediazonium, 4-((4-sulfophenyl)azo)-, chloride",C1=CC(=CC=C1N=NC2=CC=C(C=C2)S(=O)(=O)O)[N+]#N.[Cl-],,,,,,
6267,106268,4-[(4-Sulfophenyl)diazenyl]benzenediazonium,C1=CC(=CC=C1N=NC2=CC=C(C=C2)S(=O)(=O)O)[N+]#N,,,,,,
6268,106269,CID 106269,C1=CC(=CC(=C1)Cl)C(=O)NC2=CC(=C(C=C2)S(=O)(=O)[O-])N.[Na+],,,,,,
6269,106270,2-Amino-4-[(3-chlorobenzoyl)amino]benzenesulfonic acid,C1=CC(=CC(=C1)Cl)C(=O)NC2=CC(=C(C=C2)S(=O)(=O)O)N,,,,,,
6270,106271,Trisodium 6-amino-3-((4-((4-((7-amino-1-hydroxy-3-sulphonato-2-naphthyl)azo)phenyl)amino)-3-sulphonatophenyl)azo)-4-hydroxynaphthalene-2-sulphonate,C1=CC(=CC=C1NC2=C(C=C(C=C2)N=NC3=C(C=C4C=CC(=CC4=C3O)N)S(=O)(=O)[O-])S(=O)(=O)[O-])N=NC5=C(C=C6C=CC(=CC6=C5O)N)S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
6271,106272,6-Amino-3-[p-[4-(7-amino-1-hydroxy-3-sulfo-2-naphthylazo)-2-sulfoanilino]phenylazo]-4-hydroxy-2-naphthalenesulfonic acid,C1=CC(=CC=C1NC2=C(C=C(C=C2)N=NC3=C(C=C4C=CC(=CC4=C3O)N)S(=O)(=O)O)S(=O)(=O)O)N=NC5=C(C=C6C=CC(=CC6=C5O)N)S(=O)(=O)O,,,,,,
6272,106273,5-(Benzoylamino)-2-sulphobenzenediazonium chloride,C1=CC=C(C=C1)C(=O)NC2=CC(=C(C=C2)S(=O)(=O)O)[N+]#N.[Cl-],,,,,,
6273,106274,5-Benzoylamino-2-sulfobenzenediazonium,C1=CC=C(C=C1)C(=O)NC2=CC(=C(C=C2)S(=O)(=O)O)[N+]#N,,,,,,
6274,106275,"1-Naphthalenediazonium, 4-((4,8-disulfo-2-naphthalenyl)azo)-, chloride",C1=CC=C2C(=C1)C(=CC=C2[N+]#N)N=NC3=CC4=C(C=CC=C4S(=O)(=O)O)C(=C3)S(=O)(=O)O.[Cl-],,,,,,
6275,106276,"4-[(4,8-Disulfo-2-naphthalenyl)azo]-1-naphthalenediazonium",C1=CC=C2C(=C1)C(=CC=C2[N+]#N)N=NC3=CC4=C(C=CC=C4S(=O)(=O)O)C(=C3)S(=O)(=O)O,,,,,,
6276,106277,CID 106277,CC1=C(C(=CC=C1)NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)[O-])OC.[Na+],,,,,,
6277,106278,"1-Amino-4-(2-methoxy-3-methylanilino)-9,10-dioxoanthracene-2-sulfonic acid",CC1=C(C(=CC=C1)NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)O)OC,,,,,,
6278,106279,"Benzenediazonium, 4-[2-(4-nitro-2-sulfophenyl)ethenyl]-3-sulfo-, chloride",C1=CC(=C(C=C1[N+]#N)S(=O)(=O)O)C=CC2=C(C=C(C=C2)[N+](=O)[O-])S(=O)(=O)O.[Cl-],,,,,,
6279,106280,CID 106280,C1=CC(=C(C=C1[N+]#N)S(=O)(=O)O)C=CC2=C(C=C(C=C2)[N+](=O)[O-])S(=O)(=O)O,,,,,,
6280,106281,"Octadecanamide, N-[2-[(aminocarbonyl)(2-hydroxyethyl)amino]ethyl]-",CCCCCCCCCCCCCCCCCC(=O)NCCN(CCO)C(=O)N,,,,,,
6281,106282,CID 106282,C1=CC=C2C(=C1)N=C(O2)SCCCS(=O)(=O)[O-].[Na+],,,,,,
6282,106283,"3-(1,3-Benzoxazol-2-ylthio)propane-1-sulfonic acid",C1=CC=C2C(=C1)N=C(O2)SCCCS(=O)(=O)O,,,,,,
6283,106284,"1,4-Bis(2-sulfo-p-toluidino)anthraquinone, diammonium salt",CC1=CC(=C(C=C1)NC2=C3C(=C(C=C2)NC4=C(C=C(C=C4)C)S(=O)(=O)O)C(=O)C5=CC=CC=C5C3=O)S(=O)(=O)O.N.N,,,,,,
6284,106285,"Poly(oxy-1,2-ethanediyl), alpha-hexyl-omega-hydroxy-, phosphate",CCCCCCOCCOP(=O)(O)O.OP(=O)(O)O,,,,,,
6285,106286,2-(Hexyloxy)ethyl dihydrogen phosphate,CCCCCCOCCOP(=O)(O)O,,,,,,
6286,106287,2-Decoxycarbonyl-5-octoxycarbonylbenzoic acid,CCCCCCCCCCOC(=O)C1=C(C=C(C=C1)C(=O)OCCCCCCCC)C(=O)O,,,,,,
6287,106288,"3-Hydroxy-2,2-dimethylpropyl octadec-9-enoate",CCCCCCCCC=CCCCCCCCC(=O)OCC(C)(C)CO,,,,,,
6288,106289,CID 106289,CC(C)CCCCCOCC(COCCCCCC(C)C)OS(=O)(=O)[O-].[Na+],,,,,,
6289,106290,"1,3-Bis[(6-methylheptyl)oxy]propan-2-yl hydrogen sulfate",CC(C)CCCCCOCC(COCCCCCC(C)C)OS(=O)(=O)O,,,,,,
6290,106291,CID 106291,[H+].CC([N-]C1=CC(=O)C(=NN=C2C(=O)C=CC3=C2C(=CC=C3)[N-]C(C)[O-])C=C1[N+](=O)O)O.CC(=O)NC1=CC=CC2=C1C(=NN=C3C=C(C(=CC3=O)NC(=O)C)N([O-])[O-])C(=O)C=C2.[Cr+3],,,,,,
6291,106292,CID 106292,CC(=O)NC1=CC=CC2=C1C(=NN=C3C=C(C(=CC3=O)NC(=O)C)N([O-])[O-])C(=O)C=C2,,,,,,
6292,106293,CID 106293,CC(NC1=CC=CC2=C1C(=NN=C3C=C(C(=CC3=O)NC(C)O)[N+](=O)O)C(=O)C=C2)O,,,,,,
6293,106294,Oleyl isostearate,CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C,,,,,,
6294,106295,Edetate diammonium copper,C(CN(CC(=O)O)CC(=O)[O-])N(CC(=O)O)CC(=O)[O-].N.N.[Cu+2],,,,,,
6295,106296,"Platinum(2+), bis(1,2-ethanediamine-kappaN,kappaN')-, (SP-4-1)-, bis(bis(cyano-kappaC)aurate(1-))",[C-]#N.[C-]#N.[C-]#N.[C-]#N.C(CN)N.C(CN)N.[Pt+2].[Au+].[Au+],,,,,,
6296,106297,"1,3-Dioxacyclotridecan-2-one",C1CCCCCOC(=O)OCCCC1,,,,,,
6297,106298,"2,6-Dimethyl-4-nonylphenol",CCCCCCCCCC1=CC(=C(C(=C1)C)O)C,,,,,,
6298,106299,"4,7,10,13-Tetraazahexadecanedinitrile",C(CNCCNCCNCCNCCC#N)C#N,,,,,,
6299,106300,N-(5-Chloro-2-methoxyphenyl)-3-hydroxy-4-[[2-methoxy-5-[(phenylamino)carbonyl]phenyl]azo]naphthalene-2-carboxamide,COC1=C(C=C(C=C1)Cl)NC(=O)C2=CC3=CC=CC=C3C(=C2O)N=NC4=C(C=CC(=C4)C(=O)NC5=CC=CC=C5)OC,,,,,,
6300,106301,4-[[5-(Aminocarbonyl)-2-chlorophenyl]azo]-3-hydroxy-N-phenylnaphthalene-2-carboxamide,C1=CC=C(C=C1)NC(=O)C2=CC3=CC=CC=C3C(=C2O)N=NC4=C(C=CC(=C4)C(=O)N)Cl,,,,,,
6301,106302,"2-Naphthalenecarboxamide, 3-hydroxy-4-[(2-methoxy-5-nitrophenyl)azo]-N-(2-methoxyphenyl)-",COC1=C(C=C(C=C1)[N+](=O)[O-])N=NC2=C(C(=CC3=CC=CC=C32)C(=O)NC4=CC=CC=C4OC)O,,,,,,
6302,106303,"4-Imidazolidinone, 1-ethyl-5-[(1-ethyl-2-pyrrolidinylidene)ethylidene]-3-methyl-2-thioxo-",CCN1CCCC1=CC=C2C(=O)N(C(=S)N2CC)C,,,,,,
6303,106304,"Benzenesulfonic acid, 3-amino-4-(tetradecyloxy)-",CCCCCCCCCCCCCCOC1=C(C=C(C=C1)S(=O)(=O)O)N,,,,,,
6304,106305,n-[2-(Tetradecyloxy)phenyl]acetamide,CCCCCCCCCCCCCCOC1=CC=CC=C1NC(=O)C,,,,,,
6305,106306,"Benzoxazolium, 3-ethyl-5,6-dimethyl-2-[2-(phenylamino)ethenyl]-, iodide",CC[N+]1=C(OC2=C1C=C(C(=C2)C)C)C=CNC3=CC=CC=C3.[I-],,,,,,
6306,106307,"3-Ethyl-5,6-dimethyl-2-[2-(phenylamino)ethenyl]benzoxazol-3-ium",CC[N+]1=C(OC2=C1C=C(C(=C2)C)C)C=CNC3=CC=CC=C3,,,,,,
6307,106308,"1-Propanol, 3-[(2-amino-4,5-dichlorophenyl)amino]-",C1=C(C(=CC(=C1Cl)Cl)NCCCO)N,,,,,,
6308,106309,"2H-Pyrrolium, 1-ethyl-3,4-dihydro-5-methyl-, perchlorate",CC[N+]1=C(CCC1)C.[O-]Cl(=O)(=O)=O,,,,,,
6309,106310,1-Ethyl-2-methyl-1-pyrroline-1-ium,CC[N+]1=C(CCC1)C,,,,,,
6310,106311,CID 106311,CCCCOCCOCC(=O)[O-].[Na+],,,,,,
6311,106312,2-(2-butoxyethoxy)acetic Acid,CCCCOCCOCC(=O)O,,,,,,
6312,106313,CID 106313,CCCCCCOCCOCCOCC(=O)[O-].[Na+],,,,,,
6313,106314,2-[2-(2-Hexoxyethoxy)ethoxy]acetic acid,CCCCCCOCCOCCOCC(=O)O,,,,,,
6314,106315,CID 106315,C1=CC=C(C(=C1)C(=O)[O-])NCC(=O)O.[Na+],,,,,,
6315,106316,"Cyclopropanamine, N-methyl-N-propyl-",CCCN(C)C1CC1,,,,,,
6316,106317,CID 106317,C1=CC=C(C=C1)N=NC2=C(C(=NN=C3C=CC(=O)C(=C3)C(=O)[O-])C(=O)C4=C2C=C(C(=NNC5=CC=C(C=C5)N(O)O)C4=N)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
6317,106318,CID 106318,C1=CC=C(C=C1)N=NC2=C(C(=NN=C3C=CC(=O)C(=C3)C(=O)O)C(=O)C4=C2C=C(C(=NNC5=CC=C(C=C5)N(O)O)C4=N)S(=O)(=O)O)S(=O)(=O)O,,,,,,
6318,106319,CID 106319,C1=CC=C(C=C1)N=NC2=C(C(=NNC3=CC(=C(C=C3)O)C(=O)[O-])C(=O)C4=C2C=C(C(=NNC5=CC=C(C=C5)N)C4=N)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
6319,106320,CID 106320,C1=CC=C(C=C1)N=NC2=C(C(=NNC3=CC(=C(C=C3)O)C(=O)O)C(=O)C4=C2C=C(C(=NNC5=CC=C(C=C5)N)C4=N)S(=O)(=O)O)S(=O)(=O)O,,,,,,
6320,106321,CID 106321,COC1=CC=C(C=C1)N=NC2=C(C=C3C=C(C=CC3=C2O)NC(=O)C4=CC=C(C=C4)N)S(=O)(=O)[O-].[Na+],,,,,,
6321,106322,7-[(4-Aminobenzoyl)amino]-4-hydroxy-3-[(4-methoxyphenyl)diazenyl]naphthalene-2-sulfonic acid,COC1=CC=C(C=C1)N=NC2=C(C=C3C=C(C=CC3=C2O)NC(=O)C4=CC=C(C=C4)N)S(=O)(=O)O,,,,,,
6322,106323,CID 106323,CC1=CC(=C(C=C1)OC)N=NC2=C(C=C3C=C(C=CC3=C2O)NC(=O)C4=CC=C(C=C4)N)S(=O)(=O)[O-].[Na+],,,,,,
6323,106324,7-[(4-Aminobenzoyl)amino]-4-hydroxy-3-[(2-methoxy-5-methylphenyl)diazenyl]naphthalene-2-sulfonic acid,CC1=CC(=C(C=C1)OC)N=NC2=C(C=C3C=C(C=CC3=C2O)NC(=O)C4=CC=C(C=C4)N)S(=O)(=O)O,,,,,,
6324,106325,"Benzene, 2,5-dibromo-1-methoxy-3-methyl-",CC1=CC(=CC(=C1Br)OC)Br,,,,,,
6325,106326,"Bis(2,4,6-tribromophenyl) carbonate",C1=C(C=C(C(=C1Br)OC(=O)OC2=C(C=C(C=C2Br)Br)Br)Br)Br,,,,,,
6326,106327,"1,2-Dimethyl-3-(benzyl)-5-(trifluoromethyl)-1H-benzimidazolium bromide",CC1=[N+](C2=C(N1CC3=CC=CC=C3)C=C(C=C2)C(F)(F)F)C.[Br-],,,,,,
6327,106328,"1,2-Dimethyl-3-phenylmethyl-5-trifluoromethyl-1H-benzimidazol-3-ium",CC1=[N+](C2=C(N1CC3=CC=CC=C3)C=C(C=C2)C(F)(F)F)C,,,,,,
6328,106329,"1,5-Naphthalenedisulfonic acid, 3-[(2-hydroxy-1-naphthalenyl)azo]-, barium salt (1:1)",C1=CC=C2C(=C1)C=CC(=C2N=NC3=CC4=C(C=CC=C4S(=O)(=O)[O-])C(=C3)S(=O)(=O)[O-])O.[Ba+2],,,,,,
6329,106330,"3-[(2-Hydroxy-1-naphthalenyl)azo]-1,5-naphthalenedisulfonic acid",C1=CC=C2C(=C1)C=CC(=C2N=NC3=CC4=C(C=CC=C4S(=O)(=O)O)C(=C3)S(=O)(=O)O)O,,,,,,
6330,106331,"Benzenesulfonic acid, 5-chloro-2-[(2-hydroxy-1-naphthalenyl)azo]-4-methyl-, calcium salt (2:1)",CC1=CC(=C(C=C1Cl)S(=O)(=O)[O-])N=NC2=C(C=CC3=CC=CC=C32)O.CC1=CC(=C(C=C1Cl)S(=O)(=O)[O-])N=NC2=C(C=CC3=CC=CC=C32)O.[Ca+2],,,,,,
6331,106332,"1,5-Naphthalenedisulfonic acid, 3-[(1-hydroxy-2-naphthalenyl)azo]-, barium salt (1:1)",C1=CC=C2C(=C1)C=CC(=C2O)N=NC3=CC4=C(C=CC=C4S(=O)(=O)[O-])C(=C3)S(=O)(=O)[O-].[Ba+2],,,,,,
6332,106333,"3-[(1-Hydroxynaphthalen-2-yl)diazenyl]naphthalene-1,5-disulfonic acid",C1=CC=C2C(=C1)C=CC(=C2O)N=NC3=CC4=C(C=CC=C4S(=O)(=O)O)C(=C3)S(=O)(=O)O,,,,,,
6333,106334,"1,5-Naphthalenedisulfonic acid, 2-[(2-hydroxy-1-naphthalenyl)azo]-, calcium salt (1:1)",C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C4=C(C=C3)C(=CC=C4)S(=O)(=O)[O-])S(=O)(=O)[O-])O.[Ca+2],,,,,,
6334,106335,CID 106335,C(CCCCCCCCC(=O)O)CCCCCCCCS(=O)(=O)[O-].[Na+],,,,,,
6335,106336,18-sulfooctadecanoic Acid,C(CCCCCCCCC(=O)O)CCCCCCCCS(=O)(=O)O,,,,,,
6336,106337,"9,12-Octadecadienenitrile, (Z,Z)-",CCCCCC=CCC=CCCCCCCCC#N,,,,,,
6337,106338,"Benzenediazonium, 4-((2-chloro-5-sulfophenyl)azo)-, chloride",C1=CC(=CC=C1N=NC2=C(C=CC(=C2)S(=O)(=O)O)Cl)[N+]#N.[Cl-],,,,,,
6338,106339,4-[(2-Chloro-5-sulfophenyl)diazenyl]benzenediazonium,C1=CC(=CC=C1N=NC2=C(C=CC(=C2)S(=O)(=O)O)Cl)[N+]#N,,,,,,
6339,106340,"1,3,5-Triazine-2,4-disulfenamide, 6-(diethylamino)-",CCN(CC)C1=NC(=NC(=N1)SN)SN,,,,,,
6340,106341,"Tetradec-1-ene-1,14-disulfonic acid",C(CCCCCCS(=O)(=O)O)CCCCCC=CS(=O)(=O)O,,,,,,
6341,106342,"Octadecanamide, N-(2-cyanoethyl)-N-(2-((2-((1-oxooctadecyl)amino)ethyl)amino)ethyl)-",CCCCCCCCCCCCCCCCCC(=O)NCCNCCN(CCC#N)C(=O)CCCCCCCCCCCCCCCCC,,,,,,
6342,106343,"7,8,9,10,11,12,20,21,22,23,24,25-Dodecahydrodibenzo[i,t][1,4,7,12,15,18]hexaazacyclodocosine-5,13,18,26(6h,19h)-tetrone",C1CNC(=O)C2=CC=CC=C2C(=O)NCCNCCNC(=O)C3=CC=CC=C3C(=O)NCCN1,,,,,,
6343,106344,Bis(2-(2-hydroxyethoxy)ethyl)octylamine,CCCCCCCCN(CCOCCO)CCOCCO,,,,,,
6344,106345,"2-Naphthalenesulfonic acid, 7-amino-4-[[(4-methylphenyl)sulfonyl]oxy]-",CC1=CC=C(C=C1)S(=O)(=O)OC2=C3C=CC(=CC3=CC(=C2)S(=O)(=O)O)N,,,,,,
6345,106346,"Benzoic acid, 2-hydroxy-5-[[(8-hydroxy-3,6-disulfo-1-naphthalenyl)amino]sulfonyl]-",C1=CC(=C(C=C1S(=O)(=O)NC2=C3C(=CC(=C2)S(=O)(=O)O)C=C(C=C3O)S(=O)(=O)O)C(=O)O)O,,,,,,
6346,106347,"2-Naphthalenesulfonic acid, 7-amino-4-[(phenylsulfonyl)oxy]-",C1=CC=C(C=C1)S(=O)(=O)OC2=C3C=CC(=CC3=CC(=C2)S(=O)(=O)O)N,,,,,,
6347,106348,2-Amino-N-ethyl-5-methyl-N-phenylbenzenesulphonamide,CCN(C1=CC=CC=C1)S(=O)(=O)C2=C(C=CC(=C2)C)N,,,,,,
6348,106349,"1-Naphthalenesulfonic acid, 5-hydroxy-4-(phenylamino)-",C1=CC=C(C=C1)NC2=C3C(=C(C=C2)S(=O)(=O)O)C=CC=C3O,,,,,,
6349,106350,"Benzoic acid, 2-[[(4-chloro-3-nitrophenyl)sulfonyl]amino]-",C1=CC=C(C(=C1)C(=O)O)NS(=O)(=O)C2=CC(=C(C=C2)Cl)[N+](=O)[O-],,,,,,
6350,106351,"Benzenesulfonamide, N-ethyl-2-methyl-5-nitro-N-phenyl-",CCN(C1=CC=CC=C1)S(=O)(=O)C2=C(C=CC(=C2)[N+](=O)[O-])C,,,,,,
6351,106352,"Benzenesulfonamide, N-(2-hydroxyethyl)-2-methyl-5-nitro-",CC1=C(C=C(C=C1)[N+](=O)[O-])S(=O)(=O)NCCO,,,,,,
6352,106353,1-Cyclohexyl-4-(4-nitrophenoxy)benzene,C1CCC(CC1)C2=CC=C(C=C2)OC3=CC=C(C=C3)[N+](=O)[O-],,,,,,
6353,106354,"Benzenesulfonamide, 3-(4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)-N-(2-hydroxyethyl)-",CC1=NN(C(=O)C1)C2=CC(=CC=C2)S(=O)(=O)NCCO,,,,,,
6354,106355,"beta-Alanine, N-[4-(cyclohexylamino)-9,10-dihydro-9,10-dioxo-1-anthracenyl]-",C1CCC(CC1)NC2=C3C(=C(C=C2)NCCC(=O)O)C(=O)C4=CC=CC=C4C3=O,,,,,,
6355,106356,Disodium 2-dodecyl 4-sulphonatophthalate,CCCCCCCCCCCCOC(=O)C1=C(C=CC(=C1)S(=O)(=O)[O-])C(=O)[O-].[Na+].[Na+],,,,,,
6356,106357,2-Dodecoxycarbonyl-4-sulfobenzoic acid,CCCCCCCCCCCCOC(=O)C1=C(C=CC(=C1)S(=O)(=O)O)C(=O)O,,,,,,
6357,106358,"Glycine, N-methyl-N-(1-oxododecyl)-, ammonium salt",CCCCCCCCCCCC(=O)N(C)CC(=O)O.N,,,,,,
6358,106359,"9-Phenanthrenol, 10-(2-pyrimidinylazo)-",C1=CC=C2C(=C1)C3=CC=CC=C3C(=C2N=NC4=NC=CC=N4)O,,,,,,
6359,106360,"1-Propanaminium, 3-[[[4-[3-(4-chlorophenyl)-4,5-dihydro-1H-pyrazol-1-yl]phenyl]sulfonyl]amino]-N-(2-hydroxyethyl)-N,N-dimethyl-, formate (salt)",C[N+](C)(CCCNS(=O)(=O)C1=CC=C(C=C1)N2CCC(=N2)C3=CC=C(C=C3)Cl)CCO.C(=O)[O-],,,,,,
6360,106361,"3-[[[4-[[4,5-Dihydro-3-(4-chlorophenyl)-1H-pyrazol]-1-yl]phenyl]sulfonyl]amino]-N-(2-hydroxyethyl)-N,N-dimethyl-1-propanaminium",C[N+](C)(CCCNS(=O)(=O)C1=CC=C(C=C1)N2CCC(=N2)C3=CC=C(C=C3)Cl)CCO,,,,,,
6361,106362,"2,7-Naphthalenedisulfonic acid, 4-[[4-[[[(5-hydroxy-7-sulfo-2-naphthalenyl)amino]carbonyl]amino]-5-methoxy-2-methylphenyl]azo]-6-[(phenylsulfonyl)oxy]-",CC1=CC(=C(C=C1N=NC2=C3C=C(C(=CC3=CC(=C2)S(=O)(=O)O)S(=O)(=O)O)OS(=O)(=O)C4=CC=CC=C4)OC)NC(=O)NC5=CC6=CC(=CC(=C6C=C5)O)S(=O)(=O)O,,,,,,
6362,106363,"Isopropylidenedi-1,4-phenylene bis(2-aminobenzenesulphonate)",CC(C)(C1=CC=C(C=C1)OS(=O)(=O)C2=CC=CC=C2N)C3=CC=C(C=C3)OS(=O)(=O)C4=CC=CC=C4N,,,,,,
6363,106364,"2-Amino-N-(3,4-dimethylphenyl)-2-oxoethanimidic acid",CC1=C(C=C(C=C1)NC(=O)C(=O)N)C,,,,,,
6364,106365,"Manganate(2-), [[N,N'-1,2-ethanediylbis[N-[(carboxy-kappaO)methyl]glycinato-kappaN,kappaO]](4-)]-, dipotassium, (OC-6-21)-",C(CN(CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].[K+].[K+].[Mn+2],,,,,,
6365,106366,Nitrilotriacetic acid ammonium zinc salt,C(C(=O)O)N(CC(=O)[O-])CC(=O)[O-].N.[Zn+2],,,,,,
6366,106367,CID 106367,C1=CC=C(C(=C1)N=NC2=C(C3=C(C=C(C=C3C=C2S(=O)(=O)[O-])S(=O)(=O)[O-])N=NC4=C(C=C(C(=C4)N=NC5=CC=C(C=C5)NC6=C(C=C(C=C6)N=NC7=CC(=C(C=C7)[O-])C(=O)[O-])S(=O)(=O)[O-])O)O)[O-])O.[Na+].[Na+].[Na+].[Na+].[Cu+2],,,,,,
6367,106368,"5-[[4-[4-[[2,4-Dihydroxy-5-[[8-hydroxy-7-[(2-hydroxyphenyl)diazenyl]-3,6-disulfonaphthalen-1-yl]diazenyl]phenyl]diazenyl]anilino]-3-sulfophenyl]diazenyl]-2-hydroxybenzoic acid",C1=CC=C(C(=C1)N=NC2=C(C3=C(C=C(C=C3C=C2S(=O)(=O)O)S(=O)(=O)O)N=NC4=C(C=C(C(=C4)N=NC5=CC=C(C=C5)NC6=C(C=C(C=C6)N=NC7=CC(=C(C=C7)O)C(=O)O)S(=O)(=O)O)O)O)O)O,,,,,,
6368,106369,Tribenzylammonium acetate,CC(=O)O.C1=CC=C(C=C1)CN(CC2=CC=CC=C2)CC3=CC=CC=C3,,,,,,
6369,106370,"Hexanoic acid, 2,2,3,3,4,4,5,6,6,6-decafluoro-5-(trifluoromethyl)-, compd. with ethanamine (1:1)",CCN.C(=O)(C(C(C(C(C(F)(F)F)(C(F)(F)F)F)(F)F)(F)F)(F)F)O,,,,,,
6370,106371,"Decanoic acid, 2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,10,10,10-octadecafluoro-9-(trifluoromethyl)-, compd. with ethanamine (1:1)",CCN.C(=O)(C(C(C(C(C(C(C(C(C(F)(F)F)(C(F)(F)F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)O,,,,,,
6371,106372,"Octanoic acid, 2,2,3,3,4,4,5,5,6,6,7,8,8,8-tetradecafluoro-7-(trifluoromethyl)-, compd. with ethanamine (1:1)",CCN.C(=O)(C(C(C(C(C(C(C(F)(F)F)(C(F)(F)F)F)(F)F)(F)F)(F)F)(F)F)(F)F)O,,,,,,
6372,106373,"Dodecanoic acid, 2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,12,12,12-docosafluoro-11-(trifluoromethyl)-, compd. with ethanamine (1:1)",CCN.C(=O)(C(C(C(C(C(C(C(C(C(C(C(F)(F)F)(C(F)(F)F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)O,,,,,,
6373,106374,"Benzenediazonium, 3-methoxy-4-(1-pyrrolidinyl)-, salt with 2-hydroxy-5-sulfobenzoic acid (1:1)",COC1=C(C=CC(=C1)[N+]#N)N2CCCC2.C1=CC(=C(C=C1S(=O)(=O)[O-])C(=O)O)O,,,,,,
6374,106375,"Benzenediazonium, 4-[bis(phenylmethyl)amino]-2,5-diethoxy-, sulfate (1:1)",CCOC1=CC(=C(C=C1[N+]#N)OCC)N(CC2=CC=CC=C2)CC3=CC=CC=C3.OS(=O)(=O)[O-],,,,,,
6375,106376,"4-[Bis(phenylmethyl)amino]-2,5-diethoxybenzenediazonium",CCOC1=CC(=C(C=C1[N+]#N)OCC)N(CC2=CC=CC=C2)CC3=CC=CC=C3,,,,,,
6376,106377,"N-[2-(3-ethyl-2-heptadec-8-enyl-4,5-dihydroimidazol-1-ium-1-yl)ethyl]octadec-9-enamide;ethyl sulfate",CCCCCCCCC=CCCCCCCCC1=[N+](CCN1CC)CCNC(=O)CCCCCCCC=CCCCCCCCC.CCOS(=O)(=O)[O-],,,,,,
6377,106378,"N-[2-(3-ethyl-2-heptadec-8-enyl-4,5-dihydroimidazol-1-ium-1-yl)ethyl]octadec-9-enamide",CCCCCCCCC=CCCCCCCCC1=[N+](CCN1CC)CCNC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
6378,106379,"Benzenesulfonyl chloride, 2-(acetylamino)-3,5-dimethoxy-",CC(=O)NC1=C(C=C(C=C1S(=O)(=O)Cl)OC)OC,,,,,,
6379,106380,"2-Naphthalenecarboxamide, 4-[[5-(aminocarbonyl)-2-methoxyphenyl]azo]-3-hydroxy-N-phenyl-",COC1=C(C=C(C=C1)C(=O)N)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)NC4=CC=CC=C4)O,,,,,,
6380,106381,"2-Naphthalenecarboxamide, 4-[[5-(aminocarbonyl)-2-methylphenyl]azo]-3-hydroxy-N-(2-methylphenyl)-",CC1=C(C=C(C=C1)C(=O)N)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)NC4=CC=CC=C4C)O,,,,,,
6381,106382,"Octadecanamide, N-(2-cyanoethyl)-N-(2-((2-((1-oxooctadecyl)amino)ethyl)amino)ethyl)-, triacetate",CCCCCCCCCCCCCCCCCC(=O)NCCNCCN(CCC#N)C(=O)CCCCCCCCCCCCCCCCC.CC(=O)O.CC(=O)O.CC(=O)O,,,,,,
6382,106383,CID 106383,C1=CC(=CC=C1NN=C(N)S)S(=O)(=O)[O-].[K+],,,,,,
6383,106384,CID 106384,C1=CC(=CC=C1NN=C(N)S)S(=O)(=O)O,,,,,,
6384,106385,"Benzenediazonium, 5-((butylsulfonyl)amino)-2-methoxy-, chloride, compd. with zinc chloride (ZnCl2)",CCCCS(=O)(=O)NC1=CC(=C(C=C1)OC)[N+]#N.[Cl-].[Cl-].[Cl-].[Zn+2],,,,,,
6385,106386,5-[(Butylsulfonyl)amino]-2-methoxybenzenediazonium,CCCCS(=O)(=O)NC1=CC(=C(C=C1)OC)[N+]#N,,,,,,
6386,106387,"Benzenediazonium, 2-methyl-5-nitro-, chloride, compd. with zinc chloride (ZnCl2)",CC1=C(C=C(C=C1)[N+](=O)[O-])[N+]#N.[Cl-].[Cl-].[Cl-].[Zn+2],,,,,,
6387,106388,Fast Red RC Salt,COC1=C(C=C(C=C1)Cl)[N+]#N.[Cl-].[Cl-].[Cl-].[Zn+2],,,,,,
6388,106389,"Benzenediazonium, 2,5-dichloro-, chloride, compd. with zinc chloride (ZnCl2)",C1=CC(=C(C=C1Cl)[N+]#N)Cl.[Cl-].[Cl-].[Cl-].[Zn+2],,,,,,
6389,106390,2-(2-Ethoxybut-1-enyl)-5-phenyl-3-(3-sulphonatopropyl)benzoxazolium,CCC(=CC1=[N+](C2=C(O1)C=CC(=C2)C3=CC=CC=C3)CCCS(=O)(=O)[O-])OCC,,,,,,
6390,106391,"3-[2-(2-Ethoxybut-1-enyl)-5-phenyl-1,3-benzoxazol-3-ium-3-yl]propane-1-sulfonic acid",CCC(=CC1=[N+](C2=C(O1)C=CC(=C2)C3=CC=CC=C3)CCCS(=O)(=O)O)OCC,,,,,,
6391,106392,"1,1,12,12-Dodecanetetracarboxylic acid",C(CCCCCC(C(=O)O)C(=O)O)CCCCC(C(=O)O)C(=O)O,,,,,,
6392,106393,"Tetrasodium dodecane-1,1,12,12-tetracarboxylate",C(CCCCCC(C(=O)[O-])C(=O)[O-])CCCCC(C(=O)[O-])C(=O)[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
6393,106394,"2-Naphthalenecarboxamide, N,N'-(methylenedi-4,1-phenylene)bis[3-hydroxy-, disodium salt",C1=CC=C2C=C(C(=CC2=C1)C(=O)NC3=CC=C(C=C3)CC4=CC=C(C=C4)NC(=O)C5=CC6=CC=CC=C6C=C5[O-])[O-].[Na+].[Na+],,,,,,
6394,106395,"2-Naphthalenecarboxamide, N,N'-(methylenedi-4,1-phenylene)bis[3-hydroxy-",C1=CC=C2C=C(C(=CC2=C1)C(=O)NC3=CC=C(C=C3)CC4=CC=C(C=C4)NC(=O)C5=CC6=CC=CC=C6C=C5O)O,,,,,,
6395,106396,CID 106396,CC1=C(C=C(C=C1)N=NN(C)CC(=O)[O-])Cl.[Na+],,,,,,
6396,106397,2-[[(3-Chloro-4-methylphenyl)diazenyl]-methylamino]acetic acid,CC1=C(C=C(C=C1)N=NN(C)CC(=O)O)Cl,,,,,,
6397,106398,CID 106398,C1=CC=C2C=C(C=CC2=C1)NC(=O)C3=CC4=CC=CC=C4C=C3[O-].[Na+],,,,,,
6398,106399,CID 106399,COC1=C(C=C(C=C1)Cl)NC(=O)C2=CC3=CC=CC=C3C=C2[O-].[Na+],,,,,,
6399,106400,"Palladate(2-), [[N,N'-1,2-ethanediylbis[N-[(carboxy-kappaO)methyl]glycinato-kappaN,kappaO]](4-)]-, dipotassium, (SP-4-2)-",C(CN(CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].[K+].[K+].[Pd+2],,,,,,
6400,106401,"Nickelate(3-), (N,N-bis((phosphono-kappaO)methyl)glycinato(5-)-kappaN,kappaO)-, triammonium, (T-4)-",C(C(=O)O)N(COP(O)[O-])COP(O)[O-].N.N.N.[Ni+2],,,,,,
6401,106402,"N,N-Bis{[(dihydroxyphosphanyl)oxy]methyl}glycine",C(C(=O)O)N(COP(O)O)COP(O)O,,,,,,
6402,106403,Trisodium nickelous N-carboxymethylnitrilodi(methylenephosphonate),C(C(=O)[O-])N(COP([O-])[O-])COP([O-])[O-].[Na+].[Na+].[Na+].[Ni+2],,,,,,
6403,106404,"(4-((5-Chloro-2-hydroxyphenyl)azo)benzene-1,3-diolato)copper",C1=CC(=C(C=C1O)O)N=NC2=C(C=CC(=C2)Cl)O.[Cu],,,,,,
6404,106405,"Benzenediazonium, 3-chloro-4-(cyclohexylmethylamino)-, (T-4)-tetrachlorozincate(2-) (2:1)",CN(C1CCCCC1)C2=CC(=C(C=C2)[N+]#N)Cl.CN(C1CCCCC1)C2=CC(=C(C=C2)[N+]#N)Cl.[Cl-].[Cl-].[Cl-].[Cl-].[Zn+2],,,,,,
6405,106406,2-Chloro-4-[cyclohexyl(methyl)amino]benzenediazonium,CN(C1CCCCC1)C2=CC(=C(C=C2)[N+]#N)Cl,,,,,,
6406,106407,"Benzenediazonium, 3-chloro-4-(dibutylamino)-, (T-4)-tetrachlorozincate(2-) (2:1)",CCCCN(CCCC)C1=C(C=C(C=C1)[N+]#N)Cl.CCCCN(CCCC)C1=C(C=C(C=C1)[N+]#N)Cl.[Cl-].[Cl-].[Cl-].[Cl-].[Zn+2],,,,,,
6407,106408,3-Chloro-4-(dibutylamino)benzenediazonium,CCCCN(CCCC)C1=C(C=C(C=C1)[N+]#N)Cl,,,,,,
6408,106409,4-(Hexahydro-1H-azepin-1-yl)benzenediazonium trichlorozincate,C1CCCN(CC1)C2=CC=C(C=C2)[N+]#N.[Cl-].[Cl-].[Cl-].[Zn+2],,,,,,
6409,106410,4-[(Hexahydro-1H-azepin)-1-yl]benzenediazonium,C1CCCN(CC1)C2=CC=C(C=C2)[N+]#N,,,,,,
6410,106411,CID 106411,CC1=C(C=CC(=C1S(=O)(=O)[O-])N=NC2=C(C(=CC3=CC=CC=C32)C(=O)[O-])O)Cl.[Ca+2],,,,,,
6411,106412,4-[(4-Chloro-3-methyl-2-sulfophenyl)azo]-3-hydroxy-2-naphthalenecarboxylic acid,CC1=C(C=CC(=C1S(=O)(=O)O)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)O)O)Cl,,,,,,
6412,106413,"Tetradecanoyl fluoride, 2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,10,10,11,11,12,12,13,14,14,14-hexacosafluoro-13-(trifluoromethyl)-",C(=O)(C(C(C(C(C(C(C(C(C(C(C(C(C(F)(F)F)(C(F)(F)F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)F,,,,,,
6413,106414,"1,3,5-Trimethylcyclotrisiloxane",C[SiH]1O[SiH](O[SiH](O1)C)C,,,,,,
6414,106415,"Silicic acid, 2-ethylbutyl ester",CCC(CC)CO[Si](O)(O)O,,,,,,
6415,106416,1-Aminononadecane,CCCCCCCCCCCCCCCCCCCN,,,,,,
6416,106417,1-(10-Methylundecyl)-3-phenoxybenzene,CC(C)CCCCCCCCCC1=CC(=CC=C1)OC2=CC=CC=C2,,,,,,
6417,106418,Butyl neoheptanoate,CCCCOC(=O)CCC(C)(C)C,,,,,,
6418,106419,"Cyclohexanamine;3,6-dibutylnaphthalene-1-sulfonate",CCCCC1=CC2=C(C=C1)C(=CC(=C2)CCCC)S(=O)(=O)[O-].C1CCC(CC1)N,,,,,,
6419,106420,CID 106420,CC1=C(C=CC(=C1)O)N=NC2=C3C=CC(=CC3=C(C=C2)N=NC4=CC=CC=C4)S(=O)(=O)[O-].[Na+],,,,,,
6420,106421,5-[(4-Hydroxy-2-methylphenyl)diazenyl]-8-phenyldiazenylnaphthalene-2-sulfonic acid,CC1=C(C=CC(=C1)O)N=NC2=C3C=CC(=CC3=C(C=C2)N=NC4=CC=CC=C4)S(=O)(=O)O,,,,,,
6421,106422,CID 106422,CCOC1=CC(=C(C=C1)N=NC2=C3C=CC(=CC3=C(C=C2)N=NC4=CC=CC=C4)S(=O)(=O)[O-])C.[Na+],,,,,,
6422,106423,5-[(4-Ethoxy-2-methylphenyl)diazenyl]-8-phenyldiazenylnaphthalene-2-sulfonic acid,CCOC1=CC(=C(C=C1)N=NC2=C3C=CC(=CC3=C(C=C2)N=NC4=CC=CC=C4)S(=O)(=O)O)C,,,,,,
6423,106424,CID 106424,CCCCCCCCC=CC(CCCCCCC(=O)OCCCC)S(=O)(=O)[O-].[Na+],,,,,,
6424,106425,1-Butoxy-1-oxooctadec-9-ene-8-sulfonic acid,CCCCCCCCC=CC(CCCCCCC(=O)OCCCC)S(=O)(=O)O,,,,,,
6425,106426,CID 106426,CCCCCCCCC=CCCCCCCCC1=[N+](CCN1CC)CCO.OS(=O)(=O)[O-],,,,,,
6426,106427,"1-Ethyl-2-(heptadec-8-en-1-yl)-3-(2-hydroxyethyl)-4,5-dihydro-1H-imidazol-3-ium",CCCCCCCCC=CCCCCCCCC1=[N+](CCN1CC)CCO,,,,,,
6427,106428,Methacrylamidopropyltrimethylammonium chloride,CC(=C)C(=O)NCCC[N+](C)(C)C.[Cl-],,,,,,
6428,106429,"N,N,N-Trimethyl-3-((2-methylacryloyl)amino)propan-1-aminium",CC(=C)C(=O)NCCC[N+](C)(C)C,,,,,,
6429,106430,"Benzenesulfonyl chloride, 4-(acetylamino)-5-methoxy-2-methyl-",CC1=CC(=C(C=C1S(=O)(=O)Cl)OC)NC(=O)C,,,,,,
6430,106431,"Acetamide, N-[4-[(2-hydroxyethyl)sulfonyl]-2,5-dimethoxyphenyl]-",CC(=O)NC1=CC(=C(C=C1OC)S(=O)(=O)CCO)OC,,,,,,
6431,106432,"1,3-Propanediamine, N-(3-aminopropyl)-N-methyl-N'-(2-nitrophenyl)-",CN(CCCN)CCCNC1=CC=CC=C1[N+](=O)[O-],,,,,,
6432,106433,CID 106433,C1=CC(=CN=C1)CCCS(=O)(=O)[O-].[Na+],,,,,,
6433,106434,3-Pyridin-3-ylpropane-1-sulfonic acid,C1=CC(=CN=C1)CCCS(=O)(=O)O,,,,,,
6434,106435,"Hexanamide, N-[3-[(12-aminododecyl)amino]propyl]-6-[(1-oxohexyl)amino]-",CCCCCC(=O)NCCCCCC(=O)NCCCNCCCCCCCCCCCCN,,,,,,
6435,106436,"1-Propanaminium, 3,3'-((9,10-dihydro-9,10-dioxo-1,4-anthracenediyl)diimino)bis(N,N,N-triethyl-, (T-4)-tetrachlorozincate(2-) (1:1)",CC[N+](CC)(CC)CCCNC1=C2C(=C(C=C1)NCCC[N+](CC)(CC)CC)C(=O)C3=CC=CC=C3C2=O.[Cl-].[Cl-].[Cl-].[Cl-].[Zn+2],,,,,,
6436,106437,"3,7-Dimethylocta-2,6-dien-1-yl nonanoate",CCCCCCCCC(=O)OCC=C(C)CCC=C(C)C,,,,,,
6437,106438,"N-Cyano-N',N''-bis(methoxymethyl)guanidine",COCNC(=NCOC)NC#N,,,,,,
6438,106439,"Pyrazine, 2-methoxy-6-(2-methylpropyl)-",CC(C)CC1=CN=CC(=N1)OC,,,,,,
6439,106440,"Benzene, 1,3-bis(1,1-dimethylethyl)-5-methoxy-",CC(C)(C)C1=CC(=CC(=C1)OC)C(C)(C)C,,,,,,
6440,106441,2-Isopropyl-6-methoxypyrazine,CC(C)C1=CN=CC(=N1)OC,,,,,,
6441,106442,(2-Isopropoxyethyl)benzene,CC(C)OCCC1=CC=CC=C1,,,,,,
6442,106443,2-Ethyl-5-methoxypyrazine,CCC1=CN=C(C=N1)OC,,,,,,
6443,106444,"Benzenemethanol, 4-amino-alpha-(4-aminophenyl)-alpha-[4-(phenylamino)phenyl]-",C1=CC=C(C=C1)NC2=CC=C(C=C2)C(C3=CC=C(C=C3)N)(C4=CC=C(C=C4)N)O,,,,,,
6444,106445,"Benzenamine, 4,4'-((4-imino-2,5-cyclohexadien-1-ylidene)methylene)bis(N-phenyl-, monohydrochloride",C1=CC=C(C=C1)[NH2+]C2=CC=C(C=C2)C(=C3C=CC(=NC4=CC=CC=C4)C=C3)C5=CC=C(C=C5)N.[Cl-],,,,,,
6445,106446,"4,4'-[(4-Imino-2,5-cyclohexadien-1-ylidene)methylene]bis(N-phenylbenzenamine)",C1=CC=C(C=C1)NC2=CC=C(C=C2)C(=C3C=CC(=NC4=CC=CC=C4)C=C3)C5=CC=C(C=C5)N,,,,,,
6446,106447,CID 106447,C1=CC=C2C(=C1)C(=CC=C2S(=O)(=O)O)N=NC3=C4C=C(C=CC4=C(C=C3)N=NC5=C6C=C(C=CC6=C(C=C5)N)S(=O)(=O)O)S(=O)(=O)[O-].[Na+],,,,,,
6447,106448,4-[[4-[(4-Amino-7-sulfo-1-naphthalenyl)azo]-7-sulfo-1-naphthalenyl]azo]-1-naphthalenesulfonic acid,C1=CC=C2C(=C1)C(=CC=C2S(=O)(=O)O)N=NC3=C4C=C(C=CC4=C(C=C3)N=NC5=C6C=C(C=CC6=C(C=C5)N)S(=O)(=O)O)S(=O)(=O)O,,,,,,
6448,106449,CID 106449,CC1=CC(=C(C=C1)NC2=C3C(=C(C=C2)NC4=C(C=C(C=C4)C)S(=O)(=O)[O-])C(=O)C5=CC=CC=C5C3=O)S(=O)(=O)O.[Na+],,,,,,
6449,106450,"Cuprate(2-), (7-amino-4-(hydroxy-kappaO)-3-((2-(hydroxy-kappaO)-4-((2-(sulfooxy)ethyl)sulfonyl)phenyl)azo-kappaN1)-2-naphthalenesulfonato(4-))-, dihydrogen",[H+].[H+].C1=CC2=C(C(=C(C=C2C=C1N)S(=O)(=O)[O-])N=NC3=C(C=C(C=C3)S(=O)(=O)CCOS(=O)(=O)[O-])[O-])[O-].[Cu+2],,,,,,
6450,106451,7-Amino-4-hydroxy-3-[[2-hydroxy-4-(2-sulfooxyethylsulfonyl)phenyl]diazenyl]naphthalene-2-sulfonic acid,C1=CC2=C(C(=C(C=C2C=C1N)S(=O)(=O)O)N=NC3=C(C=C(C=C3)S(=O)(=O)CCOS(=O)(=O)O)O)O,,,,,,
6451,106452,"Cuprate(3-), (5-amino-4-(hydroxy-kappaO)-3-((2-(hydroxy-kappaO)-4-((2-(sulfooxy)ethyl)sulfonyl)phenyl)azo-kappaN1)-2,7-naphthalenedisulfonato(5-))-, trihydrogen",[H+].[H+].[H+].C1=CC(=C(C=C1S(=O)(=O)CCOS(=O)(=O)[O-])[O-])N=NC2=C(C3=C(C=C(C=C3C=C2S(=O)(=O)[O-])S(=O)(=O)[O-])N)[O-].[Cu+2],,,,,,
6452,106453,"5-Amino-4-hydroxy-3-[[2-hydroxy-4-(2-sulfooxyethylsulfonyl)phenyl]diazenyl]naphthalene-2,7-disulfonic acid",C1=CC(=C(C=C1S(=O)(=O)CCOS(=O)(=O)O)O)N=NC2=C(C3=C(C=C(C=C3C=C2S(=O)(=O)O)S(=O)(=O)O)N)O,,,,,,
6453,106454,"Titanium, (2-(amino-kappaN)ethanolato-kappaO)(2-(bis(2-hydroxyethyl)amino-kappaN)ethanolato-kappaO)bis(2-propanolato)-",CC(C)O.CC(C)O.C(CO)N.C(CO)N(CCO)CCO.[Ti],,,,,,
6454,106455,2-Cyclohexylvinyl 2-butenoate,CC=CC(=O)OC=CC1CCCCC1,,,,,,
6455,106456,"Ethyl deca-2,6-dienoate",CCCC=CCCC=CC(=O)OCC,,,,,,
6456,106457,"Hexanal, 3,3,5-trimethyl-",CC(C)CC(C)(C)CC=O,,,,,,
6457,106458,"1,3-Dioxolane-2-ethanol, 2-methyl-, acetate",CC(=O)OCCC1(OCCO1)C,,,,,,
6458,106459,Dec-2-enenitrile,CCCCCCCC=CC#N,,,,,,
6459,106460,Non-6-enenitrile,CCC=CCCCCC#N,,,,,,
6460,106461,CID 106461,[B+3].CCN(CC)C1=C(C=C(C(=C1)OCC)[N+]#N)OCC.[F-].[F-].[F-].[F-],,,,,,
6461,106462,"Benzenamine, 2,5-diethoxy-N,N-diethyl-4-nitro-",CCN(CC)C1=CC(=C(C=C1OCC)[N+](=O)[O-])OCC,,,,,,
6462,106463,"Benzenamine, 2,5-diethoxy-4-(1-pyrrolidinyl)-",CCOC1=CC(=C(C=C1N)OCC)N2CCCC2,,,,,,
6463,106464,"Acetamide, N-(2,5-diethoxyphenyl)-N-ethyl-",CCN(C1=C(C=CC(=C1)OCC)OCC)C(=O)C,,,,,,
6464,106465,"1-Chloro-2,5-dibutoxybenzene",CCCCOC1=CC(=C(C=C1)OCCCC)Cl,,,,,,
6465,106466,CID 106466,[B+3].CCOC1=CC(=C(C=C1[N+]#N)OCC)N2CCCC2.[F-].[F-].[F-].[F-],,,,,,
6466,106467,"2,5-Diethoxy-4-(1-pyrrolidinyl)benzenediazonium",CCOC1=CC(=C(C=C1[N+]#N)OCC)N2CCCC2,,,,,,
6467,106468,"Acetamide, N-(2,5-diethoxy-4-nitrophenyl)-N-ethyl-",CCN(C1=CC(=C(C=C1OCC)[N+](=O)[O-])OCC)C(=O)C,,,,,,
6468,106469,"1-(2,5-Diethoxy-4-nitrophenyl)pyrrolidine",CCOC1=CC(=C(C=C1N2CCCC2)OCC)[N+](=O)[O-],,,,,,
6469,106470,"1,4-Dibutoxy-2,5-dichlorobenzene",CCCCOC1=CC(=C(C=C1Cl)OCCCC)Cl,,,,,,
6470,106471,1-(2-Ethoxy-5-methyl-4-nitrophenyl)pyrrolidine,CCOC1=C(C=C(C(=C1)[N+](=O)[O-])C)N2CCCC2,,,,,,
6471,106472,"1,4-Benzenediamine, 2,5-diethoxy-N-ethyl-",CCNC1=C(C=C(C(=C1)OCC)N)OCC,,,,,,
6472,106473,"2,5-Dimethoxy-4-morpholinoaniline",COC1=CC(=C(C=C1N)OC)N2CCOCC2,,,,,,
6473,106474,1-(2-Ethoxy-4-nitrophenyl)pyrrolidine,CCOC1=C(C=CC(=C1)[N+](=O)[O-])N2CCCC2,,,,,,
6474,106475,"Ethyl (3,4-dimethoxyphenyl)iminoacetate hydrochloride",CCOC(=O)C(=N)C1=CC(=C(C=C1)OC)OC.Cl,,,,,,
6475,106476,"alpha-Imino-3,4-dimethoxybenzeneacetic acid ethyl ester",CCOC(=O)C(=N)C1=CC(=C(C=C1)OC)OC,,,,,,
6476,106477,"Hexanamide, 6-hydroxy-N,N-bis(2-hydroxyethyl)-",C(CCC(=O)N(CCO)CCO)CCO,,,,,,
6477,106478,"Cyclohexanamine, N-cyclohexyl-, phosphate (3:1)",C1CCC(CC1)[NH2+]C2CCCCC2.C1CCC(CC1)[NH2+]C2CCCCC2.C1CCC(CC1)[NH2+]C2CCCCC2.[O-]P(=O)([O-])[O-],,,,,,
6478,106479,"10-Undecenoic acid, 2-[(2-hydroxyethyl)amino]ethyl ester",C=CCCCCCCCCC(=O)OCCNCCO,,,,,,
6479,106480,"10-Undecenoic acid, iminodi-2,1-ethanediyl ester",C=CCCCCCCCCC(=O)OCCNCCOC(=O)CCCCCCCCC=C,,,,,,
6480,106481,5-Hydroxyisophthalamide,C1=C(C=C(C=C1C(=O)N)O)C(=O)N,,,,,,
6481,106482,"1-Naphthalenol, 2,4-dinitroso-",C1=CC=C2C(=C1)C(=CC(=C2O)N=O)N=O,,,,,,
6482,106483,"Acetamide, N-[2-[(2-bromo-4,6-dinitrophenyl)azo]-5-(dimethylamino)-4-methoxyphenyl]-",CC(=O)NC1=CC(=C(C=C1N=NC2=C(C=C(C=C2Br)[N+](=O)[O-])[N+](=O)[O-])OC)N(C)C,,,,,,
6483,106484,"Acetamide, N-[2-[(2-bromo-4,6-dinitrophenyl)azo]-5-[(2-cyanoethyl)methylamino]-4-methoxyphenyl]-",CC(=O)NC1=CC(=C(C=C1N=NC2=C(C=C(C=C2Br)[N+](=O)[O-])[N+](=O)[O-])OC)N(C)CCC#N,,,,,,
6484,106485,"2-(2-Heptadec-8-enyl-4,5-dihydroimidazol-1-yl)ethanol;octadec-9-enoic acid",CCCCCCCCC=CCCCCCCCC1=NCCN1CCO.CCCCCCCCC=CCCCCCCCC(=O)O,,,,,,
6485,106486,"1,6-Hexanediaminium, N,N,N',N'-tetrabutyl-N,N'-diethyl-, bis(ethyl sulfate)",CCCC[N+](CC)(CCCC)CCCCCC[N+](CC)(CCCC)CCCC.CCOS(=O)(=O)[O-].CCOS(=O)(=O)[O-],,,,,,
6486,106487,"N,N,N',N'-Tetrabutyl-N,N'-diethyl-1,6-hexanediaminium",CCCC[N+](CC)(CCCC)CCCCCC[N+](CC)(CCCC)CCCC,,,,,,
6487,106488,"1-Butanaminium, N,N-dibutyl-N-ethyl-, sulfate (1:1)",CCCC[N+](CC)(CCCC)CCCC.OS(=O)(=O)[O-],,,,,,
6488,106489,Tributylethylammonium ethyl sulphate,CCCC[N+](CC)(CCCC)CCCC.CCOS(=O)(=O)[O-],,,,,,
6489,106490,Ethylammonium perfluoro(13-methyltetradecanoate),CCN.C(=O)(C(C(C(C(C(C(C(C(C(C(C(C(C(F)(F)F)(C(F)(F)F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)O,,,,,,
6490,106491,"4'-(Trans-4-pentylcyclohexyl)-[1,1'-biphenyl]-4-carbonitrile",CCCCCC1CCC(CC1)C2=CC=C(C=C2)C3=CC=C(C=C3)C#N,,,,,,
6491,106492,"Itaconic acid, methyl ester",COCOC(=O)CCC(=O)O,,,,,,
6492,106493,"Benzenediazonium, 2,5-diethoxy-4-(ethylamino)-, (T-4)-tetrachlorozincate(2-) (2:1)",CCNC1=CC(=C(C=C1OCC)[N+]#N)OCC.CCNC1=CC(=C(C=C1OCC)[N+]#N)OCC.[Cl-].[Cl-].[Cl-].[Cl-].[Zn+2],,,,,,
6493,106494,"2,5-Diethoxy-4-(ethylamino)benzenediazonium",CCNC1=CC(=C(C=C1OCC)[N+]#N)OCC,,,,,,
6494,106495,2-[2-Cyano-3-[4-(diethylamino)phenyl]prop-2-enoyl]oxyethyl-trimethylazanium;benzoate,CCN(CC)C1=CC=C(C=C1)C=C(C#N)C(=O)OCC[N+](C)(C)C.C1=CC=C(C=C1)C(=O)[O-],,,,,,
6495,106496,"1,3,5-Triazine-2,4,6-triamine, N,N',N''-tris(methoxymethyl)-N,N',N''-tris[(octadecyloxy)methyl]-",CCCCCCCCCCCCCCCCCCOCN(COC)C1=NC(=NC(=N1)N(COC)COCCCCCCCCCCCCCCCCCC)N(COC)COCCCCCCCCCCCCCCCCCC,,,,,,
6496,106497,CID 106497,CC1=CC(N=C(N1C2=CC=C(C=C2)C(=O)O)S)(C)C,,,,,,
6497,106498,"Disodium hydrogen (N,N-bis(2-(bis(carboxymethyl)amino)ethyl)glycinato(5-))magnesate(3-)",[H+].C(CN(CC(=O)[O-])CC(=O)[O-])N(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Mg+2],,,,,,
6498,106499,"Magnesate(3-), [N,N-bis[2-[[(carboxy-kappaO)methyl](carboxymethyl)amino-kappaN]ethyl]glycinato(5-)-kappaN,kappaO]-, trisodium",C(CN(CC(=O)[O-])CC(=O)[O-])N(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Na+].[Mg+2],,,,,,
6499,106500,"2-[2-(N-acetylanilino)ethenyl]-3-ethyl-1,3-benzoxazol-3-ium-5-sulfonate",CC[N+]1=C(OC2=C1C=C(C=C2)S(=O)(=O)[O-])C=CN(C3=CC=CC=C3)C(=O)C,,,,,,
6500,106501,"2-[2-(N-acetylanilino)ethenyl]-3-ethyl-1,3-benzoxazol-3-ium-5-sulfonic acid",CC[N+]1=C(OC2=C1C=C(C=C2)S(=O)(=O)O)C=CN(C3=CC=CC=C3)C(=O)C,,,,,,
6501,106502,CID 106502,C1CSCC1S(=O)(=O)CCCS(=O)(=O)[O-].[K+],,,,,,
6502,106503,3-(Thiolan-3-ylsulfonyl)propane-1-sulfonic acid,C1CSCC1S(=O)(=O)CCCS(=O)(=O)O,,,,,,
6503,106504,"1,2,4-Benzenetricarboxylic acid, compd. with 2-phenyl-1H-imidazole-1-propanenitrile (1:1)",C1=CC=C(C=C1)C2=NC=CN2CCC#N.C1=C(C=C(C=C1C(=O)O)C(=O)O)C(=O)O,,,,,,
6504,106505,CID 106505,C1=CC(=C(C(=C1N=O)[O-])N=O)O.[Na+],,,,,,
6505,106506,"Acetic acid, hydroxy-, compd. with 4,4'-[1,3-phenylenebis(azo)]bis[1,3-benzenediamine] acetate formate",CC(=O)O.C1=CC(=CC(=C1)N=NC2=C(C=C(C=C2)N)N)N=NC3=C(C=C(C=C3)N)N.C(C(=O)O)O.C(=O)O,,,,,,
6506,106507,"Benzenesulfonic acid, 3-(4,5-dihydro-5-imino-3-methyl-1H-pyrazol-1-yl)-",CC1=NN(C(=N)C1)C2=CC(=CC=C2)S(=O)(=O)O,,,,,,
6507,106508,"Bis(2,4,6-triisopropyl-3-isocyanatophenyl)carbodiimide",CC(C)C1=CC(=C(C(=C1N=C=NC2=C(C(=C(C=C2C(C)C)C(C)C)N=C=O)C(C)C)C(C)C)N=C=O)C(C)C,,,,,,
6508,106509,"Methanaminium, N-(4-((4-(dimethylamino)phenyl)phenylmethylene)-2,5-cyclohexadien-1-ylidene)-N-methyl-, tetracosa-mu-oxododecaoxo(mu12-(phosphato(3-)-O:O:O:O':O':O':O'':O'':O'':O''':O''':O'''))dodecamolybdate(3-) (3:1)",C.C.CN(C)C1=CC=C(C=C1)C(C2C=CC(=[N+](C)C)C=C2)C3=CC=CC=C3.CN(C)C1=CC=C(C=C1)C(C2C=CC(=[N+](C)C)C=C2)C3=CC=CC=C3.CN(C)C1=CC=C(C=C1)C(C2C=CC(=[N+](C)C)C=C2)C3=CC=CC=C3,,,,,,
6509,106510,"4-{[4-(Dimethylamino)phenyl](phenyl)methyl}-N,N-dimethylcyclohexa-2,5-dien-1-iminium",CN(C)C1=CC=C(C=C1)C(C2C=CC(=[N+](C)C)C=C2)C3=CC=CC=C3,,,,,,
6510,106511,Einecs 268-392-8,C.C.CNC1=CC=C(C=C1)C(C2C=CC(=[N+](C)C)C=C2)C3=CC=C(C=C3)N(C)C.CNC1=CC=C(C=C1)C(C2C=CC(=[N+](C)C)C=C2)C3=CC=C(C=C3)N(C)C.CNC1=CC=C(C=C1)C(C2C=CC(=[N+](C)C)C=C2)C3=CC=C(C=C3)N(C)C,,,,,,
6511,106512,"[4-[[4-(Dimethylamino)phenyl]-[4-(methylamino)phenyl]methyl]cyclohexa-2,5-dien-1-ylidene]-dimethylazanium",CNC1=CC=C(C=C1)C(C2C=CC(=[N+](C)C)C=C2)C3=CC=C(C=C3)N(C)C,,,,,,
6512,106513,"Hexahydro-1,3,5-tris(o-tolyl)-1,3,5-triazine trihydrochloride",CC1=CC=CC=C1N2CN(CN(C2)C3=CC=CC=C3C)C4=CC=CC=C4C.Cl.Cl.Cl,,,,,,
6513,106514,"1,3,5-Tris(o-tolyl)-hexahydro-s-triazine",CC1=CC=CC=C1N2CN(CN(C2)C3=CC=CC=C3C)C4=CC=CC=C4C,,,,,,
6514,106515,"1H-Imidazole-1-ethanamine, 2-(8-heptadecenyl)-4,5-dihydro-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)",CCCCCCCCC=CCCCCCCCC1=NCCN1CCN.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,,,,,,
6515,106516,"2-(2-Heptadec-8-enyl-4,5-dihydroimidazol-1-yl)ethanamine;2-hydroxyacetic acid",CCCCCCCCC=CCCCCCCCC1=NCCN1CCN.C(C(=O)O)O,,,,,,
6516,106517,CID 106517,CCCCCCCCC=CCCCCCCCC1=NCCN1CCN.C(=O)(O)O,,,,,,
6517,106518,"Benzenamine, 3-(ethylthio)-N-phenyl-",CCSC1=CC=CC(=C1)NC2=CC=CC=C2,,,,,,
6518,106519,"1-Propanaminium, N-ethyl-N,N-dimethyl-3-[(1-oxopropyl)amino]-, ethyl sulfate",CCC(=O)NCCC[N+](C)(C)CC.CCOS(=O)(=O)[O-],,,,,,
6519,106520,"N-Ethyl-N,N-dimethyl-3-[(1-oxopropyl)amino]-1-propanaminium",CCC(=O)NCCC[N+](C)(C)CC,,,,,,
6520,106521,(4-Ethylphenyl)acetaldehyde,CCC1=CC=C(C=C1)CC=O,,,,,,
6521,106522,"Benzeneacetaldehyde, 2,4-dimethyl-",CC1=CC(=C(C=C1)CC=O)C,,,,,,
6522,106523,Dodec-3-en-1-al,CCCCCCCCC=CCC=O,,,,,,
6523,106524,"Butanamide, 4-hydroxy-N-(2-hydroxyethyl)-N-methyl-",CN(CCO)C(=O)CCCO,,,,,,
6524,106525,"Ethanol, 2-((4-((6-methoxy-2-benzothiazolyl)azo)phenyl)methylamino)-",CN(CCO)C1=CC=C(C=C1)N=NC2=NC3=C(S2)C=C(C=C3)OC,,,,,,
6525,106526,"2-Hydroxyethyl 2-benzyl-1,3-dioxolane-2-propionate",C1COC(O1)(CCC(=O)OCCO)CC2=CC=CC=C2,,,,,,
6526,106527,"Methyl 2-benzyl-1,3-dioxolane-2-propionate",COC(=O)CCC1(OCCO1)CC2=CC=CC=C2,,,,,,
6527,106528,"3-Furancarboxylic acid, 5-(phenylmethyl)-, 2-hydroxyethyl ester",C1=CC=C(C=C1)CC2=CC(=CO2)C(=O)OCCO,,,,,,
6528,106529,"1,1-Diethoxydec-2-ene",CCCCCCCC=CC(OCC)OCC,,,,,,
6529,106530,Diisopentyl thiomalate,CC(C)CCOC(=O)CC(C(=O)OCCC(C)C)S,,,,,,
6530,106531,"6,6-Diethoxyhex-2-ene",CCOC(CCC=CC)OCC,,,,,,
6531,106532,2-Methyl-5-oxo-1-cyclopenten-1-yl isovalerate,CC1=C(C(=O)CC1)OC(=O)CC(C)C,,,,,,
6532,106533,"2,7-Naphthalenedisulfonic acid, 5-amino-4-hydroxy-3-[[4'-[(2-hydroxy-3,6-disulfo-1-naphthalenyl)azo]-3,3'-dimethoxy[1,1'-biphenyl]-4-yl]azo]-, tetrasodium salt",COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C4=C(C=C(C=C4C=C3S(=O)(=O)[O-])S(=O)(=O)[O-])N)O)OC)N=NC5=C6C=CC(=CC6=CC(=C5O)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
6533,106534,"5-Amino-4-hydroxy-3-[[4-[4-[(2-hydroxy-3,6-disulfonaphthalen-1-yl)diazenyl]-3-methoxyphenyl]-2-methoxyphenyl]diazenyl]naphthalene-2,7-disulfonic acid",COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C4=C(C=C(C=C4C=C3S(=O)(=O)O)S(=O)(=O)O)N)O)OC)N=NC5=C6C=CC(=CC6=CC(=C5O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
6534,106535,"1,3-Naphthalenedisulfonic acid, 7-((4-((2-methyl-4-((4-nitrobenzoyl)amino)phenyl)azo)phenyl)azo)-, disodium salt",CC1=C(C=CC(=C1)NC(=O)C2=CC=C(C=C2)[N+](=O)[O-])N=NC3=CC=C(C=C3)N=NC4=CC5=C(C=C(C=C5C=C4)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
6535,106536,"7-[[4-[[2-Methyl-4-[(4-nitrobenzoyl)amino]phenyl]diazenyl]phenyl]diazenyl]naphthalene-1,3-disulfonic acid",CC1=C(C=CC(=C1)NC(=O)C2=CC=C(C=C2)[N+](=O)[O-])N=NC3=CC=C(C=C3)N=NC4=CC5=C(C=C(C=C5C=C4)S(=O)(=O)O)S(=O)(=O)O,,,,,,
6536,106537,"1,3-Naphthalenedisulfonic acid, 7-((4-((2-methyl-4-((sulfomethyl)amino)phenyl)azo)phenyl)azo)-, trisodium salt",CC1=C(C=CC(=C1)NCS(=O)(=O)[O-])N=NC2=CC=C(C=C2)N=NC3=CC4=C(C=C(C=C4C=C3)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
6537,106538,"7-[[4-[[2-Methyl-4-(sulfomethylamino)phenyl]diazenyl]phenyl]diazenyl]naphthalene-1,3-disulfonic acid",CC1=C(C=CC(=C1)NCS(=O)(=O)O)N=NC2=CC=C(C=C2)N=NC3=CC4=C(C=C(C=C4C=C3)S(=O)(=O)O)S(=O)(=O)O,,,,,,
6538,106539,"1,3-Naphthalenedisulfonic acid, 7-((4-((sulfomethyl)amino)phenyl)azo)-, trisodium salt",C1=CC(=CC=C1NCS(=O)(=O)[O-])N=NC2=CC3=C(C=C(C=C3C=C2)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
6539,106540,"7-[[4-(Sulfomethylamino)phenyl]diazenyl]naphthalene-1,3-disulfonic acid",C1=CC(=CC=C1NCS(=O)(=O)O)N=NC2=CC3=C(C=C(C=C3C=C2)S(=O)(=O)O)S(=O)(=O)O,,,,,,
6540,106541,"Acetic acid, ((4-((4-((4-amino-7-sulfo-1-naphthalenyl)azo)-7-sulfo-1-naphthalenyl)azo)phenyl)amino)oxo-, trisodium salt",C1=CC(=CC=C1NC(=O)C(=O)[O-])N=NC2=C3C=C(C=CC3=C(C=C2)N=NC4=C5C=C(C=CC5=C(C=C4)N)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
6541,106542,2-[4-[[4-[(4-Amino-7-sulfonaphthalen-1-yl)diazenyl]-7-sulfonaphthalen-1-yl]diazenyl]anilino]-2-oxoacetic acid,C1=CC(=CC=C1NC(=O)C(=O)O)N=NC2=C3C=C(C=CC3=C(C=C2)N=NC4=C5C=C(C=CC5=C(C=C4)N)S(=O)(=O)O)S(=O)(=O)O,,,,,,
6542,106543,Trisodium 4-hydroxy-7-((((5-hydroxy-6-((2-methoxyphenyl)azo)-7-sulphonato-2-naphthyl)amino)carbonyl)amino)-3-((2-methoxy-5-sulphonatophenyl)azo)naphthalene-2-sulphonate,COC1=C(C=C(C=C1)S(=O)(=O)[O-])N=NC2=C(C=C3C=C(C=CC3=C2O)NC(=O)NC4=CC5=CC(=C(C(=C5C=C4)O)N=NC6=CC=CC=C6OC)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
6543,106544,4-Hydroxy-7-[[5-hydroxy-6-[(2-methoxy-5-sulfophenyl)diazenyl]-7-sulfonaphthalen-2-yl]carbamoylamino]-3-[(2-methoxyphenyl)diazenyl]naphthalene-2-sulfonic acid,COC1=C(C=C(C=C1)S(=O)(=O)O)N=NC2=C(C=C3C=C(C=CC3=C2O)NC(=O)NC4=CC5=CC(=C(C(=C5C=C4)O)N=NC6=CC=CC=C6OC)S(=O)(=O)O)S(=O)(=O)O,,,,,,
6544,106545,"2,7-Naphthalenedisulfonic acid, 4-[(4-amino-5-methoxy-2-methylphenyl)azo]-5-hydroxy-",CC1=CC(=C(C=C1N=NC2=C3C(=CC(=C2)S(=O)(=O)O)C=C(C=C3O)S(=O)(=O)O)OC)N,,,,,,
6545,106546,"Benzeneacetic acid, 2,4-dinitro-, ethyl ester",CCOC(=O)CC1=C(C=C(C=C1)[N+](=O)[O-])[N+](=O)[O-],,,,,,
6546,106547,"1-Naphthalenamine, 4-[(2-bromo-4,6-dinitrophenyl)azo]-N-ethyl-",CCNC1=CC=C(C2=CC=CC=C21)N=NC3=C(C=C(C=C3Br)[N+](=O)[O-])[N+](=O)[O-],,,,,,
6547,106548,"Hexanoic acid, 6-amino-, 2,2-bis(hydroxymethyl)butyl ester",CCC(CO)(CO)COC(=O)CCCCCN,,,,,,
6548,106549,"Tetrasodium;6-amino-5-hydroxy-4-[[4-[4-[(4-hydroxy-3,8-disulfonatonaphthalen-2-yl)diazenyl]-3-methoxyphenyl]-2-methoxyphenyl]diazenyl]naphthalene-1,7-disulfonate",COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C(=C4C=CC=C(C4=C3)S(=O)(=O)[O-])O)S(=O)(=O)[O-])OC)N=NC5=C6C(=C(C=C5)S(=O)(=O)[O-])C=C(C(=C6O)N)S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
6549,106550,"6-Amino-5-hydroxy-4-[[4-[4-[(4-hydroxy-3,8-disulfonaphthalen-2-yl)diazenyl]-3-methoxyphenyl]-2-methoxyphenyl]diazenyl]naphthalene-1,7-disulfonic acid",COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C(=C4C=CC=C(C4=C3)S(=O)(=O)O)O)S(=O)(=O)O)OC)N=NC5=C6C(=C(C=C5)S(=O)(=O)O)C=C(C(=C6O)N)S(=O)(=O)O,,,,,,
6550,106551,"Trisodium 4-((4'-((6-amino-1-hydroxy-3-sulphonato-2-naphthyl)azo)-3,3'-dimethoxy(1,1'-biphenyl)-4-yl)azo)-3-hydroxynaphthalene-2,7-disulphonate",COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C=C4C=C(C=CC4=C3O)N)S(=O)(=O)[O-])OC)N=NC5=C6C=CC(=CC6=CC(=C5O)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
6551,106552,"4-[[4-[4-[(6-Amino-1-hydroxy-3-sulfonaphthalen-2-yl)diazenyl]-3-methoxyphenyl]-2-methoxyphenyl]diazenyl]-3-hydroxynaphthalene-2,7-disulfonic acid",COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C=C4C=C(C=CC4=C3O)N)S(=O)(=O)O)OC)N=NC5=C6C=CC(=CC6=CC(=C5O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
6552,106553,"1,3-Naphthalenedisulfonic acid, 4-amino-6-[[4'-[(1,8-dihydroxy-3,6-disulfo-2-naphthalenyl)azo]-3,3'-dimethoxy[1,1'-biphenyl]-4-yl]azo]-5-hydroxy-, tetrasodium salt",COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C4=C(C=C(C=C4C=C3S(=O)(=O)[O-])S(=O)(=O)[O-])O)O)OC)N=NC5=C(C6=C(C=C5)C(=CC(=C6N)S(=O)(=O)[O-])S(=O)(=O)[O-])O.[Na+].[Na+].[Na+].[Na+],,,,,,
6553,106554,"4-Amino-6-[[4-[4-[(1,8-dihydroxy-3,6-disulfonaphthalen-2-yl)diazenyl]-3-methoxyphenyl]-2-methoxyphenyl]diazenyl]-5-hydroxynaphthalene-1,3-disulfonic acid",COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C4=C(C=C(C=C4C=C3S(=O)(=O)O)S(=O)(=O)O)O)O)OC)N=NC5=C(C6=C(C=C5)C(=CC(=C6N)S(=O)(=O)O)S(=O)(=O)O)O,,,,,,
6554,106555,CID 106555,C1=CC(=CC=C1NN=C2C(=CC3=C(C2=N)C(=O)C(=NNC4=CC=C(C=C4)[N+](=O)[O-])C(=C3)S(=O)(=O)[O-])S(=O)(=O)[O-])[N+](=O)[O-].[Na+].[Na+],,,,,,
6555,106556,CID 106556,C1=CC(=CC=C1NN=C2C(=CC3=C(C2=N)C(=O)C(=NNC4=CC=C(C=C4)[N+](=O)[O-])C(=C3)S(=O)(=O)O)S(=O)(=O)O)[N+](=O)[O-],,,,,,
6556,106557,"2,7-Naphthalenedisulfonic acid, 3-hydroxy-4-((4'-((1-hydroxy-6-(phenylamino)-3-sulfo-2-naphthalenyl)azo)-3,3'-dimethoxy(1,1'-biphenyl)-4-yl)azo)-, trisodium salt",COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C=C4C=C(C=CC4=C3O)NC5=CC=CC=C5)S(=O)(=O)[O-])OC)N=NC6=C7C=CC(=CC7=CC(=C6O)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
6557,106558,"3-Hydroxy-4-((4'-((1-hydroxy-6-(phenylamino)-3-sulpho-2-naphthyl)azo)-3,3'-dimethoxy(1,1'-biphenyl)-4-yl)azo)naphthalene-2,7-disulphonic acid",COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N=NC3=C(C=C4C=C(C=CC4=C3O)NC5=CC=CC=C5)S(=O)(=O)O)OC)N=NC6=C7C=CC(=CC7=CC(=C6O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
6558,106559,"Benzenebutanenitrile, beta-oxo-alpha-[3-(trifluoromethyl)phenyl]-",C1=CC=C(C=C1)CC(=O)C(C#N)C2=CC(=CC=C2)C(F)(F)F,,,,,,
6559,106560,"Benzenesulfonic acid, 4-amino-, compd. with cyanoguanidine (1:1)",C1=CC(=CC=C1N)S(=O)(=O)O.C(#N)N=C(N)N,,,,,,
6560,106561,"Phenol, pentabromo-, aluminum salt",C1(=C(C(=C(C(=C1Br)Br)Br)Br)Br)[O-].C1(=C(C(=C(C(=C1Br)Br)Br)Br)Br)[O-].C1(=C(C(=C(C(=C1Br)Br)Br)Br)Br)[O-].[Al+3],,,,,,
6561,106562,"Phenol, 2,4,6-tribromo-, aluminum salt",C1=C(C=C(C(=C1Br)[O-])Br)Br.C1=C(C=C(C(=C1Br)[O-])Br)Br.C1=C(C=C(C(=C1Br)[O-])Br)Br.[Al+3],,,,,,
6562,106563,Tetrabromophthlaic acid monomagnesium salt,C1(=C(C(=C(C(=C1Br)Br)Br)Br)C(=O)[O-])C(=O)[O-].[Mg+2],,,,,,
6563,106564,Cerium(3+) neodecanoate,CC(C)(C)CCCCCC(=O)[O-].CC(C)(C)CCCCCC(=O)[O-].CC(C)(C)CCCCCC(=O)[O-].[Ce+3],,,,,,
6564,106565,"Phenol, ethyl-2-methyl-5-(1-methylethyl)-",CCC1=C(C(=CC(=C1)C(C)C)O)C,,,,,,
6565,106566,"2,4-Dibenzylphenol",C1=CC=C(C=C1)CC2=CC(=C(C=C2)O)CC3=CC=CC=C3,,,,,,
6566,106567,"Urea, N,N''-(methylenedi-4,1-phenylene)bis(N'-(dodecylphenyl)-",CCCCCCCCCCCCN(C1=CC=CC=C1)C(=O)NC2=CC=C(C=C2)CC3=CC=C(C=C3)NC(=O)N(CCCCCCCCCCCC)C4=CC=CC=C4,,,,,,
6567,106568,"Trimellitic acid, monododecyl ester",CCCCCCCCCCCCOC(=O)C1=C(C=CC(=C1)C(=O)O)C(=O)O,,,,,,
6568,106569,2-(Methyl((pentadecafluoroheptyl)sulphonyl)amino)ethyl acrylate,CN(CCOC(=O)C=C)S(=O)(=O)C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
6569,106570,4-(2-Ethoxy-5-methyl-4-nitrophenyl)morpholine,CCOC1=C(C=C(C(=C1)[N+](=O)[O-])C)N2CCOCC2,,,,,,
6570,106571,"1-Cyclopentene-1-acetic acid, 2-ethylbutyl ester",CCC(CC)COC(=O)CC1=CCCC1,,,,,,
6571,106572,"Disodium 1-(2-(carboxymethoxy)ethyl)-1-(carboxymethyl)-4,5-dihydro-2-undecyl-1H-imidazolium chloride",CCCCCCCCCCCC1=NCC[N+]1(CCOCC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Cl-],,,,,,
6572,106573,"2,2-bis[[3-(Hexylthio)-1-oxopropoxy]methyl]propane-1,3-diyl bis[3-(hexylthio)propionate]",CCCCCCSCCC(=O)OCC(COC(=O)CCSCCCCCC)(COC(=O)CCSCCCCCC)COC(=O)CCSCCCCCC,,,,,,
6573,106574,CID 106574,CC1=C[CH]N(C(=C1)C)CC(=O)O,,,,,,
6574,106575,"3-Aminomethylpinane, hydrochloride",CC1C(CC2CC1C2(C)C)CN.Cl,,,,,,
6575,106576,Pinane-3-(methylamine),CC1C(CC2CC1C2(C)C)CN,,,,,,
6576,106577,"Urea, N,N''-(4-methyl-1,3-phenylene)bis[N'-octadecadienyl-",CCCCCC=CCC=CCCCCCCCCNC(=O)NC1=CC(=C(C=C1)C)NC(=O)NCCCCCCCCC=CCC=CCCCCC,,,,,,
6577,106578,Chloro(2-(4-(chloromethyl)phenyl)ethyl)dimethylsilane,C[Si](C)(CCC1=CC=C(C=C1)CCl)Cl,,,,,,
6578,106579,N'-(3-(Trimethoxysilyl)propyl)-N-((vinylphenyl)methyl)ethylenediamine,CO[Si](CCCNCCNCC1=CC(=CC=C1)C=C)(OC)OC,,,,,,
6579,106580,Ethylene (3-isocyanatomethylphenyl)-carbamate,C1=CC(=CC(=C1)NC(=O)OCCOC(=O)NC2=CC=CC(=C2)CN=C=O)CN=C=O,,,,,,
6580,106581,Monotridecyl trimellitate,CCCCCCCCCCCCCOC(=O)C1=C(C=CC(=C1)C(=O)O)C(=O)O,,,,,,
6581,106582,"N,N'-(Iminobis(ethyleneiminoethylene))distearamide diacetate",CCCCCCCCCCCCCCCCCC(=O)NCCNCCNCCNCCNC(=O)CCCCCCCCCCCCCCCCC.CC(=O)O.CC(=O)O,,,,,,
6582,106583,CID 106583,CC1=C(C=CC(=C1)N)N=NC2=CC=CC3=CC(=CC(=C32)S(=O)(=O)[O-])S(=O)(=O)O.[Na+],,,,,,
6583,106584,"8-[(4-Amino-2-methylphenyl)azo]naphthalene-1,3-disulfonic acid",CC1=C(C=CC(=C1)N)N=NC2=CC=CC3=CC(=CC(=C32)S(=O)(=O)O)S(=O)(=O)O,,,,,,
6584,106585,"4-Methylbenzenesulfonate;3-methyl-2-[5-(3-methyl-1,3-benzoxazol-3-ium-2-yl)penta-2,4-dienylidene]-1,3-benzoxazole",CC1=CC=C(C=C1)S(=O)(=O)[O-].CN1C2=CC=CC=C2OC1=CC=CC=CC3=[N+](C4=CC=CC=C4O3)C,,,,,,
6585,106586,CID 106586,CN1C2=CC=CC=C2OC1=C/C=C/C=C/C3=[N+](C4=CC=CC=C4O3)C,,,,,,
6586,106587,"Glycine, N-tridecyl-",CCCCCCCCCCCCCNCC(=O)O,,,,,,
6587,106588,"Azane;3-[bis(4-amino-3-sulfophenyl)methylidene]-6-imino-5-methylcyclohexa-1,4-diene-1-sulfonic acid",CC1=CC(=C(C2=CC(=C(C=C2)N)S(=O)(=O)O)C3=CC(=C(C=C3)N)S(=O)(=O)O)C=C(C1=N)S(=O)(=O)O.N.N,,,,,,
6588,106589,[[4-Methyl-4-(prop-2-enoylamino)pentan-2-ylidene]amino] acetate,CC(=NOC(=O)C)CC(C)(C)NC(=O)C=C,,,,,,
6589,106590,"1-Cyclohexyl-2,5-dihydro-1H-pyrrole",C1CCC(CC1)N2CC=CC2,,,,,,
6590,106591,"2-Naphthalenol, 5-amino-8-((2-chlorophenyl)azo)-",C1=CC=C(C(=C1)N=NC2=C3C=C(C=CC3=C(C=C2)N)O)Cl,,,,,,
6591,106592,"Formic acid, compd. with 4-(phenylazo)-1,3-benzenediamine (2:1)",C1=CC=C(C=C1)N=NC2=C(C=C(C=C2)N)N.C(=O)O.C(=O)O,,,,,,
6592,106593,6-Methylheptyl benzoate,CC(C)CCCCCOC(=O)C1=CC=CC=C1,,,,,,
6593,106594,Dibutyltin;docosanoic acid,CCCCCCCCCCCCCCCCCCCCCC(=O)O.CCCCCCCCCCCCCCCCCCCCCC(=O)O.CCCC[Sn]CCCC,,,,,,
6594,106595,CID 106595,CCCC[Sn]CCCC.CCCC[Sn]CCCC.C1CCC(CC1)OC(=O)C=CC(=O)O.C1CCC(CC1)OC(=O)C=CC(=O)O.C(=CC(=O)O)C(=O)O,,,,,,
6595,106596,CID 106596,CCCC[Sn]CCCC.CCCC[Sn]CCCC.C1=CC=C(C=C1)COC(=O)C=CC(=O)O.C1=CC=C(C=C1)COC(=O)C=CC(=O)O.C(=CC(=O)O)C(=O)O,,,,,,
6596,106597,4-Oxo-4-phenylmethoxybut-2-enoic acid,C1=CC=C(C=C1)COC(=O)C=CC(=O)O,,,,,,
6597,106598,CID 106598,CCCCCCCC[Sn]CCCCCCCC.CCOC(=O)C=CC(=O)O.CCOC(=O)C=CC(=O)O,,,,,,
6598,106599,Methyl 3-[2-(dimethylamino)ethenyl]-2-nitrobenzoate,CN(C)C=CC1=C(C(=CC=C1)C(=O)OC)[N+](=O)[O-],,,,,,
6599,106600,Methyl 4-heptylbenzoate,CCCCCCCC1=CC=C(C=C1)C(=O)OC,,,,,,
6600,106601,"1,7-Anthracenedisulfonic acid, 8-amino-5-bromo-9,10-dihydro-9,10-dioxo-, dipotassium salt",C1=CC2=C(C(=C1)S(=O)(=O)[O-])C(=O)C3=C(C(=CC(=C3C2=O)Br)S(=O)(=O)[O-])N.[K+].[K+],,,,,,
6601,106602,"1,6-Anthracenedisulfonic acid, 5-amino-8-bromo-9,10-dihydro-9,10-dioxo-, dipotassium salt",C1=CC2=C(C(=C1)S(=O)(=O)[O-])C(=O)C3=C(C=C(C(=C3C2=O)N)S(=O)(=O)[O-])Br.[K+].[K+],,,,,,
6602,106603,"1,8-Pyrenedione, 2,7-dibromo-3,6-dihydroxy-",C1=CC2=C3C(=CC=C4C3=C1C(=C(C4=O)Br)O)C(=C(C2=O)Br)O,,,,,,
6603,106604,"Methanol, [[3-[2-(dimethylamino)ethoxy]propyl]imino]bis-",CN(C)CCOCCCN(CO)CO,,,,,,
6604,106605,"Ethanaminium, 2-cyano-N-[2-[(2-cyanoethyl)amino]ethyl]-N-ethyl-N-[2-[(1-oxooctadecyl)amino]ethyl]-, ethyl sulfate",CCCCCCCCCCCCCCCCCC(=O)NCC[N+](CC)(CCC#N)CCNCCC#N.CCOS(=O)(=O)[O-],,,,,,
6605,106606,2-Cyano-N-[2-[(2-cyanoethyl)amino]ethyl]-N-ethyl-N-[2-[(1-oxooctadecyl)amino]ethyl]ethanaminium,CCCCCCCCCCCCCCCCCC(=O)NCC[N+](CC)(CCC#N)CCNCCC#N,,,,,,
6606,106607,"2-Butenedioic acid (2Z)-, cyclohexyl 2-methylpropyl ester",CC(C)COC(=O)C=CC(=O)OC1CCCCC1,,,,,,
6607,106608,"Cuprate(3-), [mu-[4-(hydroxy-kappaO)-7-[[[[5-(hydroxy-kappaO)-6-[[2-(hydroxy-kappaO)phenyl]azo-kappaN1]-7-sulfo-2-naphthalenyl]amino]carbonyl]amino]-3-[[2-(hydroxy-kappaO)-5-sulfophenyl]azo-kappaN1]-2-naphthalenesulfonato(7-)]]di-, trisodium",C1=CC=C(C(=C1)N=NC2=C(C=C3C=C(C=CC3=C2[O-])NC(=O)NC4=CC5=CC(=C(C(=C5C=C4)[O-])N=NC6=C(C=CC(=C6)S(=O)(=O)[O-])[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])[O-].[Na+].[Na+].[Na+].[Cu+2].[Cu+2],,,,,,
6608,106609,4-Hydroxy-7-[[5-hydroxy-6-[(2-hydroxy-5-sulfophenyl)diazenyl]-7-sulfonaphthalen-2-yl]carbamoylamino]-3-[(2-hydroxyphenyl)diazenyl]naphthalene-2-sulfonic acid,C1=CC=C(C(=C1)N=NC2=C(C=C3C=C(C=CC3=C2O)NC(=O)NC4=CC5=CC(=C(C(=C5C=C4)O)N=NC6=C(C=CC(=C6)S(=O)(=O)O)O)S(=O)(=O)O)S(=O)(=O)O)O,,,,,,
6609,106610,Einecs 268-511-3,[H+].CCN(CC)C1=CC=C(C=C1)N=NC2=NC=NN2C.[Cl-].[Cl-].[Cl-].[Zn+2],,,,,,
6610,106611,"N,N-Diethyl-4-(1-methyl-1H-1,2,4-triazole-5-ylazo)aniline",CCN(CC)C1=CC=C(C=C1)N=NC2=NC=NN2C,,,,,,
6611,106612,"9-Octadecenoic acid (9Z)-, compd. with 4-methylmorpholine (1:1)",CCCCCCCCC=CCCCCCCCC(=O)O.CN1CCOCC1,,,,,,
6612,106613,"2,7-Naphthalenedisulfonic acid, 5-(acetylamino)-4-hydroxy-3-[(3-phosphonophenyl)azo]-, disodium salt",CC(=O)NC1=C2C(=CC(=C1)S(=O)(=O)[O-])C=C(C(=C2O)N=NC3=CC(=CC=C3)P(=O)(O)O)S(=O)(=O)[O-].[Na+].[Na+],,,,,,
6613,106614,"5-(Acetylamino)-4-hydroxy-3-((3-phosphonophenyl)azo)naphthalene-2,7-disulphonic acid",CC(=O)NC1=C2C(=CC(=C1)S(=O)(=O)O)C=C(C(=C2O)N=NC3=CC(=CC=C3)P(=O)(O)O)S(=O)(=O)O,,,,,,
6614,106615,CID 106615,C1=CC(=CC(=C1)P(=O)(O)O)N=NC2=C(C=C3C=C(C(=C(C3=C2)N)N=NC4=C(C=CC(=C4)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
6615,106616,"2-Naphthalenecarboxamide, 4-[[5-(aminocarbonyl)-2-methoxyphenyl]azo]-N-(4-chloro-2,5-dimethoxyphenyl)-3-hydroxy-",COC1=C(C=C(C=C1)C(=O)N)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)NC4=CC(=C(C=C4OC)Cl)OC)O,,,,,,
6616,106617,CID 106617,CCCCCCCCC=CCCCCCCCCNC1=C(C=C(C=C1)OC)S(=O)(=O)[O-].[Na+],,,,,,
6617,106618,5-Methoxy-2-(octadec-9-enylamino)benzenesulfonic acid,CCCCCCCCC=CCCCCCCCCNC1=C(C=C(C=C1)OC)S(=O)(=O)O,,,,,,
6618,106619,"2,2'-((4-((3,5-Dinitro-2-thienyl)azo)-3-methylphenyl)imino)bisethyl diacetate",CC1=C(C=CC(=C1)N(CCOC(=O)C)CCOC(=O)C)N=NC2=C(C=C(S2)[N+](=O)[O-])[N+](=O)[O-],,,,,,
6619,106620,CID 106620,C1=CC(=CC(=C1)S(=O)(=O)[O-])NC2=NC(=NC(=N2)Cl)NC3=CC(=C(C=C3)NN=C4C(=CC5=C(C4=N)C(=O)C(=NNC6=C(C=C(C=C6)NC7=NC(=NC(=N7)NC8=CC(=CC=C8)S(=O)(=O)[O-])Cl)S(=O)(=O)[O-])C(=C5)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],,,,,,
6620,106621,CID 106621,C1=CC(=CC(=C1)S(=O)(=O)O)NC2=NC(=NC(=N2)Cl)NC3=CC(=C(C=C3)NN=C4C(=CC5=C(C4=N)C(=O)C(=NNC6=C(C=C(C=C6)NC7=NC(=NC(=N7)NC8=CC(=CC=C8)S(=O)(=O)O)Cl)S(=O)(=O)O)C(=C5)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
6621,106622,"Benzenesulfonic acid, 3-dodecyl-, compd. with 2-aminoethanol (1:1)",CCCCCCCCCCCCC1=CC(=CC=C1)S(=O)(=O)O.C(CO)N,,,,,,
6622,106623,CID 106623,CC(C)CCCCCOP(=O)([O-])OCCCCCC(C)C.[Na+],,,,,,
6623,106624,"Phosphoric acid, monoisooctyl ester, disodium salt",CC(C)CCCCCOP(=O)([O-])[O-].[Na+].[Na+],,,,,,
6624,106625,"Phosphoric acid, isooctyl ester",CC(C)CCCCCOP(=O)(O)O,,,,,,
6625,106626,"Phosphoric acid, diisooctyl ester, compd. with 2,2',2''-nitrilotris[ethanol] (1:1)",CC(C)CCCCCOP(=O)(O)OCCCCCC(C)C.C(CO)N(CCO)CCO,,,,,,
6626,106627,"Phosphoric acid, monoisooctyl ester, compd. with 2,2',2''-nitrilotris[ethanol] (1:2)",CC(C)CCCCCOP(=O)(O)O.C(CO)N(CCO)CCO.C(CO)N(CCO)CCO,,,,,,
6627,106628,Ditridecyl phenyl phosphite,CCCCCCCCCCCCCOP(OCCCCCCCCCCCCC)OC1=CC=CC=C1,,,,,,
6628,106629,"1H-Pyrazolium, 5-((4-(diethylamino)phenyl)azo)-2-(2-hydroxyethyl)-1-(phenylmethyl)-, chloride",CCN(CC)C1=CC=C(C=C1)N=NC2=CC=[N+](N2CC3=CC=CC=C3)CCO.[Cl-],,,,,,
6629,106630,5-[[4-(Diethylamino)phenyl]azo]-2-(2-hydroxyethyl)-1-(phenylmethyl)-1H-pyrazol-2-ium,CCN(CC)C1=CC=C(C=C1)N=NC2=CC=[N+](N2CC3=CC=CC=C3)CCO,,,,,,
6630,106631,Distearyl phenyl phosphite,CCCCCCCCCCCCCCCCCCOP(OCCCCCCCCCCCCCCCCCC)OC1=CC=CC=C1,,,,,,
6631,106632,"Benzoic acid, 4-amino-, cobalt(2+) salt (2:1)",C1=CC(=CC=C1C(=O)[O-])N.C1=CC(=CC=C1C(=O)[O-])N.[Co+2],,,,,,
6632,106633,"1,3-Propanediaminium, N,N,N,N',N'-pentamethyl-N'-(3-(octyloxy)propyl)-, dichloride",CCCCCCCCOCCC[N+](C)(C)CCC[N+](C)(C)C.[Cl-].[Cl-],,,,,,
6633,106634,"N,N,N,N',N'-Pentamethyl-N'-[3-(octyloxy)propyl]-1,3-propanediaminium",CCCCCCCCOCCC[N+](C)(C)CCC[N+](C)(C)C,,,,,,
6634,106635,"1-Propanamine, 3-(dodecyloxy)-, acetate",CCCCCCCCCCCCOCCCN.CC(=O)O,,,,,,
6635,106636,"N-[3-(Octyloxy)propyl]propane-1,3-diamine",CCCCCCCCOCCCNCCCN,,,,,,
6636,106637,"1-Propanaminium, N,N,N-trimethyl-3-(tridecyloxy)-, chloride",CCCCCCCCCCCCCOCCC[N+](C)(C)C.[Cl-],,,,,,
6637,106638,"N,N,N-Trimethyl-3-(tridecyloxy)-1-propanaminium",CCCCCCCCCCCCCOCCC[N+](C)(C)C,,,,,,
6638,106639,Trimethyl-3-(octyloxy)propylammonium chloride,CCCCCCCCOCCC[N+](C)(C)C.[Cl-],,,,,,
6639,106640,"N,N,N-Trimethyl-3-(octyloxy)-1-propanaminium",CCCCCCCCOCCC[N+](C)(C)C,,,,,,
6640,106641,"1,4-Benzenediamine, N,N'-bis(1-methylheptylidene)-",CCCCCCC(=NC1=CC=C(C=C1)N=C(C)CCCCCC)C,,,,,,
6641,106642,"1,3-Propanediamine, N-(3-methoxypropyl)-",COCCCNCCCN,,,,,,
6642,106643,"1,3-Propanediamine, N-[3-(pentadecyloxy)propyl]-",CCCCCCCCCCCCCCCOCCCNCCCN,,,,,,
6643,106644,"Ethanaminium, N-(4-((4-(diethylamino)phenyl)phenylmethylene)-2,5-cyclohexadien-1-ylidene)-N-ethyl-, benzoate",CCN(CC)C1=CC=C(C=C1)C2=CC=C(C=C2)C=C3C=CC(=[N+](CC)CC)C=C3.C1=CC=C(C=C1)C(=O)[O-],,,,,,
6644,106645,"[4-[[4-[4-(Diethylamino)phenyl]phenyl]methylidene]cyclohexa-2,5-dien-1-ylidene]-diethylazanium",CCN(CC)C1=CC=C(C=C1)C2=CC=C(C=C2)C=C3C=CC(=[N+](CC)CC)C=C3,,,,,,
6645,106646,"1,3-Dioxa-2-thia-4-silacycloheptane, 4-chloro-4-methyl-, 2,2-dioxide",C[Si]1(CCCOS(=O)(=O)O1)Cl,,,,,,
6646,106647,"Carbonic acid, compd. with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:2)",C(C(CO)(CO)N)O.C(C(CO)(CO)N)O.C(=O)(O)O,,,,,,
6647,106648,"2,3-Dihydro-9-hydroxy-7H-furo[3,2-g][1]benzopyran-7-one",C1COC2=C1C=C3C=CC(=O)OC3=C2O,,,,,,
6648,106649,"3,6,7-Benzofurantriol, triacetate",CC(=O)OC1=C(C2=C(C=C1)C(=CO2)OC(=O)C)OC(=O)C,,,,,,
6649,106650,"2,3-Dihydrobenzofuran-6,7-diol diacetate",CC(=O)OC1=C(C2=C(CCO2)C=C1)OC(=O)C,,,,,,
6650,106651,"1H-Benzimidazolium, 5-chloro-3-ethyl-2-methyl-1-[3-(triethylammonio)propyl]-, bis(ethyl sulfate)",CCN1C(=[N+](C2=C1C=C(C=C2)Cl)CCC[N+](CC)(CC)CC)C.CCOS(=O)(=O)[O-].CCOS(=O)(=O)[O-],,,,,,
6651,106652,6-Chloro-1-ethyl-2-methyl-3-[3-(triethylammonio)propyl]-1H-benzimidazolium,CCN1C(=[N+](C2=C1C=C(C=C2)Cl)CCC[N+](CC)(CC)CC)C,,,,,,
6652,106653,"1H-Benzimidazole-1-propanamine, 5-chloro-N,N-diethyl-2-methyl-",CCN(CC)CCCN1C(=NC2=C1C=CC(=C2)Cl)C,,,,,,
6653,106654,"Naphth[2,1-d]oxazolium, 2-[3-[5-chloro-3-ethyl-1,3-dihydro-1-[3-(triethylammonio)propyl]-2H-benzimidazol-2-ylidene]-1-propenyl]-3-ethyl-, bis(ethyl sulfate)",CCN1C2=C(C=CC(=C2)Cl)N(C1=CC=CC3=[N+](C4=C(O3)C5=CC=CC=C5C=C4)CC)CCC[N+](CC)(CC)CC.CCOS(=O)(=O)[O-].CCOS(=O)(=O)[O-],,,,,,
6654,106655,Einecs 265-338-5,CCCCCCCCCCCCCCCCCC(=O)OC(C)CN(CCN(CC(C)O)CC(C)O)CC(C)OC(=O)CCCCCCCCCCCCCCCCC.COS(=O)(=O)O,,,,,,
6655,106656,1-[2-[Bis(2-hydroxypropyl)amino]ethyl-(2-octadecanoyloxypropyl)amino]propan-2-yl octadecanoate,CCCCCCCCCCCCCCCCCC(=O)OC(C)CN(CCN(CC(C)O)CC(C)O)CC(C)OC(=O)CCCCCCCCCCCCCCCCC,,,,,,
6656,106657,"Hexabutyl 2,2',2''-[(butylstannylidyne)tris(thio)]trisuccinate",CCCCOC(=O)CC(C(=O)OCCCC)S[Sn](CCCC)(SC(CC(=O)OCCCC)C(=O)OCCCC)SC(CC(=O)OCCCC)C(=O)OCCCC,,,,,,
6657,106658,"1,4-Methanoazulen-7(1H)-one, octahydro-1,5,5,8a-tetramethyl-",CC1(CC(=O)CC2(C3C1CC2(CC3)C)C)C,,,,,,
6658,106659,"Disodium;4-[2-(octadeca-2,17-dienoylamino)ethoxy]-4-oxo-2-sulfonatobutanoate",C=CCCCCCCCCCCCCCC=CC(=O)NCCOC(=O)CC(C(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
6659,106660,"4-[2-(Octadeca-2,17-dienoylamino)ethoxy]-4-oxo-2-sulfobutanoic acid",C=CCCCCCCCCCCCCCC=CC(=O)NCCOC(=O)CC(C(=O)O)S(=O)(=O)O,,,,,,
6660,106661,Monomethacryloxyisopropyl phthalate,CC(COC(=O)C(=C)C)OC(=O)C1=CC=CC=C1C(=O)O,,,,,,
6661,106662,"5-Acetamido-4-((2-bromo-4,6-dinitrophenyl)azo)-2-methoxy-N-(1-methylpentyl)aniline",CCCCC(C)NC1=C(C=C(C(=C1)NC(=O)C)N=NC2=C(C=C(C=C2Br)[N+](=O)[O-])[N+](=O)[O-])OC,,,,,,
6662,106663,"Acetamide, N-[4-methoxy-3-[(1-methylpentyl)amino]phenyl]-",CCCCC(C)NC1=C(C=CC(=C1)NC(=O)C)OC,,,,,,
6663,106664,"1-Phenyl-2-nitro-1,3-diacetoxypropane",CC(=O)OCC(C(C1=CC=CC=C1)OC(=O)C)[N+](=O)[O-],,,,,,
6664,106665,alpha-(Ethoxymethyl)-2-nitroimidazole-1-ethanol,CCOCC(CN1C=CN=C1[N+](=O)[O-])O,,,,,,
6665,106666,"1,3-Cyclohexanedimethanamine, N,N,N',N'-tetrakis(oxiranylmethyl)-",C1CC(CC(C1)CN(CC2CO2)CC3CO3)CN(CC4CO4)CC5CO5,,,,,,
6666,106667,3-Methyloct-1-en-3-yl acetate,CCCCCC(C)(C=C)OC(=O)C,,,,,,
6667,106668,"Pentanamide, N-(5-amino-2-chlorophenyl)-2-chloro-4,4-dimethyl-3-oxo-",CC(C)(C)C(=O)C(C(=O)NC1=C(C=CC(=C1)N)Cl)Cl,,,,,,
6668,106669,"Sulfamic acid, diethyl-, dodecyl ester",CCCCCCCCCCCCOS(=O)(=O)N(CC)CC,,,,,,
6669,106670,"Methyl 2,5-dimethyl-2-vinylhex-4-enoate",CC(=CCC(C)(C=C)C(=O)OC)C,,,,,,
6670,106671,"1,3-Propanediamine, N-[3-(hexadecyloxy)propyl]-",CCCCCCCCCCCCCCCCOCCCNCCCN,,,,,,
6671,106672,"1-(3,3-Dimethylbicyclo[2.2.1]hept-2-yl)ethanol",CC(C1C2CCC(C2)C1(C)C)O,,,,,,
6672,106673,"Cyclohexanol, 4-(5,5,6-trimethylbicyclo(2.2.1)hept-2-yl)-",CC1C2CC(C1(C)C)CC2C3CCC(CC3)O,,,,,,
6673,106674,"4-((1R,2R,4R)-Born-2-yl)cyclohexanol",CC1(C2CCC1(C(C2)C3CCC(CC3)O)C)C,,,,,,
6674,106675,"Acetamide, N-(4,5,6,7-tetrahydro-7-oxobenzo[b]thien-4-yl)-",CC(=O)NC1CCC(=O)C2=C1C=CS2,,,,,,
6675,106676,"1-Phenanthrenecarboxylic acid, 1,2,3,4,4a,4b,5,6,10,10a-decahydro-1,4a-dimethyl-7-(1-methylethyl)-, strontium salt, (1R,4aR,4bR,10aR)-",CC(C)C1=CC2=C(CC1)C3(CCCC(C3CC2)(C)C(=O)[O-])C.CC(C)C1=CC2=C(CC1)C3(CCCC(C3CC2)(C)C(=O)[O-])C.[Sr+2],,,,,,
6676,106677,"1-Phenanthrenecarboxylic acid, 1,2,3,4,4a,4b,5,6,10,10a-decahydro-1,4a-dimethyl-7-(1-methylethyl)-, barium salt, (1R,4aR,4bR,10aR)-",CC(C)C1=CC2=C(CC1)C3(CCCC(C3CC2)(C)C(=O)[O-])C.CC(C)C1=CC2=C(CC1)C3(CCCC(C3CC2)(C)C(=O)[O-])C.[Ba+2],,,,,,
6677,106678,Bis(2-hydroxypropyl)ammonium decyl sulphate,CCCCCCCCCCCCOS(=O)(=O)O.CC(CNCC(C)O)O,,,,,,
6678,106679,TIPA-Lauryl sulfate,CCCCCCCCCCCCOS(=O)(=O)O.CCC(N(CC(C)O)CC(C)O)O,,,,,,
6679,106680,1-[Bis(2-hydroxypropyl)amino]propan-1-ol,CCC(N(CC(C)O)CC(C)O)O,,,,,,
6680,106681,"2,5,8,11-Tetraoxatridecan-13-ol, 9,12(9,13-,10,12 or 10,13)-dimethyl-",CC(CO)OCC(C)OCCOCCOC,,,,,,
6681,106682,"Anthra(2,1,9-def:6,5,10-d'e'f')diisoquinoline-1,3,8,10(2H,9H)-tetrone, 2,9-bis(5-chloro-2-methylphenyl)-",CC1=C(C=C(C=C1)Cl)N2C(=O)C3=C4C(=CC=C5C4=C(C=C3)C6=C7C5=CC=C8C7=C(C=C6)C(=O)N(C8=O)C9=C(C=CC(=C9)Cl)C)C2=O,,,,,,
6682,106683,1-Allyl-4-(4-methyl-3-pentenyl)cyclohex-3-ene-1-carbaldehyde,CC(=CCCC1=CCC(CC1)(CC=C)C=O)C,,,,,,
6683,106684,Vernaldehyde,CC(C)CCCC1=CCC(CC1)(C)C=O,,,,,,
6684,106685,Methyl glycyl-L-serinate,COC(=O)C(CO)NC(=O)CN,,,,,,
6685,106686,1-(Bis(2-hydroxyethyl)amino)-3-(decyloxy)propan-2-ol,CCCCCCCCCCOCC(CN(CCO)CCO)O,,,,,,
6686,106687,"2-Cyclohexene-1-octanoic acid, 5-carboxy-4-hexyl-, dipotassium salt",CCCCCCC1C=CC(CC1C(=O)[O-])CCCCCCCC(=O)[O-].[K+].[K+],,,,,,
6687,106688,"Butanoic acid, 4-amino-2-hydroxy-4-oxo-",C(C(C(=O)O)O)C(=O)N,,,,,,
6688,106689,"Carbonic acid, (1-methylethylidene)di-4,1-cyclohexanediyl bis[(3-ethyl-8,8,10,10-tetramethyl-1,5-dioxa-9-azaspiro[5.5]undec-3-yl)methyl] ester",CCC1(COC2(CC(NC(C2)(C)C)(C)C)OC1)COC(=O)OC3CCC(CC3)C(C)(C)C4CCC(CC4)OC(=O)OCC5(COC6(CC(NC(C6)(C)C)(C)C)OC5)CC,,,,,,
6689,106690,3-Chloromethyl-1-methylpiperidine hydrochloride,CN1CCCC(C1)CCl.Cl,,,,,,
6690,106691,"4-Piperidinecarboxylic acid, 4-hydroxy-2,2,6,6-tetramethyl-, methyl ester",CC1(CC(CC(N1)(C)C)(C(=O)OC)O)C,,,,,,
6691,106692,2-Undecyloxirane,CCCCCCCCCCCC1CO1,,,,,,
6692,106693,"Acetamide, N-(2-((2-cyano-4,6-dinitrophenyl)azo)-4-methoxy-5-((1-methylpentyl)amino)phenyl)-",CCCCC(C)NC1=C(C=C(C(=C1)NC(=O)C)N=NC2=C(C=C(C=C2[N+](=O)[O-])[N+](=O)[O-])C#N)OC,,,,,,
6693,106694,3-(4-tert-Butylphenyl)-2-methylpropanoic acid,CC(CC1=CC=C(C=C1)C(C)(C)C)C(=O)O,,,,,,
6694,106695,"3-Hexanol, 4-ethyl-3-methyl-",CCC(CC)C(C)(CC)O,,,,,,
6695,106696,"(3bS,8bR)-3,3b,4,5,8,8b,9,10-octahydroindazolo[7,6-g]indazole",C1CC2=C([C@@H]3[C@@H]1C4=C(CC3)C=NN4)NN=C2,,,,,,
6696,106697,"3,5-Dimethylcyclohex-3-ene-1-carbonitrile",CC1CC(CC(=C1)C)C#N,,,,,,
6697,106698,"3-Cyclohexene-1-carbonitrile, 2,4-dimethyl-",CC1C=C(CCC1C#N)C,,,,,,
6698,106699,"Benzenepropanal, 4-cyclopentyl-alpha-methyl-",CC(CC1=CC=C(C=C1)C2CCCC2)C=O,,,,,,
6699,106700,"6-Ethoxy-3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene",CCOC1CC2CC1C3C2C=CC3,,,,,,
6700,106701,Isopropyl 2-ethylhexanoate,CCCCC(CC)C(=O)OC(C)C,,,,,,
6701,106702,"Trisiloxane, 3-methyl-1,1,1,3,5,5,5-heptakis(1-methylpropoxy)-",CCC(C)O[Si](C)(O[Si](OC(C)CC)(OC(C)CC)OC(C)CC)O[Si](OC(C)CC)(OC(C)CC)OC(C)CC,,,,,,
6702,106703,"2,5-Furandione, dihydro-3-(2-octadecen-1-yl)-",CCCCCCCCCCCCCCCC=CCC1CC(=O)OC1=O,,,,,,
6703,106704,"2-Propanol, 1-(tert-dodecylthio)-",CC(CSCCCCCCCCC(C)(C)C)O,,,,,,
6704,106705,1-[Bis[3-(dimethylamino)propyl]amino]propan-2-ol,CC(CN(CCCN(C)C)CCCN(C)C)O,,,,,,
6705,106706,Benzyl(3-chloro-2-hydroxypropyl)dimethylammonium chloride,C[N+](C)(CC1=CC=CC=C1)CC(CCl)O.[Cl-],,,,,,
6706,106707,"N-(3-Chloro-2-hydroxypropyl)-N,N-dimethylbenzenemethanaminium",C[N+](C)(CC1=CC=CC=C1)CC(CCl)O,,,,,,
6707,106708,"Phenethylamine, alpha-butyl-",CCCCC(CC1=CC=CC=C1)N,,,,,,
6708,106709,"1,2,3,4-Tetrahydro-4a,9a-epoxy-1,4-methanoanthracene-9,10-dione",C1CC2CC1C34C2(O3)C(=O)C5=CC=CC=C5C4=O,,,,,,
6709,106710,Ethyl 2-acetyl-3-oxodecanoate,CCCCCCCC(=O)C(C(=O)C)C(=O)OCC,,,,,,
6710,106711,"3,5,5-Trimethylhexyl formate",CC(CCOC=O)CC(C)(C)C,,,,,,
6711,106712,CID 106712,CCC(CC=COC)(CC=COC)COC(=O)C,,,,,,
6712,106713,"Bicyclo[2.2.2]oct-5-ene-2-carboxylic acid, 1-methyl-4-(1-methylethyl)-, methyl ester",CC(C)C12CCC(C=C1)(C(C2)C(=O)OC)C,,,,,,
6713,106714,"3-Ethoxy-1,1,5-trimethylcyclohexane",CCOC1CC(CC(C1)(C)C)C,,,,,,
6714,106715,4-Methoxyphenyl 4-propylcyclohexanecarboxylate,CCCC1CCC(CC1)C(=O)OC2=CC=C(C=C2)OC,,,,,,
6715,106716,4-Ethoxyphenyl trans-4-propylcyclohexanecarboxylate,CCCC1CCC(CC1)C(=O)OC2=CC=C(C=C2)OCC,,,,,,
6716,106717,"3-Chloro-2-hydroxy-N,N-dimethyl-N-[2-[(2-methyl-1-oxo-2-propenyl)oxy]ethyl]-1-propanaminium",CC(=C)C(=O)OCC[N+](C)(C)CC(CCl)O,,,,,,
6717,106718,"Carbamic acid, (methylenedi-4,1-cyclohexanediyl)bis-, bis(2-oxo-1,2-diphenylethyl) ester",C1CC(CCC1CC2CCC(CC2)NC(=O)OC(C3=CC=CC=C3)C(=O)C4=CC=CC=C4)NC(=O)OC(C5=CC=CC=C5)C(=O)C6=CC=CC=C6,,,,,,
6718,106719,1-Bromo-4-(2-methylbutoxy)benzene,CCC(C)COC1=CC=C(C=C1)Br,,,,,,
6719,106720,"Phenol, 4-(2-methylbutoxy)-",CCC(C)COC1=CC=C(C=C1)O,,,,,,
6720,106721,"Benzoic acid, 4-hexyl-, 4-(2-methylbutoxy)phenyl ester",CCCCCCC1=CC=C(C=C1)C(=O)OC2=CC=C(C=C2)OCC(C)CC,,,,,,
6721,106722,"2H-Pyran-2-one, 5-(1-butenyl)-5-ethyltetrahydro-",CCC=CC1(CCC(=O)OC1)CC,,,,,,
6722,106723,1-Methyl 2-sulphooctanoate,CCCCCCC(C(=O)OC)S(=O)(=O)O,,,,,,
6723,106724,1-Methyl 2-sulphohexanoate,CCCCC(C(=O)OC)S(=O)(=O)O,,,,,,
6724,106725,"4,7-Methano-1H-indene, 5-(diethoxymethyl)-3a,4,5,6,7,7a-hexahydro-",CCOC(C1CC2CC1C3C2CC=C3)OCC,,,,,,
6725,106726,"4,7-Methano-1H-indene, 6-(diethoxymethyl)-3a,4,5,6,7,7a-hexahydro-",CCOC(C1CC2CC1C3C2C=CC3)OCC,,,,,,
6726,106727,"Butanoic acid, 2-methyl-5-(2-methyl-3-methylenebicyclo[2.2.1]hept-2-yl)-2-penten-1-yl ester",CCCC(=O)OCC(=CCCC1(C2CCC(C2)C1=C)C)C,,,,,,
6727,106728,"5-(2,3-Dimethyltricyclo[2.2.1.02,6]hept-3-yl)-2-methylpent-2-enyl butyrate",CCCC(=O)OCC(=CCCC1(C2CC3C1(C3C2)C)C)C,,,,,,
6728,106729,Allyl (3-methylbutoxy)acetate,CC(C)CCOCC(=O)OCC=C,,,,,,
6729,106730,Allyl (2-methylbutoxy)acetate,CCC(C)COCC(=O)OCC=C,,,,,,
6730,106731,"Cyclohexaneethanol, beta-methyl-4-(1-methylethyl)-",CC(C)C1CCC(CC1)C(C)CO,,,,,,
6731,106732,"(2,2-Bis((3,7-dimethyl-6-octenyl)oxy)ethyl)benzene",CC(CCC=C(C)C)CCOC(CC1=CC=CC=C1)OCCC(C)CCC=C(C)C,,,,,,
6732,106733,"2,4,6-Trimethylcyclohexylmethyl acetate",CC1CC(C(C(C1)C)COC(=O)C)C,,,,,,
6733,106734,8-(sec-Butyl)quinoline,CCC(C)C1=CC=CC2=C1N=CC=C2,,,,,,
6734,106735,"3,5,6-Trimethyl-3-cyclohexene-1-carboxaldehyde",CC1C=C(CC(C1C)C=O)C,,,,,,
6735,106736,"1-Hexanol, 1-(tetrahydro-2-furyl)-, acetate",CCCCCC(C1CCCO1)OC(=O)C,,,,,,
6736,106737,"2-Methyloctane-1,3-diyl diacetate",CCCCCC(C(C)COC(=O)C)OC(=O)C,,,,,,
6737,106738,"Benzeneethanol, beta-methyl-4-(1-methylethyl)-",CC(C)C1=CC=C(C=C1)C(C)CO,,,,,,
6738,106739,"Cyclohexanol, 2-(1,1-dimethylethyl)-4-methyl-",CC1CCC(C(C1)C(C)(C)C)O,,,,,,
6739,106740,Methyl 2-[[[4-(4-hydroxy-4-methylpentyl)-3-cyclohexenyl]methylene]amino]benzoate,CC(C)(CCCC1=CCC(CC1)C=NC2=CC=CC=C2C(=O)OC)O,,,,,,
6740,106741,"2-Hexene, 2,3,4,4-tetramethyl-",CCC(C)(C)C(=C(C)C)C,,,,,,
6741,106742,"3-Cyclohexene-1-methanol, 3,5-dimethyl-",CC1CC(CC(=C1)C)CO,,,,,,
6742,106743,"3-Cyclohexene-1-methanol, 2,4-dimethyl-",CC1C=C(CCC1CO)C,,,,,,
6743,106744,"Butanoic acid, 2-methylene-, 3-methylbutyl ester",CCC(=C)C(=O)OCCC(C)C,,,,,,
6744,106745,"3a,4,5,6,7,7a-Hexahydro-4,7-methano-1H-inden-5-yl isobutyrate",CC(C)C(=O)OC1CC2CC1C3C2CC=C3,,,,,,
6745,106746,"(2,4-Dimethylcyclohexyl)methyl acetate",CC1CCC(C(C1)C)COC(=O)C,,,,,,
6746,106747,"3a,4,5,6,7,7a-Hexahydro-4,7-methano-1H-inden-5-yl propionate",CCC(=O)OC1CC2CC1C3C2CC=C3,,,,,,
6747,106748,"3,5-Dimethylcyclohex-3-ene-1-methyl acetate",CC1CC(CC(=C1)C)COC(=O)C,,,,,,
6748,106749,"2,4-Dimethylcyclohex-3-ene-1-methyl acetate",CC1C=C(CCC1COC(=O)C)C,,,,,,
6749,106750,"2-Furancarboxaldehyde, 5-nitro-, O-[3-(2,6-dimethyl-1-piperidinyl)-2-hydroxypropyl]oxime, monohydrochloride",CC1CCCC(N1CC(CON=CC2=CC=C(O2)[N+](=O)[O-])O)C.Cl,,,,,,
6750,106751,"1-(2,6-Dimethylpiperidin-1-yl)-3-[(5-nitrofuran-2-yl)methylideneamino]oxypropan-2-ol",CC1CCCC(N1CC(CON=CC2=CC=C(O2)[N+](=O)[O-])O)C,,,,,,
6751,106752,6-Isopropylbicyclo[2.2.2]octane-2-carbaldehyde,CC(C)C1CC2CCC1C(C2)C=O,,,,,,
6752,106753,3-Methyl-5-propylcyclohexan-1-one,CCCC1CC(CC(=O)C1)C,,,,,,
6753,106754,"3-Buten-2-one, 4-(5,5-dimethyl-3-cyclohexen-1-yl)-",CC(=O)C=CC1CC=CC(C1)(C)C,,,,,,
6754,106755,"3H-Indole-3-heptanol, alpha,alpha,epsilon,3-tetramethyl-eta-(3-methyl-3H-indol-3-yl)-",CC(CCCC(C)(C)O)CC(C1(C=NC2=CC=CC=C21)C)C3(C=NC4=CC=CC=C43)C,,,,,,
6755,106756,5-Hexyl-4-methyldihydrofuran-2(3H)-one,CCCCCCC1C(CC(=O)O1)C,,,,,,
6756,106757,"3,4-Epoxyhexanol",CCC1C(O1)CCO,,,,,,
6757,106758,"1,4-Cyclohexanedimethanol, 1-ethyl-",CCC1(CCC(CC1)CO)CO,,,,,,
6758,106759,CID 106759,C1=CC=C2C(=C1)C(=O)C(S2)C(=O)[O-].[Na+],,,,,,
6759,106760,"Benzo[b]thiophene-2-carboxylic acid, 2,3-dihydro-3-oxo-",C1=CC=C2C(=C1)C(=O)C(S2)C(=O)O,,,,,,
6760,106761,alpha-Ethyl-alpha-methylpyridine-2-methanol,CCC(C)(C1=CC=CC=N1)O,,,,,,
6761,106762,"2H-Pyran-2-one, tetrahydro-6,6-dimethyl-3-(1-methylethyl)-",CC(C)C1CCC(OC1=O)(C)C,,,,,,
6762,106763,"Ethyl 1-acetyl-4,6-dimethylcyclohex-3-ene-1-carboxylate",CCOC(=O)C1(CC=C(CC1C)C)C(=O)C,,,,,,
6763,106764,2-(3-Methyl-2-butenyl)-1-vinylcyclopentyl acetate,CC(=CCC1CCCC1(C=C)OC(=O)C)C,,,,,,
6764,106765,1-Ethyl-2-(3-methylbut-2-enyl)cyclopentan-1-ol,CCC1(CCCC1CC=C(C)C)O,,,,,,
6765,106766,"6,6-Dimethoxy-2,5,5-trimethylhex-2-ene",CC(=CCC(C)(C)C(OC)OC)C,,,,,,
6766,106767,"7,18-Dioxabicyclo[15.1.0]octadecan-8-one",C1CCCCC(=O)OCCCCCC2C(O2)CCC1,,,,,,
6767,106768,"beta-Alanine, N-(3-(triethoxysilyl)propyl)-",CCO[Si](CCCNC(C)C(=O)O)(OCC)OCC,,,,,,
6768,106769,"3,3-Dimethyl-4-phenylbutan-2-ol",CC(C(C)(C)CC1=CC=CC=C1)O,,,,,,
6769,106770,"Tetrahydro-alpha,alpha,5-trimethyl-5-vinylfurfuryl acetate",CC(=O)OC(C)(C)C1CCC(O1)(C)C=C,,,,,,
6770,106771,"1(3H)-Isobenzofuranone, 3-[4-(dimethylamino)phenyl]-3-(diphenylamino)-",CN(C)C1=CC=C(C=C1)C2(C3=CC=CC=C3C(=O)O2)N(C4=CC=CC=C4)C5=CC=CC=C5,,,,,,
6771,106772,"1(3H)-Isobenzofuranone, 3-[bis(4-octylphenyl)amino]-3-[4-(dimethylamino)phenyl]-",CCCCCCCCC1=CC=C(C=C1)N(C2=CC=C(C=C2)CCCCCCCC)C3(C4=CC=CC=C4C(=O)O3)C5=CC=C(C=C5)N(C)C,,,,,,
6772,106773,4-Chlorooctan-1-ol,CCCCC(CCCO)Cl,,,,,,
6773,106774,"1H,4H-3a,8a-Epoxy-4,7-methanoazulene, hexahydro-1,4,10,10-tetramethyl-",CC1CCC23C1(O2)CC4CCC3(C4(C)C)C,,,,,,
6774,106775,"1-Penten-3-ol, 2-methyl-1-(methylbicyclo[2.2.1]hept-5-en-2-yl)-",CCC(C(=CC1(CC2CC1C=C2)C)C)O,,,,,,
6775,106776,"Cyclopentanol, 2-(2-(2,2,3-trimethyl-3-cyclopenten-1-yl)ethyl)-",CC1=CCC(C1(C)C)CCC2CCCC2O,,,,,,
6776,106777,1-Formyl-1-methyl-4-(4-methyl-4-pentenyl)-3-cyclohexene,CC(=C)CCCC1=CCC(CC1)(C)C=O,,,,,,
6777,106778,"1,4,9-Trimethylcyclododeca-1,5,9-triene",CC1CC=C(CCC=C(CCC=C1)C)C,,,,,,
6778,106779,"2-Hexen-1-ol, 4-methyl-2-propyl-",CCCC(=CC(C)CC)CO,,,,,,
6779,106780,"2-Hexen-1-ol, 4-methyl-2-propyl-, acetate",CCCC(=CC(C)CC)COC(=O)C,,,,,,
6780,106781,Trimethylolpropane valerate heptanoate,CCCCCCC(=O)OCC(CC)(CO)COC(=O)CCCC,,,,,,
6781,106782,"9-Octadecenoic acid (9Z)-, ester with 2-ethyl-2-(hydroxymethyl)-1,3-propanediol nonanoate",CCCCCCCCC=CCCCCCCCC(=O)OCC(CC)(CO)COC(=O)CCCCCCCC,,,,,,
6782,106783,"Phosphoric acid, mono(2-ethylhexyl) ester, compd. with tert-dodecanamine",CCCCC(CC)COP(=O)(O)O.CC(C)(C)CCCCCCCCN,,,,,,
6783,106784,CID 106784,CC1=CC(=CC(=C1C2(C3=CC=CC=C3S(=O)(=O)O2)C4=C(C=C(C=C4C)[O-])C(C)C)C(C)C)O.[Na+],,,,,,
6784,106785,"4-[3-(4-Hydroxy-2-methyl-6-propan-2-ylphenyl)-1,1-dioxo-2,1lambda6-benzoxathiol-3-yl]-3-methyl-5-propan-2-ylphenol",CC1=CC(=CC(=C1C2(C3=CC=CC=C3S(=O)(=O)O2)C4=C(C=C(C=C4C)O)C(C)C)C(C)C)O,,,,,,
6785,106786,CID 106786,CC1=C(C(=C(C=C1C2(C3=CC=CC=C3S(=O)(=O)O2)C4=CC(=C(C(=C4C)Br)[O-])Br)Br)O)Br.[Na+],,,,,,
6786,106787,"2H-Pyran-2-one, 5-butyl-5-ethyltetrahydro-",CCCCC1(CCC(=O)OC1)CC,,,,,,
6787,106788,"1,1-Diethoxy-2-methylundecane",CCCCCCCCCC(C)C(OCC)OCC,,,,,,
6788,106789,"3,5,5-Trimethylhexyl isobutyrate",CC(C)C(=O)OCCC(C)CC(C)(C)C,,,,,,
6789,106790,"10-Undecen-1-ol, 1-(10-undecenyloxy)-",C=CCCCCCCCCCOC(CCCCCCCCC=C)O,,,,,,
6790,106791,"1,5-Dioxaspiro[5.5]undecan-3-ol, 10-methyl-7-(1-methylethyl)-",CC1CCC(C2(C1)OCC(CO2)O)C(C)C,,,,,,
6791,106792,"[2-[Bis[(1,5-dimethyl-1-vinyl-4-hexenyl)oxy]methyl]-1-heptenyl]benzene",CCCCCC(=CC1=CC=CC=C1)C(OC(C)(CCC=C(C)C)C=C)OC(C)(CCC=C(C)C)C=C,,,,,,
6792,106793,2-Ethylhexan-1-aminium acetate,CCCCC(CC)CN.CC(=O)O,,,,,,
6793,106794,CID 106794,CCCCCCCCC=CCCCCCCCC1N(CCN1CCO)CC.CCOS(=O)(=O)O,,,,,,
6794,106795,2-(3-Ethyl-2-heptadec-8-enylimidazolidin-1-yl)ethanol,CCCCCCCCC=CCCCCCCCC1N(CCN1CCO)CC,,,,,,
6795,106796,"Tetrasodium;5-[[4-[bis(2-hydroxypropyl)amino]-6-(4-sulfonatoanilino)-1,3,5-triazin-2-yl]amino]-2-[2-[4-[[4-[bis(2-hydroxypropyl)amino]-6-(4-sulfonatoanilino)-1,3,5-triazin-2-yl]amino]-2-sulfonatophenyl]ethenyl]benzenesulfonate",CC(CN(CC(C)O)C1=NC(=NC(=N1)NC2=CC(=C(C=C2)C=CC3=C(C=C(C=C3)NC4=NC(=NC(=N4)NC5=CC=C(C=C5)S(=O)(=O)[O-])N(CC(C)O)CC(C)O)S(=O)(=O)[O-])S(=O)(=O)[O-])NC6=CC=C(C=C6)S(=O)(=O)[O-])O.[Na+].[Na+].[Na+].[Na+],,,,,,
6796,106797,"5-[[4-[Bis(2-hydroxypropyl)amino]-6-(4-sulfoanilino)-1,3,5-triazin-2-yl]amino]-2-[2-[4-[[4-[bis(2-hydroxypropyl)amino]-6-(4-sulfoanilino)-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]ethenyl]benzenesulfonic acid",CC(CN(CC(C)O)C1=NC(=NC(=N1)NC2=CC(=C(C=C2)C=CC3=C(C=C(C=C3)NC4=NC(=NC(=N4)NC5=CC=C(C=C5)S(=O)(=O)O)N(CC(C)O)CC(C)O)S(=O)(=O)O)S(=O)(=O)O)NC6=CC=C(C=C6)S(=O)(=O)O)O,,,,,,
6797,106798,CID 106798,CC1=NN(C(=O)C1N=NC2=CC=CC=C2C(=O)[O-])C3=CC=CC=C3.[Na+],,,,,,
6798,106799,"Benzoic acid, 2-[(2-methylundecylidene)amino]-, methyl ester",CCCCCCCCCC(C)C=NC1=CC=CC=C1C(=O)OC,,,,,,
6799,106800,"Octahydro-3,6,8,8-tetramethyl-1H-3a,7-methanoazulen-5-yl acetate",CC1CCC2C13CC(C2(C)C)C(C(C3)OC(=O)C)C,,,,,,
6800,106801,"Bicyclo[4.1.0]hept-4-ene-3-methanol, alpha-ethyl-4,7,7-trimethyl-",CCC(C1CC2C(C2(C)C)C=C1C)O,,,,,,
6801,106802,"6-Decen-5-ol, 6-ethyl-2-methyl-",CCCC=C(CC)C(CCC(C)C)O,,,,,,
6802,106803,"Bicyclo[3.1.0]hexan-3-one, 2-[(4-methoxyphenyl)methylene]-4-methyl-1-(1-methylethyl)-",CC1C2CC2(C(=CC3=CC=C(C=C3)OC)C1=O)C(C)C,,,,,,
6803,106804,"2(3H)-Furanone, 5-(1,3-dimethyl-1-butenyl)dihydro-",CC(C)C=C(C)C1CCC(=O)O1,,,,,,
6804,106805,"Bicyclo(2.2.1)heptane, 2-ethoxy-1,3,3-trimethyl-",CCOC1C(C2CCC1(C2)C)(C)C,,,,,,
6805,106806,"4-Penten-2-ol, 5-(2,2,3-trimethyl-3-cyclopenten-1-yl)-",CC1=CCC(C1(C)C)C=CCC(C)O,,,,,,
6806,106807,"4-Hexen-3-ol, 6-(2,2,3-trimethyl-3-cyclopenten-1-yl)-",CCC(C=CCC1CC=C(C1(C)C)C)O,,,,,,
6807,106808,"2-Propenal, 3-(2,2-dimethyl-6-methylenecyclohexyl)-2-methyl-",CC(=CC1C(=C)CCCC1(C)C)C=O,,,,,,
6808,106809,"2-Propenal, 2-methyl-3-(2,6,6-trimethyl-2-cyclohexen-1-yl)-",CC1=CCCC(C1C=C(C)C=O)(C)C,,,,,,
6809,106810,"4-Penten-2-one, 3-methyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)-",CC1=CCC(C1(C)C)C=CC(C)C(=O)C,,,,,,
6810,106811,"1H-Indole, 1,1'-(3,7-dimethyl-6-octen-1-ylidene)bis-",CC(CCC=C(C)C)CC(N1C=CC2=CC=CC=C21)N3C=CC4=CC=CC=C43,,,,,,
6811,106812,"4-Hexen-3-ol, 4-methyl-6-(2,2,3-trimethyl-3-cyclopenten-1-yl)-",CCC(C(=CCC1CC=C(C1(C)C)C)C)O,,,,,,
6812,106813,"3-Methyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)pent-4-en-2-ol",CC1=CCC(C1(C)C)C=CC(C)C(C)O,,,,,,
6813,106814,"2,2-Dimethyl-6-methylenecyclohexaneacetonitrile",CC1(CCCC(=C)C1CC#N)C,,,,,,
6814,106815,"2-Butenoic acid, 2-methyl-, 5-methyl-2-(1-methylethyl)cyclohexyl ester",CC=C(C)C(=O)OC1CC(CCC1C(C)C)C,,,,,,
6815,106816,"Butanoic acid, 2-methylene-, 5-methyl-2-(1-methylethyl)cyclohexyl ester",CCC(=C)C(=O)OC1CC(CCC1C(C)C)C,,,,,,
6816,106817,"5-Hexen-3-ol, 4-methyl-6-(2,2,3-trimethyl-3-cyclopenten-1-yl)-",CCC(C(C)C=CC1CC=C(C1(C)C)C)O,,,,,,
6817,106818,"2,3,6-Trimethylcyclohexylmethyl acetate",CC1CCC(C(C1C)COC(=O)C)C,,,,,,
6818,106819,"3-Buten-2-one, 3-methyl-4-(2,4,6-trimethyl-3-cyclohexen-1-yl)-",CC1CC(=CC(C1C=C(C)C(=O)C)C)C,,,,,,
6819,106820,"1-Penten-3-one, 1-(2,4,6-trimethyl-3-cyclohexen-1-yl)-",CCC(=O)C=CC1C(CC(=CC1C)C)C,,,,,,
6820,106821,"3-Buten-2-one, 3-methyl-4-(3,5,6-trimethyl-3-cyclohexen-1-yl)-",CC1C=C(CC(C1C)C=C(C)C(=O)C)C,,,,,,
6821,106822,"1-Penten-3-one, 1-(3,5,6-trimethyl-3-cyclohexen-1-yl)-",CCC(=O)C=CC1CC(=CC(C1C)C)C,,,,,,
6822,106823,"2-Nonanone, 3-(hydroxymethyl)-",CCCCCCC(CO)C(=O)C,,,,,,
6823,106824,CID 106824,CC(C(C)[S-])O.[Na+],,,,,,
6824,106825,CID 106825,CC(C(C)SC(C)C(C)[S-])O.[Na+],,,,,,
6825,106826,"1H-Indole-1-heptanol, eta-1H-indol-1-yl-alpha,alpha,epsilon-trimethyl-",CC(CCCC(C)(C)O)CC(N1C=CC2=CC=CC=C21)N3C=CC4=CC=CC=C43,,,,,,
6826,106827,"4-(2,4,6-Trimethylcyclohex-3-en-1-yl)but-3-en-2-one",CC1CC(=CC(C1C=CC(=O)C)C)C,,,,,,
6827,106828,6-Methyl-4-(2-methyl-1-propenyl)oct-5-en-2-one,CCC(=CC(CC(=O)C)C=C(C)C)C,,,,,,
6828,106829,"Benzoic acid, 2-[(3,5,5-trimethylhexylidene)amino]-, methyl ester",CC(CC=NC1=CC=CC=C1C(=O)OC)CC(C)(C)C,,,,,,
6829,106830,"1-Phenanthrenemethanamine, 1,2,3,4,4a,9,10,10a-octahydro-1,4a-dimethyl-7-(1-methylethyl)-, (1R,4aS,10aR)-, phosphate",CC(C)C1=CC2=C(C=C1)C3(CCCC(C3CC2)(C)CN)C.OP(=O)(O)O,,,,,,
6830,106831,Dihydroabietylamine,CC(C)C1=CC2=C(C=C1)C3(CCCC(C3CC2)(C)CN)C,,,,,,
6831,106832,"2,2-Dimethyl-1,3-propanediyl bis(2-hexyldecanoate)",CCCCCCCCC(CCCCCC)C(=O)OCC(C)(C)COC(=O)C(CCCCCC)CCCCCCCC,,,,,,
6832,106833,9-Hydroxyoctadecyl docosanoate,CCCCCCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCC(CCCCCCCCC)O,,,,,,
6833,106834,(1-Methoxyethyl)cyclohexane,CC(C1CCCCC1)OC,,,,,,
6834,106835,"2H-1,4a-Ethanonaphthalen-6(5H)-one, hexahydro-1,5,8a-trimethyl-",CC1C(=O)CCC2(C13CCCC2(CC3)C)C,,,,,,
6835,106836,"Butanedioic acid, sulfo-, 4-[1-methyl-2-[(1-oxo-9-octadecenyl)amino]ethyl] ester, disodium salt",CCCCCCCCC=CCCCCCCCC(=O)NCC(C)OC(=O)CC(C(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
6836,106837,4-{[1-(Octadec-9-enoylamino)propan-2-yl]oxy}-4-oxo-2-sulfobutanoic acid,CCCCCCCCC=CCCCCCCCC(=O)NCC(C)OC(=O)CC(C(=O)O)S(=O)(=O)O,,,,,,
6837,106838,"2-Butenedioic acid (2Z)-, mono[1-methyl-2-[[(9Z)-1-oxo-9-octadecenyl]amino]ethyl] ester",CCCCCCCCC=CCCCCCCCC(=O)NCC(C)OC(=O)C=CC(=O)O,,,,,,
6838,106839,CID 106839,CCCCCCCCCC(CCCCCCCC(=O)O)OS(=O)(=O)[O-].[Na+],,,,,,
6839,106840,"2-Octadecyl-1-(2-(carbamyloxy)ethyl)imidazolium, monoethylphosphate",CCCCCCCCCCCCCCCCCCCC(N1CCNC1)OC(=O)N.CCOP(=O)(O)O,,,,,,
6840,106841,1-Imidazolidin-1-ylicosyl carbamate,CCCCCCCCCCCCCCCCCCCC(N1CCNC1)OC(=O)N,,,,,,
6841,106842,CID 106842,CCCCCCCCCC(CCCCCCCC(=O)OCCCCCCCC(C)C)OS(=O)(=O)[O-].[Na+],,,,,,
6842,106843,8-Methylnonyl 9-(sulfooxy)octadecanoate,CCCCCCCCCC(CCCCCCCC(=O)OCCCCCCCC(C)C)OS(=O)(=O)O,,,,,,
6843,106844,"1-Phenanthrenecarboxylic acid, 1,2,3,4,4a,4b,5,6,10,10a-decahydro-1,4a-dimethyl-7-(1-methylethyl)-, palladium(2+) salt, (1R,4aR,4bR,10aR)-",CC(C)C1=CC2=CCC3C(C2CC1)(CCCC3(C)C(=O)[O-])C.CC(C)C1=CC2=CCC3C(C2CC1)(CCCC3(C)C(=O)[O-])C.[Pd+2],,,,,,
6844,106845,2(Or 3)-carboxy-4-hexylcyclohexaneoctanoic acid,CCCCCCC(CCCCC1CCCCC1)C(CC(=O)O)C(=O)O,,,,,,
6845,106846,"3,3'-((4-((2-Chloro-4,6-dinitrophenyl)azo)naphthyl)imino)bispropane-1,2-diol",C1=CC=C2C(=C1)C(=CC=C2N(CC(CO)O)CC(CO)O)N=NC3=C(C=C(C=C3Cl)[N+](=O)[O-])[N+](=O)[O-],,,,,,
6846,106847,"2-Naphthalenesulfonic acid, 3-((5-((2,3-dibromo-1-oxopropyl)amino)-2-sulfophenyl)azo)-7-((2,3-dibromo-1-oxopropyl)methylamino)-4-hydroxy-, disodium salt",CN(C1=CC2=CC(=C(C(=C2C=C1)O)N=NC3=C(C=CC(=C3)NC(=O)C(CBr)Br)S(=O)(=O)[O-])S(=O)(=O)[O-])C(=O)C(CBr)Br.[Na+].[Na+],,,,,,
6847,106848,"3-[[5-(2,3-Dibromopropanoylamino)-2-sulfophenyl]diazenyl]-7-[2,3-dibromopropanoyl(methyl)amino]-4-hydroxynaphthalene-2-sulfonic acid",CN(C1=CC2=CC(=C(C(=C2C=C1)O)N=NC3=C(C=CC(=C3)NC(=O)C(CBr)Br)S(=O)(=O)O)S(=O)(=O)O)C(=O)C(CBr)Br,,,,,,
6848,106849,Einecs 267-235-0,CC(=O)C(C(=O)NC1=C(C=CC(=C1)NC)OC)N=NC2=CC(=C(C=C2)NC(=O)C3=CC(=CC(=C3)N=NC(C(=O)C)C(=O)NC4=C(C=CC(=C4)NC)OC)NC)NC,,,,,,
6849,106850,CID 106850,CCCCCCCCCCC(C(=O)OCC(CO)O)S(=O)(=O)[O-].[Na+],,,,,,
6850,106851,"1-(2,3-Dihydroxypropoxy)-1-oxododecane-2-sulfonic acid",CCCCCCCCCCC(C(=O)OCC(CO)O)S(=O)(=O)O,,,,,,
6851,106852,"Butanamide, 2,2'-((3,3'-dichloro(1,1'-biphenyl)-4,4'-diyl)bis(azo))bis(N-(2,4-dimethoxyphenyl)-3-oxo-",CC(=O)C(C(=O)NC1=C(C=C(C=C1)OC)OC)N=NC2=C(C=C(C=C2)C3=CC(=C(C=C3)N=NC(C(=O)C)C(=O)NC4=C(C=C(C=C4)OC)OC)Cl)Cl,,,,,,
6852,106853,"Phenol, 2,6-dibromo-4-(3-(3,5-dibromo-4-butoxyphenyl)-1,1-dioxido-3H-2,1-benzoxathiol-3-yl)-",CCCCOC1=C(C=C(C=C1Br)C2(C3=CC=CC=C3S(=O)(=O)O2)C4=CC(=C(C(=C4)Br)O)Br)Br,,,,,,
6853,106854,4-(1-Hydroxyethyl)resorcinol,CC(C1=C(C=C(C=C1)O)O)O,,,,,,
6854,106855,"Methyl (2,4-dihydroxyphenyl)glycolate",COC(=O)C(C1=C(C=C(C=C1)O)O)O,,,,,,
6855,106856,"Benzeneacetic acid, alpha-amino-4-hydroxy-, ethyl ester, hydrochloride",CCOC(=O)C(C1=CC=C(C=C1)O)N.Cl,,,,,,
6856,106857,alpha-Amino-4-hydroxybenzeneacetic acid ethyl ester,CCOC(=O)C(C1=CC=C(C=C1)O)N,,,,,,
6857,106858,"Ethyl (2,4-dihydroxyphenyl)glycolate",CCOC(=O)C(C1=C(C=C(C=C1)O)O)O,,,,,,
6858,106859,"Methyl (amino(2,4-dihydroxyphenyl))acetate hydrochloride",COC(=O)C(C1=C(C=C(C=C1)O)O)N.Cl,,,,,,
6859,106860,"alpha-Amino-2,4-dihydroxybenzeneacetic acid methyl ester",COC(=O)C(C1=C(C=C(C=C1)O)O)N,,,,,,
6860,106861,"Acetamide, N-[2,3-dihydro-2-(3-hydroxy-2-quinolinyl)-1,3-dioxo-1H-inden-4-yl]-",CC(=O)NC1=CC=CC2=C1C(=O)C(C2=O)C3=NC4=CC=CC=C4C=C3O,,,,,,
6861,106862,"3(2H)-Furanone, 5-acetyl-2-[(2-furanylmethyl)thio]dihydro-2,5-dimethyl-",CC(=O)C1(CC(=O)C(O1)(C)SCC2=CC=CO2)C,,,,,,
6862,106863,Bis(2-ethylhexyl) 2-[3-(cyclohex-2-en-1-yl)propyl]-3-hexylhexanedioate,CCCCCCC(CCC(=O)OCC(CC)CCCC)C(CCCC1CCCC=C1)C(=O)OCC(CC)CCCC,,,,,,
6863,106864,"4H-Pyran-4-one, tetrahydro-3,5-bis(hydroxymethyl)-",C1C(C(=O)C(CO1)CO)CO,,,,,,
6864,106865,Ethyl 3-methylbicyclo(2.2.1)hept-5-ene-2-carboxylate,CCOC(=O)C1C(C2CC1C=C2)C,,,,,,
6865,106866,"Bicyclo[2.2.2]oct-5-ene-2-carboxaldehyde, 6-methyl-8-(1-methylethyl)-",CC1=CC2CC(C1CC2C(C)C)C=O,,,,,,
6866,106867,"1,3,3-Trimethyl-2-norbornyl butyrate",CCCC(=O)OC1C(C2CCC1(C2)C)(C)C,,,,,,
6867,106868,"1,3,3-Trimethylbicyclo(2.2.1)hept-2-yl isobutyrate",CC(C)C(=O)OC1C(C2CCC1(C2)C)(C)C,,,,,,
6868,106869,"Cyclohexanol, 2-methoxy-6-(1,7,7-trimethylbicyclo[2.2.1]hept-2-yl)-",CC1(C2CCC1(C(C2)C3CCCC(C3O)OC)C)C,,,,,,
6869,106870,"1,3-Dimethylbut-3-enyl acetate",CC(CC(=C)C)OC(=O)C,,,,,,
6870,106871,Citronellal methylanthranilate,CC(CCC=C(C)C)CC=NC1=CC=CC=C1C(=O)OC,,,,,,
6871,106872,"2,6,6,8-Tetramethyl-8-(3-methylbut-2-enoxy)tricyclo[5.3.1.01,5]undecane",CC1CCC2C13CCC(C(C3)C2(C)C)(C)OCC=C(C)C,,,,,,
6872,106873,"1,3-Dioxepane, 2-(1-phenylethyl)-",CC(C1OCCCCO1)C2=CC=CC=C2,,,,,,
6873,106874,"3,7-Nonadien-2-ol, 4,8-dimethyl-",CC(C=C(C)CCC=C(C)C)O,,,,,,
6874,106875,3-(p-Isopropylphenyl)-2-methylpropiononitrile,CC(C)C1=CC=C(C=C1)CC(C)C#N,,,,,,
6875,106876,"3-Cyclopentene-1-carboxylic acid, 4-methyl-2-oxo-3-pentyl-, methyl ester",CCCCCC1=C(CC(C1=O)C(=O)OC)C,,,,,,
6876,106877,"4,8-Decadien-3-ol, 5,9-dimethyl-",CCC(C=C(C)CCC=C(C)C)O,,,,,,
6877,106878,2-Hydroxyheptyl isobutyrate,CCCCCC(COC(=O)C(C)C)O,,,,,,
6878,106879,2-Hydroxyheptyl propionate,CCCCCC(COC(=O)CC)O,,,,,,
6879,106880,2-Methoxy-4-propylcyclohexyl acetate,CCCC1CCC(C(C1)OC)OC(=O)C,,,,,,
6880,106881,CID 106881,CCCCCCCCCCC(C(=O)OCC(CC)CCCC)S(=O)(=O)[O-].[Na+],,,,,,
6881,106882,1-(2-Ethylhexoxy)-1-oxododecane-2-sulfonic acid,CCCCCCCCCCC(C(=O)OCC(CC)CCCC)S(=O)(=O)O,,,,,,
6882,106883,CID 106883,CCCCCCCCC(C(=O)OCC(CC)CCCC)S(=O)(=O)[O-].[Na+],,,,,,
6883,106884,1-(2-Ethylhexoxy)-1-oxodecane-2-sulfonic acid,CCCCCCCCC(C(=O)OCC(CC)CCCC)S(=O)(=O)O,,,,,,
6884,106885,CID 106885,CCCCCCC(C(=O)OCC(CC)CCCC)S(=O)(=O)[O-].[Na+],,,,,,
6885,106886,1-(2-Ethylhexoxy)-1-oxooctane-2-sulfonic acid,CCCCCCC(C(=O)OCC(CC)CCCC)S(=O)(=O)O,,,,,,
6886,106887,CID 106887,CCCCC(CC)COC(=O)C(CCCC)S(=O)(=O)[O-].[Na+],,,,,,
6887,106888,1-(2-Ethylhexoxy)-1-oxohexane-2-sulfonic acid,CCCCC(CC)COC(=O)C(CCCC)S(=O)(=O)O,,,,,,
6888,106889,Ammonium 1-(2-ethylhexyl) 2-sulfolaurate,CCCCCCCCCCC(C(=O)OCC(CC)CCCC)S(=O)(=O)O.N,,,,,,
6889,106890,1-(2-Ethylhexyl) 2-sulfodecanoate ammonium salt,CCCCCCCCC(C(=O)OCC(CC)CCCC)S(=O)(=O)O.N,,,,,,
6890,106891,Ammonium 1-(2-ethylhexyl) 2-sulfooctanoate,CCCCCCC(C(=O)OCC(CC)CCCC)S(=O)(=O)O.N,,,,,,
6891,106892,Ammonium 1-(2-ethylhexyl) 2-sulfohexanoate,CCCCC(CC)COC(=O)C(CCCC)S(=O)(=O)O.N,,,,,,
6892,106893,"1,3,4-Trimethyl-5-(1-methylvinyl)cyclohexene",CC1C=C(CC(C1C)C(=C)C)C,,,,,,
6893,106894,"1,3,5-Trimethyl-4-(1-methylvinyl)cyclohexene",CC1CC(=CC(C1C(=C)C)C)C,,,,,,
6894,106895,"4-Bromo-2,2,6,6-tetramethylpiperidine",CC1(CC(CC(N1)(C)C)Br)C,,,,,,
6895,106896,"Methanone, [4-[(3,5-dimethylhexyl)oxy]-2-hydroxyphenyl]phenyl-",CC(C)CC(C)CCOC1=CC(=C(C=C1)C(=O)C2=CC=CC=C2)O,,,,,,
6896,106897,"2-Oxetanone, 4-heptadecylidene-3-tetradecyl-",CCCCCCCCCCCCCCCCC=C1C(C(=O)O1)CCCCCCCCCCCCCC,,,,,,
6897,106898,"2-Oxetanone, 3-hexadecyl-4-pentadecylidene-",CCCCCCCCCCCCCCCCC1C(=CCCCCCCCCCCCCCC)OC1=O,,,,,,
6898,106899,"(4-((4,5-Dimethylhexyl)oxy)-2-hydroxyphenyl) phenyl ketone",CC(C)C(C)CCCOC1=CC(=C(C=C1)C(=O)C2=CC=CC=C2)O,,,,,,
6899,106900,"Methanone, [2-hydroxy-4-[(3-methylheptyl)oxy]phenyl]phenyl-",CCCCC(C)CCOC1=CC(=C(C=C1)C(=O)C2=CC=CC=C2)O,,,,,,
6900,106901,"(4-((3,4-Dimethylhexyl)oxy)-2-hydroxyphenyl) phenyl ketone",CCC(C)C(C)CCOC1=CC(=C(C=C1)C(=O)C2=CC=CC=C2)O,,,,,,
6901,106902,"9,10-Anthracenediol, 9,10-dihydro-9,10-bis(phenylethynyl)-, dilithium salt",[Li+].[Li+].C1=CC=C(C=C1)C#CC2(C3=CC=CC=C3C(C4=CC=CC=C42)(C#CC5=CC=CC=C5)[O-])[O-],,,,,,
6902,106903,CID 106903,CCCCCCCCC(CCCCCCCCC(=O)OCC1CCCO1)OS(=O)(=O)[O-].[Na+],,,,,,
6903,106904,Oxolan-2-ylmethyl 10-sulfooxyoctadecanoate,CCCCCCCCC(CCCCCCCCC(=O)OCC1CCCO1)OS(=O)(=O)O,,,,,,
6904,106905,CID 106905,CCCCCCCCC(CCCCCCCCC(=O)OC)OS(=O)(=O)[O-].[Na+],,,,,,
6905,106906,Methyl 10-(sulfooxy)octadecanoate,CCCCCCCCC(CCCCCCCCC(=O)OC)OS(=O)(=O)O,,,,,,
6906,106907,CID 106907,CCOC(=O)NCC(CCSS(=O)(=O)[O-])C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F.[Na+],,,,,,
6907,106908,"7-[(Ethoxycarbonylamino)methyl]-1,1,1,2,2,3,3,4,4,5,5,6,6-tridecafluoro-9-sulfosulfanylnonane",CCOC(=O)NCC(CCSS(=O)(=O)O)C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
6908,106909,CID 106909,CCCCCCCCC(CCCCCCCCC(=O)OCC(C)C)OS(=O)(=O)[O-].[Na+],,,,,,
6909,106910,Isobutyl 10-(sulfooxy)stearate,CCCCCCCCC(CCCCCCCCC(=O)OCC(C)C)OS(=O)(=O)O,,,,,,
6910,106911,CID 106911,CCCC[SnH+]CCCC.C(C(C(=O)O)[S-])C(=O)O,,,,,,
6911,106912,2-Mercaptoethyl 2-ethylhexanoate,CCCCC(CC)C(=O)OCCS,,,,,,
6912,106913,"2-Mercaptoethyl 3,5,5-trimethylhexanoate",CC(CC(=O)OCCS)CC(C)(C)C,,,,,,
6913,106914,CID 106914,CCCC[Sn]CCCC.CC(CC(=O)OCC[S-])CC(C)(C)C.CC(CC(=O)OCC[S-])CC(C)(C)C,,,,,,
6914,106915,Bis(2-ethylhexyl) nonylphenyl phosphite,CCCCC(CC)COP(OCCCCCCCCCC1=CC=CC=C1)OCC(CC)CCCC,,,,,,
6915,106916,"Benzoic acid, 4-(1,1-dimethylethyl)-, compd. with 1-amino-2-propanol (1:1)",CC(CN)O.CC(C)(C)C1=CC=C(C=C1)C(=O)O,,,,,,
6916,106917,"3,3,5-Trimethylcyclohexyl acetate",CC1CC(CC(C1)(C)C)OC(=O)C,,,,,,
6917,106918,"3,3,5-Trimethylcyclohexyl phenylacetate",CC1CC(CC(C1)(C)C)OC(=O)CC2=CC=CC=C2,,,,,,
6918,106919,"1H-Indole-3-heptanol, eta-1H-indol-3-yl-alpha,alpha,epsilon-trimethyl-",CC(CCCC(C)(C)O)CC(C1=CNC2=CC=CC=C21)C3=CNC4=CC=CC=C43,,,,,,
6919,106920,2-Methyl-4-oxo-4H-pyran-3-yl lactate,CC1=C(C(=O)C=CO1)OC(=O)C(C)O,,,,,,
6920,106921,Propylene bis(3-octyloxiran-2-octanoate),CCCCCCCCC1C(O1)CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCC2C(O2)CCCCCCCC,,,,,,
6921,106922,2-(2-Ethylbutylidene)cyclopentan-1-one,CCC(CC)C=C1CCCC1=O,,,,,,
6922,106923,"Bicyclo(2.2.1)heptan-2-ol, 1,3,3-trimethyl-, propanoate",CCC(=O)OC1C(C2CCC1(C2)C)(C)C,,,,,,
6923,106924,"1,3,5-Triazine-2,4,6(1H,3H,5H)-trione, 1,3,5-tris((5-isocyanato-1,3,3-trimethylcyclohexyl)methyl)-",CC1(CC(CC(C1)(C)CN2C(=O)N(C(=O)N(C2=O)CC3(CC(CC(C3)(C)C)N=C=O)C)CC4(CC(CC(C4)(C)C)N=C=O)C)N=C=O)C,,,,,,
6924,106925,"3-Azabicyclo[3.3.1]nonan-1-amine, 5,7,7-trimethyl-",CC1(CC2(CC(C1)(CNC2)N)C)C,,,,,,
6925,106926,"Hexanedioic acid, 2,4,4-trimethyl-, 6-decyl 1-octyl ester",CCCCCCCCCCOC(=O)CC(C)(C)CC(C)C(=O)OCCCCCCCC,,,,,,
6926,106927,"8-Methylnonane-1,2-diamine",CC(C)CCCCCC(CN)N,,,,,,
6927,106928,"Methyltintris(2-(3,5,5-trimethylhexanoyloxy)ethylmercaptide)",CC(CC(=O)OCCS[Sn](C)(SCCOC(=O)CC(C)CC(C)(C)C)SCCOC(=O)CC(C)CC(C)(C)C)CC(C)(C)C,,,,,,
6928,106929,(Methylstannylidyne)tris(thioethylene) tris(2-ethylhexanoate),CCCCC(CC)C(=O)OCCS[Sn](C)(SCCOC(=O)C(CC)CCCC)SCCOC(=O)C(CC)CCCC,,,,,,
6929,106930,CID 106930,C(C#COCC(CS(=O)(=O)[O-])O)O.[Na+],,,,,,
6930,106931,2-Hydroxy-3-(3-hydroxyprop-1-ynoxy)propane-1-sulfonic acid,C(C#COCC(CS(=O)(=O)O)O)O,,,,,,
6931,106932,"Disodium 3,3'-(2-butyne-1,4-diylbis(oxy))bis(2-hydroxypropanesulphonate)",C(C#CCOCC(CS(=O)(=O)[O-])O)OCC(CS(=O)(=O)[O-])O.[Na+].[Na+],,,,,,
6932,106933,"1-Propanesulfonic acid, 3,3'-[2-butyne-1,4-diylbis(oxy)]bis[2-hydroxy-",C(C#CCOCC(CS(=O)(=O)O)O)OCC(CS(=O)(=O)O)O,,,,,,
6933,106934,"2,3-Dihydroxypropyl 3-mercaptopropionate",C(CS)C(=O)OCC(CO)O,,,,,,
6934,106935,"2,4-Dichloropentan-3-one",CC(C(=O)C(C)Cl)Cl,,,,,,
6935,106936,"3,7-Dimethyloctyl phenylacetate",CC(C)CCCC(C)CCOC(=O)CC1=CC=CC=C1,,,,,,
6936,106937,Decahydro-2-naphthyl isobutyrate,CC(C)C(=O)OC1CCC2CCCCC2C1,,,,,,
6937,106938,Decahydro-2-naphthyl propionate,CCC(=O)OC1CCC2CCCCC2C1,,,,,,
6938,106939,"1,3,4,5,6,7-Hexahydro-1,1,5,5-tetramethyl-2H-2,4a-methanonaphthalen-7-yl formate",CC1(CC(C=C2C13CCC(C3)C2(C)C)OC=O)C,,,,,,
6939,106940,Benzyl 2-ethylhexanoate,CCCCC(CC)C(=O)OCC1=CC=CC=C1,,,,,,
6940,106941,Cinnamyl 2-methylbutyrate,CCC(C)C(=O)OCC=CC1=CC=CC=C1,,,,,,
6941,106942,"Bicyclo[2.2.2]oct-5-ene-2-carboxylic acid, 4-methyl-1-(1-methylethyl)-, methyl ester",CC(C)C12CCC(CC1C(=O)OC)(C=C2)C,,,,,,
6942,106943,4-Isopropyl-1-methylbicyclo[2.2.2]oct-5-ene-2-carbaldehyde,CC(C)C12CCC(C=C1)(C(C2)C=O)C,,,,,,
6943,106944,CID 106944,CCCCCCCCC=CCCCCCCCCN.CC(C)CC(C)OP(=S)(OC(C)CC(C)C)S,,,,,,
6944,106945,Ethyl 3-methyl-4-oxoheptanoate,CCCC(=O)C(C)CC(=O)OCC,,,,,,
6945,106946,"Decahydro-6,9,9-trimethyl-1,4-methanonaphthalene",CC1CCC2C3CCC(C2C1)C3(C)C,,,,,,
6946,106947,"2-(2,4-Dimethyl-3-cyclohexen-1-yl)-1,3-dioxolane",CC1C=C(CCC1C2OCCO2)C,,,,,,
6947,106948,"Ethyl 4-((7-hydroxy-3,7-dimethyloctylidene)amino)benzoate",CCOC(=O)C1=CC=C(C=C1)N=CCC(C)CCCC(C)(C)O,,,,,,
6948,106949,"2-Ethyl-1,3-hexanediol diacrylate",CCCC(C(CC)COC(=O)C=C)OC(=O)C=C,,,,,,
6949,106950,CID 106950,CC(CC(=O)OCC[S-])CC(C)(C)C.CC(CC(=O)OCC[S-])CC(C)(C)C.C[Sn]C,,,,,,
6950,106951,"Oxiranecarboxylic acid, 3-methyl-3-[2-(2,6,6-trimethyl-2-cyclohexen-1-yl)ethenyl]-, methyl ester",CC1=CCCC(C1C=CC2(C(O2)C(=O)OC)C)(C)C,,,,,,
6951,106952,2-Methoxybutyl methacrylate,CCC(COC(=O)C(=C)C)OC,,,,,,
6952,106953,2-Methyloctyl methacrylate,CCCCCCC(C)COC(=O)C(=C)C,,,,,,
6953,106954,2-Methylnonyl methacrylate,CCCCCCCC(C)COC(=O)C(=C)C,,,,,,
6954,106955,2-((3-Methylundecyl)amino)ethyl methacrylate,CCCCCCCCC(C)CCNCCOC(=O)C(=C)C,,,,,,
6955,106956,"(3,3,4,5,6,6-Hexachloro-4-cyclohexene-1,2-diyl)bismethylene bismethacrylate",CC(=C)C(=O)OCC1C(C(C(=C(C1(Cl)Cl)Cl)Cl)(Cl)Cl)COC(=O)C(=C)C,,,,,,
6956,106957,"Cobaltate(2-), bis(2-(2-(5-(aminosulfonyl)-2-(hydroxy-kappaO)phenyl)diazenyl-kappaN1)-3-(oxo-kappaO)-N-phenylbutanamidato(2-))-, lithium (1:2)",[Li+].[Li+].CC(=O)C(C(=O)NC1=CC=CC=C1)N=NC2=C(C=CC(=C2)S(=O)(=O)[NH-])[O-].CC(=O)C(C(=O)NC1=CC=CC=C1)N=NC2=C(C=CC(=C2)S(=O)(=O)[NH-])[O-].[Co+2],,,,,,
6957,106958,"Benzenesulfonic acid, 4-chloro-3-nitro-, sodium salt (1:1), reaction products with hydrolyzed N-ethenylacetamide homopolymer",[Li+].[Li+].CC1=NN(C(=O)C1N=NC2=C(C=CC(=C2)S(=O)(=O)[NH-])[O-])C3=CC=CC=C3.CC1=NN(C(=O)C1N=NC2=C(C=CC(=C2)S(=O)(=O)[NH-])[O-])C3=CC=CC=C3.[Co+2],,,,,,
6958,106959,"Benzenesulfonamide, 3-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-4-hydroxy-",CC1=NN(C(=O)C1N=NC2=C(C=CC(=C2)S(=O)(=O)N)O)C3=CC=CC=C3,,,,,,
6959,106960,CID 106960,CCCCCCCCC(C(CCCCCCCC(=O)OCCOCC)S(=O)(=O)[O-])O.[Na+],,,,,,
6960,106961,1-(2-Ethoxyethoxy)-10-hydroxy-1-oxooctadecane-9-sulfonic acid,CCCCCCCCC(C(CCCCCCCC(=O)OCCOCC)S(=O)(=O)O)O,,,,,,
6961,106962,"Cyclopentanemethanamine, 5-amino-2,2,4-trimethyl-",CC1CC(C(C1N)CN)(C)C,,,,,,
6962,106963,"2H-4,7a-Ethanonaphth[1,2-b]oxirene, octahydro-3a,4,7b-trimethyl-",CC12CCCC3(C1(CCC4C3(O4)C)C)CC2,,,,,,
6963,106964,"Bicyclo[2.2.2]oct-5-ene-2-carboxaldehyde, 4-methyl-1-(1-methylethyl)-",CC(C)C12CCC(CC1C=O)(C=C2)C,,,,,,
6964,106965,"3,5,5-Trimethylhexyl nonanoate",CCCCCCCCC(=O)OCCC(C)CC(C)(C)C,,,,,,
6965,106966,"Benzene, 1-(1-methoxy-2-phenylethoxy)-4-methyl-",CC1=CC=C(C=C1)OC(CC2=CC=CC=C2)OC,,,,,,
6966,106967,"3-Buten-2-ol, 4-(2,4,6-trimethyl-3-cyclohexen-1-yl)-",CC1CC(=CC(C1C=CC(C)O)C)C,,,,,,
6967,106968,CID 106968,CC(=O)OC1CCCC=CCCC=CCC1,,,,,,
6968,106969,"1-Decanol, 1-(decyloxy)-",CCCCCCCCCCOC(CCCCCCCCC)O,,,,,,
6969,106970,2-Methoxy-2-(1-phenylethoxy)ethylbenzene,CC(C1=CC=CC=C1)OC(CC2=CC=CC=C2)OC,,,,,,
6970,106971,Borneol lactate,CC(C(=O)OC1CC2CCC1(C2(C)C)C)O,,,,,,
6971,106972,"Benzoic acid, 2-(isononylideneamino)-, methyl ester",CC(CCCCC=CC1=CC=CC=C1C(=O)OC)CN,,,,,,
6972,106973,"2-Octanol, 8,8-bis(isotridecyloxy)-2,6-dimethyl-",CC(C)CCCCCCCCCCOC(CC(C)CCCC(C)(C)O)OCCCCCCCCCCC(C)C,,,,,,
6973,106974,"9,10-Anthracenediol, ethyl-9,10-dihydro-",CCC1=C2C(C3=CC=CC=C3C(C2=CC=C1)O)O,,,,,,
6974,106975,"2-Amino-3,3,5-trimethylcyclopentanemethylamine",CC1CC(C(C1CN)N)(C)C,,,,,,
6975,106976,Butyltris[[2-[(2-ethyl-1-oxohexyl)oxy]ethyl]thio]stannane,CCCCC(CC)C(=O)OCCS[Sn](CCCC)(SCCOC(=O)C(CC)CCCC)SCCOC(=O)C(CC)CCCC,,,,,,
6976,106977,"1H-Isoindole-1,3(2H)-dione, 4,5,6,7-tetrachloro-2-cyclooctyl-",C1CCCC(CCC1)N2C(=O)C3=C(C2=O)C(=C(C(=C3Cl)Cl)Cl)Cl,,,,,,
6977,106978,"1H-Pyrazole-3-carboxylic acid, 4,5-dihydro-1-(2-methyl-4-sulfophenyl)-5-oxo-",CC1=C(C=CC(=C1)S(=O)(=O)O)N2C(=O)CC(=N2)C(=O)O,,,,,,
6978,106979,"1,2,3-Propanetricarboxylic acid, 2-hydroxy-, 1-butyl 2,3-dioctadecyl ester",CCCCCCCCCCCCCCCCCCOC(=O)CC(C(CCCC)C(=O)OCCCCCCCCCCCCCCCCCC)(C(=O)O)O,,,,,,
6979,106980,5-Carboxy-4-hexyl-2-cyclohexene-1-octanoic acid ethanolamine salt (1:1),CCCCCCC1C=CC(CC1C(=O)O)CCCCCCCC(=O)O.C(CO)N,,,,,,
6980,106981,CID 106981,CCCCC(CC)C(=O)OCC[S-].CCCCC(CC)C(=O)OCC[S-].C[Sn]C,,,,,,
6981,106982,Uranyl 2-ethylhexanoate,CCCCC(CC)C(=O)O.CCCCC(CC)C(=O)O.O=[U]=O,,,,,,
6982,106983,CID 106983,CC1CCC(C(C1)[O-])C(C)C.CC1CCC(C(C1)[O-])C(C)C.CC1CCC(C(C1)[O-])C(C)C.CC1CCC(C(C1)[O-])C(C)C.[GeH4],,,,,,
6983,106984,"Tetrakis(2-ethylhexanoic) acid, tetraanhydride with silicic acid",CCCCC(CC)C(=O)O[Si](OC(=O)C(CC)CCCC)(OC(=O)C(CC)CCCC)OC(=O)C(CC)CCCC,,,,,,
6984,106985,Bis(2-hydroxypropyl)ammonium citrate,C(CNCCCO)CO.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,,,,,,
6985,106986,3-(3-Hydroxy-propylamino)-propan-1-ol,C(CNCCCO)CO,,,,,,
6986,106987,"Gluconic acid, morpholine salt",C1COCCN1.C(C(C(C(C(C(=O)O)O)O)O)O)O,,,,,,
6987,106988,"2-Propanol, 1,1',1''-nitrilotris-, 2-hydroxy-1,2,3-propanetricarboxylate (salt)",CC(CN(CC(C)O)CC(C)O)O.C(C(=O)O)C(CC(=O)O)(C(=O)O)O,,,,,,
6988,106989,"Ethylenediaminetetraacetic acid, triisopropanolamine salt",CC(C[NH+](CC(C)O)CC(C)O)O.C(CN(CC(=O)O)CC(=O)[O-])N(CC(=O)O)CC(=O)O,,,,,,
6989,106990,2-Methylbutyl undec-10-enoate,CCC(C)COC(=O)CCCCCCCCC=C,,,,,,
6990,106991,p-Cresyl 2-methylbutyrate,CCC(C)C(=O)OC1=CC=C(C=C1)C,,,,,,
6991,106992,2-Methylheptyl acrylate,CCCCCC(C)COC(=O)C=C,,,,,,
6992,106993,"Methyl 5',6-bis(acryloyloxy)-4',5-dihydroxy-2',3-dimethyl(1,1'-bicyclohexyl)-2-carboxylate",CC1CC(C(CC1C2C(C(CC(C2OC(=O)C=C)O)C)C(=O)OC)OC(=O)C=C)O,,,,,,
6993,106994,6-(1-(1-Methylethyl)allyl)cyclohex-2-ene-1-carbaldehyde,CC(C)C(C=C)C1CCC=CC1C=O,,,,,,
6994,106995,"Hexahydro-1,1,5,5-tetramethyl-2H-2,4a-methanonaphthalen-6(5H)-one",CC1(C2CCC3(C2)C1CCC(=O)C3(C)C)C,,,,,,
6995,106996,"Butanedioic acid, dodecenyl-, 1-(2-((2-hydroxyethyl)phenylamino)ethyl) ester",CC(NC1=CC=CC=C1CCO)OC(=O)CCC(=O)OCCCCCCCCCCC=C,,,,,,
6996,106997,"2-Ethyl-1,3,3-trimethyl-2-norbornanol",CCC1(C(C2CCC1(C2)C)(C)C)O,,,,,,
6997,106998,"2-Ethyl-1,3-hexanediol, dimethacrylate",CCCC(C(CC)COC(=O)C(=C)C)OC(=O)C(=C)C,,,,,,
6998,106999,"2-(Hydroxymethyl)butane-1,3-diol",CC(C(CO)CO)O,,,,,,
6999,107000,1-Ethyl-3-methylpentylamine,CCC(C)CC(CC)N,,,,,,
7000,107001,N-(3-carbamoyl-1-carboxypropyl)-4-nitroanilinium chloride,C1=CC(=CC=C1[NH2+]C(CCC(=O)N)C(=O)O)[N+](=O)[O-].[Cl-],,,,,,
7001,107002,5-Amino-2-(4-nitroanilino)-5-oxopentanoic acid,C1=CC(=CC=C1NC(CCC(=O)N)C(=O)O)[N+](=O)[O-],,,,,,
7002,107003,"1(3H)-Isobenzofuranone, 3-[4-hydroxy-2-methyl-5-(1-methylethyl)phenyl]-3-[2-methyl-5-(1-methylethyl)-4-(phosphonooxy)phenyl]-, magnesium sodium salt (2:1:4)",CC1=CC(=C(C=C1C2(C3=CC=CC=C3C(=O)O2)C4=CC(=C(C=C4C)OP(=O)([O-])[O-])C(C)C)C(C)C)O.CC1=CC(=C(C=C1C2(C3=CC=CC=C3C(=O)O2)C4=CC(=C(C=C4C)OP(=O)([O-])[O-])C(C)C)C(C)C)O.[Na+].[Na+].[Mg+2],,,,,,
7003,107004,Propyl 10-(sulfooxy)stearate diethanolamine salt,CCCCCCCCC(CCCCCCCCC(=O)OCCC)OS(=O)(=O)O.C(CO)NCCO,,,,,,
7004,107005,Propyl 10-(sulfooxy)stearate triethanolamine salt,CCCCCCCCC(CCCCCCCCC(=O)OCCC)OS(=O)(=O)O.C(CO)N(CCO)CCO,,,,,,
7005,107006,"(Tetrahydro-4-hydroxy-3,5,5-tris(hydroxymethyl)-2H-pyran-3-yl)methyl stearate",CCCCCCCCCCCCCCCCCC(=O)OCC1(COCC(C1O)(CO)CO)CO,,,,,,
7006,107007,"Anhydroenneaheptitol 3,5-distearate",CCCCCCCCCCCCCCCCCC(=O)OCC1(COCC(C1O)(CO)COC(=O)CCCCCCCCCCCCCCCCC)CO,,,,,,
7007,107008,"2-Furanmethanaminium, N,N-dimethyl-N-2-propenyl-, chloride",C[N+](C)(CC=C)CC1=CC=CO1.[Cl-],,,,,,
7008,107009,"N,N-Dimethyl-N-(2-propenyl)-2-furanmethanaminium",C[N+](C)(CC=C)CC1=CC=CO1,,,,,,
7009,107010,"1-Nonanol, 8-methyl-, dihydrogen phosphate",CC(C)CCCCCCCOP(=O)(O)O,,,,,,
7010,107011,CID 107011,CCCCCCCCCCCCCCCCCC(=O)N(CCO)CCOC(=O)CC(C(=O)O)S(=O)(=O)[O-].N.[Na+],,,,,,
7011,107012,2-Sulfobutanedioic acid 1-hydrogen 4-[2-[(2-hydroxyethyl)(1-oxooctadecyl)amino]ethyl] ester,CCCCCCCCCCCCCCCCCC(=O)N(CCO)CCOC(=O)CC(C(=O)O)S(=O)(=O)O,,,,,,
7012,107013,"2-Cyclohexene-1-octanoic acid, 5-[[(2-ethylhexyl)oxy]carbonyl]-4-hexyl-",CCCCCCC1C=CC(CC1C(=O)OCC(CC)CCCC)CCCCCCCC(=O)O,,,,,,
7013,107014,CID 107014,CCCCCCOC(=O)C(CC(=O)OC1CCCCC1)S(=O)(=O)[O-].[Na+],,,,,,
7014,107015,"4-Cyclohexyloxy-1-hexoxy-1,4-dioxobutane-2-sulfonic acid",CCCCCCOC(=O)C(CC(=O)OC1CCCCC1)S(=O)(=O)O,,,,,,
7015,107016,"Octadecanoic acid, 10-(sulfooxy)-, 1-(2-methylpropyl) ester, compd. with 2-aminoethanol (1:1)",CCCCCCCCC(CCCCCCCCC(=O)OCC(C)C)OS(=O)(=O)O.C(CO)N,,,,,,
7016,107017,"2-Cyclohexene-1-octanoic acid, 5-(((2-ethylhexyl)oxy)carbonyl)-4-hexyl-, 2-ethylhexyl ester",CCCCCCC1C=CC(CC1C(=O)OCC(CC)CCCC)CCCCCCCC(=O)OCC(CC)CCCC,,,,,,
7017,107018,Isobutyl 10-(sulfooxy)stearate triethanolamine salt,CCCCCCCCC(CCCCCCCCC(=O)OCC(C)C)OS(=O)(=O)O.C(CO)N(CCO)CCO,,,,,,
7018,107019,"Bicyclo[2.2.1]heptane-2-propanol, beta-methyl-",CC(CC1CC2CCC1C2)CO,,,,,,
7019,107020,Gallium 2-ethylhexanoate,CCCCC(CC)C(=O)[O-].CCCCC(CC)C(=O)[O-].CCCCC(CC)C(=O)[O-].[Ga+3],,,,,,
7020,107021,Einecs 267-980-1,CCCCCCC(CCCCCCCCCCC(=O)[O-])O.CC(=O)[O-].[Ca+2],,,,,,
7021,107022,1-Methyl-2-(2-methylpropoxy)ethyl 2-chloropropionate,CC(C)COCC(C)OC(=O)C(C)Cl,,,,,,
7022,107023,"2,2-Bis((3,7-dimethyl-1,6-octadien-3-yl)oxy)ethylbenzene",CC(=CCCC(C)(C=C)OC(CC1=CC=CC=C1)OC(C)(CCC=C(C)C)C=C)C,,,,,,
7023,107024,"Ethanone, 1-(1,2,2(or 1,5,5)-trimethyl-3-cyclohexen-1-yl)-",CC(=O)C1(CCC=CC1(C)C)C,,,,,,
7024,107025,Dipotassium 2-ethylhexyl phosphate,CCCCC(CC)COP(=O)([O-])[O-].[K+].[K+],,,,,,
7025,107026,"Ethanone, 1-(octahydro-2,5,5-trimethyl-2H-2,4a-ethanonaphthalen-8-yl)-",CC(=O)C1CCC(C23C1CC(CC2)(CC3)C)(C)C,,,,,,
7026,107027,Einecs 268-023-0,CC(C)C1=CC2=C(C=C1)C3(CCCC(C3CC2)(C)COC(=O)C(=C)C)C,,,,,,
7027,107028,5-Chloro-2-methylcyclohexanecarboxylic acid,CC1CCC(CC1C(=O)O)Cl,,,,,,
7028,107029,4-Chloro-2-methylcyclohexanecarboxylic acid,CC1CC(CCC1C(=O)O)Cl,,,,,,
7029,107030,"2,4-Pentanediamine, N4-cyclohexyl-2-methyl-N2-(2-methylpropyl)-",CC(C)CNC(C)(C)CC(C)NC1CCCCC1,,,,,,
7030,107031,"1,1'-Ethylenebis(3-methylpiperidine)",CC1CCCN(C1)CCN2CCCC(C2)C,,,,,,
7031,107032,"2,3,4,6a-Tetrahydro-1H-1,3a-ethanopentalen-3-yl propionate",CCC(=O)OC1CC2CCC13C2C=CC3,,,,,,
7032,107033,"2-Methoxy-4-(5,5,6-trimethylbicyclo[2.2.1]hept-2-yl)phenol",CC1C2CC(C1(C)C)CC2C3=CC(=C(C=C3)O)OC,,,,,,
7033,107034,"7H-2,4a-Methanonaphthalen-7-one, octahydro-1,1,5,5-tetramethyl-",CC1(CC(=O)CC2C13CCC(C3)C2(C)C)C,,,,,,
7034,107035,"4a,7-Methano-4aH-naphth[1,8a-b]oxirene, octahydro-4,4,8,8-tetramethyl-",CC1(CCC2C3(C14CCC(C4)C3(C)C)O2)C,,,,,,
7035,107036,1-Heptadecanoyl-rac-glycerol,CCCCCCCCCCCCCCCCC(=O)OCC(CO)O,,,,,,
7036,107037,1-Hexadecenedisulfonic acid,CCCC(CCCCCCC(CCCC=C)S(=O)(=O)O)S(=O)(=O)O,,,,,,
7037,107038,"Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[[4-(2-hydroxypropoxy)-6-(phenylamino)-1,3,5-triazin-2-yl]amino]-, disodium salt",CC(COC1=NC(=NC(=N1)NC2=CC(=C(C=C2)C=CC3=C(C=C(C=C3)NC4=NC(=NC(=N4)NC5=CC=CC=C5)OCC(C)O)S(=O)(=O)[O-])S(=O)(=O)[O-])NC6=CC=CC=C6)O.[Na+].[Na+],,,,,,
7038,107039,"2,2'-(Ethene-1,2-diyl)bis(5-{[4-anilino-6-(2-hydroxypropoxy)-1,3,5-triazin-2-yl]amino}benzene-1-sulfonic acid)",CC(COC1=NC(=NC(=N1)NC2=CC(=C(C=C2)C=CC3=C(C=C(C=C3)NC4=NC(=NC(=N4)NC5=CC=CC=C5)OCC(C)O)S(=O)(=O)O)S(=O)(=O)O)NC6=CC=CC=C6)O,,,,,,
7039,107040,"Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 6'-(diethylamino)-3'-methyl-2'-(octylamino)-",CCCCCCCCNC1=CC2=C(C=C1C)OC3=C(C24C5=CC=CC=C5C(=O)O4)C=CC(=C3)N(CC)CC,,,,,,
7040,107041,"2'-Amino-6'-(diethylamino)-3'-methoxyspiro[isobenzofuran-1[3H],9'-[9H]xanthene]-3-one",CCN(CC)C1=CC2=C(C=C1)C3(C4=CC=CC=C4C(=O)O3)C5=CC(=C(C=C5O2)OC)N,,,,,,
7041,107042,Methyl 1-heptyl-2-oxocyclopentanecarboxylate,CCCCCCCC1(CCCC1=O)C(=O)OC,,,,,,
7042,107043,"Poly(oxy-1,2-ethanediyl), alpha-(2,3,4,5-tetramethylnonyl)-omega-hydroxy-",CCCCC(C)C(C)C(C)C(C)COCCO,,,,,,
7043,107044,Propan-2-yl 10-(sulfooxy)octadecanoate,CCCCCCCCC(CCCCCCCCC(=O)OC(C)C)OS(=O)(=O)O,,,,,,
7044,107045,"Butanedioic acid, 2-octadecenyl-",CCCCCCCCCCCCCCCC=CCC(CC(=O)O)C(=O)O,,,,,,
7045,107046,2-sec-Butyl-5-nitrobenzyl methyl ether,CCC(C)C1=C(C=C(C=C1)[N+](=O)[O-])COC,,,,,,
7046,107047,2-(Chloromethyl)-1-(1-methylpropyl)-4-nitrobenzene,CCC(C)C1=C(C=C(C=C1)[N+](=O)[O-])CCl,,,,,,
7047,107048,N-(2-Hydroxyethyl)aminoethyl steramide lactic acid salt,CCCCCCCCCCCCCCCCCC(=O)NCCNCCO.CC(C(=O)O)O,,,,,,
7048,107049,"Pyridinium, 3-carboxy-1-(2-hydroxy-3-(4-(hydroxysulfomethyl)-2-methoxyphenoxy)propyl)-, inner salt, monosodium salt",COC1=C(C=CC(=C1)C(O)S(=O)(=O)[O-])OCC(C[N+]2=CC=CC(=C2)C(=O)[O-])O.[Na+],,,,,,
7049,107050,1-[2-Hydroxy-3-[4-[hydroxy(sulfo)methyl]-2-methoxyphenoxy]propyl]pyridin-1-ium-3-carboxylic acid,COC1=C(C=CC(=C1)C(O)S(=O)(=O)O)OCC(C[N+]2=CC=CC(=C2)C(=O)O)O,,,,,,
7050,107051,Di-(tert-butyl)dodecylphenol,CCCCC(CCCCC(CCC1=CC(=CC=C1)O)C(C)(C)C)C(C)(C)C,,,,,,
7051,107052,Bornyl-2-methylcyclohexanone,CC1CC2CCC1(C2(C)C)CC3CCCCC3=O,,,,,,
7052,107053,CID 107053,CCCCCCCCC(C(CCCCCCCC(=O)N(CCCC)CCCC)O)S(=O)(=O)[O-].[Na+],,,,,,
7053,107054,18-(Dibutylamino)-10-hydroxy-18-oxooctadecane-9-sulphonic acid,CCCCCCCCC(C(CCCCCCCC(=O)N(CCCC)CCCC)O)S(=O)(=O)O,,,,,,
7054,107055,"4,5-Dihydro-1-(2-hydroxyethyl)-3-(2-hydroxy-3-sulphonatopropyl)-2-undecyl-1H-imidazolium, monosodium salt",CCCCCCCCCCCC1=[N+](CCN1CC(CS(=O)(=O)[O-])[O-])CCO.[Na+],,,,,,
7055,107056,"2-Hydroxy-3-[3-(2-hydroxyethyl)-2-undecyl-4,5-dihydroimidazol-3-ium-1-yl]propane-1-sulfonic acid",CCCCCCCCCCCC1=[N+](CCN1CC(CS(=O)(=O)O)O)CCO,,,,,,
7056,107057,"8-(1-Methoxyethoxy)-2,6-dimethyloct-2-ene",CC(CCC=C(C)C)CCOC(C)OC,,,,,,
7057,107058,CID 107058,CC1=CCC=C(C2CC(C2CC1)(C)C)CCO,,,,,,
7058,107059,Pentyl 2-methylbutyrate,CCCCCOC(=O)C(C)CC,,,,,,
7059,107060,Methyl 2-ethyl-3-oxohexanoate,CCCC(=O)C(CC)C(=O)OC,,,,,,
7060,107061,"Ethyl 2,2,4-trichlorononanoate",CCCCCC(CC(C(=O)OCC)(Cl)Cl)Cl,,,,,,
7061,107062,"2(3H)-Furanone, 3,3-dichlorodihydro-5-pentyl-",CCCCCC1CC(C(=O)O1)(Cl)Cl,,,,,,
7062,107063,"1-Propene, 3-[2-(2-methoxypropoxy)propoxy]-",CC(COCC=C)OCC(C)OC,,,,,,
7063,107064,"Benzoic acid, 2-[[[3-(4-hydroxy-4-methylpentyl)-3-cyclohexen-1-yl]methylene]amino]-, methyl ester",CC(C)(CCCC1=CCCC(C1)C=NC2=CC=CC=C2C(=O)OC)O,,,,,,
7064,107065,"Ethanone, 1-(2,3,4,7,8,8a-hexahydro-3,6,8,8-tetramethyl-1H-3a,7-methanoazulen-5-yl)-",CC1CCC2C13CC(C2(C)C)C(=C(C3)C(=O)C)C,,,,,,
7065,107066,"1-Hexanol, 3,5,5-trimethyl-, propanoate",CCC(=O)OCCC(C)CC(C)(C)C,,,,,,
7066,107067,"Ethanol, 2-[(3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-inden-5-yl)oxy]-",C1C=CC2C1C3CC2C(C3)OCCO,,,,,,
7067,107068,"3a,4,5,6,7,7a-Hexahydro-4,7-methano-1H-inden-6-yl isobutyrate",CC(C)C(=O)OC1CC2CC1C3C2C=CC3,,,,,,
7068,107069,"3,6-Dihydro-2,4-dimethyl-6-phenyl-2H-pyran",CC1CC(=CC(O1)C2=CC=CC=C2)C,,,,,,
7069,107070,"2H-Pyran, 3,6-dihydro-4,6-dimethyl-2-phenyl-",CC1C=C(CC(O1)C2=CC=CC=C2)C,,,,,,
7070,107071,"Tricyclo[5.2.1.02,6]dec-3-en-8-yl pivalate",CC(C)(C)C(=O)OC1CC2CC1C3C2C=CC3,,,,,,
7071,107072,"3a,4,5,6,7,7a-Hexahydro-4,7-methano-1H-inden-5-yl pivalate",CC(C)(C)C(=O)OC1CC2CC1C3C2CC=C3,,,,,,
7072,107073,"2-Butenoic acid, 1-cyclohexylethyl ester",CC=CC(=O)OC(C)C1CCCCC1,,,,,,
7073,107074,"2-Butenoic acid, [1,1'-bicyclopentyl]-2-yl ester",CC=CC(=O)OC1CCCC1C2CCCC2,,,,,,
7074,107075,"2-Dodecenenitrile, 4-methyl-",CCCCCCCCC(C)C=CC#N,,,,,,
7075,107076,"2-(1,3,3-Trimethylbutyl)allyl alcohol",CC(CC(C)(C)C)C(=C)CO,,,,,,
7076,107077,2-Ethylhexyl isodecyl adipate,CCCCC(CC)COC(=O)CCCCC(=O)OCCCCCCCC(C)C,,,,,,
7077,107078,"1,3-Benzenediol, 4-(hydroxyphenylmethyl)-",C1=CC=C(C=C1)C(C2=C(C=C(C=C2)O)O)O,,,,,,
7078,107079,"2,2'-(m-Tolylimino)dipropanol",CC1=CC(=CC=C1)N(C(C)CO)C(C)CO,,,,,,
7079,107080,"2,2,4-Trimethylpentane-1,3-diyl dibenzoate",CC(C)C(C(C)(C)COC(=O)C1=CC=CC=C1)OC(=O)C2=CC=CC=C2,,,,,,
7080,107081,"10-Undecenoic acid, 2-amino-1-methylethyl ester",CC(CN)OC(=O)CCCCCCCCC=C,,,,,,
7081,107082,"10-Undecenamide, N-(2-hydroxypropyl)-",CC(CNC(=O)CCCCCCCCC=C)O,,,,,,
7082,107083,"4-Cyclohexene-1,2-dicarboxylic acid, ester with 2,2-dimethyl-1,3-propanediol",CC(C)(CO)COC(=O)C1CC=CCC1C(=O)O,,,,,,
7083,107084,2-Hydroxy-3-(6-methylheptoxy)propane-1-sulfonic acid,CC(C)CCCCCOCC(CS(=O)(=O)O)O,,,,,,
7084,107085,1-[Bis(2-aminoethyl)amino]propan-2-ol,CC(CN(CCN)CCN)O,,,,,,
7085,107086,"Octadecanamide, N,N'-(iminodi-2,1-ethanediyl)bis-, monoacetate",CCCCCCCCCCCCCCCCCC(=O)NCCNC(C)NC(=O)CCCCCCCCCCCCCCCCC.CC(=O)O,,,,,,
7086,107087,N-(1-{[2-(octadecanoylamino)ethyl]amino}ethyl)octadecanamide,CCCCCCCCCCCCCCCCCC(=O)NCCNC(C)NC(=O)CCCCCCCCCCCCCCCCC,,,,,,
7087,107088,CID 107088,COC1=CC=CC=C1C(O)S(=O)(=O)[O-].[Na+],,,,,,
7088,107089,Hydroxy-(2-methoxyphenyl)methanesulfonic acid,COC1=CC=CC=C1C(O)S(=O)(=O)O,,,,,,
7089,107090,"alpha-Hydroxy-1,3-benzodioxole-5-methanesulfonic acid, monoammonium salt",C1OC2=C(O1)C=C(C=C2)C(O)S(=O)(=O)O.N,,,,,,
7090,107091,"(2H-1,3-Benzodioxol-5-yl)(hydroxy)methanesulfonic acid",C1OC2=C(O1)C=C(C=C2)C(O)S(=O)(=O)O,,,,,,
7091,107092,Ammonium alpha-hydroxy-p-methoxytoluene-alpha-sulphonate,COC1=CC=C(C=C1)C(O)S(=O)(=O)O.N,,,,,,
7092,107093,"Ammonium alpha,4-dihydroxy-3-methoxytoluene-alpha-sulphonate",COC1=C(C=CC(=C1)C(O)S(=O)(=O)O)O.N,,,,,,
7093,107094,2-Hydroxy-4-[2-hydroxy-3-(octoxy)propoxy]phenyl phenyl ketone,CCCCCCCCOCC(COC1=CC(=C(C=C1)C(=O)C2=CC=CC=C2)O)O,,,,,,
7094,107095,"2-Butanone, O-[[[[1,3,3-trimethyl-5-[[[[(1-methylpropylidene)amino]oxy]carbonyl]amino]cyclohexyl]methyl]amino]carbonyl]oxime",CCC(=NOC(=O)NCC1(CC(CC(C1)(C)C)NC(=O)ON=C(C)CC)C)C,,,,,,
7095,107096,Methyl alpha-ethylaziridine-1-acetate,CCC(C(=O)OC)N1CC1,,,,,,
7096,107097,5-Ethyl-2-methylnonan-1-ol,CCCCC(CC)CCC(C)CO,,,,,,
7097,107098,"1,3-Dimethyl-3-phenylbutyl acetate",CC(CC(C)(C)C1=CC=CC=C1)OC(=O)C,,,,,,
7098,107099,3-(4-Methyl-3-pentenyl)cyclohex-3-ene-1-carbonitrile,CC(=CCCC1=CCCC(C1)C#N)C,,,,,,
7099,107100,2-(4-Methylpent-3-enyl)cyclohex-3-ene-1-carbonitrile,CC(=CCCC1C=CCCC1C#N)C,,,,,,
7100,107101,3-Ethoxy-4-methylpentanal,CCOC(CC=O)C(C)C,,,,,,
7101,107102,CID 107102,C(C(C(C(C(C(C(=O)[O-])O)O)O)O)O)O.[K+],,,,,,
7102,107103,"1-Penten-3-one, 1-(2,6,6-trimethyl-2-cyclohexen-1-yl)-, dihydro deriv.",CCC(=O)C=CC1C(CCCC1(C)C)C,,,,,,
7103,107104,"2,6-Dimethylcyclohex-2-ene-1-carbaldehyde",CC1CCC=C(C1C=O)C,,,,,,
7104,107105,2-Hydroxy-4-(2-hydroxy-3-decyloxypropoxy)benzophenone,CCCCCCCCCCOCC(COC1=CC(=C(C=C1)C(=O)C2=CC=CC=C2)O)O,,,,,,
7105,107106,"Poly(oxy(methyl-1,2-ethanediyl)), alpha-(2-(diethylamino)ethyl)-omega-hydroxy-",CCN(CC)CCOC(C)CO,,,,,,
7106,107107,"Carbamic acid, (3-isocyanatomethylphenyl)-, oxybis(1-methyl-2,1-ethanediyl) ester",CC(COCC(C)OC(=O)NC1=CC=CC(=C1)CN=C=O)OC(=O)NC2=CC=CC(=C2)CN=C=O,,,,,,
7107,107108,Benzyl(2-hydroxy-3-((8-methylnonyl)oxy)propyl)dimethylammonium chloride,CC(C)CCCCCCCOCC(C[N+](C)(C)CC1=CC=CC=C1)O.[Cl-],,,,,,
7108,107109,"N-[2-Hydroxy-3-[(8-methylnonyl)oxy]propyl]-N,N-dimethylbenzenemethanaminium",CC(C)CCCCCCCOCC(C[N+](C)(C)CC1=CC=CC=C1)O,,,,,,
7109,107110,Mono(2-ethylhexyl) phosphate triethanolamine salt (1:2),CCCCC(CC)COP(=O)(O)O.C(CO)N(CCO)CCO.C(CO)N(CCO)CCO,,,,,,
7110,107111,1-(2-Ethylhexyl) 3-((((2-carboxyethyl)thio)phenylmethyl)thio)propionate,CCCCC(CC)COC(=O)CCSC(C1=CC=CC=C1)SCCC(=O)O,,,,,,
7111,107112,1-Propylheptyl dihydrogen phosphate,CCCCCCC(CCC)OP(=O)(O)O,,,,,,
7112,107113,"2,4-Diisopropyl-5,5-dimethyl-1,3-dioxane",CC(C)C1C(COC(O1)C(C)C)(C)C,,,,,,
7113,107114,"Phosphorothioic acid, O,O-diethyl O-tetrahydrofurfuryl ester",CCOP(=S)(OCC)OCC1CCCO1,,,,,,
7114,107115,"1,2,3,4,7,7-Hexachloro-5-(dichloromethyl)bicyclo[2.2.1]hept-2-ene",C1C(C2(C(=C(C1(C2(Cl)Cl)Cl)Cl)Cl)Cl)C(Cl)Cl,,,,,,
7115,107116,"2'-(3-Cyclohexen-1-yl)spiro(bicyclo(2.2.1)hept-5-ene-2,5'-(1,3)dioxane)",C1CC(CC=C1)C2OCC3(CC4CC3C=C4)CO2,,,,,,
7116,107117,"Phenol, 3-(1-methylpropyl)-",CCC(C)C1=CC(=CC=C1)O,,,,,,
7117,107118,3-Ethylheptan-1-ol,CCCCC(CC)CCO,,,,,,
7118,107119,"2-(3,8-Dimethyldecahydroazulen-5-yl)propan-2-ol",CC1CCC(CC2C1CCC2C)C(C)(C)O,,,,,,
7119,107120,"2,3-Diphenylpropanol",C1=CC=C(C=C1)CC(CO)C2=CC=CC=C2,,,,,,
7120,107121,Bis(2-phenylcyclopropylammonium) sulphate,C1C(C1N)C2=CC=CC=C2.C1C(C1N)C2=CC=CC=C2.OS(=O)(=O)O,,,,,,
7121,107122,4-(4-Butoxyphenyl)-2-[2-(ethylperoxy)ethyl]-4-methylmorpholin-4-ium bromide,CCCCOC1=CC=C(C=C1)[N+]2(CCOC(C2)CCOOCC)C.[Br-],,,,,,
7122,107123,4-(4-Butoxyphenyl)-2-(2-ethylperoxyethyl)-4-methylmorpholin-4-ium,CCCCOC1=CC=C(C=C1)[N+]2(CCOC(C2)CCOOCC)C,,,,,,
7123,107124,"2-Butanol, 4-(1-naphthalenylimino)-",CC(CC=NC1=CC=CC2=CC=CC=C21)O,,,,,,
7124,107125,"3-(4-Carboxyphenyl)-2,3-dihydro-1,1,3-trimethyl-1H-indene-5-carboxylic acid",CC1(CC(C2=C1C=CC(=C2)C(=O)O)(C)C3=CC=C(C=C3)C(=O)O)C,,,,,,
7125,107126,Dihydrojasmonic acid,CCCCCC1C(CCC1=O)CC(=O)O,,,,,,
7126,107127,Bis(beta-chloroethyl)-beta-chloropropylamine,CC(CN(CCCl)CCCl)Cl,,,,,,
7127,107128,Trimipramine hydrochloride,CC(CN1C2=CC=CC=C2CCC3=CC=CC=C31)CN(C)C.Cl,,,"['Substances that contain a fused three-ring moiety and are used in the treatment of depression. These drugs block the uptake of norepinephrine and serotonin into axon terminals and may block some subtypes of serotonin, adrenergic, and histamine receptors. However, the mechanism of their antidepressant effects is not clear because the therapeutic effects usually take weeks to develop and may reflect compensatory changes in the central nervous system. (See all compounds classified as Antidepressive Agents, Tricyclic.)', 'Drugs that block the transport of adrenergic transmitters into axon terminals or into storage vesicles within terminals. The tricyclic antidepressants (ANTIDEPRESSIVE AGENTS, TRICYCLIC) and amphetamines are among the therapeutically important drugs that may act via inhibition of adrenergic transport. Many of these drugs also block transport of serotonin. (See all compounds classified as Adrenergic Uptake Inhibitors.)']",,,
7128,107129,"(2,2-Dichloro-1-methylcyclopropyl)benzene",CC1(CC1(Cl)Cl)C2=CC=CC=C2,,,,,,
7129,107130,(1-Methylhexyl)ammonium sulphate,CCCCCC(C)N.OS(=O)(=O)O,,,,,,
7130,107131,"2,3,4-Trimethylvaleraldehyde",CC(C)C(C)C(C)C=O,,,,,,
7131,107132,1-tert-Butoxy-3-methyl-3-buten-2-ol,CC(=C)C(COC(C)(C)C)O,,,,,,
7132,107133,"alpha,3,7,7-Tetramethylbicyclo[4.1.0]heptane-4-methanol",CC1CC2C(C2(C)C)CC1C(C)O,,,,,,
7133,107134,2-(Morpholin-4-yl)propanenitrile,CC(C#N)N1CCOCC1,,,,,,
7134,107135,beta-Piperidinoethyl benzhydryl ether hydrochloride,C1CCNC(C1)CCOC(C2=CC=CC=C2)C3=CC=CC=C3.Cl,,,,,,
7135,107136,2-(2-Benzhydryloxyethyl)piperidine,C1CCNC(C1)CCOC(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
7136,107137,"2,6-Metheno-3-benzazocine, 3-(cyclopropylmethyl)-6,11-dimethyl-1,2,3,4,5,6-hexahydro-",CC1C2CC3=C(C1(CCN2CC4CC4)C)C=C(C=C3)OC,,,,,,
7137,107138,"2-(3,3-Dimethylallyl)-5-ethyl-2'-hydroxy-9-methyl-6,7-benzomorphan",CCC12CCN(C(C1C)CC3=C2C=C(C=C3)O)CC=C(C)C,,,,,,
7138,107139,"2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-3-(3,3-dichloro-2-propenyl)-6-ethyl-11-methyl-",CCC12CCN(C(C1C)CC3=C2C=C(C=C3)O)CC=C(Cl)Cl,,,,,,
7139,107140,"Azane;7-[chloro(difluoro)methyl]-2,2,3,3,4,4,5,5,6,6,7,8,8,8-tetradecafluorooctanoic acid",C(=O)(C(C(C(C(C(C(C(F)(F)F)(C(F)(F)Cl)F)(F)F)(F)F)(F)F)(F)F)(F)F)O.N,,,,,,
7140,107141,"7-[Chloro(difluoro)methyl]-2,2,3,3,4,4,5,5,6,6,7,8,8,8-tetradecafluorooctanoic acid",C(=O)(C(C(C(C(C(C(C(F)(F)F)(C(F)(F)Cl)F)(F)F)(F)F)(F)F)(F)F)(F)F)O,,,,,,
7141,107142,3-Diethoxyphosphinothioylsulfanyloxolan-2-one,CCOP(=S)(OCC)SC1CCOC1=O,,,,,,
7142,107143,"1,1,2-Tribromobutane",CCC(C(Br)Br)Br,,,,,,
7143,107144,[(Vinyloxy)methyl]oxirane,C=COCC1CO1,,,,,,
7144,107145,Cyclohexyl glycidyl ether,C1CCC(CC1)OCC2CO2,,,,,,
7145,107146,2-(1-Naphthyl)-4-pentenoic acid isopropylhydrazide,CC(C)NNC(=O)C(CC=C)C1=CC=CC2=CC=CC=C21,,,,,,
7146,107147,Propoctamine,CCCCC(CC)CNCC(C)(CNCC(CC)CCCC)N,,,,,,
7147,107148,"6-[3,4,5-Trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycyclohexane-1,2,3,4,5-pentol",C(C1C(C(C(C(O1)OC2C(C(C(C(C2O)O)O)O)O)O)O)O)O,,,,,,
7148,107149,3-Ethoxy-2-oxobutyraldehyde,CCOC(C)C(=O)C=O,,,['Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)'],,,
7149,107150,Aminopropylon,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)NC(=O)C(C)N(C)C,,,,,,
7150,107151,3-Pyrrolidinylbutyranilide,CC(CC(=O)NC1=CC=CC=C1)N2CCCC2,,,,,,
7151,107152,"Azulene, 1,2,3,4,5,6,7,8-octahydro-1,4-dimethyl-7-(1-methylethenyl)-, (1S,4S,7R)-",CC1CCC(CC2=C1CCC2C)C(=C)C,,,,,,
7152,107153,2-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)acetic acid,COC1=C(C=C(C=C1)C(C(=O)O)O)O,,,,,,
7153,107154,4-(Diethylamino)-2-phenylbutyronitrile,CCN(CC)CCC(C#N)C1=CC=CC=C1,,,,,,
7154,107155,Triethyl 2-phosphonopropionate,CCOC(=O)C(C)P(=O)(OCC)OCC,,,,,,
7155,107156,"O,O-Dimethyl S-(1,2-dicarbisopropoxy)ethyl phosphorodithioate",CC(C)OC(=O)CC(C(=O)OC(C)C)SP(=S)(OC)OC,,,,,,
7156,107157,Carb-N-propoxy malathion,CCCOC(=O)CC(C(=O)OCCC)SP(=S)(OC)OC,,,,,,
7157,107158,Dipropan-2-yl 2-[(dimethoxyphosphoryl)sulfanyl]butanedioate,CC(C)OC(=O)CC(C(=O)OC(C)C)SP(=O)(OC)OC,,,,,,
7158,107159,Dipropyl 2-[(dimethoxyphosphoryl)sulfanyl]butanedioate,CCCOC(=O)CC(C(=O)OCCC)SP(=O)(OC)OC,,,,,,
7159,107160,Dibutyl 2-[(dimethoxyphosphoryl)sulfanyl]butanedioate,CCCCOC(=O)CC(C(=O)OCCCC)SP(=O)(OC)OC,,,,,,
7160,107161,p-Chloroamphetamine hydrochloride,CC(CC1=CC=C(C=C1)Cl)N.Cl,,,,,,
7161,107162,Aluminum;2-methanidylpentane,CCCC(C)[CH2-].CCCC(C)[CH2-].CCCC(C)[CH2-].[Al+3],,,,,,
7162,107163,"1,2-Epoxy-6-(2,3-epoxypropoxy)hexahydro-4,7-methanoindan",C1C2CC(C1C3C2CC4C3O4)OCC5CO5,,,,,,
7163,107164,2-Aminononanedioic acid,C(CCCC(=O)O)CCC(C(=O)O)N,,,,,,
7164,107165,Cronaxil,C1=CC=C(C=C1)C(C2=CC=C(C=C2)Cl)(C3=CC=NC=C3)O,,,,,,
7165,107166,Ambrox,CC1(CCCC2(C1CCC3(C2CCO3)C)C)C,,,,,,
7166,107167,2-Bromo-4-chloro-1-(4-chlorophenyl)butan-1-one,C1=CC(=CC=C1C(=O)C(CCCl)Br)Cl,,,,,,
7167,107168,"Oxirane, 2-[2-(3,3-dimethyloxiranyl)ethenyl]-2,3-dimethyl-",CC1C(O1)(C)C=CC2C(O2)(C)C,,,,,,
7168,107169,3-Methylpiperidin-2-one,CC1CCCNC1=O,,,,,,
7169,107170,"2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-3-(2-chloro-2-propenyl)-6,11-dimethyl-",CC1C2CC3=C(C1(CCN2CC(=C)Cl)C)C=C(C=C3)O,,,,,,
7170,107171,"(1,4a-Dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthren-1-yl)methanol",CC(C)C1=CC2=C(C=C1)C3(CCCC(C3CC2)(C)CO)C,,,,,,
7171,107172,"Acetaldehyde bis(2,3-epoxypropyl)acetal",CC(OCC1CO1)OCC2CO2,,,,,,
7172,107173,"Didecyl 7-oxabicyclo[4.1.0]heptane-3,4-dicarboxylate",CCCCCCCCCCOC(=O)C1CC2C(O2)CC1C(=O)OCCCCCCCCCC,,,,,,
7173,107174,"2'-Bicyclo(2.2.1)hept-5-en-2-ylspiro(bicyclo(2.2.1)hept-5-ene-2,5'-(1,3)dioxane)",C1C2CC(C1C=C2)C3OCC4(CC5CC4C=C5)CO3,,,,,,
7174,107175,2-Hydroxymenthol,CC1CCC(C(C1O)O)C(C)C,,,,,,
7175,107176,"3,5,5-Trimethylhexanoyl peroxide",CC(CC(=O)OOC(=O)CC(C)CC(C)(C)C)CC(C)(C)C,,,,,,
7176,107177,Methyl 3-methoxyisobutyrate,CC(COC)C(=O)OC,,,,,,
7177,107178,CID 107178,C1=C[N+](=CC=C1C=NO)CCOCC[N+]2=CC=C(C=C2)C=NO.[Br-].[Br-],,,,,,
7178,107179,CID 107179,C1=C[N+](=CC=C1C=NO)CCOCC[N+]2=CC=C(C=C2)C=NO,,,,,,
7179,107180,"alpha-2'-Hydroxy-9-methyl-5-propyl-6,7-benzomorphan hydrobromide",CCCC12CCN(C(C1C)CC3=C2C=C(C=C3)O)C.Br,,,,,,
7180,107181,Niosh/PB8939500,CCCC12CCN(C(C1C)CC3=C2C=C(C=C3)O)C,,,,,,
7181,107182,"N(sup 1), N(sup 3)-Bis(2-ethylhexyl)-N(sup 1),2-dimethyl-1,2,3-propanetriamine",CCCCC(CC)CNCC(C)(CN(C)CC(CC)CCCC)N,,,,,,
7182,107183,"Dimethyl 1,2,2,2-tetrachloroethyl phosphate",COP(=O)(OC)OC(C(Cl)(Cl)Cl)Cl,,,,,,
7183,107184,"Phosphorothioic acid, O,O-diethyl S-(tetrahydro-2-oxo-3-furanyl) ester",CCOP(=O)(OCC)SC1CCOC1=O,,,,,,
7184,107185,Diethyl azodiisobutyrate,CCOC(=O)C(C)CN=NCC(C)C(=O)OCC,,,,,,
7185,107186,"4,5-Dimethoxyimidazolidine-2-one",COC1C(NC(=O)N1)OC,,,,,,
7186,107187,"4-Pentenoic acid, 2-acetyl-, methyl ester",CC(=O)C(CC=C)C(=O)OC,,,,,,
7187,107188,(2-Chloro-1-methoxyethyl)benzene,COC(CCl)C1=CC=CC=C1,,,,,,
7188,107189,alpha-Cyclopentyl-alpha-2-thienylglycollic acid,C1CCC(C1)C(C2=CC=CS2)(C(=O)O)O,,,,,,
7189,107190,"3-(Cyclopropylcarbonyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol",CC1C2CC3=C(C1(CCN2C(=O)C4CC4)C)C=C(C=C3)O,,,,,,
7190,107191,"3-(5,5,6-Trimethylbicyclo(2.2.1)hept-2-yl)cyclohexan-1-one",CC1C2CC(C1(C)C)CC2C3CCCC(=O)C3,,,,,,
7191,107192,1-(2-Hydroxy-3-sulphonatopropyl)pyridinium,C1=CC=[N+](C=C1)CC(CS(=O)(=O)[O-])O,,,,,,
7192,107193,1-(2-Hydroxy-3-sulfopropyl)pyridin-1-ium,C1=CC=[N+](C=C1)CC(CS(=O)(=O)O)O,,,,,,
7193,107194,"(R)-1-(3-Hydroxy-2,4-dioxa-7-aza-3-phosphaoct-1-yl)ethylene dipalmitate P-oxide",CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCNC)OC(=O)CCCCCCCCCCCCCCC,,,,,,
7194,107195,"2,4,4-Trimethylhexanedioic acid",CC(CC(C)(C)CC(=O)O)C(=O)O,,,,,,
7195,107196,2-Isopropoxypropanol,CC(C)OC(C)CO,,,,,,
7196,107197,2-Methylquinuclidin-3-ol,CC1C(C2CCN1CC2)O,,,,,,
7197,107198,2-Methylpentyl acrylate,CCCC(C)COC(=O)C=C,,,,,,
7198,107199,"Diethyl 1,2,2,2-tetrachloroethyl phosphate",CCOP(=O)(OCC)OC(C(Cl)(Cl)Cl)Cl,,,,,,
7199,107200,Aminopyrine butylchloral hydrate,CC1=C(C(=O)N(N1C)C2=CC=CC=C2)N(C)C.CC(C(C(O)O)(Cl)Cl)Cl,,,,,,
7200,107201,"6-11-Dihydro-11-(1-methylpiperidin-4-yl)-5H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-ol",CN1CCC(CC1)C2(C3=CC=CC=C3CCC4=C2N=CC=C4)O,,,,,,
7201,107202,Methoxyphenylacetic acid,COC(C1=CC=CC=C1)C(=O)O,,,,,,
7202,107203,(2-Methylbutyl)benzene,CCC(C)CC1=CC=CC=C1,,,,,,
7203,107204,"1,3-Cyclohexanedimethanol",C1CC(CC(C1)CO)CO,,,,,,
7204,107205,"1,3-Cyclohexanedicarboxylic acid",C1CC(CC(C1)C(=O)O)C(=O)O,,,,,,
7205,107206,"6-(((Benzyloxy)-1,3-dioxo-2-phenylpropyl)amino)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid",CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)C(C3=CC=CC=C3)C(=O)OCC4=CC=CC=C4)C(=O)O)C,,,,,,
7206,107207,3-Phenylpiperidine,C1CC(CNC1)C2=CC=CC=C2,,,,,,
7207,107208,"2,5-Dioxooxazolidine-4-propionic acid",C(CC(=O)O)C1C(=O)OC(=O)N1,,,,,,
7208,107209,"7-Acetoxy-6-(2,3-dibromopropyl)-4,8-dimethylcoumarin",CC1=CC(=O)OC2=C1C=C(C(=C2C)OC(=O)C)CC(CBr)Br,,,,,,
7209,107210,Ethyl 2-oxocyclononanecarboxylate,CCOC(=O)C1CCCCCCCC1=O,,,,,,
7210,107211,"2-Hydroxy-3,3-dimethylbutanoic acid",CC(C)(C)C(C(=O)O)O,,,,,,
7211,107212,1-(2-Isopropoxy-1-methylethoxy)propan-2-ol,CC(C)OCC(C)OCC(C)O,,,,,,
7212,107213,Dodecen-3-ol,CCCCCCCCCC(C=C)O,,,,,,
7213,107214,"2,5-Dimethyl-1,3-dioxolan-4-one",CC1C(=O)OC(O1)C,,,,,,
7214,107215,"2-Propanol, 1-(4-indanyloxy)-3-(isopropylamino)-",CC(C)NCC(COC1=CC=CC2=C1CCC2)O,,,,,,
7215,107216,"Cyclopentane-1,3-dicarboxylic acid",C1CC(CC1C(=O)O)C(=O)O,,,,,,
7216,107217,Fenchyl acetate,CC(=O)OC1C(C2CCC1(C2)C)(C)C,,,,,,
7217,107218,"2,2'-Dihydroindigo",C1=CC=C2C(=C1)C(=O)C(N2)C3C(=O)C4=CC=CC=C4N3,,,,,,
7218,107219,"4,4a,5,6,7,8-Hexahydro-4a,8-dimethylnaphthalen-2(3H)-one",CC1CCCC2(C1=CC(=O)CC2)C,,,,,,
7219,107220,Methyl 3-[dichloro(methyl)silyl]-2-methylpropanoate,CC(C[Si](C)(Cl)Cl)C(=O)OC,,,,,,
7220,107221,Methyl beta-methylaziridine-1-propionate,CC(CC(=O)OC)N1CC1,,,,,,
7221,107222,"2,3,3,3-Tetrafluoro-2-(1,1,2,2-tetrafluoro-2-(fluorosulphonyl)ethoxy)propionyl fluoride",C(=O)(C(C(F)(F)F)(OC(C(F)(F)S(=O)(=O)F)(F)F)F)F,,,,,,
7222,107223,"Propanoyl fluoride, 2,3,3,3-tetrafluoro-2-(1,1,2,3,3,3-hexafluoro-2-(1,1,2,2-tetrafluoro-2-(fluorosulfonyl)ethoxy)propoxy)-",C(=O)(C(C(F)(F)F)(OC(C(C(F)(F)F)(OC(C(F)(F)S(=O)(=O)F)(F)F)F)(F)F)F)F,,,,,,
7223,107224,3-Cyclohexenyl hydroperoxide,C1CC(CC=C1)OO,,,,,,
7224,107225,"Butanamide, 2-[(4-chloro-2-nitrophenyl)azo]-3-oxo-N-phenyl-",CC(=O)C(C(=O)NC1=CC=CC=C1)N=NC2=C(C=C(C=C2)Cl)[N+](=O)[O-],,,,,,
7225,107226,"Bis(3,5,5-trimethylhexyl) peroxydicarbonate",CC(CCOC(=O)OC(=O)OOCCC(C)CC(C)(C)C)CC(C)(C)C,,,,,,
7226,107227,2-Octylundecanedioic acid,CCCCCCCCC(CCCCCCCCC(=O)O)C(=O)O,,,,,,
7227,107228,Triisobutylphosphine,CC(C)CP(CC(C)C)CC(C)C,,,,,,
7228,107229,3-(2-Ethylhexyloxy)propionic acid,CCCCC(CC)COCCC(=O)O,,,,,,
7229,107230,"2-Hydroxy-2,4-dimethylvaleronitrile",CC(C)CC(C)(C#N)O,,,,,,
7230,107231,Methyl 2-methyl-3-mercaptopropionate,CC(CS)C(=O)OC,,,,,,
7231,107232,1-[4-(Tert-butyl)-1-cyclohexen-1-YL]pyrrolidine,CC(C)(C)C1CCC(=CC1)N2CCCC2,,,,,,
7232,107233,Methyl 2-methyl-3-(pyrrolidin-1-yl)propanoate,CC(CN1CCCC1)C(=O)OC,,,,,,
7233,107234,Methyl 2-methyl-3-(piperidin-1-yl)propanoate,CC(CN1CCCCC1)C(=O)OC,,,,,,
7234,107235,"2,3-Dimethyl-3-hexanol",CCCC(C)(C(C)C)O,,,,,,
7235,107236,"Trichloro(1,2-dibromoethyl)silane",C(C([Si](Cl)(Cl)Cl)Br)Br,,,,,,
7236,107237,2-Ethyl-2-methylsuccinonitrile,CCC(C)(CC#N)C#N,,,,,,
7237,107238,"Piperazine, 1-propionyl-2,2,4,6-tetramethyl-",CCC(=O)N1C(CN(CC1(C)C)C)C,,,,,,
7238,107239,2-Hydroxypropyl bromoacetate,CC(COC(=O)CBr)O,,,,,,
7239,107240,2-Phenoxytetrahydropyran,C1CCOC(C1)OC2=CC=CC=C2,,,,,,
7240,107241,"4-Propionyl-1,2,6-trimethylpiperazine",CCC(=O)N1CC(N(C(C1)C)C)C,,,,,,
7241,107242,"1-(2,4,6-Trimethylpiperazin-1-yl)propan-1-one",CCC(=O)N1C(CN(CC1C)C)C,,,,,,
7242,107243,1-(Furan-2-yl)ethanol,CC(C1=CC=CO1)O,,,,,,
7243,107244,"1,3-Bis(hydroxymethyl)-4,5-dimethoxyimidazolidin-2-one",COC1C(N(C(=O)N1CO)CO)OC,,,,,,
7244,107245,"3,3'-[(2,3-Dihydroxypropyl)imino]bispropiononitrile",C(CN(CCC#N)CC(CO)O)C#N,,,,,,
7245,107246,6-(Oxiran-2-yl)-7-oxabicyclo[4.1.0]heptane,C1CCC2(C(C1)O2)C3CO3,,,,,,
7246,107247,"1,3,5-Tris(2,3-epoxypropoxy)benzene",C1C(O1)COC2=CC(=CC(=C2)OCC3CO3)OCC4CO4,,,,,,
7247,107248,((p-Octylphenoxy)methyl)oxirane,CCCCCCCCC1=CC=C(C=C1)OCC2CO2,,,,,,
7248,107249,1-sec-Butyl-4-nitrobenzene,CCC(C)C1=CC=C(C=C1)[N+](=O)[O-],,,,,,
7249,107250,4-(Oxiran-2-yl)oxetan-2-one,C1C(OC1=O)C2CO2,,,,,,
7250,107251,2-Ethylhexyl 5-oxo-L-prolinate,CCCCC(CC)COC(=O)[C@@H]1CCC(=O)N1,,,,,,
7251,107252,1-Methyl-2-propylcyclohexane,CCCC1CCCCC1C,,,,,,
7252,107253,"Octahydro-2,5-methano-2H-indeno(1,2-b)oxirene",C1CC2CC1C3C2C4C(C3)O4,,,,,,
7253,107254,"4-Ethyl-2-methyl-4,5-dihydrothiazole",CCC1CSC(=N1)C,,,,,,
7254,107255,2-Chloro-9-[3-(dimethylamino)propyl]thioxanthen-9-ol,CN(C)CCCC1(C2=CC=CC=C2SC3=C1C=C(C=C3)Cl)O,,,,,,
7255,107256,"Ethyl 2,3,4,5-tetrachlorotetrahydro-2-furoate",CCOC(=O)C1(C(C(C(O1)Cl)Cl)Cl)Cl,,,,,,
7256,107257,1-(4-Bromophenyl)-n-methylpropan-2-amine,CC(CC1=CC=C(C=C1)Br)NC,,,,,,
7257,107258,p-Nitromethylamphetamine,CC(CC1=CC=C(C=C1)[N+](=O)[O-])NC,,,,,,
7258,107259,1-(4-Iodophenyl)-n-methylpropan-2-amine,CC(CC1=CC=C(C=C1)I)NC,,,,,,
7259,107260,n-Methyl-1-(2-nitrophenyl)propan-2-amine,CC(CC1=CC=CC=C1[N+](=O)[O-])NC,,,,,,
7260,107261,1-(2-chlorophenyl)-N-methylpropan-2-amine,CC(CC1=CC=CC=C1Cl)NC,,,,,,
7261,107262,1-(2-Bromophenyl)-n-methylpropan-2-amine,CC(CC1=CC=CC=C1Br)NC,,,,,,
7262,107263,"1,1,3,5-Tetramethylcyclohexane",CC1CC(CC(C1)(C)C)C,,,,,,
7263,107264,1-(2-Methylphenoxy)-2-propanol,CC1=CC=CC=C1OCC(C)O,,,,,,
7264,107265,"1,1-Diphenyl-3-dimethylaminobutane-1-ol",CC(CC(C1=CC=CC=C1)(C2=CC=CC=C2)O)N(C)C,,,,,,
7265,107266,alpha-(2-(Dimethylamino)propyl)benzhydrol hydrochloride,CC(CC(C1=CC=CC=C1)(C2=CC=CC=C2)O)N(C)C.Cl,,,,,,
7266,107267,CID 107267,C1=CC=C(C=C1)CC2C(=O)N(C(=N2)S)C3=CC=CC=C3,,,,,,
7267,107268,CID 107268,CC1C(=O)N(C(=N1)S)C2=CC=CC=C2,,,,,,
7268,107269,1-Cyclohexyl-1-butanol,CCCC(C1CCCCC1)O,,,,,,
7269,107270,"2-Imidazolidinone, 4,5-dimethoxy-1,3-bis(methoxymethyl)-",COCN1C(C(N(C1=O)COC)OC)OC,,,,,,
7270,107271,"1,3-Dioxolane, 2-(1-ethylpentyl)-",CCCCC(CC)C1OCCO1,,,,,,
7271,107272,Tetrahydroionol,CC1CCCC(C1CCC(C)O)(C)C,,,,,,
7272,107273,3-Hydroxybutyronitrile,CC(CC#N)O,,,,,,
7273,107274,CID 107274,CSCCC1C(=O)N(C(=N1)S)C2=CC=CC=C2,,,,,,
7274,107275,Octahydro-1H-indole,C1CCC2C(C1)CCN2,,,,,,
7275,107276,"[2-(4-Methylphenyl)-1,3-dioxolan-4-yl]methanol",CC1=CC=C(C=C1)C2OCC(O2)CO,,,,,,
7276,107277,alpha-Phosphinylbenzenemethanol,C1=CC=C(C=C1)C(O)[PH2]=O,,,,,,
7277,107278,alpha-[[(2-Hydroxyethyl)amino]methyl]benzyl alcohol,C1=CC=C(C=C1)C(CNCCO)O,,,,,,
7278,107279,1-Adamantyl isothiocyanate,C1C2CC3CC1CC(C2)(C3)N=C=S,,,,,,
7279,107280,"1,2,3,4-Cyclobutanetetracarboxylic dianhydride",C12C(C3C1C(=O)OC3=O)C(=O)OC2=O,,,,,,
7280,107281,"3-Methylhexane-2,5-dione",CC(CC(=O)C)C(=O)C,,,,,,
7281,107282,"4-Ethyl-1,3-dioxolan-2-one",CCC1COC(=O)O1,,,,,,
7282,107283,11-Hydroxy-10-icosanone,CCCCCCCCCC(C(=O)CCCCCCCCC)O,,,,,,
7283,107284,9-Hydroxyhexadecan-8-one,CCCCCCCC(C(=O)CCCCCCC)O,,,,,,
7284,107285,"1,1,1,3,3,3-Hexakis(1-methylpropoxy)disiloxane",CCC(C)O[Si](OC(C)CC)(OC(C)CC)O[Si](OC(C)CC)(OC(C)CC)OC(C)CC,,,,,,
7285,107286,10-Hydroxyoctadecan-9-one,CCCCCCCCC(C(=O)CCCCCCCC)O,,,,,,
7286,107287,"Methyl 2,6-diisocyanatohexanoate",COC(=O)C(CCCCN=C=O)N=C=O,,,,,,
7287,107288,"Phosphorodithioic acid, S-(2-((1,4,5,6,7,7-hexachloro-5-norbornen-2-yl)methylthio)-1-methylethyl) O,O-dimethyl ester",CC(CSC1C2C(=C(C(C1Cl)(C2(Cl)Cl)Cl)Cl)Cl)CSP(=S)(OC)OC,,,,,,
7288,107289,"4-(1,7,7-Trimethylbicyclo[2.2.1]hept-2-yl)phenol",CC1(C2CCC1(C(C2)C3=CC=C(C=C3)O)C)C,,,,,,
7289,107290,1-(4-Bromophenyl)propan-1-ol,CCC(C1=CC=C(C=C1)Br)O,,,,,,
7290,107291,"2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-3-(cyclopentylmethyl)-6,11-dimethyl-",CC1C2CC3=C(C1(CCN2CC4CCCC4)C)C=C(C=C3)O,,,,,,
7291,107292,"2,2,4-Trimethyl-1,2,3,4-tetrahydroquinoline",CC1CC(NC2=CC=CC=C12)(C)C,,,,,,
7292,107293,"3,3'-Dioxybis[3,5,5-trimethyl-1,2-dioxolane]",CC1(CC(OO1)(C)OOC2(CC(OO2)(C)C)C)C,,,,,,
7293,107294,"Methyl 3,4-epoxybutyrate",COC(=O)CC1CO1,,,,,,
7294,107295,Dimethyl 2-methyl-5-methyleneadipate,CC(CCC(=C)C(=O)OC)C(=O)OC,,,,,,
7295,107296,"benzyl N-(2,5-dioxooxolan-3-yl)carbamate",C1C(C(=O)OC1=O)NC(=O)OCC2=CC=CC=C2,,,,,,
7296,107297,"3-Methylpiperazine-2,5-dione",CC1C(=O)NCC(=O)N1,,,,,,
7297,107298,"[3,3'-Bifuran]-2,2',5,5'-tetrone, tetrahydro-",C1C(C(=O)OC1=O)C2CC(=O)OC2=O,,,,,,
7298,107299,"2,3-Dibromopropionitrile",C(C(C#N)Br)Br,,,,,,
7299,107300,"(3,4-Dihydro-2H-pyran-2-yl)methyl acrylate",C=CC(=O)OCC1CCC=CO1,,,,,,
7300,107301,"(3,4-Dihydro-2H-pyran-2-yl)methyl methacrylate",CC(=C)C(=O)OCC1CCC=CO1,,,,,,
7301,107302,"2,4,6-Tri(dimethylaminomethyl)phenol 2-ethylhexanoic acid salt (1:3)",CCCCC(CC)C(=O)O.CCCCC(CC)C(=O)O.CCCCC(CC)C(=O)O.CN(C)CC1=CC(=C(C(=C1)CN(C)C)O)CN(C)C,,,,,,
7302,107303,"2,2,6-Trimethyl-1-oxaspiro[2.5]oct-5-ene",CC1=CCC2(CC1)C(O2)(C)C,,,,,,
7303,107304,1-Acetyl-3-methylpiperidine,CC1CCCN(C1)C(=O)C,,,,,,
7304,107305,1-(Chloroacetyl)-2-methylpiperidine,CC1CCCCN1C(=O)CCl,,,,,,
7305,107306,3-(2-Oxocyclopentyl)propanenitrile,C1CC(C(=O)C1)CCC#N,,,,,,
7306,107307,"2-(2,2,3-Trimethylcyclopent-1-yl)ethyl acetate",CC1CCC(C1(C)C)CCOC(=O)C,,,,,,
7307,107308,3-Piperidinemethanol,C1CC(CNC1)CO,,,,,,
7308,107309,"Benz(a)anthracene-7,12-diol, 7,12-dihydro-",C1=CC=C2C(=C1)C=CC3=C2C(C4=CC=CC=C4C3O)O,,,,,,
7309,107310,"4,4,6-Trimethyl-2-vinyl-1,3,2-dioxaborinane",B1(OC(CC(O1)(C)C)C)C=C,,,,,,
7310,107311,"1,3-Dimethylpiperidin-4-one",CC1CN(CCC1=O)C,,,,,,
7311,107312,CID 107312,CC(C)CCCOC(=O)CC(C(=O)OCCCC(C)C)S(=O)(=O)[O-].[Na+],,,,,,
7312,107313,"Butanedioic acid, sulfo-, 1,4-bis(4-methylpentyl) ester",CC(C)CCCOC(=O)CC(C(=O)OCCCC(C)C)S(=O)(=O)O,,,,,,
7313,107314,"5,5-Dichlorobicyclo[2.2.1]hept-2-ene",C1C2CC(C1C=C2)(Cl)Cl,,,,,,
7314,107315,Ethyl 4-oxopiperidine-3-carboxylate hydrochloride,CCOC(=O)C1CNCCC1=O.Cl,,,,,,
7315,107316,Ethyl 4-oxopiperidine-3-carboxylate,CCOC(=O)C1CNCCC1=O,,,,,,
7316,107317,Tetrahydrofurfuryl hydrogen sebacate,C1CC(OC1)COC(=O)CCCCCCCCC(=O)O,,,,,,
7317,107318,2-Methylbutyl 3-phenylprop-2-enoate,CCC(C)COC(=O)C=CC1=CC=CC=C1,,,,,,
7318,107319,Ethyl oxirane-2-carboxylate,CCOC(=O)C1CO1,,,,,,
7319,107320,2-Isobutylcyclohexan-1-one,CC(C)CC1CCCCC1=O,,,,,,
7320,107321,Diethyl methylsuccinate,CCOC(=O)CC(C)C(=O)OCC,,,,,,
7321,107322,CID 107322,CCCCCCCOC(=O)CC(C(=O)OCCCCCCC)S(=O)(=O)[O-].[Na+],,,,,,
7322,107323,"2-Sulfosuccinic acid 1,4-diheptyl ester",CCCCCCCOC(=O)CC(C(=O)OCCCCCCC)S(=O)(=O)O,,,,,,
7323,107324,"2,4,4-Trimethylcyclopentanone",CC1CC(CC1=O)(C)C,,,,,,
7324,107325,"1-(Biphenyl-4-yloxy)-2,3-epoxypropane",C1C(O1)COC2=CC=C(C=C2)C3=CC=CC=C3,,,,,,
7325,107326,"1,4-Dioxanyl hydroperoxide",C1COC(CO1)OO,,,,,,
7326,107327,Cyclopentadecanol,C1CCCCCCCC(CCCCCC1)O,,,,,,
7327,107328,"1,2,6-Trimethylpiperidine",CC1CCCC(N1C)C,,,,,,
7328,107329,"2,6-Dimethyl-1,3-dioxan-4-ol",CC1CC(OC(O1)C)O,,,,,,
7329,107330,"Bicyclo[3.1.1]heptane-2-ethanol, 6,6-dimethyl-",CC1(C2CCC(C1C2)CCO)C,,,,,,
7330,107331,"6-Methylcyclohexa-1,3-diene-1-carbaldehyde",CC1CC=CC=C1C=O,,,,,,
7331,107332,Methyl 2-chloroacetoacetate,CC(=O)C(C(=O)OC)Cl,,,,,,
7332,107333,"1-(2,3-Dihydro-1,1,2,3,3-pentamethyl-1H-inden-5-yl)ethan-1-one",CC1C(C2=C(C1(C)C)C=C(C=C2)C(=O)C)(C)C,,,,,,
7333,107334,Cyclamen alcohol,CC(C)C1=CC=C(C=C1)CC(C)CO,,,,,,
7334,107335,2-(4-Amino-2-chlorophenyl)-2-phenylacetonitrile,C1=CC=C(C=C1)C(C#N)C2=C(C=C(C=C2)N)Cl,,,,,,
7335,107336,"But-2-enedioic acid;1-(2-chloro-5,6-dihydrobenzo[b][1]benzothiepin-6-yl)-4-methylpiperazine",CN1CCN(CC1)C2CC3=C(C=C(C=C3)Cl)SC4=CC=CC=C24.C(=CC(=O)O)C(=O)O,,,,,,
7336,107337,"1-(2-Chloro-5,6-dihydrobenzo[b][1]benzothiepin-6-yl)-4-methylpiperazine",CN1CCN(CC1)C2CC3=C(C=C(C=C3)Cl)SC4=CC=CC=C24,,,,,,
7337,107338,"Ethyl octahydrospiro(4,7-methano-5H-indene-5,2'-oxirane)-3'-carboxylate",CCOC(=O)C1C2(O1)CC3CC2C4C3CCC4,,,,,,
7338,107339,"Octahydro-4,7-methano-1H-indene-5-carbaldehyde",C1CC2C(C1)C3CC2CC3C=O,,,,,,
7339,107340,"1,5-Bis(2,3-epoxypropoxy)-2,2,3,3,4,4-hexafluoropentane",C1C(O1)COCC(C(C(COCC2CO2)(F)F)(F)F)(F)F,,,,,,
7340,107341,2-(4-Chlorophenyl)propan-1-amine,CC(CN)C1=CC=C(C=C1)Cl,,,,,,
7341,107342,Hexestrol dipropionate,CCC(C1=CC=C(C=C1)OC(=O)CC)C(CC)C2=CC=C(C=C2)OC(=O)CC,,,,,,
7342,107343,2-Chlorocyclooctanone,C1CCCC(=O)C(CC1)Cl,,,,,,
7343,107344,Calcium 2-hydroxy-4-(methylthio)butanoate,CSCCC(C(=O)[O-])O.CSCCC(C(=O)[O-])O.[Ca+2],,,,,,
7344,107345,"Methyl 2,4-dichloro-3-oxobutyrate",COC(=O)C(C(=O)CCl)Cl,,,,,,
7345,107346,2-Phenyl-3-(1-pyrrolidinyl)propiophenone hydrochloride,C1CCN(C1)CC(C2=CC=CC=C2)C(=O)C3=CC=CC=C3.Cl,,,,,,
7346,107347,"1,2-Diphenyl-3-pyrrolidin-1-ylpropan-1-one",C1CCN(C1)CC(C2=CC=CC=C2)C(=O)C3=CC=CC=C3,,,,,,
7347,107348,"[1,1'-Bicyclopentyl]-2-ol",C1CCC(C1)C2CCCC2O,,,,,,
7348,107349,"Bicyclo[3.1.1]hept-2-ene, 3,6,6-trimethyl-",CC1=CC2CC(C1)C2(C)C,,,,,,
7349,107350,"Phenethylamine, N-dimethylamino-alpha-methyl-, hydrochloride",CC(CC1=CC=CC=C1)NN(C)C.Cl,,,,,,
7350,107351,Hooker hrs-1879,CCOP(=O)(OCC)SC1CCS(=O)(=O)C1Cl,,,,,,
7351,107352,"2,2'-Thiodisuccinic acid",C(C(C(=O)O)SC(CC(=O)O)C(=O)O)C(=O)O,,,,,,
7352,107353,"N-acetyl-N-[(2-phenyl-2,3-dihydrochromen-4-ylidene)amino]acetamide",CC(=O)N(C(=O)C)N=C1CC(OC2=CC=CC=C12)C3=CC=CC=C3,,,,,,
7353,107354,2-Methyl-2-phenylheptan-4-ol,CCCC(CC(C)(C)C1=CC=CC=C1)O,,,,,,
7354,107355,5-Cyclohexyl-5-methylhexan-3-ol,CCC(CC(C)(C)C1CCCCC1)O,,,,,,
7355,107356,"Cyclohexanepropanol, alpha,gamma,gamma,4-tetramethyl-",CC1CCC(CC1)C(C)(C)CC(C)O,,,,,,
7356,107357,"(2,2-Dimethyl-1,3-dioxolan-4-yl)methyl anthranilate",CC1(OCC(O1)COC(=O)C2=CC=CC=C2N)C,,,,,,
7357,107358,CID 107358,CCCCC(CC)COP(=O)([O-])OCC(CC)CCCC.[K+],,,,,,
7358,107359,"1,4-Bis(1,1-dimethyl-3-hydroxy-3-morpholinyl)benzene, dibromide",C[N+]1(CCOC(C1)(C2=CC=C(C=C2)C3(C[N+](CCO3)(C)C)O)O)C.[Br-].[Br-],,,,,,
7359,107360,"2-[4-(2-Hydroxy-4,4-dimethylmorpholin-4-ium-2-yl)phenyl]-4,4-dimethylmorpholin-4-ium-2-ol",C[N+]1(CCOC(C1)(C2=CC=C(C=C2)C3(C[N+](CCO3)(C)C)O)O)C,,,,,,
7360,107361,4-(Diisopropylamino)-2-phenyl-2-(pyridin-2-YL)butanenitrile,CC(C)N(CCC(C#N)(C1=CC=CC=C1)C2=CC=CC=N2)C(C)C,,,,,,
7361,107362,5-Methyl-5-phenylhexan-3-ol,CCC(CC(C)(C)C1=CC=CC=C1)O,,,,,,
7362,107363,Bicyclo[3.2.1]octan-2-one,C1CC2CC1CCC2=O,,,,,,
7363,107364,N-[3-(2-Hydroxy-2-phenylethyl)-2-thiazolidinylidene]acetamide,CC(=O)N=C1N(CCS1)CC(C2=CC=CC=C2)O,,,,,,
7364,107365,1-(2-Benzylphenoxy)propan-2-ol,CC(COC1=CC=CC=C1CC2=CC=CC=C2)O,,,,,,
7365,107366,2-Acetyl-5-norbornene,CC(=O)C1CC2CC1C=C2,,,,,,
7366,107367,"Disodium 2,5-dichloro-4-[4-[[5-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-2-sulphonatophenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonate",CC1=NN(C(=O)C1N=NC2=C(C=CC(=C2)NC3=NC(=NC(=N3)Cl)Cl)S(=O)(=O)[O-])C4=CC(=C(C=C4Cl)S(=O)(=O)[O-])Cl.[Na+].[Na+],,,,,,
7367,107368,"2,5-Dichloro-4-[[4-[[5-[(4,6-dichloro-1,3,5-triazin-2-yl)amino]-2-sulfophenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol]-1-yl]benzenesulfonic acid",CC1=NN(C(=O)C1N=NC2=C(C=CC(=C2)NC3=NC(=NC(=N3)Cl)Cl)S(=O)(=O)O)C4=CC(=C(C=C4Cl)S(=O)(=O)O)Cl,,,,,,
7368,107369,"Quinoline, 1-ethyl-1,2,3,4-tetrahydro-2,2,4-trimethyl-",CCN1C2=CC=CC=C2C(CC1(C)C)C,,,,,,
7369,107370,"3-(o-Chlorophenoxy)-1,2-propanediol",C1=CC=C(C(=C1)OCC(CO)O)Cl,,,,,,
7370,107371,"3-(2,4,6-Trichlorophenoxy)propane-1,2-diol",C1=C(C=C(C(=C1Cl)OCC(CO)O)Cl)Cl,,,,,,
7371,107372,"2-Cyclohexen-1-one, 5-methyl-2-(1-methylethyl)-",CC1CC=C(C(=O)C1)C(C)C,,,,,,
7372,107373,"1,2,3-Tris(2,3-epoxypropoxy)benzene",C1C(O1)COC2=C(C(=CC=C2)OCC3CO3)OCC4CO4,,,,,,
7373,107374,2-Ethylhexyl nonyl sebacate,CCCCCCCCCOC(=O)CCCCCCCCC(=O)OCC(CC)CCCC,,,,,,
7374,107375,4-Bromoacetoxymethyl-m-dioxolane,C1C(OCO1)COC(=O)CBr,,,,,,
7375,107376,"2,5-Dimercaptohexanedioic acid",C(CC(C(=O)O)S)C(C(=O)O)S,,,,,,
7376,107377,2-Ethylhexyl 4-hydroxybenzoate,CCCCC(CC)COC(=O)C1=CC=C(C=C1)O,,,,,,
7377,107378,"2,2,4-Trimethyl-3-pentanol",CC(C)C(C(C)(C)C)O,,,,,,
7378,107379,"Dimethyl (4-methyl-1,3-dithiolan-2-ylidene)phosphoramidothioate",CC1CSC(=NP(=S)(OC)OC)S1,,,,,,
7379,107380,"1,2-Bis(4-hydroxyphenyl)ethane-1,2-diol",C1=CC(=CC=C1C(C(C2=CC=C(C=C2)O)O)O)O,,,,,,
7380,107381,"2,4,6-Trimethyl-4-phenyl-1,3-dioxane",CC1CC(OC(O1)C)(C)C2=CC=CC=C2,,,,,,
7381,107382,"Cyclododeca-5,9-diene-1,2-diol",C1CC=CCCC(C(CCC=C1)O)O,,,,,,
7382,107383,trans-1-(2-Methylcyclohexyl)ethan-1-one,C[C@@H]1CCCC[C@H]1C(=O)C,,,,,,
7383,107384,"1,2-Diphenylbutane",CCC(CC1=CC=CC=C1)C2=CC=CC=C2,,,,,,
7384,107385,2-Methylvaleryl chloride,CCCC(C)C(=O)Cl,,,,,,
7385,107386,"1-(5-Pyrrolidin-1-ium-1-ylidenepenta-1,3-dienyl)pyrrolidine;perchlorate",C1CCN(C1)C=CC=CC=[N+]2CCCC2.[O-]Cl(=O)(=O)=O,,,,,,
7386,107387,"1-(5-Pyrrolidin-1-ium-1-ylidenepenta-1,3-dienyl)pyrrolidine",C1CCN(C1)C=CC=CC=[N+]2CCCC2,,,,,,
7387,107388,4-(4-Methylphenyl)but-3-en-2-one,CC1=CC=C(C=C1)C=CC(=O)C,,,,,,
7388,107389,"4-(2,6-Dimethoxy-4-pentylphenyl)but-3-en-2-one",CCCCCC1=CC(=C(C(=C1)OC)C=CC(=O)C)OC,,,,,,
7389,107390,"Cholesta-1,4,6-trien-3-one",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=CC4=CC(=O)C=C[C@]34C)C,,,,,,
7390,107391,"Piperidine, 1-methyl-3-(thioxanthen-9-ylidenemethyl)-, hydrochloride",CN1CCC(CC1)C=C2C3=CC=CC=C3SC4=CC=CC=C42.Cl,,,,,,
7391,107392,1-Methyl-4-(thioxanthen-9-ylidenemethyl)piperidine,CN1CCC(CC1)C=C2C3=CC=CC=C3SC4=CC=CC=C42,,,,,,
7392,107393,(E)-3-Methyl-2-phenyl-8-(prop-1-enyl)-4H-chromen-4-one,CC=CC1=C2C(=CC=C1)C(=O)C(=C(O2)C3=CC=CC=C3)C,,,,,,
7393,107394,CID 107394,C1=CN(C(=O)NC1=O)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)OP(=O)(O)OC[C@@H]3[C@H]([C@H]([C@@H](O3)N4C=NC5=C4NC(=NC5=O)N)O)O)O,,,,,,
7394,107395,"(20R)-18,20-Epoxy-N,N-dimethyl-5alpha-pregnan-3beta-amine",C[C@@H]1[C@H]2CC[C@@H]3[C@@]2(CC[C@H]4[C@H]3CC[C@@H]5[C@@]4(CC[C@@H](C5)N(C)C)C)CO1,,,,,,
7395,107396,Hexyl 3-phenylprop-2-enoate,CCCCCCOC(=O)C=CC1=CC=CC=C1,,,,,,
7396,107397,"11beta,21-Dihydroxypregna-4,17(20)-dien-3-one",C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2[C@H](C[C@]4([C@H]3CCC4=CCO)C)O,,,,,,
7397,107398,"2,2,4-Trimethylpentenyl 2-methylpropanoate",CC(C)C(=O)OCC(C)(C)C=C(C)C,,,,,,
7398,107399,Ethyl 3-methoxybut-2-enoate,CCOC(=O)C=C(C)OC,,,,,,
7399,107400,"Hepta-1,5-dien-3-yne",CC=CC#CC=C,,,,,,
7400,107401,"3beta,17,21-Trihydroxypregn-5-en-20-one 3,17,21-tri(acetate)",CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OC(=O)C)C)C)OC(=O)C,,,,,,
7401,107402,"3beta,17-Dihydroxypregn-5-en-20-one 3,17-di(acetate)",CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OC(=O)C)C)C)OC(=O)C,,,,,,
7402,107403,Einecs 222-525-6,CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OC(=O)C)C)C)O,,,,,,
7403,107404,Setoglaucine,CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=CC=C3Cl.[Cl-],,,,,,
7404,107405,"4-{(2-Chlorophenyl)[4-(dimethylamino)phenyl]methylidene}-N,N-dimethylcyclohexa-2,5-dien-1-iminium",CN(C)C1=CC=C(C=C1)C(=C2C=CC(=[N+](C)C)C=C2)C3=CC=CC=C3Cl,,,,,,
7405,107406,"1H-Imidazole, 1,1'-(1,2-ethanediyl)bis[2-(8-heptadecenyl)-4,5-dihydro-",CCCCCCCCC=CCCCCCCCC1=NCCN1CCN2CCN=C2CCCCCCCC=CCCCCCCCC,,,,,,
7406,107407,"2-Propenoic acid, 3,3'-(azoxydi-4,1-phenylene)bis-, diethyl ester",CCOC(=O)C=CC1=CC=C(C=C1)N=[N+](C2=CC=C(C=C2)C=CC(=O)OCC)[O-],,,,,,
7407,107408,Adenylyl-(3'-5')-adenosine 3'-monophosphate,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CO)OP(=O)(O)OC[C@@H]4[C@H]([C@H]([C@@H](O4)N5C=NC6=C(N=CN=C65)N)O)OP(=O)(O)O)O)N,,,,,,
7408,107409,"11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 21-(3-cyclopentylpropionate)",C[C@H]1C[C@H]2[C@@H]3CC[C@@]([C@]3(C[C@@H]([C@@H]2[C@@]4(C1=CC(=O)C=C4)C)O)C)(C(=O)COC(=O)CCC5CCCC5)O,,,,,,
7409,107410,8-Chloro-10-[3-(methylamino)propyl]-10h-phenothiazin-3-ol,CNCCCN1C2=C(C=C(C=C2)O)SC3=C1C=C(C=C3)Cl,,,,,,
7410,107411,Dihydrostreptomycin pantothenate,C[C@H]1[C@@]([C@H]([C@@H](O1)O[C@@H]2[C@H]([C@@H]([C@H]([C@@H]([C@H]2O)O)N=C(N)N)O)N=C(N)N)O[C@H]3[C@H]([C@@H]([C@H]([C@@H](O3)CO)O)O)NC)(CO)O.CC(C)(CO)[C@H](C(=O)NCCC(=O)O)O,,,,,,
7411,107412,Beyerene,C[C@]12CC[C@H]3[C@@]4(CCCC([C@H]4CC[C@@]3(C1)C=C2)(C)C)C,,,,,,
7412,107413,Diochin,CC[N+](C)(CC)CCOC(=O)C1CC2CC[N+]1(CC2)C.[I-].[I-],,,,,,
7413,107414,Diethyl-methyl-[2-(1-methyl-1-azoniabicyclo[2.2.2]octane-2-carbonyl)oxyethyl]azanium,CC[N+](C)(CC)CCOC(=O)C1CC2CC[N+]1(CC2)C,,,,,,
7414,107415,CID 107415,C1C2([C@H]([C@@H]([C@H](O2)CO)O)O)OCC3(O1)[C@H]([C@@H]([C@H](O3)CO)O)O,,,,,,
7415,107416,N-[[1-[[4-(Hydroxyiminomethyl)pyridin-1-ium-1-yl]methylsulfanylmethyl]pyridin-1-ium-4-yl]methylidene]hydroxylamine;dichloride,C1=C[N+](=CC=C1C=NO)CSC[N+]2=CC=C(C=C2)C=NO.[Cl-].[Cl-],,,,,,
7416,107417,N-[[1-[[4-(hydroxyiminomethyl)pyridin-1-ium-1-yl]methylsulfanylmethyl]pyridin-1-ium-4-yl]methylidene]hydroxylamine,C1=C[N+](=CC=C1C=NO)CSC[N+]2=CC=C(C=C2)C=NO,,,,,,
7417,107418,N-(4-Hydroxyphenyl)-3-phenyl-2-propenamide,C1=CC=C(C=C1)C=CC(=O)NC2=CC=C(C=C2)O,,,,,,
7418,107419,Diethoxytitanium dichloride,CCO.CCO.Cl[Ti]Cl,,,,,,
7419,107420,"1,3-Dichloro-1,3-dimethyl-1,3-diphenyldisiloxane",C[Si](C1=CC=CC=C1)(O[Si](C)(C2=CC=CC=C2)Cl)Cl,,,,,,
7420,107421,Methandriol dipropionate,CCC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC[C@]4(C)OC(=O)CC)C)C,,,,,,
7421,107422,"17,21-Dihydroxypregn-4-ene-3,11,20-trione 21-heptanoate",CCCCCCC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O,,,,,,
7422,107423,Hydrocortisone caproate,CCCCCC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(C[C@@H]([C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)O)C)O,,,,,,
7423,107424,"17-alpha-Pregn-5-en-20-yne-3-beta,17-beta-diol",C[C@]12CC[C@@H](CC1=CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@]4(C#C)O)C)O,,,,,,
7424,107425,CID 107425,CCC(C)O.CC(C)O.CC(C)O.[AlH3],,,,,,
7425,107426,1-tert-Butoxy-2-methyl-3-buten-2-ol,CC(C)(C)OCC(C)(C=C)O,,,,,,
7426,107427,N-[[1-[3-[4-(hydroxyiminomethyl)pyridin-1-ium-1-yl]propyl]pyridin-1-ium-4-yl]methylidene]hydroxylamine;dichloride,C1=C[N+](=CC=C1C=NO)CCC[N+]2=CC=C(C=C2)C=NO.[Cl-].[Cl-],,,,,,
7427,107428,D-sorbose,C([C@H]([C@@H]([C@H](C(=O)CO)O)O)O)O,,,,,,
7428,107429,D-Cellobiose octaacetate,CC(=O)OC[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)OC(=O)C)OC(=O)C)OC(=O)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)COC(=O)C)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
7429,107430,N-(N-((Phenylmethoxy)carbonyl)-L-phenylalanyl)-L-glutamic acid,C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)O)NC(=O)OCC2=CC=CC=C2,,,,,,
7430,107431,Xylenol Orange tetrasodium,CC1=CC(=CC(=C1O)CN(CC(=O)[O-])CC(=O)[O-])C2(C3=CC=CC=C3OS2(=O)=O)C4=CC(=C(C(=C4)C)O)CN(CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
7431,107432,"2-[[5-[3-[3-[[Bis(carboxymethyl)amino]methyl]-4-hydroxy-5-methylphenyl]-2,2-dioxo-1,2lambda6-benzoxathiol-3-yl]-2-hydroxy-3-methylphenyl]methyl-(carboxymethyl)amino]acetic acid",CC1=CC(=CC(=C1O)CN(CC(=O)O)CC(=O)O)C2(C3=CC=CC=C3OS2(=O)=O)C4=CC(=C(C(=C4)C)O)CN(CC(=O)O)CC(=O)O,,,,,,
7432,107433,Trisodium 8-((4-((4-aminophenyl)azo)-6-sulphonatonaphthyl)azo)-5-((2-hydroxy-6-sulphonatonaphthyl)azo)naphthalene-2-sulphonate,C1=CC(=CC=C1N)N=NC2=C3C=C(C=CC3=C(C=C2)N=NC4=C5C=C(C=CC5=C(C=C4)N=NC6=C(C=CC7=C6C=CC(=C7)S(=O)(=O)[O-])O)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
7433,107434,8-[2-[4-[2-(4-Aminophenyl)diazenyl]-6-sulfo-1-naphthalenyl]diazenyl]-5-[2-(2-hydroxy-6-sulfo-1-naphthalenyl)diazenyl]-2-naphthalenesulfonic acid,C1=CC(=CC=C1N)N=NC2=C3C=C(C=CC3=C(C=C2)N=NC4=C5C=C(C=CC5=C(C=C4)N=NC6=C(C=CC7=C6C=CC(=C7)S(=O)(=O)O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
7434,107435,1-(1-Piperidinyl)-2-buten-1-one,CC=CC(=O)N1CCCCC1,,,,,,
7435,107436,"2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-3-(cyanomethyl)-6,11-dimethyl-",CC1C2CC3=C(C1(CCN2CC#N)C)C=C(C=C3)O,,,,,,
7436,107437,Oestr-4-en-17-one,C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=CCCC[C@H]34,,,,,,
7437,107438,"1,5-Benzothiazepin-4(5H)one, 2,3-dihydro-7-methyl-, 1,1-dioxide",CC1=CC2=C(C=C1)S(=O)(=O)CCC(=O)N2,,,,,,
7438,107439,D-Glucose ethylenedithioacetal,C1CSC(S1)[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O,,,,,,
7439,107440,CID 107440,C1=CC2=C(C=CN=C2C(=C1)Cl)C=NN=C(N)S,,,,,,
7440,107441,"1,5-Bis(4-hydroxyphenyl)-1,4-pentadien-3-one",C1=CC(=CC=C1C=CC(=O)C=CC2=CC=C(C=C2)O)O,,,,,,
7441,107442,"4-[2-[4-[5-(4-Chlorophenyl)-3,4-dihydropyrazol-2-yl]phenyl]sulfonylethoxy]-4-oxobut-2-enoic acid",C1CN(N=C1C2=CC=C(C=C2)Cl)C3=CC=C(C=C3)S(=O)(=O)CCOC(=O)C=CC(=O)O,,,,,,
7442,107443,(3-(Decylthio)-2-hydroxypropyl)trimethylammonium p-toluenesulphonate,CCCCCCCCCCSCC(C[N+](C)(C)C)O.CC1=CC=C(C=C1)S(=O)(=O)[O-],,,,,,
7443,107444,[3-(Decylthio)-2-hydroxypropyl]trimethylaminium,CCCCCCCCCCSCC(C[N+](C)(C)C)O,,,,,,
7444,107445,Methyl 3-acetyloxybut-2-enoate,CC(=CC(=O)OC)OC(=O)C,,,,,,
7445,107446,Glucose 6-(disodium phosphate),C([C@@H]([C@H]([C@@H]([C@H](C=O)O)O)O)O)OP(=O)([O-])[O-].[Na+].[Na+],,,,,,
7446,107447,Boc-Phe-OSu,CC(C)(C)OC(=O)N[C@@H](CC1=CC=CC=C1)C(=O)ON2C(=O)CCC2=O,,,,,,
7447,107448,Direct Red 26,COC1=CC=CC=C1N=NC2=C(C=C3C=C(C=CC3=C2O)NC(=O)NC4=CC5=CC(=C(C(=C5C=C4)O)N=NC6=CC=C(C7=CC=CC=C76)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
7448,107449,Direct Red 26 free acid,COC1=CC=CC=C1N=NC2=C(C=C3C=C(C=CC3=C2O)NC(=O)NC4=CC5=CC(=C(C(=C5C=C4)O)N=NC6=CC=C(C7=CC=CC=C76)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
7449,107450,"1,3-Bis[4-(hydroxyiminomethyl)pyridin-1-ium-1-yl]propan-2-one;dibromide",C1=C[N+](=CC=C1C=NO)CC(=O)C[N+]2=CC=C(C=C2)C=NO.[Br-].[Br-],,,,,,
7450,107451,"1,3-Bis[4-(hydroxyiminomethyl)pyridin-1-ium-1-yl]propan-2-one",C1=C[N+](=CC=C1C=NO)CC(=O)C[N+]2=CC=C(C=C2)C=NO,,,,,,
7451,107452,Einecs 222-991-0,C([C@@H]1[C@H]([C@@H]([C@](O1)(CO)OC[C@@H]2[C@H]([C@@H]([C@H](C(O2)O[C@]3([C@H]([C@@H]([C@H](O3)CO)O)O)CO)O)O)O)O)O)O,,,,,,
7452,107453,"1,1-Bis(p-anisyl)-2-(p-guanylphenyl)ethylene hydrochloride",COC1=CC=C(C=C1)C(=CC2=CC=C(C=C2)C(=N)N)C3=CC=C(C=C3)OC.Cl,,,,,,
7453,107454,"4-[2,2-Bis(4-methoxyphenyl)ethenyl]benzenecarboximidamide",COC1=CC=C(C=C1)C(=CC2=CC=C(C=C2)C(=N)N)C3=CC=C(C=C3)OC,,,,,,
7454,107455,"4-Thiazolidinone, 5-[[4-(dimethylamino)phenyl]methylene]-3-propyl-2-thioxo-",CCCN1C(=O)C(=CC2=CC=C(C=C2)N(C)C)SC1=S,,,,,,
7455,107456,"Ethanone, 1-phenyl-, 2,2-diphenylhydrazone",CC(=NN(C1=CC=CC=C1)C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
7456,107457,"Acetamide, n-[(3-ethyl-4-oxo-2-thioxo-5-thiazolidinylidene)methyl]-n-phenyl-",CCN1C(=O)C(=CN(C2=CC=CC=C2)C(=O)C)SC1=S,,,,,,
7457,107458,"Methyl 3-alpha,7-alpha-diacetoxy-12-alpha-hydroxy-5-beta-cholan-24-oate",C[C@H](CCC(=O)OC)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)OC(=O)C)C)OC(=O)C)O)C,,,,,,
7458,107459,"17,21-Dihydroxy-5alpha-pregnane-3,11,20-trione 21-acetate",CC(=O)OCC(=O)[C@]1(CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4[C@@]3(CCC(=O)C4)C)C)O,,,,,,
7459,107460,2-[4-[2-(2-Benzoxazolyl)ethenyl]phenyl]-5-methylbenzoxazole,CC1=CC2=C(C=C1)OC(=N2)C3=CC=C(C=C3)C=CC4=NC5=CC=CC=C5O4,,,,,,
7460,107461,N4-Acetylcytidine,CC(=O)NC1=NC(=O)N(C=C1)[C@H]2[C@@H]([C@@H]([C@H](O2)CO)O)O,,,,,,
7461,107462,"1-Naphthalenesulfonyl chloride, 6-diazo-5,6-dihydro-5-oxo-",C1=CC2=C(C=CC(=C2[O-])[N+]#N)C(=C1)S(=O)(=O)Cl,,,,,,
7462,107463,5-(Chlorosulfonyl)-1-hydroxy-2-naphthalenediazonium,C1=CC2=C(C=CC(=C2O)[N+]#N)C(=C1)S(=O)(=O)Cl,,,,,,
7463,107464,"Pyridinium, 2-[2-[4-(dimethylamino)phenyl]ethenyl]-1-ethyl-, iodide",CC[N+]1=CC=CC=C1C=CC2=CC=C(C=C2)N(C)C.[I-],,,,,,
7464,107465,2-[2-[4-(2-Benzoxazolyl)phenyl]ethenyl]-5-methylbenzoxazole,CC1=CC2=C(C=C1)OC(=N2)C=CC3=CC=C(C=C3)C4=NC5=CC=CC=C5O4,,,,,,
7465,107466,CID 107466,C1C(=O)N=C(N1N=CC2=CC=C(O2)[N+](=O)[O-])S,,,,,,
7466,107467,Acetic acid;octadec-9-en-1-amine,CCCCCCCCC=CCCCCCCCCN.CC(=O)O,,,,,,
7467,107468,Ethyl L-lysinate dihydrochloride,CCOC(=O)[C@H](CCCCN)N.Cl.Cl,,,,,,
7468,107469,Ethyl L-lysinate,CCOC(=O)[C@H](CCCCN)N,,,,,,
7469,107470,CID 107470,CCCCCCCCC=CCCCCCCCC(=O)O.CCCCCCCCC=CCCCCCCCC(=O)O.C[Sn]C,,,,,,
7470,107471,"(1R,9S,10R)-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2,4,6-triene",CN1CC[C@]23CCCC[C@H]2[C@@H]1CC4=CC=CC=C34,,,,,,
7471,107472,Z-Glu(OtBu)-OH,CC(C)(C)OC(=O)CC[C@@H](C(=O)O)NC(=O)OCC1=CC=CC=C1,,,,,,
7472,107473,"1-Propanaminium, 2-hydroxy-N,N,N-trimethyl-3-(octylthio)-, 4-methylbenzenesulfonate (1:1)",CCCCCCCCSCC(C[N+](C)(C)C)O.CC1=CC=C(C=C1)S(=O)(=O)[O-],,,,,,
7473,107474,"N,N,N-Trimethyl-2-hydroxy-3-(octylthio)-1-propanaminium",CCCCCCCCSCC(C[N+](C)(C)C)O,,,,,,
7474,107475,Val-val,CC(C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)N,,,,,,
7475,107476,"Choline, methanesulfonate (ester)",C[N+](C)(C)CCOS(=O)(=O)C,,,,,,
7476,107477,"6alpha,9-Difluoro-11beta,21-dihydroxy-16alpha,17-(isopropylidenedioxy)pregn-4-ene-3,20-dione 21-acetate",CC(=O)OCC(=O)[C@@]12[C@@H](C[C@@H]3[C@@]1(C[C@@H]([C@]4([C@H]3C[C@@H](C5=CC(=O)CC[C@@]54C)F)F)O)C)OC(O2)(C)C,,,,,,
7477,107478,CID 107478,C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COC(=O)C5=CC(=CC=C5)S(=O)(=O)[O-])O)C)O)F)C.[Na+],,,,,,
7478,107479,Methyl 1-benzyl-4-oxopiperidine-3-carboxylate hydrochloride,COC(=O)C1CN(CCC1=O)CC2=CC=CC=C2.Cl,,,,,,
7479,107480,Methyl 1-benzyl-4-oxopiperidine-3-carboxylate,COC(=O)C1CN(CCC1=O)CC2=CC=CC=C2,,,,,,
7480,107481,Setocyanine,CCNC1=C(C=C(C=C1)C(=C2C=CC(=NCC)C(=C2)C)C3=CC=CC=C3Cl)C.Cl,,,,,,
7481,107482,"4-[(2-Chlorophenyl)[4-(ethylimino)-3-methyl-2,5-cyclohexadien-1-ylidene]methyl]-N-ethyl-2-methylaniline",CCNC1=C(C=C(C=C1)C(=C2C=CC(=NCC)C(=C2)C)C3=CC=CC=C3Cl)C,,,,,,
7482,107483,"(20S)-17,20,21-Trihydroxypregn-4-en-3-one",C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@]4([C@H](CO)O)O)C,,,,,,
7483,107484,"Estr-5(10)-ene-3,17-dione",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2=O)CCC4=C3CCC(=O)C4,,,,,,
7484,107485,"Methyl 8-[(1s,2r)-2-octylcyclopropyl]octanoate",CCCCCCCC[C@@H]1C[C@@H]1CCCCCCCC(=O)OC,,,,,,
7485,107486,CID 107486,CCOC(C=CC=CC(OCC)OCC)OCC,,,,,,
7486,107487,N-L-Valyl-L-leucine,CC(C)C[C@@H](C(=O)O)NC(=O)[C@@H](C(C)C)N,,,,,,
7487,107488,2'-Deoxycytidine hydrochloride,C1[C@@H]([C@H](O[C@H]1N2C=CC(=NC2=O)N)CO)O.Cl,,,,,,
7488,107489,Einecs 223-651-4,CC(=O)O[C@H]1COC2(CCCC2)O[C@@]13CC[C@@H]4[C@@]3(CC(=O)[C@H]5[C@H]4CCC6=CC(=O)C=C[C@]56C)C,,,,,,
7489,107490,"2-(8-Heptadecen-1-yl)-N-[2-[2-(8-heptadecen-1-yl)-4,5-dihydro-1H-imidazol-1-yl]ethyl]-4,5-dihydro-1H-imidazole-1-ethanamine",CCCCCCCCC=CCCCCCCCC1=NCCN1CCNCCN2CCN=C2CCCCCCCC=CCCCCCCCC,,,,,,
7490,107491,"(1alpha,3beta,4alpha,6alpha)-4,7,7-Trimethylbicyclo[4.1.0]heptan-3-ol",C[C@@H]1C[C@@H]2[C@@H](C2(C)C)C[C@H]1O,,,,,,
7491,107492,"(1R-(1alpha,3alpha,4alpha,6alpha))-4,7,7-Trimethylbicyclo(4.1.0)heptan-3-ol",C[C@@H]1C[C@@H]2[C@@H](C2(C)C)C[C@@H]1O,,,,,,
7492,107493,"(1R-(1alpha,3beta,4beta,6alpha))-4,7,7-Trimethylbicyclo(4.1.0)heptan-3-ol",C[C@@H]1C[C@H]2[C@H](C2(C)C)C[C@@H]1O,,,,,,
7493,107494,CID 107494,CCCC[SnH](CCCC)CCCC.C(=CC(=O)O)C(=O)O,,,,,,
7494,107495,"Ethyl 2,2-dimethyl-4,6-dioxocyclohexanecarboxylate",CCOC(=O)C1C(=O)CC(=O)CC1(C)C,,,,,,
7495,107496,Penicillin G sulfoxide,CC1([C@@H](N2[C@H](S1=O)[C@@H](C2=O)NC(=O)CC3=CC=CC=C3)C(=O)O)C,,,,,,
7496,107497,17beta-Hydroxy-1alpha-methyl-5-alphaandrostan-3-one acetate,C[C@H]1CC(=O)C[C@H]2[C@]1([C@H]3CC[C@]4([C@H]([C@@H]3CC2)CC[C@@H]4OC(=O)C)C)C,,,,,,
7497,107498,(S)-3-Amino-4-ethoxy-4-oxobutanoic acid,CCOC(=O)[C@H](CC(=O)O)N,,,,,,
7498,107499,"1,4,6-Androstatrien-3-one-17beta-ol",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)C=CC4=CC(=O)C=C[C@]34C,,,,,,
7499,107500,"Ethenesulfonyl chloride, 2-phenyl-",C1=CC=C(C=C1)C=CS(=O)(=O)Cl,,,,,,
7500,107501,Clomestrone,C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H](C2=O)Cl)CCC4=C3C=CC(=C4)OC,,,,,,
7501,107502,5'-Iodo-5'-deoxyadenosine,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)CI)O)O)N,,,,,,
7502,107503,Methyl 4-{[(e)-(4-methoxyphenyl)methylidene]amino}benzoate,COC1=CC=C(C=C1)C=NC2=CC=C(C=C2)C(=O)OC,,,,,,
7503,107504,"Cholesta-2,4-diene",C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC=CC[C@]34C)C,,,,,,
7504,107505,CID 107505,CC1=C(C2=C(C=C1)N=C(S2)C3=CC4=C(C=C3)N=C(C=C4)C5C(=O)C6=CC=CC=C6C5=O)S(=O)(=O)[O-].[Na+],,,,,,
7505,107506,N-Benzyloxycarbonyl-L-glutamic anhydride,C1CC(=O)OC(=O)C1NC(=O)OCC2=CC=CC=C2,,,,,,
7506,107507,Non-3-enoic acid,CCCCCC=CCC(=O)O,,,,,,
7507,107508,Ethyl 1-thio-alpha-D-glucofuranoside,CCS[C@@H]1[C@@H]([C@H]([C@H](O1)[C@@H](CO)O)O)O,,,,,,
7508,107509,"3-[(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-3-oxo-2,8,9,11,12,14,15,16-octahydro-1H-cyclopenta[a]phenanthren-17-yl]propanoic acid",C[C@]12CCC(=O)C=C1C=C[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@]4(CCC(=O)O)O)C,,,,,,
7509,107510,18-Norestrone methyl ether,COC1=CC2=C(C=C1)[C@H]3CCC4[C@H]([C@@H]3CC2)CCC4=O,,,,,,
7510,107511,CID 107511,CC1(C2CCC1(C(=O)C2C(=O)O)C)C.CC1(C2CCC1(C(=O)C2C(=O)O)C)C.CC1(C2CCC1(C(=O)C2C(=O)O)C)C.O.O.[BiH3].[BiH3],,,,,,
7511,107512,Cinnamalacetone,CC(=O)C=CC=CC1=CC=CC=C1,,,,,,
7512,107513,"3H-Pyrazol-3-one, 2,4-dihydro-5-methyl-2-phenyl-4-[(phenylamino)methylene]-",CC1=C(C(=O)N(N1)C2=CC=CC=C2)C=NC3=CC=CC=C3,,,,,,
7513,107514,"(1R-(1alpha,4beta,6beta))-4,7,7-Trimethylbicyclo(4.1.0)heptan-3-one",C[C@@H]1C[C@H]2[C@H](C2(C)C)CC1=O,,,,,,
7514,107515,"(1R-(1alpha,4alpha,6alpha)-4,7,7-Trimethylbicyclo(4.1.0)heptan-3-one",C[C@H]1C[C@H]2[C@H](C2(C)C)CC1=O,,,,,,
7515,107516,"2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9-Hexadecafluorononyl acrylate",C=CC(=O)OCC(C(C(C(C(C(C(C(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
7516,107517,CID 107517,C(C=C(CO)S(=O)(=O)[O-])O.[Na+],,,,,,
7517,107518,"(E)-1,4-dihydroxybut-2-ene-2-sulfonic acid",C(/C=C(\CO)/S(=O)(=O)O)O,,,,,,
7518,107519,"Phenol, 2-methoxy-4-(1-propenyl)-, benzoate",CC=CC1=CC(=C(C=C1)OC(=O)C2=CC=CC=C2)OC,,,,,,
7519,107520,(R)-2-Chlorosuccinic acid,C([C@H](C(=O)O)Cl)C(=O)O,,,,,,
7520,107521,Galactose 6-(barium phosphate),C([C@H]([C@@H]([C@@H]([C@H](C=O)O)O)O)O)OP(=O)([O-])[O-].[Ba+2],,,,,,
7521,107522,CID 107522,C(C([C@@H]([C@@H]([C@H](C=O)O)O)O)O)OP(=O)(O)O,,,,,,
7522,107523,"6-Chloro-9beta,10alpha-pregna-4,6-diene-3,20-dione",CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)CC[C@]34C)Cl)C,,,,,,
7523,107524,"1-[3,5-Dimethyl-4-(3-phenylprop-2-enyl)piperazin-1-yl]propan-1-one",CCC(=O)N1CC(N(C(C1)C)CC=CC2=CC=CC=C2)C,,,,,,
7524,107525,"1-[2,6-Dimethyl-4-(3-phenylprop-2-enyl)piperazin-1-yl]propan-1-one",CCC(=O)N1C(CN(CC1C)CC=CC2=CC=CC=C2)C,,,,,,
7525,107526,"(2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal",C([C@H]([C@H]([C@@H]([C@H](C=O)O)O)O)O)O,"['Glucose pharmaceutical formulations (oral tablets, injections) are indicated for caloric supply and carbohydrate supplementation in case of nutrient deprivation. It is also used for metabolic disorders such as hypoglycemia.']","[""Blood glucose is an obligatory energy source for humans involved in various cellular activities, and it also acts as a signaling molecule for diverse glucose-sensing molecules and proteins. Glucose undergoes oxidation into carbon dioxide, water, and yields energy molecules in the process of glycolysis and subsequent citric cycle and oxidative phosphorylation. Glucose is readily converted into fat in the body which can be used as a source of energy as required. Under a similar conversion into storage of energy, glucose is stored in the liver and muscles as glycogen. Glucose stores are mobilized in a regulated manner, depending on the tissues' metabolic demands. Oral glucose tablets or injections serve to increase the supply of glucose and oral glucose administration is more effective in stimulating insulin secretion because it stimulates the incretin hormones from the gut, which promotes insulin secretion.""]","['Substances that sweeten food, beverages, medications, etc., such as sugar, saccharine or other low-calorie synthetic products. (From Random House Unabridged Dictionary, 2d ed) (See all compounds classified as Sweetening Agents.)']","['Polysaccharides can be broken down into smaller units by pancreatic and intestinal glycosidases or intestinal flora. Sodium-dependent glucose transporter SGLT1 and GLUT2 (SLC2A2) play predominant roles in intestinal transport of glucose into the circulation. SGLT1 is located in the apical membrane of the intestinal wall while GLUT2 is located in the basolateral membrane, but it was proposed that GLUT2 can be recruited into the apical membrane after a high luminal glucose bolus allowing bulk absorption of glucose by facilitated diffusion. Oral preparation of glucose reaches the peak concentration within 40 minutes and the intravenous infusions display 100% bioavailability.', 'Glucose can be renally excreted.', 'The mean volume of distribution after intravenous infusion is 10.6L.', 'The mean metabolic clearance rate of glucose (MCR) for the 10 subjects studied at the higher insulin level was 2.27 ± 0.37 ml/kg/min at euglycemia and fell to 1.51±0.21 ml/kg/ at hyperglycemia. The mean MCR for the six subjects studied at the lower insulin level was 1.91 ± 0.31 ml/kg/min at euglycemia.', 'Members of the IL-6 family, IL-6 and ciliary neurotrophic factor (CNTF), have been shown to increase glucose uptake and fatty acid oxidation in skeletal muscle. However, the metabolic effects of another family member, leukemia inhibitory factor (LIF), are not well characterized. Effects of LIF on skeletal muscle glucose uptake and palmitate oxidation and signaling were investigated in ex vivo incubated mouse soleus and EDL muscles from muscle-specific AMPKalpha2 kinase-dead, muscle-specific SOCS3 knockout, and lean and high-fat-fed mice. Inhibitors were used to investigate involvement of specific signaling pathways. LIF increased muscle glucose uptake in dose (50-5,000 pM/l) and time-dependent manners with maximal effects at the 30-min time point. LIF increased Akt Ser(473) phosphorylation (P) in soleus and EDL, whereas AMPK Thr(172) P was unaffected. Incubation with parthenolide abolished LIF-induced glucose uptake and STAT3 Tyr(705) P, whereas incubation with LY-294002 and wortmannin suppressed both basal and LIF-induced glucose uptake and Akt Ser(473) P, indicating that JAK and PI 3-kinase signaling is required for LIF-stimulated glucose uptake. Incubation with rapamycin and AZD8055 indicated that mammalian target of rapamycin complex (mTORC)2, but not mTORC1, also is required for LIF-stimulated glucose uptake. In contrast to CNTF, LIF stimulation did not alter palmitate oxidation. LIF-stimulated glucose uptake was maintained in EDL from obese insulin-resistant mice, whereas soleus developed LIF resistance. Lack of SOCS3 and AMPKalpha2 did not affect LIF-stimulated glucose uptake. In conclusion, LIF acutely increased muscle glucose uptake by a mechanism potentially involving the PI 3-kinase/mTORC2/Akt pathway and is not impaired in EDL muscle from obese insulin-resistant mice.', 'The aim of the work is to analyze the relationship between consumption of glucose solution by rats and its absorption, and to use this fact for assessment of the absorptive capacity of the small intestine in non anesthetized animals in vivo. Consumption of glucose solution (200 g/L) by fasted rats was recorded in the control, and after administration of phloridzin--inhibitor of glucose active transport- or 3 hours after the restriction stress. On the mathematical model we studied the relative role of factors that can influence the temporal dynamics of glucose consumption by rats. The rate of glucose consumption was observed being decreased in the presence of phloridzin (1 mM), and be increased after the stress. The results of modeling are consistent with the experimental data and show that the rate of consumption of glucose solutions considerably more depends on the transport activity of the small intestine than on glucose concentration in the solution, or on the substrate regulation of the stomach emptying. Analysis of dynamics of consumption of glucose solution by intact rats may be considered as one of promising approaches to assessing the absorptive capacity of the small intestine under natural conditions.', 'Facilitated diffusion involves carrier substance within placenta, which acts to incr rate of transfer beyond that which would be expected... glucose is apparently transferred in this manner. ...No metabolic energy may be required, & transfer is in direction of concn gradient.', 'When excesses are given IV blood sugar values usually return near normal within an hour or two, most of excess having been eliminated through kidneys, & CA 40% dialyzes into tissues with small amt destroyed by oxidation.', 'For more Absorption, Distribution and Excretion (Complete) data for D(+)-Glucose (6 total), please visit the HSDB record page.']","['Glucose can undergo aerobic oxidation in conjunction with the synthesis of energy molecules. Glycolysis is the initial stage of glucose metabolism where one glucose molecule is degraded into two molecules of pyruvate via substrate-level phosphorylation. These products are transported to the mitochondria where they are further oxidized into oxygen and carbon dioxide.', 'Growth of Escherichia coli on glucose in batch culture is accompanied by the excretion of acetate, which is consumed by the cells when glucose is exhausted. This glucose-acetate transition is classically described as a diauxie (two successive growth stages). Here, we investigated the physiological and metabolic properties of cells after glucose exhaustion through the analysis of growth parameters and gene expression. We found that E. coli cells grown on glucose in batch culture produce acetate and consume it after glucose exhaustion but do not grow on acetate. Acetate is catabolized, but key anabolic genes--such as the genes encoding enzymes of the glyoxylate shunt--are not upregulated, hence preventing growth. Both the induction of the latter anabolic genes and growth were observed only after prolonged exposure to low concentrations of acetate and could be accelerated by high acetate concentrations. We postulate that such decoupling between acetate catabolism and acetate anabolism might be an advantage for the survival of E. coli in the ever-changing environment of the intestine. The glucose-acetate transition is a valuable experimental model for comprehensive investigations of metabolic adaptation and a current paradigm for developing modeling approaches in systems microbiology. Yet, the work reported in our paper demonstrates that the metabolic behavior of Escherichia coli during the glucose-acetate transition is much more complex than what has been reported so far. A decoupling between acetate catabolism and acetate anabolism was observed after glucose exhaustion, which has not been reported previously. This phenomenon could represent a strategy for optimal utilization of carbon resources during colonization and persistence of E. coli in the gut and is also of significant interest for biotechnological applications.', 'When V. cholerae encounters nutritional stress, it activates (p)ppGpp-mediated stringent response. The genes relA and relV are involved in the production of (p)ppGpp, whereas the spoT gene encodes an enzyme that hydrolyzes it. Herein, we show that the bacterial capability to produce (p)ppGpp plays an essential role in glucose metabolism. The V. cholerae mutants defective in (p)ppGpp production (i.e. deltarelAdeltarelV and deltarelAdeltarelVdeltaspoT mutants) lost their viability because of uncontrolled production of organic acids, when grown with extra glucose. In contrast, the deltarelAdeltaspoT mutant, a (p)ppGpp overproducer strain, exhibited better growth in the presence of the same glucose concentration. An RNA sequencing analysis demonstrated that transcriptions of genes consisting of an operon for acetoin biosynthesis were markedly elevated in N16961, a seventh pandemic O1 strain, but not in its (p)ppGpp(0) mutant during glucose-stimulated growth. Transposon insertion in acetoin biosynthesis gene cluster resulted in glucose-induced loss of viability of the deltarelAdeltaspoT mutant, further suggesting the crucial role of acetoin production in balanced growth under glucose-rich environments. Additional deletion of the aphA gene, encoding a negative regulator for acetoin production, failed to rescue the (p)ppGpp(0) mutant from the defective glucose-mediated growth, suggesting that (p)ppGpp-mediated acetoin production occurs independent of the presence of AphA. Overall, our results reveal that (p)ppGpp, in addition to its well known role as a stringent response mediator, positively regulates acetoin production that contributes to the successful glucose metabolism and consequently the proliferation of V. cholerae cells under a glucose-rich environment, a condition that may mimic the human intestine.', 'Heterogeneity within the same tumor type has been described to be complex and occur at multiple levels. Less is known about the heterogeneity at the level of metabolism, within a tumor set, yet metabolic pathways are highly relevant to survival signaling in tumors. In this study, we profiled the glucose metabolism of several non-small cell lung carcinoma (NSCLC) cell lines and could show that, NSCLC display distinct glycolytic metabolism. Genetic and pharmacological perturbation of glycolysis was selectively toxic to NSCLCs with high rates of glycolysis. Furthermore, high expression of hexokinase-2, localized at the mitochondria, was a feature of the NSCLCs dependent on glucose catabolism. Our study provides evidence for quantitative metabolic diversity in NSCLCs and indicates that glucose metabolism provide differential prosurvival benefits to NSCLCs.', 'To observe the influence of different concentrations of bisphenol A (BPA) on glucose metabolism and lactate dehydrogenase (LDH) expression in rat Sertoli cells in vitro and investigate the mechanisms of BPA inducing male infertility. Using two-step enzyme digestion, we isolated Sertoli cells from male Wistar rats and constructed a primary Sertoli cell system, followed by immunohistochemical FasL staining. We randomly divided the Sertoli cells into a control group to be cultured in the serum-free minimal essential medium (MEM) plus dimethyl sulfoxide (DMSO) and three experimental groups to be treated with 100 nmol/L, 10 umol/L, and 1 mmol/L BPA, respectively, in the MEM plus DMSO. After 48 hours of treatment, we measured the proliferation of the cells by CCK-8 assay, determined the concentrations of metabolites by NMR spectroscopy, and detected the expression of LDH in the Sertoli cells by RT-PCR and Western blot. The purity of the isolated Sertoli cells was (96.05 +/- 1.28)% (n = 10). Compared with the control group, the 100 nmol/L, 10 umol/L, and 1 mmol/L BPA groups showed no remarkable changes in the proliferation of Sertoli cells ([98 +/- 8]%, [96 +/- 3]%, and [95 +/- 3]%, P >0.05), but the 10 umol/L and 1 mmol/L of BPA groups exhibited significantly decreased concentrations of intracellular glucose ([3.89 +/- 0.07] vs [3.36 +/- 0.24] and [3.04 +/- 0.21] pmol/cell, P <0.05) and lactate ([0.43 +/- 0.06] vs [0.29 +/- 0.05] and [0.20 +/- 0.03] pmol/cell, P <0.05). The expression of LDH mRNA was decreased with the increased concentration of BPA, while that of LDH protein reduced only in the 1 mmol/L BPA group (P <0.05). High-concentration BPA decreases the expression of LDH and alters glucose metabolism in Sertoli cells, and therefore may reduce the provision of lactate for germ cells and impair spermatogenesis.', 'For more Metabolism/Metabolites (Complete) data for D(+)-Glucose (9 total), please visit the HSDB record page.']","['The approximate half-life is 14.3 minutes following intravenous infusion. Gut glucose half-life was markedly higher in females (79 ± 2 min) than in males (65 ± 3 min, P < 0.0001) and negatively related to body height (r = -0.481; P < 0.0001).']"
7526,107527,Heptadecafluoro-N-(2-hydroxyethyl)-N-propyloctanesulphonamide,CCCN(CCO)S(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
7527,107528,"2-Buten-1-aminium, 4-chloro-N,N,N-trimethyl-, chloride",C[N+](C)(C)CC=CCCl.[Cl-],,,,,,
7528,107529,"4-Chloro-N,N,N-trimethylbut-2-en-1-aminium",C[N+](C)(C)CC=CCCl,,,,,,
7529,107530,CID 107530,C1=CC=NC(=C1)C(=O)NN=C[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O,,,,,,
7530,107531,Methyl 2-O-methylhexopyranoside,CO[C@H]1[C@@H]([C@@H]([C@H](OC1OC)CO)O)O,,,,,,
7531,107532,CID 107532,CCN(CC)C1=CC=C(C=C1)N(C2=CC=C(C=C2)N(CC)CC)C3=CC=C(C=C3)N(C4=CC=C(C=C4)N(CC)CC)C5=CC=C(C=C5)N(CC)CC.[F-].[F-].[F-].[F-].[F-].[F-].[SbH3],,,,,,
7532,107533,Decylthiuronium bromide,CCCCCCCCCCSC(=N)N.Br,,,,,,
7533,107534,p-Nitrophenyl N2-(benzyloxycarbonyl)-L-lysinate,C1=CC=C(C=C1)COC(=O)N[C@@H](CCCCN)C(=O)OC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
7534,107535,"Methyl 2,6,11,15-tetramethyl-17-(2,6,6-trimethylcyclohexen-1-yl)heptadeca-2,4,6,8,10,12,14,16-octaenoate",CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C(=O)OC)C)C,,,,,,
7535,107536,N-Heptylideneaniline,CCCCCCC=NC1=CC=CC=C1,,,,,,
7536,107537,"3H-Pyrazol-3-one, 2,4-dihydro-5-methyl-2-phenyl-4-(phenylazo)-",CC1=NN(C(=O)C1N=NC2=CC=CC=C2)C3=CC=CC=C3,,,,,,
7537,107538,"Ethanaminium, N,N-diethyl-N-methyl-2-[(2-methyl-1-oxo-2-propenyl)oxy]-, methyl sulfate",CC[N+](C)(CC)CCOC(=O)C(=C)C.COS(=O)(=O)[O-],,,,,,
7538,107539,beta-Methacryloxyethyl diethylmethyl ammonium,CC[N+](C)(CC)CCOC(=O)C(=C)C,,,,,,
7539,107540,"(8S,9S,10R,13S,14S)-10,13-dimethyl-17-[2-(1,2,3,6-tetrahydroxy-4-oxohexoxy)acetyl]-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one",C[C@]12CC[C@H]3[C@H]([C@@H]1CCC2C(=O)COC(C(C(C(=O)CCO)O)O)O)CCC4=CC(=O)CC[C@]34C,,,,,,
7540,107541,4-Oxo-L-proline,C1[C@H](NCC1=O)C(=O)O,,,,,,
7541,107542,21-Deoxybetamethasone 17-propionate,CCC(=O)O[C@@]1([C@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2CCC4=CC(=O)C=C[C@@]43C)F)O)C)C)C(=O)C,,,,,,
7542,107543,Methyl 3beta-hydroxy-20-oxo-30-norlupan-28-oate,CC(=O)[C@@H]1CC[C@]2([C@H]1[C@H]3CC[C@@H]4[C@]5(CC[C@@H](C([C@@H]5CC[C@]4([C@@]3(CC2)C)C)(C)C)O)C)C(=O)OC,,,,,,
7543,107544,(S)-2-Amino-3-(p-hydroxyphenyl)-N-(2-naphthyl)propionamide,C1=CC=C2C=C(C=CC2=C1)NC(=O)[C@H](CC3=CC=C(C=C3)O)N,,,,,,
7544,107545,"2-Propenoic acid, 3-[4-[butyl(2-chloroethyl)amino]phenyl]-2-cyano-, ethyl ester",CCCCN(CCCl)C1=CC=C(C=C1)C=C(C#N)C(=O)OCC,,,,,,
7545,107546,2-Ethylbut-2-enoic acid,CCC(=CC)C(=O)O,,,,,,
7546,107547,"2-Pyridineacrylic acid, 2-(4-(p-chlorophenyl)-1-piperazinyl) ethyl ester",C1CN(CCN1CCOC(=O)C=CC2=CC=CC=N2)C3=CC=C(C=C3)Cl,,,,,,
7547,107548,"2-Propenoic acid, 2-cyano-3-[4-[(4-ethoxyphenyl)methylamino]phenyl]-, ethyl ester",CCOC1=CC=C(C=C1)N(C)C2=CC=C(C=C2)C=C(C#N)C(=O)OCC,,,,,,
7548,107549,"20,22-Dihydrodigitoxigenin",C[C@]12CC[C@@H](C[C@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@@]3(CC[C@@H]4[C@H]5CC(=O)OC5)O)C)O,,,,,,
7549,107550,"2-Butene-1,4-dicarboxylic acid(Technical)",C(C=CCC(=O)O)C(=O)O,,,,,,
7550,107551,CID 107551,CCC(=C(CC)N=O)NO,,,,,,
7551,107552,2-Cyclohexylideneethanamine,C1CCC(=CCN)CC1,,,,,,
7552,107553,Nickel bis(2-ethylhexanoate),CCCCC(CC)C(=O)[O-].CCCCC(CC)C(=O)[O-].[Ni+2],,,,,,
7553,107554,"1,3,3-Trimethyl-2-[3,7,12,16-tetramethyl-18-(2,6,6-trimethylcyclohexen-1-yl)octadeca-1,3,5,7,11,13,15,17-octaen-9-ynyl]cyclohexene",CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC#CC=C(C)C=CC=C(C)C=CC2=C(CCCC2(C)C)C)C)C,,,,,,
7554,107555,"Octanoic acid, 1-naphthyl ester",CCCCCCCC(=O)OC1=CC=CC2=CC=CC=C21,,,,,,
7555,107556,Amylpenicillin,CCCCCC(=O)N[C@H]1[C@@H]2N(C1=O)[C@H](C(S2)(C)C)C(=O)O,,,,,,
7556,107557,"3-(3,4-Dimethoxyphenyl)-2-propenal",COC1=C(C=C(C=C1)C=CC=O)OC,,,,,,
7557,107558,N6-Benzoyl-2'-deoxyadenosine,C1[C@@H]([C@H](O[C@H]1N2C=NC3=C(N=CN=C32)NC(=O)C4=CC=CC=C4)CO)O,,,,,,
7558,107559,"1,3-Butanediol-1,3-dioctanoate",CCCCCCCC(=O)OCCC(C)OC(=O)CCCCCCC,,,,,,
7559,107560,"9beta,11beta-Epoxy-6alpha-fluoro-17,21-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 21-acetate",C[C@@H]1C[C@H]2[C@@H]3C[C@@H](C4=CC(=O)C=C[C@@]4([C@]35[C@@H](O5)C[C@@]2([C@]1(C(=O)COC(=O)C)O)C)C)F,,,,,,
7560,107561,l-Piperitone,CC1=CC(=O)[C@H](CC1)C(C)C,,,,,,
7561,107562,N-[1-(2-aminophenyl)-3-phenylprop-2-enylidene]hydroxylamine,C1=CC=C(C=C1)C=CC(=NO)C2=CC=CC=C2N,,,,,,
7562,107563,"6beta-Chloro-9beta,10alpha-pregn-4-ene-3,20-dione",CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@@H]3[C@H]2C[C@H](C4=CC(=O)CC[C@@]34C)Cl)C,,,,,,
7563,107564,"3,3'-Diiodo-L-thyronine",C1=CC(=C(C=C1C[C@@H](C(=O)O)N)I)OC2=CC(=C(C=C2)O)I,,,,,,
7564,107565,CID 107565,CCCCCCCCCCCCCCC=CS(=O)(=O)[O-].[Na+],,,,,,
7565,107566,Hexadec-1-ene-1-sulfonic acid,CCCCCCCCCCCCCCC=CS(=O)(=O)O,,,,,,
7566,107567,"Naphtho[1,2-d]thiazolium, 1-(3-sulfopropyl)-2-[2-[[1-(3-sulfopropyl)naphtho[1,2-d]thiazol-2(1H)-ylidene]methyl]-1-butenyl]-, inner salt",CCC(=CC1=[N+](C2=C(S1)C=CC3=CC=CC=C32)CCCS(=O)(=O)[O-])C=C4N(C5=C(S4)C=CC6=CC=CC=C65)CCCS(=O)(=O)O,,,,,,
7567,107568,"9,10-Octadecadienoic acid",CCCCCCCC=C=CCCCCCCCC(=O)O,,,,,,
7568,107569,Bis(acetato-O)dichlorotitanium,CC(=O)O.CC(=O)O.Cl[Ti]Cl,,,,,,
7569,107570,CID 107570,CC[C@@H](C=C[C@@H](C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)OC(=O)C)C)C)C(C)C,,,,,,
7570,107571,Butyl 3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate,CCCCOC(=O)C=CC1=CC(=C(C=C1)O)OC,,,,,,
7571,107572,"5-tert-Butyl 1-(2,5-dioxopyrrolidin-1-yl) (S)-2-(((phenylmethoxy)carbonyl)amino)glutarate",CC(C)(C)OC(=O)CC[C@@H](C(=O)ON1C(=O)CCC1=O)NC(=O)OCC2=CC=CC=C2,,,,,,
7572,107573,Ethyl N2-((benzyloxy)carbonyl)-L-asparaginate,CCOC(=O)[C@H](CC(=O)N)NC(=O)OCC1=CC=CC=C1,,,,,,
7573,107574,"1H-Indole, 2,3-dihydro-1,3,3-trimethyl-2-[(phenylazo)methylene]-",CC1(C2=CC=CC=C2N(C1=CN=NC3=CC=CC=C3)C)C,,,,,,
7574,107575,"3-Buten-2-one, 4-(2,4-dimethyl-3-cyclohexen-1-yl)-",CC1C=C(CCC1C=CC(=O)C)C,,,,,,
7575,107576,CID 107576,CCCCCCCCCCCCCCCCC=CS(=O)(=O)[O-].[Na+],,,,,,
7576,107577,Octadec-1-ene-1-sulfonic acid,CCCCCCCCCCCCCCCCC=CS(=O)(=O)O,,,,,,
7577,107578,5-methyl-4-[(3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-yl)methylidene]-2-phenylpyrazol-3-one,CC1=NN(C(=O)C1C=C2C(=NN(C2=O)C3=CC=CC=C3)C)C4=CC=CC=C4,,,,,,
7578,107579,2-Dichlorophosphorylethenylbenzene,C1=CC=C(C=C1)C=CP(=O)(Cl)Cl,,,,,,
7579,107580,"(8R,9S,13S,14S,17S)-4,17-dihydroxy-13-methyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-one",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=C(C(=O)CCC34)O,,,,,,
7580,107581,"9-Octadecenoic acid, 12-hydroxy-, barium salt (2:1), (9Z,12R)-",CCCCCCC(CC=CCCCCCCCC(=O)[O-])O.CCCCCCC(CC=CCCCCCCCC(=O)[O-])O.[Ba+2],,,,,,
7581,107582,"2,4-Pentanedione, 3-(2-furanylmethylene)-",CC(=O)C(=CC1=CC=CO1)C(=O)C,,,,,,
7582,107583,CID 107583,C(C(=CN=O)NO)Cl,,,,,,
7583,107584,1-Isocyanato-1-propene,CC=CN=C=O,,,,,,
7584,107585,"Pentane, 3-(chloromethyl)-",CCC(CC)CCl,,,,,,
7585,107586,CID 107586,CC(=CCCC(=CC1OCC(CO1)O)C)C,,,,,,
7586,107587,"2-Pentenoic acid, 4-oxo-",CC(=O)C=CC(=O)O,,,,,,
7587,107588,"Benzene, (2-methoxyethenyl)-",COC=CC1=CC=CC=C1,,,,,,
7588,107589,"1H-Benzimidazolium, 5,6-dichloro-1,3-diethyl-2-[2-(phenylamino)ethenyl]-, iodide",CCN1C2=CC(=C(C=C2[N+](=C1C=CNC3=CC=CC=C3)CC)Cl)Cl.[I-],,,,,,
7589,107590,"5,6-Dichloro-1,3-diethyl-2-[2-(phenylamino)ethenyl]-1H-benzimidazol-3-ium",CCN1C2=CC(=C(C=C2[N+](=C1C=CNC3=CC=CC=C3)CC)Cl)Cl,,,,,,
7590,107591,"4-[2-[4-(1,3-Benzoxazol-2-yl)phenyl]ethenyl]benzoic acid",C1=CC=C2C(=C1)N=C(O2)C3=CC=C(C=C3)C=CC4=CC=C(C=C4)C(=O)O,,,,,,
7591,107592,CID 107592,CN1CCN(CC1)C2CC3=CC=CC=C3SC4=CC=CC=C24.C(=CC(=O)O)C(=O)O,,,,,,
7592,107593,Perathiepin,CN1CCN(CC1)C2CC3=CC=CC=C3SC4=CC=CC=C24,,,,,,
7593,107594,"2,2'-(1,2-Ethenediyldi-4,1-phenylene)bis[5-(1,1,3,3-tetramethylbutyl)benzoxazole]",CC(C)(C)CC(C)(C)C1=CC2=C(C=C1)OC(=N2)C3=CC=C(C=C3)C=CC4=CC=C(C=C4)C5=NC6=C(O5)C=CC(=C6)C(C)(C)CC(C)(C)C,,,,,,
7594,107595,CID 107595,C1=CN(C(=O)N=C1N)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(O)O[C@@H]3[C@H](O[C@H]([C@@H]3O)N4C=NC5=C4NC(=NC5=O)N)CO)O)O,,,,,,
7595,107596,"9-Octadecenoic acid (9Z)-, 2,2-bis(hydroxymethyl)butyl ester",CCCCCCCCC=CCCCCCCCC(=O)OCC(CC)(CO)CO,,,,,,
7596,107597,N-Tosyl-L-aspartic acid,CC1=CC=C(C=C1)S(=O)(=O)N[C@@H](CC(=O)O)C(=O)O,,,,,,
7597,107598,"N-[1-[(2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-2-oxo-pyrimidin-4-yl]benzamide",C1[C@H]([C@@H](O[C@@H]1N2C=CC(=NC2=O)NC(=O)C3=CC=CC=C3)CO)O,,,,,,
7598,107599,"Furan, 2-(3-hexenyl)-5-methyl-",CCC=CCCC1=CC=C(O1)C,,,,,,
7599,107600,"Undec-8-ene-2,5-dione",CCC=CCCC(=O)CCC(=O)C,,,,,,
7600,107601,"5-[[4-[(4,6-Dichloro-1,3,5-triazin-2-yl)methylamino]phenyl]diazenyl]-2-[2-(4-nitro-2-sulfophenyl)ethenyl]benzenesulfonic acid",C1=CC(=CC=C1NCC2=NC(=NC(=N2)Cl)Cl)N=NC3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)[N+](=O)[O-])S(=O)(=O)O)S(=O)(=O)O,,,,,,
7601,107602,Penicillin V sulfoxide,CC1([C@@H](N2[C@H](S1=O)[C@@H](C2=O)NC(=O)COC3=CC=CC=C3)C(=O)O)C,,,,,,
7602,107603,Clocortolone Caproate,CCCCCC(=O)OCC(=O)[C@H]1[C@@H](C[C@@H]2[C@@]1(C[C@@H]([C@]3([C@H]2C[C@@H](C4=CC(=O)C=C[C@@]43C)F)Cl)O)C)C,,,,,,
7603,107604,Methyl 4-bromobutyrate,COC(=O)CCCBr,,,,,,
7604,107605,"(3r,5r)-3-Amino-5-methyl-1-phenylpyrrolidin-2-one",C[C@@H]1C[C@H](C(=O)N1C2=CC=CC=C2)N,,,,,,
7605,107606,"2-Pyrrolidinone, 3-amino-5-methyl-1-phenyl-, (Z)-",C[C@@H]1C[C@@H](C(=O)N1C2=CC=CC=C2)N,,,,,,
7606,107607,CID 107607,C1=CC=C(C=C1)C(=O)N=C(NC2=CC=CC3=CC=CC=C32)S,,,,,,
7607,107608,"3beta,17-Dihydroxy-16alpha-methylpregn-5-en-20-one",C[C@@H]1C[C@H]2[C@@H]3CC=C4C[C@H](CC[C@@]4([C@H]3CC[C@@]2([C@]1(C(=O)C)O)C)C)O,,,,,,
7608,107609,Butyl 5-oxo-L-prolinate,CCCCOC(=O)[C@@H]1CCC(=O)N1,,,,,,
7609,107610,Octyl 5-oxo-L-prolinate,CCCCCCCCOC(=O)[C@@H]1CCC(=O)N1,,,,,,
7610,107611,Octadecyl 5-oxo-L-prolinate,CCCCCCCCCCCCCCCCCCOC(=O)[C@@H]1CCC(=O)N1,,,,,,
7611,107612,"3-(2-chlorothioxanthen-9-ylidene)-N,N-diethylpropan-1-amine;hydrochloride",CCN(CC)CCC=C1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl.Cl,,,,,,
7612,107613,"3-(2-chlorothioxanthen-9-ylidene)-N,N-diethylpropan-1-amine",CCN(CC)CCC=C1C2=CC=CC=C2SC3=C1C=C(C=C3)Cl,,,,,,
7613,107614,"3-(2,6,6-Trimethyl-1-cyclohexen-1-yl)-2-propenal",CC1=C(C(CCC1)(C)C)C=CC=O,,,,,,
7614,107615,Estradiol 17-acetate 3-benzoate,CC(=O)O[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=C3C=CC(=C4)OC(=O)C5=CC=CC=C5)C,,,,,,
7615,107616,"[(3S,8S,9S,10S,13S,14S)-17-acetyl-10,13-dimethyl-11-oxo-1,2,3,4,5,6,7,8,9,12,14,15-dodecahydrocyclopenta[a]phenanthren-3-yl] acetate",CC(=O)C1=CC[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CCC4[C@@]3(CC[C@@H](C4)OC(=O)C)C)C,,,,,,
7616,107617,Isopropyl dimethyolcarbamate,CC(C)OC(=O)N(CO)CO,,,,,,
7617,107618,"5-Benzylidene-3-(benzylideneamino)-2-sulfanylidene-1,3-thiazolidin-4-one",C1=CC=C(C=C1)C=C2C(=O)N(C(=S)S2)N=CC3=CC=CC=C3,,,,,,
7618,107619,"Tetrahydro-1,3,4-tris(hydroxymethyl)imidazo[4,5-d]imidazole-2,5(1H,3H)-dione",C(N1C2C(N(C(=O)N2)CO)N(C1=O)CO)O,,,,,,
7619,107620,Methyl tetra-O-acetyl-alpha-D-mannopyranoside,CC(=O)OC[C@@H]1[C@H]([C@@H]([C@@H]([C@H](O1)OC)OC(=O)C)OC(=O)C)OC(=O)C,,,,,,
7620,107621,CID 107621,C1=CC(=CC(=C1)N(O)O)C(=N)N=O,,,,,,
7621,107622,"2-[2-[4-[2-(1,3-Benzoxazol-2-yl)ethenyl]phenyl]ethenyl]-1,3-benzoxazole",C1=CC=C2C(=C1)N=C(O2)C=CC3=CC=C(C=C3)C=CC4=NC5=CC=CC=C5O4,,,,,,
7622,107623,CID 107623,CC=CC=CC(=O)[O-].CC=CC=CC(=O)[O-].[Zn+2],,,,,,
7623,107624,"2,7-Dimethylocta-2,4,6-trienedial",CC(=CC=CC=C(C)C=O)C=O,,,,,,
7624,107625,"17-Azido-3beta,16alpha-dihydroxy-5alpha-pregnane-11,20-dione",CC(=O)[C@]1([C@@H](C[C@@H]2[C@@]1(CC(=O)[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@@H](C4)O)C)C)O)N=[N+]=[N-],,,,,,
7625,107626,"17-Hydroxypregna-4,9(11)-diene-3,20-dione 17-acetate",CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC=C3[C@H]2CCC4=CC(=O)CC[C@@]43C)C)OC(=O)C,,,,,,
7626,107627,(3xi)-5'-o-[(4-Methylphenyl)sulfonyl]adenosine,CC1=CC=C(C=C1)S(=O)(=O)OC[C@@H]2C([C@H]([C@@H](O2)N3C=NC4=C(N=CN=C43)N)O)O,,,,,,
7627,107628,"1',3',3'-Trimethyl-8-nitrospiro(2H-1-benzopyran-2,2'-indoline)",CC1(C2=CC=CC=C2N(C13C=CC4=C(O3)C(=CC=C4)[N+](=O)[O-])C)C,,,,,,
7628,107629,2-Iodobenzyl alcohol,C1=CC=C(C(=C1)CO)I,,,,,,
7629,107630,"2-Hexa-3,5-dienyl-5-methylfuran",CC1=CC=C(O1)CCC=CC=C,,,,,,
7630,107631,"2-Cyclohexen-1-one, 4-(2-butenylidene)-3,5,5-trimethyl-",CC=CC=C1C(=CC(=O)CC1(C)C)C,,,,,,
7631,107632,CID 107632,CN(C)CCC=C1C2=CC=CC=C2SC3=C1C=C(C=C3)Br.Cl,,,,,,
7632,107633,CID 107633,CN(C)CCC=C1C2=CC=CC=C2SC3=C1C=C(C=C3)Br,,,,,,
7633,107634,CID 107634,CC(C)CC(=CC(=O)C)[O-].CC(C)CC(=CC(=O)C)[O-].CC(C)CC(=CC(=O)C)[O-].[In+3],,,,,,
7634,107635,CID 107635,CC(C)CC(=CC(=O)C)[O-].[Ag+],,,,,,
7635,107636,"3-(2-Chloro-4-isocyanatophenyl)-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one",CC(C)(C)C1=NN(C(=O)O1)C2=C(C=C(C=C2)N=C=O)Cl,,,,,,
7636,107637,Curium-242,[242Cm],,,,,,
7637,107638,Cadmium-113,[115Cd],,,,,,
7638,107639,Nitrogen-15,[15NH3],,,,,,
7639,107640,Delartine,CCN1CC2(CC[C@@H](C34[C@@H]2[C@@H](C(C31)([C@]5(C[C@@H](C6C[C@@H]4[C@@H]5[C@H]6OC)OC)O)O)OC)OC)COC(=O)C7=CC=CC=C7N8C(=O)C[C@@H](C8=O)C,,,"['Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)', 'Drugs that bind to nicotinic cholinergic receptors (RECEPTORS, NICOTINIC) and block the actions of acetylcholine or cholinergic agonists. Nicotinic antagonists block synaptic transmission at autonomic ganglia, the skeletal neuromuscular junction, and at central nervous system nicotinic synapses. (See all compounds classified as Nicotinic Antagonists.)']",,,
7640,107641,Indobufen,CCC(C1=CC=C(C=C1)N2CC3=CC=CC=C3C2=O)C(=O)O,,,"['Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)', 'Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)']",,,
7641,107642,"(5aR,8aR,9R)-5-[[(4aR,7R,8R,8aS)-7,8-dihydroxy-2-thiophen-2-yl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one",COC1=CC(=CC(=C1O)OC)[C@H]2[C@@H]3[C@H](COC3=O)C(C4=CC5=C(C=C24)OCO5)OC6[C@@H]([C@H]([C@H]7[C@H](O6)COC(O7)C8=CC=CS8)O)O,,,,,,
7642,107643,N'-aminocytidine,C1=CN(C(=O)N=C1NN)C2[C@@H]([C@@H]([C@H](O2)CO)O)O,,,,,,
7643,107644,CID 107644,COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4[C@@H]5[C@H](C(O[C@@H]5OC4=C1)N6C=NC7=C6C(=O)N=C(N7)N)O,,,,,,
7644,107645,"(4S,8S)-8,16,18-trihydroxy-4-methyl-3-oxabicyclo[12.4.0]octadeca-1(14),12,15,17-tetraen-2-one",C[C@H]1CCC[C@H](CCCC=CC2=C(C(=CC(=C2)O)O)C(=O)O1)O,,,,,,
7645,107646,Thiamethoxam,CN1COCN(C1=N[N+](=O)[O-])CC2=CN=C(S2)Cl,,,"['Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)']","['Quickly and completely absorbed, rapidly distributed in the body and rapidly eliminated. The toxicokinetics and metabolism are not influenced by the route of administration, the dose level, pre-treatment, the site of label or the sex of animals.', 'In rats, thiamethoxam is absorbed rapidly and extensively, and is widely distributed, followed by very rapid elimination, mostly in the urine. The highest tissue concentrations are in skeletal muscle (10-15% of administered dose).  Very low tissue residues were reported after 7 days.  Within 24 hours, approximately 84-95% of the administered dose was excreted in urine, while 2.5-6% was excreted in the feces. Most was excreted as unchanged parent (70-80% of dose). ... Enterohepatic circulation is negligible.', 'Fifteen Tiflbm: MAG (SPF) mice/group were dosed with non-labeled thiamethoxam in diet for 29 days at 0, 100, 500, or 2500 ppm. Labeled thiamethoxam (10 mg/kg b.w.) was given by gavage to all groups on day 30, and again 72 hours later (non-labeled dietary treatments continued until termination). Mice were killed 6 hours after the second radio-labeled treatment. Investigators evaluated urine, feces, liver, plasma, and bile for radiolabel and metabolites. Regardless of dose, 58-76% of the first dose was found in urine and 24-36% of first dose in feces within 72 hours (accounting for 94-102% of administered dose). Six hours after the 2nd dose, liver contained about 0.9 to 1.5% of that dose, pooled bile from the gall bladders contained only 0.01 to 0.22% of that dose, and plasma contained 0.3 to 0.4% of that dose (no effect of pre-treatment for liver, bile, or plasma). Excreta and other samples showed no influence of dose on metabolite patterns. ...', 'Non-radiolabeled Thiamethoxam (purity >98%); Radiolabeled [Thiazol-2-(14)C] Thiamethoxam (Batch #Ko-73.1A and Ko-73.2A-1, specific activity 68.9 and 57.3 uCi/mg, respectively, purity of >97%) and [Oxadiazin-4-(14)C] Thiamethoxam (Batch Ko-75.2A-2 and Ko- 75.2A-3, specific activity of 87.0 and 84.6 uCi/mg, purity >96%) were administered to 4 or 5 Tif:RAI f (SPF) rats/sex/dose at 0.5 mg/kg, to 5 rats/sex at 0.5 mg/kg (after 14 days of unlabeled Thiamethoxam) and to 5 rats/sex at 0.5 or 100 mg/kg by oral gavage or iv. Three groups of 4 male Tiflbm:MAG (SPF) mice receiving [Thiazol-2-(14)C] Thiamethoxam for 14 days at 118 mg/kg to determine excretion and metabolic fate in mice. In rats, the dose was rapidly absorbed from the G.I. tract into the general circulation with maximum blood levels (tCmax (hr) achieved 1 to 4 hours independent of the radiolabel site, dose level or sex. Cmax  ranged from 0.17 to 0.20 ppm (low dose) and 33 to 43 ppm (high dose) and levels declined rapidly (tCmax/2 about 8 hours). Bioavailability 0.6 to 0.8 (males) and 0.7 to 0.9 (females) indicated sizable oral absorption. Absorbed material was primarily excreted via the urine (approximately 90%) compared to about 4% in feces within 24 hours. The preponderance of fecal elimination originated from biliary excretion. Half-lives in all tissues ranged from 2 to 6 hours. Comparison of metabolite patterns in mice and rats indicated that the major metabolic pathways were similar.', 'In mice, approximately 72% of the administered dose was excreted in the urine and 19% was excreted in feces.  Small but measurable amounts were detected in expired air (approximately 0.2% of dose).  Parent (33-41% of administered dose) and 2 predominant metabolites: 8-12% and 9-18% of administered dose were found.  These are the same structures that were most commonly observed in rat excreta; however, the proportions are quite different in mouse excreta.  One additional significant metabolite (mouse R6) was isolated from feces samples.  Between 30-60% of the administered dose was excreted as metabolites.']","['The major biotransformation reaction is cleavage of the oxadiazine ring to form the corresponding nitroguanidine compound (i.e., chlothianidin, the regulated metabolite in plants and livestock).', 'In the in vivo study compared rat and mouse plasma metabolite levels after 1-week or 10-week dietary exposures of 3000 ppm in rats and 2500 ppm in mice (N = 5). Plasma thiamethoxam levels were 12 and 4 ug/mL in 1-wk and 10- wk mice, and 7 and 19 ug/mL in respective rats. In mice, it appeared that metabolic induction was progressing over that interval, as CGA 265307 (downstream metabolite of both CGA 322704 and CGA 330050) increased from 2 to 5 ug/mL. CGA 322704 levels in mice stayed about the same and CGA 330050 levels were marginally reduced during this interval. In rats, CGA 322704 ranged from 1.0 to 0.6 ug/mL. Other metabolite levels were exceedingly low in rats: CGA 265307 at 0.05 to 0.09 ug/mL, and CGA 330050 at 0.10 to 0.14 ug/mL. Liver microsomal fractions were prepared from mice, rats, and humans for in vitro studies of metabolism of thiamethoxam to metabolites. In all cases, mice had the most rapid metabolic rates (i.e. for metabolism of thiamethoxam to CGA 322704, thiamethoxam to CGA 330050, CGA 322704 to CGA 265307, and CGA 330050 to CGA 265307). Rats had slightly higher metabolic rates than humans for these reactions.', 'Two male Tiflbm: RAI (SPF) rats/group were dosed once with 100 mg/kg [Oxadiazin-4-(14)C] CGA 293343 by gavage. Sacrifices were 0.5, 1, 2, 4, 6, 8, or 24 hrs after dosing. Blood was collected to assess total residues and to identify major metabolites. A TLC radiochromatogram of whole blood extracts taken 4 hrs post-dosing revealed 1 strong peak, one much lesser peak, and very little label outside those areas. The corresponding HPLC radiochromatogram revealed 2 perceptible peaks: thiamethoxam and CGA 322704. At peak levels of thiamethoxam (6 hrs after dosing), 99.8% of radiolabel was extractible. Extractible residues other than thiamethoxam and two metabolites were 1.74% of label. Maximum concentrations were at 6 hr for thiamethoxam and its metabolites. Estimated t1/2 were 2 hrs for thiamethoxam, 4 hrs for CGA 322704, and 8 hrs for CGA 265307. During the period from 0.5 to 8 hrs post-dosing, ""other"" residues graduated from 0.3% to 2.2% of extractible label. At 24 hours, total residues in blood were only 2% of the peak [6 hr] levels. Metabolic profile (as % of total radioactive residues of a given sampling time) for thiamethoxam, CGA 322704, and CGA 265307, respectively were 94.6%, 5.0%, and (below quantifiable levels) at 1 hr; 81.9%, 15.0%, and 1.2% at 6 hrs; and 15.5%, 30.6%, and 17.6% at 24 hrs. CGA 330050, a significant metabolite in mice, was not detectable.', 'Six male Tiflbm: MAG (SPF) mice/group were dosed once with 100 mg/kg [Oxadiazin-4-(14)C] Thiamethoxam by gavage. Sacrifices were 0.5, 1, 2, 4, 6, 8, or 24 hrs after dosing. Blood was collected to assess total residues and to identify major metabolites. A TLC radiochromatogram of whole blood extracts taken 1 hr post-dosing revealed 3 strong peaks, with very little label outside those areas. One of the peaks represented 2 constituents, so that the HPLC radiochromatogram revealed 4 perceptible peaks. These were thiamethoxam (dominant peak), and three metabolites: CGA 322704, CGA 265307, and CGA 330050. During the first hour, about 1.5% to 2.9% of label was non-extractible, whereas residues other than thiamethoxam and the above metabolites were below levels of detection. Kinetics parameters for TCmax (hr) 0.5 for thiamethoxam, and 2 for the three metabolites, and estimated t1/2 (hr) were 3 hr (for thiamethoxam and all metabolites). During the period from 4-8 hrs post-dosing, ""other"" residues constituted about 5% of extractible label. At 8 and 24 hours, respectively, total residues in blood were only 30% and 1% of the peak (0.5 hr) levels. Metabolic profile (as % of total radioactive residues of a given sampling time) for thiamethoxam, CGA 322704, CGA 265307, and CGA 330050, respectively were 77.5, 11.2, 3.2, and 6.6 at 0.5 hrs; 60.0, 15.7, 9.8, and 11.6 at 1 hr; and 39.5, 12.7, 30.4, and 9.0 at 8 hrs.', 'For more Metabolism/Metabolites (Complete) data for Thiamethoxam (6 total), please visit the HSDB record page.']",['The half-life times from rat tissue ranged from 2-6 hours.']
7646,107647,Fluorocitric acid,C(C(=O)O)C(C(C(=O)O)F)(C(=O)O)O,,,,,,
7647,107648,CID 107648,CC1=C[C@@H]2[C@@]3(CC1)COC(=O)C=C(CCO[C@H](C=CC=CC(=O)O[C@H]4[C@]3([C@]5(CO5)C(C4)O2)C)[C@@H](C)O)C,,,,,,
7648,107649,Beryllium(2+),[Be+2],,,,,,
7649,107650,S-Ethyl glutathione,CCSC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N,,,"['Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. (See all compounds classified as Radiation-Protective Agents.)']",,['Ethylglutathione is a known human metabolite of 1-iodoethane.'],
7650,107651,Penfluron,C1=CC(=C(C(=C1)F)C(=O)NC(=O)NC2=CC=C(C=C2)C(F)(F)F)F,,,,,,
7651,107652,"28-Hydroxy-24-(1-hydroxyethyl)-10,16-dimethylspiro[2,5,13,18,25-pentaoxahexacyclo[22.3.1.114,17.01,3.07,12.07,16]nonacosa-10,20,22-triene-15,2'-oxirane]-4,19-dione",CC1=CC2C3(CC1)COC(=O)C4C5(O4)CCOC(C5O)(C=CC=CC(=O)OC6C3(C7(CO7)C(C6)O2)C)C(C)O,,,,,,
7652,107653,alpha-Monofluoromethylhistidine,C1=C(NC=N1)CC(CF)(C(=O)O)N,,,"['Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)', 'Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)']",,,
7653,107654,(6R)-7-[[(2R)-2-(4-hydroxyphenyl)-2-[(6-methyl-4-oxo-1H-pyridine-3-carbonyl)amino]acetyl]amino]-3-[(1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,CC1=CC(=O)C(=CN1)C(=O)N[C@H](C2=CC=C(C=C2)O)C(=O)NC3[C@@H]4N(C3=O)C(=C(CS4)CSC5=NN=NN5C)C(=O)O,,,,,,
7654,107655,"(5R,6R,7S)-19-methyl-4-oxapentacyclo[9.8.0.02,8.03,5.012,17]nonadeca-1(11),2(8),9,12,14,16,18-heptaene-6,7-diol",CC1=CC2=CC=CC=C2C3=C1C4=C(C=C3)[C@@H]([C@H]([C@@H]5C4O5)O)O,,,,,,
7655,107656,2-Methyl aminochroman,CC1=C(C2=C(CCC(O2)(C)CN3CCN(CC3)C4=NC(=NC(=C4)N5CCCC5)N6CCCC6)C(=C1O)C)C.Cl.Cl,,,"['Drugs that are used to treat asthma. (See all compounds classified as Anti-Asthmatic Agents.)', 'Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)', 'Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)']",,,
7656,107657,CID 107657,CN1CC[C@H]([C@H](C1)O)C2=C3C(=C(C=C(O3)C4=CC=CC=C4Cl)O)C(=O)C=C2O,,,,,,
7657,107658,CID 107658,C(C(=O)O)C(CC(=O)O)(C(=O)O)O.[AlH3],,,,,,
7658,107659,Plutonium-242,[242Pu],,,,,,
7659,107660,CID 107660,[203PbH2],,,,,,
7660,107661,CID 107661,[208TlH],,,,,,
7661,107662,CID 107662,N.O.O.O.O.O.O.OP(=O)(O)O.[MgH2],,,,,,
7662,107663,Magnesium dihydride,[H-].[H-].[Mg+2],,,,,,
7663,107664,3-Ethyl-2-(4-hydroxyphenyl)-1-methyl-1H-inden-6-ol,CCC1=C(C(C2=C1C=CC(=C2)O)C)C3=CC=C(C=C3)O,,,,,,
7664,107665,"2-Propenoic acid, 2-methyl-, polymer with ethyl 2-propenoate",CCOC(=O)C=C.CC(=C)C(=O)O,,,,,,
7665,107666,n-Methyl-n-nitro-nitrosoguanidine,CN(C(=NN=O)N)[N+](=O)[O-],,,,,,
7666,107667,239-Plutonium citrate,C(C(=O)O)C(CC(=O)O)(C(=O)O)O.[239Pu],,,,,,
7667,107668,Butylprothiophos oxon,CCCCSP(=O)(OCC)OC1=C(C=C(C=C1)Cl)Cl,,,,,,
7668,107669,4-Hydroxydebrisoquine,C1C(C2=CC=CC=C2CN1C(=N)N)O,,,,,['4-Hydroxydebrisoquine is a known human metabolite of debrisoquine.'],
7669,107670,Chaps,C[C@H](CCC(=O)NCCC[N+](C)(C)CCCS(=O)(=O)[O-])[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,,,"['Purifying or cleansing agents, usually salts of long-chain aliphatic bases or acids, that exert cleansing (oil-dissolving) and antimicrobial effects through a surface action that depends on possessing both hydrophilic and hydrophobic properties. (See all compounds classified as Detergents.)']",,,
7670,107671,"dimethyl-(3-sulfopropyl)-[3-[[(4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]propyl]azanium",C[C@H](CCC(=O)NCCC[N+](C)(C)CCCS(=O)(=O)O)[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CC[C@H](C4)O)C)O)O)C,,,,,,
7671,107672,CID 107672,CCCC[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CC2=CC=C(C=C2)O)N,,,,,,
7672,107673,Scandium-46,[46Sc],,,,,,
7673,107674,Selenide,[Se-2],,,,,,
7674,107675,Vanadium(4+),[V+4],,,,,,
7675,107676,Amino methacrylate copolymer,CCCCOC(=O)C(=C)C.CC(=C)C(=O)OC.CC(=C)C(=O)OCCN(C)C,,,,,,
7676,107677,"(2R,3R,4R,5R)-2-[(1S,2S,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-(methylaminomethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol",C[C@@]1(CO[C@@H]([C@@H]([C@H]1NC)O)O[C@H]2[C@@H](C[C@@H](C([C@@H]2O)O[C@@H]3[C@@H](CC[C@H](O3)CNC)N)N)N)O,,,,,,
7677,107678,4'-(9-Acridinylamino)methanesulfonanilide,CS(=O)(=O)NC1=CC=C(C=C1)NC2=C3C=CC=CC3=NC4=CC=CC=C42,,,,,,
7678,107679,"Benzo(a)pyrene-9,10-diol",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4C(=C(C=C5)O)O)C=C2,,,,,,
7679,107680,"3-(Aminomethyl)-2,5,9-trimethyl-7H-furo[3,2-g]chromen-7-one",CC1=CC(=O)OC2=C(C3=C(C=C12)C(=C(O3)C)CN)C,,,"['Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms. (See all compounds classified as Photosensitizing Agents.)', 'Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)', 'Reagents with two reactive groups, usually at opposite ends of the molecule, that are capable of reacting with and thereby forming bridges between side chains of amino acids in proteins; the locations of naturally reactive areas within proteins can thereby be identified; may also be used for other macromolecules, like glycoproteins, nucleic acids, or other. (See all compounds classified as Cross-Linking Reagents.)']",,,
7680,107681,3-(N-n-Octadecylcarbamoyloxy)-2-methoxypropyl-2-thiazolinium ethyl phosphate,CCCCCCCCCCCCCCCCCCNC(=O)OCC(COP(=O)([O-])OCC[N+]1=CSC=C1)OC,,,"['Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)']",,,
7681,107682,"[3-[hydroxy-[2-(1,3-thiazol-3-ium-3-yl)ethoxy]phosphoryl]oxy-2-methoxypropyl] N-octadecylcarbamate",CCCCCCCCCCCCCCCCCCNC(=O)OCC(COP(=O)(O)OCC[N+]1=CSC=C1)OC,,,,,,
7682,107683,Pentoxyresorufin,CCCCCOC1=CC2=C(C=C1)N=C3C=CC(=O)C=C3O2,,,,,['Pentoxyresorufin has known human metabolites that include Resorufin.'],
7683,107684,CID 107684,C1=C(NC=N1)CC(C(=O)[O-])N=C(CC[NH-])[O-].[Zn+2],,,,,,
7684,107685,"1H-Indole-4,7-dione, 5-(1-aziridinyl)-3-(hydroxymethyl)-2-[(1E)-3-hydroxy-1-propen-1-yl]-1-methyl-",CN1C(=C(C2=C1C(=O)C=C(C2=O)N3CC3)CO)C=CCO,,,,,,
7685,107686,"7,7-Diphenyl-2-(1-imino-2-(2-methoxyphenyl)ethyl)perhydroisoindol-4-one",COC1=CC=CC=C1CC(=N)N2C[C@H]3[C@@H](C2)C(CCC3=O)(C4=CC=CC=C4)C5=CC=CC=C5,,,['Compounds that inhibit or block the activity of NEUROKININ-1 RECEPTORS. (See all compounds classified as Neurokinin-1 Receptor Antagonists.)'],,,
7686,107687,CID 107687,C(C(=O)O)C(CC(=O)O)(C(=O)O)O.[NaH],,,,,,
7687,107688,4-(Nitrosomethylidene)-1-[[4-(nitrosomethylidene)pyridin-1-yl]methoxymethyl]pyridine,C1=CN(C=CC1=CN=O)COCN2C=CC(=CN=O)C=C2,,,,,,
7688,107689,L-Lactic acid,C[C@@H](C(=O)O)O,['Prevention of pregnancy'],,,,,
7689,107690,Tetramethyl-lambda5-arsane,C[AsH](C)(C)C,,,,,,
7690,107691,"N,N-Diallyl-tyrosyl-alpha-aminoisobutyric acid-phenylalanyl-leucine",CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)C(C)(C)NC(=O)[C@H](CC2=CC=C(C=C2)O)N(CC=C)CC=C,,,['Agents inhibiting the effect of narcotics on the central nervous system. (See all compounds classified as Narcotic Antagonists.)'],,,
7691,107692,"S-(2-Chloro-1,1,2-trifluoroethyl)cysteine",C([C@@H](C(=O)O)N)SC(C(F)Cl)(F)F,,,,,,
7692,107693,"1,2,3,5,6,7-Hexachloronaphthalene",C1=C2C(=C(C(=C1Cl)Cl)Cl)C=C(C(=C2Cl)Cl)Cl,,,,,,
7693,107694,Diane,CC(=O)[C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C=C(C4=CC(=O)[C@@H]5CC5[C@]34C)Cl)C)OC(=O)C.C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=C3C=CC(=C4)O,,,['Compounds which inhibit or antagonize the biosynthesis or actions of androgens. (See all compounds classified as Androgen Antagonists.)'],,,
7694,107695,CID 107695,CC(=O)[C@]1(CCC2[C@@]1(CC[C@H]3C2C=C(C4=CC(=O)[C@@H]5CC5[C@]34C)Cl)C)OC(=O)C,,,,,,
7695,107696,"Cyano(4-phenoxyphenyl)methyl 3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropanecarboxylate",CC1(C(C1C(=O)OC(C#N)C2=CC=C(C=C2)OC3=CC=CC=C3)C=C(Cl)Cl)C,,,,,,
7696,107697,dl-Bremazocine,CCC12CCN([C@@H](C1(C)C)CC3=C2C=C(C=C3)O)CC4(CC4)O,,,['Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)'],,,
7697,107698,"1,2,3,4,6,7-Hexachloronaphthalene",C1=C2C(=CC(=C1Cl)Cl)C(=C(C(=C2Cl)Cl)Cl)Cl,,,,,,
7698,107699,3-Aminopropyl(diethoxymethyl)phosphinic acid,CCOC(OCC)P(=O)(CCCN)O,,,"['Drugs that bind to but do not activate GABA RECEPTORS, thereby blocking the actions of endogenous GAMMA-AMINOBUTYRIC ACID and GABA RECEPTOR AGONISTS. (See all compounds classified as GABA Antagonists.)']",,,
7699,107700,"1,1'-Ethylidenebis(tryptophan)",CC(N1C=C(C2=CC=CC=C21)C[C@@H](C(=O)O)N)N3C=C(C4=CC=CC=C43)C[C@@H](C(=O)O)N,,,,,,
7700,107701,"(20R)-17,20-Dihydroxypregn-4-en-3-one",C[C@H]([C@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@]34C)C)O)O,,,,,,
7701,107702,Altertoxin II,C1CC2(C3C4C(O4)C(=O)C5=C(C=CC(=C35)C6=C2C(=C(C=C6)O)C1=O)O)O,,,,,,
7702,107703,CID 107703,C[C@H]([C@@H](C(=CCC(C)C=C1C[C@]([C@@H]2CCCN2C1)(C)O)C)O)O,,,,,,
7703,107704,beta-Carboline-3-carboxylic acid methyl ester,COC(=O)C1=NC=C2C(=C1)C3=CC=CC=C3N2,,,"['Substances that act in the brain stem or spinal cord to produce tonic or clonic convulsions, often by removing normal inhibitory tone. They were formerly used to stimulate respiration or as antidotes to barbiturate overdose. They are now most commonly used as experimental tools. (See all compounds classified as Convulsants.)']",,,
7704,107705,"4,5-Dihydro-4,5-epoxy-1-nitropyrene",C1=CC2=C3C(=C1)C4C(O4)C5=C3C(=C(C=C5)[N+](=O)[O-])C=C2,,,,,"['4,5-Dihydro-4,5-epoxy-1-nitropyrene is a known human metabolite of 1-nitropyrene.']",
7705,107706,Sivelestat,CC(C)(C)C(=O)OC1=CC=C(C=C1)S(=O)(=O)NC2=CC=CC=C2C(=O)NCC(=O)O,,,['Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. (See all compounds classified as Serine Proteinase Inhibitors.)'],"['The single dose pharmacokinetics of adalimumab in rheumatoid arthritis (RA) patients were determined in several studies with intravenous doses ranging from 0.25 to 10 mg/kg. The distribution volume (Vss) ranged from 4.7 to 6.0 L. The systemic clearance of adalimumab is approximately 12 mL/hr. The mean terminal half-life was approximately 2 weeks, ranging from 10 to 20 days across studies. Adalimumab concentrations in the synovial fluid from five rheumatoid arthritis patients ranged from 31 to 96% of those in serum.', 'The maximum serum concentration (Cmax) and the time to reach the maximum concentration (Tmax) were 4.7 + or - 1.6 ug/mL and 131 + or - 56 hours respectively, following a single 40 mg subcutaneous administration of Humira to healthy adult subjects. The average absolute bioavailability of adalimumab estimated from three studies following a single 40 mg subcutaneous dose was 64%. The pharmacokinetics of adalimumab were linear over the dose range of 0.5 to 10.0 mg/kg following a single intravenous dose.', 'After subcutaneous administration of a single 40 mg dose, absorption and distribution of adalimumab was slow, with peak serum concentrations being reached about 5 days after administration. The average absolute bioavailability of adalimumab estimated from three studies following a single 40 mg subcutaneous dose was 64%. After single intravenous doses ranging from 0.25 to 10 mg/kg, concentrations were dose proportional. After doses of 0.5 mg/kg (approximately 40 mg), clearances ranged from 11 to 15 mL/hour, the distribution volume (Vss) ranged from 5 to 6 litres and the mean terminal phase half life was approximately two weeks. Adalimumab concentrations in the synovial fluid from several rheumatoid arthritis patients ranged from 31-96% of those in serum.']",,"['The single dose pharmacokinetics of adalimumab in rheumatoid arthritis (RA) patients were determined in several studies with intravenous doses ranging from 0.25 to 10 mg/kg. ... The mean terminal half-life was approximately 2 weeks, ranging from 10 to 20 days across studies.']"
7706,107707,N-[4-methyl-1-[[4-methyl-1-[[(2S)-4-methyl-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]carbamic acid (phenylmethyl) ester,CC(C)C[C@@H](C=O)NC(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)OCC1=CC=CC=C1,,,,,,
7707,107708,"15,16-Dihydrocyclopenta(a)phenanthren-17-one",C1CC(=O)C2=C1C3=C(C=C2)C4=CC=CC=C4C=C3,,,,,,
7708,107709,p-Nitrosophenetole,CCOC1=CC=C(C=C1)N=O,,,,,,
7709,107710,N-Hydroxy-4-aminoazobenzene,C1=CC=C(C=C1)NNC2=CC=C(C=C2)N=O,,,,,,
7710,107711,Bismuth nitrate,[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[N+](=O)([O-])[O-].[Bi+3],,,,,,
7711,107712,DL-Homocysteine thiolactone,C1CSC(=O)C1N,,,"['Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. (See all compounds classified as Radiation-Protective Agents.)']",,,
7712,107713,Fumitremorgin A,CC(=CCO[C@H]1C2=C3[C@H](CC(OO[C@@H](N3C4=C2C=CC(=C4)OC)C=C(C)C)(C)C)N5[C@@]1(C(=O)N6CCC[C@H]6C5=O)O)C,,,,,,
7713,107714,"4,15-Diacetylnivalenol",CC1=C[C@@H]2[C@]([C@@H](C1=O)O)(C3([C@@H]([C@H]([C@H](C34CO4)O2)O)OC(=O)C)C)COC(=O)C,,,,,,
7714,107715,Dihydroergocristine,CC(C)[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C,"['Dihydroergocristine is used in some countries such as Brasil as a single agent for the treatment of cerebral and peripheric vascular events. To know more about dihydroergocristine as part of the ergoloid mesylate mixture, please visit [DB01049].']","['Dihydroergocristine has been shown to present effect on memory and cognition. This activity in the brain is been reported by an increase in glutathione in age-related brain states. The reported effect on serotonin and adrenergic receptors has also been correlated to an inhibition of platelet aggregation. It has also been reported that individuals exposed to dihydroergocristine may present an amphoteric vasoregulating activity either hypotensive in hypertensive individuals or hypertensive in hypotensive individuals. This action is performed by promoting a dilating action in the contracted arteries and a tonic action in the dilated arteries and arterioles. The vasoregulating effect causes an increase in cerebral blood flow and oxygen consumption by the brain, which correlates with the brain protective function of dihydroergocristine. In Alzheimer studies, dihydroergocristine reduced the amyloid-beta levels in different cell types. To know more about dihydroergocristine as part of the ergoloid mesylate mixture, please visit [DB01049].']","['Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)', 'Drugs that bind to but do not activate ADRENERGIC RECEPTORS. Adrenergic antagonists block the actions of the endogenous adrenergic transmitters EPINEPHRINE and NOREPINEPHRINE. (See all compounds classified as Adrenergic Antagonists.)']","['Dihydroergocristine presents an absorption in the digestive tract of about 25% of the administered dose. When dihydroergocristine was orally administered in humans and the peak plasma concentration of 0.28 mcg/l was achieved after 0.46 hours. In the same report, the AUC was reported to be 0.39 mcg/l.h. To know more about dihydroergocristine as part of the ergoloid mesylate mixture, please visit [DB01049].', 'The most important elimination route of dihydroergocristine is in via the bile and it accounts for over 85% of the eliminated dose. Urine elimination accounts only for 5% of the administered dose. To know more about dihydroergocristine as part of the ergoloid mesylate mixture, please visit [DB01049].', 'Dihydroergocristine presents a large volume of distribution of 52 l/kg. To know more about dihydroergocristine as part of the ergoloid mesylate mixture, please visit [DB01049].', 'Dihydroergocristine presents a high systemic clearance rate of 2.65 l/h.hg. To know more about dihydroergocristine as part of the ergoloid mesylate mixture, please visit [DB01049].']","[""The major metabolite of dihydroergocristine is 8'-hydroxy-dihydroergocristine is produced in the liver. The modification of dihydroergocristine in the body is very extensive and it has been observed as an almost complete absence of the unchanged drug. To know more about dihydroergocristine as part of the ergoloid mesylate mixture, please visit [DB01049].""]","['The half-life of dihydroergocristine has only been studied as part of the therapeutic mixture, please refer to [DB01049].']"
7715,107716,"2,3,5,6,8,8,9,10,10-Nonachlorobornane",C([C@]1(C2[C@H]([C@@H](C1([C@H]([C@@H]2Cl)Cl)C(Cl)Cl)Cl)Cl)C(Cl)Cl)Cl,,,,,,
7716,107717,1-(Butylamino)-3-[(2-methyl-1h-indol-4-yl)oxy]propan-2-yl benzoate,CCCCNCC(COC1=CC=CC2=C1C=C(N2)C)OC(=O)C3=CC=CC=C3,,,,,,
7717,107718,"5b-Hydroxy-2,2,13b,13c-tetramethyl-9-(2-methylbut-3-en-2-yl)-2,3,5b,6,7,7a,8,13,13b,13c,14,15-dodecahydro-4h-3,15a-epoxy[1]benzoxepino[6',7':6,7]indeno[1,2-b]indol-4-one",CC1(C2C(=O)C=C3C4(CCC5CC6=C(C5(C4(CCC3(O2)O1)C)C)NC7=CC=CC(=C67)C(C)(C)C=C)O)C,,,,,,
7718,107719,N-Nitrosomethyl-2-hydroxypropylamine,CC(CN(C)N=O)O,,,,,,
7719,107720,Indoxacarb,COC(=O)[C@]12CC3=C(C1=NN(CO2)C(=O)N(C4=CC=C(C=C4)OC(F)(F)F)C(=O)OC)C=CC(=C3)Cl,['Treatment and prevention of flea infestation.'],,,,"['Metabolism in rats after oral dosing was studied using both DPX-JW062 and DPX-MP062. Most of the dose was excreted within 96 hr. Extensive metabolism to numerous minor metabolites occurs. In urine, metabolites were cleaved products (indane or trifluoromethoxyphenyl ring products), whilst in feces, major metabolites retained both these moieties. Major metabolic reactions included hydroxylation of the indane ring, hydrolysis of the carboxymethyl group from the amino nitrogen, and opening of the oxadiazine ring, which gave rise to cleaved products.']",
7720,107721,Taxiphyllin,C1=CC(=CC=C1[C@H](C#N)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O)O,,,,,,
7721,107722,7alpha-Hydroxycholesterol,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2[C@@H](C=C4[C@@]3(CC[C@@H](C4)O)C)O)C,,,,,,
7722,107723,"Phosphorodithioic acid, S-((5-chloro-2-oxo-3(2H)-benzoxazolyl)methyl) O,O-diethyl ester",CCOP(=S)(OCC)SCN1C2=C(C=CC(=C2)Cl)OC1=O,,,,,,
7723,107724,22-Hydroxycholesterol,C[C@@H]([C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C)C(CCC(C)C)O,,,,,,
7724,107725,CID 107725,CN[C@@H](C=O)[C@H]([C@@H]([C@@H](CO)O)O)O.C1=CC=NC(=C1)NS(=O)(=O)C2=CC=C(C=C2)N=NC3=CC(=C(C=C3)O)C(=O)O,,,,,,
7725,107726,CID 107726,CNC(C=O)[C@H]([C@@H]([C@@H](CO)O)O)O,,,,,,
7726,107727,"Benzo(a)pyrene-4,5-diol",C1=CC=C2C3=C4C(=CC2=C1)C(=C(C5=CC=CC(=C54)C=C3)O)O,,,,,,
7727,107728,"Aflatoxin B1 2,3-dichloride",COC1=C2C3=C(C(=O)CC3)C(=O)OC2=C4[C@@H]5[C@H]([C@@H](O[C@@H]5OC4=C1)Cl)Cl,,,,,,
7728,107729,Prodan,CCC(=O)C1=CC2=C(C=C1)C=C(C=C2)N(C)C,,,"['Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)']",,,
7729,107730,2-Fluoro-5-hydroxy-L-tyrosine,C1=C(C(=CC(=C1O)O)F)C[C@@H](C(=O)O)N,,,,,,
7730,107731,"4,4',6-Trimethylangelicin",CC1=CC2=C(C3=C1OC=C3C)OC(=O)C=C2C,,,,,,
7731,107732,2-[2-[Carboxylatomethyl-[[2-methyl-3-oxido-5-(phosphonatooxymethyl)pyridin-4-yl]methyl]amino]ethyl-[[2-methyl-3-oxido-5-(phosphonatooxymethyl)pyridin-4-yl]methyl]amino]acetate;hydron;manganese(2+),[H+].[H+].[H+].[H+].CC1=NC=C(C(=C1[O-])CN(CCN(CC2=C(C(=NC=C2COP(=O)([O-])[O-])C)[O-])CC(=O)[O-])CC(=O)[O-])COP(=O)([O-])[O-].[Mn+2],,,,,,
7732,107733,"2-Piperazinecarboxylic acid, 4-[(2E)-3-phosphono-2-propenyl]-, (2R)-",C1CN(CC(N1)C(=O)O)CC=CP(=O)(O)O,,,"['Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. (See all compounds classified as Excitatory Amino Acid Antagonists.)']",,,
7733,107734,"2,3,5,6,8,8,10,10-Octachlorobornane",C[C@@]1(C2[C@H]([C@@H](C1([C@H]([C@@H]2Cl)Cl)C(Cl)Cl)Cl)Cl)C(Cl)Cl,,,,,,
7734,107735,Pyruvate,CC(=O)C(=O)[O-],,,,,,
7735,107736,"2,6-Di-tert-butyl-4-methylene-2,5-cyclohexadienone",CC(C)(C)C1=CC(=C)C=C(C1=O)C(C)(C)C,,,,,,
7736,107737,Inositol 1-phosphate,[C@H]1([C@H](C([C@@H]([C@@H](C1O)O)O)OP(=O)(O)O)O)O,,,,,,
7737,107738,Propionylcarnitine,CCC(=O)OC(CC(=O)[O-])C[N+](C)(C)C,,,"['Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE). (See all compounds classified as Cardiotonic Agents.)', 'Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)']","[""Most (54-86%) dietary carnitine is absorbed in the small intestine and enters the bloodstream.  The kidneys efficiently conserve carnitine, so even carnitine-poor diets have little impact on the body's total carnitine content. Rather than being metabolized, excess carnitine is excreted in the urine as needed via the kidneys to maintain stable blood concentrations. /Carnitine/"", 'L-Carnitine and acylcarnitine esters are present in all tissues. In most tissues and cells, they are present in higher concn than in the circulation ... L-carnitine and acetyl-L-carnitine are concn in most tissues via the high-affinity, Na+-dependent organic cation transporter OCTN2 ... OCTN2 binds acetyl-L-carnitine and propionyl-L-carnitine with comparable affinity. This protein is highly expressed in heart, placenta, skeletal muscle, kidney, pancreas, testis, and epididymis and weakly expressed in brain, lung, and liver ... /Acylcarnitine esters/', '... At a filtered load of 50 umol/L, the efficiency of L-carnitine and acylcarnitine ester reabsorption is 90 to 98% /in kidneys/. However, as the filtered load of L-carnitine incr, as, eg after consumption of a dietary supplement or after iv infusion, the efficiency of reabsorption declines rapidly ... Clearance of acylcarnitine esters is often higher than that of nonesterified L-carnitine /in kidneys/ ... Under conditions of rapid intracellular synth of acylcarnitine esters or direct accumulation from the circulation ... a higher proportion of acylcarnitine esters in urine compared to that in the circulation /is achieved/ ... Kidneys may be substantially involved in the regulation of circulating acylcarnitine ester concn. /Aacylcarnitine ester/', '... A concn ratio of acylcarnitine esters/nonesterified L-carnitine of 0.4 or greater in plasma is ... considered abnormal ...']",,
7738,107739,3-(Propionyloxy)-4-(trimethylaminio)butanoic acid,CCC(=O)OC(CC(=O)O)C[N+](C)(C)C,,,,,,
7739,107740,CID 107740,CC(C)NC1=NC(=O)N=C(N1)N,,,,,,
7740,107741,4-Bromophenylacetylurea,C1=CC(=CC=C1CC(=O)NC(=O)N)Br,,,,,,
7741,107742,CID 107742,C[C@@H]1[C@H]([C@@]2([C@@H](C2(C)C)[C@H]3[C@]1([C@@H]4C=C(C(=O)[C@]4(CC(=C3)CO)O)C)O)C(=O)C)O,,,,,,
7742,107743,"[(2R,4S,7R,9R,10R,11S)-10,11-dihydroxy-2-(hydroxymethyl)-1,5-dimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-4-yl] 3-methylbutanoate",CC1=C[C@@H]2[C@](C[C@@H]1OC(=O)CC(C)C)(C3([C@@H]([C@H]([C@H](C34CO4)O2)O)O)C)CO,,,,,,
7743,107744,Aldophosphamide,C(COP(=O)(N)N(CCCl)CCCl)C=O,,,,,,
7744,107745,"2-[3-(3,3-Dimethyl-1-octadecylindol-1-ium-2-yl)prop-2-enylidene]-3,3-dimethyl-1-octadecylindole",CCCCCCCCCCCCCCCCCCN1C2=CC=CC=C2C(C1=CC=CC3=[N+](C4=CC=CC=C4C3(C)C)CCCCCCCCCCCCCCCCCC)(C)C,,,"['Analogs of those substrates or compounds which bind naturally at the active sites of proteins, enzymes, antibodies, steroids, or physiological receptors. These analogs form a stable covalent bond at the binding site, thereby acting as inhibitors of the proteins or steroids. (See all compounds classified as Affinity Labels.)', 'Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)']",,,
7745,107746,"7-[(1R,4S,5R,6R)-6-[(3S)-3-hydroxyoct-1-enyl]-2,3-dioxabicyclo[2.2.1]heptan-5-yl]hept-5-enoic acid",CCCCC[C@@H](C=C[C@H]1[C@H]2C[C@@H]([C@@H]1CC=CCCCC(=O)O)OO2)O,,,,,,
7746,107747,4'-(9-Acridinylamino)methanesulfon-o-anisidide,COC1=C(C=CC(=C1)NC2=C3C=CC=CC3=NC4=CC=CC=C42)NS(=O)(=O)C,,,,,,
7747,107748,co-Amilozide,C1NC2=CC(=C(C=C2S(=O)(=O)N1)S(=O)(=O)N)Cl.C1(=C(N=C(C(=N1)Cl)N)N)C(=O)N=C(N)N,,,['Agents that promote the excretion of urine through their effects on kidney function. (See all compounds classified as Diuretics.)'],,,
7748,107749,"(4R,5S)-3,5-dimethoxy-4-methyl-7-[2-[2-(7-methylocta-3,5-dien-2-yl)-1,3-thiazol-4-yl]-1,3-thiazol-4-yl]hepta-2,6-dienamide",C[C@H]([C@H](C=CC1=CSC(=N1)C2=CSC(=N2)C(C)C=CC=CC(C)C)OC)C(=CC(=O)N)OC,,,,,,
7749,107750,Bonnecor,CCOC(=O)NC1=CC2=C(CCC3=CC=CC=C3N2C(=O)CN(C)C)C=C1.Cl,,,"['A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). (See all compounds classified as Psychotropic Drugs.)', 'Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)']",,,
7750,107751,Racecadotril,CC(=O)SCC(CC1=CC=CC=C1)C(=O)NCC(=O)OCC2=CC=CC=C2,,,"['Miscellaneous agents found useful in the symptomatic treatment of diarrhea. They have no effect on the agent(s) that cause diarrhea, but merely alleviate the condition. (See all compounds classified as Antidiarrheals.)', 'Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). (See all compounds classified as Protease Inhibitors.)']",,,
7751,107752,4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)-1H-indole-2-carbonitrile,CC(C)NCC(COC1=CC=CC2=C1C=C(N2)C#N)O,,,"['Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)', 'Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)']",,,
7752,107753,"4,15-Bis(acetyloxy)-3-hydroxy-12,13-epoxytrichothec-9-en-8-yl 3-hydroxy-3-methylbutanoate",CC1=C[C@@H]2[C@](C[C@@H]1OC(=O)CC(C)(C)O)(C3([C@@H]([C@H]([C@H](C34CO4)O2)O)OC(=O)C)C)COC(=O)C,,,,,,
7753,107754,NONOate(1-),CCN(CC)N(N=O)[O-],,,,,,
7754,107755,CID 107755,C[C@H]1C=C[C@@H]2[C@](O2)([C@H](C[C@H](OC(=O)[C@H]3[C@@H](O3)C[C@@H]4C[C@H]1OC(=O)C4)[C@H](C)[C@H](C(=CC=CC(=CC5=COC(=N5)C)C)C)OC)O)C,,,,,,
7755,107756,2-(N-Acetyl-N-(2-methoxy-3-octadecylcarbamoyloxypropoxycarbonyl)aminomethyl)-1-ethylpyridinium,CCCCCCCCCCCCCCCCCCNC(=O)OCC(COC(=O)N(CC1=CC=CC=[N+]1CC)C(=O)C)OC.[Cl-],,,,,,
7756,107757,2-{[Acetyl-(2-methoxy-3-octadecylcarbamoyloxy-propoxycarbonyl)-amino]-methyl}-1-ethyl-pyridinium; iodide,CCCCCCCCCCCCCCCCCCNC(=O)OCC(COC(=O)N(CC1=CC=CC=[N+]1CC)C(=O)C)OC,,,,,,
7757,107758,"Inositol 1,3,4,5-tetrakisphosphate",[C@H]1([C@H](C([C@H]([C@H](C1OP(=O)(O)O)O)OP(=O)(O)O)OP(=O)(O)O)OP(=O)(O)O)O,,,,,,
7758,107759,Methoctramine hydrochloride,COC1=CC=CC=C1CNCCCCCCNCCCCCCCCNCCCCCCNCC2=CC=CC=C2OC.Cl.Cl.Cl.Cl,,,['Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)'],,,
7759,107760,"Fenpyroximate (Z,E)",CC1=NN(C(=C1C=NOCC2=CC=C(C=C2)C(=O)OC(C)(C)C)OC3=CC=CC=C3)C,,,,,,
7760,107761,CID 107761,CC(=O)COC(=O)CN(CC1=CC2=C(C=C1C(=O)C)OC3=C(C24C5=CC=CC=C5C(=O)O4)C=C(C(=C3)C(=O)C)CN(CC(=O)OCC(=O)C)CC(=O)OCC(=O)C)CC(=O)OCC(=O)C,,,,,,
7761,107762,2-Aminopyrene,C1=CC2=C3C(=C1)C=CC4=C3C(=CC(=C4)N)C=C2,,,,,['2-aminopyrene is a known human metabolite of 2-nitropyrene.'],
7762,107763,CID 107763,O[Si](O)(O)O.[CaH2].[CaH2],,,,,,
7763,107764,Iododeoxyuridine-125I,C1[C@@H]([C@H](O[C@H]1N2C=C(C(=O)NC2=O)[125I])CO)O,,,,,,
7764,107765,Dihydroetorphine,CCC[C@](C)([C@H]1C[C@@]23CC[C@@]1([C@H]4[C@@]25CCN([C@@H]3CC6=C5C(=C(C=C6)O)O4)C)OC)O,,,"['Compounds with activity like OPIATE ALKALOIDS, acting at OPIOID RECEPTORS. Properties include induction of ANALGESIA or NARCOSIS. (See all compounds classified as Analgesics, Opioid.)']",,,
7765,107766,alpha-Acetoxy-N-nitrosopyrrolidine,CC(=O)OC1CCCN1N=O,,,,,,
7766,107767,Dimyristoylphosphatidylglycerol,CCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(CO)O)OC(=O)CCCCCCCCCCCCC,['DL-dimyristoylphosphatidylglycerol is not an considered an active pharmacological ingredient in pharmaceutical preparations and so has no official indications.'],['DL-dimyristoylphosphatidylglycerol is a water soluble phospholipid used to solubilize drugs for injection.'],,,,
7767,107768,CID 107768,[Li+].CCCC(=O)O.[OH-],,,,,,
7768,107769,"3,N(4)-Ethenodeoxycytidine",C1[C@@H]([C@H](O[C@H]1N2C=CC3=NC=CN3C2=O)CO)O,,,,,,
7769,107770,CID 107770,C[C@@H]1CCC2[C@H]([C@H](O[C@H]3[C@@]24[C@H]1CCC(O3)(OO4)C)O)C,,,"['Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)']",,,
7770,107771,Pyronaridine,COC1=NC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NC4=CC(=C(C(=C4)CN5CCCC5)O)CN6CCCC6,,,"['Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)']",,,
7771,107772,H-Tyr-Ala-Phe-Gly-Tyr-Pro-Ser-NH2,C[C@@H](C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)NCC(=O)N[C@@H](CC2=CC=C(C=C2)O)C(=O)N3CCC[C@H]3C(=O)N[C@@H](CO)C(=O)N)NC(=O)[C@H](CC4=CC=C(C=C4)O)N,,,,,,
7772,107773,"L-Methionine, N-(3-(bis(2-chloroethyl)amino)-N-(4-fluoro-L-phenylalanyl)-L-phenylalanyl)-, ethyl ester, monohydrochloride",CCOC(=O)[C@H](CCSC)CC(=O)[C@H](CC1=CC(=CC=C1)N(CCCl)CCCl)NC(=O)[C@H](CC2=CC=C(C=C2)F)N.Cl,,,['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)'],,,
7773,107774,"ethyl (2S,5S)-5-[[(2S)-2-amino-3-(4-fluorophenyl)propanoyl]amino]-6-[3-[bis(2-chloroethyl)amino]phenyl]-2-(2-methylsulfanylethyl)-4-oxohexanoate",CCOC(=O)[C@H](CCSC)CC(=O)[C@H](CC1=CC(=CC=C1)N(CCCl)CCCl)NC(=O)[C@H](CC2=CC=C(C=C2)F)N,,,,,,
7774,107775,Arg-gly-asp-ser,C(C[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CO)C(=O)O)N)CN=C(N)N,,,"['Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)']",,,
7775,107776,"(2S)-2-amino-5-[[(2R)-1-(carboxymethylamino)-3-(1,2-dichloroethenylsulfanyl)-1-oxopropan-2-yl]amino]-5-oxopentanoic acid",C(CC(=O)N[C@@H](CSC(=CCl)Cl)C(=O)NCC(=O)O)[C@@H](C(=O)O)N,,,,,,
7776,107777,Fusarochromanone,CC1(CC(=O)C2=C(O1)C=CC(=C2N)C(=O)CC(CO)N)C,,,,,,
7777,107778,Dexanabinol,CCCCCCC(C)(C)C1=CC(=C2[C@H]3CC(=CC[C@@H]3C(OC2=C1)(C)C)CO)O,['Investigated for use/treatment in traumatic brain injuries and neurologic disorders.'],,"['Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)', 'Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)', 'Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)', 'Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. (See all compounds classified as Excitatory Amino Acid Antagonists.)']",,,
7778,107779,"2-Cyclohexene-1-carboxylicacid, 3-methyl-6-(3-methoxy-1-methyl-3-oxo-1-propenyl)-, methyl ester (9CI)",CC1=CC(C(CC1)C(=CC(=O)OC)C)C(=O)OC,,,,,,
7779,107780,"2'-Methyl-4'-(5-methyl-(1,2,4)-oxadiazol-3-yl)biphenyl-4-carboxylic acid (4-methoxy-3-(4-methylpiperazin-1-yl)phenyl)amide",CC1=C(C=CC(=C1)C2=NOC(=N2)C)C3=CC=C(C=C3)C(=O)NC4=CC(=C(C=C4)OC)N5CCN(CC5)C,,,"['Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)']",,,
7780,107781,Aceanthrylene,C1=CC=C2C3=C4C(=CC=CC4=CC2=C1)C=C3,,,,,,
7781,107782,Betamethasone phosphate,C[C@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COP(=O)(O)O)O)C)O)F)C,"['Betamethasone phosphate is indicated intramuscularly to treat allergic states, dermatologic diseases, endocrine disorders, gastrointestinal diseases, hematologic disorders, neoplastic diseases, nervous system conditions, ophthalmic diseases, renal diseases, respiratory diseases, rheumatic disorders, trichinosis with neurologic or myocardial involvement, and tuberculous meningitis with subarachnoid block or impending block. It is also used intra-articularly in the treatment of acute gouty arthritis, acute and subacute bursitis, acute nonspecific tenosynovitis, epicondylitis, rheumatoid arthritis, and synovitis of osteoarthritis. Intralesional betamethasone phospahte is indicated in the treatment of alopecia areata, discoid lupus erythematosus, keloids, lichen planus, lichen simplex chronicus, psoriatic plaques, necrobiosis lipoidica diabeticorum, and localized hypertrophic, infiltrated, inflammatory lesions of granuloma annulare.']","['Corticosteroids bind to the glucocorticoid receptor, inhibiting pro-inflammatory signals, and promoting anti-inflammatory signals. Betamethasone phosphate has a short duration of action as it is rapidly hydrolyzed to betamethasone. Corticosteroids have a wide therapeutic window as patients may require doses that are multiples of what the body naturally produces. Patients taking corticosteroids should be counselled regarding the risk of hypothalamic-pituitary-adrenal axis suppression and increased susceptibility to infections.']","['A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. (See all compounds classified as Glucocorticoids.)']","['An intramuscular injection of 3mg betamethasone acetate and 3mg betametasone phosphate reaches a betamethasone C<sub>max</sub> 33.21 ± 8.71 ng/mL, with a T<sub>max</sub> of 1.56 ± 1.32 h, and an AUC of 506.95 ± 125.03 ng\\*h/mL.', 'Corticosteroids are eliminated predominantly in the urine.', 'The volume of distribution of betamethasone in an intramuscular injection of 3mg betamethasone acetate and 3mg betamethasone phosphate is 226.00 ± 61.64 L.', 'The clearance of betamethasone in an intramuscular injection of 3mg betamethasone acetate and 3mg betamethasone phosphate is 12.62 ± 3.45 L/h.']",['Betamethasone phosphate is rapidly de-esterified to betamethasone.'],['The half life of betamethasone in an intramuscular injection of 3mg betamethasone acetate and 3mg betamethasone phosphate is 12.47 ± 1.91 h.']
7782,107783,"2-Amino-4-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl-ethylsulfonio]butanoate",CC[S+](CCC(C(=O)[O-])N)CC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O,,,,,,
7783,107784,"(3-Amino-3-carboxypropyl)-[[5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl]-ethylsulfanium",CC[S+](CCC(C(=O)O)N)CC1C(C(C(O1)N2C=NC3=C(N=CN=C32)N)O)O,,,,,,
7784,107785,CID 107785,C(C(=O)O)C(CC(=O)O)(C(=O)O)O.C(C(=O)O)C(CC(=O)O)(C(=O)O)O.[MgH2].[MgH2].[MgH2],,,,,,
7785,107786,2-Aminopropiophenone,CC(C(=O)C1=CC=CC=C1)N,,,"['A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)', 'A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). (See all compounds classified as Psychotropic Drugs.)']","['The active components of khat are absorbed orally by chewing the leaves. The peak plasma concentration of cathinone, cathine, and norephedrine are reached in 127 minutes, 183 minutes, and 200 minutes, respectively.', 'Four volunteers chewed khat leaves in an amount equivalent to one-quarter of that used in a typical khat session. Blood samples were collected up to 80 hr and the alkaloids were assayed using gas chromatography-mass spectrometry. The data were evaluated using computerized pharmacokinetic compartmental analysis. The plasma concentration-time data for the alkaloids could be described using a two-compartment model with two-segment absorption. The mucosa of the oral cavity is considered to be the first absorption segment, where the major proportion of the alkaloids is absorbed (mean +/- SD 59 +/- 21% for cathinone and 84 +/- 6% for cathine). The extraction of the alkaloids from the leaves by chewing was very effective with only 9.1 +/- 4.2% remaining as a residue. Cathinone was eliminated from the central compartment with a mean half-life of 1.5 +/- 0.8 hr. The half-life of cathine was 5.2 +/- 3.4 hr. The metabolism of cathinone to norephedrine had a substantial influence on its plasma concentration profile. Psychophysical functions were essentially unaffected by the chewing of khat.', 'Peak plasma levels of cathinone are obtained 1.5 to 3.5 hours after the onset of chewing. The mean plasma level may reach 100 ng/mL after chewing 60 g fresh khat for one hour. Cathinone is barely detectable in blood after eight hours. ... Only 2 % of cathinone is excreted unchanged in the urine.', 'A small amount of cathinone is excreted by thekidney unchanged (0.6% to 3.3%).']","['Cathinone is metabolized by keto-reduction to norephedrine and norpseudoephedrine at an approximate ratio of 9:1. ... Up to 52% of oral doses of cathinone isomers are recovered in 24 hour urine samples as aminoalcohol metabolites. Cathine is also primarily excreted in the urine: 40% of an oral dose within 6 hours and 84.6% within 24 hours.', '... After oral administration of synthesized cathinone (isomers, racemate), 22-52% was recovered in 24 hr urine samples mainly as aminoalcohol metabolites. With GC/MS, HPLC and CD, the main metabolite of S-(-)-cathinone was identified as R/S-(-)-norephedrine and the main metabolite of R-(+)-cathinone as R/R-(-)-norpseudoephedrine. Both aminoalcohols are formed by a stereospecific keto reduction.', 'First-pass metabolism of cathinone in the liver leads to the formation of norephedrine.']","['The elimination half-life of cathinone is 1.5 +/- 0.8 hours', 'The elimination half life of cathinone (given as khat) is approximately 4 hours.', 'Six drug-naive volunteers received a single dose of khat corresponding to 0.8 mg/kg body weight ... . The terminal elimination half-life was 260 +/- 102 minutes.']"
7786,107787,4-Ethoxy-5-methylpyrimidin-2-ol,CCOC1=C(C=NC(=O)N1)C,,,,,,
7787,107788,CID 107788,CC=CC1=CN2[C@@H](C1)[C@H](CC3=C(C(=C(C=C3C2=O)OC4[C@@H]([C@]([C@H]([C@@H](O4)C)NC)(C)O)O)C)O)O,,,,,,
7788,107789,CID 107789,C1CC1CN2CC[C@]34[C@@H]5C(=O)CC[C@]3([C@@H]2CC6=C4C(=C(C=C6)O)O5)O.Cl,,,,,,
7789,107790,5-Dimethylaminophenylazoindazole,CN(C)C1=CC=C(C=C1)N=NC2=CC3=C(C=C2)NN=C3,,,,,,
7790,107791,2-Nitropropane nitronate,C[C-](C)[N+](=O)[O-],,,,,,
7791,107792,2-Propanenitronic acid,CC(=[N+](O)[O-])C,,,,,,
7792,107793,Saikosaponin D,C[C@@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)O[C@H]2CC[C@]3([C@H]([C@]2(C)CO)CC[C@@]4([C@@H]3C=C[C@@]56[C@]4(C[C@H]([C@@]7([C@H]5CC(CC7)(C)C)CO6)O)C)C)C)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O)O)O)O,,,"['Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)', 'Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)', 'Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)', 'Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)']",,,
7793,107794,6-Hydroxydopa,C1=C(C(=CC(=C1O)O)O)CC(C(=O)O)N,,,,,,
7794,107795,Miserotoxin,C(C[N+](=O)[O-])CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O,,,,,,
7795,107796,CID 107796,CC1([C@@H](N2[C@H](S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)NC(=O)N4CCN(C4=O)S(=O)(=O)C)C(=O)O)C.[NaH],,,,,,
7796,107797,"(2S,6R)-3,3-dimethyl-6-[[(2R)-2-[(3-methylsulfonyl-2-oxoimidazolidine-1-carbonyl)amino]-2-phenylacetyl]amino]-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid",CC1([C@@H](N2C(S1)[C@@H](C2=O)NC(=O)[C@@H](C3=CC=CC=C3)NC(=O)N4CCN(C4=O)S(=O)(=O)C)C(=O)O)C,,,,,,
7797,107798,"1,2,3,5,7-Pentachloronaphthalene",C1=C(C=C(C2=CC(=C(C(=C21)Cl)Cl)Cl)Cl)Cl,,,,,,
7798,107799,"(1S,9S)-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol;hydrochloride",CC1[C@@H]2CC3=C([C@]1(CCN2CC=C(C)C)C)C=C(C=C3)O.Cl,,,,,,
7799,107800,"N-[4-amino-3-[3-amino-6-(1-aminoethyl)oxan-2-yl]oxy-2,5-dihydroxy-6-methoxycyclohexyl]-2-(aminomethylideneamino)-N-methylacetamide",CC(C1CCC(C(O1)OC2C(C(C(C(C2O)N(C)C(=O)CN=CN)OC)O)N)N)N,,,,,,
7800,107801,Biopol,CCC(CC(=O)O)O.CC(CC(=O)O)O,,,,,,
7801,107802,3-Hydroxypentanoic acid,CCC(CC(=O)O)O,,,,,,
7802,107803,CID 107803,C[N+]1(CC[C@]23[C@@H]4C(=O)CC[C@]2([C@@H]1CC5=C3C(=C(C=C5)O)O4)[O-])CC6CC6,,,,,,
7803,107804,2-Amino-9-(4-imidazolyl)-7-azanonanoic acid,C1=C(NC=N1)CCNCCCC[C@H](C(=O)O)N,,,,,,
7804,107805,Acridine carboxamide,CN(C)CCNC(=O)C1=CC=CC2=CC3=CC=CC=C3N=C21,,,['Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)'],,,
7805,107806,"Phosphoric acid, 2-(1-methylethyl)phenyl diphenyl ester, mixt. with triphenyl phosphate",CC(C)C1=CC=CC=C1OP(=O)(OC2=CC=CC=C2)OC3=CC=CC=C3.C1=CC=C(C=C1)OP(=O)(OC2=CC=CC=C2)OC3=CC=CC=C3,,,,,,
7806,107807,Perindopril,CCC[C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@H]2CCCC[C@H]2C[C@H]1C(=O)O,"['For the treatment of mild to moderate essential hypertension, mild to moderate congestive heart failure, and to reduce the cardiovascular risk of individuals with hypertension or post-myocardial infarction and stable coronary disease.']","['Perindopril is a nonsulfhydryl prodrug that is metabolized via first pass effect (62%) and systemic hydrolysis (38%) to perindoprilat, its active metabolite, following oral administration. Perindoprilat lowers blood pressure by antagonizing the effect of the RAAS. The RAAS is a homeostatic mechanism for regulating hemodynamics, water and electrolyte balance. During sympathetic stimulation or when renal blood pressure or blood flow is reduced, renin is released from the granular cells of the juxtaglomerular apparatus in the kidneys. In the blood stream, renin cleaves circulating angiotensinogen to ATI, which is subsequently cleaved to ATII by ACE. ATII increases blood pressure using a number of mechanisms. First, it stimulates the secretion of aldosterone from the adrenal cortex. Aldosterone travels to the distal convoluted tubule (DCT) and collecting tubule of nephrons where it increases sodium and water reabsorption by increasing the number of sodium channels and sodium-potassium ATPases on cell membranes. Second, ATII stimulates the secretion of vasopressin (also known as antidiuretic hormone or ADH) from the posterior pituitary gland. ADH stimulates further water reabsorption from the kidneys via insertion of aquaporin-2 channels on the apical surface of cells of the DCT and collecting tubules. Third, ATII increases blood pressure through direct arterial vasoconstriction. Stimulation of the Type 1 ATII receptor on vascular smooth muscle cells leads to a cascade of events resulting in myocyte contraction and vasoconstriction. In addition to these major effects, ATII induces the thirst response via stimulation of hypothalamic neurons. ACE inhibitors inhibit the rapid conversion of ATI to ATII and antagonize RAAS-induced increases in blood pressure. ACE (also known as kininase II) is also involved in the enzymatic deactivation of bradykinin, a vasodilator. Inhibiting the deactivation of bradykinin increases bradykinin levels and may sustain the effects of perindoprilat by causing increased vasodilation and decreased blood pressure.']","['Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)', 'A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. (See all compounds classified as Angiotensin-Converting Enzyme Inhibitors.)']","['Rapidly absorbed with peak plasma concentrations occurring approximately 1 hour after oral administration. Bioavailability is 65-75%. Following absorption, perindopril is hydrolyzed to perindoprilat, which has an average bioavailability of 20%. The rate and extent of absorption is unaffected by food. However, food decreases the extent of biotransformation to peridoprilat and reduces its bioavailability by 35%.', 'Perindopril is extensively metabolized following oral administration, with only 4 to 12% of the dose recovered unchanged in the urine.', '219 - 362 mL/min [oral administration]']","['Extensively metabolized, with only 4-12% of the dose recovered in urine following oral administration. Six metabolites have been identified: perindoprilat, perindopril glucuronide, perindoprilat glucuronide, a perindopril lactam, and two perindoprilat lactams. Only perindoprilat is pharmacologically active. Peridoprilat and perindoprilat glucuronide are the two main circulating metabolites.', 'Perindopril has known human metabolites that include Perindoprilat glucuronide.']","['Perindopril, 1.2 hours; Peridoprilat, 30-120 hours. The long half life of peridoprilat is due to its slow dissociation from ACE binding sites.']"
7807,107808,"(1R,3S)-5-[2-[(1S,3aS,7aS)-1-[(1R)-1-(3-hydroxy-3-methylbutoxy)ethyl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol",C[C@H]([C@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@H](C[C@@H](C3=C)O)O)C)OCCC(C)(C)O,,,,,,
7808,107809,"1-Nitropyrene-9,10-oxide",C1=CC2=C3C(=C1)C4C(O4)C5=C(C=CC(=C53)C=C2)[N+](=O)[O-],,,,,,
7809,107810,"D-Alanine, N-((hexahydro-1H-azepin-1-yl)carbonyl)-L-leucyl-1-methyl-D-tryptophyl-3-(2-pyridinyl)-",CC(C)C[C@@H](C(=O)N[C@H](CC1=CN(C2=CC=CC=C21)C)C(=O)N[C@H](CC3=CC=CC=N3)C(=O)O)NC(=O)N4CCCCCC4,,,,,,
7810,107811,CID 107811,CN(C=[N+](C)CC1=CN=C(C=C1)Cl)C#N,,,,,,
7811,107812,Hypotaurine,C(CS(=O)O)N,,,['Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)'],,,
7812,107813,Thiopyronine,CN(C)C1=CC2=C(C=C1)C=C3C=CC(=[N+](C)C)C=C3S2.[Cl-],,,,,,
7813,107814,"3,6-Bis(dimethylamino)thioxanthylium",CN(C)C1=CC2=C(C=C1)C=C3C=CC(=[N+](C)C)C=C3S2,,,,,,
7814,107815,"Chromate (CrO42-), hydrogen",O[Cr](=O)(=O)[O-],,,,,,
7815,107816,N-Acetyl-S-benzyl-L-cysteine,CC(=O)N[C@@H](CSCC1=CC=CC=C1)C(=O)O,,,,,,
7816,107817,Tabtoxin,C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC[C@@]1(CNC1=O)O)N)O,,,,,,
7817,107818,"1,2,3,4,5,6,7-Heptachloronaphthalene",C1=C2C(=C(C(=C1Cl)Cl)Cl)C(=C(C(=C2Cl)Cl)Cl)Cl,,,,,,
7818,107819,4-Hydroxy-1-(3-pyridyl)-1-butanone,C1=CC(=CN=C1)C(=O)CCCO,,,,,"[""4-Hydroxy-1-(3-pyridyl)-1-butanone (HPB) is a known thirdhand smoke metabolite of 4-(Methylnitrosoamino)-1-(3-pyridinyl)-1-butanone (NNK) and N'-Nitrosonornicotine (NNN).""]",
7819,107820,"4-Methylsulfonyl-2,2',5,5'-tetrachlorobiphenyl",CS(=O)(=O)C1=C(C=C(C(=C1)Cl)C2=C(C=CC(=C2)Cl)Cl)Cl,,,,,,
7820,107821,"[(1S,2S,6R,10S,11R,13S,14R,15R)-13-acetyloxy-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-14-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] tetradeca-2,4,6,8-tetraenoate",CCCCCC=CC=CC=CC=CC(=O)O[C@@H]1[C@H]([C@]2([C@@H](C=C(C[C@]3([C@H]2C=C(C3=O)C)O)CO)[C@H]4[C@@]1(C4(C)C)OC(=O)C)O)C,,,,,,
7821,107822,"6-Methyl-3-(1-methyl-4-phenylbutoxy)-5,6,6a,7,8,9,10,10a-octahydro-1,9-phenanthridinediol acetate",CC1C2CCC(CC2C3=C(N1)C=C(C=C3OC(=O)C)OC(C)CCCC4=CC=CC=C4)O,,,"['Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)', 'Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)']",,,
7822,107823,"5-Oxo-L-prolyl-L-histidyl-3,3-dimethyl-L-prolinamide",CC1(CCN([C@@H]1C(=O)N)C(=O)[C@H](CC2=CN=CN2)NC(=O)[C@@H]3CCC(=O)N3)C,,,,,,
7823,107824,[(1-Hydroxyquinolin-4-ylidene)amino] acetate,CC(=O)ON=C1C=CN(C2=CC=CC=C12)O,,,,,,
7824,107825,CID 107825,CC1=C[C@H]2C[C@@H]3[C@@H]([C@H](C([C@]2(C[C@@H]1OC(=O)CC(C)(C)O)COC(=O)C)(C34CO4)C)O)O,,,,,,
7825,107826,Dibenzothiophene;ethane,CC.C1=CC=C2C(=C1)C3=CC=CC=C3S2,,,,,,
7826,107827,CID 107827,C1[C@@H](C([C@@]23N1C(=N)N([C@H]([C@@H]2NC(=N3)N)COC(=O)NS(=O)(=O)O)O)(O)O)OS(=O)(=O)O,,,,,,
7827,107828,Bensulfuron,COC1=CC(=NC(=N1)NC(=O)NS(=O)(=O)CC2=CC=CC=C2C(=O)O)OC,,,,,,
7828,107829,"2-[4,7-Bis(carboxylatomethyl)-1,4,7-triaza-10-azanidacyclododec-1-yl]acetate;gadolinium(3+)",C1CN(CCN(CCN(CC[N-]1)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3],,,,,,
7829,107830,"1,4,7-Tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane",C1CN(CCN(CCN(CCN1)CC(=O)O)CC(=O)O)CC(=O)O,,,,,,
7830,107831,(E)-4-amino-5-ethoxy-2-methyl-5-oxopent-2-enylphosphonic acid,CCOC(=O)C(C=C(C)CP(=O)(O)O)N,,,,,,
7831,107832,CID 107832,C[C@@]12CC3=CC=C(C=C3)OC4=C5[C@@H](CC6=CC(=C(C=C6)O)OC7=C(C=C(C1=C7)CCN2C)OC)N(CCC5=CC(=C4O)OC)C,,,,,,
7832,107833,"Cyclohexene, 1-propyl-",CCCC1=CCCCC1,,,,,,
7833,107834,"(1R,3R,8R,24R,25S,26S)-5,13,25-trimethylspiro[2,10,16,23-tetraoxatetracyclo[22.2.1.03,8.08,25]heptacosa-4,12,18,20-tetraene-26,2'-oxirane]-11,17,22-trione",CC1=C[C@@H]2[C@@]3(CC1)COC(=O)C=C(CCOC(=O)C=CC=CC(=O)O[C@H]4[C@]3([C@]5(CO5)[C@@H](C4)O2)C)C,,,,,,
7834,107835,"17,21-Dihydroxypregn-4-en-3-one",C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CC[C@@]4(CCO)O)C,,,,,,
7835,107836,Chlorodiethylenetriamine platinum,C(C[N-]CC[NH-])[NH-].[Cl-].[Pt+4],,,,,,
7836,107837,Carbamimidic acid--nitric acid--ammonia (1/1/1),C(=O)(N)N.N.[N+](=O)(O)[O-],,,,,,
7837,107838,Tryptoline,C1CNCC2=C1C3=CC=CC=C3N2,,,"['Toxic substances from microorganisms, plants or animals that interfere with the functions of the nervous system. Most venoms contain neurotoxic substances. Myotoxins are included in this concept. (See all compounds classified as Neurotoxins.)']",,,
7838,107839,"2-[34-Butan-2-yl-8,22-dihydroxy-13-(3-hydroxybutan-2-yl)-2,5,11,14,27,30,33,36,39-nonaoxo-27lambda4-thia-3,6,12,15,25,29,32,35,38-nonazapentacyclo[14.12.11.06,10.018,26.019,24]nonatriaconta-18(26),19(24),20,22-tetraen-4-yl]acetamide",CCC(C)C1C(=O)NCC(=O)NC2CS(=O)C3=C(CC(C(=O)NCC(=O)N1)NC(=O)C(NC(=O)C4CC(CN4C(=O)C(NC2=O)CC(=O)N)O)C(C)C(C)O)C5=C(N3)C=C(C=C5)O,,,,,,
7839,107840,"1,4,5,6,7,8,8-Heptachloro-3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-indene",C1=CC(C2C1C3(C(C(C2(C3(Cl)Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
7840,107841,Ethacizine,CCN(CC)CCC(=O)N1C2=CC=CC=C2SC3=C1C=C(C=C3)NC(=O)OCC,,,"['Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)', 'A loosely defined grouping of drugs that have effects on psychological function. Here the psychotropic agents include the antidepressive agents, hallucinogens, and tranquilizing agents (including the antipsychotics and anti-anxiety agents). (See all compounds classified as Psychotropic Drugs.)']",,,
7841,107842,"(2S,6R,10S,11S)-11-but-1-en-3-ynyl-2-pent-2-en-4-ynyl-1-azaspiro[5.5]undecan-10-ol",C#CC=CC[C@@H]1CCC[C@@]2(N1)CCC[C@@H]([C@H]2C=CC#C)O,,,,,,
7842,107843,"7-[3-[4-[(4-Chlorophenyl)methyl]piperazin-1-yl]propoxy]-3,4-dimethyl-4a,8a-dihydrochromen-2-one;dihydrochloride",CC1=C(C(=O)OC2C1C=CC(=C2)OCCCN3CCN(CC3)CC4=CC=C(C=C4)Cl)C.Cl.Cl,,,,,,
7843,107844,"7-[3-[4-[(4-Chlorophenyl)methyl]piperazin-1-yl]propoxy]-3,4-dimethyl-4a,8a-dihydrochromen-2-one",CC1=C(C(=O)OC2C1C=CC(=C2)OCCCN3CCN(CC3)CC4=CC=C(C=C4)Cl)C,,,,,,
7844,107845,"17beta-Acetoxyestra-4,9,11-trien-3-one",CC(=O)OC1CC[C@@H]2[C@@]1(C=CC3=C4CCC(=O)C=C4CC[C@@H]23)C,,,,,,
7845,107846,CID 107846,C[C@@H](C(=O)N[C@H](CCCCN=C(N)N)C(=O)O)NC(=O)[C@@H](CCCNP(=O)(N)NS(=O)(=O)O)N,,,,,,
7846,107847,Dslet,C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)[C@@H](CO)NC(=O)[C@H](CC2=CC=C(C=C2)O)N)O,,,"['Compounds capable of relieving pain without the loss of CONSCIOUSNESS. (See all compounds classified as Analgesics.)', 'Substances that act in the brain stem or spinal cord to produce tonic or clonic convulsions, often by removing normal inhibitory tone. They were formerly used to stimulate respiration or as antidotes to barbiturate overdose. They are now most commonly used as experimental tools. (See all compounds classified as Convulsants.)']",,,
7847,107848,Geniposide,COC(=O)C1=CO[C@H]([C@H]2[C@@H]1CC=C2CO)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
7848,107849,Versicolorin B,C1CO[C@H]2[C@@H]1C3=C(O2)C=C4C(=C3O)C(=O)C5=C(C4=O)C=C(C=C5O)O,,,,,,
7849,107850,Morfamquat dichloride,CC1COCC(N1C(=O)C[N+]2=CC=C(C=C2)C3=CC=[N+](C=C3)CC(=O)N4C(COCC4C)C)C.[Cl-].[Cl-],,,,,,
7850,107851,Morfamquat,CC1COCC(N1C(=O)C[N+]2=CC=C(C=C2)C3=CC=[N+](C=C3)CC(=O)N4C(COCC4C)C)C,,,,,,
7851,107852,"3-[(3R,22S)-16-ethenyl-11-ethyl-4-hydroxy-3-methoxycarbonyl-12,17,26-trimethyl-7,23,24,25-tetrazahexacyclo[18.2.1.15,8.110,13.115,18.02,6]hexacosa-1,4,6,8(26),9,11,13(25),14,16,18(24),19-undecaen-22-yl]propanoic acid",CCC1=C(C2=NC1=CC3=C(C4=C([C@@H](C(=C5[C@H](CC(=CC6=NC(=C2)C(=C6C)C=C)N5)CCC(=O)O)C4=N3)C(=O)OC)O)C)C,,,,,,
7852,107853,N-Hydroxymethyl-N-methylformamide,CN(CO)C=O,,,,,,
7853,107854,Phorbol-12-myristate,CCCCCCCCCCCCCC(=O)O[C@@H]1[C@H]([C@]2([C@@H](C=C(C[C@]3([C@H]2C=C(C3=O)C)O)CO)[C@H]4[C@@]1(C4(C)C)O)O)C,,,,,,
7854,107855,12-Deoxyphorbol 13-isobutyrate,C[C@@H]1C[C@@]2([C@@H](C2(C)C)[C@H]3[C@]1([C@@H]4C=C(C(=O)[C@]4(CC(=C3)CO)O)C)O)OC(=O)C(C)C,,,,,,
7855,107856,"1,3-Propanediamine, N-(2-chloroethyl)-N'-(7-chloro-2-methoxybenzo(b)-1,5-naphthyridin-10-yl)-, dihydrochloride",COC1=NC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCNCCCl.Cl.Cl,,,,,,
7856,107857,"N-(2-chloroethyl)-N'-(7-chloro-2-methoxybenzo[b][1,5]naphthyridin-10-yl)propane-1,3-diamine",COC1=NC2=C(C3=C(C=C(C=C3)Cl)N=C2C=C1)NCCCNCCCl,,,,,,
7857,107858,4-(Isopropylamino)-2-(2-pyridyl)-2-phenylbutyramide,CC(C)NCCC(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N,,,['Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)'],,['N-Desisopropyldisopyramide is a known human metabolite of Disopyramide and disopiramide.'],
7858,107859,"n-(Hexahydro-1h-1,6-epoxypyrrolizin-7-yl)-n-methylformamide",CN(C=O)C1C2CN3C1C(O2)CC3,,,,,,
7859,107860,"Benzo(a)pyrene-7,8,9,10-tetrol, 7,8,9,10-tetrahydro-, (7R,8S,9R,10S)-rel-",C1=CC2=C3C(=C1)C=CC4=C3C(=CC5=C4[C@@H]([C@H]([C@H]([C@@H]5O)O)O)O)C=C2,,,,,,
7860,107861,Marcellomycin,CC[C@]1(C[C@@H](C2=C(C3=C(C=C2[C@H]1C(=O)OC)C(=O)C4=C(C=CC(=C4C3=O)O)O)O)O[C@H]5C[C@@H]([C@@H]([C@@H](O5)C)O[C@H]6C[C@@H]([C@@H]([C@@H](O6)C)O[C@H]7C[C@@H]([C@@H]([C@@H](O7)C)O)O)O)N(C)C)O,,,['Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)'],,,
7861,107862,"1,1'-Biphenyl, 2,2',4',5,5'-pentachloro-3-(methylsulfonyl)-",CS(=O)(=O)C1=CC(=CC(=C1Cl)C2=CC(=C(C=C2Cl)Cl)Cl)Cl,,,,,,
7862,107863,Destruxin E,CCC(C)C1C(=O)N(C(C(=O)N(C(C(=O)NCCC(=O)OC(C(=O)N2CCCC2C(=O)N1)CC3CO3)C)C)C(C)C)C,,,,,,
7863,107864,HC-Toxin,C[C@@H]1C(=O)N[C@H](C(=O)N2CCC[C@@H]2C(=O)N[C@H](C(=O)N1)C)CCCCCC(=O)C3CO3,,,,,,
7864,107865,"(9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-[(1S)-1-hydroxyethyl]-8,10-dihydro-7H-tetracene-5,12-dione",C[C@H]1[C@H]([C@H](C[C@@H](O1)OC2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=CC=CC=C5C4=O)O)([C@H](C)O)O)N)O,,,['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)'],,,
7865,107866,CID 107866,CC1=C(C(=C(OC1=O)[C@]2([C@@H](O2)C(=CC(=C[C@]3([C@H]4[C@](O4)(CO3)C)C)C)C)C)C)OC,,,,,,
7866,107867,Otenzepad,CCN(CC)CC1CCCCN1CC(=O)N2C3=CC=CC=C3C(=O)NC4=C2N=CC=C4,,,"['Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)', 'Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)']",,,
7867,107868,"3-Methylsulfonyl-4,5,3',4'-tetrachlorobiphenyl",CS(=O)(=O)C1=C(C(=CC(=C1)C2=CC(=C(C=C2)Cl)Cl)Cl)Cl,,,,,,
7868,107869,"(7S-9R,10R)-3'-Deamino-3'-(4-morpholinyl)-13-deoxy-10-hydroxycarminomycin",CCC1(CC(C2=C(C1O)C(=C3C(=C2O)C(=O)C4=C(C3=O)C=CC=C4O)O)OC5CC(C(C(O5)C)O)N6CCOCC6)O,,,,,,
7869,107870,"1,N(2)-Propanodeoxyguanosine",C1CNC2=NC3=C(C(=O)N2C1)N=CN3[C@H]4C[C@@H]([C@H](O4)CO)O,,,,,,
7870,107871,3-Chloro-4-(chloromethyl)-5-hydroxy-2(5H)-furanone,C(C1=C(C(=O)OC1O)Cl)Cl,,,,,,
7871,107872,but-2-enedioic acid;N-[4-[4-[ethyl(heptyl)amino]-1-hydroxybutyl]phenyl]methanesulfonamide,CCCCCCCN(CC)CCCC(C1=CC=C(C=C1)NS(=O)(=O)C)O.C(=CC(=O)O)C(=O)O,,,,,,
7872,107873,"(1R,2S)-1-heptyl-2-octylcyclopentane",CCCCCCCC[C@H]1CCC[C@H]1CCCCCCC,,,,,,
7873,107874,"2-(2,4-Dichloro-6-phenylphenoxy)ethylamine",C1=CC=C(C=C1)C2=C(C(=CC(=C2)Cl)Cl)OCCN,,,,,,
7874,107875,N-Hydroxy-4-(methylamino)azobenzene,CN(C1=CC=C(C=C1)N=NC2=CC=CC=C2)O,,,,,,
7875,107876,Procyanidin,C1C(C(OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)OC4(C(C(C5=C(C=C(C=C5O4)O)O)O)O)C6=CC(=C(C=C6)O)O,,,['Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)'],,,
7876,107877,CID 107877,OP(=O)(O)OP(=O)(O)[O-].[Na+],,,,,,
7877,107878,Anhydrotetrodotoxin,C([C@]1([C@@H]2[C@H]([C@@]34[C@H]5[C@@](O2)(OC1C3C(O5)N=C(N4)N)O)O)O)O,,,,,,
7878,107879,Peroxydisulfate,[O-]S(=O)(=O)OOS(=O)(=O)[O-],,,,,,
7879,107880,"6H-(1,3)Dioxolo(5,6)benzofuro(3,2-c)(1)benzopyran-6a(12aH)-ol, 3-methoxy-, (6aS-cis)-",COC1=CC2=C(C=C1)[C@H]3[C@@](CO2)(C4=CC5=C(C=C4O3)OCO5)O,,,['Substances that are destructive to protozoans. (See all compounds classified as Antiprotozoal Agents.)'],,,
7880,107881,Perhydrohistrionicotoxin,CCCCC[C@@H]1CCC[C@@]2(N1)CCC[C@@H]([C@H]2CCCC)O,,,['Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)'],,,
7881,107882,Apomorphine hydrochloride hydrate,CN1CCC2=C3[C@H]1CC4=C(C3=CC=C2)C(=C(C=C4)O)O.CN1CCC2=C3[C@H]1CC4=C(C3=CC=C2)C(=C(C=C4)O)O.O.Cl.Cl,"['Treatment of men with erectile dysfunction, which is the inability to achieve or maintain a penile erection sufficient for satisfactory sexual performance.']",,"['Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)', 'Agents that cause vomiting. They may act directly on the gastrointestinal tract, bringing about emesis through local irritant effects, or indirectly, through their effects on the chemoreceptor trigger zone in the postremal area near the medulla. (See all compounds classified as Emetics.)']",,,
7882,107883,Dihydrokainic acid,CC(C)[C@H]1CN[C@@H]([C@H]1CC(=O)O)C(=O)O,,,,,,
7883,107884,CID 107884,CC1=C(C=C(C=C1[N+](=O)[O-])N=O)N(O)O,,,,,,
7884,107885,11-Nor-9-carboxy-thc,CCCCCC1=CC(=C2C3C=C(CCC3C(OC2=C1)(C)C)C(=O)O)O,,,,,,
7885,107886,"2-[24-(2-Aminoethyl)-15-(3-aminopropyl)-3-(2-chloro-1-hydroxyethyl)-9-ethylidene-12-(1-hydroxyethyl)-18-(2-hydroxyethyl)-27-(3-hydroxytetradecanoylamino)-2,5,8,11,14,17,20,23,26-nonaoxo-1-oxa-4,7,10,13,16,19,22,25-octazacyclooctacos-6-yl]-2-hydroxyacetic acid",CCCCCCCCCCCC(CC(=O)NC1COC(=O)C(NC(=O)C(NC(=O)C(=CC)NC(=O)C(NC(=O)C(NC(=O)C(NC(=O)CNC(=O)C(NC1=O)CCN)CCO)CCCN)C(C)O)C(C(=O)O)O)C(CCl)O)O,,,,,,
7886,107887,N-Nitroso-2-hydroxymorpholine,C1COC(CN1N=O)O,,,,,,
7887,107888,"2,4,5,3',4'-Pentabromobiphenyl",C1=CC(=C(C=C1C2=CC(=C(C=C2Br)Br)Br)Br)Br,,,,,,
7888,107889,"Cyclopenta(c)pyrido(3,2-a)carbazole, 1,2,3,8-tetrahydro-",C1CC2=C3C4=CC=CC=C4NC3=C5C=CC=NC5=C2C1,,,,,,
7889,107890,CID 107890,CC1=C(C(CCC1)(C)C)CCC(=CCCC2=CC[C@@H](O[C@H]2O)C3CC(=O)O[C@H]3O)C,,,,,,
7890,107891,N-Demethyldiltiazem,CC(=O)O[C@@H]1[C@@H](SC2=CC=CC=C2N(C1=O)CCNC)C3=CC=C(C=C3)OC,,,,,['N-Demethyldiltiazem is a known human metabolite of diltiazem.'],
7891,107892,CID 107892,C[C@H]1C=CC=CC=CC=CC=CC=CC=C[C@@H](C[C@H]2[C@@H]([C@H](C[C@](O2)(C[C@H](C[C@H]([C@@H](CC[C@H](C[C@H](CC(=O)O[C@H]([C@@H]([C@@H]1O)C)C)O)O)O)O)O)O)O)C(=O)O)O[C@H]3[C@H]([C@H]([C@@H]([C@H](O3)C)O)N)O.C[C@H](CCC(=O)[O-])[C@H]1CC[C@@H]2[C@@]1([C@H](C[C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C.[Na+],,,,,,
7892,107893,CID 107893,CN(C[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)[O-])C(S)S.[Na+],,,,,,
7893,107894,"(2R,3R,4R,5S)-6-[bis(sulfanyl)methyl-methylamino]hexane-1,2,3,4,5-pentol",CN(C[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O)C(S)S,,,,,,
7894,107895,"1(6H)-Pyridazinebutanoic acid, 6-imino-3-(4-methoxyphenyl)-, monohydrobromide",COC1=CC=C(C=C1)C2=NN(C(=N)C=C2)CCCC(=O)O.Br,,,"['Drugs that bind to but do not activate GABA RECEPTORS, thereby blocking the actions of endogenous GAMMA-AMINOBUTYRIC ACID and GABA RECEPTOR AGONISTS. (See all compounds classified as GABA Antagonists.)']",,,
7895,107896,Gabazine,COC1=CC=C(C=C1)C2=NN(C(=N)C=C2)CCCC(=O)O,,,"['Drugs that bind to but do not activate GABA RECEPTORS, thereby blocking the actions of endogenous GAMMA-AMINOBUTYRIC ACID and GABA RECEPTOR AGONISTS. (See all compounds classified as GABA Antagonists.)']",,,
7896,107897,CID 107897,CC[C@@H]1C=C(C[C@@H](C[C@@H]([C@@H]2[C@H](C[C@H]([C@@](O2)(C(=O)C(=O)C3CCCC[C@H]3C(=O)OC([C@@H]([C@H](CC1=O)O)C)C(=C[C@@H]4CC[C@H]([C@@H](C4)OC)O)C)O)C)OC)OC)C)C,,,,,,
7897,107898,"1,2-Dioleoyl-3-trimethylammonium-propane (chloride salt)",CCCCCCCCC=CCCCCCCCC(=O)OCC(C[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
7898,107899,CID 107899,C1[C@H](O[C@H]([C@@H]1O)N2CNC3=C(N=C(N=C32)Cl)N)CO,,,,,,
7899,107900,"trans-1,2-Dihydro-1,2-dihydroxy-6-aminochrysene",C1=CC=C2C(=C1)C3=C(C=C2N)C4=C(C=C3)[C@@H]([C@H](C=C4)O)O,,,,,,
7900,107901,Epoxiconazol,C1=CC=C(C(=C1)[C@@H]2[C@@](O2)(CN3C=NC=N3)C4=CC=C(C=C4)F)Cl,,,"['Chemicals that kill or inhibit the growth of fungi in agricultural applications, on wood, plastics, or other materials, in swimming pools, etc. (See all compounds classified as Fungicides, Industrial.)']",,,
7901,107902,CID 107902,C1[C@@H]([C@H](O[C@H]1N2C3=C(C(=O)N=C(N3)N)NC2=O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O,,,,,,
7902,107903,"6-(4-(2,2-di(4-Fluorophenyl)ethylamino)-1-piperidinyl)-N,N'-di-2-propenyl-1,3,5-triazine-2,4-diamine",C=CCNC1=NC(=NC(=N1)N2CCC(CC2)NCC(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F)NCC=C,,,['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)'],,,
7903,107904,Dityrosine,C1=CC(=C(C=C1CC(C(=O)O)N)C2=C(C=CC(=C2)CC(C(=O)O)N)O)O,,,,,,
7904,107905,(-)-Epicatechin gallate,C1[C@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)OC(=O)C4=CC(=C(C(=C4)O)O)O,,,"['Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)', 'Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). (See all compounds classified as Protease Inhibitors.)', 'Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)']",,,
7905,107906,CID 107906,C[C@]12CCC(=O)CC1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCCC4=O)C,,,,,,
7906,107907,CID 107907,C(=O)(O)O.O.O.O.O.[AlH3].[AlH3],,,,,,
7907,107908,Phosphite,[O-]P([O-])[O-],,,,,,
7908,107909,"Phosphorane, trihydroxy-",OP(O)O,,,,,,
7909,107910,CID 107910,C=CCCCC(=NOS(=O)(=O)O)S[C@@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O,,,,,,
7910,107911,alpha-Ochratoxin,C[C@@H]1CC2=C(C=C(C(=C2C(=O)O1)O)C(=O)O)Cl,,,,,,
7911,107912,N-(2-Hydroxyethyl)valine,CC(C)C(C(=O)O)NCCO,,,,,,
7912,107913,"N-methylhexahydro-1H-1,6-epoxypyrrolizin-7-amine",CN[C@H]1[C@H]2CN3[C@@H]1C(O2)CC3,,,,,,
7913,107914,"(2S)-N-[(R)-[(2S,4R,6R)-6-[(2S)-2,3-dimethoxypropyl]-4-hydroxy-5,5-dimethyloxan-2-yl]-methoxymethyl]-2-hydroxy-2-[(2R,5R,6R)-2-methoxy-5,6-dimethyl-4-methylideneoxan-2-yl]acetamide",C[C@H]1[C@H](O[C@](CC1=C)([C@@H](C(=O)N[C@@H]([C@@H]2C[C@H](C([C@H](O2)C[C@@H](COC)OC)(C)C)O)OC)O)OC)C,,,,,,
7914,107915,(S)-2-Chloropropionic acid,C[C@@H](C(=O)O)Cl,,,,,,
7915,107916,CID 107916,C(CC(=O)[O-])C(C(=O)O)N.[Na+],,,,,,
7916,107917,1-Hydroxymidazolam,C1C2=CN=C(N2C3=C(C=C(C=C3)Cl)C(=N1)C4=CC=CC=C4F)CO,,,,,"[""1'-Hydroxymidazolam is a known human metabolite of midazolam.""]",
7917,107918,Oligoadenylate,C1=NC(=C2C(=N1)N(C=N2)[C@H]3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OC4[C@@H]([C@H](O[C@H]4N5C=NC6=C(N=CN=C65)N)COP(=O)(O)O)O)O)OP(=O)(O)OCC7[C@H]([C@H](C(O7)N8C=NC9=C(N=CN=C98)N)O)O)N,,,"['Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)', 'Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. (See all compounds classified as Protein Synthesis Inhibitors.)']",,,
7918,107919,N(delta)-(N-Methyl-N-nitrosocarbamoyl)-L-ornithine,CN(C(=O)NCCC[C@@H](C(=O)O)N)N=O,,,,,,
7919,107920,"(1R,3S,6R,8S,10R,12S,16R,18R,19R,20S,22R,25S,27R,32S,34R,36S,38R,40S,42R,43S,44S,45S,47S,48S,49S,50R,52S,54R,56R,58S,59R)-16-buta-1,3-dienyl-43,44,49,54,58-pentamethylspiro[2,7,11,17,21,26,33,37,41,46,51,57-dodecaoxadodecacyclo[30.28.0.03,27.06,25.08,22.010,20.012,18.034,58.036,56.038,52.040,50.042,47]hexaconta-4,14,23,29-tetraene-45,2'-oxolane]-19,48,59-triol",C[C@@H]1C[C@H]2[C@@H](C[C@H]3[C@H](O2)[C@H]([C@@H]([C@H]4[C@H](O3)[C@H]([C@@H]([C@@]5(O4)CCCO5)C)C)O)C)O[C@H]6C[C@@H]7[C@]([C@@H](C[C@@H]8[C@@H](O7)CC=CC[C@@H]9[C@@H](O8)C=C[C@@H]2[C@@H](O9)C=C[C@@H]3[C@@H](O2)C[C@@H]2[C@@H](O3)[C@@H]([C@@H]3[C@@H](O2)CC=C[C@@H](O3)C=CC=C)O)O)(O[C@@H]6C1)C,,,,,,
7920,107921,(S)-Mephenytoin,CC[C@@]1(C(=O)N(C(=O)N1)C)C2=CC=CC=C2,,,,,"[""S-Mephenytoin has known human metabolites that include 4'-Hydroxymephenytoin and Nirvanol.""]",
7921,107922,"6b,7a-Dihydrobenzo[1,10]acephenanthryleno[4,5-b]oxirene",C1=CC2=C3C(=C1)C=C4C5C(O5)C6=C4C3=C(C=C2)C=C6,,,,,,
7922,107923,"5-[(4R,5R)-5-hydroxy-4-[(3S)-3-hydroxyoct-1-enyl]-1-phenyl-5,6-dihydro-4H-cyclopenta[b]pyrrol-2-yl]pentanoic acid",CCCCC[C@@H](C=C[C@H]1[C@@H](CC2=C1C=C(N2C3=CC=CC=C3)CCCCC(=O)O)O)O,,,,,,
7923,107924,Asulacrine,CC1=C2C(=CC=C1)C(=C3C=CC=C(C3=N2)C(=O)NC)NC4=C(C=C(C=C4)NS(=O)(=O)C)OC,,,"['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)', 'Compounds that inhibit the activity of DNA TOPOISOMERASE II. Included in this category are a variety of ANTINEOPLASTIC AGENTS which target the eukaryotic form of topoisomerase II and ANTIBACTERIAL AGENTS which target the prokaryotic form of topoisomerase II. (See all compounds classified as Topoisomerase II Inhibitors.)']",,,
7924,107925,CID 107925,C=CCN1CC[C@]23[C@@H]4C(=NN=C5CC[C@]6([C@@H]7CC8=C9[C@]6([C@H]5OC9=C(C=C8)O)CCN7CC=C)O)CC[C@]2([C@@H]1CC1=C3C(=C(C=C1)O)O4)O,,,,,,
7925,107926,Bretazenil,CC(C)(C)OC(=O)C1=C2[C@@H]3CCCN3C(=O)C4=C(N2C=N1)C=CC=C4Br,,,['Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)'],,,
7926,107927,5-Hydroxypropafenone,CCCNCC(COC1=C(C=C(C=C1)O)C(=O)CCC2=CC=CC=C2)O,,,"['Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)', 'Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. (See all compounds classified as Adrenergic beta-Antagonists.)']",,['5-Hydroxypropafenone is a known human metabolite of Propafenone.'],
7927,107928,(-)-Devapamil,CC(C)[C@](CCCN(C)CCC1=CC(=CC=C1)OC)(C#N)C2=CC(=C(C=C2)OC)OC,,,,,,
7928,107929,"10-Ethoxydecahydro-3,6,9-trimethyl-3,12-epoxy-12H-pyrano(4,3-j)-1,2-benzodioxepin",CCOC1[C@@H]([C@@H]2CC[C@H]([C@H]3[C@]24[C@H](O1)O[C@@](CC3)(OO4)C)C)C,,,"['Agents used in the treatment of malaria. They are usually classified on the basis of their action against plasmodia at different stages in their life cycle in the human. (From AMA, Drug Evaluations Annual, 1992, p1585) (See all compounds classified as Antimalarials.)', 'Agents that act systemically to kill adult schistosomes. (See all compounds classified as Schistosomicides.)', 'Agents which are destructive to amebae, especially the parasitic species causing AMEBIASIS in man and animal. (See all compounds classified as Amebicides.)']",,,
7929,107930,Ecopipam,CN1CCC2=CC(=C(C=C2[C@@H]3[C@@H]1CCC4=CC=CC=C34)O)Cl,,,"['Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)', 'Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)']",,,
7930,107931,"methyl 4-methyl-3,7-dioxo-10-(5,6,7-trimethoxy-1H-indole-2-carbonyl)-5,10-diazatetracyclo[7.4.0.01,12.02,6]trideca-2(6),8-diene-4-carboxylate",CC1(C(=O)C2=C(N1)C(=O)C=C3C24CC4CN3C(=O)C5=CC6=CC(=C(C(=C6N5)OC)OC)OC)C(=O)OC,,,,,,
7931,107932,"Naphthalene, 1,2,4,6,7-pentachloro-",C1=C2C(=CC(=C1Cl)Cl)C(=C(C=C2Cl)Cl)Cl,,,,,,
7932,107933,Mtset,C[N+](C)(C)CCSS(=O)(=O)C.[Br-],,,"['Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh&apos;s Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)', 'Chemical agents that react with SH groups. This is a chemically diverse group that is used for a variety of purposes. Among these are enzyme inhibition, enzyme reactivation or protection, and labelling. (See all compounds classified as Sulfhydryl Reagents.)']",,,
7933,107934,Trimethyl-(2-methylsulfonylsulfanylethyl)azanium bromide,C[N+](C)(C)CCSS(=O)(=O)C,,,,,,
7934,107935,Deguelin,CC1(C=CC2=C(O1)C=CC3=C2O[C@@H]4COC5=CC(=C(C=C5[C@@H]4C3=O)OC)OC)C,,,,,,
7935,107936,gamma-Fagarine,COC1=CC=CC2=C1N=C3C(=C2OC)C=CO3,,,,,,
7936,107937,"n-(Hexahydro-1h-1,6-epoxypyrrolizin-7-yl)-n-methylacetamide",CC(=O)N(C)C1C2CN3C1C(O2)CC3,,,,,,
7937,107938,Lycopsamine,C[C@@H]([C@@](C(C)C)(C(=O)OCC1=CCN2[C@H]1[C@@H](CC2)O)O)O,,,,,,
7938,107939,"(1R,6R,7R,17R)-4-ethylidene-7-hydroxy-6,7-dimethyl-14-oxido-2,9-dioxa-14-azoniatricyclo[9.5.1.014,17]heptadec-11-ene-3,8-dione",CC=C1C[C@H]([C@@](C(=O)OCC2=CC[N+]3([C@H]2[C@@H](CC3)OC1=O)[O-])(C)O)C,,,,,,
7939,107940,Phytoporphyrin,CCC1=C(C2=CC3=NC(=C4CC(=C5C4=NC(=C5C)C=C6C(=C(C(=N6)C=C1N2)C)CC)O)C(=C3C)CCC(=O)O)C,,,,,,
7940,107941,Solenopsin A,CCCCCCCCCCC[C@H]1CCC[C@@H](N1)C,,,,,,
7941,107942,"2,3,4-Trichloro-6-(2,4-dichlorophenoxy)phenol",C1=CC(=C(C=C1Cl)Cl)OC2=CC(=C(C(=C2O)Cl)Cl)Cl,,,,,,
7942,107943,"5,7-Dihydroxy-4a,9-dimethyl-3-methylidenedecahydrofuro[2',3':5,6]cyclohepta[1,2-c]pyran-2(3h)-one",CC1CC2C(CC3(C1CC(OC3O)O)C)C(=C)C(=O)O2,,,,,,
7943,107944,Bicep,CCC1=CC=CC(=C1N(C(C)COC)C(=O)CCl)C.CCNC1=NC(=NC(=N1)Cl)NC(C)C,,,,,,
7944,107945,"3,4-Dihydrobenz(a)anthracene-3,4-diol",C1=CC=C2C=C3C(=CC2=C1)C=CC4=C3C=CC(C4O)O,,,,,,
7945,107946,"Benzene, 1-chloro-4-(2,2-dichloro-1-(4-chlorophenyl)ethenyl)-2-(methylsulfonyl)-",CS(=O)(=O)C1=C(C=CC(=C1)C(=C(Cl)Cl)C2=CC=C(C=C2)Cl)Cl,,,,,,
7946,107947,"(2S,5R)-3,3-dimethyl-7-oxo-6-[[(2R)-2-[(4-oxo-1H-1,5-naphthyridine-3-carbonyl)amino]-2-phenylacetyl]amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid",CC1([C@@H](N2[C@H](S1)C(C2=O)NC(=O)[C@@H](C3=CC=CC=C3)NC(=O)C4=CNC5=C(C4=O)N=CC=C5)C(=O)O)C,,,,,,
7947,107948,"1,9-Dideoxyforskolin",CC(=O)O[C@H]1[C@H]([C@@H]2[C@](CCCC2(C)C)([C@@H]3[C@@]1(O[C@@](CC3=O)(C)C=C)C)C)O,,,,,,
7948,107949,N'-Acetyl-4-(hydroxymethyl)phenylhydrazine,CC(=O)NNC1=CC=C(C=C1)CO,,,,,,
7949,107950,"3-Methyl-6-[3-(trifluoromethyl)phenyl]-[1,2,4]triazolo[4,3-b]pyridazine",CC1=NN=C2N1N=C(C=C2)C3=CC(=CC=C3)C(F)(F)F,,,"['Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)']",,,
7950,107951,CID 107951,CC(=CC#CC(=CC[C@@H](C(=COC(=O)C)C=COC(=O)C)OC(=O)C)C)C,,,,,,
7951,107952,Betaxolol hydrochloride,CC(C)NCC(COC1=CC=C(C=C1)CCOCC2CC2)O.Cl,,,"['Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)', 'Drugs that bind to and block the activation of ADRENERGIC BETA-1 RECEPTORS. (See all compounds classified as Adrenergic beta-1 Receptor Antagonists.)', 'Drugs that inhibit the actions of the sympathetic nervous system by any mechanism. The most common of these are the ADRENERGIC ANTAGONISTS and drugs that deplete norepinephrine or reduce the release of transmitters from adrenergic postganglionic terminals (see ADRENERGIC AGENTS). Drugs that act in the central nervous system to reduce sympathetic activity (e.g., centrally acting alpha-2 adrenergic agonists, see ADRENERGIC ALPHA-AGONISTS) are included here. (See all compounds classified as Sympatholytics.)']",,,
7952,107953,"3,3',4,4'-Tetrabromobiphenyl",C1=CC(=C(C=C1C2=CC(=C(C=C2)Br)Br)Br)Br,,,,,,
7953,107954,CID 107954,C1=CC(=CC=C1C(=O)NCCC(=O)[O-])N=NC2=CC(=C(C=C2)O)C(=O)[O-].[Na+].[Na+],,,,,,
7954,107955,"1H-Isoindole-1,3(2H)-dione, 2-(4-chloro-2-fluoro-5-(2-propynyloxy)phenyl)-4,5,6,7-tetrahydro-",C#CCOC1=C(C=C(C(=C1)N2C(=O)C3=C(C2=O)CCCC3)F)Cl,,,,,,
7955,107956,CID 107956,C[C@H]([C@@H]1[C@@H]2N(C1=O)C(=C(S2)COC(=O)N)C(=O)[O-])O.[Na+],,,,,,
7956,107957,(+)-Catechin Hydrate,C1[C@@H]([C@H](OC2=CC(=CC(=C21)O)O)C3=CC(=C(C=C3)O)O)O.O,,,,,,
7957,107958,"3-[(Tetradeca-1,3,5,7,9-pentaen-1-yl)oxy]propane-1,2-diol",CCCCC=CC=CC=CC=CC=COC[C@H](CO)O,,,,,,
7958,107959,N-(N-Acetyl-L-prolyl)-N-nitrosoglycine,CC(=O)N1CCC[C@H]1C(=O)N(CC(=O)O)N=O,,,,,,
7959,107960,CID 107960,CN1C(=C(NC2=CC=CC=N2)O)C(=O)C3=CC=CC=C3S1(=O)=O.C([C@H]1[C@H]2[C@H]([C@H]([C@@H](O1)O[C@H]3[C@@H](O[C@H]([C@@H]([C@@H]3O)O)O[C@H]4[C@@H](O[C@H]([C@@H]([C@@H]4O)O)O[C@H]5[C@@H](O[C@H]([C@@H]([C@@H]5O)O)O[C@H]6[C@@H](O[C@H]([C@@H]([C@@H]6O)O)O[C@H]7[C@@H](O[C@H]([C@@H]([C@@H]7O)O)O[C@H]8[C@@H](O[C@@H](O2)[C@@H]([C@@H]8O)O)CO)CO)CO)CO)CO)CO)O)O)O,,,,,,
7960,107961,CID 107961,C([C@@H]1[C@@H]2[C@@H](C([C@H](O1)O[C@@H]3[C@H](O[C@@H](C([C@H]3O)O)O[C@@H]4[C@H](O[C@@H](C([C@H]4O)O)O[C@@H]5[C@H](O[C@@H](C([C@H]5O)O)O[C@@H]6[C@H](O[C@@H](C([C@H]6O)O)O[C@@H]7[C@H](O[C@@H](C([C@H]7O)O)O[C@@H]8[C@H](O[C@H](O2)C([C@H]8O)O)CO)CO)CO)CO)CO)CO)O)O)O,,,,,,
7961,107962,"beta-D-Glucopyranosiduronic acid, ((2-methylpropyl)nitrosoamino)methyl",CC(C)CN(CO[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)C(=O)O)O)O)O)N=O,,,,,,
7962,107963,Hydroxycotinine,CN1[C@@H](C[C@H](C1=O)O)C2=CN=CC=C2,,,,,,
7963,107964,"Pregna-1,4,9(11)-triene-3,20-dione, 21-(4-(3,6-bis(diethylamino)-2-pyridinyl)-1-piperazinyl)-16-methyl-, hydrochloride, (16alpha)-",CCN(CC)C1=C(N=C(C=C1)N(CC)CC)N2CCN(CC2)CC(=O)[C@H]3[C@@H](C[C@@H]4[C@@]3(CC=C5[C@H]4CCC6=CC(=O)C=C[C@@]65C)C)C.Cl,,,"['Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)', 'Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)', 'Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)']",,,
7964,107965,U-74500A Free base,CCN(CC)C1=C(N=C(C=C1)N(CC)CC)N2CCN(CC2)CC(=O)[C@H]3[C@@H](C[C@@H]4[C@@]3(CC=C5[C@H]4CCC6=CC(=O)C=C[C@@]65C)C)C,,,,,,
7965,107966,"2-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)isoindoline-1,3-dione hydrobromide",COC1=CC=CC=C1N2CCN(CC2)CCCCN3C(=O)C4=CC=CC=C4C3=O.Br,,,"['Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)']",,,
7966,107967,N(2)-(4-Hydroxy-1-(1-methyl-1H-indol-3-yl)carbonyl-L-prolyl)-N-methyl-N-phenylmethyl-3-(2-naphthyl)-L-alaninamide,CN1C=C(C2=CC=CC=C21)C(=O)N3C[C@@H](C[C@H]3C(=O)N[C@@H](CC4=CC5=CC=CC=C5C=C4)C(=O)N(C)CC6=CC=CC=C6)O,,,,,,
7967,107968,S-Methylthiocitrulline,CSC(=NCCC[C@@H](C(=O)O)N)N,,,['Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)'],,,
7968,107969,Fingolimod hydrochloride,CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N.Cl,['Gilenya is indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of adult patients and paediatric patients aged 10 years and older:'],,"['Agents that affect the function of G-protein coupled SPHINGOSINE 1-PHOSPHATE RECEPTORS. Their binding to the receptors blocks lymphocyte migration and are often used as IMMUNOSUPPRESSANTS. (See all compounds classified as Sphingosine 1 Phosphate Receptor Modulators.)', 'Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)']",,,
7969,107970,Fingolimod,CCCCCCCCC1=CC=C(C=C1)CCC(CO)(CO)N,"['Fingolimod is indicated for the treatment of patients aged 10 and above with relapsing forms of multiple sclerosis, which may include clinically isolated syndrome, relapsing-remitting disease, as well as active secondary progressive disease.  This drug is being studied for administration in patients infected with COVID-19 with a high risk for acute respiratory distress syndrome, or ARDS. As of April 3 2020, this is currently not an approved indication and clinical trials are underway.']","['In multiple sclerosis, fingolimod binds to sphingosine receptors, reducing its associated neuroinflammation.In COVID-19, it may reduce lung inflammation and improve the clinical outcomes of patients with this disease.   Cardiovascular effects  Fingolimod causes a transient reduction in heart rate and AV conduction during treatment initiation. It has the potential to prolong the QT interval.']","['Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)', 'Agents that affect the function of G-protein coupled SPHINGOSINE 1-PHOSPHATE RECEPTORS. Their binding to the receptors blocks lymphocyte migration and are often used as IMMUNOSUPPRESSANTS. (See all compounds classified as Sphingosine 1 Phosphate Receptor Modulators.)']","['Fingolimod is slowly but efficiently absorbed in the gastrointestinal tract. AUC varies greatly, depending on the patient, and pharmacokinetic studies demonstrate a range of AUC values for fingolimod. The Tmax of fingolimod ranges between 12-16 hours and its bioavailability is 90-93%. Steady-state concentrations of fingolimod are achieved within 1-2 months after initiation when it is administered in a single daily dose.', 'About 81% of an oral dose of fingolimod is excreted in the urine in the form of inactive metabolites. Intact fingolimod and its active metabolite account for less than 2.5% of the dose, and can be found excreted in the feces.', 'The volume of distribution of fingolimod is about 1200±260 L. It is approximately 86% distributed in the red blood cells (RBC).', 'Fingolimod blood clearance is 6.3±2.3 L/h, according to prescribing information. Another resource mentions it ranges from 6-8 L/h.']","['Sphingosine kinase metabolizes fingolimod to an active metabolite, fingolimod phosphate. Fingolimod metabolism occurs via 3 major metabolic pathways: firstly, phosphorylation of the (S)-enantiomer of fingolimod-phosphate (pharmacologically active), secondly, oxidation by cytochrome P450 4F2 (CYP4F2), and thirdly, fatty acid-like metabolism to various inactive metabolites. The formation of inactive non-polar ceramide analogs of fingolimod also occurs during its metabolism.']",['The half-life of fingolimod and its active metabolite ranges from 6-9 days.']
7970,107971,Daidzin,C1=CC(=CC=C1C2=COC3=C(C2=O)C=CC(=C3)O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)O,,,"['Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)', 'Substances interfering with the metabolism of ethyl alcohol, causing unpleasant side effects thought to discourage the drinking of alcoholic beverages. Alcohol deterrents are used in the treatment of alcoholism. (See all compounds classified as Alcohol Deterrents.)']",,,
7971,107972,CID 107972,C1=C(OC(=C1)N(O)O)C(=N)N=O,,,,,,
7972,107973,Epn oxon,CCOP(=O)(C1=CC=CC=C1)OC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
7973,107974,Trichothecolone,CC1=C[C@@H]2[C@](CC1=O)(C3([C@@H](C[C@H](C34CO4)O2)O)C)C,,,,,,
7974,107975,Nitrovin hydrochloride,C1=C(OC(=C1)[N+](=O)[O-])C=CC(=NN=C(N)N)C=CC2=CC=C(O2)[N+](=O)[O-].Cl,,,,,,
7975,107976,"(1S,3R,4R,6S,8S,10S,13R,14R)-5,5,14-trimethyl-9-methylidenetetracyclo[11.2.1.01,10.04,8]hexadecane-3,4,6,14,16-pentol",C[C@]1(C[C@@]23C[C@H]([C@]4([C@@H](C[C@@H](C4(C)C)O)C(=C)[C@@H]2CC[C@@H]1C3O)O)O)O,,,,,,
7976,107977,Propylisopropylacetamide,CCCC(C(C)C)C(=O)N,,,,,,
7977,107978,3-Amino-N-(carboxycarbonyl)alanine,C(C(C(=O)O)NC(=O)C(=O)O)N,,,,,,
7978,107979,"8-Benziloyloxy-6,10-ethano-5-azoniaspiro(4.5)decane chloride",C1CC[N+]2(C1)C3CCC2CC(C3)OC(=O)C(C4=CC=CC=C4)(C5=CC=CC=C5)O.[Cl-],,,,,,
7979,107980,Dimatif,C1CN1P(=S)(N)N2CC2,,,,,,
7980,107981,Parinaric acid,CCC=CC=CC=CC=CCCCCCCCC(=O)O,,,"['Chemicals that emit light after excitation by light. The wave length of the emitted light is usually longer than that of the incident light. Fluorochromes are substances that cause fluorescence in other substances, i.e., dyes used to mark or label other compounds with fluorescent tags. (See all compounds classified as Fluorescent Dyes.)']",,,
7981,107982,Dihydrocapsaicin,CC(C)CCCCCCC(=O)NCC1=CC(=C(C=C1)O)OC,,,,,,
7982,107983,L-Lactide,C[C@H]1C(=O)O[C@H](C(=O)O1)C,,,,,,
7983,107984,n5-Iminoethyl-l-ornithine,CC(=NCCC[C@@H](C(=O)O)N)N,,,['Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)'],,,
7984,107985,Triptolide,CC(C)[C@@]12[C@@H](O1)[C@H]3[C@@]4(O3)[C@]5(CCC6=C([C@@H]5C[C@H]7[C@]4([C@@H]2O)O7)COC6=O)C,,,"['A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026) (See all compounds classified as Antineoplastic Agents, Alkylating.)', 'Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)', 'Agents, either mechanical or chemical, which destroy spermatozoa in the male genitalia and block spermatogenesis. (See all compounds classified as Antispermatogenic Agents.)']",,,
7985,107986,2-Methylthio-adenosine 5'-triphosphate,CSC1=NC(=C2C(=N1)N(C=N2)C3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N,,,['Compounds that bind to and activate PURINERGIC RECEPTORS. (See all compounds classified as Purinergic Agonists.)'],,,
7986,107987,4-(5-Nitro-2-furyl)thiazole,C1=C(OC(=C1)[N+](=O)[O-])C2=CSC=N2,,,,,,
7987,107988,4-O-Ethylthymidine,CCOC1=NC(=O)N(C=C1C)[C@H]2C[C@@H]([C@H](O2)CO)O,,,,,,
7988,107989,CID 107989,CC(C)N1C=C2C[C@@H]3[C@H](C[C@H](CN3C)C(=O)OC(C)C(C)O)C4=C2C1=CC=C4.C(=CC(=O)O)C(=O)O,,,,,,
7989,107990,"3-hydroxybutan-2-yl (6aR)-7-methyl-4-propan-2-yl-6,6a,8,9,10,10a-hexahydroindolo[4,3-fg]quinoline-9-carboxylate",CC(C)N1C=C2C[C@@H]3C(CC(CN3C)C(=O)OC(C)C(C)O)C4=C2C1=CC=C4,,,,,,
7990,107991,Versiconal hemiacetal acetate,CC(=O)OCCC1C(OC2=C1C(=C3C(=C2)C(=O)C4=C(C3=O)C(=CC(=C4)O)O)O)O,,,,,,
7991,107992,2-Chloro-6-(1-piperazinyl)pyrazine,C1CN(CCN1)C2=CN=CC(=N2)Cl,,,['Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)'],,,
7992,107993,"(4R)-4-[(1R,12S,15R,17R)-17-hydroxy-5,12-dimethyl-3-oxo-2,16-dioxabicyclo[13.3.1]nonadeca-4,8,10-trien-17-yl]-1,3-thiazolidin-2-one",C[C@H]1CC[C@@H]2C[C@H](C[C@@](O2)([C@@H]3CSC(=O)N3)O)OC(=O)C=C(CCC=CC=C1)C,,,,,,
7993,107994,Quinaprilat,C[C@@H](C(=O)N1CC2=CC=CC=C2C[C@H]1C(=O)O)N[C@@H](CCC3=CC=CC=C3)C(=O)O,,,"['A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility. (See all compounds classified as Angiotensin-Converting Enzyme Inhibitors.)', 'Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)']",,,
7994,107995,Iolopride,CCN1CCC[C@H]1CNC(=O)C2=C(C=CC(=C2O)I)OC,,,"['Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)', 'Substances used to allow enhanced visualization of tissues. (See all compounds classified as Contrast Media.)']",,,
7995,107996,"4-Benzofuranacetamide, N-methyl-N-(7-(1-pyrrolidinyl)-1-oxaspiro(4.5)dec-8-yl)-",CN(C1CCC2(CCCO2)CC1N3CCCC3)C(=O)CC4=C5C=COC5=CC=C4,,,"['Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)', 'Drugs intended to prevent damage to the brain or spinal cord from ischemia, stroke, convulsions, or trauma. Some must be administered before the event, but others may be effective for some time after. They act by a variety of mechanisms, but often directly or indirectly minimize the damage produced by endogenous excitatory amino acids. (See all compounds classified as Neuroprotective Agents.)']",,,
7996,107997,N-Nitroso-2-acetylaminofluorene,CC(=O)N(C1=CC2=C(C=C1)C3=CC=CC=C3C2)N=O,,,,,,
7997,107998,"2,3,4,7,8-Pentabromodibenzofuran",C1=C2C3=CC(=C(C(=C3OC2=CC(=C1Br)Br)Br)Br)Br,,,,,,
7998,107999,Ramosetron hydrochloride,CN1C=C(C2=CC=CC=C21)C(=O)[C@@H]3CCC4=C(C3)NC=N4.Cl,,,"['Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)', 'Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)']",,,
7999,108000,Ramosetron,CN1C=C(C2=CC=CC=C21)C(=O)[C@@H]3CCC4=C(C3)NC=N4,['For the treatment of nausea and vomiting and diarrhea-predominant irritable bowel syndrome in males.'],,"['Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)', 'Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)']",,,
8000,108001,"3,5-Dihydroxyphenylglycine",C1=C(C=C(C=C1O)O)C(C(=O)O)N,,,"['Drugs that bind to and activate excitatory amino acid receptors. (See all compounds classified as Excitatory Amino Acid Agonists.)', 'Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. (See all compounds classified as Excitatory Amino Acid Antagonists.)']",,,
8001,108002,"1H-Indene-2-carboxylic acid, 1-(1,3-benzodioxol-5-yl)-3-(2-(carboxymethoxy)-4-methoxyphenyl)-2,3-dihydro-5-propoxy-, (1S,2R,3S)-",CCCOC1=CC2=C(C=C1)[C@@H]([C@H]([C@@H]2C3=C(C=C(C=C3)OC)OCC(=O)O)C(=O)O)C4=CC5=C(C=C4)OCO5,,,,,,
8002,108003,Zearalanone,C[C@H]1CCCC(=O)CCCCCC2=C(C(=CC(=C2)O)O)C(=O)O1,,,,,,
8003,108004,Plutonium citrate,C(C(=O)O)C(CC(=O)[O-])(C(=O)[O-])O.C(C(=O)O)C(CC(=O)[O-])(C(=O)[O-])O.[Pu],,,,,,
8004,108005,Sodium dichromate dihydrate,O.O.[O-][Cr](=O)(=O)O[Cr](=O)(=O)[O-].[Na+].[Na+],,,,,,
8005,108006,Magnesium Chlorophyllin,CCC1=C(C2=NC1=CC3=C(C(=C([O-])[O-])C(=N3)C(=C4C(C(C(=N4)C=C5C(=C(C(=C2)[N-]5)C=C)C)C)CCC(=O)[O-])CC(=O)[O-])C)C.[Na+].[Na+].[Na+].[Cu+2],,,,,,
8006,108007,Cobalt protoporphyrin,[H+].[H+].CC1=C(C2=CC3=NC(=CC4=C(C(=C([N-]4)C=C5C(=C(C(=N5)C=C1[N-]2)C=C)C)C=C)C)C(=C3CCC(=O)[O-])C)CCC(=O)[O-].[Co+2],,,,,,
8007,108008,"Nitric acid, plutonium salt",[N+](=O)(O)[O-].[Pu],,,,,,
8008,108009,N-Acetyl-S-(2-hydroxyethyl)-L-cysteine,CC(=O)N[C@@H](CSCCO)C(=O)O,,,,,,
8009,108010,Indospicine,C(CCC(=N)N)C[C@@H](C(=O)O)N,,,,,,
8010,108011,Tuliposide A,C=C(CCO)C(=O)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O,,,,,,
8011,108012,D-Nopaline,C(C[C@@H](C(=O)O)N[C@H](CCC(=O)O)C(=O)O)CN=C(N)N,,,,,,
8012,108013,Ambroxol hydrochloride,C1CC(CCC1NCC2=C(C(=CC(=C2)Br)Br)N)O.Cl,,,"['Agents that increase mucous excretion. Mucolytic agents, that is drugs that liquefy mucous secretions, are also included here. (See all compounds classified as Expectorants.)']",,,
8013,108014,Dothistromin,C1[C@@H](O[C@H]2[C@@]1(C3=C(O2)C=C4C(=C3O)C(=O)C5=C(C=CC(=C5C4=O)O)O)O)O,,,,,,
8014,108015,N-Acetylsulfamethazine,CC1=CC(=NC(=N1)N(C(=O)C)S(=O)(=O)C2=CC=C(C=C2)N)C,,,,,,
8015,108016,"Pyrene-4,5-oxide",C1=CC2=C3C(=C1)C4C(O4)C5=CC=CC(=C53)C=C2,,,,,,
8016,108017,"7-[(1R,2R,3R)-3-Hydroxy-2-[(3R)-3-hydroxy-4,4-dimethyloct-1-enyl]-5-oxocyclopentyl]heptanoic acid",CCCCC(C)(C)[C@@H](C=C[C@H]1[C@@H](CC(=O)[C@@H]1CCCCCCC(=O)O)O)O,,,,,,
8017,108018,N-Chlorotaurine,C(CS(=O)(=O)O)NCl,['Investigated for use/treatment in eye disorders/infections.'],,"['Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)', 'Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)']",,,
8018,108019,"Methyl 2-(methoxymethylidene)-3-methyl-6-phenylhexa-3,5-dienoate",CC(=CC=CC1=CC=CC=C1)C(=COC)C(=O)OC,,,,,,
8019,108020,"(1S,9R)-1,13-diethyl-10-(furan-3-ylmethyl)-9,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol",CC[C@@]12CCN([C@@](C1(C)CC)(CC3=C2C=C(C=C3)O)C)CC4=COC=C4,,,,,,
8020,108021,N-((6-Methyl-5-oxo-3-thiomorpholinyl)carbonyl)-L-histidyl-L-prolinamide,CC1C(=O)NC(CS1)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(=O)N,,,,,,
8021,108022,S-Nitrosomercaptoethanol,C(CSN=O)O,,,"['A diverse group of agents, with unique chemical structures and biochemical requirements, which generate NITRIC OXIDE. These compounds have been used in the treatment of cardiovascular diseases and the management of acute myocardial infarction, acute and chronic congestive heart failure, and surgical control of blood pressure. (Adv Pharmacol 1995;34:361-81) (See all compounds classified as Nitric Oxide Donors.)', 'Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)', 'Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)']",,,
8022,108023,"2,3',4,4',5,5'-Hexabromobiphenyl",C1=C(C=C(C(=C1Br)Br)Br)C2=CC(=C(C=C2Br)Br)Br,,,,,,
8023,108024,Dicyanodiamide diethylenetriamine epichlorohydrin polymer,C1C(O1)CCl.C(CNCCN)N.C(#N)N=C(N)N,,,,,,
8024,108025,"(E)-5-(2-Bromovinyl)pyrimidine-2,4(1H,3H)-dione",C1=C(C(=O)NC(=O)N1)C=CBr,,,,,,
8025,108026,"Benzoic acid, 3-(acetylamino)-2,4,6-triiodo-5-((methylamino)carbonyl)-, ion(1-)",CC(=O)NC1=C(C(=C(C(=C1I)C(=O)[O-])I)C(=O)NC)I,,,,,,
8026,108027,"7,12-Dimethylbenz(a)anthracene-3,4-dihydrodiol",CC1=C2C=CC3=C(C2=C(C4=CC=CC=C14)C)C=CC(C3O)O,,,,,,
8027,108028,"Butanedioic acid, compd. with 5-methoxy-3-(1,2,3,6-tetrahydro-4-pyridinyl)-1H-indole (1:1)",COC1=CC2=C(C=C1)NC=C2C3=CCNCC3.C(CC(=O)O)C(=O)O,,,,,,
8028,108029,"5-methoxy-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole",COC1=CC2=C(C=C1)NC=C2C3=CCNCC3,,,['Endogenous compounds and drugs that bind to and activate SEROTONIN RECEPTORS. Many serotonin receptor agonists are used as ANTIDEPRESSANTS; ANXIOLYTICS; and in the treatment of MIGRAINE DISORDERS. (See all compounds classified as Serotonin Receptor Agonists.)'],,,
8029,108030,"2-(4-chlorophenyl)-1H-pyrazolo[4,3-c]quinolin-3-one",C1=CC=C2C(=C1)C3=C(C=N2)C(=O)N(N3)C4=CC=C(C=C4)Cl,,,,,,
8030,108031,"2-(dibutylamino)-1-{2,7-dichloro-9-[(4-chlorophenyl)methylidene]-9H-fluoren-4-yl}ethan-1-ol",CCCCN(CCCC)CC(C1=CC(=CC2=C1C3=C(C2=CC4=CC=C(C=C4)Cl)C=C(C=C3)Cl)Cl)O,,,,,,
8031,108032,Vinyl carbamate epoxide,C1C(O1)OC(=O)N,,,,,['Vinyl carbamate epoxide is a known human metabolite of Vinyl carbamate.'],
8032,108033,"3-Tetradeca-1,3,5,7,9-pentaenoxypropane-1,2-diol",CCCCC=CC=CC=CC=CC=COCC(CO)O,,,,,,
8033,108034,"N-(2,4-Difluorophenyl)-N-methyl-2,4-dinitro-6-(trifluoromethyl)aniline",CN(C1=C(C=C(C=C1)F)F)C2=C(C=C(C=C2[N+](=O)[O-])[N+](=O)[O-])C(F)(F)F,,,,,,
8034,108035,CID 108035,CC[C@](C)(CO)O[C@]12C=C(CC[C@@]1(C[C@@H](O2)O)C)C,,,,,,
8035,108036,"1,2,4,5,6,8-Hexachloronaphthalene",C1=C(C2=C(C(=CC(=C2Cl)Cl)Cl)C(=C1Cl)Cl)Cl,,,,,,
8036,108037,2-Acetyl-4(5)-tetrahydroxybutylimidazole,CC(=O)C1=NC=C(N1)[C@H]([C@@H]([C@@H](CO)O)O)O,,,"['Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. (See all compounds classified as Immunosuppressive Agents.)']",,,
8037,108038,"(5R,8S,11R,12S,15S,18S,19S,22R)-18-[(5S,6S)-6-methoxy-3,5-dimethyl-7-phenylhepta-1,3-dienyl]-1,5,12,15,19-pentamethyl-2-methylidene-8-(2-methylpropyl)-3,6,9,13,16,20,25-heptaoxo-1,4,7,10,14,17,21-heptazacyclopentacosane-11,22-dicarboxylic acid",C[C@H]1[C@@H](NC(=O)[C@@H](NC(=O)[C@H]([C@@H](NC(=O)[C@@H](NC(=O)[C@H](NC(=O)C(=C)N(C(=O)CC[C@@H](NC1=O)C(=O)O)C)C)CC(C)C)C(=O)O)C)C)C=CC(=C[C@H](C)[C@H](CC2=CC=CC=C2)OC)C,,,,,,
8038,108039,"Methyl 3-(4-chlorophenyl)-4,5-dihydro-4-methyl-1-(((4-(trifluoromethyl)phenyl)amino)carbonyl)-1H-pyrazole-4-carboxylate",CC1(CN(N=C1C2=CC=C(C=C2)Cl)C(=O)NC3=CC=C(C=C3)C(F)(F)F)C(=O)OC,,,,,,
8039,108040,Sepimostat mesilate,CS(=O)(=O)O.C1CN=C(N1)NC2=CC=C(C=C2)C(=O)OC3=CC4=C(C=C3)C=C(C=C4)C(=N)N,,,['Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). (See all compounds classified as Protease Inhibitors.)'],,,
8040,108041,Sepimostat,C1CN=C(N1)NC2=CC=C(C=C2)C(=O)OC3=CC4=C(C=C3)C=C(C=C4)C(=N)N,,,['Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). (See all compounds classified as Protease Inhibitors.)'],,,
8041,108042,Caffeic acid-phenethyl ester,C1=CC=C(C=C1)CCOC(=O)C=CC2=CC(=C(C=C2)O)O,,,,,,
8042,108043,N-(1-(4-(4-Fluorophenoxy)butyl)-4-piperidinyl)-N-methyl-2-benzothiazolamine,CN(C1CCN(CC1)CCCCOC2=CC=C(C=C2)F)C3=NC4=CC=CC=C4S3,,,['A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)'],,,
8043,108044,"[(2R,5S)-5-(octadecylcarbamoyloxymethyl)oxolan-2-yl]methyl 2-quinolin-1-ium-1-ylethyl phosphate",CCCCCCCCCCCCCCCCCCNC(=O)OC[C@@H]1CC[C@@H](O1)COP(=O)([O-])OCC[N+]2=CC=CC3=CC=CC=C32,,,,,,
8044,108045,1-[2-[[[[[5beta-[(Octadecylaminocarbonyloxy)methyl]tetrahydrofuran]-2beta-yl]methoxy]oxylatophosphinyl]oxy]ethyl]quinolinium,CCCCCCCCCCCCCCCCCCNC(=O)OC[C@@H]1CC[C@@H](O1)COP(=O)(O)OCC[N+]2=CC=CC3=CC=CC=C32,,,,,,
8045,108046,alpha-(4-Fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazine butanol,C1CN(CCN1CCCC(C2=CC=C(C=C2)F)O)C3=NC=C(C=N3)F,,,"['Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)']",,,
8046,108047,"1-((5-Chloronaphthalen-1-yl)sulfonyl)-1,4-diazepane hydrochloride",C1CNCCN(C1)S(=O)(=O)C2=CC=CC3=C2C=CC=C3Cl.Cl,,,['Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)'],,,
8047,108048,"1-[[2,4-Bis(hydroxyiminomethyl)pyridin-1-ium-1-yl]methoxymethyl]pyridin-1-ium-4-carboxamide;diiodide",C1=C[N+](=CC=C1C(=O)N)COC[N+]2=C(C=C(C=C2)C=NO)C=NO.[I-].[I-],,,,,,
8048,108049,"1-[[2,4-Bis(hydroxyiminomethyl)pyridin-1-ium-1-yl]methoxymethyl]pyridin-1-ium-4-carboxamide",C1=C[N+](=CC=C1C(=O)N)COC[N+]2=C(C=C(C=C2)C=NO)C=NO,,,,,,
8049,108050,3-Anilinoalanine,C1=CC=C(C=C1)NC[C@@H](C(=O)O)N,,,,,,
8050,108051,2-Hydroxyimipramine,CN(C)CCCN1C2=C(CCC3=CC=CC=C31)C=C(C=C2)O,,,,,['2-Hydroxyimipramine is a known human metabolite of imipramine.'],
8051,108052,Cafestol,C[C@@]12CCC3=C([C@H]1CC[C@]45[C@H]2CC[C@H](C4)[C@](C5)(CO)O)C=CO3,,,,,,
8052,108053,Supinine,C[C@H]([C@@](C(C)C)(C(=O)OCC1=CCN2[C@H]1CCC2)O)O,,,,,,
8053,108054,Carbon monosulfide,[C-]#[S+],,,,,,
8054,108055,alpha-Methyl-DL-phenylalanine,CC(CC1=CC=CC=C1)(C(=O)O)N,,,,,,
8055,108056,CID 108056,CON1C=C(C2=CC=CC=C21)CC(=NOS(=O)(=O)O)S[C@@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O,,,,,,
8056,108057,Digoxin Impurity J,CC1C(C(CC(O1)OC2CCC3(C(C2)CCC4C3CC(C5(C4(CCC5C6=CC(=O)OC6)O)C)O)C)O)OC7CC(C(C(O7)C)OC8CC(C(C(O8)C)OC(=O)C)O)O,,,,,,
8057,108058,Nimbin,CC1=C2[C@@H](C[C@H]1C3=COC=C3)O[C@H]4[C@@]2([C@@H]([C@@]5([C@@H]([C@H]4OC(=O)C)[C@](C=CC5=O)(C)C(=O)OC)C)CC(=O)OC)C,,,,,,
8058,108059,Nestorone,CC(=O)[C@]1(C(=C)C[C@@H]2[C@@]1(CC[C@H]3[C@H]2CCC4=CC(=O)CC[C@H]34)C)OC(=O)C,['Segesterone acetate in combination with ethinyl estradiol is indicated for use by females of reproductive potential to prevent pregnancy as a combination hormonal contraceptive (CHC). It induces contraception for thirteen 28-day cycles (1 year) following vaginal administration. The vaginal system must remain in place continuously for 3 weeks (21 days) followed by a 1-week (7-day) vaginal system-free interval. The use in females with a body mass index of >29 kg/m^2 has not been adequately evaluated.'],"['Segesterone acetate suppresses ovulation. In a Phase I randomized, placebo-controlled, randomized crossover study involving healthy adult female subjects, there was no clinically significant QTc interval prolongation following a single intravenous bolus dose of segesterone acetate. Segesterone acetate shows no androgenic, anabolic, or estrogenic activity. It also did not show uterotropic activity in ovariectomized rats. In the endometrial transformation test to assess the progestational activity, dose-dependent increases in both uterine weight was observed following subcutaneous administration of segesterone acetate.']","['Chemical substances or agents with contraceptive activity in females. Use for female contraceptive agents in general or for which there is no specific heading. (See all compounds classified as Contraceptive Agents, Female.)', 'Contraceptive agents that act on the ENDOCRINE SYSTEM. (See all compounds classified as Contraceptive Agents, Hormonal.)']","['Contraceptive vaginal rings provided sustained release of contraceptive levels of segesterone acetate over 90 days in a pharmacokinetic study of healthy women. Following vaginal administration for up to 13 cycles, segesterone acetate was absorbed into systemic administration and reached the peak plasma concentration in 2 hours in Cycle 1, Cycle 3, and Cycle 13. Concentrations declined after time to reach plasma concentration (Tmax) and became more constant after 96 hours post-dose.Over subsequent cycles of use, the peak serum concentrations of segesterone acetate decreased. In Cycle 1, 3 and 13, the peak plasma concentrations were 1147, 363, and 294 pg/mL.', 'In a pharmacokinetic study, approximately 81.4% and 7.62% of the subcutaneously-administered dose in rats was excreted via feces and urine, respectively.', 'The volume of distribution of segesterone acetate is 19.6 L/kg.', 'No pharmacokinetic data available.']","['Segesterone acetate undergoes rapid metabolism and inactivation in the liver. Based on the findings _in vitro_, the major oxidative metabolites in the serum include 5α-dihydro- and 17α-hydroxy-5α\xad-dihydro metabolites constitute about 50% of exposure relative to segesterone acetate. The metabolites are not pharmacologically active with EC50 to progesterone receptor 10-fold higher than that of the parent compound. It was shown that 3α, 5α-tetrahydrosegesterone acetate acts as an activator at the GABA-A receptors in the brain.']",['The mean (SD) half life of segesterone acetate is 4.5 (3.4) hours.']
8059,108060,Disodium;phosphoric acid;heptahydrate,O.O.O.O.O.O.O.OP(=O)(O)O.[Na+].[Na+],,,,,,
8060,108061,Disperse Blue 106,CCN(CCO)C1=CC(=C(C=C1)N=NC2=NC=C(S2)[N+](=O)[O-])C,,,,,,
8061,108062,Asiaticoside,CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CC(C(C5(C)CO)O)O)C)C)C2C1C)C)C(=O)OC6C(C(C(C(O6)COC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)C)O)O)O)O)O)O)O)O,,,['Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)'],,,
8062,108063,"Naphthalene 1,2-oxide",C1=CC=C2C3C(O3)C=CC2=C1,,,,,"['Naphthalene-1,2 Expodation is a known human metabolite of naphthalene.']",
8063,108064,Rishitin,C[C@@H]1[C@H]([C@@H](CC2=C1C[C@@H](CC2)C(=C)C)O)O,,,,,,
8064,108065,Proanthocyanidin,COC1=C(C=C(C=C1O)C2[C@@H](CC3=C(O2)C(=C(C=C3O)O)[C@@H]4[C@H]([C@H](OC5=CC(=CC(=C45)O)O)C6=CC=C(C=C6)O)O)O)O,,,"['Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)', 'Substances that are destructive to protozoans. (See all compounds classified as Antiprotozoal Agents.)']",,,
8065,108066,Diazan,C(CC(=O)C=[N+]=[N-])C(=O)C=[N+]=[N-],,,,,,
8066,108067,"2,5-Dihydroxyhexa-1,5-diene-1,6-didiazonium",C(CC(=C[N+]#N)O)C(=C[N+]#N)O,,,,,,
8067,108068,(-)-Parthenolide,CC1=CCC[C@@]2([C@@H](O2)[C@@H]3[C@@H](CC1)C(=C)C(=O)O3)C,,,"['Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)']",,,
8068,108069,Selenodiglutathione,C(CC(=O)N[C@@H](CS[Se]SC[C@@H](C(=O)NCC(=O)O)NC(=O)CC[C@@H](C(=O)O)N)C(=O)NCC(=O)O)[C@@H](C(=O)O)N,,,,,,
8069,108070,"2,3,6,7-Tetrachloronaphthalene",C1=C2C=C(C(=CC2=CC(=C1Cl)Cl)Cl)Cl,,,,,,
8070,108071,"1,2,4,6-Tetrachloronaphthalene",C1=CC2=C(C=C1Cl)C(=CC(=C2Cl)Cl)Cl,,,,,,
8071,108072,"(E)-2-((2S,3R,4S,6R)-2-hydroxy-3,4-dimethoxy-6-((2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)cyclohexylidene)acetonitrile",CO[C@H]1C[C@H](C(=CC#N)[C@@H]([C@H]1OC)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O)O)O,,,,,,
8072,108073,N-Acetyl-S-(2-carboxyethyl)-L-cysteine,CC(=O)N[C@@H](CSCCC(=O)O)C(=O)O,,,,,,
8073,108074,3'-Amino-3'-deoxythymidine,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)CO)N,,,,,,
8074,108075,Tryptoquivaline,CC(C)[C@@H](C1=NC2=CC=CC=C2C(=O)N1[C@@H]3C[C@]4([C@H]5N(C6=CC=CC=C64)C(=O)C(N5O)(C)C)OC3=O)OC(=O)C,,,,,,
8075,108076,"[(3R,3aS,3bS,5aS,6R,8aS,8bR,10aS)-2,6-diethynyl-3a,5a-dimethyl-6-propanoyloxy-2,3,3b,4,5,7,8,8a,8b,9,10,10a-dodecahydro-1H-indeno[4,5-g]inden-3-yl] propanoate",CCC(=O)O[C@@H]1C(C[C@H]2[C@]1([C@H]3CC[C@]4([C@H]([C@@H]3CC2)CC[C@]4(C#C)OC(=O)CC)C)C)C#C,,,,,,
8076,108077,N-Nitrosoatrazine,CCN(C1=NC(=NC(=N1)NC(C)C)Cl)N=O,,,,,,
8077,108078,2-chloro-N-[(4-chlorophenyl)carbamoyl]benzamide,C1=CC=C(C(=C1)C(=O)NC(=O)NC2=CC=C(C=C2)Cl)Cl,,,,,,
8078,108079,Coprine,C1CC1(NC(=O)CC[C@@H](C(=O)O)N)O,,,,,,
8079,108080,"Methanol, mixt. with nitromethane and 1,1,2-trichloro-1,2,2-trifluoroethane",C[N+](=O)[O-].CO.C(C(F)(Cl)Cl)(F)(F)Cl,,,,,,
8080,108081,N-Nitrosomethylamine,CNN=O,,,,,['N-Nitrosomethylamine is a known human metabolite of N-Nitrosodimethylamine and ethylmethylnitrosamine.'],
8081,108082,Propacetamol hydrochloride,CCN(CC)CC(=O)OC1=CC=C(C=C1)NC(=O)C.Cl,,,,,,
8082,108083,"(1S)-5,9,13-trimethyl-2-propan-2-ylcyclotetradeca-2,4,8,12-tetraen-1-ol",CC1=CCCC(=CC=C([C@H](CC(=CCC1)C)O)C(C)C)C,,,,,,
8083,108084,"4-Amino-6-methyl-1H-2,5,10,10b-tetraazafluoranthene",CC1=C2C3=C(N=CC=C3)N4C2=C(C=NC4)C(=N1)N,,,,,,
8084,108085,Sapintoxin A,C[C@@H]1[C@H]([C@@]2([C@@H](C2(C)C)[C@H]3[C@]1([C@@H]4C=C(C(=O)[C@H]4CC(=C3)CO)C)O)OC(=O)C)OC(=O)C5=CC=CC=C5NC,,,,,,
8085,108086,Acromelic acid A,C1[C@@H]([C@@H]([C@H](N1)C(=O)O)CC(=O)O)C2=CC=C(NC2=O)C(=O)O,,,,,,
8086,108087,"2-[[1-(2-amino-1,3-thiazol-4-yl)-2-[[(3S)-2-(carbamoyloxymethyl)-4-oxo-1-sulfoazetidin-3-yl]amino]-2-oxoethylidene]amino]oxyacetic acid",C1=C(N=C(S1)N)C(=NOCC(=O)O)C(=O)N[C@H]2C(N(C2=O)S(=O)(=O)O)COC(=O)N,,,,,,
8087,108088,"cis-(-)-2,3,4,4a,5,9b-Hexahydro-2,8-dimethyl-1H-pyrido(4,3-b)indole dihydrochloride",CC1=CC2=C(C=C1)N[C@H]3[C@@H]2CN(CC3)C.Cl.Cl,,,"['Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)', 'Agents that reduce the frequency or rate of spontaneous or induced mutations independently of the mechanism involved. (See all compounds classified as Antimutagenic Agents.)', 'Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)', 'An agent that causes the production of physical defects in the developing embryo. (See all compounds classified as Teratogens.)', 'Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)']",,,
8088,108089,Stobadine,CC1=CC2=C(C=C1)N[C@H]3[C@@H]2CN(CC3)C,,,"['Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)', 'Agents that reduce the frequency or rate of spontaneous or induced mutations independently of the mechanism involved. (See all compounds classified as Antimutagenic Agents.)', 'Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)', 'An agent that causes the production of physical defects in the developing embryo. (See all compounds classified as Teratogens.)', 'Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. (See all compounds classified as Antioxidants.)']",,,
8089,108090,"(1S,2R,5R,7R,12R,14S,16R,19R,20S,24R,27S,28S,29R,32R,33R,35S)-14-[(2S,3R,4R)-2,3-dihydroxy-4-methyloxan-2-yl]-28-hydroxy-5,7,9,19,29,35-hexamethyl-13,17,38,39,40,41,42,43-octaoxaoctacyclo[31.4.1.11,35.12,5.120,24.124,27.129,32.012,16]tritetraconta-8,10-diene-18,31-dione",C[C@@H]1CCO[C@@]([C@@H]1O)([C@@H]2C[C@@H]3[C@H](O2)C=CC(=C[C@@H](C[C@]4(CC[C@@H](O4)[C@]56CC[C@](O5)(C[C@@H](O6)[C@@H]7C(=O)C[C@@](O7)([C@H]([C@@H]8CC[C@]9(O8)CCC[C@H](O9)[C@H](C(=O)O3)C)O)C)C)C)C)C)O,,,,,,
8090,108091,"S-(1,2,2-trichlorovinyl)-L-cysteine",C([C@@H](C(=O)O)N)SC(=C(Cl)Cl)Cl,,,,,,
8091,108092,Tesmilifene,CCN(CC)CCOC1=CC=C(C=C1)CC2=CC=CC=C2,['Intended for the treatment of various forms of cancer.'],,"['Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. (See all compounds classified as Histamine Antagonists.)', 'Drugs or agents which antagonize or impair any mechanism leading to blood platelet aggregation, whether during the phases of activation and shape change or following the dense-granule release reaction and stimulation of the prostaglandin-thromboxane system. (See all compounds classified as Platelet Aggregation Inhibitors.)']",,['Hepatic'],
8092,108093,1-Nitro-8-nitrosopyrene,C1=CC2=C3C(=C(C=C2)[N+](=O)[O-])C=CC4=C(C=CC1=C43)N=O,,,,,,
8093,108094,2-Methoxyidazoxan,COC1(COC2=CC=CC=C2O1)C3=NCCN3,,,"['Drugs that bind to but do not activate alpha-adrenergic receptors thereby blocking the actions of endogenous or exogenous adrenergic agonists. Adrenergic alpha-antagonists are used in the treatment of hypertension, vasospasm, peripheral vascular disease, shock, and pheochromocytoma. (See all compounds classified as Adrenergic alpha-Antagonists.)']",,,
8094,108095,"(6R,7R)-pivaloyloxymethyl 7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate hydrochloride",CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)OCOC(=O)C(C)(C)C.Cl,,,,,,
8095,108096,(7R)-pivaloyloxymethyl 7-((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetamido)-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate,CC1=C(N2[C@@H]([C@@H](C2=O)NC(=O)C(=NOC)C3=CSC(=N3)N)SC1)C(=O)OCOC(=O)C(C)(C)C,,,['Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)'],,,
8096,108097,Isohexylcyanoacrylate,CC(C)CCCOC(=O)C(=C)C#N,,,,,,
8097,108098,Acetyl-leucyl-leucyl-norleucine-aldehyde,CCCC[C@@H](C=O)NC(=O)C(CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)C,,,['Exogenous and endogenous compounds which inhibit CYSTEINE ENDOPEPTIDASES. (See all compounds classified as Cysteine Proteinase Inhibitors.)'],,,
8098,108099,"Cyclohexanepropanoic acid, alpha-amino-2-(2-phosphonoethyl)-",C1CCC(C(C1)CCP(=O)(O)O)CC(C(=O)O)N,,,"['Drugs that bind to but do not activate excitatory amino acid receptors, thereby blocking the actions of agonists. (See all compounds classified as Excitatory Amino Acid Antagonists.)']",,,
8099,108100,"2-Amino-3,4,7,8-tetramethyl-3H-imidazo[4,5-F]quinoxaline",CC1=CC2=NC(=C(N=C2C3=C1N(C(=N3)N)C)C)C,,,,,,
8100,108101,"L-Valine, glycyl-L-a-glutamyl-L-prolyl-L-prolyl-L-prolylglycyl-L-lysyl-L-prolyl-L-alanyl-L-a-aspartyl-L-a-aspartyl-L-alanylglycyl-L-leucyl-Acetate",C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@@H]1CCCN1C(=O)C(CCCCN)NC(=O)CNC(=O)[C@@H]2CCCN2C(=O)[C@@H]3CCCN3C(=O)[C@@H]4CCCN4C(=O)[C@H](CCC(=O)O)NC(=O)CN,,,,,,
8101,108102,CID 108102,CC(C)[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C=O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)C,,,,,,
8102,108103,"1,2,4,6,8-Pentachloronaphthalene",C1=C(C=C(C2=C1C(=CC(=C2Cl)Cl)Cl)Cl)Cl,,,,,,
8103,108104,Sphondin,COC1=C2C(=C3C(=C1)C=CC(=O)O3)C=CO2,,,,,"['Papilio glaucus (tiger swallowtail) is a generalist that rarely encounters plants containing furanocoumarins yet is constitutively capable of metabolizing low levels of these highly toxic allelochemicals. In larvae of this species, metabolism of linear (xanthotoxin, bergapten), and angular (angelicin, sphondin), furanocoumarins can be induced up to 30-fold by the presence of xanthotoxin in their diet. Degenerate primers corresponding to conserved amino acid sequences in three insect P450s, Musca domestica (CYP6A1), Drosophila melanogaster (CYP6A2) and Papilio polyxenes (CYP6B1), were used to clone xanthotoxin-induced P450 transcripts from P. glaucus larvae by a reverse transcription-polymerase chain reaction (RT-PCR) strategy. Positive clones encoding the highly conserved F--G-R-C-G P450 signature motif were used to isolate a full-length CYP6B4v1 cDNA from a P. glaucus xanthotoxin-induced cDNA library. Sequence comparisons indicate the P. glaucus CYP6B4v1 protein sequence is 63% and 61% identical, respectively, to the P. polyxenes furanocoumarin-inducible CYP6B1v1 and CYP6B3v1 proteins. Northern analysis indicates that CYP6B4 and related transcripts are highly induced in response to xanthotoxin. Baculovirus-mediated expression of the CYP6B4v1 protein in lepidopteran cell lines demonstrates that this P450 isozyme metabolizes isopimpinellin, imperatorin, and bergapten at high rates, xanthotoxin and psoralen at intermediate rates and angelicin, sphondin, and trioxsalen only at very low rates.']",
8104,108105,Hypoglycin B,C=C1CC1CC(C(=O)O)NC(=O)CCC(C(=O)O)N,,,,,,
8105,108106,11-Hydroxyandrostenedione,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2C(C[C@]4([C@H]3CCC4=O)C)O,,,,,,
8106,108107,Benzamil,C1=CC=C(C=C1)CN=C(N)NC(=O)C2=C(N=C(C(=N2)Cl)N)N,,,,,,
8107,108108,2-Deoxy-D-arabino-hexose 6-(dihydrogen phosphate),C(C=O)[C@H]([C@@H]([C@@H](COP(=O)(O)O)O)O)O,,,,,,
8108,108109,Cholesterol beta-epoxide,C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2C[C@@H]4[C@]5([C@@]3(CC[C@@H](C5)O)C)O4)C,,,,,,
8109,108110,"(1'R,2S,3S,3'S,4'R,5R,7'S,11'R)-4'-hydroxy-1',3,4'-trimethyl-5-(2-methylprop-1-enyl)-6'-oxospiro[oxolane-2,12'-tricyclo[9.3.0.03,7]tetradec-8-ene]-8'-carbaldehyde",C[C@H]1C[C@@H](O[C@@]12CC[C@]3([C@H]2CC=C([C@@H]4[C@H](C3)[C@](CC4=O)(C)O)C=O)C)C=C(C)C,,,,,,
8110,108111,2-(4-Methylphenyl)oxirane,CC1=CC=C(C=C1)C2CO2,,,,,,
8111,108112,"3,5-Dimethyl-3'-isopropyl-L-thyronine",CC1=CC(=CC(=C1OC2=CC(=C(C=C2)O)C(C)C)C)C[C@@H](C(=O)O)N,,,,,,
8112,108113,1-Amino-8-nitropyrene,C1=CC2=C3C(=C(C=C2)[N+](=O)[O-])C=CC4=C(C=CC1=C43)N,,,,,"['1-amino-8-nitropyrene is a known human metabolite of 1,8-dinitropyrene.']",
8113,108114,Cotinine-N-oxide,CN1C(CCC1=O)C2=C[N+](=CC=C2)[O-],,,,,['Cotinine N-oxide is a known thirdhand smoke metabolite of Nicotine.'],
8114,108115,N-Hydroxyphenetidine,CCOC1=CC=C(C=C1)NO,,,,,,
8115,108116,"2-Hydroxy-1,2,3-propanetricarboxylic acid plutonium salt",C(C(=O)O)C(CC(=O)O)(C(=O)O)O.[Pu],,,,,,
8116,108117,N-(Acetyloxy)-N-(7-iodo-9H-fluoren-2-yl)acetamide,CC(=O)N(C1=CC2=C(C=C1)C3=C(C2)C=C(C=C3)I)OC(=O)C,,,,,,
8117,108118,CID 108118,C[C@H]1CC=C[C@H]2[C@H]3[C@](O3)([C@H]([C@@H]4[C@@]2(C(=O)CCC(=O)C(=O)C(=C1)C)C(=O)N[C@H]4CC5CNC6=CC=CC=C56)C)C,,,,,,
8118,108119,"2,2',6,6'-Tetranitro-4,4'-azoxytoluene",CC1=C(C=C(C=C1[N+](=O)[O-])N=[N+](C2=CC(=C(C(=C2)[N+](=O)[O-])C)[N+](=O)[O-])[O-])[N+](=O)[O-],,,,,,
8119,108120,"2,3,7-Tribromodibenzo-p-dioxin",C1=CC2=C(C=C1Br)OC3=CC(=C(C=C3O2)Br)Br,,,,,,
8120,108121,"Bromobenzene-3,4-oxide",C1=CC(=CC2C1O2)Br,,,,,,
8121,108122,5-(5-Nitro-2-furanyl)-2-thiazolamine,C1=C(OC(=C1)[N+](=O)[O-])C2=CN=C(S2)N,,,,,,
8122,108123,Entonox,[N-]=[N+]=O.O=O,,,"['The use of two or more chemicals simultaneously or sequentially to induce anesthesia. The drugs need not be in the same dosage form. (See all compounds classified as Anesthetics, Combined.)']",,,
8123,108124,CID 108124,C[C@@H]1C[C@]2(C[C@H]2[C@H]3[C@]1([C@@H]4C=C(C(=O)[C@]4(CC(=C3)COC(=O)C)O)C)O)OC(=O)CC5=CC=CC=C5,,,,,,
8124,108125,Lacinilene C 7-methyl ether,CC1=CC2=C(C=C1OC)[C@@](C(=O)C=C2C(C)C)(C)O,,,,,,
8125,108126,"7-[(1S,5R)-5-[(3S)-3-hydroxyoct-1-enyl]-4-oxocyclopent-2-en-1-yl]hept-5-enoic acid",CCCCC[C@@H](C=C[C@@H]1[C@H](C=CC1=O)CC=CCCCC(=O)O)O,,,,,,
8126,108127,"(1R,3S)-5-[2-[(1R,3aS,7aR)-1-[(2R)-5-hydroxy-6-methylheptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol",C[C@H](CCC(C(C)C)O)[C@H]1CC[C@@H]2[C@@]1(CCCC2=CC=C3C[C@H](C[C@@H](C3=C)O)O)C,,,,,,
8127,108128,2-((3-((6-Chloro-2-methoxy-9-acridinyl)amino)propyl)ethylamino)ethanol dihydrochloride,CCN(CCCNC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC)CCO.Cl.Cl,,,,,,
8128,108129,2-[3-[(6-Chloro-2-methoxy-acridin-9-yl)amino]propyl-ethyl-amino]ethanol,CCN(CCCNC1=C2C=C(C=CC2=NC3=C1C=CC(=C3)Cl)OC)CCO,,,,,,
8129,108130,Schisandrin B,CC1CC2=CC3=C(C(=C2C4=C(C(=C(C=C4CC1C)OC)OC)OC)OC)OCO3,,,"['Substances that reduce or suppress INFLAMMATION. (See all compounds classified as Anti-Inflammatory Agents.)', 'Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)']",,,
8130,108131,"5-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(3S)-3-hydroxyoct-1-enyl]cyclopentyl]-4-oxopentanoic acid",CCCCC[C@@H](C=C[C@H]1[C@@H](C[C@@H]([C@@H]1CC(=O)CCC(=O)O)O)O)O,,,,,,
8131,108132,"1,1'-Biphenyl, 2,2',3,4,5'-pentachloro-3'-(methylsulfonyl)-",CS(=O)(=O)C1=CC(=CC(=C1Cl)C2=C(C(=C(C=C2)Cl)Cl)Cl)Cl,,,,,,
8132,108133,"1,2,3,4,5,7-Hexachloronaphthalene",C1=C(C=C(C2=C1C(=C(C(=C2Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
8133,108134,Chlorpyriphos-diflubenzuron mixt.,CCOP(=S)(OCC)OC1=NC(=C(C=C1Cl)Cl)Cl.C1=CC(=C(C(=C1)F)C(=O)NC(=O)NC2=CC=C(C=C2)Cl)F,,,,,,
8134,108135,Tyrosyl-glycyl-glycyl-phenylalanyl-leucyl-arginyl-arginyl-isoleucine,CC[C@H](C)[C@@H](C(=O)O)NC(=O)C(CCCN=C(N)N)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)CNC(=O)CNC(=O)[C@H](CC2=CC=C(C=C2)O)N,,,,,,
8135,108136,2-Methyl-3-[4-(pyridin-3-ylmethyl)phenyl]prop-2-enoic acid,CC(=CC1=CC=C(C=C1)CC2=CN=CC=C2)C(=O)O,,,,,,
8136,108137,"2-Methyl-8-(phenylmethoxy)imidazo[1,2-a]pyridine-3-acetonitrile",CC1=C(N2C=CC=C(C2=N1)OCC3=CC=CC=C3)CC#N,,,"['Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)', 'Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)']",,,
8137,108138,Trapencaine,CCCCCOC1=CC=CC(=C1)NC(=O)O[C@@H]2CCCC[C@H]2N3CCCC3,,,"['Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman&apos;s The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. (See all compounds classified as Anesthetics, Local.)', 'Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)']",,,
8138,108139,"7-Methoxynaphtho(2,1-b)furan",COC1=CC2=C(C=C1)C3=C(C=C2)OC=C3,,,,,,
8139,108140,CID 108140,C1=CC(=CC=C1CO)N=[NH2+],,,,,,
8140,108141,(4-Diazenylphenyl)methanol,C1=CC(=CC=C1CO)N=N,,,,,,
8141,108142,2-((((2-Chloroethyl)nitrosoamino)carbonyl)amino)propanamide,CC(C(=O)N)NC(=O)N(CCCl)N=O,,,['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)'],,,
8142,108143,Tamibarotene,CC1(CCC(C2=C1C=CC(=C2)NC(=O)C3=CC=C(C=C3)C(=O)O)(C)C)C,['Investigated for use/treatment in leukemia (unspecified).'],"['Tamibarotene is a new synthetic retinoid drug recently approved for relapsed or refractory acute promyelocytic leukemia (APL) in Japan. It is a specific agonist for retinoic acid receptor alpha/beta. Compared to all-trans retinoic acid (ATRA), a natural retinoid indicated for a first-line treatment of APL, tamibarotene is chemically more stable and several times more potent as an inducer of differentiation in promyelocytic leukemia cells. In contrast to ATRA, whose plasma concentration declines considerably during daily administration, tamibarotene sustains plasma level probably due to a lower affinity for cellular retinoic acid binding protein. Furthermore, adverse side effects were milder than those of ATRA in clinical trials.']",,,,
8143,108144,Carboxyamidotriazole,C1=CC(=CC=C1C(=O)C2=C(C=C(C=C2Cl)CN3C(=C(N=N3)C(=O)N)N)Cl)Cl,,,"['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)', 'A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)']",,,
8144,108145,"1,2,3,5,7,8-Hexachloronaphthalene",C1=C2C(=CC(=C(C2=C(C(=C1Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
8145,108146,"1,2,3,5,6,8-Hexachloronaphthalene",C1=C2C(=C(C(=C1Cl)Cl)Cl)C(=CC(=C2Cl)Cl)Cl,,,,,,
8146,108147,Senktide,CC(C)C[C@@H](C(=O)N[C@@H](CCSC)C(=O)N)NC(=O)CNC(=O)[C@H](CC1=CC=CC=C1)N(C)C(=O)[C@H](CC2=CC=CC=C2)NC(=O)[C@H](CC(=O)O)NC(=O)CCC(=O)O,,,,,,
8147,108148,"7-[(1R,2S,3S,4S)-3-(benzenesulfonamido)-2-bicyclo[2.2.1]heptanyl]hept-5-enoic acid",C1C[C@H]2C[C@@H]1[C@@H]([C@H]2NS(=O)(=O)C3=CC=CC=C3)CC=CCCCC(=O)O,,,,,,
8148,108149,CID 108149,CCOC(=O)C1C(=C(O)OCC)C=CC2=C3C=C4C(=C(C(=N4)C=C5C(=C(C(=N5)C=C6C(=C(C(=N6)C=C(C12C)N3)C=C)C)C)CCC(=O)O)CCC(=O)O)C,,,,,,
8149,108150,Trabectedin,CC1=CC2=C([C@@H]3[C@@H]4[C@H]5C6=C(C(=C7C(=C6[C@@H](N4[C@H]([C@H](C2)N3C)O)COC(=O)[C@@]8(CS5)C9=CC(=C(C=C9CCN8)O)OC)OCO7)C)OC(=O)C)C(=C1OC)O,"['Indicated for treatment of advanced soft tissue sarcoma in patients refractory to or unsuitable to receive anthracycline or ifosfamide chemotherapy in Europe, Russia and South Korea. Approved for orphan drug status by the U.S. FDA for treatment of soft tissue sarcomas and ovarian cancer. Investigated for use/treatment in cancer/tumors (unspecified), gastric cancer, ovarian cancer, pediatric indications, sarcoma, and solid tumors.']","[""Two of the rings in the drug's structure allows it to covalently bind to the minor groove of DNA. The third ring protrudes from the DNA which lets it interact with nearby nuclear proteins. This has the additive effect of blocking cell division at the G2 phase.""]","['A class of drugs that differs from other alkylating agents used clinically in that they are monofunctional and thus unable to cross-link cellular macromolecules. Among their common properties are a requirement for metabolic activation to intermediates with antitumor efficacy and the presence in their chemical structures of N-methyl groups, that after metabolism, can covalently modify cellular DNA. The precise mechanisms by which each of these drugs acts to kill tumor cells are not completely understood. (From AMA, Drug Evaluations Annual, 1994, p2026) (See all compounds classified as Antineoplastic Agents, Alkylating.)']",['Administered intravenously.'],,['33-50 hours']
8150,108151,7-N-(2-((2-(gamma-L-Glutamylamino)ethyl)dithio)ethyl)mitomycin C,CC1=C(C(=O)C2=C(C1=O)N3C[C@H]4[C@@H]([C@@]3([C@@H]2COC(=O)N)OC)N4)NCCSSCCNC(=O)CC[C@@H](C(=O)O)N,,,"['Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. (See all compounds classified as Antibiotics, Antineoplastic.)']",,,
8151,108152,"9,12-Epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid, 2,3,9,10,11,12-hexahydro-10-methoxy-2,9-dimethyl-1-oxo-, methyl ester, (9S,10R,12R)-",C[C@@]12[C@](C[C@@H](O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CN(C6=O)C)(C(=O)OC)OC,,,['Agents that inhibit PROTEIN KINASES. (See all compounds classified as Protein Kinase Inhibitors.)'],,,
8152,108153,"Benzoic acid, 3-chloro-2-((4,6-dimethoxy-2-pyrimidinyl)thio)-6-methoxy-",COC1=C(C(=C(C=C1)Cl)SC2=NC(=CC(=N2)OC)OC)C(=O)O,,,,,,
8153,108154,"1,2,4,5,8-Pentachloronaphthalene",C1=CC(=C2C(=C1Cl)C(=CC(=C2Cl)Cl)Cl)Cl,,,,,,
8154,108155,12-Iminodaunorubicin hcl,CC1C(C(CC(O1)OC2CC(CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=N)C(=CC=C5)OC)O)(C(=O)C)O)N)O,,,,,,
8155,108156,Platelet activating factor,CCCCCCCCCCCCCCCCOC[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OC(=O)C,,,,,,
8156,108157,2-[[(2R)-2-acetyloxy-3-hexadecoxypropoxy]-hydroxyphosphoryl]oxyethyl-trimethylazanium,CCCCCCCCCCCCCCCCOC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)C,,,,,,
8157,108158,S-Chloromethylglutathione,C(CC(=O)N[C@@H](CSCCl)C(=O)NCC(=O)O)[C@@H](C(=O)O)N,,,,,,
8158,108159,CID 108159,C[C@H](C1=CC[C@@]23[C@@]1(C[C@H](C45C2=CC[C@H]6[C@@]4(CC[C@](C6)(O5)O)C)O)CNCCO3)OC(=O)C7=CC=CC=C7,,,,,,
8159,108160,"[(2S,3S,4R,5S)-2,3,4,5-Tetrahydroxy-6-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxycyclohexyl] (3R,4'S,6'S,7'R)-6-bromo-4'-hydroxy-4'-methyl-2,12',14'-trioxospiro[1H-indole-3,5'-2,9,11,13-tetrazatricyclo[8.4.0.03,7]tetradeca-1(10),2-diene]-6'-carboxylate",C[C@]1(C2=NC3=C(NC[C@H]2[C@@H]([C@@]14C5=C(C=C(C=C5)Br)NC4=O)C(=O)OC6[C@H]([C@H]([C@H]([C@@H](C6O[C@H]7[C@@H]([C@H]([C@@H](CO7)O)O)O)O)O)O)O)NC(=O)NC3=O)O,,,,,,
8160,108161,Iododoxorubicin,C[C@H]1[C@H]([C@H](C[C@@H](O1)O[C@H]2C[C@@](CC3=C2C(=C4C(=C3O)C(=O)C5=C(C4=O)C(=CC=C5)OC)O)(C(=O)CO)O)N)I,,,,,,
8161,108162,CID 108162,C1[C@@H]([C@H](O[C@H]1N2C3=C(C(=O)N=C(N3)N)N=C2NC4=C5C=CC6=CC=CC7=C6C5=C(C=C7)C=C4)CO)O,,,,,,
8162,108163,CID 108163,C1[C@H](C([C@@]23N1C(=N)N([C@H]([C@@H]2NC(=N3)N)COC(=O)NOS(=O)(=O)O)O)(O)O)OS(=O)(=O)O,,,,,,
8163,108164,tert-Butylphenyl diphenyl phosphate mixt. with triphenyl phosphate,CC(C)(C)OP(=O)(OC1=CC=CC=C1)OC2=CC=CC=C2.C1=CC=CC=C1.C1=CC=C(C=C1)OP(=O)(OC2=CC=CC=C2)OC3=CC=CC=C3,,,,,,
8164,108165,Tert-butyl diphenyl phosphate,CC(C)(C)OP(=O)(OC1=CC=CC=C1)OC2=CC=CC=C2,,,,,,
8165,108166,Nolpitantium chloride,CC(C)OC1=CC=CC(=C1)CC(=O)N2CCC[C@](C2)(CC[N+]34CCC(CC3)(CC4)C5=CC=CC=C5)C6=CC(=C(C=C6)Cl)Cl.[Cl-],,,,,,
8166,108167,Nolpitantium,CC(C)OC1=CC=CC(=C1)CC(=O)N2CCC[C@](C2)(CC[N+]34CCC(CC3)(CC4)C5=CC=CC=C5)C6=CC(=C(C=C6)Cl)Cl,,,,,,
8167,108168,Aristolochic acid II,C1OC2=C(O1)C3=C(C(=C2)C(=O)O)C(=CC4=CC=CC=C43)[N+](=O)[O-],,,,,,
8168,108169,Paclitaxel Impurity 7,CC1CCCC2(C1CC3CCC(C(C3(C)C)CC2)C)C,,,,,,
8169,108170,CID 108170,CCC(=C1C=CC(=O)C=C1)CC(=C2C=CC(=O)C=C2)CC,,,,,,
8170,108171,"3a,4,5,6,7,8,8-Heptachloro-3a,4,7,7a-tetrahydro-4,7-methanoindene",C1C=CC2(C1C3(C(=C(C2(C3(Cl)Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
8171,108172,D-Octopine,C[C@H](C(=O)O)N[C@@H](CCCN=C(N)N)C(=O)O,,,,,,
8172,108173,Tocainide hydrochloride,CC1=C(C(=CC=C1)C)NC(=O)C(C)N.Cl,,,"['Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)', 'A class of drugs that inhibit the activation of VOLTAGE-GATED SODIUM CHANNELS. (See all compounds classified as Voltage-Gated Sodium Channel Blockers.)']",,,
8173,108174,Carboxyatractylate,CC(C)CC(=O)OC1C(C(C(OC1OC2CC3(C4CCC5CC4(CCC3C(C2)(C(=O)O)C(=O)O)C(C5=C)O)C)CO)OS(=O)(=O)O)OS(=O)(=O)O,,,,,,
8174,108175,"1,N6-Ethenoadenosine",C1=CN2C=NC3=C(C2=N1)N=CN3[C@H]4[C@@H]([C@@H]([C@H](O4)CO)O)O,,,,,,
8175,108176,CID 108176,C1CN(CC1O)[N+](=O)[O-],,,,,,
8176,108177,Hexachloronaphthalene,C1=CC(=C(C2=C1C(=C(C(=C2Cl)Cl)Cl)Cl)Cl)Cl,,,,"['Absorbed by skin.', 'Rats (Sprague-Dawley, female; n = 12) were given single oral doses of Halowax 1014 (20 mg/kg body weight) or of a mixture (0.053 mg/ kg body weight) of hexachloronaphthalenes (consisting of equal amounts of 1,2,3,5,6,7-hexachloronaphthalene, 1,2,3,4,6,7-hexachloronaphthalene, and a third unidentified hexachloronaphthalene). The hepatic and adipose residue levels were measured 1, 10, 30, and 120 days after dosing. One day after exposure, the PCN pattern in the adipose tissue of the animals administered Halowax 1014 was similar to that of the technical product, but the relative levels of hepta- and octachloronaphthalenes were lower, possibly due to a less effective absorption of these compounds. However, within 10 days, the two hexa-isomers (co-eluting in gas chromatography) were dominant; after 120 days, they were the only congeners detected, their concentrations being still about 50% of that measured after 1 day. In liver samples, this selective retention was seen after only 1 day. Rats dosed with the hexachloronaphthalene mixture also showed a strong, similar retention of the 1,2,3,5,6,7- and 1,2,3,4,6,7-hexachloronaphthalene (the other unidentified hexachloronaphthalene could not be detected). The concentration ratios (based on the total concentrations of the two hexa-isomers) for liver/adipose tissue were found to be remarkably high: 7.3, 1.1, 0.8, and 0.63 at 24 hr and 10, 35, and 120 days, respectively, based on the fresh weights, or 140, 23, 17, and 13, based on the lipid weights.', 'The transfer of 1,2,3,4,6,7-hexachloronaphthalene from dam to offspring has been studied in Wistar rats orally (gavage) dosed with 1 ug 1,2,3,4,6,7-hexachloronaphthalene/kg body weight per day (in corn oil) on gestation days 14-16. Concentrations of 1,2,3,4,6,7-hexachloronaphthalene in fat of female offspring were 22.18 +/- 6.59 ug/kg (corresponding to 1.5-1.6 ng/pup) at birth (postnatal day 0) and 9.78 +/- 2.86 ug/kg (corresponding to 13-26 ng/pup) at weaning (postnatal day 21), and concentrations in fat of dams were 5.75 +/- 2.81 ug/kg at weaning; 1,2,3,4,6,7-hexachloronaphthalene was not detected in the control.']","['/In the pig/ 1,2,3,4,5,6-Hexachloronaphthalene was not metabolized.']","['The half-lives were calculated to be 41 days in the adipose tissue and 26 days in the liver /of rats/.', 'Human blood samples from three individuals exposed to PCN-contaminated rice oil in 1979 in Taiwan were monitored for the 1,2,3,4,6,7/1,2,3,5,6,7-hexachloronaphthalenes over a period of about 10 years. The measured concentrations resulted in calculated half-lives of 1.5-2.4 years.', 'Rats (Sprague-Dawley, female; n = 12) were given  a mixture (0.053 mg/kg body weight) of hexachloronaphthalenes (consisting of equal amounts of 1,2,3,5,6,7-hexachloronaphthalene, 1,2,3,4,6,7-hexachloronaphthalene, and a third unidentified hexachloronaphthalene)...The half-lives /for the two isomers, 1,2,3,5,6,7-hexachloronaphthalene and 1,2,3,4,6,7-hexachloronaphthalene/ were calculated to be 41 days in the adipose tissue and 26 days in the liver. This order of magnitude is comparable to that reported for slowly eliminated PCDF congeners in experimental animals.']"
8177,108178,"1,1'-Biphenyl, 2,2',4,5,5'-pentachloro-4'-(methylsulfonyl)-",CS(=O)(=O)C1=C(C=C(C(=C1)Cl)C2=CC(=C(C=C2Cl)Cl)Cl)Cl,,,,,,
8178,108179,Lophotoxin,CC(=C)[C@H]1C[C@@H]([C@]23[C@H](O2)[C@@H](C[C@@]4([C@@H](O4)C5=CC(=C(C1)O5)C=O)C)OC3=O)OC(=O)C,,,,,,
8179,108180,S-tert-Butyl O-ethyl ethylphosphonothioate,CCOP(=O)(CC)SC(C)(C)C,,,,,,
8180,108181,CID 108181,C1C(C([C@@]23N1C(=N[C@H]([C@@H]2NC(=N3)N)CO)N)(O)O)OS(=O)(=O)O,,,,,,
8181,108182,Zacopride,COC1=CC(=C(C=C1C(=O)NC2CN3CCC2CC3)Cl)N,,,"['Drugs that bind to but do not activate serotonin receptors, thereby blocking the actions of serotonin or SEROTONIN RECEPTOR AGONISTS. (See all compounds classified as Serotonin Antagonists.)', 'Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)']",,,
8182,108183,"[(1S,2R,6S,7S,8R,10S,11S,12R,16S,17R,18R)-6,7-Dihydroxy-8-(hydroxymethyl)-4,18-dimethyl-5-oxo-14-phenyl-16-prop-1-en-2-yl-9,13,15,19-tetraoxahexacyclo[12.4.1.01,11.02,6.08,10.012,16]nonadec-3-en-17-yl] 3-phenylprop-2-enoate",C[C@@H]1[C@H]([C@]2([C@H]3[C@H]4[C@@]1([C@@H]5C=C(C(=O)[C@]5([C@@H]([C@@]6([C@H]4O6)CO)O)O)C)OC(O3)(O2)C7=CC=CC=C7)C(=C)C)OC(=O)C=CC8=CC=CC=C8,,,,,,
8183,108184,"1,2-Epoxy-3,4-dihydroxy-1,2,3,4-tetrahydrobenzo(c)phenanthrene",C1=CC=C2C(=C1)C=CC3=C2C4=C(C=C3)C(C(C5C4O5)O)O,,,"['Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. (See all compounds classified as Carcinogens.)']",,,
8184,108185,Losartan carboxylic acid,CCCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)O)Cl,,,"['Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)', 'Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. (See all compounds classified as Anti-Arrhythmia Agents.)']",,['Losartan carboxylic acid is a known human metabolite of losartan and losartan carboxaldehyde.'],
8185,108186,"4-[[(1R)-2-[[(2R)-2-(2-Adamantyloxycarbonylamino)-3-(1H-indol-3-yl)-2-methylpropanoyl]amino]-1-phenylethyl]amino]-4-oxobutanoic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol",C[C@@](CC1=CNC2=CC=CC=C21)(C(=O)NC[C@@H](C3=CC=CC=C3)NC(=O)CCC(=O)O)NC(=O)OC4C5CC6CC(C5)CC4C6.CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O,,,"['Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)', 'Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites. (See all compounds classified as Hormone Antagonists.)', 'Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)']",,,
8186,108187,4-[[(1R)-2-[[(2R)-2-(2-adamantyloxycarbonylamino)-3-(1H-indol-3-yl)-2-methylpropanoyl]amino]-1-phenylethyl]amino]-4-oxobutanoic acid,C[C@@](CC1=CNC2=CC=CC=C21)(C(=O)NC[C@@H](C3=CC=CC=C3)NC(=O)CCC(=O)O)NC(=O)OC4C5CC6CC(C5)CC4C6,,,"['Agents that alleviate ANXIETY, tension, and ANXIETY DISORDERS, promote sedation, and have a calming effect without affecting clarity of consciousness or neurologic conditions. ADRENERGIC BETA-ANTAGONISTS are commonly used in the symptomatic treatment of anxiety but are not included here. (See all compounds classified as Anti-Anxiety Agents.)', 'Chemical substances which inhibit the function of the endocrine glands, the biosynthesis of their secreted hormones, or the action of hormones upon their specific sites. (See all compounds classified as Hormone Antagonists.)', 'Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)']",,,
8187,108188,CID 108188,CC1=C(C2=C(C=C1)NC(=NC2=O)N)SC3=CC=NC=C3.Cl.Cl,,,,,,
8188,108189,CID 108189,CC1=C(C2=C(C=C1)NC(=NC2=O)N)SC3=CC=NC=C3,,,,,,
8189,108190,"3-chloro-10,11-dihydro-5-(3-methylaminopropyl)-5H-dibenzo[a,d]cycloheptene",CNCCCC1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl,,,,,,
8190,108191,"Pyridine, 1-acetyl-1,2,3,4-tetrahydro-5-(2-piperidinyl)-",CC(=O)N1CCCC(=C1)C2CCCCN2,,,,,,
8191,108192,Testosterone glucuronide,C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)C(=O)O)O)O)O)CCC5=CC(=O)CC[C@]35C,,,,,,
8192,108193,Methylstannane,C[SnH3],,,,,,
8193,108194,CID 108194,C1C2CN(CN2C3=C(N1)NC(=NC3=O)N)C4=CC=C(C=C4)C(=O)N[C@@H](CCC(=O)O)C(=O)O,,,,,,
8194,108195,"Ruthenium Red tetrahydrate, pure",[NH2-].[NH2-].[NH2-].[NH2-].[NH2-].[NH2-].[NH2-].[NH2-].[NH2-].[NH2-].[NH2-].[NH2-].[NH2-].[NH2-].O.O.O.O.[O-2].[O-2].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Ru].[Ru+5].[Ru+5],,,,,,
8195,108196,Disulfane,SS,,,"['Any substance in the air which could, if present in high enough concentration, harm humans, animals, vegetation or materials. Substances include GASES; PARTICULATE MATTER; and volatile ORGANIC CHEMICALS. (See all compounds classified as Air Pollutants.)', 'Endogenously produced lipid-soluble gaseous molecules which function as neurotransmitters and signal mediators targeting ION CHANNELS and transporters. (See all compounds classified as Gasotransmitters.)']",,,
8196,108197,Einecs 237-979-0,[O-]P(=O)([O-])OP(=O)([O-])OP(=P)([O-])[O-],,,,,,
8197,108198,[Dihydroxy(phosphanylidene)-lambda5-phosphanyl] phosphono hydrogen phosphate,OP(=O)(O)OP(=O)(O)OP(=P)(O)O,,,,,,
8198,108199,"(1,2-Dihydroxyethyl)oxirane",C1C(O1)C(CO)O,,,,,,
8199,108200,CID 108200,C(CN(CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].O.[Na+].[Na+].[Ca+2],,,,,,
8200,108201,Desethylterbuthylazine,CC(C)(C)NC1=NC(=NC(=N1)N)Cl,,,,,,
8201,108202,"1-(4'-Ethylphenoxy)-6,7-epoxy-3,7-dimethyl-2-octene",CCC1=CC=C(C=C1)OCC=C(C)CCC2C(O2)(C)C,,,,,,
8202,108203,"(3aR,5aR,5bR,7aS,11aS,11bR,13aR,13bS)-5a,5b,8,8,11a,13b-hexamethyl-3-propan-2-yl-1,2,3,3a,4,5,6,7,7a,9,10,11,11b,12,13,13a-hexadecahydrocyclopenta[a]chrysene",CC(C)C1CC[C@]2([C@@H]1CC[C@@]3([C@@H]2CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CCCC5(C)C)C)C)C)C,,,,,,
8203,108204,3'-Hydroxymethyl-4-(dimethylamino)azobenzene,CN(C)C1=CC=C(C=C1)N=NC2=CC=CC(=C2)CO,,,,,,
8204,108205,CID 108205,CC1=CCCC(C12CC3=C4C2=C(C=C(C4=C(C5=C3C(C6(CC(=O)C(=C(N)O)C(=O)C6(C5=O)O)O)O)O)O)OC)(C)C,,,,,,
8205,108206,CID 108206,C1=NC2=C(C(=N1)N)N=C([C@@H]2C3[C@@H]([C@@H]([C@H](O3)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)O)N=[N+]=[N-],,,,,,
8206,108207,11-Nor-9-carboxy-delta-9-tetrahydrocannabinol,CCCCCC1=CC(=C2[C@@H]3C=C(CC[C@H]3C(OC2=C1)(C)C)C(=O)O)O,,,,,,
8207,108208,CID 108208,CCCN(CCC)C(=O)C(CCC(=O)OCCCN1CCN(CC1)CCOC(=O)CC2=C(N(C3=C2C=C(C=C3)OC)C(=O)C4=CC=C(C=C4)Cl)C)NC(=O)C5=CC=CC=C5.C(=CC(=O)O)C(=O)O,,,,,,
8208,108209,CID 108209,C([C@H]1[C@@H]([C@H]([C@H]([C@H](O1)OC[C@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O)O)O)O)O.C([C@H]1[C@@H]([C@H]([C@H]([C@H](O1)OC[C@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O)O)O)O)O,,,,,,
8209,108210,"4-Methylsulfonyl-2,2',3',4',5-pentachlorobiphenyl",CS(=O)(=O)C1=C(C=C(C(=C1)Cl)C2=C(C(=C(C=C2)Cl)Cl)Cl)Cl,,,,,,
8210,108211,"N-Hydroxy-3,2'-dimethyl-4-aminobiphenyl",CC1=CC=CC=C1C2=CC(=C(C=C2)NO)C,,,,,,
8211,108212,"3-Azido-1,2-propanediol",C(C(CO)O)N=[N+]=[N-],,,,,,
8212,108213,Bifendate,COC1=C2C(=C(C(=C1)C(=O)OC)C3=C4C(=C(C=C3C(=O)OC)OC)OCO4)OCO2,,,"['Drugs and compounds which inhibit or antagonize the biosynthesis or actions of CYTOCHROME P-450 ENZYMES. (See all compounds classified as Cytochrome P-450 Enzyme Inhibitors.)', 'Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund&apos;s adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. (See all compounds classified as Adjuvants, Immunologic.)', 'Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)']",,"['Bifendate has known human metabolites that include Mono-O-demethylated bdd and methyl 4-(2,3-dihydroxy-4-methoxy-6-methoxycarbonylphenyl)-7-methoxy-1,3-benzodioxole-5-carboxylate.']",
8213,108214,5-Acetylamino-6-formylamino-3-methyluracil,CC(=O)NC1=C(NC(=O)N(C1=O)C)NC=O,,,,,,
8214,108215,CID 108215,C1[C@]23[C@H]([C@@H](N=C(N2[C@H](C1(O)O)OS(=O)(=O)O)N)CO)NC(=N3)N,,,,,,
8215,108216,CID 108216,C1=CC(=NCCCN)C2=C(C3=C(C=CC(=O)C3=C4C2=C1N(N4)CNCCO)O)O,,,,,,
8216,108217,CID 108217,C[C@@H](C(=O)NCC(=O)N(C)[C@@H](CC1=CC=CC=C1)C(=O)NCCO)NC(=O)[C@H](CC2=CC=C(C=C2)O)N.CC(=O)O,,,,,,
8217,108218,N-Acetyl-S-(N-methylcarbamoyl)cysteine,CC(=O)N[C@@H](CSC(=O)NC)C(=O)O,,,,,,
8218,108219,"Phenol, 4-[(1E)-1-[4-[2-(dimethylamino)ethoxy]phenyl]-2-[4-(1-methylethyl)phenyl]-1-buten-1-yl]-, 1-(dihydrogen phosphate)",CCC(=C(C1=CC=C(C=C1)OCCN(C)C)C2=CC=C(C=C2)OP(=O)(O)O)C3=CC=C(C=C3)C(C)C,,,"['Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)', 'Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. (See all compounds classified as Estrogen Antagonists.)']",,,
8219,108220,Iometopane,CN1[C@H]2CC[C@@H]1[C@H]([C@H](C2)C3=CC=C(C=C3)I)C(=O)OC,,,"['Compounds that are used in medicine as sources of radiation for radiotherapy and for diagnostic purposes. They have numerous uses in research and industry. (Martindale, The Extra Pharmacopoeia, 30th ed, p1161) (See all compounds classified as Radiopharmaceuticals.)']",,,
8220,108221,"(S)-5-Hydroxy-6-oxo-2,6-dihydro-1H-indole-2-carboxylic acid",C1=C2C=C(C(=CC2=NC1C(=O)O)O)O,,,,,,
8221,108222,Hydroxyitraconazole,CC(C(C)O)N1C(=O)N(C=N1)C2=CC=C(C=C2)N3CCN(CC3)C4=CC=C(C=C4)OCC5COC(O5)(CN6C=NC=N6)C7=C(C=C(C=C7)Cl)Cl,,,"['Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. (See all compounds classified as Antifungal Agents.)']",,['Hydroxy-iteraconazole is a known human metabolite of itraconazole.'],
8222,108223,2-deoxy-D-glucose,C(C=O)[C@H]([C@@H]([C@@H](CO)O)O)O,"['As of July 2013, there is no approved therapeutic indication for 2-deoxyglucose. 2-deoxyglucose may have several potential indications as an adjunct to chemotherapy and radiotherapy in the treatment of solid tumors, as an antiviral treatment in herpes simplex patients, and as an antiepileptic in temporal lobe epilepsy patients.']","['Physiologically 2-deoxyglucose is an inhibitor of glycolysis, certain viruses, and seizures.']","['Drugs that are chemically similar to naturally occurring metabolites, but differ enough to interfere with normal metabolic pathways. (From AMA Drug Evaluations Annual, 1994, p2033) (See all compounds classified as Antimetabolites.)', 'Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. (See all compounds classified as Antiviral Agents.)']","['WHEN THE RENAL EXCRETION OF 2-DEOXYGLUCOSE WAS STUDIED IN DOGS AND RATS BY CONVENTIONAL CLEARANCE AND STOP-FLOW TECHNIQUES, IT WAS REABSORBED BY THE RENAL TUBULES AT AN AVG OF 68-89% OF THE FILTERED LOADS AND THE REABSORPTION SITE WAS IN THE PROXIMAL TUBULES.']",['2-DEOXY-D-GLUCOSE WAS CONVERTED TO THE 6-PHOSPHATE IN MOUSE TESTIS AND LIVER AFTER IP INJECTION OF 50 MG/KG BODY WT DAILY FOR 7 DAYS.'],
8223,108224,"(6aR,9R)-N-((S)-1-hydroxybutan-2-yl)-4,7-dimethyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide maleate",CC[C@@H](CO)NC(=O)[C@H]1CN([C@@H]2CC3=CN(C4=CC=CC(=C34)C2=C1)C)C.C(=CC(=O)O)C(=O)O,,,,,,
8224,108225,CID 108225,CC[C@@H](CO)NC(=O)C1CN([C@@H]2CC3=CN(C4=CC=CC(=C34)C2=C1)C)C,,,,,,
8225,108226,2-(Carbamoylamino)ethyl-trimethylazanium,C[N+](C)(C)CCNC(=O)N,,,,,,
8226,108227,5-Hydroxythiabendazole,C1=CC2=C(C=C1O)NC(=N2)C3=CSC=N3,,,,,['5-hydroxythiabendazole is a known human metabolite of thiabendazole.'],
8227,108228,"Octadeca-9,12-dienoate",CCCCCC=CCC=CCCCCCCCC(=O)[O-],,,,,,
8228,108229,3-{[(2-Aminoethoxy)(hydroxy)phosphoryl]oxy}-2-[(octadec-9-enoyl)oxy]propyl octadec-9-enoate,CCCCCCCCC=CCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
8229,108230,CID 108230,C1=NC2=C(N1[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)O)NC(=NC2=O)[N+](=O)[O-],,,,,,
8230,108231,"1,1,3-Triethoxyheptane",CCCCC(CC(OCC)OCC)OCC,,,,,,
8231,108232,"1,1,3-Triethoxyoctane",CCCCCC(CC(OCC)OCC)OCC,,,,,,
8232,108233,"2-Octene, 1,1-diethoxy-",CCCCCC=CC(OCC)OCC,,,,,,
8233,108234,"Tetradeca-2,4-dienal",CCCCCCCCCC=CC=CC=O,,,,,,
8234,108235,"Cyclopentanone, 2-(3-phenylpropylidene)-",C1CC(=CCCC2=CC=CC=C2)C(=O)C1,,,,,,
8235,108236,"Cyclohexenecarboxaldehyde, (4-methyl-3-pentenyl)-",CC=CCCC1C=C(CCC1C)C=O,,,,,,
8236,108237,1-(1-Methoxyethoxy)hexane,CCCCCCOC(C)OC,,,,,,
8237,108238,Propan-2-yl 2-[2-(2-ethoxyethoxy)propoxy]prop-2-enoate,CCOCCOC(C)COC(=C)C(=O)OC(C)C,,,,,,
8238,108239,"2,5-Furandione, dihydro-3-(2-tetradecen-1-yl)-",CCCCCCCCCCCC=CCC1CC(=O)OC1=O,,,,,,
8239,108240,CID 108240,CC1(C(N2C(S1)C(C2=O)N3C(=O)C(NC3(C)C)C4=CC=CC=C4)C(=O)[O-])C.[Na+],,,,,,
8240,108241,"Ethanone, 1-(1,6-dimethyl-3-(4-methyl-3-pentenyl)-3-cyclohexen-1-yl)-",CC1CC=C(CC1(C)C(=O)C)CCC=C(C)C,,,,,,
8241,108242,"1-(2,3,8,8-Tetramethyl-1,2,3,4,5,6,7,8-octahydronaphthalen-2-yl)ethanone",CC1CC2=C(CC1(C)C(=O)C)C(CCC2)(C)C,,,,,,
8242,108243,"Ethanone, 1-(1,2,3,4,5,6,7,8-octahydro-2,3,5,5-tetramethyl-2-naphthalenyl)-",CC1CC2=C(CCCC2(C)C)CC1(C)C(=O)C,,,,,,
8243,108244,1-(1-Ethoxyethoxy)hexane,CCCCCCOC(C)OCC,,,,,,
8244,108245,"2(3H)-Benzofuranone, 3-ethylhexahydro-",CCC1C2CCCCC2OC1=O,,,,,,
8245,108246,"2,5-Dimethyl-4-phenyl-4-propionyloxy-1-pyrrolidinylpropylpiperidine",CCC(=O)OC1(CC(N(CC1C)CCCN2CCCC2)C)C3=CC=CC=C3,,,,,,
8246,108247,"Piperidine, 1-(2-methyl-1-oxo-2-butenyl)-",CC=C(C)C(=O)N1CCCCC1,,,,,,
8247,108248,"2,3-Dihydro-3-methyl-1-phenyl-1H-phosphole 1-oxide",CC1CP(=O)(C=C1)C2=CC=CC=C2,,,,,,
8248,108249,"6'-(Diethylamino)-2'-(octylamino)spiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one",CCCCCCCCNC1=CC2=C(C=C1)OC3=C(C24C5=CC=CC=C5C(=O)O4)C=CC(=C3)N(CC)CC,,,,,,
8249,108250,"Isooctyl 2,3-dihydroxypropylthioacetate",CC(C)CCCCCOC(=O)CSCC(CO)O,,,,,,
8250,108251,"Cyclohexanecarboxylic acid, 2,4,4-trimethyl-6-oxo-, methyl ester",CC1CC(CC(=O)C1C(=O)OC)(C)C,,,,,,
8251,108252,"3-(p-Ethylphenoxy)-1,2-propanediol",CCC1=CC=C(C=C1)OCC(CO)O,,,,,,
8252,108253,6-[(2-Chlorophenyl)methoxycarbonylamino]-2-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoic acid,CC(C)(C)OC(=O)NC(CCCCNC(=O)OCC1=CC=CC=C1Cl)C(=O)O,,,,,,
8253,108254,2-Chloropropyl toluene-4-sulphonate,CC1=CC=C(C=C1)S(=O)(=O)OCC(C)Cl,,,,,,
8254,108255,"1H-Indene, 2,3-dihydro-1,1,3-trimethyl-5(or 6)-nitro-3-(4-nitrophenyl)-",CC1(CC(C2=C1C=C(C=C2)[N+](=O)[O-])(C)C3=CC=C(C=C3)[N+](=O)[O-])C,,,,,,
8255,108256,2-Tetradec-11-en-9-ynoxyoxane,CCC=CC#CCCCCCCCCOC1CCCCO1,,,,,,
8256,108257,"Benzenamine, 4,4'-methylenebis[N-(1,3-dimethylbutylidene)-",CC(C)CC(=NC1=CC=C(C=C1)CC2=CC=C(C=C2)N=C(C)CC(C)C)C,,,,,,
8257,108258,"1,7,7-Trimethylbicyclo(2.2.1)hept-2-yl acetoacetate",CC(=O)CC(=O)OC1CC2CCC1(C2(C)C)C,,,,,,
8258,108259,1-[(2-Piperazin-1-ylethyl)amino]propan-2-OL,CC(CNCCN1CCNCC1)O,,,,,,
8259,108260,Einecs 259-326-9,CC(=O)C1=CC=C(C=C1)C2CC3CCC2C3,,,,,,
8260,108261,"2-Cyclohexen-1-one, 2-hydroxy-6-methyl-3-(1-methylethyl)-",CC1CCC(=C(C1=O)O)C(C)C,,,,,,
8261,108262,2-(Isopropyloxy)-1-methylethyl acetate,CC(C)OCC(C)OC(=O)C,,,,,,
8262,108263,6-Heneicosyn-11-ol,CCCCCCCCCCC(CCCC#CCCCCC)O,,,,,,
8263,108264,Methyl 2-hexyldecanoate,CCCCCCCCC(CCCCCC)C(=O)OC,,,,,,
8264,108265,"Cyclohexanemethanamine, 1,3,3-trimethyl-N-(2-methylpropylidene)-5-[(2-methylpropylidene)amino]-",CC(C)C=NCC1(CC(CC(C1)(C)C)N=CC(C)C)C,,,,,,
8265,108266,"N,N-Bis(2-hydroxypropyl)dodecanamide",CCCCCCCCCCCC(=O)N(CC(C)O)CC(C)O,,,,,,
8266,108267,"cis-3a,4,5,9b-Tetrahydrobenzo(e)isoindoline hydrochloride",C1CC2=C(C=C1)C=CC3C2CNC3.Cl,,,,,,
8267,108268,"2,3,3a,8,9,9b-hexahydro-1H-benzo[e]isoindole",C1CC2=C(C=C1)C=CC3C2CNC3,,,,,,
8268,108269,"2-Methyl-2,3,3a,8,9,9b-hexahydro-1h-benzo[e]isoindole",CN1CC2C=CC3=C(C2C1)CCC=C3,,,,,,
8269,108270,"1,5-Ethano-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride",C1CC2CNCC1C3=CC=CC=C23.Cl,,,,,,
8270,108271,"10-Aza-tricyclo[6.3.2.02,7]trideca-2(7),3,5-triene",C1CC2CNCC1C3=CC=CC=C23,,,,,,
8271,108272,"3-Methyl-1,5-ethano-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride",CN1CC2CCC(C1)C3=CC=CC=C23.Cl,,,,,,
8272,108273,"10-Methyl-10-azatricyclo[6.3.2.02,7]trideca-2,4,6-triene",CN1CC2CCC(C1)C3=CC=CC=C23,,,,,,
8273,108274,"1,5-Ethano-1H-3-benzazepine-3-ethanol, 2,3,4,5-tetrahydro-, hydrochloride",C1CC2CN(CC1C3=CC=CC=C23)CCO.Cl,,,,,,
8274,108275,"2-(10-Azatricyclo[6.3.2.02,7]trideca-2,4,6-trien-10-yl)ethanol",C1CC2CN(CC1C3=CC=CC=C23)CCO,,,,,,
8275,108276,"3-Allyl-1,5-ethano-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride",C=CCN1CC2CCC(C1)C3=CC=CC=C23.Cl,,,,,,
8276,108277,"10-Prop-2-enyl-10-azatricyclo[6.3.2.02,7]trideca-2,4,6-triene",C=CCN1CC2CCC(C1)C3=CC=CC=C23,,,,,,
8277,108278,"3-Cyclopropylmethyl-1,5-ethano-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride",C1CC1CN2CC3CCC(C2)C4=CC=CC=C34.Cl,,,,,,
8278,108279,"10-(Cyclopropylmethyl)-10-azatricyclo[6.3.2.02,7]trideca-2,4,6-triene",C1CC1CN2CC3CCC(C2)C4=CC=CC=C34,,,,,,
8279,108280,"cis-2-Ethyl-3a,4,5,9b-tetrahydrobenzo(e)isoindoline hydrochloride",CCN1CC2C=CC3=C(C2C1)CCC=C3.Cl,,,,,,
8280,108281,"2-Ethyl-1,3,3a,8,9,9b-hexahydrobenzo[e]isoindole",CCN1CC2C=CC3=C(C2C1)CCC=C3,,,,,,
8281,108282,"3-Phenethyl-1,5-ethano-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride",C1CC2CN(CC1C3=CC=CC=C23)CCC4=CC=CC=C4.Cl,,,,,,
8282,108283,"10-(2-Phenylethyl)-10-azatricyclo[6.3.2.02,7]trideca-2,4,6-triene",C1CC2CN(CC1C3=CC=CC=C23)CCC4=CC=CC=C4,,,,,,
8283,108284,"Morpholinium, 4-(3-indolyl(methylthio)methylene)-, iodide",CSC(=[N+]1CCOCC1)C2=CNC3=CC=CC=C32.[I-],,,,,,
8284,108285,4-[1H-indol-3-yl(methylsulfanyl)methylidene]morpholin-4-ium,CSC(=[N+]1CCOCC1)C2=CNC3=CC=CC=C32,,,,,,
8285,108286,1-{[(1h-Indol-3-ylmethyl)sulfanyl]methylidene}piperidinium iodide,C1CC[N+](=CSCC2=CNC3=CC=CC=C32)CC1.[I-],,,,,,
8286,108287,3-(piperidin-1-ium-1-ylidenemethylsulfanylmethyl)-1H-indole,C1CC[N+](=CSCC2=CNC3=CC=CC=C32)CC1,,,,,,
8287,108288,1-({[(1H-Indol-3-yl)methyl]sulfanyl}methylidene)pyrrolidin-1-ium iodide,C1CC[N+](=CSCC2=CNC3=CC=CC=C32)C1.[I-],,,,,,
8288,108289,3-(pyrrolidin-1-ium-1-ylidenemethylsulfanylmethyl)-1H-indole,C1CC[N+](=CSCC2=CNC3=CC=CC=C32)C1,,,,,,
8289,108290,3-(Bis(2-chloropropyl)amino)-p-toluic acid,CC1=C(C=C(C=C1)C(=O)O)N(CC(C)Cl)CC(C)Cl,,,,,,
8290,108291,1-(2-(Bis(1-aziridinyl)phosphinyl)vinyl)-3-phenylurea,C1CN1P(=O)(C=CNC(=O)NC2=CC=CC=C2)N3CC3,,,,,,
8291,108292,"1-(2-(Bis(1-aziridinyl)phosphinyl)vinyl)-3-(2,4-xylyl)urea",CC1=CC(=C(C=C1)NC(=O)NC=CP(=O)(N2CC2)N3CC3)C,,,,,,
8292,108293,1-(2-(Bis(1-aziridinyl)phosphinyl)vinyl)-3-(p-bromophenyl)urea,C1CN1P(=O)(C=CNC(=O)NC2=CC=C(C=C2)Br)N3CC3,,,,,,
8293,108294,1-(2-(Bis(1-aziridinyl)phosphinyl)vinyl)-3-(p-iodophenyl)urea,C1CN1P(=O)(C=CNC(=O)NC2=CC=C(C=C2)I)N3CC3,,,,,,
8294,108295,"6H-Dibenzo(b,d)pyran-3-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-1-pentyl-, cis-(-)-",CCCCCC1=C2C3C=C(CCC3C(OC2=CC(=C1)O)(C)C)C,,,,,,
8295,108296,"1,2-Dichloro-4-(1-chloroethyl)benzene",CC(C1=CC(=C(C=C1)Cl)Cl)Cl,,,,,,
8296,108297,"1-Oxa-3,9-diazaspiro(5.5)undecan-2-one, 9-(3-(p-fluorobenzoyl)propyl)-5-methyl-",CC1CC2(CCN(CC2)CCCC(=O)C3=CC=C(C=C3)F)OC(=O)N1,,,,,,
8297,108298,"1-Oxa-3,9-diazaspiro(5.5)undecan-2-one, 5-ethyl-9-(3-(p-fluorobenzoyl)propyl)-",CCC1CC2(CCN(CC2)CCCC(=O)C3=CC=C(C=C3)F)OC(=O)N1,,,,,,
8298,108299,"1-Oxa-3,9-diazaspiro(5.5)undecan-2-one, 9-(3-(p-fluorobenzoyl)propyl)-5-phenyl-, hydrochloride",C1CN(CCC12CC(NC(=O)O2)C3=CC=CC=C3)CCCC(=O)C4=CC=C(C=C4)F.Cl,,,,,,
8299,108300,"9-[4-(4-Fluorophenyl)-4-oxobutyl]-4-phenyl-1-oxa-3,9-diazaspiro[5.5]undecan-2-one",C1CN(CCC12CC(NC(=O)O2)C3=CC=CC=C3)CCCC(=O)C4=CC=C(C=C4)F,,,,,,
8300,108301,"1-Oxa-3,9-diazaspiro(5.5)undecan-2-one, 9-(3-(p-chlorobenzoyl)propyl)-5-methyl-",CC1CC2(CCN(CC2)CCCC(=O)C3=CC=C(C=C3)Cl)OC(=O)N1,,,,,,
8301,108302,"1-Oxa-3,9-diazaspiro(5.5)undecan-2-one, 5-ethyl-9-(3-(p-chlorobenzoyl)propyl)-",CCC1CC2(CCN(CC2)CCCC(=O)C3=CC=C(C=C3)Cl)OC(=O)N1,,,,,,
8302,108303,"Cyclohexene, 4-ethoxy-1-methyl-4-(1-methylethyl)-",CCOC1(CCC(=CC1)C)C(C)C,,,,,,
8303,108304,"5-(3,4-Dichlorophenyl)-1,2,7,11b-tetrahydro-[1,3]diazepino[2,1-a]isoindol-5-ol",C1C=CC(N2CC3=CC=CC=C3C2N1)(C4=CC(=C(C=C4)Cl)Cl)O,,,,,,
8304,108305,"Benzenamine, 4,4'-(1,4-phenylenedi-2,1-ethenediyl)bis[N,N-bis(4-methylphenyl)-",CC1=CC=C(C=C1)N(C2=CC=C(C=C2)C)C3=CC=C(C=C3)C=CC4=CC=C(C=C4)C=CC5=CC=C(C=C5)N(C6=CC=C(C=C6)C)C7=CC=C(C=C7)C,,,,,,
8305,108306,"Benzoxazolium, 2-(2-(phenylamino)ethenyl)-3-(3-sulfopropyl)-, inner salt",C1=CC=C(C=C1)NC=CC2=[N+](C3=CC=CC=C3O2)CCCS(=O)(=O)[O-],,,,,,
8306,108307,2-(2-Anilinovinyl)-3-(3-sulfonatopropyl)benzoxazolium,C1=CC=C(C=C1)NC=CC2=[N+](C3=CC=CC=C3O2)CCCS(=O)(=O)O,,,,,,
8307,108308,CID 108308,CC(=O)N=C(N(C1=CC=CC=C1)C2=CC=CC=C2)S,,,,,,
8308,108309,"4,11-Dimethyltetradecane",CCCC(C)CCCCCCC(C)CCC,,,,,,
8309,108310,2-Ethylhexyl bis(nonylphenyl) phosphite,CCCCC(CC)COP(OCCCCCCCCCC1=CC=CC=C1)OCCCCCCCCCC2=CC=CC=C2,,,,,,
8310,108311,3-Methyl-5-phenylpent-1-en-3-ol,CC(CCC1=CC=CC=C1)(C=C)O,,,,,,
8311,108312,3-Methyl-5-phenylpentan-1-ol,CC(CCC1=CC=CC=C1)CCO,,,,,,
8312,108313,3-Methyl-5-phenylpentanal,CC(CCC1=CC=CC=C1)CC=O,,,,,,
8313,108314,"3,3-Dimethyl-8,9-dinorbornan-2-yl benzoate",CC1(C2CCC(C2)(C1OC(=O)C3=CC=CC=C3)C)C,,,,,,
8314,108315,2-Methyl-5-(1-methylethylidene)cyclohexyl propionate,CCC(=O)OC1CC(=C(C)C)CCC1C,,,,,,
8315,108316,"1H-Indole-2-carboxaldehyde, 2,3-dihydro-2-hydroxy-1,3,3-trimethyl-, 2-methyl-2-(4-methylphenyl)hydrazone",CC1=CC=C(C=C1)N(C)N=CC2(C(C3=CC=CC=C3N2C)(C)C)O,,,,,,
8316,108317,"Dodecanoic acid, 1-methylpentyl ester",CCCCCCCCCCCC(=O)OC(C)CCCC,,,,,,
8317,108318,sec-Butyl decanoate,CCCCCCCCCC(=O)OC(C)CC,,,,,,
8318,108319,"2-Butanone, 3-methyl-, (4-(phenylsulfonyl)phenyl)hydrazone",CC(C)C(=NNC1=CC=C(C=C1)S(=O)(=O)C2=CC=CC=C2)C,,,,,,
8319,108320,"Acetaldehyde, (1-ethyl-1,3-dihydro-3,3-dimethyl-5-(phenylsulfonyl)-2H-indol-2-ylidene)-",CCN1C2=C(C=C(C=C2)S(=O)(=O)C3=CC=CC=C3)C(C1=CC=O)(C)C,,,,,,
8320,108321,"5(4H)-Isoxazolone, 4-((1-ethyl-1,3-dihydro-3,3-dimethyl-5-(phenylsulfonyl)-2H-indol-2-ylidene)ethylidene)-3-phenyl-",CCN1C2=C(C=C(C=C2)S(=O)(=O)C3=CC=CC=C3)C(C1=CC=C4C(=NOC4=O)C5=CC=CC=C5)(C)C,,,,,,
8321,108322,"3-Methyl-2-(3,4,5-trimethoxybenzoylimino)-delta(sup 4)-1,3,4-thiadiazoline-5-sulfonamide",CN1C(=NC(=O)C2=CC(=C(C(=C2)OC)OC)OC)SC(=N1)S(=O)(=O)N,,,,,,
8322,108323,"3-Methyl-2-(2,4,6-trimethoxybenzoylimino)-delta(sup 4)-1,3,4-thiadiazoline-5-sulfonamide",CN1C(=NC(=O)C2=C(C=C(C=C2OC)OC)OC)SC(=N1)S(=O)(=O)N,,,,,,
8323,108324,"3-Methyl-2-(2,4,5-trimethoxybenzoylimino)-delta(sup 4)-1,3,4-thiadiazoline-5-sulfonamide",CN1C(=NC(=O)C2=CC(=C(C=C2OC)OC)OC)SC(=N1)S(=O)(=O)N,,,,,,
8324,108325,"2-(4-Chlorobenzoylimino)-3-methyl-delta(sup 4)-1,3,4-thiadiazoline-5-sulfonamide",CN1C(=NC(=O)C2=CC=C(C=C2)Cl)SC(=N1)S(=O)(=O)N,,,,,,
8325,108326,"2-Benzoylimino-3-methyl-delta(sup 4)-1,3,4-thiadiazoline-5-sulfonamide",CN1C(=NC(=O)C2=CC=CC=C2)SC(=N1)S(=O)(=O)N,,,,,,
8326,108327,"Spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one, 6'-(cyclohexylmethylamino)-3'-methyl-2'-(phenylamino)-",CC1=CC2=C(C=C1NC3=CC=CC=C3)C4(C5=C(O2)C=C(C=C5)N(C)C6CCCCC6)C7=CC=CC=C7C(=O)O4,,,,,,
8327,108328,Isopyrimol,CC(C)C(C1=CC=C(C=C1)Cl)(C2=CN=CN=C2)O,,,,,,
8328,108329,"Benzenamine, 4,4'-(1,2-ethanediyl)bis[N-[(4-methoxyphenyl)methylene]-",COC1=CC=C(C=C1)C=NC2=CC=C(C=C2)CCC3=CC=C(C=C3)N=CC4=CC=C(C=C4)OC,,,,,,
8329,108330,"Benzenesulfonamide, 4-[(1-butyl-5-cyano-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridinyl)azo]-N-(2-ethylhexyl)-",CCCCC(CC)CNS(=O)(=O)C1=CC=C(C=C1)N=NC2=C(C(=C(N(C2=O)CCCC)O)C#N)C,,,,,,
8330,108331,2-Dodec-7-enoxyoxane,CCCCC=CCCCCCCOC1CCCCO1,,,,,,
8331,108332,Hexamethylene bis-hydroxystearamide,CCCCCCC(CCCCCCCCCCC(=O)NCCCCCCNC(=O)CCCCCCCCCCC(CCCCCC)O)O,,,,,,
8332,108333,"5-Dimethylaminoacetyl-1,2,3,4,4a,5,6,11a,-octahydromorphanthridine hydrochloride",CN(C)CC(=O)N1CC2=CC=CC=C2CC3C1CCCC3.Cl,,,,,,
8333,108334,"1-(1,2,3,4,4a,6,11,11a-Octahydrobenzo[c][1]benzazepin-5-yl)-2-(dimethylamino)ethanone",CN(C)CC(=O)N1CC2=CC=CC=C2CC3C1CCCC3,,,,,,
8334,108335,"9-Octadecenoic acid (9Z)-, ester with 1,2,3-propanetriol diacetate",CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)C)OC(=O)C,,,,,,
8335,108336,"Cyclopentanecarboxylic acid, 2-oxo-1-pentyl-, methyl ester",CCCCCC1(CCCC1=O)C(=O)OC,,,,,,
8336,108337,"Dihydroabietyl alcohol, phthalic anhydride ester",CC(C)C1CC[C@H]2C(C1)CC[C@@H]3[C@@]2(CCC[C@@]3(C)CO)C.C1=CC=C(C(=C1)C(=O)O)C(=O)O,,,,,,
8337,108338,CID 108338,CC(C)C1CC[C@H]2C(C1)CCC3[C@@]2(CCC[C@@]3(C)CO)C,,,,,,
8338,108339,"Acetamide, 2-bromo-2-[(4-methylphenyl)sulfonyl]-",CC1=CC=C(C=C1)S(=O)(=O)C(C(=O)N)Br,,,,,,
8339,108340,"Cyclohexene, 6-(2-butenylidene)-1,5,5-trimethyl-",CC=CC=C1C(=CCCC1(C)C)C,,,,,,
8340,108341,"Imidazo[4,5-d]imidazole-2,5(1H,3H)-dione, tetrahydro-1,3,4,6-tetranitro-",C12C(N(C(=O)N1[N+](=O)[O-])[N+](=O)[O-])N(C(=O)N2[N+](=O)[O-])[N+](=O)[O-],,,,,,
8341,108342,"2,6,6-Trimethylbicyclo[3.1.1]heptane-1-thiol",CC1CCC2CC1(C2(C)C)S,,,,,,
8342,108343,Ethyl 2-methylbut-2-enoate,CCOC(=O)C(=CC)C,,,,,,
8343,108344,"3,3'-(Ureylenedimethylene)bis(3,5,5-trimethylcyclohexyl) diisocyanate",CC1(CC(CC(C1)(C)CNC(=O)NCC2(CC(CC(C2)(C)C)N=C=O)C)N=C=O)C,,,,,,
8344,108345,"1,3-Dioxane, 4-methyl-2-(2-methyl-1-propenyl)-",CC1CCOC(O1)C=C(C)C,,,,,,
8345,108346,"4-Piperidinol, 2,2,6,6-tetramethyl-1-nitroso-",CC1(CC(CC(N1N=O)(C)C)O)C,,,,,,
8346,108347,"1,3,4-Metheno-1H-cyclobuta[cd]pentalene, 1,1a,2,2,3,4,5,5,5a,5b-decachlorooctahydro-",C12C3(C4C1(C(C5(C2(C(C45Cl)(C3(Cl)Cl)Cl)Cl)Cl)(Cl)Cl)Cl)Cl,,,,,,
8347,108348,N-Acetyl-DL-homocysteine,CC(=O)NC(CCS)C(=O)O,,,,,,
8348,108349,(3S)-rel-N-Benzyl-3-benzylamino-D-aspartic acid,C1=CC=C(C=C1)CNC(C(C(=O)O)NCC2=CC=CC=C2)C(=O)O,,,,,,
8349,108350,"1-Heptyl-1,2,3,4-tetrahydro-4-methylnaphthalene",CCCCCCCC1CCC(C2=CC=CC=C12)C,,,,,,
8350,108351,"2-((1-Cyano-1,3-dimethylbutyl)azo)-4-methoxy-2,4-dimethylpentanenitrile",CC(C)CC(C)(C#N)N=NC(C)(CC(C)(C)OC)C#N,,,,,,
8351,108352,Einecs 259-756-7,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C(C4)CCC6C5CCC7(C6(CCC7C8=CC(=O)OC8)O)C)C)C)C)O)OC,,,,,,
8352,108353,"1-Imidazolidineacetamide, N-[5-[[4-[2,4-bis(1,1-dimethylpropyl)phenoxy]-1-oxobutyl]amino]-2-chlorophenyl]-alpha-(2,2-dimethyl-1-oxopropyl)-2,5-dioxo-3-(phenylmethyl)-",CCC(C)(C)C1=CC(=C(C=C1)OCCCC(=O)NC2=CC(=C(C=C2)Cl)NC(=O)C(C(=O)C(C)(C)C)N3C(=O)CN(C3=O)CC4=CC=CC=C4)C(C)(C)CC,,,,,,
8353,108354,CID 108354,CCCCCCCCCCCCCCCCC=CC1CC(=O)N(C1=O)C2=CC(=C(C=C2)Cl)NC3=NN(C(=O)C3)C4=C(C=C(C=C4Cl)Cl)Cl,,,,,,
8354,108355,"3,7-Dimethyl-3,6-octadienal",CC(=CCC=C(C)CC=O)C,,,,,,
8355,108356,"3-Penten-2-one, 5-(2,2,3-trimethyl-3-cyclopenten-1-yl)-",CC1=CCC(C1(C)C)CC=CC(=O)C,,,,,,
8356,108357,"4-Penten-2-one, 5-(2,2,3-trimethyl-3-cyclopenten-1-yl)-",CC1=CCC(C1(C)C)C=CCC(=O)C,,,,,,
8357,108358,2-sec-Butylaniline,CCC(C)C1=CC=CC=C1N,,,,,,
8358,108359,"2-Propenal, 3-(2,2,6-trimethyl-7-oxabicyclo(4.1.0)hept-1-yl)-",CC1(CCCC2(C1(O2)C=CC=O)C)C,,,,,,
8359,108360,"octahydro-1,5-methano-3H-cyclopent[c]oxepin-3-one",C1CC2C(C1)C3CC2CC(=O)O3,,,,,,
8360,108361,"Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 3'-methyl-2'-(phenylamino)-6'-(1-pyrrolidinyl)-",CC1=CC2=C(C=C1NC3=CC=CC=C3)C4(C5=C(O2)C=C(C=C5)N6CCCC6)C7=CC=CC=C7C(=O)O4,,,,,,
8361,108362,"Ethanone, 1-[10,10-dimethyl-2,6-bis(methylene)bicyclo[7.2.0]undec-5-yl]-",CC(=O)C1CCC(=C)C2CC(C2CCC1=C)(C)C,,,,,,
8362,108363,"9-((5-Chloro-1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)ethylidene)-2,3,4,4a,9,9a-hexahydro-1H-carbazolium chloride",CC1(C2=C(C=CC(=C2)Cl)[N+](=C1C=CN3C4=C(CCCC4)C5=CC=CC=C53)C)C.[Cl-],,,,,,
8363,108364,"9-[2-(5-Chloro-1,3,3-trimethylindol-1-ium-2-yl)ethenyl]-1,2,3,4-tetrahydrocarbazole",CC1(C2=C(C=CC(=C2)Cl)[N+](=C1C=CN3C4=C(CCCC4)C5=CC=CC=C53)C)C,,,,,,
8364,108365,"2-(2,5-Dimethyl-1-pyrrolidinyl)ethyl benzilate hydrochloride",CC1=CC(=C(C=C1)C)C(C2=CC=CC=C2)(C(=O)OCCN3CCCC3)O.Cl,,,,,,
8365,108366,"2-Pyrrolidin-1-ylethyl 2-(2,5-dimethylphenyl)-2-hydroxy-2-phenylacetate",CC1=CC(=C(C=C1)C)C(C2=CC=CC=C2)(C(=O)OCCN3CCCC3)O,,,,,,
8366,108367,"Benzilic acid, 3-(2,5-dimethyl-1-pyrrolidinyl)propyl ester, hydrochloride",CC1=CC(=C(C=C1)C)C(C2=CC=CC=C2)(C(=O)OCCCN3CCCC3)O.Cl,,,,,,
8367,108368,"3-Pyrrolidin-1-ylpropyl 2-(2,5-dimethylphenyl)-2-hydroxy-2-phenylacetate",CC1=CC(=C(C=C1)C)C(C2=CC=CC=C2)(C(=O)OCCCN3CCCC3)O,,,,,,
8368,108369,CID 108369,CCN=C(OCC(C)C)S,,,,,,
8369,108370,"4-(1,3-Diphenylbutyl)-o-xylene",CC1=C(C=C(C=C1)C(CC(C)C2=CC=CC=C2)C3=CC=CC=C3)C,,,,,,
8370,108371,2-axial-Hydroxy-2-equatorial-(3-chlorophenyl)quinolizidine,C1CCN2CCC(CC2C1)(C3=CC(=CC=C3)Cl)O,,,,,,
8371,108372,2-axial-Hydroxy-2-equatorial-(3-trifluorophenyl)quinolizidine,C1CCN2CCC(CC2C1)(C3=CC(=CC=C3)C(F)(F)F)O,,,,,,
8372,108373,"Octadecanoic acid, 12-hydroxy-, homopolymer, octadecanoate",CCCCCCCCCCCCCCCCCC(=O)O.CCCCCCC(CCCCCCCCCCC(=O)O)O,,,,,,
8373,108374,2-(4-Isobutylphenyl)propanenitrile,CC(C)CC1=CC=C(C=C1)C(C)C#N,,,,,,
8374,108375,2-Methoxyphenyl lactate,CC(C(=O)OC1=CC=CC=C1OC)O,,,,,,
8375,108376,"2-(5-(5-(1-(2-(Aminosulphonyl)phenyl)-3-cyclohexyl-1,2,3,4-tetrahydro-6-hydroxy-2,4-dioxo-5-pyrimidinyl)penta-2,4-dienylidene)-3-cyclohexyltetrahydro-2,4,6-trioxo-1(2H)-pyrimidinyl)benzenesulphonamide",C1CCC(CC1)N2C(=O)C(C(=O)N(C2=O)C3=CC=CC=C3S(=O)(=O)N)C=CC=CC=C4C(=O)N(C(=O)N(C4=O)C5=CC=CC=C5S(=O)(=O)N)C6CCCCC6,,,,,,
8376,108377,"1,3,3-Trimethylbicyclo[2.2.1]heptan-2-YL 3-methylbutanoate",CC(C)CC(=O)OC1C(C2CCC1(C2)C)(C)C,,,,,,
8377,108378,CID 108378,C1CC(=O)NC1C(=O)O.O.O.[AlH3],,,,,,
8378,108379,"3-(2,3-Dihydroxypropoxy)-2-hydroxypropyl acetate",CC(=O)OCC(COCC(CO)O)O,,,,,,
8379,108380,"1-Diphenylmethyl-3-methyl-3-(3,4-dimethoxybenzyl)-4-methyl-piperazine",CC1(CN(CCN1C)C(C2=CC=CC=C2)C3=CC=CC=C3)CC4=CC(=C(C=C4)OC)OC,,,,,,
8380,108381,"Bis(2-(2-(propan-2-yl)-1,3-oxazolidin-3-yl)ethyl) hexane-1,6-diylbiscarbamate",CC(C)C1N(CCO1)CCOC(=O)NCCCCCCNC(=O)OCCN2CCOC2C(C)C,,,,,,
8381,108382,3-Heptyltetrahydro-2H-pyran-2-one,CCCCCCCC1CCCOC1=O,,,,,,
8382,108383,"3H-Indolium, 2-(2-((2,4-dimethoxyphenyl)amino)ethenyl)-1,3,3-trimethyl-, formate",CC1(C2=CC=CC=C2[N+](=C1C=CNC3=C(C=C(C=C3)OC)OC)C)C.C(=O)[O-],,,,,,
8383,108384,"3H-Indolium, 2-(2-((2,4-dimethoxyphenyl)amino)ethenyl)-1,3,3-trimethyl-, sulfate (1:1)",CC1(C2=CC=CC=C2[N+](=C1C=CNC3=C(C=C(C=C3)OC)OC)C)C.OS(=O)(=O)[O-],,,,,,
8384,108385,6-Methyl-4-(4-methyl-3-pentenyl)cyclohex-3-ene-1-carbaldehyde,CC1CC(=CCC1C=O)CCC=C(C)C,,,,,,
8385,108386,6-Methyl-3-(4-methyl-3-pentenyl)cyclohex-3-ene-1-carbaldehyde,CC1CCC(=CC1C=O)CCC=C(C)C,,,,,,
8386,108387,"Ethanone, 1-(1-methyl-4-(4-methyl-3-pentenyl)-3-cyclohexen-1-yl)-",CC(=CCCC1=CCC(CC1)(C)C(=O)C)C,,,,,,
8387,108388,"1,2,3,4,5,6,7,8-Octahydro-2,5,5-trimethylnaphthalene-2-carbaldehyde",CC1(CCCC2=C1CCC(C2)(C)C=O)C,,,,,,
8388,108389,"10-Methoxy-4-(1-methylpiperidin-4-yl)-4h-benzo[4,5]cyclohepta[1,2-b]thiophene-4-ol",CN1CCC(CC1)C2(C3=C(C(=CC4=CC=CC=C42)OC)SC=C3)O,,,,,,
8389,108390,3-{[(2-Aminoethoxy)(hydroxy)phosphoryl]oxy}-2-(dodecanoyloxy)propyl dodecanoate,CCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCN)OC(=O)CCCCCCCCCCC,,,,,,
8390,108391,2-Fluoro-N-[2-hydroxy-3-(methylphenylamino)propyl]benzamide,CN(CC(CNC(=O)C1=CC=CC=C1F)O)C2=CC=CC=C2,,,,,,
8391,108392,"3-(2,3-Dibromopropoxy)propane-1,2-diol",C(C(COCC(CBr)Br)O)O,,,,,,
8392,108393,"Tris(5-oxo-L-prolinato-N1,O2)aluminium",C1CC(=O)NC1C(=O)[O-].C1CC(=O)NC1C(=O)[O-].C1CC(=O)NC1C(=O)[O-].[Al+3],,,,,,
8393,108394,Tris[2-(2-methoxypropoxy)propyl] borate,B(OCC(C)OCC(C)OC)(OCC(C)OCC(C)OC)OCC(C)OCC(C)OC,,,,,,
8394,108395,"Methyl 3-(dimethoxymethyl)-2,2-dimethylcyclopropane-1-carboxylate",CC1(C(C1C(=O)OC)C(OC)OC)C,,,,,,
8395,108396,"2-Acetyl-1,2,3,4-tetrahydro-6-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]-7-methoxyisoquinoline",CC(C)NCC(COC1=C(C=C2CN(CCC2=C1)C(=O)C)OC)O,,,,,,
8396,108397,"Butanamide, 2-chloro-N,N-dimethyl-",CCC(C(=O)N(C)C)Cl,,,,,,
8397,108398,"5,6-Dihydro-4-methyl-2-(2-methylpropyl)-2H-pyran",CC1=CC(OCC1)CC(C)C,,,,,,
8398,108399,Tetrahydro-4-methylene-2-(2-methylpropyl)-2H-pyran,CC(C)CC1CC(=C)CCO1,,,,,,
8399,108400,"3,6-Dihydro-4-methyl-2-(2-methylpropyl)-2H-pyran",CC1=CCOC(C1)CC(C)C,,,,,,
8400,108401,"2,4,6-Trichlorophenyl 5-oxo-L-prolinate",C1CC(=O)NC1C(=O)OC2=C(C=C(C=C2Cl)Cl)Cl,,,,,,
8401,108402,Methyl 1-methyl-5-oxopyrrolidine-3-carboxylate,CN1CC(CC1=O)C(=O)OC,,,,,,
8402,108403,"2,2,2-Tribromo-1-chloroethyl 2,3-dibromopropionate",C(C(C(=O)OC(C(Br)(Br)Br)Cl)Br)Br,,,,,,
8403,108404,Pentafluoropropionaldehyde methyl hemiacetal,COC(C(C(F)(F)F)(F)F)O,,,,,,
8404,108405,3-Ethylhexahydro-1-methyl-2H-azepin-2-one,CCC1CCCCN(C1=O)C,,,,,,
8405,108406,"1,1'-(2-Chloropropylidene)bis(4-methoxybenzene)",CC(C(C1=CC=C(C=C1)OC)C2=CC=C(C=C2)OC)Cl,,,,,,
8406,108407,"2-(Dimethoxymethyl)-2,5-dihydro-2,5-dimethoxyfuran",COC1C=CC(O1)(C(OC)OC)OC,,,,,,
8407,108408,"Tetracosane-8,17-diamine",CCCCCCCC(CCCCCCCCC(CCCCCCC)N)N,,,,,,
8408,108409,CID 108409,C1=CC=C2C(=C1)C(=NC2=O)NC3=CC(=C(C=C3)NC4=NC(=O)C5=CC=CC=C54)Cl,,,,,,
8409,108410,"[4-Ethenyl-2,2,4-trimethyl-3-(prop-1-en-2-yl)cyclohexyl]methyl acetate",CC(=C)C1C(C(CCC1(C)C=C)COC(=O)C)(C)C,,,,,,
8410,108411,"4-(2-Bromo-5-cyclohexyl-3-hydroxy-1-penten-1-yl)hexahydro-2H-cyclopenta(b)furan-2,5-diol",C1CCC(CC1)CCC(C(=CC2C3CC(OC3CC2O)O)Br)O,,,,,,
8411,108412,"Ethyl 4,6,6,6-tetrachloro-3,3-dimethylhexanoate",CCOC(=O)CC(C)(C)C(CC(Cl)(Cl)Cl)Cl,,,,,,
8412,108413,"Cyclopropanecarboxylic acid, 2,2-dimethyl-3-(2,2,2-trichloroethyl)-, ethyl ester",CCOC(=O)C1C(C1(C)C)CC(Cl)(Cl)Cl,,,,,,
8413,108414,"Bis(3,5,5-trimethylhexyl) maleate",CC(CCOC(=O)C=CC(=O)OCCC(C)CC(C)(C)C)CC(C)(C)C,,,,,,
8414,108415,"2,6,6-Trimethylbicyclo[3.1.1]heptane-3-carbaldehyde",CC1C(CC2CC1C2(C)C)C=O,,,,,,
8415,108416,"1-(Difluoromethoxy)-1,2,2-trifluoroethane",C(C(F)F)(OC(F)F)F,,,,,,
8416,108417,Ethyl 2-hydroxycyclopentanehexanoate,CCOC(=O)CCCCCC1CCCC1O,,,,,,
8417,108418,4-(1-Phenylethyl)-n-[4-(1-phenylethyl)phenyl]aniline,CC(C1=CC=CC=C1)C2=CC=C(C=C2)NC3=CC=C(C=C3)C(C)C4=CC=CC=C4,,,,,,
8418,108419,"2-(Bromomethyl)-2-(2,4-dichlorophenyl)-4-propyl-1,3-dioxolane",CCCC1COC(O1)(CBr)C2=C(C=C(C=C2)Cl)Cl,,,,,,
8419,108420,"2-(Bromomethyl)-2-(2,4-dichlorophenyl)-4-ethyl-1,3-dioxolane",CCC1COC(O1)(CBr)C2=C(C=C(C=C2)Cl)Cl,,,,,,
8420,108421,"Carbonimidodithioic acid, cyano-, bis(2,3-dibromopropyl) ester",C(C(CBr)Br)SC(=NC#N)SCC(CBr)Br,,,,,,
8421,108422,"1H-1,2,4-Triazole-1-acetamide, N-[5-[[4-[2,4-bis(1,1-dimethylpropyl)phenoxy]-1-oxobutyl]amino]-2-chlorophenyl]-3-chloro-alpha-(2,2-dimethyl-1-oxopropyl)-",CCC(C)(C)C1=CC(=C(C=C1)OCCCC(=O)NC2=CC(=C(C=C2)Cl)NC(=O)C(C(=O)C(C)(C)C)N3C=NC(=N3)Cl)C(C)(C)CC,,,,,,
8422,108423,"Ethyl 5,5,7-trimethyl-1-oxaspiro[2.5]octane-2-carboxylate",CCOC(=O)C1C2(O1)CC(CC(C2)(C)C)C,,,,,,
8423,108424,"Cyclohexanepropanol, alpha-ethyl-2,2,6-trimethyl-",CCC(CCC1C(CCCC1(C)C)C)O,,,,,,
8424,108425,"Cyclohexanepropanol, alpha,beta,2,2,6-pentamethyl-",CC1CCCC(C1CC(C)C(C)O)(C)C,,,,,,
8425,108426,"Cyclohexanepropanol, alpha,beta,2,2,6-pentamethyl-, acetate",CC1CCCC(C1CC(C)C(C)OC(=O)C)(C)C,,,,,,
8426,108427,"3-Methyl-4-(2,2,6-trimethylcyclohexyl)butan-2-one",CC1CCCC(C1CC(C)C(=O)C)(C)C,,,,,,
8427,108428,"1-(2,2,6-Trimethylcyclohexyl)pentan-3-one",CCC(=O)CCC1C(CCCC1(C)C)C,,,,,,
8428,108429,4-(m-Nitrostyryl)cinnoline,C1=CC=C2C(=C1)C(=CN=N2)C=CC3=CC(=CC=C3)[N+](=O)[O-],,,,,,
8429,108430,"Pentanamide, N-[2-chloro-5-[(hexadecylsulfonyl)amino]phenyl]-2-[4-[(4-hydroxyphenyl)sulfonyl]phenoxy]-4,4-dimethyl-3-oxo-",CCCCCCCCCCCCCCCCS(=O)(=O)NC1=CC(=C(C=C1)Cl)NC(=O)C(C(=O)C(C)(C)C)OC2=CC=C(C=C2)S(=O)(=O)C3=CC=C(C=C3)O,,,,,,
8430,108431,2-Methylhexyl methacrylate,CCCCC(C)COC(=O)C(=C)C,,,,,,
8431,108432,"3-(Butylamino)propane-1,2-diol",CCCCNCC(CO)O,,,,,,
8432,108433,"3-(Diisobutylamino)propane-1,2-diol",CC(C)CN(CC(C)C)CC(CO)O,,,,,,
8433,108434,"3-(N-Benzyl-N-methylamino)-1,2-propanediol",CN(CC1=CC=CC=C1)CC(CO)O,,,,,,
8434,108435,"3-(Dipropylamino)propane-1,2-diol",CCCN(CCC)CC(CO)O,,,,,,
8435,108436,2-(1-Methyl-5-oxopyrrolidin-2-yl)acetic acid,CN1C(CCC1=O)CC(=O)O,,,,,,
8436,108437,"3-(4'-bromo[1,1'-biphenyl]-4-yl)-3,4-dihydronaphthalen-1(2H)-one",C1C(CC(=O)C2=CC=CC=C21)C3=CC=C(C=C3)C4=CC=C(C=C4)Br,,,,,,
8437,108438,"4'-Bromo-alpha-(phenylmethyl)[1,1'-biphenyl]-4-methanol",C1=CC=C(C=C1)CC(C2=CC=C(C=C2)C3=CC=C(C=C3)Br)O,,,,,,
8438,108439,"4-Bromo-4'-(1-bromo-2-phenylethyl)-1,1'-biphenyl",C1=CC=C(C=C1)CC(C2=CC=C(C=C2)C3=CC=C(C=C3)Br)Br,,,,,,
8439,108440,[1-(4'-Bromobiphenyl-4-yl)-2-phenylethyl]malonic acid,C1=CC=C(C=C1)CC(C2=CC=C(C=C2)C3=CC=C(C=C3)Br)C(C(=O)O)C(=O)O,,,,,,
8440,108441,"1,5-Dimethylbicyclo[3.2.1]octan-8-ol",CC12CCCC(C1O)(CC2)C,,,,,,
8441,108442,"5,6-Dihydro-4-methyl-2-phenyl-2H-pyran",CC1=CC(OCC1)C2=CC=CC=C2,,,,,,
8442,108443,"3,6-Dihydro-4-methyl-2-phenyl-2H-pyran",CC1=CCOC(C1)C2=CC=CC=C2,,,,,,
8443,108444,"2H-Pyran, tetrahydro-4-methylene-2-phenyl-",C=C1CCOC(C1)C2=CC=CC=C2,,,,,,
8444,108445,"1,4-Benzenediol, 2,5-di-sec-dodecyl-",CCCCCCCCCCC(C)C1=CC(=C(C=C1O)C(C)CCCCCCCCCC)O,,,,,,
8445,108446,"1,2,3,3,4,5,6-Heptamethylbicyclo(2.2.2)oct-5-en-2-ol",CC1=C(C2(CCC1(C(C2(C)O)(C)C)C)C)C,,,,,,
8446,108447,Methyl 3-((((dimethylamino)methylene)amino)sulphonyl)-5-nitro-4-phenoxybenzoate,CN(C)C=NS(=O)(=O)C1=CC(=CC(=C1OC2=CC=CC=C2)[N+](=O)[O-])C(=O)OC,,,,,,
8447,108448,Methyl 3-((((dimethylamino)methylene)amino)sulphonyl)-4-phenoxy-5-(1-pyrrolidinyl)benzoate,CN(C)C=NS(=O)(=O)C1=CC(=CC(=C1OC2=CC=CC=C2)N3CCCC3)C(=O)OC,,,,,,
8448,108449,"4-((4-(Trifluoromethyl)-2-benzothiazolyl)azo)-2,5-dimethyl-N-(1-methylpropyl)aniline",CCC(C)NC1=C(C=C(C(=C1)C)N=NC2=NC3=C(C=CC=C3S2)C(F)(F)F)C,,,,,,
8449,108450,"N-sec-Butyl-2,5-xylidine",CCC(C)NC1=C(C=CC(=C1)C)C,,,,,,
8450,108451,2-Cyclohexyl-2-propyl acetate,CC(=O)OC(C)(C)C1CCCCC1,,,,,,
8451,108452,"4-(3-(3-Carboxy-5-hydroxy-1-(tetrahydro-3-thienyl)-1H-pyrazol-4-yl)allylidene)-4,5-dihydro-5-oxo-1-(tetrahydro-3-thienyl)-1H-pyrazole-3-carboxylic acid S,S,S',S'-tetraoxide",C1CS(=O)(=O)CC1N2C(=O)C(=C(N2)C(=O)O)C=CC=C3C(=NN(C3=O)C4CCS(=O)(=O)C4)C(=O)O,,,,,,
8452,108453,"3-Hexen-2-one, 5-phenyl-",CC(C=CC(=O)C)C1=CC=CC=C1,,,,,,
8453,108454,Einecs 262-223-1,CCCCCCCCC=CCCCCCCCCOC(=O)C1CCCCC1C(=O)O,,,,,,
8454,108455,"3,3-dimethylspiro[cyclopropane-1,1'-[1H]indene]-2-carboxylic acid",CC1(C(C12C=CC3=CC=CC=C23)C(=O)O)C,,,,,,
8455,108456,"2,4,8-Decatrienal, 2,5,9-trimethyl-",CC(=CCCC(=CC=C(C)C=O)C)C,,,,,,
8456,108457,CID 108457,C1C2C(C(C(O2)N3C=NC4=C(N=CN=C43)N)OC(=O)C(CC5=CC=C(C=C5)O)NC(=O)CCC(=O)O)OP(=O)(O1)O,,,,,,
8457,108458,"3,3-Dimethylspiro(cyclopropane-1,1'-(1H)indene)-2-carbonyl chloride",CC1(C(C12C=CC3=CC=CC=C23)C(=O)Cl)C,,,,,,
8458,108459,7-(beta-Diethylaminoethyl)-8-(alpha-hydroxybenzyl)theophylline hydrochloride,CCN(CC)CCN1C2=C(N=C1C(C3=CC=CC=C3)O)N(C(=O)N(C2=O)C)C.Cl,,,,,,
8459,108460,2-(Hydroxymethyl)-2-methylpentyl 2-(hydroxymethyl)-2-methylvalerate,CCCC(C)(CO)COC(=O)C(C)(CCC)CO,,,,,,
8460,108461,"Naphthalene, 1,2,3,4-tetrahydro-5-(1-phenylethyl)-",CC(C1=CC=CC=C1)C2=CC=CC3=C2CCCC3,,,,,,
8461,108462,Bis(oxiranylmethyl) oxalate,C1C(O1)COC(=O)C(=O)OCC2CO2,,,,,,
8462,108463,"Bis(2,3-epoxypropyl) malonate",C1C(O1)COC(=O)CC(=O)OCC2CO2,,,,,,
8463,108464,"5-Allyl-octahydro-4,7-methano-1H-inden-5-ol",C=CCC1(CC2CC1C3C2CCC3)O,,,,,,
8464,108465,2-alpha-Pyrrolidinyl-21-hydroxy-5-beta-pregnane-20-one,C1CCN(C1)C2CCC3CCC4C5CCC(C5CCC4C3C2)C(=O)CO,,,,,,
8465,108466,"Naphtho[1,2-d]thiazolium, 1-ethyl-2-[3-(1-ethylnaphtho[1,2-d]thiazol-2(1H)-ylidene)-2-methyl-1-propenyl]-, salt with 4-methylbenzenesulfonic acid (1:1)",CCN1C(=CC(=CC2=[N+](C3=C(S2)C=CC4=CC=CC=C43)CC)C)SC5=C1C6=CC=CC=C6C=C5.CC1=CC=C(C=C1)S(=O)(=O)[O-],,,,,,
8466,108467,[Bis[(3-phenylallyl)oxy]methyl]vinylbenzene,C=C(C1=CC=CC=C1)C(OCC=CC2=CC=CC=C2)OCC=CC3=CC=CC=C3,,,,,,
8467,108468,"4,4'-Bis((4-((2-hydroxyethyl)methylamino)-6-methoxy-1,3,5-triazin-2-yl)amino)stilbene-2,2'-disulphonic acid",CN(CCO)C1=NC(=NC(=N1)NC2=CC(=C(C=C2)C=CC3=C(C=C(C=C3)NC4=NC(=NC(=N4)OC)N(C)CCO)S(=O)(=O)O)S(=O)(=O)O)OC,,,,,,
8468,108469,"(3,3,3-Trichloro-1-propenyl)benzene",C1=CC=C(C=C1)C=CC(Cl)(Cl)Cl,,,,,,
8469,108470,Disodium 5-carboxylato-4-hexylcyclohex-2-ene-1-octanoate,CCCCCCC1C=CC(CC1C(=O)[O-])CCCCCCCC(=O)[O-].[Na+].[Na+],,,,,,
8470,108471,"beta-Ethylidene-6-methoxy-alpha,alpha-dimethylnaphthalene-2-propionic acid",CC=C(C1=CC2=C(C=C1)C=C(C=C2)OC)C(C)(C)C(=O)O,,,,,,
8471,108472,"2-Amino-1,1,2-triphenylethanol",C1=CC=C(C=C1)C(C(C2=CC=CC=C2)(C3=CC=CC=C3)O)N,,,,,,
8472,108473,"3-Phenylpropyl 5-hydroxy-3,4-dihydro-2H-pyrrole-2-carboxylate",C1CC(=O)NC1C(=O)OCCCC2=CC=CC=C2,,,,,,
8473,108474,Benzyl 5-oxopyrrolidine-2-carboxylate,C1CC(=O)NC1C(=O)OCC2=CC=CC=C2,,,,,,
8474,108475,2-Phenylethyl 5-oxopyrrolidine-2-carboxylate,C1CC(=O)NC1C(=O)OCCC2=CC=CC=C2,,,,,,
8475,108476,4-Phenylbutyl 5-oxoprolinate,C1CC(=O)NC1C(=O)OCCCCC2=CC=CC=C2,,,,,,
8476,108477,"5,6-Dimethylheptan-1-ol",CC(C)C(C)CCCCO,,,,,,
8477,108478,2-((4-Methyl-2-nitrophenyl)azo)-3-oxo-N-2-pyridylbutyramide,CC1=CC(=C(C=C1)N=NC(C(=O)C)C(=O)NC2=CC=CC=N2)[N+](=O)[O-],,,,,,
8478,108479,CID 108479,CCC(C(=O)NC1=CC=C(C=C1)NC2=NN(C(=O)C2)C3=C(C=C(C=C3Cl)Cl)Cl)OC4=C(C=C(C=C4)C(C)(C)CC)C(C)(C)CC,,,,,,
8479,108480,2-Methylbutyl methacrylate,CCC(C)COC(=O)C(=C)C,,,,,,
8480,108481,"8-Hexadecenal, 14-methyl-, (8Z)-",CCC(C)CCCCC=CCCCCCCC=O,,,,,,
8481,108482,"1,5-Bis(4-(2,3-epoxypropyloxy)phenyl)penta-1,4-dien-3-one",C1C(O1)COC2=CC=C(C=C2)C=CC(=O)C=CC3=CC=C(C=C3)OCC4CO4,,,,,,
8482,108483,"1-Phthalanpropylamine, N,3-dimethyl-1-phenyl-, oxalate",CC1C2=CC=CC=C2C(O1)(CCCNC)C3=CC=CC=C3.C(=O)(C(=O)O)O,,,,,,
8483,108484,N-methyl-3-(3-methyl-1-phenyl-3H-2-benzofuran-1-yl)propan-1-amine,CC1C2=CC=CC=C2C(O1)(CCCNC)C3=CC=CC=C3,,,,,,
8484,108485,"2-(1-Methylpiperidin-2-yl)-2,2-diphenylethan-1-ol--hydrogen chloride (1/1)",CN1CCCCC1C(CO)(C2=CC=CC=C2)C3=CC=CC=C3.Cl,,,,,,
8485,108486,"2-(1-Methylpiperidin-2-yl)-2,2-diphenylethanol",CN1CCCCC1C(CO)(C2=CC=CC=C2)C3=CC=CC=C3,,,,,,
8486,108487,"3-((2-Hydroxydodecyl)methylamino)propane-1,2-diol",CCCCCCCCCCC(CN(C)CC(CO)O)O,,,,,,
8487,108488,"3,3'-(Octadecylimino)bispropane-1,2-diol",CCCCCCCCCCCCCCCCCCN(CC(CO)O)CC(CO)O,,,,,,
8488,108489,2-[[2-(2-Bromopropanoylamino)acetyl]amino]acetic acid,CC(C(=O)NCC(=O)NCC(=O)O)Br,,,,,,
8489,108490,"2,4,6,8-Tetramethyl-2,4,6,8-tetrakis(3-(oxiranylmethoxy)propyl)cyclotetrasiloxane",C[Si]1(O[Si](O[Si](O[Si](O1)(C)CCCOCC2CO2)(C)CCCOCC3CO3)(C)CCCOCC4CO4)CCCOCC5CO5,,,,,,
8490,108491,"1,1'-(Methylphosphoryl)bis(2-methylaziridine)",CC1CN1P(=O)(C)N2CC2C,,,,,,
8491,108492,"Diethyl 3,3'-(vinylenedi-4,1-phenylene)bisacrylate",CCOC(=O)C=CC1=CC=C(C=C1)C=CC2=CC=C(C=C2)C=CC(=O)OCC,,,,,,
8492,108493,10-(1-Methyl-3-piperidyl)-3-methoxyphenothiazine,CN1CCCC(C1)N2C3=C(C=C(C=C3)OC)SC4=CC=CC=C42,,,,,,
8493,108494,Promonta,CN1CCCCC1CN2C3=CC=CC=C3SC4=CC=CC=C42,,,,,,
8494,108495,Methyltris(tri-sec-butoxysilyloxy)silane,CCC(C)O[Si](OC(C)CC)(OC(C)CC)O[Si](C)(O[Si](OC(C)CC)(OC(C)CC)OC(C)CC)O[Si](OC(C)CC)(OC(C)CC)OC(C)CC,,,,,,
8495,108496,"Benzoxazolium, 3-octadecyl-2-(3-(3-octadecyl-2(3H)-benzoxazolylidene)-1-propenyl)-, salt with 4-methylbenzenesulfonic acid (1:1)",CCCCCCCCCCCCCCCCCCN1C2=CC=CC=C2OC1=CC=CC3=[N+](C4=CC=CC=C4O3)CCCCCCCCCCCCCCCCCC.CC1=CC=C(C=C1)S(=O)(=O)[O-],,,,,,
8496,108497,3-Octadecyl-2-[3-(3-octadecylbenzoxazol-2(3H)-ylidene)-1-propenyl]benzoxazol-3-ium,CCCCCCCCCCCCCCCCCCN1C2=CC=CC=C2OC1=CC=CC3=[N+](C4=CC=CC=C4O3)CCCCCCCCCCCCCCCCCC,,,,,,
8497,108498,2-Chloro-3-(phenylsulphonyl)acrylonitrile,C1=CC=C(C=C1)S(=O)(=O)C=C(C#N)Cl,,,,,,
8498,108499,1-(Cyclopropylmethyl)-2-(nitromethylene)pyrrolidine,C1CC(=C[N+](=O)[O-])N(C1)CC2CC2,,,,,,
8499,108500,"Docosane-1,2-diol",CCCCCCCCCCCCCCCCCCCCC(CO)O,,,,,,
8500,108501,"2,4-Dimethyl-3-thiazoline",CC1N=C(CS1)C,,,,,,
8501,108502,"Naphtho(1,2-d)thiazolium, 1-(3-sulfopropyl)-2-((3-(3-sulfopropyl)-2(3H)-benzothiazolylidene)methyl)-, inner salt, compd. with N,N-diethylethanamine (1:1)",CCN(CC)CC.C1=CC=C2C(=C1)C=CC3=C2[N+](=C(S3)C=C4N(C5=CC=CC=C5S4)CCCS(=O)(=O)O)CCCS(=O)(=O)[O-],,,,,,
8502,108503,"2-[1-(3-Sulfopropyl)naphtho[1,2-d]thiazol-2(1H)-ylidenemethyl]-3-(3-sulfonatopropyl)benzothiazol-3-ium",C1=CC=C2C(=C1)C=CC3=C2[N+](=C(S3)C=C4N(C5=CC=CC=C5S4)CCCS(=O)(=O)O)CCCS(=O)(=O)O,,,,,,
8503,108504,(Z)-1-(1-Ethoxyethoxy)hex-3-ene,CCC=CCCOC(C)OCC,,,,,,
8504,108505,"1,1-Diethoxy-2-amyl-3-phenyl-2-propene",CCCCCC(=CC1=CC=CC=C1)C(OCC)OCC,,,,,,
8505,108506,"3,6-Dimethyloctan-3-yl acetate",CCC(C)CCC(C)(CC)OC(=O)C,,,,,,
8506,108507,"3-Methoxy-3,7-dimethylocta-1,6-diene",CC(=CCCC(C)(C=C)OC)C,,,,,,
8507,108508,"9-[2-Hydroxy-3-[(2-hydroxyethyl)thio]propoxy]-7,11-dioxa-3,15-dithiaheptadecane-1,5,13,17-tetrol",C(CSCC(COCC(COCC(CSCCO)O)OCC(CSCCO)O)O)O,,,,,,
8508,108509,"3-Ethylthio-1,2-propanediol",CCSCC(CO)O,,,,,,
8509,108510,"N,N'-bis[2-(2-aminoethyl)octadecanoyl]decanediamide",CCCCCCCCCCCCCCCCC(CCN)C(=O)NC(=O)CCCCCCCCC(=O)NC(=O)C(CCCCCCCCCCCCCCCC)CCN,,,,,,
8510,108511,Einecs 262-423-9,C=C1CS(=O)C2C(C(=O)N2C1C(=O)OCC3=CC=C(C=C3)[N+](=O)[O-])NC(=O)COC4=CC=CC=C4,,,,,,
8511,108512,"Pseudourea, 2,2'-(2-butenylene)dithiodi-, dihydrochloride",C(C=CCSC(=N)N)SC(=N)N.Cl.Cl,,,,,,
8512,108513,[(E)-4-carbamimidoylsulfanylbut-2-enyl] carbamimidothioate,C(/C=C/CSC(=N)N)SC(=N)N,,,,,,
8513,108514,"3,7-Dimethyloctyl ethyl oxalate",CCOC(=O)C(=O)OCCC(C)CCCC(C)C,,,,,,
8514,108515,Citronellyl ethyl oxalate,CCOC(=O)C(=O)OCCC(C)CCC=C(C)C,,,,,,
8515,108516,3-Methyl-4-(1-phenyl-2-propylamino)-2-phenylmorpholine hydrochloride,CC1C(OCCN1NC(C)CC2=CC=CC=C2)C3=CC=CC=C3.Cl,,,,,,
8516,108517,3-methyl-2-phenyl-N-(1-phenylpropan-2-yl)morpholin-4-amine,CC1C(OCCN1NC(C)CC2=CC=CC=C2)C3=CC=CC=C3,,,,,,
8517,108518,Nonan-3-yl acetate,CCCCCCC(CC)OC(=O)C,,,,,,
8518,108519,Isonicotinaldehyde O-ethyloxime,CCON=CC1=CC=NC=C1,,,,,,
8519,108520,"2H-Pyran, tetrahydro-4-methylene-2-(2-methyl-1-propenyl)-",CC(=CC1CC(=C)CCO1)C,,,,,,
8520,108521,"2-(2-Anilinovinyl)-3-methyl-2-thiazolinium, iodide",C[N+]1=C(SCC1)C=CNC2=CC=CC=C2.[I-],,,,,,
8521,108522,"4,5-Dihydro-3-methyl-2-[2-(phenylamino)ethenyl]thiazol-3-ium",C[N+]1=C(SCC1)C=CNC2=CC=CC=C2,,,,,,
8522,108523,"1-Ethyl-1,3,3-trimethylindan",CCC1(CC(C2=CC=CC=C21)(C)C)C,,,,,,
8523,108524,"2,3-Butanedione, dioxime, disodium salt",CC(=N[O-])C(=N[O-])C.[Na+].[Na+],,,,,,
8524,108525,"2-N,3-N-dioxidobutane-2,3-diimine",CC(=N[O-])C(=N[O-])C,,,,,,
8525,108526,"Pyrimido[1,2-a]indol-2(1H)-one, 10a-[2-[4-(dimethylamino)phenyl]ethenyl]-3,4,10,10a-tetrahydro-10,10-dimethyl-",CC1(C2=CC=CC=C2N3C1(NC(=O)CC3)C=CC4=CC=C(C=C4)N(C)C)C,,,,,,
8526,108527,"p-(4,5-Dihydro-4-((2-methoxy-5-methyl-4-((2-(sulphooxy)ethyl)sulphonyl)phenyl)azo)-3-methyl-5-oxo-1H-pyrazol-1-yl)benzenesulphonic acid",CC1=CC(=C(C=C1S(=O)(=O)CCOS(=O)(=O)O)OC)N=NC2C(=NN(C2=O)C3=CC=C(C=C3)S(=O)(=O)O)C,,,,,,
8527,108528,2-(m-Chlorophenyl)thiazolidine,C1CSC(N1)C2=CC(=CC=C2)Cl,,,,,,
8528,108529,"2,4-Tridecadienal",CCCCCCCCC=CC=CC=O,,,,,,
8529,108530,CID 108530,CC(C)CC(C)OCC(CS(=O)(=O)[O-])O.[Na+],,,,,,
8530,108531,2-Hydroxy-3-(4-methylpentan-2-yloxy)propane-1-sulfonic acid,CC(C)CC(C)OCC(CS(=O)(=O)O)O,,,,,,
8531,108532,"2(3H)-Furanone, dihydro-5-(5-methoxy-1,5-dimethylhexyl)-",CC(CCCC(C)(C)OC)C1CCC(=O)O1,,,,,,
8532,108533,"2(3H)-Furanone, 5-(1,5-dimethyl-4-hexen-1-yl)dihydro-",CC(CCC=C(C)C)C1CCC(=O)O1,,,,,,
8533,108534,Cyclohexyldimethylammonium lactate,CC(C(=O)O)O.CN(C)C1CCCCC1,,,,,,
8534,108535,"Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis(5-((4-methoxy-6-(phenylamino)-1,3,5-triazin-2-yl)amino)-, compd. with 2,2',2''-nitrilotris(ethanol) (1:2)",COC1=NC(=NC(=N1)NC2=CC(=C(C=C2)C=CC3=C(C=C(C=C3)NC4=NC(=NC(=N4)NC5=CC=CC=C5)OC)S(=O)(=O)O)S(=O)(=O)O)NC6=CC=CC=C6.C(CO)N(CCO)CCO.C(CO)N(CCO)CCO,,,,,,
8535,108536,"5-[(4-Anilino-6-methoxy-1,3,5-triazin-2-yl)amino]-2-[2-[4-[(4-anilino-6-methoxy-1,3,5-triazin-2-yl)amino]-2-sulfophenyl]ethenyl]benzenesulfonic acid",COC1=NC(=NC(=N1)NC2=CC(=C(C=C2)C=CC3=C(C=C(C=C3)NC4=NC(=NC(=N4)NC5=CC=CC=C5)OC)S(=O)(=O)O)S(=O)(=O)O)NC6=CC=CC=C6,,,,,,
8536,108537,"1-Ethyl-2,4-dimethylcyclohexane",CCC1CCC(CC1C)C,,,,,,
8537,108538,"Phosphonic acid, P-(hydroxyphenylmethyl)-, dibutyl ester",CCCCOP(=O)(C(C1=CC=CC=C1)O)OCCCC,,,,,,
8538,108539,Butyltintris(2-ethylhexyl 3-mercaptopropionate),CCCCC(CC)COC(=O)CCS[Sn](CCCC)(SCCC(=O)OCC(CC)CCCC)SCCC(=O)OCC(CC)CCCC,,,,,,
8539,108540,Ethyl bicyclo[2.2.1]heptane-2-carboxylate,CCOC(=O)C1CC2CCC1C2,,,,,,
8540,108541,"Benzoic acid, 4-(2-(4-(5-methyl-2-benzoxazolyl)phenyl)ethenyl)-",CC1=CC2=C(C=C1)OC(=N2)C3=CC=C(C=C3)C=CC4=CC=C(C=C4)C(=O)O,,,,,,
8541,108542,CID 108542,[Li+].CCC(COC1=CC=C(C=C1)N=NC2=C(C=C(C(=C2)C)N=NC3=CC(=CC=C3)S(=O)(=O)[O-])OC)O,,,,,,
8542,108543,3-[[4-[[4-(2-Hydroxybutoxy)phenyl]diazenyl]-5-methoxy-2-methylphenyl]diazenyl]benzenesulfonic acid,CCC(COC1=CC=C(C=C1)N=NC2=C(C=C(C(=C2)C)N=NC3=CC(=CC=C3)S(=O)(=O)O)OC)O,,,,,,
8543,108544,3-Chloroheptan-4-one,CCCC(=O)C(CC)Cl,,,,,,
8544,108545,4-Chlorononan-5-one,CCCCC(=O)C(CCC)Cl,,,,,,
8545,108546,"3-Chloro-2,6-dimethylheptan-4-one",CC(C)CC(=O)C(C(C)C)Cl,,,,,,
8546,108547,"2,5-Cyclohexadien-1-one, 4-((4-((4-((4-methoxyphenyl)amino)phenyl)amino)phenyl)imino)-",COC1=CC=C(C=C1)NC2=CC=C(C=C2)NC3=CC=C(C=C3)N=C4C=CC(=O)C=C4,,,,,,
8547,108548,1-(2-Chloro-3-methylbutanoyl)urea,CC(C)C(C(=O)NC(=O)N)Cl,,,,,,
8548,108549,"2-(2,4-Dinitrophenylmethylene)-1-ethyl-1,2-dihydroquinoline",CCN1C(=CC2=C(C=C(C=C2)[N+](=O)[O-])[N+](=O)[O-])C=CC3=CC=CC=C31,,,,,,
8549,108550,CID 108550,CCCCCCCCCCCCC(C(=O)NC1=CC(=C(C=C1)Cl)NC2=NN(C(=O)C2)C3=C(C=C(C=C3Cl)Cl)Cl)OC4=CC(=C(C=C4)O)C(C)(C)C,,,,,,
8550,108551,(Pentan-2-yl)(pentyl)amine,CCCCCNC(C)CCC,,,,,,
8551,108552,"1,5-Naphthalenedisulfonic acid, 2-[[1-hydroxy-6-(methylamino)-3-sulfo-2-naphthalenyl]azo]-",CNC1=CC2=CC(=C(C(=C2C=C1)O)N=NC3=C(C4=C(C=C3)C(=CC=C4)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
8552,108553,"1,4-Pentadien-3-one, 1,5-bis(4-(diethylamino)phenyl)-",CCN(CC)C1=CC=C(C=C1)C=CC(=O)C=CC2=CC=C(C=C2)N(CC)CC,,,,,,
8553,108554,"4-[(2,4-Dimethoxyphenyl)azo]-2,4-dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one",CC1=NN(C(=O)C1N=NC2=C(C=C(C=C2)OC)OC)C3=CC=CC=C3,,,,,,
8554,108555,"4-((4-Chloro-2,5-dimethoxyphenyl)azo)-2,4-dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one",CC1=NN(C(=O)C1N=NC2=CC(=C(C=C2OC)Cl)OC)C3=CC=CC=C3,,,,,,
8555,108556,5-(1-Ethoxyethoxy)pent-1-yne,CCOC(C)OCCCC#C,,,,,,
8556,108557,6-(1-Ethoxyethoxy)hex-2-yn-1-ol,CCOC(C)OCCCC#CCO,,,,,,
8557,108558,6-(1-Ethoxyethoxy)hex-2-en-1-ol,CCOC(C)OCCCC=CCO,,,,,,
8558,108559,1-Chloro-6-(1-ethoxyethoxy)hex-2-ene,CCOC(C)OCCCC=CCCl,,,,,,
8559,108560,1-(1-Ethoxyethoxy)tridec-4-en-7-yne,CCCCCC#CCC=CCCCOC(C)OCC,,,,,,
8560,108561,"Acetamide, N-(4,4-dicyano-1,3-butadienyl)-N-phenyl-",CC(=O)N(C=CC=C(C#N)C#N)C1=CC=CC=C1,,,,,,
8561,108562,(3-(Dihexylamino)allylidene)malononitrile,CCCCCCN(CCCCCC)C=CC=C(C#N)C#N,,,,,,
8562,108563,N-Butyl-2-ethylhexylamine,CCCCC(CC)CNCCCC,,,,,,
8563,108564,"2-[3-(Oxiranylmethoxy)propyl]-2,4,6,8-tetramethylcyclotetrasiloxane",C[SiH]1O[SiH](O[Si](O[SiH](O1)C)(C)CCCOCC2CO2)C,,,,,,
8564,108565,S-Acetyl-1-phenyl thiourea,CC(=O)SC(N)NC1=CC=CC=C1,,,,,,
8565,108566,"1-Ethyl-2-(8-heptadecenyl)-4,5-dihydro-1-(2-hydroxyethyl)-1H-imidazolium ethyl sulphate",CCCCCCCCC=CCCCCCCCC1=NCC[N+]1(CC)CCO.CCOS(=O)(=O)[O-],,,,,,
8566,108567,"1-Ethyl-2-(8-heptadecen-1-yl)-1-(2-hydroxyethyl)-4,5-dihydro-1H-imidazol-1-ium",CCCCCCCCC=CCCCCCCCC1=NCC[N+]1(CC)CCO,,,,,,
8567,108568,"Cyclopentanecarboxylic acid, 1-butyl-2-oxo-, methyl ester",CCCCC1(CCCC1=O)C(=O)OC,,,,,,
8568,108569,"6-(Dimethylamino)-2-(2-(2,5-dimethyl-1-phenyl-1H-pyrrol-3-yl)vinyl)-1-methylquinolinium methyl sulphate",CC1=CC(=C(N1C2=CC=CC=C2)C)C=CC3=[N+](C4=C(C=C3)C=C(C=C4)N(C)C)C.COS(=O)(=O)[O-],,,,,,
8569,108570,"Phenol, 2,5-dimethyl-4-(3-morpholinylmethyl)-, hydrochloride",CC1=CC(=C(C=C1O)C)CC2COCCN2.Cl,,,,,,
8570,108571,"2,5-Dimethyl-4-(morpholin-3-ylmethyl)phenol",CC1=CC(=C(C=C1O)C)CC2COCCN2,,,,,,
8571,108572,Ethyl 2-cyano-3-methylhept-4-ynoate,CCC#CC(C)C(C#N)C(=O)OCC,,,,,,
8572,108573,Ethanolamine acetate,CC(=O)O.C(CO)N,,,,,,
8573,108574,3-(2-Methoxyethoxy)propylamine,COCCOCCCN,,,,,,
8574,108575,"Phosphoric acid, mono(4-nitrophenyl) ester, sodium salt",C1=CC(=CC=C1[N+](=O)[O-])OP(=O)(O)[O-].[Na+],,,,,,
8575,108576,Methanetrisulphonic acid,C(S(=O)(=O)O)(S(=O)(=O)O)S(=O)(=O)O,,,,,,
8576,108577,CID 108577,CCCCCCCCCCCCCCCCCC(=O)O.C1=CC=C(C=C1)C(=O)O.O.[AlH3],,,,,,
8577,108578,5-Chloro-2-hydroxypyrimidine,C1=C(C=NC(=O)N1)Cl,,,,,,
8578,108579,Ethyl hept-4-enoate,CCC=CCCC(=O)OCC,,,,,,
8579,108580,"7,9-Dodecadien-1-ol, (7E,9Z)-",CCC=CC=CCCCCCCO,,,,,,
8580,108581,"7,9-Dodecadien-1-ol, acetate, (7E,9Z)-",CCC=CC=CCCCCCCOC(=O)C,,,,,,
8581,108582,"5-Decyne, 1-chloro-",CCCCC#CCCCCCl,,,,,,
8582,108583,Ethyl phosphoramidothioic acid O-(2-chloro-4-(methylthio)phenyl) O-methyl ester,CCNP(=S)(OC)OC1=C(C=C(C=C1)SC)Cl,,,,,,
8583,108584,2-[2-[Bis[2-(2-hydroxyethoxy)ethyl]amino]ethoxy]ethanol,C(COCCO)N(CCOCCO)CCOCCO,,,,,,
8584,108585,"1H-Isoindole-1,3(2H)-dione, 4,4'-[(1-methylethylidene)bis(4,1-phenyleneoxy)]bis[2-methyl-",CC(C)(C1=CC=C(C=C1)OC2=CC=CC3=C2C(=O)N(C3=O)C)C4=CC=C(C=C4)OC5=CC=CC6=C5C(=O)N(C6=O)C,,,,,,
8585,108586,"1H-Isoindole-1,3(2H)-dione, 5,5'-[(1-methylethylidene)bis(4,1-phenyleneoxy)]bis[2-methyl-",CC(C)(C1=CC=C(C=C1)OC2=CC3=C(C=C2)C(=O)N(C3=O)C)C4=CC=C(C=C4)OC5=CC6=C(C=C5)C(=O)N(C6=O)C,,,,,,
8586,108587,2-Ethoxyethyl isobutyrate,CCOCCOC(=O)C(C)C,,,,,,
8587,108588,"Zinc, bis(2-(amino-kappaN)-4-methoxybenzenethiolato-kappaS)-, (T-4)-",COC1=CC(=C(C=C1)[S-])N.COC1=CC(=C(C=C1)[S-])N.[Zn+2],,,,,,
8588,108589,2-Amino-4-methoxybenzenethiol,COC1=CC(=C(C=C1)S)N,,,,,,
8589,108590,"Ethanol, 2-(2,4-dimethylphenoxy)-",CC1=CC(=C(C=C1)OCCO)C,,,,,,
8590,108591,"D-Galactose, (4-nitrophenyl)hydrazone",C1=CC(=CC=C1N=NC[C@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O)[N+](=O)[O-],,,,,,
8591,108592,"1,3-Dibutyl-2-thiobarbituric acid",CCCCN1C(=O)CC(=O)N(C1=S)CCCC,,,,,,
8592,108593,"Benzoxazolium, 3-hexyl-2-methyl-, iodide",CCCCCC[N+]1=C(OC2=CC=CC=C21)C.[I-],,,,,,
8593,108594,3-Hexyl-2-methylbenzoxazol-3-ium,CCCCCC[N+]1=C(OC2=CC=CC=C21)C,,,,,,
8594,108595,"Benzoxazolium, 2-methyl-3-(3-sulfopropyl)-, inner salt",CC1=[N+](C2=CC=CC=C2O1)CCCS(=O)(=O)[O-],,,,,,
8595,108596,"3-(2-Methyl-1,3-benzoxazol-3-ium-3-yl)propane-1-sulfonic acid",CC1=[N+](C2=CC=CC=C2O1)CCCS(=O)(=O)O,,,,,,
8596,108597,p-Cumylphenyl acrylate,CC(C)(C1=CC=CC=C1)C2=CC=C(C=C2)OC(=O)C=C,,,,,,
8597,108598,1-Butoxyhexane,CCCCCCOCCCC,,,,,,
8598,108599,"Hexanedioic acid, bis[3-bromo-2,2-bis(bromomethyl)propyl] ester",C(CCC(=O)OCC(CBr)(CBr)CBr)CC(=O)OCC(CBr)(CBr)CBr,,,,,,
8599,108600,p-Tolylhydrazinium sulphate,CC1=CC=C(C=C1)NN.OS(=O)(=O)O,,,,,,
8600,108601,Benzenediazonium hydroxide,C1=CC=C(C=C1)[N+]#N.[OH-],,,,,,
8601,108602,Aminooxyacetamide hydrochloride,C=C(N)ON.Cl,,,,,,
8602,108603,O-(1-aminoethenyl)hydroxylamine,C=C(N)ON,,,,,,
8603,108604,"1,7-Naphthalenedisulfonic acid, 4-[[3-[(2-chloroethyl)sulfonyl]benzoyl]amino]-5-hydroxy-6-[(2-sulfophenyl)azo]-",C1=CC=C(C(=C1)N=NC2=C(C3=C(C=CC(=C3C=C2S(=O)(=O)O)S(=O)(=O)O)NC(=O)C4=CC(=CC=C4)S(=O)(=O)CCCl)O)S(=O)(=O)O,,,,,,
8604,108605,2-Chloroethyl 3-oxobutanoate,CC(=O)CC(=O)OCCCl,,,,,,
8605,108606,CID 108606,C1=CC(=CC=C1C(=O)C(=O)[O-])O.[Na+],,,,,,
8606,108607,Pyromellitic acid 2-phenyl-2-imidazoline salt (1:1),C1CN=C(N1)C2=CC=CC=C2.C1=C(C(=CC(=C1C(=O)O)C(=O)O)C(=O)O)C(=O)O,,,,,,
8607,108608,"2-Propenoic acid, 2-[[[(3-isocyanatomethylphenyl)amino]carbonyl]oxy]ethyl ester",C=CC(=O)OCCOC(=O)NC1=CC=CC(=C1)CN=C=O,,,,,,
8608,108609,CID 108609,[H-].[B+3].CC[CH-]C.CC[CH-]C.CC[CH-]C.[K+],,,,,,
8609,108610,2-(Hexylamino)ethanol,CCCCCCNCCO,,,,,,
8610,108611,"2,5-Dimethyl-3,6-diphenylpyrazine",CC1=C(N=C(C(=N1)C2=CC=CC=C2)C)C3=CC=CC=C3,,,,,,
8611,108612,"1,4-Benzenedicarboxamide, N,N'-dichloro-",C1=CC(=CC=C1C(=O)NCl)C(=O)NCl,,,,,,
8612,108613,CID 108613,CCCCCCCCCCCCCC(=O)NC1=CC(=C(C=C1)Cl)NC2=NN(C(=O)C2)C3=C(C=C(C=C3Cl)Cl)Cl,,,,,,
8613,108614,CID 108614,C(CSS(=O)(=O)[O-])N.[Na+],,,,,,
8614,108615,CID 108615,CCCCCCOS(=O)(=O)[O-].[K+],,,,,,
8615,108616,"Thiazolium, 3-ethyl-4,5-dihydro-2-methyl-, iodide",CC[N+]1=C(SCC1)C.[I-],,,,,,
8616,108617,Oblnpkkgvnwytk-uhfffaoysa-,CC[N+]1=C(SCC1)C,,,,,,
8617,108618,CID 108618,C=CCCCCCCCCCCCCCS(=O)(=O)[O-].[Na+],,,,,,
8618,108619,14-Pentadecene-1-sulfonic acid,C=CCCCCCCCCCCCCCS(=O)(=O)O,,,,,,
8619,108620,"Manganese abietate, technical",CC(C)C1=CC2=CC[C@@H]3[C@@]([C@H]2CC1)(CCC[C@@]3(C)C(=O)[O-])C.[Mn+2],,,,,,
8620,108621,"Benzenesulfonamide, 3-((ethylphenylamino)methyl)-N,N-dimethyl-",CCN(CC1=CC(=CC=C1)S(=O)(=O)N(C)C)C2=CC=CC=C2,,,,,,
8621,108622,Butyl 5-oxohexanoate,CCCCOC(=O)CCCC(=O)C,,,,,,
8622,108623,2-Amino-5-(diethylamino)toluene Monohydrochloride,CCN(CC)C1=CC(=C(C=C1)N)C.Cl,,,,,,
8623,108624,"Palmitamide, N-isobutyl-",CCCCCCCCCCCCCCCC(=O)NCC(C)C,,,,,,
8624,108625,"1,1-Diethoxynonane",CCCCCCCCC(OCC)OCC,,,,,,
8625,108626,"2-(4,5-Dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzene-1,4-disulphonic acid",CC1=NN(C(=O)C1)C2=C(C=CC(=C2)S(=O)(=O)O)S(=O)(=O)O,,,,,,
8626,108627,2-Acetylaminodibenzothiophene,CC(=O)NC1=CC2=C(C=C1)SC3=CC=CC=C32,,,,,,
8627,108628,"13,14-Dihydrobisbenzothiazolo(3,2-d:2',3'-g)(1,4)diazepin-12-ium bromide",C1C[N+]2=C(C=C3N1C4=CC=CC=C4S3)SC5=CC=CC=C52.[Br-],,,,,,
8628,108629,"13,14-Dihydrobisbenzothiazolo[3,2-d:2',3'-g][1,4]diazepin-12-ium",C1C[N+]2=C(C=C3N1C4=CC=CC=C4S3)SC5=CC=CC=C52,,,,,,
8629,108630,"4,7-Methano-1H-indenol, 3a,4,5,6,7,7a-hexahydro-, acetate",CC(=O)OC1=CCC2C1C3CCC2C3,,,,,,
8630,108631,(S)-1-Acetyl-alpha-amino-1H-imidazole-4-propanamide,CC(=O)N[C@@H](CC1=CN=CN1)C(=O)N,,,,,,
8631,108632,6-Heneicosyn-11-one,CCCCCCCCCCC(=O)CCCC#CCCCCC,,,,,,
8632,108633,"1H-Imidazolium, 1-[2-(carboxymethoxy)ethyl]-1-(carboxymethyl)-4,5-dihydro-2-nonyl-, hydroxide, disodium salt",CCCCCCCCCC1=NCC[N+]1(CCOCC(=O)[O-])CC(=O)[O-].[OH-].[Na+].[Na+],,,,,,
8633,108634,"2-[1-[2-(Carboxymethoxy)ethyl]-2-nonyl-4,5-dihydroimidazol-1-ium-1-yl]acetic acid",CCCCCCCCCC1=NCC[N+]1(CCOCC(=O)O)CC(=O)O,,,,,,
8634,108635,Nonacos-14-ene,CCCCCCCCCCCCCCC=CCCCCCCCCCCCCC,,,,,,
8635,108636,3-(4-((2-Cyano-4-nitrophenyl)azo)-N-(2-hydroxyethyl)anilino)propionitrile,C1=CC(=CC=C1N=NC2=C(C=C(C=C2)[N+](=O)[O-])C#N)N(CCC#N)CCO,,,,,,
8636,108637,Benzyl 2-phenylethyl ether,C1=CC=C(C=C1)CCOCC2=CC=CC=C2,,,,,,
8637,108638,"2,3-Diaminopropanoic acid hydrochloride",C(C(C(=O)O)N)N.Cl,,,,,,
8638,108639,"Ethyl 3,4-dihydroquinoline-1(2h)-carboxylate",CCOC(=O)N1CCCC2=CC=CC=C21,,,,,,
8639,108640,"Benzoxazolium, 3-ethyl-2-methyl-5-phenyl-, iodide",CC[N+]1=C(OC2=C1C=C(C=C2)C3=CC=CC=C3)C.[I-],,,,,,
8640,108641,"3-Ethyl-2-methyl-5-phenyl-1,3-benzoxazol-3-ium",CC[N+]1=C(OC2=C1C=C(C=C2)C3=CC=CC=C3)C,,,,,,
8641,108642,"1H-Isoindole-1,3(2H)-dione, 2-[2-(ethylphenylamino)ethyl]-",CCN(CCN1C(=O)C2=CC=CC=C2C1=O)C3=CC=CC=C3,,,,,,
8642,108643,"2-Anthracenesulfonic acid, 1-amino-9,10-dihydro-4-[(4-methoxyphenyl)amino]-9,10-dioxo-",COC1=CC=C(C=C1)NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)O,,,,,,
8643,108644,"3,3,4,4,4-Pentafluorobutan-1-ol",C(CO)C(C(F)(F)F)(F)F,,,,,,
8644,108645,Methyl nicotinoylacetate,COC(=O)CC(=O)C1=CN=CC=C1,,,,,,
8645,108646,"o-Toluic acid, alpha-(p-fluorobenzoyl)-",C1=CC=C(C(=C1)CC(=O)C2=CC=C(C=C2)F)C(=O)O,,,,,,
8646,108647,Potassium ferric ethylenediaminetetraacetate,C(CN(CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].[K+].[Fe+3],,,,,,
8647,108648,"Silane, dichloro(3-chloropropyl)propyl-",CCC[Si](CCCCl)(Cl)Cl,,,,,,
8648,108649,"1-Oxa-3,9-diazaspiro(5.5)undecan-2-one, 9-(3-(p-fluorobenzoyl)propyl)-",C1CNC(=O)OC12CCN(CC2)CCCC(=O)C3=CC=C(C=C3)F,,,,,,
8649,108650,"1-Oxa-3,9-diazaspiro(5.5)undecan-2-one, 9-(3-(p-chlorobenzoyl)propyl)-",C1CNC(=O)OC12CCN(CC2)CCCC(=O)C3=CC=C(C=C3)Cl,,,,,,
8650,108651,CID 108651,CC1=CC(=CC(=C1Cl)C)[O-].[Na+],,,,,,
8651,108652,"N,N-diheptylnitrous amide",CCCCCCCN(CCCCCCC)N=O,,,,,,
8652,108653,"2H-Benzimidazol-2-one, 1,3-dihydro-6-chloro-1-phenyl-",C1=CC=C(C=C1)N2C3=C(C=CC(=C3)Cl)NC2=O,,,,,,
8653,108654,"1,2,3,6-Tetrahydro-2,2,6,6-tetramethyl-4-pyridinecarboxylic acid, ethyl ester",CCOC(=O)C1=CC(NC(C1)(C)C)(C)C,,,,,,
8654,108655,"[(2-Hydroxyethyl)azanediyl]di(ethane-2,1-diyl) dioctadec-9-enoate",CCCCCCCCC=CCCCCCCCC(=O)OCCN(CCO)CCOC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
8655,108656,Methyl 3-(o-(hexadecyloxy)phenyl)-3-oxopropionate,CCCCCCCCCCCCCCCCOC1=CC=CC=C1C(=O)CC(=O)OC,,,,,,
8656,108657,"(2-Chloro-4,6-dimethylphenyl)hydrazine",CC1=CC(=C(C(=C1)Cl)NN)C,,,,,,
8657,108658,"Benzoic acid, 4-methyl-, [4-(methoxycarbonyl)phenyl]methyl ester",CC1=CC=C(C=C1)C(=O)OCC2=CC=C(C=C2)C(=O)OC,,,,,,
8658,108659,"Methanone, [4-(1,1-dimethylethyl)phenyl](4-hydroxyphenyl)-",CC(C)(C)C1=CC=C(C=C1)C(=O)C2=CC=C(C=C2)O,,,,,,
8659,108660,Silver succinimide,C1CC(=O)N=C1[O-].[Ag+],,,,,,
8660,108661,3-Chloro-4-morpholinoaniline,C1COCCN1C2=C(C=C(C=C2)N)Cl,,,,,,
8661,108662,"6-Octenal, 7-methyl-3-methylene-",CC(=CCCC(=C)CC=O)C,,,,,,
8662,108663,"3,7-Dimethylocta-2,6-dienyl 3-methylbut-2-enoate",CC(=CCCC(=CCOC(=O)C=C(C)C)C)C,,,,,,
8663,108664,ethyl (12R)-12-hydroxyoctadec-9-enoate,CCCCCC[C@H](CC=CCCCCCCCC(=O)OCC)O,,,,,,
8664,108665,"Benzilic acid, 3-(dimethylamino)propyl ester, hydrochloride",CN(C)CCCOC(=O)C(C1=CC=CC=C1)(C2=CC=CC=C2)O.Cl,,,,,,
8665,108666,"3-(Dimethylamino)propyl 2-hydroxy-2,2-diphenylacetate",CN(C)CCCOC(=O)C(C1=CC=CC=C1)(C2=CC=CC=C2)O,,,,,,
8666,108667,3-(Diethylamino)propyl benzilate hydrochloride,CCN(CC)CCCOC(=O)C(C1=CC=CC=C1)(C2=CC=CC=C2)O.Cl,,,,,,
8667,108668,"3-(Diethylamino)propyl 2-hydroxy-2,2-diphenylacetate",CCN(CC)CCCOC(=O)C(C1=CC=CC=C1)(C2=CC=CC=C2)O,,,,,,
8668,108669,CID 108669,C1C(=O)NC(=NC1=O)NC#N,,,,,,
8669,108670,CID 108670,CC1=C(C2=C(C=C1)N=C(S2)C3=CC=C(C=C3)N=NC4C(=O)NC(=NC4=O)NC#N)S(=O)(=O)O,,,,,,
8670,108671,CID 108671,CC1=C(C2=C(C=C1)N=C(S2)C3=CC=C(C=C3)N=NC4C(=O)NC(=NC4=O)NC#N)S(=O)(=O)O.C(CO)N(CCO)CCO,,,,,,
8671,108672,"1,4,7,10,13,16-Hexaoxacyclooctadecane, compd. with acetonitrile (1:2)",CC#N.CC#N.C1COCCOCCOCCOCCOCCO1,,,,,,
8672,108673,"1,2-Dihydroxy-4'-chlorobiphenyl",C1=CC(=CC=C1C2=CC(=C(C=C2)O)O)Cl,,,,,,
8673,108674,"Butylamine, N,N-bis(2-chloroethyl)-, hydrochloride",CCCCN(CCCl)CCCl.Cl,,,,,,
8674,108675,1-Chloro-2-(chloromethyl)-3-fluorobenzene,C1=CC(=C(C(=C1)Cl)CCl)F,,,,,,
8675,108676,"(7S,12S)-7,12-Dimethylbenzo(b)phenanthrene-7,12-diol",C[C@]1(C2=C(C3=CC=CC=C3C=C2)[C@@](C4=CC=CC=C41)(C)O)O,,,,,,
8676,108677,"Benz[a]anthracene-7,12-diol, 7,12-dihydro-7,12-dimethyl-, cis-",C[C@@]1(C2=C(C3=CC=CC=C3C=C2)[C@@](C4=CC=CC=C41)(C)O)O,,,,,,
8677,108678,9-Octadecenoic acid phenylmethylester,CCCCCCCCC=CCCCCCCCC(=O)OCC1=CC=CC=C1,,,,,,
8678,108679,2-Ethoxy-1-naphthoyl Chloride,CCOC1=C(C2=CC=CC=C2C=C1)C(=O)Cl,,,,,,
8679,108680,1-Bromo-4-(2-chloroethoxy)benzene,C1=CC(=CC=C1OCCCl)Br,,,,,,
8680,108681,"Neodecanoic acid, barium salt",CC(C)(C)CC(C)(C)CC(=O)[O-].CC(C)(C)CC(C)(C)CC(=O)[O-].[Ba+2],,,,,,
8681,108682,Decyl stearate,CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCC,,,,,,
8682,108683,"1-Ethyl-2,3,3-trimethyl-5-(phenylsulphonyl)-3H-indolium iodide",CC[N+]1=C(C(C2=C1C=CC(=C2)S(=O)(=O)C3=CC=CC=C3)(C)C)C.[I-],,,,,,
8683,108684,"1-Ethyl-2,3,3-trimethyl-5-(phenylsulfonyl)-3H-indolium",CC[N+]1=C(C(C2=C1C=CC(=C2)S(=O)(=O)C3=CC=CC=C3)(C)C)C,,,,,,
8684,108685,"3H-Indole, 2,3,3-trimethyl-5-(phenylsulfonyl)-",CC1=NC2=C(C1(C)C)C=C(C=C2)S(=O)(=O)C3=CC=CC=C3,,,,,,
8685,108686,Benzo[b]thiophene-2-carbonitrile,C1=CC=C2C(=C1)C=C(S2)C#N,,,,,,
8686,108687,"Titanium bis(hexane-1,6-diolate)",C(CCC[O-])CCO.[Ti+4],,,,,,
8687,108688,"2-(4-Bromobenzoylimino)-3-methyl-delta(sup 4)-1,3,4-thiadiazoline-5-sulfonamide",CN1C(=NC(=O)C2=CC=C(C=C2)Br)SC(=N1)S(=O)(=O)N,,,,,,
8688,108689,"(4,4-Dimethyl-2,5-dioxo-1,3-imidazolidinediyl)di-2,1-ethanediyl 3-mercaptopropionate",CC1(C(=O)N(C(=O)N1CCOC(=O)CCS)CCOC(=O)CCS)C,,,,,,
8689,108690,"Acetamide, N-[2-[(2-cyano-6-iodo-4-nitrophenyl)azo]-5-(diethylamino)phenyl]-",CCN(CC)C1=CC(=C(C=C1)N=NC2=C(C=C(C=C2I)[N+](=O)[O-])C#N)NC(=O)C,,,,,,
8690,108691,"Benzenesulfonamide, 4-chloro-N-(2-hydroxyethyl)-N-methyl-",CN(CCO)S(=O)(=O)C1=CC=C(C=C1)Cl,,,,,,
8691,108692,"3-((4-((2,6-Dibromo-4-nitrophenyl)azo)phenyl)ethylamino)propiononitrile",CCN(CCC#N)C1=CC=C(C=C1)N=NC2=C(C=C(C=C2Br)[N+](=O)[O-])Br,,,,,,
8692,108693,CID 108693,[Li+].CC(C)(CO)C(C(=O)[O-])O,,,,,,
8693,108694,CID 108694,C1=CC=C(C=C1)CN(CC2=CC=CC=C2)C(=S)[S-].[Na+],,,,,,
8694,108695,Methyl [4-(methoxycarbonyl)phenyl]methyl terephthalate,COC(=O)C1=CC=C(C=C1)COC(=O)C2=CC=C(C=C2)C(=O)OC,,,,,,
8695,108696,"Glycine, N-(carboxymethyl)-N-(1,1-diphosphonoethyl)-",CC(N(CC(=O)O)CC(=O)O)(P(=O)(O)O)P(=O)(O)O,,,,,,
8696,108697,Disodium 2-(phosphonatooxy)acrylate,C=C(C(=O)[O-])OP(=O)(O)[O-].[Na+].[Na+],,,,,,
8697,108698,"9,10-Anthracenedione, 1,5-bis[(4-phenoxyphenyl)amino]-",C1=CC=C(C=C1)OC2=CC=C(C=C2)NC3=CC=CC4=C3C(=O)C5=C(C4=O)C(=CC=C5)NC6=CC=C(C=C6)OC7=CC=CC=C7,,,,,,
8698,108699,"Octadecanoic acid, 2-[(2-hydroxyethyl)(1-oxooctadecyl)amino]ethyl ester",CCCCCCCCCCCCCCCCCC(=O)N(CCO)CCOC(=O)CCCCCCCCCCCCCCCCC,,,,,,
8699,108700,9-Bromo-1-nonanol,C(CCCCO)CCCCBr,,,,,,
8700,108701,"2,6-Dichloro-3-(trichloromethyl)pyridine",C1=CC(=NC(=C1C(Cl)(Cl)Cl)Cl)Cl,,,,,,
8701,108702,"2-(4-Iodobenzoylimino)-3-methyl-delta(sup 4)-1,3,4-thiadiazoline-5-sulfonamide",CN1C(=NC(=O)C2=CC=C(C=C2)I)SC(=N1)S(=O)(=O)N,,,,,,
8702,108703,"Acetamide, N-[3-[(2-cyanoethyl)(2-hydroxyethyl)amino]phenyl]-",CC(=O)NC1=CC(=CC=C1)N(CCC#N)CCO,,,,,,
8703,108704,"4,4'-Methylenebis(3-methoxy-2-naphthoic) acid",COC1=C(C2=CC=CC=C2C=C1C(=O)O)CC3=C(C(=CC4=CC=CC=C43)C(=O)O)OC,,,,,,
8704,108705,"Benzene, chlorododecylphenoxy-",CCCCCCCCCCCCC1=C(C(=CC=C1)OC2=CC=CC=C2)Cl,,,,,,
8705,108706,"Benzene, butylchlorophenoxy-",CCCCC1=CC=C(C=C1)OC2=CC(=CC=C2)Cl,,,,,,
8706,108707,1-(2-Chloro-4-nitrophenyl)pyrrolidine,C1CCN(C1)C2=C(C=C(C=C2)[N+](=O)[O-])Cl,,,,,,
8707,108708,2-(Dibenzylamino)ethanethiol,C1=CC=C(C=C1)CN(CCS)CC2=CC=CC=C2,,,,,,
8708,108709,"2-Phenyl-3-(1H-1,2,4-triazol-5-ylazo)-1H-indole",C1=CC=C(C=C1)C2=C(C3=CC=CC=C3N2)N=NC4=NC=NN4,,,,,,
8709,108710,1-Butylsulfanylbutane; rhodium(3+); trichloride,CCCCSCCCC.CCCCSCCCC.CCCCSCCCC.[Cl-].[Cl-].[Cl-].[Rh+3],,,,,,
8710,108711,4-(2-Chloro-4-nitrophenyl)morpholine,C1COCCN1C2=C(C=C(C=C2)[N+](=O)[O-])Cl,,,,,,
8711,108712,"1,9-Dimethyluric acid",CN1C2=C(C(=O)N(C(=O)N2)C)NC1=O,,,,,,
8712,108713,"7,9-Dihydro-3,9-dimethyl-1H-purine-2,6,8(3H)-trione",CN1C2=C(C(=O)NC(=O)N2C)NC1=O,,,,,,
8713,108714,9-Methyluric acid,CN1C2=C(C(=O)NC(=O)N2)NC1=O,,,,,,
8714,108715,"7,9-Dihydro-3,7,9-trimethyl-1H-purine-2,6,8(3H)-trione",CN1C2=C(N(C(=O)NC2=O)C)N(C1=O)C,,,,,,
8715,108716,CID 108716,CCC=CCC(OC)OC,,,,,,
8716,108717,"Cyclohexanecarboperoxoic acid, 1,1,3,3-tetramethylbutyl ester",CC(C)(C)CC(C)(C)OOC(=O)C1CCCCC1,,,,,,
8717,108718,Dimethyl 2-sulphoterephthalate,COC(=O)C1=CC(=C(C=C1)C(=O)OC)S(=O)(=O)O,,,,,,
8718,108719,Manganese edta complex,[H+].[H+].C(CN(CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].[Mn+2],,,,,,
8719,108720,"Pyrimidine, 4-chloro-2-ethylamino-6-(4-methylpiperazino)-5-methylthio-",CCNC1=NC(=C(C(=N1)Cl)SC)N2CCN(CC2)C,,,,,,
8720,108721,"Pyrimidine, 4-chloro-2-(tert-butylamino)-6-(4-methylpiperazino)-5-methylthio-",CC(C)(C)NC1=NC(=C(C(=N1)Cl)SC)N2CCN(CC2)C,,,,,,
8721,108722,4-Chloro-6-(2-hydroxyethylpiperazino)-2-methylamino-5-methylthiopyrimidine,CNC1=NC(=C(C(=N1)Cl)SC)N2CCN(CC2)CCO,,,,,,
8722,108723,"Pyrimidine, 2-acetylamino-4-chloro-6-(4-methylpiperazino)-5-methyl-",CC1=C(N=C(N=C1Cl)NC(=O)C)N2CCN(CC2)C,,,,,,
8723,108724,1-Ethyl-2-((3-methyl-2(3H)-benzothiazolylidene)methyl)quinolinium 4-methylbenzenesulfonate,CC[N+]1=C(C=CC2=CC=CC=C21)C=C3N(C4=CC=CC=C4S3)C.CC1=CC=C(C=C1)S(=O)(=O)[O-],,,,,,
8724,108725,"2-Naphthalenesulfonic acid, 8-hydroxy-5,7-dinitro-, barium salt (1:1)",C1=CC2=C(C=C1S(=O)(=O)[O-])C(=C(C=C2[N+](=O)[O-])[N+](=O)[O-])[O-].[Ba+2],,,,,,
8725,108726,4-Phenylquinolin-8-amine,C1=CC=C(C=C1)C2=C3C=CC=C(C3=NC=C2)N,,,,,,
8726,108727,Decyl chloroformate,CCCCCCCCCCOC(=O)Cl,,,,,,
8727,108728,CID 108728,CC1=CC(=C(C=C1)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)[O-])O)S(=O)(=O)[O-].CC1=CC(=C(C=C1)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)[O-])O)S(=O)(=O)[O-].[Ca+2].[Sr+2],,,,,,
8728,108729,"Glycine, N-(2-hydroxybenzoyl)-, methyl ester",COC(=O)CNC(=O)C1=CC=CC=C1O,,,,,,
8729,108730,"Carbonochloridothioic acid, S-dodecyl ester",CCCCCCCCCCCCSC(=O)Cl,,,,,,
8730,108731,Didansylcadaverine,CN(C)C1=CC=CC2=C1C=CC=C2S(=O)(=O)NCCCCCNS(=O)(=O)C3=CC=CC4=C3C=CC=C4N(C)C,,,,,,
8731,108732,Einecs 259-697-7,CC(C)(C)C1=CC=C(C=C1)OP(=NC2CCCCC2)(OC3=CC=C(C=C3)C(C)(C)C)S,,,,,,
8732,108733,"Benzoxazolium, 2-methyl-5-phenyl-3-(4-sulfobutyl)-, inner salt",CC1=[N+](C2=C(O1)C=CC(=C2)C3=CC=CC=C3)CCCCS(=O)(=O)[O-],,,,,,
8733,108734,"4-(2-Methyl-5-phenyl-1,3-benzoxazol-3-ium-3-yl)butane-1-sulfonic acid",CC1=[N+](C2=C(O1)C=CC(=C2)C3=CC=CC=C3)CCCCS(=O)(=O)O,,,,,,
8734,108735,"Benzothiazolium, 2-methyl-3-(4-sulfobutyl)-, inner salt",CC1=[N+](C2=CC=CC=C2S1)CCCCS(=O)(=O)[O-],,,,,,
8735,108736,"4-(2-Methyl-1,3-benzothiazol-3-ium-3-yl)butane-1-sulfonic acid",CC1=[N+](C2=CC=CC=C2S1)CCCCS(=O)(=O)O,,,,,,
8736,108737,"3,4-Dichlorodiphenyl ether",C1=CC=C(C=C1)OC2=CC(=C(C=C2)Cl)Cl,,,,,,
8737,108738,Ethyl (diphenylphosphino)acetate,CCOC(=O)CP(C1=CC=CC=C1)C2=CC=CC=C2,,,,,,
8738,108739,"Benzenamine, N-(2-chloroethyl)-N-ethyl-4-[(4-nitrophenyl)azo]-",CCN(CCCl)C1=CC=C(C=C1)N=NC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
8739,108740,"Ethanol, 2,2'-((4-((2,6-dichloro-4-nitrophenyl)azo)phenyl)imino)bis-, diacetate (ester)",CC(=O)OCCN(CCOC(=O)C)C1=CC=C(C=C1)N=NC2=C(C=C(C=C2Cl)[N+](=O)[O-])Cl,,,,,,
8740,108741,"Ethanol, 2,2'-[[4-[(2,6-dibromo-4-nitrophenyl)azo]phenyl]imino]bis-, diacetate (ester)",CC(=O)OCCN(CCOC(=O)C)C1=CC=C(C=C1)N=NC2=C(C=C(C=C2Br)[N+](=O)[O-])Br,,,,,,
8741,108742,"5-beta-Pregnane-3-alpha,11-alpha,20-beta-triol",C[C@H]([C@H]1CC[C@@H]2[C@@]1(C[C@H]([C@H]3[C@H]2CC[C@H]4[C@@]3(CC[C@H](C4)O)C)O)C)O,,,,,,
8742,108743,"Benzenamine, 4-(3-(trimethoxysilyl)propoxy)-",CO[Si](CCCOC1=CC=C(C=C1)N)(OC)OC,,,,,,
8743,108744,[(2-Chlorophenyl)hydrazono]malononitrile,C1=CC=C(C(=C1)NN=C(C#N)C#N)Cl,,,,,,
8744,108745,Carbonyl cyanide 2-nitrophenylhydrazone,C1=CC=C(C(=C1)NN=C(C#N)C#N)[N+](=O)[O-],,,,,,
8745,108746,"1,1-Dichloro-4-methylpenta-1,3-diene",CC(=CC=C(Cl)Cl)C,,,,,,
8746,108747,"[1,1'-Biphenyl]-3,4'-dicarboxylic acid, dimethyl ester",COC(=O)C1=CC=C(C=C1)C2=CC(=CC=C2)C(=O)OC,,,,,,
8747,108748,"Dimethyl [1,1'-biphenyl]-2,4'-dicarboxylate",COC(=O)C1=CC=C(C=C1)C2=CC=CC=C2C(=O)OC,,,,,,
8748,108749,"Methyl 4-((2,4-diamino-5-pyrimidinyl)methyl)-2,6-dimethoxybenzoate",COC1=CC(=CC(=C1C(=O)OC)OC)CC2=CN=C(N=C2N)N,,,,,,
8749,108750,"1-Methylethyl 4-((2,4-diamino-5-pyrimidinyl)methyl)-2,6-dimethoxybenzoate",CC(C)OC(=O)C1=C(C=C(C=C1OC)CC2=CN=C(N=C2N)N)OC,,,,,,
8750,108751,"Benzenemethanol, 4-((2,4-diamino-5-pyrimidinyl)methyl)-2,6-dimethoxy-",COC1=CC(=CC(=C1CO)OC)CC2=CN=C(N=C2N)N,,,,,,
8751,108752,"Benzamide, 4-((2,4-diamino-5-pyrimidinyl)methyl)-2,6-dimethoxy-",COC1=CC(=CC(=C1C(=O)N)OC)CC2=CN=C(N=C2N)N,,,,,,
8752,108753,"Benzonitrile, 4-((2,4-diamino-5-pyrimidinyl)methyl)-2,6-dimethoxy-",COC1=CC(=CC(=C1C#N)OC)CC2=CN=C(N=C2N)N,,,,,,
8753,108754,"2,4-Diamino-5-(3,5-dimethoxy-4-(methoxymethyl)benzyl)pyrimidine",COCC1=C(C=C(C=C1OC)CC2=CN=C(N=C2N)N)OC,,,,,,
8754,108755,"Diazene, bis[1-(1,1-dimethylethyl)-2,2-dimethylpropyl]-, 1,2-dioxide",CC(C)(C)C(C(C)(C)C)N([N+](=O)C(C(C)(C)C)C(C)(C)C)[O-],,,,,,
8755,108756,"4-tert-Butyl-3-hydroxy-2,6-xylylacetonitrile",CC1=CC(=C(C(=C1CC#N)C)O)C(C)(C)C,,,,,,
8756,108757,"Cyclohexanebutanoic acid, cadmium salt",C1CCC(CC1)CCCC(=O)[O-].C1CCC(CC1)CCCC(=O)[O-].[Cd+2],,,,,,
8757,108758,"1H-Tetrazole, 5-phenyl-, barium salt",C1=CC=C(C=C1)C2=NN=N[N-]2.C1=CC=C(C=C1)C2=NN=N[N-]2.[Ba+2],,,,,,
8758,108759,"1H-Tetrazole, 5-phenyl-, calcium salt",C1=CC=C(C=C1)C2=NN=N[N-]2.C1=CC=C(C=C1)C2=NN=N[N-]2.[Ca+2],,,,,,
8759,108760,Einecs 259-779-2,C1=CC=C2C(=C1)C(=O)OC23C4=CC(=C(C=C4OC5=C3C(=C(C(=C5)O)Br)[Hg])O)Br.O,,,,,,
8760,108761,"(2',7'-Dibromo-3',6'-dihydroxy-3-oxospiro[2-benzofuran-1,9'-xanthene]-1'-yl)mercury",C1=CC=C2C(=C1)C(=O)OC23C4=CC(=C(C=C4OC5=C3C(=C(C(=C5)O)Br)[Hg])O)Br,,,,,,
8761,108762,"Thiosulfuric acid, disodium salt, monohydrate",O.[O-]S(=O)(=S)[O-].[Na+].[Na+],,,,,,
8762,108763,"Benzene, 2,4-dichloro-1-[(4-chlorophenyl)thio]-",C1=CC(=CC=C1SC2=C(C=C(C=C2)Cl)Cl)Cl,,,,,,
8763,108764,"Ethanethioic acid, S-(2,5-dimethyl-3-furanyl) ester",CC1=CC(=C(O1)C)SC(=O)C,,,,,,
8764,108765,3-(Acetylthio)-2-methylfuran,CC1=C(C=CO1)SC(=O)C,,,,,,
8765,108766,"Benzothiazolium, 3-(2-carboxyethyl)-2-methyl-, bromide",CC1=[N+](C2=CC=CC=C2S1)CCC(=O)O.[Br-],,,,,,
8766,108767,3-(2-Carboxyethyl)-2-methylbenzothiazol-3-ium,CC1=[N+](C2=CC=CC=C2S1)CCC(=O)O,,,,,,
8767,108768,"Acetamide, n-[4-(octyloxy)phenyl]-",CCCCCCCCOC1=CC=C(C=C1)NC(=O)C,,,,,,
8768,108769,"Butanoic acid, 3,3-bis((1,1-dimethylethyl)dioxy)-, ethyl ester",CCOC(=O)CC(C)(OOC(C)(C)C)OOC(C)(C)C,,,,,,
8769,108770,Coumarin 343,C1CC2=C3C(=C4C(=C2)C=C(C(=O)O4)C(=O)O)CCCN3C1,,,,,,
8770,108771,"1-Anthracenesulfonic acid, 9,10-dihydro-9,10-dioxo-, ammonium salt",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=CC=C3)S(=O)(=O)O.N,,,,,,
8771,108772,Carbethoxymethyl-alpha-picolinium bromide,CCOC(=O)C[N+]1=CC=CC=C1C.[Br-],,,,,,
8772,108773,1-(2-Ethoxy-2-oxoethyl)-2-methylpyridinium,CCOC(=O)C[N+]1=CC=CC=C1C,,,,,,
8773,108774,"Octadecanamide, N-[3-[bis(2-hydroxyethyl)amino]propyl]-",CCCCCCCCCCCCCCCCCC(=O)NCCCN(CCO)CCO,,,,,,
8774,108775,3-Ethoxybenzamide,CCOC1=CC=CC(=C1)C(=O)N,,,,,,
8775,108776,4-Ethoxybenzamide,CCOC1=CC=C(C=C1)C(=O)N,,,,,,
8776,108777,"(1,1-Dimethoxyethoxy)cyclohexane",CC(OC)(OC)OC1CCCCC1,,,,,,
8777,108778,"1,3,3-Trimethyl-2-((methylphenylhydrazono)methyl)-3H-indolium chloride",CC1(C2=CC=CC=C2[N+](=C1C=NN(C)C3=CC=CC=C3)C)C.[Cl-],,,,,,
8778,108779,"9,10-Anthracenedione, 1-amino-4,5-dihydroxy-8-[(4-methoxyphenyl)amino]-",COC1=CC=C(C=C1)NC2=C3C(=C(C=C2)O)C(=O)C4=C(C=CC(=C4C3=O)N)O,,,,,,
8779,108780,Stearamidopropyl morpholine,CCCCCCCCCCCCCCCCCC(=O)NCCCN1CCOCC1,,,,,,
8780,108781,4-[3-(Stearoylamino)propyl]morpholinium lactate,CCCCCCCCCCCCCCCCCC(=O)NCCCN1CCOCC1.CC(C(=O)O)O,,,,,,
8781,108782,Isostearamidopropyl dimethylamine lactate,CC(C)CCCCCCCCCCCCCCC(=O)NCCCN(C)C.CC(C(=O)O)O,,,,,,
8782,108783,"Bis[2-[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]ethyl] 3,3'-thiobispropionate",CC(C)(C)C1=CC(=CC(=C1O)C(C)(C)C)CCOC(=O)CCSCCC(=O)OCCC2=CC(=C(C(=C2)C(C)(C)C)O)C(C)(C)C,,,,,,
8783,108784,"1-Oxaspiro[4.5]decan-6-ol, 2,6,10,10-tetramethyl-, (2R,5R,6S)-rel-",C[C@@H]1CC[C@]2(O1)[C@@](CCCC2(C)C)(C)O,,,,,,
8784,108785,"1-Oxaspiro(4.5)decan-6-ol, 2,6,10,10-tetramethyl-, acetate, (2R,5S,6R)-rel-",C[C@@H]1CC[C@@]2(O1)[C@](CCCC2(C)C)(C)OC(=O)C,,,,,,
8785,108786,"1-Oxaspiro(4.5)decan-6-ol, 2,6,10,10-tetramethyl-, acetate, (2R,5R,6R)-rel-",C[C@@H]1CC[C@]2(O1)[C@](CCCC2(C)C)(C)OC(=O)C,,,,,,
8786,108787,"1-Oxaspiro(4.5)decan-6-ol, 2,6,10,10-tetramethyl-, acetate, (2R,5R,6S)-rel-",C[C@@H]1CC[C@]2(O1)[C@@](CCCC2(C)C)(C)OC(=O)C,,,,,,
8787,108788,"Di-mu-chlorodichlorobis((3,4-eta)-4-methylpent-3-en-2-one)diplatinum",CC(=CC(=O)C)C.CC(=CC(=O)C)C.[Cl-].[Cl-].[Cl-].[Cl-].[Pt+2].[Pt+2],,,,,,
8788,108789,"7-((4-Chloro-6-((3-sulphophenyl)amino)-1,3,5-triazin-2-yl)amino)-4-hydroxy-3-((4-methoxy-2-sulphophenyl)azo)naphthalene-2-sulphonic acid",COC1=CC(=C(C=C1)N=NC2=C(C=C3C=C(C=CC3=C2O)NC4=NC(=NC(=N4)NC5=CC(=CC=C5)S(=O)(=O)O)Cl)S(=O)(=O)O)S(=O)(=O)O,,,,,,
8789,108790,"2,9-Bis(ethoxypropyl)anthra(2,1,9-def:6,5,10-d'e'f')diisoquinoline-1,3,8,10(2H,9H)-tetrone",CCOCCCN1C(=O)C2=C3C(=CC=C4C3=C(C=C2)C5=C6C4=CC=C7C6=C(C=C5)C(=O)N(C7=O)CCCOCC)C1=O,,,,,,
8790,108791,"Pyridinium, 2-[(4-aminophenyl)azo]-1-methyl-, methyl sulfate",C[N+]1=CC=CC=C1N=NC2=CC=C(C=C2)N.COS(=O)(=O)[O-],,,,,,
8791,108792,2-[(4-Aminophenyl)azo]-1-methylpyridinium,C[N+]1=CC=CC=C1N=NC2=CC=C(C=C2)N,,,,,,
8792,108793,Calcium bis(2-iodylbenzoate),C1=CC=C(C(=C1)C(=O)[O-])I(=O)=O.C1=CC=C(C(=C1)C(=O)[O-])I(=O)=O.[Ca+2],,,,,,
8793,108794,2-Iodoxybenzoic acid,C1=CC=C(C(=C1)C(=O)O)I(=O)=O,,,,,,
8794,108795,"1,3,4-Thiadiazole, 2,5-bis(tert-dodecyldithio)-",CCCCCCCCCC(C)(C)SSC1=NN=C(S1)SSC(C)(C)CCCCCCCCC,,,,,,
8795,108796,"1-Heptanone, 1-[1,1'-biphenyl]-4-yl-",CCCCCCC(=O)C1=CC=C(C=C1)C2=CC=CC=C2,,,,,,
8796,108797,4-Hexylbiphenyl,CCCCCCC1=CC=C(C=C1)C2=CC=CC=C2,,,,,,
8797,108798,"1,1'-Biphenyl, 4-heptyl-",CCCCCCCC1=CC=C(C=C1)C2=CC=CC=C2,,,,,,
8798,108799,N-(N'-Methyl-N'-nitroso(aminomethyl))benzamide,CN(CNC(=O)C1=CC=CC=C1)N=O,,,,,,
8799,108800,"2,7-Dichloro-4-methylquinoline",CC1=CC(=NC2=C1C=CC(=C2)Cl)Cl,,,,,,
8800,108801,"6-Amino-1,2-dihydro-3H-indazol-3-one",C1=CC2=C(C=C1N)NNC2=O,,,,,,
8801,108802,Einecs 261-853-4,COC(=O)C1=C(C=C(C=C1)NC(=O)C2=C(C=CC(=C2)Cl)Cl)N,,,,,,
8802,108803,"2-(1-Ethylpropyl)-5,5-dimethyl-1,3-dioxane",CCC(CC)C1OCC(CO1)(C)C,,,,,,
8803,108804,Diisohexadecyl adipate,CC(C)CCCCCCCCCCCCCOC(=O)CCCCC(=O)OCCCCCCCCCCCCCC(C)C,,,,,,
8804,108805,(3-Aminophenyl)uronium chloride,C1=CC(=CC(=C1)NC(=O)N)N.Cl,,,,,,
8805,108806,(3-Aminophenyl)urea,C1=CC(=CC(=C1)NC(=O)N)N,,,,,,
8806,108807,3-Amino-4-propoxybenzoic acid,CCCOC1=C(C=C(C=C1)C(=O)O)N,,,,,,
8807,108808,"(3aalpha,4alpha,6alpha,7alpha,7aalpha)-3a,4,5,6,7,7a-Hexahydro-4,7-methano-1H-indene-6-carboxaldehyde",C1C=C[C@H]2[C@@H]1[C@@H]3C[C@H]2C[C@H]3C=O,,,,,,
8808,108809,"4,7-Methano-1H-indene-5-carboxaldehyde, 3a,4,5,6,7,7a-hexahydro-, (3aR,4S,5R,7S,7aR)-rel-",C1C=C[C@@H]2[C@H]1[C@@H]3C[C@H]([C@H]2C3)C=O,,,,,,
8809,108810,"3-(1,1-Dimethylethyl)-2-phenyloxazolidine-5-methanol",CC(C)(C)N1CC(OC1C2=CC=CC=C2)CO,,,,,,
8810,108811,Benzyl 3-aminopyrazinecarboxylate,C1=CC=C(C=C1)COC(=O)C2=NC=CN=C2N,,,,,,
8811,108812,"1-Ethylpiperazine-2,3-dione",CCN1CCNC(=O)C1=O,,,,,,
8812,108813,"4-Ethyl-2,3-dioxopiperazine-1-carbonyl chloride",CCN1CCN(C(=O)C1=O)C(=O)Cl,,,,,,
8813,108814,"beta-Alanine, N-[4-[(2-bromo-6-chloro-4-nitrophenyl)azo]phenyl]-N-(3-methoxy-3-oxopropyl)-, methyl ester",COC(=O)CCN(CCC(=O)OC)C1=CC=C(C=C1)N=NC2=C(C=C(C=C2Br)[N+](=O)[O-])Cl,,,,,,
8814,108815,1-[Bis(tridecyloxy)methoxy]tridecane,CCCCCCCCCCCCCOC(OCCCCCCCCCCCCC)OCCCCCCCCCCCCC,,,,,,
8815,108816,Tris(tridecyl) borate,B(OCCCCCCCCCCCCC)(OCCCCCCCCCCCCC)OCCCCCCCCCCCCC,,,,,,
8816,108817,"9,10-Anthracenedione, 1-amino-2-(4-bromophenoxy)-4-hydroxy-",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3O)OC4=CC=C(C=C4)Br)N,,,,,,
8817,108818,Bromotriphenylpropylphosphorane,CCCP(C1=CC=CC=C1)(C2=CC=CC=C2)(C3=CC=CC=C3)Br,,,,,,
8818,108819,Bromopentyltriphenylphosphorane,CCCCCP(C1=CC=CC=C1)(C2=CC=CC=C2)(C3=CC=CC=C3)Br,,,,,,
8819,108820,Diethyl allylisobutylmalonate,CCOC(=O)C(CC=C)(CC(C)C)C(=O)OCC,,,,,,
8820,108821,Diethyl (3-methylbutyl)allylmalonate,CCOC(=O)C(CCC(C)C)(CC=C)C(=O)OCC,,,,,,
8821,108822,2-(3-Aminophenyl)acetamide hydrochloride,C1=CC(=CC(=C1)N)CC(=O)N.Cl,,,,,,
8822,108823,2-(3-Aminophenyl)acetamide,C1=CC(=CC(=C1)N)CC(=O)N,,,,,,
8823,108824,"4-Amino-6-tert-butyl-3,4-dihydro-3-mercapto-1,2,4-triazin-5(2H)-one",CC(C)(C)C1=NNC(N(C1=O)N)S,,,,,,
8824,108825,"[1,1'-Biphenyl]-4-carboxylic acid, 4'-pentyl-, 4-pentylphenyl ester",CCCCCC1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)OC3=CC=C(C=C3)CCCCC,,,,,,
8825,108826,"Benzoic acid, 4-butyl-, 4'-propyl[1,1'-biphenyl]-4-yl ester",CCCCC1=CC=C(C=C1)C(=O)OC2=CC=C(C=C2)C3=CC=C(C=C3)CCC,,,,,,
8826,108827,"Benzoic acid, 4-butyl-, 4'-pentyl[1,1'-biphenyl]-4-yl ester",CCCCCC1=CC=C(C=C1)C2=CC=C(C=C2)OC(=O)C3=CC=C(C=C3)CCCC,,,,,,
8827,108828,"[1,1'-Biphenyl]-4-carbonyl chloride, 4'-pentyl-",CCCCCC1=CC=C(C=C1)C2=CC=C(C=C2)C(=O)Cl,,,,,,
8828,108829,4-Bromo-2-chlorobenzoic acid,C1=CC(=C(C=C1Br)Cl)C(=O)O,,,,,,
8829,108830,"2-Propanone, 1-phenyl-3-[3-(trifluoromethyl)phenyl]-",C1=CC=C(C=C1)CC(=O)CC2=CC(=CC=C2)C(F)(F)F,,,,,,
8830,108831,Allyl glycinate,C=CCOC(=O)CN,,,,,,
8831,108832,"Piperazine 1,3,4,5-tetrahydroxycyclohexane-1-carboxylate",C1CNCCN1.C1[C@@H](C([C@H](CC1(C(=O)O)O)O)O)O,,,,,,
8832,108833,N6-(1-Oxodecyl)-L-lysine,CCCCCCCCCC(=O)NCCCC[C@@H](C(=O)O)N,,,,,,
8833,108834,1-(4-Isobutylphenyl)propan-1-one,CCC(=O)C1=CC=C(C=C1)CC(C)C,,,,,,
8834,108835,Methyl 2-oxo-1-pyrrolidineacetate,COC(=O)CN1CCCC1=O,,,,,,
8835,108836,Methyl 3-sulfamoylbenzoate,COC(=O)C1=CC(=CC=C1)S(=O)(=O)N,,,,,,
8836,108837,Ethyl 3-sulfamoylbenzoate,CCOC(=O)C1=CC(=CC=C1)S(=O)(=O)N,,,,,,
8837,108838,Pentadecyl dihydrogen phosphate,CCCCCCCCCCCCCCCOP(=O)(O)O,,,,,,
8838,108839,"Carbamimidothioic acid, cyanomethyl ester, monohydrochloride",C(C#N)SC(=N)N.Cl,,,,,,
8839,108840,2-(Carbamimidoylsulfanyl)acetonitrile,C(C#N)SC(=N)N,,,,,,
8840,108841,Tris(isotridecyl) borate,B(OCCCCCCCCCCC(C)C)(OCCCCCCCCCCC(C)C)OCCCCCCCCCCC(C)C,,,,,,
8841,108842,"2-Chlorophenyl 2,2,2-trichloroethyl chlorophosphate",C1=CC=C(C(=C1)OP(=O)(OCC(Cl)(Cl)Cl)Cl)Cl,,,,,,
8842,108843,Diethylmethyl(2-((2-methyl-1-oxoallyl)oxy)ethyl)ammonium bromide,CC[N+](C)(CC)CCOC(=O)C(=C)C.[Br-],,,,,,
8843,108844,6-Amino-5-((4-aminophenyl)azo)-4-hydroxynaphthalene-2-sulphonic acid,C1=CC(=CC=C1N)N=NC2=C(C=CC3=CC(=CC(=C32)O)S(=O)(=O)O)N,,,,,,
8844,108845,"N,N-bis(2-hydroxyethyl)octadeca-9,12,15-trienamide",CCC=CCC=CCC=CCCCCCCCC(=O)N(CCO)CCO,,,,,,
8845,108846,4-(5-Heptylpyrimidin-2-yl)benzonitrile,CCCCCCCC1=CN=C(N=C1)C2=CC=C(C=C2)C#N,,,,,,
8846,108847,4-(5-Pentylpyrimidin-2-yl)benzonitrile,CCCCCC1=CN=C(N=C1)C2=CC=C(C=C2)C#N,,,,,,
8847,108848,"1-(2,4-Bis(isopropyl)phenyl)butane-1,3-dione",CC(C)C1=CC(=C(C=C1)C(=O)CC(=O)C)C(C)C,,,,,,
8848,108849,"2,2,4,4-Tetrachloro-3-butenal",C(=C(Cl)Cl)C(C=O)(Cl)Cl,,,,,,
8849,108850,Cyanobutadiene,C#CC#CC#N,,,,,,
8850,108851,N2-(1-Oxohexadecyl)-L-lysine,CCCCCCCCCCCCCCCC(=O)N[C@@H](CCCCN)C(=O)O,,,,,,
8851,108852,"2,2-Dichloro-1-(4-phenoxyphenyl)ethanone",C1=CC=C(C=C1)OC2=CC=C(C=C2)C(=O)C(Cl)Cl,,,,,,
8852,108853,N-(4-(Ethyl(2-hydroxyethyl)amino)phenyl)acetamide,CCN(CCO)C1=CC=C(C=C1)NC(=O)C,,,,,,
8853,108854,CID 108854,C1=CC2=C(C=COC2=CC1=O)O,,,,,,
8854,108855,3-Bromo-2-fluorotoluene,CC1=C(C(=CC=C1)Br)F,,,,,,
8855,108856,2-Bromo-3-fluorotoluene,CC1=C(C(=CC=C1)F)Br,,,,,,
8856,108857,"Benzenesulfonic acid, 3-((4-amino-5-methoxy-2-methylphenyl)azo)-",CC1=CC(=C(C=C1N=NC2=CC(=CC=C2)S(=O)(=O)O)OC)N,,,,,,
8857,108858,"2,2'-Methylenebis(4,6-bis((dimethylamino)methyl)phenol)",CN(C)CC1=CC(=C(C(=C1)CN(C)C)O)CC2=C(C(=CC(=C2)CN(C)C)CN(C)C)O,,,,,,
8858,108859,Butyl dibromoacetate,CCCCOC(=O)C(Br)Br,,,,,,
8859,108860,Butyl tribromoacetate,CCCCOC(=O)C(Br)(Br)Br,,,,,,
8860,108861,Phosphomethyl phosphonic acid deoxythymidylate ester,CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)(O)OP(=O)(CP(=O)(O)O)O)O,,,,,,
8861,108862,"4-Chloro-2,5-dimethylbenzenethiol",CC1=CC(=C(C=C1Cl)C)S,,,,,,
8862,108863,Dibutyltin;16-methylheptadecanoic acid,CCCC[Sn]CCCC.CC(C)CCCCCCCCCCCCCCC(=O)O.CC(C)CCCCCCCCCCCCCCC(=O)O,,,,,,
8863,108864,"1-Amino-4-((4-chloro-3-sulphophenyl)amino)-9,10-dihydro-9,10-dioxoanthracene-2-sulphonic acid",C1=CC=C2C(=C1)C(=O)C3=C(C2=O)C(=C(C=C3NC4=CC(=C(C=C4)Cl)S(=O)(=O)O)S(=O)(=O)O)N,,,,,,
8864,108865,2-Mercaptoethyl 3-mercaptopropionate,C(CS)C(=O)OCCS,,,,,,
8865,108866,CID 108866,C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C4=C(C=C3)C(=CC=C4)S(=O)(=O)[O-])S(=O)(=O)[O-])O,,,,,,
8866,108867,Einecs 262-006-1,CCCCCCCCCCCCCCOP(=O)(C1=CC=CC=C1)OCCCCCCCCCCCCCC,,,,,,
8867,108868,2-Hydroxy-3-chloro-5-nonyl-benzophenone oxime,CCCCCCCCCC1=CC(=C(C(=C1)Cl)O)C(=NO)C2=CC=CC=C2,,,,,,
8868,108869,"Butanamide, N-(3-aminophenyl)-3-oxo-, monohydrochloride",CC(=O)CC(=O)NC1=CC=CC(=C1)N.Cl,,,,,,
8869,108870,N-(3-aminophenyl)-3-oxobutanamide,CC(=O)CC(=O)NC1=CC=CC(=C1)N,,,,,,
8870,108871,Pivaloylacetonitrile,CC(C)(C)C(=O)CC#N,,,,,,
8871,108872,2-[4-(Hexyloxy)phenyl]acetic acid,CCCCCCOC1=CC=C(C=C1)CC(=O)O,,,,,,
8872,108873,"N,N'-(2-Methyl-1,3-phenylene)bis(pyrrolidine-1-carboxamide)",CC1=C(C=CC=C1NC(=O)N2CCCC2)NC(=O)N3CCCC3,,,,,,
8873,108874,"2,2,2-Trichloroethyl phosphorodichloridite",C(C(Cl)(Cl)Cl)OP(Cl)Cl,,,,,,
8874,108875,"1,2-Dihydro-6-hydroxy-4-methyl-2-oxo-5-[[2-(3-phenyl-1,2,4-oxadiazol-5-YL)phenyl]azo]nicotinonitrile",CC1=C(C(=O)NC(=C1C#N)O)N=NC2=CC=CC=C2C3=NC(=NO3)C4=CC=CC=C4,,,,,,
8875,108876,"Pyrrolidine, 1-(3-methyl-1-oxobutyl)-",CC(C)CC(=O)N1CCCC1,,,,,,
8876,108877,9-Tetradecyn-1-ol,CCCCC#CCCCCCCCCO,,,,,,
8877,108878,"N-(3,5-Bis(1,1-dimethylethyl)-2-hydroxyphenyl)acetamide",CC(=O)NC1=CC(=CC(=C1O)C(C)(C)C)C(C)(C)C,,,,,,
8878,108879,"Benzenepropanoic acid, 3-phenylpropyl ester",C1=CC=C(C=C1)CCCOC(=O)CCC2=CC=CC=C2,,,,,,
8879,108880,Glucoheptonolactone,C([C@H]([C@H]([C@H]1[C@H](C(C(=O)O1)O)O)O)O)O,,,,,,
8880,108881,CID 108881,C1=NC2=C(N1)C(=O)N=C(N2)N.Br,,,,,,
8881,108882,Tetrabutyl thiopyrophosphate,CCCCOP(=S)(OCCCC)OP(=S)(OCCCC)OCCCC,,,,,,
8882,108883,"3-(2,3-Dihydro-1,3-dioxo-1H-inden-2-yl)-7-hydroxybenzo(f)quinoline-9-sulphonic acid",C1=CC=C2C(=C1)C(=O)C(C2=O)C3=CC=C4C(=CC=C5C4=CC(=CC5=O)S(=O)(=O)O)N3,,,,,,
8883,108884,"4,5-Dihydro-1-phenyl-3-(2,4,6-trimethylphenyl)-1H-pyrazole",CC1=CC(=C(C(=C1)C)C2=NN(CC2)C3=CC=CC=C3)C,,,,,,
8884,108885,"(2,3,5,6-2H4)Terephthalic acid",[2H]C1=C(C(=C(C(=C1C(=O)O)[2H])[2H])C(=O)O)[2H],,,,,,
8885,108886,Diisopropyl tetrasulphide,CC(C)SSSSC(C)C,,,,,,
8886,108887,"Benzene, 1,1'-[oxybis(methyleneoxy)]bis[2,4,6-trichloro-",C1=C(C=C(C(=C1Cl)OCOCOC2=C(C=C(C=C2Cl)Cl)Cl)Cl)Cl,,,,,,
8887,108888,Timodine,C[C@]12CCC(=O)C=C1CC[C@@H]3[C@@H]2C(C[C@]4([C@H]3CC[C@@]4(C(=O)CO)O)C)O,,,,,,
8888,108889,"Disulfide, tert-dodecyl trichloromethyl",CCCCCCCCCC(C)(C)SSC(Cl)(Cl)Cl,,,,,,
8889,108890,Carbazine 720,CC1=C(C2(C(=C(C1=O)C)C)C3=CC(=O)C=CC3=NC4=C2C=C(C=C4)[O-])C,,,,,,
8890,108891,"7-Hydroxy-2',3',5',6'-tetramethylspiro[acridine-9(2H),1'-[2,5]cyclohexadiene]-2,4'-dione",CC1=C(C2(C(=C(C1=O)C)C)C3=CC(=O)C=CC3=NC4=C2C=C(C=C4)O)C,,,,,,
8891,108892,"2-Propenoic acid, 2-(phosphonooxy)-, tripotassium salt",C=C(C(=O)[O-])OP(=O)([O-])[O-].[K+].[K+].[K+],,,,,,
8892,108893,"Benzoxazolium, 3-ethyl-2-methyl-, salt with 4-methylbenzenesulfonic acid (1:1)",CC[N+]1=C(OC2=CC=CC=C21)C.CC1=CC=C(C=C1)S(=O)(=O)[O-],,,,,,
8893,108894,2-((4-(Phenylamino)-1-naphthyl)azo)benzoic acid,C1=CC=C(C=C1)NC2=CC=C(C3=CC=CC=C32)N=NC4=CC=CC=C4C(=O)O,,,,,,
8894,108895,Trimethylolpropane monostearate,CCCCCCCCCCCCCCCCCC(=O)OCC(CC)(CO)CO,,,,,,
8895,108896,"4-((4-((1-(((2,4-Dimethoxyphenyl)amino)carbonyl)-2-oxopropyl)azo)phenyl)azo)benzenesulphonic acid",CC(=O)C(C(=O)NC1=C(C=C(C=C1)OC)OC)N=NC2=CC=C(C=C2)N=NC3=CC=C(C=C3)S(=O)(=O)O,,,,,,
8896,108897,"4-(2-Chlorophenylazo)-2,5-dimethoxyaniline",COC1=CC(=C(C=C1N)OC)N=NC2=CC=CC=C2Cl,,,,,,
8897,108898,"2,2-Bis(methylsulfonyl)propane",CC(C)(S(=O)(=O)C)S(=O)(=O)C,,,,,,
8898,108899,CID 108899,C1=C(C=C(C(=C1I)O)I)S(=O)(=O)[O-].[K+],,,,,,
8899,108900,3-Formamido-4-hydroxyphenylarsonic acid,C1=CC(=C(C=C1[As](=O)(O)O)NC=O)O,,,,,,
8900,108901,Calcium 4-aminobenzoate (1:2),C1=CC(=CC=C1C(=O)[O-])N.C1=CC(=CC=C1C(=O)[O-])N.[Ca+2],,,,,,
8901,108902,Heptyl decanoate,CCCCCCCCCC(=O)OCCCCCCC,,,,,,
8902,108903,"1-N,4-N-dimethylbenzene-1,4-diamine;sulfuric acid",CNC1=CC=C(C=C1)NC.CNC1=CC=C(C=C1)NC.OS(=O)(=O)O,,,,,,
8903,108904,"1,3,5,7-Tetraazatricyclo(3.3.1.13,7)decane monobenzoate",C1N2CN3CN1CN(C2)C3.C1=CC=C(C=C1)C(=O)O,,,,,,
8904,108905,"(2R,3R,4R,5S)-hexane-1,2,3,4,5,6-hexol;octanoic acid",CCCCCCCC(=O)O.C([C@H]([C@H]([C@@H]([C@H](CO)O)O)O)O)O,,,,,,
8905,108906,"2-(Bromomethyl)-2-(2,4-dichlorophenyl)-1,3-dioxolane",C1COC(O1)(CBr)C2=C(C=C(C=C2)Cl)Cl,,,,,,
8906,108907,Dinonylnaphthalenedisulphonic acid,CCCCCCCCCC1=C2C(=CC(=CC2=C(C=C1)S(=O)(=O)O)S(=O)(=O)O)CCCCCCCCC,,,,,,
8907,108908,"((6,8-Dibutyl-2,4,6,8-tetramethylcyclotetrasiloxane-2,4-diyl)di(oxy))bis(diethylamine)",CCCC[Si]1(O[Si](O[Si](O[Si](O1)(C)ON(CC)CC)(C)ON(CC)CC)(C)CCCC)C,,,,,,
8908,108909,"10-Undecenamide, N,N-bis(2-hydroxyethyl)-",C=CCCCCCCCCC(=O)N(CCO)CCO,,,,,,
8909,108910,"2,2-Dimethylpropane-1,3-diyl bis(3-hydroxypivalate)",CC(C)(CO)C(=O)OCC(C)(C)COC(=O)C(C)(C)CO,,,,,,
8910,108911,"[1,1'-Bicyclohexyl]-1-carboxylic acid",C1CCC(CC1)C2(CCCCC2)C(=O)O,,,,,,
8911,108912,Behenamidopropyl dimethylamine,CCCCCCCCCCCCCCCCCCCCCC(=O)NCCCN(C)C,,,,,,
8912,108913,CID 108913,C(C(C(C(F)(F)F)(F)F)(F)F)(C(C(C(F)(F)S(=O)(=O)[O-])(F)F)(F)F)(F)F.[K+],,,,,,
8913,108914,1-Chloro-5-iodopentane,C(CCCl)CCI,,,,,,
8914,108915,Butyl 2-bromo-2-methylpropionate,CCCCOC(=O)C(C)(C)Br,,,,,,
8915,108916,"4-Amino-6-(trichlorovinyl)benzene-1,3-disulphonyl dichloride",C1=C(C(=CC(=C1N)S(=O)(=O)Cl)S(=O)(=O)Cl)C(=C(Cl)Cl)Cl,,,,,,
8916,108917,"Ethanol, 2,2',2''-nitrilotris-, compd. with 1H-benzotriazole (1:1)",C1=CC2=NNN=C2C=C1.C(CO)N(CCO)CCO,,,,,,
8917,108918,4-Ethyloct-2-enoic acid,CCCCC(CC)C=CC(=O)O,,,,,,
8918,108919,4-Ethylhexenoic acid,CCC(CC)C=CC(=O)O,,,,,,
8919,108920,"1-(4'-Bromo[1,1'-biphenyl]-4-yl)-2-phenylethan-1-one",C1=CC=C(C=C1)CC(=O)C2=CC=C(C=C2)C3=CC=C(C=C3)Br,,,,,,
8920,108921,"9,10-Anthracenedione, 1,8-bis(methylamino)-",CNC1=CC=CC2=C1C(=O)C3=C(C2=O)C=CC=C3NC,,,,,,
8921,108922,"Silane, dodecyldiethoxymethyl-",CCCCCCCCCCCC[Si](C)(OCC)OCC,,,,,,
8922,108923,Ethyl 3-amino-5-(trifluoromethyl)-1H-indazole-1-carboxylate,CCOC(=O)N1C2=C(C=C(C=C2)C(F)(F)F)C(=N1)N,,,,,,
8923,108924,"1,4,7,10,13,16-Hexaoxacyclooctadecane, compd. with acetonitrile (1:1)",CC#N.C1COCCOCCOCCOCCOCCO1,,,,,,
8924,108925,"1,4-Dioxa-7,10-diazacyclododecane",C1CNCCOCCOCCN1,,,,,,
8925,108926,Isooctadecyl stearate,CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C,,,,,,
8926,108927,"Methyl (5beta,7alpha)-7-acetoxy-3,12-dioxocholan-24-oate",C[C@H](CCC(=O)OC)[C@H]1CC[C@@H]2[C@@]1(C(=O)C[C@H]3[C@H]2[C@@H](C[C@H]4[C@@]3(CCC(=O)C4)C)OC(=O)C)C,,,,,,
8927,108928,"1H-Pyrrole-2,5-dione, 1-(3-fluoranthenyl)-",C1=CC=C2C(=C1)C3=C4C2=CC=CC4=C(C=C3)N5C(=O)C=CC5=O,,,,,,
8928,108929,CID 108929,CCCC(CCC)C(=O)[O-].[BiH3],,,,,,
8929,108930,N2-(1-Oxotetradecyl)-L-arginine,CCCCCCCCCCCCCC(=O)N[C@@H](CCCN=C(N)N)C(=O)O,,,,,,
8930,108931,"Phosphonic acid, (1-hydroxyethylidene)bis-, tripotassium salt",CC(O)(P(=O)(O)[O-])P(=O)([O-])[O-].[K+].[K+].[K+],,,,,,
8931,108932,Carbethoxymethyltrimethylammonium bromide,CCOC(=O)C[N+](C)(C)C.[Br-],,,,,,
8932,108933,"Phosphorous acid, dodecyl bis[4-[1-(4-hydroxyphenyl)-1-methylethyl]phenyl] ester",CCCCCCCCCCCCOP(OC1=CC=C(C=C1)C(C)(C)C2=CC=C(C=C2)O)OC3=CC=C(C=C3)C(C)(C)C4=CC=C(C=C4)O,,,,,,
8933,108934,Zinc orotate,C1=C(NC(=O)NC1=O)C(=O)[O-].C1=C(NC(=O)NC1=O)C(=O)[O-].[Zn+2],,,,,,
8934,108935,"Pyridinium, 3-carboxy-1-methyl-, salt with 4-methylbenzenesulfonic acid (1:1)",CC1=CC=C(C=C1)S(=O)(=O)[O-].C[N+]1=CC=CC(=C1)C(=O)O,,,,,,
8935,108936,"N,N-Diethyl-4-((4-trifluoromethylbenzothiazol-2-yl)azo)aniline",CCN(CC)C1=CC=C(C=C1)N=NC2=NC3=C(C=CC=C3S2)C(F)(F)F,,,,,,
8936,108937,"2-Benzothiazolamine, 4-(trifluoromethyl)-",C1=CC(=C2C(=C1)SC(=N2)N)C(F)(F)F,,,,,,
8937,108938,"3,3'-Dimethylbenzidine dihydrochloride",CC1=C(C=CC(=C1)C2=CC(=C(C=C2)N)C)N.Cl.Cl,,,,,,
8938,108939,"(17beta)-Androsta-2,4-dieno(2,3-d)isoxazol-17-ol",C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC5=C(C[C@]34C)C=NO5,,,,,,
8939,108940,Cyclohexylpropyl acetate,CC(=O)OCCCC1CCCCC1,,,,,,
8940,108941,"5-Chloro-1-methyl-1H-indole-2,3-dione",CN1C2=C(C=C(C=C2)Cl)C(=O)C1=O,,,,,,
8941,108942,"5-((2,3-Dihydro-1,3-dioxo-1H-benz(de)isoquinolin-6-yl)azo)-1,2-dihydro-6-hydroxy-4-methyl-2-oxonicotinonitrile",CC1=C(C(=O)NC(=C1C#N)O)N=NC2=C3C=CC=C4C3=C(C=C2)C(=O)NC4=O,,,,,,
8942,108943,"Methane; 3,3,5,5-tetramethylhexanoic acid",C.CC(C)(C)CC(C)(C)CC(=O)O,,,,,,
8943,108944,Hexahydro-2-oxo-N-vinyl-1H-azepine-1-carboxamide,C=CNC(=O)N1CCCCCC1=O,,,,,,
8944,108945,"4,4'-((2-Chlorophenyl)methoxymethylene)bis(N-ethyl-o-toluidine)",CCNC1=C(C=C(C=C1)C(C2=CC(=C(C=C2)NCC)C)(C3=CC=CC=C3Cl)OC)C,,,,,,
8945,108946,5-Hydroxy-2-nitrobenzyl alcohol,C1=CC(=C(C=C1O)CO)[N+](=O)[O-],,,,,,
8946,108947,2-Methyl-3-nitrobenzyl chloride,CC1=C(C=CC=C1[N+](=O)[O-])CCl,,,,,,
8947,108948,"2-Methylcyclohexa-1,4-diene-1-carbaldehyde",CC1=C(CC=CC1)C=O,,,,,,
8948,108949,"Phosphoric acid, decyl ester",CCCCCCCCCO.OP(=O)(O)O,,,,,,
8949,108950,"2,2'-((2-((2-Hydroxyethyl)amino)ethyl)imino)bisethanol",C(CN(CCO)CCO)NCCO,,,,,,
8950,108951,"2,2'-((2-((2-((2-Hydroxyethyl)amino)ethyl)amino)ethyl)imino)bisethanol",C(CNCCO)NCCN(CCO)CCO,,,,,,
8951,108952,CID 108952,CCCCCCCCCCCCOC(=O)CC[S-].CCCCCCCCCCCCOC(=O)CC[S-].CCCCCCCC[Sn]CCCCCCCC,,,,,,
8952,108953,CID 108953,CCCCCCCC[Sn]CCCCCCCC.COC(=O)C=CC(=O)O.COC(=O)C=CC(=O)O,,,,,,
8953,108954,"Isopropyl 3,3-dimethylbutyrate",CC(C)OC(=O)CC(C)(C)C,,,,,,
8954,108955,2-[2-[Bis(carboxylatomethyl)amino]ethyl-(carboxylatomethyl)amino]acetate;hydron;lutetium(3+),[H+].C(CN(CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].[Lu+3],,,,,,
8955,108956,Dipentaerythritol pentaacrylate,C=CC(=O)OCC(CO)(COCC(COC(=O)C=C)(COC(=O)C=C)COC(=O)C=C)COC(=O)C=C,,,,,,
8956,108957,"4,6-Dichloro-1-nitroanthraquinone",C1=CC2=C(C=C1Cl)C(=O)C3=C(C=CC(=C3C2=O)[N+](=O)[O-])Cl,,,,,,
8957,108958,"Benzoxazolium, 5-phenyl-2-((5-phenyl-3-(3-sulfopropyl)-2(3H)-benzoxazolylidene)methyl)-3-(3-sulfopropyl)-, hydroxide, inner salt",C1=CC=C(C=C1)C2=CC3=C(C=C2)OC(=[N+]3CCCS(=O)(=O)[O-])CC4=[N+](C5=C(O4)C=CC(=C5)C6=CC=CC=C6)CCCS(=O)(=O)[O-],,,,,,
8958,108959,"3-[5-Phenyl-2-[[5-phenyl-3-(3-sulfopropyl)-1,3-benzoxazol-3-ium-2-yl]methyl]-1,3-benzoxazol-3-ium-3-yl]propane-1-sulfonic acid",C1=CC=C(C=C1)C2=CC3=C(C=C2)OC(=[N+]3CCCS(=O)(=O)O)CC4=[N+](C5=C(O4)C=CC(=C5)C6=CC=CC=C6)CCCS(=O)(=O)O,,,,,,
8959,108960,"1,4-Cyclohexanedicarboxamide, N,N'-dichloro-",C1CC(CCC1C(=O)NCl)C(=O)NCl,,,,,,
8960,108961,"1,3-Dimethoxy-5-(2-methyloctan-2-yl)benzene",CCCCCCC(C)(C)C1=CC(=CC(=C1)OC)OC,,,,,,
8961,108962,"3-Hydroxy-2,2-bis(hydroxymethyl)propyl octanoate",CCCCCCCC(=O)OCC(CO)(CO)CO,,,,,,
8962,108963,"1,2,3,6-Tetrahydro-1-methyl-4-(2-methyl-1,3-dioxolan-2-yl)pyridine",CC1(OCCO1)C2=CCN(CC2)C,,,,,,
8963,108964,Ethyl 5-acetyl-2-benzyloxybenzoate,CCOC(=O)C1=C(C=CC(=C1)C(=O)C)OCC2=CC=CC=C2,,,,,,
8964,108965,Ethyl homovanillate,CCOC(=O)CC1=CC(=C(C=C1)O)OC,,,,,,
8965,108966,"Benzoic acid, 4-[[2-(acetylamino)-4-(diethylamino)phenyl]azo]-",CCN(CC)C1=CC(=C(C=C1)N=NC2=CC=C(C=C2)C(=O)O)NC(=O)C,,,,,,
8966,108967,"Naphtho[2,1-B]thiophene-1-OL",C1=CC=C2C(=C1)C=CC3=C2C(=CS3)O,,,,,,
8967,108968,"Triethylamine, 2-(N,N-di-(2'-pyridyl))amino-, dihydrochloride",CCN(CC)CCN(C1=CC=CC=N1)C2=CC=CC=N2.Cl.Cl,,,,,,
8968,108969,"N,N-diethyl-N',N'-dipyridin-2-ylethane-1,2-diamine",CCN(CC)CCN(C1=CC=CC=N1)C2=CC=CC=N2,,,,,,
8969,108970,4-(2-Hydrazinoethoxy)phenol hydrogen sulfate,C1=CC(=CC=C1O)OCCNN.OS(=O)(=O)O,,,,,,
8970,108971,4-(2-Hydrazinylethoxy)phenol,C1=CC(=CC=C1O)OCCNN,,,,,,
8971,108972,"Triisooctyl 3,3',3''-((octylstannylidyne)tris(thio))trispropionate",CCCCCCCC[Sn](SCCC(=O)OCCCCCC(C)C)(SCCC(=O)OCCCCCC(C)C)SCCC(=O)OCCCCCC(C)C,,,,,,
8972,108973,"1-Propanaminium, N,N,N-trimethyl-3-[[(9Z)-1-oxo-9-octadecenyl]amino]-, methyl sulfate",CCCCCCCCC=CCCCCCCCC(=O)NCCC[N+](C)(C)C.COS(=O)(=O)[O-],,,,,,
8973,108974,Trimethyl-[3-(octadec-9-enoylamino)propyl]azanium,CCCCCCCCC=CCCCCCCCC(=O)NCCC[N+](C)(C)C,,,,,,
8974,108975,2-(Pentabromophenoxy)ethanol,C(COC1=C(C(=C(C(=C1Br)Br)Br)Br)Br)O,,,,,,
8975,108976,Threo-4-hydroxy-L-lysine,C(CN)[C@H](C[C@@H](C(=O)O)N)O,,,,,,
8976,108977,"(R-(R*,R*))-2-(2-((Dichloroacetyl)amino)-3-hydroxy-3-(4-nitrophenyl)propoxy)-2-oxoethyl hexadecanoate",CCCCCCCCCCCCCCCC(=O)OCC(=O)OC[C@H]([C@@H](C1=CC=C(C=C1)[N+](=O)[O-])O)NC(=O)C(Cl)Cl,,,,,,
8977,108978,"2,3,5-Trichloro-4-(propylthio)pyridine",CCCSC1=C(C(=NC=C1Cl)Cl)Cl,,,,,,
8978,108979,CID 108979,CCN(CC)CC1=C(C2=C(C(=C(OC2=CC1=O)C3=CC(=C(C=C3)O)O)OC4[C@@H]([C@H]([C@@H]([C@H](O4)CO[C@H]5[C@@H]([C@@H]([C@H]([C@@H](O5)O)O)O)O)O)O)O)O)O,,,,,,
8979,108980,Diphenyl tridecyl phosphite,CCCCCCCCCCCCCOP(OC1=CC=CC=C1)OC2=CC=CC=C2,,,,,,
8980,108981,"N-(4,6-Bis(allyloxy)-1,3,5-triazin-2-yl)-N'-phenylbenzene-1,4-diamine",C=CCOC1=NC(=NC(=N1)NC2=CC=C(C=C2)NC3=CC=CC=C3)OCC=C,,,,,,
8981,108982,Bis(2-mercaptoethyl) succinate,C(CC(=O)OCCS)C(=O)OCCS,,,,,,
8982,108983,Bis(2-mercaptoethyl) glutarate,C(CC(=O)OCCS)CC(=O)OCCS,,,,,,
8983,108984,"Decanedioic acid, bis(2-mercaptoethyl) ester",C(CCCCC(=O)OCCS)CCCC(=O)OCCS,,,,,,
8984,108985,1-L-Alanyl-D-proline,C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)N,,,,,,
8985,108986,"1H-Benz[f]indene-1,3(2H)-dione, 5,6,7,8-tetrabromo-2-(3-hydroxy-2-quinolinyl)-",C1=CC=C2C(=C1)C=C(C(=N2)C3C(=O)C4=C(C3=O)C=C5C(=C4)C(=C(C(=C5Br)Br)Br)Br)O,,,,,,
8986,108987,5-Piperidino-2-pentanone hydrochloride,CC(=O)CCCN1CCCCC1.Cl,,,,,,
8987,108988,5-Piperidin-1-ylpentan-2-one,CC(=O)CCCN1CCCCC1,,,,,,
8988,108989,2-(Benzyloxy)acetaldehyde,C1=CC=C(C=C1)COCC=O,,,,,,
8989,108990,CID 108990,CCCCCCCCCCCCCCOC(=O)C=CC(=O)O.CCCCCCCCCCCCCCOC(=O)C=CC(=O)O.CCCC[Sn]CCCC,,,,,,
8990,108991,4-Oxo-4-tetradecoxybut-2-enoic acid,CCCCCCCCCCCCCCOC(=O)C=CC(=O)O,,,,,,
8991,108992,CID 108992,CCCCCCCCCCCCCOC(=O)C=CC(=O)O.CCCCCCCCCCCCCOC(=O)C=CC(=O)O.CCCC[Sn]CCCC,,,,,,
8992,108993,1-Tridecyl 2-butenedioate,CCCCCCCCCCCCCOC(=O)C=CC(=O)O,,,,,,
8993,108994,"4-Bromo-3,5-dihydroxy-N,N-bis(2-hydroxyethyl)benzamide",C1=C(C=C(C(=C1O)Br)O)C(=O)N(CCO)CCO,,,,,,
8994,108995,2-Ethoxyethyl chloroacetate,CCOCCOC(=O)CCl,,,,,,
8995,108996,"Tetrasodium N,N'-(3,3'-dimethoxy(1,1'-biphenyl)-4,4'-diyl)bis(N-(carboxylatomethyl)aminoacetate)",COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N(CC(=O)[O-])CC(=O)[O-])OC)N(CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
8996,108997,"3,3'-Dimethoxybenzidine-N,N,N',N'-tetraacetic acid",COC1=C(C=CC(=C1)C2=CC(=C(C=C2)N(CC(=O)O)CC(=O)O)OC)N(CC(=O)O)CC(=O)O,,,,,,
8997,108998,1-(Hydroxymethyl)-3-octadecylurea,CCCCCCCCCCCCCCCCCCNC(=O)NCO,,,,,,
8998,108999,2-(Perfluorotetradecyl)ethanol,C(CO)C(C(C(C(C(C(C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
8999,109000,2-Chloro-4-fluorobenzonitrile,C1=CC(=C(C=C1F)Cl)C#N,,,,,,
9000,109001,"3-(diethylamino)-N,N-dimethylprop-2-enamide",CCN(CC)C=CC(=O)N(C)C,,,,,,
9001,109002,6-(1H-Imidazol-1-yl)-6-oxohexanoic acid,C1=CN(C=N1)C(=O)CCCCC(=O)O,,,,,,
9002,109003,"Phosphorodichloridic acid, (1-methylethyl)phenyl ester",CC(C)C1=CC=CC=C1OP(=O)(Cl)Cl,,,,,,
9003,109004,"2-[(2-Hydroxyethyl)(methyl)amino]-1,1-diphenylethanol",CN(CCO)CC(C1=CC=CC=C1)(C2=CC=CC=C2)O,,,,,,
9004,109005,1-(Cyclododec-1-en-1-yl)ethan-1-one,CC(=O)C1=CCCCCCCCCCC1,,,,,,
9005,109006,"Carbamic acid, (3-isocyanatomethylphenyl)-, oxydi-2,1-ethanediyl ester",C1=CC(=CC(=C1)NC(=O)OCCOCCOC(=O)NC2=CC=CC(=C2)CN=C=O)CN=C=O,,,,,,
9006,109007,1-(Cyclopropylmethyl)pyrrolidin-2-one,C1CC(=O)N(C1)CC2CC2,,,,,,
9007,109008,"2,4-Dichloro-6-methyl-3-(1-methylethyl)phenol",CC1=CC(=C(C(=C1O)Cl)C(C)C)Cl,,,,,,
9008,109009,Ethyl cyanomethylcarbamate,CCOC(=O)N(C)C#N,,,,,,
9009,109010,"(1s,4r,6s)-1,3,3-Trimethyl-2-oxabicyclo[2.2.2]octan-6-ol",C[C@]12CC[C@H](C[C@@H]1O)C(O2)(C)C,,,,,,
9010,109011,Thorium selenide,[Se]=[Th]=[Se],,,,,,
9011,109012,2-Mercapto-N-(4-(phenylamino)phenyl)acetamide,C1=CC=C(C=C1)NC2=CC=C(C=C2)NC(=O)CS,,,,,,
9012,109013,"2,2'-Dithiobis(4-pentylphenol)",CCCCCC1=CC(=C(C=C1)O)SSC2=C(C=CC(=C2)CCCCC)O,,,,,,
9013,109014,2-Amino-4-phenylpyridine,C1=CC=C(C=C1)C2=CC(=NC=C2)N,,,,,,
9014,109015,2-(2-Pyridylthio)benzothiazole,C1=CC=C2C(=C1)N=C(S2)SC3=CC=CC=N3,,,,,,
9015,109016,"1,2,3,4-Tetrahydrophthalazine hydrochloride",C1C2=CC=CC=C2CNN1.Cl,,,,,,
9016,109017,1H-Benzimidazole-2-acetamide,C1=CC=C2C(=C1)NC(=N2)CC(=O)N,,,,,,
9017,109018,"2-(Ethyl(4-((5-nitro-2,1-benzisothiazol-3-yl)azo)phenyl)amino)ethyl butylcarbamate",CCCCNC(=O)OCCN(CC)C1=CC=C(C=C1)N=NC2=C3C=C(C=CC3=NS2)[N+](=O)[O-],,,,,,
9018,109019,"3-(Ethyl(4-((5-nitro-2,1-benzisothiazol-3-yl)azo)phenyl)amino)-N-(2-hydroxyethyl)-N-methylpropionamide",CCN(CCC(=O)N(C)CCO)C1=CC=C(C=C1)N=NC2=C3C=C(C=CC3=NS2)[N+](=O)[O-],,,,,,
9019,109020,"Benzenamine, 4,4',4''-methylidynetris[N,N-dipropyl-",CCCN(CCC)C1=CC=C(C=C1)C(C2=CC=C(C=C2)N(CCC)CCC)C3=CC=C(C=C3)N(CCC)CCC,,,,,,
9020,109021,"1,3-Propanediol, 2-((4,6-bis(1-aziridinyl)-s-triazin-2-yl)amino)-",C1CN1C2=NC(=NC(=N2)NC(CO)CO)N3CC3,,,,,,
9021,109022,"2-{[4,6-Bis(aziridin-1-yl)-1,3,5-triazin-2-yl]amino}-2-methylpropane-1,3-diol",CC(CO)(CO)NC1=NC(=NC(=N1)N2CC2)N3CC3,,,,,,
9022,109023,Tridecan-7-yl acetate,CCCCCCC(CCCCCC)OC(=O)C,,,,,,
9023,109024,Isonicotinaldehyde O-isopropyloxime,CC(C)ON=CC1=CC=NC=C1,,,,,,
9024,109025,"2,4,8,10-Tetraoxa-3,9-diphosphaspiro(5.5)undecane, 3,9-bis(2-chloroethoxy)-",C1C2(COP(O1)OCCCl)COP(OC2)OCCCl,,,,,,
9025,109026,3-Chloro-4-(diethylamino)benzenediazonium tetrachlorozincate (2:1),CCN(CC)C1=C(C=C(C=C1)[N+]#N)Cl.CCN(CC)C1=C(C=C(C=C1)[N+]#N)Cl.[Cl-].[Cl-].[Cl-].[Cl-].[Zn+2],,,,,,
9026,109027,"Benzenediazonium, 4-(ethylamino)-3-methyl-, (T-4)-tetrachlorozincate(2-) (2:1)",CCNC1=C(C=C(C=C1)[N+]#N)C.CCNC1=C(C=C(C=C1)[N+]#N)C.[Cl-].[Cl-].[Cl-].[Cl-].[Zn+2],,,,,,
9027,109028,"Benzamide, 4-nitro-N-[3-(triethoxysilyl)propyl]-",CCO[Si](CCCNC(=O)C1=CC=C(C=C1)[N+](=O)[O-])(OCC)OCC,,,,,,
9028,109029,"4-(3-Methyl-5-oxo-4,5-dihydro-1H-pyrazol-1-yl)benzoic acid",CC1=NN(C(=O)C1)C2=CC=C(C=C2)C(=O)O,,,,,,
9029,109030,Estrobin,CCOC1=CC=C(C=C1)C(=C(C2=CC=CC=C2)Br)C3=CC=C(C=C3)OCC,,,,,,
9030,109031,Triphenylbromononylphosphorane,CCCCCCCCCP(C1=CC=CC=C1)(C2=CC=CC=C2)(C3=CC=CC=C3)Br,,,,,,
9031,109032,"1,1'-(4-Methyl-1,3-phenylene)bis(3-methylurea)",CC1=C(C=C(C=C1)NC(=O)NC)NC(=O)NC,,,,,,
9032,109033,Zirconium arsenide (ZrAs),[As]#[Zr],,,,,,
9033,109034,"Benzenediazonium, 4-(ethyl(phenylmethyl)amino)-, (OC-6-11)-hexachlorostannate(2-) (2:1)",CCN(CC1=CC=CC=C1)C2=CC=C(C=C2)[N+]#N.CCN(CC1=CC=CC=C1)C2=CC=C(C=C2)[N+]#N.[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Sn+4],,,,,,
9034,109035,2-Hexyloctanoic acid,CCCCCCC(CCCCCC)C(=O)O,,,,,,
9035,109036,N-Butyl-m-toluidine,CCCCNC1=CC=CC(=C1)C,,,,,,
9036,109037,1-(2-(Dicyclohexylamino)ethyl)-1-methyl-piperidinium chloride,C[N+]1(CCCCC1)CCN(C2CCCCC2)C3CCCCC3.[Cl-],,,,,,
9037,109038,N-cyclohexyl-N-[2-(1-methylpiperidin-1-ium-1-yl)ethyl]cyclohexanamine,C[N+]1(CCCCC1)CCN(C2CCCCC2)C3CCCCC3,,,,,,
9038,109039,"(2,6-Dichlorophenyl) (4-hydroxyphenyl) ketone",C1=CC(=C(C(=C1)Cl)C(=O)C2=CC=C(C=C2)O)Cl,,,,,,
9039,109040,"beta-Alanine, N-[3-(acetylamino)phenyl]-N-(3-methoxy-3-oxopropyl)-, methyl ester",CC(=O)NC1=CC(=CC=C1)N(CCC(=O)OC)CCC(=O)OC,,,,,,
9040,109041,"Benzoic acid, 4-[[2-(acetylamino)-4-[bis(3-methoxy-3-oxopropyl)amino]phenyl]azo]-, methyl ester",CC(=O)NC1=C(C=CC(=C1)N(CCC(=O)OC)CCC(=O)OC)N=NC2=CC=C(C=C2)C(=O)OC,,,,,,
9041,109042,"Isobutyl 2,4-hexadienoate",CC=CC=CC(=O)OCC(C)C,,,,,,
9042,109043,"Ethanol, 2,2'-[[3-methyl-4-[(3-phenyl-1,2,4-thiadiazol-5-yl)azo]phenyl]imino]bis-",CC1=C(C=CC(=C1)N(CCO)CCO)N=NC2=NC(=NS2)C3=CC=CC=C3,,,,,,
9043,109044,"Ethanol, 2-[butyl[4-[(3-phenyl-1,2,4-thiadiazol-5-yl)azo]phenyl]amino]-",CCCCN(CCO)C1=CC=C(C=C1)N=NC2=NC(=NS2)C3=CC=CC=C3,,,,,,
9044,109045,"2-Naphthalenecarboxamide, N-(2,5-dimethoxyphenyl)-3-hydroxy-4-[(4-methoxyphenyl)azo]-",COC1=CC=C(C=C1)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)NC4=C(C=CC(=C4)OC)OC)O,,,,,,
9045,109046,"2-Naphthalenecarboxamide, N-(2,5-dimethoxyphenyl)-4-[(2-ethoxyphenyl)azo]-3-hydroxy-",CCOC1=CC=CC=C1N=NC2=C(C(=CC3=CC=CC=C32)C(=O)NC4=C(C=CC(=C4)OC)OC)O,,,,,,
9046,109047,"2-Naphthalenecarboxamide, N-(2,5-dimethoxyphenyl)-3-hydroxy-4-[(2-methoxyphenyl)azo]-",COC1=CC(=C(C=C1)OC)NC(=O)C2=CC3=CC=CC=C3C(=C2O)N=NC4=CC=CC=C4OC,,,,,,
9047,109048,"2-Naphthalenecarboxamide, N-(2,5-dimethoxyphenyl)-4-[(4-ethoxyphenyl)azo]-3-hydroxy-",CCOC1=CC=C(C=C1)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)NC4=C(C=CC(=C4)OC)OC)O,,,,,,
9048,109049,"2-Naphthalenecarboxamide, 4-[(4-ethylphenyl)azo]-3-hydroxy-N-(4-methoxyphenyl)-",CCC1=CC=C(C=C1)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)NC4=CC=C(C=C4)OC)O,,,,,,
9049,109050,"2-Naphthalenecarboxamide, N-(2,5-dimethoxyphenyl)-4-[(2-ethylphenyl)azo]-3-hydroxy-",CCC1=CC=CC=C1N=NC2=C(C(=CC3=CC=CC=C32)C(=O)NC4=C(C=CC(=C4)OC)OC)O,,,,,,
9050,109051,"Benzyl 3,3-dimethylbutyrate",CC(C)(C)CC(=O)OCC1=CC=CC=C1,,,,,,
9051,109052,"Phosphorodichloridic acid, 3-bromo-2-(bromomethyl)-2-(chloromethyl)propyl ester",C(C(CCl)(CBr)CBr)OP(=O)(Cl)Cl,,,,,,
9052,109053,"2,4,8,10-Tetraoxa-3,9-diphosphaspiro[5.5]undecane, 3,9-bis[3-bromo-2,2-bis(bromomethyl)propoxy]-, 3,9-dioxide",C1C2(COP(=O)(O1)OCC(CBr)(CBr)CBr)COP(=O)(OC2)OCC(CBr)(CBr)CBr,,,,,,
9053,109054,CID 109054,CC1=CC(=C(C=C1)NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)[O-])C.[Na+],,,,,,
9054,109055,"1-Amino-4-(2,4-dimethylanilino)-9,10-dioxoanthracene-2-sulfonic acid",CC1=CC(=C(C=C1)NC2=CC(=C(C3=C2C(=O)C4=CC=CC=C4C3=O)N)S(=O)(=O)O)C,,,,,,
9055,109056,"3-Chloro-n,n-bis(3-chloropropyl)propan-1-amine",C(CN(CCCCl)CCCCl)CCl,,,,,,
9056,109057,"Phenol, 3,3'-[1,2-ethanediylbis(oxy)]bis-",C1=CC(=CC(=C1)OCCOC2=CC=CC(=C2)O)O,,,,,,
9057,109058,2-tert-Butyl-6-(3-tert-butyl-2-hydroxy-5-methylbenzyl)-4-methylphenyl acrylate,CC1=CC(=C(C(=C1)C(C)(C)C)O)CC2=C(C(=CC(=C2)C)C(C)(C)C)OC(=O)C=C,,,,,,
9058,109059,2-(2-Hydroxy-3-tert-butyl-5-methylbenzyl)-4-methyl-6-tert-butylphenyl methacrylate,CC1=CC(=C(C(=C1)C(C)(C)C)O)CC2=C(C(=CC(=C2)C)C(C)(C)C)OC(=O)C(=C)C,,,,,,
9059,109060,"4-Piperidinecarboxylic acid, 2,2,6,6-tetramethyl-, ethyl ester",CCOC(=O)C1CC(NC(C1)(C)C)(C)C,,,,,,
9060,109061,trans-4-(4-Propylcyclohexyl)benzonitrile,CCCC1CCC(CC1)C2=CC=C(C=C2)C#N,,,,,,
9061,109062,4-(trans-4-Butylcyclohexyl)benzonitrile,CCCCC1CCC(CC1)C2=CC=C(C=C2)C#N,,,,,,
9062,109063,trans-4-(4-Pentylcyclohexyl)benzonitrile,CCCCCC1CCC(CC1)C2=CC=C(C=C2)C#N,,,,,,
9063,109064,trans-4-(4-Heptylcyclohexyl)benzonitrile,CCCCCCCC1CCC(CC1)C2=CC=C(C=C2)C#N,,,,,,
9064,109065,"N-Allyl-2,2-dichloro-N-(3-(trifluoromethyl)phenyl)acetamide",C=CCN(C1=CC=CC(=C1)C(F)(F)F)C(=O)C(Cl)Cl,,,,,,
9065,109066,"1H-Imidazo(4,5-b)quinoxalinium, 1,2,3-trimethyl-, 4-methylbenzenesulfonate (1:1)",CC1=CC=C(C=C1)S(=O)(=O)[O-].CC1=[N+](C2=NC3=CC=CC=C3N=C2N1C)C,,,,,,
9066,109067,"1,2,3-Trimethyl-1H-imidazo[4,5-b]quinoxalin-3-ium",CC1=[N+](C2=NC3=CC=CC=C3N=C2N1C)C,,,,,,
9067,109068,CID 109068,C1=CC=C2C(=C1)C=CC(=C2N)S(=O)(=O)[O-].[Na+],,,,,,
9068,109069,"2-[(4R,5S,6S,7R,9R,15R,16R)-6-[(2R,3R,4S,5S,6R)-4-(dimethylamino)-3,5-dihydroxy-6-methyloxan-2-yl]oxy-16-ethyl-4-hydroxy-15-(hydroxymethyl)-5,9,13-trimethyl-2,10-dioxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde",CC[C@@H]1[C@H](C=C(C=CC(=O)[C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(=O)O1)O)C)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)C)O)N(C)C)O)CC=O)C)C)CO,,,,,,
9069,109070,"6,7,9,10,12,13,15,16,23,24,26,27,29,30-Tetradecahydrodibenzo[b,N][1,4,7,10,13,16,19,22,25]nonaoxacycloheptacosine",C1COCCOC2=CC=CC=C2OCCOCCOCCOC3=CC=CC=C3OCCOCCO1,,,,,,
9070,109071,CID 109071,CC(C)C1=CC=C(C=C1)[O-].[Na+],,,,,,
9071,109072,"Benzenediazonium, 2-methoxy-5-methyl-4-[(3-sulfophenyl)azo]-, inner salt",CC1=CC(=C(C=C1N=NC2=CC(=CC=C2)S(=O)(=O)[O-])OC)[N+]#N,,,,,,
9072,109073,"Benzenediazonium, 2-methoxy-5-methyl-4-((3-sulfophenyl)azo)-",CC1=CC(=C(C=C1N=NC2=CC(=CC=C2)S(=O)(=O)O)OC)[N+]#N,,,,,,
9073,109074,p-Anisyl acetoacetate,CC(=O)CC(=O)OCC1=CC=C(C=C1)OC,,,,,,
9074,109075,Disperse Red 278,CC(=O)NC1=C(C=CC(=C1)N(CCC(=O)OC)CCC(=O)OC)N=NC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
9075,109076,"1,2-Cyclobutanedione, 3,4-bis[3,5-bis(1,1-dimethylethyl)-4-oxo-2,5-cyclohexadien-1-ylidene]-",CC(C)(C)C1=CC(=C2C(=C3C=C(C(=O)C(=C3)C(C)(C)C)C(C)(C)C)C(=O)C2=O)C=C(C1=O)C(C)(C)C,,,,,,
9076,109077,"1,3-Cyclobutanedione, 2,4-bis[3,5-bis(1,1-dimethylethyl)-4-oxo-2,5-cyclohexadien-1-ylidene]-",CC(C)(C)C1=CC(=C2C(=O)C(=C3C=C(C(=O)C(=C3)C(C)(C)C)C(C)(C)C)C2=O)C=C(C1=O)C(C)(C)C,,,,,,
9077,109078,"1-Propanamine, N-(2-ethylbutylidene)-2-methyl-",CCC(CC)C=NCC(C)C,,,,,,
9078,109079,Bis(4-aminobenzoato-O)(isooctadecanoato-O)(propan-2-olato)titanium,CC(C)CCCCCCCCCCCCCCC(=O)O.CC(C)O.C1=CC(=CC=C1C(=O)O)N.C1=CC(=CC=C1C(=O)O)N.[Ti],,,,,,
9079,109080,Diisostearoyl ethylene titanate,CC(C)CCCCCCCCCCCCCCC(=O)O.CC(C)CCCCCCCCCCCCCCC(=O)O.C(CO)O.[Ti],,,,,,
9080,109081,1-(2-Chloro-2-ethylbutanoyl)urea,CCC(CC)(C(=O)NC(=O)N)Cl,,,,,,
9081,109082,"2-Pyridinecarboxylic acid, 3-((1-ethyl-2-methyl-1H-indol-3-yl)carbonyl)-",CCN1C(=C(C2=CC=CC=C21)C(=O)C3=C(N=CC=C3)C(=O)O)C,,,,,,
9082,109083,"Acetic acid, bromo-, 2,2,2-trifluoroethyl ester",C(C(=O)OCC(F)(F)F)Br,,,,,,
9083,109084,"Titanium, tris(2-methyl-2-propenoato-kappaO)(2-propanolato)-, (T-4)-",CC(C)O.CC(=C)C(=O)O.CC(=C)C(=O)O.CC(=C)C(=O)O.[Ti],,,,,,
9084,109085,Isopropyl triacryloyl titanate,CC(C)O.C=CC(=O)O.C=CC(=O)O.C=CC(=O)O.[Ti],,,,,,
9085,109086,"1-Pentene, 5,5,5-trichloro-2-methyl-",CC(=C)CCC(Cl)(Cl)Cl,,,,,,
9086,109087,"2-Pentene, 5,5,5-trichloro-2-methyl-",CC(=CCC(Cl)(Cl)Cl)C,,,,,,
9087,109088,C.I Basic Red 9 mononitrate,C1=CC(=N)C=CC1=C(C2=CC=C(C=C2)N)C3=CC=C(C=C3)N.[N+](=O)(O)[O-],,,,,,
9088,109089,Butyl 3-(trichlorostannyl)propionate,CCCCOC(=O)CC[Sn](Cl)(Cl)Cl,,,,,,
9089,109090,"Phosphonic acid, [3-[[5-(aminocarbonyl)-1-ethyl-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridinyl]azo]phenyl]-",CCN1C(=C(C(=C(C1=O)N=NC2=CC(=CC=C2)P(=O)(O)O)C)C(=O)N)O,,,,,,
9090,109091,CID 109091,COC1=CC=CC=C1NCS(=O)(=O)[O-].[Na+],,,,,,
9091,109092,"Propanenitrile, 3-[[2-chloro-4-[(6-nitro-2-benzothiazolyl)azo]phenyl]amino]-",C1=CC(=C(C=C1N=NC2=NC3=C(S2)C=C(C=C3)[N+](=O)[O-])Cl)NCCC#N,,,,,,
9092,109093,2-(2-Methylpropyl)-1H-imidazole,CC(C)CC1=NC=CN1,,,,,,
9093,109094,Ethyl 2-oxopyrrolidine-1-acetate,CCOC(=O)CN1CCCC1=O,,,,,,
9094,109095,Amyl nonanoate,CCCCCCCCC(=O)OCCCCC,,,,,,
9095,109096,m-(p-Toluidino)phenol,CC1=CC=C(C=C1)NC2=CC(=CC=C2)O,,,,,,
9096,109097,(Isooctadecanoato-O)bis(methacrylato-O)(propan-2-olato)titanium,CC(C)CCCCCCCCCCCCCCC(=O)O.CC(C)O.CC(=C)C(=O)O.CC(=C)C(=O)O.[Ti],,,,,,
9097,109098,"Carbamic acid, butyl-, 2-[(2-cyanoethyl)[4-[(4-nitrophenyl)azo]phenyl]amino]ethyl ester",CCCCNC(=O)OCCN(CCC#N)C1=CC=C(C=C1)N=NC2=CC=C(C=C2)[N+](=O)[O-],,,,,,
9098,109099,Tridec-4-en-7-yn-1-ol,CCCCCC#CCC=CCCCO,,,,,,
9099,109100,[4-[2-(Diaminomethylidene)hydrazinyl]phenyl]iminourea,C1=CC(=CC=C1NN=C(N)N)N=NC(=O)N,,,,,,
9100,109101,Methyl 2-(4-isobutylphenyl)propanoate,CC(C)CC1=CC=C(C=C1)C(C)C(=O)OC,,,,,,
9101,109102,4-(((Heptadecafluorooctyl)sulphonyl)methylamino)butyl methacrylate,CC(=C)C(=O)OCCCCN(C)S(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
9102,109103,(4-Chloro-o-phenylenediammine)dichloroplatinum (II),C1=CC(=C(C=C1Cl)N)N.[Cl-].[Cl-].[Pt+2],,,,,,
9103,109104,Tetraisopropyl thiopyrophosphate,CC(C)OP(=S)(OC(C)C)OP(=S)(OC(C)C)OC(C)C,,,,,,
9104,109105,3-Hydrazinoquinoline dihydrochloride,C1=CC=C2C(=C1)C=C(C=N2)NN.Cl.Cl,,,,,,
9105,109106,3-Hydrazinylquinoline,C1=CC=C2C(=C1)C=C(C=N2)NN,,,,,,
9106,109107,1-Decanesulfonyl chloride,CCCCCCCCCCS(=O)(=O)Cl,,,,,,
9107,109108,N-Ethylheptadecafluoro-N-(3-(trimethoxysilyl)propyl)octanesulphonamide,CCN(CCC[Si](OC)(OC)OC)S(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
9108,109109,CID 109109,C1=CC=C2C(=C1)C=CC(=C2N=NC3=CC(=CC4=C3C(=O)C(=NN=C5C=C(C=C(C5=O)N(O)O)S(=O)(=O)O)C(=C4)S(=O)(=O)O)S(=O)(=O)O)O,,,,,,
9109,109110,CID 109110,C1C(=O)N(C(=S)S1)CCS(=O)(=O)[O-].[K+],,,,,,
9110,109111,"2-(4-Oxo-2-thioxo-1,3-thiazolidin-3-yl)ethanesulfonic acid",C1C(=O)N(C(=S)S1)CCS(=O)(=O)O,,,,,,
9111,109112,"Ethanol, 2,2'-[(1H-benzotriazol-1-ylmethyl)imino]bis-",C1=CC=C2C(=C1)N=NN2CN(CCO)CCO,,,,,,
9112,109113,"2-Butenoic acid, 2-methyl-, 2-methyl-2-propenyl ester, (2E)-",CC=C(C)C(=O)OCC(=C)C,,,,,,
9113,109114,2-Methylpropyl 2-methylbut-2-enoate,CC=C(C)C(=O)OCC(C)C,,,,,,
9114,109115,"1H-Imidazole-4,5-dimethanol, 2-phenyl-",C1=CC=C(C=C1)C2=NC(=C(N2)CO)CO,,,,,,
9115,109116,Cyclooctyl methyl carbonate,COC(=O)OC1CCCCCCC1,,,,,,
9116,109117,CID 109117,C1=CC(=O)C(=N)C=C1N(O)[O-].[Na+],,,,,,
9117,109118,CID 109118,C1=CC(=O)C(=N)C=C1N(O)[O-],,,,,,
9118,109119,CID 109119,C1=CC=C2C(=C1)C3=CC(=C(C=C3N2)O)C(=O)[O-].[Na+],,,,,,
9119,109120,CID 109120,C1=CC2=C(C(=CC(=C2C(=C1)[N+](=O)[O-])S(=O)(=O)[O-])O)[N+]#N,,,,,,
9120,109121,2-Hydroxy-5-nitro-4-sulphonaphthalene-1-diazonium,C1=CC2=C(C(=CC(=C2C(=C1)[N+](=O)[O-])S(=O)(=O)O)O)[N+]#N,,,,,,
9121,109122,"Disodium 1,1-bis(carboxymethyl)-4,5-dihydro-2-undecyl-1H-imidazolium chloride",CCCCCCCCCCCC1=NCC[N+]1(CC(=O)[O-])CC(=O)[O-].[Na+].[Na+].[Cl-],,,,,,
9122,109123,"Sodium;2-[1-(2-hydroxyethyl)-2-undecyl-4,5-dihydroimidazol-1-ium-1-yl]acetate;chloride",CCCCCCCCCCCC1=NCC[N+]1(CCO)CC(=O)[O-].[Na+].[Cl-],,,,,,
9123,109124,"Octadecanamide, N,N'-1,2-ethanediylbis[N-ethyl-",CCCCCCCCCCCCCCCCCC(=O)N(CC)CCN(CC)C(=O)CCCCCCCCCCCCCCCCC,,,,,,
9124,109125,"Octadecanamide, N-[[2-[bis(2-hydroxyethyl)amino]ethoxy]methyl]-",CCCCCCCCCCCCCCCCCC(=O)NCOCCN(CCO)CCO,,,,,,
9125,109126,Hexyl isodecyl phthalate,CCCCCCOC(=O)C1=CC=CC=C1C(=O)OCCCCCCCC(C)C,,,,,,
9126,109127,5-Tert-butylquinoline,CC(C)(C)C1=C2C=CC=NC2=CC=C1,,,,,,
9127,109128,"Naphthalenesulfonic acid, dipentyl-",CC(C)CCC1=C2C(=CC=C(C2=CC=C1)S(=O)(=O)O)CCC(C)C,,,,,,
9128,109129,"3-(4-Benzoylphenyl)-1,1-dimethylurea",CN(C)C(=O)NC1=CC=C(C=C1)C(=O)C2=CC=CC=C2,,,,,,
9129,109130,Bamipine dihydrochloride,CN1CCC(CC1)N(CC2=CC=CC=C2)C3=CC=CC=C3.Cl.Cl,,,"['Drugs that bind to but do not activate histamine receptors, thereby blocking the actions of histamine or histamine agonists. Classical antihistaminics block the histamine H1 receptors only. (See all compounds classified as Histamine Antagonists.)']",,,
9130,109131,"1,3-Dioxepin, 2-hexyl-4,7-dihydro-",CCCCCCC1OCC=CCO1,,,,,,
9131,109132,3-(6-Methylpyridin-2-yl)propan-1-ol,CC1=NC(=CC=C1)CCCO,,,,,,
9132,109133,"1H-Indole-3-carboxamide, N,N-bis(phenylmethyl)-",C1=CC=C(C=C1)CN(CC2=CC=CC=C2)C(=O)C3=CNC4=CC=CC=C43,,,,,,
9133,109134,"3-Ethoxy-N,N-diethyl-4-nitrosoaniline",CCN(CC)C1=CC(=C(C=C1)N=O)OCC,,,,,,
9134,109135,"9,10-Anthracenedione, 1,8-bis(2,4-dinitrophenoxy)-4,5-dinitro-",C1=CC(=C(C=C1[N+](=O)[O-])[N+](=O)[O-])OC2=C3C(=C(C=C2)[N+](=O)[O-])C(=O)C4=C(C=CC(=C4C3=O)OC5=C(C=C(C=C5)[N+](=O)[O-])[N+](=O)[O-])[N+](=O)[O-],,,,,,
9135,109136,"Methyl octahydro-4,7-methano-1H-indenecarboxylate",COC(=O)C1CCC2C1C3CCC2C3,,,,,,
9136,109137,"Benzenesulfonic acid, 2,5-dichloro-4-(4,5-dihydro-3-methyl-5-oxo-4-(2-phenyldiazenyl)-1H-pyrazol-1-yl)-, compd. with 2-ethyl-N-(2-ethylhexyl)-1-hexanamine (1:1)",CCCCC(CC)CNCC(CC)CCCC.CC1=NN(C(=O)C1N=NC2=CC=CC=C2)C3=CC(=C(C=C3Cl)S(=O)(=O)O)Cl,,,,,,
9137,109138,"Formic acid, compd. with rel-(alphaR)-alpha-((1R)-1-aminoethyl)benzenemethanol (1:1)",C[C@H]([C@@H](C1=CC=CC=C1)O)N.C(=O)O,,,,,,
9138,109139,"2-Propanol, 1,1'-[[[2-(3-chloro-2-hydroxypropoxy)phenyl]methylene]bis(4,1-phenyleneoxy)]bis[3-chloro-",C1=CC=C(C(=C1)C(C2=CC=C(C=C2)OCC(CCl)O)C3=CC=C(C=C3)OCC(CCl)O)OCC(CCl)O,,,,,,
9139,109140,5-Methyl-2-(propan-2-yl)cyclohexyl 5-oxoprolinate,CC1CCC(C(C1)OC(=O)C2CCC(=O)N2)C(C)C,,,,,,
9140,109141,CID 109141,CCCCCCC1C=CC(CC1C(=O)[O-])CCCCCCCC(=O)O.[K+],,,,,,
9141,109142,CID 109142,CCCCCCC1C=CC(CC1C(=O)O)CCCCCCCC(=O)[O-].[Na+],,,,,,
9142,109143,"Butanedioic acid, dodecenyl-, oxydi-2,1-ethanediyl ester",C=CCCCCCCCCCCC(CC(=O)OCCOCCOC(=O)CC(CCCCCCCCCCC=C)C(=O)O)C(=O)O,,,,,,
9143,109144,5(or 6)-Carboxy-4-hexyl-2-cyclohexene-1-octanoic acid compd. with 2-amino-2-methyl-1-propanol,CCCCCCC1C=CC(CC1C(=O)O)CCCCCCCC(=O)O.CC(C)(CO)N,,,,,,
9144,109145,Diammonium N-stearyl sulfosuccinamate,CCCCCCCCCCCCCCCCCCNC(=O)CC(C(=O)O)S(=O)(=O)O.N.N,,,,,,
9145,109146,"2,2-Bis(hydroxymethyl)propane-1,3-diol; 2-ethylhexanoic acid; nonanoic acid; octanoic acid",CCCCCCCCC(=O)O.CCCCCCCC(=O)O.CCCCC(CC)C(=O)O.C(C(CO)(CO)CO)O,,,,,,
9146,109147,2-(1h-Imidazol-1-yl)propan-1-ol,CC(CO)N1C=CN=C1,,,,,,
9147,109148,"Octadecanoic acid, (4-ethyl-2-heptadecyl-4,5-dihydro-4-oxazolyl)methyl ester",CCCCCCCCCCCCCCCCCC1=NC(CO1)(CC)COC(=O)CCCCCCCCCCCCCCCCC,,,,,,
9148,109149,1-Chloro-3-(N-ethyl-m-toluidino)propan-2-ol hydrochloride,CCN(CC(CCl)O)C1=CC=CC(=C1)C.Cl,,,,,,
9149,109150,"2-Propanol, 1-chloro-3-(N-ethyl-m-toluidino)-",CCN(CC(CCl)O)C1=CC=CC(=C1)C,,,,,,
9150,109151,"5-Amino-1,3,3-trimethylcyclohexanemethylamine toluene-p-sulphonate",CC1=CC=C(C=C1)S(=O)(=O)O.CC1(CC(CC(C1)(C)CN)N)C,,,,,,
9151,109152,Disodium 4-oxo-3-sulfonato-4-(tridecyloxy)butanoate,CCCCCCCCCCCCCOC(=O)C(CC(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
9152,109153,4-Oxo-3-sulfo-4-tridecoxybutanoic acid,CCCCCCCCCCCCCOC(=O)C(CC(=O)O)S(=O)(=O)O,,,,,,
9153,109154,"Cyclopentanone, 2-(3,7-dimethyl-2,6-octadienyl)-",CC(=CCCC(=CCC1CCCC1=O)C)C,,,,,,
9154,109155,CID 109155,CCCCCC[C@H](CC=CCCCCCCCC(=O)O)O.C1COCCN1,,,,,,
9155,109156,CID 109156,CCCCCCCCC=CCCCCCCCC(=O)NCCN(CCO)CC(CS(=O)(=O)[O-])O.[Na+],,,,,,
9156,109157,2-Hydroxy-3-[(2-hydroxyethyl){2-[(octadec-9-enoyl)amino]ethyl}amino]propane-1-sulfonic acid,CCCCCCCCC=CCCCCCCCC(=O)NCCN(CCO)CC(CS(=O)(=O)O)O,,,,,,
9157,109158,CID 109158,CCCCCCCCCC(CCCCCCCC(=O)N(C)C1=CC=CC=C1)OS(=O)(=O)[O-].[Na+],,,,,,
9158,109159,[1-(N-methylanilino)-1-oxooctadecan-9-yl] hydrogen sulfate,CCCCCCCCCC(CCCCCCCC(=O)N(C)C1=CC=CC=C1)OS(=O)(=O)O,,,,,,
9159,109160,"N-(2,3-Dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxo-2-[[2-(trifluoromethyl)phenyl]azo]butyramide",CC(=O)C(C(=O)NC1=CC2=C(C=C1)NC(=O)N2)N=NC3=CC=CC=C3C(F)(F)F,,,,,,
9160,109161,Butyl 2-oxocyclohexanepropionate,CCCCOC(=O)CCC1CCCCC1=O,,,,,,
9161,109162,"L-Glycero-L-ido-heptonic acid, cyclic 5,6-ester with boric acid, disodium salt",B1(OC(C(O1)C(C(C(C(=O)[O-])[O-])O)O)CO)O.[Na+].[Na+],,,,,,
9162,109163,"2,3,4-Trihydroxy-4-[2-hydroxy-5-(hydroxymethyl)-1,3,2-dioxaborolan-4-yl]butanoic acid",B1(OC(C(O1)C(C(C(C(=O)O)O)O)O)CO)O,,,,,,
9163,109164,"Spiro[12H-benzo[a]xanthene-12,1'(3'H)-isobenzofuran]-3'-one, 9-(diethylamino)-4-[(phenylmethyl)amino]-",CCN(CC)C1=CC2=C(C=C1)C3(C4=CC=CC=C4C(=O)O3)C5=C(O2)C=CC6=C5C=CC=C6NCC7=CC=CC=C7,,,,,,
9164,109165,"6'-(diethylamino)-2'-[[3-(trifluoromethyl)phenyl]amino]spiro[isobenzofuran-1(3H),9'-[9H]xanthene]-3-one",CCN(CC)C1=CC2=C(C=C1)C3(C4=CC=CC=C4C(=O)O3)C5=C(O2)C=CC(=C5)NC6=CC=CC(=C6)C(F)(F)F,,,,,,
9165,109166,"Butanedioic acid, 2-(1-dodecen-1-yl)-, 4-tridecyl ester",CCCCCCCCCCCCCOC(=O)CC(C=CCCCCCCCCCC)C(=O)O,,,,,,
9166,109167,"3-Butenal, 2,3-dimethyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-",CC1=CCCC(C1C=C(C)C(C)C=O)(C)C,,,,,,
9167,109168,"1,1'-((3,7-Dimethyl-6-octen-1-ylidene)bis(oxy-2,1-ethanediyl))bis(benzene)",CC(CCC=C(C)C)CC(OCCC1=CC=CC=C1)OCCC2=CC=CC=C2,,,,,,
9168,109169,"4,7-Methano-1H-indene-2-carboxylic acid, octahydro-, ethyl ester",CCOC(=O)C1CC2C3CCC(C3)C2C1,,,,,,
9169,109170,"3-Cyclohexene-1-carboxaldehyde, 3,5-dimethyl-6-propyl-",CCCC1C(C=C(CC1C=O)C)C,,,,,,
9170,109171,"4,7-Methano-1H-indene-5-carboxylic acid, octahydro-, ethyl ester",CCOC(=O)C1CC2CC1C3C2CCC3,,,,,,
9171,109172,"Benzoic acid, 2-[[4-(6,6-dimethyl-2-cyclohexen-1-yl)-2-methyl-3-butenylidene]amino]-, methyl ester",CC(C=CC1C=CCCC1(C)C)C=NC2=CC=CC=C2C(=O)OC,,,,,,
9172,109173,"1-Allyl-2,4,6-trimethylcyclohex-3-ene-1-carbaldehyde",CC1CC(=CC(C1(CC=C)C=O)C)C,,,,,,
9173,109174,"3-Cyclohexene-1-carboxaldehyde, 1-methyl-2-(1-methylethenyl)-",CC(=C)C1C=CCCC1(C)C=O,,,,,,
9174,109175,"2-Butyl-2-ethyl-5,7-dimethyl-3,4-octadienal",CCCCC(CC)(C=C=C(C)CC(C)C)C=O,,,,,,
9175,109176,"1,1'-(Methylimino)bis(3-chloropropan-2-ol)",CN(CC(CCl)O)CC(CCl)O,,,,,,
9176,109177,"3H-Indolium, 2-[2-[4-[(2-hydroxyethyl)methylamino]phenyl]ethenyl]-1,3,3-trimethyl-, chloride",CC1(C2=CC=CC=C2[N+](=C1C=CC3=CC=C(C=C3)N(C)CCO)C)C.[Cl-],,,,,,
9177,109178,"2-[2-[4-[(2-Hydroxyethyl)(methyl)amino]phenyl]ethenyl]-1,3,3-trimethyl-3H-indolium",CC1(C2=CC=CC=C2[N+](=C1C=CC3=CC=C(C=C3)N(C)CCO)C)C,,,,,,
9178,109179,"4-Oxazolemethanol, 4-ethyl-2-(8-heptadecen-1-yl)-4,5-dihydro-",CCCCCCCCC=CCCCCCCCC1=NC(CO1)(CC)CO,,,,,,
9179,109180,1-(1-Methylpentadecyl)-4-phenoxybenzene,CCCCCCCCCCCCCCC(C)C1=CC=C(C=C1)OC2=CC=CC=C2,,,,,,
9180,109181,5-Ethyl-2-methylnonanal,CCCCC(CC)CCC(C)C=O,,,,,,
9181,109182,"4-Hydroxy-3,6,10-trimethylundec-9-en-2-one",CC(CCC=C(C)C)CC(C(C)C(=O)C)O,,,,,,
9182,109183,"1,1-Dimethoxy-2-methylundecane",CCCCCCCCCC(C)C(OC)OC,,,,,,
9183,109184,"8,12-Dimethyltridec-11-en-6-one",CCCCCC(=O)CC(C)CCC=C(C)C,,,,,,
9184,109185,"3-Undecen-2-one, 10-hydroxy-3,6,10-trimethyl-",CC(CCCC(C)(C)O)CC=C(C)C(=O)C,,,,,,
9185,109186,alpha-Isobutylbenzyl acetate,CC(C)CC(C1=CC=CC=C1)OC(=O)C,,,,,,
9186,109187,"Octane, 1,1-dimethoxy-3,7-dimethyl-",CC(C)CCCC(C)CC(OC)OC,,,,,,
9187,109188,"Cyclohexanol, 3-(5,5-dimethyl-6-methylenebicyclo[2.2.1]hept-2-yl)-",CC1(C2CC(C(C2)C1=C)C3CCCC(C3)O)C,,,,,,
9188,109189,"Octadecanamide, 12-hydroxy-N-octadecyl-",CCCCCCCCCCCCCCCCCCNC(=O)CCCCCCCCCCC(CCCCCC)O,,,,,,
9189,109190,Perfluoro-2-nonylpentahydropyran,C1(C(C(OC(C1(F)F)(F)F)(C(C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)F)(F)F)(F)F,,,,,,
9190,109191,1-(6-Methyl-3-(4-methyl-3-pentenyl)-3-cyclohexen-1-yl)propan-1-one,CCC(=O)C1CC(=CCC1C)CCC=C(C)C,,,,,,
9191,109192,1-(6-Methyl-4-(4-methyl-3-pentenyl)-3-cyclohexen-1-yl)propan-1-one,CCC(=O)C1CC=C(CC1C)CCC=C(C)C,,,,,,
9192,109193,"1-(2,3,8,8-Tetramethyl-1,2,3,5,6,7,8,8a-octahydronaphthalen-2-yl)ethanone",CC1C=C2CCCC(C2CC1(C)C(=O)C)(C)C,,,,,,
9193,109194,"Ethanone, 1-(1,2,3,4,6,7,8,8a-octahydro-2,3,8,8-tetramethyl-2-naphthalenyl)-",CC1CC2=CCCC(C2CC1(C)C(=O)C)(C)C,,,,,,
9194,109195,Bis(2-ethylhexyl) hydrogen phosphate;2-methylundecan-2-amine,CCCCCCCCCC(C)(C)N.CCCCC(CC)COP(=O)(O)OCC(CC)CCCC,,,,,,
9195,109196,"2-Undecanamine, 2-methyl-",CCCCCCCCCC(C)(C)N,,,,,,
9196,109197,"Cyclohexanesulfonyl fluoride, decafluoro(1,1,2,2,2-pentafluoroethyl)-",C1(C(C(C(C(C1(F)F)(F)F)(F)S(=O)(=O)F)(F)F)(F)F)(C(C(F)(F)F)(F)F)F,,,,,,
9197,109198,Diethanolamine salt of sulfated oleic acid,CCCCCCCCCC(CCCCCCCC(=O)O)OS(=O)(=O)O.C(CO)NCCO,,,,,,
9198,109199,"Hexanedioyl dichloride, diethyl-",CCC(CC(=O)Cl)C(CC)CC(=O)Cl,,,,,,
9199,109200,Ethyloctanedioyl dichloride,CCC(CCCC(=O)Cl)CCC(=O)Cl,,,,,,
9200,109201,Calcium 12-(acetoxy)octadecanoate,CCCCCCC(CCCCCCCCCCC(=O)[O-])OC(=O)C.CCCCCCC(CCCCCCCCCCC(=O)[O-])OC(=O)C.[Ca+2],,,,,,
9201,109202,12-Acetoxystearic acid,CCCCCCC(CCCCCCCCCCC(=O)O)OC(=O)C,,,,,,
9202,109203,"1,2,4-Benzenetricarboxylic acid, 2-ethylhexyl ester",CCCCC(CC)CO.C1=CC(=C(C=C1C(=O)O)C(=O)O)C(=O)O,,,,,,
9203,109204,"3-(2-Hydroxy-3-octadeca-9,11-dienoyloxypropoxy)carbonylbenzoic acid",CCCCCCC=CC=CCCCCCCCC(=O)OCC(COC(=O)C1=CC=CC(=C1)C(=O)O)O,,,,,,
9204,109205,"Bicyclo[2.2.1]hept-5-ene-2,3-dicarboxylic acid, 1,4,5,6,7,7-hexachloro-, hexyl ester",CCCCCCOC(=O)C1C(C2(C(=C(C1(C2(Cl)Cl)Cl)Cl)Cl)Cl)C(=O)O,,,,,,
9205,109206,"1,2,4-Benzenetricarboxylic acid, ester with 1,2-propanediol phosphate",CC(COC(=O)C1=C(C=CC(=C1)C(=O)O)C(=O)O)OP(=O)(O)O,,,,,,
9206,109207,"Alcohols, C32-36-branched",CCCCC(CCC(CCCC(C)CC(C)CO)CC(C)C)CC(CC)CCCC(CCCC)C(C)CC,,,,,,
9207,109208,"Sulfonic acids, C8-18-alkane, chloro",CC(CC(CCCCS(=O)(=O)O)Cl)Cl,,,,,,
9208,109209,5-Butyl-5-ethyldihydrofuran-2(3H)-one,CCCCC1(CCC(=O)O1)CC,,,,,,
9209,109210,"2-Naphthalenesulfonamide, 6-amino-N-(2-hydroxypropyl)-",CC(CNS(=O)(=O)C1=CC2=C(C=C1)C=C(C=C2)N)O,,,,,,
9210,109211,Popso,C1CN(CCN1CC(CS(=O)(=O)O)O)CC(CS(=O)(=O)O)O,,,,,,
9211,109212,CID 109212,CCCCCCCCC=CCCCCCCCC(=O)OCCC(C)CC(CCC(CC)CC(C)C(CC)CC(C)CCCC(C)CCCCCC)C(C)C,,,,,,
9212,109213,"Octadecanoic acid, C32-36-branched alkyl esters",CCCCCCCCCCCCCCCCCC(=O)OCCC(C)CC(CCC(CC)CC(C)C(CC)CC(C)CCCC(C)CCCCCC)C(C)C,,,,,,
9213,109214,"Octadecanoic acid, branched and linear",CCCCC(CC)CCCCCC(C)CCCC(=O)O,,,,,,
9214,109215,"Citric acid, ammonium iron(3+) manganese(2+) zinc salt",C.C.C.CC(CC(=O)O)(CC(=O)O)C(=O)O.N,,,,,,
9215,109216,Ferric ferrous 2-ethylhexanoate,C.C.CCCCC(CC)C(=O)O,,,,,,
9216,109217,"3,5,5-Trimethylhexanoic acid, iron(2+) iron(3+) salt",C.C.CC(CC(=O)O)CC(C)(C)C,,,,,,
9217,109218,"3-Furansulfonic acid, tetrahydro-2,5-dioxo-",C1C(C(=O)OC1=O)S(=O)(=O)O,,,,,,
9218,109219,"3,5,5-Trimethylhexanoic acid, iron salt",CC(CC(=O)[O-])CC(C)(C)C.CC(CC(=O)[O-])CC(C)(C)C.[Fe+2],,,,,,
9219,109220,"Phenol, compd. with 1,1',1''-nitrilotris[2-propanol] (1:1)",CC(CN(CC(C)O)CC(C)O)O.C1=CC=C(C=C1)O,,,,,,
9220,109221,"[1,1'-Biphenyl]-2-ol, compd. with 1,1',1''-nitrilotris[2-propanol] (1:1)",CC(CN(CC(C)O)CC(C)O)O.C1=CC=C(C=C1)C2=CC=CC=C2O,,,,,,
9221,109222,"Benzene, 2-methoxy-1-(1-methoxyethoxy)-4-(2-propenyl)-",CC(OC)OC1=C(C=C(C=C1)CC=C)OC,,,,,,
9222,109223,"3,5-Dimethylcyclohexylmethyl acetate",CC1CC(CC(C1)COC(=O)C)C,,,,,,
9223,109224,"3,7-Dimethyloctyl formate",CC(C)CCCC(C)CCOC=O,,,,,,
9224,109225,"1,2-Butanediol, 2-butoxy-, 1-acetate",CCCCOC(CC)(COC(=O)C)O,,,,,,
9225,109226,"1,3'-Bipyridinium, 1',2'-dihydro-6'-hydroxy-4'-methyl-2'-oxo-5'-(phenylazo)-, malate",CC1=C(C(=O)NC(=C1N=NC2=CC=CC=C2)O)[N+]3=CC=CC=C3.C(C(C(=O)[O-])O)C(=O)O,,,,,,
9226,109227,"[1',2'-Dihydro-6'-hydroxy-4'-methyl-2'-oxo-5'-(phenylazo)-1,3'-bipyridin]-1-ium",CC1=C(C(=O)NC(=C1N=NC2=CC=CC=C2)O)[N+]3=CC=CC=C3,,,,,,
9227,109228,"5'-((2,5-Dichlorophenyl)azo)-1',2'-dihydro-6'-hydroxy-4'-methyl-2'-oxo-1,3'-bipyridinium malate",CC1=C(C(=O)NC(=C1N=NC2=C(C=CC(=C2)Cl)Cl)O)[N+]3=CC=CC=C3.C(C(C(=O)[O-])O)C(=O)O,,,,,,
9228,109229,"5-[(2,5-dichlorophenyl)diazenyl]-6-hydroxy-4-methyl-3-pyridin-1-ium-1-yl-1H-pyridin-2-one",CC1=C(C(=O)NC(=C1N=NC2=C(C=CC(=C2)Cl)Cl)O)[N+]3=CC=CC=C3,,,,,,
9229,109230,"Phosphoric acid, monooctyl ester, compd. with 1-amino-2-propanol",CCCCCCCCOP(=O)(O)O.CC(CN)O,,,,,,
9230,109231,3-Methyl-6-methyleneoctan-3-ol,CCC(=C)CCC(C)(CC)O,,,,,,
9231,109232,"Formic acid, compd. with alpha-methyl-1H-imidazole-1-ethanol (1:1)",CC(CN1C=CN=C1)O.C(=O)O,,,,,,
9232,109233,alpha-Methyl-1H-imidazole-1-ethanol,CC(CN1C=CN=C1)O,,,,,,
9233,109234,"2,5,8,11-Tetramethyldodec-6-yne-5,8-diol",CC(C)CCC(C)(C#CC(C)(CCC(C)C)O)O,,,,,,
9234,109235,Einecs 269-360-6,CCCCCCC1C=CC(CC1C(=O)O)CCCCCCCC(=O)O.C(CO)N(CCO)CCO,,,,,,
9235,109236,3-Hydroxynonyl isobutyrate,CCCCCCC(CCOC(=O)C(C)C)O,,,,,,
9236,109237,3-Hydroxynonyl formate,CCCCCCC(CCOC=O)O,,,,,,
9237,109238,"1,1'-(Isopropylidenebis(p-phenyleneoxy))bis(3-(bis(2-aminoethyl)amino)propan-2-ol)",CC(C)(C1=CC=C(C=C1)OCC(CN(CCN)CCN)O)C2=CC=C(C=C2)OCC(CN(CCN)CCN)O,,,,,,
9238,109239,"Benzenesulfonamide, 3-((1-(4-chlorophenyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl)azo)-4-hydroxy-N-methyl-",CC1=NN(C(=O)C1N=NC2=C(C=CC(=C2)S(=O)(=O)NC)O)C3=CC=C(C=C3)Cl,,,,,,
9239,109240,"2-Chloro-4-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-YL)azo]-5-hydroxybenzenesulphonamide",CC1=NN(C(=O)C1N=NC2=CC(=C(C=C2O)S(=O)(=O)N)Cl)C3=CC=CC=C3,,,,,,
9240,109241,"7-[4,5-dihydro-3-methyl-5-oxo-4-(phenylazo)-1H-pyrazol-1-yl]-3-hydroxynaphthalene-1-sulphonic acid",CC1=NN(C(=O)C1N=NC2=CC=CC=C2)C3=CC4=C(C=C(C=C4C=C3)O)S(=O)(=O)O,,,,,,
9241,109242,Disodium;4-[2-[2-(octadec-9-enoylamino)ethoxy]ethoxy]-4-oxo-2-sulfonatobutanoate,CCCCCCCCC=CCCCCCCCC(=O)NCCOCCOC(=O)CC(C(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
9242,109243,4-(2-{2-[(Octadec-9-enoyl)amino]ethoxy}ethoxy)-4-oxo-2-sulfobutanoic acid,CCCCCCCCC=CCCCCCCCC(=O)NCCOCCOC(=O)CC(C(=O)O)S(=O)(=O)O,,,,,,
9243,109244,4-Methyl-1-oxaspiro(5.5)undecene,CC1CC2(CCCCC2)OC=C1,,,,,,
9244,109245,"Ethyl 2-[[[2,4(or3,5)-dimethyl-3-cyclohexen-1-yl]methyl]amino]benzoate",CCOC(=O)C1=CC=CC=C1NCC2CCC(=CC2C)C,,,,,,
9245,109246,"Benzeneacetaldehyde, ar,alpha-diethyl-",CCC1=CC(=CC=C1)C(CC)C=O,,,,,,
9246,109247,"1,2,3-Propanetriyl tris(2-hexyldecanoate)",CCCCCCCCC(CCCCCC)C(=O)OCC(COC(=O)C(CCCCCC)CCCCCCCC)OC(=O)C(CCCCCC)CCCCCCCC,,,,,,
9247,109248,"2-Heptyl-3,4-bis(9-isocyanatononyl)-1-pentylcyclohexane",CCCCCCCC1C(CCC(C1CCCCCCCCCN=C=O)CCCCCCCCCN=C=O)CCCCC,,,,,,
9248,109249,"1-(2-Hydroxy-2-phenylethyl)pyrrolidine-2,5-dione",C1CC(=O)N(C1=O)CC(C2=CC=CC=C2)O,,,,,,
9249,109250,"1H-Benzimidazolium, 1-(2-(acetyloxy)-3-sulfopropyl)-5,6-dichloro-3-ethyl-2-methyl-, inner salt",CCN1C(=[N+](C2=CC(=C(C=C21)Cl)Cl)CC(CS(=O)(=O)[O-])OC(=O)C)C,,,,,,
9250,109251,"2-Acetyloxy-3-(5,6-dichloro-3-ethyl-2-methylbenzimidazol-1-ium-1-yl)propane-1-sulfonic acid",CCN1C(=[N+](C2=CC(=C(C=C21)Cl)Cl)CC(CS(=O)(=O)O)OC(=O)C)C,,,,,,
9251,109252,CID 109252,CCCCCCCCCCCCCCCC1=CC(=CC=C1)OC(CC)C(=O)NC2=CC(=C(C=C2)Cl)NC3=NN(C(=O)C3)C4=C(C=C(C=C4Cl)Cl)Cl,,,,,,
9252,109253,"Benzoic acid, 4-(1,1-dimethylethyl)-, compd. with 1,1',1''-nitrilotris[2-propanol] (1:1)",CC(CN(CC(C)O)CC(C)O)O.CC(C)(C)C1=CC=C(C=C1)C(=O)O,,,,,,
9253,109254,"N,N'-Ethylenebis(bis(2-hydroxypropyl)amine) toluene-p-sulphonate",CC1=CC=C(C=C1)S(=O)(=O)O.CC(CN(CCN(CC(C)O)CC(C)O)CC(C)O)O,,,,,,
9254,109255,Hexachlorocyclopentane,C1C(C(C(C1(Cl)Cl)Cl)(Cl)Cl)Cl,,,,,,
9255,109256,"1,3-Dioxane, 2-(2,6-dimethyl-1,5-heptadienyl)-4,4,6-trimethyl-",CC1CC(OC(O1)C=C(C)CCC=C(C)C)(C)C,,,,,,
9256,109257,"2,4-Dimethyl-2-(4-methylpent-3-enyl)-1,3-dioxolane",CC1COC(O1)(C)CCC=C(C)C,,,,,,
9257,109258,"Pyridinium, 2-amino-1-(oxiranylmethyl)-, chloride",C1C(O1)CN2C=CC=CC2=N.Cl,,,,,,
9258,109259,1-(Oxiran-2-ylmethyl)pyridin-2-imine,C1C(O1)CN2C=CC=CC2=N,,,,,,
9259,109260,"Cyclohexaneacetic acid, alpha-ethyl-1-hydroxy-, calcium salt (2:1)",CCC(C(=O)[O-])C1(CCCCC1)O.CCC(C(=O)[O-])C1(CCCCC1)O.[Ca+2],,,,,,
9260,109261,5(or 6)-Methyl-7(or 8)-(1-methylethyl)bicyclo[2.2.2]oct-5-ene-2-carbaldehyde,CC1=C2CC(C(C1)C(C2)C(C)C)C=O,,,,,,
9261,109262,"Bicyclo(2.2.2)oct-5-ene-2-carboxaldehyde, 3,5(or 3,6)-dimethyl-7(or 8)-(1-methylethyl)-",CC1=C2CC(C(C1)(C(C2)C(C)C)C)C=O,,,,,,
9262,109263,"Ethanone, 1-(5(or 6)-methyl-7(or 8)-(1-methylethyl)bicyclo(2.2.2)oct-5-en-2-yl)-",CC1=C2CC(C(C1)C(C2)C(=O)C)C(C)C,,,,,,
9263,109264,"1-Penten-3-ol, 1-(2,6,6-trimethyl-1-cyclohexen-1-yl)-",CCC(C=CC1=C(CCCC1(C)C)C)O,,,,,,
9264,109265,Mono(1-methylheptyl) phthalate,CCCCCCC(C)OC(=O)C1=CC=CC=C1C(=O)O,,,,,,
9265,109266,"Glycine, N-(2-((2-hydroxyethyl)(1-oxododecyl)amino)ethyl)-N-(2-hydroxy-3-sulfopropyl)-, disodium salt",CCCCCCCCCCCC(=O)N(CCN(CC(CS(=O)(=O)[O-])O)CC(=O)[O-])CCO.[Na+].[Na+],,,,,,
9266,109267,2-[2-[Dodecanoyl(2-hydroxyethyl)amino]ethyl-(2-hydroxy-3-sulfopropyl)amino]acetic acid,CCCCCCCCCCCC(=O)N(CCN(CC(CS(=O)(=O)O)O)CC(=O)O)CCO,,,,,,
9267,109268,"Glycine, N-(2-hydroxyethyl)-N-(2-((2-hydroxy-3-sulfopropyl)(1-oxododecyl)amino)ethyl)-, disodium salt",CCCCCCCCCCCC(=O)N(CCN(CCO)CC(=O)[O-])CC(CS(=O)(=O)[O-])O.[Na+].[Na+],,,,,,
9268,109269,2-[2-[Dodecanoyl-(2-hydroxy-3-sulfopropyl)amino]ethyl-(2-hydroxyethyl)amino]acetic acid,CCCCCCCCCCCC(=O)N(CCN(CCO)CC(=O)O)CC(CS(=O)(=O)O)O,,,,,,
9269,109270,"8-(2,2-Diethoxyethoxy)-2,6-dimethyloct-2-ene",CCOC(COCCC(C)CCC=C(C)C)OCC,,,,,,
9270,109271,"1-Octadecanol, 9,10-dibromo-, hydrogen phosphate, calcium salt",CCCCCCCCC(C(CCCCCCCCOP(=O)([O-])OCCCCCCCCC(C(CCCCCCCC)Br)Br)Br)Br.CCCCCCCCC(C(CCCCCCCCOP(=O)([O-])OCCCCCCCCC(C(CCCCCCCC)Br)Br)Br)Br.[Ca+2],,,,,,
9271,109272,"Bis(9,10-dibromooctadecyl) hydrogen phosphate",CCCCCCCCC(C(CCCCCCCCOP(=O)(O)OCCCCCCCCC(C(CCCCCCCC)Br)Br)Br)Br,,,,,,
9272,109273,CID 109273,CCCCCCCCC=CCCCCCCCC(=O)NCCOC(=O)C(CC(=O)O)S(=O)(=O)[O-].C(CO)N(CCO)CCO.[Na+],,,,,,
9273,109274,4-[2-(Octadec-9-enoylamino)ethoxy]-4-oxo-3-sulfobutanoic acid,CCCCCCCCC=CCCCCCCCC(=O)NCCOC(=O)C(CC(=O)O)S(=O)(=O)O,,,,,,
9274,109275,"1,6,7,8-Tetrahydro-1,4,6,6,8,8-hexamethyl-as-indacen-3(2H)-one",CC1CC(=O)C2=C1C3=C(C=C2C)C(CC3(C)C)(C)C,,,,,,
9275,109276,"4-Ethoxy-2,6-dipropyl-1,3-dioxane",CCCC1CC(OC(O1)CCC)OCC,,,,,,
9276,109277,CID 109277,CCCCC(CC)C(=O)OCC[S-].CCCCC(CC)C(=O)OCC[S-].CCCC[Sn]CCCC,,,,,,
9277,109278,CID 109278,CCCC[Sn]CCCC.C(C(C[S-])O)O.C(C(C[S-])O)O,,,,,,
9278,109279,"(Butylstannylidyne)tris(thioethylene) tris(3,5,5-trimethylhexanoate)",CCCC[Sn](SCCOC(=O)CC(C)CC(C)(C)C)(SCCOC(=O)CC(C)CC(C)(C)C)SCCOC(=O)CC(C)CC(C)(C)C,,,,,,
9279,109280,6-Isopropyl-3-methylcyclohexen-1-yl acetate,CC1CCC(C(=C1)OC(=O)C)C(C)C,,,,,,
9280,109281,2-((((5-(((2-(Ethyl((undecafluoropentyl)sulphonyl)amino)ethoxy)carbonyl)amino)-2-methylphenyl)amino)carbonyl)oxy)propyl methacrylate,CCN(CCOC(=O)NC1=CC(=C(C=C1)C)NC(=O)OC(C)COC(=O)C(=C)C)S(=O)(=O)C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
9281,109282,2-((((5-(((2-(Ethyl((nonafluorobutyl)sulphonyl)amino)ethoxy)carbonyl)amino)-2-methylphenyl)amino)carbonyl)oxy)propyl methacrylate,CCN(CCOC(=O)NC1=CC(=C(C=C1)C)NC(=O)OC(C)COC(=O)C(=C)C)S(=O)(=O)C(C(C(C(F)(F)F)(F)F)(F)F)(F)F,,,,,,
9282,109283,"4-Oxazolemethanol, 4,5-dihydro-4-methyl-2-(9Z)-9-octadecenyl-, hydrofluoride",CCCCCCCCC=CCCCCCCCCC1=NC(CO1)(C)CO.F,,,,,,
9283,109284,"(4-methyl-2-octadec-9-enyl-5H-1,3-oxazol-4-yl)methanol",CCCCCCCCC=CCCCCCCCCC1=NC(CO1)(C)CO,,,,,,
9284,109285,CID 109285,CCCCCCCCCCCC(C=NN=CC(CCCCCCCCCC)O)O,,,,,,
9285,109286,Hydrogen (2-ethylhexan-1-olato)tris(propan-2-olato)aluminate,[H+].CCCCC(CC)C[O-].CC(C)[O-].CC(C)[O-].CC(C)[O-].[Al+3],,,,,,
9286,109287,"Dipotassium 1,5-dihydroxypentane-1,5-disulphonate",C(CC(O)S(=O)(=O)[O-])CC(O)S(=O)(=O)[O-].[K+].[K+],,,,,,
9287,109288,"1,5-Dihydroxypentane-1,5-disulfonic acid",C(CC(O)S(=O)(=O)O)CC(O)S(=O)(=O)O,,,,,,
9288,109289,"9-Octadecenoic acid (9Z)-, [[2-[bis(2-hydroxypropyl)amino]ethyl]imino]bis(1-methyl-2,1-ethanediyl) ester",CCCCCCCCC=CCCCCCCCC(=O)OC(C)CN(CCN(CC(C)O)CC(C)O)CC(C)OC(=O)CCCCCCCC=CCCCCCCCC,,,,,,
9289,109290,"9-Octadecenoic acid (9Z)-, 1,2-ethanediylbis[[(2-hydroxypropyl)imino](1-methyl-2,1-ethanediyl)] ester",CCCCCCCCC=CCCCCCCCC(=O)OC(C)CN(CCN(CC(C)O)CC(C)OC(=O)CCCCCCCC=CCCCCCCCC)CC(C)O,,,,,,
9290,109291,"Calcium;2,3,4,5,6,7-hexahydroxyheptanoate",C(C(C(C(C(C(C(=O)[O-])O)O)O)O)O)O.C(C(C(C(C(C(C(=O)[O-])O)O)O)O)O)O.[Ca+2],,,,,,
9291,109292,"Lysine diisocyanate methyl ester, trimethylolpropane adduct",CCC(COC(=O)NCCCCC(C(=O)OC)N=C=O)(COC(=O)NCCCCC(C(=O)OC)N=C=O)COC(=O)NCCCCC(C(=O)OC)N=C=O,,,,,,
9292,109293,"2-Methylbutyl 2,6-dimethyloctanoate",CCC(C)CCCC(C)C(=O)OCC(C)CC,,,,,,
9293,109294,"2-(6,6-Dimethylbicyclo(3.1.1)hept-2-en-2-yl)ethyl formate",CC1(C2CC=C(C1C2)CCOC=O)C,,,,,,
9294,109295,"2-Propanol, 1,1'-[iminobis(2,1-ethanediylimino)]bis-",CC(CNCCNCCNCC(C)O)O,,,,,,
9295,109296,"4,7,10,13-Tetraazahexadecane-2,15-diol",CC(CNCCNCCNCCNCC(C)O)O,,,,,,
9296,109297,"4,7,10,13,16-Pentaazanonadecane-2,18-diol",CC(CNCCNCCNCCNCCNCC(C)O)O,,,,,,
9297,109298,"1-Piperazineethanol, 4-[2-[(2-hydroxypropyl)amino]ethyl]-alpha-methyl-",CC(CNCCN1CCN(CC1)CC(C)O)O,,,,,,
9298,109299,cis-N-(Cyclohexylthio)hexahydrophthalimide,C1CCC(CC1)SN2C(=O)C3CCCCC3C2=O,,,,,,
9299,109300,"Ethane, 1,2-bis(4-(1,3-dimethylbutyl)aminophenoxy)-",CC(C)CC(C)NC1=CC=C(C=C1)OCCOC2=CC=C(C=C2)NC(C)CC(C)C,,,,,,
9300,109301,"Bicyclo[2.2.2]oct-5-ene-2-carbonitrile, 5-methyl-7-(1-methylethyl)-",CC1=CC2C(CC1CC2C(C)C)C#N,,,,,,
9301,109302,"1-Propanone, 1-(octahydro-3,5,5-trimethyl-2-naphthalenyl)-",CCC(=O)C1CC2C=CCC(C2CC1C)(C)C,,,,,,
9302,109303,"1-Propanone, 1-(octahydro-3,8,8-trimethyl-2-naphthalenyl)-",CCC(=O)C1CC2C(CC1C)C=CCC2(C)C,,,,,,
9303,109304,"1,1,3-Trichloro-2,4,4-tris(4-morpholino)-1-butene",C1COCCN1C(C(C(=C(Cl)Cl)N2CCOCC2)Cl)N3CCOCC3,,,,,,
9304,109305,"2-Cyclohexene-1-octanoic acid, 5-carboxy-4-hexyl-, compd. with 2,2'-iminobis(ethanol) (1:1)",CCCCCCC1C=CC(CC1C(=O)O)CCCCCCCC(=O)O.C(CO)NCCO,,,,,,
9305,109306,CID 109306,CC1C(C(CC(O1)OC2C(OC(CC2O)OC3C(OC(CC3O)OC4CCC5(C4CCC6C5CCC7(C6(CCC7C8=CC(=O)OC8)O)C)C)C)C)OC(=O)C9C(C(C(C(O9)O)O)O)O)O,,,,,,
9306,109307,2-Hydroxypropyl octanoate,CCCCCCCC(=O)OCC(C)O,,,,,,
9307,109308,2-Hydroxy-2-[2-(2-hydroxy-3-octadec-9-enoyloxypropoxy)-2-oxoethyl]-4-octadecoxy-4-oxobutanoic acid,CCCCCCCCCCCCCCCCCCOC(=O)CC(CC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)O)(C(=O)O)O,,,,,,
9308,109309,"Hexanedioic acid, mixed 2-butoxyethyl and 2-ethylhexyl esters",CCCCC(CC)COC(=O)CCCCC(=O)OCCOCCCC,,,,,,
9309,109310,"3,18-Diethyl-7,14-dioxa-3,18-diazaicosane-5,16-diol dihydrochloride",CCN(CC)CC(COCCCCCCOCC(CN(CC)CC)O)O.Cl.Cl,,,,,,
9310,109311,"3,18-Diethyl-7,14-dioxa-3,18-diazaicosane-5,16-diol",CCN(CC)CC(COCCCCCCOCC(CN(CC)CC)O)O,,,,,,
9311,109312,"3,3'-(Hexane-1,6-diylbis(oxy))bis(2-hydroxypropyltrimethylammonium) dichloride",C[N+](C)(C)CC(COCCCCCCOCC(C[N+](C)(C)C)O)O.Cl.Cl,,,,,,
9312,109313,"3,3'-[1,6-Hexanediylbis(oxy)]bis(2-hydroxy-N,N,N-trimethyl-1-propanaminium)",C[N+](C)(C)CC(COCCCCCCOCC(C[N+](C)(C)C)O)O,,,,,,
9313,109314,"1-Propanaminium, 2-hydroxy-N,N,N-trimethyl-3-(tridecyloxy)-, chloride",CCCCCCCCCCCCCOCC(C[N+](C)(C)C)O.[Cl-],,,,,,
9314,109315,"2-Hydroxy-N,N,N-trimethyl-3-(tridecyloxy)-1-propanaminium",CCCCCCCCCCCCCOCC(C[N+](C)(C)C)O,,,,,,
9315,109316,"2-Propanol, 1-chloro-3-(tridecyloxy)-",CCCCCCCCCCCCCOCC(CCl)O,,,,,,
9316,109317,"Benzenesulfonyl chloride, decylmethyl-",CCCCCCCC(C)CCC1=CC(=CC=C1)S(=O)(=O)Cl,,,,,,
9317,109318,"3,7-Dimethyloct-1-en-3-yl acetate",CC(C)CCCC(C)(C=C)OC(=O)C,,,,,,
9318,109319,(-)-Menthyl isobutyrate,CC1CCC(C(C1)OC(=O)C(C)C)C(C)C,,,,,,
9319,109320,"Butanoic acid, 2-methyl-, 3,7-dimethyloctyl ester",CCC(C)C(=O)OCCC(C)CCCC(C)C,,,,,,
9320,109321,"2-Propanol, 1-[[4-[(4-aminophenyl)methyl]phenyl]amino]-3-phenoxy-",C1=CC=C(C=C1)OCC(CNC2=CC=C(C=C2)CC3=CC=C(C=C3)N)O,,,,,,
9321,109322,"7-Thiabicyclo[2.2.1]heptane, 1-methyl-4-(1-methylethyl)-",CC(C)C12CCC(S1)(CC2)C,,,,,,
9322,109323,"2,3,5,5-Tetramethylhexanal",CC(CC(C)(C)C)C(C)C=O,,,,,,
9323,109324,CID 109324,C1=CC=C(C(=C1)C(O)S(=O)(=O)[O-])Cl.[Na+],,,,,,
9324,109325,(2-Chlorophenyl)(hydroxy)methanesulfonic acid,C1=CC=C(C(=C1)C(O)S(=O)(=O)O)Cl,,,,,,
9325,109326,Nickel glycerophosphate,C(C(COP(=O)([O-])[O-])O)O.[Ni+2],,,,,,
9326,109327,"1,1'-(Isopropylidenebis(p-phenyleneoxy))bis(3-(diallylamino)propan-2-ol)",CC(C)(C1=CC=C(C=C1)OCC(CN(CC=C)CC=C)O)C2=CC=C(C=C2)OCC(CN(CC=C)CC=C)O,,,,,,
9327,109328,"1H-Benzimidazole-1-ethanol, 6-chloro-alpha,2-dimethyl-",CC1=NC2=C(N1CC(C)O)C=C(C=C2)Cl,,,,,,
9328,109329,2-Methyl-5-chloro-3-(beta-acetoxypropyl)benzimidazole,CC1=NC2=C(N1CC(C)OC(=O)C)C=C(C=C2)Cl,,,,,,
9329,109330,6-Butyl-6-hydroxy-5-dodecanone,CCCCCCC(CCCC)(C(=O)CCCC)O,,,,,,
9330,109331,"Cyclohexanone, methyl(1-methylethyl)-",CC1CC(CCC1=O)C(C)C,,,,,,
9331,109332,"4,7,7-Trimethyl-6-thiabicyclo[3.2.1]octane",CC1CCC2CC1SC2(C)C,,,,,,
9332,109333,2-Hydroxy-3-morpholinopropanesulfonic Acid,C1COCCN1CC(CS(=O)(=O)O)O,,,,,,
9333,109334,Tapso,C(C(CS(=O)(=O)O)O)NC(CO)(CO)CO,,,,,,
9334,109335,"2-[[2-Chloro-5-(trifluoromethyl)phenyl]azo]-N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxobutyramide",CC(=O)C(C(=O)NC1=CC2=C(C=C1)NC(=O)N2)N=NC3=C(C=CC(=C3)C(F)(F)F)Cl,,,,,,
9335,109336,"Formic acid, compd. with 2-[2-[[4-[3-(4-chlorophenyl)-4,5-dihydro-1H-pyrazol-1-yl]phenyl]sulfonyl]ethoxy]-N,N-dimethyl-1-propanamine (1:1)",CC(CN(C)C)OCCS(=O)(=O)C1=CC=C(C=C1)N2CCC(=N2)C3=CC=C(C=C3)Cl.C(=O)O,,,,,,
9336,109337,"1-Propanamine, 2-[2-[[4-[3-(4-chlorophenyl)-4,5-dihydro-1H-pyrazol-1-yl]phenyl]sulfonyl]ethoxy]-N,N-dimethyl-",CC(CN(C)C)OCCS(=O)(=O)C1=CC=C(C=C1)N2CCC(=N2)C3=CC=C(C=C3)Cl,,,,,,
9337,109338,2-Hydroxy-2-methyl-7-phenylpentadecan-3-one,CCCCCCCCC(CCCC(=O)C(C)(C)O)C1=CC=CC=C1,,,,,,
9338,109339,CID 109339,CCC(C)COC1=C(C=C(C=C1)C=CC)OC,,,,,,
9339,109340,"1,6-Octadiene, 7-methyl-3-methylene-, acetylated",CC(=CCCC(COC(=O)C)C=C)C,,,,,,
9340,109341,"Alcohols, C>10-secondary, beta-(bis(hydroxyethyl)amino)",CCCC(CCCCCC(C)N(CCO)CCO)O,,,,,,
9341,109342,"Alcohols, C>10-secondary, beta-(dimethylamino)",CCCC(CCCCCC(C)N(C)C)O,,,,,,
9342,109343,"Alcohols, C>10-secondary, beta-((3-(dimethylamino)propyl)amino)",CCC(CCCCCCC(C)NCCCN(C)C)O,,,,,,
9343,109344,"Alcohols, C>10-secondary, beta-((2-aminoethyl)amino)",CCCCC(CCCCC(C)NCCN)O,,,,,,
9344,109345,"Alcohols, C>10-secondary, beta-(2-hydroxyethoxy)",CCC(CCCCCCC(C)OCCO)O,,,,,,
9345,109346,Dibutyl ((dipropoxyphosphinothioyl)thio)succinate,CCCCOC(=O)CC(C(=O)OCCCC)SP(=S)(OCCC)OCCC,,,,,,
9346,109347,Dibutyl [[bis[(2-ethylhexyl)oxy]phosphinothioyl]thio]succinate,CCCCC(CC)COP(=S)(OCC(CC)CCCC)SC(CC(=O)OCCCC)C(=O)OCCCC,,,,,,
9347,109348,[3-(4-Dodecylphenoxy)-2-hydroxypropyl]trimethylammonium chloride,CCCCCCCCCCCCC1=CC=C(C=C1)OCC(C[N+](C)(C)C)O.[Cl-],,,,,,
9348,109349,"3-(4-Dodecylphenoxy)-2-hydroxy-N,N,N-trimethyl-1-propanaminium",CCCCCCCCCCCCC1=CC=C(C=C1)OCC(C[N+](C)(C)C)O,,,,,,
9349,109350,CID 109350,COC1=C(C=C(C=C1)C(O)S(=O)(=O)[O-])OC.[Na+],,,,,,
9350,109351,"(3,4-Dimethoxyphenyl)-hydroxymethanesulfonic acid",COC1=C(C=C(C=C1)C(O)S(=O)(=O)O)OC,,,,,,
9351,109352,CID 109352,CCCCCCCCCC(CCCCCCCC(=O)O)OS(=O)(=O)[O-].[K+],,,,,,
9352,109353,1-sec-Butyl-3-nitrobenzene,CCC(C)C1=CC(=CC=C1)[N+](=O)[O-],,,,,,
9353,109354,CID 109354,CCCCCCCCCC(CCCCCCCC(=O)OCCC)S(=O)(=O)[O-].[Na+],,,,,,
9354,109355,1-Oxo-1-propoxyoctadecane-9-sulfonic acid,CCCCCCCCCC(CCCCCCCC(=O)OCCC)S(=O)(=O)O,,,,,,
9355,109356,"3-Buten-2-one, 4-(trimethylcyclohexenyl)-",CC1CC(=CC(C1C)C=CC(=O)C)C,,,,,,
9356,109357,"Dodecylbenzenesulfonic acid, tris(2-hydroxypropyl)diethylenetriammonium salt",CCCCCCCCCCCCC1=CC(=CC=C1)S(=O)(=O)[O-].CC(CNCCNCCN(CC(C)O)CC(C)O)O,,,,,,
9357,109358,1-[2-[2-[Bis(2-hydroxypropyl)amino]ethylamino]ethylamino]propan-2-ol,CC(CNCCNCCN(CC(C)O)CC(C)O)O,,,,,,
9358,109359,"Dioctyl 2,4,4-trimethyladipate",CCCCCCCCOC(=O)CC(C)(C)CC(C)C(=O)OCCCCCCCC,,,,,,
9359,109360,"Hexanedioic acid, 2,4,4-trimethyl-, 1-decyl 6-octyl ester",CCCCCCCCCCOC(=O)C(C)CC(C)(C)CC(=O)OCCCCCCCC,,,,,,
9360,109361,Einecs 270-377-6,CC1CCC(CC1CNC(=O)ON=C(C)C)(C)CNC(=O)ON=C(C)C,,,,,,
9361,109362,"1-((2-Phenyl-2-imidazolin-1-yl)carbonylaminomethyl)-3-((2-phenyl-2-imidazolin-1-yl)carbonylamino)-1,5,5-trimethylcyclohexane",CC1(CC(CC(C1)(C)CNC(=O)N2CC=NC2C3=CC=CC=C3)NC(=O)N4CC=NC4C5=CC=CC=C5)C,,,,,,
9362,109363,"Didecyl 2,2,4-trimethyladipate",CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C(=O)OCCCCCCCCCC,,,,,,
9363,109364,"3-[(6-Amino-2,2,4-trimethylhexyl)amino]propanenitrile",CC(CCN)CC(C)(C)CNCCC#N,,,,,,
9364,109365,"Propanenitrile, 3-[(6-amino-2,4,4-trimethylhexyl)amino]-",CC(CC(C)(C)CCN)CNCCC#N,,,,,,
9365,109366,"1-((2-Phenyl-4-methyl-2-imidazolin-1-yl)carbonylaminomethyl)-3-((2-phenyl-4-methyl-2-imidazolin-1-yl)carbonylamino)-1,5,5-trimethylcyclohexane",CC1=NC(N(C1)C(=O)NCC2(CC(CC(C2)(C)C)NC(=O)N3CC(=NC3C4=CC=CC=C4)C)C)C5=CC=CC=C5,,,,,,
9366,109367,"Benzene, [3-(1-methoxy-2-phenylethoxy)-1-propen-1-yl]-",COC(CC1=CC=CC=C1)OCC=CC2=CC=CC=C2,,,,,,
9367,109368,"Cyclohexanepropanol, alpha-(1-methylethyl)-",CC(C)C(CCC1CCCCC1)O,,,,,,
9368,109369,4-Methyl-1-phenylpentan-3-ol,CC(C)C(CCC1=CC=CC=C1)O,,,,,,
9369,109370,"3H-Pyrazol-3-one, 4-[(4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-ylidene)methyl]-2,4-dihydro-5-methyl-",CC1=NNC(=O)C1C=C2C(=NNC2=O)C,,,,,,
9370,109371,"6,8-Bis(hydroxymethyl)-7,7-dimethyl-1,6-dihydronaphthalen-2-one",CC1(C(C=C2C=CC(=O)CC2=C1CO)CO)C,,,,,,
9371,109372,"Alcohols, C11-13-branched, ethoxylated",CCCC(C)CCC(C)CCOCC,,,,,,
9372,109373,"Alcohols, C>10, beta-(methylamino)-",CCCCCCCCCC(C)NC,,,,,,
9373,109374,"1-Octanamine, N,N-dioctyl-, branched",CCCCCCCCN(CCCC(CC)C(C)C)CC(C)C(CC)CC,,,,,,
9374,109375,"Amines, C18-22-tert-alkyl, ethoxylated",CCOCCCCCCCCC(C(C)CCN)C(C)C(C)C,,,,,,
9375,109376,"Titanium, ((hydroxy-kappaO)acetato(2-)-kappaO)bis(12-hydroxyoctadecanoato-kappaO)-, (T-4)-",CCCCCCC(CCCCCCCCCCC(=O)O)O.CCCCCCC(CCCCCCCCCCC(=O)O)O.C(C(=O)O)O.[Ti],,,,,,
9376,109377,"1,2-Benzenedicarboxylic acid, 2-ethyl-2-[[(2-methyl-1-oxo-2-propenyl)oxy]methyl]-1,3-propanediyl didecyl ester",CCCCCCCCCCOC(=O)C1=CC=CC=C1C(=O)OCC(CC)(COC(=O)C2=CC=CC=C2C(=O)OCCCCCCCCCC)COC(=O)C(=C)C,,,,,,
9377,109378,(T-4)-[2-(Hydroxy-kappaO)acetato(2-)-kappaO]bis[(9Z)-12-hydroxy-9-octadecenoato-kappaO]titanium,CCCCCCC(CC=CCCCCCCCC(=O)O)O.CCCCCCC(CC=CCCCCCCCC(=O)O)O.C(C(=O)O)O.[Ti],,,,,,
9378,109379,"4,6-Dimethyl-2,4,6,8-tetraphenyl-1-nonene",CC(CC(C)(CC(C)(CC(=C)C1=CC=CC=C1)C2=CC=CC=C2)C3=CC=CC=C3)C4=CC=CC=C4,,,,,,
9379,109380,Butyl 2-ethylhexanoate,CCCCC(CC)C(=O)OCCCC,,,,,,
9380,109381,"1-(2-Ethylhexylamino)-4-(isopropylamino)-9,10-anthracenedione",CCCCC(CC)CNC1=C2C(=C(C=C1)NC(C)C)C(=O)C3=CC=CC=C3C2=O,,,,,,
9381,109382,2-Hydroxyheptyl formate,CCCCCC(COC=O)O,,,,,,
9382,109383,"Tripentaerythritol, tetraisononanoate, tetra-2-ethylhexanoate",CCCCC(CC)C(=O)OCC(COCC(COCC(COC(=O)CCCCCC(C)C)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC)(COC(=O)CCCCCC(C)C)COC(=O)CCCCCC(C)C)(COC(=O)CCCCCC(C)C)COC(=O)C(CC)CCCC,,,,,,
9383,109384,"2-((3-((2-Ethylhexanoyl)oxy)-2-(((2-ethylhexanoyl)oxy)methyl)-2-(((isononanoyl)oxy)methyl)propoxy)methyl)-2-(((2-ethylhexanoyl)oxy)methyl)propane-1,3-diyl bis(isononanoate)",CCCCC(CC)C(=O)OCC(COCC(COC(=O)CCCCCC(C)C)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC)(COC(=O)CCCCCC(C)C)COC(=O)CCCCCC(C)C,,,,,,
9384,109385,"2-Propanol, 1-((2-((2-((2-aminoethyl)amino)ethyl)amino)ethyl)amino)-3-phenoxy-",C1=CC=C(C=C1)OCC(CNCCNCCNCCN)O,,,,,,
9385,109386,Einecs 270-602-8,CC(C)CC(C)O.OP(=O)(O)O,,,,,,
9386,109387,"1-Penten-3-one, 4-methyl-1-(2,6,6-trimethyl-2-cyclohexen-1-yl)-",CC1=CCCC(C1C=CC(=O)C(C)C)(C)C,,,,,,
9387,109388,CID 109388,C(C1C(C(C(O1)(CNC(CC(=O)O)C(=O)[O-])O)O)O)O.[Na+],,,,,,
9388,109389,"2-[[2,3,4-Trihydroxy-5-(hydroxymethyl)oxolan-2-yl]methylamino]butanedioic acid",C(C1C(C(C(O1)(CNC(CC(=O)O)C(=O)O)O)O)O)O,,,,,,
9389,109390,"Magnesium, bis(D-glycero-D-ido-heptonato)-",C(C(C(C(C(C(C(=O)[O-])O)O)O)O)O)O.C(C(C(C(C(C(C(=O)[O-])O)O)O)O)O)O.[Mg+2],,,,,,
9390,109391,"Cobalt, bis(D-glycero-D-ido-heptonato)-",C(C(C(C(C(C(C(=O)[O-])O)O)O)O)O)O.C(C(C(C(C(C(C(=O)[O-])O)O)O)O)O)O.[Co+2],,,,,,
9391,109392,"Copper, bis(D-glycero-D-ido-heptonato)-",C(C(C(C(C(C(C(=O)[O-])O)O)O)O)O)O.C(C(C(C(C(C(C(=O)[O-])O)O)O)O)O)O.[Cu+2],,,,,,
9392,109393,"Manganese, bis(D-glycero-D-ido-heptonato)-",C(C(C(C(C(C(C(=O)[O-])O)O)O)O)O)O.C(C(C(C(C(C(C(=O)[O-])O)O)O)O)O)O.[Mn+2],,,,,,
9393,109394,"Zinc, bis(D-glycero-D-ido-heptonato)-",C(C(C(C(C(C(C(=O)[O-])O)O)O)O)O)O.C(C(C(C(C(C(C(=O)[O-])O)O)O)O)O)O.[Zn+2],,,,,,
9394,109395,"Acetic acid, decyl ester, branched",CCCC(CCOC(=O)C)C(C)CC,,,,,,
9395,109396,3-Ethyl-4-methylpentyl acetate,CCC(CCOC(=O)C)C(C)C,,,,,,
9396,109397,CID 109397,CCCCCCCCC=C(CCCCCCCC(=O)OCC(C)CC)S(=O)(=O)O,,,,,,
9397,109398,"1,3-Propanediamine, N-(3-(tridecyloxy)propyl)-, branched and linear, diacetate",CCCC(COCCCN(CCCNOC(=C)C)OC(=C)C)C(C)CCC(C)CC,,,,,,
9398,109399,"1,3-Propanediamine, N-(3-(decyloxy)propyl)-, branched and linear",CCCC(C)C(CCC)COCCCNCCCN,,,,,,
9399,109400,"N-[3-(Isotridecyloxy)propyl]propane-1,3-diamine",CC(C)CCCCCCCCCCOCCCNCCCN,,,,,,
9400,109401,"Propanenitrile, 3-(tridecyloxy)-, branched and linear",CCC(CC)CCC(C)CC(CC)OCCC#N,,,,,,
9401,109402,"Silane, trichlorohexyl-, branched and linear",CCC(C(C)Cl)(C(O[Si](O)(O)O)Cl)Cl,,,,,,
9402,109403,"Benzenesulfonamide, N-(6-amino-3,5,5-trimethylhexyl)-4-methyl-",CC1=CC=C(C=C1)S(=O)(=O)NCCC(C)CC(C)(C)CN,,,,,,
9403,109404,Menthyl N-(3-triethoxysilylpropyl)carbamate,CCO[Si](CCCNC(=O)OC1CC(CCC1C(C)C)C)(OCC)OCC,,,,,,
9404,109405,"Butanedioic acid, sulfo-, mono[2-[[(9Z)-1-oxo-9-octadecenyl]amino]ethyl] ester, disodium salt",CCCCCCCCC=CCCCCCCCC(=O)NCCOC(=O)CC(C(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
9405,109406,4-{2-[(Octadec-9-enoyl)amino]ethoxy}-4-oxo-2-sulfobutanoic acid,CCCCCCCCC=CCCCCCCCC(=O)NCCOC(=O)CC(C(=O)O)S(=O)(=O)O,,,,,,
9406,109407,"1,2-Ethanediaminium, N,N'-bis(3-chloro-2-hydroxypropyl)-N,N,N',N'-tetramethyl-, dichloride",C[N+](C)(CC[N+](C)(C)CC(CCl)O)CC(CCl)O.[Cl-].[Cl-],,,,,,
9407,109408,"N,N'-Bis(3-chloro-2-hydroxypropyl)-N,N,N',N'-tetramethyl-1,2-ethanediaminium",C[N+](C)(CC[N+](C)(C)CC(CCl)O)CC(CCl)O,,,,,,
9408,109409,"4-(2,2-Dimethyl-6-methylidenecyclohexyl)butan-2-yl acetate",CC(CCC1C(=C)CCCC1(C)C)OC(=O)C,,,,,,
9409,109410,"2-Propanol, 1,1'-iminobis-, benzoate (1:1)",CC(CNCC(C)O)O.C1=CC=C(C=C1)C(=O)O,,,,,,
9410,109411,"3-Penten-2-ol, 3-methyl-5-(2,2,3-trimethyl-3-cyclopenten-1-yl)-",CC1=CCC(C1(C)C)CC=C(C)C(C)O,,,,,,
9411,109412,"6-(2,2,3-Trimethylcyclopent-3-en-1-yl)hex-5-en-3-ol",CCC(CC=CC1CC=C(C1(C)C)C)O,,,,,,
9412,109413,"2-Octanol, 2,6-dimethyl-, 2-acetate",CCC(C)CCCC(C)(C)OC(=O)C,,,,,,
9413,109414,1-(1-Ethoxyethoxy)pent-2-yne,CCC#CCOC(C)OCC,,,,,,
9414,109415,"Decahydrospiro[furan-2(3H),5'-[4,7]methano[5h]indene]",C1CC2C(C1)C3CC2CC34CCCO4,,,,,,
9415,109416,"2-Furanmethanol, tetrahydro-alpha-pentyl-",CCCCCC(C1CCCO1)O,,,,,,
9416,109417,"1-(3,5,6-Trimethyl-3-cyclohexen-1-yl)ethanone",CC1C=C(CC(C1C)C(=O)C)C,,,,,,
9417,109418,"(2,4-Dimethylcyclohexyl)methanol",CC1CCC(C(C1)C)CO,,,,,,
9418,109419,"3,5-Dimethylcyclohexanemethanol",CC1CC(CC(C1)CO)C,,,,,,
9419,109420,"3-Pentanone, 1-(2,6,6-trimethyl-2-cyclohexen-1-yl)-",CCC(=O)CCC1C(=CCCC1(C)C)C,,,,,,
9420,109421,"1,3-Dioxolane, 2,4-dimethyl-2-[2-(2,6,6-trimethyl-2-cyclohexen-1-yl)ethyl]-",CC1COC(O1)(C)CCC2C(=CCCC2(C)C)C,,,,,,
9421,109422,Methyl 2-oxo-1-(2-pentynyl)cyclopentanecarboxylate,CCC#CCC1(CCCC1=O)C(=O)OC,,,,,,
9422,109423,"5-Hexen-3-one, 6-(2,2,3-trimethyl-3-cyclopenten-1-yl)-",CCC(=O)CC=CC1CC=C(C1(C)C)C,,,,,,
9423,109424,"Cyclohexanemethanamine, 1,3,3-trimethyl-N-(1-methylethylidene)-5-((1-methylethylidene)amino)-",CC(=NCC1(CC(CC(C1)(C)C)N=C(C)C)C)C,,,,,,
9424,109425,"Spiro[isobenzofuran-1(3H),9'-[9H]xanthen]-3-one, 2'-[(2-chlorophenyl)amino]-6'-(diethylamino)-",CCN(CC)C1=CC2=C(C=C1)C3(C4=CC=CC=C4C(=O)O3)C5=C(O2)C=CC(=C5)NC6=CC=CC=C6Cl,,,,,,
9425,109426,"2,4,9-Tribromo-1,5-dichlorodecane",CC(CCCC(C(CC(CCl)Br)Br)Cl)Br,,,,,,
9426,109427,"1-Tridecanamine, N-tridecyl-, branched",CCCCCCCCCCCCCNCC(CCC)C(CCC)CCCC,,,,,,
9427,109428,"1,2-Benzenedicarboxylic acid, mono-C9-11-branched alkyl esters, C10-rich",CCCCC(CCC)CCOC(=O)C1=CC=CC=C1C(=O)OCC(CCC)CC(C)CC,,,,,,
9428,109429,"1,2-Benzenedicarboxylic acid, monohexyl ester, branched and linear",CCCC(CC)COC(=O)C1=CC=CC=C1C(=O)O,,,,,,
9429,109430,"1,2,4-Benzenetricarboxylic acid, mixed branched and linear heptyl and nonyl and undecyl esters",CCCC(C)C(CC)COC(=O)C1=C(C=C(C=C1)C(=O)OCCCCC(CC)C(C)CC)C(=O)OCC(CC)C(C)C,,,,,,
9430,109431,"1,2,4-Benzenetricarboxylic acid, tri-C7-9-branched and linear alkyl esters",CCCC(CC)COC(=O)C1=CC(=C(C=C1)C(=O)OCC(C)C(C)CC)C(=O)OCC(CC)CCC,,,,,,
9431,109432,Chlorinated dioctyl terephthalate,CCCC(C(CC(COC(=O)C1=CC=C(C=C1)C(=O)OCCCC(C(C(CC(Cl)Cl)Cl)Cl)Cl)Cl)Cl)Cl,,,,,,
9432,109433,"2,3-Dimethylpentyl 2-ethylpentyl heptanedioate",CCCC(CC)COC(=O)CCCCCC(=O)OCC(C)C(C)CC,,,,,,
9433,109434,Tris(2-ethylbutyl) 2-ethylheptyl orthosilicate,CCCCCC(CC)CO[Si](OCC(CC)CC)(OCC(CC)CC)OCC(CC)CC,,,,,,
9434,109435,"2-Butanone, 3-[(2-furanylmethyl)thio]-3-hydroxy-",CC(=O)C(C)(O)SCC1=CC=CO1,,,,,,
9435,109436,"1,1'-[5-(2-Hydroxyethyl)-1,3,5-triazinane-1,3-diyl]dipropan-2-ol",CC(CN1CN(CN(C1)CC(C)O)CCO)O,,,,,,
9436,109437,"1,3,5-Triazine-1,3,5(2H,4H,6H)-triethanol, alpha-methyl-",CC(CN1CN(CN(C1)CCO)CCO)O,,,,,,
9437,109438,2-Ethylhexan-1-amine;octadec-9-enoic acid,CCCCCCCCC=CCCCCCCCC(=O)O.CCCCC(CC)CN,,,,,,
9438,109439,"2H-Pyran, tetrahydro-2-(12-tetradecen-9-ynyloxy)-",CC=CCC#CCCCCCCCCOC1CCCCO1,,,,,,
9439,109440,"2-Pentenedioic acid, 4-(3,7-dimethyloctylidene)-3-methyl-, disodium salt, (2Z,4E)-",CC(C)CCCC(C)CC=C(C(=CC(=O)[O-])C)C(=O)[O-].[Na+].[Na+],,,,,,
9440,109441,"4-(3,7-Dimethyloctylidene)-3-methylpent-2-enedioic acid",CC(C)CCCC(C)CC=C(C(=CC(=O)O)C)C(=O)O,,,,,,
9441,109442,"Magnesium, bromo[8-[(tetrahydro-2H-pyran-2-yl)oxy]-1-octynyl]-",[C-]#CCCCCCCOC1CCCCO1.[Mg+2].[Br-],,,,,,
9442,109443,"1,4-Benzenedicarboxamide, N,N'-bis(2-hydroxy-1-methyl-2-phenylethyl)-",CC(C(C1=CC=CC=C1)O)NC(=O)C2=CC=C(C=C2)C(=O)NC(C)C(C3=CC=CC=C3)O,,,,,,
9443,109444,"1,4-Benzenedicarboxamide, N,N'-bis(2-hydroxy-2-phenylethyl)-",C1=CC=C(C=C1)C(CNC(=O)C2=CC=C(C=C2)C(=O)NCC(C3=CC=CC=C3)O)O,,,,,,
9444,109445,6-(Isopropyl)-3-methylcyclohex-2-en-1-yl formate,CC1=CC(C(CC1)C(C)C)OC=O,,,,,,
9445,109446,CID 109446,CCCCCCCCC(C(CCCCCCCC(=O)OCCCC)S(=O)(=O)[O-])O.[Na+],,,,,,
9446,109447,1-Butoxy-10-hydroxy-1-oxooctadecane-9-sulfonic acid,CCCCCCCCC(C(CCCCCCCC(=O)OCCCC)S(=O)(=O)O)O,,,,,,
9447,109448,Pigment Yellow 155,CC(=O)C(C(=O)NC1=CC=C(C=C1)NC(=O)C(C(=O)C)N=NC2=C(C=CC(=C2)C(=O)OC)C(=O)OC)N=NC3=C(C=CC(=C3)C(=O)OC)C(=O)OC,,,,,,
9448,109449,"3,5,8,10-Tetraoxadodecane, 4,9-diethyl-6-methyl-",CCC(OCC)OCC(C)OC(CC)OCC,,,,,,
9449,109450,"Amines, di-C12-15-alkylmethyl",CCCCCCCC(C)CCCCNCCCCCCCCC(C)CCC,,,,,,
9450,109451,4-Methyl-1-heptanol,CCCC(C)CCCO,,,,,,
9451,109452,"Nonane-1,8-diol",CC(CCCCCCCO)O,,,,,,
9452,109453,8-Bromo-9-chlorododec-1-ene,CCCC(C(CCCCCC=C)Br)Cl,,,,,,
9453,109454,"7-Bromo-6-methoxy-2,7-dimethyloctan-1-ol",CC(CCCC(C(C)(C)Br)OC)CO,,,,,,
9454,109455,"2-Methoxy-4-(4-methyl-1,3-dioxolan-2-yl)phenol",CC1COC(O1)C2=CC(=C(C=C2)O)OC,,,,,,
9455,109456,"6-Methoxy-2,7-dimethyloct-6-en-1-ol",CC(CCCC(=C(C)C)OC)CO,,,,,,
9456,109457,"2-Ethoxy-4-(4-methyl-1,3-dioxolan-2-yl)phenol",CCOC1=C(C=CC(=C1)C2OCC(O2)C)O,,,,,,
9457,109458,Isocyclogeraniol,CC1CC(=CC(C1CO)C)C,,,,,,
9458,109459,2-Aminobutyl hydrogen sulfate,CCC(COS(=O)(=O)O)N,,,,,,
9459,109460,"1-(Bis(2-(1,3-dimethylbutylideneamino)ethyl)amino)-3-phenoxypropan-2-ol",CC(C)CC(=NCCN(CCN=C(C)CC(C)C)CC(COC1=CC=CC=C1)O)C,,,,,,
9460,109461,"2,4-Pentanediamine, N2-cyclohexyl-4-methyl-",CC(CC(C)(C)N)NC1CCCCC1,,,,,,
9461,109462,CID 109462,CCCCCCCCC(CCCCCCCCC(=O)OCC(CC)CCCC)OS(=O)(=O)[O-].[Na+],,,,,,
9462,109463,2-Ethylhexyl 10-sulfooxyoctadecanoate,CCCCCCCCC(CCCCCCCCC(=O)OCC(CC)CCCC)OS(=O)(=O)O,,,,,,
9463,109464,Phenylacetaldehyde diisoamyl acetal,CC(C)CCOC(CC1=CC=CC=C1)OCCC(C)C,,,,,,
9464,109465,gamma-Methylbenzenehexanenitrile,CC(CCC#N)CCC1=CC=CC=C1,,,,,,
9465,109466,"Butanal, 3-(heptyloxy)-2-oxo-",CCCCCCCOC(C)C(=O)C=O,,,,,,
9466,109467,Citronellyl anthranilate,CC(CCC=C(C)C)CCOC(=O)C1=CC=CC=C1N,,,,,,
9467,109468,Tetrahydroionyl acetate,CC1CCCC(C1CCC(C)OC(=O)C)(C)C,,,,,,
9468,109469,"3-Buten-2-ol, 3-methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-, 2-acetate",CC1=CCCC(C1C=C(C)C(C)OC(=O)C)(C)C,,,,,,
9469,109470,"2-Butenal, 2-methyl-4-(2,6,6-trimethyl-2-cyclohexen-1-yl)-",CC1=CCCC(C1CC=C(C)C=O)(C)C,,,,,,
9470,109471,"1,3-Propanediol, 2-((2,3-dibromopropoxy)methyl)-2-ethyl-, ester with boric acid (H3BO3) (3:1)",B(OCC(CC)(CO)COCC(CBr)Br)(OCC(CC)(CO)COCC(CBr)Br)OCC(CC)(CO)COCC(CBr)Br,,,,,,
9471,109472,"2-Methyl-1-(2,2,6-trimethylcyclohex-3-en-1-yl)pent-1-en-3-one",CCC(=O)C(=CC1C(CC=CC1(C)C)C)C,,,,,,
9472,109473,N-(2-Sulfoethyl)-2-thio-4-ketotetrahydrooxazole,CCN1C(=O)C(OC1=S)S(=O)(=O)O,,,,,,
9473,109474,"Pentaric acid, calcium salt",C(C(C(=O)[O-])O)(C(C(=O)[O-])O)O.[Ca+2],,,,,,
9474,109475,"2,3,4-Trihydroxypentanedioic acid",C(C(C(=O)O)O)(C(C(=O)O)O)O,,,,,,
9475,109476,"4,4,6-Trimethyl-alpha-propyl-1,3-dioxane-2-propanol",CCCC(CCC1OC(CC(O1)(C)C)C)O,,,,,,
9476,109477,"1,3-Dioxane, 2-(3,7-dimethyl-6-octenyl)-4,4,6-trimethyl-",CC1CC(OC(O1)CCC(C)CCC=C(C)C)(C)C,,,,,,
9477,109478,"Acetic acid, butoxyhydroxy-, butyl ester",CCCCOC(C(=O)OCCCC)O,,,,,,
9478,109479,"Decanoic acid, mixed diesters with octanoic acid and propylene glycol",CCCCCCCCCC(=O)O.CCCCCCCC(=O)O.CC(CO)O,,,,,,
9479,109480,Bis(diethyleneglycoxy)titanium dilactate,CC(C(=O)O)O.CC(C(=O)O)O.C(COCCO)O.C(COCCO)O.[Ti],,,,,,
9480,109481,"Benzenamine, ar-(1,7,7-trimethylbicyclo(2.2.1)hept-2-yl)-N-((1,7,7-trimethylbicyclo(2.2.1)hept-2-yl)phenyl)-",CC1C2CCC(C1C3=CC=C(C=C3)NC4=CC=CC(=C4)C5C(C6CCC5C6(C)C)C)C2(C)C,,,,,,
9481,109482,6-Methyldecan-1-amine,CCCCC(C)CCCCCN,,,,,,
9482,109483,"Amines, C15-18-sec-alkyl",CCCCCCCCC(C)CCCCCN,,,,,,
9483,109484,2-Chloroundecyl hydrogen sulfate,CCCCCCCCCC(COS(=O)(=O)O)Cl,,,,,,
9484,109485,Di-mu-chlorochlorotris(dimethyl orthoborato-O'')dialuminium,B([O-])(OC)OC.B([O-])(OC)OC.B([O-])(OC)OC.[Al+3].[Al+3].[Cl-].[Cl-],,,,,,
9485,109486,Einecs 268-272-5,[Li+].CC1=NN(C(=C1N=NC2=C(C=CC(=C2)S(=O)(=O)N)[O-])[O-])C3=CC=CC=C3.CC1=NN(C(=C1N=NC2=C(C=CC(=C2)S(=O)(=O)N)[O-])[O-])C3=CC=CC=C3.[Cr+3],,,,,,
9486,109487,3-(1-Phenyl-3-methyl-5-hydroxy-1H-pyrazol-4-ylazo)-4-hydroxybenzenesulfonamide,CC1=C(C(=O)N(N1)C2=CC=CC=C2)N=NC3=C(C=CC(=C3)S(=O)(=O)N)O,,,,,,
9487,109488,Dicyclopentadienyl propionate,CCC(=O)OC1=C2C3CCC(C3)C2C=C1,,,,,,
9488,109489,"1,3-Diethyl-2-methyl-1H-benzimidazole (SP-4-1)-tetrachloroaurate",CCN1C(=[N+](C2=CC=CC=C21)CC)C.[Cl-].[Cl-].[Cl-].[Cl-].[Au+3],,,,,,
9489,109490,"1,3-Diethyl-2-methyl-1H-benzimidazol-3-ium",CCN1C(=[N+](C2=CC=CC=C21)CC)C,,,,,,
9490,109491,"1-Allyl-1,1-dimethyl-2-stearoylhydrazinium chloride",CCCCCCCCCCCCCCCCCC(=O)N[N+](C)(C)CC=C.[Cl-],,,,,,
9491,109492,Dimethyl-(octadecanoylamino)-prop-2-enylazanium,CCCCCCCCCCCCCCCCCC(=O)N[N+](C)(C)CC=C,,,,,,
9492,109493,"Benzoxazolium, 3-(2-carboxyethyl)-2-[2-(phenylamino)ethenyl]-, bromide",C1=CC=C(C=C1)NC=CC2=[N+](C3=CC=CC=C3O2)CCC(=O)O.[Br-],,,,,,
9493,109494,3-(2-Carboxyethyl)-2-(2-anilinoethenyl)benzoxazolium,C1=CC=C(C=C1)NC=CC2=[N+](C3=CC=CC=C3O2)CCC(=O)O,,,,,,
9494,109495,"Benzoxazolium, 3-(2-carboxyethyl)-2-methyl-, bromide",CC1=[N+](C2=CC=CC=C2O1)CCC(=O)O.[Br-],,,,,,
9495,109496,3-(2-Carboxyethyl)-2-methylbenzoxazolium,CC1=[N+](C2=CC=CC=C2O1)CCC(=O)O,,,,,,
9496,109497,"Dimagnesium 4,4'-carbonyldiphthalate",C1=CC(=C(C=C1C(=O)C2=CC(=C(C=C2)C(=O)[O-])C(=O)[O-])C(=O)[O-])C(=O)[O-].[Mg+2].[Mg+2],,,,,,
9497,109498,"Dicupric 4,4'-carbonyldiphthalate",C1=CC(=C(C=C1C(=O)C2=CC(=C(C=C2)C(=O)[O-])C(=O)[O-])C(=O)[O-])C(=O)[O-].[Cu+2].[Cu+2],,,,,,
9498,109499,"Tetracesium 4,4'-carbonyldiphthalate",C1=CC(=C(C=C1C(=O)C2=CC(=C(C=C2)C(=O)[O-])C(=O)[O-])C(=O)[O-])C(=O)[O-].[Cs+].[Cs+].[Cs+].[Cs+],,,,,,
9499,109500,"Tetrarubidium 4,4'-carbonyldiphthalate",C1=CC(=C(C=C1C(=O)C2=CC(=C(C=C2)C(=O)[O-])C(=O)[O-])C(=O)[O-])C(=O)[O-].[Rb+].[Rb+].[Rb+].[Rb+],,,,,,
9500,109501,"Tetrasodium 4,4'-carbonyldiphthalate",C1=CC(=C(C=C1C(=O)C2=CC(=C(C=C2)C(=O)[O-])C(=O)[O-])C(=O)[O-])C(=O)[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
9501,109502,"Phosphoric acid, dibutyl ester, compd. with 4-tetrapropylenebenzenamine (1:1)",CCCCCCCCCCCCC1=CC=C(C=C1)N.CCCCOP(=O)(O)OCCCC,,,,,,
9502,109503,3-Methylphenyl hydrogen sulfate,CC1=CC(=CC=C1)OS(=O)(=O)O,,,,,,
9503,109504,"Silane, [2-[3(or 4)-(chloromethyl)phenyl]ethyl]trimethoxy-",CO[Si](CCC1=CC=C(C=C1)CCl)(OC)OC,,,,,,
9504,109505,"Decanoic acid, mixed esters with dipentaerythritol, octanoic acid and valeric acid",CCCCCCCCCC(=O)O.CCCCCCCC(=O)O.CCCCC(=O)O.C(C(CO)(CO)COCC(CO)(CO)CO)O,,,,,,
9505,109506,"Octanoic acid, mixed diesters with hexanoic acid and triethylene glycol",CCCCCCCC(=O)O.CCCCCC(=O)O.C(COCCOCCO)O,,,,,,
9506,109507,Allyl trimethylhexanoate,CCC(C)(C)CCCC(=O)OCC=C,,,,,,
9507,109508,2-(2-Methyl-1H-imidazol-1-YL)-1-propanol,CC1=NC=CN1C(C)CO,,,,,,
9508,109509,CID 109509,[Li+].[B-](CC)(CC)(C1=CC=CC=C1)C2=CC=CC=C2,,,,,,
9509,109510,Diethyl(diphenyl)boranuide,[B-](CC)(CC)(C1=CC=CC=C1)C2=CC=CC=C2,,,,,,
9510,109511,CID 109511,[Li+].[B-](C)(C)(C1=CC=CC=C1)C2=CC=CC=C2,,,,,,
9511,109512,Dimethyl(diphenyl)boranuide,[B-](C)(C)(C1=CC=CC=C1)C2=CC=CC=C2,,,,,,
9512,109513,"1H-Benz[f]indene-1,3(2H)-dione, 5,8-dibromo-2-(3-hydroxy-2-quinolinyl)-",C1=CC=C2C(=C1)C=C(C(=N2)C3C(=O)C4=CC5=C(C=CC(=C5C=C4C3=O)Br)Br)O,,,,,,
9513,109514,CID 109514,C1=CC=C2C(=C1)C=CC(=C2N=NC3=CC=CC4=C3C=CC(=C4)S(=O)(=O)[O-])O.[Na+],,,,,,
9514,109515,C2BL8C9Zwy,C1=CC=C2C(=C1)C=CC(=C2N=NC3=CC=CC4=C3C=CC(=C4)S(=O)(=O)O)O,,,,,,
9515,109516,"Isooctadecanamide, N-[2-[(2-aminoethyl)amino]ethyl]-",CC(C)CCCCCCCCCCCCCCC(=O)NCCNCCN,,,,,,
9516,109517,Diisooctyl p-octylphenyl phosphite,CCCCCCCCC1=CC=C(C=C1)P(=O)(OCCCCCC(C)C)OCCCCCC(C)C,,,,,,
9517,109518,"Carbamic acid, (3-isocyanatomethylphenyl)-, [[(diethoxyphosphinyl)methyl]imino]di-2,1-ethanediyl ester",CCOP(=O)(CN(CCOC(=O)NC1=CC=CC(=C1)CN=C=O)CCOC(=O)NC2=CC=CC(=C2)CN=C=O)OCC,,,,,,
9518,109519,CID 109519,C1=CC(=CC(=C1)S(=O)(=O)[O-])NC2=NC(=NC(=N2)Cl)NC3=CC(=C(C=C3)S(=O)(=O)[O-])NN=C4C(=CC5=C(C4=N)C(=O)C(=NNC6=C(C=CC(=C6)NC7=NC(=NC(=N7)NC8=CC(=CC=C8)S(=O)(=O)[O-])Cl)S(=O)(=O)[O-])C(=C5)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],,,,,,
9519,109520,CID 109520,C1=CC(=CC(=C1)S(=O)(=O)O)NC2=NC(=NC(=N2)Cl)NC3=CC(=C(C=C3)S(=O)(=O)O)NN=C4C(=CC5=C(C4=N)C(=O)C(=NNC6=C(C=CC(=C6)NC7=NC(=NC(=N7)NC8=CC(=CC=C8)S(=O)(=O)O)Cl)S(=O)(=O)O)C(=C5)S(=O)(=O)O)S(=O)(=O)O,,,,,,
9520,109521,"beta-Alanine, N-(2-methoxy-5-nitrophenyl)-, 2-methoxyethyl ester",COCCOC(=O)CCNC1=C(C=CC(=C1)[N+](=O)[O-])OC,,,,,,
9521,109522,2-Methoxyethyl N-(5-amino-2-methoxyphenyl)-beta-alaninate,COCCOC(=O)CCNC1=C(C=CC(=C1)N)OC,,,,,,
9522,109523,"2-Naphthalenesulfonic acid, 4-hydroxy-3-[(4-methoxy-2-sulfophenyl)azo]-6-(methylamino)-",CNC1=CC2=C(C(=C(C=C2C=C1)S(=O)(=O)O)N=NC3=C(C=C(C=C3)OC)S(=O)(=O)O)O,,,,,,
9523,109524,CID 109524,CC(=O)CNC1=CC2=C(C(=C(C=C2C=C1)S(=O)(=O)[O-])N=NC3=CC(=CC=C3)P(=O)(O)O)O.[Na+],,,,,,
9524,109525,4-Hydroxy-6-(2-oxopropylamino)-3-[(3-phosphonophenyl)diazenyl]naphthalene-2-sulfonic acid,CC(=O)CNC1=CC2=C(C(=C(C=C2C=C1)S(=O)(=O)O)N=NC3=CC(=CC=C3)P(=O)(O)O)O,,,,,,
9525,109526,CID 109526,C1=CC(=CC(=C1)P(=O)(O)O)N=NC2C(=NN(C2=O)C3=CC=C(C=C3)S(=O)(=O)[O-])C(=O)O.[Na+],,,,,,
9526,109527,"4,5-Dihydro-5-oxo-4-((3-phosphonophenyl)azo)-1-(4-sulphophenyl)-1H-pyrazole-3-carboxylic acid",C1=CC(=CC(=C1)P(=O)(O)O)N=NC2C(=NN(C2=O)C3=CC=C(C=C3)S(=O)(=O)O)C(=O)O,,,,,,
9527,109528,"Benzoic acid, 2-[3-(2,4-dichlorophenyl)-1-ethyl-2-triazenyl]-5-sulfo-, disodium salt",CCN(C1=C(C=C(C=C1)S(=O)(=O)[O-])C(=O)[O-])N=NC2=C(C=C(C=C2)Cl)Cl.[Na+].[Na+],,,,,,
9528,109529,"2-[[(2,4-Dichlorophenyl)diazenyl]-ethylamino]-5-sulfobenzoic acid",CCN(C1=C(C=C(C=C1)S(=O)(=O)O)C(=O)O)N=NC2=C(C=C(C=C2)Cl)Cl,,,,,,
9529,109530,"Ethanesulfonic acid, 2,2'-[(2,2'-dimethoxy[1,1'-biphenyl]-4,4'-diyl)bis(1-methyl-2-triazene-3,1-diyl)]bis-, disodium salt",CN(C1=CC(=C(C=C1)C2=C(C=C(C=C2)N(C)N=NCCS(=O)(=O)[O-])OC)OC)N=NCCS(=O)(=O)[O-].[Na+].[Na+],,,,,,
9530,109531,2-[[3-methoxy-4-[2-methoxy-4-[methyl-(2-sulfoethyldiazenyl)amino]phenyl]-N-methylanilino]diazenyl]ethanesulfonic acid,CN(C1=CC(=C(C=C1)C2=C(C=C(C=C2)N(C)N=NCCS(=O)(=O)O)OC)OC)N=NCCS(=O)(=O)O,,,,,,
9531,109532,"Ethanesulfonic acid, 2,2'-[(3,3'-dichloro[1,1'-biphenyl]-4,4'-diyl)bis(1-methyl-2-triazene-3,1-diyl)]bis-, disodium salt",CN(C1=C(C=C(C=C1)C2=CC(=C(C=C2)N(C)N=NCCS(=O)(=O)[O-])Cl)Cl)N=NCCS(=O)(=O)[O-].[Na+].[Na+],,,,,,
9532,109533,2-[[2-chloro-4-[3-chloro-4-[methyl-(2-sulfoethyldiazenyl)amino]phenyl]-N-methylanilino]diazenyl]ethanesulfonic acid,CN(C1=C(C=C(C=C1)C2=CC(=C(C=C2)N(C)N=NCCS(=O)(=O)O)Cl)Cl)N=NCCS(=O)(=O)O,,,,,,
9533,109534,Diethylaminoethyl stearamide phosphate,CCCCCCCCCCCCCCCCCC(=O)NCC[NH+](CC)CC.OP(=O)(O)[O-],,,,,,
9534,109535,"Benzoic acid, 2-[(6-amino-1-hydroxy-3-sulfo-2-naphthalenyl)azo]-",C1=CC=C(C(=C1)C(=O)O)N=NC2=C(C=C3C=C(C=CC3=C2O)N)S(=O)(=O)O,,,,,,
9535,109536,"Octanamide, N-[2-[[2-[[2-[(2-aminoethyl)amino]ethyl]amino]ethyl]amino]ethyl]-",CCCCCCCC(=O)NCCNCCNCCNCCN,,,,,,
9536,109537,"2-Naphthalenecarboxamide, 4-((4-chloro-2-methylphenyl)azo)-3-hydroxy-N-(2-methylphenyl)-",CC1=CC=CC=C1NC(=O)C2=CC3=CC=CC=C3C(=C2O)N=NC4=C(C=C(C=C4)Cl)C,,,,,,
9537,109538,"2-Naphthalenecarboxamide, N-(2,5-dichlorophenyl)-3-hydroxy-4-[[2-methoxy-5-[(phenylamino)carbonyl]phenyl]azo]-",COC1=C(C=C(C=C1)C(=O)NC2=CC=CC=C2)N=NC3=C(C(=CC4=CC=CC=C43)C(=O)NC5=C(C=CC(=C5)Cl)Cl)O,,,,,,
9538,109539,Dipotassium 2-butoxyethyl phosphate,CCCCOCCOP(=O)([O-])[O-].[K+].[K+],,,,,,
9539,109540,"1,2-Ethanediamine, N-(2-aminoethyl)-, 4-methylbenzenesulfonate",CC1=CC=C(C=C1)S(=O)(=O)O.C(CNCCN)N,,,,,,
9540,109541,"Platinum, [2-(amino-kappaN)ethanolato(2-)-kappaO]-",C(CO)[NH-].[Pt],,,,,,
9541,109542,1-Benzyl-3-carboxylatopyridinium sodium chloride,C1=CC=C(C=C1)C[N+]2=CC=CC(=C2)C(=O)[O-].[Na+].[Cl-],,,,,,
9542,109543,"2-[5-[2-(3-Ethyl-5,6-dimethyl-1,3-benzoxazol-2-ylidene)ethylidene]-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]acetic acid",CCN1C2=C(C=C(C(=C2)C)C)OC1=CC=C3C(=O)N(C(=S)S3)CC(=O)O,,,,,,
9543,109544,CID 109544,CCCCCCOC(=O)CC(C(=O)OCC(CC)CCCC)S(=O)(=O)[O-].[Na+],,,,,,
9544,109545,"1-(2-Ethylhexoxy)-4-hexoxy-1,4-dioxobutane-2-sulfonic acid",CCCCCCOC(=O)CC(C(=O)OCC(CC)CCCC)S(=O)(=O)O,,,,,,
9545,109546,"Propanenitrile, 3-[[2-(acetyloxy)ethyl][4-[(6-nitro-2-benzothiazolyl)azo]phenyl]amino]-",CC(=O)OCCN(CCC#N)C1=CC=C(C=C1)N=NC2=NC3=C(S2)C=C(C=C3)[N+](=O)[O-],,,,,,
9546,109547,"1,5-Dihydroxy-4-[(2-hydroxyethyl)amino]-8-(phenylamino)anthraquinone",C1=CC=C(C=C1)NC2=C3C(=C(C=C2)O)C(=O)C4=C(C=CC(=C4C3=O)O)NCCO,,,,,,
9547,109548,"Acetaldehyde, [(3Z)-3-hexen-1-yloxy]-",CCC=CCCOCC=O,,,,,,
9548,109549,"Cyclopentanone, 2-(3-hexenyl)-",CCC=CCCC1CCCC1=O,,,,,,
9549,109550,cis-3-Hexenyl cinnamate,CCC=CCCOC(=O)C=CC1=CC=CC=C1,,,,,,
9550,109551,(Z)-hex-3-enyl 2-oxopropanoate,CCC=CCCOC(=O)C(=O)C,,,,,,
9551,109552,Hex-2-en-1-yl 2-hydroxybenzoate,CCCC=CCOC(=O)C1=CC=CC=C1O,,,,,,
9552,109553,Hex-2-en-1-yl phenylacetate,CCCC=CCOC(=O)CC1=CC=CC=C1,,,,,,
9553,109554,"1,1-Dimethoxydec-4-ene",CCCCCC=CCCC(OC)OC,,,,,,
9554,109555,Dihydrogen bis(2-((6-amino-1-hydroxy-3-sulpho-2-naphthyl)azo)benzoato(3-))chromate(2-),[H+].[H+].C1=CC(=C(C=C1C2=CC(=C(C=C2)N=NC3=C(C=C4C=C(C=CC4=C3O)N)S(=O)(=O)[O-])C(=O)[O-])C(=O)[O-])N=NC5=C(C=C6C=C(C=CC6=C5O)N)S(=O)(=O)[O-].[Cr+2],,,,,,
9555,109556,2-[(6-Amino-1-hydroxy-3-sulfonaphthalen-2-yl)diazenyl]-5-[4-[(6-amino-1-hydroxy-3-sulfonaphthalen-2-yl)diazenyl]-3-carboxyphenyl]benzoic acid,C1=CC(=C(C=C1C2=CC(=C(C=C2)N=NC3=C(C=C4C=C(C=CC4=C3O)N)S(=O)(=O)O)C(=O)O)C(=O)O)N=NC5=C(C=C6C=C(C=CC6=C5O)N)S(=O)(=O)O,,,,,,
9556,109557,CID 109557,C(C(=O)[O-])OC=C(N)[O-].[Ni+2],,,,,,
9557,109558,CID 109558,C(C(=O)O)OC=C(N)O,,,,,,
9558,109559,CID 109559,C(C(=O)[O-])OC=C(N)[O-].[Co+2],,,,,,
9559,109560,"Methanaminium, N,N,N-trimethyl-, (OC-6-11)-hexahydroxyplatinate(2-) (2:1)",C[N+](C)(C)C.C[N+](C)(C)C.[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Pt+4],,,,,,
9560,109561,CID 109561,C1=CC=C2C(=C1)[N+](=C(O2)CC=CC3=[N+](C4=CC=CC=C4O3)CCC(=O)[O-])CCC(=O)[O-],,,,,,
9561,109562,CID 109562,C1=CC=C2C(=C1)[N+](=C(O2)CC=CC3=[N+](C4=CC=CC=C4O3)CCC(=O)O)CCC(=O)O,,,,,,
9562,109563,"Benzenemethanamine, 4-nitro-N-propyl-, monohydrochloride",CCCNCC1=CC=C(C=C1)[N+](=O)[O-].Cl,,,,,,
9563,109564,N-4-Nitrobenzyl-N-n-propylamine,CCCNCC1=CC=C(C=C1)[N+](=O)[O-],,,,,,
9564,109565,Zinc ammonium citrate,C(C(=O)O)C(CC(=O)[O-])(C(=O)[O-])O.N.[Zn+2],,,,,,
9565,109566,2-(hydroxymethyl)-1-[N'-(hydroxymethyl)carbamimidoyl]guanidine;hydrochloride,C(N=C(N)NC(=NCO)N)O.Cl,,,,,,
9566,109567,"1,5-Bis(hydroxymethyl)biguanide",C(N=C(N)NC(=NCO)N)O,,,,,,
9567,109568,"9-Octadecenoic acid (9Z)-, 2-ethoxyethyl ester",CCCCCCCCC=CCCCCCCCC(=O)OCCOCC,,,,,,
9568,109569,"Ethanaminium, 2-hydroxy-N,N-dimethyl-N-(2-((1-oxooctadecyl)amino)ethyl)-, methyl sulfate (salt)",CCCCCCCCCCCCCCCCCC(=O)NCC[N+](C)(C)CCO.COS(=O)(=O)[O-],,,,,,
9569,109570,"2-Hydroxy-N,N-dimethyl-N-[2-[(1-oxooctadecyl)amino]ethyl]ethanaminium",CCCCCCCCCCCCCCCCCC(=O)NCC[N+](C)(C)CCO,,,,,,
9570,109571,2-Hydroxyethyl-dimethyl-[2-(octadec-9-enoylamino)ethyl]azanium;methyl sulfate,CCCCCCCCC=CCCCCCCCC(=O)NCC[N+](C)(C)CCO.COS(=O)(=O)[O-],,,,,,
9571,109572,2-Hydroxyethyl-dimethyl-[2-(octadec-9-enoylamino)ethyl]azanium,CCCCCCCCC=CCCCCCCCC(=O)NCC[N+](C)(C)CCO,,,,,,
9572,109573,"N,N',N'',N'''-(Carbonylbis(nitrilodiethylene))tetrastearamide diacetate",CCCCCCCCCCCCCCCCCC(=O)NCCN(CCNC(=O)CCCCCCCCCCCCCCCCC)C(=O)N(CCNC(=O)CCCCCCCCCCCCCCCCC)CCNC(=O)CCCCCCCCCCCCCCCCC.CC(=O)O.CC(=O)O,,,,,,
9573,109574,"Octadecanamide, N,N',N'',N'''-(carbonylbis(nitrilodi-2,1-ethanediyl)tetrakis-",CCCCCCCCCCCCCCCCCC(=O)NCCN(CCNC(=O)CCCCCCCCCCCCCCCCC)C(=O)N(CCNC(=O)CCCCCCCCCCCCCCCCC)CCNC(=O)CCCCCCCCCCCCCCCCC,,,,,,
9574,109575,Stearamidoethyl ethanolamine monophosphate,CCCCCCCCCCCCCCCCCC(=O)NCCNCCO.OP(=O)(O)O,,,,,,
9575,109576,"2-Heptadecyl-1-(2-hydroxyethyl)-4,5-dihydro-1H-imidazolium dihydrogen phosphate",CCCCCCCCCCCCCCCCCC1=[N+](CCN1)CCO.OP(=O)(O)[O-],,,,,,
9576,109577,1-(2-Hydroxyethyl)-2-heptadecyl-1-imidazoline-1-ium,CCCCCCCCCCCCCCCCCC1=[N+](CCN1)CCO,,,,,,
9577,109578,"2,7-Naphthalenedisulfonic acid, 4-(acetylamino)-5-hydroxy-6-[[4-[[2-(sulfooxy)ethyl]sulfonyl]phenyl]azo]-",CC(=O)NC1=C2C(=CC(=C1)S(=O)(=O)O)C=C(C(=C2O)N=NC3=CC=C(C=C3)S(=O)(=O)CCOS(=O)(=O)O)S(=O)(=O)O,,,,,,
9578,109579,CID 109579,C1=CC(=CC=C1NC2=C(C=C(C=C2)N(O)O)S(=O)(=O)O)N=NC3=CC(=NC4=C(C=C(C=C4)[N+](=O)[O-])S(=O)(=O)O)C=CC3=O,,,,,,
9579,109580,"Butane, 1-[2-(1,1-dimethylethoxy)ethoxy]-",CCCCOCCOC(C)(C)C,,,,,,
9580,109581,"2-Amino-3,4-dimethylphenol",CC1=C(C(=C(C=C1)O)N)C,,,,,,
9581,109582,"2-(2-Heptadecyl-4,5-dihydro-1H-imidazol-1-yl)ethyl stearate",CCCCCCCCCCCCCCCCCC1=NCCN1CCOC(=O)CCCCCCCCCCCCCCCCC,,,,,,
9582,109583,1-(2-Stearoyloxyethyl)-2-heptadecylimidazoline acetate,CCCCCCCCCCCCCCCCCC1=NCCN1CCOC(=O)CCCCCCCCCCCCCCCCC.CC(=O)O,,,,,,
9583,109584,CID 109584,CCCCCCCCP(=O)([O-])OCC.[K+],,,,,,
9584,109585,Ethyl hydrogen octylphosphonate,CCCCCCCCP(=O)(O)OCC,,,,,,
9585,109586,"Hexanoic acid, 6-[(hydroxymethyl)(phenylsulfonyl)amino]-, compd. with 2,2',2''-nitrilotris[ethanol] (1:1)",C1=CC=C(C=C1)S(=O)(=O)N(CCCCCC(=O)O)CO.C(CO)N(CCO)CCO,,,,,,
9586,109587,6-[(Hydroxymethyl)(phenylsulfonyl)amino]hexanoic acid,C1=CC=C(C=C1)S(=O)(=O)N(CCCCCC(=O)O)CO,,,,,,
9587,109588,1-(2-Cyanoethyl)-2-[4-[(2-ethoxyethyl)ethylamino]phenyl]benz[cd]indolium chloride,CCN(CCOCC)C1=CC=C(C=C1)C2=[N+](C3=CC=CC4=C3C2=CC=C4)CCC#N.[Cl-],,,,,,
9588,109589,1-(2-Cyanoethyl)-2-[4-[(2-ethoxyethyl)ethylamino]phenyl]benz[cd]indol-1-ium,CCN(CCOCC)C1=CC=C(C=C1)C2=[N+](C3=CC=CC4=C3C2=CC=C4)CCC#N,,,,,,
9589,109590,2-[[4-(Diethylamino)phenyl]azo]-6-ethoxy-3-ethylbenzothiazolium chloride,CC[N+]1=C(SC2=C1C=CC(=C2)OCC)N=NC3=CC=C(C=C3)N(CC)CC.[Cl-],,,,,,
9590,109591,2-[[4-(Diethylamino)phenyl]azo]-6-ethoxy-3-ethylbenzothiazol-3-ium,CC[N+]1=C(SC2=C1C=CC(=C2)OCC)N=NC3=CC=C(C=C3)N(CC)CC,,,,,,
9591,109592,3-[[4-[(2-Cyanoethyl)ethylamino]phenyl]azo]-7-(diethylamino)-5-phenylphenazinium chloride,CCN(CC)C1=CC2=[N+](C3=C(C=CC(=C3)N=NC4=CC=C(C=C4)N(CC)CCC#N)N=C2C=C1)C5=CC=CC=C5.[Cl-],,,,,,
9592,109593,3-[[4-[(2-Cyanoethyl)ethylamino]phenyl]azo]-7-(diethylamino)-5-phenylphenazin-5-ium,CCN(CC)C1=CC2=[N+](C3=C(C=CC(=C3)N=NC4=CC=C(C=C4)N(CC)CCC#N)N=C2C=C1)C5=CC=CC=C5,,,,,,
9593,109594,"3H-Indolium, 1,3,3-trimethyl-2-[1-(methylphenylhydrazono)ethyl]-, chloride",CC(=NN(C)C1=CC=CC=C1)C2=[N+](C3=CC=CC=C3C2(C)C)C.[Cl-],,,,,,
9594,109595,"1,3,3-Trimethyl-2-[1-(2-methyl-2-phenylhydrazono)ethyl]-3H-indolium",CC(=NN(C)C1=CC=CC=C1)C2=[N+](C3=CC=CC=C3C2(C)C)C,,,,,,
9595,109596,"3H-Indolium, 5-chloro-2-[2-[4-[(2-hydroxyethyl)methylamino]phenyl]ethenyl]-1,3,3-trimethyl-, chloride",CC1(C2=C(C=CC(=C2)Cl)[N+](=C1C=CC3=CC=C(C=C3)N(C)CCO)C)C.[Cl-],,,,,,
9596,109597,"5-Chloro-2-[2-[4-[(2-hydroxyethyl)(methyl)amino]phenyl]ethenyl]-1,3,3-trimethyl-3H-indolium",CC1(C2=C(C=CC(=C2)Cl)[N+](=C1C=CC3=CC=C(C=C3)N(C)CCO)C)C,,,,,,
9597,109598,"3H-Indolium, 1,3,3-trimethyl-2-[[methyl(4-phenoxyphenyl)hydrazono]methyl]-, chloride",CC1(C2=CC=CC=C2[N+](=C1C=NN(C)C3=CC=C(C=C3)OC4=CC=CC=C4)C)C.[Cl-],,,,,,
9598,109599,"1,3,3-Trimethyl-2-[[2-methyl-2-(4-phenoxyphenyl)hydrazono]methyl]-3H-indolium",CC1(C2=CC=CC=C2[N+](=C1C=NN(C)C3=CC=C(C=C3)OC4=CC=CC=C4)C)C,,,,,,
9599,109600,"3H-Indolium, 1,3,3-trimethyl-2-[[methyl(4-methylphenyl)hydrazono]methyl]-, chloride",CC1=CC=C(C=C1)N(C)N=CC2=[N+](C3=CC=CC=C3C2(C)C)C.[Cl-],,,,,,
9600,109601,"1,3,3-Trimethyl-2-[[2-methyl-2-(4-methylphenyl)hydrazono]methyl]-3H-indolium",CC1=CC=C(C=C1)N(C)N=CC2=[N+](C3=CC=CC=C3C2(C)C)C,,,,,,
9601,109602,"Propanamide, N-[2-[(2-cyano-6-iodo-4-nitrophenyl)azo]-5-(dimethylamino)phenyl]-",CCC(=O)NC1=C(C=CC(=C1)N(C)C)N=NC2=C(C=C(C=C2I)[N+](=O)[O-])C#N,,,,,,
9602,109603,"beta-Alanine, N-[3-(acetylamino)-4-[(2-chloro-4-nitrophenyl)azo]phenyl]-N-(3-ethoxy-3-oxopropyl)-, ethyl ester",CCOC(=O)CCN(CCC(=O)OCC)C1=CC(=C(C=C1)N=NC2=C(C=C(C=C2)[N+](=O)[O-])Cl)NC(=O)C,,,,,,
9603,109604,"Benzenemethanaminium, N,N-dimethyl-3-sulfo-N-(3-sulfophenyl)-, inner salt, calcium salt",C[N+](C)(CC1=CC(=CC=C1)S(=O)(=O)[O-])C2=CC(=CC=C2)S(=O)(=O)[O-].C[N+](C)(CC1=CC(=CC=C1)S(=O)(=O)[O-])C2=CC(=CC=C2)S(=O)(=O)[O-].[Ca+2],,,,,,
9604,109605,"N,N-Dimethyl-3-sulfonato-N-(3-sulfobenzyl)benzenaminium",C[N+](C)(CC1=CC(=CC=C1)S(=O)(=O)O)C2=CC(=CC=C2)S(=O)(=O)O,,,,,,
9605,109606,"Thiols, C4-10, gamma-omega-perfluoro",C(CS)C(C(F)(F)F)(F)F,,,,,,
9606,109607,2-(Perfluorobutyl)ethanethiol,C(CS)C(C(C(C(F)(F)F)(F)F)(F)F)(F)F,,,,,,
9607,109608,Perfluoroalkyl(C8-C18)ethyl mercaptan,C(CS)C(C(C(CC(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
9608,109609,CID 109609,C1=CC(=C(C=C1C2=CC(=C(C=C2)[O-])NNC3=C(C4=C(C=C(C=C4C=C3S(=O)(=O)[O-])S(=O)(=O)[O-])O)[O-])O)N=NC5=C(C=CC6=CC(=CC(=C65)[O-])S(=O)(=O)[O-])[O-].[Na+].[Na+].[Na+].[Cu+2].[Cu+2],,,,,,
9609,109610,"3-[2-[5-[4-[(2,8-Dihydroxy-6-sulfonaphthalen-1-yl)diazenyl]-3-hydroxyphenyl]-2-hydroxyphenyl]hydrazinyl]-4,5-dihydroxynaphthalene-2,7-disulfonic acid",C1=CC(=C(C=C1C2=CC(=C(C=C2)O)NNC3=C(C4=C(C=C(C=C4C=C3S(=O)(=O)O)S(=O)(=O)O)O)O)O)N=NC5=C(C=CC6=CC(=CC(=C65)O)S(=O)(=O)O)O,,,,,,
9610,109611,CID 109611,[Li+].[B-](C1=CC=C(C=C1)F)(C2=CC=C(C=C2)F)(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F,,,,,,
9611,109612,Tetra(4-fluorophenyl) boronanion,[B-](C1=CC=C(C=C1)F)(C2=CC=C(C=C2)F)(C3=CC=C(C=C3)F)C4=CC=C(C=C4)F,,,,,,
9612,109613,"Cuprate(3-), (mu-(4-(2-(3,3'-di(hydroxy-kappaO)-4'-(2-(1-(hydroxy-kappaO)-6-(phenylamino)-3-sulfo-2-naphthalenyl)diazenyl-kappaN1)(1,1'-biphenyl)-4-yl)diazenyl-kappaN1)-3-(hydroxy-kappaO)-2,7-naphthalenedisulfonato(7-)))di-, sodium (1:3)",C1=CC=C(C=C1)NC2=CC3=CC(=C(C(=C3C=C2)[O-])N=NC4=C(C=C(C=C4)C5=CC(=C(C=C5)[O-])N=NC6=C7C=CC(=CC7=CC(=C6[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Cu+2].[Cu+2],,,,,,
9613,109614,"4-[[5-[4-[(6-Anilino-1-hydroxy-3-sulfonaphthalen-2-yl)diazenyl]-3-hydroxyphenyl]-2-hydroxyphenyl]diazenyl]-3-hydroxynaphthalene-2,7-disulfonic acid",C1=CC=C(C=C1)NC2=CC3=CC(=C(C(=C3C=C2)O)N=NC4=C(C=C(C=C4)C5=CC(=C(C=C5)O)N=NC6=C7C=CC(=CC7=CC(=C6O)S(=O)(=O)O)S(=O)(=O)O)O)S(=O)(=O)O,,,,,,
9614,109615,2-Amino-2-methylpropan-1-ol;2-[methyl(octadec-9-enoyl)amino]acetic acid,CCCCCCCCC=CCCCCCCCC(=O)N(C)CC(=O)O.CC(C)(CO)N,,,,,,
9615,109616,"7,10-Bis(hydroxymethyl)-3,3-dimethoxy-2-oxa-7,10-diaza-3-silaundecan-11-ol",CO[Si](CCCN(CCN(CO)CO)CO)(OC)OC,,,,,,
9616,109617,2-(3-Hydroxyphenoxy)ethyl acetate,CC(=O)OCCOC1=CC=CC(=C1)O,,,,,,
9617,109618,"3,7-Dimethyl-1-[2,2,2-trichloro-1-(3,7-dimethylocta-2,6-dienoxy)ethoxy]octa-2,6-diene",CC(=CCCC(=CCOC(C(Cl)(Cl)Cl)OCC=C(C)CCC=C(C)C)C)C,,,,,,
9618,109619,"Benzeneacetic acid, compd. with isoquinoline (1:1)",C1=CC=C(C=C1)CC(=O)O.C1=CC=C2C=NC=CC2=C1,,,,,,
9619,109620,Ethyl 2-methyl-4-oxo-4H-pyran-3-yl carbonate,CCOC(=O)OC1=C(OC=CC1=O)C,,,,,,
9620,109621,3-Methylphenyl hexanoate,CCCCCC(=O)OC1=CC=CC(=C1)C,,,,,,
9621,109622,"Octadecanamide, N-(2-hydroxyethyl)-N-[2-[(1-oxooctadecyl)amino]ethyl]-, phosphate (1:1) (salt)",CCCCCCCCCCCCCCCCCC(=O)NCCN(CCO)C(=O)CCCCCCCCCCCCCCCCC.OP(=O)(O)O,,,,,,
9622,109623,"1H-Imidazolium, 1-ethyl-2-(8-heptadecenyl)-4,5-dihydro-3-(2-hydroxyethyl)-, ethyl sulfate (salt)",CCCCCCCCC=CCCCCCCCC1=[N+](CCN1CC)CCO.CCOS(=O)(=O)[O-],,,,,,
9623,109624,"2-Benzothiazolamine, 4-hydrazino-",C1=CC(=C2C(=C1)SC(=N2)N)NN,,,,,,
9624,109625,"Glycine, N-[2-[(carboxymethyl)(2-hydroxyethyl)amino]ethyl]-N-(1-oxododecyl)-, disodium salt",CCCCCCCCCCCC(=O)N(CCN(CCO)CC(=O)[O-])CC(=O)[O-].[Na+].[Na+],,,,,,
9625,109626,2-[2-[Carboxymethyl(dodecanoyl)amino]ethyl-(2-hydroxyethyl)amino]acetic acid,CCCCCCCCCCCC(=O)N(CCN(CCO)CC(=O)O)CC(=O)O,,,,,,
9626,109627,"Propanenitrile, 3-(2-butoxyethoxy)-",CCCCOCCOCCC#N,,,,,,
9627,109628,CID 109628,CCCCOCCOCCC(=O)[O-].[K+],,,,,,
9628,109629,"2,5-Di-o-toluidinoterephthalic acid",CC1=CC=CC=C1NC2=CC(=C(C=C2C(=O)O)NC3=CC=CC=C3C)C(=O)O,,,,,,
9629,109630,2-(2-(3-Aminopropoxy)ethoxy)ethanol hydroxyacetic acid salt,C(CN)COCCOCCO.C(C(=O)O)O,,,,,,
9630,109631,Chromium(3+) perfluorooctanoate,C(=O)(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)[O-].C(=O)(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)[O-].C(=O)(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)[O-].[Cr+3],,,,,,
9631,109632,2-Phenoxyethyl 18-phenyloctadecanoate,C1=CC=C(C=C1)CCCCCCCCCCCCCCCCCC(=O)OCCOC2=CC=CC=C2,,,,,,
9632,109633,Benzeneoctadecanol,C1=CC=C(C=C1)CCCCCCCCCCCCCCCCCCO,,,,,,
9633,109634,Benzyl 11-phenylundecanoate,C1=CC=C(C=C1)CCCCCCCCCCC(=O)OCC2=CC=CC=C2,,,,,,
9634,109635,"Phenol, 4-chloro-3,5-dimethyl-, triester with boric acid (H3BO3)",B(OC1=CC(=C(C(=C1)C)Cl)C)(OC2=CC(=C(C(=C2)C)Cl)C)OC3=CC(=C(C(=C3)C)Cl)C,,,,,,
9635,109636,CID 109636,CC(C(=O)[O-])OC1=CC=CC2=CC=CC=C21.[Na+],,,,,,
9636,109637,"Hexanoic acid, 4-methylphenyl ester",CCCCCC(=O)OC1=CC=C(C=C1)C,,,,,,
9637,109638,6-tert-Butylquinoline,CC(C)(C)C1=CC2=C(C=C1)N=CC=C2,,,,,,
9638,109639,3-Phenylpropyl octanoate,CCCCCCCC(=O)OCCCC1=CC=CC=C1,,,,,,
9639,109640,6-Isobutylquinoline,CC(C)CC1=CC2=C(C=C1)N=CC=C2,,,,,,
9640,109641,Heptyl undecylenate,CCCCCCCOC(=O)CCCCCCCCC=C,,,,,,
9641,109642,"Amines, di-C12-18-alkyl",CCCCCCCCCCCCCCCNCCCCCCCCCCCCCCC,,,,,,
9642,109643,"Alcohols, C14-18, ethoxylated",CCCCCCCCCCCCCCOCC,,,,,,
9643,109644,Decyl ethyl ether,CCCCCCCCCCOCC,,,,,,
9644,109645,"1,1,2-Trifluoro-1,3-butadiene",C=CC(=C(F)F)F,,,,,,
9645,109646,"Amides, C10-16, N,N-bis(hydroxyethyl)",CCCCCCCCCCCCCN(CCO)CCO,,,,,,
9646,109647,"N,N-Bis(2-hydroxyethyl)undecanamide",CCCCCCCCCCC(=O)N(CCO)CCO,,,,,,
9647,109648,CID 109648,CCCCC=CCCCCCCCCCCCCN(CCO)CCO,,,,,,
9648,109649,Hexadec-7-en-1-amine,CCCCCCCCC=CCCCCCCN,,,,,,
9649,109650,Oleyl amine ethoxylate (3-50EO),CCOCCCCCCC=CCCCCCCCCN,,,,,,
9650,109651,Chloroisobutylmethylaluminium,CC(C)C[Al](C)Cl,,,,,,
9651,109652,"Phenol, 3,4-bis(1-methylethyl)-",CC(C)C1=C(C=C(C=C1)O)C(C)C,,,,,,
9652,109653,"3,4-Diisopropylphenyl diphenyl phosphate",CC(C)C1=C(C=C(C=C1)OP(=O)(OC2=CC=CC=C2)OC3=CC=CC=C3)C(C)C,,,,,,
9653,109654,"2-[(5-Amino-2,4-dimethylphenyl)sulphonyl]ethyl hydrogen sulphate",CC1=CC(=C(C=C1N)S(=O)(=O)CCOS(=O)(=O)O)C,,,,,,
9654,109655,"Octadecanamide, N-(2-aminoethyl)-N-[2-[(1-oxooctadecyl)amino]ethyl]-",CCCCCCCCCCCCCCCCCC(=O)NCCN(CCN)C(=O)CCCCCCCCCCCCCCCCC,,,,,,
9655,109656,"Ethanol, 2,2'-[(2-hydroxyethyl)imino]bis-, 1,1'-bis(dihydrogen phosphate)",C(CO)N(CCOP(=O)(O)O)CCOP(=O)(O)O,,,,,,
9656,109657,"Triethanolamine, diphosphate ester, tetra(triethanolamine) salt",C(CO)N(CCO)CCO.C(CO)N(CCOP(=O)(O)O)CCOP(=O)(O)O.C(CO)N(CCOP(=O)(O)O)CCOP(=O)(O)O.C(CO)N(CCOP(=O)(O)O)CCOP(=O)(O)O.C(CO)N(CCOP(=O)(O)O)CCOP(=O)(O)O,,,,,,
9657,109658,CID 109658,C1=CC=C(C=C1)NC2=C3C(=C(C=C2)N=NC4=CC=C(C=C4)NN=C5C(=CC6=C(C5=N)C(=O)C(=NNC7=CC=CC=C7)C(=C6)S(=O)(=O)[O-])S(=O)(=O)[O-])C=CC=C3S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
9658,109659,CID 109659,C1=CC=C(C=C1)NC2=C3C(=C(C=C2)N=NC4=CC=C(C=C4)NN=C5C(=CC6=C(C5=N)C(=O)C(=NNC7=CC=CC=C7)C(=C6)S(=O)(=O)O)S(=O)(=O)O)C=CC=C3S(=O)(=O)O,,,,,,
9659,109660,"Disodium 7-[[2-(acetylamino)-4-[(5-chloro-2,6-difluoro-4-pyrimidinyl)amino]phenyl]azo]naphthalene-1,3-disulphonate",CC(=O)NC1=C(C=CC(=C1)NC2=C(C(=NC(=N2)F)F)Cl)N=NC3=CC4=C(C=C(C=C4C=C3)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
9660,109661,"7-({2-Acetamido-4-[(5-chloro-2,6-difluoropyrimidin-4-yl)amino]phenyl}diazenyl)naphthalene-1,3-disulfonic acid",CC(=O)NC1=C(C=CC(=C1)NC2=C(C(=NC(=N2)F)F)Cl)N=NC3=CC4=C(C=C(C=C4C=C3)S(=O)(=O)O)S(=O)(=O)O,,,,,,
9661,109662,CID 109662,C1=CC(=CC=C1N=NC2=CC(=C(C=C2[O-])[O-])N=NC3=CC(=CC4=C3C(=O)C(=NN=C5C=C(C=C(C5=O)[N+](=O)O)N(O)O)C(=C4)S(=O)(=O)[O-])S(=O)(=O)[O-])[N+](=O)O.[Na+].[Na+],,,,,,
9662,109663,CID 109663,C1=CC(=CC=C1N=NC2=CC(=C(C=C2O)O)N=NC3=CC(=CC4=C3C(=O)C(=NN=C5C=C(C=C(C5=O)[N+](=O)O)N(O)O)C(=C4)S(=O)(=O)O)S(=O)(=O)O)[N+](=O)O,,,,,,
9663,109664,"Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[[4-chloro-6-[(4-sulfophenyl)amino]-1,3,5-triazin-2-yl]amino]-, dipotassium disodium salt",C1=CC(=CC=C1NC2=NC(=NC(=N2)Cl)NC3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)NC5=NC(=NC(=N5)NC6=CC=C(C=C6)S(=O)(=O)[O-])Cl)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[K+].[K+],,,,,,
9664,109665,"5-[[4-Chloro-6-(4-sulfoanilino)-1,3,5-triazin-2-yl]amino]-2-[2-[4-[[4-chloro-6-(4-sulfoanilino)-1,3,5-triazin-2-yl]amino]-2-sulfophenyl]ethenyl]benzenesulfonic acid",C1=CC(=CC=C1NC2=NC(=NC(=N2)Cl)NC3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)NC5=NC(=NC(=N5)NC6=CC=C(C=C6)S(=O)(=O)O)Cl)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
9665,109666,1-Bromo-4-ethoxy-2-methylbenzene,CCOC1=CC(=C(C=C1)Br)C,,,,,,
9666,109667,"Dipotassium;disodium;5-[[4-[bis(2-hydroxyethyl)amino]-6-(4-sulfonatoanilino)-1,3,5-triazin-2-yl]amino]-2-[2-[4-[[4-[bis(2-hydroxyethyl)amino]-6-(4-sulfonatoanilino)-1,3,5-triazin-2-yl]amino]-2-sulfonatophenyl]ethenyl]benzenesulfonate",C1=CC(=CC=C1NC2=NC(=NC(=N2)N(CCO)CCO)NC3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)NC5=NC(=NC(=N5)NC6=CC=C(C=C6)S(=O)(=O)[O-])N(CCO)CCO)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[K+].[K+],,,,,,
9667,109668,"4,4'-Bis[2-(diethanolamino)-4-(4'-sulphoanilino)-s-triazin-6-ylamino]stilbene-2,2'-disulfonic acid",C1=CC(=CC=C1NC2=NC(=NC(=N2)N(CCO)CCO)NC3=CC(=C(C=C3)C=CC4=C(C=C(C=C4)NC5=NC(=NC(=N5)NC6=CC=C(C=C6)S(=O)(=O)O)N(CCO)CCO)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
9668,109669,"Benzamide, 4-((1-(((2-methoxyphenyl)amino)carbonyl)-2-oxopropyl)azo)-N-(4-((1-(((2-methoxyphenyl)amino)carbonyl)-2-oxopropyl)azo)phenyl)-",CC(=O)C(C(=O)NC1=CC=CC=C1OC)N=NC2=CC=C(C=C2)C(=O)NC3=CC=C(C=C3)N=NC(C(=O)C)C(=O)NC4=CC=CC=C4OC,,,,,,
9669,109670,"Benzamide, 4-((2-hydroxy-1-naphthalenyl)azo)-N-(4-((2-hydroxy-1-naphthalenyl)azo)phenyl)-",C1=CC=C2C(=C1)C=CC(=C2N=NC3=CC=C(C=C3)C(=O)NC4=CC=C(C=C4)N=NC5=C(C=CC6=CC=CC=C65)O)O,,,,,,
9670,109671,"Benzenesulfonic acid, 2-[bis[4-[ethyl[(3-sulfophenyl)methyl]amino]phenyl]methyl]-",CCN(CC1=CC(=CC=C1)S(=O)(=O)O)C2=CC=C(C=C2)C(C3=CC=C(C=C3)N(CC)CC4=CC(=CC=C4)S(=O)(=O)O)C5=CC=CC=C5S(=O)(=O)O,,,,,,
9671,109672,"Benzenediazonium, 4-(hexahydro-1H-azepin-1-yl)-, (T-4)-tetrachlorozincate(2-) (2:1)",C1CCCN(CC1)C2=CC=C(C=C2)[N+]#N.C1CCCN(CC1)C2=CC=C(C=C2)[N+]#N.[Cl-].[Cl-].[Cl-].[Cl-].[Zn+2],,,,,,
9672,109673,"Benzenamine, 3-methyl-4-(1-pyrrolidinyl)-, monohydrochloride",CC1=C(C=CC(=C1)N)N2CCCC2.Cl,,,,,,
9673,109674,"1,4-Benzenediamine, 2-chloro-N1,N1-diethyl-",CCN(CC)C1=C(C=C(C=C1)N)Cl,,,,,,
9674,109675,"2,5-Cyclohexadien-1-one, 2-chloro-4-[[4-(diethylamino)-2-methylphenyl]imino]-",CCN(CC)C1=CC(=C(C=C1)N=C2C=CC(=O)C(=C2)Cl)C,,,,,,
9675,109676,2-(2-(3-Aminopropoxy)ethoxy)ethanol hydrochloride,C(CN)COCCOCCO.Cl,,,,,,
9676,109677,"Ethanaminium, N-(4-((2-chlorophenyl)(4-((2-cyanoethyl)ethylamino)phenyl)methylene)-2,5-cyclohexadien-1-ylidene)-2-cyano-N-ethyl-, chloride",CCN(CCC#N)C1=CC=C(C=C1)C(=C2C=CC(=[N+](CC)CCC#N)C=C2)C3=CC=CC=C3Cl.[Cl-],,,,,,
9677,109678,"N-[4-[(2-Chlorophenyl)[4-[(2-cyanoethyl)ethylamino]phenyl]methylene]-2,5-cyclohexadien-1-ylidene]-2-cyano-N-ethylethanaminium",CCN(CCC#N)C1=CC=C(C=C1)C(=C2C=CC(=[N+](CC)CCC#N)C=C2)C3=CC=CC=C3Cl,,,,,,
9678,109679,"Phosphoric acid, dimethyl ester, compd. with 4-tetrapropylenebenzenamine (1:1)",CCCCCCCCCCCCC1=CC=C(C=C1)N.COP(=O)(O)OC,,,,,,
9679,109680,"Phosphoric acid, monobutyl ester, compd. with 4-tetrapropylenebenzenamine (1:2)",CCCCCCCCCCCCC1=CC=C(C=C1)N.CCCCCCCCCCCCC1=CC=C(C=C1)N.CCCCOP(=O)(O)O,,,,,,
9680,109681,Trichloracetaldehyde di(phenylethyl)acetal,C1=CC=C(C=C1)CCOC(C(Cl)(Cl)Cl)OCCC2=CC=CC=C2,,,,,,
9681,109682,Propylene glycol monoisostearate,CC(C)CCCCCCCCCCCCCCC(=O)OCC(C)O,,,,,,
9682,109683,Tris(hexadecyloxy)ethoxysilane,CCCCCCCCCCCCCCCCO[Si](OCC)(OCCCCCCCCCCCCCCCC)OCCCCCCCCCCCCCCCC,,,,,,
9683,109684,"Pyrazine, 2-methyl-3-(2-methylpropoxy)-",CC1=NC=CN=C1OCC(C)C,,,,,,
9684,109685,"1-(Carboxylatomethyl)-2-heptyl-4,5-dihydro-1-(2-hydroxyethyl)-1H-imidazolium",CCCCCCCC1=NCC[N+]1(CCO)CC(=O)[O-],,,,,,
9685,109686,"1,2,4-Benzenetricarboxylic acid, isooctyl ester",CC(C)CCCCCO.C1=CC(=C(C=C1C(=O)O)C(=O)O)C(=O)O,,,,,,
9686,109687,"2,5-Di(nonyl)phenol; 4-nonylphenol; phosphoric acid",CCCCCCCCCC1=CC=C(C=C1)O.CCCCCCCCCC1=CC(=C(C=C1)CCCCCCCCC)O.OP(=O)(O)O,,,,,,
9687,109688,"2,5-Dinonylphenol",CCCCCCCCCC1=CC(=C(C=C1)CCCCCCCCC)O,,,,,,
9688,109689,"Phosphoric acid, butyl 2-ethoxyethyl ester",CCCCOP(=O)(O)OCCOCC,,,,,,
9689,109690,Heptyl nonyl hydrogen phosphate,CCCCCCCCCOP(=O)(O)OCCCCCCC,,,,,,
9690,109691,2-[2-Hydroxyethyl(octadec-9-enoyl)amino]ethyl dihydrogen phosphate,CCCCCCCCC=CCCCCCCCC(=O)N(CCO)CCOP(=O)(O)O,,,,,,
9691,109692,"Decanedioic acid, 2-butoxyethyl ester",CCCCOCCOC(=O)CCCCCCCCC(=O)O,,,,,,
9692,109693,"2-Butenedioic acid (2Z)-, isodecyl ester",CC(C)CCCCCCCOC(=O)C=CC(=O)O,,,,,,
9693,109694,"1,2-Benzenedicarboxylic acid, mixed isooctyl and 2-phenoxyethyl esters",CCCCCCC(C)OC(=O)C1=CC=CC=C1C(=O)O.C1=CC=C(C=C1)OCCOC(=O)C2=CC=CC=C2C(=O)O,,,,,,
9694,109695,2-[(2-Phenoxyethoxy)carbonyl]benzoic acid,C1=CC=C(C=C1)OCCOC(=O)C2=CC=CC=C2C(=O)O,,,,,,
9695,109696,CID 109696,CCCCOC(=O)C=CC(=O)O.C1CCC(CC1)OC(=O)C=CC(=O)O,,,,,,
9696,109697,"1,1,1,2,2,3,3-Heptafluoro-5-iodopentane",C(CI)C(C(C(F)(F)F)(F)F)(F)F,,,,,,
9697,109698,"Acetic acid, hydroxy-, compd. with N-(2-((2-hydroxyethyl)amino)ethyl)isooctadecanamide (1:1)",CC(C)CCCCCCCCCCCCCCC(=O)NCCNCCO.CC(=O)O,,,,,,
9698,109699,N-[2-[(2-Hydroxyethyl)amino]ethyl]-16-methylheptadecanamide,CC(C)CCCCCCCCCCCCCCC(=O)NCCNCCO,,,,,,
9699,109700,"Naphtho[2,1-b]pyrylium, 3-[2-(2-hydroxy-1-naphthalenyl)-1-methylethenyl]-, chloride",CC(=CC1=C(C=CC2=CC=CC=C21)O)C3=[O+]C4=C(C=C3)C5=CC=CC=C5C=C4.[Cl-],,,,,,
9700,109701,1-(2-Benzo[f]chromen-4-ium-3-ylprop-1-enyl)naphthalen-2-ol,CC(=CC1=C(C=CC2=CC=CC=C21)O)C3=[O+]C4=C(C=C3)C5=CC=CC=C5C=C4,,,,,,
9701,109702,CID 109702,CC(=O)O.C(C[O-])O.C(C[O-])O.[Zn+2].[SbH3],,,,,,
9702,109703,"1-Naphthalenesulfonic acid, 2-[(1-hydroxy-2-naphthalenyl)azo]-, barium salt (2:1)",C1=CC=C2C(=C1)C=CC(=C2O)N=NC3=C(C4=CC=CC=C4C=C3)S(=O)(=O)[O-].C1=CC=C2C(=C1)C=CC(=C2O)N=NC3=C(C4=CC=CC=C4C=C3)S(=O)(=O)[O-].[Ba+2],,,,,,
9703,109704,2-[(1-Hydroxynaphthalen-2-yl)diazenyl]naphthalene-1-sulfonic acid,C1=CC=C2C(=C1)C=CC(=C2O)N=NC3=C(C4=CC=CC=C4C=C3)S(=O)(=O)O,,,,,,
9704,109705,"Phenol, 4-(1,1-dimethylethyl)-2,3-dimethyl-",CC1=C(C=CC(=C1C)O)C(C)(C)C,,,,,,
9705,109706,"Phenol, 2-(1,1-dimethylethyl)-3,6-dimethyl-",CC1=C(C(=C(C=C1)C)O)C(C)(C)C,,,,,,
9706,109707,"Benzenesulfonic acid, 3-chloro-5-[(2-hydroxy-1-naphthalenyl)azo]-4-methyl-, calcium salt (2:1)",CC1=C(C=C(C=C1Cl)S(=O)(=O)[O-])N=NC2=C(C=CC3=CC=CC=C32)O.CC1=C(C=C(C=C1Cl)S(=O)(=O)[O-])N=NC2=C(C=CC3=CC=CC=C32)O.[Ca+2],,,,,,
9707,109708,"2-Naphthalenesulfonic acid, 1-[(2-hydroxy-1-naphthalenyl)azo]-, barium salt (2:1)",C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C=CC4=CC=CC=C43)S(=O)(=O)[O-])O.C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C=CC4=CC=CC=C43)S(=O)(=O)[O-])O.[Ba+2],,,,,,
9708,109709,1-[(2-Hydroxynaphthalen-1-yl)diazenyl]naphthalene-2-sulfonic acid,C1=CC=C2C(=C1)C=CC(=C2N=NC3=C(C=CC4=CC=CC=C43)S(=O)(=O)O)O,,,,,,
9709,109710,3-Chloro-4-methyl-5-nitrobenzenesulfonic acid,CC1=C(C=C(C=C1Cl)S(=O)(=O)O)[N+](=O)[O-],,,,,,
9710,109711,"1,5-Naphthalenedisulfonic acid, 3-(acetylamino)-",CC(=O)NC1=CC2=C(C=CC=C2S(=O)(=O)O)C(=C1)S(=O)(=O)O,,,,,,
9711,109712,"2,7-Naphthalenedisulfonic acid, 4-[(3-aminobenzoyl)amino]-5-hydroxy-",C1=CC(=CC(=C1)N)C(=O)NC2=C3C(=CC(=C2)S(=O)(=O)O)C=C(C=C3O)S(=O)(=O)O,,,,,,
9712,109713,"2-Naphthalenesulfonic acid, 6-(acetylamino)-",CC(=O)NC1=CC2=C(C=C1)C=C(C=C2)S(=O)(=O)O,,,,,,
9713,109714,"2-Naphthalenesulfonic acid, 4-hydroxy-7-[(1-oxodecyl)amino]-",CCCCCCCCCC(=O)NC1=CC2=CC(=CC(=C2C=C1)O)S(=O)(=O)O,,,,,,
9714,109715,"Benzoic acid, 2-chloro-5-[(phenylamino)sulfonyl]-",C1=CC=C(C=C1)NS(=O)(=O)C2=CC(=C(C=C2)Cl)C(=O)O,,,,,,
9715,109716,Disodium dodecyl 4-sulphonatophthalate,CCCCCCCCCCCCOC(=O)C1=C(C=C(C=C1)S(=O)(=O)[O-])C(=O)[O-].[Na+].[Na+],,,,,,
9716,109717,2-Dodecoxycarbonyl-5-sulfobenzoic acid,CCCCCCCCCCCCOC(=O)C1=C(C=C(C=C1)S(=O)(=O)O)C(=O)O,,,,,,
9717,109718,"Propanamide, N-[3-[bis(2-hydroxyethyl)amino]phenyl]-",CCC(=O)NC1=CC(=CC=C1)N(CCO)CCO,,,,,,
9718,109719,"[1,1'-Biphenyl]-3-sulfonic acid, 4'-(acetylamino)-4-[(3-aminobenzoyl)amino]-",CC(=O)NC1=CC=C(C=C1)C2=CC(=C(C=C2)NC(=O)C3=CC(=CC=C3)N)S(=O)(=O)O,,,,,,
9719,109720,"1,3-Benzenedisulfonic acid, 4-amino-5-methyl-",CC1=CC(=CC(=C1N)S(=O)(=O)O)S(=O)(=O)O,,,,,,
9720,109721,"Mono(p-nitrophenyl) phosphate 2-amino-2-(hydroxymethyl)-1,3-propanediol salt (1:2)",C1=CC(=CC=C1[N+](=O)[O-])OP(=O)(O)O.C(C(CO)(CO)N)O.C(C(CO)(CO)N)O,,,,,,
9721,109722,"N-(3-(Tetradecyloxy)propyl)-1,3-propanediamine",CCCCCCCCCCCCCCOCCCNCCCN,,,,,,
9722,109723,"N-[3-(tetradecyloxy)propyl]propane-1,3-diamine acetate",CCCCCCCCCCCCCCOCCCNCCCN.CC(=O)O,,,,,,
9723,109724,"N-(3-myristyloxypropyl)-1,3-propanediamine propionic acid salt",CCCCCCCCCCCCCCOCCCNCCCN.CCC(=O)O,,,,,,
9724,109725,Pentadecyl octadecanoate,CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCC,,,,,,
9725,109726,CID 109726,CCOC(=O)OC1=CC(=C(C=C1)OC(=O)OCC)CCC(=C2CCCC2=O)[O-].CCOC(=O)OC1=CC(=CC(=C1)CCC(=C2CCCC2=O)[O-])OC(=O)OCC.[Cu+2],,,,,,
9726,109727,[4-Ethoxycarbonyloxy-2-[3-hydroxy-3-(2-oxocyclopentylidene)propyl]phenyl] ethyl carbonate,CCOC(=O)OC1=CC(=C(C=C1)OC(=O)OCC)CCC(=C2CCCC2=O)O,,,,,,
9727,109728,CID 109728,CCOC(=O)OC1=CC(=CC(=C1)CCC(=C2CCCC2=O)O)OC(=O)OCC,,,,,,
9728,109729,"1,5-Naphthalenedisulfonic acid, 3-[(4-amino-1-naphthalenyl)azo]-, disodium salt",C1=CC=C2C(=C1)C(=CC=C2N=NC3=CC4=C(C=CC=C4S(=O)(=O)[O-])C(=C3)S(=O)(=O)[O-])N.[Na+].[Na+],,,,,,
9729,109730,"3-(4-Amino-1-naphthylazo)-1,5-naphthalenedisulfonic acid",C1=CC=C2C(=C1)C(=CC=C2N=NC3=CC4=C(C=CC=C4S(=O)(=O)O)C(=C3)S(=O)(=O)O)N,,,,,,
9730,109731,CID 109731,CC(=O)NC1=CC=C(C=C1)N=NC2=C(C=C3C=C(C=CC3=C2O)N)S(=O)(=O)[O-].[Na+],,,,,,
9731,109732,3-[(4-Acetamidophenyl)diazenyl]-7-amino-4-hydroxynaphthalene-2-sulfonic acid,CC(=O)NC1=CC=C(C=C1)N=NC2=C(C=C3C=C(C=CC3=C2O)N)S(=O)(=O)O,,,,,,
9732,109733,"Phenol, 4-[[4-[(3-nitrophenyl)azo]phenyl]azo]-",C1=CC(=CC(=C1)[N+](=O)[O-])N=NC2=CC=C(C=C2)N=NC3=CC=C(C=C3)O,,,,,,
9733,109734,CID 109734,C1=CC2=C(C=C1N)NC(=N2)SCCCS(=O)(=O)[O-].[Na+],,,,,,
9734,109735,3-[(6-amino-1H-benzimidazol-2-yl)sulfanyl]propane-1-sulfonic acid,C1=CC2=C(C=C1N)NC(=N2)SCCCS(=O)(=O)O,,,,,,
9735,109736,CID 109736,C1CCOC1.C1[CH-]C=CC2=CC=CC=C21.[Na+],,,,,,
9736,109737,"12-Sulfooctadeca-9,12-dienoic acid",CCCCCC=C(CC=CCCCCCCCC(=O)O)S(=O)(=O)O,,,,,,
9737,109738,9-Sulfooctadec-9-enoic acid,CCCCCCCCC=C(CCCCCCCC(=O)O)S(=O)(=O)O,,,,,,
9738,109739,Acetic acid;azane;phenylmercury,CC(=O)O.C1=CC=C(C=C1)[Hg].N.N,,,,,,
9739,109740,"Hydrazinium(1+), (OC-6-21)-[[N,N'-1,2-ethanediylbis[N-[(carboxy-kappaO)methyl]glycinato-kappaN,kappaO]](4-)]cobaltate(2-) (2:1)",C(CN(CC(=O)[O-])CC(=O)[O-])N(CC(=O)[O-])CC(=O)[O-].[NH3+]N.[NH3+]N.[Co+2],,,,,,
9740,109741,Einecs 269-256-0,C1=CC=C2C(=C1)C(=CC=C2N=NC3=CC4=C(C=CC=C4S(=O)(=O)[O-])C(=C3)S(=O)(=O)[O-])N=NC5=C6C=CC(=CC6=C(C=C5)N)S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
9741,109742,"3-[[4-[(4-Amino-6-sulfonaphthalen-1-yl)diazenyl]naphthalen-1-yl]diazenyl]naphthalene-1,5-disulfonic acid",C1=CC=C2C(=C1)C(=CC=C2N=NC3=CC4=C(C=CC=C4S(=O)(=O)O)C(=C3)S(=O)(=O)O)N=NC5=C6C=CC(=CC6=C(C=C5)N)S(=O)(=O)O,,,,,,
9742,109743,"3-Amino-2-hydroxy-4,4,6,6-tetramethylcyclohex-2-en-1-one hydrochloride",CC1(CC(C(=O)C(=C1N)O)(C)C)C.Cl,,,,,,
9743,109744,"3-Amino-2-hydroxy-4,4,6,6-tetramethylcyclohex-2-en-1-one",CC1(CC(C(=O)C(=C1N)O)(C)C)C,,,,,,
9744,109745,"Phosphoric acid, dipentyl ester, compd. with morpholine (1:1)",CCCCCOP(=O)(O)OCCCCC.C1COCCN1,,,,,,
9745,109746,CID 109746,C1=CC(=CC2=C(C=C(C=C21)S(=O)(=O)O)S(=O)(=O)[O-])N.N.[K+],,,,,,
9746,109747,CID 109747,C1=CC=C(C=C1)NC2=CC3=CC(=CC(=C3C=C2)O)S(=O)(=O)[O-].[Na+],,,,,,
9747,109748,"Benzenesulfonic acid, 3-chloro-4-[[4-[ethyl(phenylmethyl)amino]phenyl]azo]-",CCN(CC1=CC=CC=C1)C2=CC=C(C=C2)N=NC3=C(C=C(C=C3)S(=O)(=O)O)Cl,,,,,,
9748,109749,"5-Hydroxy-4-((o-nitrophenyl)azo)-1-phenylpyrazole-3-carboxylic acid, ethyl ester",CCOC(=O)C1=C(C(=O)N(N1)C2=CC=CC=C2)N=NC3=CC=CC=C3[N+](=O)[O-],,,,,,
9749,109750,"1,3-Benzenediol, 4-[(2,4-dimethylphenyl)azo]-6-[(3,4-dimethylphenyl)azo]-",CC1=CC(=C(C=C1)N=NC2=C(C=C(C(=C2)N=NC3=CC(=C(C=C3)C)C)O)O)C,,,,,,
9750,109751,CID 109751,CC(=O)NC1=C2C(=C(C=C1)[N+](=O)O)C(=O)C3=C(C2=O)C(=NC(=O)C)C=CC3=[N+]([O-])[O-],,,,,,
9751,109752,CID 109752,CC(=O)NC1=C2C(=C(C=C1)[N+](=O)O)C(=O)C3=C(C2=O)C(=NC(=O)C)C=CC3=[N+](O)[O-],,,,,,
9752,109753,"9,10-Anthracenedione, 1-amino-8-[(2,4-dibromophenyl)amino]-4,5-dihydroxy-",C1=CC(=C(C=C1Br)Br)NC2=C3C(=C(C=C2)O)C(=O)C4=C(C=CC(=C4C3=O)N)O,,,,,,
9753,109754,"1,3-Benzenediol, 4-[(2,4-dimethylphenyl)azo]-6-[(2-methylphenyl)azo]-",CC1=CC(=C(C=C1)N=NC2=C(C=C(C(=C2)N=NC3=CC=CC=C3C)O)O)C,,,,,,
9754,109755,"4-[(2,5-Dimethylphenyl)azo]-2-[(2-methylphenyl)azo]-1,3-benzenediol",CC1=CC(=C(C=C1)C)NN=C2C=CC(=O)C(=NNC3=CC=CC=C3C)C2=O,,,,,,
9755,109756,"Ethanol, 2-[[2-(2-hydroxyethoxy)ethyl]methylamino]-",CN(CCO)CCOCCO,,,,,,
9756,109757,"1,7-Anthracenedisulfonic acid, 9,10-dihydro-9,10-dioxo-, disodium salt",C1=CC2=C(C(=C1)S(=O)(=O)[O-])C(=O)C3=C(C2=O)C=CC(=C3)S(=O)(=O)[O-].[Na+].[Na+],,,,,,
9757,109758,4-Hydroxy-7-[(3-nitrobenzoyl)amino]-2-naphthalenesulfonic acid,C1=CC(=CC(=C1)[N+](=O)[O-])C(=O)NC2=CC3=CC(=CC(=C3C=C2)O)S(=O)(=O)O,,,,,,
9758,109759,CID 109759,C1=CC(=CC(=C1)S(=O)(=O)[O-])N=NC2=CC=C(C=C2)N.[Na+],,,,,,
9759,109760,"Disodium 8-((4-amino-2,5-dimethoxyphenyl)azo)-5-((3-sulphonatophenyl)azo)naphthalene-2-sulphonate",COC1=CC(=C(C=C1N)OC)N=NC2=C3C=C(C=CC3=C(C=C2)N=NC4=CC(=CC=C4)S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+],,,,,,
9760,109761,"8-[(4-Amino-2,5-dimethoxyphenyl)diazenyl]-5-[(3-sulfophenyl)diazenyl]naphthalene-2-sulfonic acid",COC1=CC(=C(C=C1N)OC)N=NC2=C3C=C(C=CC3=C(C=C2)N=NC4=CC(=CC=C4)S(=O)(=O)O)S(=O)(=O)O,,,,,,
9761,109762,"2,7-Naphthalenedisulfonic acid, 4,4'-(1,4-phenylenebis(imino(6-chloro-1,3,5-triazine-4,2-diyl)imino))bis(5-hydroxy-6-((2-sulfophenyl)azo)-, hexasodium salt",C1=CC=C(C(=C1)N=NC2=C(C3=C(C=C(C=C3C=C2S(=O)(=O)[O-])S(=O)(=O)[O-])NC4=NC(=NC(=N4)NC5=CC=C(C=C5)NC6=NC(=NC(=N6)Cl)NC7=C8C(=CC(=C7)S(=O)(=O)[O-])C=C(C(=C8O)N=NC9=CC=CC=C9S(=O)(=O)[O-])S(=O)(=O)[O-])Cl)O)S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+].[Na+],,,['Chemicals and substances that impart color including soluble dyes and insoluble pigments. They are used in INKS; PAINTS; and as INDICATORS AND REAGENTS. (See all compounds classified as Coloring Agents.)'],,,
9762,109763,"1-Hexadecanaminium, N,N,N-trimethyl-, sulfate (1:1)",CCCCCCCCCCCCCCCC[N+](C)(C)C.OS(=O)(=O)[O-],,,,,,
9763,109764,CID 109764,CC1=CC(=O)N=C2N1NC(=N2)CSC(=N)N.Cl,,,,,,
9764,109765,CID 109765,CC1=CC(=O)N=C2N1NC(=N2)CSC(=N)N,,,,,,
9765,109766,Benzyltriphenylphosphonium tetrachlorocadmate,C1=CC=C(C=C1)C[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4.C1=CC=C(C=C1)C[P+](C2=CC=CC=C2)(C3=CC=CC=C3)C4=CC=CC=C4.[Cl-].[Cl-].[Cl-].[Cl-].[Cd+2],,,,,,
9766,109767,"Chromate(1-), diaquabis[2-hydroxybenzoato(2-)-O1,O2]-, sodium",C1=CC=C(C(=C1)C(=O)[O-])[O-].C1=CC=C(C(=C1)C(=O)[O-])[O-].O.O.[Na+].[Cr+3],,,,,,
9767,109768,"9,10-Anthracenedione, 1,4,5,8-tetraamino-ar,ar-dibromo-",C1=CC(=C2C(=C1N)C(=O)C3=C(C2=O)C(=C(C(=C3N)Br)Br)N)N,,,,,,
9768,109769,"Octadecanamide, N-(2-((3-amino-3-oxopropyl)(2-(bis(3-amino-3-oxopropyl)amino)ethyl)amino)ethyl)-, monoacetate",CCCCCCCCCCCCCCCCCC(=O)NCCN(CCC(=O)N)CCN(CCC(=O)N)CCC(=O)N.CC(=O)O,,,,,,
9769,109770,N-[2-[(3-Amino-3-oxopropyl)[2-[bis(3-amino-3-oxopropyl)amino]ethyl]amino]ethyl]octadecanamide,CCCCCCCCCCCCCCCCCC(=O)NCCN(CCC(=O)N)CCN(CCC(=O)N)CCC(=O)N,,,,,,
9770,109771,"Octadecanamide, N-(3-amino-3-oxopropyl)-N-(2-((3-amino-3-oxopropyl)(2-((1-oxooctadecyl)amino)ethyl)amino)ethyl)-, monoacetate",CCCCCCCCCCCCCCCCCC(=O)NCCN(CCC(=O)N)CCN(CCC(=O)N)C(=O)CCCCCCCCCCCCCCCCC.CC(=O)O,,,,,,
9771,109772,N-(3-Amino-3-oxopropyl)-N-[2-[(3-amino-3-oxopropyl)[2-[(1-oxooctadecyl)amino]ethyl]amino]ethyl]octadecanamide,CCCCCCCCCCCCCCCCCC(=O)NCCN(CCC(=O)N)CCN(CCC(=O)N)C(=O)CCCCCCCCCCCCCCCCC,,,,,,
9772,109773,"Octadecanamide, N-[2-[bis(3-amino-3-oxopropyl)amino]ethyl]-N-[2-[(1-oxooctadecyl)amino]ethyl]-, monoacetate",CCCCCCCCCCCCCCCCCC(=O)NCCN(CCN(CCC(=O)N)CCC(=O)N)C(=O)CCCCCCCCCCCCCCCCC.CC(=O)O,,,,,,
9773,109774,N-[2-[Bis(3-amino-3-oxopropyl)amino]ethyl]-N-[2-[(1-oxooctadecyl)amino]ethyl]octadecanamide,CCCCCCCCCCCCCCCCCC(=O)NCCN(CCN(CCC(=O)N)CCC(=O)N)C(=O)CCCCCCCCCCCCCCCCC,,,,,,
9774,109775,CID 109775,CCOC1=C(C=C(C=C1)N=NC2=CC3=CC=CC=C3C(=C2)N=NC4=CC(=CC=C4)S(=O)(=O)[O-])C.[Na+],,,,,,
9775,109776,3-[[3-[(4-Ethoxy-3-methylphenyl)diazenyl]naphthalen-1-yl]diazenyl]benzenesulfonic acid,CCOC1=C(C=C(C=C1)N=NC2=CC3=CC=CC=C3C(=C2)N=NC4=CC(=CC=C4)S(=O)(=O)O)C,,,,,,
9776,109777,CID 109777,CCOC1=CC=CC2=C1C(=O)C3=C(C=CC(=C3C2=O)NC4=CC=CC=C4S(=O)(=O)[O-])NC5CCCCC5.[Na+],,,,,,
9777,109778,"2-[[4-(Cyclohexylamino)-5-ethoxy-9,10-dioxoanthracen-1-yl]amino]benzenesulfonic acid",CCOC1=CC=CC2=C1C(=O)C3=C(C=CC(=C3C2=O)NC4=CC=CC=C4S(=O)(=O)O)NC5CCCCC5,,,,,,
9778,109779,"3-Pyridinecarbonitrile, 5-[(3,4-dichlorophenyl)azo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-(phenylamino)-",CC1=C(C(=O)N(C(=C1C#N)O)NC2=CC=CC=C2)N=NC3=CC(=C(C=C3)Cl)Cl,,,,,,
9779,109780,"3-Pyridinecarbonitrile, 5-[(3-chlorophenyl)azo]-1,2-dihydro-6-hydroxy-4-methyl-2-oxo-1-(phenylamino)-",CC1=C(C(=O)N(C(=C1C#N)O)NC2=CC=CC=C2)N=NC3=CC(=CC=C3)Cl,,,,,,
9780,109781,"Propanamide, 3-chloro-N-[2-[(2-cyano-4-nitrophenyl)azo]-5-(diethylamino)phenyl]-",CCN(CC)C1=CC(=C(C=C1)N=NC2=C(C=C(C=C2)[N+](=O)[O-])C#N)NC(=O)CCCl,,,,,,
9781,109782,"Carbamic acid, [2-[(2-chloro-4-nitrophenyl)azo]-5-(diethylamino)phenyl]-, 2-ethoxyethyl ester",CCN(CC)C1=CC(=C(C=C1)N=NC2=C(C=C(C=C2)[N+](=O)[O-])Cl)NC(=O)OCCOCC,,,,,,
9782,109783,"2-Naphthalenesulfonic acid, 3-((2,5-dimethyl-4-sulfophenyl)azo)-4-hydroxy-7-((2,5,6-trichloro-4-pyrimidinyl)amino)-, disodium salt",CC1=CC(=C(C=C1S(=O)(=O)[O-])C)N=NC2=C(C=C3C=C(C=CC3=C2O)NC4=C(C(=NC(=N4)Cl)Cl)Cl)S(=O)(=O)[O-].[Na+].[Na+],,,,,,
9783,109784,"3-[(2,5-Dimethyl-4-sulfophenyl)diazenyl]-4-hydroxy-7-[(2,5,6-trichloropyrimidin-4-yl)amino]naphthalene-2-sulfonic acid",CC1=CC(=C(C=C1S(=O)(=O)O)C)N=NC2=C(C=C3C=C(C=CC3=C2O)NC4=C(C(=NC(=N4)Cl)Cl)Cl)S(=O)(=O)O,,,,,,
9784,109785,"3,6,9,12,15,18,21,24,27-Nonaoxanonacosan-1-ol, 29-(2,4-dipentylphenoxy)-",CCCCCC1=CC(=C(C=C1)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO)CCCCC,,,,,,
9785,109786,"3,6,9,12,15,18,21,24,27-Nonaoxanonacosan-1-ol, 29-(2,4-bis(1,1-dimethylethyl)phenoxy)-",CC(C)(C)C1=CC(=C(C=C1)OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO)C(C)(C)C,,,,,,
9786,109787,CID 109787,C1CN2CCN(C2=N1)C=NN=C(N)N3CCN4C3=NCC4.OS(=O)(=O)O,,,,,,
9787,109788,Ethyl (7-hydroxy-1-naphthyl)-carbamate,CCOC(=O)NC1=CC=CC2=C1C=C(C=C2)O,,,,,,
9788,109789,"5-Benzoxazolesulfonamide, 2,3-dihydro-N-methyl-2-oxo-",CNS(=O)(=O)C1=CC2=C(C=C1)OC(=O)N2,,,,,,
9789,109790,"2-Bromo-3,5-diethyltoluene",CCC1=CC(=C(C(=C1)C)Br)CC,,,,,,
9790,109791,"Benzoic acid, 2-[[(5-amino-2-methylphenyl)sulfonyl]amino]-",CC1=C(C=C(C=C1)N)S(=O)(=O)NC2=CC=CC=C2C(=O)O,,,,,,
9791,109792,"Acetamide, N-[2-[(2-cyano-6-iodo-4-nitrophenyl)azo]-5-(diethylamino)-4-methoxyphenyl]-",CCN(CC)C1=C(C=C(C(=C1)NC(=O)C)N=NC2=C(C=C(C=C2I)[N+](=O)[O-])C#N)OC,,,,,,
9792,109793,"Propanenitrile, 3-[[4-[(2-bromo-6-methyl-4-nitrophenyl)azo]-3-methylphenyl](2-hydroxyethyl)amino]-",CC1=CC(=CC(=C1N=NC2=C(C=C(C=C2)N(CCC#N)CCO)C)Br)[N+](=O)[O-],,,,,,
9793,109794,"Methanesulfonamide, N-[2-[ethyl(3-methyl-4-nitrosophenyl)amino]ethyl]-, monohydrochloride",CCN(CCNS(=O)(=O)C)C1=CC(=C(C=C1)N=O)C.Cl,,,,,,
9794,109795,"2,7-Naphthalenedisulfonic acid, 5-amino-3-((4'-((7-amino-1-hydroxy-3-sulfo-2-naphthalenyl)azo)(1,1'-biphenyl)-4-yl)azo)-4-hydroxy-, disodium salt",C1=CC(=CC=C1C2=CC=C(C=C2)N=NC3=C(C=C4C=CC(=CC4=C3O)N)S(=O)(=O)[O-])N=NC5=C(C6=C(C=C(C=C6C=C5S(=O)(=O)O)S(=O)(=O)[O-])N)O.[Na+].[Na+],,,,,,
9795,109796,"Tetralithium 4,4'-carbonyldiphthalate",[Li+].[Li+].[Li+].[Li+].C1=CC(=C(C=C1C(=O)C2=CC(=C(C=C2)C(=O)[O-])C(=O)[O-])C(=O)[O-])C(=O)[O-],,,,,,
9796,109797,"Tricesium hydrogen 4,4'-carbonylbisphthalate",C1=CC(=C(C=C1C(=O)C2=CC(=C(C=C2)C(=O)[O-])C(=O)[O-])C(=O)[O-])C(=O)O.[Cs+].[Cs+].[Cs+],,,,,,
9797,109798,"Trirubidium hydrogen 4,4'-carbonylbisphthalate",C1=CC(=C(C=C1C(=O)C2=CC(=C(C=C2)C(=O)[O-])C(=O)[O-])C(=O)[O-])C(=O)O.[Rb+].[Rb+].[Rb+],,,,,,
9798,109799,"Tripotassium hydrogen 4,4'-carbonylbisphthalate",C1=CC(=C(C=C1C(=O)C2=CC(=C(C=C2)C(=O)[O-])C(=O)[O-])C(=O)[O-])C(=O)O.[K+].[K+].[K+],,,,,,
9799,109800,"Trisodium hydrogen 4,4'-carbonylbisphthalate",C1=CC(=C(C=C1C(=O)C2=CC(=C(C=C2)C(=O)[O-])C(=O)[O-])C(=O)[O-])C(=O)O.[Na+].[Na+].[Na+],,,,,,
9800,109801,"Trilithium hydrogen 4,4'carbonylbisphthalate",[Li+].[Li+].[Li+].C1=CC(=C(C=C1C(=O)C2=CC(=C(C=C2)C(=O)[O-])C(=O)[O-])C(=O)[O-])C(=O)O,,,,,,
9801,109802,CID 109802,C1=CC=C2C(=C1)C=C(C(=C2CC3=C(C(=CC4=CC=CC=C43)C(=O)[O-])O)O)C(=O)[O-].[Cs+].[Cs+],,,,,,
9802,109803,CID 109803,C1=CC=C2C(=C1)C=C(C(=C2CC3=C(C(=CC4=CC=CC=C43)C(=O)[O-])O)O)C(=O)[O-].[Rb+].[Rb+],,,,,,
9803,109804,CID 109804,C1=CC=C2C(=C1)C=C(C(=C2CC3=C(C(=CC4=CC=CC=C43)C(=O)[O-])O)O)C(=O)[O-].[K+].[K+],,,,,,
9804,109805,CID 109805,CC[N-]S(=O)(=O)C1=CC=C(C=C1)C.[K+],,,,,,
9805,109806,CID 109806,CC1=C(C=CC=C1Cl)NCS(=O)(=O)[O-].[Na+],,,,,,
9806,109807,(3-Chloro-2-methylanilino)methanesulfonic acid,CC1=C(C=CC=C1Cl)NCS(=O)(=O)O,,,,,,
9807,109808,"9,10-Anthracenedione, 1,4,5-triamino-8-(methylamino)-",CNC1=C2C(=C(C=C1)N)C(=O)C3=C(C=CC(=C3C2=O)N)N,,,,,,
9808,109809,"9,10-Anthracenedione, 1-(butylamino)-4-(methylamino)-",CCCCNC1=C2C(=C(C=C1)NC)C(=O)C3=CC=CC=C3C2=O,,,,,,
9809,109810,"Glycine, N-(carboxymethyl)-N-(2-hydroxyethyl)-, compd. with 1,4-diazabicyclo[2.2.2]octane (2:1)",C1CN2CCN1CC2.C(CO)N(CC(=O)O)CC(=O)O.C(CO)N(CC(=O)O)CC(=O)O,,,,,,
9810,109811,"Formic acid, compd. with 1,4-diazabicyclo(2.2.2)octane",C1CN2CCN1CC2.C(=O)O,,,,,,
9811,109812,"2-[[4-[(2,5-Dimethylphenyl)diazenyl]-2,3-dimethylphenyl]hydrazinylidene]-6-[[4-[(2-methoxyphenyl)diazenyl]-2,5-dimethylphenyl]hydrazinylidene]cyclohex-4-ene-1,3-dione",CC1=CC(=C(C=C1)C)N=NC2=C(C(=C(C=C2)NN=C3C(=O)C=CC(=NNC4=C(C=C(C(=C4)C)N=NC5=CC=CC=C5OC)C)C3=O)C)C,,,,,,
9812,109813,"1,3-Benzenediol, 4,6-bis[[2-methoxy-4-[(2-methoxyphenyl)azo]phenyl]azo]-",COC1=CC=CC=C1N=NC2=CC(=C(C=C2)N=NC3=CC(=C(C=C3O)O)N=NC4=C(C=C(C=C4)N=NC5=CC=CC=C5OC)OC)OC,,,,,,
9813,109814,"1,3-Benzenediol, 4-[[4-[(2,4-dimethylphenyl)azo]-2-methoxyphenyl]azo]-6-[[4-[(2-methoxyphenyl)azo]-2,5-dimethylphenyl]azo]-",CC1=CC(=C(C=C1)N=NC2=CC(=C(C=C2)N=NC3=CC(=C(C=C3O)O)N=NC4=CC(=C(C=C4C)N=NC5=CC=CC=C5OC)C)OC)C,,,,,,
9814,109815,"2,6-Bis[(2-methylphenyl)azo]-1,3-benzenediol",CC1=CC=CC=C1NN=C2C=CC(=O)C(=NNC3=CC=CC=C3C)C2=O,,,,,,
9815,109816,"2-Naphthalenesulfonic acid, 7-amino-4-hydroxy-3-((4-((4-sulfophenyl)azo)phenyl)azo)-, diammonium salt",C1=CC(=CC=C1N=NC2=CC=C(C=C2)S(=O)(=O)O)N=NC3=C(C=C4C=C(C=CC4=C3O)N)S(=O)(=O)O.N.N,,,,,,
9816,109817,"2-Naphthalenesulfonic acid, 6-amino-3-[(4-chloro-5-methyl-2-sulfophenyl)azo]-4-hydroxy-, disodium salt",CC1=CC(=C(C=C1Cl)S(=O)(=O)[O-])N=NC2=C(C=C3C=CC(=CC3=C2O)N)S(=O)(=O)[O-].[Na+].[Na+],,,,,,
9817,109818,6-Amino-3-[(4-chloro-5-methyl-2-sulfophenyl)diazenyl]-4-hydroxynaphthalene-2-sulfonic acid,CC1=CC(=C(C=C1Cl)S(=O)(=O)O)N=NC2=C(C=C3C=CC(=CC3=C2O)N)S(=O)(=O)O,,,,,,
9818,109819,"1-Naphthalenesulfonic acid, 8-(phenylamino)-5-((3-nitrophenyl)azo)-, sodium salt",C1=CC=C(C=C1)NC2=C3C(=C(C=C2)N=NC4=CC(=CC=C4)[N+](=O)[O-])C=CC=C3S(=O)(=O)[O-].[Na+],,,,,,
9819,109820,8-Anilino-5-[(3-nitrophenyl)diazenyl]naphthalene-1-sulfonic acid,C1=CC=C(C=C1)NC2=C3C(=C(C=C2)N=NC4=CC(=CC=C4)[N+](=O)[O-])C=CC=C3S(=O)(=O)O,,,,,,
9820,109821,"Tetrasodium 7,7'-(carbonylbis(imino(3-methoxy-4,1-phenylene)azo))bisnaphthalene-1,3-disulphonate",COC1=C(C=CC(=C1)N=NC2=CC3=C(C=C(C=C3C=C2)S(=O)(=O)[O-])S(=O)(=O)[O-])NC(=O)NC4=C(C=C(C=C4)N=NC5=CC6=C(C=C(C=C6C=C5)S(=O)(=O)[O-])S(=O)(=O)[O-])OC.[Na+].[Na+].[Na+].[Na+],,,,,,
9821,109822,"1,3-Naphthalenedisulfonic acid, 7,7'-[carbonylbis[imino(3-methoxy-4,1-phenylene)azo]]bis-",COC1=C(C=CC(=C1)N=NC2=CC3=C(C=C(C=C3C=C2)S(=O)(=O)O)S(=O)(=O)O)NC(=O)NC4=C(C=C(C=C4)N=NC5=CC6=C(C=C(C=C6C=C5)S(=O)(=O)O)S(=O)(=O)O)OC,,,,,,
9822,109823,Trisodium 8-((4-((4-aminophenyl)azo)-6-sulphonatonaphthyl)azo)-5-((2-hydroxy-7-sulphonatonaphthyl)azo)naphthalene-2-sulphonate,C1=CC(=CC2=C1C=CC(=C2N=NC3=C4C=CC(=CC4=C(C=C3)N=NC5=C6C=CC(=CC6=C(C=C5)N=NC7=CC=C(C=C7)N)S(=O)(=O)[O-])S(=O)(=O)[O-])O)S(=O)(=O)[O-].[Na+].[Na+].[Na+],,,,,,
9823,109824,8-[[4-[[4-[(4-Aminophenyl)diazenyl]-6-sulfonaphthalen-1-yl]diazenyl]-6-sulfonaphthalen-1-yl]diazenyl]-7-hydroxynaphthalene-2-sulfonic acid,C1=CC(=CC2=C1C=CC(=C2N=NC3=C4C=CC(=CC4=C(C=C3)N=NC5=C6C=CC(=CC6=C(C=C5)N=NC7=CC=C(C=C7)N)S(=O)(=O)O)S(=O)(=O)O)O)S(=O)(=O)O,,,,,,
9824,109825,CID 109825,CCCCC(CC)CNC(=O)OC1=CC(=C(C=C1)C)OC(=O)NCCN(C)C.CCC(=O)O,,,,,,
9825,109826,[5-(2-ethylhexylcarbamoyloxy)-2-methylphenyl] N-[2-(dimethylamino)ethyl]carbamate,CCCCC(CC)CNC(=O)OC1=CC(=C(C=C1)C)OC(=O)NCCN(C)C,,,,,,
9826,109827,Propylene glycol diundecanoate,CCCCCCCCCCC(=O)OCC(C)OC(=O)CCCCCCCCCC,,,,,,
9827,109828,2-Methyl-5-oxo-1-cyclopenten-1-yl butyrate,CCCC(=O)OC1=C(CCC1=O)C,,,,,,
9828,109829,CID 109829,COC1=CC=CC=C1NC(=O)C2=CC3=CC=CC=C3C(=C2O)N=NC4=CC(=CC=C4)S(=O)(=O)[O-].[Na+],,,,,,
9829,109830,3-[[2-Hydroxy-3-[(2-methoxyphenyl)carbamoyl]naphthalen-1-yl]diazenyl]benzenesulfonic acid,COC1=CC=CC=C1NC(=O)C2=CC3=CC=CC=C3C(=C2O)N=NC4=CC(=CC=C4)S(=O)(=O)O,,,,,,
9830,109831,"2-((1-(2-Ethylphenyl)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-4-yl)azo)benzoic acid",CCC1=CC=CC=C1N2C(=O)C(C(=N2)C)N=NC3=CC=CC=C3C(=O)O,,,,,,
9831,109832,"Benzenesulfonic acid, 3-[[4-[[4-[(2-cyanoethyl)ethylamino]phenyl]azo]-3-methoxyphenyl]azo]-",CCN(CCC#N)C1=CC=C(C=C1)N=NC2=C(C=C(C=C2)N=NC3=CC(=CC=C3)S(=O)(=O)O)OC,,,,,,
9832,109833,CID 109833,CCN(CC1=CC=C(C=C1)S(=O)(=O)[O-])C2=CC=C(C=C2)N=NC3=C(C=C(C(=C3)C)N=NC4=CC=CC=C4OC)OC.[Na+],,,,,,
9833,109834,4-[[N-ethyl-4-[[2-methoxy-4-[(2-methoxyphenyl)diazenyl]-5-methylphenyl]diazenyl]anilino]methyl]benzenesulfonic acid,CCN(CC1=CC=C(C=C1)S(=O)(=O)O)C2=CC=C(C=C2)N=NC3=C(C=C(C(=C3)C)N=NC4=CC=CC=C4OC)OC,,,,,,
9834,109835,CID 109835,C1=CC(=C2C(=C1N)C(=O)C3=C(C2=O)C(=C(C=C3N)S(=O)(=O)[O-])O)O.[Na+],,,,,,
9835,109836,"4,5-Diamino-1,8-dihydroxy-9,10-dioxoanthracene-2-sulfonic acid",C1=CC(=C2C(=C1N)C(=O)C3=C(C2=O)C(=C(C=C3N)S(=O)(=O)O)O)O,,,,,,
9836,109837,CID 109837,CCOC1=CC=C(C=C1)N=NC2=C3C=CC(=CC3=C(C=C2)N=NC4=CC=CC=C4OC)S(=O)(=O)[O-].[Na+],,,,,,
9837,109838,5-[(4-Ethoxyphenyl)diazenyl]-8-[(2-methoxyphenyl)diazenyl]naphthalene-2-sulfonic acid,CCOC1=CC=C(C=C1)N=NC2=C3C=CC(=CC3=C(C=C2)N=NC4=CC=CC=C4OC)S(=O)(=O)O,,,,,,
9838,109839,CID 109839,C1=CC=C(C=C1)NC2=C3C(=C(C=C2)S(=O)(=O)[O-])C=CC(=NN=C4C=C(C=C(C4=O)N(O)O)Cl)C3=O.[Na+],,,,,,
9839,109840,CID 109840,C1=CC=C(C=C1)NC2=C3C(=C(C=C2)S(=O)(=O)O)C=CC(=NN=C4C=C(C=C(C4=O)N(O)O)Cl)C3=O,,,,,,
9840,109841,"1H-Pyrazole-3-carboxylic acid, 1-(3-aminophenyl)-4-((2-methoxy-4-((3-sulfophenyl)azo)phenyl)azo)-, disodium salt",COC1=C(C=CC(=C1)N=NC2=CC(=CC=C2)S(=O)(=O)[O-])N=NC3=CN(N=C3C(=O)[O-])C4=CC=CC(=C4)N.[Na+].[Na+],,,,,,
9841,109842,1-(3-Aminophenyl)-4-[[2-methoxy-4-[(3-sulfophenyl)diazenyl]phenyl]diazenyl]pyrazole-3-carboxylic acid,COC1=C(C=CC(=C1)N=NC2=CC(=CC=C2)S(=O)(=O)O)N=NC3=CN(N=C3C(=O)O)C4=CC=CC(=C4)N,,,,,,
9842,109843,"Benzenesulfonic acid, 3-(5-amino-3-methyl-1H-pyrazol-1-yl)-4-chloro-",CC1=NN(C(=C1)N)C2=C(C=CC(=C2)S(=O)(=O)O)Cl,,,,,,
9843,109844,Phenyl-2-aminobenzenesulfonate,C1=CC=C(C=C1)OS(=O)(=O)C2=CC=CC=C2N,,,,,,
9844,109845,o-Chlorophenyl o-aminobenzenesulphonate,C1=CC=C(C(=C1)N)S(=O)(=O)OC2=CC=CC=C2Cl,,,,,,
9845,109846,"1-Naphthalenesulfonic acid, 7-[(4-aminobenzoyl)amino]-3-hydroxy-",C1=CC(=CC=C1C(=O)NC2=CC3=C(C=C(C=C3C=C2)O)S(=O)(=O)O)N,,,,,,
9846,109847,Disodium 8-(phenylamino)-5-[[4-(phenylazo)-6-sulphonato-1-naphthyl]azo]naphthalene-1-sulphonate,C1=CC=C(C=C1)NC2=C3C(=C(C=C2)N=NC4=C5C=CC(=CC5=C(C=C4)N=NC6=CC=CC=C6)S(=O)(=O)[O-])C=CC=C3S(=O)(=O)[O-].[Na+].[Na+],,,,,,
9847,109848,8-(Phenylamino)-5-((4-(phenylazo)-(6or7)-sulpho-1-naphthyl)azo)naphthalene-1-sulphonic acid,C1=CC=C(C=C1)NC2=C3C(=C(C=C2)N=NC4=C5C=CC(=CC5=C(C=C4)N=NC6=CC=CC=C6)S(=O)(=O)O)C=CC=C3S(=O)(=O)O,,,,,,
9848,109849,"Benzenesulfonic acid, 3-amino-4-[(4-methylphenyl)sulfonyl]-",CC1=CC=C(C=C1)S(=O)(=O)C2=C(C=C(C=C2)S(=O)(=O)O)N,,,,,,
9849,109850,"Propanamide, N-[3-[bis[2-(2-cyanoethoxy)ethyl]amino]-4-methoxyphenyl]-",CCC(=O)NC1=CC(=C(C=C1)OC)N(CCOCCC#N)CCOCCC#N,,,,,,
9850,109851,"1-Propen-2-ol, 1,1',1''-(1,3,5-trithiane-2,4,6-triyl)tris-",CC(=CC1SC(SC(S1)C=C(C)O)C=C(C)O)O,,,,,,
9851,109852,N-(5-Chloro-2-methylphenyl)-3-hydroxy-4-[[2-methoxy-5-[(phenylamino)carbonyl]phenyl]azo]naphthalene-2-carboxamide,CC1=C(C=C(C=C1)Cl)NC(=O)C2=CC3=CC=CC=C3C(=C2O)N=NC4=C(C=CC(=C4)C(=O)NC5=CC=CC=C5)OC,,,,,,
9852,109853,"1-(2-Sulfo-p-toluidino)-4-(p-toluidino)anthraquinone, ammonium salt",CC1=CC=C(C=C1)NC2=C3C(=C(C=C2)NC4=C(C=C(C=C4)C)S(=O)(=O)O)C(=O)C5=CC=CC=C5C3=O.N,,,,,,
9853,109854,5-Methyl-2-[[4-(4-methylanilino)-1-anthraquinonyl]amino]-1-benzenesulfonic acid,CC1=CC=C(C=C1)NC2=C3C(=C(C=C2)NC4=C(C=C(C=C4)C)S(=O)(=O)O)C(=O)C5=CC=CC=C5C3=O,,,,,,
9854,109855,"2-Propenoic acid, 4-[methyl[(pentadecafluoroheptyl)sulfonyl]amino]butyl ester",CN(CCCCOC(=O)C=C)S(=O)(=O)C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
9855,109856,"2-Propenoic acid, 4-[methyl[(tridecafluorohexyl)sulfonyl]amino]butyl ester",CN(CCCCOC(=O)C=C)S(=O)(=O)C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
9856,109857,"2-Propenoic acid, 4-[methyl[(undecafluoropentyl)sulfonyl]amino]butyl ester",CN(CCCCOC(=O)C=C)S(=O)(=O)C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
9857,109858,"tert-Hexadecanethiol, gold(3+) salt",CC(C)(C)CCCCCCCCCC(C)(C)[S-].CC(C)(C)CCCCCCCCCC(C)(C)[S-].CC(C)(C)CCCCCCCCCC(C)(C)[S-].[Au+3],,,,,,
9858,109859,"2,12,12-Trimethyltridecane-2-thiol",CC(C)(C)CCCCCCCCCC(C)(C)S,,,,,,
9859,109860,Palladium(2+) neodecanoate,CC(C)(C)CC(C)(C)CC(=O)[O-].CC(C)(C)CC(C)(C)CC(=O)[O-].[Pd+2],,,,,,
9860,109861,Lanthanum(3+) neodecanoate,CC(C)(C)CC(C)(C)CC(=O)[O-].CC(C)(C)CC(C)(C)CC(=O)[O-].[La],,,,,,
9861,109862,CID 109862,CCCCCCCCC=CCCCCCCCC1=NC(CO1)(CO)CO.CCCCCCCCC=CCCCCCCCC(=O)O,,,,,,
9862,109863,"4,4(5H)-Oxazoledimethanol, 2-(8-heptadecenyl)-",CCCCCCCCC=CCCCCCCCC1=NC(CO1)(CO)CO,,,,,,
9863,109864,"1H-Benzimidazolesulfonic acid, 2-heptadecyl-",CCCCCCCCCCCCCCCCCC1=NC2=C(N1)C=CC=C2S(=O)(=O)O,,,,,,
9864,109865,Eglinazine,CCNC1=NC(=NC(=N1)Cl)NCC(=O)O,,,,,,
9865,109866,"Sorbitan, diisooctadecanoate",CC(C)CCCCCCCCCCCCCCC(=O)OCC(C1C(C(CO1)O)O)OC(=O)CCCCCCCCCCCCCCC(C)C,,,,,,
9866,109867,"1,5-Naphthalenedisulfonic acid, 2-[[8-[[3-[(5-chloro-2,6-difluoro-4-pyrimidinyl)amino]benzoyl]amino]-1-hydroxy-3,6-disulfo-2-naphthalenyl]azo]-, tetrasodium salt",C1=CC(=CC(=C1)NC2=C(C(=NC(=N2)F)F)Cl)C(=O)NC3=C4C(=CC(=C3)S(=O)(=O)[O-])C=C(C(=C4O)N=NC5=C(C6=C(C=C5)C(=CC=C6)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+],,,,,,
9867,109868,"2-[(8-{3-[(5-Chloro-2,6-difluoropyrimidin-4-yl)amino]benzamido}-1-hydroxy-3,6-disulfonaphthalen-2-yl)diazenyl]naphthalene-1,5-disulfonic acid",C1=CC(=CC(=C1)NC2=C(C(=NC(=N2)F)F)Cl)C(=O)NC3=C4C(=CC(=C3)S(=O)(=O)O)C=C(C(=C4O)N=NC5=C(C6=C(C=C5)C(=CC=C6)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
9868,109869,"1,4-Dichloro-2-(dichloromethyl)benzene",C1=CC(=C(C=C1Cl)C(Cl)Cl)Cl,,,,,,
9869,109870,"3,6,9,12,15-Pentaoxapentacosan-1-ol, dihydrogen phosphate, compd. with 2,2',2''-nitrilotris(ethanol) (1:2)",CCCCCCCCCCOCCOCCOCCOCCOCCOP(=O)(O)O.C(CO)N(CCO)CCO.C(CO)N(CCO)CCO,,,,,,
9870,109871,"Phosphoric acid dihydrogen 3,6,9,12,15-pentaoxapentacosan-1-yl ester",CCCCCCCCCCOCCOCCOCCOCCOCCOP(=O)(O)O,,,,,,
9871,109872,"1-Ethyl-2-(heptadec-16-en-1-yl)-1-(2-hydroxyethyl)-4,5-dihydro-1h-imidazol-1-ium ethyl sulfate",CC[N+]1(CCN=C1CCCCCCCCCCCCCCCC=C)CCO.CCOS(=O)(=O)[O-],,,,,,
9872,109873,1-Ethyl-2-(16-heptadecenyl)-1-(2-hydroxyethyl)-2-imidazoline-1-ium,CC[N+]1(CCN=C1CCCCCCCCCCCCCCCC=C)CCO,,,,,,
9873,109874,"Benzenesulfonic acid, 4-hydroxy-3-[[[[[(2-hydroxy-5-sulfophenyl)methyl]amino]carbonyl]amino]methyl]-5-methyl-, diammonium salt",CC1=CC(=CC(=C1O)CNC(=O)NCC2=C(C=CC(=C2)S(=O)(=O)O)O)S(=O)(=O)O.N.N,,,,,,
9874,109875,4-Hydroxy-3-[[(2-hydroxy-5-sulfophenyl)methylcarbamoylamino]methyl]-5-methylbenzenesulfonic acid,CC1=CC(=CC(=C1O)CNC(=O)NCC2=C(C=CC(=C2)S(=O)(=O)O)O)S(=O)(=O)O,,,,,,
9875,109876,"2-(2-Heptadec-8-enyl-4,5-dihydroimidazol-1-yl)ethanol;trifluoroborane",B(F)(F)F.B(F)(F)F.CCCCCCCCC=CCCCCCCCC1=NCCN1CCO,,,,,,
9876,109877,"3,7-Bis(diethylamino)-1-ethoxyphenoxazin-5-ium nitrate",CCN(CC)C1=CC2C(=NC3=C(O2)C=C(C=C3OCC)N(CC)CC)C=C1.[N+](=O)(O)[O-],,,,,,
9877,109878,"9-ethoxy-3-N,3-N,7-N,7-N-tetraethyl-4aH-phenoxazine-3,7-diamine",CCN(CC)C1=CC2C(=NC3=C(O2)C=C(C=C3OCC)N(CC)CC)C=C1,,,,,,
9878,109879,"Spiro[1,3-benzodioxole-2,1'-cyclohexane], 5,6-dinitro-",C1CCC2(CC1)OC3=C(O2)C=C(C(=C3)[N+](=O)[O-])[N+](=O)[O-],,,,,,
9879,109880,2-(Methylthio)-1-(3-sulphonatopropyl)quinolinium,CSC1=[N+](C2=CC=CC=C2C=C1)CCCS(=O)(=O)[O-],,,,,,
9880,109881,3-(2-Methylsulfanylquinolin-1-ium-1-yl)propane-1-sulfonic acid,CSC1=[N+](C2=CC=CC=C2C=C1)CCCS(=O)(=O)O,,,,,,
9881,109882,CID 109882,CCN(CC)CC.CC(=CC1=[N+](C2=CC=CC=C2S1)CCCS(=O)(=O)O)C=C3N(C4=CC=CC=C4S3)CCCS(=O)(=O)[O-],,,,,,
9882,109883,"Spiro[cyclohexane-1,2'-[1,3]dioxolo[4,5-f]benzothiazolium], 6'-methyl-7'-(3-sulfopropyl)-, inner salt",CC1=[N+](C2=CC3=C(C=C2S1)OC4(O3)CCCCC4)CCCS(=O)(=O)[O-],,,,,,
9883,109884,"3-(6-Methylspiro[[1,3]dioxolo[4,5-f][1,3]benzothiazol-7-ium-2,1'-cyclohexane]-7-yl)propane-1-sulfonic acid",CC1=[N+](C2=CC3=C(C=C2S1)OC4(O3)CCCCC4)CCCS(=O)(=O)O,,,,,,
9884,109885,"2,3-Quinoxalinediamine, N,N'-di-2-propenyl-, mono(4-methylbenzenesulfonate)",CC1=CC=C(C=C1)S(=O)(=O)O.C=CCNC1=NC2=CC=CC=C2N=C1NCC=C,,,,,,
9885,109886,"2,3-Quinoxalinediamine, N,N'-di-2-propenyl-",C=CCNC1=NC2=CC=CC=C2N=C1NCC=C,,,,,,
9886,109887,"Pentanedioic acid, compd. with N,N-diethylcyclohexanamine (1:1)",CCN(CC)C1CCCCC1.C(CC(=O)O)CC(=O)O,,,,,,
9887,109888,"Pentanedioic acid, compd. with N,N-diethylcyclohexanamine (1:2)",CCN(CC)C1CCCCC1.CCN(CC)C1CCCCC1.C(CC(=O)O)CC(=O)O,,,,,,
9888,109889,"Butanedioic acid, compd. with N,N-diethylcyclohexanamine (1:1)",CCN(CC)C1CCCCC1.C(CC(=O)O)C(=O)O,,,,,,
9889,109890,"Butanedioic acid, compd. with N,N-diethylcyclohexanamine (1:2)",CCN(CC)C1CCCCC1.CCN(CC)C1CCCCC1.C(CC(=O)O)C(=O)O,,,,,,
9890,109891,"3-[2-[3-(3-Ethyl-5-methyl-1,3-benzothiazol-2-ylidene)-2-(furan-2-yl)prop-1-enyl]benzo[e][1,3]benzothiazol-1-ium-1-yl]propane-1-sulfonate",CCN1C2=C(C=CC(=C2)C)SC1=CC(=CC3=[N+](C4=C(S3)C=CC5=CC=CC=C54)CCCS(=O)(=O)[O-])C6=CC=CO6,,,,,,
9891,109892,"3-[2-[3-(3-Ethyl-5-methyl-1,3-benzothiazol-2-ylidene)-2-(furan-2-yl)prop-1-enyl]benzo[e][1,3]benzothiazol-1-ium-1-yl]propane-1-sulfonic acid",CCN1C2=C(C=CC(=C2)C)SC1=CC(=CC3=[N+](C4=C(S3)C=CC5=CC=CC=C54)CCCS(=O)(=O)O)C6=CC=CO6,,,,,,
9892,109893,"Ethanone, 2-(3-ethyl-5-methyl-2(3H)-benzothiazolylidene)-1-(2-furanyl)-",CCN1C2=C(C=CC(=C2)C)SC1=CC(=O)C3=CC=CO3,,,,,,
9893,109894,"Propanenitrile, 3-(tridecyloxy)-",CCCCCCCCCCCCCOCCC#N,,,,,,
9894,109895,"Propanenitrile, 3-((3-(tridecyloxy)propyl)amino)-",CCCCCCCCCCCCCOCCCNCCC#N,,,,,,
9895,109896,3-Chloro-4-(phenylazo)aniline,C1=CC=C(C=C1)N=NC2=C(C=C(C=C2)N)Cl,,,,,,
9896,109897,"Benzene-1,2,4,5-d4, 3-chloro-6-nitro-",[2H]C1=C(C(=C(C(=C1[N+](=O)[O-])[2H])[2H])Cl)[2H],,,,,,
9897,109898,"Benzen-2,3,5,6-d4-amine-d2, 4-nitro-",[2H]C1=C(C(=C(C(=C1N([2H])[2H])[2H])[2H])[N+](=O)[O-])[2H],,,,,,
9898,109899,"Acetamide, N-(4-nitrophenyl-2,3,5,6-d4)-",[2H]C1=C(C(=C(C(=C1NC(=O)C)[2H])[2H])[N+](=O)[O-])[2H],,,,,,
9899,109900,"3-Cyclobutene-1,2-dione, 3-chloro-4-(4-morpholinyl)-",C1COCCN1C2=C(C(=O)C2=O)Cl,,,,,,
9900,109901,"2-Cyclobuten-1-one, 2,4,4-trichloro-3-(4-morpholinyl)-",C1COCCN1C2=C(C(=O)C2(Cl)Cl)Cl,,,,,,
9901,109902,2-[Carboxymethyl(2-hydroxyethyl)amino]acetic acid;dibutyltin,CCCC[Sn]CCCC.C(CO)N(CC(=O)O)CC(=O)O,,,,,,
9902,109903,Einecs 269-444-2,CC1=NN(C(=O)C1N=NC2=C(C=CC(=C2)S(=O)(=O)N)[O-])C3=CC=CC=C3.CC(=O)NC1=CC=CC2=C1C(=C(C=C2)[O-])N=NC3=C(C=CC(=C3)S(=O)(=O)N)[O-].[Co+3],,,,,,
9903,109904,"7H-Dibenz[f,ij]isoquinoline-4-sulfonic acid, 2-methyl-7-oxo-",CC1=NC2=C(C=CC3=C2C(=C1)C4=CC=CC=C4C3=O)S(=O)(=O)O,,,,,,
9904,109905,"9,10-Anthracenedione, 1-[(2,6-dibromo-4-methylphenyl)amino]-4-hydroxy-",CC1=CC(=C(C(=C1)Br)NC2=C3C(=C(C=C2)O)C(=O)C4=CC=CC=C4C3=O)Br,,,,,,
9905,109906,"1-(2-Chlorophenyl)-3-methyl-1H-pyrazole-4,5-dione 4-((4-dodecylphenyl)hydrazone)",CCCCCCCCCCCCC1=CC=C(C=C1)N=NC2=C(NN(C2=O)C3=CC=CC=C3Cl)C,,,,,,
9906,109907,"2-Naphthalenecarboxamide, 4-[(4-chloro-2-methylphenyl)azo]-N-(4-dodecylphenyl)-3-hydroxy-",CCCCCCCCCCCCC1=CC=C(C=C1)NC(=O)C2=CC3=CC=CC=C3C(=C2O)N=NC4=C(C=C(C=C4)Cl)C,,,,,,
9907,109908,4-Dodecylbenzenediazonium chloride,CCCCCCCCCCCCC1=CC=C(C=C1)[N+]#N.[Cl-],,,,,,
9908,109909,4-Dodecylbenzenediazonium,CCCCCCCCCCCCC1=CC=C(C=C1)[N+]#N,,,,,,
9909,109910,"Benzoxazolium, 2-[3-[1-[2-(acetyloxy)-3-sulfopropyl]-5,6-dichloro-3-ethyl-1,3-dihydro-2H-benzimidazol-2-ylidene]-1-propen-1-yl]-3-ethyl-, inner salt",CCN1C2=CC(=C(C=C2N(C1=CC=CC3=[N+](C4=CC=CC=C4O3)CC)CC(CS(=O)(=O)[O-])OC(=O)C)Cl)Cl,,,,,,
9910,109911,"2-Acetyloxy-3-[5,6-dichloro-3-ethyl-2-[3-(3-ethyl-1,3-benzoxazol-3-ium-2-yl)prop-2-enylidene]benzimidazol-1-yl]propane-1-sulfonic acid",CCN1C2=CC(=C(C=C2N(C1=CC=CC3=[N+](C4=CC=CC=C4O3)CC)CC(CS(=O)(=O)O)OC(=O)C)Cl)Cl,,,,,,
9911,109912,"N-[2-[2-[(5-acetamido-3-ethyl-1,3-benzoxazol-3-ium-2-yl)methylidene]butylidene]-3-ethyl-1,3-benzoxazol-5-yl]acetamide;perchlorate",CCC(=CC1=[N+](C2=C(O1)C=CC(=C2)NC(=O)C)CC)C=C3N(C4=C(O3)C=CC(=C4)NC(=O)C)CC.[O-]Cl(=O)(=O)=O,,,,,,
9912,109913,5-(Acetylamino)-2-[2-[[5-(acetylamino)-3-ethylbenzoxazol-2(3H)-ylidene]methyl]-1-butenyl]-3-ethylbenzoxazol-3-ium,CCC(=CC1=[N+](C2=C(O1)C=CC(=C2)NC(=O)C)CC)C=C3N(C4=C(O3)C=CC(=C4)NC(=O)C)CC,,,,,,
9913,109914,CID 109914,CCN1C2=CC=CC=C2OC1=CC=C3C(=O)N(C(=S)N3CC(=O)[O-])C4=CC=CC=C4.[Na+],,,,,,
9914,109915,"1-Imidazolidineacetic acid, 5-[(3-ethyl-2(3H)-benzoxazolylidene)ethylidene]-4-oxo-3-phenyl-2-thioxo-",CCN1C2=CC=CC=C2OC1=CC=C3C(=O)N(C(=S)N3CC(=O)O)C4=CC=CC=C4,,,,,,
9915,109916,"3-Thiazolidineacetic acid, 5-(3-ethyl-2(3H)-benzothiazolylidene)-4-oxo-2-thioxo-, compd. with N,N-diethylethanamine (1:1)",CCN1C2=CC=CC=C2SC1=C3C(=O)N(C(=S)S3)CC(=O)O.CCN(CC)CC,,,,,,
9916,109917,5-(3-Ethylbenzothiazol-2(3H)-ylidene)-4-oxo-2-thioxothiazolidin-3-acetic acid,CCN1C2=CC=CC=C2SC1=C3C(=O)N(C(=S)S3)CC(=O)O,,,,,,
9917,109918,"1-Pentanesulfonamide, 1,1,2,2,3,3,4,4,5,5,5-undecafluoro-N-(4-hydroxybutyl)-N-methyl-",CN(CCCCO)S(=O)(=O)C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
9918,109919,"1-Octanesulfonamide, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-N-(4-hydroxybutyl)-N-methyl-",CN(CCCCO)S(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
9919,109920,"1-Hexanesulfonamide, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-N-(4-hydroxybutyl)-N-methyl-",CN(CCCCO)S(=O)(=O)C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
9920,109921,"1-Heptanesulfonamide, N-ethyl-1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-N-[3-(trimethoxysilyl)propyl]-",CCN(CCC[Si](OC)(OC)OC)S(=O)(=O)C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
9921,109922,"9,10-Anthracenedione, 1,4-bis[(2,6-dibromo-4-methylphenyl)amino]-",CC1=CC(=C(C(=C1)Br)NC2=C3C(=C(C=C2)NC4=C(C=C(C=C4Br)C)Br)C(=O)C5=CC=CC=C5C3=O)Br,,,,,,
9922,109923,"9,10-Anthracenedione, 1,4-bis[(2,4-dimethylphenyl)amino]-",CC1=CC(=C(C=C1)NC2=C3C(=C(C=C2)NC4=C(C=C(C=C4)C)C)C(=O)C5=CC=CC=C5C3=O)C,,,,,,
9923,109924,"Phenol, 2,2'-[cyclohexylidenebis[(2-methyl-4,1-phenylene)azo]]bis[4-butyl-",CCCCC1=CC(=C(C=C1)O)N=NC2=C(C=C(C=C2)C3(CCCCC3)C4=CC(=C(C=C4)N=NC5=C(C=CC(=C5)CCCC)O)C)C,,,,,,
9924,109925,3-Ethylamino-p-cresol sulfate,CCNC1=C(C=CC(=C1)O)C.CCNC1=C(C=CC(=C1)O)C.OS(=O)(=O)O,,,,,,
9925,109926,"N,N-Diethyl-m-aminophenol sulfate",CCN(CC)C1=CC(=CC=C1)O.CCN(CC)C1=CC(=CC=C1)O.OS(=O)(=O)O,,,,,,
9926,109927,"2-Propen-1-amine, N-methyl-N-2-propenyl-, acetate",CC(=O)O.CN(CC=C)CC=C,,,,,,
9927,109928,CID 109928,CC(C)CCCCCCCCCC=CCCCCC1CC(=O)N(C1=O)C2=CC(=C(C=C2)Cl)NC3=NN(C(=O)C3)C4=C(C=C(C=C4Cl)Cl)Cl,,,,,,
9928,109929,"2-Naphthalenecarboxamide, N-(5-chloro-2,4-dimethoxyphenyl)-3-hydroxy-4-[(2-methoxy-5-nitrophenyl)azo]-",COC1=C(C=C(C=C1)[N+](=O)[O-])N=NC2=C(C(=CC3=CC=CC=C32)C(=O)NC4=CC(=C(C=C4OC)OC)Cl)O,,,,,,
9929,109930,"2-Naphthalenecarboxamide, 4-[(5-chloro-2-methoxyphenyl)azo]-3-hydroxy-N-(2-methylphenyl)-",CC1=CC=CC=C1NC(=O)C2=CC3=CC=CC=C3C(=C2O)N=NC4=C(C=CC(=C4)Cl)OC,,,,,,
9930,109931,"2-Naphthalenecarboxamide, 4-[[5-(aminocarbonyl)-2-methoxyphenyl]azo]-N-(5-chloro-2,4-dimethoxyphenyl)-3-hydroxy-",COC1=C(C=C(C=C1)C(=O)N)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)NC4=CC(=C(C=C4OC)OC)Cl)O,,,,,,
9931,109932,Disodium 3-hydroxy-4-((1-(sulphonatomethyl)-2-naphthyl)azo)-2-naphthoate,COS(=O)(=O)C1=C(C=CC2=CC=CC=C21)N=NC3=C(C(=CC4=CC=CC=C43)C(=O)[O-])[O-].[Na+].[Na+],,,,,,
9932,109933,3-Hydroxy-4-[(1-methoxysulfonylnaphthalen-2-yl)diazenyl]naphthalene-2-carboxylic acid,COS(=O)(=O)C1=C(C=CC2=CC=CC=C21)N=NC3=C(C(=CC4=CC=CC=C43)C(=O)O)O,,,,,,
9933,109934,N-(2-ethylhex-2-enyl)aniline,CCCC=C(CC)CNC1=CC=CC=C1,,,,,,
9934,109935,Pentaerythritol dibehenate,CCCCCCCCCCCCCCCCCCCCCC(=O)OCC(CO)(CO)COC(=O)CCCCCCCCCCCCCCCCCCCCC,,,,,,
9935,109936,Heptachlorocyclopentane,C1(C(C(C(C1(Cl)Cl)Cl)(Cl)Cl)Cl)Cl,,,,,,
9936,109937,"4-Amino-1,2-dihydro-1,5-dimethyl-3-oxo-2-phenyl-3H-pyrazolium dihydrogen phosphate",CC1=C(C(=O)N([NH+]1C)C2=CC=CC=C2)N.OP(=O)(O)[O-],,,,,,
9937,109938,"Pyridinium, 1-methyl-4-[(methylphenylhydrazono)methyl]-, methyl sulfate",C[N+]1=CC=C(C=C1)C=NN(C)C2=CC=CC=C2.COS(=O)(=O)[O-],,,,,,
9938,109939,1-Methyl-4-(2-methyl-2-phenylhydrazonomethyl)pyridinium,C[N+]1=CC=C(C=C1)C=NN(C)C2=CC=CC=C2,,,,,,
9939,109940,"1-Propanaminium, N-(2-amino-2-oxoethyl)-N,N-dimethyl-3-[(1-oxododecyl)amino]-, chloride",CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(=O)N.[Cl-],,,,,,
9940,109941,"N-(2-Amino-2-oxoethyl)-N,N-dimethyl-3-[(1-oxododecyl)amino]-1-propanaminium",CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(=O)N,,,,,,
9941,109942,CID 109942,C1=CC(=C(C=C1NC2=NC(=NC(=N2)N)Cl)NN=C3C(=CC4=C(C3=O)C(=N)C(=NNC5=C(C=CC(=C5)S(=O)(=O)[O-])S(=O)(=O)[O-])C(=C4)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-].[Na+].[Na+].[Na+].[Na+].[Na+],,,,,,
9942,109943,CID 109943,C1=CC(=C(C=C1NC2=NC(=NC(=N2)N)Cl)NN=C3C(=CC4=C(C3=O)C(=N)C(=NNC5=C(C=CC(=C5)S(=O)(=O)O)S(=O)(=O)O)C(=C4)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O,,,,,,
9943,109944,"2-Chloroethyl 2-[[3-[[4-[[4-[[5-(2-chloroethoxycarbonyl)-2-methylphenyl]diazenyl]-3-hydroxynaphthalene-2-carbonyl]amino]-2,5-dimethylphenyl]carbamoyl]-2-hydroxynaphthalen-1-yl]diazenyl]-3-methylbenzoate",CC1=C(C(=CC=C1)C(=O)OCCCl)N=NC2=C(C(=CC3=CC=CC=C32)C(=O)NC4=CC(=C(C=C4C)NC(=O)C5=CC6=CC=CC=C6C(=C5O)N=NC7=C(C=CC(=C7)C(=O)OCCCl)C)C)O,,,,,,
9944,109945,Nonadecafluorononanesulfonyl fluoride,C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(C(C(C(C(F)(F)S(=O)(=O)F)(F)F)(F)F)(F)F)(F)F,,,,,,
9945,109946,"Pentadecafluoro-1-heptanesulfonic acid, ammonium salt",C(C(C(C(F)(F)F)(F)F)(F)F)(C(C(C(F)(F)S(=O)(=O)O)(F)F)(F)F)(F)F.N,,,,,,
9946,109947,"1-Hexanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-, ammonium salt",C(C(C(C(F)(F)S(=O)(=O)O)(F)F)(F)F)(C(C(F)(F)F)(F)F)(F)F.N,,,,,,
9947,109948,"Undecafluoro-1-pentanesulfonic acid, ammonium salt",C(C(C(F)(F)F)(F)F)(C(C(F)(F)S(=O)(=O)O)(F)F)(F)F.N,,,,,,
9948,109949,"Pentanoic acid, nonafluoro-, ammonium salt",C(=O)(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)O.N,,,,,,
9949,109950,1-Decanesulfonyl fluoride,CCCCCCCCCCS(=O)(=O)F,,,,,,
9950,109951,"1-Heptanesulfonamide, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-N-methyl-",CNS(=O)(=O)C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
9951,109952,"1-Hexanesulfonamide, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-N-methyl-",CNS(=O)(=O)C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
9952,109953,"1,2,3,5-Benzenetetracarbonyl tetrachloride",C1=C(C=C(C(=C1C(=O)Cl)C(=O)Cl)C(=O)Cl)C(=O)Cl,,,,,,
9953,109954,"N,N-Diethyl-6,8-dimethyl-9H-fluoren-3-amine",CCN(CC)C1=CC2=C(CC3=C(C=C(C=C32)C)C)C=C1,,,,,,
9954,109955,"Benzenesulfonic acid, 4-chloro-, iron(3+) salt",C1=CC(=CC=C1S(=O)(=O)[O-])Cl.C1=CC(=CC=C1S(=O)(=O)[O-])Cl.C1=CC(=CC=C1S(=O)(=O)[O-])Cl.[Fe+3],,,,,,
9955,109956,"(2,4,4-Trimethylpent-2-yl)-N-phenyl-1-naphthylamine",CC(C)(C)CC(C)(C)C1=CC2=C(C=C1)C(=CC=C2)NC3=CC=CC=C3,,,,,,
9956,109957,5-Decyn-1-ol,CCCCC#CCCCCO,,,,,,
9957,109958,"9,10-Anthracenediol, 6-ethyl-1,2,3,4-tetrahydro-",CCC1=CC2=C(C=C1)C(=C3CCCCC3=C2O)O,,,,,,
9958,109959,"Benzimidazo[1,2-b]benzo[g]isoquinoline",C1=CC=C2C(=C1)N=C3N2C=C4C=C5C=CC=CC5=CC4=C3,,,,,,
9959,109960,"(2-Hydroxy-1,1-dimethylethyl)ammonium toluene-4-sulphonate",CC1=CC=C(C=C1)S(=O)(=O)O.CC(C)(CO)N,,,,,,
9960,109961,"2-Propenoic acid, 2-[ethyl[(undecafluoropentyl)sulfonyl]amino]ethyl ester",CCN(CCOC(=O)C=C)S(=O)(=O)C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
9961,109962,"1-Butanesulfonamide, 1,1,2,2,3,3,4,4,4-nonafluoro-N-(phenylmethyl)-",C1=CC=C(C=C1)CNS(=O)(=O)C(C(C(C(F)(F)F)(F)F)(F)F)(F)F,,,,,,
9962,109963,"1-Pentanesulfonamide, 1,1,2,2,3,3,4,4,5,5,5-undecafluoro-N-(phenylmethyl)-",C1=CC=C(C=C1)CNS(=O)(=O)C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
9963,109964,"1-Hexanesulfonamide, 1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-N-(phenylmethyl)-",C1=CC=C(C=C1)CNS(=O)(=O)C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
9964,109965,"1-Heptanesulfonamide, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,7-pentadecafluoro-N-(phenylmethyl)-",C1=CC=C(C=C1)CNS(=O)(=O)C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
9965,109966,(3-(((Heptadecafluorooctyl)sulphonyl)(3-sulphopropyl)amino)propyl)(2-hydroxyethyl)dimethylammonium hydroxide,C[N+](C)(CCCN(CCCS(=O)(=O)O)S(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)CC[O-],,,,,,
9966,109967,"3-(((Perfluorooctyl)sulfonyl)(3-sulfopropyl)amino)-N-(2-hydroxyethyl)-N,N-dimethylpropanaminium",C[N+](C)(CCCN(CCCS(=O)(=O)O)S(=O)(=O)C(C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)CCO,,,,,,
9967,109968,"1-Butanesulfonamide, 1,1,2,2,3,3,4,4,4-nonafluoro-N-methyl-",CNS(=O)(=O)C(C(C(C(F)(F)F)(F)F)(F)F)(F)F,,,,,,
9968,109969,"1-Pentanesulfonamide, 1,1,2,2,3,3,4,4,5,5,5-undecafluoro-N-methyl-",CNS(=O)(=O)C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
9969,109970,CID 109970,CCCCCCCCCCCCCCCCCC(=O)NCCN(CCO)CC(=O)[O-].[Na+],,,,,,
9970,109971,"Glycine, N-[2-(carboxymethoxy)ethyl]-N-[2-[(1-oxooctyl)amino]ethyl]-, disodium salt",CCCCCCCC(=O)NCCN(CCOCC(=O)[O-])CC(=O)[O-].[Na+].[Na+],,,,,,
9971,109972,N-[2-(carboxymethoxy)ethyl]-N-[2-(octanoylamino)ethyl]glycine,CCCCCCCC(=O)NCCN(CCOCC(=O)O)CC(=O)O,,,,,,
9972,109973,"Glycine, N-[2-(carboxymethoxy)ethyl]-N-[2-[(1-oxododecyl)amino]ethyl]-, disodium salt",CCCCCCCCCCCC(=O)NCCN(CCOCC(=O)[O-])CC(=O)[O-].[Na+].[Na+],,,,,,
9973,109974,N-[2-(Carboxymethoxy)ethyl]-N-[2-(dodecanoylamino)ethyl]glycine,CCCCCCCCCCCC(=O)NCCN(CCOCC(=O)O)CC(=O)O,,,,,,
9974,109975,CID 109975,CCCCCCCCCCCC1=[N+](CCN1CCO)CC(=O)[O-].[Na+],,,,,,
9975,109976,"Glycine, N-[2-(carboxymethoxy)ethyl]-N-[2-[(1-oxodecyl)amino]ethyl]-, disodium salt",CCCCCCCCCC(=O)NCCN(CCOCC(=O)[O-])CC(=O)[O-].[Na+].[Na+],,,,,,
9976,109977,N-[2-(Carboxymethoxy)ethyl]-N-[2-(decanoylamino)ethyl]glycine,CCCCCCCCCC(=O)NCCN(CCOCC(=O)O)CC(=O)O,,,,,,
9977,109978,"Piperidinium, 1-methylene-, 1-piperidinecarbodithioate",C=[N+]1CCCCC1.C1CCN(CC1)C(=S)[S-],,,,,,
9978,109979,1-Methylenepiperidinium,C=[N+]1CCCCC1,,,,,,
9979,109980,But-2-enyl carbamimidothioate;hydrochloride,CC=CCSC(=N)N.Cl,,,,,,
9980,109981,Carbamimidothioic acid 2-butenyl ester,C/C=C/CSC(=N)N,,,,,,
9981,109982,"Propanoic acid, 3-(butylthio)-, ethyl ester",CCCCSCCC(=O)OCC,,,,,,
9982,109983,"1,3-Benzenedicarboxylic acid, compd. with 1-phenyl-1H-imidazole (1:2)",C1=CC=C(C=C1)N2C=CN=C2.C1=CC=C(C=C1)N2C=CN=C2.C1=CC(=CC(=C1)C(=O)O)C(=O)O,,,,,,
9983,109984,(3-Methylbutoxy)acetic acid,CC(C)CCOCC(=O)O,,,,,,
9984,109985,"1-(1,1,3,3,6-pentamethyl-2H-inden-5-yl)but-2-en-1-one",CC=CC(=O)C1=CC2=C(C=C1C)C(CC2(C)C)(C)C,,,,,,
9985,109986,Butyltintris(2-mercaptoethyl nonanoate),CCCCCCCCC(=O)OCCS[Sn](CCCC)(SCCOC(=O)CCCCCCCC)SCCOC(=O)CCCCCCCC,,,,,,
9986,109987,"8-Oxa-3,5-dithia-4-stannadecan-1-ol, 4-[[2-(acetyloxy)ethyl]thio]-4-butyl-9-oxo-, acetate",CCCC[Sn](SCCOC(=O)C)(SCCOC(=O)C)SCCOC(=O)C,,,,,,
9987,109988,CID 109988,CCCCCCCCC(=O)OCC[S-].CCCCCCCCC(=O)OCC[S-].C[Sn]C,,,,,,
9988,109989,CID 109989,CCCCCCCCCCCCCCCC(=O)OCC[S-].CCCCCCCCCCCCCCCC(=O)OCC[S-].CCCC[Sn]CCCC,,,,,,
9989,109990,2-Mercaptoethyl palmitate,CCCCCCCCCCCCCCCC(=O)OCCS,,,,,,
9990,109991,CID 109991,CC(C)CCCOS(=O)(=O)[O-].[Na+],,,,,,
9991,109992,"1-Pentanol, 4-methyl-, 1-(hydrogen sulfate)",CC(C)CCCOS(=O)(=O)O,,,,,,
9992,109993,CID 109993,C(C(=O)O)N(COP(=O)O)COP(=O)O,,,,,,
9993,109994,"7-Benzofurandiazonium, 2,3-dihydro-2,2-dimethyl-, sulfate (2:1)",CC1(CC2=C(O1)C(=CC=C2)[N+]#N)C.CC1(CC2=C(O1)C(=CC=C2)[N+]#N)C.[O-]S(=O)(=O)[O-],,,,,,
9994,109995,"2,3-Dihydro-2,2-dimethyl-7-benzofurandiazonium",CC1(CC2=C(O1)C(=CC=C2)[N+]#N)C,,,,,,
9995,109996,"2,2-Dimethoxyundecane",CCCCCCCCCC(C)(OC)OC,,,,,,
9996,109997,"2-Propenoic acid, 2-[butyl[(pentadecafluoroheptyl)sulfonyl]amino]ethyl ester",CCCCN(CCOC(=O)C=C)S(=O)(=O)C(C(C(C(C(C(C(F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F)(F)F,,,,,,
9997,109998,"Benzothiazolium, 3-ethyl-2-[2-(2-furanyl)-2-oxoethylidene]-2,3-dihydro-3,5-dimethyl-, methyl sulfate",CC[N+]1(C2=C(C=CC(=C2)C)SC1=CC(=O)C3=CC=CO3)C.COS(=O)(=O)[O-],,,,,,
9998,109999,"2-(3-Ethyl-3,5-dimethyl-1,3-benzothiazol-3-ium-2-ylidene)-1-(furan-2-yl)ethanone",CC[N+]1(C2=C(C=CC(=C2)C)SC1=CC(=O)C3=CC=CO3)C,,,,,,
9999,110000,"Spiro[cyclohexane-1,2'-[1,3]dioxolo[4,5-f]benzothiazolium], 7'-ethyl-6'-methyl-, iodide",CC[N+]1=C(SC2=CC3=C(C=C21)OC4(O3)CCCCC4)C.[I-],,,,,,
